Search is not available for this dataset
text
stringlengths 4.99k
445k
|
---|
# Introduction
Many researchers' results indicate that patients with adolescent idiopathic
scoliosis, (AIS) suffer from back pain more frequently than healthy populations.
It was found that the incidence of back pain in patients with scoliosis treated
conservatively was lower than that of the AIS study group (11% vs. 32%).
It was revealed that the stabilization of scoliosis with a brace may decrease
the likelihood of back pain induced by the altered scoliotic spinal mechanics,
and presumably a failure to stabilize the spine (curve progression) may increase
the incidence of spinal pain. Additionally, some associations between types of
orthoses and pain intensity in AIS patients have been discovered.
Considering the incidence of spinal pain in the long-term follow-up to treatment
for AIS, most results refer to patients treated surgically. For instance,
Danielsson et al. indicated that, more than 20 years after the completion of
treatment with a brace, AIS patients had significantly more degenerative lumbar
disc changes than the controls. They indicated that, even if conservatively-
treated patients admitted to having pain more often than the control group,
their pain was mostly mild, analgesics were rarely used, and no patient had a
major functional deficit. Weinstein et al. presented a 50-year follow-up of non-
operatively treated late-onset persons with scoliosis. Overall, AIS patients
were found to be “productive and functional at a high level” with some
restraints due to back pain and cosmetic concerns. Meanwhile, Gabos et al., in a
study of long-term radiographic and functional outcomes of females with AIS who
had completed a Wilmington orthosis treatment, found that there was no
significant overall difference between the group who had undergone orthotic
treatment and the control group in terms of back pain or physical, functional or
personal care activities. However, patients reported significantly greater
difficulty with selected positional activities. However, it must be emphasized
that these findings may relate either to the condition of scoliosis or the
wearing of the brace and it is not possible to make such a distinction.
At the same time, very little has been written about problems in the cervical
spine and neck pain-related difficulties in performing everyday activities in
AIS patients, especially in a long-term follow-up after the completion of brace
treatment. The first signs of a problem were described by Moskowitz et al., who
reviewed 61 patients who had had a posterior spine fusion for any type of
scoliosis 25 years previously (range 20–30 yrs). An unexpectedly high incidence
of cervical complaints (57%) was reported amongst those patients. Hilibrand et
al. published a radiographic study of the sagittal alignment of the cervical
spine in patients with AIS. As this was a study only of alignment and only in
adolescents, no comments could be made regarding adult pain problems or the
assessment of cervical degeneration. Edgar and Mehta, in the only study
involving the long-term follow-up of fused and unfused persons with scoliosis,
found an incidence of cervicodorsal pain in 7.8% of the unfused patients and in
17.6% of the surgically treated patients.
Therefore, taking into account some inconsistencies between study results
relating to back and neck pain in AIS patients after completing Milwaukee brace
treatment and, in particular, the lack of comprehensive long-term assessments of
cervical pain in adult persons with scoliosis, special emphasis should be placed
on the following research questions: do adult persons with scoliosis treated
with a Milwaukee brace during adolescence have more lower back pain (LBP) and
neck pain compared with non-scoliotic subjects? How does spinal pain affect the
daily life and the activities of these patients? Is there any correlation
between the intensity of the pain, radiographic data and brace treatment-related
variables? Thus, we aimed to provide a complex assessment of adult females with
scoliosis treated with a Milwaukee brace, in a minimum 23-yrs follow-up. To sum
up, the purpose of this report is to explore the long-term outcomes in terms of
back and neck pain and functionality, in relation to radiological, clinical,
pulmonary function and socio-demographic data.
Our hypothesis is that no difference is expected between study and control
groups in terms of socio-demographic characteristics, pain level and neck- or
low back pain-disability. In addition, we assumed that there will be a
significant relationship between pain intensity, patients’ everyday activities
and radiographic, clinical, pulmonary and brace treatment-related variables. All
study aims have been achieved.
# Material and methods
## Study design
Results concerning back- and neck pain and function in consecutively selected
adult AIS females (scoliosis group-SG) treated with a Milwaukee brace were
evaluated. Based on an extensive search of Pediatric Orthopedics and
Traumatology Clinic charts, we retrospectively reviewed the clinical records and
radiographs of all female patients who had successfully completed a course of
treatment with the Milwaukee orthosis between 1974 and 1990. In those patients,
the Risser sign 4 and minimum two years post-menarche was defined as a maturity,
after that time the brace treatment was completed. Forty patients met the
criteria for inclusion, but due to change some personal details (such as address
or family name after getting married), not all of them were contacted. Finally,
30 women returned for a follow-up evaluation. To make the obtained data more
reliable, an age- and sex-matched control group of 42 healthy individuals
(healthy controls group–HG) was selected and asked to complete the same
questionnaires as the patient group.
## Study protocol
Study participants from both groups were examined using the same protocol,
except for the radiological evaluation. The contents of interview in both study
groups included age, work, marital status, number of children, incidence of
caesarian sections and complications during delivery, educational level, place
of residence and the pursuit of active hobbies. In addition, to evaluate the
implications of the brace for back and neck pain and functionality, all study
participants were asked to fill in the same series of questionnaires.
## Clinical and radiological examination
Clinical and radiological examinations were performed three times, before and
after completing the treatment and then in the follow-up, and were taken in an
upright position with the iliac ala exposed in an anterior-posterior projection.
Data concerning former treatment regimens and radiological findings were
gathered from reviews of charts and radiographs. The physical examinations were
performed by AO, the 3<sup>rd</sup> study author, and the radiographic
measurements were conducted by JG and MG, the 2<sup>nd</sup> and the
5<sup>th</sup> study authors, respectively.
The success rate at maturity was calculated according to Nachemson and Peterson,
who defined a successful treatment as an increase in the curve of less than 6°
from the start of bracing. The change in curvature from the end of treatment
until the follow-up examination was also assessed. Pulmonary function, in terms
of vital capacity (VC), was evaluated three times, before and after completing
the treatment and then in the follow-up. The VC examinations at the present
follow-up were performed by ML, the 4<sup>th</sup> study author.
## Healthy controls
The exclusion criteria for the control group were as follows: previous back
surgery or significant scoliosis, which was ruled out by clinical examination,
including using Perdriolli’s scoliometer. None of the controls had a trunk
rotation of more than 5°, according to Danielsson et al..
## Patient sample
Thirty AIS patients, with a minimum of 23-yrs of follow-up after completing
Milwaukee brace treatment, were included in the study. All treatments were
completed before the patient reached 19 yrs of age. In all cases, scoliosis had
not been detected before the age of 10 and was not combined with any major
spinal deformities at the time when the brace treatment was implemented. In
addition, patients were excluded from the study if they, at the time of the
follow-up examinations, suffered from any other disease leading to trunk
deformity. The investigated sample sizes are equivalent (p = 0.157).
During the whole treatment non-compliance monitoring such as temperature probe
was not used. The average values were based on interviews with patients during
the clinical examination. In addition, to make the obtained data more credible,
daily duration of brace wearing was confirmed during the separate interviews
carried out with parents.
## Ethical issues
All study participants were informed in detail about the objective of the study.
They understood that they would be anonymous and that their personal information
would not be disclosed. All participants signed written informed consent forms
in order to participate in the study. The study was approved by the Bioethics
Commission of Poznan University of Medical Sciencesand was carried out following
universal ethical principles.
## Evaluation of neck and back pain-related disability
Polish versions of Revised Oswestry Low Back Pain Disability Index (RODI),
Rolland-Morris Questionnaire (RMQ), Quebec Back Pain Disability Scale (QDS),
Neck Disability Index (NDI) and Copenhagen Neck Functional Disability Scale
(CNFDS) enabled us to assess the intensity of cervical and lumbar pain and the
ability to perform everyday activities among both study samples.
*The RODI* is a revised version of the original Oswestry Disability Index and
focuses on, alongside the subjective evaluation of pain intensity, the degree to
which everyday activities such as personal care, lifting, walking, sitting,
rising/standing, sleep, social life, traveling and changes in pain intensity are
affected. The answers are marked on a six-point scale (from 0 to 5), where 0
corresponds to no limitations on functional status, and 5 indicates maximum
restrictions. The maximum sum of points from all the sections is 50. In order to
present the general result in percentage values, reflecting the extent to which
the ability to carry out everyday activities is restricted, the total is divided
by 2. A result of 0–4 points is interpreted as no limitation to everyday
activities, 5–14 points indicates mild limitation, 15–24 points is moderate
limitation, 25–34 points indicates a serious disorder, and a score over 34
points is evidence of disability.. The RODI's psychometric properties have been
well established. The RODI correlates with other outcome measures aiming at
measuring disability due to LBP. The RODI shows good construct validity because
it was used as the standard of comparison for other outcome measures assessing
LBP-induced disability. Internal consistency has been shown to be at the
acceptable level by different authors. Cronbach alpha ranges from 0.71 to 0.87.
Test-retest reliability has been shown to be high. Values range from r *=* 0.83
to 0.99 and vary according to the time interval between measurements. The longer
the wait between repeated measure, the lower the score becomes. Intraclass
correlation coefficient values from 0.84 to 0.94 have been reported.
Responsiveness has been reported to be high. The most common method for
measuring responsiveness found in the current literature search was a receiver
operating characteristic curve. It can also be used to estimate the minimum
clinically important difference (MCID). Values for the area under the curve
range from 0.723 to 0.94. The MCID has been reported to be between 4 and 10.5
points.
*The RMQ* is widely used to evaluate the degree of disability due to lumbosacral
back pain. It comprises 24 statements requiring a “yes”/”no” answer. The total
score can range from 0 (no disability) to 24 (severe disability). The subjects
were divided into the following four disability groups according to their
scores: low degree of disability: 4–10 points, moderate: 11–17 and severe:
18–24. If the result was ≤ 3, the patient was considered to have no disability.
Test-retest reliability of RMQ was 0.91, and Cronbach's alpha coefficients in
outpatients with low back pain diagnosed with a musculoskeletal origin were
0.90, 0.84, 0.89, 0.92. Considering responsiveness in patients experiencing
lower back pain, the Standard Response Mean was 0.55 (95% CI = -0.54 to 1.64).
*The QDS* is comprised of 20 questions and 6 domains, reflecting everyday
activities such as sleep/rest; sitting/rising; walking; moving;
bending/squatting; lifting heavy objects. The responses are marked on a scale of
0–5, where 0 corresponds to no limitations, whereas 5 signifies maximum
restrictions to everyday functional status. The overall result varies from 0 (no
worsening of spine function) to 100 (maximum restrictions on functional status).
Test-retest reliability of QDS was 0.92, and Cronbach's alpha coefficient was
0.96. The scale correlated as expected with other measures of disability, pain,
medical history, and utilization variables, work-related variables, and socio-
demographic characteristics. Significant changes in disability over time, and
differences in change scores between patients that were expected to differ in
the direction of change were also fund.
*The NDI* questionnaire assesses pain intensity and related limitations to
cervical spine function during everyday activities. The NDI is comprised of 10
questions regarding: pain intensity, personal care, lifting, reading, headaches,
concentration, work, driving, sleeping, and recreation. Each item is scored from
0 (no disability) to 5 (total disability). The maximum possible score is 50.
However, the total score obtained is often doubled to give a percentage score,
out of 100. The interpretation is as follows: 0–20 normal, 21–40 mild
disability, 41–60 moderate, 61–80 severe and \<80 complete or exaggerated
disability. Test-retest reliability of NDI resulted in good statistical
significance (Pearson's r = 0.89). The Cronbach alpha coefficients were
calculated from a pool of questionnaires completed by 52 such subjects resulting
in a total index alpha of 0.80, with all items having individual alpha scores
above 0.75. Concerning concurrent validity, NDI scores were compared to scores
on the McGill Pain Questionnaire, with similar moderately high correlations
(0.69–0.70), whereas the responsiveness was excellent (effect size = 0.85).
*The CNFDS* consists of 15 items that evaluate the impact of neck pain. Three
items evaluate pain severity directly, including the patient’s perception of the
future impact of neck pain, eight items evaluate disability during everyday
activities and four items focus on social interaction and recreation. There are
three possible answers to select from each item; ‘‘yes” (2 points),
‘‘occasionally” (1 point), and ‘‘no” (0 points). For items 1–5, however, the
scoring is reversed and here “yes” carries a score of 0, “occasionally” 1 and
“no” 2. The highest score attainable is 30, indicating the worst possible
impact, and the lowest is 0, where no impact of neck pain can be identified.
The Cronbach's alpha coefficient of the CNFDS for internal consistency was 0.9
for the entire scale, and the coefficients for individual items were all greater
than 0.88. Disability scale scores correlated strongly to pain scores as well as
to doctor and patient global assessments, indicating good construct validity.
Relative changes in disability scores demonstrated a moderately strong
correlation to changes in pain scores after treatment. Scale scores correlated
weakly to all physical measurements. The disability scale demonstrated excellent
practicality and reliability. The scale accurately reflects patient perceptions
regarding functional status and pain as well as doctor's global assessment and
is responsive to change over long periods of time.
## Statistical analysis
For statistical quantitative (numerical) features, e.g. age, apical translation,
Cobb angle, number of children or questionnaire results, we calculated the mean,
a 95% confidence interval, the range and standard deviation (SD). With respect
to qualitative features (information that has aspects that are impossible to be
measured), e.g. curve type, educational level, marital status or place of
residence, we gave the number of units that belong to the described categories
of a given feature and respective percentages. To determine if the investigated
sample sizes are equivalent, the chi-square test was used. The chi-square test
was used to compare qualitative features between persons with scoliosis and
healthy controls. In addition, a Mann-Whitney test was utilized to compare
differences between both groups in regard to quantitative characteristics. To
establish relations between quantitative data such as e.g. age, duration of
brace application, apical translation, Cobb angle, and questionnaire results, we
used Spearman's rank correlation (marked as rS). To determine dependency between
quantitative and qualitative characteristics, e.g. between questionnaire
numerical data and marital status, place of residence or curve type, ANOVA
Kruskal-Wallis test was used. A *p\<*0.05 indicates statistical significance.
Statistical calculations were performed by Statistica software. See the
supplementary material file containing clinical, radiological, socio-demographic
and questionnaire data.
# Results
## Patient clinical and radiological data
Patients’ follow-up period was mean 27.77 yrs ± SD 3.30 (range 23–35). The
Milwaukee brace was worn for a mean of 22.9 hrs daily ± SD 0.31 (range 22–23).
The duration of treatment was mean 45.47 months ± SD 20.00 (range 24–104).
Following the criteria of the Scoliosis Research Society regarding the location
of the apex, thoracic scoliosis was identified in 21 patients (70%),
thoracolumbar in 2 patients (6.67%) and lumbar curves were identified in 7 AIS
females (23.33%). Radiographic examinations at the beginning of brace the
treatment resulted in Risser Grade 0 in 19 patients (63.33%), Risser Grade I in
2 patients (6.67%), and Risser Grade II in 9 patients (30%). Risser Grade IV was
identified after completing treatment in all patients involved in the study
(100%). The European Risser sign was used to define skeletal maturity status.
The success rate at maturity, according to Nachemson and Peterson, was
identified in 16 patients (53.33%). Five patients (16.67%) were eligible for
scoliosis surgery after completing the brace treatment, but refused to undergo
an operation. Change in spine curvature from the end of treatment until the
follow-up was mean 9.1 angles ± SD 7.64 (range 0–27). Mean VC was 2526.67
cm<sup>3</sup> ± SD 561.98 in the pretreatment evaluation, 2983.33
cm<sup>3</sup> ± SD 617.05 after treatment and 2569.64 cm<sup>3</sup> ± SD
591.41 in the final evaluation. For additional clinical and radiological
characteristics of the patient sample, see.
## Socio-demographic data
The age of the patients during the follow-up was mean 41.13 yrs ± SD 3.87 (range
35–55), whereas age of the controls was mean 42.05 yrs ± SD 7.41 (range 22–61).
Twenty-eight females with AIS (93.4%) and 29 healthy controls (69%) were
married. Of 30 female patients, 29 (96.67%) had children, and the number of
children was mean 2.0 ± SD 0.83 (range 0–4), whereas in HC group 33 females
(78.57%) had children, and the number of children in this subgroup was mean 1.48
± SD 0.99 (range 0–3). The rate of cesarean section was 30% (9 patients) in SG
and 27.3% (9 controls) in HG. Ten patients (34.48%) and 8 controls (23.53%) had
experienced problems during delivery (for additional data, see).
## Low back pain and function
Regarding RODI, patients scored mean 13.67 ± SD 6.84 and healthy controls scored
mean 5.26 ± SD 5.40. Regarding results expressed as percentage values, SG scored
27.34%, whereas HG scored 10.52%, which is interpreted as moderate and minimal
disability respectively. In SG, 8 patients (26.67%) showed minimal disability,
16 subjects (53.33%) reported moderate disability and severe disability was
indicated in 6 patients (20%), whereas 37 healthy controls (88.10%) reported
minimal disability, and 4 and 1 participants, that is, 9.52% and 2.38%
respectively, suffered moderate and severe restrictions in everyday activities.
The value of the RMQ was mean 5.60 ± SD 4.68 in the SG, indicating a low degree
of disability, and mean 1.79 ± SD 2.35 in HG, meaning no disability. In SG 12
patients (40%) reported no disability, 13 subjects (43.34%) reported low degree
of disability, moderate disability was indicated in 4 patients (13.33%), and
severe disability was identified in 1 patient (3.33%). 26 healthy controls
(85.72%) reported no disability, and 5 and 1 participants, or 11.90% and 2.38%
respectively, revealed low and moderate levels of restriction. The mean QDS-PL
scores were 23.28 Mean ± SD 14.53 in SG and 8.23 Mean ± SD 7.79 in HG.
Considering the results for particular criteria, the highest scores, relating to
the most severe limitations, are related to moving and leaning/squatting in both
study samples (mean 5.13 ± SD 2.92, mean 4.24 ± SD 3.19 in SG and mean 1.81 ± SD
1.69, mean 1.57 ± SD 1.84 in HG respectively).
## Cervical pain and functionality
The value of the NDI general result equaled mean 11.66 ± SD 7.43 in SG and mean
4.38 ± SD 4.02 in HG. Considering results expressed as percentage values, SG
scored 23.32%, whereas HG scored 8.76%, which is interpreted as mild and no
disability respectively.
In SG 5 patients (16.67%) reported no disability, 15 subjects (50%) reported
mild disability, moderate disability was indicated in 8 patients (26.67%) and 2
patients (6.67%) demonstrated severe restrictions to their everyday activities,
whereas 27 healthy controls (64.29%) reported no disability, and 14 and 1
participants, or 33.33% and 2.38% respectively, revealed mild and moderate
levels of disability.
Concerning the CNPDS total score, patients scored mean 12.63 ± SD 3.48, whereas
the value in the healthy control sample was mean 2.14 ± SD 3.48. The highest
values among both SG and HG concern the disability subscale (mean 8.17 ± SD
4.2.57 and mean 1.24 ± SD 1.75 respectively).
## Comparative analyses
Among a variety of socio-demographic variables which might be affected by an
individual’s spinal function, significant differences could be found between the
groups such as marital status (p = 0.043; patients from SG got married more
often), educational level (p = 0.008; patients from SG achieved lower levels of
education), place of residence (p = 0.028, patients from SG lived more often in
smaller town and cities), working time per week (p = 0.013, patients from SG
spent less time each week on work-related activities), no. of children (p =
0.046, patients from SG had more children) and time spent on active hobbies per
week (p = 0.038, patients from SG spend less hrs each week on active hobbies).
For details, see.
It was also revealed, regarding RODI, RMQ, QDS, NDI and CNFDS (both for total
scores and individual domains), statistically significant differences (p
\<0.001), between both samples, have been confirmed, indicating higher levels of
pain, and neck and lower back pain-related disability among persons with
scoliosis. For details see.
In particular, regarding RODI, significant differences concerning personal care,
lifting, walking, sitting, rising/standing, social life, traveling and changes
in pain intensity (p \< 0.001), except for sleeping (p = 0.099) were confirmed.
For details see.
## Associations between pain, functionality, clinical and radiological factors
Considering lower back pain-related physical impairment, we identified
significant associations between RMQ and BMI before treatment (rS = -0.44) and
Cobb angle after completing the treatment (rS = 0.36). We also identified
significant associations between particular subscales of QDS (moving and BMI
before treatment (rS = -0.42)), VC before treatment (rS = -0.39), between
lifting and Cobb angle during follow-up examinations (rS = 0.38) and between
total score and apical translation after completing the treatment (rS = 0.38)
and thoracic kyphosis during the follow-up (rS = 0.39).
## Correlational analysis by means of socio-demographic characteristics
Considering neck pain, a significant correlation was discovered between the
level of education and CNPDS total score (patients with secondary education
declared lower neck pain-related disability than patients with a university
education, p = 0.035). Moreover, the level of education was found to be
associated with pain severity, social interaction and disability (patients with
an occupational education reported lower neck pain-related disability than
patients with a university education, p = 0.012, p = 0.028 and p = 0.039,
respectively). For details see.
## Associations between neck and low back pain-related disability
As seen in, all total scores of RODI, RMQ, QDS, NDI and CNFDS display a
significant intercorrelation. The strongest associations, above rS = 0.50,
regard relationships between RODI and RMQ (rS = 0.76) QDS (rS = 0.70), NDI (rS =
0.69) and CNFDS (rS = 0.60). RMQ was associated with QDS (rS = 0.71) and NDI (rS
= 0.69), whereas QDS correlated with NDI (rS = 0.80) and CNFDS (rS = 0.60). NDI
was also associated with CNFDS (rS = 0.81). For details results see.
# Discussion
The aim of this report was to elucidate the long-term outcomes of back and neck
pain and functionality in a group of patients treated with a Milwaukee brace.
The Milwaukee brace has been a standard of nonsurgical treatment for scoliosis
since 1954. The Milwaukee brace, which should be worn for 23 hours every day, is
most effective for the treatment of adolescent idiopathic scoliosis. Spinal
deformity is corrected with the Milwaukee brace, in theory, by both passive and
active forces. Passive correction is achieved by direct pressure from the pads
or by traction from the brace design. Active correction is believed to occur
through active movement of the body away from pressure points, as the patient’s
muscles acted to pull the trunk away from contact with the lateral pads or chin
support.
The Milwaukee brace remains the orthosis with the longest clinical history and
the highest reported success rate in halting the progression of AIS, with the
caveat that, because of the prior lack of standardization in bracing studies,
direct comparison with studies of alternative brace designs is problematic.
Currently, the Milwaukee brace is primarily prescribed for patients with
thoracic apices above Th7, for control of upper thoracic sagittal deformities,
and for other spinal deformities not amenable to treatment with lower-profile
designs. A number of long-term follow-up studies on AIS have been published.
However, most of them refer to patients treated surgically, with no comparison
group of healthy controls. Furthermore, to date, assessment of spinal pain in
persons with scoliosis in long-term evaluations has been mainly limited to LBP-
related disability. To our knowledge, this is the first study of patients at
least 23 years after the completion of Milwaukee brace treatment, involving a
detailed evaluation of cervical pain and disability influencing everyday
activities. A control group of randomly-selected healthy females was also
included for comparative purposes.
Several authors have claimed that idiopathic scoliosis is not associated with a
higher incidence of back pain. For example, as mentioned above, Gabos et al.
indicated that there was no significant overall difference between the group who
had undergone orthotic treatment and the control group in terms of back pain,
physical, functional and self-care activities.
Lange et al. evaluated the long-term outcome in AIS patients 12 years or more
after treatment with the Boston brace. 12% of patients reported that they had
consulted a physician for back complaints during the last year before follow-up,
and 28% had had physiotherapy. Overall, back function was considered excellent,
good or fair in 95% of the patients.
Haefeli et al. in a retrospective study on patients 10 to 60 years of age after
nonoperative treatment for AIS investigated long-term outcome regarding pain,
disability, psychological disturbance, and health-related quality of life
(HRQOL). Although pain, disability, HRQOL, and general psychological well-being
were found to be quite satisfactory, curve size was found to be a significant
predictor of pain in the long term. Danielsson and Hallerman investigated
consecutively-selected patients with idiopathic scoliosis, who were invited to a
clinical follow-up at least 10 years after treatment with a brace or surgery.
Overall, 77% reported back pain, but analgesic use was rare and 88% had normal
back function as measured by the ODI. They concluded that most braced and
surgically treated patients had a normal quality of life and that their physical
functionality was only mildly impaired. Despite frequent back pain, back
function was not severely affected. In the examined group of AIS patients, back
pain and pain-related disability was a significant problem when compared to
healthy controls, which confirms our primary hypothesis. The difference is
statistically significant at p \< 0.001 for RODI, RMQ and QDS, both in terms of
total score and certain everyday activities such as walking, moving, lifting or
leaning/squatting. Moreover, according to RODI, 73.33% of patients reported a
moderate or severe degree of disability, whereas, in line with the RMQ criteria,
moderate or severe disability was reported by just 16.63% of respondents.
However, mean levels of disability, according to RMQ, are still higher among SG.
In addition, according to QDS subscales, the highest levels of disability
involved difficulties with activities such as moving and leaning/squatting.
Those results are contrary to conclusions drawn by the Danielsson and Hallerman,
Lange et al. or Danielsson and Nachemson studies.
Considering the associations between LBP-related disability and clinical and
radiological factors, Danielsson and Nachemson indicated that pain and reduced
back function was not related to a variety of curve-related factors, including
degenerative lumbar disc changes. This lack of correlation between curve and
functional outcome scores have been previously reported. Ramirez et al.
indicated that back pain after brace treatment for AIS correlated with a family
history of scoliosis, sport activities, and with curve progression during
treatment, with the latter being the most significant. Patients with painful
scoliosis which progresses during the bracing should be fully evaluated for an
underlying non-idiopathic cause, but curve progression is the most likely
explanation for the development of pain. The incidence of pain is significantly
increased in patients with a family history of scoliosis or in patients engaged
in sport activities. According to Ramirez et al. pain incidence was found not to
correlate with age at presentation, age at brace initiation, length of follow-
up, gender, menarchal status, and limb-length discrepancy. Curve magnitude at
presentation or at the time of brace prescription and skeletal maturity also did
not show any correlation with symptoms. Interestingly, our study result
confirmed significant associations between RMQ and BMI before treatment, Cobb
angle after completing the treatment, and between particular subscales of QDS:
moving and BMI before treatment, VC before treatment, between lifting and Cobb
angle at follow-up examinations and between total score and apical translation
after completing the treatment and thoracic kyphosis at follow-up examinations.
This indicates that back pain is associated, among others, with curve
progression in a long follow-up after Milwaukee brace treatment. However, those
results may relate either to the condition of scoliosis or the wearing of the
brace and it is not possible to make such a distinction.
As previously stated, very little has been said on neck pain and cervical pain-
related restrictions in performing everyday activities, such as social
interaction and recreational activities, especially in long-term follow-up after
the completion of brace treatment. As previously stated, Moskowitz et al.
revealed an unexpectedly high incidence of cervical complaints (57%) amongst AIS
patients treated surgically in a 25-years follow-up, whereas Edgar and Mehta
found an incidence of cervicodorsal pain in 7.8% of the unfused persons with
scoliosis and in 17.6% of the surgically treated patients. Interestingly,
results derived from the current study confirm our primary hypothesis and
support results derived from previous research conducted by e.g. Moskovitz et al
or Mehta et al. Regarding NDI results, most patients (83.34%) report mild,
moderate or severe disability, whereas most of the controls (64.29%) reported no
disability. Referring to CNPDS scores, SG revealed higher levels of restrictions
regarding the function of the cervical spine, regarding pain level, disability
and social interactions. Moreover, neck pain-related disability is not, unlike
LBP-related restrictions, associated with current or past deformity-related
scoliosis parameters, such Cobb angle or apical translation.
Furthermore, some interesting associations discovered between the level of
education and CNPDS must be discussed. It was revealed that patients with
university education declared higher levels of neck pain-related disability than
patients with lower levels of education. Those results are in accordance with
several cross-sectional studies which also have found a positive association
between the duration of occupational sitting and occurrence of pain in the
neck–shoulder region, while prospective studies found associations between
sitting and neck–shoulder pain. It is well documented that white-collar workers
spend a substantial proportion of their time at work sitting. Thus,
investigations of associations between sitting and neck–shoulder disorders are
often conducted on workers in what is usually considered “sedentary”
occupations, such as office-based jobs.
In addition, concerning associations between all study questionnaires, we
identified intercorrelations between neck and lower back pain-related
disability. Bearing in mind the advantages and disadvantages of the
correlational study design, we cannot provide a conclusive reason as to why this
relationship exists, but at the same time we are able to make some predictions
e.g. about the incidence of neck pain, based on the LBP already reported by AIS
patients.
## Study limitations
Some limitations of the current study must be pointed out. Firstly, a long-term
assessment of conservative treatment of AIS is necessarily retrospective, since
the tools specific to LBP- and neck pain-related disability assessment, such as
RODI or NDI, were not available at the time when the conservative treatment was
implemented. Secondly, the response rate (n = 30) was relatively low. Thirdly,
the current study specifically investigated female patients only, which may have
had an impact on the distribution of scores and limit the scope of the findings.
Fourthly, brace compliance monitoring was a speculation and lastly, as indicated
above, a correlational study cannot be used to draw conclusions about the causal
relationships between selected variables. To sum up, we cannot determine which
is the cause and which is the effect in the relationships between e.g. neck- and
LBP-related disability, which are significantly intercorrelated.
## Clinical and future research implications
Despite the aforementioned limitations, we can provide clinicians with reliable
data concerning the incidence of lumbar and cervical pain and disability in the
long-term follow-up after completing a Milwaukee brace treatment. In addition,
we believe long-term follow-up studies can provide reliable information to
patients who will undergo conservative treatment for AIS. Further
investigations, with a longer follow-up and in a group of patients treated
surgically for comparative purposes, are needed to improve upon the results of
our research.
## Conclusions
This retrospective examination of the function of the lumbar and cervical spine,
in a highly specific subset of patients, revealed that persons with scoliosis
treated in adolescence with a Milwaukee brace display significant limitations in
everyday activities, due to LBP- and neck-related impairment. In addition, back
pain is associated with curve progression in a long follow-up after conservative
treatment. Moreover, LBP-related disability coexists with restrictions
experienced due to neck pain.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Outsourcing is the transfer of the continuous management responsibility of a
client party or service user to a third party, referred to as a vendor or
provider, to perform an IT service under a contract of service level agreement.
Outsourcing has since become a well-established academic subject because of its
rapidly developing practice. Outsourcing determinations, outsourcing methods,
challenges identified in outsourcing etc. are some of the hot topics in the
literature.
Some of the advantages of outsourcing include ensuring maximum profit, lower
costs, increased productivity, flexibility in meeting service needs, higher
quality, redirecting company resources to core activities, more customer
satisfaction, continuity and risk management, faster time to market, access to
skilled resources, flexibility to focus on key areas, and faster and better
services.
Proponents of IT outsourcing have underlined the importance of managing
outsourced relationships. "A long-term commitment, shared risk and benefits, a
sense of reciprocal cooperation, and other features congruent with concepts and
theories of participatory decision making" is what a relationship is
characterised as. While IT outsourcing interactions have gotten some attention
in the literature, just a few academics have looked at the client-supplier IT
outsourcing relationship.
Collaboration across corporate boundaries is a necessary component of today’s
company. This type of client-vendor relationship frequently goes beyond the
typical contractual restrictions agreed upon at the start of collaboration. The
risks and advantages of joint labours, as well as investments and work load, are
evenly distributed among the collaborative partners. Inter- and intra-
organizational collaboration helps businesses gain a competitive advantage.
Bidirectional trust, reciprocal dependency, and a win-win mindset between
partners are the foundations of long-term working relationships. Collaboration
is typically developed by businesses to reduce the costs of collecting the
necessary information/understanding, capabilities, and competencies for well-
organized professional operations.
All IT outsourcing contracts include components of collaboration, virtual
cooperation, and the demands of increasingly sophisticated systems. But one of
the most essential variables in deciding the success or failure of virtual
collaboration is trust. Good relationships are tactical assets that necessitate
the ongoing management effort and focus.
An outsourcing project’s success or failure is determined by a number of
elements, including project size, duration, and, most importantly, contract
design and management among different stakeholders. Therefore, additional
research is required to understand how various parts of outsourcing interact and
what the further consequences of the dynamics of these factors are on various
organizational outcomes.
Outsourcing has progressed through several stages of client-vendor
relationships. Such phases of the relationship are briefly illustrated via the
framework in as
1\. Dyadic outsourcing relationship
A client in a dyadic relationship relies on only one vendor to meet all of their
demands, which might range from simple to complex. The majority of research in
the literature considers such relationship as one-to-one, implying that one
client seeks services independently of others, and suppliers do the same.
2\. Multi-vendor relationship
In a one-to-many relationship, a client seeks out more than one vendor to supply
their services in order to meet the client’s needs or achieve its goals, and
information regarding the division of labor is shared and discussed with all
parties to the agreement.
3\. Co-sourcing relationship
A many-to-one or co-sourcing relationship is described as a collaboration
between multiple clients for the delivery of a service through a single vendor
contract.
4\. Complex outsourcing relationship
The phrase complex relationship or complex outsourcing relationship (COR), which
is the subject of this study, refers to a relationship between several clients
and multiple vendors (i.e., many-to-many), in which multiple clients rely on
multiple vendors to meet their needs under the same contract.
OR
Multiple vendor organizations may work for multiple client organizations through
the same contractual agreement or connection in a "complex outsourcing
relationship (COR). It is worth noting that this study’s focus is on such a
phase or relationship, which is exceptionally difficult to manage owing to the
complexity of the situation and the various types of stakeholders involved. The
aforementioned phases and types of outsourcing relationships are shown in.
Good relationships and carefully drafted contracts have a significant impact on
outsourcing. However, there is a lack of comprehensive guidance in this area,
specifically in the context of complex outsourcing relationships, due to the
dearth of studies described in the literature. Outsourcing has become more
complex and diversified as a result of the expansion of numerous actors
connected via a contract, such as a client and one or more vendors, each with
their own unique qualities. Furthermore, because of its complexity, complex
outsourcing typically necessitates interactions among various stakeholders from
diverse regions and cultures, making it significantly more challenging to manage
than traditional outsourcing. Moreover, complex outsourcing when compared to
other types of outsourcing is extremely difficult because it necessitates a
variety of control and coordination mechanisms for project management, which
proportionally increases the risk of project failure.
Therefore, in light of these points, this study aims to identify the challenges
and practices in the context of complex outsourcing relationships.
Based on this hypothesis, the authors of this study formulated the following
research question:
1. **RQ. 1:** What are the key challenges, as identified in the literature,
faced by multiple stakeholders (clients and vendors) in the context of
complex outsourcing relationships?
2. **RQ. 2:** What are the practices/solutions, as identified in the
literature, faced by multiple stakeholders (clients and vendors) in the
context of complex outsourcing relationships?
The remainder of this paper is structured as follows. Background information is
provided in Section II. Section III provides a detailed description of the
research methodology. The conclusions of this investigation are presented in
section IV. The study’s shortcomings are discussed in Section V, and conclusions
and future work are discussed in Section VI. The remaining sections provide
further information.
# Background
In support of a thorough software, the author proposed a robust architecture for
security and compliance challenges. Furthermore, by establishing software
requirements based on a study of work patterns of service providers acting in
complex IT outsourcing agreements and proposing a software architecture that
meets these requirements, this study contributes to filling the gap in software
support.
In COR setups, there are a number of solutions that focus on IT infrastructure
compliance, but they are typically ineffective and inefficient and do not work
well in general. I am not aware of any solutions that support all of the
services we use, necessitating the use of multiple solutions.
Complex IS outsourcing initiatives have distinct tasks and stakeholder
connections compared to standard IS outsourcing projects.
Because of the growing worldwide distribution of IT services, which involves
complex interorganizational connections and the dispersion of decision rights
and responsibilities across numerous organizations, a thorough understanding of
governance procedures is required.
The authors build and offer a theoretical framework for explaining various types
of outsourcing partnerships, as well as an analysis of why client organizations
seeking IT services might choose more collaborative or complicated outsourcing
arrangements than dyadic interactions. Moreover, the authors believe that the
COR relationships in the future will be more in use.
The authors suggested a methodology and decision-making approach for examining
incentive schemes and creating outsourcing contracts that benefit both the
outsourcer and vendor in COR.
Complex outsourcing contracts are difficult to manage and of themselves, but
when time zone differences, language barriers, significant distance, rare face-
to-face meetings, and diversity–all of which are common offshore deal
companions–the task becomes exponentially more difficult.
Organizations that deal with complex outsourcing arrangements on a regular basis
have intelligently implemented the lifecycle model explained in this article.
Many companies struggle to properly manage one or more complex outsourcing
agreements, generate value, and mitigate risk.
This research examines the significance of trust in complex contracts and
relationships frameworks that underpin global outsourcing, as well as the
difficult conflict-resolution procedures that can be employed to restore trust.
In, the authors want to see what an Indian supplier considers to be significant
in order to manage some big and complex outsourcing partnerships, and
specifically, how reciprocally profitable and long-term partnerships are
developed and maintained with European customers.
By offering a descriptive framework incorporating essential governance
variables, this article seeks to deliver a good understanding for managing
complex-type IT-outsourcing agreements. The findings of the analysis, as well as
the framework itself, demonstrate the numerous complex difficulties that arise
when managing sophisticated IT outsourcing partnerships.
# Research methodology
We conducted a systematic literature review to collect relevant data from the
literature, which is a more complete and rigorous method than the traditional
literature review (OLR). The SLR was carried out in three stages: planning,
execution, and reporting.
## Search strategy
To conduct an SLR, we tracked Kitchenham’s guidelines and Mendes et al.. In
addition, depending on the study objectives, we used the population,
intervention, comparison, and outcomes (PICO) criteria to select keywords and
build search strings.
**Population:** Clients and Vendors in Complex Outsourcing Relationships
**Intervention:** Challenges, Practices
**Comparison:** For the sake of this investigation, no comparisons are made.
**Relevance Outcomes:** To Assist Clients and Vendors in Complex Outsourcing
Relationships
Furthermore, to build the search strings, we employed Boolean connectors AND and
OR to connect the features of PICO.
## Search strings
To avoid a search break by different database constraints, we developed three
different strings.
**String 1:** ((“Complex outsourcing” OR “Complex software outsourcing” OR
“Complex Information Systems outsourcing” OR “complex IT outsourcing” OR
“complex outsourcing relationship”) AND (Challenges OR issues OR barriers OR
risks OR Practices OR solutions).
**String 2:** ((“Complex outsourcing relationship” OR “Complex software
outsourcing relationship” OR “Complex Information Systems outsourcing
relationship” OR “complex IT outsourcing relationship” OR “Complex outsourcing”)
AND
(Challenges OR barriers OR issues OR risks OR Practices OR solutions) AND
(“Relationship management in complex outsourcing” OR “Co-ordination in complex
outsourcing” OR “Communication in complex outsourcing” OR “Contract management
in complex outsourcing” OR “Task allocation in complex outsourcing” OR “Trust
building in Complex outsourcing”))
**String 3:** (("Complex software outsourcing" OR "Complex IS/IT outsourcing" OR
"complex outsourcing") AND ("Challenges" OR "issues" OR "barriers" OR "risks" OR
"Practices" OR "solutions" solutions))
## Literature resources
Using our search strings, we applied our search for famous libraries, such as
IEEE Xplore, Google Scholar, ACM, Wiley Online Library, SpringerLink, and
ScienceDirect. We also used the snowballing method to further support our
research questions and not to miss any important data. It is worth noting that
we started the search on 21<sup>th</sup> February, 2021, and systematically
completed it on 8<sup>th</sup> April, 2021.
## Criteria for study selection
The strings and authors’ recommendations were backed up by the researchers.
Initially, we added a string to the library for metadata. The same procedure was
followed to avoid interference with the title, abstract, or keyword
restrictions. Each paper was properly documented by the first author, who kept a
complete record. Based on this phase, other authors assessed the papers and
assigned pertinent information for each paper, as well as its title and
abstract.
We established the following inclusion and exclusion criteria based on the
aforementioned principles for SLR.
### Inclusion criteria
Such criteria specify which portions of the literature will be considered for
inclusion in the selection. Based on such criteria, we have only analyzed items
that are relevant to complex outsourcing. The inclusion criteria were as
follows:
- Articles in full text of the English language.
- Sources only relevant to COR.
- Studies that describe the COR challenges.
- Studies that describe the COR practices.
- Studies published in journals and conferences.
- White papers and standardized reports from trustworthy organizations.
### Exclusion criteria
Such criteria specify which pieces of literature are not included for
consideration. The exclusion criteria were as follows:
- Studies, not relevant to our research questions.
- Studies of other than English language.
- Incomplete Studies.
- Duplicate studies
- Thesis or magazine and/or web articles.
The search outcomes are presented in. We retrieved 281 publications from a total
of 1372 using the inclusion criteria. Using the exclusion criteria, we narrowed
it to 85 papers. During data extraction, the principal author finished each
step, which was then examined by other authors.
The primary goal of quality assessment was to identify and eliminate lower-
quality studies and to determine the validity of a study’s conclusions.
## Criteria for quality assessment
We created the assessment criteria using the guidelines and updates for the SLR
from previous studies. In this way, we formulated the questions given in prior
to the implementation of such criteria. Furthermore, we employed a three-tiered
scale to rate each question in the reviewed papers. Yes, no, or partial. We
assigned values of 1 to Yes, 0.5, partly, and 0 to No in order to produce
quantitative results.
Furthermore, the work had to be graded on an average of 0.5. The principal
author was in charge of applying the assessment parameter for quality to the
studies, whereas the remaining authors were responsible for confirming the same
assessments on a minority group of previously nominated studies. A few papers
were omitted from the study using the same mechanism. However, as seen in, after
going through the entire process, the final number of studies was 85. Any
discrepancies were resolved through additional discussion. Any discrepancies
were resolved through additional discussion.
## Data extraction
Counting the challenges and their practices is a difficult task because the
majority of the challenges and practices from such areas are cascading in
nature. Nonetheless, we discovered 11 primary challenges with 67 practices from
a total of 85 papers. The identified challenges and their practices are
presented in the next section via Tables, respectively. Furthermore, the papers
extracted via the SLR are presented in with the respective IDs and Title.
# Results and discussion
The goal of this research is to uncover the key issues and practices experienced
by multiple stakeholders (such as clients and vendors) when dealing with COR.
The following are the challenges that we have identified and analyzed after
thorough conduction of the SLR in such areas.
## Challenges in COR
presents the 11 key challenges with the given frequencies as follows:
1. **1. Control and Coordination Challenges**:
‘Control and Coordination’ are one amongst the major challenge in COR. Control
refers to a company’s capability to command or manage scattered events so that
they meet the company’s goals. The ability of a company to coordinate these
disparate activities is referred to as coordination.
1. **2. Decision Problems**:
Information system outsourcing decisions are difficult to make because they
entail a number of elements, including (a) establishing and managing a long-term
partnership with an independent agent, and (b) revealing the critical
organizational assets for controlling outside agents. When the same matter is
evaluated from the perspective of COR, it becomes more challenging.
1. **3. High Cost**:
The overall cost, for example, the hidden cost, estimated cost, control cost,
coordination cost, etc., for outsourcing is high in the case of COR.
1. **4. Security and Compliance Challenges**:
Security and Compliance is a composite challenge, including six sub-challenges
(see above) in the context of COR. It is worth noting that this particular
challenge focused on the cloud version of COR.
1. **5. Risky Contracts**:
Managing risk is also a major issue, specifically in the context of COR, where
multiple stakeholders from different cultures and zones are involved.
Furthermore, large or complex IT contracts, which are nearly always incomplete,
enhance the chance of risk in a variety of ways.
1. **6. Poor Human Resource Management (HRM)**:
People and staff management becomes extremely difficult in the situation of COR,
where multiple personnel from various cultural and zone variances are
coordinated, particularly in a security-related system.
1. **7. IT Transitions Difficulties**:
One reason for this failure is the complication of information system
outsourcing transitions. In the case of COR, where several clients and vendors
are involved, the transaction will undoubtedly grow more complicated.
1. **8. Poor Contract Management**:
Contract management, also known as the hard side, is one of the biggest issues
and is discussed in more detail in the literature. For pre-contract, the
supplier’s standard type contracts should not be utilized, even as a starting
point, for complex outsourcing arrangements involving large sums of money,
because they are always structured in favor of the outsourced vendor.
1. **9. Different Cultural Issues**:
Because of the increased level of uncertainty associated with the crossing of
organisational, geographical and cultural boundaries, complex IS outsourcing
strategies even become more complex.
1. **10. General Management Complexities**:
With several development centres in different time zones, geographies, and
cultures, managing the complex outsourcing relationships is intrinsically tough.
Furthermore, management becomes much more difficult when IT is mostly outsourced
to one or more IT services providers i.e. COR.
1. **11. Modern Technological Challenges**:
Technology Challenges, Strategic Decision Challenges, Vendor Management
Challenges, and Vendor Selection Challenges are the four key kinds of challenges
often faced where more than one stackholders are involved.
## Analysis of these challenges based on research methodology used
To analyze and well furnish the outcomes of the SLR, we further categorized the
results of the identified challenges on 8 different commonly used research
methodologies. The methodologies are Experimentation/Testing, Case Study/Case
Studies, Empirical Survey, Interviews, Ordinary Literature Review (OLR),
Systematic Literature Review (SLR), Others (i.e. Main Path Analysis and Content
Analysis, Mixed Method (.i.e more than one method), as shown in. During the
analysis, we concluded that Experimentation/Testing methodology has been used
more in the literature in this domain. Because in these studies, models or
methods were used to check or test the challenges quantitavely, for example,
measuring the cost or taking decisions. Similarly, the second mostly used
methodologies are Case Study/Case Studies or Empirical Survey. Once again the
reason behind this analysis was to collect empirically sound data in the real
context of a case. The Mixed Methodology shows progressive results in this
particular area and that’s why it is reported at number three position in the
list etc.
## Analysis of these challenges based on publication period
Although, we did not put any date boundaries of data during the accomplishment
of an SLR, but during the analysis, we pointed out a major contribution shift
from a theoretical to practical implementation by the organizations in COR
context. Therefore, based on this knowledge, we divided the publication era into
two periods such as papers published before 2014 and papers published in 2014
and onwards, as shown in. We can further conclude from the analysis of that COR
is one of the most prominent research areas to date. Because sufficient number
of studies are published in the second period (i.e., in 2014 and onwards).
## Analysis of these challenges based on publication venue
gives an analysis based on publication channel. We divided the publication
channels into three categories, such as papers published in
Conference/Proceeding, Journal Papers, Technical Reports/Research Working
Papers. From the analysis of, it is clearly visible that the majority of papers
were published in Journals. This analysis once again is an evidence that COR is
always a strong research area in the literature.
## Practices for identified challenges
However, it was quite difficult to accurately account for the concerned
practices for the stated challenges due to the cascading nature of data.
Nonetheless, we organized them to the best of our efforts and identified 67
practices for the the aforementioned challenges. Moreover, due to the time and
space constraints, we present these practices for the concerned challenges in
tabular form, as depicted in Tables to below.
# Limitations and threats to validity
We did our best to conduct a systematic literature review as a study approach,
including ensuring the pertinency of appropriate string selection and a
sufficient sample size, but it is still conceivable that we have overlooked some
crucial information. In order to reduce the danger of construct validity in
terms of the usage of digital libraries, we narrowed our focus to pertinent and
famous computing libraries, but again it was confined to the very few libraries.
We have listed the publications in for interested visitors to minimize the
danger of the study’s internal validity. To prevent such dangers, each component
of our SLR was confirmed via a rigorous approach and intermittent review
processes by the participating researchers. The identification method has been
used in the literature for similar investigations multiple times. It should be
noted that the majority of the studies we gathered were from the COR database.
However, only a few of them, or portions of them, do not properly identify the
COR data, giving the context a hazy picture. Furthermore, only papers written in
English were chosen.
# Conclusion
The benefits of a complex IT outsourcing arrangement include enhanced cost
certainty and lower expenses, increased scalability, and flexibility on demand.
Complex outsourcing, on the other hand, demands interactions between many
stakeholders from various areas and cultures, making it substantially more
difficult to manage than regular outsourcing. Complex outsourcing is also more
challenging than other forms of outsourcing since it needs a variety of control
and coordination mechanisms for project management, which increases the chance
of project failure accordingly. In this regard, a more systematic research is
needed to uncover the important difficulties and techniques in this area in
order to overcome project failure in complex outsourcing relationships. As a
result, this study uses systematic literature review as a research method and
serves as a pioneering effort to achieve the aforementioned goals. The authors
highlighted 11 key issues after receiving the SLR data, with 67 practises in
hand from a total of 85 publications. The authors want to build a comprehensive
framework based on their findings in the future by using some strong approaches
like as AHP and fuzzy logic, etc.
# Supporting information
We are grateful to other members of the Software Engineering Research Group
(SERG) for their valuable feedback and support during the research process.
10.1371/journal.pone.0262710.r001
Decision Letter 0
Haldorai
Anandakumar
Academic Editor
2022
Anandakumar Haldorai
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
15 Nov 2021
PONE-D-21-28732Challenges And Practices Identification In Complex Outsourcing
Relationship: A Systematic Literature ReviewPLOS ONE
Dear Dr. Khan,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
Please submit your revised manuscript by Dec 30 2021 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:A
rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Anandakumar Haldorai, PhD
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2\. Please amend your Methods section to include the date range for the search.
Please also state the latest date on which the search was performed.
3\. We note that the grant information you provided in the ‘Funding Information’
and ‘Financial Disclosure’ sections do not match.
When you resubmit, please ensure that you provide the correct grant numbers for
the awards you received for your study in the ‘Funding Information’ section.
4\. Please note that in order to use the direct billing option the corresponding
author must be affiliated with the chosen institute. Please either amend your
manuscript to change the affiliation or corresponding author, or email us at
<[email protected]> with a request to remove this option.
5\. Please update your submission to use the PLOS LaTeX template. The template
and more information on our requirements for LaTeX submissions can be found at
<http://journals.plos.org/plosone/s/latex>.
6\. Please review your reference list to ensure that it is complete and correct.
If you have cited papers that have been retracted, please include the rationale
for doing so in the manuscript text, or remove these references and replace them
with relevant current references. Any changes to the reference list should be
mentioned in the rebuttal letter that accompanies your revised manuscript. If
you need to cite a retracted article, indicate the article’s retracted status in
the References list and also include a citation and full reference for the
retraction notice.
Additional Editor Comments:
Please carefully address the issues raised in the comments and, up front in your
revised paper. Your revised paper will be sent to the same reviewers, as well as
possibly new reviewers, for evaluation.
Make sure the Abstract briefly describes the paper as it is used in abstracting
and citation services. Keep the Abstract between 200 words. Do not use any
references in the Abstract.
Spell out each acronym the first time used in the body of the paper. Spell out
acronyms in the Abstract only if used there.
Include a list of six to ten key words after the Abstract.
You may ignore any suggestion of including self-references by reviewers if not
applicable.
Include a paragraph at the end of the Introduction describing the organization
of the paper.
Make sure that the Conclusion briefly summarizes the results of the paper it
should not repeat phrases from the Introduction. Keep the Conclusion to about
300 words. Do not use any references or acronyms in the Conclusion.
Make sure all figures and tables are referred to in the body of the paper.
It is recommended to use a professional native English-speaking editor. Papers
with less than excellent English will not be published even if technically
perfect.
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Partly
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: No
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The structure of the paper is good, however, it needs the
following modifications to be published in the journal.
1\. Abstract need to be revised to specify the demand for the review.
2\. In introduction part, authors should provide more priority about outsourcing
relationship.
3\. The methodology of the proposed review is complex and readers find problems
in understanding the procedure.
4\. There is a need for more research papers that present more detailed
information about outsourcing relationships and its advantages.
5\. Finally, the conclusion part need a rigorous revision.
Reviewer \#2: It’s a great work and great sense of methodology and great
analyzing and I wish to see more relate study and more upgrades with the same
concept of research in the future and keep it up and good work
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: **Yes: **Haitham Medhat Abdelaziz Elsayed Aboulilah
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0262710.r002
Author response to Decision Letter 0
21 Dec 2021
Rebuttal Letter
Original Manuscript ID: PONE-D-21-28732
Original Article Title: “Challenges And Practices Identification In Complex
Outsourcing Relationship: A Systematic Literature Review”
To: PLOS ONE
Re: Response to reviewers
Dear Editor,
Thank you for allowing a resubmission of our manuscript, with an opportunity to
address the reviewers’ comments.
We are uploading
\(1\) Our point-to-point response to the comments below (response to reviewer(s)
and academic editor, respectively)
\(2\) A marked-up coy with track changes (Revised Manuscript with Track Changes)
\(3\) An unmarked version without track changes (Manuscript)
Best regards,
\<author name\> et al.
Reviewer#1, Concern \# 1:
Reviewer’s comment: Abstract need to be revised to specify the demand for the
review
Authors’ response: Many thanks for your kind suggestion. We have revised the
abstract by adding such specific demand.\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Reviewer#1, Concern \# 2:
Reviewer’s comment: In introduction part, authors should provide more priority
about outsourcing relationship.
Authors’ response: We have added few more papers having specific focus on
outsourcing relationships in the introduction section of the manuscript.\_\_\_\_
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Reviewer#1, Concern \# 3:
Reviewer’s comment: The methodology of the proposed review is complex and
readers find problems in understanding the procedure.
Authors’ response: We have performed systematic literature review (SLR) as a
research methodology. We have followed the SLR guidelines from \[25, 26\],
respectively. SLR is widely used research methodology in software engineering
and we have used this method in our previous work having Doi as follows:
10.1109/ACCESS.2021.3085707,
10.1016/[j.infsof.2010.08.003](http://j.infsof.2010.08.003), and
10.1109/ICGSE.2009.28 etc.
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Reviewer#1, Concern \# 4:
Reviewer’s comment: There is a need for more research papers that present more
detailed information about outsourcing relationships and its advantages.
Authors’ response: Our search is based on our pre-defined search string that was
constructed during the planning phase of the SLR, i.e., SLR protocol. During the
implementation phase of the SLR protocol, the search phase was completed in
April, 2021. Now, according to this concern, we have added some more latest
papers, through snowballing technique, relevant to outsourcing relationships.
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Reviewer#1, Concern \# 5:
Reviewer’s comment: Finally, the conclusion part need a rigorous revision.
Authors’ response: We have revised the whole manuscript specifically the
conclusion section.
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
NOTE: We have further addressed the Journal Requirements as follows:
Concern \# 1:
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
Authors’ response: We have followed the PLOS ONE’S style and format in the
revised manuscript.
Concern \# 2:
2\. Please amend your Methods section to include the date range for the search.
Please also state the latest date on which the search was performed.
Authors’ response: We have amended the Methods section, accordingly. Please see
the change tracked at page 8 under the Literature Resources section of Research
Methodology. During the implementation phase of the SLR protocol, the search
phase was completed in April, 2021.
Concern \# 3:
3\. We note that the grant information you provided in the ‘Funding Information’
and ‘Financial Disclosure’ sections do not match.
When you resubmit, please ensure that you provide the correct grant numbers for
the awards you received for your study in the ‘Funding Information’ section.
Authors’ response: No fund has been issued to us by any organization/agency. It
is solely accomplished by the authors. However, the publication charges are
sponsored by the Qatar university.
Concern \# 4:
4\. Please note that in order to use the direct billing option the corresponding
author must be affiliated with the chosen institute. Please either amend your
manuscript to change the affiliation or corresponding author, or email us at
<[email protected]> with a request to remove this option.
Authors’ response: ?
Concern \# 5:
5\. Please update your submission to use the PLOS LaTeX template. The template
and more information on our requirements for LaTeX submissions can be found at
<http://journals.plos.org/plosone/s/latex>.
Authors’ response: We have updated the manuscript according to the PLOS LaTeX
template, by following the given link.
Concern \# 6:
6\. Please review your reference list to ensure that it is complete and correct.
If you have cited papers that have been retracted, please include the rationale
for doing so in the manuscript text, or remove these references and replace them
with relevant current references. Any changes to the reference list should be
mentioned in the rebuttal letter that accompanies your revised manuscript. If
you need to cite a retracted article, indicate the article’s retracted status in
the References list and also include a citation and full reference for the
retraction notice.
Authors’ response: We have reviewed the references list and revised it properly,
and ensured its correctness and completeness. We have added the references of
additional papers which we have included now, as according to reviewers’
suggestions. Furthermore, we have removed/retracted the references of excluded
papers, because these references have been removed during merging and updating
the table data for further improvements.
Additional Editor Comments:
Concerns \#:
\- Please carefully address the issues raised in the comments and, up front in
your revised paper. Your revised paper will be sent to the same reviewers, as
well as possibly new reviewers, for evaluation.
\- Make sure the Abstract briefly describes the paper as it is used in
abstracting and citation services. Keep the Abstract between 200 words. Do not
use any references in the Abstract.
\- Spell out each acronym the first time used in the body of the paper. Spell
out acronyms in the Abstract only if used there.
\- Include a list of six to ten key words after the Abstract.
\- You may ignore any suggestion of including self-references by reviewers if
not applicable.
\- Include a paragraph at the end of the Introduction describing the
organization of the paper.
\- Make sure that the Conclusion briefly summarizes the results of the paper it
should not repeat phrases from the Introduction. Keep the Conclusion to about
300 words.
\- Do not use any references or acronyms in the Conclusion.
\- Make sure all figures and tables are referred to in the body of the paper.
\- It is recommended to use a professional native English-speaking editor.
Papers with less than excellent English will not be published even if
technically perfect.
Authors’ response: We have addressed all the mentioned comments/concerns,
accordingly.
NOTE: It is worth noting that we have revised or renamed few challenges, and
similarly, merged together some of the previously identified practices for
improvements. In this way, we finally collected 67 practices for 11 identified
challenges.
10.1371/journal.pone.0262710.r003
Decision Letter 1
Haldorai
Anandakumar
Academic Editor
2022
Anandakumar Haldorai
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
3 Jan 2022
Challenges And Practices Identification In Complex Outsourcing Relationship: A
Systematic Literature Review
PONE-D-21-28732R1
Dear Dr. Khan,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Anandakumar Haldorai, PhD
Academic Editor
PLOS ONE
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
Reviewer \#2: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The paper is acceptable in its current form. No need to modify.
The author had addressed the comments
Reviewer \#2: It’s nice research paper and really good analysis with a perfect
methodology and based on good theoretical and looking forward to see more papers
can doing with same content and research base as same as the current one cause
really it’s open for opportunity to creat a new one, wish you all the best
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: **Yes: **Haitham Medhat Abdelaziz Elsayed Aboulilah
10.1371/journal.pone.0262710.r004
Acceptance letter
Haldorai
Anandakumar
Academic Editor
2022
Anandakumar Haldorai
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
17 Jan 2022
PONE-D-21-28732R1
Challenges and practices identification in complex outsourcing relationships: A
systematic literature review
Dear Dr. Khan:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Anandakumar Haldorai
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Boron neutron capture therapy (BNCT) requires the selective delivery of boron-10
(<sup>10</sup>B) to tumor cells. Following irradiation with neutrons, the
nuclear capture and spontaneous fission reactions produce <sup>4</sup>He and
<sup>7</sup>Li nuclei along with 2.4 MeV. These high-linear energy transfer
(LET) particles travel less than ten micrometers from their sites of origin;
therefore, they are only lethal to those cells that bind or internalize
<sup>10</sup>B in sufficient concentrations. The effectiveness of BNCT is
dependent upon the amount of <sup>10</sup>B delivered per cell. BNCT has been
used in the experimental treatment of a number of different tumors, such as
Glioblastoma, skin melanomas, head and neck cancer **, mesothelioma,
and diffuse liver metastases and could provide a useful treatment option for
tumors that are unaffected by conventional therapies or that are difficult to
remove surgically. When metastases spread through an entire organ, the use of a
selective BNCT agent might allow the selective destruction of each of the
individual cells of the tumor nodules without requiring their selective
irradiation (13). Selective <sup>10</sup>B incorporation into cancer cells
requires boron carrier molecules that exhibit a particular affinity toward the
targeted cells. A wide range of boron carriers has been designed, synthesized,
and evaluated during the past several decades, including liposomes.
Liposomes are slightly more advantageous for the selective delivery of
<sup>10</sup>B to murine EMT-6 tumors due to increased tumor cell growth rates
and the incorporation of liposome components into the cellular membrane.
Additionally, the often tortuous and leaky tumor vasculature allows the
accumulation of boron within the tumor interstitium. Liposome delivery to the
tumors depends upon the blood supply to the tumors, with a higher blood supply
resulting in a higher <sup>10</sup>B accumulation and lower blood supply
culminating in lower boron accumulation in the tumors.
Macrophage/monocytes are professional phagocytes and phagocytize cell debris,
foreign particles such as bacteria, fungi and parasites or liposomes and other
particles of similar size. The phagocytosis of liposomes results in boron
accumulation in macrophages/monocytes. Neutron irradiation may result in BNCT
reaction and the energy released could modify macrophages to either tumor
promoting or tumor inhibiting phenotype. Macrophage polarization is the hallmark
of the innate immune response against cancer and pathogenic invasion. The extent
of macrophage modification is dependent on the microenvironmental factors and
decides the fate of macrophage polarization. The polarization of macrophages is
multifaceted due to the plasticity of macrophages which can accommodate signals
from pathogens, injured tissues, and the basal tissue microenvironment. The
polarization of macrophages is under the control of pathways which regulate the
survival of the cell by either prolonging or reducing macrophage development and
viability. The tissue microenvironment, microbial products, and cytokines decide
the fate of macrophage polarization. The activation of macrophages influences
other branches of the immune system due to these cells being the essential
modulators and effectors of the immune response. A hypothesis put forward that
subsets of T helper cells can be distinguished based on the cytokines secreted
after their activation. These subsets mediate distinct regulatory and effector
functions. In 1960s Mackaness introduced the term macrophage activation
(classical activation) about infection to describe the antigen-dependent but
non-specific anti-microbial response of macrophages to BCG (bacillus Calmette-
Guerin), and Listeria upon subsequent exposure. Later the enhanced microbicidal
activity was linked to T helper type 1 responses, along with IFNγ release by
antigen-activated immune cells \[\] and these microbicidal effects regulated
by TH1 and IFNγ also account for cytotoxic and antitumoral effects ().
Stein, Doyle, and colleagues postulated that IL-4 and IL-13 induces an
alternative activation phenotype due to the discovery of the mannose receptor
which selectively enhances the TH2 response in murine macrophages. The
alternative activation is an entirely different phase than classical activation,
but different from deactivation. In other words, the lack of a classical
activation does not entail loss of activation.
Macrophages in mice with TH1 and TH2 backgrounds differed in the propensity to
react to the classic stimuli (IFNγ or lipopolysaccharide or both). The ability
to respond to stimuli carves a vital difference in metabolic pathways in
macrophages. The macrophage nomenclature of M1 and M2 is similar and based on
the activation of the T helper type cells, i.e., the macrophages which activate
TH1 cells belong to the M1 phenotype, while M2 macrophages activate TH2 cells.
For example, M1 macrophages following LPS or IFN stimuli release toxic nitric
oxide (NO), while M2 macrophages release polyamines (). The official
report for the alternative activation of macrophages in vivo similar to the
observation of Mackness for pathogens came from the observation of Allen, de
Baetselier, Brombacher, and colleagues in parasite infection. The parasite
elicits a strong IgE and TH2 response \[\]. Montavani and colleagues grouped
the macrophage activating factors in two functionally polarized states to
integrate the phenotypic similarities and differences. The macrophages were
grouped based on their effects on select markers as M1 (IFNγ and LPS or TNF-α),
M2a (IL-4), M2c {IL-10 and glucocorticoids (GCs).
# Results
## Optimizing the boron delivery to the EMT-6 tumors for effective boron neutron capture therapy (BNCT)
We evaluated the boron accumulation in EMT-6 tumors of different sizes and
observed that boron accumulation was extremely low in larger tumors
(approximately 400 mg) but was significantly higher in smaller tumors
(approximately 100 mg). These results suggest smaller EMT-6 tumors are more
amenable to boron delivery. We further tested the boron distribution by
incorporating fluorescein dye in liposome in order to track the boron
distribution in tumors of varying size. distribution. We observed the uniform
distribution of fluorescence in small tumors while fluorescence in large tumors
was spotty and did not cover the large tumor area.. We evaluated the necrosis
present in EMT-6 tumors ranging from 100–400 mg in size. Various 10-μm
cryosections of the EMT-6 tumors revealed that necrosis progressively increases
with the size of the tumor. These regions represent oxygen deprivation areas
and hence cell death by mostly necrosis.
Blood vessels are vital for the growth and development of tumors and the
delivery of nutrients and drugs. As we have shown above, boron distribution is
affected by tumor size. We examined tumor vasculature by staining tumor sections
with an anti-CD31 antibody labeled with Fluorescein Isothiocyanate (FITC). CD31
staining of the EMT-6 tumor sections revealed that smaller EMT-6 tumors have a
higher amount of CD31 staining than the larger EMT-6 tumors.
## Immunomodulatory effect of BNCT in EMT-6 tumors
After optimizing the delivery of boron compounds in tumor tissue, we then moved
to irradiation studies. One set of EMT-6 tumor laden mice received neutron
irradiation, and the second set did not receive radiation but only the liposomes
for biodistribution. Time kinetics of of boron distribution in tumor and blood
revealed that tumors had approximately 60 ppm of boron and blood had 10 ppm of
boron. The optimal tumor/blood ratio and optimal boron concentration in tumors
was observed 54 hrs post systemic delivery of boron-rich liposomes. We used 54
hrs as optimal time point for optimal boron dose in all our irradiation
experiments. We used this time point for all the irradiation studies. In the
blood, peripheral blood mononuclear cells (PBMCs) are most likely to assimilate
liposomes and hence boron, than other components of the blood.
Analysis of blood following irradiation revealed that irradiation did not cause
damage to the PBMCs despite these cells carrying boron which is why the total
population of PBMCs remain unchanged. IL-12 is a known anti-tumor cytokine and
also protect against infection caused by invading pathogens. In tumor
microenvironment the intruding macrophages are modified to suppress IL-12
expression and enhance IL-10 expression. IL-10 suppresses anti-tumor immune
response by modifying macrophages to release tumor promoting factors. Analysis
of expression of IL-12 and IL-10 suggested that the PBMCs switched their
phenotype to anti-tumor phenotype with increased levels of interleukin-12
(IL-12) and decreased IL-10 levels. We observed that irradiation of EMT-6 tumor-
bearing mice significantly inhibited tumor growth in these mice. The point of
significance in the tumor growth inhibition started at around 15 days (P = 0.04)
and kept on increasing till the time study was ended at 22 days (P = 0.001) due
to large tumor sizes and discomfort and restricted movement of neutron only
irradiated mice.
Time kinetics of boron distribution following direct tumor injection of boron-
rich lipososmes suggested that the boron concetration did not decrease
substantially. Direct injection of boron-rich liposomes into tumor did not have
any effect on PBMCs cytokine profile following irradiation which remained as low
IL-12 and high IL-10 levels. Caspases play important roles in the induction of
cells. The caspase staining with FLICA (Fluorescent inhibitor of Caspase) to
assess apoptosis following irradiation revealed that the tumors injected
directly with boron-rich liposomes has significantly elevated caspase activity
than the systemic delivery of boron-rich liposomes to the tumors. Irradiation of
tumor-bearing mice following direct injection of boron-rich liposomes did not
show increased inhibition of EMT-6 tumor growth despite the presence of boron at
more than double the concentration compared to intravenous delivery. Infact the
inhibition of tumor growth did not reach the point of significance.
# Discussion
Selective delivery of boron forms the basis of effective BNCT for the treatment
of solid tumors. The capture of low-energy neutrons by <sup>10</sup>B
results in fission reactions leading to the generation of high energy He2+ and
Li3+ particles which traverse the path of 5–10 μm in diameter from initial point
and hence are lethal to the cells carrying boron in sufficient concentrations.
The results of our study indicate that boron distribution in the tumors is
critical for effective BNCT therapy. We have shown that the size of the tumor is
inversely proportional to the accumulation of boron compounds. We have further
demonstrated that the reasons for low boron distribution include the high levels
of necrosis and the fewer number of blood vessels observed in larger EMT-6
tumors. In other words, vascularization of EMT-6 tumors is inversely
proportional to the necrosis in these tumors. Further vascularization of EMT-6
tumors directly proportional to the distribution of boron rich liposomes in
these tumors and thus affect the efficiency of BNCT in treating the mammary
tumors. Our results further reveal that boron-rich liposomes assimilated by
PBMCs activated and modified these cells to an anti-tumor phenotype and aided in
the inhibition of tumor growth. We observed that the tumor growth following
systemic or direct tumor delivery of boron-rich liposomes revealed that the
initial effects of irradiation in terms of caspase activity was higher in tumors
directly injected with boron-rich liposomes than tumors receiving boron-rich
liposomes systemically, however the long term effect on tumor growth were
significantly higher in tumors receiving boron-rich liposomes systemically.
These results suggest that vascular and liposomal delivery of boron compounds
might have immunomodulatory effects and hence overtakes the overall impact on
tumor growth. Eventhough the initial caspase activity is higher in tumor
sections and cells obtained from the mice receiving direct tumoral injecrtion of
boron rich liposomes, but overall tumor inhibition is lower than in the mice
receiving systemic delivery. The plausible reason for the differential effect
could be that intra-tumoral boron delivery produces acute effects while immune
system modulation could produce long lasting effect. Similar, plausible
immunomodulatory effects were seen in a study where rats implanted with colon
tumors in both right and left legs followed by exposure to neutron beam in one
leg resulted in significant reduction of tumors non-exposed leg. In this study
boronophenylalanine (BPA) as a source of boron for BNCT reaction. Furthermore,
cancer cells damaged by irradiation can also undergo autophagy to chew-up the
damaged part to prevent cell death. In this study, we are showing initial
results where boron-rich liposomes can modify the PBMCs to antitumor phenotype.
Radiation therapy is the conventional treatment modality along with chemotherapy
following surgical removal of tumor tissue to prevent relapse perpetrated by
residual tumor tissue or cells. These therapies, however also result in severe
side effects in patients thereby affecting their quality of life. There are two
forms of radiation therapy, one is whole body irradiation therapy or radiation
of exposed part making it somewhat taregeted, however the radiation does not
differentiate between cancerous or non-cancerous tissue or cells, and the other
is a specific therapy where radiation only affects the cells carrying the target
molecule. In our study we observed little to no boron distribution in tissues
such as heart, brain, kidney and lungs thereby preventing off target effects. We
did not see the irradiation effects on noncancerous tissue probalby due to low
boron distribution and hence proving our initial point of BNCT being a more
targeted therapy than other forms of irradiation. The immunomodulatory effects
occurring due to systemic delivery of boron molecules needs to be studied
comprehensively. We are sharing our initial observation here for the scientific
community so that it can ponder upon the therapeutic effects of BNCT before
writing it off as another means of radiation therapy. BNCT has the potential to
become an essential form of treatment for various cancers. However, most of the
compounds developed for use in BNCT generally do not demonstrate significant
inhibition of tumor growth, which could be the result of poor distribution of
boron in tumors and also the mode of delivery. We suggest that for BNCT to be an
effective therapy for inhibition of tumor growth or prevention of relapse in
patients, the delivery of boron-rich compounds should be systemic and by nano
drug delivery systems. The nano-delivery systems will deliver boron to the PBMCs
which might activate these cells and help in the elimination of tumors.
# Materials and methods
## Animals
All work was performed by the general protocols of animal care, and experimental
design committee and the experiments outlined in this study are on file and have
been approved by the University of Missouri Committee on the Humane Care of
Laboratory Animals (CHCLA). All animal caretakers and laboratory personnel have
appropriate approvals based on specific American Association for Laboratory
Animal Care (AALAC)-approved training programs. The facilities are regularly
inspected by University Committee and by unannounced visits directed by the
Federal Government. We obtained BALB/c mice from Harlan Sprague (Indianapolis,
IN). Minimum of 10 mice were used in all the mice experiments listed in this
study. All the animal experiments were done according the ACUC protocol \# 7993.
## Reagents, and cell lines
We purchased Distearoyl-*sn*-glycero-3-phosphocholine (DSPC) from Avanti Polar
Lipids (Alabaster, AL), Cholesterol from Sigma-Aldrich (St. Louis, MO) and
syringe filters from Corning (Lowell, MA). The Sephadex G-25 gel used in the
study was purchased from Sigma-Aldrich (St. Louis, MO). We bought the anti-CD31
FITC antibody from Thermo Fisher Scientific (Rockford, IL), the tissue-freezing
medium from the Molecular Cytology Core Facility (University of Missouri,
Columbia, MO), the EtBRIII (necrosis study) from Enzo Life Sciences
(Farmingdale, NY). Lastly, the EMT-6 cells from ATCC (Manassas, VA).
## MAC/TAC liposome preparation
First, 0.1675 g of 1,2-distearoyl-*sn*-glycero-3-phosphocholine (DSPC) was added
to a 16 x 100 mm glass tube. Next, 0.0820 g of cholesterol (Sigma-Aldrich, St.
Louis, MO) and 0.0505 g K\[*nido*-7-
CH<sub>3</sub>(CH<sub>2</sub>)<sub>15</sub>−7,8-
C<sub>2</sub>B<sub>9</sub>H<sub>ll</sub>\] (MAC) was added to achieve 0.3 g
total of a 1:1:0.6 molar ratio of the respective components. The mixture was
dissolved in chloroform and methanol before being vortexed, dried by a nitrogen
stream until a film formed and then further dried for 12 hrs in a vacuum. Next,
6 ml of sterile, aqueous 250 mM (1000 mOsM) Na<sub>3</sub> \[1-(2'-
B<sub>10</sub>H<sub>9</sub>)-2-NH<sub>3</sub>B<sub>10</sub>H<sub>8</sub>\]
(TAC), which had been adjusted to pH seven via the addition of 1 M HCl, was
added to the vacuum-dried lipid mixture. The mixture was vortexed then sonicated
for 30 minutes at 65°C using a Sonics & Materials Vibracell and a 1/8” standard
tapered microtip probe. Following sonication, the liposome mixture was purified
from unincorporated materials via size-exclusion chromatography using Sephadex
G-25 (medium) filtration with phosphate buffered lactose (9% w/v lactose, five
mM phosphate, pH 7.4) as the eluting buffer solution. The collected and combined
liposome suspension was then filtered and sterilized by passage through two 0.2
μm Corning syringe filters directly into an autoclave-sterilized, sealed serum
bottle. Particle sizing was achieved utilizing a Zetatrac particle analyzer from
Microtrac, Inc. (Montgomeryville, PA).
## Cell culture, tumor induction, and experimental design
We obtained EMT6 cells from American Type Culture Collection (ATCC) and cultured
in DMEM medium supplemented with 10% FBS as recommended by ATCC. TrypLE buffer
(Life Technologies) was used to dissociate cells in log phase, DMEM + 10% FBS
was added to stop TrypLE reaction. The cells were pelleted down using accuspin
3R centrifuge (Fisher Scientific) at 323 × *g* for 8 min at room temperature,
followed by resuspension of cell pellet in 1X phosphate buffered saline (PBS).
Cells number was counted using an Automatic Cell Counter (Life Technologies).
For tumor induction, one million EMT6 cells (1 × 10<sup>**6**</sup> cells/mouse)
per mouse were inoculated into female BALB/c (n = 5/set) mice’s right flank. The
mice were typically weighed around 20 ± 1 g for all the studies listed in this
manuscript as described previously.
## Quantitative analysis of boron distribution in mice tissues using ICP-OES
BALB/c mice (n = 5/time point) were implanted with EMT-6 tumors in the right
flank of these mice. When the tumor size reached the desired size, the mice were
injected with TAC/MAC liposomes either intravenous or directly into tumors for
indicated time points. The injected dose of liposomes contained the boron at
concentration of 350 μg or 17.5 μg 10B/gram of body mass. The mice were then
euthanized by first anaesthetizing with cocktail of 10 mg/kg xylazine and 80
mg/kg ketamine followed by cervical dislocation. We collected tissue samples
(blood and tumor) in clean, and dry tubes following intravenous or direct
injections. Optima-grade nitric acid (1 ml) was added to the blood and tumor
samples and allowed to sit followed by shaking. Also, 100 μl of scandium
(200μg/ml) was added to each pressure vessel to serve as a standard for all
samples. We used CEM Mar microwave for tissue digestion followed by measurement
of tube weight after sample dilution. The samples were transferred to
appropriately labeled 50-mL conical tubes and analyzed by ICP. Plasma was used
as the source of light to excite the samples. The light intensities of
calibrants were used to calculate the sample boron concentration. The calibrants
(7 ml each) and a blank were placed in the auto-sampler and analyzed. We used a
blank between each sample analysis, and a spiked solution was used approximately
every four samples to ensure proper instrument function.
## Time kinetics for biodistribution studies
The biodistribution studies BALB/c mice (n = 5/set) were implanted with EMT-6
tumor cells. The mice were injected with boron-rich liposomes for different time
points either systemically or direct tumor injections. The mice euthanized and
tumors and blood were harvested and analyzed for boron conc by ICP-OES. Boron
levels in tumor tissue following systemic delivery of boron-rich liposomes
peaked in 54 h. At 54 h, boron concentration in the tumors was 67.8 μg
<sup>10</sup>B per gram tumor, and the tumor/blood boron ratio was 10:1. As
clearance of boron from blood proceeded more rapidly than loss from tumors, the
tumor/blood ratio continued to increase till 54 hrs. We used 54 hrs as an
optimum time point for irradiation.
## Study of tumor necrosis
The BALB/c mice (n = 5/set) were injected with EMT-6 cells at a density of
1X10<sup>6</sup> per mouse and allowed to grow to tumors of different sizes (80
mg-400 mg). Tumors harvested following euthanization as described above. The
tumors were then incubated overnight in 4% paraformaldehyde and then washed with
1X PBS. The tumors were incubated in a 30% sucrose solution at 4°C overnight
before being washed in a solution of 30% sucrose in distilled water. The tumors
were then frozen in tissue-freezing medium (TFM) and sectioned in 10-μm-thick
slices. The sections were then stained with EtBRIII and observed using a
confocal microscope at a wavelength of 600 nm, and images taken of the sections.
## CD31 staining of the tumor section
BALB/c mice (n = 5/set) were implanted with EMT-6 tumor cells in the right
flank. Tumors were allowed to grow to indicated sizes and sectioned as described
above and previously. Briefly, the tumor sections were stained with anti-mouse
CD31-FITC overnight at 4°C. The sections were then washed with 1X PBS and
observed under a confocal microscope at an excitation wavelength of 488 nm, and
images taken of the sections.
## Neutron irradiation
BALB/c mice (n = 5/set) were implanted with EMT-6 cells in the right flank. When
tumors were 80- to the 150-mm<sup>3</sup> in volume, <sup>10</sup>B-enriched
boronated liposome suspensions were administered to the mice either via tail-
vein or direct tumor injections. The mice were administered intraperitoneally
(i.p.) with cocktails of 10mg/kg xylazine and 80mg/ml of ketamine, and Cu/Au
flux wires were implanted on the left and right thorax of each mouse before
irradiation. <sup>6</sup>LiCO<sub>3</sub> was used to shield the head, thorax,
and cranial abdomen of the mice during irradiation to avoid possible
complications which also helped in improving the specificity of the treatment.
Once the mice were placed in positioning gallantry, the gallantry was introduced
in the irradiation chamber and irradiated for 30–45 mins. A camera was set to
monitor the discomfort in the mice during irradiation. Mice were taken out of
the irradiation chamber and allowed to recover from anesthesia followed by a
collection of the Cu/Au wires from the irradiated mice. The dose of irradiation
was calculated as described ealeir
## Therapeutic effect studies
The effect of BNCT was determined based on tumor volume changes during the
course of the study. The control group was not administered with the boron while
receiving the same amount of irradiation as the boron group. Calipers were used
to measure the tumor volumes during the course of the study. Mice were
euthanized when tumor volume reached 2000 mm<sup>**3**</sup>, or the mice showed
visible discomfort in moving and accessing the food and water **. For
effective BNCT mediated effects on tumors the total thermal (0–0.414 eV) neutron
fluence must be at least 1 × 10<sup>**12**</sup> neutrons/cm<sup>**2**</sup>. A
30–45 min exposure to the University of Missouri Research Reactor neutron beam
provides a total thermal neutron fluence of 1.6–2,4 × 10<sup>**12**</sup> which
was sufficient to produce desired therapeutic effects on EMT-6 tumors. Boron
dose and irradiation dose are calculated in.
## PBMCs count
The BALB/c mice (n = 5) injected with TAC/MAC liposomes for 48 hrs were either
irradiated or left non-irradiated. Followed by a collection of blood through the
heart puncture in a heparinized tube to prevent blood clotting. We isolated
PBMCs by gradient centrifugation on Histopaque (Sigma, St Louis, MO) solution.
The automatic cell counter was used to determine the PMBCs in blood collected
from both irradiated and non-irradiated mice.
## Quantitation of cytokines in PBMCs following irradiation
Total RNA was prepared from PBMCs isolated from above mice using the RNeasy mini
kit (Qiagen). cDNA was made using the High Capacity cDNA Kit (Applied
Biosystems), and PCR amplification of cDNA was performed using the Taqman probe-
based gene expression assay (Applied Biosystems) as previously described. The
probes for IL-12 (Mm01288989_m1) and IL-10 (Mm00439614_m1) were used to
determine the PBMCs polarization status.
## Caspase activity in tumors following irradiation
EMT-6 tumors were grown in four sets of BALB/c mice (n = 5/set) which either
received direct tumor injection or tail vein injection for otpimum time point of
54 hrs when tumors reached the size of 100-150mg. Boron distribution in tumor
and blood was done by ICP-OES in two sets of mice (direct tumor or tail vein
injection). Other two sets (direct tumor tail vein injection) were irradiated as
described previously. The tumors were then incubated overnight in 4%
paraformaldehyde and then washed with 1X PBS, followed by incubation in a 30%
sucrose solution at 4°C overnight before being washed in a solution of 30%
sucrose in distilled water. The tumors were then frozen in tissue-freezing
medium (TFM) and sectioned into 10-μm-thick slices. The sections were then
stained with EtBRIII and observed using a confocal microscope at a wavelength of
600 nm, and images taken of the sections.
We thank the staff of the Animal Facility at the Dalton Cardiovascular Research
Center for allowing us to house our mice, which enabled us to run our
experiments more efficiently.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
The hippocampus is a target of corticosterone (CORT) modulatory actions, with
high levels of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR)
expression. Traditionally, CORT had been thought to be synthesized exclusively
in the adrenal cortex, reaching the brain via blood circulation. *De novo*
synthesis of CORT from PROG in the brain has been doubted partly because brain
CORT disappears after adrenalectomy (ADX) in rats. However, recent evidence
shows that the hippocampus expresses steroidogenic enzymes required for
corticosteroid synthesis, including cytochromes P450scc, P450(11β1), P450(11β2),
and 3β-hydroxysteroid dehydrogenase (3β-HSD). Some of these enzymes are also
necessary for sex-steroid synthesis. Yet, the complete corticosteroid synthesis
of ‘pregnenolone (PREG) → progesterone (PROG)→ deoxycorticosterone (DOC)→CORT or
aldosterone (ALDO)’ in the hippocampus has not been proven. Although previous
studies have shown parts of the corticosteroid synthesis pathway in brain,
including, PREG→PROG and DOC→CORT and DOC→ALDO, the conversion of PROG→DOC to be
demonstrated. Cytochrome P450(c21) (DOC synthase), a key enzyme catalyzing the
conversion of PROG to DOC, has not been detected in the hippocampus, although
mRNA expression has been demonstrated in other brain regions including the
hypothalamus, cortex, cerebellum and striatum.
In the current study, we demonstrated expression and activity of P450(c21) and
the complete metabolism of PROG→DOC→CORT in rat hippocampus. In addition to
P450(c21), expression of cytochrome P450(2D4), another candidate for DOC
synthase, was also observed. Further, the net hippocampus-derived CORT content
was determined in ADX rats by mass-spectrometric analysis. We further
investigated the effect of low dose CORT on spinogenesis of hippocampal neurons
in order to show a possible role of hippocampus-derived CORT.
# Results
## Molecular biological analysis of corticosteroid synthesizing enzymes
Cellular localization and expression of enzymes responsible for CORT synthesis
including P450(c21), P450(2D4), P450(11β1), P450(11β2), and 11β-HSD (types 1 and
2) were examined. Typical RT-PCR patterns of mRNA transcripts are shown in.
Because the expression level of P450(c21) is extremely low in the hippocampus,
we performed careful primer design using minimization of Gibbs free energy (ΔG)
upon hybridization of primers with target sequences. We also choose primers with
ΔG for 5 bases in 3′-side of the primer to be larger than average ΔG for
improved specificity, because the specificity of primer-target recognition is
mainly governed by 3′-side sequence of the primer. In the current study, ΔG for
5 bases in 3′-side of the P450(c21) primer was –6 kcal/mol, which was larger
than the average ΔG for the P450(c21) primer ( = \<1?show=\[to\]?\>–8 kcal/mol).
As a result, we succeeded the detection of P450(c21) mRNA.
Relative number of transcripts, expressed in the hippocampus of adult male rats,
was in the order of 1/20,000 of that in the adrenal gland for P450(c21), almost
same level of that in the liver for P450(2D4), in the order of 1/10,000 of that
in the adrenal gland for P450(11β1), in the order of 1/5,000 of that in the
adrenal gland for P450(11β2), approximately 1/50 of that in the liver for
11β-HSD (type 1), and approximately 1/500 of that in the kidney for 11β-HSD
(type 2). The mRNA expression levels of P450(c21), P450(11β1), P450(11β2) and
11β-HSD (type 2) in the hippocampus were lower than those in the hypothalamus.
The expression level of P450(2D4) in the hippocampus was almost equal of that in
the hypothalamus. The expression level of 11β-HSD (type 2) was higher than that
in the hypothalamus.
The cellular localization of P450(2D4), P450(11β1) and P450(c21) was identified
using *in situ* hybridization and immunohistochemical staining. Significant
expressions of both P450(2D4) and P450(11β1) were observed in pyramidal neurons
(CA1, CA3) and granule neurons (DG) and these enzymes were weakly expressed in
glial cells. The weak expression of P450(c21) was observed in pyramidal and
granule neurons. Because the expression level of mRNA for P450(c21) was very
low, the Tyramide signal amplification system was used to obtain sufficient
sensitivity.
## Cellular and Subcellular localization of enzymes for corticosteroid synthesis
Immunoelectron microscopic analysis using postembedding immunogold was performed
in order to determine the localization of enzymes for corticosteroid synthesis
(P450(c21), P450(2D4), P450(11β1) and 3β-HSD) in the hippocampus. This method is
particularly useful to detect enzymes with extremely low expression level such
as P450(c21). All enzymes were mainly localized in principal neurons including
pyramidal neurons of CA1 and CA3 regions as well as granule neurons of the DG.
Weak expression was observed in some glial cells. P450(c21) and P450(2D4) were
localized not only in the endoplasmic reticulum but also in both the axon
terminals and dendritic spines of principal neurons. P450(11β1) was localized in
both the mitochondria and synapses of principal neurons. We also observed 3β-HSD
in the synapses in addition to the endoplasmic reticulum.
The subcellular localization of these enzymes was confirmed by western blot with
purified fractions of postsynaptic density, endoplasmic reticulum and
mitochondria.
## Mass-spectrometric analysis of corticosteroids in the hippocampus
The concentration of CORT and DOC was determined in steroid extracts from adult
male rat hippocampus using a chromatogram analysis of the fragmented ions. After
selection of mother ions, fragmentation and detection were performed via MS/MS
procedures. Chromatographic profiles for the fragmented ions of CORT (m/z = 121)
showed a clear peak with the retention time of 3.19 min which was the same as
that of the fragmented ion of the standard CORT, indicating a good specificity
of the analysis. In the chromatographic profiles of the fragmented ion of DOC
(m/z = 97), a single peak was observed at 3.73 min.
In order to determine the net corticosteroids synthesis in the hippocampus, we
used ADX rats to eliminate adrenal-derived steroids (CORT and DOC) via the blood
circulation. Results are summarized in. Two weeks after ADX, the concentrations
of CORT in the hippocampus and plasma were 2.4 ng/g wet weight ( = 6.9 nM) and
0.8 ng/ml (2.3 nM), respectively. The DOC concentration was 1.9 ng/g wet weight
(5.9 nM) in the hippocampus, and 0.5 ng/ml (1.4 nM) in plasma, respectively.
Even at 4 weeks after the ADX, the level of CORT did not decrease further from
the level at two weeks within experimental error (±2.1 nM, SEM). These results
imply that the circulation-derived CORT in the hippocampus was cleaned up
already at two weeks after ADX, therefore 6.9 nM is solely hippocampus-
synthesized CORT.
## Validation of mass-spectrometric analysis
To confirm the assay accuracy, the hippocampal homogenate spiked with known
amounts of the steroids was prepared and its concentration of steroid was
determined. Satisfactory accuracy was obtained, supporting the accuracy of
determined hippocampal steroid content in. The limits of quantifications (LOQs)
were defined in as the lowest value with an acceptable accuracy (91.6–107.1 %)
and precision (i.e. RSD\<11 %). The results of intra- and inter-assay were shown
in. The RSD for intra- and inter-assay was less than 10.2 % and 10.9 %,
respectively. These results indicate that the present method is highly
reproducible and accurate.
In addition, we observed approximately 0.68 nM of 11-deoxycortisol (roughly 1/10
of DOC) in the hippocampus. Because P450(17α) is expressed in the hippocampus,
DOC→11-deoxycortisol → cortisol pathway may also work.
## Hippocampal corticosteroid metabolism
Analysis of the pathway of corticosteroid metabolism is necessary, because mass-
spectrometric determination shows only the contents of individual steroids. The
metabolism of radioactive steroids in hippocampal slices was investigated using
normal phase HPLC. Hippocampal slices were incubated with 5×10<sup>6</sup> cpm
of <sup>3</sup>H-labeled steroid substrate for 5 h. Typical results of HPLC
analysis are illustrated in. A significant production of DOC from
<sup>3</sup>H-PROG was observed. The incubation buffer contains 100 nM of
finasteride, a specific inhibitor of 5α-reductase, in order to reduce the
conversion to 5α-reduced metabolites such as allopregnanolone. Because of the
strong activity of 5α-reductase and 3α-HSD, some 5α-dihydro PROG and TH-PROG
(allopregnanolone) were produced even in the presence of finasteride. In the
absence of finasteride, the production of DOC and CORT were very weak to
observe. When <sup>3</sup>H-DOC was used as a substrate, CORT from DOC was
produced. The conversion of CORT to other steroids was very weak, indicating
that CORT is stably present once it produced.
## Low dose effect of CORT on spinogenesis of hippocampal neurons
To determine the potential physiological significance of nanomolar
concentrations of hippocampal CORT, we investigated CORT effects on dendritic
spine density and morphology in hippocampal ‘acute’ slices. It should be noted
that CORT levels were depleted in control ‘acute’ slices, containing only 1.9 nM
CORT following 2 h recovery incubation in ACSF. Treatment with exogenous 10 nM
CORT for 1 h significantly increased the total spine density (1.18 spines/µm)
compared with control slices (0.98 spines/µm, with no exogenous CORT).On the
other hand, treatment with 100 nM CORT only slightly increased the total spine
density.
Morphological changes in spine head diameter induced by 1 h CORT administration
were also assessed. Spines were classified into three categories based on head
diameters: small-head spines (0.2–0.4 µm): middle-head spines (0.4–0.5 µm): and
large-head spines (0.5–1.0 µm). Morphological categorization of spines into
three subclasses enabled complex responses in spine subpopulations upon CORT
application to be distinguished. Treatment with 10 nM CORT significantly
increased the density of small-head spines from 0.58 (control) to 0.81
spines/µm, while the density of middle-head spines (approx. 0.28 spines/µm) and
large-head spines (approx. 0.12 spines/µm) was not significantly altered.
Morphological changes induced by 100 nM CORT were smaller than those induced by
10 nM CORT. The majority of spines (\>95%) had a distinct head and neck,
therefore these analysis cover major populations of spines.
# Discussion
In the current study, we clarified the complete pathway for corticosteroid
synthesis ‘PREG→PROG→DOC→CORT’ in hippocampal neurons. We demonstrated for the
first time the expression, neuronal localization and activity of P450(c21) in
the hippocampus. In addition, the localization of P450(2D4), another enzyme
participating in DOC synthesis, was demonstrated.
## Previous investigations of brain corticosteroids
### PROG→DOC conversion and P450(c21) expression
To date, direct evidence of DOC synthesis in the adult brain had not been
reported. No expression of P450(c21) in the rat/mouse hippocampus has been
reported, although a few studies have reported weak expression of P450(c21) mRNA
in some regions of the rat brain such as hypothalamus, striatum, cerebellum. As
an exception, weak expression of P450(c21) mRNA was observed in the human
hippocampus, with levels 1/20,000 of that of the adrenal gland. Thus far, it has
been believed that P450(c21) is not physiologically active in the hippocampus,
and all CORT in the hippocampus is derived from the adrenal glands via the blood
circulation. Although P450(2D4) has been known as the drug metabolizing P450,
recently, it has been demonstrated that P450(2D4) can also convert PROG to DOC
in hippocampus. Therefore, both P450(c21) and P450(2D4) could contribute to DOC
production. We observed the evidence of conversion of PROG to DOC, confirming de
novo synthesis of DOC.
### DOC→CORT conversion and P450(11β1) expression
The expression of P450(11β1) in the hippocampus has been described in several
studies and neuronal localization of P450(11β1) has been demonstrated using
immunohistochemistry. We observed the localization of P450(11β1) in cell bodies
of pyramidal and granule neurons at mRNA and protein level. Gomez-Sanchez and
co-workers observe a weak CORT production from <sup>3</sup>H-DOC, roughly 0.4
pmol/mg/3 h in the hippocampus. However, they doubted *de novo* synthesis of
CORT from PROG since CORT levels in whole brain were nigligible after
adrenalectomy (ADX) of rats. According to their report, CORT in the whole brain
of five ADX rats was below the detection limit, but four ADX rats had measurable
CORT in the brain (0.6 ng/g = 1.8 nM). Therefore, their results do not
completely eliminate a possibility of the presence of brain-synthesized CORT. It
should be noted that the expression level of P450(11β1) in the hippocampus does
not change upon ADX. In the hippocampus of ADX rats we observed the direct
conversion of DOC to CORT as well as low, but physiologically significant level
of CORT. The expression of P450(11β1) (both mRNA and protein) in neurons
supports endogenous synthesis. Interestingly, the expression level of P450(11β1)
is roughly 10-fold more in the cortex than in the hippocampus.
## Functional significance of hippocampus-synthesized corticosteroids
The low nanomolar level of CORT, synthesized in the hippocampal neurons, may
play a essential role in enhancement of synaptic plasticity, in contrast to the
deleterious effects (e.g., neuronal cell death or shrinkage of dendrites)
elicited by micromolar plasma CORT secreted from the adrenal gland under
stressful conditions. In the current study, low dose CORT (10 nM) enhanced
spinogenesis, particularly increasing the density of small-head spines. It has
been previously demonstrated that nanomolar doses of CORT (10 nM) drives the Erk
MAP kinase pathway, increasing both the expression and phosphorylation of MAP
kinase. Taken together, hippocampus-synthesized CORT (approx. 7 nM) might induce
spinogenesis via activation of the Erk MAP kinase pathway.
Earlier studies have also shown a range of beneficial effects of nanomolar doses
of CORT including strengthened signaling, neuroprotection as well as a potential
role in development. In vivo, low plasma levels of CORT increased the amplitude
of population spike, as did application of low concentration (5–50 nM) of CORT
to CORT-depleted slices. Low doses of CORT may also have neuroprotective
effects. For example, low dose CORT attenuates dexamethasone – induced apoptosis
in dentate gyrus via MR signaling pathway. Nanomolar low dose of CORT may also
play a role in neuronal development, with 5–10 nM CORT found to enhance
differentiation of neural stem cells by inducing the expression of astrocyte
marker GFAP (J Kanno, K Igarashi, K Tanemura, H Asano, K Nakashima.,
14<sup>th</sup> Int Cong of Endocrinol, Kyoto, 2010, P8-3-1).
Importantly, all the 7 nM of hippocampal CORT could participate in modulation of
neuronal functions such as spinogenesis, because corticosteroid binding globulin
(CBG) and serum albumin are not present in the hippocampus, therefore all the
hippocampal synthesized CORT should be biologically active. The persistence of a
significant concentration of corticosterone in the plasma (2 nM) even after ADX
may be derived from local synthesis in other peripheral tissue such as
adipocytes. Although we have a significant concentration of CORT in the plasma,
the majority (95–98%) of plasma CORT may be biologically inactive in basal
conditions, with the majority of plasma CORT (90%) bound to CBG and a large
proportion of the remaining CORT bound to serum albumin. Although basal plasma
CORT levels range between 100 and 300 nM, biologically active free CORT
comprises only 2–5% of the total plasma CORT levels.
## Moderate CORT level is kept by weak CORT production in the hippocampus
A trace amount of endogenous DOC and CORT had been very difficult to detect by
<sup>3</sup>H-steroid metabolism analysis, because many different pathways exist
other than PROG→DOC→CORT. Therefore, we employed mass-spectrometric assay for
detection of a trace amount of these steroids in the hippocampus of ADX rats. We
determined the concentrations of DOC and CORT to be 5.8 nM and 6.9 nM,
respectively. These values are comparable to hippocampus-synthesized sex
steroids such as estradiol (roughly 7 nM), testosterone (3 nM) and
dihydrotestosterone (0.6 nM).
Because the volume of hippocampus is very small (nearly 0.1 mL for one whole
hippocampus), the calculated concentrations were relatively high in nM range for
DOC and CORT. The absolute contents of DOC and CORT were only around 0.27 ng and
0.34 ng in one hippocampus with a weight of 0.14 g, respectively. Although
steroid production capacity is strong in the adrenal gland, circulation levels
of steroids are diluted due to approx. 20 mL of blood (200-fold of the
hippocampal volume). Though the hippocampal expression levels of enzymes (such
as P450(c21) and P450(11β1)) are roughly 1/20,000 and 1/10,000 of those in the
adrenal, they need to fill only small hippocampal volume (1/200 of the blood
volume).
It should be noted that the hippocampus-synthesized CORT is stably present for
even 5 h once produced, resulting in keeping the CORT level sufficient for
modulation of synaptic plasticity. It may be due to roughly 1000-fold higher
expression level of 11β-HSD (type 1) in the hippocampus than that of 11β-HSD
(type 2) as judged from the cycle number of PCR. Because 11β-HSD (type 1)
converts 11-dehydrocorticosterone (inactive form) to CORT, hippocampal CORT is
prevented from inactivating once produced. On the other hand, in peripheral
tissues such as kidney, the expression level of 11β-HSD (type2) is higher than
that of 11β-HSD (type1).
## Role of MR and GR
In ADX rats, the stress due to application of ether anesthetics before
decapitation did not increase hippocampal CORT level to a high stress-level
(e.g., 0.5–1 µM), therefore hippocampus-synthesized CORT (roughly 7 nM) may not
play a role in the negative feedback by occupying many GR. Under basal
conditions, all MR may be occupied by ALDO or CORT. Negative feedback would be
induced by adrenal CORT. In response to stress, 0.5–1 µM adrenal CORT, a part of
which penetrates into the hippocampus, could further occupy many unoccupied GR
in the hippocampus and could replace ALDO on MR.
## Conclusion
The hippocampus is equipped with not only sex-steroid synthesis systems , but
also corticosteroid synthesis systems. Synaptic localization of important
enzymes including P450(c21), P450(2D4) and P450(11β1) suggests a potential
synaptocrine function of corticosteroids in hippocampal neurons. These enzymes
are also localized in the endoplasmic reticulum (microsome) and mitochondria of
hippocampal neurons, suggesting potential synaptocrine function of
corticosteroid synthesis in hippocampal neurons. The current study opens new
field of investigations concerning possible physiological function of
hippocampus-synthesized nanomolar CORT, such as modulation of synaptic
plasticity.
# Materials and Methods
## Animals
Young adult male Wistar rats (12-week old) were purchased from Saitama
Experimental Animals Supply (Japan). All animals were maintained under a 12 h
light/12 dark exposure and free access to food and water. Adrenalectomy (ADX)
and sham operations were performed two-weeks before the experiments. The
experimental procedure of this research was approved by the Committee for Animal
Research of the University of Tokyo (The permission number is 19–10.).
## Chemicals
Corticosterone (CORT), deoxycorticosterone (DOC) and progesterone (PROG) were
purchased from Sigma (USA). \[−<sup>13</sup>C<sub>3</sub>\]PROG was from Hayashi
Pure Chemical (Japan). CORT-d<sub>8</sub> and DOC-d<sub>8</sub> were from CDN
Isotope Inc. (Canada). Finasteride was from Aska Pharma Medical (Japan).
\[<sup>3</sup>H\] or \[<sup>14</sup>C\] labeled steroids were purchased from
Perkin Elmer (USA) and their specific activities were 76.5 Ci/mmol
(\[1,2,6,7-<sup>3</sup>H\]-CORT) and 102 Ci/mmol
(\[1,2,6,7-<sup>3</sup>H\]-PROG). \[1,2-<sup>3</sup>H\]-DOC (50 Ci/mmol) was
purchased from Muromachi Yakuhin (Japan).
## RT-PCR and Southern hybridization
The procedures were the same as described elsewhere. Rats were deeply
anesthetized with ethyl ether and decapitated. The brains were then removed.
Total RNAs including mRNA were isolated from adult rat tissues such as the
hippocampus, hypothalamus, adrenal gland, kidney and liver, using a total RNA
Purification Kit (Nippongene, Japan). The purified RNAs were quantified on the
basis of the absorbance at 260/280 nm, and treated with RNase-free DNase to
eliminate the possibility of genomic DNA contamination. The purified RNAs were
reverse-transcribed, using a M-MLV Reverse Transcriptase (Promega, USA). The
oligonucleotides for PCR amplification were designed as illustrated in. The PCR
protocols comprised application of a 30 sec denaturation period at 95°C, a 2 sec
annealing period at individual temperature for each enzyme, and a 30 sec
extension at 72°C, for individual number of cycles for each enzyme. For
semiquantitative analysis, the RT-PCR products were separated on 2% agarose
gels, stained with ethidium bromide, and analyzed with a fluorescence gel
scanner (Atto, Japan) and Image J software, in comparison with standard curves
obtained from PCR of diluted RT products (between 1/100 and 1/10,000 in
dilution), from adrenal gland, kidney and liver.
To confirm the expression, Southern hybridization was performed. The amplified
RT-PCR products of steroidogenic enzymes were directly cloned into TA-cloning
vector (Promega, USA), and sequenced. The resulting sequence was identical to
the reported cDNA sequences of these enzymes. These cloned products were used as
the template of DNA probes for Southern hybridization. After transfer of the RT-
PCR products from agarose gels to nylon membrane (Hybond N+, Amersham, USA),
Southern hybridization was performed with <sup>32</sup>P-labeled cDNA probes for
these enzymes. The Southern hybridization signals were then measured using a
BAS-1000 Image analyzer (Fuji film, Japan).
## *In situ* hybridization of hippocampal slices
Rats were deeply anesthetized with ethyl ether and decapitated. The brains were
removed and the hippocampus was dissected. Preparation of adult hippocampal
slices fixed with 4% paraformaldehyde, was performed essentially as described in
elsewhere. The postfixed brain tissue was frozen-sliced coronally at 15 µm
thickness with a cryostat (Leica, Germany) and slices were immediately mounted
on the slide glass at −18°C. Digoxigenin (DIG)-labeled sense and antisense cRNA
probes were *in vitro* transcribed from PCR products of P450(11β1), P450(2D4)
and P450(c21) by using T7 or Sp6 promoters inherent in pGEM-T-Easy vector. The
hippocampal slices were treated with 10 µg/mL of Proteinase K (Wako, Japan) for
10–20 minutes, and then postfixed with fixative solution for 10 minutes. After
acetylation with acetic anhydride and dehydration, the mRNA in hippocampal
slices were hybridized with 0.5 µg/mL of DIG-labeled sense or antisense cRNA
probes. In order to digest and wash out the excess cRNA probes, the slices were
treated with RNase A (Wako, Japan) and stringent washes after hybridization. For
P450(11β1) and P450(2D4), the slices were incubated with alkaline phosphatase-
conjugated anti-DIG antibody (Roche Diagnosis, USA) (1/1000) for 30 min. After
washing the hippocampal slices twice, target mRNAs were visualized by color
development with 0.45 mg/mL of nitro blue tetrazolium chloride (NBT) and 0.175
mg/mL of 5-bromo-4-chloro-3-indoryl phosphate (BCIP) (Roche Diagnosis, USA) for
12 h. For P450(c21), the sections were incubated with horseradish peroxidase-
conjugated anti-DIG antibody (Roche, USA) (1/1000) for 30 min. To amplify
signals of *in situ* hybridization, the slides were incubated with dinitrophenyl
labeled amplification reagent using the TSA Plus DNP (AP) System (Perkin Elmer,
USA) and stained with NBT/BCIP for 12 h.
## Post-embedding immunogold method for electron microscopy
Rat hippocampal slices were prepared in essentially the same manner as described
elsewhere, except that slicing was performed at 4°C using a vibratome instead of
frozen slicing. Brains from five animals were used and from each brain, a single
representative coronal section including the dorsal hippocampus was processed
for ultrathin sectioning. Freeze substitution and low-temperature embedding of
the specimens was performed as described previously. Briefly, slices were
plunged into liquid propane. The samples were immersed in uranyl acetate in
anhydrous methanol (−90<sup>°</sup>C), then infiltrated with Lowicryl HM20 resin
(Electron Microscopy Sciences, USA); polymerization was performed with
ultraviolet light. Ultrathin sections were cut using a Reichert-Jung
ultramicrotome. For immunolabeling, sections were incubated with primary
antibody for 3β-HSD(type1) (1∶500), P450(c21) (1∶2000), P450(2D4) (1∶500) or
P450(11β) (1∶1000) in the above diluent overnight, then incubated with secondary
gold-tagged (10 nm) Fab fragment in Tris-buffered saline (TBS). Sections were
counter-stained with 1 % uranyl acetate, and viewed on a JEOL 1200EX electron
microscope (Japan). Images were captured using the CCD camera (Advanced
Microscopy Techniques, USA). Controls omitting the primary antibody were
performed and no immunogold labeling was observed. Controls of preadsorption
incubating with purified antigens were also performed and no immunogold labeling
was observed.
## Mass-spectrometric assay of steroids
Detailed procedures are described elsewhere.
### Step 1) Purification of steroids from hippocampi with normal phase HPLC
The preparation of hippocampal homogenates from slices and the extraction of
steroids were performed as described elsewhere. <sup>3</sup>H-steroids (20,000
cpm each) were added to homogenates as internal standards. The steroid extracts
were applied to a C<sub>18</sub> Amprep solid phase column (Amersham
Biosciences, USA) to remove contaminating fats. Then the steroids were separated
into fractions of CORT, DOC and PROG using a normal phase HPLC system (Jasco,
Japan) with an elution solvent of hexane: isopropylalcohol: acetic acid
= 98∶2∶1. A silica gel column (Cosmosil 5SL, Nacalai Tesque, Japan) was used.
By monitoring <sup>3</sup>H-steroids, the recovery of CORT, DOC and PROG were
35±1%, 34±1%, and 42±1%, respectively, after extraction, C<sub>18</sub> column
treatment and normal phase HPLC separation. Plasma was prepared by
centrifugation from trunk blood collected from decapitated rats.
### Step 2) Determination of the concentration for CORT, DOC and PROG using LC-MS/MS
At first, 100 pg of isotope labeled steroids (<sup>13</sup>C<sub>3</sub>-PROG,
DOC-d<sub>8</sub> and CORT-d<sub>8</sub>) were added to steroid extracts
prepared via *Step 1*). The LC-MS/MS system, which consisted of a reverse phase
LC (Agilent 1100, Agilent Technologies, USA) coupled with an API 5000 triple-
stage quadrupole mass spectrometer (Applied Biosystems, USA), was operated with
electrospray ionization in the positive-ion mode.
The LC chromatographic separation was performed on a Cadenza CD-C<sub>18</sub>
column (3×150 mm, 3 µm, Imtakt Japan). Detailed conditions for column
purification were described in of Supporting Information. In the multiple
reaction monitoring mode, the instrument monitored the m/z transition, from 347
to 121 for CORT, from 331 to 97 for DOC, and from 315 to 109 for PROG,
respectively. Here, m and z represent the mass and charge of a steroid
derivative, respectively.
To examine specificity of LC-MS/MS analysis, samples were spiked with steroid
isotopes as internal standards. Though the m/z transitions were different
between CORT (from m/z = 347 to 121) and CORT-d<sub>8</sub> (from m/z = 355 to
125), their retention times were the same, because the affinity of CORT for LC-
column is same as that for CORT-d<sub>8</sub>. In case of other steroids, there
is also no difference in the retention time between steroids and their isotopes,
though the m/z transitions were different. Isotope-labeled steroid derivatives
were also used for internal standards in order to measure recovery of steroids.
The recovery of CORT, DOC and PROG were determined as 89±8%, 75±4% and 71±6%,
respectively, after purification and MS/MS detection. Total recovery during all
the steps was determined via <sup>3</sup>H- and isotope-labeled steroids in
*Step 1*) and *Step 2*).
The limits of quantification for steroids were measured with blank samples,
prepared alongside hippocampal samples through the whole extraction,
fractionation and purification procedures. The limits of quantification for
CORT, DOC and PROG were 2 pg, 1 pg, and 2 pg per 0.1 g of hippocampal tissue or
1 mL of plasma, respectively.
From the calibration curve using standard steroids dissolved in blank samples,
the linearity was observed between 2 pg and 4000 pg for CORT, between 1 pg and
1000 pg for DOC, and between 2 pg and 4000 pg for PROG, respectively.
Male Wistar rats were anesthetized with pentobarbital and placed in a
stereotaxic Because the LC-MS/MS enabled to determine the exact level of CORT in
the brain, we applied LC-MS/MS to observe the circadian rhythm of CORT level in
the cerebrospinal fluid (CSF) in combination with the transverse microdialysis.
Microdialysate was collected from the cisterna magna in freely moving male
Wistar rats every hour. Narishige apparatus (SR-5, Narishige, Japan) inserting a
transverse dialysis tube placed at the cisterna magna under the guidance of a
stainless steel wire attached in a horizontal position to a stereotaxic holder.
The rats were allowed roughly 1 week to recover from the surgery. Thereafter,
the animals were moved to an acrylic test box with the transverse probe being
perfused with a Ringer's solution (138 mM NaCl, 2.4 mM KCl, 1.2 mM
CaCl<sub>2</sub>, \[pH 7.0\]) at 1 µL/min. Daily samples of CSF from the
cisterna magna were automatically collected every hour in a small vial. The rats
had free access to food placed on the floor of the test box and to water given
from the lid of the box.
## Metabolism analysis of radioactive steroids using normal phase HPLC
Procedures were essentially the same as previously described in elsewhere. The
hippocampus from one rat was sliced into 400 µm thickness with a vibratome and
incubated with 5×10<sup>6</sup> cpm of \[<sup>3</sup>H\]-steroids at 30°C for 5
h in 4 ml of physiological saline containing 1.2 mM Mg<sup>2+</sup>. The
incubation medium was gassed with 95% O<sub>2</sub> and 5% CO<sub>2</sub> during
the incubation in order to keep the activity of hippocampal neurons. After
termination of the reaction, the slices were homogenized. A portion of the
purified radioactive metabolites (total of 10<sup>6</sup> cpm) was analyzed
using an HPLC system. Procedures used for the analysis of steroid metabolites
from hippocampal homogenates with normal phase HPLC were the same as described
in *Step 1*) of Mass-spectrometric assay. Fraction radioactivity was measured
using a liquid scintillation spectrometer LS6500 (Beckman, USA). The rate of
steroid production was normalized as products (cpm) /g wet weight /5 h.
## Imaging and analysis of dendritic spine density and morphology
### Slice preparation
Twelve weeks male rats were deeply anesthetized with ethyl ether and
decapitated. Immediately after decapitation, the brain was removed from the
skull and placed in ice-cold oxygenated (95% O<sub>2</sub>, 5% CO<sub>2</sub>)
artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 5 KCl, 1.25
NaH<sub>2</sub>PO<sub>4</sub>, 2 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub>, 22
NaHCO<sub>3</sub>, and 10 D-glucose (all from Wako); pH was set at 7.4.
Hippocampal slices, 400 µm thick, were prepared with a vibratome (Dosaka,
Japan). These slices were ‘freshly prepared’ slices without ACSF incubation.
Slices were then incubated in oxygenated ACSF for 2 h (slice recovery processes)
in order to obtain conventional ‘acute’ slices. These acute slices were then
incubated at room temperature with CORT for 1 h. Then, slices were prefixed with
4% paraformaldehyde at 4°C for 2–4 h.
**Spine imaging and analysis** with confocal microscopy was performed as
described previously.
### Current injection of neurons by Lucifer Yellow
Neurons within slices were visualized by an injection of Lucifer Yellow under a
Nikon E600FN microscope (Japan) equipped with a C2400–79H infrared camera
(Hamamatsu Photonics, Japan) and with a 40× water immersion lens (Nikon). Dye
was injected with a glass electrode filled with 5% Lucifer Yellow for 15 min,
using Axopatch 200B (Axon Instruments, USA). Approximately five neurons within a
100–200 µm depth from the surface of a slice were injected (Duan H et al.,
2002). After labeling, slices were fixed again with 4% paraformaldehyde at 4°C
overnight.
### Confocal laser microscopy and morphological analysis
Imaging was performed from sequential z-series scans with LSM5 PASCAL confocal
microscope (Zeiss, Germany). For analysis of spines, three-dimensional images
were constructed from approximately 40 sequential z-series sections of neurons
scanned every 0.45 µm with a 63× water immersion lens, NA 1.2 (Zeiss). The
excitation and emission wavelengths were 488 nm and 515 nm, respectively. The
applied zoom factor (3.0) yielded 23 pixels per 1 µm. The z-axis resolution was
approximately 0.71 µm. The confocal lateral resolution was approximately 0.26
µm. Our resolution limits were regarded as sufficient to allow the determination
of the density of thorns or spines. Confocal images were then deconvoluted using
AUTODEBLUR software (AutoQuant, USA). The density of spines as well as the head
diameter was analyzed with Spiso-3D (automated software calculating geometrical
parameters of spines) developed by Kawato's group of Bioinformatics Project.
Spiso-3D has an equivalent capacity with Neurolucida (MicroBrightField, USA),
furthermore, Spiso-3D considerably reduces human errors and experimenter labor.
We analyzed the secondary dendrites in the stratum radiatum, lying between 100
and 250 µm from the soma. The spine density was calculated from the number of
spines having a total length of 50–80 µm. Spine shapes were classified into
three categories as follows. (1) A small-head spine whose head diameter is
0.2–0.4 µm. (2) A middle-head spine whose head diameter is 0.4–0.5 µm. (3) A
large-head spine whose head diameter is 0.5–1.0 µm. These three categories were
useful to distinguish complex responses upon CORT application. Because the
majority of spines (\>95%) had a distinct head and neck, and stubby spines and
filopodium did not contribute much to overall changes, we analyzed spines having
a distinct head. While counting the spines in the reconstructed images, the
position and verification of spines was aided by rotation of three-dimensional
reconstructions and by observation of the images in consecutive single planes.
## Statistical analysis
Data were expressed as mean ± SEM. For, an unpaired, two-tailed *t*-test, under
the assumption of unequal variances, was utilized to test the significance of
observed differences between groups. Several numbers of independent experiments
from different animals were used to determine the parameters of *t*-distribution
for the test. For analysis of spinogenesis, we used Tukey–Kramer post hoc
multiple comparisons test when one way ANOVA tests yielded P\<0.05.
# Supporting Information
Dr. Seijiro Honma (Aska Pharma Medical) is acknowledged for collaboration of
mass-spectrometric analysis. Prof. John Morrison (Mount Sinai School of
Medicine) is acknowledged for immunoelectron microscopic analysis. Prof. J. Ian
Mason (University of Edinburgh), Dr. Fumiko Mitani (Keio University) and Prof.
Yoshihiko Funae (Oosaka City University) are acknowledged for their kind gifts
of 3β-HSD antibody, P450(11β1) antibody, and P450(2D4) antibody, respectively.
[^1]: Conceived and designed the experiments: SH YH SK. Performed the
experiments: SH YH HI YK YO GM HM TK. Analyzed the data: SH YH YK SK.
Contributed reagents/materials/analysis tools: SK TY DN. Wrote the paper: SK
SH YH AB.
[^2]: The authors have declared that no competing interests exist.
|
The authors have discovered that an indexing error occurred in the code for the
analysis of the article. Despite this error, the general conclusions of the
article remain supported by the data: ecosystem functions across trophic levels
are linked to functional and phylogenetic diversity. Furthermore, phylogenetic
and functional diversity measures explain variation in ecosystem functions
beyond that which is explained by traditional diversity measures such as species
richness. After rerunning analysis, functional diversity is no longer the best
predictor of zooplankton biomass. Rather, functional diversity, together with
phylogenetic diversity, explains all the variation explained by species
richness, along with additional unique variation. All together, this indexing
error resulted in errors in Figs and and and and Tables and and and and, as well
as in the Abstract, Results, Discussion, and Conclusion sections.
Please see the corrected Figs and and Tables and here; please view the corrected
and Figs and and Tables and below.
Please see the corrected Abstract, Results, Discussion, and Conclusion text
here.
In the Abstract, there is an error in the ninth sentence. This sentence should
be replaced with the following two sentences:
“Measures of zooplankton phylogenetic diversity and trait-based functional
diversity together explained all the variation in zooplankton community biomass
that was explained by species richness, in addition to unique variation that was
not explained by species richness alone. In contrast, phytoplankton abundance
was best predicted by zooplankton phylogenetic diversity, which explained all
variation explained by any of the three types of diversity indices.”
In the Zooplankton community characteristics subsection of the Results section,
there are a number of errors in the first and second paragraph. The correct
first and second paragraphs are:
“Average pond species richness was 4.65, ranging from 3 to 7, with a regional
richness of 10. Across all ponds, zooplankton community biomass was 334.77 μg
L<sup>-1</sup> on average, ranging from 2.66 to 1398.85 μg L<sup>-1</sup>.
Species richness was positively, albeit weakly, related to the number of
zooplankton present in our samples (R<sup>2</sup> = 0.29; *p* = 0.006). However,
the rarefaction curves saturated in the majority of samples (87%), suggesting
that our estimates of richness were not greatly biased by differences in the
abundance of zooplankton amongst the ponds (Figure S5).
*Daphnia pulex* comprised 44.9% of the zooplankton biomass over all ponds and
was present in 14 of the 23 ponds. The next most abundant taxon, *Harpactocoid*
copepods, comprised 26.4% of the zooplankton biomass in all ponds and was
present in 21 of the 23 ponds. *Acanthocyclops vernalis* comprised 10.6% of the
zooplankton biomass in all ponds and was present in 15 of the 23 ponds. This
species is carnivorous as an adult but was retained in our analysis because it
consumes phytoplankton in its juvenile stages \[44\]. There were seven rarer
taxa, *Alonella sp*., *Ceriodaphnia dubia*, *Chydorus sphaericus*,
Harpacticoida, *Sida crystallina*, *Simocephalus sp*., and *Tropocyclops
prasinus mexicanus*, that each made up less than 5% of the average biomass.
Phytoplankton abundance was 6.56 μg chl *a* L<sup>-1</sup> on average, ranging
from undetectable to 33 μg L<sup>-1</sup>. Zooplankton species richness was not
related to either chlorophyll *a* (R<sup>2</sup> = 0.10; *p* = 0.140) or total
phosphorous (R<sup>2</sup> = 0.11; *p* = 0.131).”
In the Zooplankton community biomass subsection of the Results section, there
are a number of errors. The correct Zooplankton community biomass subsection is:
“Three out of the 11 diversity measures tested explained a significant
proportion of variance in zooplankton community biomass, and in all cases, there
was a positive influence of diversity on biomass. These significant models
included taxonomic, functional, and phylogenetic measures. Species richness (SR;
; R<sup>2</sup> = 0.38; *p* = 0.008) and abundance weighted standard effect size
mean pairwise distance (sesMPD<sub>ab</sub>; ; R<sup>2</sup> = 0.34; *p* =
0.003), were jointly selected (equal AIC) as the best single diversity measure
predictors of zooplankton community biomass. Species richness (SR) exhibited a
unimodal relationship with zooplankton community biomass, where the highest
biomass was found in ponds with intermediate species richness. This unimodal
relationship between species richness and community zooplankton biomass
outperformed a model that assumed a linear relationship (R<sup>2</sup> = 0.14,
*p* = 0.077). Presence absence weighted functional evenness (Feve<sub>pa</sub>)
explained the third highest proportion of variance of the single diversity
measure models (; R<sup>2</sup> = 0.27; *p* = 0.010).
Based on variation partitioning, SR, Feve<sub>pa</sub>, and sesMPD<sub>ab</sub>
together explained 45% of the variation in zooplankton community biomass, and
overlapped in explaining 10% of the variation. SR and Feve<sub>pa</sub>
overlapped to explain 11% of the variation. SR and sesMPD<sub>ab</sub>
overlapped to explain 12% of the variation. Feve<sub>pa</sub> and
sesMPD<sub>ab</sub> overlapped to explain 1% of the variation. SR,
Feve<sub>pa</sub>, and sesMPD<sub>ab</sub> uniquely explained 0%, 2%, and 8% of
the variation respectively.
Three of the five traits (trophic group, raptorial vs. filter feeding, and body
length) individually explained a significant amount of variance in zooplankton
biomass and body length outperformed the best functional diversity measures
although ΔAIC was small.
The best performing model of environmental variables for predicting zooplankton
community biomass consisted of elevation and ln TP, and explained a significant
amount of variation (R<sup>2</sup> = 0.39; *p* = 0.007). However, when either
sesMPD<sub>ab</sub> or species richness was included in the model, none of these
environmental variables remained as significant predictors, although the models
outperformed all other models. Chlorophyll *a* did not explain a significant
amount of variance in zooplankton community biomass (R<sup>2</sup> = 0.02; *p* =
0542).
The pathway between sesMPD<sub>ab</sub> (chosen for use in the SEM models
because it performed equally well to SR and was the best predictor when combined
with the environmental variables) and zooplankton community biomass, was always
significant, regardless of how we specified the effect of environment in our
SEM. The most parsimonious model, based on AIC, only included the direct pathway
from sesMPD<sub>ab</sub>. This suggests that our linear models adequately
capture the relationship between diversity and zooplankton biomass.”
In the Phytoplankton abundance subsection of the Results section, there are a
number of errors. The correct Phytoplankton abundance subsection is:
“Four out of the 11 zooplankton diversity measures explained a significant
proportion of variance in chlorophyll *a*, and in all cases there was a negative
influence of diversity on chlorophyll *a*. These significant models included
functional and phylogenetic, but not taxonomic diversity measures. The best
single diversity measure for predicting chlorophyll *a* was the phylogenetic
diversity measure sesMPD<sub>pa</sub> (R<sup>2</sup> = 0.44; *p* = 0.001). There
was one outlier in this relationship, which was found to have significant
influence (Cook’s distance \> 0.5) on the analysis (—unfilled point).
Chlorophyll *a* was not detectable in this pond, although the predicted
concentration should have been relatively high based on the measured zooplankton
phylogenetic diversity. We cannot be sure if this chlorophyll *a* concentration
is a measurement error, so we compared model fit with and without including it.
Removing this outlier from our analysis did not have a large effect on the slope
of the relationship but greatly improved the model fit (dashed line;
R<sup>2</sup> = 0.63, *p* \<0.001).
The functional diversity measure with the lowest AIC was abundance weighted
functional evenness (FEve<sub>pa</sub>; R<sub>2</sub> = 0.34, *p* = 0.004).
However, this model slope was highly sensitive to the inclusion of the outlier,
and the next best functional diversity measure FRic had a similar AIC but was
not as influenced by the outlier and so we have elected to use FRic as our best
functional diversity measure. FRic had a positive relationship with chlorophyll
*a* (R<sub>2</sub> = 0.28, *p* = 0.010) and excluding the outlying pond did not
change the slope of the relationship but improved the model fit (R<sup>2</sup> =
0.49, *p* \< 0.001). The best measure of taxonomic diversity was species
richness (SR; ; R<sup>2</sup> = 0.10; *p* = 0.140), but no taxonomic diversity
measure was able to explain a significant portion of variance in chlorophyll
*a*. Again, excluding the outlying pond did not change the slope of the
relationship but improved the model fit (dashed line; R<sup>2</sup> = 0.22, *p*
= 0.02).
Based on variation partitioning, SR, FRic, and sesMPD<sub>pa</sub> together
explained 37% of the variation in chlorophyll *a*. However, all variation
explained was captured by sesMPD<sub>pa</sub>, either alone (4%) or with SR
(11%) or FRic (30%). SR and FDiv each uniquely did not contribute to explaining
variation in chlorophyll *a*, nor did the overlap between all three indices, and
this resulted in less variation explained by the three indices together than
that explained by sesMPD<sub>pa</sub> on its own, because adjusted R<sup>2</sup>
penalizes for the additional degrees of freedom used in the combined model.
Two of the five traits (raptorial vs. filter feeding, and feeding type)
individually explained a significant amount of variance in chlorophyll *a*. No
single trait performed as well as the best phylogenetic diversity measure
(sesMPD<sub>pa</sub>).
The best performing model for chlorophyll *a* containing only environmental
variables consisted of ln DIC, ln depth, ln pH, ln wet days and ln TP but was
not significant (*p* = 0.052). The model combining these environmental variables
plus sesMPD<sub>pa</sub> did not perform as well as the model with
sesMPD<sub>pa</sub> alone. Neither zooplankton community biomass nor *D*.
*pulex* biomass explained a significant amount of variation in chlorophyll *a*
(Community Biomass R<sup>2</sup> = 0.02; *p* = 0.542; *D*. *pulex*–R<sup>2</sup>
= 0.07; *p* = 0.221).
The pathway between sesMPD<sub>pa</sub> and chlorophyll *a*, was always
significant, regardless of how we specified the effect of environment in our SEM
(Figure S8). Matching to the SEM with zooplankton community biomass, the most
parsimonious model explaining variation in chlorophyll *a* did not include
environment, but it included the direct pathway from sesMPD<sub>pa</sub>. This
again suggests that our linear models adequately capture the relationship
between diversity and chlorophyll *a*.”
In the Discussion section, there are errors in the second, fourth, and fifth
paragraph. The correct second paragraph is:
“As predicted, we found that positive diversity ecosystem function relationships
emerged most clearly when measures of functional and phylogenetic diversity were
used, and that these measures explained variation in ecosystem function beyond
that explained by taxonomic diversity measures, such as species richness.
Previous studies relating the diversity of animals to ecosystem function have
relied on taxonomic diversity measures \[47,48\], knowledge of the functional
complementarity of species \[49,50\], single traits \[13\] or on taxonomic
differences \[16\], but see \[14\]. Species richness, phylogenetic diversity
(sesMPD<sub>ab</sub>), and functional diversity (Feve<sub>pa</sub>) all
explained significant amounts of variation in zooplankton biomass. Furthermore,
none of this variation was explained solely by species richness, whereas
phylogenetic diversity and functional diversity each explained additional unique
variation. Although we found a subset of single traits (e.g. trophic group,
raptorial vs. filter feeding, and body length) performed almost as well in
predicting zooplankton biomass, only body size explained as much variation as
the best diversity measures. In contrast, phylogenetic diversity
(sesMPD<sub>pa</sub>) was the best predictor of phytoplankton consumption, and
no additional variation was uniquely explained by species richness and
functional diversity (FRic). These findings suggest that metrics that
quantitatively integrate trait or phylogenetic information have the potential to
improve our understanding of variation in the functioning of complex multi-
trophic ecosystems.”
The fourth paragraph of the Discussion section is no longer relevant after the
reanalysis and should be removed.
The correct fifth paragraph of the Discussion is:
“No single diversity index was consistently the best predictor of ecosystem
function, and the degree to which they explained unique variation differed
depending on the measured function. While taxonomic diversity (SR<sup>2</sup>)
explained the most variation in zooplankton biomass, all of this variation was
captured by either phylogenetic diversity (sesMPD<sub>ab</sub>) or functional
diversity (Feve<sub>pa</sub>), which each captured additional unique variation.
In contrast, phylogenetic diversity (sesMPD<sub>pa</sub>) explained the most
variation in phytoplankton abundance and although both species richness and
functional diversity (FRic) explained overlapping variation, these were subsets
of that explained by phylogenetic diversity. These findings suggest that the
three types of diversity indices capture some of the same functional differences
in community composition. This is perhaps unsurprising because functional traits
and niche differences are often phylogenetically conserved \[10,52\], as
reflected by the high overall correlation between the traits and phylogeny.
However, the diversity measures did not overlap completely in the variance in
ecosystem function that they explained, and each function was best predicted by
a different diversity measure. For example, body size showed little phylogenetic
signal, but was predictive of zooplankton community biomass, and this
correlation may explain why functional diversity explained unique variation not
captured by phylogenetic diversity for this ecosystem function. In contrast, the
fact that phylogenetic diversity explained additional variation in phytoplankton
abundance to that explained by functional traits is suggestive of other
important, but unmeasured, functional differences that covary with phylogeny.
Each class of metric thus captured some unique aspect of the way that the
communities use resources \[53\], highlighting the value of combining different
diversity metrics in models explaining ecosystem function.“
In the Conclusion, there is an error in the third sentence of the second
paragraph. The correct sentence is:
“Zooplankton biomass production is best explained by a combination of functional
and phylogenetic diversity, whereas suppression of phytoplankton production was
best explained by phylogenetic diversity.”
# Supporting information
|
# Introduction
Plastid and mitochondria are essential organelles in plant cells. Chloroplasts
conduct photosynthesis in the presence of sunlight and mitochondria indirectly
supply energy within plant cells; together they form the powerhouses of the
cell. Both chloroplasts and mitochondria possess their own genomes. The
chloroplast (cp) genome and mitochondrial (mt) genomes are often used for the
study of plant evolution. From the information of all sequenced cp genomes, most
of them range from 120 to 160 kb in length and have GC contents of 30 to 40%.
The quadripartite organization is shared by almost all cp genomes, consisting of
a large-single-copy region (LSC; 80–90 kb) and a small-single-copy region (SSC;
16–27 kb), as well as two copies of inverted repeats (IRs) of ∼20 to 28 kb in
size. The gene content and structure of angiosperm cp genome is highly
conserved. Expansion and contraction of the IR as well as gene and intron losses
have been documented in a wide range of angiosperms.
The mt genome plays crucial roles in plant development and productivity. In
comparison to other non-plant eukaryotes, plants have large and complex mt
genomes. Mt genomes of seed plants are unusually large and vary in size at least
in an order of magnitude. Much of these variations occur within a single family.
Seed plant mitochondrial genomes are characteristic for their very low mutation
rate, frequent uptake of foreign DNA by intracellular and horizontal gene
transfer, and dynamic structure. The evolving land plants have gained new
mechanisms to facilitate more frequent gene exchanges between mt and cp genomes
as well as between mt and nuclear genomes, which make mt genomes increase their
sizes..
In the past several years, we have witnessed a dramatic increase in the number
of complete organellar genomes, especially those of plants. Until now, there are
206 complete cp genomes and 47 mt genomes having been deposited in GenBank
Organelle Genome Resoures. With the emergence of next-generation sequencers, new
approaches for genome sequencing have been gradually applied due to their high-
throughput, time-saving, and low-cost advantages. With a new gene-based strategy
and combining data from the two next-generation sequence platforms,
pyrosequencing (Roche GS FLX) and ligation-based sequencing (Life Technologies
SOLiD), we successfully assembled cp and mt genomes of resurrection plant *B.
hygrometrica (Bunge) R. Br*. *B. hygrometrica* or *Bh* is a small
dicotyledenous, homiochlorophyllous resurrection plant in the Gesneriaceae
family, and it is widespread in China, inhabiting shallow rock crevices from
humid tropical regions to arid temperate zones. In this study, we analyze
genomic features and structures of both cp and mt genomes of *B. hygrometrica*.
Through organellar genome comparison with other lower plants and angiosperms, we
provide information for the better understanding of organellar genome evolution
in land plants.
# Results and Discussion
## Features of *B. hygrometrica* cp genome and mt genome
The *Bh* cp genome is 153,493 bp in length and has a GC content of 37.59%.
Similar to those of other angiosperms, the *Bh* cp genome maps as a circular
molecule with the typical quadripartite structure: a pair of IRs (25,450 bp,
covering 16.6%) separated by the LSC (84,692 bp, covering 55.1%) and SSC (17,901
bp, 11.7%) regions. It encodes 147 predicted functional genes and 19 of them are
duplicated in the IR regions. Among these 147 genes, we identified 103, 36, and
8 protein-coding, tRNA, and rRNA genes, respectively ( **and**). 38% of the
genome is non-coding, including introns, intergenic spacers, and pseudogenes.
All the rRNA genes (*rrn16*, *rrn23*, *rrn5* and *rrn4.5*) and 7 tRNA (*trnI-
CAU*, *trnL-CAA*, *trnV-GAC*, *trnI-GAU*, *trnA-UGC*, *trnR-ACG*, and *trnN-
GUU*) genes are located in IR regions. Similar to other dicot species, *Bh* has
two genes (*rps19* and *trnH*) located in the position of IR/LSC junctions. This
is different in monocots, such as rice and maize, whose cpDNAs have a fully
duplicated *rps19* gene in the IR/LSC junctions. The average length of
intergenic regions is 385 bp, varying from 1 to 2,221 bp. There are 4 cases of
overlapping genes (*psbD-psbC*, *ndhK-ndhC*, *atpE-atpB*, and *ycf1-ndhF*),
resulting in an average coding density (including conserved genes, unique ORFs
and introns) of 1/1,058 bp. The cp genome has 19 intron-containing genes with 12
in protein-coding genes and 7 in tRNA genes. In terms of size, gene content, and
intron composition, *Bh* cpDNA closely is mapped to *Olea europaea* cpDNA
(155,872 bp, GC 37%) among all angiosperms. Sequence alignment shows that 93%
(142,189 bp) of the *Bh* cp genome sequence are covered by that of *O. europaea*
with 95.4% identity. 36 tRNAs are detected, enabling *B. hygrometrica* cp genome
to decode all 61 codons. All of 3 stop codons are present with UAA being the
most frequently used (UAA 40%, UAG 33% and UGA 27%). Phylogenetic analyses,
which were constructed by 63 protein-coding sequences from 12 cp genomes (one
green algae as outgroup, one land and 10 seed plants) , indicates that the
phylogenetic position of *B. hygrometrica* is closer and older than *V.
vinifera* among the analyzed dicots.
The *Bh* master mt genome is assembled into a circular molecule of 510,519 bp in
length and has an average GC content of 43.27%. This size is bigger than the mt
genome of *A. thaliana* (366,924 bp), but smaller than *Vitis vinifera* (773,279
bp) among dicots. With only 12% of coding sequences, the largest part (88%) of
this genome is non-coding, containing 1.45% repeat and 10.52% cp-derived
sequences. The mt genome has 65 genes, including 33 protein-coding, 4 rRNA, and
28 tRNA genes, and 10 genes have exon-intron structure. Similar to other
angiosperms, the *Bh* mitochondrion uses the canonical genetic code. All 61
codons are present in mt genome, and UAA (46%) is the most frequently-used stop
codon. The known 33 protein-coding genes in mt genome are similar to other
published angiosperm mt genomes, such as 9 subunits of NADH dehydrogenase
(complex I), 5 subunits of ATP synthase (Complex V), and 3 subunits of
cytochrome c oxidase (complex IV). Compared to other angiosperms, we observed
that there is one *sdh3* and no *sdh4* in *Bh* mt genome. There are 3 copies of
*sdh3* in mt genome of *Nicotiana tabacum*, and both *sdh3* and *sdh4* are
present in that of *V. vinifera*. The *Bh cox1* has an intron/exon structure
that is unlike other higher seed plants. There are two 5S rRNA (*rrn5*) copies
and one copy of rrn5 from its cp genome. The best sequence alignment score
belongs to *V. vinifera* mt genome, with 23% (119,377 bp) of *Bh* mt genome
being alignable to that of *V. vinifera* with 94.2% identity.
Plant cells often contain multiple clones or copies of cp and genomes, and thus
the organellar genomes can be regarded as a population with genetic
heterogeneity. Polymorphic sites can be detected by aligning thousands of high
quality reads to assembling of the cp or mt genome. Our SNP analysis shows that
there is no intervarietal SNPs (intraSNPs) found in *Bh* cp genome. However, we
identified 729 SNPs in *Bh* mt genome and SNPs in mt genome occurred at a rate
of 1 in 700 bp. We only detected 9 SNPs in gene regions with 2, 1, 1, and 5 in
*rrn5*, *rrn26*, *trnM-CAU*, and *rrn18*, respectively. There are no intraSNPs
detected in known protein-coding gene regions. The intraSNPs have been
demonstrated to be present in both cp and mt genomes of rice,. As an indicator
for the heterogeneous nature of cp and mt populations, the intravarietal
polymorphisms provide us useful markers for the future genetic studies on *B.
hygrometrica*.
## Structural dynamics of *Bh* mitochondrial genome in ontogeny
All previous studies on complete sequencing of flowering plant mt genomes are
based on the master circle (MC) hypothesis,. Arrieta-Montiel et al. reported on
the structural dynamics of the common bean mt genome. The analysis of 10
recombinant clones supports existence of the MC molecule in wheat mt genome.
However, the result of field-inversion electrophoresis suggests that
*Physcombitrella* mt genome does not consist of a multipartite structure, as
seen in angiosperms. As mitochondrial gene orders are significantly different
between lower plants and higher flowering plants, the multipartite structures as
seen among angiosperms may originate during the evolution of pteridophytes or
seed plants.
Repeat prediction by REPuter shows that there are 14 repeat pairs in *Bh* mt
genome. Since not all the repeats are involved in recombination, from the mt
assembly we detected 3 repeat-specific contigs that are candidates for the
recombination among the MC and other isomeric (IO) and subgenomic molecules,
which have been confirmed by SOLiD sequencing. Those 3 repeat contigs are the
repeat pairs of two palindromic matches (1,474 bp and 843 bp) and one forward
match (222 bp). By aligning all SOLiD long mate-pair reads to both ends of the
repeats, we constructed the MC and 4 isomeric molecules. These subgenomic
molecules are not discussed further because we have yet to find significant
differences among the sequence reads.
The length of recombinant repeats (222 bp, 843 bp, and 1,474 bp) of *Bh* is
different from that of *V. radiata*, and demonstrates the recombination across
short mt repeats (38–297 bp). The longer repeats are reminiscent of those found
in other angiosperm mitochondrial genomes, which are involved in mt genome
rearrangements and can result in stoichiometric shifting of subgenomic mt genome
topologies, occasionally beyond detection level for one (or more) of alternative
DNA topologies. The 3 recombinant repeats are located in gene-rich regions and
split mt genome into 6 segments. Each segment has some essential conserved
genes, such as *nad1 e4* and *rps13* in segment A, and *atp6*, *nad2 e3-5* and
*coxb* in segment B. From this point, it is possible that the mt genome of *Bh*
do not have subgenomic molecules. There are 4 genes (*nad1*, *nad2*, *nad5* and
*sdh3*) with exon-intron structure separated by the recombinant repeats. The
*nad1* gene in MC molecule is cross-strand gene with exon 4 in positive strand
and exon 1–3 in negative strand. Recombination involving introns might lead to
rearranged molecules without loss of essential genes. In all rearranged 4
isomeric molecules, the Trans-splicing genes are different, and the IO3 molecule
has all 4 Trans-splicing genes. Trans-splicing status of group II intron widely
distributes in the mt genome of higher plant. We compared gene structures of 15
mt genomes from lower to higher plants, and found 3 conserved genes (*nad1*,
*nad2*, and *nad5*) as well as other higher plants contain trans-splicing
intron, while there is no intron in those genes of *Chara vulgaris*. The 3 genes
structure supported the multipartite structures formed by multiple recombination
may arise with the earliest tracheophytes, and can be a molecular signature of
plant evolution.
## Comparative analysis of cp genome organization
We compared 12 cp genomes ranging from green algae to angiosperm. The GC
contents of cp genome are lowest in lower plants (Charophyta and Bryophyta) but
highest in Cycads. Monocots seem to have slightly higher GC contents than dicots
among their cp genomes. The genome size and structure of cp genomes are also
different in those cp genomes. For example, *C. vulgaris* (184,933 bp;
Charophyta) has the largest genome while the smallest genome is found in lower
plant *Marchantia polymorpha* (121,024 bp). The genome size of angiosperms is
more stable than lower plants with dicots larger than monocots. Compared to
lower pants, the most variable portions of angiosperm cp genomes are percentages
of IRs (34% in *A. thaliana*) and LSC (54.5% in *A. thaliana*) regions. This is
the result of IR expansion into the LSC region from green algae to angiosperm.
The cp genome contains genes that encode structural and functional components of
the organelle. Although some genes and gene clusters are well conserved among
all plants, the overall structure of cp genomes show remarkable differences.
First, there are 63 core protein-coding genes, shared among all plants, whereas
there are 3 additional core genes (*chlB*, *chlL* and *ycf12*) only found in the
lower plant lineage (Charophyta, Bryophyta, and Cycads). The 63 core cp genes
are involved in photosynthesis, energy metabolism, and other housekeeping
functions. Second, there are 10 genes (*psaM*, *rpl5*, *rpl12*, *rpl19*, *tufA*,
*ycf20*, *ycf62*, *ycf66*, *odpB*, and *ftsH*) are unique to green algae. All of
them reside in the LSC region except *ycf20* gene that is duplicated in IR
regions. Compared to seed plants, there is only one gene, ribosomal protein L21
(*rpl21*) is conserved in both green algae and liverwort. Third, all four
ribosomal RNA genes (*rrn4.5*, *rrn5*, *rrn16*, and *rrn23*) have 2 copies in IR
regions except the 2 copies of *rrn4.5* that is lost in Charophyta. Fourth, gene
loss and transfer to the nucleus is a common feature of cp genomes. We detected
3 genes (*petL*, *petN*, and *ycf3*) that are lost at the base of the Bryophyta
lineage and 2 genes (*accD* and *ycf2*) are lost in monocots as compared to
dicots. There are also some species-specific gene lost events, such as *psaJ* in
*O. sativa* and *nadJ*-*ccsA* lost in *O. europaea*. The unique loss of *psbZ*
in LSC region testifies the convergent evolution of *B. hygrometrica* and *O.
europaea*.
The order of cp genes in plants is not constant, changing among different
regions of the genome as large gene clustering become rare. Among 63 core
protein-coding genes, 50 are always reside in LSC region, 5 (*psaC*, *ndhD*,
*ndhE*, *ndhG*, and *ndhI*) in SSC region, and 8 (*ndhA*, *ndhB*, *ndhF*,
*ndhH*, *rpl2*, *rpl23*, *rpl32* and *rps7*) in variable positions among 12
examined cp genomes. No conserved protein-coding genes are found constant in IR
regions. These mobile genes may serve as an indication of lineage markers, since
4 of them (*ndhB*, *rpl2*, *rpl23*, and *rps7*) locate on LSC region in lower
plants and migrated to IR regions in higher plants. Genes residing in the
boundary of LSC/IRA or IRB/LSC are usually ribosomal proteins S12 (*rps12*) in
higher plants and the position-conserved *ycf1* is more likely present in the
boundary of IRA/SSC and SSC/IRB in dicots.
## Comparative analysis of plant mt genomes
The plant mt genomes are exceptionally variable in size, structure, and sequence
content and the accumulation of repetitive sequences contributes the most to
such variation. From the feature comparison of 15 plant mt genomes, we noticed
that their genome sizes vary from 67,737 bp in *C. vulgaris* to 773,279 bp in
*V. vinifera*. Recently, the large mt genome have been reported in *Cucurbita
pepo* with 982,833 bp. The GC contents of these genomes are also variable from
40 to 47*%*. There is a massive difference of coding sequences between lower and
higher plants. The coding sequence in *C. vulgaris* is 90.7%, whereas it is
4.94% in *Tripsacum dactyloides*. Repeat content ranges from 1 to 41% among seed
plants and are smallest in *B. hygrometrica*, composed of only 1.45% of the
genome. Both large (\>1,000 nt) and small (\<50 nt) repeats affect recombination
in seed plants. The protein-coding genes and tRNAs in mt genomes also vary
largely because of the large number of function-unknown proteins or ORFs in mt
genomes and frequent plastid DNA insertions including cp tRNA genes.
We also carefully examined conserved genes in different plant lineages. First,
there are 14 conserved core protein-coding genes shared among all lineages,
including seven subunits of NADH dehydrogenase (Complex I), one subunit of
ubichinol cytochrome c reductase (Complex III), three subunits of cytochrome c
oxidase (Complex IV), and three subunits of ATP synthase (Complex V). All these
genes play important roles either in proton movement across the inner membrance
of the mitochondrion or electron transfer reactions in the respiratory chain.
However, the gene structures are not conserved among them, and only two genes
(*nad4* and *cox2*) have exon-intron structures in all mt genomes. For
comparison, there are 9 genes (*nad3*, *nad4L*, *nad6*, *nad9*, *cob*, *cox3*,
*atp1*, *atp9*, and *ccmFN*) without exon-intron structure in both seed and
early land plants and with exon-intron structure at least in one lower plant.
Intron structure in mt genes is common as we only detected 6 genes (*sdh3*,
*sdh4*, *atp4*, *atp8*, *ccmB*, and *ccmFN*) have no introns among all plants.
Second, gene loss is more frequent in dicots than monocots, as genes in
cytochrome c biogenesis are lost in both *B. vulgaris* and *A. thaliana*. Three
species (*Nicotiana tabacum*, *V. vinifera* and *B. hygrometrica*) gained *sdh3*
as in this study. The number of ribosomal protein genes is different in various
plant mt genomes. Most ribosomal proteins (23) are present in *V. vinifera*
genome. Contrast to higher plants, there is no *matR* detected in liverwort and
green algae in this study. However, it is reported that in mosses, Takakia and
Sphagnum have part of *matR*. Most of mt genomes in plants have 3 ribosomal RNAs
(*rrn5*, *rrn18*, and *rrn26*), but there are multiple copies found in
angiosperms (such as *T. aestivum* and *B. vulgaris*). Copy number-variable mt
genes are reported in wheat, rice, and maize. In summary, since the gene coding
fraction is much less among mt genomes as compared to cp genomes, even conserved
genes are also variable in gene content, structure, and intron positioning.
## Plastid DNA insertions in mt genome
One of the important events in determining mt genome size in angiosperms is the
frequent capture of sequences from the cp genome. A recently study demonstrates
frequent DNA transfer from cp to mt genomes occur as far back as the common
ancestor of the extant gymnosperms and angiosperms, about 300 MYA and the
frequency of cp-derived sequence transfer is positively correlated with
variations in mt genome size. For instance, *B. hygrometrica* mt genome contains
fragments of cp origin, ranging from 50 to 5,146 bp in length. The total
fraction of cp-derived sequences present in *Bh* mt genome is 53,440 bp, 10.5%
of the whole mt genome. Most of these insertions are conserved, as evidenced
from the observation that 45 out 80 insertions (over 50 bp) are identified in mt
genomes of other plants. The average GC content between old insertions (at least
found one homolog in the mt genomes of other plants) and new insertions (no
homologs found in other mt genomes) is obviously different. The average GC
content of old insertions (41.59%) is distinct from that of mt genomes (43.27%)
as well as the average GC content of new insertions (35.32%) is close to the GC
content of cp genomes (37.59%;). The result suggests positive correlations
between the GC content of cp genomes and new insertions (coefficient value
r<sup>2</sup> = 0.69) and between the GC content of mt genomes and old
insertions (coefficient value r<sup>2</sup> = 0.64). There is a significant
difference between the GC content of old and new insertions (T test: *P\<0.01*).
All of cp-derived sequences in lower plants are old insertion, and it is strange
to see there are no new insertions from cp genomes during the evolution of *A.
thaliana*. Compared to other angiosperms, the most striking feature of *Bh* mt
genome is thefrequent sequence transfer from the cp genome in its recent
evolution. Cp-derived sequence analyses may provide clues for the understanding
functional indications of DNA insertions from cp in mt genomes.
We also analyzed the inserted cp genomic sequences to mt genomes. First, there
are 85 cp-derived fragments in the *Bh* mt genome. Most of them, especially
protein-coding sequences, have no intact gene structure or have
frameshifts/indels and the fact suggests that theses cp-derived sequences are
degenerated and lack functional constraints. However, protein-coding genes such
as ribosomal proteins and tRNAs originated from cp genomes appear still
functional in *Bh* mt genome. Similar genes are also seen in other angiosperms.
Second, it is curious to investigate the locations of cp-derived sequences in cp
DNAs to see if any particular regions in cp genomes are hotspots of DNA
transfer. Among 80 transferred sequence fragments in *Bh* cp genome, 45, 7, and
28 are from LSC, SSC, and IR regions, respectively. The numbers of fragments
appear correlating to the lengths of LSC (84,692 bp), SSC (17,901 bp) and IRs
(50,900 bp), and such correlations are also seen in other angiosperms, including
maize, rice, wheat, and tobacco. In conclusion, DNA transfer from cp genomes to
mt genomes in angiosperms occurs randomly as it has been proposed earlier by
Mastsuo et al in rice.
## tRNAs transfer between cp and mt genomes
To investigate whether mt genomes encodes a full set of tRNAs species necessary
for protein synthesis in the organelle, we identified 28 tRNA genes from the
complete *Bh* assembly based on tRNA structures and realized that all 61 codons
are used by *Bh* mitochondria. However, the tRNA genes encoded by the mt genome
alone are not sufficient to decode all codons; for instance, *trnA* is missing
in *Bh*, and it suggests that the role of the missing tRNA is supplied by either
cp or nuclear genomes. tRNAs originated from plastids are called cp-derived
tRNAs and their counterparts are native mt tRNAs. Half of the 28 mt tRNAs in
*B.hygrometrica* are identified as cp-derived tRNAs and 19 amino acids are
encoded by only one codon except for leucine (UAA and CAA) and serine (GCU, UGA,
and GGA).
In contrast to the protein coding genes, mt tRNA genes appear constantly being
transferred from cp genomes during the evolution of angiosperms ( **and**), and
the proportion of cp-derived tRNAs in mt genomes increases from 8% in Charophyta
to 55% in dicotyledonous plants. There are 17 cp-derived tRNAs and 14 mt native
tRNAs in mt genome of *V. vinifera*, which has the most cp-derived tRNAs among
dicotyledonous plants. Seven mt-native tRNA genes (*trnD-GUC*, *trnE-UUC*,
*trnI-CAU*, *trnK-UUU*, *trnM-CAU*, *trnS-GCU*, *trnS-UGA* and *trnW-GUA*) and
one cp-derived tRNA gene (*trnF-GAA*) are common to all 15 species. Compared to
the mt native tRNA genes in lower plants, there are three tRNA genes (*trnH-
GUG*, *trnN-GUU*, and *trnW-GUA*) integrated as part of large cp genomic
fragments into mt genomes among angiosperms. This indicates that frequent DNA
transfer from cp to mt genomes occur as far back as the emergence of seed
plants. We detected two different tRNAs transfer events in seed plants. One is
*trnC-GCA* transfer in monocots and the other involves two (*trnD-GUC* and
*trnQ-UUG*) gene transfer events in dicots. Cp-derived tRNA genes replace their
mt counterparts were identified in all sequenced angiosperms, even in gymnosperm
*Cyas* mtDNA. But these replacement not occurred in *Marchantia*,
*Reclinomonas*, *Cyanidioschyzon*, *Nephroselmis*, *Chara*, and
*Physcomitrella*.The mt-native tRNA gene (*trnG-GCC*) had all been lost in
monocots and six mt-native genes (*trnA-UGC*, *trnG-UCC*, *trnL-UAG*, *trnR-
UCU*, *trnR-ACG*, and *trnT-GGU*) are mostly lost in all angiosperms.
## Gene gain and loss in plant organelle genome
Starting from *Bh* organellar genomes, we have analyzed in a systematic way
representative cp and mt genomes of various lineages and our results provide
information for a better understanding of organellar genome evolution and
function. Sequence-based phylogenetic analysis clearly supports the conclusion
that *Bh* is much close to *V. vinifera*. Structural dynamics of *Bh* mt genome
suggest that the multipartite structures may have started during the evolution
of seed plants. However, mechanisms for rapid mt genome rearrangement and
expansion among plant lineages remain enigmatic. Based on eleven known cp and mt
genomes of different lineages, we showed a strong relationship between the
changing organellar genomes among angiosperms, and some of the lineage-
associated gene gain and loss may provide excellent markers for phylogenetic
studies. For instance, there are 9 cp and 4 mt genes lost during the evolution
from green algae to lower land plants. It seems that monocots have a faster rate
of evolution than dicots in organellar genomes in our study, because 3 cp and 9
mt genes are lost in monocots and only 2 mt genes are lost in dicots. In
additional, gene structures and positioning of cp and mt genomes are also very
informative for the understanding of land plant evolution. In agreement with the
results of several previous studies, most of the transferred angiosperm
sequences from cp to mt genomes become degenerated and are regarded as junk
sequences, whereas some of the cp-derived tRNAs are still functional in mt
genomes. As more plant organellar genome sequences become available, the
evolution of plant organellar genomes will unveil its details and mechanisms.
# Materials and Methods
## Genome sequencing and assembly
We developed an efficient procedure for *Bh* organellar genome sequencing and
assembly using whole genome data from 454 GS FLX sequencing platform. Briefly,
we collected fresh leaves and extracted genomic DNA for 454 GS FLX sequencing
(see manuals of GS FLX Titanium for detail). In order to validate genome
assembly and to make sure for the assembly of the master circle or MC, we
construed two mate-pair libraries (2×50 bp) for SOLiD 4.0 sequencing platform
with insert sizes of 1–2 kb and 3–4 kb by following the SOLiD Library
Preparation Guide. The method for assembling organellar genome was based on
correlation between contig read depth and copy number in the genome. We first
filtered cp reads from the raw data according known plant cp genome sequences
and then assembled the “clean” read into cp genome into the major segments:
large-single-copy (SSC), small-single-copy (SSC) and inverted repeats (IRs)
regions. The mt genome assembly is more complicated than that of cp genomes. We
filtered the contigs including mt conserve genes (such as NADH dehydrogenase and
succinate dehydrogenase) and removed the contamination of cp sequences. The
gene-based method for assembling mt genome has been reported earlier. Mapping
all the SOLiD mate-pair reads to mt contigs with Bioscope, we obtained the major
contig relationship map in the repeat regions to assemble the MC.
## Genome annotation
The cp genome was annotated by using the program DOGMA (Dual Organellar GenoMe
Annotator) coupled with manual corrections for start and stop codons. Protein-
coding genes are identified by using the plastid/bacterial genetic code. Codon
usage is predicted by using CodonW (<http://codonw.sourceforge.net/>). We
construct a custom-designed amino acid database for protein-coding genes and
nucleotide databases for rRNA and tRNA genes, compiled from all previously
annotated plant mt genomes available at the organelle genomic biology website at
NCBI (<http://www.ncbi.nlm.nih.gov/genomes/ORGANELLES/organelles.html>). NCBI
BlastX and BlastN searches of the mt genome against the databases allow us to
find protein and RNA genes, respectively. All BlastN and BlastX searches are
carried out by using the default settings with e-value 1e-10. Putative RNA
editing sites are inferred to create proper start and stop codons as well as to
remove internal stop codons. We also used tRNAscan-SE to corroborate tRNA
boundaries identified by BlastN. The annotated GenBank files of the cp and mt
genomes of *Bh* are used to draw gene maps using OrganellarGenome DRAW tool
(OGDRAW). The maps were then examined for further comparison of gene order and
content.
## Analyses on SNPs, repeats, and cp-derived sequences
We identified intra-specific SNPs in both cp and mt genomes. Using BioScope, we
mapped two runs of SOLiD mate-pair reads to both cp and mt genomes (BioScope
Software User Guide). We carried out repeat sequence analysis using the REPuter
web-based interface (<http://bibiserv.techfak.uni-bielefeld.de/reputer/>),
including forward, palindromic, reverse and complemented repeats with a minimal
length of 50 bp. Transposable elements and other repeated elements were mapped
with RepeatMasker Web Server (<http://www.repeatmasker.org/cgi-
bin/WEBRepeatMasker>) running under the cross_match search engine. Cp-derived
sequences are identified with BlastN search of mt genomes against *Bh* annotated
cp genomes (Identity ≥80%, E-value≤1e-5, and Length ≥50 bp). The cp-derived
sequences were then aligned to all known plant mt genomes by using BlastN
(Identity ≥80%, E-value≤1e-5, and Coverage ≥50%). tRNAs transferred to the mt
genome were identified by aligning to all tRNAs in the cp genome of the same
species by using BlastN (Identity ≥80%, E-value≤1e-5, and Coverage ≥50%).
## Phylogenetic Analysis
We compare the *Bh* cp genome with other plant organellar genomes, and use the
homologous protein-coding sequences to construct phylogenetic tree. Sixty-three
cp protein sequences (*psaA*, *psaB*, *psaC*, *psaI*, *psbA*, *psbB*, *psbC*,
*psbD*, *psbE*, *psbF*, *psbH*, *psbI*, *psbJ*, *psbK*, *psbL*, *psbM*, *psbN*,
*psbT*, *petA*, *petB*, *petD*, *petG*, *atpA*, *atpB*, *atpE*, *atpF*, *atpH*,
*atpI*, *rbcL*, *rpoA*, *rpoB*, *rpoC1*, *rpoC2*, *ndhA*, *ndhB*, *ndhC*,
*ndhD*, *ndhE*, *ndhF*, *ndhG*, *ndhH*, *ndhI*, *ndhJ*, *rpl2*, *rpl14*,
*rpl16*, *rpl20*, *rpl22*, *rpl23*, *rpl32*, *rpl33*, *rpl36*, *rps2*, *rps3*,
*rps4*, *rps7*, *rps8*, *rps11*, *rps14*, *rps18*, *clpP*, *cemA*, and *ycf4*)
from 12 different organisms are aligned and concatenated into a dataset of
196,313 amino acids.
We align amino acid sequences from individual genes using MUSCLE v3.8.31 ,
remove ambiguously aligned regions in each alignment using GBLOCKS 0.91b, and
concatenate the aligned sequences. We use maximum likelihood method and PhyML
v3.0 under Jones-Taylor-Thornton (JTT and gamma distribution of rates across
sites with four categories) model of sequence evolution to construct
phylogenetic trees. Confidence of branch points is estimated based on 100
bootstrap replications. We obtained the best tree after heuristic search with
the help of Modelgenerator.
## Accession Numbers
The GenBank accession numbers for the sequences mentioned in this article are as
follows: *Chara vulgaris*, NC_008097 and NC_005255; *Marchantia polymorpha*,
NC_001319 and NC_001660; *Megaceros aenigmaticus*, NC_012651; *Cycas
taitungensis*, NC_009618 and NC_010303; *Triticum aestivum*, NC_002762 and
NC_007579; *Oryza sativa*, NC_001320 and NC_011033; *Sorghum bicolor*, NC_008602
and NC_008360; *Tripsacum dactyloides*, NC_008362; *Zea mays*, NC_001666 and
NC_007982; *Beta vulgaris*, NC_002511; *Brassica napus*, NC_008285; *Arabidopsis
thaliana*, NC_000932 and NC_001284; *Nicotiana tabacum*, NC_001879 and
NC_006581; *Vitis vinifera*, NC_007957 and NC_012119; *Olea europaea*,
NC_013707; *Boea hygrometrica*, JN107811 and JN107812.
# Supporting Information
We thank Beijing Institute of Genomics, Chinese Academy of Sciences for
technical support from. We also wish to thank Liancheng Huang for his
preparation of the *B. hygrometrica* materials for this project.
[^1]: Conceived and designed the experiments: JY XD SH. Performed the
experiments: XW XZ. Analyzed the data: TZ YF. Contributed
reagents/materials/analysis tools: XD. Wrote the paper: TZ YF.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
Pancreatic cancer is one of the most lethal cancers, and its 5-year survival
rate is only 4%. It is characterized by excessive desmoplasia, which plays a
crucial role in its aggressive behavior. Recently, research on cancer biology
has focused on cancer–stroma interactions. Interactions between cancer cells and
stromal tissues are essential for the development and progression of tumors.
Therapies targeting cancer–stroma interactions may represent a new approach for
the control of pancreatic cancer.
Pancreatic stellate cells (PSCs) have been identified as the principal source of
the excessive extracellular matrix observed in chronic pancreatitis and
pancreatic adenocarcinoma. Similar to hepatic stellate cells, an important cell
type for extracellular matrix production in hepatic fibrosis, PSCs store fat
droplets containing vitamin A within their cytoplasm. PSCs become activated upon
stimulation by various autocrine or paracrine factors. They express α-smooth
muscle actin (α-SMA) and produce various extracellular matrix proteins. Soluble
factors secreted by activated PSCs promote the proliferation, migration,
invasion, and survival of pancreatic cancer cells against gemcitabine therapy.
Thus, PSCs play an important role in cancer–stroma interactions in pancreatic
cancer.
Several reports suggest that stromal cells, such as myofibroblasts and
mesenchymal cells, isolated from various human tissues exhibit different
phenotypes. We previously reported that CD10<sup>+</sup> PSCs enhance the
progression of pancreatic cancer cells. These observations indicate that PSCs
have functional heterogeneity and further suggest that PSCs may contain several
other cell subpopulations that individually or synergistically affect the
progression of pancreatic cancer. Detailed characterization of the PSCs in
pancreatic cancer would help to clarify the mechanism underlying the
interactions between cancer cells and stromal cells, and may provide novel
targets for stroma-directed therapies.
CD271 (also known as nerve growth factor receptor, NGFR or p75NTR) is a
neurotrophin receptor that has been implicated in the paracrine growth
regulation of a number of neuronal and non-neuronal tumor types. Recent studies
have focused on CD271 because it was identified as a marker of human mesenchymal
stem cells and it has been evaluated as an important cancer stem cell marker in
melanoma. CD271 might be a marker of a specific functional subpopulation, such
as stemness. In the pancreas, CD271 expression in PSCs has been detected.
However, CD271 expression rapidly decreased after cell isolation from pancreatic
tissues. Therefore, the role of CD271 expression in PSCs remains unclear.
The aim of this study was to identify the specific PSCs that affect the
progression of cancer cells by focusing on the expression of CD271. We further
assessed the significance of CD271 expression in PSCs.
# Materials and Methods
## Ethics statement
The study was approved by the Ethics Committee of Kyushu University (approval
number, 23–64) and conducted according to the Ethical Guidelines for Human
Genome/Gene Research enacted by the Japanese Government and the Helsinki
Declaration. All the patients provided signed informed consent approving the use
of their tissues for unspecified research purposes. For all experiments
involving mice, the animals were housed in laminar-flow cabinets under specific
pathogen-free conditions in facilities approved by Kyushu University (approval
number, A24-112-0).
## Patients and pancreatic tissues
Pancreatic cancer tissues were obtained from 105 patients who underwent
pancreatic resection for pancreatic cancer at our institution. The
clinicopathologic characteristics of the patients are described in. Survival was
measured from the time of pancreatic resection until death. Prognosis was
determined in September 2011. The median overall survival time was 23.5 months
(range, 1–114 months). Sixty-two patients died during follow-up. All tissues
adjacent to the specimens were evaluated histologically according to the
criteria of the World Health Organization. The tumor stage was assessed
according to the Union for International Cancer Control (UICC). We also obtained
31 normal pancreas (NP) samples from intact pancreas tissues resected for bile
duct cancer, benign solid-pseudopapillary tumor or neuroendocrine tumor for use
as control tissues. We further collected 10 pancreatic intraepithelial neoplasia
(PanIN) and 39 intraductal papillary mucinous neoplasm (IPMN) samples.
## Immunohistochemical procedures and evaluation
Immunohistochemical staining was performed using a Histofine SAB-PO Kit
(Nichirei, Tokyo, Japan). Tissues were sectioned to a thickness of 4 µm and were
incubated with mouse monoclonal anti-CD271 antibody (1∶100; Santa Cruz
Biotechnology, Santa Cruz, CA) or mouse monoclonal anti-α-SMA antibody (1∶50;
Dako, Glostrup, Denmark) overnight at 4°C. Cells were considered to be
positively immunostained when the membrane or cytoplasm was stained. We
identified activated PSCs based on the cell morphology (spindle-shaped cells)
and their identities were confirmed by α-SMA staining. We counted the number of
cells in at least 10 fields per section at 200× magnification. To account for
the heterogeneity in CD271 expression, the distribution of CD271 immunostaining
was evaluated as percentages of the stained cells and scored as follows: 0, 0%;
1, \<25%; 2, 26–50%; 3, 51–75%; or 4, 76–100%. Similarly, the staining intensity
was scored as follows: 0, no staining; 1, weak staining; 2, moderate staining;
or 3, strong staining. Finally, we calculated the staining score by multiplying
the percentage score by the intensity score. In the pancreatic cancer cells, we
divided the samples into high staining \>3 and low staining \<2 groups. All
slides were evaluated independently by two investigators without any knowledge
of the clinical features of each case.
## Cells and culture conditions
Human PSCs were isolated from fresh pancreatic surgical specimens using the
outgrowth method in our laboratory. The PSC cell type was confirmed by
morphology (stellate-like or spindle-shaped cells) and by immunofluorescence
staining for α-SMA and vimentin. PSC1 and PSC3-9 were isolated from pancreatic
cancer. PSC2 and PSC10 were isolated from benign pancreatic cyst. PSC11 and
PSC12 were isolated from normal pancreatic area of pancreatic cancer tissues. In
addition, we evaluated two pancreatic cancer cell lines, SUIT-2 (Health Science
Research Resources Bank, Osaka, Japan) and Capan-2 (American Type Culture
Collection, Manassas, VA). SK-N-MC, a human neuroepithelioma cell line (American
Type Culture Collection), was purchased as a positive control for CD271
expression. Cells at passages 3 to 8 were used for assays. The cells were
maintained as previously described.
## Immunofluorescence staining and Laser-Scanning confocal microscopy
PSCs (1×10<sup>5</sup>) were plated on glass-bottom dishes (Matsunami, Osaka,
Japan) and incubated for 24 hours. In cultures with supernatant, cells were
incubated in 10% fetal bovine serum (FBS)/DMEM with supernatant derived from
pancreatic cancer cells for 72 hours. The cells were then fixed with methanol,
blocked with 3% bovine serum albumin in phosphate-buffered saline solution
(PBS), and incubated with a mouse monoclonal anti-α-SMA antibody (1∶50; Dako), a
rabbit monoclonal anti-vimentin antibody (1∶50; Cell Signaling Technology,
Beverly, MA) and a mouse monoclonal anti-CD271 antibody (1∶50; Santa Cruz
Biotechnology) overnight at 4°C. Subsequently, the cells were incubated with
Alexa 488-conjugated anti-mouse IgG or 546-conjugated anti-rabbit IgG (Molecular
Probes, Eugene, OR) for 1 hour. Nuclear DNA was counterstained with
4′,6-diamidino-2-phenylindole (0.05 µg/mL). A laser-scanning confocal
fluorescent microscope (A1R; Nicon, Tokyo, Japan) was used, and images were
managed using NIS-Elements software (Nikon).
## Flow cytometry analysis
Cultured cells were obtained from subconfluent monolayer cultures and incubated
with a fluorescein isothiocyanate (FITC)-conjugated anti-CD271 antibody
(Miltenyi Biotec, Auburn, CA). Mouse IgG1 K Isotype Control FITC (Miltenyi
Biotec) was used as a negative control. The labeled cells were analyzed by flow
cytometry using a FACS Calibur (Becton Dickson and Company, Franklin Lakes, NJ).
## Real-time quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from cultured cells using a High Pure RNA Isolation Kit
(Roche Diagnostics, Mannheim, Germany) and DNase I (Roche Diagnostics). Real-
time qRT-PCR was performed using a QuantiTect SYBR Green Reverse Transcription-
PCR Kit (Qiagen, Tokyo, Japan) and a Chromo4 Real-Time PCR Detection System
(Bio-Rad Laboratories, Hercules, CA). Primers for CD271 and β-actin were
purchased from Takara Bio Inc. (Tokyo, Japan). The sequences of the
oligonucleotide primers used in this study were as follows: CD271,
5′-TCAGTGGCATGGCTCCAGTC-3′ (forward) and 5′-GCAGTATCCAGTCTCAGCCCAAG-3′
(reverse); β-actin, 5′-TGGCACCCAGCACAATGAA-3′ (forward) and
5′-CTAAGTCATAGTCCGCCTAGAAGCA-3′ (reverse). Each reaction mixture was initially
incubated at 50°C for 30 min to allow reverse transcription. PCR amplification
was then initiated by incubation at 95°C for 15 min to activate the polymerase,
followed by 40 cycles of 95°C for 5 s, 60°C for 20 s, and 72°C for 30 s. The
expression levels of genes were calculated using a standard curve constructed
using total RNA from SK-N-MC cells. The expression levels were normalized to the
β-actin expression levels as an internal control, and expressed as the ratio of
expression of the target gene to that of β-actin. All samples were run in
triplicate. No detectable PCR products were amplified without prior reverse
transcription. The accuracy and integrity of the PCR products were confirmed
using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA).
## In vitro coculture system
*In vitro* cocultures were performed using 6-well cell culture insert companion
plates and 3.0-µm cell culture inserts (Becton Dickinson Labware, Franklin
Lakes, NJ) as previously described. SUIT-2 and Capan-2 cells (5×10<sup>5</sup>)
were seeded separately into the upper chambers at 24 hours after seeding two
types of PSCs (5×10<sup>5</sup>) into the lower chambers.
## Culture with a cancer cell-derived supernatant
SUIT-2 and Capan-2 cells were cultured under FBS-free conditions for 48 hours.
Thereafter, we collected the supernatants from the cancer cells and adjusted
them to 10% FBS. The cancer cell-derived supernatants were then added to
previously seeded PSCs for subsequent culture.
## Functional separation by Matrigel invasion assay
Six-well cell culture insert companion plates and 8.0-µm cell culture inserts
(Becton Dickinson Labware) were coated with Matrigel (150 µg/well; BD
Biosciences, Bedford, MA). PSCs (5×10<sup>5</sup> cells/2 mL) were seeded into
the upper chambers. Previously, cancer cells (5×10<sup>5</sup>) were seeded into
the lower chambers. Thereafter, the cells were cultured for 72 hours.
Subsequently, we removed the cells from both sides of the upper chambers using
trypsin. After two centrifugations, we extracted mRNA from the cells. Each
experiment was carried out in triplicate wells, and independent experiments were
repeated three times.
## In vivo experiments
SUIT-2 pancreatic cancer cells and two types of PSCs were used for *in vivo*
experiments. Cells were divided into three groups, comprising SUIT-2 cells
alone, SUIT-2 cells with PSC1 cells, and SUIT-2 cells with PSC2 cells. SUIT-2
cells (5×10<sup>5</sup>) and PSCs (5×10<sup>5</sup>) suspended in 100 µL of PBS
were cotransplanted into the pancreatic tail of 6-week-old female SCID mice (FOX
CHASE SCID®, C.B-17/lcr-scid/scidJcl; Clea Japan Inc., Tokyo, Japan). Six mice
were used in each group. The tumors were resected on days 8, 15, and 22 after
implantation. The tissues were fixed in 10% neutral-buffered formalin and
embedded in paraffin. Four µm tissue sections were stained with a mouse
monoclonal anti-α-SMA antibody (Dako) and a rabbit monoclonal anti-CD271
antibody (Millipore, Billerica, MA).
## Statistical analysis
Values are expressed as means ± SD. Comparisons between two groups were
performed using Student's *t*-test. Statistical significance was defined as
values of p\<0.05. A χ<sup>2</sup> test was used to analyze the correlations
between CD271 expression and the clinicopathologic characteristics observed in
the immunohistochemical analyses. Survival analyses were undertaken using the
Kaplan–Meier method, and the curves were compared using the log-rank test. To
evaluate independent prognostic factors associated with survival, a multivariate
Cox proportional-hazards regression analysis was used, with CD271 expression, pT
category, lymph node metastasis, UICC stage, perilymphatic invasion,
perivascular invasion, and pathological margin as covariates. All statistical
analyses were performed using JMP 8.0 software (SAS Institute, Cary, NC).
# Results
## Stromal cells express CD271 in pancreatic ductal adenocarcinoma (PDAC)
To evaluate CD271 expression in pancreatic tissues, we performed
immunohistochemistry for CD271. Consistent with a previous report, we observed
strong staining of nerves as a positive control. The epithelial cells of normal
pancreatic ducts showed no expression of CD271, and PDAC cells were unstained.
In normal pancreas (NP), stromal cells around the pancreatic duct were rarely
stained. However, we observed that stromal cells were strongly stained around
pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous
neoplasm (IPMN). In PDAC tumors, stromal cells around pancreatic cancer cells
were partly stained. However, CD271<sup>+</sup> stromal cells were not adjacent
to cancer cells in PDAC, and were strongly stained at the edge rather than the
center of the tumors. CD271 high staining in stromal cells was present in 6.5%
(2/31) of NP, 30.0% (3/10) of PanIN, 27.6% (29/105) of PDAC and 84.6% (33/39) of
IPMN. The CD271 high staining rates were significantly higher in stromal cells
of IPMN (p\<0.0001) and PDAC (p = 0.0069) than those in stromal cells of NP.
## Stromal CD271 expression independently correlated with good prognosis
We evaluated correlations between stromal CD271 expression and the
clinicopathologic factors of PDAC. Although differences did not reach
statistical significance, pT1/pT2, no lymph node metastasis, UICC stage I, no
perilymphatic invasion, no perivascular invasion, and pathological
margin/negative were observed more frequently in the stromal CD271high staining
group than in the stromal CD271 low staining group. Interestingly, stromal CD271
expression was associated with a good prognosis in pancreatic cancer
(p = 0.0040). The median survival times for CD271 high staining and CD271 low
staining patients were 62 and 18.5 months, respectively. Next, we performed a
multivariate survival analysis based on the Cox proportional hazard model for
all parameters found to be significant by univariate analyses, including stromal
CD271 expression, pT category, lymph node metastasis, UICC stage, perilymphatic
invasion, perivascular invasion, and pathologic margin positivity. Stromal CD271
expression was found to be an independent prognostic marker in pancreatic cancer
patients, and the relative risk of stromal CD271 expression was 0.495.
## CD271 stromal cells are a subpopulation of activated PSCs
To characterize the CD271<sup>+</sup> stromal cells, we performed
immunohistochemistry for α-SMA, a marker for activated PSCs, on serial PDAC
sections. We found that α-SMA was expressed in most stromal cells around cancer
cells and neoplastic tubules. CD271<sup>+</sup> stromal cells were restricted to
areas with strong α-SMA expression. These findings indicate that
CD271<sup>+</sup> stromal cells are a subpopulation of activated PSCs.
## CD271 expression in human PSCs
We isolated five primary cultures of PSCs from fresh human pancreatic tissues,
and their identity was confirmed by immunofluorescence staining. PSCs were
stellate-like or spindle-shaped and expressed α-SMA and vimentin. In these
immunofluorescence analyses, we did not detect CD271 expression in PSCs (data
not shown). Next, we evaluated CD271 expression in 12 primary cultures of human
PSCs using flow cytometry, and found CD271-positive rates of 0.0–2.1% in PSCs.
## CD271<sup>+</sup> PSCs are increased through cancer–stroma interactions
We investigated the effects of PSCs on the phenotype of cancer cells using a
coculture system. We used two pancreatic cancer cell lines, SUIT-2 and Capan-2,
and two primary cultures of human PSCs isolated from PDAC and benign pancreatic
cysts. After monoculture or coculture with pancreatic cancer cells for 72 hours,
we evaluated CD271 expression in PSCs using flow cytometry and real-time qRT-
PCR. By flow cytometry analyses, we observed the percentage of CD271<sup>+</sup>
cells was higher in coculture than in monoculture (0.7% vs. 0.1%). By real-time
qRT-PCR analyses, the level of CD271 mRNA expression in two cultures of PSCs was
significantly higher in coculture with pancreatic cancer cells than in the
monoculture (p\<0.001). Next, we collected supernatant from SUIT-2 pancreatic
cancer cells, and added it to two primary cultures of PSCs. We compared the
levels of CD271 mRNA expression among monocultures, cultures with the cancer
cell-derived supernatant, and cocultures with pancreatic cancer cells for 72
hours. The level of CD271 mRNA expression was highest in cocultures with
pancreatic cancer cells. In addition, the level of CD271 mRNA expression was
higher in cultures with the cancer cell-derived supernatant than in monocultures
(p = 0.0053). By immunofluorescence analyses, we detected CD271 expression in
PSCs was slightly increased in culture with the cancer cell-derived supernatant
in contrast to monocultures.
## CD271 expression decreases after the transient increase in expression when cocultured with pancreatic cancer cells
We used a coculture system consisting of two pancreatic cancer cell lines,
SUIT-2 and Capan-2, and two primary cultures of human PSCs to evaluate the time-
dependent changes in CD271 mRNA expression. After monoculture or coculture of
PSCs with pancreatic cancer cells for 1 to 5 days, we evaluated the level of
CD271 mRNA expression in PSCs. In monocultures, the expression of CD271 mRNA in
PSCs did not change. However, in cocultures with pancreatic cancer cells, the
level of CD271 mRNA expression increased on day 3 (p = 0.0249) and peaked at day
4 (p\<0.0001). Interestingly, the levels of CD271 mRNA expression decreased the
day after peak expression (p\<0.0001). Next, we collected supernatant from
Capan-2 pancreatic cancer cells, added it to two primary cultures of PSCs and
evaluated the time-dependent changes in CD271 mRNA expression. In cultures with
supernatant, the level of CD271 mRNA expression increased on day 2 (p\<0.0001)
and then decreased on day 4 (p\<0.0001). Similar to coculture with pancreatic
cancer cells, CD271 expression decreased after the transient increase in
expression when cocultured with supernatant.
## CD271 expression is decreased in PSCs migrating through Matrigel toward pancreatic cancer cells
Next, we evaluated CD271 expression in PSCs after functional separation using
Matrigel invasion assay. In this culture system involving upper chambers coated
with Matrigel, we evaluated SUIT-2 pancreatic cancer cells and two primary
cultures of human PSCs. PSCs in the upper chambers were incubated for 72 hours
in culture with pancreatic cancer cells in the lower chambers, or as controls
without pancreatic cancer cells in the lower chambers. PSCs were collected from
the top and bottom sides of the upper chambers separately. The top side-derived
PSCs were cells that did not migrate toward the cancer cells through the
Matrigel and remained in the upper chambers. The bottom side-derived PSCs were
cells that migrated toward the pancreatic cancer cells through Matrigel and
collected on the bottom side of the upper chambers. We then analyzed CD271 mRNA
expression levels in the top or bottom side-derived PSCs to evaluate the
functional differences between CD271<sup>+</sup> and CD271<sup>−</sup> PSCs. The
level of CD271 mRNA expression was highest in top side-derived PSCs after
culture with pancreatic cancer cells (p\<0.001). Interestingly, the level of
CD271 mRNA expression in the bottom side-derived PSCs migrating toward the
pancreatic cancer cells was lower than that in the top side-derived PSCs that
did not move toward cancer cells (p\<0.01). In controls, there were no
differences in CD271 mRNA expression levels between top and bottom side-derived
PSCs, and these levels were low compared with the levels of CD271 mRNA
expression in cultures with pancreatic cancer cells.
## CD271<sup>+</sup> PSCs are present in tumor margins/periphery and are absent in the tumor core
To evaluate the localization of CD271<sup>+</sup> PSCs *in vivo*, we
transplanted SUIT-2 pancreatic cancer cells into the pancreatic tail of SCID
mice, or cotransplanted them with two primary cultures of human PSCs. We
euthanized the mice on days 8, 15, or 22, and evaluated the localization of
CD271<sup>+</sup> PSCs in the xenograft tumors. Stromal CD271 expression was
detected at all days after transplantation, regardless of transplantation or
cotransplantation. Stromal CD271 high staining rates were 50% (3/6), 60% (3/5),
and 67% (4/6) on days 8, 15, and 22, respectively. In every case, we detected
CD271 expression on nerve bundles as a positive control, and found that
pancreatic cancer cells never expressed CD271. We confirmed the presence of
activated PSCs by a spindle-shaped morphology and by α-SMA staining. Activated
PSCs existed in the xenograft tumors and normal pancreatic areas around the
tumors. However, CD271<sup>+</sup> PSCs only existed in the normal pancreatic
areas around the xenograft tumors, and were absent in the tumor core.
# Discussion
Previously, Trim et al., reported that CD271 was expressed in PSCs. Haas et al.,
also reported that CD271 was slightly expressed in PSCs and that the level of
CD271 mRNA expression rapidly decreased in primary rat PSCs during culture. We
found that CD271<sup>+</sup> PSCs existed in surgical pancreatic tissues using
immunohistochemistry. However, qRT-PCR and flow cytometry analyses revealed that
CD271 expression in PSCs isolated from pancreatic tissues was very weak. These
findings suggest that CD271 expression in primary human PSCs also rapidly
decreased during culture.
We found that CD271 mRNA expression was transiently increased in PSCs cocultured
with pancreatic cancer cells, suggesting that pancreatic cancer cells enhance
CD271 expression in PSCs. However, the present immunohistochemical analyses
revealed that CD271<sup>+</sup> PSCs also existed around PanIN and IPMN,
precancerous lesions. Furthermore, Trim et al., reported that CD271<sup>+</sup>
PSCs were found in tissues from chronic pancreatitis patients. These
observations suggest the appearance of CD271<sup>+</sup> PSCs is not specific to
malignant diseases, and is related to desmoplasia. Haas et al., reported that
CD271 mRNA expression was enhanced in PSCs by transforming growth factor beta
(TGFβ), a strong profibrogenic activator of PSCs. Addition of TGFβ to PSCs
slightly increased the level of CD271 mRNA expression in PSCs, but without a
significant difference (data not shown). Although TGFβ secreted from pancreatic
cancer cells may be related to CD271 expression in PSCs, it is possible that
other soluble factors also affect CD271 expression.
Interestingly, CD271<sup>+</sup> stromal cells were not adjacent to pancreatic
cancer cells in PDAC as observed by immunohistochemical analyses. *In vivo*,
CD271 expression decreased after the transient increase in expression in PSCs
cocultured with pancreatic cancer cells. These findings suggest that CD271
expression is decreased in PSCs following long-term interactions with pancreatic
cancer cells. In pancreatic cancer tissues, CD271 high staining cases have a
better prognosis than CD271 low staining cases. Progression of PDAC may cause
the decrease of CD271 positive rate of PSCs due to the long-term influences of
pancreatic cancer cells.
The functional role of CD271<sup>+</sup> PSCs remains unclear. Previous reports
identified CD271 as a marker of activated PSCs. However, CD271 expression in
PSCs rapidly decreased during primary culture, even though α-SMA expression in
PSCs remained after several passages of primary cultures. Recently, several
articles have reported that normal fibroblasts, which prevented tumor growth and
invasiveness, became reprogrammed by unknown mechanisms to co-evolve with
epithelial tumor cells and provide an environment conducive to tumor initiation
and progression. CD271 expression may be a marker for such a reprogramming
stage, suggesting that CD271 expression is a temporary marker of PSCs in the
early stages of interaction with pancreatic cancer cells. Previously, we
reported that CD10<sup>+</sup> PSCs enhanced the malignant progression of
pancreatic cancer. CD10<sup>+</sup> PSCs existed near pancreatic cancer cells,
and the existence of CD10<sup>+</sup> PSCs suggested a poor prognosis. In the
present study, we found that CD10 mRNA expression continuously increased in
cocultures with pancreatic cancer cells but did not decrease in PSCs migrating
through Matrigel toward pancreatic cancer cells (data not shown). In contrast,
CD271<sup>+</sup> PSCs existed near pancreatic tumors, but were separate from
pancreatic cancer cells, rather than adjacent, and the existence of
CD271<sup>+</sup> PSCs was an independent factor for good prognosis. These
findings suggest that CD271<sup>+</sup> PSCs may play a defensive role in
pancreatic carcinogenesis and/or progression of pancreatic cancer, and that
long-term interactions with cancer cells may reduce the number of
CD271<sup>+</sup> PSCs. However, CD271<sup>+</sup> PSCs were too difficult to
isolate after primary cultures. Therefore, we were unable to evaluate directly
the function of CD271<sup>+</sup> PSCs, and further investigations are required.
In conclusion, CD271<sup>+</sup> PSCs existed near pancreatic cancer tumors, and
CD271 expression correlated with a better prognosis of human pancreatic cancer.
A short interaction with cancer cells transiently increased the expression of
CD271 in PSCs, while a long interaction with cancer cells decreased CD271
expression in PSCs. CD271<sup>+</sup> PSCs appeared during the early stages of
cancer–stroma interactions. Taken together, the present findings suggest that
the CD271<sup>+</sup> subpopulation of PSCs may play a role in the resistance to
pancreatic carcinogenesis and progression of pancreatic cancer.
# Supporting Information
The authors thank the Research Support Center, Graduate School of Medical
Sciences, Kyushu University, for technical support.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: KF KO KM NI MT. Performed the
experiments: KF DE SK. Analyzed the data: KF KS NI SA. Contributed
reagents/materials/analysis tools: KF DE SK NI TO ST MT. Wrote the paper: KF
KO KM NI MT.
|
# Introduction
The genus *Cryptosporidium* is a multispecies complex with extensive genetic
variation. Approximately 27 species and more than 60 genotypes have been
identified. A wide diversity of *Cryptosporidium spp*. and subtypes infect
humans, and each may have a range of transmission routes of public-health
significance. DNA analysis of *Cryptosporidium* parasites from humans has shown
the anthroponotic *C*. *hominis* and the zoonotic *C*. *parvum* to be the most
common cause of human cryptosporidial infections, with 90% of reported cases
attributed to them. Recently an additional 8 species have been identified
as causes of cryptosporidiosis in humans, including *C*. *meleagridis*, *C*.
*felis*, *C*. *canis*, *C*. *suis*, *C*. *muris*, *C*. *fayeri*,
*C*.*ubiquitum*, and *C*. *cuniculus*. The contribution of these species to
human cryptosporidiosis varies globally and has been documented to be associated
with seasonality, demographics, immune status, and contact with reservoir hosts.
Further intra-species variation has been observed in *Cryptosporidium* isolates
which further classifies species to the subtype family and subtype levels. To
date six *C*. *hominis* subtype families (Roman numeral I) and 11 *C*. *parvum*
subtype families (Roman numeral II) have been identified. Six subtype families
have also been identified in *C*. *meleagridis* (Roman numeral III) and *C*.
*fayeri* (Roman numeral IV).
Advances in molecular biology and full genome sequencing has contributed to
knowledge on molecular epidemiology and better understanding of the biology and
transmission of cryptosporidiosis in humans, as well as associations of
different species or subtypes to clinical manifestations and infection risk
factors, such as age and HIV status. In addition, information gained from such
studies provides support for treatment, prevention and control strategies.
Amplification and sequencing of one or more genetic loci (markers) have been
used for the differentiation of *Cryptosporidium* species, genotypes and
subtypes. In particular, a PCR-RFLP tool that targets \~830-bp fragment of the
small subunit (SSU) rRNA gene and uses *SspI* and *VspI* restriction enzymes for
genotyping is commonly used, due to the multi-copy nature of the gene and
presence of semi-conserved and hyper-variable regions. Other genotyping tools
based on the oocyst wall protein (COWP) gene have narrow specificity and only
amplify DNA of *C*. *parvum*, *C*. *hominis*, *C*. *meleagridis*, and
species/genotypes closely related to *C*. *parvum* hence this technique is
rarely used for diverse samples.
Mini- and micro-satellites, or simple sequence repeats, constitute a rich source
of polymorphism and have been extensively used for high-resolution genotyping
and subtyping. In particular, the *GP60* gene is useful for such studies as it
contains multiple regions with high mutation rates, including a ‘hyper-variable’
microsatellite region. The *GP60* gene is the most polymorphic marker identified
so far in the *Cryptosporidium* genome and exhibits extensive sequence
differences in the non-repeat regions, which categorize *C*. *parvum* and *C*.
*hominis* each to several subtype families. Within each subtype family,
differences are attributed to the number of trinucleotide repeats (TCA, TCG or
TCT microsatellite). Molecular analysis of the *GP60* gene has facilitated the
identification of transmission pathways and zoonotic disease contamination
sources and highlighted the importance of certain genetic variants to human
health, and the public health risk posed by particular *Cryptosporidium*
subtypes. There are also significant differences in clinical presentations and
virulence among some common *C*. *hominis* subtype families in
cryptosporidiosis- endemic areas. Although cryptosporidiosis is prevalent in Sub
Saharan Africa, information on the molecular characteristics of *Cryptosporidium
spp*. is scant. In Kenya particularly, *Cryptosporidium* has been found to be a
major cause of diarrhoea in children, yet information on genetic diversity of
circulating *Cryptosporidium* spp. and subtypes in different populations is
limited.
The aim of this study was to determine the prevalence, epidemiology and the
genetic diversity of *Cryptosporidium spp*. isolated from children with
diarrhoea, presenting at outpatient clinics in Mukuru informal settlement, or
admitted at the Mbagathi District Hospital. The understanding of this
relationship may represent the starting point for further extended studies on
the epidemiology and genetic diversity of *Cryptosporidium* in different
populations, and establish routes of transmission and intervention measures.
# Materials and Methods
## DNA isolation
Genomic DNA was extracted from faecal specimens that were positive for
*Cryptosporidium* from an earlier published study (Mbae *et al*., 2013)using
QiAmp<sup>®</sup> DNA stool Mini kit (Qiagen, Crawley, West Sussex, United
Kingdom) with slight modifications. Briefly 200 μl of fecal suspension was
washed five times with triple-distilled water by centrifugation. To this
suspension 1.4 ml of ASL buffer was added and subjected to five times thawing
(80°C) and freezing (-80°C) to rupture the rigid oocysts. The genomic DNA was
eluted in 50 μl of Nuclease free water and stored at -20°C until use.
## Species and genotype identification
PCR Amplification targeting the *Cryptosporidium* 18S rRNA and restriction
fragment length polymorphism (RFLP) of the PCR amplicon were used to genotype
*Cryptosporidium* isolates essentially as described. Briefly, a two stage nested
PCR of the 18S rRNA gene was done; the primary PCR amplified a 1,325 bp, using
forward primer `5’-TTCTAGAGCTAATACATGCG-3’` and reverse primer
`5’-CCCATTTCCTTCGAAACAGGA-3’`. The illustra<sup>™</sup> PuReTaq Ready-To-Go PCR
Beads (GE Healthcare, UK) was used for amplification in a 25 μl final volume, to
the beads (2.5 units of puRe Taq DNA polymerase, 200 μM of each dNTP, 10 mM
Tris-HCl pH 9.0, 50 mM KCl, 1.5 mM MgCl<sub>2</sub>), 0.25 μM of each primer, an
extra 1.5 mM MgCl<sub>2</sub>, 21.25 μl of nuclease free water and 1.0 μl of DNA
were added. The secondary amplification of an internal fragment of between
826–864 bp was done using forward primer`5’-GGAAGGGTTGTATTTATTAGATAAAG-3’`and
reverse primer `5’-CTCATAAGGTGCTGAAGGAGTA-3’`. The same conditions described for
primary PCR were used for the secondary PCR reaction except 0.5 μM of each
primer, 20 μl of nuclease free water and 1 μl of the primary PCR product were
added to the beads. Two step restriction digestion of the secondary PCR
productswas carried in a total reaction volume of 40 μl. The reaction mix
composed of; 15 μl of the secondary PCR amplicon as the template, 2 μl (20
units) of *SspI* (Promega) and 4 μl of 1 X restriction buffer. The second set of
restriction digestion using *VspI* (Promega) enzyme was also performed in a
total reaction volume of 40 μl, consisting of 1 μl (10–12 units) of the enzyme,
with similar volumes of buffer and PCR amplicons as the *SspI* reaction.
Digestion was carried out in a water bath at 37°C for a minimum of 4 hours. The
digestion products were resolved on 2% agarose gel stained with ethidium bromide
and visualized under UV. Fragment sizes were then compared with the expected
banding patterns from known *Cryptosporidium* species and genotypes as
previously published for species/genotype identification. DNA sequencing was
carried out only on isolates that did not give distinct bands for confirmation.
## C. parvum and C. hominis subtyping
Subtyping of *C*. *parvum* and*C*. *hominis* was carried out by a *GP60*-based
tool, which amplified an\~850 bp fragment of the *GP60* gene, and the sequences
obtained analysed for identification of subtype families and subtypes, as
described previously. In the primary PCR forward primer (AL3531
`5’-ATAGTCTCCGCTGTATTC-3’`) and reverse primer (AL3535
`5’-GAGATATATCTTGGTGCG-3’`) were used, while the forward primer (AL3532
`5’-TCCGCTGTATTCTCAGCC-3’`) and reverse primer (AL3534
`5’-GCAGAGGAACCAGCATC-3’`) were used for the nested PCR. The same conditions
described for 18rRNA PCR were used for *GP60* semi-nested PCR. Reaction mixtures
containing the correct size fragment were purified using QIAquick PCR
purification kit (Qiagen, Crawley, West Sussex, United Kingdom) according to the
manufacturer's protocol.
## Sequencing of GP60 PCR products
The purified nested PCR amplicons of *Cryptosporidium* isolates of *GP60* gene,
were sequenced in both directions using forward primer AL3532 and reverse primer
AL3534. Bidirectional sequencing of DNA samples using ABI3730 and Big Dye
terminator v3.1 kit was carried out at the International Livestock Research
Institute, BeCA laboratories, Nairobi, Kenya. Base calling for each sequence run
was done using Sequence Analysis v5.2 software Sequences received were first
edited and consensus sequence generated from the forward and reverse sequence
using CLC DNA workbench 6.1. Each consensus sequence from individual isolates
was used for the identification of *Cryptosporidium GP60* subtypes. Basic local
alignment search tool (BLAST)
([www.ncbi.nlm.nih.gov/blast](http://www.ncbi.nlm.nih.gov/blast)) was used to
assess identity and degrees of similarities with *CryptosporidiumGP60* subtypes
in the GenBank as well as compared with other reference sequences of *C*.
*parvum* and *C*. *hominis* subtypes from different geographical regions.
Multiple sequence alignment of *Cryptosporidium* isolates with GenBank reference
sequences of *C*. *parvum* and *C*. *hominis* subtypes were aligned using
ClustalX 2.1. The phylogenetic analysis of the *GP60* gene nucleotide sequence
data were conducted using the software package MEGA vs.5.05. The evolutionary
relationship was inferred using the Neighbor-Joining method. Branches that had
less than 50% bootstrap value were collapsed. The tree was rooted using *C*.
*meleagridis* (Accession No. AF401499) as the outgroup.
The previously established nomenclature system was used to differentiate subtype
families and subtypes within each species. All the *GP60Cryptosporidium*
sequences were analysed for ‘‘TCA” microsatellite region. *GP60* sub genotype
results analysis display high mutation rates, in particular, a ‘‘hyper-variable”
microsatellite region. The *GP60* sub-genotype ‘‘TCA” micro satellite region,
showed triplet cordons were categorized according to the number of trinucleotide
repeats coding for the amino acid serine. *Cryptosporidium GP60*subtypes consist
of a variable number of ‘‘A” (TCA), ‘‘G” (TCG), ‘‘T” (TCT) and ‘‘R” (ACATCA).
The PCR-RFLP of the *18S rRNA* gene and sequence analysis of the *GP60*gene
locus provided information on the genetic inter-relationships of the
C*ryptosporidium spp*. in the study population.
## Statistical analysis
Data from the questionnaires was entered into a Microsoft access database using
EpiInfo<sup>™</sup> version 3.3 (CDC, 2004). Data cleaning procedures were
performed before importing data for analysis into Stata 9.2 (Stata Corporation,
Texas USA) for analysis. Frequencies and proportions for patients’
characteristics categorized by cryptosporidium species, families and subtypes
were calculated and reported.
Univariate analyses were used to identify potential patients’ characteristics,
clinical symptoms and seasonality correlates of infection with particular
cryptosporidium species and assessed for significance to determine suitability
for multivariate logistic regression analyses. Odds ratios were used to describe
associations and a p-value of \<0.05 was considered significant.
## Ethical approval
The study was approved by the Kenya National Ethical Review Committee. All
guardians of participating children were informed of the study objectives and
voluntary consent was sought before inclusion.
# Results
## Genotyping Cryptosporidium from faecal samples
A total of 151 out of 187 samples positive by microscopy from a previously
published study. were genotyped. Thirty six samples that were positive by
microscopy did not give an amplication by 18S rRNA PCR. Results from PCR-RFLP
analysis of 18S rRNA PCR revealed banding patterns distinctive of four different
species. Majority of the isolates;125/151(82.78%),were identified as *C*.
*hominis*, making it the most predominant species identified in the study
population. Among these, 71(56.8%) were outpatients and 54 (43.2%) inpatients.
*C*. *parvum* was identified in 18/151(11.92%), 6 (33.3%) of which were from
outpatients and 12 (66.67%) from inpatients. Among the other samples,
4/151(2.64%) were identified as *C*. *felis*. Three (75%) of *C*. *felis*
positive samples were isolated from inpatients and 1(25%) from outpatients.
Lastly, *C*. *meleagridis* was seen in 2/151(1.32%) of the samples analysed, and
these came from children recruited at the outpatient clinics. Mixed infection
with *C*. *parvum* and *C*. *hominis* was seen from an outpatient. Occurrence of
these species in relation to patient type (inpatients and outpatients) is shown
in.
## Sub-typing C. parvum and C. hominis using GP60 based tool
A total of 101 isolates were successfully amplified using the *GP60* gene
target, and the nested PCR amplicons sequenced. The remaining samples did not
give amplification with the *GP60* PCR, while one sample that had not amplified
with 18S rRNA PCR amplified with *GP60* PCR. Of these, 82/101 (81.2%) were
identified as *C*. *hominis*, while 19/101 (18.8%) were *C*. *parvum*.
Age-specific distribution of cryptosporidiosis due to the two species showed the
highest prevalence in the 0–24 months -old age group, with all children except
one (18/19, 94.8%), infected with *C*. *parvum* belonging to this age-group. The
odd one was isolated in an older child in the 49–60 months-old age group. With
*C*. *hominis*, highest prevalence was observed in 0–12 months age group
(45.7%), followed by 13–24 months age-group (33.3%), while 13.6% were isolated
in 25–36 month age-group. Only 3 isolates were from those over 36 months old.
There were more patients infected with *C*. *parvum* among the inpatients
(63.2%), while equal numbers were infected with *C*. *parvum* among HIV infected
and HIV uninfected children, with 9 cases in each group. Prevalence of *C*.
*hominis* was 53.7% and 46.3% among outpatients and inpatients, respectively,
while more HIV negative children were infected with *C*. *hominis* as compared
with HIV positive children (68.4% vs. 31.6%) respectively. However the
difference in these groups was not significant.
Associated clinical manifestations varied between the different *Cryptosporidium
spp*. Generally, *C*. *hominis* infections were associated with more diverse and
severe clinical manifestations of fever, vomiting, abdominal pains and acute
diarrhoea. Vomiting was observed in 84% of those infected with *C*. *hominis*
and 68.4% of *C*. *parvum* infections, while fever was reported among the 72% of
*C*. *hominis* and 53% of *C*. *parvum* infections. More children infected with
*C*. *hominis* presented with chronic diarrhoea than those infected with *C*.
*parvum*: 35% versus 26%, respectively. More cases of cryptosporidiosis due to
*C*. *hominis* were identified during the wet season compared to dry season (80%
*vs*.81.6%), and the same pattern was observed with *C*. *parvum* infections.
These differences were not however significant (73.4% *vs*. 26%).
## Microsatellite analysis of *CryptosporidiumGP60* subtypes and subtype families
Phylogenetic relationships based on*GP60* nucleotides of the *C*. *hominis*
sequences clustered isolates from this study into five distinct subtype families
and one subtype family of *C*. *parvum*. The *C*. *hominis* subtype families
identified among 82 isolates were; Ia, (n = 5, 6.1%), Ib, (n = 20, 24.4%), Id,
(n = 31, 37.8%), 1e, (n = 23, 28%) and If (n = 3, 3.7%). Among subtype family
Ia, four subtypes were found: IaA7R1 (in two cases), IaA25R5 (in one case),
IaA27R3 (in one case) and IaA30R3 (in one case). Within subtype family Ib, only
two subtypes were identified with subtype IbA9G3 being the most common, present
in 17 cases and 1bA9G3R2 which was present in 3 cases. Subtype family Id showed
the highest diversity of *C*. *hominis* with 10 subtypes. These included IdA22,
being the most common in 14 cases, IdA25 in 5 cases, IdA24 and IdA15G1 in 3
cases each while subtypes IdA19, IdA21, IdA20, IdA18, IdA17G1 and IdA23G1 were
identified in one case each. Subtype family Ie was the least diverse with
subtype Ie11G3T3R1 in 19 samples, while 4 samples belonged to subtype IeA11G3T3.
Subtype family If had 3 subtypes, comprising IfA19G1, IfA14G1, IfA12G1and these
were identified in one case each.
Nucleotide sequence of *GP60* in *C*. *parvum* recognized the presence of a
single subtype family, IIc from positive patients and all belonged to subtype
IIcA5G3R2.
*C*. *hominis* distribution across age groups was indiscriminate, with subtype
families Ia, Ib, Id and Ie more frequently isolated in younger children than
older ones. Isolation of the three cases of subtype If were confined to children
within age group 0–12 months- old category. Subtype family Ia was isolated from
HIV positive outpatients with a single isolate from HIV negative patient.
Subtypes IA25R5, IaA27R3 and IaA27R1 were all from HIV negative outpatients,
while IaA30R3 was identified in an outpatient HIV infected child. The most
common subtype identified, IbA9G3, was present in four HIV infected outpatients
and two HIV infected inpatients, with the rest being among HIV negative
children. Two of the subtypes IbA9G3R2 were detected in HIV positive inpatients
and 1 in HIV negative outpatient.
The most common subtype within subtype family Id, i.e. IdA22 was identified in 6
HIV negative inpatients, 4 HIV negative outpatients, 3 HIV positive inpatients
and 1 HIV positive outpatient. Almost equal numbers were infected with subtype
family Ie at the outpatient and inpatient settings (11cases and 12 cases
respectively). Two out of the three subtype family If cases were in inpatients
who were HIV negative and one was from an HIV positive outpatient Detailed
distribution of subtype families isolated based on HIV status, patient type, age
and other factors is shown in.
Patterns of clinical manifestations also varied among *C*. *hominis* subtype
families. All the 5 subtype Ia infections were associated with chronic diarrhoea
with none associated with acute diarrhoea, while all the other subtypes were
associated with acute diarrhoea. Notably 3 subtype If cases were associated
acute diarrhoea. All the subtype families except Ie, showed similar patterns of
distribution with vomiting, abdominal pains and fever.
## Phylogenetic relationships of C. hominis and C. parvumbased on GP60 subtyping tool
Phylogenetic analysis of the *GP60* gene, from selected *Cryptosporidium*
isolates showed two distinct clades; clade 1 and 2. Clade 1, was composed of,
four main sub-clades i –iv. Sub-clade i was composed of an admixture of subtype
(Ib, If, Ie, Ia, Id), from Kenyan isolates. Sub-clade ii, contained the subtype
Ib, with Kenya isolates clustering very closely with isolates from Australia.
The sub-clade III, was composed of subtype Ie with the Kenyan isolates
comparable with Nigeria isolates from retrieved from GenBank. Sub-clade IV was
composed of isolates from the subtype If, that clustered with South Africa
isolates retrieved from the GenBank. The second major clade 2, was composed of
two sub-clades, i and ii, that were contained subtype families Id and Ia
respectively. Multiple sequence alignment of *Cryptosporidium* subtype Id
against references Genbank sequences, indicated single point
mutations/substitution within the sequences.
Representative phylogenetic relationship within the *C*. *parvum* isolates had
two distinct clades. Clade I was composed mainly of Kenyan isolates, that
clustered with bootstrap values of \>50% with reference isolates from Australia
and India and Uganda, with Clade II composed of distinct *C*. *parvum* isolates
from Kenya, that did not cluster with any of the reference samples from the
Genbank. The accession numbers of the reference sequences are indicated on the
dendrograms.
# Discussion
The present study produced data on the importance of *Cryptosporidium spp*., and
the predominant species and subtypes circulating in this patient population of
children presenting with diarrhoea in an informal settlement of Nairobi. The
results also show the epidemiologic heterogeneity of *Cryptosporidium spp*. in
the population. PCR-RFLP analysis demonstrated the existence of at least four
species of *Cryptosporidium* in the study population; *C*. *hominis*, *C*.
*parvum*, *C*. *felis* and *C*. *meleagridis*. Of these four species, *C*.
*hominis* which is almost exclusively a human parasitewas the most common
with a prevalence of 82.7%. The other three are zoonotic species but are
commonly associated with human cryptosporidiosis. Previous studies on the
prevalence of *Cryptosporidium* species and genotypes infecting children in
Kenya also found that *C*. *hominis* was the dominant species, and *C*.
*parvum*, *C*. *meleagridis*, and *C*. *muris* were identified in HIV-infected
persons. More outpatients (54%) than inpatients (46%) were infected with *C*.
*hominis*, while more inpatients (63%) than outpatients (37%) were infected with
*C*. *parvum*. This may imply that *C*. *parvum* caused more severe disease than
*C*. *hominis*. This agrees with findings by Cama et al., (2007), where *C*.
*parvum* was seen to be more pathogenic. There was equal number of HIV infected
and uninfected children found to have *C*. *parvum*, while more HIV negative
children were infected with *C*. *hominis*.
This study involved children living in the urban informal settlement of Nairobi,
where they live in overcrowded rooms and belong to low socioeconomic classes
with poor hygiene and sanitation, but may have minimal direct contact with
animals, hence the few zoonotic species. However, the presence of these few
zoonotic species including *C*. *felis*, and *C*. *meleagridis* indicates that
animal reservoirs are still important. The distribution of *Cryptosporidium*
species and genotypes in a population is an indication of the potential
infection source, thus, person-to-person transmission probably played an
important role in cryptosporidiosis epidemiology in the children in this study.
On the other hand, it is difficult to confirm with certainty that the zoonotic
species of *Cryptosporidium* were transmitted directly from animal to child,
rather than via contamination of water, food, or hands with animal or human
faeces. These findings are consistent with results from previous studies in
paediatric populations in Africa and other developing countries, where 79–90% of
infections are caused by *C*. *hominis*. In Malaysia and Kuwait, the same four
species were identified, however in their study, *C*. *parvum* was the most
frequently detected species followed by *C*. *hominis*.
*Cryptosporidium felis* is one of the five most common *Cryptosporidium spp*.
that are responsible for human cryptosporidiosis. *C*.*felis* was first
described in humans in Kenya by Gatei *et al*., (2006b) in two children, and
this is the second study to report *C*. *felis* in children in Kenya.
*C*. *meleagridis*, one of the zoonotic species identified in this study has
previously been recognized as an important human pathogen in Africa (Kenya),
Peru, India and Thailand. *C*. *muris* and *C*. *canis* identified in an earlier
study by were not among the species isolated in this study. However, an earlier
report of possible asymptomatic *C*. *muris* infection in healthy persons and in
an immunocompromised patient by suggest that this may be yet another
*Cryptosporidium* species with a zoonotic potential.
Given that *C*. *parvum* and *C*. *hominis* constituted 88% of the
*Cryptosporidium* infections in the paediatric population studied here, a
further evaluation of the genetic variation within each of these two species was
carried out using partial *gp40/15* or *GP60*subtyping tool, which is currently,
the most common locus for identifying *Cryptosporidium* subtype families and
subtypes. Understanding the subtypes of *C*. *hominis* and *C*. *parvum* may
provide clues into the mechanisms of transmission and infection of these
organisms and lay foundations for effective prevention and treatment strategies.
The *GP60* analysis of the analysed isolates in this study revealed the high
genetic variation of *GP60* subtype families and subtypes in the study
population, in which 5 different subtype families and 21 different subtypes
within *C*. *hominis* were identified. These included subtype families Ia, Ib,
Id, Ie and If, and each had different subtypes. Similar subtype families were
reported in children in Uganda, except that they did not detect any subtype
family If. In S. Africa and Sweden, the same range of *C*.*hominis* subtype
families have been recently reported.
Four different subtypes within subtype family Ia were reported. A study in
Indian urban children identified subtype family Ia to be the most common.
Although less frequently reported than *C*. *hominis* Ib, subtype *C*. *hominis*
Ia is more genetically diverse at the sub-genotypic level. However, only four
subtypes were identified in the study population, which included IaA25R5,
IaA27R3, IaA30R3 and IaA7R1. While 3 of the subtypes (IaA27R3, IaA30R3, IaA7R1)
have been reported in various parts of the world, subtype IaA25R5 has not been
published previously.
Worldwide, IbA9G3 and IbA10G2 are the two common subtypes within the Ib subtype
family. IbA9G3, which is one of the subtypes in this study is commonly seen in
humans in Malawi, India, and has been isolated in children and in baboons (Li
*et al*., 2011). Subtype IbA10G2, commonly seen in South Africa, Botswana, and
European countries, and isolated in HIV infected in Jamaica, and known to be
responsible for more than half of the waterborne outbreaks of gastroenteritis
was not isolated in this study. However subtype IbA9G3R2 which was present in 3
cases has not been reported in other areas before.
One of the striking findings in our study is the predominance of, and high
genetic diversity of subtype family Id in the study population; 31(31%) *C*.
*hominis* isolates were identified as subtype Id. This is much higher than
prevalence reported earlier, as reviewed by Jex and Gasser, (2010). Subtype
IdA22 was the most common as also observed previously by Gatei (2006a or b). In
the present study, a relatively rare subtype IdA21 that has only been reported
from South Africa, Jordan and China was detected. Subtype IdA24, isolated in 3
children has previously been reported in Kenyan children, in the US, in a
waterborne outbreak of gastroenteritis and in Jordan. Within subtype family Id,
subtype IdA15G1, also reported in this study, is usually the most commonly
reported. On the other hand, to the best of our knowledge, subtype IdA23G1,
which was isolated from an inpatient has not been reported previously.
Therefore, the diversity of Id subtype populations might indicate the presence
of a unique *C*. *hominis* genotype transmission in Kenya.
Subtype family Ie is presently of low genetic diversity with only 3 subtypes
reported. The *C*. *hominis* Ie subtype identified, IeA11G3T3, has been reported
in human infections from other developing countries, such as Nigeria, and the
predominance of subtype IeA11G3T3 in our study agrees with findings by Hira *et
al*., (2011). This subtype was also previously isolated from HIV infected
persons in Jamaica and Kenya. Likewise, most infections with subtype Ie in
humans are caused by IeA11G3T3, but our study identified a less common subtype,
Ie11G3T3R1.
The 3 subtypes within the If subtype family reported in this study were;
IfA19G1, IfA14G1 and IfA12G1. To the best of our knowledge, this is the first
report of subtype If in East Africa and second in humans in Africa after it was
detected in South Africa by Samra *et al*., 2012. However one of the subtypes
IfA12G2, although not found in this study, has recently been reported in baboons
in Kenya. The genetic diversity within the subtype family If differs from the
subtypes isolated in Bangladesh where all the 11 isolates were identified as
IfA13G1, but in agreement with the study in South African children where two of
the subtypes in our study; IfA14G1 and IfA12G1were reported. However subtype
IfA19G1, reported in this study, has not previously been reported in Africa.
All 19 *C*. *parvum* samples in our study were of the IIc subtype family. The
*C*. *parvum* allelic family IIc has been frequently recorded and described
almost exclusively in humans. Our findings are similar to those observed in
Nigeria by Molloy, and Cama, where IIc was the most common subtype family of
*C*. *parvum*. Subtype families IIa and IId which are commonly reported in
different parts of the world and are zoonotic were not identified in the present
study.
Variation within clades of the same subtype family could be attributed to repeat
motif difference; however there was lack of distinct clustering based on either
HIV status or patient type (inpatient and outpatient). The most dominant *C*.
*hominis* subtype isolated from HIV positive patients was Id (n = 7) and Ib (n =
7) with least genotype Ia and If (n = 1 each).
We observed differences in clinical manifestations among subtype families of
*C*. *hominis*: morepersons infected with subtype families Ib, Id and Ie were
observed to present with fever, abdominal pains, vomiting and acute diarrhoea,
whereas infections with subtype family Ia none had acute diarrhoea. This finding
is supported by an earlier study that showed that subtype Id was more virulent
than other *C*. *hominis* subtype families in Peruvian HIV-positive people, but
differs with another study that reported that subtype family Ib may be more
pathogenic than Ia, Id, and Ie due to its significant association with
diarrhoea, nausea, vomiting and general malaise. On the other hand, the Peru
study indicated that infections with the Ia and Ie subtype families were more
likely asymptomatic. These results demonstrated that different *Cryptosporidium*
subtypes and subtype families may be linked to different clinical
manifestations. Indeed, further detailed investigations are warranted in order
to improve understanding of these associations.
In conclusion, we demonstrate high genetic diversity of *C*. *hominisGP60*
subtype families, and children in the study area may have different clinical
responses to infections with different *C*. *hominis* subtype families.
Considering that *C*. *hominis* was the predominant species in the study
population confirms that transmission in children in this area is predominantly
anthroponotic.
# Supporting Information
We would like to acknowledge financial support from Wellcome Trust programme,
Kilifi (strategic award, 084538) and the National Council of Science, Technology
and Innovation (NACOSTI). The children of Mukuru/Mbagathi and their
parents/guardians who participated in the study. Special thanks to the entire
field, clinical and laboratory staff of the Kenya Medical Research Institute,
Mukuru clinics and Mbagathi District hospital, involved in collection of all the
data used in this project. This article is published with permission from the
Director, KEMRI.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: CM SK AW. Performed the
experiments: CM EM. Analyzed the data: AW CM BN JW. Contributed
reagents/materials/analysis tools: SK CM AW JW BN. Wrote the paper: CM.
Planning, coordination and supervision of data collection in the field; data
entry and cleaning: CM. Revised the manuscript: SK EM JW.
|
# Introduction
B cell Chronic Lymphocytic Leukemia (CLL) is an adult leukemia characterized by
the accumulation of B cells in the blood, bone marrow and secondary lymphoid
tissues due to apparent survival advantages and/or apoptosis resistance of these
cells *in vivo*. There is significant heterogeneity in the disease progression
between CLL patients. A more aggressive form of the disease, which results in
lower patient survival time, correlates with markers including unmutated
immunoglobulin heavy chain variable region (IgHV) status and high expression of
the tyrosine kinase ZAP-70 (ZAP-70+). Although the accumulation of a monoclonal
population of CD5+/CD19+ B cells is characteristic of both prognostic groups,
aggressive CLL appears to have some distinct characteristics and signaling
properties compared to indolent CLL.
Despite their enhanced survival *in vivo*, when CLL cells from patients are
cultured *in vitro*, they rapidly undergo apoptosis under conditions that
support the survival of normal B cells, underscoring the dependence of these
cells on survival cues from the microenvironment. In the microenvironment,
marrow stromal cells are believed to secrete factors that promote CLL cell
survival in patients; correspondingly, when monocytes isolated from peripheral
blood of CLL patients are cultured, they differentiate into “Nurse-like cells”
(NLCs) that promote CLL survival *in vitro*. One of the factors known to be
secreted by these NLCs and to support CLL survival, is the chemokine, CXCL12
(SDF-1). Additionally, CXCR4, the receptor for CXCL12, is overexpressed on CLL
cells compared to normal B cells, and thus has the potential for enhanced
responsiveness to CXCL12 signaling. Although another chemokine receptor, CXCR7,
can also bind CXCL12 and was previously shown to be expressed on B cells,
surface expression of CXCR7 was not observed on CLL B cells. Therefore the
CXCL12 signaling effects are likely mediated exclusively by CXCR4 in these
cells.
While chemokines and their G-protein coupled receptors are best known for their
role in directing the migration of immune cells, it is clear that these proteins
are involved in many other biological functions. The CXCL12/CXCR4 axis is
critical for developmental processes including lymphopoiesis, and central
nervous system and cardiac development, and knockout of either the ligand or
receptor in mice results in embryonic lethality. Due to the involvement of
CXCL12/CXCR4 in migration, angiogenesis, and development, it is not surprising
that this axis is often exploited by cancer cells for metastasis as well as
survival and proliferation. However, the specific molecular mechanisms by which
these various functions are effectuated and how these signaling pathways target
different downstream signaling molecules in cancer cells compared to non-
malignant counterpart cells is largely unknown. Similarly, while it is known
that Akt and ERK1/2 are activated by CXCL12 in CLL, the downstream targets of
these pathways and activation of other pathways have not been elucidated.
Despite the upregulation of CXCR4 and strong Akt and ERK signaling demonstrated
by CLL cells in response to CXCL12, the CLL cells actually migrate less
efficiently to CXCL12 than B cells from healthy donors in a transwell migration
assay. Thus, in CLL cells, it appears that signaling downstream of CXCL12/CXCR4
may be redirected towards survival signaling in lieu of cell migration. To
better characterize the signaling responses to CXCL12 stimulation, primary CLL
cells isolated from 5 patients were subjected to phosphoproteomic analysis by
liquid chromatography and tandem mass spectrometry (LC-MS/MS). Rather than
attempting to characterize the complete phosphoproteome of CLL cells, this
approach was designed to generate new hypotheses about the CXCL12/CXCR4
signaling network in CLL survival, and to identify downstream proteins that
might be good therapeutic targets. While many phosphoproteins were identified in
the CLL cells, comparison of spectral counts between CXCL12 stimulated and
unstimulated cells allowed identification of proteins phosphorylated as a
consequence of CXCL12/CXCR4 signaling. With follow-up experiments, the tumor
suppressor PDCD4 was validated as a downstream phosphorylation target of CXCL12
signaling in all CLL patient cells examined (n = 10) and HSP27 was similarly
validated in a subset of CLL patients (∼25%). Although these proteins have been
previously linked to cancer cell survival, they have not been previously
associated with CLL nor has PDCD4 been established as a downstream
phosphorylation target of CXCL12 signaling. Furthermore, a number of other
proteins (many of which do not have commercially available phospho-specific
antibodies available) have been proposed as potential downstream phosphorylation
targets of CXCL12 stimulation based on spectral count analysis of the CLL
phosphoproteomics data.
# Methods
## Cells and reagents
Peripheral blood mononuclear cells (PBMCs) were obtained from leukopheresis
samples of CLL patients following written consent at the Rebecca and John Moores
Cancer Center at the University of California San Diego (UCSD), in compliance
with the Declaration of Helsinki. These studies were approved by the
Institutional Review Board of UCSD. PBMCs were isolated by Ficoll-Paque (GE
Healthcare) density gradient centrifugation as previously described. The
isolated PBMCs were used fresh and cultured for phosphoproteomics analysis or
frozen as liquid nitrogen stocks in 90% heat inactivated fetal bovine serum
(FBS)/10% DMSO for follow-up analysis by western blot. PBMCs used in the
proteomics experiments were determined to be \>90% CLL B cells as assessed by
CD5+/CD19+ staining and flow cytometry analysis. For western blot validation,
CLL B cells were purified from the PBMCs by negative selection using the
magnetic associated cell sorting (MACS) (Miltenyi Biotec, Auburn, CA) by
depletion of CD14+ (monocytes) and CD2+ (T cells) cells, leading to \>99% CLL B
cell purity. Normal B cells were purified from PBMCs from healthy donors (San
Diego Blood Bank) using the MACS B cell Isolation Kit II (Miltenyi Biotec,
Auburn, CA) according to the manufacturer's protocol and were determined to be
\>90% pure by flow analysis staining for CD19+/CD3-/CD14- cells. RPMI-1640
glutamax media and FBS were obtained from Gibco (Invitrogen, Carlsbad, CA).
## Recombinant CXCL12 preparation
CXCL12 was expressed recombinantly in BL21 *E. coli* as previously described. In
brief, CXCL12 was expressed as a His-tag fusion protein and purified from
inclusion bodies. Bacterial cell pellets were sonicated and washed with
deoxycholate following resuspension in 10 mM Tris pH 8.0 with 1 mM
MgCl<sub>2</sub>, 200 µg DNAse, and Complete Protease Inhibitor Cocktail (EDTA-
free) (Roche, Indianapolis, IN). Protein was then solubilized in 6 M Guanadine-
HCl, 100 mM sodium phosphate, 10 mM Tris-Cl, pH 8.0, using a dounce homogenizer.
CXCL12 was purified over a Ni-NTA column and refolded with Hampton Fold-It
Buffer \#8 (Hampton Research, Aliso Viejo, CA), then dialyzed and concentrated
using Amicon Ultra centrifugal concentrators (MWCO = 5000). The His-tag was
removed by cleaving with enterokinase (NEB, Ipswich, MA) at a 1∶100,000 molar
ratio overnight at room temperature. CXCL12 was then purified by HPLC and the
identity and purity was validated by ESI mass spectrometry. Transwell migration
assays on Jurkat cells were used to validate functionality of the purified
CXCL12.
## Migration assays
Transwell migration assays (Corning, Corning, NY) were performed on purified CLL
B cells and B cells from healthy donors using inserts with a 6.5 mm diameter,
5.0 µm pore size. Cells were resuspended at 2.5×10<sup>6</sup> cells/mL in
RPMI+10%FBS and 100 µL of cell suspension was added to the inserts. CXCL12 was
diluted over a concentration range of 0 nM to 500 nM in a 600 µL total volume of
RPMI+10%FBS in the bottom wells. As a positive control and cell count reference,
cells were added directly to the wells without inserts. Transwell migration was
conducted for 2 h at 37°C/5%CO<sub>2</sub>. Cells that had migrated into the
bottom wells were then collected and counted by flow cytometry on a FACSCalibur
(BD Biosciences, San Jose, CA). Data was normalized to no chemokine control and
percent migration was calculated from the positive reference control.
## Preparation of CLL lysates for proteomics
CLL cell lysates for phosphoproteomic analysis were prepared as previously
described. Briefly, 3×10<sup>9</sup> total CLL PBMCs were washed with sterile
PBS and resuspended at 1×10<sup>7</sup> cells/mL in serum-free RPMI-1640 media.
The CLL cell suspension was distributed evenly into five 15 cm plates
(6×10<sup>8</sup> cells/plate) (Corning Inc, Corning, NY) and cultured for 2 h
at 37°C/5% CO<sub>2</sub> prior to stimulation with CXCL12. CLL cells were then
either unstimulated or stimulated for 3 min, 10 min, 30 min, or 60 min with 30
nM CXCL12. All plates were harvested at the same time with 3 mL ice cold
cytoplasmic lysis buffer containing 10 mM HEPES, pH 7.9, 1.5 mM
MgCl<sub>2</sub>, 10 mM KCl, 0.5 mM dithiothreitol (DTT) (Sigma, St. Louis, MO),
Complete Protease Inhibitor Cocktail (Roche Diagnostics, Indianapolis, IN), and
Halt Phosphatase Inhibitor Cocktail (Pierce, Rockford, IL) for 30 min on ice.
Lysates were clarified by centrifugation at 20,000 rcf for 20 min at 4°C. The
supernatants were distributed into protein LoBind Eppendorf tubes (Eppendorf,
Westbury, NY) and stored at –80°C. The total protein concentration of the CLL
lysates was determined using a BCA protein assay (Pierce, Rockford, IL).
## IMAC phosphopeptide enrichment
IMAC enrichment was performed as previously described. Briefly, 2 mg of CLL
lysates were denatured with 1% sodium dodecyl sulfate (SDS) (Fisher Scientific,
Pittsburgh, PA), reduced with 10 mM DTT, and alkylated with iodoacetamide
(Sigma, St. Louis, MO). Proteins were then precipitated with 50% ethanol/50%
acetone/0.1% acetic acid (HAC). The pellets were resuspended in 6 M urea/0.1 M
Tris, pH 8.0, and vortexed to solubilize the protein. The urea concentration was
then diluted five-fold by addition of 50 mM Tris, pH 8.0 and protein was
digested overnight at 37°C using sequencing-grade modified trypsin (Promega,
Madison, WI) at a ratio of 1∶50 (trypsin:protein). Trypsin was inactivated by
acidification of the digests with trifluoroacetic acid to 0.3 to 0.5% (v/v).
Prior to IMAC enrichment, peptide mixtures were desalted with 50 mg Sep-pak C18
cartridges (Waters Corp, Milford, MA). IMAC beads were prepared by stripping Ni-
NTA spin column resin (Qiagen, Valencia, CA) and recharging the beads with 100
mM FeCl<sub>3</sub> (Fluka reagent, Sigma, St. Louis, MO). IMAC beads were then
packed into gel loading tips with glass wool and conditioned with 25%
Acetonitrile (ACN)/0.1% HAC. Nonspecific peptides were removed by washing twice
with 30 µL of 25% ACN/0.1% HAC/0.1 M NaCl, twice with 0.1% HAC, and twice with
30 µL of Milli-Q H<sub>2</sub>O. Phosphopeptides were eluted with a total volume
of 50 µL over three elutions with 1% phosphoric acid. All fractions were
collected in protein LoBind Eppendorf tubes, speed-vac dried, and stored at
–20°C until MS analysis. Analysis of IMAC washes and flow through by LC-MS/MS
confirmed successful binding of phosphopeptides to the IMAC columns as less than
0.1% of these peptides were found to be phosphorylated, and the few that were
detected were redundant with phosphopeptides identified in the IMAC enriched
samples.
## Mass spectrometry and data processing
IMAC-enriched CLL peptides were resuspended in Milli-Q H<sub>2</sub>O +0.1%HAC
and analyzed by reversed-phase, C18 capillary liquid chromatography and tandem
mass spectrometry (LC-MS/MS) on a Thermo-Finnigan LTQ ion trap mass
spectrometer. The capillary LC columns (∼17 cm) were pulled and packed in-house
using deactivated fused silica (100 µm) (Agilent, Santa Clara, CA) as previously
described. Angiotensin II (Sigma-Aldrich, St. Louis, MO) was run after every two
CLL sample runs as a control for column performance. The standard method used
for all samples was as follows: 95% A/5% B (buffer A = 0.1% HAC in HPLC-grade
Milli-Q H<sub>2</sub>O, buffer B = 0.1% HAC in HPLC-grade ACN) for 20 min, 60%
A/40% B for 30 min, 20% A/80% B for 6 min, followed by a final washing step of
95% A/5% B for 30 min at 250 µl/min. A flow rate of 200 to 500 nL/min through
the capillary column was achieved by splitting the flow of solvent before it
reached the column. Samples were run in data-dependent mode in which the
spectrometer performed one full MS scan followed by six MS/MS scans of the top
six most intense ions in the parent spectrum with an *m/z* ranging from 400 to
2000. The dynamic exclusion list was varied in order to get a range of coverage
and spectral counts. The standard dynamic exclusion list applied had a repeat
count of 1, a repeat duration of 30 s, an exclusion size of 100, an exclusion
duration of 180 s, and an exclusion mass width of 1.50. Other variations
included a list of the top 25 peptides with a repeat duration of 60 s, an
exclusion of the top 5 most abundant peptides, and a dynamic exclusion list
turned off. The spray voltage was 1.8 kV. On average, the scan rate in this
experiment ranged from four to eight scans per second.
A comprehensive phosphoproteomics data set from cells of one particular patient
(CLL A) with unmutated IgHV and ZAP-70+ status (indicative of more aggressive
disease) was collected from two separate triplicate runs and one duplicate run
in order to obtain good coverage and number of spectra for comparison.
Phosphoproteomics analyses of 4 additional CLL patients' cells (CLL B – E) (each
run in single triplicate experiments) were also performed to ensure
reproducibility between different patient cells and stimulations. CLL B, D and E
also had more aggressive (high ZAP-70) characteristics (high ZAP-70) while CLL C
was of the indolent (low ZAP-70) subgroup. Following data collection, RAW data
files were converted to mzXML data files using the program ReAdW
(<http://tools.proteomecenter.org/ReAdW.php>). Data analysis of the MS/MS
spectra was performed using the open-access database search tool, InsPecT, with
the UniProt human database, the UniProt shuffled human decoy database as well as
common contaminants databases (e.g. keratin). Peptide sequencing searches were
defined for tryptic cleavage restraints and to allow for modification of up to
two phosphorylation sites (Ser, Thr, or Tyr) on a peptide. Spectra were sorted
by *p*-values according to the InsPecT scoring function and the target decoy
database was used as a measure of the overall quality of MS/MS data. Peptides
smaller than 7 amino acids and peptides with more than one missed cleavage were
excluded from analysis. Peptides with a false discovery rate (FDR) of less than
1–2% were manually validated for positive identification.
## Western blots and antibody reagents
For western blot analysis, patient CLL cells used for phosphoproteomics as well
as additional patient's cells were used. Purified CLL B cells were cultured in
serum-free RPMI at 1×10<sup>7</sup> cells/mL for 2 h at 37°C/5%CO<sub>2</sub>
and then stimulated with 30 nM CXCL12 over an hour time course (unstimulated, 3,
10, 30 and 60 min) or for 4 h, 10 h, and 24 h for PDCD4 degradation analysis.
For inhibitor studies, CLL cells were pre-treated with 40 µM AMD3100 (Sigma) or
200 ng/ml Pertussis toxin (List Biological Laboratories) for 1 h prior to
stimulation with CXCL12. Coculture of CLL cells with NLCs was performed as
previously described, and then the CLL cells were collected and centrifuged for
harvest. Cells were lysed on ice for 30 min in Ripa buffer (10 mM Tris pH 7.4,
150 mM NaCl, 1% Triton X, 0.1% Na-Deoxycholate, 0.1%SDS and 5 mM EDTA)
containing Complete Protease Inhibitor Cocktail (Roche, Palo Alto, CA) and Halt
Phosphatase Inhibitors (Pierce). Lysates were clarified by centrifugation at
20,000 rcf for 10 min at 4°C. A BCA protein assay (Pierce) was performed to
determine total protein concentration and 20 µg of total protein was loaded into
each well of a Criterion 4–12% Bis-Tris gel and run with the XT MES buffer
system (Bio-Rad, Hercules, CA). Gels were transferred onto PVDF membranes (Bio-
Rad), blocked with 5% milk-TBST, and incubated overnight at 4°C with primary
antibodies. Blots were washed 3 times for 10 min with Tris Buffered Saline +0.1%
Tween (TBST) and then incubated for 1 h at room temperature with secondary
antibodies conjugated to HRP, washed again 3 times with TBST and then developed
with Amersham ECL-plus (GE-healthcare) or SuperSignal West femto-sensitivity
reagent (Pierce). Blots were stripped with Restore western blot stripping
solution (Pierce) for 10 min at room temperature and then re-probed with other
antibodies and/or β-actin as a loading control. Primary antibodies were diluted
into 5% BSA-TBST at recommended concentrations. Phospho-PDCD4 and PDCD4
antibodies were obtained from Rockland Immunochemicals. Phospho-p38, phospho-
HSP27, HSP27, phospho-S6K, and β-actin were obtained from Cell Signaling
Technology. Densitometry analysis was performed using ImageJ software (NIH) and
normalized to β-actin loading controls.
## Flow cytometry
CLL B cells or normal B cells were purified for flow cytometry analysis. Cells
were washed and resuspended in a 0.5% bovine serum albumin (BSA) (Sigma) in
Phosphate Buffered Saline (PBS) solution and stained for CXCR7 expression using
an APC-conjugated antibody (clone 11G8) (R&D systems) or an APC-conjugated IgG1
isotype control according to manufacturer's protocol (R&D systems). Flow
cytometry data was collected on a FACSCalibur cytometer (BD Biosciences) and
analyzed using FlowJo software.
# Results
## Normal B cells migrate with higher efficacy and potency to CXCL12 than CLL B cells, despite having lower levels of CXCR4
Chemokines, including CXCL12, are best known for their role in directing cell
migration, but it is well established that they can also induce cell survival
and proliferation. This observation can be rationalized by the fact that some of
the major pathways involved in cell migration (e.g. PI3K/Akt and Raf/MEK/ERK),
are also important for survival and proliferation signaling. However, little is
known regarding the extent to which there is overlap or divergence of the
upstream and downstream effectors of these pathways in the context of migration
versus survival/proliferation. Since it has been established that CLL cells have
up-regulated expression of CXCR4 compared to normal B cells, and that CXCL12
stimulation of CLL cells activates Akt and ERK1/2 pathways, transwell migration
assays were performed on purified CLL B cells and normal B cells to compare
their ability to migrate towards CXCL12.
Surprisingly, the normal B cells showed a significantly greater (p\<0.0001)
ability to migrate to CXCL12, with respect to both efficacy (4.5+/−1.2%
migration in normal vs. 0.85+/−0.48% migration in CLL cells) and potency (∼10 nM
in normal vs ∼50 nM in CLL cells). Although it was expected that the CLL cells
would have the stronger migratory response due to higher CXCR4 expression, these
results are consistent with previously published observations that showed weak
migration of CLL cells to CXCL12 compared to a much more robust response to the
CCR7 ligands, CCL19 and CCL21. These data suggest that the downstream effects of
CXCR4 may be redirected for survival rather than migration, and led us to
consider what other pathways or downstream targets of Akt or ERK1/2 might be
activated to bias the CXCL12 signaling response towards survival. Taking a
global approach to this question, we performed mass spectrometry-based
phosphoproteomics analysis of unstimulated and CXCL12-stimulated CLL cells.
## Characterization of phosphopeptides/phosphoproteins in CXCL12-stimulated CLL cells via mass spectrometry
Fresh PBMCs from 5 CLL patients were stimulated over an hour time course with
CXCL12, and lysates were generated for IMAC enrichment and LC-MS/MS analysis.
Multiple (3 separate duplicate or triplicate experiments with variable
acquisition methods) phosphoproteomics data sets were acquired on lysates from
the cells of a patient with ZAP-70+ aggressive CLL, referred to as “CLL A”, in
order to ensure good coverage of the proteomic space. Smaller phosphoproteomics
data sets (single triplicate experiments) were collected from cells of 4
additional patients (CLL B to E) for comparison.
Protein lysates from the CLL cells were trypsin digested and enriched for
phosphopeptides via immobilized metal affinity chromatography (IMAC) to yield a
highly enriched population of phosphorylated peptides. Phosphopeptides were
analyzed by LC-MS/MS using a linear iontrap (LTQ) mass spectrometer. Data was
processed using the InsPecT database search algorithm and the spectra were
manually inspected for validation (see flow diagram).
Over 10,000 spectra were collected from the combined phosphoproteomics analysis
of unstimulated as well as stimulated CLL cells, which was comprised of 1470
phosphopeptides (\>1200 unique phosphosites) from 696 phosphoproteins. In
general, a \>30% enrichment of annotated phosphopeptides was achieved from our
IMAC procedure, which is on par with other phosphopeptide enrichment studies of
mammalian cells.
To ensure that good coverage of the CLL A data set was obtained, a comparison
was made of the overlapping phosphoproteins identified in the CLL A data sets
and the smaller CLL B - E data sets. 538 of the 696 total phosphoproteins
(\>77%) identified in the CLL A data sets were also identified in data sets B -
E, suggesting detection of the majority of phosphopeptides detectable by these
methods. Also, many of the non-overlapping phosphoproteins identified in CLL B
to E but not in CLL A were isoform variants of phosphoproteins detected in CLL
A. depicts the overlap of CLL B - E with CLL A and the matrix shows overlap
between all of the CLL samples.
## Identification of phosphoproteins with prior correlations to CLL and other leukemias
Adding confidence to our phosphoproteomics results, a number of hematopoietic-
specific phosphoproteins as well as phosphoproteins with prior implications in
CLL and other leukemias were identified. highlights 9 of the phosphoproteins
detected with previous links to CLL/leukemia, including Hematopoietic cell-
specific Lyn substrate (Hcls1) and SH2-containing inositol phosphatase-1
(SHIP-1). The phosphorylation status of both Hcls1 and SHIP-1 have been shown to
correlate with disease aggressiveness and shorter mean survival, consistent with
the aggressive characteristics of CLL A.
Also included in are phosphoproteins which have been linked to CLL but not
necessarily phosphorylation status, including HSP90, B cell novel protein 1,
promyelocitic leukemia protein, and formin-like 1 (FMNL1),. These proteins have
general implications in CLL, but whether differences in phosphorylation status
affect the activity or function in disease is unclear. A few additional proteins
including minichromosome maintenance protein 2 and stathmin 1 have been linked
to disease progression of other leukemias, but not directly to CLL and thus
warrant further investigation in CLL. Many of these phosphoproteins did not
appear to exhibit changes in phosphorylation in response to CXCL12 or spectral
numbers were too low to make an assessment of stimulation response, but HSP-90
and Mcm2 could be potential phosphorylation targets and are thus also
highlighted as proteins of interest in.
## Identification of novel downstream targets of CXCL12/CXCR4 signaling in CLL
To semi-quantitatively assess whether phosphorylation of some of the proteins is
a consequence of CXCL12 stimulation, spectral counts from the mass spectrometry
runs on the stimulated samples off CLL A were compared to those from
unstimulated samples. Select candidate targets of CXCL12-induced phosphorylation
are reported in along with their associated spectral counts. A number of known
targets of survival signaling pathways including programmed cell death factor 4
(PDCD4) and heat shock protein 27 (HSP27) were identified as having more
spectral counts in the stimulated versus unstimulated samples, and were selected
for validation by western blot and further analysis, discussed in detail later.
Validation was performed on lysates from CLL cells used in phosphoproteomics
analysis (lettered CLL A to E) as well as additional patient cells not examined
by phosphoproteomics (CLL1, CLL2, etc) in order to determine consistency of
these responses across different patients, since CLL is a heterogeneous disease.
Some of the phosphoproteins identified in this study have been previously
implicated in cancer malignancy such as Mcm2 and adenylyl cyclase associated
protein (CAP1), while little information is available on some of the other
potential targets including small acidic protein. Although two of the proteins
(PDCD4 and HSP27) are validated herein as targets of CXCL12-signaling in CLL,
the remaining phosphoproteins, while beyond the scope of this work, pose
interesting targets for future investigations.
## CXCL12 induces the phosphorylation and degradation of PDCD4
PDCD4 is one of the phosphoproteins that appeared to be induced by CXCL12
stimulation based on spectral counts. It is a known tumor suppressor, and
downstream phosphorylation target of Akt, which is known to be activated by
CXCL12 in CLL cells. A phospho-specific antibody is also commercially available,
making it attractive for follow-up studies. As a tumor suppressor protein,
PDCD4 has been implicated in a number of cancers where it is often inhibited
and/or downregulated, disrupting its ability to inhibit eIF4A translational and
AP-1 transcriptional activity, processes that are important for cell growth and
survival. Phosphorylation of PDCD4 is known to occur by Akt and p70 S6Kinase
(p70S6K) which inhibits its activity and leads to its ubiquitination and
proteosomal degradation.
Three separate phosphopeptides from PDCD4 were detected from our analysis:
R.FVSpEGDGGR.V (Ser457), R.SGLTVPTSpPK.G (Ser94) and R.DSGRGDSpVSDSGSDALR.S
(Ser76). The R.FVSpEGDGGR.V phosphopeptide corresponds to Ser457
phosphorylation, a site known to be phosphorylated by Akt. Therefore, multiple
CLL patient samples were examined for PDCD4 phosphorylation in response to
CXCL12 by western blot. An increase in phosphorylation of PDCD4 at Ser457 was
observed upon CXCL12 stimulation in CLL A cells, as well as all 9 additional CLL
patient cells examined (representative western blot). Increases in PDCD4
phosphorylation levels was variable between patients and ranged from 1.7-fold to
7.4-fold and averaged to approximately 3.4-fold (n = 10), as quantified by
densitometry analysis of western blots. Although variability was noted, this
variation did not cluster according to disease aggressiveness.
As a control to ensure that the phosphorylation was dependent on CXCL12/CXCR4
signaling and to determine if the effects were dependent on signaling through
the G-protein, Gi, CLL cells were pretreated with the small molecule CXCR4
antagonist, AMD3100, or the Gi-inhibitor, pertussis toxin (PTx) prior to a 3 min
stimulation with CXCL12. As shown in, both AMD3100 and PTx completely abrogated
phosphorylation suggesting it is CXCR4 and G-protein signaling dependent.
Furthermore, to ensure that phosphorylation of PDCD4 has relevance in a more
physiological context, the levels of PDCD4 phosphorylation were examined in CLL
cells that had been cultured with NLCs (+) compared to those without NLCs (−).
As with CXCL12 stimulation, the coculture of CLL cells with NLCs led to an
increase in the phosphorylated levels of PDCD4.
Since the phosphorylation of PDCD4 is known to lead to its ubiquitination and
degradation, we examined levels of total PDCD4 over a 24 h time period (0, 4, 10
and 24 h) following CXCL12 stimulation. As shown in, 24 h post-stimulation
resulted in PDCD4 degradation to ∼45% of starting levels.
Additionally, although it is well established that Akt is phosphorylated
downstream of CXCL12 signaling in CLL cells, it has not been established whether
p70S6K, another kinase known to phosphorylate PDCD4 leading to its
ubiquitination and degradation, is activated in CLL cells by CXCL12. Western
blot analysis revealed that phosphorylation and thus activation of p70S6K
(Thr389) was induced by CXCL12-stimulation in the CLL cells.
## HSP27 expression and phosphorylation is variable in CLL cells
The other phosphoprotein investigated further was HSP27 (phosphopeptide:
R.QLSphosSGVEIR.H, Ser82) (mass spectrum shown). HSP27 was also selected due to
spectral counts indicative of phosphorylation upon CXCL12 activation of CXCR4,
its implications in cancer and protection from apoptosis, and the availability
of a phospho-specific antibody at the Ser82 phosphorylation site. Additionally,
HSP27 is an interesting target since it is downstream of p38-MAPK signaling
which has not received much attention in association with CLL and therefore
represents a pathway with potentially novel implications in CLL survival.
Interestingly, while PDCD4 was found to be a common target of CXCL12 signaling
in all CLL samples examined, phospho-HSP27 and total HSP27 protein were only
detectable by western blot in a subset of ∼25% (3 out of 12) of CLL patients
examined (representative western blot). Nevertheless, HSP27 was indeed present
and did exhibit an increase in phosphorylation upon CXCL12 stimulation in the
CLL A patient samples from which the phosphoproteomics data was collected. Since
p38-MAPK is known to be upstream of HSP27 phosphorylation, we also examined p38
phosphorylation among the CLL patient samples; correspondingly, we observed
detectable p38 phosphorylation only in the samples that also exhibited the HSP27
phosphorylation (CLL A). Although no common factor could be determined among the
patients examined with detectable HSP27, a larger sample size might identify
common features of these cells and determine whether HSP27 is influencing the
survival of this subset of CLL patients.
# Discussion
CLL is the most common leukemia in the Western world. The accumulation of CLL B
cells is believed to result from low rates of precursor cell proliferation and
via recruitment of accessory cells that create a supportive microenvironment by
producing factors that foster CLL survival. The chemokine, CXCL12, is one of the
cytokines produced by cells in the microenvironment that enhances CLL survival
*in vitro* and likely *in vivo*. Although chemokines are best known for their
role as chemoattractants, we show here that CLL cells are much less capable of
migrating to CXCL12 compared to CLL B cells, despite an upregulation of CXCR4 on
the CLL cells. While the low levels of migration may still play a role *in
vivo*, it is evident that the CXCL12/CXCR4 axis is also networked into pathways
involved in survival. In contrast, CXCR7, the other receptor of CXCL12, is not
expressed on the surface of CLL cells although it is expressed on normal B
cells. Thus, while there is overlap in signaling pathways activated by CXCL12 in
CLL cells and normal B cells, the differences in migration and CXCR7 expression,
and the potential bias towards survival in CLL cells, suggest significant
differences in the role that the CXCL12/CXCR4 axis plays in the context of the
normal and pathological cells.
Phosphoproteomics analysis of CXCL12-stimulated CLL cells was performed in an
effort to determine potential downstream signaling targets that could contribute
to the survival and malignancy of CLL cells. As these are precious non-renewable
primary patient cells, the intent of our phosphoproteomics approach was to
generate hypotheses rather than an exhaustive analysis of the CLL
phosphoproteome. Therefore, while it would be ideal to use a number of phospho-
enrichment strategies in addition to IMAC (e.g. TiO<sub>2</sub>) and to employ
additional liquid chromatography separation steps besides C18 (e.g. hydrophilic
interaction liquid chromatography (HILIC)) to expand the number of
phosphoproteins identified, we focused our efforts on well established methods.
Along these lines, the use of quantitative phosphoproteomics strategies is
limited since these cells do not replicate and cannot be cultured long term.
Thus, stable isotope labeling of amino acids in cell culture (SILAC) is not
possible. Post-digest labeling with iTRAQ or ICAT isotopic labels is also
difficult due to limited sample availability, limitations in instrumentation
(one-third rule with the LTQ spectrometer restricting detection of the labels in
the low molecular weight range), and the labile nature of phosphates and labels
which causes reduced fragmentation and detection in MS/MS spectra. While
understanding its limitations, spectral counting was employed as a semi-
quantitative assessment of the CXCL12-stimulation responses and several
candidates were followed up by western blot validation. In addition to the above
examples with PDCD4 and HSP27, which showed that the spectral counting provides
a relatively good approximation of stimulation response, spectral counts
reflecting fairly even levels of phosphorylated p21-activated kinase (PAK2),
another target of the PI3K pathway, was also confirmed by western blot in all
six patient cells probed for phospho-PAK2 (Ser141).
Through this phosphoproteomics approach, we were able to confidently identify
close to 700 phosphoproteins in the CLL samples, including numerous proteins
previously implicated in CLL disease. Additionally, we identified many proteins
that appear to exhibit changes in phosphorylation levels in response to CXCL12.
This data led to the identification and validation of several previously unknown
phosphorylation targets of CXCL12 signaling. Typical approaches (e.g. western
blot) for investigating signaling in response to stimuli require *a priori*
knowledge of specific targets and the availability of phospho-specific
antibodies, which limits the ability to globally assess cellular signaling
events. Furthermore, validation studies of CLL cells are difficult since their
viability in culture is limited. They are also difficult to manipulate through
transfection and transduction since they do not divide in culture or infect well
(e.g. they require high MOI and/or pre-activation of cells with CD40L and IL-4
which could complicate interpretation of signaling analysis). Therefore, this
mass-spectrometry-based approach seemed the most effective method for gaining
new insight into the function of CXCL12 on CLL cell survival and possibly
disease aggressiveness. Although not done in this study, comprehensive MS
analysis of many patients may help to distinguish variations between patients,
and with disease stratification and the identification of judicious therapeutic
targets.
To our knowledge, this is the first report demonstrating that PDCD4 is a
phosphorylation target downstream of CXCL12 signaling in CLL or other cell
types. This finding is exciting due to the established role of PDCD4 as a tumor
suppressor and as a substrate of Akt. Although little is known regarding the
function of two of the phosphorylation sites of PDCD4 (Ser94 and Ser76)
identified from the LC-MS/MS analysis, phosphorylation at Ser457 near the
C-terminus of the protein is a well-established site with known functional
implications. Phosphorylation at Ser457 by Akt has been shown to result in
nuclear translocation of PDCD4 and a decrease in its ability to inhibit
AP-1-mediated transcription and eIF4A-mediated translation, ; although Ser67
phosphorylation was not directly identified in our LC-MS/MS analysis, it is
likely that this sight is also phosphorylated in response to CXCL12 stimulation
since PDCD4 degradation was observed following stimulation. In combination,
these effects may reduce the growth regulating/tumor-suppressor capacity of
PDCD4, thereby contributing to CLL cell survival and the malignancy phenotype.
Validation of PDCD4 phosphorylation also led to the identification of p70S6K
phosphorylation and activation downstream of CXCL12 signaling in CLL cells.
Based on the phosphoproteomics analysis, HSP27 appeared to be another promising
phosphorylation target of CXCL12-signaling. HSP27 and several other HSPs have
received attention in the context of cancer due to their cytoprotective/anti-
apoptotic functions. Specifically, HSP27 indirectly inhibits cytochrome c
release and caspase activation and it sequesters cytosolic cytochrome c. It also
promotes degradation of the inhibitor of NF-kB (IkB) and p27kip, and interacts
with and supports the activity of Akt under stressful conditions, all leading to
protection from apoptosis. We identified the presence of phosphorylated and
total HSP27 protein and its upstream activator p38-MAPK in a subset (∼25%) of
cell samples from different CLL patients. Of note, the observed variability in
signaling between different CLL patient cells highlights the underlying
heterogeneity of the disease. Furthermore, it serves as a reminder of how
different parameters including patient differences (age and gender), variations
in clinical course such as aggressiveness, stage and prognosis, and different
treatments (e.g. chemotherapy, gene therapy, etc) may alter how the cells
respond to different stimuli. Such variability is not unprecedented as Messmer
*et al* (submitted manuscript) have demonstrated differences in CXCL12-mediated
MEK and ERK activation in different ZAP-70 subgroups of CLL, and Montresor *et
al* demonstrated differences in CXCL12-mediated lymphocyte function-associated
antigen-1 (LFA-1) activation in normal B cells compared to CLL B cells and
amongst the cells of different CLL patients. Thus, it is reasonable to expect
that different patients will exhibit different responses to stimuli, whether it
is a survival stimulus from the microenvironment or a therapeutic agent used to
treat the disease.
These results showing patient variability in HSP27 expression emphasize the
strength of utilizing primary cells for understanding disease pathogenesis as
opposed to cell lines, which are much more homogenous, but can be less
insightful and sometimes misleading. While there was considerable overlap in the
phosphoproteins identified from LC-MS/MS analysis between different patients
(CLL A – E), more comprehensive MS analysis of multiple patients may help to
distinguish variations in signaling responses between patients. Along these
lines, since HSP27 is often induced following stressful cellular events such as
treatment with chemotherapeutics, its induction in certain patients could
reflect a response to treatment. For example, lymphoma cells which did not
express Hsp27 were sensitive to apoptosis while those expressing Hsp27 were
resistant to apoptosis induced by Bortezomib (PS-341), a proteasome inhibitor.
Silencing of Hsp27 in the resistant lymphoma cells then rendered them
susceptible to Bortezomib-induced death, demonstrating its link in resistance to
this chemotherapeutic treatment. Thus, a larger patient sample size may reveal
if expression of HSP27 is induced by certain chemotherapeutics or in particular
subsets of patients and whether there is any correlation to refractory disease,
as resistance to chemotherapy is one of the major hurdles in treating CLL.
Herein we present follow-up data to PDCD4 and HSP27, although there are numerous
other candidate phosphoprotein targets of CXCL12 signaling in CLL cells that
have been proposed. A summary of our findings from phosphoproteomics analysis
combined with some previously established pathways of CXCL12 signaling in CLL
are summarized in a signaling diagram. Overall, our data suggests that CXCL12
may preferentially activate survival signaling pathways rather than those
involved in cell migration in CLL cells, although some of the pathway components
(Gi, Erk, Akt) are common nodes. We have demonstrated that the use of
phosphoproteomics is a feasible and informative means of evaluating signaling
responses to CXCL12 in CLL, which could be employed for investigating a variety
of other stimuli in these or other primary cells. Through phosphoproteomics
detection and western blot validation, PDCD4 was found to be a common
phosphorylation target of CXCL12-signaling in CLL while HSP27 was present in
only a subset of CLL patients. Although our focus was on CXCL12 as a survival
factor, it is likely that other growth and survival stimuli may synergistically
activate these pathways and downstream targets. Therefore, PDCD4 and HSP27,
which have previous implications in regulation of apoptosis and carcinogenesis,
may represent potential therapeutic targets for treatment of CLL. In fact, small
molecule stabilizers of PDCD4, that enhance its function as a tumor suppressor
by inhibiting its degradation, are currently being developed due to its
potential as a therapeutic target for numerous cancers. Such agents could prove
to be useful agents in combination with other therapeutic modalities for the
treatment of CLL.
# Supporting Information
We gratefully acknowledge the contributions of Dr. Huilin Zhou and Marie
Reichart for guidance with the IMAC technique, Larry Gross, Dario Meluzzi and
Mike Meehan for assistance with LC-MS/MS and Dr. Steve Bark and Dr. Elizabeth
Komives for many useful discussions and critical reading of this work.
[^1]: Conceived and designed the experiments: MO CLS DM PCD TMH. Performed
the experiments: MO CLS. Analyzed the data: MO CLS. Contributed
reagents/materials/analysis tools: TJK DM PCD. Wrote the paper: MO.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
The foetal and developmental origins of adult disease may also be relevant to
the aetiology of dementia. Late-life leg length and skull circumference provide
useful information about the nutritional environment in early life, and brain
development, respectively. Adult leg length is sensitive to diet in infancy,
specifically breast feeding and energy intake. Increasing population height is
mainly accounted for by increasing leg length, linked to improvements in
childhood nutrition. Skull dimensions are a long-term and stable marker of
early-life brain size.
Inverse associations between skull circumference and prevalent Alzheimer’s
disease (AD) were reported in five cross-sectional studies: three of which were
community based, from the USA, Brazil, and Korea, and two of communities of
Catholic nuns from the US and Germany. There are two negative reports, both
small case-control studies with cases recruited from clinical services. In the
only cohort study an inverse association was noted with incident AD among
Japanese-Americans. Leg length was inversely cross-sectionally related to
dementia prevalence in Brazil, and among women in a population-based study in
Korea, and with cognitive impairment among Caribbean migrants to the UK. In the
only cohort study, from the USA, knee height was inversely associated with
incident dementia, but among women only. This was a post hoc finding, and the
interaction with gender was not statistically significant.
In the baseline phase of the 10/66 Dementia Research Group studies in Latin
America, China and India, longer legs and larger skulls were independently
associated with a lower prevalence of dementia. There was little heterogeneity
of estimates among sites. Earlier reports of effect modification were not
replicated. The aims of the current analysis based upon the incidence phase of
the 10/66 Dementia Research Group surveys are similar, although the outcome is
now incident dementia, and we explore the role of reverse causality.
Specifically we aim to
1. test hypotheses that longer leg lengths and larger skull circumferences
are associated with a lower incidence of dementia in large, representative
population-based dementia-free cohorts, checking for consistency across
diverse urban and rural settings in Latin America, and China
2. test for effect modification, with a priori hypotheses based upon
previously observed associations any protective effect of longer leg length
on dementia incidence is modified by gender (stronger in women) any
protective effect of greater skull circumference on dementia incidence is
modified by education (stronger among the least educated), or gender
(stronger in women)
3. assess the possibility that reverse causality may have accounted for
previously observed cross-sectional associations by testing whether
cognition at baseline is associated with changes in leg and skull
measurements from baseline to follow-up reduction in leg lengths and skull
circumferences are associated with the incidence of dementia.
# Materials and methods
The 10/66 population-based baseline and incidence wave study protocols are
published in an open access journal, and the profile of the resultant cohort has
also been described. Relevant details are provided here. One-phase population-
based surveys were carried out of all residents aged 65 years and over in
geographically defined catchment areas (urban sites in Cuba, Dominican Republic,
Puerto Rico and Venezuela, and urban and rural sites in Mexico, Peru, and
China). Baseline surveys were completed between 2003 and 2007, other than in
Puerto Rico (2007–2009). The target sample was 2000 for each country, and 3000
for Cuba. The baseline survey included clinical and informant interviews, and
physical examination. Incidence waves were subsequently completed, with a
mortality screen, between 2007 and 2011 (2011–2013 in Puerto Rico) aiming for
3–4 years follow-up in each site. Assessments were identical to baseline
protocols for dementia ascertainment, and similar in other respects. We
revisited participants’ residences on up to five occasions. If no longer
resident, we sought information on their vital status and current residence from
contacts recorded at baseline. If moved away, we sought to re-interview them,
even outside the catchment area. If deceased, we recorded the date, and
completed an informant verbal autopsy, including evidence of cognitive and
functional decline suggestive of dementia onset between baseline assessment and
death.
## Measures
The 10/66 survey interview generates information regarding dementia diagnosis,
mental disorders, physical health, anthropometry, demographics, an extensive
dementia and chronic diseases risk factor questionnaire, disability, and health
service utilisation. Only assessments relevant to the analyses of associations
between leg length, skull circumference and dementia incidence are described in
detail here.
### Anthropometric measures
Skull circumference was measured using a cloth tape measure encircling the
nuchal tuberosity and the brow. Leg length was measured, standing (or lying down
if not feasible), from the highest point of the iliac crest to the lateral
malleolus. In the event of deformity the non-deformed leg was measured. Both
dimensions were measured, to the nearest centimeter, at both time points.
### Sociodemographic variables
Age was determined at baseline interview from stated age, documentation and
informant report, and, if discrepant, according to an event calendar. We also
recorded sex, and education level (none/ did not complete primary/ completed
primary/ secondary/ tertiary).
### Frailty
At baseline, we assessed four of the five indicators of the Fried physical
frailty phenotype; exhaustion, weight loss, slow walking speed and low energy
expenditure. Since hand grip strength was not measured we considered
participants as frail if they fulfilled two or more of the four frailty
indicators.
### Dementia
Dementia diagnosis according to the 10/66 Dementia Research Group methodology
(referred to throughout as ‘incident dementia’) is allocated to those scoring
above a cutpoint of predicted probability for dementia, calculated using
coefficients from a logistic regression equation developed, calibrated and
validated cross-culturally in the 25 centre 10/66 pilot study, applied to
outputs from a) a structured clinical interview, the Geriatric Mental State,
b) two cognitive tests; the Community Screening Instrument for Dementia (CSI-D)
COGSCORE and the modified CERAD 10 word list learning task delayed
recall, and c) informant reports of cognitive and functional decline from
the CSI-D RELSCORE. For those who died between baseline and follow-up we
diagnosed ‘probable incident dementia’ by applying three criteria:
1. A score of more than two points on the RELSCORE, from the post-mortem
informant interview, with endorsement of either ‘deterioration in memory’ or
‘a general deterioration in mental functioning’ or both, and
2. an increase in RELSCORE of more than two points from baseline, and
3. the onset of these signs noted more than six months prior to death.
In the baseline survey, the first criterion would have detected those with
either DSM-IV or 10/66 dementia with 73% sensitivity and 92% specificity.
Prevalence and incidence of dementia in the current cohorts has been
reported.
## Analyses
We used STATA version 11 for all analyses.
For each site
1. we describe participants’ characteristics; age, sex, educational level,
mean leg length, and skull circumference
2. we model the effect of covariates on dementia incidence using a
competing-risks regression derived from Fine and Gray’s proportional
subhazards model. This is based on a cumulative incidence function,
indicating the probability of failure (dementia onset) before a given time,
acknowledging the possibility of a competing event (case dementia-free
death). In our analysis of baseline data, men had larger skulls and longer
legs than women in all sites, while in most sites older people had smaller
skulls and shorter legs, consistent with birth cohort effects. Better
education was generally associated with larger skulls and longer legs. Age,
gender and education were also the major determinants of incident dementia
in this cohort. We therefore controlled for age, gender, and education when
modelling the effects of leg length (quarters) and skull circumference
(quarters) on dementia incidence, comparing the longest or largest quarters
with the shortest or smallest. We report fully adjusted sub-hazard ratios
(ASHR) with robust 95% confidence intervals adjusted for household
clustering. As a sensitivity analysis, we also estimate the linear effect of
leg length and skull circumference (per centimetre) on dementia incidence,
controlling for the same covariates. We fit the models separately for each
site and then use a fixed effects meta-analysis to combine them. Higgins
I<sup>2</sup> quantifies the proportion of between-site variability
accounted for by heterogeneity, as opposed to sampling error; up to 40%
heterogeneity is conventionally considered negligible, while up to 60% may
reflect moderate heterogeneity.
3. we test for effect modification of linear effects of leg length on
dementia by gender, and of skull circumference upon dementia by gender and
education, by extending the adjusted models by appropriate interaction
terms.
4. we estimate correlations between baseline and follow-up measures of
skull circumference and leg length, and explore the possibility of reverse
causation by a) comparing change in leg length and skull circumference by
baseline cognitive status (cognitively normal, versus ‘cognitive impairment
no dementia (CIND), versus dementia), and b) testing whether change in leg
length or skull circumference is associated with incident dementia.
Participation in the study was by signed informed consent, or by signed
independently witnessed verbal consent for participants who could not read or
write. The study protocol and the consent procedures were approved by the King's
College London research ethics committee and in all countries where the research
was carried out: 1- Medical Ethics Committee of Peking University the Sixth
Hospital (Institute of Mental Health, China); 2- the Memory Institute and
Related Disorders (IMEDER) Ethics Committee (Peru); 3- Finlay Albarran Medical
Faculty of Havana Medical University Ethical Committee (Cuba); 4- Hospital
Universitario de Caracas Ethics Committee (Venezuela); 5- Consejo Nacional de
Bioética y Salud (CONABIOS, Dominican Republic); 6- Instituto Nacional de
Neurología y Neurocirugía Ethics Committee (Mexico); 7- University of Puerto
Rico, Medical Sciences Campus Institutional Review Board (IRB)
# Results
## Sample characteristics
Across the 10 sites, 15,027 interviews were completed at baseline. Response
proportions varied between 72% and 98%. The ‘at risk’ cohort comprised 13,587
dementia-free persons aged 65 years and over. Mean age at baseline varied from
72.0 to 75.4 years, lower in rural than urban sites and in China than in Latin
America. Women predominated over men in all sites, accounting for between 53%
and 67% of participants, by site. Educational levels were lowest in rural Mexico
(83% not completing primary education), Dominican Republic (70%), rural China
(69%), and urban Mexico (54%) and highest in urban Peru (9%), Puerto Rico (20%),
and Cuba (23%). In other sites, between a third and a half of participants had
not completed primary education. There was significant between site variation in
leg length (shorter legs in rural compared with urban sites; F = 64.7, p\<0.04),
and skull circumference (no obvious pattern of variation; F = 82.3, p\<0.001).
Site accounted for 5.5% of the variance in skull circumference, and 4.4% of the
variance in leg length. From the ‘at risk’ cohort, 2,443 participants (18.0%)
were lost to follow-up; 10,540 with baseline skull circumference data were
followed up for 40,466 person years, and 10,400 with baseline leg length data
were followed up for 39,954 person years. In the skull circumference cohort,
there were 1,766 deaths, of which 1,605 were judged to be dementia-free, and
1,009 cases of incident dementia were observed (of which, 161 were ‘probable’
cases diagnosed retrospectively from post-mortem informant interviews).
## Leg length and incident dementia
In all sites other than Cuba, there was a non-significant trend towards inverse
associations between leg length and incident dementia. The pooled meta-analysed
adjusted sub-hazard ratio (ASHR) for leg length (longest vs. shortest quarter)
was 0.80 (95% CI, 0.66–0.97) with no heterogeneity between sites (I<sup>2</sup>
= 0%). The linear effect, per centimetre of leg length, was also statistically
significant when pooled across sites (SHR 0.986, 95% CI 0.977–0.995,
I<sup>2</sup> = 0%). The interaction between leg length (per quarter) and gender
(male versus female) was not statistically significant (pooled ASHR 1.03, 95% CI
0.90–1.18, I<sup>2</sup> = 38.3%).
## Skull circumference and incident dementia
There was no evidence for an association between skull circumference and
incident dementia in any site, or after meta-analysis, whether comparing
quarters with the largest and smallest skulls (ASHR 1.02, 95% CI, 0.84–1.25,
I<sup>2</sup> = 0%), or the linear effect per centimetre of skull circumference
(ASHR 0.987, 95% CI 0.960–1.015, I<sup>2</sup> = 0%). The interaction between
skull circumference (per quarter) and gender (male versus female) was
statistically significant (pooled ASHR 0.86, 95% CI 0.75–0.98, I<sup>2</sup> =
0.0%), but in the reverse direction to that hypothesized with a greater
protective effect of larger skulls in men than in women. In a further
exploratory analysis stratified by gender the effect of skull circumference did
not attain statistical significance either in men (pooled ASHR 0.91, 95% CI
0.81–1.02, I<sup>2</sup> = 0.0%), or in women (pooled ASHR 1.07, 95% CI
0.99–1.15, I<sup>2</sup> = 0.0%). There was a non-significant trend towards an
interaction between skull circumference and education (per level) (pooled ASHR
0.986, 95% CI 0.971–1.001, I<sup>2</sup> = 32.1), also in the opposite direction
to that hypothesized, with a greater protective effect at higher educational
levels.
## Changes in leg length and skull circumference measures
Correlations between baseline and follow-up skull circumferences (0.53) and leg
lengths (0.43) were generally modest. They also varied among sites; Cuba (skull
circumference 0.62, leg length 0.50), Dominican Republic (0.48, 0.34), Puerto
Rico (0.47, 0. 51), Peru urban (0.83, 0.70), Peru rural (0.44, 0.36), Venezuela
(0.56, 0.37), Mexico urban (0.64, 0.46), Mexico rural (0.56, 0.46), China urban
(0.51, 0.50), China rural (0.20, 0.21). Inspection of the distribution of change
scores revealed some biologically implausible differences at the extremes of the
distributions. Even after exclusion of the outliers (top and bottom 5% of the
change score distributions), there was a tendency for both skull circumferences
(mean difference -0.20, 95% CI -0.23 to -0.17 cms) and leg lengths (mean
difference -0.99, 95% CI -1.12 to -0.85 cms) to be smaller on the second
measurement occasion. Apparent shortening of leg length was more marked among
those with dementia at baseline, than in those with CIND, and those who were
cognitively normal. Changes in skull circumference did not differ between those
with dementia at baseline and those who were cognitively normal.
## Post hoc sensitivity analyses
Given modest correlations between baseline and follow-up measures of skull
circumference and leg length, we repeated the regressions reported in, limited
to those individuals with baseline and follow-up anthropometric assessments, and
excluding the 10% with the most discrepant baseline and follow-up measures. This
restriction did not affect the main findings (skull circumference pooled AHR
1.05, 95% confidence intervals 0.80–1.36, I<sup>2</sup> = 37.9%; leg length AHR
0.76, 95% CI 0.60–0.97, I<sup>2</sup> = 0.0%). Given the association between
baseline dementia status and subsequent change in measured leg length, we
assessed the association of change in leg length (per centimetre) with incident
dementia, controlling for age, gender and education. The pooled effect size (AHR
1.006, 95% CI 0.992–1.020, I<sup>2</sup> = 19.3%) did not suggest any
association. Neither was change in skull circumference associated with incidence
of dementia (pooled AHR 1.016, 95% CI 0.961–1.074, I<sup>2</sup> = 7.7%). Since
anthropometric measures were not available at follow-up on those who were
deceased, these analyses could not take account of the competing risk of
dementia free death, and were simple Cox’s Proportional Hazard regressions.
Finally, other than baseline cognitive status, physical frailty seemed to be the
most prominent independent determinant of change in leg length, (adjusted mean
difference, controlling for age, gender, education and CIND, -1.19, 95% CI -1.89
to -0.70 cms). We therefore repeated the regression for the effect of baseline
leg length on incident dementia (reported) controlling for frailty in addition
to age, education and gender, and there was only a very small attenuation of the
effect (ASHR 0.82, 95% CI 0.67–0.99, I<sup>2</sup> = 0%).
# Discussion
## Main findings
This study provides additional support for the salience of early life
development to late-life dementia risk. However, while the hypothesis that
longer legs are associated with a reduced risk of incident dementia was
supported, the hypothesis that larger skulls would also be associated with a
reduced risk was not. The association between longer legs and reduced dementia
risk was independent of age, gender, education and physical frailty, and there
was no heterogeneity of effect across sites. There was no evidence that the
effect of leg length on incident dementia was modified by gender. The effect of
skull circumference on incident dementia was modified by gender, but in the
contrary direction to the only previous report, from a cross-sectional study
from Korea.
## Strengths and weaknesses of the study
The associations were assessed longitudinally, in large population-based
dementia-free cohorts, comprising rural and urban catchment area sites in the
Caribbean, Latin America, and China. Fixed effect meta-analysis was
appropriately applied to increase the precision of our estimates, given the
negligible heterogeneity for all of the associations studied. There have been
only two previous longitudinal studies of these associations, neither of which
approached the power and precision conferred by our 10,000 participants and
40,000 person years of follow-up.
A unique aspect of our approach was the repeated anthropometric measures at
baseline and follow-up. The moderate agreement for the repeated measures,
particularly for skull circumference suggested random measurement error, with
potential for underestimation of the true effect of these exposures upon
dementia risk. In a post-hoc analysis, the inverse association between leg
length and incident dementia was more pronounced when excluding those with more
discrepant baseline and follow-up leg length measurements, suggesting regression
dilution bias. Random measurement error might have been reduced by more
appropriate measurement methods (for example knee height or sitting minus total
height), and more training and quality control. We also found a consistent
tendency for both leg and skull dimensions to be smaller on the second
measurement occasion. For legs, but not skulls, this was more pronounced for
those with dementia at baseline than those who were cognitively normal. Although
mortality was high among those with dementia, and those who died did not have a
second anthropometric assessment, selective mortality seems an unlikely
explanation. Leg lengths, per se, are unlikely to shorten other than after hip
fracture. However, our measurement approach, measuring standing leg length, may
have led to apparent shortening (and, in some cases, lengthening) due to
difficulty in keeping the knee joint fully extended, particularly for those with
arthritis, sarcopaenia, general fatigue, and, possibly, cognitive impairment.
Physical frailty (capturing several of these elements) was associated with leg
length shortening. Given these findings, the possibility of reverse causation,
or residual confounding cannot be positively excluded. However, the association
between baseline leg length and incident dementia persisted after controlling
for physical frailty, and there was no association between change in leg length
(or skull circumference) and incident dementia. Finally, losses to follow up may
have led to attrition bias, if for example those with longer legs who developed
dementia were selectively more likely to refuse, or not be traced. However,
losses to follow-up for reasons other than death were negligible to modest, and
were not generally associated with the important determinants of dementia risk.
The possible biasing effects of attrition through death were addressed, in part,
through post mortem ascertainment of probable incident dementia, and the
competing risk regression.
## Contextualisation with other research
Our finding of an inverse association between leg length and incident dementia
is consistent with findings from the baseline phase of our study, and with three
other cross-sectional studies and one longitudinal study. We did not confirm an
inverse association between skull circumference and incident dementia previously
reported in one cohort study of Japanese-Americans, and also observed cross-
sectionally in the baseline phase of our study, and in five other cross-
sectional studies. Any suggestion that the association of skull circumference
with incident dementia might be modified by gender must remain tentative, given
the absence of a main effect, and that the observed interaction is in the
opposite direction to that reported in the only other study to test for this
interaction, a cross-sectional study from Korea. Our finding is therefore
contrary to our a priori hypothesis, and may well be accounted for by Type 1
error. Further research may clarify this issue.
The relationships between birthweight, subsequent growth, and cognitive
development are well established, with possible ‘sensitive periods’ in infancy,
childhood and adolescence. In a recent analysis of historical cohort data from
the UK MRC National Survey of Health and Development, trunk and leg length were
inversely associated with cognitive function at age 53 years. These associations
attenuated after controlling for adverse early life circumstances, and were
entirely accounted for controlling for cognition at age 15 years. Hence early-
life skeletal growth may be a marker for cognitive development, and associations
of adult leg length with late-life cognition and dementia risk may be accounted
for by tracking of cognitive ability across the life course, and the cognitive
reserve hypothesis, respectively. This would not, however, adequately account
for the discrepancy, in our analyses, between leg length and skull circumference
as predictors of incident dementia. Although adult leg length and height is
mainly influenced by early growth and its determinants, legs continue to grow
for up to a decade after skull growth is complete; skull circumference and leg
length may therefore be markers of different phases, and, possibly, different
aspects of the developmental process. Shorter limb length is associated with
cardiovascular risk factors in later life, particularly those linked to insulin
resistance. This may be another mediating pathway, best explored in birth
cohorts with mid-life assessment of cardiovascular risk profiles.
Leg length, in contrast to trunk height, and skull circumference are thought to
be stable across the adult life course. We found few previous studies of changes
in measured leg length and skull dimensions in older populations. As we
highlighted in our previous cross-sectional analysis, in a report from our 10/66
DRG site in Chennai, India where follow-up was limited to those with dementia or
cognitive impairment, reassessment of skull circumferences and leg lengths three
years after baseline indicated that leg lengths did diminish, but at a similar
rate in those with and without dementia, while skull circumferences did not.
Furthermore, in the previous cross-sectional analysis, we found no associations
between dementia severity and either leg length or skull circumference. This
concurs with findings from a longitudinal computed tomography study of skull
dimensions of people with dementia.
# Conclusions
Our cohort study clarifies the association between markers of early life
development; leg length (an inverse association) and skull circumference (no
association) and the incidence of dementia in late life. It addresses previous
unresolved concerns regarding direction of causality through repeated measures
of leg and skull dimensions. Main effects and interactions are estimated with
much more power and precision than had been previously possible. Findings from
previous studies in high income countries, can now be generalised to diverse
urban and rural settings in Latin America and China.
Consistent findings across settings and previous studies provide quite strong
support for an association between adult leg length and dementia incidence in
late-life, with early life nutrition most plausibly implicated as the antecedent
cause. While attention has focused upon education as a modifiable risk factor
for dementia, much less has been accorded to other developmental factors. Mean
male adult height, after a long period of relative stability, has increased by
5-10cms since 1920 in high income countries. This secular trend may, in part,
explain recent trends towards a declining incidence of dementia in high income
countries, which are not adequately accounted for by improvements in education
and cardiovascular risk profile. Our findings would predict a 7% reduction in
the incidence of dementia with each five centimetre increment in height. Further
clarification of these associations could inform predictive models of future
incidence, prevalence and numbers affected, and invigorate global efforts to
improve childhood nutrition, growth and development.
[^1]: Michael E Dewey is a statistical advisor for PLOS Medicine. All other
authors have declared that no competing interests exist.
|
# Introduction
Many studies have examined the association between tobacco smoking and breast
cancer risk. However, the findings have been controversial. Some studies have
reported no increased risk, while others have reported increased risk for
passive smoking exposure. The review by Canadian expert panel showed that the
evidence for a relationship between passive smoking and breast cancer remained
tenuous, although they suggested that the relationship between passive smoking
and breast cancer in younger, primarily premenopausal women was consistent with
causality. The most recent review suggested that the role of passive smoking was
less clear.
In China, traditionally, few women are smokers, but the rate of passive smoking
has known to be high. A survey conducted between 2005 and 2007 showed a high
rate of 43.6%. Even higher level of passive smoking was reported in younger
women and in rural areas. Some studies have evaluated the association between
passive smoking and breast cancer risk among Chinese women. Although most
studies reported the positive association of passive smoking with breast cancer
risk, these studies had relatively smaller sample size with 108 to 704 study
subjects, and few studies have used quantitative measures to evaluate the
exposures of passive smoking both at home and in the workplace. Inadequate
evaluations of exposure may result in an under-estimation of the risks, if they
do exist. We conducted this case-control study in Guangdong Province, China to
investigate the association of passive smoking at home and in the workplace with
breast cancer risk.
# Materials and Methods
## Ethics Statement
The procedures and protocols of the study were approved by The Ethical Committee
of School of Public Health, Sun Yat-sen University. All participants signed
informed consent forms before the interview.
## Study Subjects
Breast cancer cases and controls were recruited through two stages. The first
stage was conducted from June 2007 to August 2008 and the second stage was from
September 2011 to September 2013. Potential case patients were recruited from
inpatients admitted to the surgical units of two affiliated hospitals of Sun
Yat-sen University. Eligible cases were female subjects with histologically
confirmed breast cancer diagnosed no more than 3 months before the interview,
aged 25–70 years and natives of Guangdong province or having lived in Guangdong
for at least 5 years. Women were excluded if they had a history of breast cancer
or other cancers. Totally, 925 eligible cases were identified and 896 were
interviewed, with a response rate of 96.9%.
Control subjects were patients admitted to the same hospitals during the same
time period as the case subjects. Eligibility criteria for controls were the
same as described for the cases except that they had no history of any cancers.
They were frequency matched with cases by age (5-year interval) and residence
(rural/urban). These patients presented with a wide spectrum of non-neoplastic
conditions including eye disorders (glaucoma, uveitis, keratitis, pterygium,
dacryocystitis, and optic neuritis), ear-nose-throat diseases (sudden deafness,
acute bacterial/viral otitis media, sinusitis, deviation of nasal septum,
tonsillitis), trifacial neuralgia, varicose veins, osteoarthritis, degenerate
joint disease, orthopedics diseases, facial paralysis and acute appendicitis. In
total, 939 controls were identified and 912 were interviewed, with 2.9% patients
refused to participate.
## Data Collection
A structured questionnaire was used to collect information through face-to-face
interview by trained interviewers. The collected information included socio-
demographic and anthropometric parameters, dietary habits, menstrual and
reproductive factors, use of hormone and contraceptive drugs, family history of
cancer, alcohol drinking, active smoking, passive smoking history, disease
history, and physical activity. The interview time was limited to exposures that
occurred before diagnosis date for cases and the interview date for controls.
Relevant medical information, medical diagnosis, and histological findings were
abstracted from the hospital medical records.
Women were classified as non-smokers if they reported never smoking or smoking
less than 100 cigarettes over their lifetime. Passive smoking history was
collected for two exposure sources. First, the subject was asked whether her
husband or other family members ever smoked in her house, then she was asked the
average number of cigarettes they smoked per day and the number of years she had
been exposed at home. Second, the subject was asked whether someone ever smoked
within three meters around her in her workplace, then she was asked the number
of people and the number of years she had been exposed in the workplace. Women
were categorized as having been exposed to passive smoking if they reported ever
being exposed to tobacco smoke at home or in the workplace. Among women who were
passive smokers, the duration or intensity of exposure with smoker-years,
cigarettes/day or pack-years of exposure were calculated. Smoker-years were
defined as sum of the number of years of exposure to each smoker. Total smoker-
years were calculated as the sum of smoker-years at home and in the workplace.
Pack-years were defined as the number of years of exposure multiplied by the
pack of cigarettes (1 pack = 20 cigarettes) smoked per day for a given smoker.
Pack-years were summed across smokers to generate a total pack-years measure.
Body mass index (BMI) was calculated by dividing weight (kg) by height
(m<sup>2</sup>). Menopausal status was defined as at least 12 months since the
last menstrual cycle. Women were considered to be premenopausal if they were
currently menstruating, or if they were not menstruating because of a
hysterectomy and younger than 50 years old. Women were defined as postmenopausal
if they had either undergone a natural menopause, or surgery to remove both
ovaries, or if their ovarian function was unknown but they were older than 50
years.
## Statistical analysis
Since the socio-demographic and established breast cancer risk factors of the
two-stage study subjects are comparable, we pooled the two stage data for these
analyses. The analysis excluded 41 subjects (19 cases and 22 controls) who
reported past or current history of personal tobacco smoking. Analyses were
based on the remaining 1767 non-smokers (877 cases and 890 controls).
Differences in characteristics were assessed by using either *χ*<sup>*2*</sup>
tests for categorical variables or t tests for continuous variables.
Unconditional logistic regression models were used to estimate odds ratios (OR)
and 95% confidence intervals (CI) for the association between passive smoking
and breast cancer risk. Based on the comparison of baseline characteristics
between cases and controls, the following variables, BMI, physical activity, age
at menarche, age at first live birth, age at menopause, history of benign breast
disease, and mother/sister/ daughter with breast cancer, were selected to be
adjusted for as potential confounding factors. Age, residence and study stage
were also controlled for in all logistic models. Tests for trend were performed
by entering categorical variables as continuous parameters in the models.
Stratified analyses by menopausal status were conducted. As breast cancer is a
heterogeneous disease with estrogen receptor (ER) and progesterone receptor (PR)
subtypes, stratified analyses by ER/PR status were also conducted. All analyses
were performed using SPSS 13.0 (SPSS Inc., Chicago, Illinois, USA). All tests
were two-sided, with *P* values \< 0.05 indicating statistical significance.
# Results
Compared to controls, cases were more likely to have higher BMI, an earlier age
at menarche, a later age at first live birth, a later age at menopause, a
history of benign breast disease and a family history of breast cancer, and were
less likely to be physically active. All of the above variables were considered
potential confounders and adjusted for in subsequent analyses. No significant
differences were found between cases and controls in socio-demographic factors,
including marital status, educational level, occupation, and household income,
or in reproductive factors, including nulliparous, number of live births, months
of breast feeding, menopausal status, and use of an oral contraceptive.
As shown in, of all subjects, 495 (56.4%) cases and 442 (49.7%) controls
reported ever having been exposed to passive smoking at home or in the
workplace. Compared with women who were never exposed to passive smoking, women
who were ever exposed had a higher risk of breast cancer, with the adjusted OR
(95% CI) of 1.35 (1.11–1.65). When subjects were categorized according to
sources of exposure, 39.7% of cases and 37.4% of controls were exposed only at
home, 7.1% of cases and 7.2% of controls were exposed only in the workplace, and
9.7% of cases and 5.1% of controls reported both exposures. The adjusted ORs
(95% CIs) of breast cancer were 1.30 (1.05–1.61) for passive smoking exposure
only at home, 1.05 (0.71–1.56) for passive smoking exposure only in the
workplace and 2.17 (1.45–3.23) for both exposures, compared with women unexposed
to passive smoking.
Passive smoking exposure at home was examined in detail. Women who were ever
exposed to passive smoking at home (53.1% cases and 45.8% controls) had a higher
risk of breast cancer compared with women who were never exposed to passive
smoking, with the adjusted OR (95% CI) of 1.30 (1.05–1.61). Dose-response
relationships between breast cancer risk and smoker-years, cigarettes per day
and pack-years of exposure at home were observed (*P*<sub>trend</sub> = 0.003,
0.006 and 0.009, respectively). Compared with women with no passive smoking
exposure, the adjusted ORs (95% CIs) of more than 26 smoker-years, more than 16
cigarettes per day and more than 16 pack-years of exposure at home were 1.66
(1.21–2.26), 1.56 (1.17–2.09) and 1.61 (1.17–2.19), respectively.
Analysis on the association between passive smoking exposure at workplace and
breast cancer risk (418 cases and 465 controls) showed no association, with the
adjusted OR (95% CI) of 1.19 (0.80–1.78) comparing women who were ever exposed
to tobacco smoke in the workplace with never exposed women. No significant
association was found between smoker-years of exposure in the workplace and
breast cancer risk (*P*<sub>trend</sub> = 0.313).
A strong dose-response relationship and a positive association were observed
between total smoker-years of passive smoking exposure at home and in the
workplace and breast cancer risk. Compared with women who were never exposed to
passive smoking, the adjusted ORs (95% CIs) was 0.95 (0.70–1.29) for 1–16
smoker-years, 1.34 (1.04–1.74) for 17–30 smoker-years, and 1.95 (1.43–2.66) for
more than 31 smoker-years, respectively (*P*<sub>trend</sub> \< 0.001).
Analyses stratified by menopausal status showed a positive association between
passive smoking and breast cancer risk, primarily among postmenopausal women.
Compared with non-exposed women, the adjusted OR (95% CI) was 1.83 (1.29–2.60)
for women with any passive smoking exposure and 1.80 (1.24–2.61) for women ever
exposure to passive smoking at home. The significant dose-response relationships
between breast cancer risk and smoker-years, cigarettes per day and total pack-
years of exposure at home were also found only among postmenopausal women
(*P*<sub>trend</sub> = 0.001, \< 0.001 and 0.001, respectively). But the
significant dose-response relationship between total smoker-years of any
exposure and breast cancer risk was found in both pre/post-menopausal women. No
significant association was found between passive smoking in the workplace and
breast cancer risk in both the pre/post-menopausal women.
We also evaluated the relationship between passive smoking and breast cancer
risk stratified by ER and PR status, excluding 92 (10.5%) cases with no ER/PR
information. These analyses included 567 ER+ cases, 218 ER- cases, 596 PR+ cases
and 189 PR- cases. A positive association was observed in all subtypes of ER and
PR status, although the associations among women with ER+/PR+, and ER+/PR- or
ER-/PR+ breast cancer tumors were not statistically significant.
# Discussion
This study found that passive smoking exposure was associated with an increased
risk of breast cancer. The significant dose-response relationship between total
smoker-years and breast cancer risk was found in both the pre and post-
menopausal women, and in all ER/PR subtypes of breast cancer. This study also
showed that passive smoking exposure at home was associated with increased risk
of breast cancer, and there were significant dose-response relationships in
smoker-years, cigarettes/day and total pack-years. However, no evidence of a
relationship between passive smoking exposure in the workplace and breast cancer
risk was found.
Results from previous studies on passive smoking and breast cancer risk were
inconclusive. Some studies suggested an increased risk with passive smoking
exposure and others showed no effect. A meta-analysis containing seven cohort
studies and twelve case-control studies supported the notion that passive
smoking exposure was positively associated with breast cancer risk (relative
risk = 1.27, 95% CI = 1.11–1.45). A later meta-analysis reported the combined
relative risk of breast cancer in the 17 studies with retrospective reporting of
exposure was 1.21 (1.11–1.32), based on a total of 5696 breast cancer women. The
result of the present study is consistent with that reported from the meta-
analyses, showing a positive association between passive smoking and an
increased risk of breast cancer.
The observed association between passive exposure to tobacco smoke and breast
cancer risk is biologically plausible. Tobacco smoke contains over a dozen fat-
soluble compounds that are known to induce mammary tumors in rodents. Studies
have strongly suggested that breast tissue is a target for the carcinogenic
effects of tobacco smoke. DNA adducts with derivatives of tobacco smoke are more
common in the breast tissue of smokers than that of non-smokers. It has been
demonstrated that most of the tobacco smoke is not inhaled by the smokers and
the highest amounts of many components, such as carbon monoxide, nicotine,
benzene, formaldehyde, N-nitrosamines, nickel and tar, are found in side-stream
smoke. Moreover, the vapor-phase constituents from side-stream smoke are also
more quickly absorbed into blood and lymph systems than the particulate-phase
particulates found in main stream smoke.
This study found a significant dose-response relationship between total smoker-
years of any exposure and breast cancer risk. Some previous studies have
reported increased breast cancer risks for various duration of exposure, or
regardless of duration of exposure. However, many studies have not observed any
linear dose–response relationship between passive smoking and breast cancer risk
. In this study, every smoker around passive smokers were considered and
smoker-years was used. This may reflect a better measure to evaluate the
duration and intensity of passive smoke exposure than years.
Inconsistencies in exposure assessment methods may contribute to the
inconsistent findings across studies. Ideally, an exhaustive assessment of
exposure to passive smoking should include the duration and intensity of
childhood home exposure, adult home exposure, and workplace exposure. However,
some passive smoking studies relied on husband's smoking history as the index of
exposure and did not quantify additional sources of exposure. This may lead to
possibly non-differential misclassification of the exposure status and may
dilute the risk estimates. In the present study, we had no information on
childhood home exposure. Although more recent studies considered childhood
exposure, almost universally, these studies tend to report null results for
breast cancer risk. This may in part be due to the fact that self-report of
parental smoking is subject to even greater error.
Analyses according to sources of passive smoking exposure were also conducted. A
positive association and significant dose-response relationships in smoker-
years, cigarettes/day and total pack-years were found. Our findings are
consistent with that observed in some home exposure studies. However, a number
of home exposure studies found null association. Some of these studies solely
relied on husband's smoking history as the index of home exposure, and most
studies had no information on workplace exposure. As such, inadequate passive
smoke exposure assessment (for example, ignoring occupational exposure) could
result in classifying those with only workplace exposure as “unexposed”, thus
leading to underestimates of risks, if they should exist. In the present study,
we collected detailed information on home and workplace passive smoke exposure,
and used no any exposure as the referent group.
We observed no significant association between workplace exposure to passive
smoking and risk of breast cancer. Our results are in accordance with most other
previous results. However, a case-control study conducted in Shanghai, China,
found some evidence of a slightly elevated breast cancer risk associated with
workplace exposure of 5 hr. or more per day (OR = 1.6, 95% CI = 1.0–2.4; *P*
<sub>trend</sub> = 0.02) among women who worked during the 5 years after
excluding the influence of home exposure.
A cohort study conducted among California teachers observed an increased risk in
the most highly exposed subgroup of postmenopausal women exposed in adulthood
(age ≥20 years) (hazard ratio = 1.25, 95%CI = 1.01–1.56). Another cohort study
observed a 32% excess risk of breast cancer associated with the most extensive
exposure to passive smoking among postmenopausal women who had never been active
smokers. Other epidemiological studies also showed a statistically significant
positive association between passive smoking and breast cancer risk in
postmenopausal women. Consistent with these results, our study also provided
strong supporting evidence that passive smoking was associated with an increased
risk of breast cancer in postmenopausal women. One possible explanation for the
positive association of passive smoking with breast cancer in the postmenopausal
only might be related to the anti-estrogenic effects of passive smoking. Smoking
women have an earlier menopause and thus fewer years of menstruation. And
cigarette smoking alters estrogen metabolism, which may contribute to the
absence of a positive association of passive smoking with premenopausal breast
cancer. However, some reports suggested that passive smoking was associated with
an increased risk of breast cancer among premenopausal women or both pre/post-
menopausal women. Since this was a stratified analysis, chance findings might
arise. More studies with a larger sample size might be needed to confirm this
association.
Some studies have examined the association between passive smoking and breast
cancer risk by ER/PR status, and yielded inconsistent results \[, , –\]. Tong
*et al*. reported that passive smoking exposure from partners was associated
with increased risk of ER+/PR+ breast cancer among non-smoking Chinese urban
women. Morabia *et al* found that passive smoking increased the risk of both ER+
and ER- breast cancer. However, other studies found no significant association
between passive smoking and breast cancer risk stratified by ER/PR status. Our
study found a strong positive association between passive smoking and all
subtypes of ER/PR status of breast cancer, although the association was
statistically non-significant for some subtypes.
## Strengths
The present study has some strengths. We conducted detailed comprehensive
measurements of passive smoking exposure at home and in the workplace, including
duration and intensity of exposure (e.g., smoker-years, cigarettes/day and pack-
years).The data were collected using face-to-face interviews by trained
interviewers and the response rates of cases and controls were relatively high.
Furthermore, some major potential confounding factors were adjusted in all
logistic regression models.
## Limitations
This study had some limitations. First, selection bias was inevitable in
hospital-based case-control studies. To minimize this bias, great attempt was
made to recruit controls from patients with a wide spectrum of non-neoplastic
conditions. Moreover, the high participation rate (96.9% and 97.1% for cases and
controls, respectively) and high comparability in socio-demographic factors
between the two groups indicated that selection bias should not be a serious
problem. Second, recall bias was also of concern in case-control studies. To
reduce recall bias, we tried to interview patients as soon as diagnosis was made
and take great effort to interview cases before their surgery. Third, limited
sample size in some subgroups might lead to limited power to detect the
associations. Fourth, there were some missing data on the duration or intensity
of exposure, which may lead to an under estimation of the association. But the
percentage of missing data was less than 5%. Fifth, this study had no
information on genetic polymorphisms, which had been reported to modify the
association of passive smoking with breast cancer risk.
# Conclusions
In summary, this study suggested that passive smoking was associated with an
increased risk of breast cancer among non-smoking Chinese women. A stronger
positive association with breast cancer was seen among postmenopausal women and
all subtypes of ER/PR status of breast cancer. Future studies are needed to
confirm these results.
# Supporting Information
We greatly appreciate the participation of the study subjects and the
contributions of students in the data collection.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: BL SCH CXZ. Performed the
experiments: BL LW MSL. Analyzed the data: BL LW. Contributed
reagents/materials/analysis tools: XFM FYL. Wrote the paper: BL SCH CXZ.
|
# Introduction
Legume root and stem nodules fix atmospheric dinitrogen (N<sub>2</sub>) yielding
anabolic-N, which augments growth and reproduction of host plants. In these
nodules, the biochemical conversion of N<sub>2</sub> to ammonium is owed to
endosymbiotic rhizobia (bacteroids) who carry the N<sub>2</sub> fixation genes
encoding the dinitrogenase complex. Whether N<sub>2</sub> fixation occurs in
legume nodules or in pure cultures of diazotrophic (able to use N<sub>2</sub> as
sole N-source) bacteria, hydrogen gas (H<sub>2</sub>) is then co-produced. From
subsequent mechanistic studies of dinitrogenase activity, H<sub>2</sub> co-
production is both stoichiometric and requires 2 ATP per H<sub>2</sub> formed.
Yet in agronomic surveys, many legume nodules typically evolve H<sub>2</sub> at
high levels, and such H<sub>2</sub> evolution rates correlate with N<sub>2</sub>
fixation rates. However, in certain symbiotic legume nodules, bacteroids avidly
fix N<sub>2</sub> yet reproducibly evolve little or no H<sub>2</sub>. As this
endogenous H<sub>2</sub> production consumes metabolic energy, H<sub>2</sub>
recycling, which recoups that energy, allows increased efficiency of
N<sub>2</sub> fixation and, in principle, increased plant biomass yields –. This
symbiotic nodule H<sub>2</sub> recycling capability correlates with specific
bacteroid strains, although host legume cultivars also contribute to
H<sub>2</sub> recycling and yield. Indeed, in biochemical assays, bacteroids
isolated from H<sub>2</sub> recycling (non-evolving) nodules show high levels of
respiratory uptake hydrogenase activity.
H<sub>2</sub> recycling during N<sub>2</sub> fixation was first observed with
the aerobe *Azotobacter vinelandii*, a diazotroph but not a legume symbiont. In
pure culture, *A. vinelandii* induces a particulate (respiratory) hydrogenase
activity which oxidizes H<sub>2</sub> at the expense of and tolerant of
O<sub>2</sub>. In following studies with legume nodule bacteroids, such uptake
hydrogenase activity was also affirmed. In the ensuing forty years,
hydrogenases, extensively studied, have proven both biochemically diverse and
broadly distributed across bacteria and archaea. Among aerobes and
microaerophiles able to use H<sub>2</sub> as energy source, uptake hydrogenase
activities are typically classified as group I: heterodimeric, globular,
hydrophilic proteins carrying a heteronuclear Ni,Fe-catalytic center; group I
hydrogenases are generally O<sub>2</sub> tolerant. In cellular terms, the group
I, Ni,Fe uptake hydrogenases are tightly associated with respiratory membranes
via integral diheme *b-*type cytochromes, required for physiological activity,
\[Bernhard\]. As the group I cell membrane-peripheral complexes face the
periplasm, or cell exterior, they may be termed *exo-*hydrogenases.
*Azorhizobium caulinodans*, a microaerophilic α-*proteobacterium* originally
isolated as nodule endosymbiont of the host legume *Sesbania rostrata*, is
capable of N<sub>2</sub> fixation both *in planta* and in pure diazotrophic
culture. Recently, we discovered in *A. caulinodans* a second, novel respiratory
hydrogenase encoded by the seven-gene *hyq* operon. The inferred Hyq hydrogenase
includes six different structural proteins, including a heterodimeric Ni,Fe-
catalytic center hydrogenase conserved with group I enzymes. From bioinformatic
analyses, the remaining four Hyq proteins are all membrane-integral. Because all
six Hyq hydrogenase subunits are NADH:quinone oxidoreductase (respiratory
complex I) homologs, the Hyq complex is classified with the reversible group IV
hydrogenases. Given structural and functional homology to respiratory complex I,
the Ni,Fe-catalytic center heterodimers of group IV complexes associated with
respiratory membranes presumably face the cell-interior and thus may be termed
*endo*-hydrogenases.
# Results
## In symbiotic legume nodules both *exo*- and *endo*-hydrogenases recycle H<sub>2</sub> produced by N<sub>2</sub> fixation
To assess physiological roles for both bacteroid Hup *exo*- and Hyq
*endo-*hydrogenases in symbiotic legume nodules fixing N<sub>2</sub> and
recycling H<sub>2</sub>, *A. caulinodans* haploid derivatives carrying precise
(to the nucleotide pair) in-frame deletions of *hup* and *hyq* structural genes
encoding the conserved catalytic subunits of, respectively, *exo*- and
*endo*-hydrogenases were constructed and verified by nucleotide sequencing of
mutant loci. Specifically, *A. caulinodans exo*-hydrogenase null mutants carried
in-frame, precise, complete *hupSL* deletions; *endo-*hydrogenase null mutants
comprised precise, complete *hyqRBCEFGI* operon deletions. As well, haploid
recombinant double-mutants carrying both *exo*- and *endo*-hydrogenase null
alleles were also constructed. Pure *A. caulinodans* cultures were used to
inoculate both stems and roots of *S. rostrata* seedlings aseptically germinated
and individually cultivated under N-limitation. In *S. rostrata*, symbiotic
nodules are developmentally determinate, not meristematic. While both stem- and
root-nodules subsequently developed on inoculated plants only, as they are
invariably absent on uninoculated plants, stem nodules were chosen for further
study. Three week-old and five week-old determinate stem nodules were excised
from inoculated plants and individually tested for N<sub>2</sub> fixation
activity, assaying acetylene-dependent ethylene production by gas chromatography
with flame ionization detection. Excised stem nodules all showed similar (±15%)
high levels of acetylene reduction activity when normalized per fresh nodule
biomass. Accordingly, all *A. caulinodans* strains tested were assigned both
nodulation-competent (Nod<sup>+</sup>) and N<sub>2</sub> fixation-competent
(Fix<sup>+</sup>) phenotypes.
Additional excised nodules from these *S. rostrata* plants were simultaneously
tested under air for H<sub>2</sub> evolution activity using gas chromatography
coupled to a reducing-compound photometric detector. In kinetic studies with
excised nodules elicited by *A. caulinodans* strains 61305R (parental), 66081
(*exo*-hydrogenase mutant) and 66132 (*endo*-hydrogenase mutant), H<sub>2</sub>
evolution was nonexistent. Whereas, nodules elicited by double (*exo*- and
*endo*-hydrogenase) mutant 66204 evolved H<sub>2</sub> at very high rates
comparable to those measured for acetylene reduction. Thus, H<sub>2</sub>
evolution by double-mutant 66204-elicited nodules was quantitatively owed to
N<sub>2</sub> fixation (dinitrogenase) activity. Results with five week-old
determinate nodules from additional *S. rostrata* plants entirely corroborated
results with three week-old nodules (data not presented). Pure bacterial
cultures were reestablished from aseptically crushed nodules and strain
identities verified by nucleotide sequencing of *hup* and *hyq* loci. In
conclusion, *A. caulinodans* bacteroids in *S. rostrata* nodules employ both
*exo*- and *endo-*hydrogenases to recycle endogenous H<sub>2</sub> produced by
N<sub>2</sub> fixation. Moreover, H<sub>2</sub> recycling is quantitative,
entirely accounting for N<sub>2</sub> fixation activities. Yet as measured by
H<sub>2</sub> evolution rates, bacteroid *exo*- and *endo*-hydrogenase are
interchangeable and individually are fully competent to handle endogenous
H<sub>2</sub> recycling in symbiotic *S. rostrata* nodules.
## N<sub>2</sub> fixing, microaerophilic α-proteobacteria able to recycle H<sub>2</sub> carry *exo*- and *endo*-hydrogenase gene-sets
From bioinformatic analyses, orthologous *hyq<sup>+</sup>* operons encoding
*endo*-hydrogenase are generally present in N<sub>2</sub> fixing microaerophiles
able to recycle endogenous H<sub>2</sub>. These strains include both free-living
diazotrophs as well as certain rhizobia, such as *B. japonicum,* the
endosymbiont of *Glycine max* (soy). In *Rhizobium leguminosarum*, a metastable
species with several descendant biovars each with genomes comprised of variable
multipartite replicons, H<sub>2</sub> recycling capability in symbiotic legume
nodules varies among strains. As well, both the
*hup*<sup>+</sup>/hyp<sup>+</sup> (*exo*-hydrogenase) and the *hyq*<sup>+</sup>
(*endo*-hydrogenase) gene-sets are also variables,. Yet other diverse rhizobia
(*e.g. Sinorhizobium meliloti* 1021; *Mesorhizobium loti* MAFF303099; *Rhizobium
etli* CFN42; *Rhizobium sp*. NGR234) all incapable of H<sub>2</sub> recycling in
symbiotic legume nodules, completely lack both *hup*<sup>+</sup>/hyp<sup>+</sup>
and *hyq*<sup>+</sup> gene-sets. As the *hyq<sup>+</sup>* operon is also absent
from anaerobic (fermentative) diazotrophs, fully aerobic diazotrophs (*e.g.
Azotobacter spp*.), and non-diazotrophs generally, Hyq *endo*-hydrogenase seems
co-selected with N<sub>2</sub> fixation in microaerophilic (non-fermentative)
α-proteobacteria. Nevertheless, in every N<sub>2</sub> fixing microaerophile
with both *exo*- and *endo*-hydrogenases, these gene-sets, as well the *nif*
genes encoding N<sub>2</sub> fixation activities are all unlinked. Moreover, *A.
caulinodans* haploid strains carrying complete (20-gene)
*hup<sup>+</sup>/hyp<sup>+</sup>* (including *hupSL<sup>+</sup>*) operon
deletions entirely lacking *exo*-hydrogenase and ancillary activities,
nevertheless retain full H<sub>2</sub> recycling activity both in pure cultures
and in *S. rostrata* stem nodules. As well, *Rhodocista centenaria* (aka
*Rhodospirillum centenum*) SW, which possesses the *hyq*<sup>+</sup> operon but
not the *hup<sup>+</sup>/hyp<sup>+</sup>* operon, completely recycles
H<sub>2</sub> in diazotrophic culture (data not presented). Accordingly, these
*exo*- and *endo*-hydrogenase gene-sets seem fully autonomous.
# Discussion
Among legume-*Rhizobium* symbioses, H<sub>2</sub> recycling was first reported
in *Pisum sativum* (garden pea) nodules elicited by specific *Rhizobium
leguminosarum* bv. *viciae* strains. Genetic studies were subsequently
undertaken with \[*Brady*\]*Rhizobium japonicum* strains able to recycle
H<sub>2</sub> in *Glycine max* (soy) nodules. Many subsequent studies with
H<sub>2</sub> recycling legume nodules all presumed uptake hydrogenase activity
a single entity. These studies include combined genetic and physiological
analyses which might have challenged this assertion. For the case of *A.
caulinodans*, single mutants W58, U58 as well as *hupSL* impaired strain
ORS571.2 all were reported to suffer substantial to complete loss of uptake
hydrogenase activity. Such conclusions are incompatible with the present
finding: *A. caulinodans* employs two structurally and functionally distinct,
genetically-independent, respiratory hydrogenases to recycle endogenous
H<sub>2</sub> produced by N<sub>2</sub> fixation.
Whereas, early on the investigative timeline, *B. japonicum* single mutants
unable to be cultured autotrophically on exogenous H<sub>2</sub> yet still able
to recycle endogenous H<sub>2</sub> in soy nodules were identified. As these
strains showed induction of uptake hydrogenase activity in cultures shifted to
O<sub>2</sub> limitation (≤11 µ*M* DOT), they were perhaps understandably
considered transcriptional control mutants hypersensitive to O<sub>2</sub>. With
the benefit of hindsight, this phenotype is precisely that expected of true
loss-of-function point mutants affecting *hup* operon structural genes encoding
Hup *exo*-hydrogenase activity, were the observed limiting-DOT uptake
hydrogenase activity in fact owed to Hyq *endo-*hydrogenase. In *A.
caulinodans*, *hyq* operon expression requires NifA as transactivator, and the
p*nifA<sup>+</sup>* promoter is in turn strongly transactivated by Fnr, which
process requires physiological O<sub>2</sub> limitation in diazotrophic culture.
In principle, both *exo*- and *endo*-hydrogenase gene-sets, despite being
encoded at disparate loci in all organisms identified, might nevertheless share
a common genetic predisposition, allowing strategic single mutations to convey
dual loss-of-function. However, as strains carrying complete *hyq* operon
deletions still possess wild-type Hup *exo-*hydrogenase activity, and *vice
versa*, evidence for any genetic, post-transcriptional interaction or
interdependence between the two gene-sets is entirely lacking.
As shown previously, in pure diazotrophic (N<sub>2</sub> as sole N-source)
cultures, *A. caulinodans exo-*hydrogenase knockout mutants grow as wild-type,
whereas *endo*-hydrogenase knockout mutants exhibit slow growth. Are *exo*- and
*endo*-hydrogenase H<sub>2</sub> recycling efficiencies in pure culture and in
legume nodules then demonstrably different? Or, do diazotrophic phenotypes imply
additional *endo-*hydrogenase function(s), *e.g.* chemiosmotic work associated
with membrane ion translocation not undertaken by *exo*-hydrogenase? Obviously,
effective *exo*- and *endo-*hydrogenase cellular concentrations and/or
distributions might be dissimilar in legume nodules and in pure diazotrophic
cultures, even though both *hup<sup>+</sup>/hyp<sup>+</sup>* (*exo*-hydrogenase)
and *hyq*<sup>+</sup> (*endo*-hydrogenase) gene-sets are then strongly
transcribed. Because *hup* mutants suffer loss of chemoautotrophy with exogenous
H<sub>2</sub> as energy substrate, *exo-*hydrogenase kinetic behavior may
constitute simple diffusion control. Because *hyq* mutants do not adversely
impact chemoautotrophy with exogenous H<sub>2</sub>, *endo-*hydrogenase kinetic
behavior might not constitute simple diffusion control. A critical test of this
hypothesis is still lacking. Diazotrophic liquid batch cultures typically employ
constant sparging with relatively high gas-phase exhaust rates (0.5
min<sup>−1</sup>), complicating kinetic behavior and analysis of cellular
processes with gaseous substrate(s) subject to simple diffusion control. In such
pure liquid diazotrophic batch cultures bacterial densities typically reach
10<sup>8</sup> cc<sup>−1</sup>, whereas in determinate *S. rostrata* nodules,
bacteroid densities approach 10<sup>11</sup> cc<sup>−1</sup>, the latter
obviously more conducive to endogenous H<sub>2</sub> recycling under simple
diffusion control. Notwithstanding, given their apparent co-selection in
N<sub>2</sub> fixing micoaerophilic α-proteobacteria capable of H<sub>2</sub>
recycling, *exo*- and *endo*-hydrogenases likely possess additional, distinctive
functionalities yet to be elucidated.
# Methods
## Bacterial strains and culture conditions
*Azorhizobium caulinodans* ORS571 wild-type (strain 57100), originally isolated
from *Sesbania rostrata* stem-nodules, was cultured as previously described. As
57100 wild-type is a pyridine nucleotide auxotroph, to serve as ‘virtual’ wild-
type, all experiments reported here employ *A. caulinodans* 61305R, a 57100
derivative carrying an IS*50*R insertion in the (catabolic) nicotinate
hydroxylase structural gene. Precise, in-frame deletion mutants were constructed
by a ‘crossover PCR’ method. Haploid *exo*-hydrogenase knockout mutants each
carry a *hup*Δ*SL2* allele in which the (upstream) *hupS* translation initiation
codon is fused in-frame to a synthetic 21np linker sequence fused in-frame to
the (downstream) *hupL* termination codon. Similarly, haploid *endo*-hydrogenase
mutants each carry a *hyq*Δ*RI7* allele, in which the *hyqRBCEFGI* operon has
been replaced by a deletion allele comprising the *hyqR* initiation codon fused
in-frame to the 21np linker sequence fused in-frame to the *hyqI* termination
codon. After gene replacement, haploid strains carrying deletion alleles were
verified by PCR and DNA sequencing analyses.
## *Sesbania rostrata* nodulation tests
*S. rostrata* plants were germinated, cultivated aseptically, and stem
inoculated with pure *A. caulinodans* strain cultures as described. Either three
or five weeks post-inoculation, stem nodules were detached, weighed,
individually placed in septated vials. Dinitrogenase activity was assayed
kinetically by acetylene reduction and product ethylene was measured by gas
chromatography with flame-ionization detection. H<sub>2</sub> evolution was
assayed kinetically and measured by gas chromatography with reducing compound
photometer detection (RCP1; Peak Laboratories LLC, Mountain View, CA.), both at
atmospheric pressure and 29°C. Enzymatic activities are expressed per gram
nodule fresh-biomass at 29°C.
The authors thank Henk Vreman (Stanford University), Steve Hartman and Alex Lowe
(Peak Laboratories LLC) for technical assistance with gas chromatographic
H<sub>2</sub> analyses.
[^1]: Conceived and designed the experiments: RL. Performed the experiments:
CC NR JM. Analyzed the data: CC NR JM DC RL. Contributed
reagents/materials/analysis tools: RL. Wrote the paper: RL.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
The ability of cancer cells to invade or metastasize to distant organs is linked
to their ability to traverse the extracellular matrix. The extracellular matrix
(ECM) is a heterogeneous protein matrix that consists of a variety of collagens,
laminins, fibronectin and proteoglycans. Matrix metalloproteinases (MMP) cleave
and remodel ECM components, and increased activity of some of the MMPs,
including MMP2, 9, and 14 can promote cancer cell invasion *in vivo*.
MMP13 (collagenase-3) was originally identified in human breast cancer tissue.
It is secreted from cells as an inactive zymogen that can be activated by the
MMP2/MMP14/tissue inhibitor of metalloproteinase (TIMP2) complex or by plasmin.
MMP13 acts in the extracellular environment as a potent collagenase capable of
degrading a variety of collagens. *Mmp13* mRNA is expressed in a subpopulation
of myofibroblasts in invasive ductal breast carcinomas, but rarely in normal
breast, benign breast lesions and ductal carcinoma in situ (DCIS).
Interestingly, the presence of microinvasion in DCIS is associated with focal
expression of *Mmp13* mRNA in stromal fibroblasts. Direct comparison of the
*Mmp13* mRNA expression pattern with that of the *Mmp2*, *Mmp11* and *Mmp14*
mRNAs indicates that *Mmp13* is unique in this respect since these other MMPs
are also present in DCIS in the absence of invasion. These observations raise
the question as to whether MMP13 is a rate-limiting proteinase that mediates the
initial steps in breast cancer invasion.
The role of MMPs and other ECM-degrading proteinases during breast cancer
progression has been studied using a variety of murine mammary tumor models. In
one model, tumors are induced by expressing the polyoma middle T oncogene under
the mouse mammary tumor virus LTR (MMTV-PyMT) leading to early onset hyperplasia
in the mammary glands. The PyMT-oncogene induced mammary tumors go through
typical pre-invasive, invasive and metastatic phases similarly to human breast
cancer. The onset of tumorigenesis in the MMTV-PyMT mouse model is observed at
2–3 weeks after birth, and the non-invasive early stage tumors, mammary
intraepithelial neoplasia (MIN), progress into invasive carcinomas at 7–9 weeks
after birth. Transition to invasive carcinoma takes place in the central core of
the tumors, where epithelial atypia and nuclear pleomorphism first appear.
Tumors isolated from 13-week-old mice, late stage tumors, show evidence of
dedifferentiation and squamous metaplasia and have spread to the lungs and lymph
nodes. The tumors share both morphological and molecular characteristics with
human invasive ductal carcinomas,. Furthermore, we have reported that *Mmp2*,
*3, 11, 13* and *14* mRNAs are expressed in the stromal compartment in a series
of late stage MMTV-PyMT tumors, similar to the expression in human ductal breast
cancers. In late stage tumors, *Mmp13* mRNA shows high, focal expression in
stromal cell populations. Since this expression pattern is similar to what we
have observed in human breast cancers, we chose the MMTV-PyMT mouse breast tumor
model to test the functional role of MMP13 in breast cancer progression and
metastasis.
# Materials and Methods
## Mice
MMTV-PyMT and *Mmp13<sup>−/−</sup>* mice have previously been described. Both
strains were backcrossed more than 8 generations to FVB/n. The two strains were
intercrossed and the resulting *MMTV-PyMT;Mmp13<sup>+/−</sup>* male offspring
were mated with female *Mmp13<sup>+/−</sup>* mice to establish sibling cohorts
of *MMTV-PyMT;Mmp13<sup>+/+</sup>* and *MMTV-PyMT;Mmp13<sup>−/−</sup>* females.
All animal experiments were conducted according to institutional guidelines and
approved by the Danish Animal Experiments Inspectorate. A concurrent health
report compliant with the guidelines of the Federation of European Laboratory
Animal Science Associations revealed no infections.
## Genotyping
Genotyping was performed on chromosomal DNA purified from tail tips in a single
PCR reaction using *MMTV-PyMT* primers, control wt *plasminogen* primers and
*Mmp13* primers (MMP13_in5 anti: GGT GGT ATG AAC AAG TTT TCT GAG C, MMP13_in2:
CAG ACC CTA CAG TGC CAG ATT TTA G, MMP13_ex5: TGA TGA CGT TCA AGG AAT TCA GTT
T). Bands representing *MMTV-PyMT* transgene (159 bp), *plasminogen* (268 bp),
wt *Mmp13* (572 bp) and *Mmp13* knock-out allele (672 bp) were identified by
agarose gel electrophoresis.
## Quantitative real time PCR
Mice were anesthetized by intraperitoneal administration of a 1∶1 mixture of
Dormicum (Roche A/S, Basel, Switzerland) and Hypnorm (Janssen-Cilag Ltd, High
Wycombe, UK) and sacrificed by intracardial perfusion with 10 ml ice-cold
phosphate-buffered saline (PBS). For analysis of *Mmp13* mRNA expression during
normal mammary gland development and MMTV-PyMT tumorigenesis, the \#4 mammary
glands were isolated from MMTV-PyMT mice and wild type FVB/n mice at 3, 5, 7, 9,
11 and 13 weeks (n = 5 for each age and genotype). For analyses of the
expression of other MMPs and TIMPs, tumors from 11-week old *MMTV-
PyMT;Mmp13<sup>+/+</sup>* (n = 6) and *MMTV-PyMT;Mmp13<sup>−/−</sup>* mice were
used (n = 6). Total mRNA was isolated from 100 mg tissue using the Qiagen RNeasy
midi Kit (Qiagen, West Sussex, UK). The purified RNA samples were treated with
DNase I for 15 minutes at 37°C to remove residual DNA. Reverse transcription was
performed essentially as described followed by TaqMan qPCR performed as
described using an ABI7900 (Applied Biosystems, Foster City, CA) and primers
specified in except that *Mmp13* primers were chosen from the universal probe
library (number 105, Roche Applied Science, Burgess Hill, UK), left: CTT TTC CTC
CTG GAC CAA ACT, right: TCA TGG GCA GCA ACA ATA AA. Gene expression levels
relative to 18S were calculated.
## In situ hybridization
13-week-old mice were anesthetized as above and perfused intracardially with 10
mL PBS followed by 10 mL of 4% paraformaldehyde (PFA). Mammary tumors were
dissected from glands \#1–3 and \#4, fixed in 4% formalin for 5–7 days at 4°C
and paraffin embedded. *In situ* hybridization was performed on samples from
*MMTV-PyMT;Mmp13<sup>+/+</sup>* mice (n = 10) with <sup>35</sup>S labeled RNA
probes for MMP13 as described previously. No *Mmp13* mRNA signal was detected
in tumors from *MMTV-PyMT;Mmp13<sup>−/−</sup>* mice (n = 4).
## Immunohistochemistry
For immunohistochemical staining of α-smooth muscle-actin (mouse mAb, Dako,
Glostrup, Denmark) and CD204 (rat mAb clone 2F8, Serotec, Oxford, UK), sections
were heat-treated at 98°C in TEG buffer (10 mmol/L Tris, 0.5 mmol/L EGTA, pH
9.0) for 5 minutes in a T/T Micromed microwave processor (Milestone, Sorisol,
Italy). The α-smooth muscle-actin antibody was mixed with biotinylated anti-
mouse Fab fragments using the Animal Research Kit (Dako) and used for staining
following the recommendations of the manufacturer. The rat mAb against CD204 was
detected with rabbit anti-rat antibodies followed by Envision-Rabbit reagent
(Dako). All antibody incubation steps were performed in an OptiMax automated
immunostainer (BioGenex, San Ramon, CA). Immunohistochemical staining combined
with *in situ* hybridization was performed on mouse glands \#1–3 tumor samples
from *MMTV-PyMT;Mmp13<sup>+/+</sup>* mice (n = 6) as described previously. The
sections were developed with DAB chromogene, fixed for 40 minutes in 4% PFA, and
washed three times with sterile water. After dehydration, the sections were
incubated with <sup>35</sup>S-labeled *Mmp13* antisense probes and further
treated according to the *in situ* hybridization as described previously.
## Morphometric analysis of mammary gland whole mounts
The \#4 mammary glands were isolated from 4- and 6-week-old *MMTV-
PyMT;Mmp13<sup>+/+</sup>* mice (n = 4 and n = 4, respectively) and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice (n = 3 and n = 7, respectively) and prepared for
whole mount as described. The whole mounts were photographed using a DFC320 CCD
camera (Leica Microsystems, Wetzlar, Germany) and the ductal epithelial invasion
determined by measuring the distance from the branch point closest to the nipple
to the three most far-reaching ducts and the edge of the fat pad. The
penetration is presented as the mean of the three measures of ductal penetration
related to the length to the edge of the fat pad. All measurements were done
using the Leica IM500 software.
## Tumor growth and lung metastasis
Tumor growth in *MMTV-PyMT;Mmp13<sup>+/+</sup>* mice (n = 38) and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice (n = 25) was followed by weekly palpations of all
10 mammary glands. The length and width of all palpable tumors were measured by
caliper. The tumor volume (assuming that tumors took the shape of an ellipsoid)
was calculated using the formula: *V* = (*π*/6)×*W*<sup>2</sup>×*L*, where
*L* = length and *W* = width. At 13 weeks, *MMTV-PyMT;Mmp13<sup>+/+</sup>* mice
(n = 35) and *MMTV-PyMT;Mmp13<sup>−/−</sup>* mice (n = 25) were anesthetized and
perfusion fixed (three mice had been terminated before due to extensive tumor
burden). The lungs were removed for determination of the metastasis burden by
stereological analysis using Cavalieri's principle as described previously.
## Tumor grading
Nuclear grading of the MMTV-PyMT tumors was performed on haematoxylin and eosin
(H&E) stained sections from the \#1–3 tumors of *MMTV-PyMT;Mmp13<sup>+/+</sup>*
mice (n = 34) and *MMTV-PyMT;Mmp13<sup>−/−</sup>* mice (n = 24). We defined
grade I tumors as tumors with adenoma and atypia in Mammary Intraepithelial
Neoplasia (MIN)-like foci and containing up to 5% of MIN with grade II nuclear
pleiomorphy. Grade II tumors (“Early carcinoma”) were tumors with widespread
invasive carcinoma with grade II nuclear pleiomorphy and contained areas with
MIN Grade I/II. Grade III tumors (“Late carcinoma”) were tumors with focal or
widespread invasive carcinoma with grade III nuclear pleiomorphy that also
contained areas with Grade I and II carcinoma. Most tumors with grade III
carcinoma showed areas of squamous metaplasia.
## Quantification of angiogenesis
Mice were anesthetized as above and 100 µL of 1 mg/mL FITC-conjugated
*Lycopersicon esculentum* (tomato) lectin (Vector labs) injected *i.v.* in the
tail vein. After 5 min, the mice were cardiac perfused with 4% PFA in PBS at
120–140 mm Hg until the flow-through fluid was clear. Tumors were dissected and
post-fixed in 4% PFA overnight, incubated in increasing sucrose concentrations
(12%, 15%, 18% in PBS), embedded in Tissue-Tek O.C.T. compound and thick
sections (30–40 µm) cut. The tissue sections were stained with 1∶500 solution of
Propidium Iodide in PBS (Molecular probes, P-3566) for 1 hour and the slides
were mounted with Gel/Mount (Biomeda, \#M01). Confocal image stacks with 1-µm
spacing were collected from the most vascularized area in the middle of the
tumors using a 20x lens with a Solamere micro-lensed spinning disk confocal
microscope (Solamere Technologies, Salt Lake City UT) equipped with an
intensified charge-coupled device (ICCD) camera (XRMega-10EX S-30, Stanford
Photonics, Palo Alto, CA). The acquired images were analyzed with Bitplane
Imaris version 5.5 for Windows software using ‘filament tracer’ with an
approximate filament diameter set at 1.5. Minor manual corrections of the
computerized filaments were uniformly done. Vessel (segment) average diameter,
length and volume, were exported to a Microsoft Excel file and analyzed using
GraphPad 4 statistical software. Eight tumors from *MMTV-
PyMT;Mmp13<sup>+/+</sup>* and nine tumor from *MMTV-PyMT;Mmp13<sup>−/−</sup>*
were analyzed. All image acquisition and analysis was done blindly.
## Cell proliferation analysis
*MMTV-PyMT;Mmp13<sup>+/+</sup>* mice (n = 19) and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice (n = 19) were injected *i.p.* with 2 mg
bromodeoxyuridine (BrdU, Sigma-Aldrich) 2 hours before euthanasia. The mice were
anesthetized, perfusion fixed, the tumors isolated and fixed in 4% PFA and
finally paraffin embedded as described above. For immunohistochemistry, we used
a rat mAb against BrdU at 2 µg/mL (clone BU1/75-ICR1, Abcam, Cambridge, UK). The
BrdU labeled cells were counted as a percentage of the total number of
epithelial tumor cells using CastGRID (Visiopharm, Hørsholm, Denmark)
essentially as previously described. In brief, frames of 9391 µm<sup>2</sup>
were systematically but randomly placed over the BrdU stained sections with a
final magnification of 658 on the monitor. All BrdU positive neoplastic cells
within the frames were counted to give total numbers varying from 250–400. The
total number of neoplastic cells within the frames was estimated based on the
usage of systematic and randomly positioned reference points.
## Collagen evaluation
Serial sections (3-µm thick) from mammary tumor glands \#1–3 obtained from
13-week-old *MMTV-PyMT;Mmp13<sup>+/+</sup>* mice (n = 26) and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice (n = 21) were stained with haematoxylin and eosin
(H&E) or picrosirius red (PSR). Areas with invasive tumor were identified in H&E
stained sections. The same areas were then analyzed in the PSR stained sections
by obtaining 2.3×1.8 mm images with a charge-coupled device (CCD) camera (Leica)
under linearly polarized light using a Leica DMRBE microscope. In linearly
polarized light, thick collagen bundles appear orange-red and thin collagen
fibers green. Images were analyzed with MetaMorph software for collagen content.
Total collagen was identified with Hue-Saturation-Intensity (HSI) intervals
0–256, 1–256 and 70–256, respectively. For thin fibrillar collagen, HSI settings
of 26–83, 70–135, and 57–155 were applied to all the images. All image
acquisition and analysis was done blindly. The area covered by total collagen,
thin fibrillar collagen, and the fraction of thin fibrillar collagen was
calculated and used for statistical analysis (t-test).
## Statistics
For statistical analyses of the tumor burdens obtained by caliber measurements,
the total tumor volumes were logarithmically transformed and analyzed using a
general linear model with repeated measures. Only measurements obtained from
week 7 to 13 were included in this analysis. Estimates were obtained using
generalized estimating equations (SAS v9.1). Statistical interaction between
genotype and time were evaluated for the entire observation period considering
repeated measures (SAS). For statistical analyses of the metastasis burdens, the
values were logarithmically transformed and analyzed using a general linear
model.
# Results
## Mmp13 is expressed by myofibroblasts in invasive stage MMTV-PyMT tumors
*Mmp13* mRNA is expressed by a subpopulation of myofibroblasts in human invasive
ductal breast carcinomas, but is rarely expressed in normal breast, benign
breast lesions and ductal carcinoma in situ (DCIS). To determine if the
expression level of MMP13 changes during tumor progression in the MMTV-PyMT
mouse model, *Mmp13* mRNA levels were assessed in tumor tissue from mice at 3-13
weeks of age by qPCR. The level of *Mmp13* mRNA was highly increased in MMTV-
PyMT tumors after 7-weeks of age, with the highest levels found in older mice,
corresponding to late stage tumors. *Mmp13* mRNA levels were low in normal
mammary glands at all ages. The increase in *Mmp13* mRNA thus took place during
the time of transition to invasive stages in this tumor model.
To determine where *Mmp13* was expressed, we performed *in situ* hybridization
in tumors from 13-week-old mice, containing different stages of nuclear grading.
The *Mmp13* mRNA signal was seen in stromal fibroblast-like cells located in the
tumor core in areas with invasive grade II and III carcinoma (“late carcinoma”),
but was generally absent in the tumor periphery that was dominated by normal-
looking mammary tissue, hyperplasia or MIN grade I and II. In particular,
*Mmp13* mRNA positive cells were often seen in stromal branches located close to
the tumor cores with focal necrosis. Sporadic *Mmp13* mRNA positive single cells
and small cell clusters were also found in areas with strongly keratinized,
squamous metaplastic changes. This focal expression of *Mmp13* in the tumor core
was very different from the expression of *Mmp2* and *Mmp14*, which were found
throughout the tumor stroma, including at the tumor periphery ( e–h), and in
areas with hyperplasia, grade I and grade II MIN (not shown).
The localization of the cells that expressed *Mmp13* suggested that they were
myofibroblasts. Using combined *in situ* hybridization and immunohistochemical
staining, we verified that most of the *Mmp13* mRNA positive cells were positive
for the myofibroblast marker α-smooth muscle-actin, paralleling the expression
we found in human breast cancers. Myofibroblasts are prevalent in the invasive
MMTV-PyMT tumors, but only a small subpopulation was positive for *Mmp13* mRNA.
We noted that some of the *Mmp13* mRNA positive myofibroblasts were located in
narrow bands between tumor cell clusters. CD204 positive macrophages did not
express *Mmp13* mRNA and the location of the *Mmp13* mRNA positive cells was not
consistent with myoepithelial cells (data not shown), supporting our conclusion
that the stromal *Mmp13* mRNA expressing cells were myofibroblasts.
## Early tumor formation does not require MMP13 in MMTV-PyMT
The expression levels and patterns of *Mmp13* mRNA suggested that the proteinase
would play a role in the transition to the invasive stages. To determine the
role of MMP13 in mouse mammary tumor progression, we took a genetic approach
using *Mmp13<sup>−/−</sup>* mice. We verified that the absence of MMP13 did not
affect the development of the mammary epithelium and therefore would not affect
tumor progression indirectly by influencing the number of mammary epithelial
cells. We next crossed the MMTV-PyMT mice with *Mmp13<sup>−/−</sup>* mice and
measured the total hyperplastic area on whole-mounts of mammary glands from mice
at age 4 or 6 weeks, before the transition to invasive carcinoma. No difference
was found between *MMTV-PyMT;Mmp13<sup>+/+</sup>* and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice , consistent with the lack of *Mmp13* mRNA
expression at the early cancer stage.
## MMP13 is not required for tumor growth, tumor vascularization or metastasis in MMTV-PyMT mammary carcinomas
*Mmp13* mRNA was induced in tumors from mice of 7–9 weeks-of-age, and we
therefore expected that MMP13 would be required in the later stages of
tumorigenesis, possibly affecting tumor growth and metastasis. We followed tumor
growth in a cohort of littermate MMTV-*PyMT;Mmp13<sup>+/+</sup>* (n = 38) and
*MMTV-PyMT;Mmp13<sup>−/−</sup>* females (n = 25) by weekly palpations and
caliper measurements until 13 weeks of age, when tumors were isolated for
histological examination and the lungs isolated to determine metastasis burden.
A minor reduction in the growth of the tumors in *MMTV-PyMT;Mmp13<sup>−/−</sup>*
mice were seen at 8, 9, 11, 12 weeks, but this was not reproduced in a different
cohort. Furthermore, there were no differences in cancer cell proliferation
between tumors from *MMTV-PyMT;Mmp13<sup>+/+</sup>* and *MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice at 8 or 11 weeks of age as determined by BrdU-
labeling. In addition, histological examination and nuclear grading of the
tumors revealed no significant differences in the percentages of tumors that had
progressed to grade III, late-stage carcinoma (8% of the *MMTV-
PyMT;Mmp13<sup>−/−</sup>* vs. 18% of MMTV-*PyMT;Mmp13<sup>+/+</sup>* tumors).
Furthermore, analyses of H&E stained sections revealed no differences in the
presence of necrosis or stroma between tumors from *MMTV-
PyMT;Mmp13<sup>−/−</sup>* and MMTV-*PyMT;Mmp13<sup>+/+</sup>* mice (not shown).
Finally, no effects were seen on tumor vascularization, when analyzing vessel
diameter, length, or volume in 3D reconstructions of vessels in tumors of
lectin-perfused mice. Thus, the absence of MMP13 did not influence progression
in the primary tumors.
Since MMP13 is upregulated concomitantly with the onset of cancer cell
dissemination in the MMTV-PyMT model, we determined the metastatic burden in the
lungs from end-stage *MMTV-PyMT;Mmp13<sup>+/+</sup> and MMTV-
PyMT;Mmp13<sup>−/−</sup>* mice using a morphometric approach. Although there was
a trend for a reduced lung metastatic volume in the absence of MMP13, this was
not significant (.2 mm<sup>3</sup> for *MMTV-PyMT;Mmp13<sup>+/+</sup>*, n = 35;
0.7 mm<sup>3</sup> for *MMTV-PyMT;Mmp13<sup>−/−</sup>*, n = 25, *p* = 0.34). We
therefore conclude that the absence of MMP13 does not affect lung metastasis in
the MMTV-PyMT breast cancer model.
## There are no compensatory changes in expression of MMPs or TIMPs in MMTV-PyMT;Mmp13<sup>−/−</sup> tumors
Since we found no changes in tumor progression in the absence of MMP13, we
explored the possibility that the lack of MMP13 activity was compensated for by
changes in expression of other MMPs or in their inhibitors, the TIMPs. However,
there were no significant differences in the mRNA levels for MMP2, -3, -8, -9,
-10, -11, -12, -13, -14 or TIMP1, -2, -3, or -4 in tumors with and without MMP13
from 11-week-old mice by qPCR.
## Increased amounts of thin collagen fibers is found in the absence of MMP13 in invasive areas of MMTV-PyMT tumors
To determine whether any effects of MMP13 could be seen on its major substrate,
fibrillar collagen, we evaluated the fibrillar collagen content in invasive
areas of the tumors by picrosirius red staining of tumor sections. Although
total collagen was not affected by the absence of MMP13, the fraction of thin
collagen fibers relative to total collagen was increased significantly by ∼30%
in the invasive areas of tumors from MMTV-*PyMT;Mmp13<sup>−/−</sup>* mice
(t-test, p = 0.007). Thus, MMP13 played a role in collagen metabolism in
invasive areas of MMTV-PyMT tumors, but this did not affect tumor progression.
# Discussion
In this study, we analyzed the effects of absence of MMP13 activity on the
progression of MMTV-PyMT mammary carcinoma. Our previous studies of human DCIS
with early invasion led us to hypothesize that MMP13 would be a fibroblast-
derived, potential rate-limiting proteinase in the transition from non-invasive
to invasive breast carcinoma. Interestingly, a recent study reported
upregulation of several MMPs, including MMP13, at the transition from non-
invasive to invasive breast cancer cells in an *in vitro* model. However,
although *Mmp13* mRNA also was strongly induced in a subpopulation of
myofibroblasts in MMTV-PyMT mammary carcinomas, concurrent with early transition
to invasive carcinoma, there were no effects on tumor cell proliferation, tumor
growth, lung metastasis, vascularization or differentiation of the primary
tumors by the absence of MMP13. We excluded that the lack of effects was due to
compensatory transcriptional changes of other MMPs or their inhibitors expressed
in the MMTV-PyMT tumors.
MMP13 has a broad substrate profile that includes several fibrillar collagens,
tenascin, fibronectin and proteoglycans. *Mmp13* mRNA was found in carcinoma-
associated fibroblasts located in the central areas of the MMTV-PyMT tumors,
where tumor dedifferentiation and invasion is prominent. In these areas, we
found increased thin collagen fibers relative to total collagen in *MMTV-
PyMT;Mmp13<sup>−/−</sup>* compared to *MMTV-PyMT;Mmp13<sup>+/+</sup>* tumors,
indicating that MMP13 influences collagen fiber formation and/or metabolism of
fibrillar collagen in the MMTV-PyMT stroma. Mice lacking *Mmp13* display no
major phenotypic abnormalities, but a significant contribution of MMP13 in
collagen metabolism has been reported during bone development, skeletal
regeneration and in atherosclerotic plaques.
We found that most of the *Mmp13* mRNA expressing cells in the MMTV-PyMT tumors
are carcinoma-associated myofibroblasts. The myofibroblast is an abundant cell
type in the MMTV-PyMT tumors (this study) as it is in invasive human breast
cancers. There are several reports suggesting that carcinoma-associated
myofibroblasts promote cancer progression. In addition, proteins expressed by
myofibroblasts, such as PAI-1 and uPA, are associated with poor prognosis for
breast cancer patients. It is unknown what induces *Mmp13* in the breast
carcinoma-associated myofibroblasts, but the restricted expression of *Mmp13* in
dense fibrous stromal septae within the central parts of the invasive MMTV-PyMT
tumors suggests a locally expressed tumor-cell derived factor. *In vitro*
studies have shown that IL-1α, IL-1β, and transforming growth factor-β1, in
particular, can induce *Mmp13* mRNA expression in fibroblasts. Interestingly,
TGFβ signaling through fibroblast-expressed TGFβ receptor type II has a
considerable impact on tumor growth. *Mmp13* mRNA expressing myofibroblasts are
often found in the tumor core close to areas with necrosis suggesting that MMP13
may be upregulated in response to hypoxia for stimulation of angiogenesis.
Indeed, *Mmp13* mRNA is induced by hypoxia in various cell lines – including
fibroblasts , and vasculature of ossification sites and migration of endothelial
cells into cartilage is impaired in *Mmp13<sup>−/−</sup>* mice. However, our
measurements of vascular diameter, length and volumes in MMTV-PyMT tumors did
not reveal any effect of MMP13 on tumor vascularization.
It has been reported that *Mmp8* and *Mmp9* mRNAs are upregulated during bone
development in the ossification sites in *Mmp13<sup>−/−</sup>* mice and that
*Mmp8* mRNA is upregulated during skin wound healing in *Mmp13<sup>−/−</sup>*
mice. We tested whether the mRNA expression levels of several MMPs were changed
in *MMTV-PyMT;Mmp13<sup>−/−</sup>* tumors, but found no significant changes. We
found that tumor progression in the MMTV-PyMT model was associated with strong
upregulation of the *Mmp13* mRNA level as compared to the normal mammary gland.
Preliminary results suggest that *Mmp10* and *Mmp12* mRNA also are upregulated,
while *Mmp2*, -3, -8, -9, -11, and -14 are not (TXP, CP, DE, unpublished data).
This suggests that the three MMPs are upregulated by a common mechanism and
potentially implicates MMP10 and MMP12 in tumorigenesis in the MMTV-PyMT model
even though *MMP10* and *MMP12* mRNAs were not significantly upregulated in the
*MMTV-PyMT;Mmp13<sup>−/−</sup>* tumors compared to MMTV-PyMT wild type tumors.
However, we cannot exclude that differences exist at the level of enzyme
activity or that other classes of proteolytic enzymes compensate for the absence
of MMP13. The expression of *Mmp13* mRNA is strongly restricted compared to the
expression of *Mmp2* and *Mmp14* mRNAs that are expressed in a broader group of
(myo)fibroblasts. We have previously reported that mRNAs for several MMPs,
including *Mmp2*, *Mmp3*, *Mmp11* and *Mmp14* are expressed in the MMTV-PyMT
tumor stroma. Of these MMPs, MMP2 and MMP14 may have substrates in common with
MMP13, for example, both are also collagenases *in vivo*. Therefore MMP2, MMP14
or the activity of other MMPs may compensate for the lack of MMP13 in the *MMTV-
PyMT;Mmp13<sup>−/−</sup>* tumors.
It is possible that MMP13 plays both promoting and inhibiting roles during
cancer progression, resulting in a neutral net effect in its absence in the
MMTV-PyMT model. Tumor promoting and inhibiting functions have been found for
MMP9 in the human papilloma virus (HPV) 16 skin cancer model where the absence
of *Mmp9* reduced the number of tumors, but the tumors that formed were more
aggressive. A tumor protective role of a number of matrix degrading proteases,
including MMP8 and MMP12, has been described. These studies emphasize the need
for better understanding the role not only of the individual proteases but also
of their separate activities in cancer progression.
Breast cancer progression in humans may have a larger contribution from the
stromal environment than murine tumors, since human tissue have a more
fibroblast-rich stroma than murine. Nevertheless, the MMTV-PyMT breast cancer
model shares many histological and molecular characteristics with human luminal
breast cancer, but it differs from human ductal carcinoma in one interesting
aspect: the myoepithelial cells, which represent a cellular barrier for tumor
cells and are an important source for basement membrane, are partly lost early
during *MMTV-PyMT* oncogene-induced tumor progression. The absence of an intact
myoepithelial barrier may lead to pre-invasive precursor lesions different from
human DCIS and render MMP13 a dispensable proteinase in the critical transition
phase from non-invasive to invasive carcinoma. Thus, despite the presence of a
heterogeneous stromal environment and the appearance of a considerable
myofibroblast population in the MMTV-PyMT tumors, myofibroblasts may play a
minor role for the overall progression of the MMTV-PyMT tumor compared to human
breast cancer. Therefore, models in which transition from DCIS to invasive
carcinoma occurs similar to in human tumors are needed to definitely rule out a
role of MMP13 in breast cancer.
In conclusion, we found that the absence of MMP13 in the MMTV-PyMT mice did not
result in any differences in tumor progression to invasive and metastatic breast
carcinoma. Carcinoma-associated fibroblasts have been shown to facilitate tumor
progression through stimulation of angiogenesis, growth factor secretion and
invasion. However, there are no good markers allowing systematic sub-
classification of these cells. Thus, even though MMP13 itself apparently is
dispensable for tumor progression in the MMTV-PyMT model, its restricted
expression in myofibroblasts in invasive regions suggests that it marks a
subpopulation of carcinoma-associated fibroblasts that are involved in the
transition to invasive carcinoma.
Charlotte Lønborg, Lotte Frederiksen, Öznur Turan and Birthe Larsen for
excellent technical assistance and John Post for photographic assistance.
[^1]: Conceived and designed the experiments: BSN ME ZW LRL. Performed the
experiments: BSN ME CJP TXP LRL. Analyzed the data: BSN ME FR HAA CJP TXP
IJC LRL. Contributed reagents/materials/analysis tools: DRE ZW. Wrote the
paper: BSN ME. Critically revised the manuscript: DRE ZW LL.
[^2]: Current address: Exiqon A/S, Diagnostic Product Development, Vedbæk,
Denmark
[^3]: Current address: Department of Clinical Biochemistry, Rigshospitalet,
Copenhagen, Denmark
[^4]: The authors have declared that no competing interests exist.
|
# Introduction
Long-term cryopreservation of female genetic material could be very useful for
assisted reproductive technologies including breeding programs. However,
obtaining viable embryos from cryopreserved oocytes has proved to be a difficult
and inefficient labor in most mammals. Vitrification is a cryopreservation
procedure characterized by a high concentration of cryoprotectants and high
cooling rate that mostly prevents the formation of ice crystals and replaces, at
least for oocytes and embryos, the standard method of slow freezing. Unlike slow
freezing, in which extracellular water crystallizes generating an osmotic
gradient that dehydrate cells, in vitrification, extra and intracellular
compartments vitrify after cellular dehydration. Different vitrification devices
have been designed in order to decrease the vitrified volume, thus increasing
the cooling rate and reducing the exposure to cryoprotectants to minimize its
toxic and osmotic hazardous effects (for review, see). Still, in spite of the
several advances in the field, the development of oocyte vitrification in cattle
seems to have reached a *plateau*. In line with this, although similar rates of
survival and development have been achieved by different methods, the rates of
development of bovine oocytes after vitrification are still low.
A major site of injury during mammalian oocyte cryopreservation is the plasma
membrane. Part of the damage caused at the membrane level is induced by the
change from a fluid state to an ordered state as temperature is reduced below
the transition temperature of the membrane. Graham and co-workers prevented this
damage by the addition of cholesterol to sperm membrane of different domestic
animals in order to increase membrane fluidity at low temperatures and make it
more tolerant to cryopreservation. To add cholesterol to the membrane and to
increase its cholesterol level, they used methyl-β-cyclodextrin (MβCD), a cyclic
oligosaccharide which has a high affinity for inclusion of cholesterol and other
sterols in its hydrophobic cavity. Modulation of plasma membrane cholesterol to
increase post-cryopreservation survival is currently a booming topic for the
male gamete of different species (for review, see) but has been little addressed
in oocytes. Previously, Horvath and Seidel and, more recently, Spricigo et al.
reported the use of this method to add cholesterol to bovine oocytes prior to
vitrification. Horvarth and Seidel claimed that cholesterol could enter mature
oocytes through the *cumulus* cells and the *zona pellucida*, improving its
viability after vitrification in a chemically defined system. Spricigo et al.
improved nuclear maturation after treating immature bovine oocytes with
cholesterol loaded MβCD prior to vitrification. However, these effects were not
reflected in the production of embryos *in vitro*. Whereas Horvath and Seidel
analyzed the presence and absence of serum in their assays, Spricigo et al. used
fetal calf serum in order to load MβCD with cholesterol from serum, and also
during the recovery of *cumulus*-oocyte complexes (COCs), *in vitro* maturation
and vitrification. More recently, rabbit oocytes with increased cholesterol
content by exposure to MβCD/cholesterol complexes were found to fail to improve
their developmental competence after either vitrification or slow freezing. In
none of these previous studies was the possibility of removing the added
cholesterol analyzed after warming to recover membrane conditions prior to
vitrification. Previous research has shown that whereas an excess of cholesterol
does not affect meiotic progression, it induces mouse egg activation and it may
cause female infertility. Conversely, a sub-physiological level of cholesterol
in mouse oocytes causes a delay in second polar body extrusion and low
fertilization rates. Cholesterol mediates membrane curvature during fusion
events and recent advances start to reveal common mechanisms also in gamete
interaction. It is clear that abnormal levels of membrane cholesterol could
adversely affect fertilization and subsequent embryo development. Moreover,
membrane cholesterol segregates laterally in small domains (10–200 nm) rich in
sterols (cholesterol) and sphingolipids (sphingomyelin, gangliosides) known as
membrane rafts. Gangliosides are glycosphingolipids that contain sialic acid in
their structure and, particularly, ganglioside GM1 has been found in the mouse
oocyte and in the cleavage furrow of embryos. These specialized microdomains
permit plasma membrane sub-compartmentalization and formation of signaling
platforms that mediate physiological responses. It has been shown that membrane
raft integrity is necessary to efficiently accomplish fertilization in the mouse
oocyte. However, the importance of preserving membrane rafts in
postcryopreserved bovine oocytes as well as in mammalian oocytes in general
still remains unexplored. Exploring the effect of vitrification on membrane
rafts may be particularly relevant considering the important role they play in
cell signaling and gamete interaction.
In order to increase the survival of bovine oocytes after cryopreservation, we
proposed not only to increase cholesterol level of oocyte membranes before
vitrification but also to remove the added cholesterol after warming to recover
its original level. In this respect, MβCD is a unique tool to modulate membrane
cholesterol in living cells. The high affinity of MβCD for cholesterol can be
used not only to generate cholesterol inclusion complexes that donate
cholesterol to the membrane but also to remove cholesterol from biological
membranes when used free of cholesterol. The objectives of this study were to:
(1) modulate cholesterol from membranes of bovine oocytes during vitrification,
(2) determine the time of exposure to MβCD at which oocyte viability is not
compromised, (3) quantify cholesterol incorporation by oocytes and *cumulus*
cells, and (4) evaluate possible disturbance of membrane organization caused by
cryopreservation through the analysis of the raft marker GM1 in living oocytes.
Further understanding how bovine oocytes modulate cholesterol under these
experimental conditions is a starting point to increase cryotolerance and to
improve developmental competence of vitrified-warmed oocytes.
# Materials and methods
## 1- Chemicals and reagents
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO,
USA) unless otherwise stated.
## 2- Oocyte collection and *in vitro* maturation
### 2.1 Oocyte collection
Bovine ovaries from cycling beef heifers (*Bos taurus*) were collected from
local slaughterhouses and transported within 60–90 minutes in a thermic
container to the laboratory. COCs were aspirated from follicles ranging from 2
to 8 mm in diameter by a vacuum system. COCs with homogeneous ooplasm and more
than four complete layers of *cumulus* cells, corresponding to grades 1 and 2
according to de Loos et al., were selected under a stereomicroscope and washed 3
times in phenol red-free HEPES buffered Synthetic Oviductal Fluid (H-SOF)
supplemented with 1% polyvinyl alcohol (PVA) (w:v).
### 2.2 *In vitro* maturation
Selected COCs were incubated in four-well culture plates (NUNC, Thermo Fisher
Scientific, Loughborough, Leicestershire, UK) in groups of 60 per well, with 400
μl of serum- and gonadotropin-free maturation medium: M199 with 0.1 mg/ml
L-glutamine and 2.2 mg/ml NaHCO<sub>3</sub> supplemented with 10 ng/ml epidermal
growth factor (EGF), 30 μg/ml hyaluronic acid, and 100 μM cysteamine as anti-
oxidant. COCs were incubated for 20 hours at 38.5°C under 5% CO<sub>2</sub> in
humidified air. When necessary, *cumulus* cells were removed either mechanically
or by a brief exposure to 1 mg/ml hyaluronidase (Type IV-S from bovine testes),
and *zona pellucida* (ZP) was dissolved with 1 mg/ml pronase (protease from
*Streptomyces griseus*) under visual monitoring. ZP-free oocytes were rapidly
washed 5 times and kept at 38.5°C under 5% CO<sub>2</sub> in humidified air for
1-hour recovery. Experimental groups were defined as COCs matured in chemically
defined medium, namely (1) without treatment (control), (2) loaded with
cholesterol the last 45 minutes or 2 hours of maturation, (3) loaded with
cholesterol the last 45 minutes or 2 hours of maturation and subsequently
depleted of cholesterol for the same periods of time.
## 3- Cholesterol enrichment and depletion with methyl-β-cyclodextrin
MβCD complexed with cholesterol or alone was used to enrich and remove
cholesterol from cell membranes, respectively. A stock solution of MβCD (0.5 M)
in M199 was stored at 4°C in a glass tube. MβCD/cholesterol complexes (molar
ratio 8:1) were prepared in M199 according to Christian et al.. Briefly,
cholesterol in chloroform:methanol 1:1 (v:v) was completely dried under a stream
of nitrogen. A 15 mM MβCD aqueous solution was subsequently added to the dried
material. The mixture was clarified by vigorous mixing, sonicated in bath
sonication for 1–3 minutes and incubated in a rotating water bath at 37°C
overnight. Before using the solution, it was filtered through a 0.45 μm syringe
filter and equilibrated at the incubator.
COCs with partially removed *cumulus* cells (2–3 *cumulus* cell layers) and the
bulk of *cumulus* cells were incubated separately with 15 mM MβCD/cholesterol
for 45 minutes or 2 hours at 38.5°C under 5% CO<sub>2</sub> in humidified air
during the last period of *in vitro* maturation. In addition, in order to remove
the added cholesterol from membranes, COCs were incubated with different
concentrations of “empty” MβCD for 45 minutes or 2 hours. Before incubation with
fluorescent probe Amplex® Red, oocytes were completely denuded.
## 4- Vitrification and warming
COCs with partially removed *cumulus* cells (2–3 *cumulus* cell layers) were
vitrified with the surface device Cryotech® (ex Cryotop®) using vitrification
and warming solutions of known composition. These protein free solutions were
adapted from the literature available replacing serum by the synthetic polymer
PVA. Phenol red- and calcium-free H-SOF supplemented with 1% PVA was used to
handle COCs and as base medium to prepare vitrification and warming solutions.
Vitrification was performed following the protocol of Zhou et al. with some
modifications. Briefly, COCs with 2–3 *cumulus* cell layers were vitrified with
heated stage at 39°C (except for cholesterol loaded COCs that were vitrified at
room temperature) and vitrification solutions at room temperature (25–27°C).
COCs were equilibrated for 10 minutes in Equilibration Solution (ES) with 7.5%
ethylene glycol and 7.5% DMSO and vitrified in Vitrification Solution (VS) with
15% ethylene glycol, 15% DMSO and 0.5M sucrose for 45–60 seconds including
mounting onto Cryotech® (3 COCs/Cryotech®) and plunging into liquid nitrogen.
Almost all VS was removed to leave only a thin layer covering the COCs. Warming
was performed stepwise into decreasing sucrose solutions (1 M for 1 minute and
0.5 M for 3 minutes) and subsequently washed twice for 5 minutes in H-SOF/PVA.
The heated stage was used at 39°C and warming solutions were maintained at 37°C
during the whole procedure. Recovery of COCs was achieved at the incubator for 2
hours.
## 5- *In situ* detection of activated caspases
Apoptosis was analyzed in living cells through detection of activated caspases
with a specific fluorescent inhibitor (VAD-FMK-FITC, Calbiochem®). Caspase
inhibitor (VAD-FMK) conjugated to FITC is cell permeable, nontoxic and
irreversibly binds to activated caspases in apoptotic cells. Denuded oocytes
were incubated in 1:300 VAD-FMK-FITC in M199 for 45 minutes at 38.5°C under 5%
CO<sub>2</sub> in humidified air. Oocytes were washed in H-SOF/PVA with 1:500
propidium iodide (Calbiochem®) to assess membrane integrity. They were finally
mounted for detection by fluorescence microscopy using a B-2A filter (microscope
Nikon TE-300; Nikon, Tokyo, Japan). Oocytes showing brilliant green fluorescence
were considered caspase positive.
## 6- Quantification of free cholesterol and cholesterol esters by Amplex® Red
Based on an enzyme-coupled reaction that detects both free cholesterol and
cholesteryl esters, cholesterol levels were measured through a fluorometric
method (Amplex® Red Cholesterol Assay Kit, Molecular Probes®) using an SLM model
4800 spectrofluorimeter (SLM Instruments, Urbana, IL) with a vertically
polarized light beam from a Hannovia 200-W Hg/Xe arc lamp, obtained by a Glan-
Thompson polarizer (4-nm excitation and emission slits), and 3- x 3-mm quartz
cuvettes. Temperature for the assay (37°C) was set with a thermostat-controlled
circulating bath (Haake, Darmstadt, Germany). Free cholesterol was measured
performing incubation for 30 minutes in the dark. The fraction of cholesterol
that is in the form of cholesterol esters was determined adding cholesterol
esterase after free cholesterol measurement (time zero) and recording
measurements after 30, 60 and 90 minutes. The latter incubation-time was the
maximum at which all measurements reached a *plateau*. Measurements were
performed in samples of 45–50 matured oocytes and the corresponding *cumulus*
cells derived from MβCD-treated or untreated COCs. Fluorescence was measured
with an excitation of 560 nm and emission of 590 nm. Background fluorescence
determined for the non-cholesterol control sample was subtracted from each
value. Cholesterol content was expressed as pmol of cholesterol per oocyte and
nmol of cholesterol per mg of protein for *cumulus* cells. Protein content of
*cumulus* cells was quantified by a direct method using a spectrophotometer
(Picodrop, P100, UK).
## 7- Live cell imaging of lipids
### 7.1 Staining of lipid droplets with Nile Red
Denuded oocytes were incubated with 1 μg/ml Nile Red (Molecular Probes®) in
H-SOF/PVA for 5 minutes at room temperature. The fluorescent lipophilic dye was
excited by a 450 to 500 nm line and yellow emission was detected with a B-2A
filter. Digital photographs of the equatorial part of the oocyte were taken with
a 20X objective in an epifluorescence inverted microscope (Eclipse TE-300;
Nikon, Tokyo, Japan) connected to a DS-Fi1c camera (Nikon, Tokyo, Japan).
Fluorescence intensity from oocytes was measured using ImageJ (Fiji) software.
Barceló-Fimbres and Seidel validated the use of Nile Red to quantify the content
of cytoplasmic neutral lipids in bovine oocytes and embryos.
### 7.2 Fluorescent cholesterol in living oocytes
A stock solution (5 mM) of the fluorescent cholesterol analog, BODIPY-
cholesterol (BPY-chol; Avanti Polar Lipids), was prepared in ethanol and stored
in a dark glass tube under nitrogen at -20°C. Working solution (1 μM) was
obtained diluting the stock in M199 medium (amount of ethanol less than 1%).
Pulse-labeling was performed incubating COCs, *cumulus*-free oocytes and ZP-free
oocytes with BPY-chol for 5 minutes at 38.5°C. Oocytes were immediately washed
and subsequently imaged to avoid internalization of the lipid probe. Digital
photographs were taken with a 20X objective in an epifluorescence inverted
microscope (Eclipse TE-300; Nikon, Tokyo, Japan) connected to a DS-Fi1c camera
(Nikon, Tokyo, Japan). Quantification of fluorescence intensity at the plasma
membrane was measured in ZP-free oocytes by outlining regions of interest (ROI)
in background corrected images using ImageJ (Fiji).
### 7.3 Localization of the raft marker lipid GM1
Glycosphingolipid GM1 was detected in living *cumulus*-free oocytes by using the
fluorescent-labeled cholera toxin B subunit (CTB-AF<sup>488</sup>, Molecular
Probes®), which binds specifically to the ganglioside. Oocytes were incubated at
38.5°C for 10 minutes in M199 supplemented with CTB-AF<sup>488</sup> (20 μg/ml),
washed with H-SOF/PVA, mounted and immediately imaged in an epifluorescence
inverted microscope (Eclipse TE-300; DS-Fi1c camera, Nikon, Tokyo, Japan) to
avoid internalization of toxin-GM1. Quantification of fluorescence intensity at
the plasma membrane was measured by outlining regions of interest (ROI) in
background corrected images using ImageJ (Fiji).
## 8- Statistical analysis
Statistical analysis was carried out using InfoStat software. Fluorescence
intensity was analyzed through Student’s t test when two mean values were
compared and analysis of variance (ANOVA) when more than two mean values were
compared, followed by *post hoc* test analysis of multiple comparisons
Bonferroni or Fisher’s Least Significant Difference (LSD Fisher). Caspase
variable (binomial distribution) was compared using Generalized Linear Mixed
Models (GLMM) with Binomial family, logit link function and LSD Fisher contrast.
Cholesterol content was analyzed through ANOVA and *post hoc* tests of
Bonferroni for autumn-spring samples and LSD Fisher for winter-summer samples.
Differences were considered significant at *P*\<0.05.
# Results
## Effect of cholesterol incorporation and depletion on oocyte viability
Cholesterol-binding drug MβCD was used in order to increase membrane cholesterol
content before vitrification and to remove the added cholesterol after warming.
COCs with partially removed *cumulus* cells were incubated with 15 mM
MβCD/cholesterol for either 45 minutes or 2 hours during the last period of *in
vitro* maturation. Matured COCs were subsequently vitrified-warmed and depleted
of cholesterol within the period of recovery at the incubator. COCs loaded with
cholesterol for 45 minutes were depleted of cholesterol for 45 minutes with 4.25
mM MβCD after warming and maintained in M199 at the incubator until completing 2
hours. COCs loaded with cholesterol for 2 hours were depleted of cholesterol
with 8.5 mM MβCD for the same period of time.
To ensure that the treatment with MβCD produced no alterations in the membrane
with negative implications in viability, programmed cell death (apoptosis)
indicator was analyzed. Detection of activated caspases was analyzed in live
cells by a fluorescent specific inhibitor (FITC-VAD-FMK). This permeable
fluorescent probe binds irreversibly to activated caspases in apoptotic cells
allowing direct detection by fluorescence microscopy. Moreover, these assays
were carried out in the presence of propidium iodide to assess possible
alterations in membrane integrity. This method allowed the analysis of the
possible effect of modulating cholesterol (enrichment/removal) in vitrification
as well as the effect of vitrification itself and the toxicity caused by
exposure to vitrification and warming solutions. Results revealed that
vitrification generated 12% of oocytes with activated caspases while fresh
oocytes presented only \~1% of oocytes caspase positive. In addition, when
cholesterol was incorporated into oocytes for 2 hours prior to vitrification and
removed after warming, the percentage of caspase activation was 26% higher than
that in the vitrified control (12%). No statistical difference in caspase
activation was found when cholesterol was incorporated into oocytes for 45
minutes before vitrification and removed after warming, with respect to the
vitrified control. Moreover, no statistical difference was found in caspase
activation compared to the fresh control. Interestingly, cholesterol modulation
of oocytes for 45 minutes showed a similar level of caspase positive oocytes
with respect to toxicity control (5% vs 7%, respectively) in which untreated
oocytes were exposed to vitrification and warming solutions with no
vitrification. In addition, oocytes were not positive for propidium iodide
(except for some isolated case) in any of the experimental groups analyzed. On
the contrary, when *cumulus* cells were left during incubation with fluorescent
probes, they showed caspase/propidium iodide positive staining at both
incubation times.
## Estimation of relative cholesterol incorporation into bovine oocytes
Taking into account that modulation of cholesterol for 45 minutes did not affect
the apoptotic status of oocyte post-vitrification, fluorescent cholesterol
analog BPY-chol was used to estimate the extent of cholesterol incorporation
under these experimental conditions. COCs, *cumulus*-free oocytes and ZP-free
oocytes were incubated with 1 μM BPY-chol after MβCD/cholesterol treatment of
COCs for 45 minutes. Incubation was performed until finding a time-point (5
minutes) at which the fluorescent cholesterol was highly located at the plasma
membrane of the oocyte. That cholesterol incorporation mediated by
MβCD/cholesterol complexes occurred effectively as well as its extent were both
rapidly verified. An increase in fluorescence intensity was observed under all
conditions analyzed (lower panels) but quantification of fluorescence was
performed in ZP-free oocytes. Cholesterol-specific fluorescence in the plasma
membrane increased \~43% after MβCD/cholesterol treatment compared to BPY-chol-
control oocytes.
## Response of bovine oocytes to cholesterol removal
Once incubation times with MβCD/cholesterol (45 minutes) and BPY-chol (5
minutes) were determined, we analyzed the response of oocytes to cholesterol
depletion with no previous cholesterol loading or vitrification. Interestingly,
ZP-intact oocytes incubated with 15 mM “empty” MβCD for 45 minutes showed
effects only at lipid droplet level. In order to simplify the contribution of
any other unknown variable and to effectively assess cholesterol removal, ZP-
free oocytes were directly exposed to 15 mM MβCD. Even under this direct
exposure, treated oocytes showed no difference in membrane BPY chol fluorescence
level compared to controls (upper panels). Conversely, MβCD-treated oocytes
showed marked differences in the distribution of lipid droplets (LD) observed in
transmission images (middle panels). The cortex of MβCD-treated oocytes was
devoid of LD compared to untreated oocytes. Fluorescent probe Nile Red was in
fact used to visualize these differences in the distribution of LD in MβCD-
treated oocytes. Nile Red is a lipophilic probe that fluoresces yellow with
neutral lipids stored in LD, such as triacylglycerols and cholesterol esters.
Absence of LD in the oocyte cortex was confirmed by specific staining with Nile
Red in live oocytes (lower panels). Quantification of Nile Red fluorescence
intensity showed a decrease of the emitted fluorescence in ZP-free oocytes of
the MβCD-treated group. When ZP-intact oocytes were exposed to MβCD under the
same conditions, this distribution pattern of LD was observed in 35.5 ± 4.2% of
the oocytes, with the cortex showing a lesser extent of absence of LD.
## Quantification of free cholesterol and cholesterol esters in bovine oocytes and *Cumulus* cells
To quantify cholesterol incorporation by oocytes and *cumulus* cells, we used a
highly sensitive fluorometric method that detects both free cholesterol
(membrane cholesterol) and cholesterol esters (stored in LD) using an enzyme
coupled reaction. After free cholesterol is measured (time zero), the
cholesterol fraction in the form of cholesterol esters is determined by adding a
cholesterol esterase within the samples. Measurements were performed in fresh
oocytes and *cumulus* cells from untreated COCs, from COCs incubated with
MβCD/cholesterol complexes for 45 minutes, and from COCs firstly loaded with
cholesterol for 45 minutes and subsequently depleted of cholesterol with empty
MβCD for another 45 minutes. An interesting finding revealed that the content of
membrane cholesterol in bovine oocytes varies among seasonal periods.
Cholesterol was therefore quantified all throughout the seasons. Membrane
cholesterol level of oocytes from autumn was observed to be the same as that of
spring oocytes, whereas winter oocytes showed a membrane cholesterol level
similar to that of summer oocytes. Likewise, a difference of 3 pmol of membrane
cholesterol per oocyte was found between autumn-spring and winter-summer
oocytes, the latter showing the lowest cholesterol level. No differences were
found in basal membrane cholesterol of *cumulus* cells among seasons. However,
when analyzed grouped in both seasonal periods, autumn-spring *cumulus* cells
showed a higher membrane cholesterol level than winter-summer cells (p = 0.04).
Therefore, cholesterol incorporation and recovery to its original level was
analyzed with respect to controls in autumn-spring oocytes versus winter-summer
ones and the same criterion was used for the corresponding *cumulus* cells.
After incubation with MβCD/cholesterol, oocytes showed an increase of membrane
cholesterol of \~2.5 pmol/oocyte, regardless of the season. C*umulus* cells
showed \~2-fold more membrane cholesterol than controls in both seasonal groups.
Recovery of original cholesterol levels after incubation of cholesterol-loaded
COCs with 4.25 mM MβCD was achieved for both oocytes and *cumulus* cells
regardless of the season.
Cholesterol esterase hydrolyzed cholesterol esters stored in cytoplasmic LD of
autumn-spring oocytes until reaching a *plateau* after 60 minutes of incubation
with the enzyme. This behavior, which was observed under all conditions
analyzed, represents -in terms of cholesterol content- total oocyte cholesterol
(free cholesterol + esterified cholesterol). As to winter-summer oocytes,
hydrolysis of cholesterol esters reached the maximum level after 90 minutes of
enzymatic incubation. Under control conditions, cholesterol esters represented
38% of the total cholesterol content of autumn-spring oocytes while they
represented \~60% of the total cholesterol content of winter-summer oocytes. In
absolute terms, oocyte cholesterol esters remained unchanged among seasonal
periods. In *cumulus* cells, \~30% of total cholesterol corresponded to the
ester fraction in autumn-spring but accounted only for 19% in winter-summer.
Hydrolysis of cholesterol esters in *cumulus* cells was more evident during the
first 30 minutes of incubation with the enzyme for both seasonal groups.
## Effect of vitrification on raft marker lipid GM1
The relevance of functional membrane rafts in postcryopreserved bovine oocytes
has not been fully explored to date. The degree of compromise of raft marker
lipid GM1 in vitrification was analyzed using a fluorescent-labeled cholera
toxin B subunit which binds specifically to the ganglioside and permits its
identification in living cells. Bovine oocytes showed enrichment in membrane
rafts evidenced by the presence of the glycolipid GM1 all along the membrane of
living oocytes. As the size of membrane rafts is smaller than the resolution of
light microscopy, this uniform distribution of the GM1-associated fluorescence
was expected. (upper and middle panel) shows how vitrification affected both
localization and level of GM1 at the plasma membrane. The decrease of
GM1-associated fluorescence caused by vitrification either did not occur or, if
it did, it was at least restored when cholesterol was incorporated into oocytes
before vitrification and removed after warming, thus indicating that GM1
related-raft integrity is being preserved by cholesterol modulation. On the
other hand, under these experimental conditions, membrane cholesterol showed no
differences in terms of BPY-chol fluorescence levels between fresh oocytes and
postvitrified treated oocytes. Postvitrified control oocytes showed a tendency
to decrease BPY-chol fluorescence at the plasma membrane. However, the
measurement of BPY-chol fluorescence after enzyme treatment to remove ZP after
warming revealed high variability and therefore no statistical differences could
be observed among the experimental groups. Membrane cholesterol was nonetheless
maintained after warming by previously removing the added cholesterol with a
concentration of empty MβCD but quite lower (4.25 mM) than that used to enrich
membrane cholesterol (15 mM).
# Discussion
Biological membranes undergo a change from a fluid state to an ordered state as
temperature is reduced below the transition temperature of the membrane (\~10°C
in the mature bovine oocyte). This phenomenon is dependent on their lipid
composition. Membranes with high cholesterol:phospholipid ratio or either with
polyunsaturated fatty acids or short chain fatty acids are less sensitive to
sub-physiological temperatures. Bovine oocytes are particularly susceptible to
chilling which occurs at different cellular levels, such as the *zona
pellucida*, plasma membrane, meiotic spindles and cytoskeleton. Cholesterol is
the major non-polar lipid of mammalian cell membranes, where it typically
accounts for 20–25% of total membrane lipid content. The planar structure of
cholesterol confers special biophysical properties that contribute to generate a
semipermeable barrier and to regulate membrane fluidity. Exposing cells to
MβCD/cholesterol complexes containing saturating amounts of cholesterol leads to
cholesterol enrichment depending on the concentration, exposure duration and
cell type. Exposure times to “empty” MβCD required to remove cellular
cholesterol are generally much shorter than those needed to enrich a membrane
that already has its original cholesterol level. To our knowledge, two studies
have been conducted in bovine oocytes using MβCD as a strategy to load
cholesterol in their membranes prior to vitrification. In the first study, the
authors showed that cholesterol diffused through *cumulus* cells and reached the
oocyte but failed to reflect these effects in the production of embryos. The
same methodology was applied later in immature bovine oocytes. In this case,
both the presence of serum and the compact structure of the *cumulus* of
immature oocytes could have limited the availability of MβCD/cholesterol
complexes, affecting the results collected. Overall, the low success reported in
these studies could be due to two main reasons which, to our knowledge, have not
been taken into account to date. (1) Incubations with MβCD/cholesterol complexes
were performed for 25–60 minutes at the concentrations typically used for sperm
(0.5–2 mM MβCD). The lipid mass representing the plasma membrane of an oocyte
(diameter \~80–100 μm), which also has numerous *microvilli*, compared to a cell
as a sperm, is significantly higher. Therefore, the concentrations and/or
incubation times assayed could not have been sufficient to effectively increase
the level of cholesterol in the membranes of oocytes. (2) If before
vitrification, there was a genuine incorporation of cholesterol into the oocyte
plasma membrane, after warming it would be necessary to remove the added
cholesterol to recover the physiological level of cholesterol at the membrane.
In the cholesterol-loaded sperm, this scenario seems not to affect them to a
great extent since cryopreservation itself produces an efflux of cholesterol
that may recover -either totally or partially- cholesterol levels in the
membrane after thawing (this being the reason why it is said that sperm undergo
"cryocapacitation"). In the present work, we have increased MβCD/cholesterol
concentration and we have analyzed two incubation times (45 minutes and 2
hours). We have also hypothesized that removal of cholesterol after warming
better preserves the organization of the plasma membrane by recovering its
original cholesterol level.
*In situ* detection of activated caspases revealed that modulation of
cholesterol for 45 minutes does not affect oocyte apoptotic status. On the
contrary, incubation for 2 hours increases apoptosis after vitrification. Based
on this, it can by hypothesized that the level of apoptosis of oocytes loaded
with cholesterol for 45 minutes, vitrified and recovered (cholesterol removed),
could be due at least by the cytotoxicity caused by cryoprotectants since no
differences were found with respect to the toxicity control group. However, no
significant differences were found either between the apoptotic level of these
oocytes and the fresh controls. It was, in fact, the only experimental group
that showed this condition compared to fresh oocytes, thus indicating a level of
cell death closer to that of fresh oocytes. Interestingly, it has been shown
that cholesterol protects the phospholipid bilayer from oxidative damage. Also,
most part of *cumulus* cells was found to be positive for caspases and propidium
iodide, a marker of cell viability that penetrates when the membrane loses
integrity. Vitrification protocols are not particularly designed to preserve
*cumulus* cells but the oocyte, with the large volume that this cell type
presents. This raises a controversy at the moment of vitrifying bovine oocytes
with the corona *radiata* and some layers of *cumulus* cells to proceed to the
subsequent *in vitro* fertilization (IVF), as is usually done. In mammals,
fertilization rates in oocytes without *cumulus* are markedly low. Furthermore,
intracytoplasmic sperm injection (ICSI), which is performed with success in
human and mouse denuded oocytes (without *cumulus*), still remains inefficient
in the bovine. Because vitrified bovine oocytes lack great part of viable
*cumulus* cells capable of responding to the signaling cascades generated by
sperm, further studies should converge in the adaptation of an IVF protocol for
denuded (and vitrified) oocytes. Recent research has demonstrated that the
presence of several layers of *cumulus* cells during vitrification reduces the
survival of bovine matured oocytes. This research also showed that vitrifying
oocytes either with a few layers of *cumulus* cells or without *cumulus* cells,
but co-incubated with fresh COCs during fertilization, may lead to higher
survival and embryo development.
Our data showed that cholesterol was incorporated into the oocyte plasma
membrane as evidenced by comparative labeling of the fluorescent probe BPY-chol.
However, direct exposure of ZP-free oocytes to empty MβCD was not sufficient to
achieve cholesterol removal in oocytes with physiological levels of cholesterol.
Instead, it affected the distribution of oocyte LD which may reflect that
cholesterol repletion occurs at the plasma membrane. It seems possible that
cholesterol removal occurs concomitantly to cholesterol replenishment driven by
cortical LD through specific hydrolysis of cholesterol esters stored within
these organelles, thus maintaining BPY-chol labeling at the plasma membrane.
Macro-autophagy of LD, termed lipophagy, is a physiological mechanism to degrade
LD in some circumstances. It is important to note that this effect was only
observed in oocytes with physiological levels of cholesterol exposed to MβCD but
not in cholesterol-loaded oocytes in which excess cholesterol was fairly simple
to remove. Nevertheless, under this experimental condition (ZP-free oocytes
exposed to MβCD), restructuring or even disturbance of the underlying
cytoskeleton cannot be discarded. At present, LD have gain notoriety due to
increasing evidence related to their roles in many aspects of health and
disease. The prevalence of metabolic syndromes, obesity, steatosis and
atherosclerosis has prompted further biomedical research on LD since early
embryo stages or even at the oocyte level.
On the other hand, earlier studies have addressed the analysis of the fatty acid
composition of total phospholipids, major phospholipid sub-classes and
triacylglycerols from bovine oocytes and embryos. However, none of these studies
have quantified oocyte cholesterol levels, except for the work of Kim et al. who
measured total cholesterol content. More recently, mass spectrometry has
provided new insights into the composition of different molecular species of
phospholipids, free fatty acids, and triacylglycerols present in single oocytes
and preimplantation embryos. Relative abundance of squalene, a key intermediate
in cholesterol biosynthesis, showed higher levels in bovine immature oocytes
compared to *in vitro* matured oocytes analyzed through this approach. In our
work, an analytical strategy has been conducted to quantify free cholesterol and
esterified cholesterol in bovine oocytes and *cumulus* cells. An interesting
finding revealed that the level of membrane cholesterol in bovine oocytes varies
among seasonal periods. In contrast, cholesterol esters remained stable among
seasons. These variations at the membrane level were enough to account for the
differences also found in total cholesterol. Even when no design was performed
to detect a direct effect of the season, in particular, these results could be
quite close to show this effect. For subsequent analysis, oocytes were grouped
into autumn-spring and winter-summer oocytes taking into account similar levels
found in membrane cholesterol among seasons. Autumn and spring oocytes evidenced
the highest content of membrane cholesterol as well as of total cholesterol.
Equal amount of total cholesterol was found by Kim and co-workers in bovine
oocytes matured in a serum-free medium (9.2 pmol per oocyte), irrespective of
the season. However, when oocytes were matured in the presence of fetal bovine
serum, cholesterol content was significantly higher (15.1 pmol per oocyte) which
can be explained by the fact that serum provides a variety of lipids including
cholesterol. On the other hand, our results showed that the differences found in
total cholesterol of *cumulus* cells were explained by the differences found in
the content of membrane cholesterol and of cholesterol esters. Furthermore,
membrane cholesterol of *cumulus* cells showed the same pattern as that of
oocytes when grouped in these seasonal categories. Our results demonstrate that
the whole COC is dynamic in terms of cholesterol homeostasis.
In addition, both oocytes and *cumulus* cells increased membrane cholesterol
after incubation with MβCD/cholesterol and recovered the original level,
regardless of the season. Also, total cholesterol was restored to physiological
levels. Interestingly, cholesterol-loaded oocytes from winter and summer showed
that membrane cholesterol levels were the same to those of autumn-spring oocytes
at basal conditions. Similar profiles were also observed in the cholesterol
ester fraction and total cholesterol. Altogether, these results suggest a
distinctive cholesterol metabolic status of COCs among seasons. In dairy cows, a
seasonal study showed a higher percentage of saturated fatty acids in
phospholipids of germinal vesicle oocytes and granulosa cells during summer
whereas mainly mono- and polyunsaturated fatty acids (PUFA) predominated during
winter. Biophysical analysis of oocyte membranes revealed that the lipid phase
transition decreased 6°C between summer and winter. These alterations in
membrane composition were associated with decreased developmental competence
during high ambient temperature months. Conditions of heat stress may aggravate
the negative energy balance of dairy cows contributing to the metabolic
imbalance responsible for reduced fertility. Heat stress seems, in fact, to be
relevant for reproductive performance of cows in tropical and subtropical
climates. In this respect, *in vivo* produced embryos of *Bos indicus* during
the rainy season, compared to those produced in the dry season, had a lower
number of apoptotic cells in fresh embryos as well as after freezing. A
connection between nutrition and quality of oocytes and embryos has been
suggested. Nevertheless, even when there is some coincidence in that PUFA rich
diets have beneficial effects on bovine oocyte and embryo quality correlation to
changes in gamete lipid composition still remains to be established. It has also
been proposed that PUFA uptake by the oocyte is selective and highly regulated
to avoid the risk of cellular damage. A recent study has shown that dietary PUFA
supplementation has no effect on the relative abundance of phosphatidylcholine
or sphingomyelin molecular species in bovine blastocysts produced *in vitro*. As
to cholesterol, it is known that plants only have minor amounts of cholesterol
and that the diet is therefore not a cholesterol source for herbivorous,
however, a particular nutritional condition may influence the metabolic status
of oocytes and embryos. Cholesterol may account for up to 45 mol% of the
membrane´s total lipid content in animal cells. Measuring only choline-
phospholipids and total cholesterol, Kim et al. showed that cholesterol to
phospholipid ratio is important in bovine oocytes. Our work provides new data on
unesterified cholesterol and cholesterol esters in bovine oocytes and *cumulus*
cells at different seasonal periods.
Taking into account that cryopreservation may disturb plasma membrane
organization required for fertilization, we analyzed putative raft molecule GM1
in living oocytes. Gangliosides have been found to be involved in multiple
physiological functions, and it is important to understand how their
distribution is regulated in the cell membrane. It has been shown that the
clustering of both GM1 and GM3 at the plasma membrane depends primarily on
membrane cholesterol levels and also on intact actin cytoskeleton. To our
knowledge, this is the first report in which ganglioside GM1 is described in the
bovine oocyte. Vitrification was observed to clearly affect the localization and
level of GM1 at the plasma membrane. In line with this, dispersion of GM1
clusters by chilling was reported in mouse fibroblast analyzed by immunoelectron
microscopy after quick-freezing and freeze-fracture. However, when cholesterol
was incorporated into oocytes before vitrification and removed after warming,
GM1 levels at the plasma membrane were not altered or at least restored.
Likewise, membrane cholesterol was maintained after warming. Cholesterol
modulation during vitrification and warming could therefore be a useful tool to
preserve membrane raft integrity. A glycosylphosphatidylinositol (GPI)-anchored
protein named Juno has been identified as the sperm receptor at the plasma
membrane of mammalian oocytes. GPI-anchored proteins are enriched in non-
invaginated membrane rafts highlighting how important plasma membrane
organization is for fertilization. Further analyses will be needed to address
membrane lipid compromise during vitrification of bovine oocytes. Emerging
studies in embryos have found differences between fresh and vitrified bovine
blastocysts in certain molecular species of choline-phospholipids and
triacylglycerols.
Cholesterol is a key contributory factor to membrane properties, particularly
membrane fluidity. This is the first study conducted to date on free cholesterol
and cholesterol esters in bovine oocytes and *cumulus* cells. Interestingly,
cholesterol levels differed among seasonal periods revealing a distinctive
metabolic status of COCs. Also, the whole COC showed a dynamic organizational
structure in terms of cholesterol homeostasis. Modulation of membrane
cholesterol by MβCD improved oocyte survival after vitrification yielding levels
of cell death closer to those of fresh oocytes. Oocytes effectively incorporated
membrane cholesterol prior to vitrification and recovered their original level
after cholesterol removal. Cholesterol modulation also preserved membrane
localization of the raft lipid GM1 after vitrification, thus suggesting its
possible role as a cryotolerance marker. Future studies on the biophysical
properties of oocyte and *cumulus* cell membranes will provide new insights to
understand the role of lipid behavior in the developmental competence of
cryopreserved oocytes.
The authors thank translator Viviana Soler for controlling the use of English
language and Adriana Lauro for her technical assistance in oocyte collection and
handling.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** JB SSA RHA. **Formal analysis:** JB JRC SSA
RHA. **Funding acquisition:** JB SSA RHA. **Investigation:** JB GLR JRC SSA.
**Methodology:** JB GLR SSA RHA. **Project administration:** JB SSA RHA.
**Resources:** JB JRC SSA RHA. **Visualization:** JB SSA RHA. **Writing –
original draft:** JB SSA RHA. **Writing – review & editing:** SSA RHA.
|
# Worrying me softly with your tweets: Anxiety contagion between leaders and followers in computer-mediated communication during COVID-19
Emotional contagion, “a process in which a person or group influences the
emotions or behavior of another person or group through the conscious or
unconscious induction of emotion states and behavioral attitudes” \[, p. 50\],
plays an important role in several domains, including social interactions and
leadership. Previous work has identified that in face-to-face leader-follower
interactions, leaders do not only transfer emotions to their followers via
tacit, subconscious processes, but also can transfer emotions deliberately “with
the intention of attaining certain interactions or task outcomes” \[, p. 659\].
Leaders are likely to influence follower affect, due to leaders’ status role,
which corresponds to access to resources and authority to shape the work
environment as leaders see fit. However, less is known about the transfer of
emotions between organizational leaders and followers in computer-mediated
communication (CMC) on public social media platforms such as Twitter. The
presented research addresses this gap.
Based on emotional contagion, we explore the relationship between leader and
follower anxiety. We focus on anxiety due to its state <u>and</u> trait
properties. And while previous studies have focused on the dispositional
differences and situational characteristics that trigger anxiety, a longitudinal
examination of the transfer of leader anxiety to followers, in particular using
CMC, has not been conducted. In this respect, our study responds to the need of
understanding further emotional contagion in organizational life by examining a
widely used and powerful means of communication between leaders and followers.
Finally, we explore possible changes in the transfer of anxiety from leaders to
followers before and during a threatening situation, namely the COVID-19
pandemic. Anxiety is considered the default crisis emotion, given that
individuals in a crisis (i.e., a particularly threatening) situation experience
anxiety more intensely and frequently than any other crisis emotion \[incl.
anger, fear or sadness; \]. Hence, we examine whether during a crisis the
occurrence and impact of anxiety contagion from leaders to followers differ
compared to normal circumstances. We examine this particular phenomenon in an
exploratory manner, using an innovative ML approach to detect both state and
trait anxiety in a large sample of 197 leaders and 958 followers and derive
43,283 daily indications of anxiety from posts and interactions on the Twitter
platform by leaders and followers over 316 days.
## Emotional contagion in face-to-face and computer-mediated communication
Emotional contagion constitutes the transfer and sharing of emotions from one
person to another. As stated by Barsade, Coutifaris, emotional contagion is 1)
comprised of distinct emotions (e.g., anger, anxiety), 2) “occurs via
subconscious and conscious processes that transpire when people are both
elicitors and targets of emotional contagion” \[(p. 138), \] occurs on an
interpersonal level and finally 4) not only influences “how people feel but also
what they subsequently think and do” \[p. 138\].
Based on this definition, we examine emotional contagion as a social influence,
in which “\[person\] A has power over \[person\] B to the extent that \[A\] can
get B to do something that B would otherwise not do” \[, pp. 202–203\], while
the power of person A over person B is affective in nature. If person A is
successful in transferring their emotions to person B, person B non-consciously
imitates the communicated affect, which leads to convergence in both interaction
partners’ emotions. Importantly, previous research oftentimes equates emotions
with affect–a term that comprises all aspects of subjective feelings. To stay
consistent with past research and avoid confusion, throughout this manuscript,
we use the term emotional contagion when describing the transfer of anxiety, as
part of follower affect. Similar to previous studies (Barsade, 2018), we do
distinguish between emotions, short-term affective reactions to stimuli, and
dispositional affect, a trait-like predisposition to experience certain feelings
at any given time.
The majority of scholars have studied the occurrence and underpinnings of
emotional contagion in face-to-face interactions \[for a review see \]. However,
there is some indication that emotional contagion is not only possible in CMC
but also that emotions effectively can spread both directly and indirectly in
social networks such as social media. For example, Cheshin, Rafaeli confirmed
that the transfer of emotion also occurs in virtual teams and that these “text-
based communications of emotion were detected and ‘caught’ by partners
interacting via text-based instant messaging” (p. 3)\]. And in dyadic CMC
interactions partners exchanged messages slower and used shorter messages when
experiencing negative emotions, compared to participants experiencing neutral
emotions. Interaction partners in CMC could also distinguish discrete emotions
in messages, namely anger or happiness. Hence, it seems clear that when
communicating electronically individuals may influence others affectively and
even impact behavioral outcomes.
Yet, the majority of existing studies have examined emotional contagion in CMC
using text-based communication on Web 1.0 platforms, i.e. communication between
two individuals via text, largely ignoring another mainstream means of
communication–social media. Barsade, Coutifaris point out, social media
platforms are much more open, interactive, and dynamic, allowing communication
between an individual and entire groups or communities at once. Hence, social
media platforms allow researchers to study the effects of emotion transfer from
leader to several followers (i.e., from A→B and A→C) simultaneously. Indeed,
previous studies have found that emotions <u>can</u> spread between users via
CMC on social media platforms, and can do so from one user to several others.
Yet, less is known about the spread of discrete emotions via CMC, in particular,
whether some emotions are more likely to be spread and transferred to others.
And as the use of public social media platforms is becoming more prevalent and
accepted by both organizations and employees, we argue that more attention needs
to be paid to the study of emotional contagion from leaders to followers, and
its repercussions on follower affect, via CMC.
## Anxiety contagion between leaders and followers
Anxiety is characterized by negative valence and high arousal, as well as
cognitive appraisals of uncertainty and low control and is a transient emotional
response to an event- or situation-specific context. Throughout this paper
anxiety is based on the presented sub-clinical definition, as opposed to the
clinical diagnosis of anxiety. This transient episode of anxiety, triggered by a
threatening or uncertain situation, is referred to as state anxiety. State
anxiety is short in duration, unlike mood or other forms of dispositional
affect, and is particularly important in the transfer of emotion in
communication because anxiety is functional and “can facilitate constructive
behavior”. For example, in response to situation-specific threats, anxious
individuals are more likely to detect and recognize potential threats, protect
themselves or others, and in general, become more vigilant. Hence, anxiety can
help individuals adapt to potentially threatening and harmful environmental
demands, especially when facing overwhelming threats such as a crisis. However,
most previous research has not focused on the transfer of anxiety but rather
negative and positive affect in general.
In addition, to the best of our knowledge, no previous studies have examined
anxiety contagion between organizational leaders and followers using social
media. Yet, based on previous evidence of emotional contagion between users of
social networks and the signaling power that organizational leaders possess, we
would expect leader state anxiety via CMC to influence follower state anxiety
over time.
1. *Hypothesis 1*: *In CMC*, *leader state anxiety positively predicts
follower state anxiety*.
## The role of trait anxiety
It is important to note that the predisposition to anxiety can vary between
individuals in regards to both intensity <u>and</u> frequency. Hence, some
individuals have a greater tendency to experience anxiety, known as trait
anxiety. Trait anxiety, in combination with state anxiety, influences an
individual’s magnitude of experienced anxiety in any given situation.
Individuals who are predisposed to experience anxiety (i.e., trait anxiety) tend
to perceive situations as more threatening, pay more attention to presented
negative information, and tend to experience stronger physiological and
psychological sensations. Therefore, trait anxiety plays a significant role in
determining the intensity and frequency of experienced state anxiety.
Concerning the leader-follower relationship, we know that leader trait
affectivity can influence contagion susceptibility but also can “influence
leaders’ ability to influence others through emotion” \[, p. 658\].
Hence, we would expect followers of high trait anxiety leaders to be more used
to their leader displaying heightened anxiety to situations in general. Hence,
it is likely that when leaders express heightened state anxiety, followers of
trait anxious leaders are likely to express less state anxiety compared to
followers of leaders who rarely exhibit anxiety. We hypothesize the following:
1. *Hypothesis 2*: *In CMC*, *leader trait anxiety moderates the
relationship between leader state anxiety and follower state anxiety*, *in
that followers of highly trait anxious leaders experience less increased
state anxiety than followers of low trait anxious leaders*.
## The role of context
While more anxious leadership could be associated with more anxious followers in
general, this might change due to context, such as a crisis as “individuals
differ in their adaptation to events, with some individuals changing their set
point and others not changing in reaction to some external event” \[, p. 306\].
Hence, we argue that the transfer of anxiety from organizational leaders (i.e.,
individuals with resources and authority) to their followers would be
particularly useful to examine considering the critical role anxiety plays in
crises. Accordingly, we examine the relationship between leader and follower
anxiety in pre-and during crisis contexts, namely the COVID-19 pandemic.
### Emotional contagion during the COVID-19 pandemic
With terms such as “social distancing” and “flattening the curve” becoming part
of everyday vocabulary, the COVID-19 pandemic is the most challenging health
crisis of the 21<sup>st</sup> century. Coronavirus officially was declared a
worldwide pandemic by 11<sup>th</sup> March 2020 by the World Health
Organization, with governmental work-from-home orders following shortly
thereafter. Employees soon found themselves in a new and, for most, quite
unfamiliar social territory, with homes all over the world converting into
offices, schools, daycares, gyms, etc. while communication to the outside world
mainly moved online. The changing working conditions and the increased economic
pressures have led to a wider socioeconomic crisis, typically followed by
adverse working conditions for employees. Given the increased need for remote
working, managers and employees alike have turned to CMC as a primary means of
communication.
Yet, research on information communication and sharing in a crisis (or crisis-
like situation) is limited. One study examined how communication on Twitter
occurs during the Great East Japan Earthquake in 2011 and concurs with findings
of related studies that negative feelings, such as worry and anxiety, were more
likely to be shared online than neutral or positive feelings. As information
grows explosively in a crisis, people flock online, especially to public
communication platforms such as Twitter, to communicate and share information
with others. Individuals also rely on these platforms to discover and evaluate
how others have been affected by a crisis and in turn can use these platforms to
emotionally influence others. In sum, via social media individuals are both
influenced by and “influence each other more instantly and frequently” \[, p.
2033\]. Therefore, communication on social media platforms provides a feasible
alternative to study emotional contagion between leaders and followers,
especially in the case of a crisis marked by social distancing and a strong
reliance on CMC between organizational members.
Nevertheless, it is important to remember that not all crises are the same, nor
do all crises impact all individuals to the same degree. For example, Barsade,
Coutifaris suggest that in the last financial crisis, individuals who were in
financial distress were more likely influenced by the anxiety described in the
press and social media, and making the transferred anxiety their own, which in
turn affected behavioral outcomes such as restricted spending. However, in the
case of the COVID-19 pandemic, the affective impact of the crisis itself is not
yet clearly defined. On the one hand, previous studies have found that state
anxiety levels have increased for entire populations, on the other hand, recent
studies have also found that exogenous individual differences such as age, risk
behavior, and resilience also influence state anxiety.
In short, the COVID-19 crisis provides a unique setting, in which interactions
between leaders and followers may be studied in extreme circumstances, and
compared to CMC in normal circumstances (i.e., before the onset of the COVID-19
pandemic). Yet, due to the uniqueness of the COVID-19 crisis concerning its
(universal vs. individualized) influence on employees’ affect, we hesitate to
form specific hypotheses regarding pre-and-during-crisis differences in the
relationship between leader and follower anxiety. Hence, we decided to examine
the COVID-19 pandemic context as a possible moderating factor in an exploratory
manner.
# Methodology
Due to the state- and trait-like properties of anxiety, it is crucial to study
follower anxiety over time. The presented study overcomes typical diary study
limitations (e.g., high dropout rates of respondents) by applying anxiety and
personality detection algorithms on a large sample of leaders and followers. The
final sample comprised 197 leaders and 958 followers in 79 companies engaging in
CMC on the public social media platform Twitter. This resulted in a total of
43,283 matched daily leader-follower observations. The respective minimal
anonymized data can be found on Open Science Framework
(<https://osf.io/3r8z7/>). The collection method complied with the terms and
conditions for the websites from which the data was collected.
## Sample and procedure
Our methodology comprises five key steps. The first step involves the
preparation and pre-processing of our dataset. Using an initial database of
organizational leaders and employees
([https://crunchbase.com](https://crunchbase.com/)), and their social media
information, we selected organizations and respective employee social media data
based on the number of listed social media handles. An organization was included
as long as it listed at least ten employees and their public social media
information in our dataset. We define leaders as C-suite executives, i.e.,
individuals with a job title of e.g., Chief Executive Officer (or CEO), Chief
Financial Officer (or CFO), etc. The remaining individuals were classified as
followers. Notably, we only included employees from the United States of
America, as the anxiety detection algorithm was trained exclusively on U.S. data
(see section “Predicting state and trait anxiety”). We recognize that this
categorization approach is limited, primarily for two reasons. Firstly, this
distinction between leaders and followers does not allow us to match followers
with their direct supervisors. However, C-suite executives are largely
recognized as senior organizational leaders, and therefore wield greater
signaling power, which in turn influences all employees. Secondly, one could
argue that high-level leaders might be inclined to censor their social media
communications to ensure that a positive message is conveyed. Such
communications also might be crafted with assistance from the organization’s
communications team or even HR since they enhance employee voice. While we agree
with this argument, we would add that because emotional contagion can occur both
purposefully or intendedly, leaders’ communications still affect their followers
even if leaders are not themselves tweeting. In other words, emotional contagion
still occurs independently whether emotions are communicated on purpose or
unintentionally.
In addition, to further ensure the validity and accuracy of provided information
of leaders and followers and increase the robustness of the provided data, we
manually searched all included leaders and followers on the LinkedIn platform
([https://linkedin.com](https://linkedin.com/)). Doing so allowed us to confirm
that leaders and their respective followers were indeed employed in their
respective organizations throughout the examined timeframe, including pre-and
post-onset of the COVID-19 pandemic.
Finally, we chose to include gender as an additional control in our model,
because gender is an exogenous variable that cannot be influenced by the outcome
variable. Due to the limitations of the Twitter API (twitteR Package
documentation - <https://rpubs.com/Kyleen1991/594933>), a maximum of 3,200
tweets per profile were extracted.
### Predicting state and trait anxiety
In the second step, we annotate the dataset with an anxiety prediction
algorithm. Extracted tweets of all available leaders and followers curated in
the previous step were annotated using the anxiety detection algorithm as
described in Gruda and Hasan. This algorithm was trained on a dataset of 600
randomly selected tweets from 10,386 users, scored by 604 zero-acquaintance
human raters from the United States based on a six-item short-form of the
Spielberger State-Trait Anxiety Inventory \[STAI; \]. On average, each tweet was
rated five times. Each tweet was assigned an anxiety score of between 1 (“Not at
all”; low anxiety) and 4 (“Very much”; high anxiety) by each rater. Two types of
features were extracted from the texts of the tweets. The first type of feature
is based on the pre-trained Global Vectors for Word Representation (Glove)
embedding. The second type of feature comprises the unigram and bigram terms
(including emojis) and the corresponding term frequency (TF). The ML algorithm
was implemented as two Linear Ridge Regression models corresponding to the sets
of features described earlier. For the prediction of anxiety scores of non-
labeled tweets, the average of the two predicted scores from the two models is
taken as the final score. The training procedure involved the use of a 6-fold
cross-validation resampling plan and resulted in a model with R<sup>2</sup> =
0.49 and a Root-Mean-Square Error (RMSE) of 0.52. The trained model was
validated using a set of 3.33 million tweets. The model predicted the anxiety
scores of the tweets to be between 1 and 4 for 99.7% of the tweets (*M* = 2.34,
*SD* = 0.36).
Trait anxiety was accounted for using the same algorithm as described above.
Given that trait anxiety is traditionally measured as the frequency of anxiety
experiences, in this study trait anxiety constituted a 30 day average of anxiety
scores per user, derived from available tweets before the examined period
(before 5<sup>th</sup> October 2019). This provided us with approximately one
month of anxiety ratings per individual (i.e., leaders and followers) in our
dataset.
Manual evaluation of the predicted anxiety scores for our dataset showed that
the scores were highly correlated with the emotion expressed in the tweets. For
instance, the tweet *“Thank you everyone—it’s been a busy week*! *We love our
wonderful \[…\] community*!*”* was predicted to have an anxiety score of 1.7217,
while the tweet “*How it feels to be a web team fighting DDoS \[…\]*” was
assigned an anxiety score of 2.5432. Finally, the tweet *“\[…\] no no no*. *Not
a happy place*.*”* was scored 3.099.
### Predicting the Big-Five personality traits
Emotional contagion susceptibility may be influenced by individual differences.
Hence, we measure and control for all Big Five leader and follower personality
traits. Previous work \[e.g., –\] has shown that personality traits can be
measured accurately and successfully in online contexts using social media data.
Therefore, in our third step, each Twitter profile was fed into the IBM Watson
Personality Insights API, which extracts and analyzes social media textual data
to identify personality traits based on linguistic analysis.
IBM Watson relies on an open-vocabulary machine-learning approach and is used to
compute raw trait scores and subsequently compare raw scores to a reference
sample of 1,000,000 individuals. A pre-condition for using this service is that
the examined Twitter profiles need to be public and have a minimum of 100 words
across tweets. The provided mean absolute error indicates the difference between
estimated or predicted scores and actual scores. The IBM Watson Personality
Insights algorithm provides a Watson estimates error rate of ca. 12%. In
addition, the IBM Watson algorithm also provides six individual facets for each
Big Five personality dimension. All facets were combined into higher-order Big
Five personality dimensions (all Cronbach α ≥.70, except for Openness to
Experience: α =.68, see). Although a higher Cronbach alpha could have been
achieved in the case of Openness to Experience by excluding the facet
“adventureness” (α =.73), we decided to include all facets to ensure a full
picture of the examined data.
### Post-annotation dataset consolidation
Our fourth step comprised the consolidation of state and trait anxiety scores
(Step 2) with predicted Big-five personality traits (Step 3). From the resulting
dataset, we formed pairwise combinations between leaders and followers, within
companies, based on the time of the tweet. For example, tweets by followers from
1<sup>st</sup> March 2020 were paired with leader tweets of the same day.
Due to the maximum number of (3,200) tweets limitations by the Twitter API, and
since we also examine the role of context, specifically the COVID-19 crisis, as
a secondary research question, we focused our main analyses on matched leader-
follower observations between 5<sup>th</sup> October 2019 and 13<sup>th</sup>
August 2020. Doing so provided us with a somewhat balanced dataset of 158 days
before and 158 days after the onset of COVID-19. We classified the onset of
COVID-19 to be the 11<sup>th</sup> March 2020, during which COVID-19 was
officially declared a worldwide pandemic by the World Health Organization.
Finally, since leaders and followers are nested within companies, we excluded
companies with less than four daily leader-follower observations. Put
differently, we disregarded cases in which there were less than four posted
dyads between leaders and their respective followers on the same day. This
threshold was identified as the bottom 10% of our dataset and was implemented to
ensure data reliability on a company level. This final step resulted in a total
of 43,283 matched daily leader-follower observations between 197 leaders and 958
followers across 79 companies.
### Analytical strategy
In our dataset, followers are nested within leader-follower dyads, which in turn
are nested within companies; observations in our dataset are not independent.
Hence, we use a multi-level cross-classified mixed-effects model for repeated
measures to test our hypotheses. We define a three-level model with random
intercepts at the company level. To compare the overall goodness of fit across
models, we used the Aikake Information Criterion (AIC) and the Bayesian
Information Criterion (BIC), which facilitate a comparison of mixed models with
different numbers of levels and predictors. All analyses were conducted using
Stata 16.0.
# Results
Summary statistics and pairwise correlations of variables on the leader and
follower level are shown in. Results of our multi-level cross-classified mixed-
effects model for repeated measures are shown in.
All outlined models in include various control variables, as noted below in the
respective table. To minimize the potential of an unaccounted “third variable”
causing a shift in both leader and follower state anxiety on the same day, we
apply a multi-day lagged regression design. Doing so allows us to test the
following: if a leader posts a highly (or less) anxious tweet today, are
respective followers more likely to post (less) anxious tweets on subsequent
days? The proposed lag analysis also allowed us to account for potential sleeper
effects of the leader-follower anxiety influence.
In we present the results of this multi-day lagged regression design, namely by
examining whether leader state anxiety on Day 1 predicts follower state anxiety
on Day 2, controlling for both leader and follower state anxiety (Day 0 and Day
1), respectively. We also controlled for possible spillover effects of follower
state anxiety on preceding days (i.e., Day 0 and Day 1) and of leader state
anxiety on preceding days (i.e., Day 0). The main two-way interaction was
significant (M2: *b* = 0.10, *SE* = 0.05, *z* = -2.08, *p* = 0.037).
## Context as a moderating factor
We further examine our findings in the context of the COVID-19 pandemic. To do
so, we created a dummy variable, which specifies the pre-and-post onset of
COVID-19 (11<sup>th</sup> March 2020, the WHO declares COVID-19 a worldwide
pandemic). Model 3 includes the examined three-way interaction and all
considered controls (identical to M1 and M2). We find a significant three-way
interaction, between leader state- and trait-anxiety on follower anxiety and the
pre-and-post onset of the COVID-19 pandemic(M3: *b* = -0.19, *SE* =.09, *z* =
-2.10, *p* = 0.036). To better understand this interaction, we plotted the
results of the complete model (M3) in.
Graphing this three-way interaction (5<sup>th</sup> and 95<sup>th</sup>
percentile) showed that in the case of less trait anxious leaders, leader state
anxiety on Day 1 was associated positively with high follower state anxiety on
the next day during the pandemic (simple slope = 0.06, *SE* = 0.02, *z* = 3.53,
*p* \<.001). Hence, it seems that in a crisis context, followers of less trait
anxious leaders seemed to be most impacted by increased leader state anxiety
than followers of more trait anxious leaders.
In the case of trait anxious leaders, this trend was not significant (simple
slope = -0.02, *SE* = 0.01, *z* = -1.26, *p* \> 0.10). Results before the onset
of the COVID-19 pandemic were even less pronounced and proved to be not
significant both in the case of less trait anxious (simple slope = 0.01, *SE* =
0.01, *z* = 1.03, *p* \> 0.10) as well as trait anxious leaders (simple slope =
0.01, *SE* = 0.01, *z* = 0.60, *p* \> 0.10).
### Robustness checks
We also tested the same three-way interaction using a continuous-time variable
instead of the aforementioned dummy variable. Results remained unchanged with
the examined three-way interaction between leader state anxiety (Day 1)
predicting follower state anxiety (Day 2) over time (*b* =.00, *SE* = 0.00, *z*
= -2.29, *p* = 0.02).
# Discussion
Previous research has found that leaders effectively transfer emotions to their
followers in face-to-face communications. However, less clarity exists
concerning the transfer of emotion via CMC in a naturally occurring environment.
In this study, we find that leader state anxiety predicts follower state
anxiety, even when accounting for a series of leader and follower personality
traits and demographics (e.g., leader and follower trait anxiety, gender, etc.).
We also find that follower state anxiety is a function of both leader state-
(i.e., leaders’ experience of event-specific anxiety over time) and leader trait
anxiety (i.e., leaders’ tendency to experience anxiety in general). Hence,
followers of highly trait anxious leaders and who are experiencing increased
state anxiety (e.g., due to COVID-19 pandemic and its repercussions), experience
less state anxiety than followers of less trait anxious leaders. Put
differently, followers of leaders who do not tend to be anxious in general
(unrelated to a specific event), seem to be less used to their leaders’ affect
and might be more susceptible to their leaders’ increased state anxiety. This
could be because followers of trait anxious leaders might discount their
leaders’ expressed anxiety and instead look for emotional cues from other
important people in their lives (e.g., peers, colleagues, etc.), while the same
is not the case for followers of less trait anxious leaders. Relational
individual differences might play a role here as well \[e.g., \].
# Implications
We argue that the study of anxiety as a follower outcome is particularly
important because the experience of anxiety can have destructive consequences,
including depleted self-regulation, and increased and prolonged emotional
exhaustion. In addition, anxious individuals, in their aim to lower their
anxiety oftentimes reach out to others for advice, but also are more likely to
accept un-advantageous or even inappropriate and harmful advice from others.
Finally, the transfer of anxiety from leader to follower is important because it
can serve as a precursor of the subsequent cascading emotional contagion between
team members, which can determine team affect over time. Hence, we suggest that
even low rates of “anxiety spread” may be meaningful in influencing team
members’ affect over time.
We found that the proposed effects seem to be dependent on the contextual
effects of the COVID-19 pandemic. The COVID-19 crisis emerged very fast with an
all-encompassing impact on individuals, organizations, and communities. Although
there are similarities between the COVID-19 pandemic and previous crises
regarding economic consequences, the COVID-19 crisis brings to the forefront
critical health and safety issues as well. For example, social distancing
created serious knock-on effects on the way people communicate, collaborate, and
work. This in turn means that the use of social platforms of communication
increased dramatically with various consequences including mental health. In our
study, we found that the transfer of anxiety via social media from leaders to
followers is stronger throughout the pandemic compared to the examined pre-
pandemic period. In that sense, we suggest that the role of crisis context is of
particular importance in transferring anxiety between leaders and followers and
should not be ignored. The crisis context makes people more vulnerable and
stressed resulting in decreasing their commitment to organizational leaders and
their organization overall. In this respect, leaders need to understand that
during a crisis everything counts, even the words they are publicly expressing
via social media. There is a specific trend for leaders to try to take more
responsibility and respond to employees’ demands during a crisis period.
However, this seems not to be always the ideal action, since some evidence
suggests that leaders’ effort to take responsibility during a crisis and
communicate their thoughts can harm their own as well as their followers’ well-
being. This also seems to be the case when communicating online based on the
results of this study. Since social media is becoming a dominant way of
triggering collective behavior in organizations; leaders that once used to
influence their follower’s anxiety levels in face-to-face communication, seem to
equally affect their emotional status by simply tweeting. In this respect, our
study demonstrates the potential negative implications of leadership
communication via social media by highlighting the impact of being a
communicative leader under adverse situations on follower well-being. Based on
our findings, one clear implication is related to the way that leaders can use
social media communication. We suggest that leaders should be more aware of the
impact of their communication to others using CMC and learn to behave more
strategically, specifically avoiding comments on issues that might be be
perceived as negative by their employees. In addition, mentoring programs or
even CMC training could potentially help leaders develop their social media
communication skills.
# Limitations and future research
Our study is not without limitations. Firstly, although our applied ML
methodology allows us to score millions of tweets across a long period of time,
it could be argued that social media profiles might not reflect actual
personality but rather an idealized form of user representation. Yet, previous
research has found strong support for assessing personality traits in social
media posts. Indeed, we would argue that the anxiety detection algorithm
specifically is superior to self-report ratings of anxiety because the onset of
anxiety is not always immediately evident to the experiencing person and lead to
an increased likelihood of burnout and exhaustion over time if not recognized.
However, due to the behavioral residue in CMC, more accurate changes in anxiety
can be detected.
Secondly, one could argue that the leader-follower dyads in the present paper
are not sufficient, since we do not guarantee that followers actually read their
leaders’ posts. Based on the work of Kramer, we argue that it would not be
computationally feasible to assess whether followers read all of their leaders’
posts. For example, a follower viewing their leaders’ newsfeed likely will be
presented with the most recent or important (i.e., pinned) posts, with more
posts appearing on each page-down, which go unread. It would be unlikely to
expect that social media users’ affect is influenced by unread posts. Hence, our
decision to not systematically include or exclude followers based on which
leader posts followers had viewed constitutes an error, which would only make it
more difficult to find statistically significant results. Yet, we do find that
leaders’ tweets are significantly associated with follower state anxiety as
expressed in followers’ subsequent posts.
Thirdly, we recognize that we could have restricted our data collection approach
to followers who actively commented on their leaders’ posts. While this might
have increased our observed effect size, we chose not to restrict our sample in
this way, due to possible existing disclosure norms. We argue that it is likely
that even if the transferred leader emotion is not felt by their followers,
followers might feel required to respond, most likely in agreement with and in
support of their leaders’ respective post content and tone. This is likely
because a) organizational leaders hold positions of status, authority, and power
over lower-ranked employees and b) interactions on Twitter constitute public
statements. Moreover, leaders who communicate using social media usually do not
direct their posts to specific followers but rather use these platforms to
communicate with entire communities. Hence, by not restricting our sample to
only responding followers, we can be confident that any observed effects are not
due to disclosure norms or proximal communication. Finally, although the
presented regression models are based on multi-day lagged analyses, in which a
variable on a given day predicts another variable on subsequent days, this study
is not based on an experimental research design and therefore causal claims
cannot be made to the same extent. However, we would argue that studying wide-
reaching phenomena such as the effect of a real (not simulated) crisis context
in such a large sample would be difficult if not impossible to do using a truly
experimental research design, as randomizing participants into various
experimental conditions is likely not feasible and brings with ethical
considerations as well. Instead, the presented approach allows the study of
interactions in a naturally occurring non-obtrusive manner.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Adipose tissue is a specialized, loose connective tissue laden with adipocytes
and sometimes stored in ectopic locations, such as near muscle, liver, the
heart, and within the abdominal cavity. Adipose tissue usually infiltrates
within or around the muscle fibers, with adipose tissue infiltration “within”
the muscle referred to as intramuscular adipose tissue or “IntraMAT”. IntraMAT
is an important measure in research, and in older individuals and patients with
Duchenne muscular dystrophy, IntraMAT is inversely associated with insulin
resistance, force generation, and a range of functional ability tests (e.g.,
6-minute walk distance, gait speed, sit-to-stand, stair descent time, and timed
up and go tests). Furthermore, studies show that IntraMAT values of the lower
limb muscles, such as the thigh muscles, increase with age. IntraMAT values
therefore aid in our understanding of insulin resistance, muscle functional
ability, and muscle quality and could be used to create thresholds that identify
patients who may be at risk of developing type 2 diabetes in the future. The
values could also help in identifying patients with early myopathy as a window
into muscular dystrophy, for example.
Magnetic resonance imaging (MRI) is a powerful tool to assess the quality and
quantity of human skeletal muscles, and to investigate the IntraMAT of target
muscles, T1-weighted (T1W) imaging and the Dixon method have been frequently
used in previous studies. IntraMAT has been calculated based on T1W images
combined with segmentation analysis in previous studies. The Dixon method is an
alternate, relatively inventive technique for the evaluation of fat fractions
based on the different precessional frequencies of water and lipid protons.
Previous studies confirmed that IntraMAT content by both the T1W and Dixon
methods were consistent or correlated with muscle biopsy, which is the gold
standard to measure IntraMAT. The IntraMAT content in the thigh measured by the
three-point Dixon (3PD) method was approximately 3% in younger men and 6% in
older men. Others have reported specific muscle values: 3.0% for younger and
5.4% for older men in the vastus lateralis (VL) and 3.9% for younger and 7.2%
for older men in the biceps femoris-long head (BF-L). Recently, a study reported
no significant difference (*P* = 0.83) between the fat fractions determined by
two-point Dixon (2PD) and lipocytes assessed by histological analysis taken from
muscle biopsies, indicating that the Dixon technique is reliable for the
quantification of IntraMAT. However, T1W imaging has been widely used for the
diagnosis of diseases as well as in medical imaging research. Previous studies
with T1W imaging have used histograms to separate skeletal muscle tissue and
adipose tissue based on differences in pixel intensity, which mainly comes from
differences in the spin-lattice relaxation times between skeletal muscle and
adipose tissues, whereas others have used different muscle and adipose tissue
threshold settings for discrimination \[, –\]. We previously reported that
IntraMAT content using T1W images is 4.6% in the VL and 16.2% in the BF-L in
older subjects (70.7 ± 3.8 years). These values are slightly higher than those
taken by 3PD images (0.8% for VL and 9% for BF-L). Several factors affect
IntraMAT content between two imaging techniques, including subject
characteristics, differences in spatial resolution, and differences in the
sensitivity of the imaging apparatus to adipose tissues located inside and
outside of the muscle cells.
The proportion of IntraMAT by 2PD is consistent with the results of histological
evaluations from biopsy specimens, and a correlation between the proportion of
IntraMAT by T1W and biopsy results has been reported. It is therefore plausible
that IntraMAT values of T1W and 2PD may match; yet, to the best of our
knowledge, no study has tested the agreement between T1W imaging and Dixon
imaging for IntraMAT content on the same subjects using the same locations.
Thus, the purpose of this study was to compare IntraMAT content determined by
2PD imaging and T1W imaging, calculated using thresholding techniques. This
study is useful for judging whether there is inconsistency in the IntraMAT
contents by the two methods reported in previous studies. Those results are
instrumental for selecting the imaging method used for diagnosis of IntraMAT in
diseased patients. We hypothesized that IntraMAT values obtained with T1W would
be slightly higher than those taken using 2PD.
# Methods
## Subjects
Nineteen younger men (26.2 ± 4.9 years, 22.2 ± 2.2 kg/m<sup>2</sup>) and 13
older men (72.2 ± 6.0 years, 23.9 ± 1.6 kg/m<sup>2</sup>) volunteered to
participate in this study. Subjects were widely recruited healthy and non-obese
(BMI \< 25.0 kg/m<sup>2</sup>) volunteers using a poster in the library. This
experiment was conducted as a prospective study in 2016. Before the experiment,
the procedure, purposes, risks, use data for research and benefits associated
with the study were explained and written consent was obtained with all
subjects. This study was approved by the Research Ethics Committee (Nagoya
University; 2016–0254) and the investigation was performed according to the
principles outlined in the Declaration of Helsinki.
## MRI acquisition
Subjects were assessed with a 3.0 T whole-body MRI scanner (MAGNETOM Verio,
Siemens Healthcare Diagnostics K.K., Tokyo, Japan). Subjects were placed in a
supine position and images of the thigh were acquired using a body coil. We took
consecutive images of the entire thigh using T1W and 2PD imaging. We defined the
mid-thigh according to markers attached at the middle point between the greater
trochanter and the lateral condyle of the femur. The durations for image
acquisition were 4 min for the T1W and 8 min for the 2PD. T1W spin-echo
transaxial images of the right thigh were collected with the following
sequences: three-dimensional, TR = 604 ms; TE = 12 ms; flip angle = 120°;
optimized field of view = 256 × 256 mm; slice thickness = 10 mm; and interslice
gap = 0 mm. All subjects were instructed to remain as still as possible. In-
phase and out-of-phase water and fat transaxial images were obtained to create
water and fat images for analysis. 2PD images of the right thigh were acquired
with the following sequences: three-dimensional, TR = 20 ms; TE1 = 2.450 ms; TE2
= 3.675 ms; flip angle = 9°; optimized field of view = 288 × 288 mm; slice
thickness = 5 mm; and interslice gap = 0 mm.
We calculated the cross-sectional area (CSA) of the thigh in younger and older
subjects from T1W and 2PD images to ensure that the same locations were being
compared. As a result, CSAs of the thigh were not significantly different
between T1W and 2PD values (T1W, 196.2 ± 30.7 cm<sup>2</sup>; 2PD, 195.3 ± 31.0
cm<sup>2</sup>). Therefore, we were able to measure the same area of the thigh
using T1W and 2PD imaging.
## Analysis of thigh composition
MR images were read in random order for the analysis. We measured CSA of
skeletal muscle and IntraMAT of the VL, adductor magnus (AM), and BF-L at the
mid-thigh. Serial axial images were used to help identify muscle boundaries.
### 1) T1-weighted images
We used the Medical Image Processing, Analysis and Visualization software
(version 4.4.0; National Institutes of Health, Bethesda, MD) to analyze images
on a personal computer. The MRI data analysis procedure was essentially the same
as described in previously studies. Briefly, we first corrected for image
heterogeneity caused by suboptimal radiofrequency coil uniformity, or gradient-
driven eddy currents, using a well-established nonparametric nonuniform
intensity normalization (N3) algorithm. This step was essential for subsequent
analyses that assume homogenous signal intensities across images. Optimized
image correction parameters (N3) were determined (end tolerance, 0.0001; maximum
iterations, 100; signal threshold, 1; field distance, 25 mm; subsampling factor,
4; Kernel full width, half maximum of 0.15; Wiener filter noise, 0.01), and the
same parameters were applied to all images. Second, we calculated the CSA of
IntraMAT content at the mid-thigh in T1W images using the threshold method, as
described previously. We then drew six regions of interest (ROIs) of 25
mm<sup>2</sup> each, with three ROIs on the vastus intermedius and three ROIs on
the subcutaneous adipose tissue. The vastus intermedius, which is 99% skeletal
muscle, was chosen to obtain a pure skeletal muscle peak in the pixel
number–signal intensity histogram. The total number of pixels within the six
ROIs was used to produce a frequency distribution and histogram of all pixels
and signal intensities.
To separate muscle and adipose tissues in the pixel number–signal intensity
histogram with minimal investigator bias, we implemented the Otsu threshold
method, a reliable histogram-shape–based thresholding technique used in medical
imaging analysis. To minimize manual tracing-induced errors on thresholding
values, the mean of three trials was used, and the values were applied to the
VL, AM, and BF-L. After carefully tracing the edge of each muscle, the following
parameters were calculated: 1) the total number of pixels within the ROI; 2) the
number of pixels with a signal intensity lower than the threshold value
(skeletal muscle); and 3) the number of pixels with a value higher than the
threshold value (IntraMAT). The IntraMAT content for each muscle was then
calculated using the following equation:
<img src="info:doi/10.1371/journal.pone.0231156.e001" id="pone.0231156.e001g" />
IntraMAT content
(
%
)
=
(
IntraMAT pixel numbers
)
/
\[
(
skeletal muscle pixel numbers
)
\+
(
IntraMAT pixel numbers
)
\]
×
100
### 2). Water and fat images by 2-point Dixon
Dixon images were analyzed using ImageJ (version 1.44; National Institutes of
Health, Bethesda, MD, USA). ROIs were drawn to match the corresponding T1W image
voxel locations for fat and water, calculated using the 3.5 ppm chemical shift
between water and lipid at 3.0 T. From these VOIs, the mean signal intensities
from water and fat images by 2PD were measured to create a Dixon-based fat–water
ratio using the following equation:
<img src="info:doi/10.1371/journal.pone.0231156.e002" id="pone.0231156.e002g" />
IntraMAT content
(
%
)
=
100
×
Fat
mean intensity
/
(
Water
mean intensity
\+
Fat
mean intensity
)
### Reproducibility analysis
Manual segmentation of the thigh muscle compartments was repeated twice in 10
randomly selected subjects by one researcher with 5 years of experience in
muscle image analysis to assess intra-observer reproducibility of the
segmentation process. Intraclass correlation coefficient \[(ICC 2.1)\] in
individual muscles indicated values ranging between 0.92 to 0.97 in T1W and 0.89
to 0.99 in 2PD for IntraMAT content (all *P* \< 0.001).
## Statistical analysis
IntraMAT content calculated by the two MRI methods were compared using Student’s
unpaired *t*-test. We compared IntraMAT content by the two MRI methods between
the younger and the older men using Student’s unpaired *t*-test. We estimated
agreement using the 95% limits of agreement method developed by Bland and
Altman, where the difference between the adipose tissue obtained with water and
fat images by T1W and 2PD imaging is plotted against their means. The limits of
agreement were between 1.96 SD and -1.96 SD. All continuous variables are
expressed as the mean ± SD; a two-tailed *P* \< 0.05 was considered to indicate
statistical significance. All statistical analyses were performed using IBM SPSS
statistics (version 22.0; IBM, Tokyo, Japan).
# Results
shows the IntraMAT content and range for the VL, AM, and BF-L. IntraMAT content
in the VL determined by T1W imaging was not significantly different from that
determined by 2PD; however, IntraMAT contents in the AM and BF-L were
significantly higher with T1W than with 2PD imaging. In the older group,
IntraMAT content was significantly higher than in the younger group in all
muscles and with both the T1W and 2PD methods.
The relationship between IntraMAT content determined using T1W and 2PD is shown
in 2. There was a high positive correlation between these two values using T1W
and 2PD for the different muscles (VL; r = 0.735, *P* \< 0.01, AM; r = -0.717,
*P* \< 0.01, BF-L; r = 0.790, *P* \< 0.01, VL + AM + BF-L; r = 0.686, *P* \<
0.01;).
shows the Bland-Altman plot of IntraMAT content for each of the three muscles
determined using the T1W and 2PD methods. The limits of agreement were between
1.96 SD and -1.96 SD. However, Bland-Altman plots showed that the Pearson r
(difference versus mean) was -0.698 to -0.914 (*P* \< 0.01;); therefore, a
proportional bias was observed in all muscles. This suggests that subjects with
higher IntraMAT contents showed larger differences between the two imaging
modalities.
The limits of agreement in the differences between T1W and 2PD vs. the mean of
the two measurements were between 1.96 SD and −1.96 SD.
Mean value, ------ 95% limits of agreement. Y = 0 is a line of perfect average
agreement.
Thus, we next investigated why there were such differences in IntraMAT content
between the two methods for different muscles. compares a representative T1W
image, its respective binary image, and the fat image from 2PD for three
subjects with relatively higher, middle, and lower IntraMAT contents. Comparing
the arrow portions of the T1W image with the binary image and the 2PD fat image,
it is clear that the portions of adipose tissue do not coincide. This tendency
was observed particularly in subjects with high IntraMAT in T1W images (Figs).
Moreover, in subjects with a large difference in IntraMAT content between T1W
and 2PD, we found a difference in the thresholds in T1W and boundary values of
the muscle and adipose tissue when applying the 2PD IntraMAT content to the T1W
image.
Finally, we selected 10 subjects at random (five young subjects and five older
subjects) and calculated the difference in the threshold in T1W and boundary
values for muscle and adipose tissue and the values after applying the IntraMAT
content of the 2PD to the T1W image for those subjects. Interestingly, there was
a high negative correlation between these two values for the different muscles
(VL; r = -0.874, *P* \< 0.01, BF-L; r = -0.944, *P* \< 0.01, VL + BF-L; r =
-0.955, *P* \< 0.01;). This result indicates that the difference in IntraMAT
content between T1W and 2PD methods depends on the threshold setting.
Difference in IntraMAT content (%) = 2PD’s IntraMAT content − T1W’s IntraMAT
content. Difference in signal intensity (AU): Threshold of muscle and adipose
tissue on T1W images − boundary value of muscle and adipose tissue when applying
2PD IntraMAT content to T1W images.
# Discussion
The main findings of this study were that: 1) IntraMAT content was significantly
higher in T1W images than in 2PD images for the AM and the BF-L, but not the VL;
and 2) systematic errors were found between T1W and 2PD imaging techniques that
can be explained by variations in the threshold setting.
Many attempts have been made to calculate adipose tissue content within soft
tissues, such as skeletal muscle, heart, and liver, using the Dixon method in
healthy subjects and those with diseases. Previous studies have reported that
IntraMAT content of the VL by the Dixon method ranged from 3.0 to 3.2% in
younger subjects. However, in the present study, the IntraMAT content by 2PD for
young subjects was 10.9 ± 1.2% in the VL, which was three times higher than that
found in previous studies. Imaging methods (2PD or 3PD), differences in volume
and cross-sectional area, subject characteristics or physical activity levels
could all explain these differences in IntraMAT values.
In the present study, the IntraMAT content by T1W was two times higher than that
found in previous studies. A previous study reported that IntraMAT contents of
the VL were 3.6% and 7.7% in younger and older subjects, respectively, who were
men and women. Subject characteristics, physical activity levels, and sex
differences could all explain these differences in IntraMAT values. We showed
that IntraMAT content in the VL and BF-L were 7% and 19%, respectively, in the
older group, and 3% and 13%, respectively, in the younger group. The IntraMAT in
the BF-L was thus 3- to 4-fold higher than that in the VL. Overend and
colleagues, who used computed tomography (CT) imaging for relatively non-
contractile tissue (i.e., IntraMAT and connective tissues) within the quadriceps
and hamstring muscle groups, found that IntraMAT was 3.6% and 5.4%,
respectively, in younger subjects, and 7.7% and 13.6%, respectively, in older
subjects. This difference in content aligns with our findings, and thus, it is a
reasonable finding that the levels of adipose tissue within the VL were less
than that in the BF-L. We also previously measured intramyocellular lipids
(IMCL) and extramyocellular lipids (EMCL) using <sup>1</sup>H magnetic resonance
spectroscopy (<sup>1</sup>H-MRS) in male and female subjects across a broad age
range, and found collective lipid levels ranging from 9.4 to 40.2 mmol/kg wet
weight, respectively, in the VL and from 10.5 to 94.0 mmol/kg wet weight,
respectively, in the BF-L. Accordingly, it is plausible that IntraMAT in the VL
is likely to be lower than that in the BF-L on various imaging modalities,
including MRI, CT, and <sup>1</sup>H-MRS.
Although IntraMAT content in the AM and BF-L by T1W were significantly higher
(by 3.0% and 8.7%, respectively) than that found by 2PD, there was no difference
in IntraMAT content for VL between the two methods, suggesting that the absolute
conformity of the IntraMAT content was muscle-specific. Thus, particular
attention must be paid to the differences noted for AM and BF-L between the two
methods. As shown in, T1W and threshold-adjusted T1W images gave the same
IntraMAT values as that found with 2PD; i.e., 2PD boundary value, located at the
right edge of the muscle peak in the VL, indicated that almost all of the ROI
was skeletal muscle using this thresholding technique. The 2PD threshold was
higher than that for T1W, and this may have led to false results in terms of the
amount of adipose tissue in the AM and BF-L, even though the area was
categorized as skeletal muscle tissue. As a result, IntraMAT content determined
by T1W was significantly higher than that determined by 2PD in the AM and BF-L.
The further assessments conducted in show that the difference in IntraMAT
content determined by T1W and 2PD was almost perfectly associated with
differences in threshold values in randomly selected subjects; i.e. differences
were dependent on signal intensity. This result suggests that the difference in
IntraMAT by T1W and 2PD was closely related but dependent on threshold settings.
This would be the main reason for the systematic errors in the Bland-Altman
analysis of VL, BF-L and AM shown in.
Inhomogeneity of the magnetic field in the MR system may also affect IntraMAT
content values for AM and BF-L. Indeed, a previous study reported that the
magnetic field on T1W images was not constant, with correction necessary to
rectify for such inhomogeneity effects. We used the well-established N3
algorithm to correct for shading in the images due to heterogeneity linked to
suboptimal radiofrequency coil uniformity or gradient-driven eddy currents.
Although we confirm that shading was much decreased compared with the original
MR image, there is still some shading evident (e.g., from anterior to posterior
or medial to lateral). We expect that these persistent shading defects may have
influenced our IntraMAT values. In addition, we considered that the location of
muscles and imaging methods could be related changes in the signal-to-noise
ratio (SNR). We measured SNR with the subtraction method, which is the most
commonly used method. In this method, a difference image was obtained by
subtracting two identical images. We measured the SNR between T1W and water
images, and T1W and fat images for 10 subjects, in the same size ROI of four
corners (ROI 1 to ROI 4) to compare the SNR between the ROIs. The SNR in ROI 4
was a significantly higher than in ROI 1, but there was no significant
difference between the other ROIs. In this study, VL was on the ROI 3 side, AM
was on the ROI 2 side, and BF-L was on the ROI 4 side. These results suggest
that the effect of SNR was not observed independent of the location of muscles
in this study. Unfortunately, we could not use the same voxel size between the
T1W and 2PD imaging methods because of the MR device; therefore, the effect of
the SNR on the results of IntraMAT could not be excluded. Furthermore, the
effect of local distortion in the MR by distance of the center of the gantry to
the body coil and the measurement site could also be related to the difference
in IntraMAT content between T1W and 2PD. Thus, this study had some important
limitations. Further human and phantom experiments under stable conditions of
voxel size, SNR, and specific absorption rate would be required to reveal what
caused the difference in IntraMAT content between T1W and 2PD.
Importantly, T1W has been used to measure IntraMAT in previous studies, with a
close relationship between IntraMAT content by T1W and histochemical analysis of
muscle biopsies. Furthermore, T1W can be used in any MRI systems from lower to
higher magnetic fields. However, the Dixon method is recommended for MRI with a
1.5T or higher because of its technical limitations in being able to clearly
distinguish between water and fat signals. IntraMAT content by both T1W and 2PD
methods was consistent or correlated with muscle biopsy in previous studies,
However, when T1W imaging is used, extra care must be taken of the IntraMAT
content discrepancy with 2PD found in this study.
The discrepancy in IntraMAT contents of the T1W and 2PD methods is unknown in
this study. We previously showed that IntraMAT content by T1W primarily
represents EMCL, not IMCL, in the VL and BF-L muscles. On one hand, this could
be because a relatively 5 to 10 times larger amount of lipids accumulates in the
interstitium compared with the cytoplasm of the muscle cells. On the other hand,
Fischer et al. (2014) reported that IntraMAT content by 2PD was closely related
with the sum of IMCL and EMCL contents detected by <sup>1</sup>H-MRS (r = 0.918
to 0.990, *P* \< 0.001). However, it has not been established that IntraMAT
contents by both T1W and 2PD methods reflected EMCL only, as shown by Akima et
al., or IMCL and EMCL, as shown in Fischer et al. using <sup>1</sup>H-MRS. The
major limitation in the present study was that we did not directly compare
biopsy or <sup>1</sup>H-MRS results with MR images (T1W and 2PD), and we did not
detect the exact changes in fat content (IMCL and EMCL) or total adipose tissue
content. Therefore, it is important that additional research is carried out to
confirm the validity of segmentation analyses for T1W and 2PD images by
combining IMCL and EMCL data with <sup>1</sup>H-MRS or histochemical analysis.
# Conclusions
Although there was no significant difference between T1W and 2PD in IntraMAT
content for the VL, the IntraMAT content using T1W was significantly higher in
the AM and BF-L as compared with the 2PD method. We suggest that this is
primarily because of differences in threshold settings when using T1W,
particularly for measurements of the BF-L. Thus, these results suggest that care
should be taken when selecting an imaging modality for IntraMAT, especially for
patients who would be suspected of having higher IntraMAT values.
The authors gratefully thank the volunteers for participation as well as Dr.
Haruo Isoda, radiological technologist, Mr. Akira Ishizuka (Graduate School of
Medicine, Nagoya University), and nurse, Yoko Onoda. This study was supported in
part by a Grant-in-Aid for JSPS Research Fellow (to MO) and a Suzuken Memorial
Foundation and Editage Grant (to NT).
10.1371/journal.pone.0231156.r001
Decision Letter 0
Sanada
Kiyoshi
Academic Editor
2020
Kiyoshi Sanada
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
14 Nov 2019
PONE-D-19-29508
Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images
PLOS ONE
Dear Dr. Ogawa,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
We would appreciate receiving your revised manuscript by Dec 29 2019 11:59PM.
When you are ready to submit your revision, log on to
<https://www.editorialmanager.com/pone/> and select the 'Submissions Needing
Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter.
To enhance the reproducibility of your results, we recommend that if applicable
you deposit your laboratory protocols in protocols.io, where a protocol can be
assigned its own identifier (DOI) such that it can be cited independently in the
future. For instructions see: <http://journals.plos.org/plosone/s/submission-
guidelines#loc-laboratory-protocols>
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). This letter should be uploaded as separate file and labeled
'Response to Reviewers'.A marked-up copy of your manuscript that highlights
changes made to the original version. This file should be uploaded as separate
file and labeled 'Revised Manuscript with Track Changes'.An unmarked version of
your revised paper without tracked changes. This file should be uploaded as
separate file and labeled 'Manuscript'.
Please note while forming your response, if your article is accepted, you may
have the opportunity to make the peer review history publicly available. The
record will include editor decision letters (with reviews) and your responses to
reviewer comments. If eligible, we will contact you to opt in or out.
We look forward to receiving your revised manuscript.
Kind regards,
Kiyoshi Sanada, PhD
Academic Editor
PLOS ONE
Journal Requirements:
1\. When submitting your revision, we need you to address these additional
requirements.
Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_m
ain_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_f
ormatting_sample_title_authors_affiliations.pdf>
2\. Please provide additional details regarding participant consent. In the
ethics statement in the Methods and online submission information, please ensure
that you have specified who gave consent and whether it was informed.
3\. We note that you have indicated that data from this study are available upon
request. PLOS only allows data to be available upon request if there are legal
or ethical restrictions on sharing data publicly. For information on
unacceptable data access restrictions, please see
<http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-
access-restrictions>.
In your revised cover letter, please address the following prompts:
a\) If there are ethical or legal restrictions on sharing a de-identified data
set, please explain them in detail (e.g., data contain potentially identifying
or sensitive patient information) and who has imposed them (e.g., an ethics
committee). Please also provide contact information for a data access committee,
ethics committee, or other institutional body to which data requests may be
sent.
b\) If there are no restrictions, please upload the minimal anonymized data set
necessary to replicate your study findings as either Supporting Information
files or to a stable, public repository and provide us with the relevant URLs,
DOIs, or accession numbers. Please see
<http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-
identify and prepare clinical data for publication. For a list of acceptable
repositories, please see <http://journals.plos.org/plosone/s/data-
availability#loc-recommended-repositories>.
We will update your Data Availability statement on your behalf to reflect the
information you provide.
4\. Please amend either the abstract on the online submission form (via Edit
Submission) or the abstract in the manuscript so that they are identical.
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: In this manuscript, the author aimed to compare intramuscular
adipose tissue content determined by two-point Dixon imaging and T1-weighted
imaging, calculated using thresholding techniques. This study showed that there
was no significant difference between T1W and 2PD in IntraMAT content for the
VL, whereas the IntraMAT content using T1W was significantly higher in the AM
and BF-L as compared with the 2PD method. Additionally, this is primarily
because of differences in threshold settings when using T1W. This manuscript may
be potentially interesting and clinical significance, however, there are several
key concerns that need to be addressed.
Major comments:
1\. The authors concluded that T1W imaging is likely to be the better option for
IntraMAT measurements. It is ambiguous about the process of this conclusion.
Therefore, the authors need to discuss the more clearly. IntraMAT content
determined by T1W was significantly higher than that determined by 2PD in the AM
and BF-L. Which value is appropriate?
2\. What is the gold standard to assess IntraMAT? T1W? Dixon? biopsies? Please
describe in the introduction.
3\. Is the order of measurement randomized? Can the authors clarify the study
protocols?
4\. In the Table 1, the authors should present the comparison between young and
older. It will be interesting to know whether the effects of aging differ
between T1W and 2PD methods.
5\. Instead of showing only the relationship between difference in IntraMAT
contents and difference in signal intensity, Figure should present the
relationship between IntraMAT content determined by T1W and 2PD
6\. In the Figure 3, is there the representative image of Lower IntraMAT?
7\. the authors described “the IntraMAT content of this study by 2PD which was
three times higher than that found in previous studies”. How is T1W compared to
previous studies? Please discuss.
Minor comments:
1\. Please change “positive correlation” to “negative correlation” (page 14,
line 7).
Reviewer \#2: The paper brings some original data and I have read it with a
great interest. Nevertheless I have few comments and suggestions:
The MR image shows a change in contrast when there is a distance change from the
magnetic field center in the gantry.
Therefore, in addition to this experimental data, 1) Change the subject's
imaging position, 2) After imaging at a site away from the center of the bore,
recalculate to see if similar results are obtained.
In addition, the calculated MR signal intensity depends on the voxel size.
Therefore, change the Voxel size and verify that similar results are obtained.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files to be
viewed.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic tool,
<https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS
requirements. To use PACE, you must first register as a user. Registration is
free. Then, login and navigate to the UPLOAD tab, where you will find detailed
instructions on how to use the tool. If you encounter any issues or have any
questions when using PACE, please email us at <[email protected]>. Please note
that Supporting Information files do not need this step.
10.1371/journal.pone.0231156.r002
Author response to Decision Letter 0
5 Jan 2020
Journal Requirements:
Q1. When submitting your revision, we need you to address these additional
requirements.
Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_m
ain_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_f
ormatting_sample_title_authors_affiliations.pdf>
A1. I confirmed PLOS ONE style templates and changed our maniscript.
Q2. Please provide additional details regarding participant consent. In the
ethics statement in the Methods and online submission information, please ensure
that you have specified who gave consent and whether it was informed.
A2.I added Ethics Statement in online and manuscript. However, if you need to
more information, please tell me.
Q3. We note that you have indicated that data from this study are available upon
request. PLOS only allows data to be available upon request if there are legal
or ethical restrictions on sharing data publicly. For information on
unacceptable data access restrictions, please see
<http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-
access-restrictions>.
In your revised cover letter, please address the following prompts:
a\) If there are ethical or legal restrictions on sharing a de-identified data
set, please explain them in detail (e.g., data contain potentially identifying
or sensitive patient information) and who has imposed them (e.g., an ethics
committee). Please also provide contact information for a data access committee,
ethics committee, or other institutional body to which data requests may be
sent.
b\) If there are no restrictions, please upload the minimal anonymized data set
necessary to replicate your study findings as either Supporting Information
files or to a stable, public repository and provide us with the relevant URLs,
DOIs, or accession numbers. Please see
<http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-
identify and prepare clinical data for publication. For a list of acceptable
repositories, please see <http://journals.plos.org/plosone/s/data-
availability#loc-recommended-repositories>.
We will update your Data Availability statement on your behalf to reflect the
information you provide.
A3.Our data contain potentially identifying information and ethics committee
didn't allow the connecting internet those data. Data are available from Ethics
Committee for researchers who meet the criteria for access to confidential data.
Ethics committee of Nagoya University Graduate School of Medicine
Address: Nagoya University 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan
E-mail: <[email protected]>
Q4. Please amend either the abstract on the online submission form (via Edit
Submission) or the abstract in the manuscript so that they are identical.
A4. We apologize for this oversight. We confirmed and changed our abstract in
manuscript and online.
Q5. Your ethics statement must appear in the Methods section of your manuscript.
If your ethics statement is written in any section besides the Methods, please
move it to the Methods section and delete it from any other section. Please also
ensure that your ethics statement is included in your manuscript, as the ethics
section of your online submission will not be published alongside your
manuscript.
A5. We deleted ethics statement in end of our manuscript. We written ethics
statement in Methods.
10.1371/journal.pone.0231156.r003
Decision Letter 1
Sanada
Kiyoshi
Academic Editor
2020
Kiyoshi Sanada
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
29 Jan 2020
PONE-D-19-29508R1
Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images
PLOS ONE
Dear Dr. Ogawa,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
We would appreciate receiving your revised manuscript by Mar 14 2020 11:59PM.
When you are ready to submit your revision, log on to
<https://www.editorialmanager.com/pone/> and select the 'Submissions Needing
Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter.
To enhance the reproducibility of your results, we recommend that if applicable
you deposit your laboratory protocols in protocols.io, where a protocol can be
assigned its own identifier (DOI) such that it can be cited independently in the
future. For instructions see: <http://journals.plos.org/plosone/s/submission-
guidelines#loc-laboratory-protocols>
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). This letter should be uploaded as separate file and labeled
'Response to Reviewers'.A marked-up copy of your manuscript that highlights
changes made to the original version. This file should be uploaded as separate
file and labeled 'Revised Manuscript with Track Changes'.An unmarked version of
your revised paper without tracked changes. This file should be uploaded as
separate file and labeled 'Manuscript'.
Please note while forming your response, if your article is accepted, you may
have the opportunity to make the peer review history publicly available. The
record will include editor decision letters (with reviews) and your responses to
reviewer comments. If eligible, we will contact you to opt in or out.
We look forward to receiving your revised manuscript.
Kind regards,
Kiyoshi Sanada, PhD
Academic Editor
PLOS ONE
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
Reviewer \#2: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The authors have addressed my major concerns, and the manuscript
has much improved. I have no further comments for the authors.
Reviewer \#2: I understand your response.
It can be inferred from the text that T1w and the 2PD method was performed
continuously. Since it is described as "consective," it is not necessary to
describe it as "continuously."
As you know and use it, MR devices have different image data and contrast (power
from changes in SN and SAR) depending on continuous imaging and shimming
conditions. These problems have been corrected in the image conversion process.
If it is far from the center of the gantry, the effect of local distortion, due
to MR, also appears.
It is not a matter of continuity, but the MR system. In addition, the distance
between the body-coil and the measurement site is also an issue.
This paper is a valuable paper that utilizes an uncomplicated evaluation and
hopes for future development. Therefore, it is essential that the reliability of
the published data is established and whether the reader can obtain comparative
data by the same method. I understand your response is giving up its
verification.
The previous advice does not consider continuous imaging as a problem but points
out the reproducibility of data. I highly recommend you to describe problems
with MR equipment properly. The advice for voxel size is the same.
These points should also be considered in the limitations.
If you use a method that can be evaluated easily, it is recommended that you
consider it properly.
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files to be
viewed.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic tool,
<https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS
requirements. To use PACE, you must first register as a user. Registration is
free. Then, login and navigate to the UPLOAD tab, where you will find detailed
instructions on how to use the tool. If you encounter any issues or have any
questions when using PACE, please email us at <[email protected]>. Please note
that Supporting Information files do not need this step.
10.1371/journal.pone.0231156.r004
Author response to Decision Letter 1
11 Mar 2020
Dear Dr. Sanada and Reviewer \#2
We wish to express our deep appreciation to the reviewer for the insightful
comment on our manuscript. We apologize for not answering your previous question
perfectly.
We have worked hard to incorporate your feedback and hope you will agree that
that these revisions have made our manuscript suitable for publication in PLOS
ONE.
Sincerely,
Madoka
10.1371/journal.pone.0231156.r005
Decision Letter 2
Sanada
Kiyoshi
Academic Editor
2020
Kiyoshi Sanada
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
18 Mar 2020
Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images
PONE-D-19-29508R2
Dear Dr. Ogawa,
We are pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
complies with all outstanding technical requirements.
Within one week, you will receive an e-mail containing information on the
amendments required prior to publication. When all required modifications have
been addressed, you will receive a formal acceptance letter and your manuscript
will proceed to our production department and be scheduled for publication.
Shortly after the formal acceptance letter is sent, an invoice for payment will
follow. To ensure an efficient production and billing process, please log into
Editorial Manager at <https://www.editorialmanager.com/pone/>, click the "Update
My Information" link at the top of the page, and update your user information.
If you have any billing related questions, please contact our Author Billing
department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to enable them to help maximize its impact. If they
will be preparing press materials for this manuscript, you must inform our press
team as soon as possible and no later than 48 hours after receiving the formal
acceptance. Your manuscript will remain under strict press embargo until 2 pm
Eastern Time on the date of publication. For more information, please contact
<[email protected]>.
With kind regards,
Kiyoshi Sanada, PhD
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
Reviewer \#2: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: (No Response)
Reviewer \#2: I have no further comments for the authors.
I read the revised version. Although the experimental data can be easily
measured by using the MR device, the verification of the data becomes uncertain
if the experiment is performed without understanding its essence. I think the
paper is more polite than the previous one.
I am looking forward to reading your future paper.
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
10.1371/journal.pone.0231156.r006
Acceptance letter
Sanada
Kiyoshi
Academic Editor
2020
Kiyoshi Sanada
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
23 Mar 2020
PONE-D-19-29508R2
Comparing intramuscular adipose tissue on T1-weighted and two-point Dixon images
Dear Dr. Ogawa:
I am pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please notify them
about your upcoming paper at this point, to enable them to help maximize its
impact. If they will be preparing press materials for this manuscript, please
inform our press team within the next 48 hours. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information please contact <[email protected]>.
For any other questions or concerns, please email <[email protected]>.
Thank you for submitting your work to PLOS ONE.
With kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Kiyoshi Sanada
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
[^2]: Current address: Nippon Sport Science University, Setagaya-ku, Tokyo,
Japan
|
# Introduction
Mouse parvovirus (MPV) is a commonly recognized infectious agent relatively
prevalent in mouse colonies and found in cell culture which can impact research
results, such as potentiate rejection of tumor allograft. Elimination of MPV
from infected colonies relies principally on rederivation; however, there are
aspects of MPV infection that suggest mice may become immune tolerant, for
example MPV has been detected in the gametes of mice. Since parvoviruses
replicate readily in rapidly dividing tissues such as a growing embryo, and
gametes may be infected with MPV, vertical transmission of the virus could lead
to early *in utero* exposure. There have been recent studies demonstrating
rederivation by embryo transfer may not be effective at eliminating minute virus
of mice (MVM), a parvovirus similar to MPV. In these studies, fertilized oocytes
and morulae were exposed to varying concentrations of MVM. Recipient dams and
their progeny receiving embryos infected with as little as 100 ID<sub>50</sub>
seroconverted to MVM. The antibody titers of the progeny dissipated after 20
weeks suggesting they were maternal antibodies, and the authors mentioned
unpublished observation that MVM was shed in the experimental colonies for up to
one year. One plausible cause for this phenomenon is immune tolerance due to *in
utero* exposure.
Within the last several years, we have confirmed MPV seropositivity in three
separate immunocompetent mouse breeding rooms, resulting in attempts to
eliminate the virus from the colony. On each occasion, at least 100 mice in the
colony were tested, and none were identified as seropositive. Although a large
representative number of mice were tested, not all mice were tested, so the use
of microisolator caging may have sequestered low prevalence breaks within the
room, and even within a cage, variation among cage mates could occur. We have
also had experiences in which sentinel mice would seroconvert to MPV and
subsequent sentinel testing was seronegative for several months, only to be
followed by another seropositive sentinel. The cost of confirming or culling
colonies due to erratic serological responses can be significant. This erratic
serologic detection in sentinels is not uncommon based on conversations with
colleagues and presentations at the national meetings. The sporadic nature of
the serologic detection of MPV suggested the possibility that the immune
response to this pathogen is not consistent with the typical exposure-
seroconversion responses noted for most pathogens. The primary rational for
pursuing this study was to determine if immune tolerance was responsible for the
sporadic serologic responses seen in colony mice during an MPV serologic screen.
If parvovirus persists following *in utero* exposure, it could explain the
seroconversion of naïve sentinels, but failure to confirm MPV in subsequent
serologic screening of colony animals.
For a host to develop an appropriate immune response to pathogens, T cell
development occurs in the thymus to make CD4+ or CD8+ T cells. In addition,
these cells must undergo positive and negative selection. Positive selection
enables T cells to recognize self major histocompatibility complex, while
negative selection removes T cells that react to self antigens. The end result
is CD4+ and CD8+ T cells capable of recognizing foreign antigens. The mouse
thymus begins development at embryonic day 10–12 and is not completely developed
until 3–4 weeks after birth. Early experiments with mice have demonstrated one
can induce tolerance to foreign antigens if they are introduced in the neonatal
period prior to thymic maturation. More recently administration of adeno-
associated viral vectors *in utero* and at 2 days post-partum failed to develop
detectable antibodies to the viral vector and subsequent challenge with the
adeno-associated virus demonstrated tolerance as viral vector expression
continued up to 11 months. Immune tolerance due to *in utero* exposure to viral
pathogens has been demonstrated with lymphocytic choriomeningitis virus of mice,
and pestiviruses such as bovine viral diarrhea virus and hog cholera. Similarly,
we hypothesized that mice exposed *in utero* develop tolerance to MPV infection
resulting in the inability to mount a serologic response following post natal
challenge with persistent infection. However, we found that offspring mice
exposed *in utero* by oral inoculation of the dam do not develop tolerance to
MPV infection.
# Materials and Methods
## Mice
Eighteen female and six male, 10–12 week old outbred Crl:CD1(ICR) mice were
purchased from Charles River Laboratories (Wilmington, MA) which were pathogen
free for Sendai virus, pneumonia virus of mice, mouse hepatitis virus, minute
virus of mice, mouse parvovirus, mouse norovirus, Theiler’s murine encephalitis
virus, reovirus, rotavirus, lymphocytic choriomeningitis virus, ectromelia
virus, mouse adenovirus, mouse cytomegalovirus, K virus, polyoma virus,
Hantavirus, lactate dehydrogenase elevating virus, mouse thymic virus,
*Bordetella bronchiseptica*, CAR bacillus, *Citrobacter rodentium*,
*Corynebacterium kutcherii*, *Helicobacter species*, *Klebsiella oxytoca*,
*Mycoplasma pulmonis*, *Pasteurella pneumotropica*, *Salmonella species*,
*Streptobacillus moniliformis*, *Streptococcus pneumonia*, *Clostridium
piliforme*, pinworms, and ectoparasites. Mice were housed in individually
ventilated caging (Thoren Caging System, Inc, Hazelton, PA). Mice were provided
Teklad Irradiated Diet 2918 (Harlan Laboratories, Madison, WI) and filter
sterilized water and allowed to acclimate for 7 days prior to initiating the
studies. All mice were maintained under a 12:12-h light:dark cycle at
temperatures of 21 to 24°C. All animal experiments were approved by the Colorado
State University Institutional Animal Care and Use Committee (09-143A-01) and
carried out with the recommendations in the *Guide for the Care and Use of
Laboratory Animals* of the National Institutes of Health.
## Experimental Infections
Mice were maintained in harems of three females to one male and allowed to breed
naturally. Females were checked for vaginal plugs daily to confirm mating.
Following successful plugs, female mice were separated. Thirteen time-pregnant
female mice were inoculated with 50 ID50 of MPV1e, a mouse passaged strain of
MPV, via oral gavage at day 5 and 12 gestation as previously described. Briefly,
MPV1e was isolated from a naturally occurring infection and was maintained by
oral inoculation of naïve mice with filter-sterilized tissue homogenate. The
ID50 was determined in in weaning mice by oral inoculation of serial dilutions.
Four control time-mated female mice received a control inoculation of 100
microliters of phosphate buffered saline at day 5 and 12 gestation. The pups
were fostered to time-mated, MPV negative dams prior to the presence of a milk
spot. Once fostered, the original dams were euthanized by asphyxiation with
carbon dioxide, blood was collected by cardiocentesis, and feces was collected
for PCR analysis.
At 21 days, mice were weaned from the foster dams. Foster dams were euthanized,
and blood and tissues collected as described above. Blood from the tail vein and
feces were collected from weanling mice to confirm MPV negative status. After
weanling mice were confirmed MPV seronegative and PCR negative, 10 male and 10
female mice were orally challenged by gastric gavage with MPV1e, and 5 of each
sex received mock inoculum as control, as described above and tested weekly by
fecal PCR. Four weeks post-inoculation, mice were euthanized with carbon
dioxide. Blood and feces were collected to evaluate viral presence by serology
and PCR, respectively.
## Mouse parvovirus Assays
Mice were monitored for fecal shedding by PCR every other day post-inoculation
for the first 7 days to confirm MPV infection. Feces was collected and
homogenized in PBS as previously described, and DNA isolated from fecal pellets
using a Qiagen DNA extraction kit according to the manufacturer’s instructions.
Quantitative (real time) PCR reactions were performed in a BioRad iCycler using
well established primers and cycle times.
Serum was collected by centrifugation of blood at 3,000 rpm for 10 minutes and
diluted 1:5 in saline. Serologic assays using the Multiplex Fluorometric
ImmunoAssay® were performed by Charles River Laboratories using their
established protocols to evaluate MPV specific antibodies. Capture antigens used
on the Multiplesx Fluorometric ImmunoAssay® platform included the non-structural
protein NS-1 and two virus capsid proteins (VP-2) for MPV-1 and MPV-2.
## Statistical Analysis
Analysis was done using SAS 9.4 (SAS Institute, Inc., Cary, NC). Fisher’s exact
test was used to compare positive rates (PCR or serology) across inoculation
groups (sham/sham, MPV/sham, sham/MPV, MPV/MPV). A separate test was conducted
for each testing method and day (PCR- 0, 2, 4, 6, and 28; serology 0 and 28).
Similarly, Fisher’s exact test was used to compare conception rates across
inoculation groups (sham and MPV). A homoscedastic two-tailed *t*-test was used
to compare litter size between MPV and sham infected dams. P-values less than
0.05 were considered statistically significant.
# Results
## Mouse parvovirus infectivity
Of the thirteen pregnant mice inoculated with MPV at day 5 and 12 gestation,
eleven of them were confirmed infected by fecal PCR. The foster dams were all
fecal PCR negative for MPV. The weanling mice were all PCR and serologically
negative to MPV prior to infection. After confirming they were MPV negative, 21
day old weanling mice from MPV inoculated or sham inoculated dams were assigned
to two groups for subsequent MPV challenge. Group 1 had 20 mice (10 females, 10
males) from sham inoculated dams that received a sham inoculation; group 2 had 9
mice (5 females, 4 males) from MPV inoculated dams that received a sham
inoculation; group 3 had 20 mice (10 females, 10 males) from MPV inoculated dams
that received a sham MPV challenge inoculation; and group 4 had 23 mice (11
females, 12 males) from MPV inoculated dams that received an MPV challenge
inoculation.
Serum and feces were collected from weanling mice at day 2, 4, 6 and 28 days
post inoculation for serology and PCR evaluation. Sham inoculated mice from sham
inoculated (Group 1) and MPV inoculated dams (Group 2) were consistently
negative at all time points. Fecal PCR results for MPV inoculated mice from sham
inoculated dams (Group 3) demonstrated 19 of 20 mice were MPV positive for at
least one time point, and fecal PCR assays for MPV inoculated mice from MPV
inoculated dams (Group 4) demonstrated 18 of 23 mice were MPV positive for at
least one time point. All foster dams were serologically negative to MPV after
mice were weaned.
Antibodies to MPV were not detected in the weanling mice originating from either
sham or MPV inoculated dams prior to MPV inoculation. At the conclusion of the
study, there were no serum antibodies detected in the sham inoculated mice from
sham (Group 1) or MPV infected dams (Group 2). Serum antibodies were detected in
all MPV inoculated mice from both sham (Group 3) and MPV infected dams (Group
4). demonstrates the frequency of positive fecal PCR assays over time for each
group and pre- and post-inoculation serology results.
## Conception rates and litter size
Seventeen of the 18 mice bred successfully as indicated by the presence of a
vaginal plug. Following oral inoculation with MPV1e, five of the 13 MPV infected
dams (38%) had pups. All four of the sham inoculated dams (100%) had viable
pups. The litter sizes varied greatly between the two groups, although it was
not statistically significant (p = 0.08). The litter size of the MPV infected
mice ranged from 1–13 with an average litter size of 6.5, while the sham
inoculated mice had a litter size ranging from 8–13 with an average of 10. While
this is notable, it was not statistically significant (p = 0.24).
# Discussion
Clearly, our hypothesis that mice exposed *in utero* develop tolerance to MPV
infection resulting in the inability to mount a serologic response following
post natal challenge with persistent infection was not supported in this study.
The mice exposed *in utero* to MPV were able to mount an antibody response to
MPV challenge post natal suggesting that oral inoculation of MPV at gestational
day 5 and 12 does not result in an immune tolerance in their offspring.
Pregnant mice were inoculated with mouse parvovirus at day 5 and 12 gestation.
The initial inoculation of MPV would result in a viremia at approximately 12
days gestation, coinciding with thymic development at embryonic day 10–12. The
subsequent inoculation at day 12 gestation corresponded with thymic development
in an effort to maximize thymic exposure to MPV. At this point in thymic
development, the T cells would recognize the parvoviral antigens as self,
resulting in immune tolerance. This would manifest itself with the inability to
mount an antibody response to MPV as an adult, yet continue to have virus
persist within the mice. This was not the case in this experiment as all MPV
challenged mice seroconverted after exposure *in utero*; therefore, minimizing
the chances that immune tolerance is responsible for the sporadic serology
responses typically seen in endemic MPV mouse colonies.
There are several studies that indicate that immune tolerance to specific
antigens can be induced if the antigen is present during thymic development,
including post natal thymic development. In an early experiment demonstrating
this phenomenon, CBA mice were inoculated *in utero* with adult tissue cells
from an A strain mouse. CBA feti were exposed by a surgical laparotomy and given
an intra-embryonic injection of adult tissues from an A strain mouse. The
offspring of the CBA mice were subsequently capable of accepting skin grafts
from A strain mice, whereas, those that were not exposed *in utero* rejected the
skin grafts. The cause for the acceptance of the skin graft from a different
mouse strain resulted from immune tolerance induced by early fetal exposure to
the antigen. This technique is still used experimentally to overcome the immune
response. For example, adeno-associated viral vector used in gene therapy often
result in an immune response to the vector and the transgene. To overcome this,
immune tolerance was induced in mice via the administration of the protein *in
utero* and at day 2 post natal. *In utero* exposure was done by surgically
exposing the feti and injecting the antigen intramuscularly. Neonatal exposure
was generated via an intramuscular injection at 2 days post natal. In both sets
of experiments and routes, challenge with antigen resulted in immune tolerance
as demonstrated by a failure to induce an antibody response to the protein.
These provide examples of inducing immune tolerance from *in utero* exposure by
very invasive means. It is unlikely that this invasive type of exposure would
occur in conventional mouse colonies. Because the primary route of infection of
MPV is fecal-oral, the oral route of inoculation was chosen to best mimic
exposure in a traditional mouse colony. These mice failed to develop immune
tolerance with post natal inoculation. Similarly, tolerance was not induced to a
viral vector when fetal mice were exposed to the antigen at day 13 to 15
gestation by intramuscular injection. It is certainly possible that the route of
inoculation or the concentration of the inoculum was insufficient to induce
tolerance; however, the route is typical of what may occur in a conventional
mouse facility at a dose that likely exceeds what may be found by the fecal-oral
route of exposure. Although every parameter was not investigated, this study
does not support that immune tolerance could be an explanation for perceived
hidden infections in mouse colonies.
The most common method to eliminate pathogens from mouse colonies is
rederivation or embryo transfer, and previous studies have demonstrated
successful rederivation of MPV-infected mice by embryo transfer. Since
parvoviruses have a predilection for rapidly dividing cells, such as the growing
embryo or fetus, one potential complication with this procedure is vertical
transmission of pathogens which could result in embryo infection, and
consequently immune tolerance. When pregnant mice were challenged with MPV
orally in this study, the offspring seroconverted to subsequent MPV challenge
after maternal antibodies were found not to be present. Thus the common oral
route of transmission in a conventional mouse facility does not result in *in
utero* exposure sufficient to result in immune tolerance of the progeny,
suggesting vertical transmission is not an important mode of transmission.
Therefore rederivation or embryo transfer procedures would be effective in
eliminating mouse parvovirus from mouse colonies.
There have been several reports using cross fostering of neonatal mice to
eliminate murine pathogens. This includes mouse hepatitis virus, Theiler’s
murine encephalomyelitis virus, mouse rotavirus and *Helicobacter hepaticus*.
These studies removed neonates from their dams 24–48 hours after birth and
placed them with pathogen free foster dams in a new cage. One study performed an
iodine dip of the neonates prior to placing with the foster dam to treat any
pathogens on the neonates prior to transfer. When neonates from MPV infected
dams were removed prior to developing a milk spot and placed on foster dams in
new cages, the mice remained MPV negative by fecal PCR and serology up to 7
weeks of age. Furthermore, their foster dams did not develop antibody titers to
MPV suggesting that the pups were not infected while in their original home cage
prior to transferring them to the foster dam. While a more extensive study would
need to be performed to confirm these observations, it appears that cross
fostering may be useful to eliminate MPV from mouse colonies since our study
failed to demonstrate *in utero* transmission.
One final observation from this study was the reduced litter size in the MPV
infected dams. While there was not a statistically significant difference, the
MPV infected dams had reduced conception rates and reduced litter sizes. This
may be due to the effects of MPV infection on the developing embryos, similar to
the effects human parvovirus may have during pregnancy in people.
These results demonstrate that pregnant mice infected with MPV via the oral
route do not induce immune tolerance in the offspring. This information bodes
well for those using rederivation, embryo transfer or cross fostering as a means
to eliminate MPV from their mouse colonies as vertical transmission does not
appear to be significant.
# Supporting Information
We would like to thank Elisa French for technical assistance and animal care.
This work was funded by a grant from the American College of Laboratory Animal
Medicine Foundation and Merck & Co., Inc. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the
manuscript. The authors have declared no financial or non-financial competing
interest exist.
MPV mouse parvovirus
MVM minute virus of mice
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: LVK KSH. Performed the
experiments: LVK CA KSH. Analyzed the data: LVK CA KSH. Contributed
reagents/materials/analysis tools: LVK KSH. Wrote the paper: LVK CA KSH.
|
# Introduction
The fact that many insect species are difficult to be discriminated at the
morphological level, as well as the huge number of cryptic species, makes the
global species count uncertain. The adoption of DNA-based molecular markers
represents a satisfactory alternative. Since the proposal of DNA barcoding in
2003, subunit I (658 bp) of the mitochondrial cytochrome C oxidase (COX) gene
(namely COI) became the most universal marker for species identification in the
animal kingdom. The recently developed Barcode Index Number (BIN) system
(Ratnasingham and Hebert, 2013) can act as a powerful alternative to
morphological species that easily distinguishes the occurrence of diversity or
possible speciation. Technically speaking, this system complements the
molecular-based approaches of species identification to strengthen and support
the evolutionary analysis in insects.
Documentation of insect diversity in the Sahara-Arabian region including Saudi
Arabia has recently taken place as the biodiversity data available for this
region is insufficient, compared with those in Canada or the US. Documentation
based on the criteria of the International Union for Conservation of Nature
allows recognizing invasive alien species or list threatened species. Malaise
traps were successfully used in scoring richness of insect species and
biodiversity surveillance in regions that are difficult-to-access and/or in the
absence of formal taxonomic assignments.
COX enzyme functionally participates in the electron transport chain by reducing
oxygen and pumping protons across the inner mitochondrial membrane. The encoded
protein of COI comprising 219 amino acids (AAs) consists of six polypeptide
chains and a few metallic ligands. The latter includes two iron atoms bound in
two heme groups, three coppers, one zinc and one magnesium. Changes in the AA
sequence within the COI region likely reduce cellular energy metabolism,
especially when changes occur close to the active sites of the enzyme. Purifying
selection predominantly occurs for animal mitochondrial protein-coding genes,
thus, results in the scarce of AA substitutions, especially in the COX genes.
However, evidence of nonsynonymous AA substitution supports the notion of
positive selection generally in animal and specifically in class Insecta. Due to
the functional constraints criterion, changes should be biased to the
nonfunctioning regions of the gene supporting the claim that evolution is not
neutral. Positive selection for changes in mitochondrial proteins during
evolution could be caused by lifestyle changes, and this has been observed in
snakes changing their metabolic rate to complement lifestyle.
In this work, we introduce a model study on the COI subunit of specimens of six
insect orders collected from Saudi Arabia to generate DNA barcodes and detect
variation among species and orders at the AA level. Based on the latter, changes
in COI protein structure at the three-dimensional model are projected. Through
this model study, we gained new insights into the possible mechanisms by which
COI protein evolves in insects living in Saudi Arabia.
# Materials and methods
For sample collection, a Malaise trap (<u>Hutcheson and Jones, 1999; Hill et
al., 2005</u>) was installed at Hada Al-Sham station, King Abdulaziz University
(KAU) located in the western region (near Makkah) of Saudi Arabia
(21.795<sup>o</sup>N, 39.711<sup>o</sup>E). Samples were collected on a weekly
basis for four weeks (May 1–28, 2017) into 95% ethanol and stored at -20°C for
further analysis. Specimens were morphologically classified down to the species
level, then total DNAs were recovered from individual tissue samples according
to Evans and Paulay. PCR was performed to recover the COI gene fragment (650 bp)
as described by Ashfaq et al. and amplicons were shipped to Macrogen (South
Korea) for Sanger sequencing. Recovered sequences were checked for quality and
those meeting the standard criteria were further assigned to subsequent
analysis. Good quality sequences were trimmed and algorithmically aligned with
Clustal Omega with strict parameters and the resulting alignments were manually
refined before translation. Deduced AA sequences were recovered consulting the
invertebrate mitochondrial code. Samples with nucleotide deletions were excluded
upon DNA multi-sequence alignment, and only in-frame AA sequences were retained.
A consensus sequence of Odonata (accession no. JN294479) was used as a reference
for comparison. This order is the most ancient in the hexapoda insect phenogram.
Binary data matrices were entered into TFPGA (version 1.3) and analyzed using
qualitative routine to generate a similarity coefficient. Dissimilarity
coefficients were used to construct dendrograms using unweighted pair group
method with arithmetic average (UPGMA) and sequential hierarchical and nested
clustering (Neighbor-Joining or NJ) routine using NTSYSpc (version 2.10, Exeter
software). Phylogeny tree generated by Bybee et al., was taken as a reference
ancestral order for testing insect lineage and evolution.
The AA sequence of cattle (*Bos taurus*) was used as a reference for detecting
changes of COI protein of selected species at the 3D structure level. We
recruited the bovine protein X-ray structure (Protein Data Bank ID 1OCC) as a
homology model of the COI barcode region to build 3D structures of selected
insect species using the I-TASSER Suite. Distance measurements between AAs, on
one side, and the two heme ligands referenced as 515 and 516, on the other side,
were estimated using UCSF Chimera 1.13.1. Electrostatic potential of the COI
protein was estimated using DeepView—Swiss-PdbViewer (v4.1)
(<http://www.expasy.org/spdbv>)
Nucleotide substitution patterns, e.g., synonymous (S) and nonsynonymous (N),
were generated using the Estimate Substitution Matrix feature in MEGA v. 6 and
estimates of the numbers of S and N substitutions per site were made using the
joint Maximum Likelihood reconstructions of ancestral states of codon
substitution and Felsenstein model of nucleotide substitution. Changes in AA
sequences were scored referring to the consensus sequence of Odonata.
# Results and discussion
COI barcode was analyzed at the DNA and protein levels for insects living in
Saudi Arabia in order to gain new insights as to how this gene and its encoded
protein evolve among different insect orders. A number of 560 samples were
collected by the Malaise trap within a period of four weeks. Photographs were
taken for all specimens, while the number was eventually narrowed to one
photograph per species as shown in. DNAs were purified from these samples and
the recovered mitochondrial COI gene fragments were sequenced. We projected to
include only sequences with ≥ 634 nucleotides encoding all loops and helices of
the COI protein. The number of deduced AAs is 211 starting at codon position 12
referring to the numbering made by Pentinsaari et al.. Based on the rigid
quality control criterion, the number of samples was narrowed to 175 for further
analysis. The consensus DNA sequence of Odonata was included for comparison as
this order has an ancient phylogenetic position being the representative of the
first ancient winged insects in the hexapoda phylogeny. This order has
extensively been used as a reference in contemporary evolutionary genomic
studies. BLAST analysis indicated that a number of 30 species representing six
insect orders were collected during the course of this study. Two of which
belong to Hemimetabolous, e.g., Blattodea (one species) and Hemiptera (five
species), while four belong to Holometabolous, e.g., Hymenoptera (six species),
Coleoptera (six species), Lepidoptera (five species) and Diptera (seven
species). One of the Hymenopteran species was not precisely identified at both
the morphological and molecular levels, while showed the closest relationship
(98%) with *Apoidea* sp.
Multiple DNA sequence alignment indicated that a number of 265 nucleotides out
of 634 are common (conserved) in the recovered COI barcode, while the rest
varied among orders and species as shown in. A phylogenetic tree constructed
from the sequences indicated the close relationship between the species of
Odonata and Blattodea as both orders are hemimetabolous. Recent research
indicated that Blattodea is the closest among the six orders of the present
study to Odonata. Interestingly, a close relationship was shown between species
of Hemiptera and Hymenoptera although the first is hemimetabolous, while the
second is holometabolous. Species of Coleoptera were shown in close relationship
with those of Diptera.
As it is the case with animal mitochondrial DNA, the DNA COI barcode sequences
analyzed for the six orders is AT-biased (e.g., AT content = \~68%) as shown in.
The AT content was lowest (\~57%) for the nucleotides in the first position of
all codons, while \~58% in the second position and as high as \~90% in the third
position. The G nucleotide has proven to be the least degenerate among the four
nucleotides in the third position. Interestingly, A nucleotide in the second
position was unexpectedly low (\<15%), while C was high (\~25%). No G nucleotide
was scored in the third position for four species namely *Hymenoptera* sp.,
*Belenois aurota*, *Asyndetus* sp. and *Carpomya vesuviana*. The first two
species are Hymenoperan and Lepidopteran, respectively, while the other two are
Dipteran. The lowest C nucleotide in the third position was scored for the two
Hymenoptran species *Tachytes crassus* (\<2%) and *Nomioides facilis* (\<1%).
Amino acid sequences of COI barcode were sorted out in this study based on their
chemical properties into standard groups: nonpolar aliphatic (G, A, V, L, M and
I), polar uncharged (S, T, C, P, N and Q), aromatic (F, Y and W), positively
charged (K, R and H) and negatively charged (D and E). The barcode sequences of
different species largely encode nonpolar AAs. There are differences in the AA
composition of the barcode sequences among orders. Alanine (A) and valine (V)
are lower in barcodes of Hymenopteran species as well as of the Hemipteran
species *Batracomorphus angustatus* compared with those of the other orders. On
the other hand, lysine (K) is exclusively encoded by barcodes of the latter
species although there are very few. Four species of the latter two orders)
Hymenoptera and Hemiptera) also exclusively encode cysteine (C). The two AAs K
and C do not exist in the sequence of cattle COI barcode. We speculate that they
appeared due to AA substitutions in several positions of the animal AA sequence
of the barcode of *Batracomorphus angustatus*. Three other AAs seem to be
encoded in very small amounts in few orders such as glutamine (Q), tyrosine (Y)
and glutamic acid (E). Similar results were previously reached by Pentinsaari et
al. when studying Coleopteran and Lepidopteran species. The scarcity of these
AAs in barcodes can possibly be compensated by AAs of the same chemical groups
at the same position in the polypeptide chain. For example, tyrosine (Y) exists
in three positions, e.g., 38, 113 and 215. The position in the middle is
conserved among the six orders, while substituted to phenylalanine (F) in the
other two positions. The two AAs exist in the same chemical group (aromatic).
Interestingly, the five rare AAs (C, K, Q, Y, and E) are encoded by twofold
degenerate codons. Cysteine in the COI region exists in four species of
Hymenoptera and one species in Hemiptera although in very small amounts, while
completely absent in other species of the six orders. Changes in cysteine in the
barcode sequence can severely affect the secondary structure as well as the
stabilization of tertiary and quaternary structures of the COI protein.
Multiple AA sequence alignment of the COI barcode of the 30 species is shown in.
The encoded AA sequences of the DNA barcode fragment across the six orders cover
211 AAs starting from position 12 to 222 based on the numbering made by
Pentinsaari et al.. This portion of the barcode includes the enzymatically
active part of COX mediating electron transfer from Cu to heme. Amino acid
sequence variation in each position was scored in which we referred to conserved
AAs by asterisks while increasing variability by reducing the number from 9 to
1. Based on the criterion followed by Pentinsaari et al. (2016), the
substitution of AAs with the same chemical property at any given position is not
considered to significantly influence enzyme function. This also depicts the
substitution of AAs from one chemical group to the other in a position far from
the enzyme ligands. However, substitutions that change the AA chemical group
occur close to the enzyme ligands, may likely influence enzyme function. As
indicated earlier, the secondary structure of the barcode region includes six
α-helices connected by five loops. The loops encompass 62 AAs of which
all the eight-plus 11 AAs of loops 1–2 and 3–4, respectively, vary among the six
orders. AAs in loop 2–3 vary in three out of the eight AAs, while 10 out of 23
and five of 12 for loops 3–4 and 5–6, respectively. The loop 3–4 is important
for pointing towards the heme group at the active site of the COI protein. The
higher number of conserved AAs in this study was expected due to the narrow
genetic distances among the six insect orders compared with those shown by
Pentinsaari et al. across the Metazoan barcodes. The number of the conserved AAs
of the barcode sequence among the six insect order is 102 including the known 23
conserved AAs among Metazoan. Overall, AA variations occurring at positions in
the helices 3, 4 and 5 likely have less influence on enzyme function compared
with that in the helices 1 or 2. Besides, AA variations are more pronounced in
loops than in helices.
Functional constraints during the evolution of the insect COI barcode was
checked in the predicted three-dimensional structure in terms of the distances
between AAs and the two heme ligands referred to as hemes 515 and 516. The
analysis indicated a number of 16 AAs mostly in close proximity with heme 515.
These AAs exist in helices 2 (10) and 1 (4) and loop 3–4 (2). They are Thr (T),
Ser (S), Ile (I), Arg (R), Thy (Y), Ile (I), Val (V), His (H), Ala (A), Met (M),
Ile (I), Met (M), Val (V), Ile (I), Gly (G) and Trp (W). They exist at codon
positions 15, 18, 21, 22, 38, 41, 42, 45, 46, 49, 50, 53, 54, 57, 109 and 110,
respectively. Six of them at positions 15, 21, 38, 41, 42 and 57 vary among the
six insect orders, while the rest are conserved. We selected *Batrachedra
amydraula* as a model barcode of the insect conserved sequences for the 16 AAs
in the heme 515 vicinity in which the predicted 3D structure was generated. We
mainly focused on four AAs that directly share six bonds with hemes 515 and 516.
These AAs are R (position 22), Y (position 38), H (position 45) and W (position
110). Two bonds exist between H at position 45 and heme 515 and two other bonds
exist between W and the two heme ligands 515 and 516. Chemical bonds occur
between NH1 molecule of R (position 22) and OMA molecule of heme 515, while OH
molecule of Y (position 38) and O1A molecule of heme 515. Two chemical bonds
occur between NE2 molecule of H (position 45) side chain and both NA and NC
molecules of heme 515. W (position 110) shares N atom of its backbone with O1D
molecule of heme 515 and NE1 molecule of its side chain with O2D molecule of
heme 516. Distances between the four selected AAs and heme ligands of COI
barcode are shown in. All the four AAs are \< 4 Å apart from the respective heme
ligand.
for the AA multiple sequence alignment indicated that the four AAs are conserved
among insect orders except for tyrosine (position 38) that unexpectedly showed
substitution to phenylalanine in two Hymenopteran species, e.g, *Camponotus
maculatus* and *Monomorium junodi*. These two AAs differ in the occurrence of an
OH molecule at the side chain of tyrosine, which is lacking in phenylalanine.
The predicted 3D structure of *Camponotus maculatus* was investigated at this
position in order to detect the possible severity accompanying this
substitution. Tyrosine and phenylalanine share the same chemical group, however,
the structure indicates no chemical bonding between the AA and heme 515 albeit
the possible occurrence of Van der Waals interaction. This is the result of
polarity change due to substitution that increases the chance of splitting heme
from the protein. We speculate that this change in the 3D structure of COI and
its consequence can impair the process of electron transfer from Cu to heme,
thus, potentially affect energy metabolism in the mitochondria. depicts the
alignment of the predicted three-dimensional structures of COI proteins of
*Batrachedra amydraula* and *Camponotus maculatus*. The figure indicates the
occurrence of a hydrogen bond between tyrosine of the first insect at position
38 and Heme 515 while lacking bond between phenylalanine of the second insect at
the same position. The figure also underpins poor alignment of loop 1–2 or 4–5
of the two insect species, which reflects the high rate of varied AA in these
two regions in line with the results of Pentinsaari et al. and those of the
present study. The three-dimensional structure of the protein also indicates
that the change from tyrosine to phenylalanine resulted in the loss of bonding
with heme, thus likely affect energy metabolism. The phenylalanine appears to
form a proper geometric complementarity; however, lacks electrostatic
complementarity due to the absence of the hydroxyl group that contributes to the
electrostatic interaction with the heme, resulting in an increase in
hydrophobicity. This suggests that the protein retains its structure, but not
all of its functions. Moreover, the absence of a single hydrogen bond, computing
the electrostatic potential showed no clear difference when tyrosine is
substituted with phenylalanine.
Phylogenetic tree based on multiple AA sequence alignment of COI barcode
indicated that Hymenoptera is the most genetically distant of all the six insect
orders under study. The tree structure complements that of the tree generated
based on multiple DNA sequence alignment in which Blattodea was shown to be
closest to Odonata. The same criterion applies to the relatedness between the
two orders Hemiptera and Hymenoptera and the two other orders Coleoptera and
Diptera. We further analyzed the six varied AAs at positions 15, 21, 38, 41, 42
and 57, existing within the distance of \< 4Å from heme 515, in terms of
transitions from one biochemical group to the other. At position 15 of the COI
protein, threonine is changed to either serine with the same chemical group
(polar uncharged) or methionine (two-codon AA) with different chemical groups
(nonpolar) in all species of Hymenoptera and Hemiptera, respectively. At
position 21, the substitution of isoleucine to valine in the same chemical group
(nonpolar) has taken place in only *Melanotus villosus* species. At position 38,
the substitution of tyrosine to phenylalanine in the same chemical group has
taken place in the two Hymenopteran species *Monomorium junodi* and *Camponotus
maculatus*. At position 41, the substitution of isoleucine (two-codon AA) to
either leucine (six-codon AA) or methionine (two-codon AA) in the same chemical
group (nonpolar) has taken place in Hymenopteran species except for *Camponotus
maculatus*. An extra substitution at the same position has taken place to valine
also in the same chemical group (nonpolar). At position 42, the substitution of
valine to isoleucine in the same chemical group has taken place in Hymenopteran
species, which was not fully detected at the species level. Interestingly,
substitution at position 57 from isoleucine (nonpolar) to phenylalanine in a
different chemical group (aromatic) has taken place in all Hymenopteran species.
The AA transitions from one chemical group to the other might result in impaired
energy metabolism. The study indicated a small distance between Hymenoptera and
Hemiptera in the phylogenetic tree than between Coleoptera and Hemiptera. The
data of AA substitution support our speculation that Hymenoptera is the most
genetically distant of all the other insect orders under study. As Hymenopteran
species are shown closely related to Hemipteran species and the fact that
Hymenopteran species showed AA substitutions in five out of the six varied AAs
in close proximity with the heme ligand indicate that Hymenoptera might be among
the oldest insect orders.
The estimated nucleotide substitution matrices in the COI barcode of the six
orders generally showed a slightly higher probability of transversion compared
with transition. The probability of transversion ranged between \~40% for the
Coleopteran species *Melanotus villosus* and \~65% for the Hymenopteran species
*Tachytes crassus*. Substitutions of A followed by T to any other nucleotide
represents the lowest probability compared with the rest. Changes from C to T
followed by G to A showed the highest transition frequency compared with the
others. These two high transition frequencies justify the high TA ratio in
insect orders and the bias against G or C during evolution. Both Coleoptera and
Diptera showed the most notable bias against G.
Maximum Likelihood computations of codon-by-codon synonymous (s) and
nonsynonymous (n) substitutions in COI protein were conducted using the HyPhy
software package in which Odonata was used as the reference ancestral order. The
total number of nonsynonymous codons is 109, out of 211, of which 102 of them
showed positive values at different rates across the six orders. The other seven
codons showed negative dN-dS values, hence, listed under purifying selection.
Hymenoperan followed by Hemipteran species are severely under positive selection
as the values of dN-dS were positive in 90 and 61 out of the 102 codons,
respectively. Twenty-two extremely high positive dN-dS values (\> 1.0) in 13
codons were scored for species only of these two orders; the most frequent are
codons 98 (A, a four-codon AA) for Hymenopteran species and 126 (S, an eight-
codon AA) for Hemipteran species. On the other hand, the only species (e.g.,
*Balta vilis*) of Blattodea showed positive dN-dS values for as low as 17
codons. This low number reflects the close relatedness of this order with
Odonata in line with the results of the phylogenetic analysis. The other three
orders, e.g., Lepidoptera, Coleoptera, and Diptera showed a total of 30, 38 and
34 positive dN-dS values across species, respectively. This indicates that most
codons of COI barcode in these three orders seem to be mostly under purifying
selection. There are 16 unique codons to a given species of either Hymenopteran
(13 codons) or Hemipteran (3 codons) that are under positive selection. These
Hymenopteran species are *Camponotus maculatus* (1 codon), *Hymenoptera* sp. (4
codons), *Nomioides facilis* (3 codons) and *Tachytes crassus* (4 codons), while
Hemipteran species is *Batracomorphus angustatus* (4 codons). On the other hand,
10 codons frequently showed positive selection across most species of the six
orders; five of them are located in the helix regions and five are located in
the loop regions. Positions of these codons are 16, 23, 27, 48, 81, 118, 119,
123, 162 and 199. As for the dN-dS values in terms of domain structure, the
results indicated that percentages of codons under positive selection are \~ 80,
31, 61, 52, 40 and 9% in helices 1 to 6, while 100, 38, 52, 100 and 33% in loops
1–2 to 5–6, respectively. These results indicate that codons in helices 2, 5 and
6 and in loops 2–3 and 5–6 are mostly conserved and are under strong purifying
selection.
The study indicates that COI barcodes can provide insights by which the encoded
protein evolve and function in insect at different taxonomic scales. The COI or
Folmer region is basically used for species identification based on variations
at the DNA level. The region is sufficiently conserved within species, while
variable among species. This region is located in the enzymatically active part
of COI, thus involved in the respiratory chain by transferring electrons from Cu
to heme. Accordingly, this region is under functional constraints and mutations
in close proximity with heme ought to be lethal. There is less evolutionary
pressure against variation in positions within the extra-membranous loop
structures (e.g., loops 1–2 at AA positions 27–34, 3–4 at AA positions 102–124
and 4–5 at AA positions 156–166). This conclusion was previously reached by
Panchenko et al.. Amino acids in the two highly conserved loops (e.g., loops 2–3
and 5–6) seem important in holding the two sides of the enzyme and avoid severe
conformational changes. However, tryptophan within the variable loop 3–4 at
position 99 rigidly evolves as it is the only AA of COI protein that bonds with
the two hemes. Another AA in positions close to the active site is rigid
membrane-embedded α-helices undergo functional constraints and restricted
evolution (negative evolution). A similar pattern of variation was observed in
the protein encoded by mitochondrial ribosomal RNA gene, where the loops freely
evolve.
The study generally indicated that almost half the positions of the AA of the
barcode region are variable, however, they are mostly beyond the atomic
interaction distance of the heme groups as previously reported. Six of these AAs
exist within a distance of \>4Å with four of them changed to AAs of the same
chemical groups. However, the three-dimensional structure of the protein
indicates that the change from tyrosine to phenylalanine resulted in the loss of
bonding with heme, thus likely affect energy metabolism.
Estimates of dN-dS were used for detecting codons under either positive or
purifying selection. dS is the number of synonymous substitutions per site (s/S)
and dN is the number of nonsynonymous substitutions per site (n/N). Positive
values indicate the overabundance of nonsynonymous substitutions in these
positions. During evolution, positive (Darwinian) selection promotes the sweeps
of new beneficial alleles, and negative (or purifying) selection impedes the
spread of harmful alleles. The results indicated that 102 codons are under
positive selection and tend to evolve more rapidly.
Phenotypic plasticity or polyphenism is another potential player of evolutionary
changes and shaping of ecosystems that allows species to phenotypically adapt to
different environmental conditions during evolution. This type of evolutionary
force is not genome structure-based, rather, it relies on the differential gene
expression (gene expression-biased) and is particularly prominent in insects.
Gene expression bias is predominant in molecular evolution when selection
becomes less effective at removing deleterious alleles. Studying polyphenism
provides insight into the molecular basis of phenotypic differentiation during
evolution. This approach is ideal especially for cases where low genetic
differences exist among species.
Hymenopteran species have the highest AA variation in line with the presumed
age of the order that is likely among the oldest, thus had a long time to
molecularly evolve by changing AA sequence. Previous reports speculated that
differences in patterns of variation, substitution, and selection among insect
orders are due to the number of metabolism-related factors that are high in
actively flying insect species (like Hymenoptera) than in non-flying species.
Selection is biased towards the higher active metabolic rate and the increase of
the resting metabolic rate. Pentinsaari et al. indicated a higher relative rate
of CT/GA transitions in the insect is the result of higher oxidative damage to
DNA. This high variation is the result of a weak purifying selection in
Hymenopteran species. We strongly recommend making wet laboratory analysis to
support whether the changes in AAs consequently affect metabolism in the target
species or not. The overall results argue the possible evolutionary position of
Hymenopteran species among those of other insect orders living in Saudi Arabia,
especially Hemiptera and Coleoptera.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
According to John Gray's best-seller, Men Are from Mars, Women Are from Venus,
males and females not only communicate differently but also think, feel,
perceive, respond, love, and appreciate differently. Such differences can be
reflected in the domain of emotion regulation. Emotion regulation refers to a
person's ability to regulate one's own and others' emotional states and is
regarded as a crucial component of emotional intelligence. Numerous behavioral
studies have suggested that males score higher than females with regard to self-
report measurement of emotion regulation ability and other similar constructs.
For example, using the Trait-Meta Mood Scale (TMMS), Amelang and Steinmayr
(2006) and Extremera, Durán and Rey (2007) found that males had higher mood
repair scores. Using the Wong and Law Emotional Intelligence Scale (WLEIS),
Kong, Zhao and You (2012) found that males scored higher in emotion regulation
ability. Using the Trait Emotional Intelligence Questionnaire (TEIQue),
Mikolajczak, Luminet, Leroy and Roy (2007) found that males had higher self-
control scores, and finally, using the Emotional Quotient Inventory (EQI), Bar-
On, Brown, Kirkcaldy and Thomé (2000) found that males scored higher in stress
tolerance and impulse control. However, some studies found inconsistent results
in the sex differences in emotional intelligence. For example, using Brain
Resource Inventory for Emotional Intelligence Factors (BRIEF), Craig et al.
(2009) found that females scored higher on Empathy than males, whereas males
scored higher on Self-concept, so females scored higher on the total scale than
males. Using the Trait Emotional Intelligence Questionnaire, Mikolajczak et al.
(2007) found that females scored higher on Emotionality, whereas males scored
higher on Self-Control and Sociability, as a result, males scored higher on the
total scale than females. The discrepancy may be due to the choice of
measurement instrument, but these inconsistent findings are not accidental,
which may reflect the gender differences in many emotional aspects. These sex
differences may be explained by the “extreme male brain theory of autism”
proposed by Baron-Cohen (2002). According to this theory, the masculine brain
predominantly seeks to understand and construct systems (i.e., “systemize”),
whereas the feminine brain is predominantly structured to feel empathy (i.e.,
“empathize”). Here we focused on emotional regulation ability and used magnetic
resonance imaging (MRI) to investigate the sex-specific neural basis of this
ability.
Previous functional neuroimaging studies have mainly focused on emotion
regulation strategies (e.g., cognitive reappraisal); such studies have
demonstrated that both subcortical regions and cortical regions are involved in
emotion regulation strategies. Subcortical regions include the amygdala,
hippocampus and cerebellum. Cortical regions include the prefrontal cortex
(dorsolateral prefrontal cortex (DLPFC), ventromedial prefrontal cortex (VMPFC),
orbitofrontal cortex (OFC), and the anterior cingulate cortex (ACC)) and the
insular cortex. However, emotion regulation ability is differentiated from
emotion regulation strategies because emotion regulation ability reflects
effective choices and flexible application of different strategies for managing
emotionally charged situations. Recently, several structural neuroimaging
studies have explored the neuroanatomical basis of emotion regulation ability,
but the results are less clear. For instance, Killgore et al. (2012) found that
emotion regulation ability correlated positively with regional gray matter
volume (rGMV) in the bilateral VMPFC, while Takeuchi et al. (2011) found that
emotion regulation ability correlated with regional gray matter density (rGMD)
in the right anterior insula, the right cerebellum, the precuneus, and the
medial prefrontal cortex. Koven, Roth, Garlinghouse, Flashman and Saykin (2011)
found that better mood repair was related to larger rGMV in three clusters in
frontal and inferior parietal areas. Despite the limited statistical power
caused by the relatively small sample size used in these studies, we speculate
that sex differences may be another significant factor in these inconsistent
findings.
To our knowledge, there are three functional neuroimaging studies that have
explored sex-related differences on cognitive reappraisal strategies (for a
review see Ref.). Using an effortful reappraisal task, in which participants
consciously maintained or down-regulated their negative emotions, two of the
studies reported stronger prefrontal activity in males, while the third study
found stronger prefrontal activity in females. In addition, the third study
reported that the amygdala was more activated in females, while the two other
studies failed to find an effect of gender on amygdala activity,. One possible
reason for this inconsistency is that the regulation instructions for
participants varied across the studies, and thus different types and number of
reappraisal strategies may have been used. Although the results are mixed, these
findings indicate distinct roles for prefrontal and subcortical regions in
emotion regulation between males and females. However, to the best of our
knowledge, no study has directly explored the sex-linked neuroanatomical
correlates of emotion regulation ability.
To investigate this issue, here we extended the previous studies in three ways.
First, we assessed each participant's general ability to regulate emotions in
daily life using a well-established self-report questionnaire (WLEIS). Second,
we used voxel-based morphometry (VBM) to examine structural differences
underlying emotion regulation ability in a large sample size of males and
females (N = 299; 159 females). Functional and structural MRI studies are
believed to complement each other, but structural MRI studies are particularly
suitable for describing the neural correlates of emotion regulation ability
because the short reappraisal tasks in functional MRI studies may hardly tap the
cognitive-affective processes involving the whole range of emotion regulation
ability. Finally, a large sample size of young adults was used in this study,
which will provide a higher statistical power to test and identify the sex-
specific neural correlates of emotion regulation ability. Given that males have
better emotion regulation skills than females, we hypothesized that males and
females would show differences with regard to the brain regions involved in
emotion regulation ability. Specifically, we hypothesized that males' emotion
regulation ability would be more strongly associated with rGMV in cortical
regions, particularly in the prefrontal cortex, which is associated with
cognitive processes. Similarly, females would mainly have a stronger association
between emotion regulation ability and rGMV in regions (e.g., the amygdala) that
are implicated in emotional processes.
# Methods
## Participants
College students (N = 299; 159 females; mean age = 21.55 years, SD = 1.01)
from Beijing Normal University, Beijing, China, participated in this study. Both
behavioral and MRI protocols were approved by the Institutional Review Board of
Beijing Normal University. Written informed consent was obtained from all
participants prior to the experiment. Two participants were excluded due to
missing items or erroneous reports in the questionnaire. Another five
participants were removed from further analyses due to extraordinary scanner
artifacts or abnormal brain structures (e.g., unusually large ventricles). Thus,
292 participants contributed to our study findings (133 males, mean age = 21.57
years, SD = 1.00; 159 females. mean age = 21.54 years, SD = 1.02).
## Psychological measurement
Participants' emotion regulation ability was assessed using the 4-item
Regulation of Emotion (ROE) scale of the WLEIS. The ROE scale measures
individuals' ability to regulate their emotions and their ability to quickly
recover from psychological stress; sample items include, “I am quite capable of
controlling my own emotions” and “I can always calm down quickly when I am very
angry.” Participants were then instructed to indicate the extent to which they
agree or disagree with each statement using a 7-point Likert-type scale. Higher
scores in the ROE scale indicate better emotion regulation ability. The scale
has been demonstrated to have high internal consistency, convergent/discriminant
validity with related constructs of loneliness, positive affect, negative
affect, depression, and empathy, and good concurrent validity with other emotion
regulation measures, including the Optimism/Mood Regulation subscale of the
Schutte' Emotional Intelligence Scale, the Repair of Emotion subscale of Trait
Meta-Mood Scale, and the Emotional Control Questionnaire.
## MRI acquisition
Participants were scanned using a Siemens 3T scanner (MAGENTOM Trio, a Tim
system) with a 12-channel phased-array head coil at BNU Imaging Center for Brain
Research, Beijing, China. MRI structural images were acquired using a 3D
magnetization prepared rapid gradient echo (MP-RAGE) T1-weighted sequence
(TR/TE/TI = 2530/3.39/1100 ms, flip angle = 7 degrees, FOV = 256×256 mm). One
hundred and twenty-eight contiguous sagittal slices were acquired with 1×1-mm
in-plane resolution and 1.33-mm slab thickness for whole brain coverage.
## Image Processing for VBM
VBM was employed to characterize the neuroanatomical differences in gray matter
volume (GMV) and the neuroanatomical correlates of behavioral performance across
participants. In this study, VBM was performed using SPM8 (Statistical
Parametric Mapping, Wellcome Department of Imaging Neuroscience, London, UK),
with an optimized VBM protocol on T1-weighted structural MRI images. First,
image quality was assessed by manual visual inspection. Five participants whose
images had excessive scanner artifacts or showed gross anatomical abnormalities
were excluded. Second, the origin of the brain was manually set to the anterior
commissure for each participant. Third, images were segmented into four distinct
tissue classes: gray matter, white matter, cerebrospinal fluid, and everything
else (e.g., skull and scalp) using a unified segmentation approach. Forth, the
MNI152 template was used to spatially normalize the gray matter images for each
participant using the Diffeomorphic Anatomical Registration through Exponential
Lie algebra (DARTEL) registration method. DARTEL registration involves
repetitively computing the study-specific template based on the average tissue
probability maps of all participants and then warping all participants' tissue
maps into a generated template to improve the alignment. Fifth, gray matter
voxel values were modulated by multiplying the Jacobian determinants derived
from the normalization procedure to preserve the volume of tissue from each
structure after warping. The modulated gray matter images were then smoothed
using an 8-mm full width at half maximum (FWHM) isotropic Gaussian kernel.
Finally, to exclude noisy voxels, the modulated images were masked using
absolute masking with a threshold of 0.2. The masked-modulated gray matter
images were used for further statistical analyses.
## Statistical Analysis of VBM
Sex difference in the correlation between emotion regulation ability and rGMV
was tested using the condition by covariate interaction analysis. The
interaction analysis treated sex as a condition, the score of emotion regulation
ability as a covariate of interest, and the total GMV and age as covariates of
no interest. Statistical analysis was performed using a general linear model
(GLM). Multiple comparison correction was performed by setting the voxel-wise
intensity threshold at *p*\<0.05 and a cluster-level threshold determined by
Monte Carlo simulations (10,000 iterations) conducted in the AlphaSim program
within AFNI. Accordingly, significant effects were reported when the volume of a
cluster was greater than the Monte Carlo simulation determined minimum cluster
size on whole brain GMV (i.e., 943 voxels), above which the probability of type
I error was below 0.01.
To test the specificity of correlation, we also detected the neuroanatomical
correlates of individual differences in emotion regulation ability in the whole
sample. Statistical analysis treated total GMV, age and sex as confounding
covariates and the score of emotion regulation ability as a covariate of
interest. The threshold for statistical significance was also set at MC-cluster-
corrected *p*\<0.05 and significant effects were reported when the volume of a
cluster was greater than 943 voxels.
# Results
The summed score for the ROE scale was used as an index of emotion regulation
ability, whereby higher scores indicated a better ability. Demographic
characteristics for the participants are presented in. As indicated in, measures
of emotion regulation ability, use of emotion ability, self-emotion appraisal
ability, and others-emotion appraisal ability had good internal consistency.
Moreover, emotion regulation ability was moderately and positively related to
use of emotion ability (*r* = 0.36, *p*\<0.001), self-emotion appraisal ability
(*r* = 0.44, *p*\<0.001), and others-emotion appraisal ability (*r* = 0.28,
*p*\<0.001), thus indicating that the ROE scale has good discriminant validity.
The independent sample t-test analyses revealed no significant sex differences
in age (*t* = 0.29; *p* = 0.77) and use of emotion ability (*t* = 1.15;
*p* = 0.25), self-emotion appraisal ability (*t* = 0.83; *p* = 0.41), and
others-emotion appraisal ability (*t* = −1.28; *p* = 0.20). Importantly, we
found a significant difference in emotion regulation ability between male and
female groups (*t*(290) = 2.92, *p* = 0.004, Cohen's d = 0.34), which is
consistent with previous findings that males have higher levels of emotion
regulation ability than females. Next, we examined whether the sex-specific
differences in emotion regulation, as observed in the behavioral measurements,
had distinct neural substrates.
To do this, we conducted a condition by covariate interaction analysis with sex
as a condition and the score of emotion regulation ability as a covariate of
interest. We revealed a significant interaction of sex by emotion regulation
ability in two anatomical clusters: one in the right DLPFC (MNI coordinate: 20,
28, 60; Cluster-corrected *p*\<0.01) and the other that extends from the left
brainstem to the left hippocampus, the left amygdala and the insular cortex (MNI
coordinate: 0, −14, −10; Cluster-corrected *p*\<0.01). Brain structures involved
in the second cluster are known as central parts of the limbic system.
Specifically, males showed a stronger positive relation between emotion
regulation ability and rGMV in the right DLPFC (r = 0.30, p\<0.001), relative to
females (r = −0.08, p\>0.05). In contrast, females showed a stronger positive
relation between emotion regulation ability and rGMV in the other anatomical
cluster (r = 0.20, p\<0.05), relative to females (r = −0.11, p\>0.05). The
anatomical location of these clusters identified by the VBM analysis in this
study was close to regions identified by fMRI using emotion regulation tasks. In
addition, we tested the gender differences of rGMV in these two clusters. We
found that males had larger rGMV in these two clusters than females
(*ps*\<0.001).
To test the specificity of these correlations, we also detected the
neuroanatomical correlates of individual differences in emotion regulation
ability in the whole sample. A significant positive correlation between emotion
regulation ability and rGMV was found in a cluster that included the left
precuneus (MNI coordinate: −2, −72, 32; Cluster-corrected *p*\<0.01). Taken
together, these results suggest that the left hippocampus and the left amygdala,
as well as the right DLPFC, have a sex-specific correlation with emotion
regulation ability.
# Discussion
The aim of the present study was to investigate the sex-linked neuroanatomical
basis of emotion regulation ability in a large sample of young healthy adults.
As expected, males reported higher levels of emotion regulation ability relative
to females, which is consistent with previous behavioral findings that males
have a greater ability to regulate emotions than females. More importantly, VBM
analysis revealed males relying more on the right DLPFC and females relying more
on limbic regions including the left hippocampus, the left amygdala and insular
cortex. Thus, the present study provides the first empirical evidence for sex-
related neuroanatomical basis of emotion regulation ability.
Males demonstrated a stronger positive relation between emotion regulation
ability and rGMV in the right DLPFC, which is in line with previous VBM and
lesion studies that report involvement of the DLPFC in emotion regulation
ability using a self-report emotion regulation ability assessment. Moreover,
numerous fMRI studies have consistently shown increased neural activity in the
DLPFC when participants are instructed to deploy a variety of emotion regulation
strategies, including cognitive reappraisal and expressive suppression,. The
DLPFC is known for its critical role in cognitive control, working memory, and
response selection. Taken together, recruitment of the DLPFC may facilitate
emotion regulation through a range of effortful cognitive processes, such as
selecting, shifting, and maintaining regulation strategies. For example, the
DLPFC may be used to direct attention to reappraisal-relevant stimulus features
and hold in mind reappraisal goals as well as the content of one's reappraisal.
Our finding that the DLPFC has a male-specific correlation with emotion
regulation ability seems to support behavioral observations that report males
use more rational and detachment coping strategies in a stressful environment
than females.
In contrast, we found that females' emotion regulation ability was associated
with rGMV in the anatomical cluster that extends from the left brainstem to the
left hippocampus, the left amygdala and the insular cortex, which are implicated
in emotional processes. Numerous fMRI studies have demonstrated that the
hippocampus, the amygdala and the insular cortex are involved in successful
emotion regulation,. In particular, the amygdala plays a critical role in
detecting, as well as attending to and encoding affectively arousing and
threatening stimuli into memory, and its hyperactivation is associated with a
variety of affective disorders. The hippocampus is involved in establishing
declarative or episodic memory for autobiographic events. Therefore, recruitment
of the hippocampus and amygdala may help females to accurately perceive
emotional events and detect cues that signal potential threats, thus
facilitating their regulation of emotion. The insular cortex is a fundamental
multimodal sensory integration region, and has highly reciprocal connections
with cortical (e.g., the anterior cingulate and prefrontal cortex) and
subcortical regions (e.g., amygdala and basal ganglia). It is involved in the
experience of bodily self-awareness, emotional processing, sexual memory, and
regulating autonomic functions, and possibly plays a pathophysiological function
in anxiety disorders and emotion dysregulation. The insular cortex, as well as
the hippocampus and the left amygdala are central components of the limbic
system that has been extensively implicated in many emotional processes such as
emotional memory and emotion recognition. This may be consistent with the
findings of previous behavioral studies that report females use emotion-focused
coping strategies more frequently when under stress.
These results may contribute to our understanding of sex differences in
disorders and maladaptive behaviors that are associated with emotion regulation
ability. For example, it has been reported that hippocampal and amygdala volume
are smaller in depressed females than that in normal participants, and, more
specifically, than in depressed males,. This is in accordance with our findings
that rGMV in the hippocampus and the amygdala is more strongly associated with
emotion regulation ability in females than in males, which in part supports the
finding of a higher prevalence of affective disorders (e.g., depression) in
females. On the other hand, maladaptive behaviors (e.g., aggressive behavior
and alcohol-related problems) are more prevalent in males. The finding that rGMV
in the DLPFC is more strongly associated with emotion regulation ability in
males than in females, similarly suggests that maladaptive behaviors might
result from difficulties in the cognitive control of emotions.
In conclusion, our study provides the first evidence for the sex-specific
neuroanatomical basis of emotion regulation ability. Specifically, we found that
females' emotion regulation ability is associated with rGMV in emotion-focused
brain regions, whereas males' emotion regulation ability tends to be associated
with rGMV in brain regions implicated in cognitive processes. However, several
limitations need to be addressed for future research. First, we assessed each
participant's emotion regulation ability using a self-report questionnaire.
Although this questionnaire predicts real-world outcomes, such as well-being and
depressive symptomatology, it would perhaps be useful to employ objective
measures of emotion regulation ability when examining sex-specific neuroanatomy
involved in the process in order to examine convergence across diverse measures.
Second, only healthy participants were recruited, and therefore, it is unknown
whether our results relate to clinical samples. Given the relationship between
emotion dysregulation and affective disorders, studying emotion regulation
ability in a clinical population is necessary to improve our understanding of
emotion regulation deficits and to provide insight into treatment implications.
Third, this study is a cross-sectional design, which does not draw causal
inferences. Future investigations should ideally utilize longitudinal designs to
examine changes in emotion regulation ability over the course of development.
[^1]: The authors have declared that no competing interests exist.
[^2]: Analyzed the data: FK ZZ XW LH. Wrote the paper: FK ZZ JL. Designed
research: FK JL. Performed research: FK ZZ JL. Contributed unpublished
reagents/analytic tools: ZZ LH XW YS.
|
# Introduction
There are more than 40 species in the genus *Borrelia*, currently divided into
the Lyme borreliosis (LB) and Relapsing fever (RF) groups with human pathogens
confirmed in both of these. Whilst the major focus has been on Lyme disease
borreliae the health burden of Relapsing fever (RF) species is now being
recognized. *B*. *miyamotoi* classified in the RF group was first identified in
Japan in 1995 and subsequently found in many countries including the USA, Europe
and England. A prior study of *Borrelia* infections in ticks in Ireland
identified three species, *B burgdorferi*, *B garinii*, *B valaisiana* (VS116)
plus un-typeable *Borrelia* species.
In order to ensure detection of a wide range of *Borrelia* species that might be
present in Ireland experiments were carried out to identify PCR primers for
species that have been reported in Europe.
In the current study, we used a pair of genus-specific PCR primers to amplify a
highly conserved segment with single-nucleotide polymorphisms of the borrelial
16S rRNA gene shared by all known pathogenic borrelial strains to survey the
borrelial infections among the *I*. *ricinus* ticks collected in Ireland. Since
this PCR amplicon is 357/358 bp long, the PCR products can be used as the
template for direct Sanger sequencing for amplicon validation and for
speciation. This metagenomic 16S rRNA gene sequencing assay is most suitable for
molecular diagnosis of borrelial infections in human-biting ticks and in
clinical specimens in Europe because of the great diversity of causative agents
in European Lyme borreliosis which needs a broad-spectrum tool to detect the
target DNA from various borrelial strains and to prepare the template for Sanger
sequencing to ensure diagnostic accuracy.
In the present study, we developed a protocol for using a single pair of genus-
specific PCR primers to amplify a highly conserved segment with hypervariable
regions of the borrelial 16S rRNA gene for detection of all species of
*Borrelia* infecting the *I*. *ricinus* ticks collected in Ireland and to use
the positive crude nested PCR products as the templates for direct Sanger
sequencing to determine the species of the *Borrelia* detected.
# Materials and methods
## *Ixodes* tick collection and extraction
Unfed, questing *I*. *ricinus* nymphs were collected by “flagging”, which
involves brushing the vegetation with a white towel from which the ticks can
then be removed. Nymphs were chosen for analysis since they occur in greater
numbers than adult ticks, and pose the greatest risk to humans. In late May and
early June 2018, samples were taken at six localities within Ireland, designed
to provide a representative view of tick borrelial infection across the country.
The following areas were sampled (county in parenthesis): Killarney (Kerry),
Kilmacthomas (Waterford), Clifden (Galway-West), Portumna (Galway-South),
Glendalough (Wicklow), and Glenveagh (Donegal) and their locations are shown on
the accompanying map of Ireland. No permission to access tick collection sites
were required. All ticks were collected along the verges of public roads without
requiring access to private land. There were no known endangered or protected
species at any of the collection sites which all had public right of way access
Each individual sample was made up of at least 5 sub-samples taken at different
points within a locality to minimize any sampling bias. Distance between sub-
sampling points was never less than 100 m.
The collected ticks were disinfected in 70% ethanol, air-dried on filter paper
and sent to Milford Molecular Diagnostics Laboratory in Milford, Connecticut,
U.S.A. to be tested. The general procedure for extraction of the crude DNA from
archived ticks and for Sanger sequencing detection of the borrelial 16S rRNA
gene previously published was followed. Initially, 300 ticks were analyzed, 50
from each of the six sampled locations listed above.
On the day of testing, each dried tick was placed in a 1.5 mL plastic tube and
immersed in 300 μL of 0.7 mol/L NH<sub>4</sub>OH overnight at room temperature.
On the following day, the test tubes were heated at 95°C to 98°C for 20 minutes
with closed caps, followed by 10 minutes with open caps. After the test tubes
were cooled to room temperature and the carcass of the tick discarded, 700 μL of
95% ethanol and 30 μL of 3 mol/L sodium acetate (Sigma) were added to each
NH<sub>4</sub>OH digestate. The precipitated crude DNA was spun down in the
pellet after centrifugation at \~ 16,000 x g for 5 minutes, washed in 1 mL of
70% ethanol, air dried, and re-dissolved in 100 μL of
tris(hydroxymethyl)aminomethane hydrochloride–EDTA (TE) buffer, pH 7.4 (Sigma)
by heating the DNA extract at 95°C to 98°C for 5 minutes. After a final
centrifugation at \~ 16,000 x g for 5 minutes, the supernatant was used for
molecular detection of borrelial 16S rRNA genes by nested PCR amplification.
## Molecular detection of borrelial 16S rRNA genes
A 3μL aliquot of the crude DNA extract was used to initiate a primary PCR,
followed by a same-nested PCR using a pair of M1/M2 borrelial genus-specific
primers in a total 25 μL low-temperature PCR mixture for a 30-cycle
amplification at primary PCR, followed by another 30-cycle amplification at the
same-nested PCR. In carrying out the same-nested PCR, a single pair of M1
(`5'-ACGATGCACACTTGGTGTTAA-3'`) and M2 (`5' TCCGACTTATCACCGGCAGTC-3'`) primers
were used for both primary PCR and nested PCR so that a small amount of the
primary PCR products was re-amplified with the same pair of PCR primers in a new
PCR mixture. An original target DNA segment in the PCR mixture might have been
amplified for 60 cycles exponentially by the same pair of primers to increase
the sensitivity of detection. The PCR amplicons of the 357-bp 16S rRNA gene
segment of the *B*. *burgdorferi* sensu lato complex and the corresponding
358-bp 16S rRNA gene segment of the relapsing fever borreliae, both defined by
the M1 and M2 PCR primer pair, were visualized by agarose gel electrophoresis of
the nested PCR products. The same-nested PCR products were used as the template
for Sanger reaction without purification.
A positive *Borrelia coriaceae* DNA and a negative (no extract) reagent control
were routinely included in each run of our experiments, as detailed in a
previously published reference
## Sanger sequencing confirmation of *Borrelia* species
For DNA sequencing, the positive nested PCR products were transferred by a
micro-glass rod into a Sanger reaction tube containing 1 μL of 10 μmolar
sequencing primer, 1 μL of the BigDye Terminator (v 1.1/Sequencing Standard
Kit), 3.5 μL 5× buffer, and 14.5 μL water in a total volume of 20 μL for 20
enzymatic primer extension/termination reaction cycles according to the protocol
supplied by the manufacturer (Applied Biosystems, Foster City, CA, USA). After a
dye-terminator cleanup with a Centri-Sep column (Princeton Separations,
Adelphia, NJ, USA), the reaction mixture was loaded in an automated ABI 3130
four-capillary Genetic Analyzer for sequence analysis.
Sanger sequencing of positive 357/358 bp M1/M2 same-nested PCR products is
capable of accurate identification of many species including, *B*. *valaisiana*,
*B*. *afzelii*, *B*. *mayonii*, *B*. *spielmanii*, *B*. *lusitaniae*, *B*.
*recurrentis*, *B*. *miyamotoi*, *B*. *hermsii*, *B*. *lonestari*, *B*.
*coriaceae* and several other members in the relapsing fever group based on
known species-specific single-nucleotide polymorphisms in the gene segment.
The “genus-specific” M1/M2 PCR primer pair can amplify a “core genome” of all
pathogenic borreliae for the purpose of detection. However, to design a pair of
reliable PCR primers to amplify a segment of borrelial 16S rRNA gene with
single-nucleotide polymorphism among various borrelial strains turned out to be
challenging. It took several weeks of experimental work before we found 3 PCR
primers to generate a 282-bp heminested PCR amplicon useful as the template for
Sanger sequencing to distinguish *B*. *garinii* from *B*. *burgdorferi* and to
discriminate among the various *B*. *garinii* strains. The sequences of these 3
heminested PCR primers are listed as follows.
Primary PCR Forward Primer Bg1: `5’- GACGTTAATTTATGAATAAGC -3’`
Primary PCR Reverse Primer Bg 6: `5’- TTAACACCAAGTGTGCATCGT– 3’`
Heminested PCR Forward Primer Bg5: `5’- CGGGATTATTGGGCGTAAAGGGTGAG-3’`
Heminested PCR Reverse Primer Bg 6: `5’- TTAACACCAAGTGTGCATCGT– 3’`
Reference sequences were retrieved from the GenBank, the Bg5/Bg6 heminested PCR
primer pair defines a 282 bp segment of the borrelial 16S rRNA gene with single-
nucleotide polymorphisms. These were used to discriminate *Borrelia burgdorferi*
strain B31 (ID# [CP019767](https://www.ncbi.nlm.nih.gov/nucleotide/CP019767.1?re
port=genbank&log$=nuclalign&blast_rank=3&RID=NPJ52KA801R)), *Borrelia garinii*
BgVir (ID# [CP003151)](https://www.ncbi.nlm.nih.gov/nucleotide/CP003151.1?report
=genbank&log$=nuclalign&blast_rank=17&RID=NPF83DHW014), *Borrelia garinii*
strain Bernie (ID# [D89900)](https://www.ncbi.nlm.nih.gov/nucleotide/D89900.1?re
port=genbank&log$=nuclalign&blast_rank=3&RID=NPGTV1D5014), *Borrelia garinii*
strain T25 (ID# [AB035388) and](https://www.ncbi.nlm.nih.gov/nucleotide/AB035388
.1?report=genbank&log$=nuclalign&blast_rank=1&RID=NGYV838S014) *Borrelia
garinii* strain L20 (ID# [X85198).](https://www.ncbi.nlm.nih.gov/nucleotide/X851
98.1?report=genbank&log$=nuclalign&blast_rank=50&RID=N8ZTRD0H01R)
However, after the first 300 ticks were tested, it was realized that the
extracellular DNA of the *Borrelia* 16S rRNA gene in the crude DNA extract from
the ticks was not stable on storage even at -20° C. By the time when the Bg5 and
Bg6 heminested PCR primers were readied to be put into routine practice, the
borrelial 16S rRNA gene DNA in 9 of the 12 samples initially found to be
positive for *B*. *burgdorferi* sensu lato already degraded and were no longer
amplifiable with any PCR primers. Therefore, an additional series of 50 ticks
from each of the Portumna and Kilmacthomas samples were analyzed for the
specific purpose of species confirmation and strain determination of the *B*.
*garinii* isolates.
# Results
## Multiple *Borrelia* species found in *I*. *ricinus* ticks in Ireland
The same-nested PCR amplification of a 357/358 bp segment of borrelial 16S rRNA
gene by the M1/M2 genus-specific PCR primers followed by Sanger sequencing of
the nested PCR products provided metagenomic evidence of *B*. *burgdorferi*
sensu lato (B.b.s.l.), *B*. *valaisiana* and *B*. *miyamotoi* infection in the
ticks collected in Ireland. Samples of the 16S rRNA gene sequencing with the M2
primer in support of these molecular diagnoses are illustrated by the 3 selected
electropherograms presented in.
## Strain diversity of *B*. *garinii*
Sanger sequencing of the PCR amplicon with the reverse M1 primer proved that
none of the *B*. *burgdorferi* sensu lato isolates were *B*. *afzelii*. A
177-base sequence of the 282-bp amplicon defined by the Bg5 and Bg6 heminested
PCR primers distinguished the heterogeneous strains of *B*. *garinii* from *B*.
*burgdorferi* and *B*. *bavariensis* due to the presence of single-nucleotide
polymorphisms among strain BgVir {1}, strain 25 {2} and strain Bernie {3} of the
*B*. *garinii* species and distinguished these strains from *B*. *burgdorferi*
sensu stricto {4}. Alignment of these four 177-base reference sequences
retrieved from the GenBank showing single-nucleotide polymorphisms is presented
below with the ending 26-base Bg5 primer site underlined.
{1}CCTTCGCCTCCGGTATTCTTTCTGATATCAACAGATTCCACCCTTACACCAGAAATTCTAACTTCCTCTATCAGACT
CTAGAC
{2}·············································································
······ {3}······································································
············T
{4}·············································································
······
{1}ATATAGTTTCCAACATAGTTCCACAGTTGAGCTGTGGTATTTTATGCATAGACTTATATATCCGCCTA<u>CTCACC
CTTTACGCC</u>
{2}································C····C······························<u>······
·········</u>
{3}····································································<u>······
·········</u>
{4}··················G·················································<u>······
·········</u>
{1}<u>CAATAATCCCG</u> *B*. *garinii* Strain BgVir Sequence ID: CP003151
(Range:447801–447977)
{2}<u>···········</u> *B*. *garinii* Strain T25 Sequence ID: AB035388 (Range:
684–508)
{3}<u>···········</u> *B*. *garinii* Strain Bernie Sequence ID: D89900
(Range:692–516)
(4}<u>···········</u> *B*. *burgdorferi* strain B31 Sequence ID: CP019767
(Range: 444582–444758)
The corresponding electropherograms of these four 177-base sequences (1–4),
using the Bg6 sequencing primer, are illustrated in, arranged from top to bottom
in numerical order of sequences 1–4 as Strain BgVir, Strain T25, Strain Bernie
and *B*. *burgdorferi* strain B31.
A reverse sequencing with Bg5 primer of the 282-bp PCR amplicon confirmed that
the isolates identified as strains BgVir were not strain SL20 (Sequence ID:
X85198) because there is no single-nucleotide polymorphism located near the Bg6
primer site of the amplicon which is unique for strain SL20.
## Tick infection rates varied with locations
We conducted two surveys. Survey 1 consisted of 300 ticks collected in six
locations showing 15 of the 300 ticks (5%) infected with *B*. *burgdorferi*
sensu lato of which 3 were confirmed to be *B*. *garinii* (2 matching strain
Bernie and 1 matching strain BgVir), 2 were *B*. *valaisiana* and 10 were not
speciated. Survey 2 consisted of 100 ticks collected in two of the six locations
previously surveyed, showing 5 of the 100 ticks (5%) infected by borrelial
species, including 4 isolates of *B*. *garinii* (3 matching strain BgVir and 1
matching strain T25) and 1 isolate of *B*. *miyamotoi*. The *Borrelia* infection
rates varied from 2% to 12% depending on the locations of the tick collection.
It is noteworthy that all *B*. *burgdorferi* sensu lato isolates in Survey 2
were confirmed to be *B*. *garinii* as the Bg5/BG6 PCR followed by Sanger
sequencing for speciation was carried out without delay after initial detection
by M1/M2 PCR. The final species distributions in different locations were
summarized in.
## Selection of PCR primers for 16S rRNA gene PCR and sequencing
We used the “genus-specific” M1/M2 primer pair to generate a PCR amplicon for
Sanger reaction to detect all species of the B.b.s.l. complex and the relapsing
fever borreliae, in particular *B*. *miyamotoi*. And a heminested PCR system to
amplify an adjacent 282 bp segment defined by the Bg5 and Bg6 primers. When the
Bg5/Bg6 nested PCR products were used as the DNA sequencing template for
confirmation of *B*. *miyamotoi* in tick samples, the electropherograms showed
numerous ambiguous base calling peaks as a result of co-amplification of
unwanted DNAs in the sample extract. When the sequencing electropherogram
generated by the M1/M2 primer PCR products from the same tick extract showed no
ambiguous base calling labels.
## Degradation of 16S rRNA gene DNA in samples
We also observed that free borrelial 16S rRNA gene DNA in crude extracts from
the ticks was unstable even in TE buffer stored at -20°C for an extended period
of time. For example, when the NH<sub>4</sub>OH extracts of the 50 ticks from
the Portumna area were processed for M1/M2 same-nested PCR screening on July 20,
2018, 3 samples were positive for borrelial 16S rRNA gene DNA, with a robust
357/358 bp band on lanes 11, 15 and 25 which eventually proved to be *B*.
*garinii* strain BgVir, *B*. *miyamotoi* and *B*. *garinii* BgVir, respectively.
When the NH<sub>4</sub>OH extracts of the 50 ticks from the Kilmacthomas area
were processed for M1/M2 same-nested PCR screening on July 24, 2018, 2 samples
were positive for borrelial 16S rRNA gene DNA, with a robust 357/358 bp band on
lanes 372 and 382 which eventually proved to be *B*. *garinii* with sequence
matching strain BgVir and *B*. *garinii* strain T25, respectively. However, when
the same-nested PCR was repeated on these 5 NH<sub>4</sub>OH extracts after 7
days and 3 days storage in a -20°C freezer, respectively, the 16S rRNA gene DNA
in sample 11 was no longer detectable and the intensities of the nested PCR
bands using the same extracts of samples 15, 25, 372 and 382 as primary PCR
templates for amplification under identical experimental conditions decreased
markedly over a period of 3–7 days, as demonstrated on the agarose gel dated
July 27, 2018. The image of the gel electrophoresis dated July 27, 2018 also
showed that nested PCR is generally required for detection of borrelial
infections by 16S rRNA gene analysis. Primary PCR products are usually invisible
after gel electrophoresis.
# Discussion
This is the first time that *B*. *miyamotoi* has been detected in a tick
collected in Ireland.
Our study shows that *I*. *ricinus* ticks in Ireland are infected by a diversity
of pathogenic borreliae. The number of species and strain diversity may prove to
be greater if surveys with larger samples are carried out. For example, in our
two surveys *B*. *miyamotoi* and *B*. *garinii* were demonstrated only during
Survey 2, but not in Survey 1. Our results demonstrate that *Borrelia*-infected
tick populations exist in the south-east of Ireland, an area hitherto not
considered to be significantly tick-infested and hence not considered an area of
risk to humans for contraction of Lyme borreliosis.
In the prior work carried out by Kirstein et al tick infection rates were
reported between 3.5% and 26.7% depending on the locations of tick collection
using reverse line blot or PCR. In the current study, we used metagenomic 16S
rRNA gene sequencing to survey the *I*. *ricinus* ticks, and found the overall
rate of borrelial infection to be 5%, with a range from 2% to 12% depending on
the locations of tick collection. In Glenveagh (Donegal) there were two
different strains of *B*. *garinii* with sequences that matched BgVir, and
Bernie). This compares to infected nymphs collected in Glenveagh National Park
20 years earlier which were reported to be positive for *B*. *valasiana*
(labeled as strain VS116). We identified *B*. *valaisiana* in Gelendalough and
Killarney, and *B*. *miyamoti* plus *B*. *garinii* in Portumna.
For the purpose of patient care, it is probably not necessary to determine the
species or strain of the *Borrelia* infection in order to initiate timely
antibiotic treatment. But, for serological diagnosis a knowledge of the
borrelial species and strains carried by the human-biting ticks collected in the
endemic areas is crucial since polymorphism of ospC, and variation of the VlsE
antigens among species and strains of *B*. *burgdorferi* sensu lato have been
well documented in the literature. There is limited information regarding the
sensitivity of commercial tests for different species of *Borrelia*. The
manufacturers of Western Blot antibody tests specify the target species. In
Europe these are typically *B*. *afzelii*, *B*. *burgdorferi* and *B*.
*garinii*. A study of the most frequently used C6 synthetic peptide ELISA test
for initial screening does appear to have variable sensitivity for some species
but with no data available for many of the European species including *B*.
*valaisiana* identified as prevalent in Ireland in this study.
In summary, our study confirms that the genus-specific M1/M2 PCR primers can
amplify a highly conserved segment of the borrelial 16S rRNA gene for Sanger
sequencing-based molecular diagnosis of tick-borne borreliae. Three species of
*Borrelia* were identified with *B*. *garinii* the most common (70% of those
speciated), followed by *B*. *valaisiana* (20%), and for the first time in
Ireland *B*. *miyamotoi* (10%). This study and future expanded surveillance of
the Borrelia species and prevalence will contribute to optimized testing for
patients and to help quantify the risks and potential burden of human *Borrelia*
infections in Ireland.
# Supporting information
[^1]: SHL is Director of Milford Molecular Diagnostics Laboratory. There are
no patents, products in development or marketed products associated with
this research to declare. This does not alter our adherence to PLOS ONE
policies on sharing data and materials.
|
# Introduction
The *Mare medi terraneum* (in Latin) describes the Mediterranean as a “sea in
the middle of the land.” This basin is the largest (2,969,000 km<sup>2</sup>)
and deepest (average 1,460 m, maximum 5,267 m) enclosed sea on Earth.
Situated at the crossroads of Africa, Europe, and Asia, the Mediterranean coasts
have witnessed the flourishing and decline of many civilizations. The region was
an important route for merchants and travelers of ancient times, allowing for
trade and cultural exchange, and today it is notable for contributions to global
economy and trade. Its coasts support a high density of inhabitants, distributed
in 21 modern states, and it is one of the top tourist destinations in the world,
with 200 million tourists per year.
The Mediterranean Sea connects through the Strait of Gibraltar to the Atlantic
Ocean in the west and through the Dardanelles to the Sea of Marmara and the
Black Sea in the northeast. In the southeast, the Suez Canal links the
Mediterranean to the Red Sea and the Indian Ocean. In the Strait of Sicily, a
shallow ridge at 400 m depth separates the island of Sicily from the coast of
Tunisia and divides the sea into two main subregions: the western (area = 0.85
million km<sup>2</sup>) and the eastern (area = 1.65 million km<sup>2</sup>).
General oceanographic conditions in the Mediterranean have been previously
described in detail \[e.g., –\]. It is a concentration basin: evaporation is
higher in its eastern half, causing the water level to decrease and salinity to
increase from west to east. The resulting pressure gradient pushes relatively
cool, low-salinity water from the Atlantic across the Mediterranean basin. This
water warms up to the east, where it becomes saltier and then sinks in the
Levantine Sea before circulating west and exiting through the Strait of
Gibraltar. The climate in the region is characterized by hot, dry summers and
cool, humid winters. The annual mean sea surface temperature shows a high
seasonality and important gradients from west to east and north to south. The
basin is generally oligotrophic, but regional features enrich coastal areas
through changing wind conditions, temporal thermoclines, currents and river
discharges, and municipal sewage. The basin is characterized by strong
environmental gradients, in which the eastern end is more oligotrophic than the
western. The biological production decreases from north to south and west to
east and is inversely related to the increase in temperature and salinity.
The Mediterranean has narrow continental shelves and a large area of open sea.
Therefore, a large part of the Mediterranean basin can be classified as deep sea
and includes some unusual features: (1) high homothermy from 300–500 m to the
bottom, where temperatures vary from 12.8°C–13.5°C in the western basin to
13.5°C–15.5°C in the eastern, and (2) high salinity of 37.5–39.5 psu. Unlike in
the Atlantic Ocean, where temperature decreases with depth, there are no thermal
boundaries in the deep sea of the Mediterranean. Shelf waters represent 20% of
the total Mediterranean waters, compared with the 7.6% of the world oceans, and
therefore play a proportionally greater role here than in the world's oceans.
Shelves in the south are mainly narrow and steep (e.g., Moroccan, Algerian, and
Libyan coasts, with the exception of the Gulf of Gabés), while those in the
north are wider (e.g., the north and central Adriatic Sea, the Aegean Sea, and
the Gulf of Lions). These features influence the morphology and constrain the
connections to the Atlantic, the Red Sea, and the Indian Ocean.
The enclosed Mediterranean had a varied geological history, including isolation
from the world ocean, that led to its near drying out during the Messinian
crisis (5.96 million years ago) and to drastic changes in climate, sea level,
and salinity. The geological history, biogeography, ecology, and human history
have contributed to the Mediterranean's high cultural and biological diversity.
The recent marine biota in the Mediterranean Sea is primarily derived from the
Atlantic Ocean, but the wide range of climate and hydrology have contributed to
the co-occurrence and survival of both temperate and subtropical organisms. High
percentages of Mediterranean marine species are endemic. This sea has as well
its own set of emblematic species of conservation concern, such as sea turtles,
several cetaceans, and the critically endangered Mediterranean monk seal
(*Monachus monachus*). It is the main spawning grounds of the eastern Atlantic
bluefin tuna (*Thunnus thynnus*) \[e.g., –\]. There are several unique and
endangered habitats, including the seagrass meadows of the endemic *Posidonia
oceanica*, vermetid reefs built by the endemic gastropod *Dendropoma petraeum*,
coralligenous assemblages \[e.g., –\], and deep-sea and pelagic habitats that
support unique species and ecosystems \[e.g., –\]. Many sensitive habitats exist
within the coastal ecosystems. There are 150 wetlands of international
importance for marine and migrating birds, and some 5,000 islands and islets.
The region has numerous laboratories, universities, and research institutes
dedicated to exploring the sea around them \[e.g., \]. In addition to the unique
geologic, biogeographic, physical, and ecological features, our current
understanding of the high biodiversity of the Mediterranean Sea is built on the
long tradition of study dating from the times of the Greeks and Romans.
Historical documentation began with Aristotle, who contributed to the
classification and description of marine biodiversity, and was followed by the
work of Plinius (Historia naturalis, liber IX) in the first century B.C., Carl
von Linné in the eighteenth century, and many others to the middle of the
nineteenth century \[e.g., –\]. The first deep-sea investigations began at the
end of the nineteenth century \[e.g., –\]. The expeditions of the R.V. “Calypso”
by Jacques-Yves Cousteau in the Mediterranean during the 1950s and 1960s
provided as well valuable material that supported many important publications on
the Mediterranean diversity. The history of ecological research and species
discovery in the region has been thoroughly reviewed by Riedl, Margalef, and
Hofrichter, though mostly confined to the western Mediterranean.
Numerous detailed taxonomic inventories now exist, most of which are specific to
sub-regions or to a range of organisms \[e.g.,, among many others\]. Efforts
continue to provide complete datasets of taxonomic groups for the entire basin
\[e.g., –\], although they need periodic updates. Freely available databases for
macroorganism inventory include the Medifaune database, the Food and Agriculture
Organization Species Identification Field Guide for Fishery Purposes, the FNAM
(Fishes of the North-Eastern Atlantic and the Mediterranean) atlas, and the
ICTIMED database.
However, Web-based datasets often lack updates because of limitations in funding
or expertise, and in general, the marine biodiversity of the Mediterranean is
less known than its terrestrial counterpart. There are still important gaps at
population, community, habitat, and sub-region levels, as well as in basic
information about taxonomy distribution, abundance, and temporal trends of
several groups. In some areas biodiversity data exist, but it is not easily
accessible, because the inventories are not publicly available. Data are also
lacking to evaluate the conservation status of many species.
The Mediterranean region has been inhabited for millennia, and ecosystems have
been altered in many ways \[e.g.,\]. Therefore, impacts of human activities are
proportionally stronger in the Mediterranean than in any other sea of the world.
Therefore, combined natural and anthropogenic events shaped the biodiversity of
the Mediterranean Sea in the past and are likely to continue to do so. Within
this complex framework, our aims were threefold:
1. Review available estimates of Mediterranean marine biodiversity,
including new estimates of less conspicuous organisms, updating previous
checklists, and incorporating living organisms from microbes to top
predators.
2. Describe the main spatial and temporal patterns of biodiversity,
including innovative ways of describing these patterns.
3. Summarize the main drivers of change and threats to marine biodiversity.
We have collated available information, generated coherent patterns, and
identified the current state of knowledge and information gaps, challenges, and
prospects for future research. We embrace the concept of biodiversity in its
broader definition as the variation of life at all levels of biological
organization, but we have focused our efforts on documenting species-level
diversity.
# Methods
## Diversity estimates
### Total estimates of biodiversity
We used our updated taxonomic estimates of species diversity to revise the total
estimate of Mediterranean marine biodiversity and to compare it with previous
studies. We assessed online data availability by comparing these estimates with
global and regional datasets that store an important portion of Mediterranean
information, including the World Register of Marine Species database (WoRMS),
Marbef Data System (European Register of Marine Species, ERMS) and the Ocean
Biogeographic Information System (OBIS), FishBase and SeaLifeBase, AquaMaps, and
ICTIMED,. We also calculated the percentage that Mediterranean species of
macrophytes and metazoans make up of their global counterpart, by comparing our
estimates with global number of marine species according to Bouchet and Green
and Short for flowering plants, and Groombridge and Jenkins for other
[Vertebrata](http://www.eol.org/pages/2774383) species.
### Estimates by taxonomic group
We combined an extensive literature analysis with expert opinions to update
publicly available estimates of major taxa and to revise and update several
species lists. While most of this information has been incorporated into the
supporting materials, here we present detailed summaries of the diversity of
some specific groups inhabiting either the extreme ends of the food web
(microbes and predators) or the deep-sea environment that represents the most
prevalent habitat type in the Mediterranean Sea. In addition, we provide an
overview of the newly introduced species. We also identified information gaps by
taxonomic group and assessed species discoveries over time for several taxa to
visualize the rates of diversity description.
and summarize specific information for each taxonomic group for which such
analysis is possible, and lists the experts contributing to this synthesis. also
lists several experts and taxonomic guides by taxa, although it is not an
exhaustive list of experts by taxonomic group in the Mediterranean Sea. provides
methodological specifications and the detailed taxonomic review of several
groups too, as well as revised checklists, detailed references, and additional
information.
To classify the estimates of organisms, we followed the taxonomic classification
by WoRMS. This classification is followed in the other regional syntheses of
marine diversity of the Census of Marine Life (Census) and enables comparison
between regions. We therefore used a practical division of the
[Eukarya](http://www.eol.org/pages/2908256) into Plantae, Animalia, Protists,
and Chromists even though the current kingdom division in the eukaryotes ranges
between 6 and 12 and few coincide with these traditional divisions. However, we
placed together Archaea and Bacteria because little information exists for
either of these divisions.
Our review included only generic information on prokaryotic (Bacteria and
Archaea) and eukaryotic (Protists) marine microbes and detailed quantification
of diversity of a few groups, such as seaweeds and seagrasses (a
phylogenetically heterogeneous group of eukaryotic photosynthetic organisms) and
metazoans (invertebrates and vertebrates). Within Animalia, we especially
focused on the phyla [Porifera](http://www.eol.org/pages/3142),
[Cnidaria](http://www.eol.org/pages/1745) (with emphasis on benthic forms),
Mollusca, Annelida (with emphasis on Polychaeta),
[Arthropoda](http://www.eol.org/pages/164) (with emphasis on Decapoda, Cumacea,
and [Mysidacea](http://www.eol.org/pages/4291563)),
[Bryozoa](http://www.eol.org/pages/2060),
[Echinodermata](http://www.eol.org/pages/1926),
[Sipuncula](http://www.eol.org/pages/8871), some other invertebrates forming
part of the meiobenthos (Nematoda, benthic Harpacticoida
\[[Crustacea](http://www.eol.org/pages/2598871): Copepoda\], benthic
Foraminifera, and [Gastrotricha](http://www.eol.org/pages/8728)), Tunicata (with
emphasis on Ascidiacea), and the subphylum
[Vertebrata](http://www.eol.org/pages/2774383). We did not include the Fungi
occurring in the Mediterranean Sea (which are reported to be approximately 140
species).
## Depiction of patterns
### Spatial and bathymetric patterns
To describe spatial patterns, we used published available information by region
or subregions and by taxonomic group regarding sighting locations, home ranges,
or general information on distribution of species in the Mediterranean Sea. We
also included information on biodiversity patterns by depth, reviewing data of
several taxa available in the literature.
Spatial patterns of benthic primary producers and invertebrate species were
explored at the scale of large regions or basins. When available, we used
detailed spatial data, mostly available in the form of expert-drawn maps or
sighting locations, to map spatial patterns of vertebrate species using GIS
(geographical information system) software (ArcView by ESRI). For each 0.1×0.1
degree grid cell within the Mediterranean, we estimated the species richness of
different taxonomic groups as the sum of the species co-occurring by overlapping
expert-drawn distribution maps. We compiled data about exotic fish species from
the CIESM (The Mediterannean Science Commission) atlas, and the paper by
Quignard and Tomasini. Data for other fish species were available from the FNAM
atlas and data compiled by Ben Rais Lasram et al.. We used maps of species
occurrence and sighting locations as point data to draw the distributional
ranges of resident marine mammals and turtles, but we excluded nonresident or
visiting species from the species richness maps. We represented the latter
information as point data showing their sighting locations,. The current
distribution of Mediterranean monk seal was drawn by integrating information in
recent literature,. Information on the distribution of seabird colonies around
the Mediterranean, and of Audouin's gull *Larus audouinii* in particular, was
collected from different observations.
In our analysis, we considered those regions with uncertain or insufficient data
(mainly identified by a question mark in distribution maps) as “no occurrence.”
However, we recognize that the absence of data may well reflect a lack of study
effort in a given area rather than actual absence of a species, and thus we used
the missing data to identify regions that are insufficiently studied. Moreover,
available data have been collected mainly from the 1980s to 2000s. Therefore,
species richness maps generated in this study should be considered as cumulative
distribution maps rather than current distributions.
We also used the global species distribution model AquaMaps to generate
standardized range maps of species occurrence. AquaMaps is a modified version of
the relative environmental suitability (RES) model developed by Kaschner et al..
This is an environmental envelope model that generates standardized range maps,
within which the relative probability of occurrence for marine species is based
on the environmental conditions in each 0.5×0.5 degree cell of a global grid
(see specifications of Mediterranean AquaMaps). We produced AquaMaps of
predicted patterns of biodiversity for different taxa in the Mediterranean by
overlaying the respective subsets of the 685 available distribution maps for
Mediterranean species and counting all species predicted to occur in a given
cell. We assumed a species to be present in each cell for which the species-
specific predicted relative probability of occurrence was greater than zero. For
the prediction of marine mammal biodiversity, we used a probability threshold of
species occurrence of at least 0.4 to define presence in a given area, since
there is some evidence that lower probabilities for species in this taxa often
describe a species' potential rather than its occupied niche. We then used these
predictions to visualize species richness patterns by selected latitudinal and
longitudinal transects. These results were compared with the maps generated
using regional distributions and sighting locations.
### Temporal patterns
The analysis of temporal changes in Mediterranean marine biodiversity requires
the integration of diverse data from paleontological, archaeological,
historical, and fisheries data, as well as ecological surveys and monitoring
data \[e.g., –\]. We summarized temporal changes of diversity using studies that
dealt with this challenge using available data that informed on changes over
past centuries and millennia. We integrated historical records of Mediterranean
monk seals and sea turtles around the Mediterranean to explore examples of
historical spatial changes,.
For the north Adriatic Sea, we analyzed data from Lotze et al., who used a
multidisciplinary approach to assess the ecological changes and overall shift in
diversity over historical time scales in 12 estuaries and coastal seas
worldwide, including the north Adriatic Sea. They assessed the number of species
that became depleted (\>50% decline), rare (\>90% decline), or extirpated
(locally extinct) in the north Adriatic Sea over past centuries and millennia,
based on records for 64 species or species groups that used to be of ecological
or economic importance in the Adriatic Sea. These records included marine
mammals, birds, reptiles, fish, invertebrates, and plants and were grouped into
ten distinct cultural periods.
## Threats to biodiversity
Changes in diversity are partially driven by anthropogenic factors, in addition
to natural forces. Therefore, our last aim was to identify and quantify the
importance of historical and current human-induced drivers and threats to marine
biodiversity.
We used the aggregated results presented by Lotze et al. and explicitly
separated the data available for the north Adriatic Sea as an example to explore
historical threats in the Mediterranean. Those authors evaluated human impacts
that caused or contributed to the depletion or extirpation of species in the
north Adriatic Sea over historical time scales.
We also identified current human threats to diversity using published data on
specific taxa and areas of the Mediterranean and the opinion of experts. Each
expert was asked to (1) list main threats to diversity for their taxonomic
expertise group using data available and experience, and (2) rank those threats
from 1 to 5, taking into account the relative importance of each threat to the
biodiversity (0: no importance, 1: lowest in importance, 5: highest in
importance). The experts repeated the ranking exercise considering data
available and projecting their results 10 years into the future.
In addition and to visualize the impacts of climate warming on species
diversity, we documented the mean location of February (the coldest month of the
year in the Mediterranean) sea surface isotherms (°C) for the period 1985 to
2006, integrating several data sources. We also generated current and projected
future temperature maps, which we compared with sea surface temperature (SST)
data from the 1980s. First, we compiled weekly SST data from the National
Climatic Data Center (National Operational Model Archive and Distribution System
Meteorological Data Server, NOMADS, NOAA Satellite and Information Service), and
interpolated maps at 0.1° resolution. Next, we averaged weekly SST values from
1981 to 1984 for each 0.1° grid cell. Last, we used the Mediterranean model
OPAMED8 based on the A2 IPCC scenario to visualize the future climate. This
model considers main forcing parameters (river runoffs, exchanges with connected
seas, and wind regimes) and was used to generate climate data for the middle
(2041–2060) and the end of the twenty-first century (2070–2099).
Finally, we visualized potential hot spots for conservation efforts by linking
predicted species distributions from the AquaMaps model to status information
reported by the International Union for Conservation of Nature. From the
available AquaMaps, a total of 110 maps belonged to vertebrate species that had
been classified as critically endangered, endangered, vulnerable, or near
threatened in the Mediterranean Sea. This represented the 16% of all species
included in the Mediterranean AquaMaps. We subsequently mapped the richness of
these species using a probability threshold of more than 0.4, which usually
corresponds to the most frequently used and ecologically most important
habitats.
# Results
## Diversity estimates in the Mediterranean
Our analysis revealed approximately 17,000 species occurring in the
Mediterranean Sea. Of these, at least 26% were prokaryotic (Bacteria and
Archaea) and eukaryotic (Protists) marine microbes. However, the data available
for Bacteria, Archaea, and Protists were very limited, so these estimates have
to be treated with caution (see next section), as well as data for several
invertebrate groups (such as [Chelicerata](http://www.eol.org/pages/2579982),
[Myriapoda](http://www.eol.org/pages/2631567), and Insecta).
Within the Animalia, the greater proportion of species records were from
subphylum [Crustacea](http://www.eol.org/pages/2598871) (13.2%) and phyla
Mollusca (12.4%), Annelida (6.6%), Platyhelminthes (5.9%),
[Cnidaria](http://www.eol.org/pages/1745) (4.5%), the subphylum
[Vertebrata](http://www.eol.org/pages/2774383) (4.1%),
[Porifera](http://www.eol.org/pages/3142) (4.0%),
[Bryozoa](http://www.eol.org/pages/2060) (2.3%), the subphylum Tunicata (1.3%),
and [Echinodermata](http://www.eol.org/pages/1926) (0.9%). Other invertebrate
groups encompassed 14% of the species, and Plantae included 5%. Detailed
biodiversity estimates of main taxonomic groups of benthic macroscopic primary
producers and invertebrates are summarized in and documented in in detail.
Available information showed that the highest percentage of endemic species was
in [Porifera](http://www.eol.org/pages/3142) (48%), followed by
[Mysidacea](http://www.eol.org/pages/4291563) (36%), Ascidiacea (35%), Cumacea
(32%), [Echinodermata](http://www.eol.org/pages/1926) (24%),
[Bryozoa](http://www.eol.org/pages/2060) (23%), seaweeds and seagrasses (22%),
Aves (20%), Polychaeta (19%), Pisces (12%), Cephalopoda (10%), and Decapoda
(10%). The average of the total endemics was 20.2%. In some groups the
percentage of endemics was now lower than in the past, partly due to new finding
of Mediterranean species in adjacent Atlantic waters.
## The biodiversity of the “smallest”
An important bulk of species diversity was attributed to the prokaryotic
(Bacteria and Archaea) and eukaryotic (Protists) marine microbes. However, the
differences in the methodologies and types of studies and the continuously
changing state of our knowledge of marine microbial diversity make it difficult
to provide species estimates for the Mediterranean (or from anywhere else) and
establish comparisons.
Current methods cannot yet provide reliable estimates of the microbial richness
of a system \[e.g., \] because of (i) our limited capacity to describe
morphological variability in these organisms, (ii) the limited development and
the biases associated with molecular techniques used to identify them, even with
the use of the most powerful of these techniques, and (iii) the uncertainty in
determining a “microbial species” and where to draw the line that differentiates
one species from another. Morphological variability is used to describe
diversity of some groups of microbes, such as ciliates and microphytoplankton,
but this is not useful for most nano- and almost all picoplanktonic organisms,
including all Archaea and most Bacteria. Therefore, until recently, surveys of
microbial diversity were mainly limited to those taxa with enough features to be
described under an optical microscope. Among phytoplankton, the best-studied
groups included thecate dinoflagellates, diatoms, coccolithophores, and
silicoflagellates. Among microzooplankton, groups like tintinnids, foraminifers,
or radiolarians attracted most attention. Much less information is available on
“naked” auto- or heterotrophic flagellates and on small picoplankton species.
However, researchers have made efforts to obtain estimates of the dominant
microbial species in Mediterranean waters. The expansion of electron microscopy
in the last decades of the twentieth century helped to untangle inconsistencies
in the distribution of some described species and to consolidate the
establishment of a biogeography of many protist taxa. More recently, molecular
techniques (metagenomics) have been used to enumerate the microorganisms present
in a given sample and have completely transformed the field by changing ideas
and concepts. These advances have highlighted the problems with the species
concept when applied to microbial communities, which may be based on morphology,
biology, or phylogeny. Furthermore, different methodologies have biases that
give different views of microbial diversity \[e.g.,\], and now we know that
microdiversity is a general characteristic of microbial communities, making the
delimitation of “diversity” units difficult. To avoid some of the problems with
the “species” delimitation, some authors prefer to use “functional diversity”:
the amount and types of microbial proteins (e.g., functions) in the sample
\[e.g., \], rather than “species” diversity.
According to the compilation published in Hofrichter, the number of described
protist species in the Mediterranean is approximately 4,400. However, this
estimate requires cautious interpretation and it is likely that many
morphospecies, more or less well described, will include a number of cryptic or
pseudocryptic variants \[e.g., \]. Molecular methods have recently uncovered new
sequences that are being associated with the organisms they represent.
Fingerprinting techniques have been used to compare microbial communities and
establish the scale of variability of these communities. For example, Schauer et
al. determined that, along the coastal northwestern Mediterranean, the time of
the year was more important than exact location in determining bacterial
community structure. Acinas et al. and Ghiglione et al. showed that microbial
communities tend to be similar in the horizontal scale and much more variable on
the vertical scale, but these techniques are not appropriate to determine the
number of species present and usually refer only to the dominant organisms.
Recent application of new methodologies (such as metagenomics and 454-tag
sequencing) will in the near future provide more accurate estimates.
All studies to date concur in identifying members of the SAR11 group as some of
the most abundant Mediterranean bacteria, comprising 25–45% of the reported
sequences \[e.g.,\]. These are followed by other Alphaproteobacteria, which tend
to be more common in coastal regions and during algal blooms (such as
*[Roseobacter](http://www.eol.org/pages/11716174)*-like). Cyanobacteria
(*Prochlorococcus* and *Synechococcus*), diverse culturable (Alteromonadales)
and unculturable Gammaproteobacteria and Bacteroidetes form the rest of the
diversity with some differences with depth and with distance from land. Several
studies have concentrated in the diversity of subgroups of these abundant
bacteria in the Mediterranean \[e.g., ,\].
Additionally, the diversity of deep samples and the communities from which they
are taken have received considerable attention in the Mediterranean. Specific
and likely unique ecotypes of some bacteria appear at certain depths, \[e.g.,
\], free-living communities appear to be as complex as epipelagic communities,
and appear to vary seasonally, as do surface communities. The deep-sea
Mediterranean maintains several extremely peculiar and interesting ecosystems,
such as the deep hypersaline anoxic “lakes” in the Ionian Sea that are reported
to include several new and little-known microbial lineages \[e.g., \].
Some studies have shown that bacterial richness peaks in tropical latitudes
\[e.g., \] and concluded that at Mediterranean latitudes the number of
detectable “operational taxonomic units” (OTUs) is between 100 and 150. Zaballos
et al. arrived at a similar value that, once extrapolated, indicated a value of
approximately 360 OTUs for surface waters. A slightly lower value was estimated
for the coastal Blanes Bay Microbial Observatory \[e.g., \] based on a different
approach. Archaeal richness is known to be lower than bacterial richness \[e.g.,
\], and this has been seen in the Mediterranean and in other oceans. Results of
these new sequencing techniques suggest that microbial richness in the sea is
much higher because of the presence of a “rare biosphere” composed of very few
individuals of many distinct organism types. Application of this technique to
data from the northwestern Mediterranean indicates that the numbers should be
raised to about 1,000 “bacterial species” per sample. Again, the real magnitude
of bacterial richness in the Mediterranean cannot be appreciated with the
techniques available.
A similar situation to that with prokaryotes occurs with small eukaryotes, which
are photosynthetic, heterotrophic, or mixotrophic organisms. These small
eukaryotes are found in abundances of 10<sup>3</sup>–10<sup>4</sup>
ml<sup>−1</sup> and have low morphological variability. Thus we must rely on
molecular techniques to grasp their diversity. Molecular work has allowed the
discovery of new groups of eukaryotes present in this smallest size class.
The study of Mediterranean protists has benefited from the early establishment
of marine laboratories and a number of illustrated books and checklists \[e.g.,
–\]. More recent inventories can be found in Velasquez and Cruzado and Velasquez
for diatoms, Gómez for dinoflagellates and Cros for coccolithophorids. The
compilation of northwestern Mediterranean diatom taxa of Velasquez records 736
species and 96 genera. The checklist of Gómez contains 673 dinoflagellate
species in 104 genera.
Cros lists 166 species of coccolithophorids of the northwestern Mediterranean
and revised the classification of several important taxa \[see also 160\].
Recently, the discovery of a number of combination coccospheres bearing holo-
and heterococcoliths fostered the recognition that holococcolithophores do not
belong to a separate family, as previously accepted, but are part of a life
cycle that includes holo- and heterococcolithophore stages. The biodiversity of
photosynthetic nano- and picoflagellates other than coccolithophores is poorly
known for most groups, as may be expected from the difficulties involved in
their identification. However, in the last decade, work using optical and
electron microscopy, often in combination with molecular and culturing
techniques, has considerably increased the taxonomic knowledge of many of these
groups and has highlighted the potential existence of much cryptic or unknown
diversity \[e.g.,\].
There are few taxonomic surveys of heterotrophic flagellates \[e.g., \],
although many phytoplankton studies based on microscopy also included taxa from
these groups. Massana et al. describes a high diversity of picoeukaryotic
sequences, belonging to two groups of novel alveolates (I with 36% and II with
5% of clones), dinoflagellates (17%), novel stramenopiles (10%), prasinophytes
(5%), and cryptophytes (4%). Later work has shown that these novel stramenopiles
are free-living bacterivorous heterotrophic flagellates.
Most of the biodiversity work on ciliates has focused on tintinnids or loricate
ciliates, while studies involving naked ciliates tend to use groupings based on
ecological morphotypes and only rarely include detailed taxonomical work
\[e.g.,–\]. Numbers of species ranging from 40 to 68 were recorded in one to
several-year surveys of various Mediterranean sites \[among others 154\]. Other
groups, such as the Foraminifera, which have calcium carbonate tests, and the
Radiolaria, which produce siliceous or strontium sulfate skeletons, have been
the subject of many stratigraphical and paleoceanographical studies. However,
biodiversity work on living Foraminifera and Radiolaria in the Mediterranean is
scarce \[e.g.,\]. Hofrichter provided a systematic summary of the main groups
and species of both autotrophic and heterotrophic protists found in the
Mediterranean.
## The biodiversity at high trophic levels
Species that occupy the upper trophic levels, normally beyond the level of
secondary consumers, are classified as predators. They have lower diversity than
other taxonomic groups, but information available is usually more detailed. We
reviewed data available for fish, seabirds, marine mammals, and turtles in the
Mediterranean Sea.
Ground-breeding species such as seabirds (gulls and terns) are counted using
census bands and monitored by satellite tracking. However, procellariiforms
reproduce in caves and burrows in cliffs on remote, inaccessible islets, and
census methods to estimate population densities are not totally reliable.
Population models, based on demographic parameters, allow researchers to
estimate extinction probabilities. A census of marine mammals or turtles
normally uses transect data collected from aerial or boat-based sighting surveys
developed to assess abundance, while movement patterns are tracked with
transmitters and monitored by satellite tracking as well. Fish species are
mainly studied using scuba diving or fishing techniques.
There is still some discussion about diversity estimates for these taxonomic
groups. For fish species, for example, several estimates of Mediterranean
diversity exist: Quignard lists a total of 562 fish species occurring in the
Mediterranean Sea; Whitehead et al. mention 589; Fredj and Maurin list a total
of 612 species (and identified 30 species as uncertain); and Quignard and
Tomasini register 664 species. Hofrichter summarizes 648 species, and Golani et
al. report a total of 650 fishes. Fish diversity estimates also change as new
species are described or reclassified. The updated list of exotic fish species
reveals that the Mediterranean currently contains 116 exotic species, although
more species are likely to be cited. There is also a long-standing controversy
regarding genetic differentiation among a few fish populations and sub-basins,
especially of commercial species due to management implications (for example for
the European anchovy *Engraulis encrasicolus*), although results are still under
debate \[e.g., \].
Approximately 80 fish species are elasmobranchs, although the status of some is
uncertain because of infrequency or uncertain reporting \[e.g., ,\]. According
to Cavanagh and Gibson, nine of these elasmobranch species may not breed in the
Mediterranean, while some are rare because the Mediterranean represents the edge
of their distribution ranges. Only four batoid species are Mediterranean
endemics: the Maltese skate (*Leucoraja melitensis*), the speckled skate (*Raja
polystigma*), the rough ray (*R. radula*), and the giant devilray (*Mobula
mobular*).
Nine species of marine mammals are encountered regularly in the Mediterranean.
Of these species, five belong to the Delphinidae, and one each to the Ziphiidae,
Physeteridae, Balaenopteridae, and Phocidae. Other 14 species are sporadically
sighted throughout the basin and are considered “visitors” or “non-residents.”
Of the seven living species of sea turtles, two (the green and the loggerhead
*Chelonia mydas* and *Caretta caretta* - Cheloniidae) commonly occur and nest in
the Mediterranean, and one (leatherback turtle *Dermochelys coriacea* -
Dermochelyidae) is regularly sighted but there is no evidence of nesting sites.
The other two (hawksbill and Kemp's riddle turtles *Eretmochelys imbricata* and
*Lepidochelys kempi* - Cheloniidae) are extremely rare and considered to be
vagrants in the Mediterranean.
Seabirds from the Mediterranean have a low diversity (15 species) and their
population densities are small, consistent with a relatively low-productivity
ecosystem compared with open oceans, and particularly with upwelling regions.
Ten of the Mediterranean species are gulls and terns (Charadriiformes), four are
shearwaters and storm petrels (Procellariiformes), and one is a shag
(Pelecaniformes). Three of the ten species are endemics.
## What is hidden in the deep?
Because of the large size of the Mediterranean deep-sea ecosystems, our
knowledge of the benthic deep-sea diversity is incomplete. In the past 20 years,
several studies on deep-sea sediment diversity have been undertaken in various
oceans \[e.g.,\] but have been limited to a few taxonomic groups. However, due
to technological improvements that render the deep waters more accessible, the
deep-sea benthos of the Mediterranean has received increased attention and there
is progress toward a more comprehensive view of the levels, patterns, and
drivers of deep-sea biodiversity in this semienclosed basin.
Its paleoecological, topographic, and environmental characteristics suggest that
the Mediterranean Sea is a suitable model for investigating deep-sea
biodiversity patterns along longitudinal, bathymetric and energetic gradients
across its different regions. There are few areas with depths greater than 3,000
m, and typically bathyal or abyssal taxonomic groups are limited. Cold-water
stenothermal species that elsewhere represent the major part of the deep-sea
fauna are also unknown in the Mediterranean Sea. The Mediterranean abyssal
macrobenthos comprises a large number of eurybathic species and only 20–30 true
abyssal species. In the western basin, where the depth does not exceed 3,000 m,
the abyssal fauna is less abundant than in the deeper eastern basin, where
abyssal species are dominant in the Matapan trench, which is more than 5,050 m
deep. The close affinity between Mediterranean and Atlantic congeneric deep-
water species suggests that the ancestors of the Mediterranean bathyal endemic
species moved from the Atlantic when conditions were favorable (i.e. when larvae
of deep Atlantic fauna was able to enter in the Western Mediterranean due to
hydrodynamic and physico-chemical conditions allowed it).
According to Pérès, the deep-water fauna of the Mediterranean has a lower degree
of endemism than that of the Atlantic at similar depths. So while the
Mediterranean basin is recognized as one of the most diverse regions on the
planet, the deep sea in the Mediterranean may contain a much lower diversity
than deep-sea regions of the Atlantic and Pacific oceans. The reasons for such a
low diversity may be related to (a) the complex paleoecological history
characterized by the Messinian salinity crisis and the almost complete
desiccation of the basin, and (b) the Gibraltar sill that is, potentially, a
physical barrier to the colonization of larvae and deep-sea benthic organisms
from the richer Atlantic fauna. These factors may explain the composition of the
benthos in the deep sea of the Mediterranean. It may also be that the high deep-
sea temperatures (about 10°C higher than in the Atlantic Ocean at the same
depth) have led to a Mediterranean deep-sea fauna that consists of
reproductively sterile pseudopopulations that are constantly derived through
larval inflow. These postulates were based on the analysis of the macrobenthos,
characterized by life cycles with meroplanktonic larvae that are spread by
currents.
However, the populations of the most common benthic mollusks in depths greater
than 1,000 m off the Israeli coast are composed of both adult and juvenile
specimens, and one species, *Yoldia micrometrica*, the most common and abundant
species in the eastern Mediterranean, is unrecorded from the westernmost part of
the sea. In addition, and though much reduced in diversity and richness compared
with the deep-sea fauna of the western and central basins of the Mediterranean,
the Levantine bathybenthos is composed of autochthonous, self-sustaining
populations of opportunistic, eurybathic species that have settled there
following the last sapropelic event.
Macpherson and Briggs have suggested that within the Atlantic-Mediterranean
region, the fauna (including invertebrates and fishes) of the Mediterranean is
more diverse than that of the Atlantic and displays considerable endemism. For
strictly deep-dwelling species (e.g., the deep-water decapod crustacean family
Polychelidae), the Gibraltar sill is not an impenetrable barrier for some deep-
waters macrobenthic species. Moreover, available hypotheses did not consider
meiofauna diversity, which is characterized by direct development but also by a
small size, which allows organisms' resuspension and drifting over wide regions.
This is consistent with information on the most abundant deep-sea phylum, the
Nematoda, which often accounts for more than 90% of total meiofauna abundance.
Nematode diversity has been investigated only in a few areas of the deep sea in
the Mediterranean: slopes of the Gulf of Lions, Catalan margin and Corsica,
Tyrrhenian basin, and Eastern Mediterranean \[e.g., –\]. Recent collections from
a limited number of sites throughout the Mediterranean basin (at approximately
1,000 m, 3,000 m, and 4,000 m depth), suggest that, conversely to what was
expected, the deep-sea nematode fauna of the Mediterranean basin is rather
diverse.
At bathyal and abyssal depths, levels of nematode genera and species richness
are similar to those reported from other deep-sea areas of the world oceans. In
the deep sea of the Mediterranean, small-bodied taxa (e.g., meiofauna) can reach
a high diversity, and with the presence of a high prokaryotic diversity in the
sediments of the deep-sea Mediterranean, this may change the view that the
Mediterranean deep-sea biota is impoverished in comparison with its Atlantic
counterpart. Endemic macrobenthic species account for approximately 13–15% of
total species number at depths from 200 m to 1,000 m, and approximately 20% at
2,000 m. These estimates are similar for each taxon and are further supported by
the continuous discovery of new species (both within the highly diverse Nematoda
and in rare phyla such as the [Loricifera](http://www.eol.org/pages/1537)) in
different sectors of the deep Mediterranean. Therefore, the general conclusion
that the biodiversity is high in coastal systems and low in the deep sea of the
Mediterranean might not hold true. Detailed references about the deep
Mediterranean can be found in.
## New biodiversity
The biodiversity of the Mediterranean is definitively influenced by the
introduction of new species \[e.g.,–\]. Since the first review of exotic species
in the Mediterranean, the studies in this topic have intensified. Now more than
600 metazoan species have been recorded as alien, these representing 3.3% of the
total estimates (and for detailed information by taxonomic group). However, this
estimate is continuously increasing and may be as high as 1,000 species if
unicellular aliens and foraminiferans are included \[e.g.,\].
Most of these introductions are littoral and sublittoral benthic or demersal
species (or their symbionts). Because the shallow coastal zone, and especially
the benthos, has been extensively studied and is more accessible than deeper
waters, new arrivals probably will be encountered and identified in shallow
waters. The species most likely to be introduced by the predominant pathways
(the Suez Canal, vessels, and mariculture) are shallow-water species.
A taxonomic classification of the alien species showed that the alien phyla most
frequently recorded are Mollusca (33%),
[Arthropoda](http://www.eol.org/pages/164) (18%), Chordata (17%), Rhodophyta
(11%), and Annelida (8%). The data are presumably most accurate for large and
conspicuous species that are easily distinguished from the native biota and for
species that occur along a frequently sampled or fished coast and for which
taxonomic expertise is readily available. Data are entirely absent for many of
the small members of invertebrate phyla. Thus, the true numbers of alien species
are certainly downward biased.
The native range of the alien species in the Mediterranean was most commonly the
Indo-Pacific Ocean (41%), followed by the Indian Ocean (16%), and the Red Sea
(12%), while some species have a pantropical or circumtropical distribution
(19%). The actual origins of the Mediterranean populations of a species widely
distributed in the Indo-Pacific Ocean may be their populations in the Red Sea,
both from the Indian or Pacific oceans, or a secondary introduction from already
established populations in the Mediterranean itself \[e.g., \]. However, and
with few notable exceptions \[e.g.,\], the source populations of alien species
in the Mediterranean have not been assessed by molecular means. Even so, it is
clear that most alien species in the Mediterranean are thermophilic and
therefore originated in tropical seas. The exceptions are exotic algae, of which
the largest numbers are in the Gulf of Lions and the northern Adriatic, and a
few other examples \[e.g., \].
As far as can be deduced, the majority of aliens in the Mediterranean entered
through the Suez Canal (Erythrean aliens) (53%), and an additional 11% were
introduced primarily through the Canal and then dispersed by vessels.
Introductions from vessels from other parts of the world account for 22% of
introduced species, and aquaculture accounts for 10%. A further 2% arrived with
the introduction of aquaculture and were secondarily spread by vessels. The
means of introduction differ greatly among the phyla: whereas of the alien
macrophytes, 41% and 25% were introduced through mariculture and vessels,
respectively, the majority of alien crustaceans, mollusks, and fish are
Erythrean aliens (59%, 64%, and 86%, respectively), and mariculture
introductions are few (4%, 5%, and 4%, respectively) \[, B.S. Galil, personal
observation\].
The numbers of alien species that have been recorded over the past century have
increased in recent decades. The increasing role of the Mediterranean as a hub
of international commercial shipping, a surge in the development of marine
shellfish farming over the last 25 years, and the continued enlargement of the
Suez Canal have contributed to the resurgence of introductions since the 1950s.
Many introduced species have established permanent populations and extended
their range: 214 alien species have been recorded from three or more peri-
Mediterranean countries, and 132 have been recorded from four or more countries
\[, B.S. Galil, personal observation\].
A comparison of the alien species recorded along the Mediterranean coasts of
Spain and France and an equivalent length of coast in the Levantine Sea (from
Port Said, Egypt, to Marmaris, Turkey) showed marked differences in their
numbers, origin, and means of introduction. There are nearly four times as many
alien species along the Levantine coast (456 species) as along the western coast
of the Mediterranean (111 species). The majority of aliens in the Eastern
Mediterranean entered through the Suez Canal (68% of the total, 14% vessel-
transported, 2% mariculture), whereas mariculture (42%), vessels (38%), or both
(5%) are the main means of introduction in the Western Mediterranean \[, B.S.
Galil, in preparation\]. Climate change favors the introduction of Red Sea
species in the southeastern Mediterranean and their rapid spreading northwards
and westwards (see section 4.2c and d). It similarly favors species coming from
the African Atlantic coasts to enter the western basin.
## Spatial patterns of Mediterranean biodiversity
### Longitudinal and latitudinal patterns
Describing the distribution of marine diversity is as important as quantifying
it. In the Mediterranean, a northwestern-to-southeastern gradient of species
richness was observed in most groups of invertebrate species analyzed here, with
a highly heterogeneous distribution of species in the different regions (and for
detailed information). We noticed only a few exceptions. For example, while
there was the same number of *Euphausia* species in the western and central
basins, estimates for several other invertebrate groups were higher in the
Aegean Sea than in central areas of the Mediterranean. These exceptions may be
due to different species tolerance to environmental factors (such as temperature
and salinity), connectivity between regions, and to the lack of data in some
regions.
We found similar results for vertebrate species. There was a decreasing gradient
from northwest to the southeast, while the sea around Sicily had the highest
richness (375 species per 0.1×0.1 degree cell), followed by other northwestern
coastal and shelf areas. The distribution of elasmobranch species was not
homogenous either, showing a higher concentration of species in the west. The
endemic richness gradient of fish species was more pronounced with latitude, the
north side exhibiting a greater richness, and the Adriatic appearing as a hot
spot of endemism with 45 species per cell. Spatial patterns also showed how most
of Mediterranean coastal waters have been colonized by exotic species. The
highest richness of exotic species occurred along the Israeli coast.
Marine mammals were concentrated in the Western Mediterranean and Aegean seas.
Of the nine resident marine mammals, eight were found in the western part of the
basin. This distribution pattern was also observed for the visiting marine
mammals. Two of the three resident sea turtles (loggerhead, green, and
leatherback turtles) occurred in the central Mediterranean and Aegean seas,
while the two visiting turtles were absent from the eastern side. There were
fewer seabird colonies and seabird density was lower in the southeast than the
northwest.
Spatial patterns of benthic biodiversity in the deep sea are poorly known in
comparison with other ecosystems. Available information is scarce and our maps
and estimates include only approximations for the deep sea. In this context,
metazoan meiofauna and, in particular, nematodes can be used to describe the
biodiversity patterns in the deep sea. Deep-sea nematode diversity appears to be
related to that of other benthic components such as foraminifers, macrofauna,
and the richness of higher meiofauna taxa in the deep sea. Results for the deep
sea of the Mediterranean show a clear longitudinal biodiversity gradient that
also occurs along the open slopes, where values decrease eastward, from
Catalonia to the margins of southern Crete. The analysis of the Nematoda
indicates that at equally deep sites, nematode diversity decreases from the
western to the eastern basin and longitudinal gradients are evident when
comparing sites at 3,000 m or 1,000 m depth. Complementary information on
spatial patterns of the deep Mediterranean fauna can be found in.
Additional information from the literature on spatial patterns of Mediterranean
marine diversity suggests that the measurement of local *α*-diversity is not
sufficient to draw a clear picture for the whole Mediterranean basin. Whittaker
defined *α*-diversity as the number of species found in a sample (or within a
habitat), *β*-diversity as the extent of species replacement along environmental
gradients (termed “turnover diversity” by Gray), and *γ-*diversity as the
diversity of the whole region. The analysis of *β-*diversity of Nematoda among
different sites in the deep sea of the Mediterranean and across bathymetric and
longitudinal gradients reveals an extremely high species turnover. By comparing
nematode assemblages at (a) different depths, (b) similar depths in two
different basins, and (c) similar depths within the same basin, the
dissimilarity of biodiversity among deep-sea samples is always greater than 70%.
On average, the dissimilarity of nematode diversity between western and eastern
Mediterranean at about 3,000 m depth is greater than 80% and at similar depths
the dissimilarity between Atlantic and Western Mediterranean exceeds 90%. These
findings indicate that each region is characterized by the presence of a
specific assemblage and species composition. This has important implications for
estimating the overall regional diversity (*γ*-diversity) but also suggests the
presence of high biogeographic complexity in the Mediterranean. However, these
patterns may not hold for all the taxonomic groups, and a broader comparison is
needed.
### Spatial patterns predicted with AquaMaps
Predicted patterns of overall species richness based on AquaMaps showed a
concentration of species in coastal and continental waters most pronounced in
the Western Mediterranean, Adriatic, and Aegean seas. Less than half of the
species were predicted to occur in the deeper waters of the central
Mediterranean, and biodiversity was particularly low in offshore waters at the
eastern end. Given the overall proportion of ray-finned fishes in AquaMaps
dataset, overall biodiversity patterns from these figures were largely dominated
by Actinopterygii. The concentration in coastal waters was more pronounced in
the map focusing on these taxa. Predicted species richness of elasmobranchs was
similar to that for Actinopterygii, but rays and sharks occurred farther
offshore, especially in the waters of Tunisia and Libya. The Aegean Sea,
especially its northern sector, also showed high invertebrate species richness,
which was otherwise low in most of the remaining central and eastern basin.
Biodiversity patterns for the marine mammals contrasted with patterns for fishes
and invertebrates in that many species were also predicted to occur in the
offshore western and central basin waters, and particularly in slope waters. The
biodiversity patterns of sea turtles broadly mimic those of the other more
species-rich taxa in that there was a concentration in coastal areas and a
decline in species richness from the northwest to the southeast.
Therefore, there were similarities and differences between expert-drawn maps and
modeling results. The pattern describing species richness of ray-finned fish was
similar overall, but for the elasmobranchs there were some noticeable
differences. While both methods identified areas around Sicily, the coast of
Tunisia, and the Western Mediterranean as high diversity hot spots, the Adriatic
and Aegean seas showed up as high in species richness only in the predicted
maps. Both types of analyses arrived at similar patterns for marine mammals,
although the lack of distinction between resident and visitor species in the
AquaMaps analysis hampered the direct comparison of diversity patterns for these
taxa. Nevertheless, differences could be seen around the Aegean and Alboran
seas. Maps of sea turtle diversity showed peaks in the western region based on
both types of analysis, but there were a few discrepancies regarding the eastern
Mediterranean. AquaMaps analysis of predicted species richness of invertebrates
also showed a geographical gradient.
Latitudinal transects corresponding to cross sections through the species
richness map highlighted the importance of coastal habitats for fishes and
invertebrates. These habitats were represented by peaks in species numbers in
areas corresponding to shelf waters. Cross-section gradients followed a similar
pattern for fishes and invertebrates; large variations were mostly determined by
depth changes along the respective transects. There was also an overarching
trend of decreasing species richness from western to eastern waters, a trend
that became particularly pronounced in the southern transects. Marine mammal
transects diverged from the general trend in that species richness was less
directly linked to depth variation. Changes in fish and invertebrate species
richness along three different longitudinal cross sections again followed
similar depth contours. Marine mammal longitudinal biodiversity patterns in the
Western Mediterranean followed a different trend with highest numbers predicted
to occur in deeper waters, such as the southern Tyrrhenian Sea. There appeared
to be a general decrease of diversity from northern to southern regions.
### Bathymetric patterns
Because seaweeds and seagrasses are photosynthetic organisms, their development
is limited to shallow areas where there is enough light for growth. They are
distributed between the mediolittoral zone and the deepest limit of the
circalittoral zone, situated at 110 m in the clearest waters of the western
Mediterranean and a bit deeper in the even more oligotrophic waters of the
eastern part. Their growth occurs only on the continental shelves and the
uppermost parts of seamounts above 150 m depth. Seaweeds, which have a limited
distribution across the whole bathymetric gradient, show an increase in species
richness from the highest levels of the mediolittoral rocks down to the lower
infralittoral and upper circalittoral communities. There they display the
highest species richness, as many as 150 species reported in a surface of 1,600
cm<sup>2</sup> at 18 m depth. Species richness then decreases along the
circalittoral zone from the shallowest down to the deepest parts, becoming nil
at the beginning of the bathyal zone.
The pattern of a generally decreasing diversity with increasing depth was also
documented here for invertebrate and fish species and is consistent with
previous studies \[e.g.,\]. Diversity was concentrated in coastal areas and
continental shelves, mainly above 200 m depth. However, patterns did not
necessarily show a monotonic decrease with depth. For example, more polychaete
species inhabited shallow waters than deep waters, particularly below 1,000 m
deep, but this pattern was less clear when looking at maximum ranges of depth.
It is not clear whether this is a real pattern of lower deep-sea diversity or a
result of the lack of proper faunistic studies in the Mediterranean at those
depths. Larger numbers of cumacean species were found in shallow waters of 0–99
m depth (48 species) and between 200 m and 1,400 m depth, but species richness
decreased below this depth (references in). The highest endemism (43.8%) was
found between 0 and 99 m depth. The largest number of mysidaceans (54 species)
was also found in shallow waters less than100 m deep. At depths between 100 m
and 1,000 m, 27 species were found, and below 1,000 m, 21 species. The level of
endemism was also higher in the 0–100 m depth interval (29 species, 78.4% of
total endemism) than in the 100–1,000 m interval (3 species, 8.1%) or below
1,000 m (5 species, 13.5%), in line with results obtained for cumaceans. The
circalittoral zone was the region with highest anthozoan species richness (61.8%
by numbers of species) followed by the infralittoral (57.6%) and bathyal (40%)
zones. Half of the total number of species were restricted to one of the infra-,
circa-, or bathyal zones, and 9.7% were eurybathic, while the remaining species
(40%) were intermediate in depth distribution. We also found exceptions to the
pattern of decreasing diversity with depth. The bathymetric range of
Mediterranean sipunculans was generally quite wide. Most of the Mediterranean
records were bathyal, whereas there were few sublittoral records.
Other studies carried out on depth-related distribution of marine biodiversity
in the deep sea of the Mediterranean available form the literature suggest a
generally unimodal pattern of species richness, the highest values of which are
observed at intermediate depths (about 2,000 m) and lower values at upper
bathyal (\<2,000 m) and abyssal (\>2,000 m) plains. More recent studies,
however, have demonstrated that such patterns are not always recognizable
\[e.g., –\]. In open slope systems, bathymetric gradients of species diversity
have been widely documented \[e.g., –\]. In the Mediterranean, nematode
diversity also decreases with depth, but the degree of species decrease is
limited and ample ranges of biodiversity are observed at the same depth. These
results suggest that the eurybathy of the Mediterranean fauna (3,613 species)
could be lower than previously reported. For example, analysis of all the
existing nematode diversity data from the Aegean Sea showed that there is a
gradual increase of diversity with depth from the littoral zone down to the
bathyal areas (2,000 m) (N. Lampadariou, personal observation). Complementary
information on bathymetric patterns of the deep Mediterranean fauna are explored
with detail in.
## Temporal trends
Available data from the literature show that environmental factors have led to
profound changes in the abundance, distribution, and composition of
Mediterranean marine species in the distant past \[e.g.,\]. For example, during
the Cretaceous, the Mediterranean Sea (called Tethys) was connected to the
Atlantic on its western side and the Indo-Pacific on its eastern side. The two
oceans contributed very different faunas to the Tethys. During the Miocene, the
Tethys was isolated from the Indo-Pacific Ocean and at the Messinian stage, the
connection with the Atlantic Ocean was also closed. During this Messinian
salinity crisis, the Mediterranean underwent severe desiccation that drove most
species to extinction. Although some shallow areas remained on the two sides of
the Siculo-Tunisian Strait, and there were many allopatric speciations, , the
reopening of the Strait of Gibraltar 5 million years ago led to restocking of
the Mediterranean with fauna and flora from the Atlantic. Up to the nineteenth
century, the Mediterranean had been connected with the eastern Atlantic Ocean
only.
In this section, however, we summarized main changes since the end of the last
ice age (approximately 12,000 years ago). During this time there were notable
climate-driven fluctuations but also human-induced changes due to the long
periods of exploration and exploitation, and more recently the reopening to the
Red Sea through the Suez Canal, the globalization of commerce and trade,
increasing pollution and eutrophication of coastal areas, habitat modification
and loss, and finally the looming climate change.
Early evidence of human interaction with marine fauna in the Mediterranean Sea
comes from the Paleolithic period and continues through the Mesolithic and
Neolithic periods (approximately 20,000–4000 B.C.). Zooarchaeological remains
are found in Franchthi Cave in the southern Argolid, Greece, Las Cuevas de Nerja
in southern Spain, Athlit Yam, a submerged site south of Haifa Bay in Israel,
Cape Andreas Kastros in Cyprus, and the Strait of Gibraltar. In Greece, fish
bones of large tuna, Sparidae and Mugillidae, were found. Zooarchaeological
remains in Spain include 20 taxa and show changes in mean fish size and range
over time that have been considered as indication of overfishing. At Cape
Andreas Kastros in Cyprus and in Athilit Yam, 90% of the remains are grey
trigger fish (*Balistes capriscus*), which points to intensive fishing
regardless of size. In Gibraltar, remains of Mediterranean monk seals and
mollusks consumed by humans were found. However, stable isotope analyses of
human bones show that between 10,000 and 8000 B.C., the main Mediterranean
coastal populations did not rely significantly on marine food.
Since the fifth century B.C., humans have exploited marine resources. Aristotle,
in his zoological works dating to the fourth century B.C., focuses his
scientific interest on fish and invertebrates exploited by humans in various
ways. Fisheries in the Aegean communities by that period are characterized by
variability both in the nature and abundance of the exploited fish and in the
manner of their exploitation. Mollusks and other invertebrates are part of the
diet of ancient Greeks, and their consumption is connected with the treatment or
prevention of various health problems and diseases. Bath sponges of the genera
*Spongia* and *Hippospongia*, collected by skillful divers, are widely exploited
for household and personal hygiene purposes, and play a principal role in
medical practice.
Commercial fishing and fish processing activities play an important role in the
Pontic economy. The export of fish and fish products, including salt-fish
(*tarichos*) and fish sauce (*garum*) mainly from European anchovy to the Aegean
Sea, continue into the Roman period. These products are exported from the
western Mediterranean, but g*arum* is forgotten in the west by the tenth
century, although it is still prepared in Constantinople in the fifteenth and
sixteenth centuries. Naval trade traffic becomes intense, and invasions of
islands from the mainland are already common, and they result in the beginning
of the introduction of alien species in those ecosystems. Some of these
introductions (rats, carnivores) trigger the extirpation of many seabird
colonies, and they have shaped the current distribution of several seabird
species.
Seafood becomes increasingly popular toward the end of Roman domination,
probably because of the proximity of, and access to, marine resources. There is
historical evidence of overfishing in some parts of the Western Mediterranean in
the early Imperial period. Even then, certain fishing techniques are prohibited
to manage or counteract the decline in fish stocks (such as fishing by torch
lights at night), and efforts are made to boost natural availability with
introduced fish and shellfish stocks. For example, the parrot fish (*Sparisoma
cretense*) is captured in the Aegean Sea and released in the Tyrrhenian Sea.
There are also pictorial remains that show fishing gear and a large variety of
targeted species during Roman times. Gastropods, the red coral *Corallium
rubrum*, and several species of sponges were exploited on an industrial scale.
Fishing, fish processing, industrial exploitation of several marine species, and
development of improved fishing gear continue during the Byzantine period.
Various literary sources point out that targeted species, among them the
currently overfished tuna, are conspicuous. There is a 200-year gap between the
Moslem conquest of the Near East and northern Africa and the appearance in the
ninth century of the first Arabic written sources. In northern Africa, the first
written evidence dates from the tenth century and refers to fishing gear used to
catch mullets, Atlantic bluefin tuna (with large spears), and fish in shallow
waters. Zooarchaeological material from the Israeli coastline dating from the
Byzantine through the Moslem Crusader and Mamluk periods (fourteenth century)
points to a high consumption of marine and freshwater fish that are still fished
in Israel today, such as the thin-lipped grey mullet (*Liza ramada*), Sparidae,
and the parrot fish. There is noticeable fishing activity dating from the
Byzantine, Moslem (tenth century), and later Norman periods (eleventh to
thirteenth centuries) in southern Italy and in Sicily, where Atlantic bluefin
tuna is the main target species exploited by traps (*tonnara*).
Harvesting of the gastropods *Hexaplex trunculus* and *Bolinus brandaris* is an
example of the successive exploitation of marine resources from the Iron Age
until the thirteenth century in the Eastern Mediterranean. These species are
specifically harvested for the purple pigments extracted from their shells and
used to dye clothes. This harvest disappear from the Levantine area in the late
twelfth century, and from Greece a century later, although both species are
still abundant to this day. Another example of human exploitation of marine
resources from historical times is the hunting of seabirds on islands,
particularly of shearwaters, which probably constituted the only source of
protein in periods of scarcity especially on small islands. In places such as
Formentera (Balearic Islands), humans contribute to the depletion, and partial
extinction, of Balearic shearwaters (*Puffinus mauretanicus*), with consequences
at the level of the marine trophic web.
Human impacts on marine biodiversity grow increasingly stronger as the
Mediterranean cities and ports continue to grow and more recent centuries
witnessed substantial advances in technology. It is assumed that since the
fourteenth century, the adoption of new fishing methods (such as the *tonnara*,
a sort of drift net mainly used for tuna fishing) in the Western Mediterranean,
their spread to southern Italy, , and their introduction to the Adriatic in the
seventeenth century, increase fishing catches. Fishing catches increase to an
extent that even the early fishermen organizations (sixteenth century), such as
*Cofradias* in Catalonia and the *Prud*'*homies* in Provence, are concerned
about possible negative effects on exploited stocks. Such effects are further
intensified by the increasing industrialization in the nineteenth century, with
an increase in the efficiency of existing fishing gear (e.g., otter trawl) and
the introduction of new ones (such as midwater pelagic trawls, hydraulic
dredges, and iron-toothed dredges). Industrialized fishing had severe impacts on
species, habitats, and ecosystems. Several studies also show historical changes
in fish communities of different regions of the basin \[e.g.,–\]. These findings
point to a general severe depletion of top predators in the basin, including
Atlantic bluefin tuna, which is considered critically endangered according to
the declining trend observed in the Atlantic and the Mediterranean in the last
50 years. Historical fluctuations in the abundance of this species have been
described on the basis of a centuries-long time-series of tuna trap catches,
starting in the seventeenth century, and suggested to be linked to climate
fluctuations.
Despite this comparative wealth of historic information about temporal trends
mainly linked to the history of human exploitation of Mediterranean marine
biodiversity, many unknowns remain in spatial and chronological gaps from
prehistoric periods to the present. Ancient, medieval, and early modern records
contain qualitative rather than quantitative data, and it is difficult to depict
general diversity trends at either a species or ecosystem level at the scale of
the whole Mediterranean.
Interesting results do emerge from analyses of specific regions. The overall
trends reported by Lotze et al. for the north Adriatic Sea indicated that
prehistoric people had no measurable effect on marine resources around this
basin (see for species included in the analysis). This changed during the
Classical period (500 B.C. to A.D. 600), and especially during Roman times, when
reports of species depletion and overexploitation in coastal waters increased.
It is possible that marine species recovered from heavy exploitation after the
collapse of the Roman Empire, as has been documented for terrestrial resources.
However, human population increased during the Medieval period (approximately
A.D. 600 to 1500), increasing the pressure on marine resources. With the onset
of the industrialization in Europe in the nineteenth century, signs of species
depletions and rareness increased and accelerated throughout the twentieth
century, when the first extirpations of species were also recorded. Biodiversity
did not decrease, however, because some species were newly introduced into the
Adriatic Sea. No temporal trend is known for alien species in the Adriatic Sea,
so we showed a timeline of mollusk invasions in the Mediterranean as a whole,
which started in the late nineteenth century and accelerated during the
twentieth century. The depletion of formerly abundant species and the invasion
of new species caused a shift in species composition and diversity in the north
Adriatic Sea. Local species depletions and extirpations mostly occurred among
large species, including marine mammals, birds, reptiles, and commercial fish
and invertebrates, while species invasions were mainly by smaller species at
lower trophic levels, such as invertebrates and algae. Such fundamental changes
in species composition had effects on the structure and functioning of food webs
and ecosystems.
Population declines have also been noted among marine mammals throughout the
Mediterranean. These species include sperm whales, which have been declining
since the end of the 1980s ; short-beaked common dolphins, which began to
decline around the 1970s, ; common bottlenose dolphins, which have decreased by
at least 30% over the past 60 years, ; and striped dolphins, which have been in
decline since the early 1990s. The Mediterranean monk seal, in particular, was
deliberately hunted during the Roman period, and it disappeared in the greatest
part of the Mediterranean basin during the early 1900s. Currently, it mainly
occurs in small, isolated areas of the Greek and Turkish coasts, and northwest
African coastal waters, but the presence of Mediterranean monk seal in some of
these areas is uncertain. There are fewer loggerhead and green turtles
throughout the Mediterranean, although historical records were available to
determine the severity of their population decline. Known nesting sites
especially for the loggerhead turtle disappeared in several areas of the basin.
Although the population trends for most seabird species are not well known, all
reliable long-term information suggests that most seabird species have recovered
on the European coasts during the last three decades. This recovery is due to
more restrictive conservation policies at national and international levels.
With the exception of shearwaters, seabird species show relatively stable
population trends. Gulls and terns, after two decades (1980s and 1990s) of sharp
increase in their densities (up to an average 13% annual growth rate in
Audouin's gull), are now in dynamic equilibrium. Sparse data on shags suggest a
slow recovery in the last two decades. Storm petrel populations are stable at
the few long-term monitored sites, but many suitable breeding sites have been
destroyed since historical times along coastlines. Paleontological records
confirm that the distribution of many species was much larger, even occupying
habitats in the interior of large islands relatively far from the sea, where
recolonization is now impossible. Population recoveries of Mediterranean
seabirds must be considered only partial, and only occurring where protection is
effective.
## Threats to diversity and hot spots
As shown above, anthropogenic factors have influenced the general patterns and
temporal trends of Mediterranean marine diversity with varying degrees of
intensity. Quantifying the importance of each threat is essential for future
analysis.
Lotze et al. provided data to evaluate the human impacts that caused or
contributed to the depletion or extirpation of species in the north Adriatic Sea
over historical time scales. Exploitation stood out as the most important factor
causing or contributing to 93% of depletions and 100% of local extinctions or
extirpations. Habitat loss or destruction was the second-most-important human
impact, followed by eutrophication, introduced predators, disease, and general
disturbance. While 64% of depletions and 88% of local extinctions were caused by
a single human impact, in all other cases the combination of two or several
human causes was responsible for the decline or loss. This highlights the
importance of cumulative human impacts, especially in coastal ecosystems, with
emphasis on species with commercial interest.
Recently, anthropogenic drivers and threats to diversity increased and further
diversified in the Mediterranean, as observed elsewhere. Published information
and the opinion by experts identified and ranked current threats to diversity in
the Mediterranean. The sum of the ranking (0–5 for each threat) showed that for
13 large taxonomic groups, habitat loss and degradation are considered the
primary impact on diversity, followed by exploitation, pollution, climate
change, eutrophication and species invasions. These were the most conspicuous
threats and also affect the greatest number of taxonomic groups. Other threats
to diversity were maritime traffic (collisions with vessels) and aquaculture.
Within 10 years from now, habitat degradation and exploitation were predicted to
retain the predominant roles, while pollution and climate change will likely
increase in importance, followed by eutrophication. Of all current threats to
biodiversity in the Mediterranean, climate change was predicted to show the
largest growth in importance within the next 10 years (10.8%), followed by
habitat degradation (9.2%), exploitation (6.2%), and pollution, eutrophication,
and invasion of species (4.6% each).
shows past changes and projected future increases in sea surface temperature
(SST) in the Mediterranean Sea. The 15°C isotherm, whose one-century
climatological mean crosses the Straits of Sicily, may have moved northward in
recent times. This can imply that a number of tropical Atlantic species that
entered the Mediterranean during the last interglacial (125,000 to 110,000 years
ago) will reenter the Western Mediterranean in the near future. In the meantime,
in the Western Mediterranean, the “14°C divide”, the one-century climatological
mean of the surface isotherm for February that coincides with a frontal system
created by mesoscale eddies in the Algerian Basin and that may act as a barrier
to dispersal, has apparently moved northward in recent times. The southern
sectors of the Mediterranean harbor many native warm-water species that do not
occur or get much rarer in the northern sectors. These “southerners” are
apparently confined by the 14°C divide. Perhaps not coincidentally, many of
these native but “meridional” warm-water species have colonized the northern
sectors, which are thus facing a process of “meridionalization” \[e.g.,\]. In
addition, the mean SST made in early 1980s revealed that the warmest area of the
Mediterranean was the Levantine Basin, with a mean SST of 21.8°C, and the
coolest areas were the Gulf of Lions and the Ligurian Sea, with a mean SST of
16.9°C. Climate models predicted that by 2041–2060, the major part of the
Mediterranean will become warmer except the northern Adriatic, which is expected
to become cooler (OPAMED8 model based on the A2 IPCC scenario). By 2070–2099,
the Mediterranean is projected to warm by 3.1°C, the last cool enclaves being
the Gulf of Lions and the northern Adriatic, with a mean SST of 18°C.
Taking into account data regarding marine biodiversity and threats, we mapped
vertebrate endangered species and have tried to locate potential hot spot areas
of special concern for conservation in the Mediterranean. The first attempt
included fish, marine mammals, and sea turtles, which are considered important
sentinels for ocean health. The identified hot spots highlighted the ecological
importance of most of the western Mediterranean shelves. The Strait of Gibraltar
and adjacent Alboran Sea and African coast were identified as representing
important habitat for many threatened or endangered vertebrate species. The most
threatened invertebrate species in the Mediterranean, the limpet *Patella
ferruginea*, is also distributed along this area. Both the northern Adriatic and
Aegean seas also showed concentrations of endangered, threatened, or vulnerable
species. Other equally species-rich waters along the northeast African coast,
and the southern Adriatic Sea, were of lesser concern for the protection of
endangered species.
# Discussion
## Estimates and patterns of marine diversity in the Mediterranean Sea
Our estimate of 17,000 species for marine biodiversity in the Mediterranean
updated and exceeded previous values, which were on the order of 8,000–12,000
species. In comparison with the 1992 estimate, the total number of recorded
species has increased substantially. As a result of recent efforts and
improvements in analytical methods and instruments, our estimates of
invertebrates and protists, in particular, have undergone an upward revision in
recent years. Current estimates of sponges, cnidarians, polychaetes, mollusks,
arthropods, echinoderms, ascidians, and other invertebrates all exceed those
dating back to the early 1990s. However, since most microbial diversity is
basically unknown, global numbers and their evolution are uncertain.
Estimates from global databases that include Mediterranean information up to
September 2009 range from 4% and 25% of the total species diversity estimated in
our study. They covered vertebrate taxa fairly comprehensively, but other
taxonomic groups were underrepresented. WoRMS included 8,562 records of
Mediterranean marine species, which represented 50% of species registered in
this study. Mediterranean databases such as ICTIMED (specialized in fish
diversity) included about 70% of fish diversity reported in our study.
Total estimates of Mediterranean species of macrophytes and metazoans
represented 6.4% of their global counterpart. Macrophytes showed the highest
percentage of shared species with global estimates, and Heterokontophyta and
Magnoliophyta scored the highest (17.2% and 11.7%, respectively). Among
metazoans, Mediterranean sponges showed the highest percentage (12.4%), followed
by polychaetes (9.4%) and cnidarians (7.7%). Other groups represented much lower
percentages of the total, such as echinoderms (2.2%), fish species (4%), and
mollusks (4%).
Previous studies claim the existence of a gradient of species richness from the
northwest to the southeast Mediterranean \[e.g.,–\], in agreement with
differences in key environmental variables, such as latitude, salinity,
temperature, and water circulation, in addition to the distance from the Strait
of Gibraltar. Our results confirmed this general decreasing trend and showed
that the distribution of marine diversity in the Mediterranean is highly
heterogeneous.
The Western Mediterranean displays the highest values of species richness,
likely owing to the influx of Atlantic species and the wide range of
physicochemical conditions. The central Mediterranean, Adriatic, and Aegean seas
are areas of second-highest species richness, although with exceptions. The
Adriatic Sea sometimes displays lower species numbers because of restricted
exchange with the western basin, decreasing depth toward the north, the presence
of fresh water, and the larger amplitude of temperature variations. However,
this basin shows a large number of endemics possibly owing to its higher
isolation. The Aegean Sea normally follows the western areas, mainly because of
its more direct exchange with the western basin and its higher habitat
diversity. The Levantine Basin and southeastern side have in general the lowest
species richness, which is due to the unfavorable conditions prevailing in the
area (such as high salinity) as well as the less intensive sampling effort.
In fact, a lack of data is evident in several eastern and southern regions of
the Mediterranean basin. This may have strongly influenced some of our results
regarding spatial patterns, so generalizations have to be made carefully. Marine
research in the Mediterranean has been regionally biased, reflecting sparse
efforts along the southern and easternmost rim. It has even been suggested that
the relative species richness of different taxa by sector of the Mediterranean
is a better indicator of the level of research effort than of true species
richness. Therefore, as new species are assessed in the eastern and southern
areas, patterns may be modified. Moreover, the diversity in the eastern end is
more influenced by species introductions. The Suez Canal, opened in 1869, has
restored the connection between the Mediterranean and the Indian Ocean, and in
recent years we have witnessed an exponential increment in the number of Indo-
Pacific species recorded in the Eastern Mediterranean \[e.g.,\]. This trend will
continue to influence the biodiversity of the Mediterranean Sea.
In addition, the data used to draw spatial patterns were collected from the
1980s to 2000s, so results may differ from the current situation and may
represent potential ranges and values rather than current ones. However,
similarities exist between results achieved with distribution maps drawn with
expert data and predicted results using AquaMaps models. These similarities
indicated that the species richness maps resulting from this study are a useful
first attempt to represent comprehensive species richness patterns at the
Mediterranean scale. Differences encountered using both methods may be due to
limitations of the data. By their nature, expert-drawn maps or sightings often
represent underestimates of total species distributions because of the absence
or lack of effort in certain areas (in our case the southern shorelines of
Mediterranean along the coasts of northern Africa and the eastern sites) and the
inability to detect rarer species without sufficient efforts. On the other side,
AquaMaps model predictions do not currently factor human impacts or ecological
interactions and may be closer to fundamental or historical niche rather than
realized niche. Therefore some AquaMaps predictions may represent overestimates
(a good example is the Mediterranean monk seal; see
[www.aquamaps.org](http://www.aquamaps.org)). Besides, the relative probability
of occurrence calculated from AquaMaps does not distinguish between a rare
species that might only have been sighted once in a given cell, and a more
abundant species that might be sighted every day. AquaMaps rely exclusively on
data accessible through OBIS/GBIF, which currently contains few Mediterranean
records. Therefore, for many species, occurrence was inferred from habitat use
outside of the Mediterranean. Because the Mediterranean environment represents
some environmental extremes (such as salinity and temperature records),
occurrences in the eastern part may not have been captured adequately by
AquaMaps, and this could partially explain the low values in this region. These
limitations are extended to our first attempt to depict hot spot areas in the
Mediterranean. The eastern region hosts important populations of elasmobranchs
and marine mammals that are currently threatened, but their probability of
occurrence estimated by AquaMaps model is lower than 0.4. Further studies should
be able to reconcile both mapping sources and confirm or correct patterns.
Explanations for the observed heterogeneity of species richness in the
Mediterranean Sea include the threshold of the Siculo-Tunisian Strait that
divides the Mediterranean into two basins, and the paleo-biogeographical history
of the Mediterranean Sea. The western basin shows more biological similarity
with the Atlantic Ocean, hosting a higher number of cold-temperate species,
while the eastern basin shows more biological similarities with the Indo-
Pacific, and hosts a larger number of subtropical species. The Siculo-Tunisian
Strait still partially acts as a barrier to the dispersal of many species
between the two basins and constitutes their meeting point.
Diversity differences between areas may also reflect changes in water masses and
circulation, as well as changes in temperature and salinity. The diversity of
some groups is definitively influenced by this temperature gradient. For the
sipunculans, richness may be linked to the temperature of the water masses
during the year, which reflects a physiological barrier between cold and warm
water for cold- and warm-water species. For example, *Golfingia margaritacea* is
mainly a temperate and boreal species, and its presence in the Mediterranean may
indicate the prevalence of colder water masses. In contrast, other thermophilic
species, such as *Phascolion convestitum* and *Aspidosiphon elegans*, have been
proposed as Lessepsian migrants.
Diversity distribution in the Mediterranean is also associated with a
productivity gradient. Higher productivity areas show higher diversity partially
because they are important feeding and reproductive sites for several taxa. Most
of these areas occur in the Western Mediterranean and the northern Adriatic
that, for example, host many species of fish, seabirds, marine mammals, and
turtles \[e.g.,\]. Their distribution is associated with feeding habits
\[e.g.,\]. Moreover, some fish, seabirds, sea turtles, and mammals show
opportunistic feeding behavior, exploiting discards from trawling and purse
seines, and to a lesser extent from artisanal long-lining \[e.g., –\]. In
developed Mediterranean countries, discards from trawl fishing can be up to 400%
of the commercially valuable catches, and such amounts of food, which may be
predictable in space and time, are scavenged by many species. Most Mediterranean
marine mammals are predominantly offshore and prefer deep-water habitats, but a
few species can venture to inshore waters and scavenge fishery discards.
The three main categories explaining the drivers of biodiversity in the deep
Mediterranean are (i) bathymetric gradients, which are associated with
increasing pressure and decreasing food availability in deeper sediments; (ii)
geographical and physicochemical features, which are responsible for the north-
northwest–south-southeast gradient in trophic conditions; and (iii)
environmental heterogeneity (e.g., grain size distribution, habitat complexity,
distribution of food inputs). Our understanding of the mechanisms driving deep-
sea biodiversity patterns is still limited, but some of the factors frequently
invoked are (a) sediment grain size and substrate heterogeneity ; (b)
productivity, organic content, or microbial activity ; (c) food resources ; (d)
oxygen availability ; (e) water currents ; and (f) occasional catastrophic
disturbances. Thus, the spatial distribution of available energy may influence
the distribution of benthic abundance, biomass, and biodiversity,. Food
availability depends almost entirely on the supply of energy from the water
column and decreases with depth, which may explain most of the variability
between the observed spatial patterns of the benthic biodiversity in the deep
Mediterranean Sea.
## Threats to diversity
In the past, geological and physical changes lie at the root of the most
dramatic changes in biodiversity in the Mediterranean Sea. Today, human
activities are essential elements to consider as well, and several of them
threaten marine diversity. The most important threats in this region are habitat
loss, degradation and pollution, overexploitation of marine resources, invasion
of species, and climate change.
### Habitat degradation, pollution, and eutrophication
Our results show that habitat degradation and loss is currently the most
widespread threat and was also important in the past. Human interventions, such
as coastal modification, that can be traced back to before the Roman period,
have important consequences for diversity. Coastal development, sediment
loading, and pollution reduced the extent of important habitats for marine
diversity, such as seagrass meadows, oyster reefs, maërl, and macroalgal beds,
and affected Mediterranean ecosystem functioning well before the 1900s. Most
species depend strongly on their habitats (such as bryozoans, sponges,
echinoderms, benthic decapods, and organisms of the suprabenthos and
meiobenthos); hence, its loss and degradation have major effects on marine
diversity.
Cultural eutrophication, in particular in semienclosed basins such as the
Adriatic Sea, can also be traced back for centuries. This phenomenon reached its
peak in the late 1980s and, in addition to fishing, may be the cause of the
sequence of jellyfish outbreaks, red tides, bottom anoxia events leading to
benthic mass mortalities, and mucilage events that have occurred in recent
ecological history of the Adriatic Sea. Direct and indirect pollution is
generated directly from the coast, or through fluvial contributions, and ends up
in the sea. Pollution affects a wide range of marine species \[e.g.,–\] and is
of primary concern for the conservation of the deep-sea ecosystems.
The main threats for most seabirds and marine turtles in the Mediterranean arise
from habitat degradation and loss. The breeding habitat for seabirds is
relatively well protected along the northern Mediterranean shore, but the
protection of many seabird colonies and hot spots is less effective along the
southern shore because of limited resources. Marine wind farms, which are
expected to increase in some countries, may represent a new conservation concern
for seabird populations. Marine turtles are also affected primarily by
degradation of habitats but also by marine pollution, driftnets, gillnet and
longline by-catches, and boat strikes. The continuing increase of coastal
settlements is important for the region's economic activity, but it is also
causing intense environmental degradation through excessive coastal development,
further pollution, and consumption of natural resources, all of which add
pressure to coastal areas and the marine environment.
### Exploitation of marine species
This study also illustrates that the oldest and one of the most important
maritime activities that has become a threat to diversity is human exploitation
of marine resources. People around the Mediterranean have exploited marine
resources since earliest times. Maybe not surprisingly, negative effects of the
exploitation of the Mediterranean marine biodiversity were first reported in the
fourth century B.C. by Aristotle. He mentioned that scallops had vanished from
their main fishing ground (Gulf of Kalloni, in Lesvos Island) since fishermen
began using an instrument that scratched the bottom of the sea. Early records of
overfishing and depletion of coastal resources become evident during Roman and
medieval times and are driven by human population growth and increasing demand
and the increasing commercialization and trade of food and products.
The current high demand for marine resources continues and has resulted in high
levels of fishing or harvesting intensity. Several fish resources are highly
exploited or overexploited \[e.g.,–\]. Other organisms that are exploited or
affected by exploitation in the Mediterranean include macrophytes, sponges,
cnidarians, echinoderms, mollusks, arthropods, polychaetes, ascidians, and other
invertebrates \[e.g.,–\].
The threats to currently endangered marine mammals and sea turtles include
unwanted by-catch, as well as historical exploitation. For sea turtles, the
overall mortality rate caused by entanglement in fishing gear and by habitat
degradation is poorly known, but for marine mammals the major threats clearly
derive from human activities: direct or indirect effects of exploitation, such
as prey depletion, direct killing, and fishery by-catch,. At sea, threats to
seabirds mainly come from fisheries, particularly by-catch in longlining.
Fishing is being expanded toward deeper areas and is threatening several
ecosystems \[e.g.,\], while management effectiveness in the Mediterranean is
low. Fishing activity may also be the cause of ecosystem structural and
functional changes and ecosystem degradation \[e.g.,–\].
### Bioinvasions
A few Mediterranean invasive aliens have drawn the attention of scientists,
managers, and media for the conspicuous impacts on the native biota attributed
to them. A pair of coenocytic chlorophytes, *Caulerpa taxifolia* and *Caulerpa
racemosa* var. cylindracea, are the most notorious invaders due to their high
impact on marine benthic ecosystems, thus the best-studied invasive species in
the Mediterranean. Other work has traced the impacts of invasive aliens that
entered the Mediterranean from the Red Sea through the Suez Canal and displaced
native species.
Tropical species have been entering the Mediterranean through either the Suez
Canal (Lessepsian migration) or the Strait of Gibraltar for decades, and mainly
by ship transportation. The Mediterranean is highly susceptible to ship-
transported bioinvasions: one-fifth of the alien species recorded in the
Mediterranean were first introduced by vessels. In 2006, 13,000 merchant vessels
made 252,000 calls at Mediterranean ports, and an additional 10,000 vessels
passed through the sea (REMPEC/WG.29/INF.9). The increase in shipping-related
invasions may be attributed to the increase in shipping volume throughout the
region, changing trade patterns that result in new shipping routes, improved
water quality in port environments, augmented opportunities for overlap with
other introduction vectors, and increasing awareness and research effort. The
swarms of the vessel-transported American comb jelly (*Mnemiopsis leidyi*) that
spread across the Mediterranean from Israel to Spain in 2009 raise great concern
because of their notorious impacts on the ecosystem and fisheries \[ansamed.info
and 360\].
Moreover, with the development of large-scale marine aquaculture (mariculture)
in the late twentieth century, the commercially important alien shellfish
*Crassostrea gigas* and *Ruditapes philippinarum* were intentionally introduced
to the Mediterranean. The high permeability of aquaculture facilities,
transport, and transplantation of these species have resulted in many
unintentional introductions: oyster farms have become veritable gateways into
Mediterranean coastal waters for alien macrophytes. The massive “official” and
“unofficial” importation of foreign spat (young bivalves both before and after
they become adherent) in the 1970s and 1980s coincided with a marked increase of
alien species around oyster farms, and the aliens were considered to have
arrived with the oysters. Segments of the industry may still resort to illegal
importation: neither the Turkish authorities nor the UN Food and Agricultural
Organization were aware of the importation of the bilaterally ablated female
banana prawn (*Fenneropenaeus merguiensis*) that was found in the Bay of
Iskenderun, Turkey.
Although some aliens are responsible for reducing the population of some native
species, others have become locally valuable fishery resources. Some Erythrean
aliens were exploited commercially almost as soon as they entered the Levantine
Sea, and their economic importance was quickly acknowledged. Levantine fisheries
statistics record the growing prominence of the Erythrean aliens: the Erythrean
prawns are highly prized and, beginning in the 1970s, a shrimp fishery developed
in the Levantine Sea. Nearly half of the trawl catches along the Levantine coast
consist of Erythrean fish, but the commercially exploitable species were
accompanied each summer by swarms of the scyphozoan jellyfish *Rhopilema
nomadica*, washed ashore along the Levantine coast. The shoals of jellyfish
adversely affect tourism, fisheries, and coastal installations, and severe
jellyfish envenomations require hospitalization. The recent spread of the silver
stripe blaasop (*Lagocephalus sceleratus*) and the striped catfish (*Plotosus
lineatus*) pose severe health hazards. Other work has traced the impacts of
invasive aliens that entered the Mediterranean from the Red Sea through the Suez
Canal and displaced native species.
Pronounced thermal fluctuations and a significant increase in the average
temperature of the waters in the Mediterranean during the past two decades have
coincided with an enlarged pool of warm-water alien species that have become
established and expanded their distributions (see next section). These
thermophilic aliens have a distinct advantage over the native Mediterranean
biota. Though no extinction of a native species is yet attributable to invasion
of new species, sudden declines in abundance, concurrent with proliferation of
aliens, have been recorded. Examination of the profound ecological impacts of
some of the most conspicuous invasive alien species underscores their role,
among many anthropogenic stressors, in altering the infralittoral benthic
communities. Local population losses and niche contraction of native species may
not induce immediate extirpation, but they may trigger reduction of genetic
diversity and loss of ecosystem functions and processes, and habitat structure.
### Impacts of climate change
Climate change is exerting a major effect on Mediterranean marine biodiversity
through seawater warming \[e.g., –\]. The increase in seawater temperature has
affected the distribution and abundance of native and alien species, and has had
both direct and indirect effects on invertebrates and fish \[e.g.,, see \]. The
increase in water temperature in the Mediterranean also alters jellyfish
population dynamics \[e.g., \] and may act in addition to indirect fishing
impacts \[e.g., \].
Seawater of the Mediterranean Sea has been warming since at least the 1970s.
Rising temperature enlarges the pool of alien species that could establish
themselves, enables the warm-water species (native and alien) present in the sea
to expand beyond their present distributions, and provides the thermophilic
aliens with a distinct advantage over the native Mediterranean biota. The
appearance of numerous allochthonous species of tropical origin is leading to
what is called the “tropicalization” of the Mediterranean Sea. Although tropical
invaders have been recorded in the northernmost sectors of the Mediterranean
\[e.g.,\], tropicalization is especially obvious in the southern sectors, where
species of tropical origin now form a significant portion of the biota.
Tropical species have been entering the Mediterranean through either the Suez
Canal (Lessepsian migration) or the Strait of Gibraltar for decades , but they
used to remain in the eastern or western basin, respectively. Thus it conformed
to the traditional physiographic and biogeographic subdivision of the
Mediterranean. However, in the last two decades, the number of tropical species
that have also spread through the entire basin is growing. Examples of Erythrean
aliens that crossed the Strait of Sicily include algae, a seagrass, many
invertebrates and fish \[e.g.,–\]. Species coming from the tropical Atlantic
have traveled the opposite way to reach the Levantine Sea \[e.g.,\]. The Strait
of Sicily is today a crossroad for species of distinct tropical origins
(Atlantic and Indo-Pacific), expanding their range longitudinally within the
Mediterranean.
If the southern sectors of the Mediterranean are being “tropicalized” (higher
occurrence of tropical aliens) and the northern sectors “meridionalized”
(increased proportion of indigenous thermophilic species), it is uncertain what
will happen to those species of boreo-Atlantic origin, which entered the
Mediterranean during glacial periods and have been established in the northern
and colder areas of the basin. Because they cannot move farther northward, they
may dramatically decrease or even be at risk of extirpation. Although the total
extinction of flora and fauna from a basin as wide as the Mediterranean may be
unrealistic, the signs of increased rarity or even disappearance of cold-water
species deserve further investigation,. An example is the deep-water white
coral, *Lophelia pertusa*, reefs of which have become rare in the Mediterranean.
These coldest parts of the Mediterranean (Gulf of Lions, northern Adriatic)
could act as a sanctuary for cold-temperate species, but if warming intensifies,
those areas may act as traps without any cooler water for escape.
Global warming may cause thermophilic species of the southern Mediterranean to
appear more frequently in the northern and colder parts \[e.g.,–\], and an
increasing colonization by southern exotic species may be seen. But there may
also be habitat fragmentation and local extinction of species unable to
undertake migrations. Lack of (evidence of) species extinctions, coupled with
establishment of alien species, is apparently leading to an increased species
richness of the Mediterranean, a much debated issue. Richness is increasing at
the whole-basin scale (*γ*-diversity), but it is difficult to establish what is
happening at local scales (α-diversity) in coastal areas. Instances of species
replacement \[e.g.,–,\], and mass mortalities due to high temperature or
pathogens \[e.g.,–\] and perhaps aliens have been observed. Climate warming,
moving physiological barriers and inducing the spatial overlap between alien and
indigenous species, causes biotic homogenization and hence a depression in
β-diversity. Thus, the relationship between tropicalization, meridionalization,
and biodiversity is not straightforward.
In general, the establishment of tropical invasive aliens may cause
Mediterranean communities to lose their particular character and to become
similar to their tropical analogs, especially in the southern portions of the
basin. *Cladocora caespitosa*, the most important shallow-water zooxanthellate
species living in the Mediterranean, was more abundant and built more
conspicuous formations during periods of the Quaternary, when the Mediterranean
climate was subtropical. However, warming episodes in recent summers coincided
with mass-mortality events of this coral \[e.g., \]. Hence, it is unlikely that
the Mediterranean in the future will contain significant coral constructions.
The overwhelming number of Lessepsian immigrants will move the composition of
the biota more and more like that of the Red Sea, but Mediterranean communities
will probably look like those that today characterize southern Macaronesia and
the Cape Verde region, with scanty coral and abundant algae \[e.g., \], rather
than those of the Red Sea and the Indo-Pacific.
Seawater acidification may also be a threat to Mediterranean marine
biodiversity. The most obvious consequence of the increased concentration of
CO<sub>2</sub> in seawater is a reduced rate of biogenic calcification in marine
organisms. This could affect both planktonic and benthic communities. Calcifying
phytoplankton (coccolithophores) play a significant role in the primary
productivity of the oligotrophic Mediterranean Sea, whereas many benthic
habitats are engineered by sessile organisms that lay down carbonate crusts.
Calcareous red algae are the builders of coralligenous reefs, one of the most
important Mediterranean ecosystems, and seawater acidification will probably
impair their role. However, noncalcifying photosynthetic plants, such as
frondose algae and seagrasses, may take advantage of a greater availability of
CO<sub>2</sub>. But large, erect species of brown algae as well as Mediterranean
seagrass are now in decline because of the environmental degradation, induced
primarily by human activities.
## The unknowns and limitations
The study of Mediterranean marine diversity over many years has produced a
significant amount of information. Yet this information remains incomplete with
the discovery and description of new species, especially of smaller, less
conspicuous and cryptic biota. The biodiversity in the Mediterranean Sea may be
in fact much higher than is currently known.
We do not have credible measures of microbial richness, but development of new
technologies will allow us to decide whether this is knowable or not. The
description of microbial diversity is probably better approached through the
continued study at selected sites, such as the Microbial Observatories, for
which data exist on both identification methodologies and the functioning of the
ecosystem. Current Mediterranean observatories are at Blanes Bay, Gulf of
Naples, Villefranche's Point B, Dyfamed station, and the Mola and SOLA stations
in Banyuls. Sites in the southern and eastern Mediterranean are still to be
added.
Further exploration and taxonomic work on seaweeds and seagrasses is needed in
all the African countries (mainly in Libya and Egypt), the Levantine Sea
(Israel, Lebanon, Cyprus, Syria), and the Aegean Sea (Greece and Turkey).
Phycological surveys are also required in Croatia, because several species (and
even genera) described from the Adriatic have never been found again and require
taxonomic reevaluation. We do not expect a significant increase in the rate of
description of new species, but the description of new macroalgal species
continues \[e.g., ,\]. A large number of species are poorly known, and our
checklist includes several *taxa inquirenda*. Accurate morphological studies,
and new molecular tools, are required to decipher the taxonomy of several
genera, including *Ectocarpus*, *Cystoseira*, *Acrochaetium*,
*[Polysiphonia](http://www.eol.org/pages/9653)*, and *Ulva*.
A similar situation exists for the invertebrates. Most of the small fauna of the
Mediterranean are typical of current scientific knowledge: in one of the best-
known geographic areas of the world, there are many regions and habitats that
remain insufficiently studied, and several taxonomic groups in deep-sea areas
and portions of the southern region are still poorly known. The description of
new species is still a high priority. As illustrative examples, the accumulation
curves for cumaceans, mysids, polychaetes, and ascidians discovered (described
or first recorded) show that no asymptote has been reached, and there has been
no slowing in the rate of discovery for less conspicuous species in the
Mediterranean, as it is observed when analyzing accumulation curves in other
parts of the world.
The shortage of taxonomists for many groups is a particularly serious problem
worldwide, and it also applies to the Mediterranean Sea. Several of the main
invertebrate specialists have retired or are close to retirement and few are
being replaced. Many samples are not being properly identified, which leads to a
corresponding underestimation of biodiversity. The current spread of invasive
species requires serious taxonomic attention. Many, if not most, taxonomic
groups are subject to anthropogenic threats in one way or another, and
researchers must work against time to avoid losing valuable biological
information. Undescribed invertebrate species may become extinct before we even
know of their existence. In addition, and paradoxically, some of the commonest
and most accessible ecosystems such as beaches, among other habitats in the
Mediterranean, have been poorly studied,.
Sampling biases are another source of uncertainty in the estimation of marine
biodiversity. In particular, the three-dimensional character of marine
ecosystems requires much more study at depths where light penetration is
perceived as important but is poorly understood. Light intensity decreases with
increasing depth and species perform extensive migrations within the water
column or along the seabed. Endobenthic species display rhythms of emergence,
including burying or burrowing within the substrate and sheltering in natural
holes. Marine species react to light intensity cycles, which may include
movements in and out of our sampling windows. Information gathered without
attention to such rhythmicity will affect perceived population distribution,
biomass, and estimated biodiversity. These issues have been integral to land
ecology since the early twentieth century but have been rarely considered in the
marine environment. In the Mediterranean, Sardà et al. considered this problem
during day-night sampling at and below the end of the twilight zone (1,000 m
depth) and observed day-night fluctuations in their catches. Midday and midnight
trawl catches at different depths during October showed great differences in
fish, cephalopod, and crustacean species composition and relative abundance in
the deeper areas. Waveform analysis of crustacean catches showed behavioral
rhythms that affected presence or absence from catches made at different times
during a 24-hour cycle. Because trawl surveying is one of the commonest methods
of sampling in marine waters, and is one of the most used in the Mediterranean
Sea, future biodiversity studies should correct for the practice of sampling
only during daytime. In addition, observations of important diel variation in
the fauna associated with seagrasses include a notable increase of species
richness and abundance in nighttime samples. This issue brings together the
problem of biodiversity and climate change due to expected changes in species
migrations and rhythmicity.
While Mediterranean vertebrate species are better known than the invertebrates,
our understanding is still incomplete and often outdated. The FNAM atlas, which
contains data collected and edited during the 1980s and 1990s, is based on
regional data and expert knowledge and is the only record of geographic ranges
for all Mediterranean fish species. Several areas of the southern Mediterranean
have never been surveyed scientifically. Long-term monitoring programs are
absent or unavailable for many countries. Since vertebrate species may be useful
indicators of changes in ocean food webs, a major challenge that remains is to
achieve time-series sampling of species diversity, abundance, and habitat data.
These time series should have large spatial and temporal scales to develop
useful indicators of changes in Mediterranean marine ecosystems and provide
measures of ecological connections and ecosystem services.
A clearer identification of hot spot areas will require the inclusion of new
data on macroalgae and seagrasses, invertebrates, and seabirds. Most of the
Mediterranean seabird species (with the exception of some large gulls) are
protected by European laws because of their small or declining populations or
the small number of breeding sites. Nine species are included in Annex II of the
EU list of endangered or threatened species. The Balearic shearwater is
critically endangered, and the monitored colonies of Cory's and Mediterranean
shearwaters are slowly declining. Although information is incomplete for
macroalgae and invertebrates, a total of 11 species of macroalgae, 3 of
flowering plants, 9 of sponges, 3 of cnidarians, 17 of mollusks, 2 of crustacean
decapods, and 3 of echinoderms are now listed as endangered or threatened in the
Annex II of the Barcelona Convention for the Protection of the Marine
Environment and the Coastal Region of the Mediterranean (1995). A recent
proposal (2009) for amendments in the annex II increased to four the number of
flowering plants and to 16 plus all the species of the genus *Cystoseira* (with
the exception of *C. compressa*) the number of endangered species of macroalgae.
## Conclusions
The Mediterranean Sea is a region of high biodiversity that ranks among the best
known in the world, although much work remains to be done. The description of
new species, especially of invertebrates and protists, undergoes upward
revision, and new discoveries continually modify previous estimates. Increased
efforts are required in taxonomy and sampling of poorly known ecosystems and on
long-term monitoring programs of species and habitats. The invasion of alien
species will continue to change the biodiversity of the Mediterranean Sea and
requires continuous monitoring.
The first attempt to integrate the spatial data and temporal trends presented
here enables one to visualize macroecological patterns at the Mediterranean
scale. These results depict a region of high diversity and heterogeneity, but
they also evidence the need for further study of geographical areas that are
largely unexplored, mainly the African coasts and certain zones of the
southeastern basin and the deep sea.
Our study illustrates that the Mediterranean is a complex region where
ecological and human influences meet and strongly interact, posing a large and
growing potential impact to marine biodiversity. Although much is known about
individual threats, knowledge is very limited about how multiple impacts will
interact. Therefore, there is the need to develop comprehensive analysis of
conservation and management initiatives to preserve Mediterranean biodiversity.
Owing to the Mediterranean physically, ecologically, and socioeconomically steep
gradients, this region may be seen as a model of the world's oceans and a
suitable laboratory to study marine ecosystems and decipher future trends.
In addition to further sampling and taxonomic efforts, much of what remains to
be done requires free distribution of publicly available data from national and
regional research initiatives. This will facilitate database updates and enable
scientific discussion. Marine surveys are not always accessible at the regional
level and, when available, data coverage is often incomplete. Regional
initiatives (such as MedObis) provide promising platforms for the integration of
efforts devoted to marine biodiversity within the Mediterranean region, but they
must be kept up to date. Individual and collaborative research efforts must
continue to advance our knowledge of marine biodiversity in the Mediterranean
Sea and narrow down the unknowns.
# Supporting Information
The authors gratefully acknowledge the support given by the European Census of
Marine Life, the Census of Marine Life, and the Fisheries Centre (University of
British Columbia, Canada). They thank Charles Griffiths, Michele DuRand, Dale
Langford, and Iain Taylor for edition and correction of the paper.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
The organisms in the euryarchaeal order Halobacteriales are generally extreme
halophiles requiring at least 1.5 M salt and growing optimally at 3.5–4.5 M
salt, although some have recently been found to grow at lower salt
concentrations. The haloarchaea are found in the water and sediment of salt
lakes and salterns, and also in saline soils. Their mechanism of adaptation to
high salinity involves the accumulation of molar concentrations of KCl in the
cytoplasm and the production of proteins with a higher number of negative
charges than in other organisms. Bacteria of the order Halanaerobiales and the
genus *Salinibacter* also accumulate KCl internally. Other halophilic organisms
accumulate compatible solutes such as glycerol or glycine betaine to counter
high external salt concentrations, but this is energetically more costly than
accumulation of KCl.
The haloarchaea are heterotrophs, growing with amino acids and/or carbohydrates
as carbon and energy sources. They are either aerobic or facultatively anaerobic
using various electron acceptors. Glycerol is a particularly important nutrient
for haloarchaea as it is produced by eukaryotic algae in high-salt environments.
Dihydroxyacetone, produced by *Salinibacter ruber*, can also be present at high
concentrations. While some haloarchaea are capable of growth on a wide range of
compounds, others are very limited in their metabolism. The most extreme example
of this is *Haloquadratum walsbyi*, which has only been found to grow well on
pyruvate or dihydroxyacetone.
Six haloarchaeal genomes have been sequenced previously, and analyses of the
genomes have been published for *Halobacterium salinarum* NRC-1, *Halobacterium
salinarum* R1, *Haloarcula marismortui*, *Natronomonas pharaonis*,
*Haloquadratum walsbyi*, and *Haloferax volcanii*. Since the two *H. salinarum*
genomes are very similar, we included only strain NRC-1 in the analysis. Here we
present an analysis of these five genomes along with five new genomes, four of
which (*Halogeometricum borinquense*, *Halomicrobium mukohataei*, *Halorhabdus
utahensis* and *Haloterrigena turkmenica*) were sequenced as part of the Genomic
Encyclopedia of Bacteria and Archaea (GEBA) project. The remaining genome,
*Halorubrum lacusprofundi*, was sequenced as part of a Joint Genome Institute
Community Sequencing Program project to sequence diverse archaeal genomes. With
this work we are doubling the amount of genomic information from these
extremophilic organisms and derive novel information and conclusions about the
breadth of their metabolic capabilities.
# Methods
## Genome sequencing
Sequencing and annotation of *H. borinquense*, *H. mukohataei*, *H. utahensis*,
and *H. turkmenica* have been previously described. A publication describing the
sequencing and annotation of *H. lacusprofundi* is in preparation. Genome
sequences are available from GenBank. Genome analysis was carried out within the
Integrated Microbial Genomes Expert Review (IMG-ER) system.
## Sequence data used in phylogenetic analysis
Protein sequences from 19 *Halobacteria* and outgroup (*Methanomicrobia*)
genomes were retrieved from the IMG website (<http://img.jgi.doe.gov/>) or from
NCBI (*Methanocella paludicola SANAE*; NC_013665). *Methanomicrobia* appear as
sister group of *Halobacteriaceae* in a recent comprehensive 16S rRNA tree.
Accession numbers for the genomes used in this study are listed in.
## Orthologs and alignments
All-against-all protein BLAST was performed using mpiBLAST version 1.5
(<http://www.mpiblast.org/>), a parallel implementation of NCBI BLAST, using
soft masking instead of complexity filtering. To determine orthologs, BLAST
e-values were transformed using our own re-implementation of the OrthoMCL
algorithm in conjunction with MCL version 08-312 (<http://micans.org/mcl/>)
using an inflation parameter of 3.0 (slightly deviating from the default, 2.0,
thus yielding slightly more clusters). The transformation of the e-values
corrects for genome-specific biases as, e.g., caused by a GC bias ; after
transformation, the BLAST results are reduced to the reciprocal best hits for
each pair of genomes, which are then clustered using the MCL algorithm. OrthoMCL
clusters containing inparalogs were reduced by selecting the most ‘central’ of
several sequences from the same genome, that is, the sequence with the highest
sum of within-cluster BLAST scores. The reduced OrthoMCL clusters were aligned
using MUSCLE version 3.7 under default settings. The program scan_orphanerrs
from the RASCAL package version 1.3.4 was applied to detect orphan sequences
(overall poorly aligned genes) within the alignments. After removal of orphan
sequences (if present), poorly aligned columns and divergent regions were
eliminated with GBLOCKS version 0.91b using a minimum block length of two amino
acids and allowing gap positions in all sequences. Each OrthoMCL cluster was
also assigned to a COG category using a majority-rule approach. Above-mentioned
parameter settings for ortholog determination and alignment filtering had
previously been optimized using a genome-scale dataset for *Actinobacteria* type
strains (unpublished data). During this optimization, it also turned out that
modifying the program parameters had comparatively little influence on the
phylogenetic outcome.
## Phylogenetic inference
Filtered OrthoMCL cluster alignments comprising at least four sequences were
concatenated to form a supermatrix for phylogenetic analysis. Maximum likelihood
(ML) phylogenetic trees were inferred from the supermatrix with the Pthreads-
parallelized RAxML package version 7.2.5, applying fast bootstrapping with
subsequent search for the best tree, the autoMRE bootstopping criterion and the
LG model of amino acid evolution in conjunction with gamma-distributed
substitution rates and empirical amino acid frequencies (F). Among all amino
acid models implemented in RAxML (except GTR, which was rejected for performance
reasons), LGF was the empirically preferred one, as it produced the highest
likelihood if optimized on a RAxML parsimony starting tree. Tree searches under
the maximum parsimony (MP) criterion were conducted with PAUP\* version 4b10
using 100 rounds of random sequence addition and subsequent TBR branch swapping,
saving no more than 10 best trees per round and collapsing potential zero-length
branches during tree search. MP bootstrap support was calculated with PAUP\*
using 1,000 replicates with 10 rounds of heuristic search per replicate.
## Assessing incongruence between gene trees and species tree
After reducing the OrthoMCL cluster alignments to ingroup sequences, congruence
between gene trees and the species tree was assessed by calculating partitioned
Bremer support (PBS), for each OrthoMCL cluster using the newick.tcl script in
conjunction with PAUP\*. The Bremer support value for a certain bipartition
(split) in the tree topology is the difference between the score (number of
steps) of the best-known MP tree in which this split does not occur (forced
using a converse constraint) and the score of the unconstrained best-known MP
tree. While the total Bremer support must be positive, PBS values may be
positive, zero, or negative, indicating that the OrthoMCL cluster supports the
split, contains no information, or prefers another topology, respectively. As
the total PBS (summed over all branches) for each cluster positively correlated
with both its number of genes and its number of informative characters, the
residuals from a linear regression with these two independent variables were
determined. The residuals were used to determine their correlation with the COG
categories and classes and the clusters most in conflict with the species tree
(i.e., those with the most negative total PBS).
## Spectral clustering
Protein sequences for the ten halophiles were downloaded from IMG-ER. We applied
a spectral clustering procedure, for discriminating between groups of homologous
proteins. The proteins are represented as nodes in a connected undirected graph
with edges that carry weights based on node-to-node similarity according to the
protein identity. The clustering procedure is analogous to a random walk of a
particle moving on this graph from one node to another. In each node the
particle moves to another node based on the probabilities corresponding to the
weights of the edges. The amount of time the particle spends in a given subgraph
will determine whether this is indeed a cluster of its own or not. After
infinite time, the distinction between these subgraphs will become more clear,
and to model this we calculated the normalized transition matrix at equilibrium.
The eigenvalues of the transition matrix provide a measure of how distinct (or
entwined) subgraphs are in relation to each other. An eigenvalue (or strength of
partition) of 1 suggests a complete distinction between two subgraphs, while an
eigenvalue of 0 suggests that no further partitions can be made. The
eigenvectors are ordered by their eigenvalues in descending order, and the graph
is successively partitioned while the second eigenvalue is greater than 0.8. As
a result, a graph is partitioned into one or more subgraphs until the
distinction between subgraphs becomes less clear. In this work, the choice of
0.8 as a cutoff suggests a balance between partitioning only fully non-
homologous proteins and allowing proteins with weak similarities to be separated
into subgraphs.
## Proteases and glycosyl hydrolases
The heat maps and clustering of secreted proteases and glycosyl hydrolases were
generated using hierarchical clustering with the program Cluster and visualized
with TreeView (<http://rana.lbl.gov/EisenSoftware.htm>). Glycosyl hydrolases
were identified based on Pfam domains. Proteases were obtained from MEROPS. Non-
peptidase homologues were eliminated from the analysis. Signal peptides were
identified with SignalP.
# Results
## Orthologs and alignments
The number of aligned and filtered OrthoMCL clusters containing at least four
entries (i.e., genes from distinct genomes) was 3,853, their length ranging from
22 to 1650 amino acids (262.542 on average). The concatenated supermatrix thus
comprised 1,011,575 columns, including 708,296 variable and 353,936 parsimony-
informative characters.
## Phylogenetic inference
The ML phylogeny inferred from the concatenated gene alignments is shown in
(species tree) together with ML and MP bootstrap support values. The final
highest log likelihood obtained was −12,342,390.79, whereas the single best MP
tree (excluding uninformative sites) had a score of 1,409,187. ML and MP
topologies were identical. Support was maximum (100%) for all branches under ML,
and maximum for all but four branches under MP; only a single branch entirely
lacked support under MP. As only one genome per genus was included in the
sample, there is no taxonomic subdivision of *Halobacteriaceae* to compare the
tree with. However, outgroup taxonomy was well recovered, the tree showing the
monophyly of *Methanomicrobiales*, *Methanosarcinales*, and
*Methanosarcinaceae*, each of which were represented with at least two genomes.
## Incongruence between gene trees and species tree
After reducing the dataset to the ingroup taxa and to the OrthoMCL clusters
present in at least four ingroup genomes, total PBS per OrthoMCL cluster ranged
between 142 and −219 (average: 4.941, standard deviation: 19.588, median: 1,
MAD: 8.896). These data are plotted against the number of parsimony-informative
characters in supplementary. Within a total of 2,891 OrthoMCL clusters, 1,506
genes showed overall positive support and 764 showed overall negative support.
Trees inferred from the five clusters least congruent with the species tree are
depicted in. They are uniformly characterized by high bootstrap support for
groupings in conflict with the species tree estimate. Total PBS values per
cluster vary between the COG categories (which could be assigned to 2,213
clusters; see); on average, COGs related to information storage and processing
display higher PBS than those associated with metabolism or cellular processes
and signaling; but individual COG categories may differ from this general trend.
## Core clusters
We used a spectral clustering method to generate gene clusters from the
haloarchaeal genomes. There were 887 core clusters, those found in all of the
haloarchaeal genomes, and these accounted for 40% to 50% of the genes in each
genome. As expected, the core clusters contain genes involved in basic cellular
processes such as transcription, translation, DNA replication, DNA repair, RNA
modification, protein modification, and protein secretion. The core clusters
also include many genes involved in biosynthesis of essential metabolites –
amino acids, purines and pyrimidines, lipids, and cofactors. This is somewhat
unexpected as the haloarchaea are heterotrophs, but they appear to be relatively
self-sufficient in being able to make most essential metabolites. Biosynthetic
pathways in the haloarchaea have recently been reviewed, so we will not go into
more detail here. The number of genes in each genome belonging to all clusters
ranges from 78% to 88%, showing that 12% to 22% of the genes in each genome have
no hits to genes in the other halophile genomes.
## Signature clusters
We also identified signature gene clusters, those that are shared by all
haloarchaea but are not found in any other archaea. There are 112 of these
clusters, 89 of which contain proteins with completely unknown function. Of the
clusters with a predicted function, two are protein kinases related to the
*Bacillus subtilis* PrkA protein. These two kinase genes are adjacent to each
other on the chromosome in all haloarchaeal genomes and are always found with
two other genes: one with a domain of unknown function DUF444, and one related
to *B. subtilis* SpoVR, the function of which is unknown. Proteins of these
three families are found together on the chromosome in many other microbial
genomes suggesting functional linkage.
Halophiles are known to accumulate gamma-glutamyl-cysteine, and two of the
signature clusters may be involved in gamma-glutamyl-cysteine metabolism.
Cluster 491.1× contains proteins related to glutamate-cysteine ligase, and the
*H. volcanii* member of cluster 491.1× was recently shown to have glutamate-
cysteine ligase activity. Cluster 1151× includes genes related to glutathione
S-transferase, which inactivates toxic compounds by linking them to glutathione.
In the halophiles, these may function as gamma-glutamylcysteine S-transferases.
## Habitat-specific clusters
Of the ten haloarchaea with sequenced genomes, four were isolated from water and
four were isolated from soil or sediment. The ones isolated from water are *H.
walsbyi*, *N. pharaonis*, *H. marismortui*, and *H. borinquense*. *H.
mukohataei* and *H. turkmenica* were isolated from saline soils, while *H.
volcanii* and *H. utahensis* were isolated from lake sediments. The water
halophiles and soil/sediment halophiles do not form separate clades in the
phylogenetic tree. We looked for clusters present in all water-isolated
halophiles that are not present in soil/sediment halophiles and *vice versa*.
There were no clusters specific to water halophiles and only three specific to
soil/sediment haloarchaea. Proteins belonging to two of the soil/sediment-
specific clusters (326.1.0× and 2168×) are often found in the vicinity of
nucleotide-sugar metabolic enzymes and glycosyl transferases, suggesting they
are involved in cell wall biosynthesis.
Since there were few protein clusters completely specific to the water or
soil/sediment halophiles, we looked for clusters present in three out of four
organisms from one group and absent from the other group. There were 16 clusters
present in three out of four water halophiles, of which 11 contain hypothetical
proteins and four have only general functional annotations. The only cluster
with a specific annotation is cluster 1816×, formate-tetrahydrofolate ligase.
Of the 26 clusters found in three out of four soil/sediment halophiles and not
present in water halophiles, 11 are hypothetical proteins. Several of the
clusters are involved in polysaccharide degradation. These include a glycosyl
hydrolase of family GH4, an alpha-L-arabinofuranosidase of family GH51, a
polysaccharide deacetylase and a trehalose utilization protein. Two additional
clusters present in three out of four soil/sediment halophiles encode a
monooxygenase and an acyltransferase, which are found adjacent to each other on
the chromosome and flanked by two IucA/IucC family proteins. These proteins are
likely to be involved in siderophore synthesis. *H. borinquense* has three
IucA/IucC family proteins but lacks the monooxygenase and acyltransferase, thus
it is unclear if it has a complete siderophore biosynthesis pathway.
## All-but-one clusters
We also looked for clusters conserved in all but one genome. These probably
indicate recent gene losses in each species. The genomes fell into two groups –
those that had 20 or less such clusters and those that had greater than 60. The
three genomes that had greater than 60 clusters lost were *H. salinarum*, *H.
walsbyi*, and *H. utahensis*. Many of the clusters lost from *H. salinarum* are
involved in amino acid synthesis, including genes for the synthesis of
glutamate, lysine, ornithine, methionine, and branched chain amino acids. To
make up for this, *H. salinarum* does not have more amino acid transporters or
secreted proteases than the other haloarchaea, but it is one of only two of the
haloarchaea to have a putative peptide symporter of the OPT family (TC 2.A.67).
Symporters have low affinity but high capacity, suggesting that *H. salinarum*
may prefer to live where there is an ample supply of peptides. Of the clusters
not present in *H. walsbyi*, many are involved in flagellum biosynthesis and
chemotaxis. However, *H. walsbyi* has a set of gas vesicle proteins to enable
motility in the absence of flagella. The clusters in all except *H. utahensis*
include several enzymes involved in cobalamin synthesis and several enzymes of
biotin utilization and propionate metabolism. *H. utahensis* appears to lack the
enzymes for the early steps of cobalamin biosynthesis up to the incorporation of
cobalt, but all of the halophiles, including *H. utahensis*, contain the enzymes
for the later steps of cobalamin biosynthesis. Biotin and propionate metabolism
are discussed further below.
## Central metabolism
Some haloarchaea are known to use the semi-phosphorylated Entner-Doudoroff (ED)
pathway for glucose degradation, and genes encoding enzymes of this pathway have
been identified in several haloarchaea. With the addition of the new genomes, we
find that the semi-phosphorylated Entner-Doudoroff pathway is likely to be
present in all sequenced haloarchaea except *N. pharaonis*, which does not
utilize carbohydrates. Aldolases belonging to two different protein families may
be involved. All of the halophiles except *H. salinarum* and *N. pharaonis* have
one or more bacterial-type 2-keto-3-deoxy-6-phosphogluconate (KDPGlc) aldolase
(COG0800). Also all except *N. pharaonis* have at least one potential aldolase
related to the characterized *Sulfolobus* aldolase (COG0329), which is active on
KDPGlc and unphosphorylated 2-keto-3-deoxygluconate (KDGlc). The enzymes of the
semi-phosphorylated Entner-Doudoroff pathway are highly conserved in sequence
among the haloarchaea, suggesting descent from a common ancestor.
The standard Embden-Meyerhof pathway of glycolysis appears to be incomplete in
the halophiles as no 6-phosphofructokinase could be identified. This agrees with
previous experimental studies and analysis. Gluconeogenesis is likely to be
present in all of the halophile genomes with the possible exception of *H.
utahensis*. All except *H. utahensis* have phosphoenolpyruvate (PEP) synthase
and/or pyruvate, phosphate dikinase (COG0574). In addition, *H. lacusprofundi*
and *H. turkmenica* have ATP-utilizing PEP carboxykinase (COG1866). In *H.
utahensis* the only enzyme that potentially can generate PEP for gluconeogenesis
is pyruvate kinase. All except *H. utahensis* have a fructose 1,6-bisphosphatase
belonging to the same family as the *E. coli* Fbp enzyme (COG0158). All of the
halophiles including *H. utahensis* have at least one gene belonging to COG0483,
which includes inositol phosphatases and some archaeal fructose
1,6-bisphosphatases. *H. utahensis* has two genes belonging to this family, but
they are weakly related to characterized fructose 1,6-bisphosphatases. These
findings suggest that *H. utahensis* may lack the gluconeogenesis pathway or
have an unusual gluconeogenesis pathway.
Unlike the rest of the archaea, halophiles are thought to use the oxidative
pentose phosphate pathway for generation of pentoses. This pathway also
generates NADPH for anabolic pathways. All except *H. utahensis* have a probable
6-phosphogluconate dehydrogenase (COG1023), the key enzyme of this pathway. In
contrast, *H. utahensis* is the only sequenced haloarchaeon to have
transaldolase (Huta_0859) and transketolase (Huta_0860 and Huta_0861), the
enzymes of the non-oxidative pentose phosphate pathway. For NADPH generation,
*H. utahensis* possesses genes encoding a NAD/NADP transhydrogenase
(Huta_2005–2007). None of the other haloarchaea has the genes for this enzyme.
The presence of these enzymes only in *H. utahensis* suggests that they may have
been acquired through lateral transfer, but phylogenetic analysis was unable to
identify the donor (data not shown).
## Nutrient transport
presents an overview of nutrient transport in the haloarchaea. All of the
haloarchaea have at least five symporters for amino acids and at least two ABC
transporters for peptides. Since all except *H. salinarum* can synthesize most
or all amino acids, this suggests that amino acids are an important carbon and
energy source even in the species that can grow on carbohydrates. All of the
haloarchaea also have at least one symporter for nucleosides or nucleobases.
Carbohydrate transport is variable. Only half of the halophiles have symporters
for sugars, and either none or one ABC transporter for sugars is found in the
non-carbohydrate-utilizing organisms. Surprisingly no transporters for sugars
could be identified in the *H. utahensis* genome, suggesting that it uses
uncharacterized families of sugar transporters.
There appears to be a connection between some transporters and universal stress
protein A (UspA) family proteins. Most amino acid transporters of the amino
acid-polyamine-organocation (APC) family are either fused to a UspA domain or
adjacent on the chromosome to a UspA protein, and some are both fused and
adjacent to UspA family proteins (e.g. Htur_0566). This appears to be specific
for the APC family as other potential amino acid symporters of the
neurotransmitter∶sodium symporter (NSS) family and the dicarboxylate/amino
acid∶cation symporter (DAACS) family are not associated with UspA family
proteins. Several transporters of the formate-nitrite transporter (FNT) family
are also fused or adjacent to UspA domains (Hmuk_1674, HQ1451A, NP6264A,
Hlac_2299, and Htur_2705). The FNT family proteins with associated UspA domains
are closely related to each other and to a transporter from *H. marismortui*
that lacks a UspA domain (rrnAC0187). They are likely to be formate transporters
as the *H. marismortui* and *H. mukohataei* proteins are adjacent to enzymes of
folate metabolism. Another transporter with adjacent UspA proteins is a putative
acetate transporter of the solute∶sodium symporter (SSS) family. This
transporter is found in seven of the ten halophile genomes (e.g. NP5136A), and
in all cases is followed by a UspA domain protein. In six of the seven genomes
with this transporter, it is close on the chromosome to two acetyl-CoA
synthetase genes (e.g. NP5128A and NP5132A). The transporter has highest
similarity to subfamily 7 of the SSS family, which includes acetate, propionate,
and phenylacetate transporters (see the Transporter Classification Database at
[www.tcdb.org](http://www.tcdb.org)). UspA family proteins are expressed during
many stressful conditions, and they are known to bind ATP, but their exact
molecular function is unknown. The UspA domains associated with transporters may
play a regulatory role, or may be involved in maintaining transporter function
during stressful conditions. A recent report shows that a UspA domain protein is
involved in regulation of a transporter.
## Secreted proteases
Since the halophiles have numerous transporters for amino acids and peptides, we
analyzed the distribution of secreted proteases within their genomes. Only
secreted proteases were considered because these are likely to be involved in
the utilization of proteins as a nutrient source, while intracellular and
integral membrane proteases are involved in a variety of cellular processes. We
included proteases that have signal peptides as well as proteins that are likely
to be attached to the membrane with the protease domain outside the cell. Signal
peptidases (family S26) were excluded from the analysis since they have a
specific cellular function. The numbers of secreted proteases in the genomes
ranged from 3 to 11. Hierarchical clustering shows that the halophiles fall into
two groups with respect to protease distribution. The main feature separating
these groups appears to be the presence or absence of secreted members of
protease family S8, which includes subtilisin as well as halolysins from
halophilic archaea. The organisms having secreted S8 proteases do not correspond
to a habitat-specific or phylogenetic group. The presence of at least three
secreted proteases in each genome suggests that all of the halophiles may be
capable of degradation of extracellular proteins.
## Amino acid utilization
Since all of the halophiles have at least five amino acid symporters and two
peptide ABC transporters, we investigated pathways of amino acid utilization to
see if all of the halophiles are capable of using many amino acids. A summary is
provided in. Three degradation pathways were found in all of the ten genomes.
All of them had an alanine dehydrogenase similar to the enzyme characterized in
*Archaeoglobus fulgidus*. This enzyme could potentially be involved in synthesis
of alanine as well as its degradation. All had at least one asparaginase from
COG0252 or COG1446. Finally all of them had a pyruvoyl-dependent arginine
decarboxylase similar to the enzyme characterized in *Methanocaldococcus
jannaschii* and agmatinase. This combination of enzymes produces putrescine and
urea from arginine. Additional enzymes of arginine utilization were present in
some genomes. Six of the genomes have arginase, which produces ornithine and
urea. None of the genomes had ornithine decarboxylase, but all of the ones that
have arginase also have ornithine cyclodeaminase which produces proline.
Several other amino acid degradation pathways are found in a subset of the
genomes. The glycine cleavage system is found in all genomes except those of *H.
walsbyi* and *H. utahensis*. This enzyme complex produces CO<sub>2</sub>,
NH<sub>3</sub>, methylene-tetrahydrofolate (THF), and NADH. Methylene-THF has a
variety of possible uses within the cell. Another pathway found in all but *H.
walsbyi* and *H. utahensis* is isoleucine degradation. A 2-oxoacid dehydrogenase
complex involved in isoleucine degradation was recently identified in *H.
volcanii*, and seven of the other halophiles have genes with at least 68%
similarity to the *H. volcanii* genes, indicating that they probably have the
same function. Five of the genomes have tryptophanase, which produces pyruvate
from tryptophan. A histidine degradation pathway with formiminoglutamate as an
intermediate is also found in five of the genomes. Seven have proline
dehydrogenase, but only *H. lacusprofundi* has pyrroline-5-carboxylate
dehydrogenase to complete proline conversion to glutamate. All of the genomes
have threonine dehydratase, but this may be used only for biosynthesis. Five of
the genomes in addition have threonine aldolase, which produces glycine and
acetaldehyde. Finally, all of the genomes have glutamate dehydrogenase, which
may have a biosynthetic role. Four of the genomes have glutamate mutase and
methylaspartate ammonia-lyase. These are the first two enzymes of a four-step
pathway that produces acetate and pyruvate from glutamate with mesaconate and
citramalate as intermediates. However, these two enzymes are likely to be
involved in a new pathway for acetate assimilation.
Many of the pathways for amino acid degradation are found in a subset of the
genomes. They could have been acquired independently by lateral gene transfer or
lost in some species. The genes for amino acid degradation in the halophiles are
closely related in sequence, suggesting that the common ancestor of haloarchaea
was able to degrade many amino acids and that some organisms have lost these
pathways.
## Polysaccharide degradation
According to the distribution of glycosyl hydrolase domains and carbohydrate-
binding modules, halophilic archaea can be divided into 3 groups: those that may
be capable of degrading plant biomass (*H. utahensis*, *H. turkmenica* and to a
lesser extent *H. marismortui* and *H. volcanii*), those harboring family 18
glycosyl hydrolases with possible chitinase activity (*H. salinarum*, *H.
mukohataei* and *H. borinquense*) and organisms that are unlikely to degrade any
externally provided polysaccharides (*H. lacusprofundi*, *H. walsbyi* and *N.
pharaonis*).
*H. utahensis* and *H. turkmenica* have the two largest sets of proteins with
glycosyl hydrolase domains among halophilic archaea (43 and 44, respectively).
However, their glycosyl hydrolase complements are markedly different. While *H.
utahensis* has five proteins of GH10 family and two proteins of GH11 family,
which probably have xylanase activity, *H. turkmenica* has only one GH10 protein
and no GH11 members. The abundance of predicted xylanases in the *H. utahensis*
genome is in agreement with experimental data that showed xylan-degrading
activity of this archaeon. The *H. utahensis* genome contains seven GH5 family
proteins and one GH9 family protein (as compared to three and zero in *H.
turkmenica* genome). These proteins may have endo-beta-glucanase activity, thus
enabling *H. utahensis* to degrade components of the plant cell wall. One of the
GH5 proteins in *H. utahensis* (Huta_2387) has been shown experimentally to have
cellulolytic activity (T. Zhang et al., in press). *H. utahensis* also has two
GH94 proteins that may have cellobiose or cellodextrin phosphorylase activity.
On the other hand, the *H. turkmenica* genome encodes four GH32 family proteins
predicted to have beta-fructosidase (levanase or invertase) activity that are
absent from the *H. utahensis* genome, while both genomes have several GH2
family proteins that may have beta-galactosidase activity.
Three of the genomes from haloarchaea isolated from soil or sediment encode
enzymes involved in degradation of pectin. The backbone chains of pectin are
made up of either homogalacturonan or rhamnogalacturonan with various side
chains, and the main chains are linked together by α-1,5-arabinan chains. *H.
turkmenica* has four family 1 polysaccharide lyases (PL) which likely have
pectate lyase activity, three of which are close together on the chromosome
(Htur_4783, Htur_4785, Htur_4789). Also in the vicinity of these three genes is
a family 2 polysaccharide lyase related to pectate lyases (Htur_4786) and two
glycosyl hydrolases, one of which may have polygalacturonase activity
(Htur_4790). The other *H. turkmenica* PL1 family protein (Htur_4440) is close
to one of two pectin methylesterases (Htur_4438) and a rhamnogalacturonan
acetylesterase (Htur_4445). *H. turkmenica* also has two family 11
polysaccharide lyases (Htur_3890, Htur_3891) that are highly similar to a *B.
subtilis* rhamnogalacturonan lyase and a GH105 protein similar to the RhiN
protein of *Dickeya* (formerly *Erwinia*) *chrysanthemi*, which is involved in
degradation of rhamnogalacturonate oligosaccharides. *H. utahensis* and *H.
volcanii* have much lower capacity for pectin degradation: *H. utahensis* has
two probable pectate lyases from family 1, while *H. volcanii* has one pectate
lyase and one pectin methylesterase. In addition to enzymes capable of degrading
the main chains of pectin, *H. turkmenica*, *H. utahensis*, and *H. volcanii*
have GH43, GH51, and GH93 glycosyl hydrolases with similarity to endo- and exo-
arabinases that may be capable of degrading the arabinan linking chains of
pectin.
## Galactose utilization
*H. lacusprofundi* and *H. mukohataei* have been shown to grow on galactose, but
the genome sequences suggest that other haloarchaea can also utilize galactose.
Also the genome sequences show that two different pathways for galactose
metabolism may exist in haloarchaea: the Leloir pathway in *H. utahensis*, and
the De Ley-Doudoroff pathway in *H. lacusprofundi*, *H. marismortui*, *H.
volcanii*, *H. borinquense*, *H. mukohataei*, and *H. turkmenica*. *H.
utahensis* is the only haloarchaeon with genes encoding the three enzymes of the
Leloir pathway. No other archaeon possesses a gene for hexose 1-phosphate
uridylyltransferase (COG1085, Huta_2170), and *H. volcanii* is the only other
haloarchaeon to have a probable galactokinase (HVO_1487). Six haloarchaea
(listed above) have genes with high similarity (65–75%) to *E. coli* galactonate
dehydratase, one of the enzymes of the De Ley-Doudoroff pathway. Phylogenetic
analysis shows that the genes for galactonate dehydratase in the haloarchaea
cluster together (data not shown). In the De Ley-Doudoroff pathway, after
2-dehydro-3-deoxygalactonate (KDGal) is formed by galactonate dehydratase, it is
phosphorylated by KDGal kinase to form 2-dehydro-3-deoxy-6-phosphogalactonate
(KDPGal). KDPGal is then split by KDPGal aldolase to form pyruvate and
glyceraldehyde 3-phosphate. None of the halophiles has a gene related to known
KDGal kinases (COG3734). KDPGal aldolases belong to the same family as
bacterial-type KDPGlc aldolases of the Entner-Doudoroff pathway (COG0800). *H.
lacusprofundi* has two proteins related to KDGlc kinase and two proteins related
to bacterial-type KDPGlc aldolase. One kinase (Hlac_2870) and aldolase
(Hlac_2860) are close on the chromosome to each other and to galactonate
dehydratase (Hlac_2866), beta-galactosidase (Hlac_2868), and a probable alpha-
galactosidase (Hlac_2869), suggesting that the kinase and aldolase may be
involved in the utilization of galactose via the De Ley-Doudoroff pathway.
Similarly, *H. volcanii* has three COG0800 proteins, one of which (HVO_A0329) is
close on the chromosome to a KDPGlc kinase-related protein (HVO_A0328),
galactonate dehydratase (HVO_A0331) and beta-galactosidase (HVO_A0326). Some of
the halophiles that have galactonate dehydratase only have one protein related
to KDGlc kinase and KDPGlc aldolase. It is possible that in these organisms the
proteins are bifunctional, working with both KDGlc and KDGal, similar to the
proteins of the *Sulfolobus solfataricus* ED pathway.
## Fructose utilization
Fructose can be utilized by some haloarchaea: *H. marismortui*, *H.
borinquense*, *H. utahensis*, and *H. turkmenica* have been shown to grow on
fructose, while *H. mukohataei* has been shown to grow on sucrose and thus will
likely also metabolize fructose. The enzyme ketohexokinase was characterized in
*Haloarcula vallismortis* but the gene was not identified. *H. marismortui*, *H.
volcanii*, and *H. turkmenica* each have one transporter of the
phosphotransferase system (PTS), and operon evidence suggests that these are
fructose transporters that produce fructose 1-phosphate. The PTS transporters
from *H. volcanii* and *H. turkmenica* are close on the chromosome to putative
fructose 1-phosphate kinases (COG1105), while in *H. volcanii* the PTS proteins
are also close to fructose bisphosphate aldolase. In addition to the three
haloarchaea with PTS transporters, *H. utahensis* and *H. mukohataei* also have
putative fructose 1-phosphate kinases. In *H. mukohataei* the fructose
1-phosphate kinase (Hmuk_2661) is close on the chromosome to fructose
bisphosphate aldolase (Hmuk_2663) and another putative sugar kinase (Hmuk_2662)
which may be a ketohexokinase. Surprisingly *H. borinquense* does not have a
member of COG1105, despite its known ability to grow on fructose. The protein
sequences of all components of the PTS system transporter and fructose
1-phosphate kinase are strongly conserved among the halophiles.
## Xylose utilization
The pathway by which *H. volcanii* utilizes xylose has recently been
characterized. The pathway involves formation of xylonate, followed by two
dehydratase steps to generate 2-oxoglutarate semialdehyde. This pathway also
appears to be present in *H. turkmenica* and *H. lacusprofundi*, both of which
were not previously known to utilize xylose. *H. marismortui* is known to
produce acid from xylose, and it appears to have 2-dehydro-3-deoxyxylonate
dehydratase and xylose dehydrogenase, but it does not have a gene with high
similarity to the *H. volcanii* xylonate dehydratase. *H. utahensis* is known to
degrade xylan and to be able to grow on xylose, and it uses a different pathway
for xylose degradation. It has a xylose isomerase (COG2115, Huta_2443) and
xylulokinase (TIGR01312, Huta_2446). The resulting D-xylulose 5-phosphate then
feeds into the non-oxidative pentose phosphate pathway. *H. utahensis* is the
only one of the sequenced haloarchaea to have transaldolase and transketolase of
the non-oxidative PPP, which allows it to use this pathway of xylose
utilization. *H. borinquense* is known to utilize xylose, but it does not have
identifiable genes for either of the pathways found in the other haloarchaea.
Phylogenetic analysis of xylose isomerase using both neighbor joining (Clustal
W) and Bayesian (MrBayes) methods show that *H. utahensis* xylose isomerase
branches deeply within Firmicutes with high bootstrap support (not shown), but
xylulokinase did not associate closely to any group of organisms.
## Glucuronate utilization
Both *H. utahensis* and *H. turkmenica* have putative glucuronate isomerase
(COG1904) and mannonate dehydratase (COG1312), suggesting that they may utilize
glucuronate by the same pathway as found in *E. coli*. This pathway produces
KDGlc which feeds into the Entner-Doudoroff pathway. *H. utahensis* also has a
probable alpha-glucuronidase (Huta_0871) belonging to glycosyl hydrolase family
67, that is adjacent on the chromosome to glucuronate isomerase (Huta_0870) and
mannonate dehydratase (Huta_0869). *H. lacusprofundi* has a putative mannonate
dehydratase but no glucuronate isomerase, therefore it is unclear whether it has
the capacity to break down glucuronate. Since *H. lacusprofundi* is known to
grow on mannose, it is possible that mannonate dehydratase is used in a pathway
for mannose degradation.
## L-arabinose utilization
None of the haloarchaea have been shown to grow on L-arabinose, but the genomes
suggest that it may be utilized by some haloarchaea. *H. utahensis*, *H.
volcanii*, and *H. turkmenica* all have putative alpha-L-arabinofuranosidases
(COG3534). In *H. utahensis* the arabinofuranosidase (Huta_1152) is close on the
chromosome to L-arabinose isomerase (Huta_1154) and ribulose 5-phosphate
4-epimerase (Huta_1149), suggesting that *H. utahensis* uses the known bacterial
pathway of L-arabinose degradation. A gene similar to ribulokinase was not found
in *H. utahensis*, but there is a gene with similarity to xylulokinases
(Huta_1150) close to the arabinose degradation genes. Huta_2446 is likely to be
a xylulokinase in *H. utahensis* (see above), and Huta_1150 may be a
ribulokinase, completing the pathway. This pathway produces D-xylulose
5-phosphate which enters the non-oxidative pentose phosphate pathway. *H.
utahensis* is the only haloarchaeon to have the non-oxidative pentose phosphate
pathway, which allows it to use this pathway, and it is also the only
haloarchaeon to have L-arabinose isomerase.
## N-acetylglucosamine utilization
Since the presence of family 18 glycosyl hydrolases in *H. salinarum*, *H.
mukohataei* and *H. borinquense* indicates that they may possess chitinase
activity and use chitin as a growth substrate, we attempted to identify enzymes
for subsequent degradation of chitooligosaccharides, N-acetyl-glucosamine or
glucosamine. We found that *H. mukohataei* likely possesses a beta-N-
acetylhexosaminidase (Hmuk_3174) that has 51% similarity to characterized
enzymes from *Streptomyces thermoviolaceus* and *Bacillus subtilis*. A
chitobiose deacetylase has been identified in *Thermococcus kodakaraensis*
belonging to COG2120, which includes other carbohydrate deacetylases. Both *H.
mukohataei* and *H. borinquense* have genes belonging to this family, although
they are distantly related to the *T. kodakaraensis* enzyme. None of the
organisms with family 18 glycosyl hydrolases has been tested for growth on
N-acetylglucosamine or glucosamine, so the presence of chitinase activity and
chitinolytic pathway in haloarchaea needs further experimental elucidation.
## Glycerol metabolism and transport
The haloarchaea encode genes for two different glycerol utilization pathways.
All except *N. pharaonis* have a glycerol kinase and glycerol 3-phosphate
dehydrogenase, and the genes for both enzymes are found close together on the
chromosome. Another pathway involving glycerol dehydrogenase and
dihydroxyacetone kinase is present only in *H. lacusprofundi*. *H. volcanii* and
*H. walsbyi* have a dihydroxyacetone kinase without glycerol dehydrogenase, and
this may be used for metabolism of dihydroxyacetone from the environment. *H.
salinarum* encodes a glycerol dehydrogenase but no dihydroxyacetone kinase.
Only *H. mukohataei* has an identifiable glycerol transporter within the genome.
It encodes a member of the Major Intrinsic Protein (MIP) family adjacent to
glycerol kinase, providing strong evidence for a glycerol transport function.
All other haloarchaea that have a glycerol kinase have an uncharacterized
membrane protein adjacent (e.g. rrnAC0550), and we predict that these genes
encode a new family of glycerol transporters. *H. borinquense* has two glycerol
kinases and both have this uncharacterized membrane protein family adjacent to
the kinase gene. There are also bacterial homologs of this membrane protein
family, and many of them are adjacent to genes involved in glycerol or
propanediol metabolism.
## Propionate metabolism
*H. lacusprofundi* is the only halophile that has been shown to grow on
propionate, but all of the haloarchaeal genomes, with the exception of *H.
utahensis*, contain genes that may encode the methylmalonate pathway for
conversion of propionate to succinyl-CoA. All except *H. utahensis* have
methylmalonyl-CoA epimerase (TIGR03081) and methylmalonyl-CoA mutase (COG1884
and COG2185). Also they have a biotin carboxylase protein (COG4770) and a
carboxyltransferase protein (pfam01039), subunits of a biotin-dependent
carboxylase. All except *H. utahensis* also contain a biotin-protein ligase
(COG0340) and a BioY family biotin transporter (pfam02632). Propionate or
propionyl-CoA may be produced intracellularly from the breakdown of fatty acids,
amino acids, or other compounds, or these organisms may be able to use
propionate from the environment produced as a result of fermentation.
## Glycine betaine metabolism and transport
Glycine betaine is a compatible solute which is likely to be present in high-
salt environments. All of the haloarchaeal genomes except that of *H.
mukohataei* encode members of the betaine/carnitine/choline transporter (BCCT)
family, which transport glycine betaine and related compounds. Most have one or
two members of this family, but *H. turkmenica* has seven. In addition, *H.
turkmenica* has an ABC transporter for compatible solutes. Four of the
haloarchaeal genomes – *H. marismortui*, *H. walsbyi*, *H. volcanii*, and *H.
turkmenica* – encode one or two genes with high similarity to dimethylglycine
oxidase from *Arthrobacter globiformis*. In all four genomes these oxidase genes
are close on the chromosome to BCCT family transporters. The presence of these
enzymes and transporters raises the possibility that some of the halophiles may
be able to utilize glycine betaine, dimethylglycine, and/or sarcosine. However,
in *H. walsbyi*, betaine was not found to enhance growth and *H. utahensis*
could not grow on betaine.
# Discussion
## Phylogenetic inference
Our analysis of the ten haloarchaeal genomes provided a phylogenetic tree in
which all nodes were well-supported. We here followed the ‘total evidence’
approach for inferring the species tree, which dictates that the best
phylogenetic hypothesis is the one based on all available data , and that
conflict between the species tree and gene trees can at least as well as *via*
inferring the gene trees be quantified after combined analysis. Total evidence
has been criticized as a ‘verificationist’ approach, particularly by researchers
who question the concept of a microbial tree of life (TOL) in general. Other
authors counter that concatenated analysis is well rooted in the ‘Popperian
principles of background knowledge and corroboration’, and that whether a TOL
exists can be assessed, among other means, by checking for high branch support,
which would indicate a strong treelike signal, and by comparing previous
phylogenetic or taxonomic hypotheses. These issues are of considerable
importance for the future of Prokaryote classification. The mostly maximal
bootstrap support observed here indicates that *Halobacteriaceae* have evolved
in manner consistent with a TOL, which is supported by the majority of the
genes. Moreover, our supermatrix tree is fully in agreement with the current
taxonomy of ingroup and outgroup, whereas considerable conflict was observed in
a recent total evidence analysis of *Pasteurellaceae*. The single exception is
the branch connecting *H. borinquense* and *H. walsbyi*, which is supported by
700 genes and contradicted by 565 ones, yielding a total positive support of
2,422 steps and a total negative support of −2,366 steps. Considerable
incongruence between gene trees may thus be responsible for the low support
under MP, but even this branch is maximally supported under ML.
## Incongruence between gene trees and species tree
While our results are in agreement with the optimistic view regarding TOL
inference from supermatrices, they nevertheless also indicate that disagreement
with the species tree is considerable for some genes ( and). It is possible to
distinguish the effects of artifacts of the phylogenetic inference method,
caused e.g. by a low signal-to-noise-ratio, from those of horizontal gene
transfer (HGT) because in the former case a correlation between gene length and
the extent of disagreement between gene tree and species tree occurs. This
correlation is significant in our analysis, but a number of genes appear as
outliers of the regression, indicating distinct causes of incongruence such as
HGT. The distribution of the median total PBS values over the COG categories
reveals that genes related to information processing and storage are more in
accordance with the species tree, corresponding to the view that such genes are
less frequently horizontally transferred between organisms. However, many
exceptions from this rule exist, as also observed in a recent analysis of a
comprehensive genomic dataset of Prokaryotes. In any case, total evidence
analysis in conjunction with partitioned Bremer support apparently worked well
in identifying those genes most in disagreement with the species trees. Among
the five ‘worst’ gene trees, those for L-lactate permease, Tyrosyl-tRNA
synthetase and Cobalamin biosynthesis protein CobN did not comprise any ingroup
paralogs in their OrthoMCL clusters; thus, horizontal gene transfer is the most
likely explanation for their considerable incongruence with the species tree.
HGT between *Candidatus Desulforudis audaxviator* and *Archaea* has been
suggested in the literature for CobN and between *Opisthokonta* and *Archaea*
for Tyrosyl-tRNA synthetase. In contrast, the OrthoMCL clusters containing
either Glucosamine 6-phosphate synthetase or Acyl-coenzyme A synthetase
comprised a combination set of inparalogs and possible outparalogs; that is,
their disagreement with our species tree estimate is most likely due to a
complicated gene duplication/gene loss pattern which may not optimally have been
resolved by the OrthoMCL algorithm.
## Soil/sediment vs. water halophiles
While there were few habitat-specific clusters, soil/sediment halophiles were
found to have more glycosyl hydrolases as well as genes involved in siderophore
synthesis and cell wall metabolism. Some of the halophiles analyzed here were
isolated from water (*H. walsbyi*, *N. pharaonis*, *H. marismortui*, *H.
borinquense*), while others were isolated from soil (*H. mukohataei*, *H.
turkmenica*) or lake sediment (*H. volcanii*, *H. utahensis*). We looked for
gene clusters found exclusively in the water halophiles or in the soil/sediment
halophiles, but very few clusters were found. There may be several explanations
for this finding. One possibility is that the change from water to sediment or
*vice versa* has happened several times independently, and different changes in
the genome occurred during each round of adaptation. This explanation is
supported by the fact that the water and soil/sediment halophiles do not form
separate clades in the species phylogenetic tree. Another potential explanation
is that the division between water and sediment is not clear-cut. Even though
some of these organisms were isolated from water or sediment, they may live part
of the time in both environments. Nevertheless, there were some clusters with
known functions found in the soil/sediment group and not in the water group. The
soil/sediment halophiles tend to have greater numbers of glycosyl hydrolases.
Each of the four soil/sediment halophiles has between 15 and 44 glycosyl
hydrolases, while the haloarchaea isolated from water have between zero and
twelve glycosyl hydrolases. The soil/sediment halophiles also have clusters
involved in siderophore synthesis that are missing from the water group. This
may be explained by the fact that siderophores are less likely to diffuse away
from the producing organism in soil or sediment. Finally the soil/sediment group
has two clusters likely to be involved in cell wall metabolism. This may
indicate a reaction to the more complex environments that they inhabit.
## Uniqueness of *H. utahensis*
Differences in central metabolism in *H. utahensis* may make it easier for this
organism to grow on pentoses. One of the findings from this study is that *H.
utahensis* is substantially different from the other halophiles in its central
metabolism. It may lack gluconeogenesis, and it appears to use the non-oxidative
pentose phosphate pathway and a transhydrogenase instead of the oxidative
pentose phosphate pathway used by other haloarchaea. It has the fewest amino
acid degradation pathways of any of the sequenced haloarchaea, and thus appears
to be the only one of the ten haloarchaea studied here that is specialized only
for carbohydrate utilization.
The use of the non-oxidative pentose phosphate pathway may allow for more
flexibility in the ability to utilize pentoses as carbon and energy sources. *H.
utahensis* is known to degrade xylan and can grow on xylose. The other
halophiles have a different xylose degradation pathway that produces
2-oxoglutarate. The xylose and L-arabinose degradation pathways of *H.
utahensis* are likely to feed into the pentose phosphate pathway, thus producing
fructose 6-phosphate and glyceraldehyde 3-phosphate from phosphorylated
pentoses. However, the fate of fructose 6-phosphate is unclear. Halophiles are
thought to lack phosphofructokinase, but several including *H. utahensis* have
putative fructose 1-phosphate kinase. A possible pathway for fructose
utilization would involve the conversion of fructose 6-phosphate to fructose
1-phosphate, followed by phosphorylation to form fructose 1,6-bisphosphate,
which would then enter the Embden-Meyerhof pathway. However, further
experimental work will be needed to determine how pentoses are metabolized in
*H. utahensis*.
## Distribution of catabolic pathways
The distribution of catabolic pathways and the protein sequence conservation of
the associated enzymes suggest that the ancestor of haloarchaea could degrade
many amino acids but few carbohydrates. The haloarchaea possess pathways for the
utilization of amino acids, carbohydrates, and other compounds. The amino acid
degradation pathways are found in four to ten of the genomes, and the sequences
of the enzymes are closely related, suggesting that they were present in the
ancestor of haloarchaea. Three of the genomes have five or fewer amino acid
catabolic pathways (*H. walsbyi*, *H. utahensis*, and *N. pharaonis*), while the
remaining genomes have at least seven pathways. *H. walsbyi* and *N. pharaonis*
also have few glycosyl hydrolases and carbohydrate utilization pathways, and
they use very few compounds as energy and carbon sources. *H. utahensis* on the
other hand has a large number of glycosyl hydrolases and sugar utilization
pathways, showing that it has become specialized for growth on carbohydrates.
In contrast to amino acid utilization pathways, alternative pathways are used
for sugar catabolism. For example, *H. utahensis* uses a different xylose
degradation pathway than the others, and fructose phosphorylation can occur via
the phosphotransferase system or ketohexokinase. In addition, *H. borinquense*
is known to grow on fructose and xylose, but it lacks the catabolic enzymes
found in other haloarchaea. However, some genes and pathways are highly
conserved. The enzymes of the semi-phosphorylated Entner-Doudoroff pathway are
closely related in sequence, suggesting that glucose utilization by this pathway
was present in the haloarchaeal ancestor. Fructose 1-phosphate kinase is found
in five haloarchaeal genomes and is highly conserved. Similarly galactonate
dehydratase is found in six of the ten genomes and forms a single phylogenetic
group. Overall it appears that the ancestor of haloarchaea was able to use up to
ten amino acids as energy and carbon sources, while its ability to use sugars
was limited.
## Biotechnological applications
Halophilic glycosyl hydrolases have potential uses in polysaccharide degradation
related to biofuel production. An unexpected result from this analysis was the
high number of glycosyl hydrolases in two of the organisms. *H. utahensis* has
numerous genes related to cellulases and xylanases, while *H. turkmenica* has a
large number of predicted pectin-degrading enzymes. Salt-adapted glycosyl
hydrolases from haloarchaea may have applications in the depolymerization of
plant material for biofuel production. Plant material is pretreated in order to
remove lignin and hemicellulose and to reduce the crystallinity of cellulose.
Several different methods are used, some of which involve incubation with acid
or base. After treatment with these chemicals, a neutralization step is required
before further processing, and this produces a salty solution. Salt-adapted
glycosyl hydrolases may be useful at this point in the process. Also, treatment
of plant material with ionic liquids has been shown to reduce the crystallinity
of cellulose and enhance its hydrolysis. One of the glycosyl hydrolase family 5
enzymes of *H. utahensis* has been shown to be a cellulase and to be active in
an ionic liquid (T. Zhang et al., in press). Carrying out hydrolysis of
lignocellulose under high-salt conditions has the advantage that the possibility
of contamination is low.
# Supporting Information
[^1]: Conceived and designed the experiments: H-PK NK. Performed the
experiments: IA CS MG KM SDH IP NI. Analyzed the data: IA CS MG IP NI.
Contributed reagents/materials/analysis tools: KM SDH. Wrote the paper: IA
MG NI.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
In recent decades, studies have been addressing a possible contribution of
traffic related air pollution to allergic diseases. Interestingly, tyrosine
residues of pollen allergens are efficiently nitrated by the air pollutants
nitrogen dioxide and ozone at levels reached in urban air. In sera of birch
pollen-allergic patients, the levels of IgE recognizing nitrated major birch
pollen allergen Bet v 1.0101 (referred to as Bet v 1 nitro) were significantly
higher compared to IgE specific for unmodified Bet v 1.0101 (Bet v 1) and in
mouse models, nitrated Bet v 1 and nitrated Ovalbumin are more potent allergens
when compared to their unmodified forms. These findings suggest that post-
translational modifications (PTMs), such as nitration, can increase the
potential of pollen allergens to trigger immune responses and might play a role
in the emergence of allergies.
PTMs within the human body have been observed and characterized in numerous
studies. Although the majority of PTMs are required for the biological function
of the proteins, several modifications were also identified in the context of
autoimmune diseases. Nitrated proteins were found to be present in multiple
sclerosis, Alzheimer's disease, M. Parkinson, and atherosclerosis and are a
hallmark of inflammation,. Some modified self proteins induce immune responses
leading to the generation of antibodies which recognize the modified and/or the
unmodified protein. These findings suggest that PTMs might alter processing and
presentation of proteins by professional antigen presenting cells, leading to
the generation of new antigenic epitopes and potential induction of a T cell
response.
The presentation of protein fragments via HLA-DR molecules by antigen presenting
cells, such as mature dendritic cells (DCs), is a key event in the induction of
a T cell response. After internalization by dendritic cells, proteins are
enzymatically cleaved within endolysosomal compartments. Some of the resulting
peptides, which are of considerably variable length, bind to HLA-DR molecules in
a sequence dependent and HLA-DM-edited manner. It has been established that PTMs
can increase the peptide binding affinity to MHC class II molecules, or
interfere with the proteolysis of proteins. This may, in addition to the
alterations introduced by the modified amino acid residue itself, result in the
generation of new, naturally processed HLA-DR associated peptides, potentially
giving rise to T cell epitopes. For some PTMs, such as maleylation – and
nitration, there is evidence that protein uptake by antigen presenting cells can
be altered.
We have studied whether there is a difference between the peptides derived from
the allergen Bet v 1 presented via HLA-DR and those derived from post-
translationally chemically modified Bet v 1 nitro. For this purpose, immature
DCs were loaded with unmodified Bet v 1 or Bet v 1 nitro. After affinity
purification of the HLA-DR peptide complexes, the HLA-DR associated peptides
were isolated by acidic elution and identified by liquid chromatography-mass
spectrometry and the identified Bet v 1 or Bet v 1 nitro derived peptides were
compared with respect to peptide clusters, peptide length variants and copy
number of peptides.
Since changes in the pattern of presented HLA-DR associated peptides on DCs can
also change the recognition by T lymphocytes, and since the conversion of
tyrosine to nitrotyrosine has already been shown to affect the reactivity of T
cells for other proteins, we also addressed the question whether peripheral
blood mononuclear cells (PBMCs) loaded with Bet v 1 nitro can activate T
lymphocytes more efficiently than PBMCs loaded with unmodified Bet v 1. For this
purpose Bet v 1-specific T cell lines were generated from birch pollen allergic
patients and T cell proliferation towards unmodified Bet v 1 or Bet v 1 nitro
was analyzed.
# Results
## Structural analysis and nitration of the allergen Bet v 1 and human serum albumin
The UCSF-Chimera was used for the structural analysis of the seven tyrosine
residues of Bet v 1 regarding accessibility and electrostatics on the protein
databank entry 1BV1. With the exception of Y120, all tyrosine residues have
exposed 3-carbon atoms, indicating that they are available for posttranslational
modifications. Residues Y5, Y66, Y120, Y150 and Y158 are on the outside, whereas
Y81 and Y83 are exposed in the large cavity of Bet v 1. In terms of
accessibility, all tyrosine residues except Y120 are candidate targets for
nitration. In the X-ray structure, several water molecules are found in the
cavity, which indicates that there is a reasonable space and polarity in the
inside of the molecule. It has been reported that one factor determining the
selectivity of nitration is the charge environment of the tyrosine resides. The
electrostatic potential was therefore calculated using DelPhi and mapped with
the Chimera program to 1BV1. Most of the targetable groups, with the exception
of Y66, are in a negative environment, which favours nitration. We subsequently
applied GPS-YNO2, a recently developed predictor for potential nitration sites
based on sequence information. The predictor ranks Y150 and Y158 with the
highest scores, but also the inaccessible Y120 with a high score. This data does
not completely correspond to the above mentioned structural analysis and
suggests that the prediction might not be fully optimized for Bet v 1.
Overall, the data suggest that Y5, Y81, Y83, 150 and 158 are preferably
nitrated, the latter two with a remarkable high score in the GPS-YNO2
prediction. In contrast, Y66 is located in a positive electrostatic environment
and Y120 is not accessible and those two residues are probably not nitrated to
the same degree.
Treatment of Bet v 1 and human serum albumin (HSA) with TNM led to nitration of
tyrosine residues. We determined that 58.1% of all tyrosine groups within one
protein molecule were nitrated in both batches of Bet v 1 (data not shown).
Donors B01 and B02 were loaded with nitro Bet v 1 of batch 1 and donors B03–B10
were loaded with nitro Bet v 1 of batch 2. Two batches of HSA nitro were
generated with nitration grades of 21.4% and 26.3%.
## Loading of DCs with unmodified Bet v 1 or Bet v 1 nitro led to an alteration of the Bet v 1 derived peptide repertoire presented via HLA-DR
Results of the peptides identified from DCs loaded with unmodified Bet v 1 and
Bet v 1 nitro are given in. A total of 1076 to 13367 peptides containing 381 to
1347 different peptides were identified per sample generated from cells loaded
with Bet v 1, while Bet v 1 nitro derived samples gave rise to a total of 758 to
14821 peptides containing 379 to 1380 different peptides per sample. Despite
this huge number of identified naturally processed HLA-DR associated peptides
some less frequent peptides may not have been detected due to sensitivity limits
of the LC-ESI-MS/MS setup.
The majority of identified peptides were derived from a broad panel of proteins
present in the endolysosome. From this total number of different identified
peptides, an average of 0–0.8% of the peptides were derived from Bet v 1 in
samples generated from DCs loaded with unmodified Bet v 1 and 0.3–7.2% of the
total peptides were derived from Bet v 1 nitro in samples generated from DCs
loaded with Bet v 1 nitro. Thus, the percentage of different allergen-derived
peptides related to the total number of identified peptides in each sample was
considerably increased in samples generated from Bet v 1 nitro loaded DCs. All
Bet v 1 derived peptides identified from different donors are listed in
supplementary.
In none of the negative control samples, false positive Bet v 1-derived peptides
were identified, ruling out false positive identification of allergen-derived
peptides.
Allergen-derived peptides could be identified in samples generated from DCs
loaded with Bet v 1 or Bet v 1 nitro in eight out of ten donors, or in all ten
donors, respectively. Peptides were derived from all regions of the Bet v 1
protein sequence, except for region aa66–72.
It is notable that the average length of Bet v 1 derived peptides differed only
marginally in samples generated from DCs loaded with unmodified Bet v 1 (peptide
length: 22.34 on average) compared to Bet v 1 nitro (peptide length: 22.05 on
average). The sequences of naturally processed peptides found for Bet v 1
matched those identified by another study using DCs from 4 allergic patients.
## Nitration increases the number of clusters as well as the number of different length variants of Bet v 1-derived naturally processed peptides
Identified peptides “clustered” in several regions along the amino acid
sequence. In peptide samples derived from DCs loaded with unmodified Bet v 1, an
average of 0.9 peptide clusters per donor could be observed, while in samples
derived from Bet v 1 nitro loaded DCs, an average number of 2.6 peptide clusters
could be identified. In region aa66–72, containing a tyrosine residue, no
allergen derived peptides could be identified. In all other sequence regions
containing tyrosine residues, both, peptides with or without tyrosine
modification could be identified in samples generated from cells loaded with Bet
v 1 nitro. These peptides are listed in Supplementary and the data displayed in
this table indicate that all tyrosine residues were nitrated to some extent.
For all ten donors studied, peptide samples generated from Bet v 1 nitro loaded
DCs showed a higher number of Bet v 1 derived peptide length variants (with an
average of 21.2 per donor) compared to peptide samples isolated from DCs loaded
with unmodified Bet v 1 (with an average of 3 peptide length variants per
donor). Nitration of Bet v 1 resulted in a 2.9-fold increase in the number of
identified Bet v 1 a-derived peptide clusters and in a 7.2-fold increase in the
number of identified peptide length variants (i.e. 2.5-fold increase of peptide
length variant per cluster), resulting in a broader range of different peptides
being presented to T-lymphocytes.
## Nitration of Bet v 1 increases the copy number of identified Bet v 1-derived peptides
According to their amino acid composition, peptides with different sequences
exhibit different flight characteristics within electrostatic and electrodynamic
fields. Therefore, the detection efficiency for different peptides can vary,
which complicates a quantitative comparison of the identified peptides in
different samples. Overall, 94.3%+/−22.4 of the total peptides in samples
treated with Bet v 1 nitro was similar to the total number of peptides in
samples treated with unmodified Bet v 1. This implies a similar peptide loading
efficiency, recovery, and peptide distribution in samples generated from the
same donor. Thus, within the same donor it was eligible to compare quantities of
peptides with identical amino acid sequence and consequently identical flight
characteristics in the mass spectrometer within samples loaded with unmodified
Bet v 1 or Bet v 1 nitro. Therefore, peptides in samples generated from DCs
loaded with unmodified Bet v 1 were compared with the identical peptides from
samples generated from DCs loaded with Bet v 1 nitro for each donor. Peptides
with the same sequence but containing nitrated tyrosine residues were not taken
into account, since the introduction of NO<sub>2</sub> groups might alter the
flight characteristics of a peptide. Exemplarily for two different peptide
stretches aa133–157 in two different donors B05 and B07 and aa102–132 in two
different donors B06 and B08, the top matched sequences are shown in the
supplementary.
Among 17 comparable sequences, we observed in all cases an increase in the
number of allergen derived peptides in samples generated from DCs loaded with
Bet v 1 nitro ranging from 1.1-fold up to 106-fold in comparison to peptides in
samples generated from DCs loaded with unmodified Bet v 1. The mean increase in
peptides with identical sequences in DCs loaded with Bet v 1 nitro compared to
DCs loaded with unmodified Bet v 1 was 12.2 fold. This indicates that nitration
had a remarkable impact on the presentation of allergen-derived peptides, and
that DCs loaded with Bet v 1 nitro accumulated a higher copy number of Bet v 1
derived HLA-DR peptide complexes Of note an increase in allergen-derived
peptides was not only observed in sequence stretches containing tyrosine
residues but also regions devoid of tyrosine.
## Nitration of Bet v 1 leads to an enhanced proliferation of Bet v 1 specific T cell lines
In four out of five tested birch pollen allergic patient samples, the
proliferation of Bet v 1 specific T cell lines gave a higher response to Bet v 1
nitro when compared to unmodified Bet v 1 at the lowest tested concentration
(1.25 µg/ml). Statistical analysis was performed for the lowest concentration
for which the difference in proliferation between Bet v 1 and Bet v 1 nitro was
the highest (1.25 µg/ml for donors 1, 2, 4, 5 and 2.5 µg/ml for donor 3). With
*p* = 0.046, proliferation of Bet v 1 specific T cell lines in response to Bet v
1 nitro was significantly higher than proliferation induced by unmodified Bet v
1. Proliferation of Bet v 1 specific T cell lines was very low upon control
treatment with HSA or HSA nitro, showing that the presence of nitrotyrosine as
such does not induce an increased T cell response. Interestingly, increasing the
Bet v 1 concentrations had little effect on the proliferation and the difference
between native and nitrated Bet v 1 was smaller and no longer significant.
## HLA typing of donors
For donors B01–B10 used for isolation of HLA-DR associated peptides from DCs,
DRB1, DRB3, DRB4 and DRB5 alleles were determined. In general, peptide patterns
of donors sharing one allele also shared peptide clusters. Three out of four
donors with allele DRB1\*0301 shared HLA-DR associated peptides at aa1–48 and
three out of three donors with allele DRB1\*1501 shared peptides at aa130–159.
DRB1\*0701 (present in donors B02, B03 and B10) appears to be correlated with
low presentation of Bet v 1 peptides. Thus, in general, shared HLA-DRB1 alleles
correlated with the presentation of peptides derived from the same region within
Bet v 1. Interestingly, the effect of nitration on the presentation of Bet v 1
peptides seems to be independent of HLA alleles.
# Discussion
Our study demonstrates that presentation of HLA-DR associated peptides was
altered upon nitration of Bet v 1. Nitration resulted in a 2.9-fold increased
number of identified peptide clusters, a 7.2-fold increase in the overall number
of peptide length variants and a 12.2-fold increase in the copy number of
identified peptides derived from major birch pollen allergen. An increase in
allergen-derived peptide presentation was observed not only for sequence
stretches containing tyrosine residues but also in regions devoid of tyrosine.
This indicates a general change in uptake and/or processing of the Bet v 1 nitro
protein.
There could be several explanations for the increase in the presentation of Bet
v 1 nitro derived peptides; 1) an enhanced uptake of the allergen by the DCs,
which could be due to multimerization of the allergen. Consistently, for Bet v 1
nitro an elevated tendency to form dimers and trimers was observed using high
performance size exclusion chromatography and Western blot analysis (data not
shown). 2) there are membrane bound receptors recognizing nitrotyrosine; this
would facilitate the uptake of the nitrated allergen, and/or alter the
processing of the allergen within endolysosomal compartments of DCs. 3)
nitration of tyrosine residues has the potential to alter the sterical
properties and interaction with neighboring amino acids, resulting in changes of
the protein conformation and ultimately altered antigen processing. 4)
nitrotyrosine residues could render the allergen either more or less susceptible
to protease activity of degrading enzymes without affecting the processing and
presentation of unmodified proteins. A decrease in the stability of nitrated
allergens was confirmed in a recent study on food allergy. In this study, the
nitrated allergens administered orally in a mouse model had a reduced
allergenicity and were more easily digested. In contrast, intravascular
injection of nitrated food proteins did increase their allergenicity. Our data
show that the average length of allergen derived peptides differed only
marginally between samples from DCs loaded with unmodified allergen (22.34 amino
acids) or samples from DCs loaded with nitrated allergen (22.98 amino acids).
However, nitration could still affect the kinetics of nitrated Bet v 1
degradation, consequently leading to a change in the presentation kinetics of
Bet v 1-derived peptides and eventually the peptide profile which is presented
to the T-cells.
Which of the delineated processes finally contributes to the increase of Bet v 1
nitro derived peptide presentation remains unknown and the interplay seems to be
complex. Noteworthy, the nitration of human serum albumin did not lead to an
enhanced peptide presentation (data not shown); suggesting that nitration per se
does not result in enhanced peptide presentation of the nitrated protein. Thus,
the impact of nitration on antigen presentation also seems to depend on the
properties of the protein itself. However, formally we cannot rule out that the
grade of nitration impacts on antigen presentation as well.
The identification of Bet v 1 derived HLA-DR associated peptides led to the
question, whether these peptides would be recognized by T cell receptors of T
lymphocytes and if this would result in activation and proliferation of the T
lymphocytes. For this purpose PBMCs loaded with Bet v 1 nitro were assessed for
their capacity to stimulate Bet v 1 specific T cell lines. In response to Bet v
1 nitro, proliferation was significantly higher as compared to unmodified Bet v
1 using a concentration of 1.25 µg/ml protein. Increasing the protein
concentration did not in result in higher proliferation and the impact of
nitration was lower. Altogether, our data showed that nitration not only
enhanced presentation of Bet v 1 derived HLA-DR associated peptides on DCs, but
also had an impact on T cell activation.
It has been hypothesized that nitration of autologous proteins may contribute to
autoimmunity ; additionally, the fact that nitration occurs in inflamed tissue
should be taken into account. Nitration of tyrosine residues may have evolved as
a strategy to intensify immune responses against foreign proteins derived from
viruses or bacteria, while a possible contribution to autoimmunity had to be
accepted as an unfortunate side effect. Improved presentation of pathogen
derived nitrated peptides may in contrast be beneficial to the host. Tyrosine
nitration could also be seen as a danger signal – a type of stimulus which is
thought to play an important role in the regulation of immune responses.
Airborne allergens bearing nitro-tyrosine mimic nitrated foreign proteins
present in inflamed tissue, which may explain our findings that nitration of
allergens intensifies the presentation of allergen derived HLA-DR associated
peptides. Previous studies have shown increased immunogenicity of Bet v 1 nitro
compared to Bet v 1 : Sera from patients with birch pollen allergy contain
higher titers for IgE against Bet v 1 nitro compared to Bet v1; the reactivity
against Bet v 1 nitro cannot be fully removed by absorption with normal Bet v 1,
indicating a specific recognition of the nitrated allergen. The same study
showed that nitrated Bet v 1 and nitrated Ovalbumin were more potent allergens
compared to their unmodified forms when tested in mouse models.
Regarding the issue of HLA haplotypes and the predisposition to allergies
published studies show diverging results. Several studies have shown
associations between IgE reactivity and the presence of distinct HLA-DRB1
alleles; most notably in patients allergic to ragweed Amb a 5, Alternaria Alt a
1, Parietaria Par o 1, birch Bet v 1, cat Fel d 1, as well as cockroach and
house dust mite allergens. In these cases HLA-DRB1 haplotypes could favor
susceptibility to allergy. However, Jahn-Schmid et al. have recently shown that
the dominant T cell epitopes of the major ragweed allergen Amb a 1 were
presented by different HLA- DR, DP and DQ molecules. These findings suggest
that, alternatively, a broad HLA class II restriction profile might contribute
to the high allergenic properties of Amb a 1.
Several questions remain to be addressed, e.g. if and/or how nitrated proteins
may interfere with uptake and/or processing pathways of DCs or if potential
alternative uptake mechanisms for nitro-proteins e.g. via specialized receptors
expressed on DCs might exist. Furthermore, the questions whether chemical
nitration of the protein compared to nitration by NO<sub>2</sub> and ozone in
polluted air have different characteristics (e.g. act on different tyrosine
residues) and whether they contribute to nitration to a similar extent could not
be investigated in the scope of the present study. Environmental pollutants
might nitrate tyrosine residues less eagerly and more selectively than the
chemical agent used here. These aspects will have to be addressed in follow-up
investigations.
In summary, our data show that nitration has an enhancing effect on processing
and presentation of Bet v 1 derived HLA-DR associated peptides, by enhancing
both the quality and the quantity of the Bet v 1 specific peptide repertoire.
# Materials and Methods
## Allergen
Recombinant Bet v 1 isoform a (Bet v 1a/Bet v 1.0101) was purchased from Biomay,
Vienna.
## HLA-DR-specific antibody
The hybridoma cell line L243 was used for the production of monoclonal
antibodies specific for HLA-DRαβ dimers. HLA-DR specific antibodies were
purified from hybridoma supernatants by Protein A chromatography, immobilized on
CNBr-activated sepharose beads (Pharmacia) according to the manufacturer's
protocol and stored containing 0.02% sodium azide.
## Nitration of major birch pollen allergen
Recombinant Bet v 1 was dissolved in H<sub>2</sub>O at a concentration of 1
mg/ml. Protein concentration was determined using a Bio-Rad Protein assay (Bio-
Rad, Munich, Germany). Nitration of the allergen was performed with an excess of
30 tetranitromethane (TNM) molecules per tyrosine residue. To generate Bet v 1
nitro, half of the allergen solution was mixed with 0.5 M TNM/methanol solution
(Chemos, Regenstauf, Germany) to a final concentration of 12.03 mM TNM. The
other half of the allergen solution was mixed with the corresponding amount of
methanol without TNM, to generate unmodified Bet v 1. After incubation for 60
min at room temperature, the protein solutions were purified by size exclusion
chromatography using PD-10 Sephadex G-25M columns (GE Healthcare, Uppsala,
Sweden), in order to remove potential smaller protein fragments generated during
the chemical modification. The protein concentrations were determined using the
Bio-Rad Protein assay and the nitration grade was determined based on a standard
curve using nitrotyrosine by measurement of the samples at 420 nm.
## Generation of monocyte derived DCs
DCs were generated from peripheral blood mononuclear cells (PBMCs). PBMCs were
purified from buffy coats obtained from healthy donors from the blood bank in
Basel using Ficoll gradient centrifugation. Monocytes were purified from
peripheral blood mononuclear cells by positive selection using CD14-specific
antibody coated MicroBeads (Miltenyi Biotech, Auburn, CA) and differentiated to
immature DCs in complete RPMI supplemented with granulocyte macrophage-colony
stimulating factor (GM-CSF, 33 ng/ml) and interleukin-4 (IL-4, 3 ng/ml) for 5
days at 37°C and 5% CO<sub>2</sub>. DCs were shown to be in the immature state,
as characterized by very low expression of CD86 and lack of expression of CD83.
## Loading of DCs with allergens
Maturation of the immature DCs was induced after five days with LPS (1 µg/ml,
Sigma, St. Louis, MO). The DCs were either loaded with 10 µg/ml unmodified Bet v
1 or Bet v 1 nitro. Unloaded DCs served as background control. After 24 hours,
DCs were harvested after re-suspension and washing in PBS. The cell pellets were
immediately frozen at −70°C.
## Isolation of HLA-DR restricted peptides
DC pellets (obtained from 1×10<sup>7</sup> cells) were lyzed in hypotonic buffer
containing 1% Triton X-100 and protease inhibitors for 1 hour on a horizontal
shaker. The lysate was cleared from cell debris and immunoprecipitated with mAb
L243 conjugated sepharose beads. After washing with double-distilled water,
elution of peptides from HLA-DR molecules was achieved with 0.1% trifluoracetic
acid (Fluka, Buchs, Switzerland) at 37°C. The peptides were lyophilized in an
Eppendorf Concentrator 5301 (Eppendorf AG, Hamburg, Germany). Cell lysates,
before and after immunoprecipitation, were analyzed by Western Blotting using
the HLA-DRα-specific mAb 1B5 to determine the HLA-DR depletion efficacy.
## Mass spectrometry
Peptide identification was performed using multidimensional protein
identification technology (MudPIT) combining a two dimensional liquid
chromatography with a mass spectrometric analysis (LC-ESI-MS/MS). Lyophilized
peptides were resuspended in hydrophilic buffer containing 5% acetonitrile, 0.5%
acetic acid, 0.012% heptafluorbutyric acid and 1% formic acid. Peptides were
fractionated using a MudPIT column packed with C18 reversed phase material and
SCX material. Elution of the peptides from the column was performed in 10 cycles
on an UltiMate 3000 nanoflow HPLC (Dionex Corporation, Sunnyvale, CA). The first
six cycles started with a salt step with increasing concentrations of ammonium
acetate (0–225 mM) followed by a nonlinear acetonitrile gradient. The seventh
cycle consisted of a salt step with 250 mM ammonium acetate and a nonlinear
acetonitrile gradient. The last three cycles started with a salt step with 1500
mM ammonium acetate followed by a nonlinear acetonitrile gradient. The MudPIT
column was coupled to a LTQ/Orbitrap ion trap mass spectrometer (Finnigan, San
Jose, CA). Peptide identification was performed using the SEQUEST Algorithm. For
database searches, the sequence of the allergen Bet v 1 was included in a Swiss-
Prot deduced database. Peptides were evaluated according to their quality
requirements based on the sequence variables cross correlation
(*X*<sub>corr</sub>) and delta cross-correlation (dCn). Only peptides with a dCn
\>0.1 and a cross correlation of *X*<sub>corr</sub> \>1.8 for singly charged
ions, *X*<sub>corr</sub> \>2.3 for doubly charged ions and *X*<sub>corr</sub>
\>2.8 for triply charged ions were considered. Due to limited amount of
available cells and thus limited amounts of sample, multiple injections were not
feasible. Therefore each sample could only be measured once. Nevertheless, most
of the Bet v 1-derived peptides were detected several times during one run, each
resulting in a separate mass spectrum. In addition, within one sequence clusters
usually several length variants were identified and most of the presented
peptide clusters were present in several donors with the same HLA-types. This
confirmed the identity of the presented peptide stretches. As a negative control
and to rule out false positive identification of Bet v 1-derived peptides, cell-
derived peptides from mature unloaded DCs were used.
## Determination of HLA-DRB alleles
Low resolution determination of the HLA-DRB1 tissue type was performed for each
blood donor using a commercial SSO typing kit (DynalRELI SSO HLA-DRB Typing kit,
Invitrogen, Bromborrough, UK). Low resolution analysis of the HLA-DRB3/4/5
tissue type was performed using a ligation based typing approach. High
resolution analysis of HLA-DRB1 and HLA-DRB3/4/5 tissue types was performed by
nucleotide sequencing of exon 2 (BigDye Terminator Cycle Sequencing Kit, ABI,
Foster City, CA). In addition, for high resolution typing of DRB4 alleles, a
commercial SSP kit was used (Olerup SSPTM DRB4, Qiagen, Hilden, Germany).
## Patient selection
All birch pollen-allergic patients had a typical case history, specific IgE
RAST/CAP class \>3 to Bet v 1 (Pharmacia Diagnostics, Uppsala, Sweden), and
positive skin prick reactions (wheal diameter \>5 mm) to Bet v 1. All patients
gave written consent before enrolment in the study, which was approved by the
Ethics Committee of the Medical University of Vienna.
## Allergen-specific T cell lines (TCL)
PBMC were isolated from the blood of birch pollen allergic donors by Ficoll-
Hypaque density gradient centrifugation. For the generation of allergen-specific
T cells, 1.5×10<sup>6</sup> PBMCs were stimulated with 10 µg/ml unmodified Bet v
1 or Bet v 1 nitro in 24-well flat-bottom culture plates (Costar, Cambridge,
MA). On day 5, 10 U/ml human IL-2 (Boehringer Mannheim, Mannheim, Germany) were
added. On day 7, T cell blasts were enriched by density gradient centrifugation
and cultures were expanded at weekly intervals with irradiated PBMCs and IL-2.
Before the experiment, T cells were rested for 10 to 14 days. To test allergen
specificity, the T-cell lines (TCL) were stimulated in the presence of
5×10<sup>4</sup> irradiated autologous PBMCs for 48 h in duplicate with varying
concentrations of unmodified Bet v 1 (1.25 µg/ml, 2.5 µg/ml, 5 µg/ml) and
equimolar amounts of Bet v 1 nitro, respectively. After a 16 h pulse with 0.5
µCi of \[<sup>3</sup>H\]TdR (GE Healthcare, Munich, Germany), cultures were
harvested and radionuclide uptake was measured by scintillation counting. The
stimulation index (SI) was calculated as ratio between counts per minute (cpm)
of TCL, PBMCs and antigen, and cpm of TCL and PBMCs only. Delta cpm (dpm) were
calculated as cpm of TCL plus PBMCs plus protein minus cpm of TCL and PBMC only.
TCL were considered as specific when the SI was \>2.5.
## Statistical analysis
T-cell proliferation data were analyzed by Wilcoxon Signed Ranks Test using the
software package SPSS (SPSS Inc., Chicago, IL, USA).
# Supporting Information
The authors thank Dr. Martin Himly for providing data concerning the aggregation
status of the allergens and Dr. Gabriele Gadermaier for performing the amino
acid analysis. We also thank Ingrid Faé for HLA-typing and Nikolaos Berntenis
for generating the fragment spectra figures.
[^1]: Conceived and designed the experiments: AK AV AD. Performed the
experiments: AK GO SM. Analyzed the data: AK SM GF PL. Contributed
reagents/materials/analysis tools: GO FF BB PL. Wrote the paper: AK GO AV.
[^2]: Current address: Novartis Pharma AG, Basel, Switzerland
[^3]: The authors have read the journal's policy and have the following
conflicts: Barbara Bohle and Fatima Ferreira are supported by Biomay AG,
Vienna, Austria. Anne Vogt is an employee of F. Hoffmann-La Roche Ltd.
Anette Karle was an employee of F. Hoffmann-La Roche Ltd when she performed
the experiments outlined in the present manuscript. The other authors
declare no conflict of interest. This does not alter the authors' adherence
to all the PLoS ONE policies on sharing data and materials.
|
# Introduction
*Acinetobacter baumannii* (*A. baumannii*) is mainly implicated in hospital
infections and is responsible for 80% of the *Acinetobacter* infections. *A.
baumannii* can also be found on normal human skin, but it generally does not
pose a threat to a healthy person, besides the not-so-frequent skin and soft
tissue infections, infections in the surgical site, urinary tract infection,
etc. In the past 30 years, *A. baumannii* has evolved into a multidrug resistant
(MDR) opportunistic pathogen that selectively infects seriously ill patients in
intensive care unit (ICU), trauma or burn patients. The presence of intrinsic
efflux pump and high rates of genetic adaptation, contributes to adaptation
against the antibiotics. Besides, it also possesses several beta-lactamase genes
which offer resistance against beta-lactam antibiotics. *A. baumannii* has also
been developing resistance against carbapenem which had been one of the last
line of drugs against it. Combination therapies such as of colistin, polymixin
B, and tigecycline are used to treat MDR strains, but these are complex compared
to a single drug when it comes to quantification of the effect and the
validation of their safety. Due to the growing concern about MDR, new types of
antimicrobial agents are needed.
Antimicrobial peptides (AMP) are a fundamental part of the innate defense system
and are reportedly present in organisms from bacteria and fungus to humans.
Although several modes of AMP activity, including DNA damage, RNA damage and
targeting ribosomes regulatory enzymes or other proteins have been proposed, it
is generally believed that the positively charged AMPs act by disrupting the
bacterial membrane and the membrane disruption is one of the key factor for the
AMP activity. Because of this fundamental difference in the mechanism compared
to the traditional drugs, it is believed that the bacteria do not develop
resistance easily against AMPs. The low toxicity of AMPs towards human cells and
their tendency not to result in resistant strains makes them an ideal rational
choice as the next generation antimicrobial agents, possibly eventually becoming
effective drugs for *A. baumannii*.
Quantitative Structure and Activity Relationship (QSAR) is an approach in
computer aided rational drug design, which uses biophysical or biochemical
parameters of the molecules to develop a quantitative relation with the measured
activities. Once validated, the computational model can be used for predicting
the activities of the possible drug candidates and for pre-screening them.
Recent studies have developed a QSAR relation using 29 small molecule drug
candidates which act on the oxphos metabolic path of *A. baumannii*. As noted
above, since bacteria are less likely to develop resistance against AMP based
drugs, we focus on QSAR for AMPs against *A. baumannii*.
The present work has three major objectives. Several experimental groups have
independently evaluated the activity of AMP against *A. baumannii*. We curated
these experimental results against a single, well studied target, ATCC 19606
strain, whose activity is quantified using Clinical and Laboratory Standards
Institute (CLSI) or related protocols. We developed a computational model using
neural networks to rationally predict the activity from the biochemical
attributes of the AMP. Since *A. baumannii* is a growing threat, while realizing
the potential limitations of training on 75 peptides, we also predict the
activity of all the naturally occurring AMPs in the AMP database to enable a
rational screening of AMPs against *A. baumannii*.
# Methods
## Curation of data
Training QSAR models with data from multiple sources, obtained with different
protocols and on different strains can lead to poor predictive capabilities. In
order to standardize the data used in the analysis, we used three criteria for
inclusion- the tests should be on ATCC 19606 strain, with cationic antimicrobial
peptides and studied according to the CLSI or equivalent guidelines. With these
inclusion criteria, we believed that the mechanism of antibiotic action will be
similar and the data curated from different sources can be compared. Since data
availability was limited, we had to include data from different groups. AMP
sequence and activity data against *A. Baumannii* was curated from different
sources and is presented in **Table A in**. The curated AMP data set had the
activity of 75 AMPs with their length ranging from 10 to 43 amino acids and
charges in the range +1 to +12. Of these, for 63 AMPs the MIC was available
(referred to as quantitative data), and for the remaining 12, only the lower
bound of minimum inhibitory concentration (MIC) (refered to as the qualitative
data).
## Parameter computation
*in vivo* aggregation propensity is calculated by using a web-based software
AGGRESCAN. Where the aggregation propensity is calculated on the basis of
aggregation- propensity scale of amino acids. *in vitro* aggregation propensity
is calculated by using TANGO software (with ionic strength 0.02M, pH 7.0 and T =
298K), where we only consider the *β*-sheet aggregation term. Aliphatic index of
the peptides is calculated as described by Ikai. Grand average hydropathy is
calculated on the scale given by Kyte-Doolittle and the hydrophobic moment is
calculated by using HELIQUEST software. The toxicity of the AMPs was predicted
using *ToxinPred* (<http://crdd.osdd.net/raghava/toxinpred/>). The method allows
for the prediction of toxicity of peptides shorter than 50 amino acids. However,
this was not a limitation as peptides longer than that are anyways complicated
to synthesize and may not be ideal drug candidates.
## Artificial neural network
Since the available data is limited, we used used both the quantitative and the
qualitative data, albeit with different proportions, to train and test the
models. We used 63 of the MIC values from the quantitative data and 3 from the
qualitative data for which the cited lower bound was treated as the MIC for the
purpose of this analysis. We performed a 10-fold cross validation to check the
robustness of our models. To do the 10-fold cross validation, we divide the data
set into 10 different test sets, each contains 7 data points. We performed the
artificial neural network (ANN) calculation for each test set by taking 53 data
points for training and 6 data points for validation. Rest of the 9 points from
the qualitative data are used for an independent qualitative test. The activity
of the AMPs was predicted by ANN model with an open module for machine learning
called Scikit-learn in Python. For the activation function, logistic function
was used and low memory BFGS optimization algorithm was used a solver. Three
independent neural network calculations have been performed to do the 10-fold
cross validation, by using a hidden layer of 6 neurons, 8 neurons and 10
neurons. 2500 trial runs in each case were made by taking 50 different random
initializations for the input biases and 50 random choices for the training and
validation sets. We screened the results of these 2500 trials with
$R_{training}^{2} > 0.7$ and $R_{validation}^{2} > 0.6$. Two best models were
selected based on the result obtained from the 10-fold cross validation. The
models were expected to perform with $R_{test}^{2} > 0.8$ for the quantitative
data and at least 5 predictions for the qualitative data set. These models were
then used to predict the MIC values of a complete AMP database
(<https://aps.unmc.edu>).
# Results
## Curated data for AMPs and their effectiveness
The data on the activity of AMPs on *A. baumannii* is scattered in literature.
We curated the data mainly with the goal of developing a quantitative model, and
hence restricted the focus to the most commonly studied ATCC 19606 strain. To
maintain uniformity of standards, we included studies which were performed
according to CLSI or equivalent guidelines. The sequence data and the
antimicrobial activity of these peptides measured as the MIC was gathered
(**Table A in**). Overall, the comprehensive collection of the data on AMP
activity allowed a classification based on the various biophysical parameters
which are commonly used for developing a quantitative relation with activity:
(1) charge, which draws the AMPs selectively to anionic membrane, (2) length,
reflecting how it has to be commensurate with the membrane thickness for an
improved activity (3) molecular weight, which gives an idea of the bulkiness and
membrane penetration efficiency (4) hydrophobic moment (*μ*<sub>*H*</sub>),
which quantifies the amphipathic characters required to form pores in the
membrane, (5) aliphatic index, which indicates the volume of aliphatic content
(A, V, I and L) of the peptide, (6) grand average of hydropathy (GRAVY) based on
Kyte-Doolittle hydropathicity scale, (7) *in vivo* aggregation propensity,
calculated by using a web-based software AGGRESCAN and (8) *in vitro*
(*β*-sheet) aggregation propensity, calculated by using TANGO software (with
ionic strength 0.02 M, pH 7.0 and temperature 298 K). The *in vitro*
aggregation, before interaction with the membrane can at times stop proteolytic
degradation by the bacteria but in many other cases reduce the drug potency \[,
\]. Further, the aggregation propensity affects the barrel-stave and carpet
mechanisms of action differently. Toxicity of peptides obtained from ToxinPred
was categorical, and it was used only to classify the AMPs from the database as
potential drug candidates, and not for the activity prediction. The distribution
of the eight parameters for all the curated AMPs are given in **Fig A in** and
their individual relation with MIC in, which shows that each of the parameters
individually is not sufficient to describe the activity.
## Quantitative models for AMP activity
ANN model was used to obtain the relationship between the various above-
mentioned parameters and MIC values (**Methods**). A schematic of how we
developed the model is shown in **Fig B in**. The first step was to create a
model with the activity data from 75 AMPs, of which some were used for an
internal assessment of the quality of predictions. The second step was to use
the test set in the 75 AMP data analysis as a secondary validation for refining
the choice of model that can be used for making the predictions for the AMP
database. The details are as follows. Out of the 75 AMPs curated, for 12 of them
a lower bound of MIC, as being greater than a certain value (**Table B in**),
rather than a precise number was cited. To include them in the analysis, and not
to reduce the data size which is already small (75 AMPs), we created two
independent test sets, one in which a quantitative MIC comparison was made
(referred to as quantitative data) and another qualitative one in which the
calculated MIC was checked if it was more than the experimental lower bound
(referred to as qualitative data). The combined data set with quantitative and
qualitative data was used to construct training, validation and test sets
(**Methods**). We performed a 10-fold cross validation with three different
architectures with 6, 8 and 10 hidden neurons respectively. The overall error in
the architecture with 8 neurons was optimal, thus justifying a small sampling
around it with 6 and 10 neurons (**Table C in**). However, all three
architectures were satisfactory in their predictions (**Figs C**, **D and E
respectively in**), resulting in many models, which qualify for the criteria
($R_{training}^{2} > \mspace{360mu} 0.7$ & $R_{validation}^{2} > \mspace{180mu}
0.6$). Several of these models also had good predictions for the test sets,
which are about 10% of the data.
## Selecting the best model
In a traditional QSAR analysis, the choice of the best model would be guided by
the combination of the best $R_{training}^{2}$ and $R_{validation}^{2}$,
following which $R_{test}^{2}$ on a small fraction of the data, in our case 7
data points, comes as a consequence. Since the goal of screening through the
large set of potential AMPs whose activities against an extremely important
pathogen are not yet available is more ambitious than performing well on these 7
points, we performed a secondary validation check to select the best models. We
used two additional criteria: $R_{test}^{2} > 0.6$ for the quantitative and that
at least 5 predictions in qualitative data set were correct to within a factor
of 2 (**Table B in**). Two models satisfied these conditions, with
$R_{test}^{2} > 0.8$ and they were selected. The best among these models
(referred to as Model-1) obtained from the calculation with 8 hidden neurons,
had good predictions ($R_{training}^{2} = 0.975$, $R_{validation}^{2} = 0.866$
and $R_{test}^{2} = 0.827$). The experimental MIC for the quantitative data set
versus MIC values predicted from Model-1 is shown in. Results obtained from
another model (Model-2) are given in **Fig F in**.
## Predicting the results for naturally occurring AMPs
Considering the health threat *A. baumannii* is posing, and the potential of
AMPs for antibiotic-resistance-free activity, we propose a rational basis for an
*in silico* screening of AMPs active against *A. baumannii*. Our models were
used to predict the MIC values of the 2338 AMPs obtained from database
(<https://aps.unmc.edu>) of naturally occurring AMPs. We made the predictions
from Model-1 and Model-2. In order to reduce the risk of a poorly trained ANN
model with limited data, we filtered these results for a consistent prediction
that is within ΔMIC ≤ 5 *μ*g/ml for both the models. Despite the potential
statistical limitations of training and validating on 75 AMPs, a pre-screening
to rationally sort multiple AMPs with their predicted activity, *in vitro* and
*in vivo* aggregation potential, toxicity and length (a surrogate for synthetic
complexity), all are provided in and in the. The computational scripts and the
predictions are made accessible, to provide an immediate access to a pool of
rational choices that can help progress towards large scale experimental
testing, considering the extreme urgency of developing effective strategies to
combat the superbug, *A. baumannii*
## Parameter importance in model
It is important to know which are the parameters (*P*<sub>*i*</sub>) that are
most responsible for the activity on *A. baumannii*. In the combined training
and validation set used for accepting the models, we replaced
(*P*<sub>*i*</sub>) with its average \<*P*<sub>*i*</sub>\> and measure the
difference $\Delta R_{P_{i}}^{2} = R_{training + validation}^{2} - R_{training +
validation, < P_{i} >}^{2}$. $\Delta R_{P_{i}}^{2}$ is treated as reflecting the
importance of the parameter. The results obtained from Model-1 are given in and
the result obtained from another model is given in **Fig G in**. From our
calculations, we found out that the aliphatic index is the most important
parameter in both the models.
## Relevance of predictions for MDR strains
In order to reduce the uncertainties, our computational model was trained on
data standardized in three ways, *A. baumannii* strain used, choice of cationic
AMPs and measurements by CLSI method. However, considering the threat that *A.
baumannii* MDR strains are posing, it is important to ask whether our
calculations have any relevance to these clinical variants. The two limitations
of this work are the smaller data size used for training, and it was based on
ATCC 19606 strain. Interestingly, in the limited studies that we found the
activity of cationic AMPs against ATCC 19606 and other MDR strains of *A.
baumannii* are comparable, thus potentially removing the latter strain specific
data limitation for *A. baumannii*, although for other bacteria, such as *S.
aureus* the activity changes quite significantly with the strain. Drawing
confidence from this fact, we used our models to predict the activity for a few
MDR strains. The results reported in **Table D in** are encouraging at this
stage, although more such validations will be helpful in establishing the
utility of the screening models we proposed.
## Conclusions
To our knowledge, the present work is the only QSAR study for predicting AMP
activity against *A. baumannii*. The present work is different from the only
other QSAR in two different ways, using AMPs instead of small molecules for a
better tolerance to antibiotic resistance and a slightly larger set (75 AMPs
compared to 29 small molecules). Using the ANN models we developed, we could
make quantitative predictions for the entire database of naturally occuring
AMPs. We hope that our work will inspire the further studies quantifying the
activity of AMPs on *A. baumannii*, some of which may follow the activity
predictions and others that differ offer an opportunity to retrain the ANN
models.
# Supporting information
A.M. wants to thank Swagatam Barman for scientific discussions. M.K.P. wants to
thank JNCASR for stipend.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Renewable energy has been studied for a long time due to high electricity
generation costs and global warming. Sustainable energy production plays a vital
role in reducing global warming and the impact of climate change. Therefore, the
energy sector is now more focused on seeking the appropriate tools for the
widespread use of renewable energy resources. Global demand for renewable energy
rises to 30 percent relative to 435 installed capacities, with an annual growth
of 17 percent in recent years. In 2020, renewable energy provided an estimated
12% of total energy output worldwide. Wind power consumption has increased
nearly twice, while biogas consumption has increased by 2.8% over the past five
years. As a result, overall greenhouse gas emissions are decreased by 3% and
environmental damage by 23%, respectively. Estonia has taken steps to expand the
use of renewable energy in the form of the Short Assessment of Alternative
Energy Sources (AES) by 30%, 45%, and 80% between 2020, 2030, and 2050.
Renewable wind power is further categorized into short-term and long-term wind
power production. Short-term wind power varies from few minutes to a day, while
long-term wind power is based on weeks, months, or even years. Both short-term
and long-term wind data can be utilized to forecast wind power generation.
However, short-term wind power forecasting is deemed preferable compared to
long-term power forecasting. Power sectors of different countries use various
wind power forecasting methods to generate sufficient wind energy. These methods
largely focused on either mathematical or physical models, whereas the hybrid
models rely on the integration of both models is also popular in the energy
sector. Physical models can be affected by particular characteristics such as
wind turbine position, barriers, surface coarseness, and blade turbulence, etc.
Physical models are specifically used for long-term wind power forecasting.
Contrary, the mathematical models use historical wind data to estimate potential
power generation and may also take advantage of various hybrid frameworks such
as machine learning and deep learning-based power forecasting. Common
forecasting methods include Support Vector Regressor (SVR), Multi-layer
perceptron, deep neural network, as well as a combination of various related
methods.
Wind power has uncertain characteristics and weak controllability, which also
raises the problem of inconstancy and fluctuations in power systems. Apart from
that, air velocity may also be influenced by the possibility of hazardous modes
and postures. Therefore, an effective power monitoring system is needed for
efficient transmission and to resolve the power generation demands. Various
estimation strategies have been introduced and structured to examine and
estimate sustainable wind power. Wind power forecasting strategies are generally
classified into three theoretical classifications, including Forecast Analysis
(NWP), Survey Data Analysis (SDA), and a mixture of the two approaches.
Probabilistic units are typically known to estimate the relevant NWP since
these approaches have become more and more significant at periodic intervals
with better accuracy. However, it would be very difficult to develop an
efficient numerical framework without any in-depth analysis of the systems
engineering as well as the wind area atmosphere. These types of models need to
construct certain variables with the aid of illustrative variables, census data
algorithms, to overcome the association between empirical evaluation and
extracted wind properties. These methods may only need observational data for
estimates and are also fairly convincing to widespread forms of research
implementation. Despite their significance, the accuracy of these models has
been declining over time. Nowadays, most of the statistical techniques are used
in collaboration with the Artificial Neural Network (ANN), Convolution Neural
Network (CNN), Support Vector Regression (SVR), and Back Propagation Neural
Network (BPNN) respectively. Several data science algorithms have been developed
for complex database systems to efficiently use and train data to solve
forecasting problems in multiple domains. Such algorithms use specific behavior
of data and afterward generates predictive outcomes. CNN is a supervised
learning algorithm that uses a perceptron to extract estimations from adaptive
learning. Alternatively, BPNN is also a supervised learning algorithm that
determines the cumulative marginal distribution of feed-forward backpropagation
in a fully connected neural network.
The wind turbine data is based on a time series with a real-time wind speed
reading for a particular area. Wind power forecasting models mainly use these
readings along with other characteristics to predict potential power output for
that area. For short-term forecasting, minutes and hourly time series data are
more accurate as they can be used for stochastic wind signals and have been used
in many models such as Kalman filters, Box-Jenkins, as well as ANN. The Box-
Jenkins model uses probabilistic approximation and cannot be used to predict
future wind power. Therefore, their model involves a full assessment of the
distinct forecasts. The Kalman filter is considered to be a direct symmetric
estimator, as it uses a limited direct estimation feature relative to Box-
Jenkins and thus requires less computational costs. As a result, Kalman filters
are steady and needless computation, but Box-Jenkins provides more effective
results with a significant number of simulations. However, considering the risk
of diverse knowledge and extremely nonlinear wind behavior, the ANN has gained
more momentum in handling complex and dynamic information. ANN estimates
forecasting based on neural structures such as multilayer perception with formal
specifications that may not be fully suitable for wind power forecasting. The
predictive potential of these approaches falls beyond the longer forecast
horizons. As mentioned, our proposed deep learning model based on combined
approach of CNN and LSTM which has a significant advantage over certain state-
of-the-art approaches.
The main contribution of this paper is as follows:
- First, we use the NREL toolkit to analyze and extract offshore wind power
data. The collected data is further divided into three regions that span
large-scale offshore wind turbines in the United States.
- Second, wind power data is primarily based on time series, and LSTM is well-
suited to handle time series forecasting regardless of duration lags. Thus, a
combined approach of CNN and LSTM is used to analyze hidden features of
offshore winds for reliable wind power forecasting.
- Next, data is preprocessed using deep auto-encoders prior to wind power
forecasting to minimize the error ratio. Offshore winds are diverse and
continuously changing, whereas deep auto-encoders can learn low-dimensional
data efficiently and with minimal reconstruction error.
- Furthermore, the proposed CNN-LSTM forecasting model is optimized using
fine-tuned parameters for each offshore region, and the performance is
compared to the current state-of-the-art methods.
- As per empirical analysis, the proposed method demonstrated excellent
forecasting accuracy with a low error ratio at various intervals, making it
more suited approach for offshore wind power forecasting.
# Literature review
Current wind power forecasting technologies have limitations and needed to be
enhanced to estimate actual wind power generation. It is essential to
investigate the different perspectives of wind power to design an effective
model. Most recent researches have been focused on hybrid techniques to take
advantage of integrated methods. Individual approaches usually produce low
efficiency than hybrid approaches, while the hybrid approaches can be further
divided into key parts. A hybrid approach combined with computational
intelligence can be more effective and widely studied in energy and power
forecasting. For instance, Kaluri et al used predictive power of rough sets to
forecast battery power life and, Maddikunta el al used hybrid algorithmic
strategy for efficient power communication between networks. A hybrid
computational intelligence technique can learn effective model features from
wind direction and wind speed adjacent to wind turbines before actual wind power
forecasting. The outcomes of hybrid deep learning approaches recommended that
the multiple neural networks must efficiently enhance short-term wind speed
analysis for effective forecasting. Long Short-Term Memory (LSTM) is
particularly used in different adapted distinctions with high basic criteria.
For instance, Alazab et al used multi-directional LSTM model to forecast
stability of power in smart grids. However, if the interactive mechanism is not
needed, it still needs a lot of resources to converge neural networks quickly as
the existing improved version does not match hardware power acceleration. Lu et
al proposed an encoder-decoder LSTM model for wind power estimation by mapping
wind power time series data into fixed-length representations. The results
showed that the LSTM auto-encoder based preprocessing can perform better
compared to simple LSTM wind power forecasting.
The Fourier representation of linear and steady-state analysis approaches focus
on optimal filtering using Variation Mode Decomposition (VMD) and Single or
Multi-Kernel Regularized Pseudo Inverse Neural Network (MKRPINN). An Ensemble
Empirical Mode Decomposition (EEMD) further decreases the impact of projected
modeling of pseudo wind power data which is also scalable to data reduction
without any need for further specifications. Different parameter fine-tuning has
the additional advantage to acquire useful data characteristics. The one-hour
forecasting of seven locations of ground radiation showed that the wind power
forecasting performance can be improved by 30% compared to traditional benchmark
estimates. Fu et al presented a multi-step ahead technique based on RNN combined
with LSTM or GRU also known as Gated Recurrent Unit to improve wind power
forecasting accuracy. Shao et al further combined Infinite Feature Selection
(Inf-FS) with RNN to overcome short-term wind power forecasting problems.
Analysis of data from the US National Renewable Energy Laboratory (NREL) reveals
that the efficiency of short-term wind energy forecasts in spring, summer,
autumn, and winter has been greatly improved by 11 percent, 29 percent, 33
percent, and 19 percent respectively. However, the RNN has one weakness
associated with the high power of the matrix caused by its vanishing gradient.
As a result, it is difficult to determine the long-term dependence of the time
series in wind power forecasting. However, it has been found that the average
error rate and the maximum error rate of LSTM-RNN are lesser than other methods.
Lai et al proposed Long and Short Term Times Series Network (LST-Net) to resolve
the accuracy problem of time-series forecasting. The empirical evaluation showed
that the earlier evaluation of repeated trends in time series data can improve
the overall forecasting accuracy.
A conceptual hybrid method associated with Wavelet Packet Decomposition (WPD) is
proposed by Liu et al, which is a combination of CNN and LSTM to minimize the
effect of non-stationary raw data for short-term wind power forecasting. WPD
decomposes initial wind speed data based on time series into multiple sub-layer
levels where CNN and CNN-LSTM were used for high-frequency and low-frequency
evaluation. The empirical evaluation of various test samples has shown that
hybrid modeling of various wind speeds can improve the precision of short-term
wind power forecasting. Chen et al presented another hybrid approach based on
LSTM and an evolutionary algorithm named ELM for wind speed and power
forecasting. The empirical evaluation of the four evaluation parameters found
that the preferred hybrid approach had achieved the predicted outcomes from the
estimation criteria, while the projected results had an actual benefit over the
forecasting accuracy. Adopting several models as the mainstream model can only
improve the aggregate average forecasting performance. Khodayar et al proposed a
graph-based deep neural network to analyze unguided high wind positions
consisting of LSTM and graph based CNN model to overcome short-term wind speed
forecasting errors. CNN-based deep learning models are adaptable and have been
widely used in forecasting studies. For instance, Vasan et al used an ensemble
CNN model to improve forecasting accuracies. The deep learning architecture
(GCDLA) captures the temporal characteristics of the wind forecasting process. A
study of GCDLA findings has shown that hybrid approaches paired with separate
neural networks can improve the predictive accuracy of wind speeds. Chang et al
developed an improved deep learning network by selecting input features with
suitable interfaces and established two types of probabilistic forecasting
models. In previous studies, it was reported that the absence of appropriate
input features and lack of analysis and selection causes a negative impact when
forecasting is applied to high-dimensional wind power data from multi-input.
This requires a huge number of computational resources that can also influence
usability. Wang et al suggested an ensemble approach to resolving such
probabilistic wind power forecasting issues. Time-frequency classification
including distinguishing feature extraction for various wavelet transformations
along with CNN is processed to achieve desirable estimation. The empirical
evaluation showed that some uncertainties in wind power data can be identified
using ensemble approaches. Furthermore, Xiao et al proposed hybrid modified
architecture centered upon Bat Algorithm (BAT) in combination with Conjugate
Gradient (CG) process in order to forecast wind speeds.
In recent studies, Lin and Liu used high frequency SCADA data to forecast wind
power of Levenmouth offshore wind turbine. The outliers were detected and
removed from data using isolation forest filtering while a deep learning model
is finetuned to forecast offshore wind power. Although the isolation forest
filtering needs limited memory, it does not employ any distance or density
measures to eliminate outliers. As a result, the deep learning model may be
affected when applied to multiple offshore wind turbines. Zameer et al used an
ensemble ANN model along with genetic programming to overcome instability
problem of wind power. The proposed approach was tested on five windfarms and
produced reasonable outcomes. Devi et al also used ensemble strategy mainly
focused on improving the forecasting performance using LSTM-EFG model combined
with cuckoo search optimization and ensemble empirical mode decomposition. In
general, the ensemble methods are quite helpful in improving forecasting results
by combining multiple models but their improved performance is due to the
reduction in the variance component of forecasting errors generated by the
participating models. Yildiz et al used variational mode decomposition (VMD) to
convert wind power features into RGB images. The image data was then used as
input for CNN model to perform short term power forecasting. The accuracy of
image-based forecasting is effective but image pixels are not true geographical
objects due to limited pixel topology. Therefore, spectral and spatial effects
of images on CNN may further needed to be elaborated for effective wind power
forecasting. Acikgoz et al used extreme machine learning (EML) strategy to
forecast terrain-based wind power on one year data in turkey. The empirical
evaluation of seasonal performance showed improvement compared to tradition ANN
with minimal forecasting errors. However, the training and testing were
conducted on k-folds, which means that the training algorithms had to be ran
many times, which may be computationally expensive for large datasets. Niu et al
used sequence-to-sequence modeling and attention-based GRU network to improve
accuracy and stability of traditional wind power forecasting. GRU is an
alternative and improved version of LSTM but computational time of deep learning
process increases as attention mechanism applied to wind power forecasting. The
summarized comparison of recent studies on wind power forecasting is shown in.
As discussed in the literature study, classifier training is necessary from the
beginning for offshore wind power forecasting, which is also a time-consuming
practice. Secondly, ensemble-based deep learning strategies for wind power
forecasting utilize two or more DNN models, with one predictor propagating
forecasting outcomes while others improving the forecasting error. Additionally,
the wind speed is more diverse at offshore regions compared to land-based
installations, thus observations may contain a significant quantity of outlier
values. As a result, eliminating all outliers may have a negative effect on the
reliability of wind power forecasting strategies. Instead, our proposed model
employs deep auto-encoders to efficiently learn low-dimensional data ensuring
minimal reconstruction error. Furthermore, training several layers with a deep
autoencoder is more efficient than training single huge transformation based on
dimension reduction schemes. As a result, the neural network’s time-consumption
problem can be handled more precisely. In particular, a deep auto-encoding based
hybrid CNN-LSTM model can facilitate rapid feature analysis and estimation of
wind power forecasting.
# Overall methodology for wind power forecasting
Due to the turbulent and diverse real-time behavior of wind signals, predicting
accurate wind power is a difficult task. In order to evaluate the predictability
of wind power, the raw wind data is obtained from three separate offshore
Windfarms. Next, the raw wind data is analyzed and the valuable variables are
chosen that can hold worthy information from the vast range of offshore wind
turbines. In all three data sets, a sequence of five Deep Auto-Encoders (DAC) is
used to exploit hidden information and focus on meaningful features that can
facilitate the predictability of deep learning models. Our proposed deep
learning wind power forecasting methodology can efficiently compress and encode
wind data, then realizes data in minimized encoded form towards a classification
model. Furthermore, auto-encoders has been applied for dimensional reduction
that can effectively improve forecasting accuracy. The trained model is then
transferred to the deep learning model based on Convolutional Neural Network
(CNN) combined with LSTM to predict wind power on all three offshore Windfarms.
Finally, the efficiency and effectiveness of the proposed model over different
offshore Windfarms are evaluated in terms of prediction accuracy and forecasting
errors as shown in.
## Deep Auto Encoder (DAC)
DAC is a simple deep auto-encoder and feedforward artificial neural network
consisting of three basic layers, i.e., the entry layer also known as the input
layer the hidden layer responsible for applying weights using the activation
function, and the output layer to produce final results. Each node in the neural
network except input nodes is a neuron that utilizes a non-linear activation
function. Several levels, including non-linear stimulus, discriminate against
the Hidden layer by a standard DAC classifier to differentiate non-linearly
separable data.
DAC auto-encoders each with one hidden layer and hidden weights minimize the
squared error with a quadratic penalty (weight decay). Contractive auto-encoder
(CAE) is also an alternative to the weight decay DAC strategy. We used a
specific normalization that has the advantage of robustness with slight
deviations around the test points to favor interfaces that converge more
precisely on the training set. Like the Contractive auto-encoder, the DAC auto-
encoder can obtain a comparable measure of regularization on objective function
distribution as shown in.
<img src="info:doi/10.1371/journal.pone.0256381.e001" id="pone.0256381.e001g" />
J
C
A
E
=
∑
x
∈
D
n
(
L
(
x
,
g
(
f
(
x
)
)
)
\+
λ
∥
J
f
(
x
)
∥
F
2
)
Where the approximation error is L, λ hyper-parameter controls the
regularization power, $J_{f}(x) \parallel_{F}^{2}$ promotes the estimation with
training data across suburb as a constructive for feature space.
### Correlation between DAC and weight decay
Since it becomes obvious to assume Frobenius standard of Jacobian squared
corresponds towards an L2 weight decay (for instance, an activation function
*s*<sub>*f*</sub>). Having lower weights through a static scenario is also the
best solution towards reduction. However, in the case of the sigmoid non-linear
activation function, reduction and robustness can also be achieved by placing
hidden units into their saturated state. If an encoder represented as *f*
function transforms the source $x \in R^{d_{x}}$ to a hidden $h(x) \in
R^{d_{h}}$ representation, then the resulting form can be expressed as.
<img src="info:doi/10.1371/journal.pone.0256381.e005" id="pone.0256381.e005g" />
h
=
f
(
x
)
=
s
f
(
W
x
\+
b
h
)
Here *s*<sub>*f*</sub> is a type of sigmoid non-linear activation function,
while the *d*<sub>*h*</sub>×*d*<sub>*x*</sub> weight matrix W, and a bias vector
$b_{h} \in R^{d_{h}}$ are parametrized towards the encoder.
The key features of the proposed auto-encoding strategy are as follows:
1. It renders the encoding less vulnerable from its training dataset to
slight alterations.
2. Encoding is achieved by utilizing a regularization or penalty scheme to
an objective function.
3. The overall outcome is to minimize the sensitivity of the learning
representation against the training feedback.
4. Encoder activation sequences are regularized and must comply with the
Frobenius norm of the Jacobian matrix concerning input data.
5. The DAC auto-encoder is generally used similar to other auto-encoders by
activating only when the data point is not labeled by other encoding
schemes.
The unpredictable and unstable nature of the wind makes it very difficult to
extract certain wind patterns in order to precisely forecast reliable wind
energy. The instability of wind contributes to the wide range of training
samples that have a significant effect on the precision of power prediction.
First, a group of five DAC deep auto-encoders is used in all three Offshore
Windfarm datasets to extract hidden features and meaningful data patterns in a
low-dimensional space. DAC auto-encoder is an unsupervised neural network that
learns how to compress and encode information efficiently, and then learns how
to reconstruct the features of a reduced encoded representation roughly similar
to the actual input. The dataflow diagram of the proposed DAC based Deep Auto-
Encoding framework is shown in. In the proposed auto-encoder framework, the
dimensionality reduction strategy is also used for data to further improve the
efficiency of wind power forecasting during pre-processing wind data.
## Offshore Windfarm (NREL) dataset
Windfarms data is pre-processed based on offshore wind turbine data from U.S.
NREL repository consisting of multiple offshore regions. Datasets provide wind
potential and real-time measurements of wind turbines for certain intervals
located in different offshore regions. The first dataset is processed based on a
scale of 30 meters to 90 meters with a measurement duration of 1 hour, 7 hours,
and 12 hours, including the climatic data of 164,000 Windfarms. The second
Windfarm data is based on the Hawaii region of the United States, with an
average grid of 2 kilometers recorded during the month of January. Additionally,
the third Windfarm data is based on an offshore wind analytics database compiled
via different wind speed design parameters. Moreover, the real-time wind data
are evaluated for 17 years only by the MERRA time series, and the various
meteorological specifications. shows the annual wind speed measured by the NREL
on different offshore regions of the United States. Higher wind speeds indicate
the potential of power generation by offshore wind turbines in the United
States. A significant number of offshore windfarms are located in these regions,
that are also utilized in wind power forecasting analysis.
## CNN-LSTM neural network architecture
The pre-trained model is then transferred towards a CNN-LSTM neural network for
offshore wind power forecasting. The CNN-LSTM framework is used as the primary
indicator throughout this research. The proposed Convolution Neural Network
strategy has succeeded in reducing the effect of computational complexity and
has also achieved significant improvement in extracting and generalizing
features. LSTM is capable of processing 1-decision statistical analysis as well
as in making assumptions by generating an outcome for each timespan. In order to
isolate the features of precompiled results, a 1-D convolutional layer along
with the LSTM framework is implemented in this paper as a major indicator. The
designated CNN-LSTM configuration with the addition of CNN layers in the LSTM
model is shown in. The LSTM layer along with two dense layers and three fully
connected layers is configured, while max-pooling is also used within the hybrid
CNN-LSTM model. Through multiple tests, the activation function of each
convolutional layer is calculated against Parametric ReLU (PReLU), then the
sigmoid function is estimated to activate that LSTM layer. Moreover, zero
paddings have been used only between different components of convolution layers
to preserve a certain proportion.
Indeed, the convolution layer is the main focus of the convolution neural
network. Within this layer, there are also two main processes, local independent
correlation and temporal classification of outputs. To further simplify the
basic calculations, the former calculation is also adopted for the calculation
of each filtered relevant information. Although described, the performance of
the convolution layer may be enforced: $$h^{k} = f((W^{k}*x) + b_{k})$$
Where \* signify convolutional process, f (·) is the activation function,
*W*<sup>*k*</sup> and *b*<sub>*k*</sub> are the weights and biases of the
k<sup>th</sup> function.
## LSTM (long-short term memory) network
LSTM is more resourceful relative to conventional Recurrent Neural Network
(RNN). However, based on the input gate, the forget gate, and even the
corresponding output, the same weight of perception appears to be malicious. The
defined specific tasks can be observed as follows:
1. How data are excluded again from the convolutional layer is decided by
the forget gate.
2. It will change the cell state, but how much additional data throughout
the input gate will be applied to the main contribution.
3. A sigmoid function is executed as an output gate, and the cell state is
analyzed by an activation function that pairs with the sigmoid output layer
to produce the desired total output.
Although there four key LSTM parameters such as internal memory state
*c*<sub>*t*</sub>, forgot gate *f*<sub>*t*</sub>, input gate *i*<sub>*t*</sub>,
and output gate *o*<sub>*t*</sub>. The computation phase at each component is
represented using Eqs – at period t time: $$f_{t} = \sigma(W_{f}.\lbrack
x_{t},h_{t - 1}\rbrack + V_{f}.c_{t - 1} + b_{f})$$ $$i_{t} =
\sigma(W_{i}\lbrack x_{t},h_{t - 1}\rbrack + V_{i}.c_{t - 1} + b_{i})$$ $$c_{t}
= c_{t - 1}*f_{t} + i_{t}*\tanh(W_{c}\lbrack x_{t},h_{t - 1} + b_{c})$$ $$o_{t}
= \sigma(W_{o}.\lbrack x_{t} + h_{t - 1}\rbrack + V_{o}.c_{t} + b_{o})$$ $$h_{t}
= o_{t}*\tanh\left( c_{t} \right)$$
For offshore Windfarm datasets, optimum fine-tuned specifications are shown in
Tables, accordingly. In the hidden layers, the number of neurons ranges from 50
to 250, whereas the number of epochs varies from 200 to 400. All offshore
Windfarm datasets are pre-trained and saved as train models. The training model
is then used in the proposed LSTM-CNN deep learning model to predict wind power
for all three offshore Windfarms. For the input nodes, the Rectified Linear Unit
(ReLU) is used. In deep learning models, ReLU is the most widely selected
activation function. This activation function returns 0 if any negative response
is obtained, and retains input for any positive value of x. It is numerically
represented using.
<img src="info:doi/10.1371/journal.pone.0256381.e013" id="pone.0256381.e013g" />
f
(
x
)
=
x
\+
=
max
(
0
,
x
)
Where the input of the neural network is x also termed as a ramp function
identical to split-wave rectification.
The Softmax activation function is used with the output layer to evaluate
forecast errors which is also a multi-dimensional generalization of the logistic
equation. It can be used for multiple regression analysis and can also be used
as the final activation function of the neural network to stabilize the
probability distribution performance over the expected output groups. The neural
network is generally optimized for output N values for each class of
classification model, while the Softmax function can normalize these outputs by
transforming the weights to the sum of probabilities. Each value in the output
of the Softmax function is interpreted as the probabilities of being a member of
each class. It is statistically represented using.
<img src="info:doi/10.1371/journal.pone.0256381.e014" id="pone.0256381.e014g" />
σ
(
z
→
)
i
=
e
z
i
∑
j
=
1
K
e
z
j
Where *σ* signifies the softmax function, $\overset{\rightarrow}{z}$ is the
input vector, $e^{z_{i}}$ is the standard exponential function for input vector,
*K* shows the variety of sections throughout the algorithm for a multi-class,
while $e^{z_{j}}$ is a standard exponential function for output vector. In order
to build a deep learning model, the entropy function is often used to detect
accuracy loss. It considers each tensor as input and targets the same shape of a
tensor as an output. The Adam optimizer is used to assemble and configure a deep
learning model that is often known as a stochastic descending gradient. Adam
Optimizer modifies network weights and determines unique active learning rates
for each element of the deep learning architecture. The decaying mean (DM) of
the pas squared gradient is expressed using Eqs and respectively.
<img src="info:doi/10.1371/journal.pone.0256381.e018" id="pone.0256381.e018g"
/>
m
t
=
β
1
m
t
−
1
\+
(
1
−
β
1
)
g
t
<img src="info:doi/10.1371/journal.pone.0256381.e019" id="pone.0256381.e019g" />
v
t
=
β
2
v
t
−
1
\+
(
1
−
β
2
)
g
t
2
Where *m*<sub>*t*</sub> and *v*<sub>*t*</sub> are the approximate measures
during the first and second moment gradients. As a result, the respective
gradient is indicated for each moment. Adam optimizer further counteracts these
biases by estimating the bias-corrected first and second moments as shown in Eqs
and respectively.
<img src="info:doi/10.1371/journal.pone.0256381.e020" id="pone.0256381.e020g" />
m
^
t
=
m
t
1
−
β
1
t
<img src="info:doi/10.1371/journal.pone.0256381.e021" id="pone.0256381.e021g" />
v
^
t
=
v
t
1
−
β
2
t
Sparse Categorical Cross-entropy is used to compare the predicted label and true
label to calculate the accuracy loss and validation errors. Sparse Categorical
Cross-entropy is an arithmetic variant of the categorical cross-entropy loss
function which does not require the transformation of target labels into
category formats. Mathematically, the relationship between different parameters
of the loss function can be expressed using.
<img src="info:doi/10.1371/journal.pone.0256381.e022" id="pone.0256381.e022g" />
J
(
w
)
=
−
1
N
∑
i
=
1
N
\[
y
i
log
(
y
^
i
)
\+
(
1
−
y
i
)
log
(
1
−
y
^
i
)
\]
Whereas *w* indicates the parameters of the deep learning model such as weights
of the neural network, while *y*<sub>*i*</sub> represents the true label and
${\hat{y}}_{i}$ becomes the predicted label respectively.
Following the formation of the CNN-LSTM model, the number of hidden layers,
neurons, and operational parameters are fine-tuned for each offshore Windfarm.
Tables – shows the precise fine-tuned settings used in power forecasting of
Windfarms.
# Results and discussion
The Keras Interface integrated with the TensorFlow platform makes it easy to
transform layers, activation and loss functions, etc. into a variety of
prototype deep learning models. It also offers a compilation strategy for
customizing the training process in each layer, including losses, optimization,
and other built-in learning configurations to train the constructed model. The
training is effectively conducted corresponding to the input design, but also
dense layers. The training process is automatically performed by TensorFlow
corresponding to the input shape of data and dense layers. Deep learning further
drives the integration of user-defined enhanced functionality to train feature
representation in a short period to solve complex issues.
For all three Offshore Windfarms, the actual and predicted wind power is
displayed in Figs – respectively. The orange curve indicates the predicted power
by DAC-CNN-LSTM strategy while the grey curve shows the actual wind power
generated from US offshore turbines collected by NREL. In, the offshore wind
farms predicted values were generated using fine-tuned setting. There is a small
error margin between actual and predicted wind power which clearly shows
effectiveness of proposed methods for offshore wind power forecasting.
Furthermore, the R-squared correlation values of predicted and actual wind power
are 0.01 and 0.03 also shows a close association between predicted and actual
results. In the case of Figs and, the predicted and actual R-squared correlation
of Offshore Windfarm 2 is 0.07 and 0.06, while the predicted and actual R-square
correlation of Offshore Windfarm 3 is 0.01 and 0.02 respectively. The
observations in all figures reveal that predicted power is quite comparable to
actual power, with minor variations at some intervals. However, the overall
consistency between the predicted and actual power shows the flexibility and
reliability of proposed model in forecasting wind energy across multiple
offshore wind turbines.
Offshore Windfarms forecasting performance was further assessed in terms of MAE
and RMSE errors. The MAE and RMSE errors are widely used to evaluate performance
of time-series and other non-label data. In, we used boxplots to show the
distribution of errors in the form of minimum, maximum and Q1-Q3 percentile
ratios based on outcomes generated by deep learning models. The minimum MAE
error for all three Offshore Windfarms is between 0.01 to 0.04, while the
minimum RMSE for all three Offshore Windfarms is between 0.07 to 0.15
respectively. The RMSE error of DAE-CNN-LSTM is little higher than its MAE error
but the overall effectiveness of proposed model is the same. In the case of
Q1-Q3 percentile ratios, all Offshore Windfarms MAE and RMSE error is less than
0.20. The lower error percentile ratios show higher confidence level in the
evaluation and outcomes of the proposed DAE-CNN-LSTM deep learning model. The
low MAE and RMSE error also indicate that the proposed model is quite effective
in forecasting offshore wind power regardless of offshore regions.
The proposed model is also fine-tuned to attain the appropriate parameters for
individual mean absolute error (MAE), along with root mean square error (RMSE).
For fine-tuning the deep learning model, optimization function, the training
error rate, activation, and loss specifications were used for training and
testing. The (MAE, RMSE) values of Offshore Windfarm 1 are (0.02, 0.0747) and
(0.0103, 0.0786) for Offshore Windfarm 2 and (0.0324, 0.1485) for Offshore
Windfarm 3 respectively. Numerically, Eqs and were used to measure MAE and RMSE
for three Windfarms.
<img src="info:doi/10.1371/journal.pone.0256381.e024" id="pone.0256381.e024g" />
M
A
E
=
∑
i
=
1
n
\|
y
i
−
x
i
\|
n
Where the variable *y* is predicted, *x* is the actual value, *n* is the number
of observed data points. Aggregate variations among different components and
samples are rooted in terms of RMSE. The predicted value is the first, while the
actual value is the second value.
<img src="info:doi/10.1371/journal.pone.0256381.e025" id="pone.0256381.e025g" />
R
M
S
E
=
∑
t
=
1
T
(
x
1
,
t
−
x
2
,
t
)
2
T
Where expected values are *x*<sub>1,*t*</sub>, *x*<sub>2,*t*</sub> in
observation and *T* is the cumulative number of measurements or observations.
The predicted wind power error values further compared with the common state-of-
the-art algorithms, i.e., REP Tree, SVM, Random Forest, J48, Back and Forward
Procedure Ensemble Selection, and BPNN respectively. demonstrates the MAE and
RMSE errors for all three Offshore Windfarm datasets for different state-of-the-
art wind power forecasting models. In offshore windfarm 1, the MAE and RMSE are
improved relative to existing state-of-the-art methods. Comparably, the MAE and
RMSE for offshore windfarm 2 achieved better results compared to other
windfarms. Additionally, for the offshore windfarm 3, the MAE and RMSE gave
better results for the proposed model in comparison with other classification
models. The Rep tree and BPNN have improved MAE and RMSE scores (0.0229, 0.1204)
for the offshore windfarm 1 dataset, concerning our proposed model. Compared to
other approaches, the random forest performs the best MAE and RMSE prediction
scores (0.0154, 0.1022) for the offshore windfarm 2 dataset. Other than the
proposed DAE-CNN-LSTM model, the classification models such as J48 and ensemble
selection showed a strong MAE and RMSE scores (0.0446, 0.1653) for the offshore
windfarm 3 dataset. Fortunately, the outcomes of showed that our proposed model
is more flexible and reliable compared to other state-of-the-art wind power
forecasting approaches.
Furthermore, the state-of-the-art approaches such as Random Forest, J48, REP
Tree, SVM, Back and Forward Method Ensemble Selection, BPNN are also compared to
proposed DAE-CNN-LSTM strategy in terms of Normalized Mean Absolute Error (NMAE)
and the Normalized Root Mean Square Error (NRMSE) respectively. NMAE and NRMSE
are also used to evaluate the effectiveness of times-series or non-label data
under normalized scales. Thus, lowering the NRMSE value maximizes the
reliability of wind power forecasting models. shows the comparison of the
proposed model to other state-of-the-art forecasting approaches on-premise of
NMAE and NRMSE. It is certain that across all three Offshore Windfarms, our
proposed DAE-CNN-LSTM model outperforms existing state-of-the-art methods in
terms of NMAE and NRMSE. Offshore Windfarms 1–3 showed (0.0020, 0.0116),
(0.0011,0.0102) and (0.0032, 0.0105) normalized errors respectively. The NMAE
and NRMSE analyses further demonstrate that the feature engineering and
forecasting strategies are precise and quite useful in accurate forecasting
regardless of diverse behavior of offshore winds.
The dynamic forecasting plot of all three Offshore Windfarms (1, 2 and 3) in
terms of loss configuration is given in Figs. The epoch values are provided on
the x-axis and also the accuracy loss amongst all three Offshore Windfarm
datasets is specified on the y-axis. In offshore windfarm 1, the loss curve
starts at a high range on the y-axis, and loss becomes lowest and stable
approximately after the 25 epochs. Similarly, the loss curve for offshore
windfarm 2 starts at a high range on the y-axis, and approximately after the 50
epochs, it becomes stable and behaves in the same direction. Lastly, for the
offshore windfarm 3, the loss curve starts from a high range on the y-axis and
after 50 epochs, the curve is in a linear direction with the lowest and stable
loss. The accuracy loss figures are generated by fitting the trained data
against test data. The linear curve with fewer error losses indicates the
effectiveness of the proposed DAE-CNN-LSTM model on the data used for both
training and testing sets. In general, the validation loss shows how much a
model is affected by error generated by forecasting models. Low validation error
indicates the higher stability of forecasting model for different epoch
intervals.
Lastly, the R-Squared correlation is used to illustrate the association of wind
data characteristics and actual wind power generated by offshore regions. High
association between predictor (wind power) and response variable (wind speed)
indicates the probability of accurate forecasting on Offshore Windfarms by
forecasting models. R-squared describes the measure by which the uncertainty
with one component influences the fluctuation for the other component. It is a
statistical measure of how the regression line is correlated with wind power
forecasting results. The R-Squared curves are estimated for all three Offshore
Windfarms, as shown in Figs, respectively. The vertical line displays the
predicted values in the model within each curve, whereas the horizontal line
indicates the attributes of the wind data as observed values. The green dots
comprise the specification and the dynamics of the wind data as well as the
linear regression curve depicts a model strength dependent on R-Squared. We also
derived R-Squared curves to determine the performance of the proposed DAE-CNN-
LSTM model. The closer wind points along linear regression axis shows the better
variance and accuracy of the model. All three Offshore Windfarm datasets have
obtained an R-Squared correlation of 91.77%, 85.42%, 90.77% respectively. Figs –
illustrate that the data points in Offshore Windfarm 1 are more proportionate to
the linear axis compared to Offshore Windfarm 2 and Offshore Windfarm 3. As a
result, the R-squared correlation of Offshore Windfarm 1 is higher than other
Offshore Windfarm datasets. In general, Figs – demonstrates the applicability of
forecasting measures on offshore wind turbines data collected by NREL.
# Conclusion
A new hybrid approach based on deep auto-encoding and CNN-LSTM neural network is
designed to estimate wind power for offshore wind turbine datasets. The DAE
model is used as the forecasting engine for the initial outcomes. First, the
collected data was screened and those variables were selected that primarily
lead to precise predictions. The pre-trained model is then used by CNN-LSTM
neural network to forecast actual wind power. Finally, the MAE and RMSE were
estimated and their corresponding error ratios were evaluated by comparing them
with the widely studied state-of-the-art wind power forecasting models.
Experiment findings also proved that the proposed model outperforms alternative
approaches in terms effectiveness and sustainability of offshore wind power
forecasting.
To enhance forecasting performance in time series datasets, the optimizer
function and capabilities of the LSTM neural network can be further improved.
For instance, the Gated Neural Network (GRU) is a new and enhanced version of
LSTM-based neural networks that can perform faster and train better with minimal
data to train forecasting models. In future research, we intend to improve our
proposed approaches for short-term wind power forecasting by integrating GRU and
other optimization algorithms where limited data is accessible particularly for
short-term power forecasting.
[^1]: The authors have declared that no competing interests exists.
|
# Background
12 million new cases of syphilis occur each year, the majority in developing
countries. Probable active syphilis occurs in 1.5 million pregnancies and
contributes to 305,000 neonatal deaths and stillbirths each year. Half of
pregnant women with untreated syphilis will experience adverse pregnancy
outcomes, such as miscarriage, stillbirth, premature delivery, low birth weight
and neonatal infection. Congenital syphilis has been a neglected public health
problem in Sub-Saharan Africa (SSA), where syphilis prevalence among pregnant
women ranges from 1.4 to 17%.
Universal syphilis screening of pregnant women is recommended as part of the
basic antenatal care (ANC) package promoted by the World Health Organization
(WHO), since the symptoms of early syphilis too often go unnoticed and late
stages of the disease may be completely asymptomatic. Despite the availability
of screening tests and ample evidence that antenatal testing and treatment with
single-dose Benzathine Penicillin improves pregnancy outcomes and is highly
cost-effective, screening rates range from 1.7 to 79.9% of women attending
antenatal care in SSA. A recent analysis of antenatal surveillance data
estimated 66% of syphilis-associated adverse pregnancy outcomes occurred in ANC
attendees who were either not appropriately tested or treated for syphilis.
A number of key barriers to implementation of universal antenatal syphilis
screening have been identified: inconsistent supply chain, patient cost and need
to return for results, health worker absence or insufficient training, low
prioritisation by health policy implementers and use of Rapid Plasma Reagin
(RPR) as the standard diagnostic tool, which requires laboratory capacity, cold
storage and electricity. To address these barriers, new health technologies:
rapid, specific and validated point-of-care (POC) syphilis tests, have been
developed and successfully implemented in a variety of clinical settings.
However, experience gained in human immunodeficiency virus (HIV) and malaria
treatment programmes illustrates that ensuring POC test use and reliability of
results, particularly on scale-up, presents its own set of challenges.
Reliability is aided by adopting high quality test kits that are easy-to-use;
providing adequate training to all healthcare workers (HCW); and integrating
Quality Assurance/Quality Control (QA/QC) and supervision systems into
programmes from the outset. POC test implementation involves shifting testing to
non-laboratory settings and non-laboratory HCWs, often unaccustomed to
performing tests or routine QA/QC. Such task-shifting has important planning
implications for workload of HCWs in already burdened health systems, and for
testing strategy, diagnostic algorithms, QA/QC continuity and supply chain
management. Furthermore, HCW acceptance of POC tests and trust in their accuracy
are key to ensuring that tests are performed and results are acted upon.
In this paper, we explore the end-user experience of new health technology
introduction. We compare Zambian HCWs’ experience of RST usability, training and
quality systems during a highly-supported pilot project versus a pared down
national implementation programme. Through HCW and key informant interviews, we
examine how health system planning and infrastructure influenced implementation
of both pilot and first phase of Zambia’s national RST programme.
# Methodology
## Study design
### Study context
Zambia is a lower-middle income country with a population of 14.1 million,
spread over a large geographical area. 94% of pregnant women attend at least one
antenatal visit and ANC is free-of-charge. The health care system is arranged in
six tiers: outreach services, health posts, urban and rural health centres,
district hospitals, secondary referral and tertiary referral hospitals. Rural
facilities are remote, located several hours’ drive from district hubs, lacking
or with limited electricity and limited transport to convey patient samples,
results or supplies back and forth to district laboratories.
In 2010–11, a six-country pilot study, including Zambia, evaluated the
feasibility of introducing RSTs into existing maternal and child health (MCH)
programmes. The study was the first of its kind to incorporate QA systems to
monitor training and accuracy of POC test results. The non-governmental
organisation (NGO)-led Zambian study arm introduced RST into existing prevention
of mother-to-child transmission (PMTCT) of HIV services in 15 sites in two
districts: Mongu, a rural district, with a syphilis prevalence of 7%, and
Lusaka, an urban district, with a prevalence of 2.5%. It showed that integrating
RST into PMTCT programmes increased testing and treatment for syphilis in HIV
positive pregnant women without compromising HIV service delivery.
Following the pilot’s success, the Zambian Ministry of Health (MoH) rapidly
adopted RST into national policy and led the rollout of a national RST
programme, incorporating QA/QC into programme design. The rollout, supported by
the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), commenced in 2012,
initially in four underserved districts with high rates of maternal mortality:
Kalomo, Lundazi, Mansa and Nyimba. Key implementation changes were made between
pilot and rollout: supervision was reduced from monthly to quarterly and QA/QC
activities were devolved from central to district laboratory level.
Prior to the pilot, antenatal syphilis screening was carried out using the
laboratory-based RPR test when available. MCH HCWs sent blood samples to a
laboratory for batched testing, with patients usually returning for results at a
later date. In some rural facilities, non-laboratory workers performed RPR tests
without a systematic QA approach. During the pilot, RST was performed by MCH
HCWs who started same-day treatment based on a reactive RST test. National
rollout guidelines described several diagnostic algorithms, depending on RST,
RPR and Treponema pallidum haemoagglutination (TPHA) test availability at each
site. None of the sites included in this evaluation performed TPHA.
### Data collection
This qualitative evaluation used a HCW questionnaire and key informant
interviews to determine the feasibility and acceptability of introducing RST
into PMTCT services, comparing pilot and national rollout implementation phases.
The concept of “feasibility”, drawn from the health technology literature, was
defined as the process of RST programme implementation leading to end-user
acceptance and utilisation, discussed further below. Acceptability was defined
as health workers’ positive satisfaction levels and their correct and consistent
use of RST. A health economic analysis of pilot and rollout phases is presented
in our accompanying paper, Shelley et al..
The questionnaire utilised both closed questions (including five-point Likert
scales) and open-ended questions eliciting qualitative responses. The following
domains were included: RST advantages and disadvantages, patient experience,
organisational environment and workflow, training, skill and confidence in test
performance and RST acceptability. For the rollout evaluation, the pilot
questionnaire was adapted using current literature on technology acceptance;
domains on QA/QC and supervision were added; and a topic guide was designed,
covering the same domains as the questionnaire. Further adjustment, following a
pilot interview and feedback from completed MoH/EGPAF supervisory visits,
strengthened the internal validity of the study.
During the pilot assessment, SAS software (version 9.1) was used to randomly
select four sites, two in each study district. They included a district hospital
and both low and high volume health centres. Data on service and patient
volumes, staffing numbers and location, time/motion studies and cost data were
collected to document changes in syphilis and HIV testing and treatment and are
reported elsewhere. For the rollout evaluation health facilities were selected
by convenience sampling (based on MoH guidance and practical limitations such as
distance, staffing and vehicle availability) to reflect a range of urban and
rural clinical settings with varying laboratory capacity. Review of records and
key informant interviews took place at District Health Offices (DHO).
Face-to-face interviews were conducted in English with consenting health
workers, with the exception of one interview, which used a translator. In
November and December 2010, two EGPAF study staff administered the questionnaire
to pilot HCWs, including seven midwives, two nurses and seven lay counsellors.
Twenty four rollout HCWs (including four midwives, four nurses, five lay
counsellors, one clinical officer, six laboratory technicians, three
environmental health technologists and one psychosocial counsellor) were
interviewed in August 2012 by one of the authors (É.A.), an independent
researcher who accompanied MoH/EGPAF on supervisory visits. Responses were hand-
written and rollout interviews were also audio-recorded and subsequently
transcribed by the interviewer. Interviewees were selected by convenience
sampling, aiming to interview four HCWs at each pilot site and any HCW who had
ever performed RST at each rollout site. Using the MoH guideline, any errors
identified in test performance were immediately remediated post-interview and
discussed with the implementing partner. Informal interviews were held with key
informants during MoH supervisory visits to gain understanding of the planning,
implementation and costs of the national RST programme. Key informants included
EGPAF senior and pilot study staff, MoH HIV/AIDS STI Programme staff, and DHO
staff from Mansa and Kalomo districts. Data were collected in the form of field
notes recorded after each informal interview.
### Conceptual framework and analysis
A conceptual framework was created to guide the analysis, based on a model used
by Asiimwe et al. which explored the feasibility of new health technology
introduction. The framework divides the concept of feasibility into two inter-
related domains, *acceptance* and *usability*. Technology acceptance and
usability originate in the study of human-computer interaction. Usability has
been further broken down into various attributes. Here, acceptance and usability
were divided into six sub-domains: *learnability*, *willingness*, *suitability*,
*satisfaction*, *efficacy* and *effectiveness*, attributes which have been
described in other settings. The framework recognises that acceptance and
usability may be influenced by factors related to the end-user (both HCW and
client), the diagnostic tool and the health system. Health system factors
include guidelines and training, quality monitoring and evaluation, supply
chain, and policy, budget and planning.
Data from the two evaluation phases were collected, entered and analysed by
separate pilot and rollout teams. Quantitative data were double-entered,
verified and cleaned using MS Access (2007–10) and Microsoft Excel 2003
respectively. Qualitative data were entered into MAXqda (V10) and NVivo 10,
respectively, which are computer-assisted qualitative data analysis software
packages. Two authors (M.G. and É.A.) used template analysis to independently
analyse qualitative data from each phase. The initial coding template was based
on the questionnaire and included codes for: HCW acceptance and satisfaction,
patient and partner experience of RST, training, workflow and integration with
existing services and quality assurance activities and supervision. For this
paper, the authors compared data from each phase under these theme headings and
explored and refined emerging sub-themes through iterative discussion.
## Ethical considerations
The pilot study protocol and consent procedures were approved by the University
of Zambia Biomedical Research Ethics Committee (UNZAREC), the University of
Alabama at Birmingham’s Institutional Review Board, the World Health
Organization Research Ethics Review Committee and the Zambian MoH. The rollout
study protocol and consent procedures were approved by UNZAREC, the London
School of Hygiene and Tropical Medicine Research Ethics Committee and the
Zambian MoH. To minimise use of personal identifiers, verbal informed consent
was obtained from pilot HCWs and recorded on an approved consent form by
interviewers. During rollout evaluation, written informed consent was obtained
from each relevant District Health Officer and from each interviewed HCW using
an approved consent form; verbal informed consent to participate was obtained
from key stakeholders and recorded by the interviewer.
# Results
In evaluating the pilot, 16 HCW interviews were conducted at four sites, located
in two study districts (Mongu and Lusaka). In the rollout evaluation, 24 HCW
interviews were conducted in two facilities in Kalomo and five facilities in
Mansa. Informal interviews were conducted with four senior administrative and
management staff in each DHO. Using the conceptual framework, we compare and
contrast results from pilot study and rollout evaluation according to the
following themes: RST acceptance and satisfaction; RST usability; training and
guidelines; quality assurance activities and supervision; health system and
supply chain.
## RST acceptance and satisfaction
Overall, both pilot and rollout HCWs *accepted* RST as a *suitable* addition to
existing services. One rollout clinical officer stated: “ *“I would encourage
the MoH to embrace it and to roll it out in the whole country*.*”* ”
Most HCWs were strongly motivated by the opportunity to deliver a better service
and offer *effective*, same-day testing and treatment (STAT) to patients to
ensure safer pregnancies. They reported perceived increases in testing rates and
treatment access for pregnant women and their partners as well as perceived
reductions in loss to follow-up and adverse pregnancy outcomes. They were
*satisfied* with RST reliability and accuracy.
HCWs in both phases reported patient *satisfaction* with the RST but this was
notably less in the rollout: 93.8% of pilot HCWs (15/16) and 62.5% of rollout
HCWs (15/24) thought patients were somewhat or very accepting of the RST. A
rollout lay counsellor commented that patients: “*received (it) with both their
hands*.” Patient benefits reported by HCWs in both phases included: STAT,
reduced clinic waiting time, reduced travel time and increased case detection
and treatment. Reduced patient waiting time was more evident in the pilot; 68.8%
(11/16) of pilot HCWs reported a reduction compared to 39.1% (9/23) of rollout
HCWs. By contrast, several (26%, 6/23) rollout HCWs reported an increase in
patient waiting times following RST introduction.
POC technology allows patients to directly observe their test result. Rollout
HCWs reported that this, along with patient counselling, assisted in alleviating
patients’ initial distrust of RST: “ *“Every change is quite hard to
comprehend…We have to try hard so…people really adapt to new situations*,*”*
rollout lay counsellor. ”
HCWs encountered some difficulties communicating RST test results to patients,
in cases where tests were positive due to previously treated infection (and,
therefore, requiring only a single dose of BP) or in cases of partner sero-
discordance. Counselling was referred to repeatedly by all rollout interviewees
as key to client and partner acceptance of testing and treatment. Many drew on
their HIV counselling training.
## RST usability
### Health technology usability
Both pilot and rollout HCWs found the RST highly learnable; prior experience
with POC tests added to their confidence. They rated the individual steps in
test performance as easy or very easy.
> *“The \[RST\] procedure is simple*, *good and very short*,*”* > > pilot lay
counsellor.
Compared to RPR testing, it was less “cumbersome” and time-consuming to perform,
and easier to interpret. The mobility and convenience of RST allowed each stage
of syphilis testing and treatment to be performed in one facility department, or
out in the community: “ *“It’s like a supermarket*, *we do everything here…HIV
test*, *results…Hb*, *the syphilis… the same day*,*”* rollout midwife. ”
However, some aspects of RST were less user-friendly. HCWs in both phases
described difficulties reporting results within the appropriate time-frame and
with interpreting results. These difficulties were more pronounced during
rollout: only 30% (7/23) of rollout HCWs rated reporting results within the
correct time-frame as “very easy” compared to 87.5% (14/16) of pilot HCWs; half
of rollout HCWs were unsure how to correctly interpret weak positive results,
which should be reported as positive. Several described repeating the RST or
referring to the laboratory for confirmation of weak positive results; neither
practice is in accordance with guidelines.
### Usability—integration within existing services
Before RSTs were introduced at study sites, HCWs reported that, despite
inclusion in national ANC guidelines, antenatal syphilis testing using RPR was
inconsistently performed. RPR was performed at only 3 of 4 pilot sites and 6 of
9 rollout sites during the interviews. Most HCWs agreed RSTs were successfully
integrated into facility PMTCT services, (16/16 pilot and 23/24 rollout HCWs)
but there was high inter-site variability in algorithm followed and effect on
workflow. The pilot integration pattern was standard: a MCH HCW (midwife, nurse
or lay counsellor) ran both RST and HIV tests and returned results; a midwife or
nurse then initiated treatment thus *efficiently and effectively* providing
STAT. RPR confirmation was not included in the pilot protocol.
By contrast, integration at rollout sites depended on the facility’s health
system level, available HCW cadres and laboratory capacity. Fewer rollout HCWs
reported consistent delivery of STAT (83%, 20/23) compared with pilot HCWs
(100%, 16/16). This may in part be due to variable patterns of task shifting. At
larger facilities HCWs reported splitting testing steps amongst different HCWs
and different departments, which led to delays in returning results and
initiating treatment. In some cases confirmatory RPR was performed by the same
HCW; in others, clients were required to return for RPR testing or results.
Notably, midwives in one rollout facility reported a high reactivity rate of
56.3% on initial RST introduction. To verify results, they repeated RST or
referred to the laboratory, where the lab technician reported repeating RST
followed by RPR on all positive ANC samples, out of keeping with guideline
algorithms. It also proved initially confusing to some rollout HCWs that the
treatment algorithm differed in the case of negative RPR.
Pilot HCWs regarded RST as a user-friendly addition to PMTCT services which
resulted in overall time-savings, despite the additional time required to
counsel patients on both syphilis and HIV: “ “*…results are out in a short
time…thus*, *cuts on time we spend on syphilis testing giving us more time to do
other routine activities in MCH*,*”* pilot lay counsellor. ”
In the rollout, the effect on workload depended on both the role the HCW had in
syphilis testing prior to RST introduction and the algorithm employed. Those
previously involved in RPR testing reported overall time-savings irrespective of
whether they then went on to perform RPR for some clients; those *not*
previously involved felt RST introduction increased their workload and staffing
levels were insufficient to manage: “ *“I have a lot of clients …I have to see
them… counsel them and do the RST to the woman and the man*. *So*, *it becomes
difficult at times when I’m alone*. *That is in terms of staffing*,*”* rollout
midwife. ”
As a result, they deferred syphilis testing to a later ANC visit or delayed
reading test results.
## Training and guidelines
Training experiences varied between pilot and rollout, with pilot HCWs more
likely to have received training from EGPAF staff. 25% (4/16) of pilot
interviewees reported attending an EGPAF training workshop; the remainder
received on-the-job training from colleagues or EGPAF study staff; half received
remedial booster training from EGPAF during monthly supervisory visits. 29%
(7/24) of rollout interviewees attended the MoH/EGPAF-led training workshop. The
remainder (17/24) received on-the-job training from colleagues.
According to MoH staff, the rollout training workshop emphasised on-the-job
training but did not include specific “train-the-trainer” techniques. A training
manual was provided to workshop attendees but few reported using it to train
colleagues. Following training, only three (3/23) rollout HCWs used SOPs to aid
accurate testing; all (16/16) pilot HCWs used them.
Most rollout HCWs found both workshop and on-the-job training acceptable.
Several HCWs believed on-the-job training was too short and contained inaccurate
or incomplete “second-hand information”. Some HCWs described colleagues’
distrust of them as trainers, their *dissatisfaction* at missing “official”
training and their resultant *unwillingness* to perform the test: “ *“*...*they
think*, *since you’re the one who went to the workshop you will be the one to do
(the RST)*,*”* rollout counsellor. ”
## Quality assurance activities and supervision
*Acceptance* and *usability* of QA/QC activities were investigated as part of
the rollout evaluation only. 100% of rollout respondents *accepted* QA/QC
activities and recognised the potential benefits: “ *“I think it will help us
know if the test kits are working properly and you would be confident that the
result you would give would be the correct result*,*”* rollout midwife. ”
However, few rollout HCWs accurately recalled the QA/QC programme components
described in RST training manuals. A small number reported performing internal
QC to check test kit quality (e.g. ensuring the test control window was positive
before reporting results). With the exception of one PMTCT counsellor who
displayed self-*efficacy* in using RPR control samples to check kits, no HCW
reported performing systematic external QC or completing proficiency panels.
Guidelines stated that district laboratories should prepare and provide positive
and negative control samples for external QC and dried-tube specimens for
proficiency panel testing. Laboratory facilities reported performing their own
weekly QC; one district laboratory sent proficiency panels to local facilities
but no results were returned. Reported barriers to the provision of district-led
QA/QC were lack of trained staff, dedicated time, transport and reporting
infrastructure.
Supervision differed from pilot to rollout. EGPAF made monthly support visits
during the pilot and supported the MoH on quarterly supervisory visits during
rollout. Rollout HCWs expressed *willingness* to undergo supervisory visits,
describing them as an opportunity to learn and to correct mistakes. Most
believed supervision was a *suitable* and *effective* tool, which boosted morale
and encouraged HCWs to work more diligently and more accurately. Some
*dissatisfaction* with supervision was expressed; a minority felt demoralized,
intimidated or uncomfortable when observed performing tests.
## Health system and supply chain
Supply of penicillin was consistent during the pilot but was less reliable
during rollout: 12.5% (3/24) of rollout interviewees said stock-outs occurred
once a month. RST kit supply was also less reliable during rollout; half of
pilot sites (2/4) reported a stock-out on one occasion whereas almost a third of
rollout sites (7/24) reported a complete RST stock-out during the month
preceding interviews. EGPAF key informants reported that RST kits were not
supplied through the usual national supply chain but rather through the DHO
Pharmacy. This was to avoid incorrectly delivering to districts not yet involved
in rollout but it led to confusion and ruptures in RST supply.
# Discussion
This two-phased evaluation provides a detailed account of new POC test
implementation, examining the transition from an NGO-led pilot project to the
first phase of a national RST programme in Zambia. Novel, inexpensive and easy-
to-use POC tests can address inequality in access to diagnostics in lower and
middle income countries such as Zambia. However, implementation can be complex
and requires a usable test, acceptance by HCWs and patients, good quality
training, ongoing HCW support, quality monitoring systems and robust supply
chains, which are more difficult to ensure for large-scale rollout with budget
constraints. Jafari et al described a lack of quality reporting of
implementation research outcomes, other than accuracy, for syphilis POC tests,
which our study helps to address. This early programme evaluation takes place at
multiple health system levels in four Zambian districts and may inform the
Zambian MoH as they plan further phases of RST programme rollout.
Using HCW surveys and key stakeholder interviews, we examined the success of RST
implementation from the perspective of “feasibility”, a concept borrowed from
the health technology literature, which was further broken down into two
components: “acceptance” and “usability”. This study was not designed to report
impact of RST introduction into PMTCT services in Zambia, which is reported
elsewhere.
Overall, the study findings were positive with both pilot and rollout HCWs
reporting that RST largely met our criteria for *acceptability* and *usability*.
However, feasibility, as defined here, is contingent not only on end-user and
technology attributes but also on health system and programmatic factors. We
identified that several aspects of the rollout programme differed from the
pilot, particularly training, testing algorithm, QA/QC, supervision, and supply
chain; these may have negatively influenced the end-user experience and
therefore the feasibility of the RST rollout programme.
Both groups found some aspects of RST non-user-friendly but rollout HCWs
demonstrated significantly less correct and consistent use of RST, likely
influenced by less exposure to MoH/NGO-provided training and regular
supervision. Rollout on-the-job training quality appeared highly variable; the
*effectiveness* of the cascaded training model utilised in the rollout was
clearly limited. The inconsistent implementation of rollout testing and
treatment guidelines may reflect the nature of the training and scaled-down
supervision received by rollout HCWs compared to pilot HCWs and may have
influenced the quality of care delivered. The POC literature emphasises the
importance of high quality training to ensure test accuracy and reliability.
This is increasingly critical as HCWs are now expected to perform multiple rapid
tests in parallel, each with varying specifications and manufacturers’
instructions. The WHO and global health workforce alliance advocate the cascaded
model of training, or “train-the-trainer” (TTT) approach, as one way to meet the
global health workforce crisis. The effectiveness of TTT is supported by a
recent systematic review. However, there is dearth of knowledge on TTT programme
content, the training techniques that should be incorporated, or on programme
sustainability.
Rollout HCWs were *willing* to take part in cascaded training, although some
expressed resentment at missing the opportunity to attend an off-site training
workshop. This may be linked to the widespread use of per diem payments for
health workers in some low and middle-income countries, such that they have
become an expected supplement, sometimes even exceeding health sector salaries.
While these payments may encourage productivity and motivation, they have been
shown to create conflict between HCWs and even to demotivate those who don’t
receive them. Supervision and monitoring of HCWs’ performance has been shown to
increase their confidence in test performance and accuracy of test results, a
finding echoed in this study. During the pilot, rates of both HIV and syphilis
testing and treatment improved, which was attributed in part to regular
supervision.
Overall, rollout HCWs were less *satisfied* with the increased workload
resulting from the addition of another POC test to MCH services, but this was
dependent on their previous role in syphilis testing and the algorithm employed.
Our findings support a New Zealand study which showed that POC test introduction
can have important, unforeseen implications for workforce planning. Most rollout
HCWs inaccurately described the steps involved in RST performance, confusing
them with other POC tests. The assumption that integrating multiple testing
programmes serves to strengthen health systems may not always hold true. The new
dual RST and HIV POC tests, which are currently under evaluation by the WHO and
partners, may eliminate some of the problems engendered by running multiple POC
tests in parallel. Less frequent supervision may be one reason rollout HCWs
reported greater difficulty with test performance and employed a variety of
integration patterns, resulting in lower rates of STAT.
Rollout HCWs perceived lower levels of patient satisfaction than their pilot
colleagues, which may result from the longer patient waiting times reported by
some. HCWs also described difficulties around negotiating patient expectations
and understanding of test results. Similar issues have been described in the
literature on malaria rapid diagnostic test (RDT) introduction, particularly
challenging patient expectations of malaria treatment in the face of a negative
malaria test. Specific training in counselling patients and partners around RST
results may prove useful to include in further editions of RST training manuals.
The importance of QA/QC systems has been repeatedly emphasised in recent
literature on HIV and malaria POC tests. Despite this, most HIV testing
programmes in developing countries operate without them. Ensuring reliable POC
test results is of paramount importance as inaccuracies lead to incorrect
diagnosis and treatment and negatively impact patient care and cost-
effectiveness. Assuming the same issues regarding POC accuracy might beset RST
implementation, QA/QC were incorporated into both pilot study and national
rollout.
Anticipating that QA/QC could be an area of weakness during rollout, several
modules of the MoH training guide were devoted to QA, QC and monitoring
procedures. All rollout HCWs interviewed understood the rationale for QA and
demonstrated *willingness* to take part. However, the first round of rollout
supervisory visits revealed limited implementation of these procedures. Several
factors may have contributed to this: ineffective planning and communication (in
that no specific person at facility or district level was nominated to
coordinate QA/QC), lack of dedicated budget and logistics, lack of local
expertise in this type of activity which is often undertaken by NGOs, or lack of
*efficacy* on the part of local laboratory staff. This suggests that HCW
training on QA/QC was not *learnable* or *effective* in its current form.
Further research is needed to establish the ideal mix of RST QA/QC activities
which is usable, acceptable, effective and cost-effective.
Supply chain issues may have impacted rollout success. For POC tests to maximise
their potential, supplies of test kits, treatment and other consumables must be
consistently available. Weaknesses in both MoH district pharmacy and central
medical supply chains were identified, which should be addressed before
commencing further phases of the rollout.
Limitations of this study include the fact that it was a single-country case
study whose findings may not be generalizable to other countries. Interviews and
data analysis were performed by two separate research teams using slightly
different collection tools which may reduce comparability of data from pilot and
rollout phases. The pilot surveys were conducted by the implementing
organisation and surveys in both phases were carried out during supervisory
visits, increasing the risk of social desirability bias. The majority of study
findings are based on a HCW survey; data are therefore response-based and
susceptible to social desirability bias and measurement error. Convenience
sampling of interviewees may have introduced selection bias. Quantitative data
are also subject to measurement error. In addition this study design was not
able to ascertain programme impact.
The Zambian RST scale-up model incorporated many success factors defined by
Yamey in a recently proposed framework for successful scale-up of global health
interventions. However, we suggest that there are a number of aspects which
ought to be refined before further rollout of the Zambian RST programme; our
findings have been shared with the MoH and their implementing partner. The ideal
training model, supervision type and frequency and mix of QA/QC activities for
RST programmes has not been established and further implementation studies,
which also examine impact, are required.
To strengthen the cascade model of training, the MoH could adopt a comprehensive
“training of trainers” model incorporating adult education techniques and
certifying workshop attendees as “local trainers”. Integrating training with
HIV, malaria and Haemoglobin POC test training would facilitate emphasis on
differing test characteristics and reduce HCW confusion. QA programme aspects
would be strengthened by a distinct laboratory QA rollout strategy identifying
specific responsible local personnel, and facilitating them with dedicated
financing and logistics. Collaboration with those organisations already
performing monitoring and evaluation of HIV testing may prove effective.
Advocacy with the RST kit manufacturer to include positive and negative control
samples could facilitate QC testing and address some of the difficulties
experienced in communication and transport between laboratories and the
surrounding health facilities. In addition, the supply chain must be
strengthened.
# Conclusion
This study provides insight into the challenges of integrating new health
technology into existing health systems and explores the transition from pilot
study to national rollout. It illustrates programmatic experience of
implementing cascaded training and QA, QC and supervision activities. Use of a
conceptual framework adopted from a paper on health technology “usability”
facilitated the exploration of programme implementation and may prove useful in
other settings. We demonstrate that it is feasible to implement a MoH-led rapid
syphilis testing programme in Zambia, following a successful pilot, but that
issues around training, QA/QC and supply must be addressed in planning for
future phases of this and other programmes incorporating POC tests. The Zambian
MoH has already demonstrated commitment to monitoring and evaluation practices
and addressing these programme aspects should serve to strengthen the health
system as a whole.
# Supporting Information
The authors would like to acknowledge the support of the Zambian Ministry of
Health in carrying out this research. We would like to thank the health workers
who participated in the study and the staff of the District Health Offices and
health facilities who participated in Mongu, Lusaka, Kalomo and Mansa Districts.
The pilot study was made possible by the support of the Sexually Transmitted
Diseases Diagnostics Initiative of the UNICEF/UNDP/World Bank/WHO Special
Programme for Research and Training in Tropical Diseases (TDR) and the support
and coordination of The London School of Hygiene and Tropical Medicine (LSHTM).
During pilot study conception and implementation, technical support was provided
by Catherine Wilfert; Helen Kelly (LSHTM); Laura Guay (EGPAF, Washington, DC);
the Centre for Infectious Disease Research (CIDRZ); and TDR. LSHTM supported the
rollout research and Colette Fleischer contributed to rollout data collection
and analysis. The staff of the EGPAF Lusaka office provided invaluable
assistance and support. The views expressed in this article are the opinions of
the authors and do not necessarily reflect the official policies of USAID or the
US government. The authors also thank the journal reviewers for helpful comments
and suggestions for revising the original version of the manuscript.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: EMA MMG JR SS KDS TS FTP RWP
DM. Performed the experiments: EMA ATN GTM. Analyzed the data: EMA MMG JR.
Contributed reagents/materials/analysis tools: EMA MMG KDS. Wrote the paper:
EMA MMG KDS FTP JR.
[^3]: Current address: Department of International Health, Johns Hopkins
Bloomberg School of Public Health, Baltimore, Maryland, United States of
America
[^4]: Current Address: ICAP program, Mailman School of Public Health,
Columbia University, New York, United States of America
|
# Introduction
Coastal and ocean systems have played a crucial role in human evolution,
providing food, health, well-being and livelihoods since prehistoric times.
Marine biodiversity, in particular, provides enhanced nutritional benefits to
human societies, while ensuring fundamental ecosystem functions, structures and
services. Since the second half of the 18th century (Industrial Era), and
especially in recent decades, pervasive and compounded anthropogenic impacts on
ocean and coastal systems have accelerated marine biodiversity loss and
population decline, and increased the vulnerability of marine ecosystem
services. Understanding the scale of anthropogenic stressors, however, is
extremely complex and exacerbated by the paucity of long-term records on species
composition, abundance and distribution pre-dating the most recent decades of
anthropogenic impacts. This form of historical amnesia creates misconceptions
that have far-reaching consequences for sustainability and conservation actions.
For example, it may conceivably increase tolerance for progressive environmental
degradation and contribute to setting inappropriate sustainability targets and
responses by ocean stakeholders; and hence underpin their expectations as to
what is a desirable and achievable state of social-ecological systems. These are
typical symptoms of the “shifting baseline syndrome” that require locally-
impactful and globally-relevant new knowledge to engage and support stakeholders
in designing conservation pathways to ocean sustainability.
Moreover, the Intergovernmental Oceanographic Commission of the United Nations
Educational, Scientific, and Cultural Organisation (IOC-UNESCO) has recently
launched important global efforts to educate people on the oceans (Ocean
Literacy), including fundamental concepts about how oceans function and human-
ocean interdependencies. Understanding humanity’s past, present and future
relationships with the oceans are therefore of utmost importance to both the on-
going implementation of the UN Decade on Ecosystem Restoration (2021–2030;) and
the UN Decade on Ocean Science for Sustainable Development.
The southern Atlantic Forest coast of Brazil is a world biodiversity hotspot
with a long history of human-ocean interaction, and a priority region for
socially equitable sustainable development in cooperation with biological
conservation and restoration. It is also, however, a data poor region in
relation to fisheries statistics despite being the largest fish producing region
(Santa Catarina state) in the country. Stock monitoring data are regionally and
chronologically dispersed, and mostly limited to the second half of the 20th and
the first decade of the 21st centuries. In Brazil, there has been an increased
effort to expand stock reconstructions with data collected from local fisheries
and seafood wholesale market data, but these approaches are inherently limited
to only the most recent decades affected by large national fisheries subsidies,
specifically from the 1960’s to 1970’s. Overall, little is known about the
diversity of targeted species and their socio-cultural, economic and market
values before more recent political and financial support were introduced to the
fishing industry.
Historical sources can provide valuable insights into past species composition,
distribution and abundance. Among written public media documents, newspapers
offer some advantages for qualitative and quantitative historical analyses.
Newspapers generally have large distribution ranges and relatively high
frequency of issues (released on a daily to semestral basis), while digitization
programmes through public funds and advances in optical character recognition
(OCR) technology are making historical newspapers increasingly accessible.
Moreover, public media offers insights into societal (e.g. cultural, economic
and political) drivers of change, including stakeholder perception of
environmental conditions through time. Public media also shapes public opinion,
influencing peoples’ literacy of ocean, human and ecological affairs, and thus
may be a major driver of social-ecological baselines in all societies. There is
a rich body of literature conceptualising the use of newspapers for
reconstructing historical events that can help marine historical ecologists
assess data quality while framing their research in the evolving editorial and
political agenda of popular media through time.
In Brazil, newspapers have been issued since the beginning of the 19th century,
and are one of the few sources of information documenting the development of
political and economic institutions, and commercial activities over the last
centuries. Gallardo et al. have recently shown that historical newspapers
retained insightful information on the drivers of anthropogenic impacts on
coastal areas of Brazil over the last 150 years. Here we expand their approach
to derive long-term data on marine organisms targeted by Brazil’s fishing sector
between 1840 and 2019, and notably during the first half of the 20th century,
preceding “blue acceleration” of the last decades, where a major gap in
understanding still exists. We investigated historical newspapers published in
Santa Catarina state and scrutinised more than twenty thousand digitised
editions in the Brazilian Digital Newspapers and Periodicals Library (Hemeroteca
Digital Brasileira). Our aim is to uncover the diversity of species commercially
exploited, traded and consumed in southern Brazil since the late 19th century,
prior to the start of the global-level blue acceleration social-ecological
phenomena and the first large fisheries subsidies in the country. Our paper
offers new insights into the origin and changing nature of significant human
impacts on marine systems in the southwestern Atlantic Ocean; as well as
implications for ocean sustainability initiatives aiming to bring society’s
social-ecological baselines closer to historical reality.
# Material and methods
## Data collection
The sampling method follows Gallardo et al. and, in brief, it can be summarised
in the following steps: A) Historical newspapers were sourced from the Brazilian
Digital Newspapers and Periodicals Library (*Hemeroteca Digital Brasileira*,
*Fundação Biblioteca Nacional*, *BNDigital)*, made available by the National
Library Foundation (*Fundação Biblioteca Nacional*,
<https://bndigital.bn.gov.br/hemeroteca-digital/>). B) News items (e.g.
articles, opinion letters, regulations and sanctions) were sourced using the
keywords “*pesca*” (fishing) and "*peixe*" (fish), selecting the “*Locality”* as
the region of Santa Catarina using the State abbreviation “*SC*”, opting for
single decades as the “*Period”*, and including all newspapers for the selected
decades. Details of the searching facilities including OCR available through the
*BNDigital* can be found at <https://bndigital.bn.gov.br/hemeroteca-digital/>.
The keywords “*pesca*” (fishing) and "*peixe*" (fish) were chosen for the
following reasons: i) The keyword “*pesca*” captured several types of marine
resources, and also captured the word "*pescado*" which categorically addresses
different types of resources exploited by fisheries; ii) within Brazilian folk
taxonomy (ethnotaxonomy), various marine animals ("*pescado*") are classified as
“*fish*”; iii) the popular association of fish such as shrimp, lobster, oysters,
octopus and squid with crustaceans and molluscs is something very recent and
thus this nomenclature is infrequently used in everyday life; iv) given the
large diversity of organisms captured by coastal fisheries in Brazil and the
general scope of the paper (not targeting a specific species), it would be
unfeasible to extend the keywords to all potential captured organisms. C) Single
items were then assessed for duplicate results and non-relevant information
(e.g. commercial advertisements) which were then excluded. Once the search was
completed, single items were fully read in order to assess the content and
quality of information based on two inclusion criteria: i) the items focused on
coastal and ocean areas, including estuaries and coastal lagoons, or coastal
rivers; and ii) the items reported marine animals (e.g. fish, crustaceans,
molluscs, mammals, reptiles), including non-native taxa. D) An analytical
framework was created to collect and categorise content and contextual
information, which consisted of 1) a catalogue of reported taxa and their
overall trophic ecology, and 2) the type of fishing gear, when reported (SI1).
Aquatic animals were mostly reported using vernacular names, with conversion to
scientific names (using the minimum identified taxonomic level), whenever
possible, based on local literature. The catalogued animals and gear were
quantified for their absolute and relative abundances (the number of times a
species or type of gear occurred in a given number of newspaper items) and
richness (the number of different species and gear types in a given number of
newspaper items) aggregated per decade. If species *X* was reported more than
once in a single item, its abundance in the given item was counted as one.
## Data analysis
For each species, the trophic level (TL) was assigned according to data in
FishBase, using the main diet of adults. For taxa where only genus and/or family
were identified we used the average values of the main species in the region
according to SiBBr ([https://sibbr.gov.br](https://sibbr.gov.br/?lang=pt_BR)).
With this information we computed the weighted average trophic level (WATL) for
each decade. In addition, we computed fish-based piscivores/planktivores
(Pis/Pla) and invertebrates/fish (Inv/Fis) to explore changes in overall catch
composition through time. For this we used the absolute abundance of species
reported in newspapers per decade. These are simple ecological indicators that
are used here to infer changes in fishing pressure, trophic level (fishing down
the food web), biological productivity, market preferences and technological
changes. Non-native and freshwater organisms (e.g. fish, shrimp), reptiles,
birds and sea mammals were excluded from WATL, Pis/Pla, Inv/Fis analyses. The
results from Inv/Fis were compared with reconstructed and officially reported
industrial and artisanal catch data (volume in tons) for Santa Catarina from
1950 to 2015. Piscivores included fish species consuming finfish and pelagic
cephalopods, while for planktivores their diet consisted of zooplankton and
early stages of fish and jellyfish. For these two trophic categories we used
references from Quimbayo et al., complemented with other literature. When
combined, multiple indicators are expected to provide a more comprehensive
picture of historical changes in the system. Fishing gear were standardised
following the Fishing Gear Type of the ICMBio (*Centro Nacional de Pesquisa e
Conservação da Biodiversidade Marinha do Sudeste e Sul*
(<https://www.icmbio.gov.br/cepsul/artes-de-pesca.html>)). The information
collected from the newspapers were complemented with additional sources, such as
the reports of the Ministry of Agriculture (available at
<http://ddsnext.crl.edu/>). Data collection was carried out from March 2021 to
March 2022.
# Results
## Species composition and fishing technology
The keywords “*pesca*” (fishing) and “*peixe*” (fish) generated 9,190 and 14,168
matches respectively, spanning a period of 180 years (1840 to 2019). Over 23,400
newspaper reports (items) were individually assessed and read. Of these, 598
items were selected following the inclusion criteria reported above. The
selected items were reported in 57 newspapers, representing 4.7% of the total
newspapers available in the HBD for Santa Catarina over the studied time period
(n = 1206, 18th March 2022). The selected items provided information for 37
municipalities, of which 49% (n = 298) were related to Florianópolis (formerly
Desterro), the capital of the state. From 1950 onwards there was an increase in
news items from municipalities located by the Itajaí River and the northern
coastal regions of the state (e.g. Barra Velha and São Francisco do Sul), where
Brazil’s largest commercial fishing industry developed over the last decades.
The keywords “*pesca*” (fishing) and "*peixe*" (fish) captured animals from
different taxonomic groups (fish, crustaceans, molluscs, mammals, reptiles),
which is significant since in folk taxonomy several taxa are also considered as
“fish”. Native and non-native animals were mostly reported as vernacular (*v*)
and, to a lesser extent, as scientific (*s*) names, the latter sporadically
appearing in more recent decades. We found 1655 mentions of marine animals,
totaling 277 and 203 vernacular and scientific taxa respectively (SI1). As
reported by Feire and Pauly, we also found evidence that a single folk
nomenclature was used for several species (e.g. *Hypanus* sp., *Dasyatis* sp.,
*Fontitrygon* sp., *Bathytoshia* sp. = *raia prego*), and several folk
nomenclatures were also used for a single species (e.g. *Mugil liza* = *tainha*,
*tainhota*, *tanhota*, *do corso*, *facão*, *tainha-assú*). As a consequence,
attempts to correlate scientific and vernacular names were complex and not
always possible with an equal level of confidence.
Native marine fish dominated in terms of number of species, both vernacular (*v*
= 192) and scientific names (*s* = 143), as well as in abundance (n = 1,041).
This was followed by crustaceans (*v* = 17, *s* = 9, n = 181), freshwater
animals (*v* = 22, *s* = 15, n = 111), molluscs (*v* = 11, *s* = 9, n = 99), sea
mammals (*v* = 9, *s* = 7, n = 81), echinoderms (*v* = 2, *s* = 2, n = 2),
reptiles (*v* = 1, *s* = 1, n = 7) and birds (*v* = 1, *s* = 1, n = 1). Non-
native animals (including fish and crustaceans), introduced for commercial
aquaculture (e.g. tilapia, carp, channel catfish) or imported as processed food
(e.g. cod, conger, hake), also had relatively high species richness (*v* = 22,
*s* = 16) and abundance (n = 132).
The most frequently reported species was the demersal and estuarine-dependent
*tainha* (mullet, *Mugil liza*, Mugillidae, 11.3%, n = 187). Tainha appeared in
the initial period of 1880–1889 and reached maximum relative frequency in
2010–2019. Tainha was followed by *camarão* (shrimp, Penaeidae, 9.3%, n = 154)
and by pelagic and estuarine-demersal taxa including *anchova* (bluefish-
enchova, *Pomatomus saltatrix*, Pomatomidae, 3.8%, n = 63), *baleia* (whale,
several Mysticeti, 3.8%, n = 63), *cação/tubarão* (sharks, several
Elasmobranchii, 3.2%, n = 53), *bagre* (catfish, Ariidae, 2,8%, n = 47),
*corvina* (whitemouth croaker, *Micropogonias furnieri*, Sciaenidae, 2.8%, n =
47), *cascudo* (armored catfish, Loricariidae, 2.2%, n = 37), *tilapia*
(tilapia, *Oreochromis niloticus*, 2.1%, n = 35), *pescada* (drums/croakers,
Sciaenidae, 1.9%, n = 31), *robalo* (fat snook, *Centropomus parallelus*,
Centropomidae, 1.9%, n = 31), *ostra* (oyster, *Crassostrea rhizophorae*,
Ostreidae, 1.7%, n = 28), *sardinha* (sardine, Clupeidae, 1.6%, n = 27),
*garoupa* (dusky gruper, *Epinephelus marginatus*, Serranidae, 1.6%, n = 26),
among others. Some generic taxa were reported with distinct vernacular names,
such as *cação/tubarão* (e.g. *mangona*, *anequim*, *tintureira*, *baleeiro*,
*cação gralha branca*, *c*. *salteador*, *c*. *azul*) and *camarão* (e.g.
*camarão branco/legítimo/do corso*, *c*. *perereca*, *c*. *sete barbas*, *c*.
*rosa/pistola*, *c*. *cabeça azul)*. When combined, the relative abundance of
sharks and shrimps increased to 4.5% and 9.3%, respectively.
The number of items reporting marine animals using the keywords “*pesca*”
(fishing) (n = 269) and "*peixe*" (fish) (n = 329) were significantly positively
correlated with the number of newspapers for Santa Catarina available in the HDB
archives (pesca r = 0.61; R<sup>2</sup> = 0.37; p \< 0.005; peixe r = 0.52;
R<sup>2</sup> = 0.27; p \< 0.02), a pattern also observed by Gallardo et al..
Similarly, species richness and their abundances were also significantly
positively correlated with the number of newspapers (species richness, r = 0.73;
R<sup>2</sup> = 0.53; p \< 0.001, frequency, r = 0.68; R<sup>2</sup> = 0.46; p
\< 0.001) in Santa Catarina, indicating that, in absolute terms, our data is
affected by the amount of digitised newspapers available in the HDB database.
When considering the relative proportion of distinct taxonomic categories and
species, the results point to variations possibly expressing changes in socio-
cultural, economic and market importance of aquatic animals through time. Native
marine fish and sea mammals had higher relative abundance and species richness
between the decades of 1900–1909 to 1930–1939, followed by a decreasing trend
toward the most recent decades (2000–2009 and 2010–2019). By contrast, the
abundance and richness of invertebrates (molluscs, crustaceans) increased in the
decades between 1900–1909 and 1930–1939, and again in 2000–2009 and 2010–2019.
Freshwater fish and non-native species (both freshwater and marine), instead,
showed the opposite trend, with higher relative abundances and species richness
in the decades of 2000–2009 and 2010–2019 compared to previous decades.
The WATL shows the prevalence of high trophic level species over the last 180
years, including medium to large top predators such as *cherne*
(groupers—*cherne-pintado* (snowy grouper), *garoupa* (dusky grouper), *mero*
(goliath grouper)) and *tubarão/cação* (sharks—*cação mangona* (sand tiger
shark), *c*. *baleeiro* (copper shark), *c*. *gralha branca* (whitetip shark)),
among others. However, a significant decline in WATL was observed between the
late 19th and early 21st centuries (r = -0.56; R<sup>2</sup> = 0.31; p \< 0.05).
The ratio between piscivores and planktivores (Pis/Pla) was quite variable from
1880–1889 to 1960–1969 (ranging from 0.7 to 5), but maintained consistently low
values (0.6 to 1) from 1980–1989 onwards. These low trophic level species are
mostly represented by *carapeba* (possibly *caratinga* (*mojarras*,
*Eucinostomus* sp.), *gordinho* (American harvestfish, *Prepilus paru*),
*parati* (white mullet, *Mugil curema*), and several Scianidae (*cangulo*,
*pescadinhas*, *cangoá*, *guete*). Fluctuations in Pis/Pla did not correlate
with time (r = -0.01; R<sup>2</sup> = 0.0002; p \> 0.05), nevertheless, the
results from combining these indicators point to a greater relative importance
of high trophic level species (notably piscivores) from the late 19th to the mid
20th century, and a later decrease from the 1970’s and 1980’s. The high
diversity and the relative frequency of *camarão* (shrimp), *ostra* (oyster),
*marisco* (mussels), *siri* (crab), and *lula* (squid) since the late 19th
century indicates that historical fisheries targeted organisms from all trophic
levels. Interestingly, a significant increase of short-lived invertebrates (r =
0.58; R<sup>2</sup> = 0.35; p \< 0.05) is observed from 1970–1979 onwards, which
is partially consistent with their increased captures by both artisanal and
industrial fleets in the 1970’s and 1980’s in Santa Catarina.
The reported organisms were associated with a range of fishing gear (n = 43),
some of which only appeared in the late 19th and early 20th centuries (e.g.
*chae-chae*, *caçoal*) (SI1). The diversity and abundance of fishing gear did
not change as a function of time (*n* gear, r = 0.157; R<sup>2</sup> = 0.024; p
\< 0.532; frequency, r = 0.078; R<sup>2</sup> = 0.006; p \< 0.757), but were
significantly correlated with the number of newspapers (*n* gear, r = 0.641;
R<sup>2</sup> = 0.411; p \< 0.005; frequency, r = 0.806; R<sup>2</sup> = 0.649;
p \< 0.001). The broad category “*rede”* (net) dominated both in frequency (n =
132) and diversity of gear (n = 18), including variations such as anchored,
surface, bottom, drift, small mesh, large mesh, and trammel. According to ICMBio
(Fishing Gear Type), these could be tentatively assigned to drift gillnets
(*rede de emalhe*), which are some of most common fishing gear used to catch
demersal species in south Brazil, and with documented use since the 1870’s (*A
Gazeta de Joinville*, 11 february 1879). Other relatively frequently used gear
included “*aparelhos com anzol*” (use of a hook), “*tarrafa*” (cast nets), and
“*arrasto*” (trawl, beach seine), to name a few.
# Discussion
## Species composition and the impact of early fisheries subsidies
Our study revealed that historical newspapers retain insightful information on
the perceived value, diversity and abundance of marine animals in southern
Brazil over the last 180 years. We identified nearly 300 aquatic animals, the
majority of which were captured and traded by coastal communities and commercial
fisheries in Santa Catarina since the 1840’s, and others that were imported for
direct consumption or aquaculture throughout the 20th and the early 21st
centuries. The compiled information (e.g. frequency and richness), however, was
unevenly distributed across the studied time interval, with fluctuations
positively correlated with the number of digitised newspapers in the HDB
database. This highlights the challenges of extracting absolute values to
reconstruct ecological baselines from historical sources. Therefore, in order to
minimise sampling biases, we focus our discussion on the decades with greater
amounts of information in the newspapers.
Significantly, 51% of our data (n = 307) was compiled from newspapers published
between the decades of 1880–1889 and 1930–1939, which was a time interval of
unprecedented political efforts to boost the commercial fishing sector in
Brazil. For example, in 1856, the Decree 876 of 10 September authorised the
incorporation of companies for catching, salting and drying fish along the coast
and rivers of the Brazilian Empire. Later in 1912, Decree 9672 of 17 July
created the Fisheries Agency (*Inspetoria da Pesca*), replaced by the Biological
Marine Station in 1915 (Estação de Biologia Marinha, Decree 11507 of 4 March),
which promoted institutional actions for “studying and disseminating the natural
resources of Brazilian waters, to develop them as much as possible and regulate
their use". In 1933, Decree 23348 of 14 November established fish landing,
processing and commercialization sites (*entreposto de pesca*), in order to
increase efficiency of commercial fishing. Surprisingly, little is known about
the targeted species and the ecological implications of these public policies.
From the late 19th century, several fishing concessions were released to private
investors in Santa Catarina (*A Regeneração*, 12 August 1884, 12 October 1888),
while in the early 20th century, landing and seafood markets (*Entrepostos de
Pesca*) were implemented through public investments in several cities along the
Brazilian coast and increased state control of economic activities. Urban
population growth increased demand for fish, enhancing market opportunities for
private investors that greatly benefited from fiscal incentives in key urban
centres such as Rio de Janeiro and Santos. The extent of commercial fisheries
development in Santa Catarina since the early 19th century is alluded to by
export records from the city of Laguna for the years 1819 and 1820, which
documented, among other fish species, the sale of more than 1 million catfish in
2 years to several Brazilian states (Bahia, Pernambuco, Rio de Janeiro)
(*Revista Catarinense*, 1911). However, consolidated markets and long-trade
networks are better documented for later periods. Between 1910 and 1939, several
locally caught fish (e.g. mullet, bluefish-enchova, shark, catfish, black and
other types of drums) and invertebrates (e.g. shrimps, oysters, mussels) were
reported in newspapers in relation to markets (22%, n = 133), landing reports
(18%, n = 110), industrial fishing (14%, n = 83) and local food security (13%, n
= 81). They were captured for direct human consumption (seafood) as well as for
other byproducts including fishmeal, fish skin (as "sandpaper"), fish stomach
and gut (as fertiliser) and oils, which were regularly traded in local and
regional markets (*O Despertador*, 23 October 1880; *Republica*, 3 July 1903; *O
Estado*, 22 December 1933). These local catches supplied the growing demands in
urban centres (*A Gazeta*, 2 October 1935, but see also), as well as the
nutritional needs of small coastal communities (*O Estado*, 22 July 1915; *O
Dia*, 3 August 1916; *A Noticia*, 18 September 1936; Republica, 22 October
1937). We suspect that commercial fisheries equally benefited from the
specialised labour force, infrastructure and technology released with the
decline of whaling in the late 19th century.
In the case of mullet, the most cited species with various distinct vernacular
names (“*tainha”*, *“tainhota*, *“tanhota”*, *“tainha do corso”*, *“tainha
facão”*, *“tainha-assu*”), intensive exploitations were attested since the late
19th century, when the species was primarily captured during its reproductive
migration in winter (*A Regeneração*, 27 May and 7 June 1885; *O Estado*, 3 June
1915). Its fishing and processing (*escalada*, involving salting and
desiccating) mobilised entire communities (*A Regeneração*,18 June 1885; *O
Despertador*, 14 May 1881), and the catches were sold both locally (*O Estado*,
2 February and 1 March 1917) and in markets located hundreds of kilometres away,
such as São Paulo (*O Estado*, 12 June 1923). Single catch events could consist
of 30–60 thousand mullets (*O Estado*, 4 June 1941), even up to 100 thousand
specimens (*O Estado*, 16 June 1933), which were captured using relatively
simple fishing technology (gillnets and beach seine made of plant fibres).
According to the captain Vieira da Rosa, on request of the Ministry of
Agriculture in 1916, “*The most abundant fish in the state is tainha do corso*
\[winter mullet schools\]…*It can be estimated that more than one million
mullets are caught every winter…*” (*O Dia*, 8 August 1916). Considering the
average weight of modern mullet during their winter reproductive migration (2
kg, but see also *O Estado*, 12 June 1923), this would correspond to 2000 t
catch/winter, which is higher or comparable with artisanal landings/winter (May-
July) in 2017 (1423 t), 2018 (1122 t) and 2019 (2522 t) for mullets in Santa
Catarina state (data from PMAP-SC, <http://pmap-sc.acad.univali.br/index.html>).
Although the productivity of winter migratory mullet schools can be affected by
weather conditions, the reduced or equivalent landings in relation to the
significantly increased fishing efforts of the more recent years supports the
growing evidence that this species is currently overexploited in Santa Catarina.
Other species nowadays considered overexploited, such as *miraguaia* (black
drummer, *Pogonias courbina*) and *corvina* (whitemouth croaker, *Micropogonias
furnieri*), were perceived as abundant and thus intensively targeted by coastal
fisheries (*Sul Americano*, 12 August 1900, *A Noticia*, 18 February 1939, *O
Estado*, 16 August 1930). High trophic level marine fish such as *anchova*
(bluefish-enchova) and *cação-mangona* (sand tiger shark) were the main source
of livelihood and financial capital to some coastal groups, as attested to in
1901: “…*the most important trade that Ribeirão makes at the head of the
municipality*, *in the city of Florianópolis*, *is that of fish*, *which
annually yields a hundred thousand reis*, *according to a general estimate*.
*Two species of fish mainly occupy the activity of this honourable people*,
*anchova* \[bluefish-enchova\] *and a variety of cação* \[sharks\], *known
locally by the name of mangona* \[sand tiger shark\] *or xarque by the
populations of the southernmost part of the island*” (*Sul Americano*, 22 July
1902).
Newspaper evidence of fishing intensification in the early 20th century is
largely corroborated by the official reports of the Ministry of Agriculture,
which enable linking the study region discussed here (Santa Catarina) with the
widespread ecological effects of historical fishing subsidies. In 1945, reports
documented an increase of national fish production (fish byproduct) of 431% from
1934 (2112 t) to 1941 (11208 t). Brazil also shifted from importing 500 t of
canned fish to exporting around 800 t of the product in 1943, mostly to South
Africa and Guyana. This suggests that commercial fisheries in Brazil benefited
from reduced competition with foreign producers due to significant disruptions
in fishing trade from the North Atlantic, North Sea and the Baltic during World
War II. The impact of these early subsides was also evident in the first
official landing reports from the *Entreposto Federal de Pesca* in Rio de
Janeiro, which indicated a 43% increase in landings (fish, invertebrates) from
1934 (13879 t) to 1940 (19913 t). As observed in most recent statistics,
fisheries subsidies also caused a noticeable increase in overfishing and
bycatching (prevalently juvenile specimens and small fish) in the first half of
the 20th century in Brazil. According to the Ministry of Agriculture, the
confiscation of marine animals due to being under the minimum established size
(bycatching) and deterioration increased 707% between 1934 (10580 t) and 1940
(85445 t) in the same *Entreposto Federal de Pesca*. Strikingly, confiscated
fish and shellfish due to bycatching only, performed a dramatic increment of
\~6000% in just five years, from 945 t in 1934 to 57585 t in 1939. Overfishing
and bycatching, however, were not limited to marine species as official reports
expressed growing concerns about the declining catches of freshwater animals.
For example, decreasing landings of pirarucu (*Arapaima gigas*) in Belém (north
Brazil) between 1919 (1.8 t) and 1938 (1.45 t) was largely attributed to
overfishing. Other species such as manatees (*Trichechus* sp.) and arrau turtle
(*Podocnemis expansa*) also saw a decrease in abundance in the Amazon by the
1930’s, again attributed to intensive exploitation.
## Long-term change in species composition
When considering native marine fish only, the WATL shows consistently high
values between the decades of 1900–1909 (WATL = 3.6) and 1940–1949 (WATL = 3.4),
suggesting that top predators were highly desirable market items for quite some
time, even though several species were already under noticeable fishing pressure
and declining in wholesale markets. Comparison with values for 2010–2019 reveals
a sharp decline with the lowest values of the time series (WATL = 3.0).
Interestingly, other independent indicators expressed the importance of high
trophic level species in early decades, and their decreasing popularity in the
most recent news. For example, planktivorous fish (Pis/Pla) and short-lived
invertebrates (Inv/Fis) increased in their relative frequency of occurrence in
newspapers from 1970 onwards at the expense of piscivorous fish. Significantly,
long-term catch reconstructions for the coast of Santa Catarina show a similar
trend in Inv/Fis, with catches of invertebrates increasing in the 1970’s and
1980’s, although this is followed by a downtrend in more recent decades. This
possibly reflects fiscal incentives provided to the fisheries by SUDEPE from
1967 onwards, along with fishing agreements between Brazil, Uruguay and
Argentina, and the increased investment in shrimp and mollusc aquaculture. For
example, between 1966 and 1972 the number of fishing vessels employed in the
catch of pink shrimp (*Farfantepenaeus* sp.) in Rio Grande (Rio Grande do Sul)
increased from 80 to 396. In Santa Catarina shrimps were intensively exploited
between 1970 and 1990 to the extent that coastal stocks declined considerably
(*A Ponta*, July 1993,). Moreover, increased market opportunities and public
investment for farming of molluscs (e.g. mussels, oysters) and crustaceans (e.g.
prawn and shrimps) accelerated production from the second half of the 20th
century, and notably from the late 1980s onward, which may explain their
increased popularity in public media. Overall, the newspapers appear to capture
the effect of market changes due to historical overexploitation and increased
fishing efforts in Santa Catarina over the last 180 years.
From 2000–2009 the newspapers documented a substantial increase in freshwater
and non-native species. Reports of freshwater species (mostly non-native) were
primarily associated with aquaculture and imports for direct human consumption
(*Correio do Povo*, 23 February 2000; *O Município*, 15 August 2008; *O
Município*, 13–14 April 2017), along with recreational fishing (*Correio do
Povo*, 3 May 1969) and re-population of rivers (*Correio do Povo*, 9–15 August
1980; *Correio do Povo*, 7 December 2002). Such a trend conceivably reflects a
combination of factors, including the reduced contribution of local marine
stocks to domestic consumption, changes in population demography, and increased
investments in aquaculture in Brazil, notably between the 1990 and 2020.
Significantly, the growing global importance of aquaculture in recent years,
known as the “blue revolution”, currently supplies half of all seafood for human
consumption worldwide.
## Implications for marine conservation and Ocean Literacy principles
Our study reinforces the value of historical newspapers in providing insightful
information on long-term species composition, perceived abundance and the
drivers of change in marine biodiversity in Brazil. However, contrary to other
records such as official landing statistics, species composition in newspapers
reflect distinct socio-ecological contexts, spanning from production to
consumption systems, as well as considerations on the cultural and ecological
values of some species, which are subject to evolving political, ideological and
economic agendas, notably in social contexts with high levels of illiteracy as
was the case in the late 19th and early 20th centuries in Brazil. Moreover, we
acknowledge that information from newspapers is often fragmented, with
substantial temporal and spatial gaps. Nevertheless, their use in historical
ecology has proved fruitful and here we show their potential to uncover species
composition (caught or observed) and related social, economic and market values
for decades prior to monitoring programmes and scientific observations.
Specifically, the late 19th and early 20th centuries witnessed the increased
commoditization of marine resources in south Brazil. Profit- and efficiency-
seeking fisheries policies accelerated the “economy of things” at the expense of
the “economy of relationships” between communities and environments,
exacerbating unsustainable exploitation and weak governance in the following
decades. The early 20th century in particular can be considered the “incubation
chamber” of fisheries industrialization in the country, but knowledge gaps on
species composition and the ecological impacts of these early subsides may lead
to the misconception that the commercial sector was limited in extent and
volume, and that most fisheries in the late 19th and early 20th centuries were
for local subsistence or incipient local markets. Such views impinge upon our
understanding of the extent to which marine and ocean systems have been altered
by anthropogenic activities.
Newspapers provide valuable insights into the changing nature of long-term human
interaction with marine biodiversity, helping to track the origin and evolution
of Traditional Ecological Knowledge. This knowledge plays a fundamental role in
fisheries management, biological conservation and coastal livelihoods, and
newspapers reveal that it developed in a historical context of conflicts with
institutions and political and economic actors, who often associated local
fishers with backwardness, poverty, and destitution, and attributed the richness
of their fishing practices with detrimental impacts and economic
underdevelopment. The establishment of the Fishery Inspection Agency in 1912 is
an example of how political institutions attempted to override local fisheries
knowledge with “modern” knowledge in order to increase efficiency and unlock the
market potential of aquatic resources in the country: “*Until now*,
*unfortunately*, *this industry* \[fishing\], *among us*, *has not passed from
the backward and old primitive processes*, *the hook*, *the trawler and*,
*lately*, *the dynamite*, *ruthlessly damaging the creations of the coasts and
almost extinguishing several lacustrine*, *fluvial and maritime species*. *The
improved fishing gear that is currently being used*, *with great results*,
*without impoverishing the waters in which they are exercised*, *and mechanical
fishing by means of steamboats have not yet been used*…”. This market logic has
for decades contributed to dismantling traditional forms of socio-ecological
interactions. Their legacy can still be perceived among modern small-scale
fisheries and the social and political context around them.
Given their role in shaping public opinion through time, historical newspapers
offer a rich repository of shifting ecological baselines. Therefore they are
valuable resources to inform the ambitious Mission of the UN Decade of Ocean
Science for Sustainable Development to promote “Transformative ocean science
solutions for sustainable development, connecting people and our ocean”. A core
driving concept advanced by the UN Ocean Decade is to push countries to initiate
Ocean Literacy programs across the globe, in order to promote better public
understanding, communication and informed policy decisions for ocean
sustainability. By resurrecting previously hidden social-ecological baselines,
historical records can help Ocean Literacy programs advance on essential
principles and fundamental concepts about the functioning of the ocean,
including: clarity on the diversity of life and ecosystems oceans once supported
(principle 5); acknowledgment of deep, historical interconnections humans have
held with the ocean (principle 6); and more realistic baselines about the level
of human exploration of coastal marine environments (principle 7).
# Conclusion
Humans have depended on marine ecosystems as a source of food and livelihood for
thousands of years along the Brazilian coast, a process that has laid down the
foundation of a diversity of fishing cultures in the region. Over the last few
decades, increased fishing demand, overoptimistic cycles of profit-driven
subsidy programmes and weak governance models intensified commercial
exploitations, leading to unprecedented levels of catches and the decline of a
range of stocks. This work advances our understanding of this convoluted
historical process by expanding the current knowledge of captured and consumed
marine animals in southern Brazil by nearly two centuries, covering decades
predating national official landing reports and market information. Our results
highlight the utility of newspaper records in resurrecting previously lost
marine social-ecological baselines, with a high potential to support Ocean
Literacy programs to rightfully contextualise historical realities when shaping
sustainability pathways with ocean stakeholders at all levels.
# Supporting information
We would like to thank Leopoldo Cavaleri Gerhardinger and Krista McGrath for
their insightful comments on the first draft of the manuscript. The authors are
also grateful to Natalia Hanazaki and the Laboratory of Human Ecology and
Ethnobotany (Universidade Federal de Santa Catarina, Brazil).
10.1371/journal.pone.0284024.r001
Decision Letter 0
MacKenzie
Brian R.
Academic Editor
2023
Brian R. MacKenzie
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
18 Jan 2023
PONE-D-22-32178180 years of marine animal diversity as perceived by public media
in southern BrazilPLOS ONE
Dear Dr. Herbst,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
Please consider the comments of reviewer 1 regarding potential use of official
fishery statistics to support and complement your findings. This should be
possible for some of the more recent decades though probably not for the
earliest decades where official records may be more limited or non-existent.
Also please make changes according to comments of both reviewers regarding
several points for clarification and readability.
Please submit your revised manuscript by Mar 04 2023 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript: A
rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'. A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'. An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Brian R. MacKenzie, Ph. D.
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and <https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatt
ing_sample_title_authors_affiliations.pdf>
2\. We note that you have stated that you will provide repository information
for your data at acceptance. Should your manuscript be accepted for publication,
we will hold it until you provide the relevant accession numbers or DOIs
necessary to access your data. If you wish to make changes to your Data
Availability statement, please describe these changes in your cover letter and
we will update your Data Availability statement to reflect the information you
provide.
3\. We note that Figure 1 in your submission contain map image which may be
copyrighted. All PLOS content is published under the Creative Commons
Attribution License (CC BY 4.0), which means that the manuscript, images, and
Supporting Information files will be freely available online, and any third
party is permitted to access, download, copy, distribute, and use these
materials in any way, even commercially, with proper attribution. For these
reasons, we cannot publish previously copyrighted maps or satellite images
created using proprietary data, such as Google software (Google Maps, Street
View, and Earth). For more information, see our copyright guidelines:
<http://journals.plos.org/plosone/s/licenses-and-copyright>.
We require you to either (1) present written permission from the copyright
holder to publish these figures specifically under the CC BY 4.0 license, or (2)
remove the figures from your submission:
a\. You may seek permission from the original copyright holder of Figure 1 to
publish the content specifically under the CC BY 4.0 license.
We recommend that you contact the original copyright holder with the Content
Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-
permission-form.pdf>) and the following text:
“I request permission for the open-access journal PLOS ONE to publish XXX under
the Creative Commons Attribution License (CCAL) CC BY 4.0
(<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this
license allows unrestricted use and distribution, even commercially, by third
parties. Please reply and provide explicit written permission to publish XXX
under a CC BY license and complete the attached form.”
Please upload the completed Content Permission Form or other proof of granted
permissions as an ""Other"" file with your submission.
In the figure caption of the copyrighted figure, please include the following
text: “Reprinted from \[ref\] under a CC BY license, with permission from \[name
of publisher\], original copyright \[original copyright year\].”
b\. If you are unable to obtain permission from the original copyright holder to
publish these figures under the CC BY 4.0 license or if the copyright holder’s
requirements are incompatible with the CC BY 4.0 license, please either i)
remove the figure or ii) supply a replacement figure that complies with the CC
BY 4.0 license. Please check copyright information on all replacement figures
and update the figure caption with source information. If applicable, please
specify in the figure caption text when a figure is similar but not identical to
the original image and is therefore for illustrative purposes only.
The following resources for replacing copyrighted map figures may be helpful:
USGS National Map Viewer (public domain):
<http://viewer.nationalmap.gov/viewer/>
The Gateway to Astronaut Photography of Earth (public domain):
<http://eol.jsc.nasa.gov/sseop/clickmap/>
Maps at the CIA (public domain): <https://www.cia.gov/library/publications/the-
world-factbook/index.html> and <https://www.cia.gov/library/publications/cia-
maps-publications/index.html>
NASA Earth Observatory (public domain): <http://earthobservatory.nasa.gov/>
Landsat: <http://landsat.visibleearth.nasa.gov/>
USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public
domain): <http://eros.usgs.gov/#>
Natural Earth (public domain): <http://www.naturalearthdata.com/>
4\. We note that Figure 2 in your submission contain copyrighted images. All
PLOS content is published under the Creative Commons Attribution License (CC BY
4.0), which means that the manuscript, images, and Supporting Information files
will be freely available online, and any third party is permitted to access,
download, copy, distribute, and use these materials in any way, even
commercially, with proper attribution. For more information, see our copyright
guidelines: <http://journals.plos.org/plosone/s/licenses-and-copyright>.
We require you to either (1) present written permission from the copyright
holder to publish these figures specifically under the CC BY 4.0 license, or (2)
remove the figures from your submission:
a\. You may seek permission from the original copyright holder of Figure 2 to
publish the content specifically under the CC BY 4.0 license.
We recommend that you contact the original copyright holder with the Content
Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-
permission-form.pdf>) and the following text:
“I request permission for the open-access journal PLOS ONE to publish XXX under
the Creative Commons Attribution License (CCAL) CC BY 4.0
(<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this
license allows unrestricted use and distribution, even commercially, by third
parties. Please reply and provide explicit written permission to publish XXX
under a CC BY license and complete the attached form.”
Please upload the completed Content Permission Form or other proof of granted
permissions as an ""Other"" file with your submission.
In the figure caption of the copyrighted figure, please include the following
text: “Reprinted from \[ref\] under a CC BY license, with permission from \[name
of publisher\], original copyright \[original copyright year\].”
b\. If you are unable to obtain permission from the original copyright holder to
publish these figures under the CC BY 4.0 license or if the copyright holder’s
requirements are incompatible with the CC BY 4.0 license, please either i)
remove the figure or ii) supply a replacement figure that complies with the CC
BY 4.0 license. Please check copyright information on all replacement figures
and update the figure caption with source information. If applicable, please
specify in the figure caption text when a figure is similar but not identical to
the original image and is therefore for illustrative purposes only.
5\. Please include captions for your Supporting Information files at the end of
your manuscript, and update any in-text citations to match accordingly. Please
see our Supporting Information guidelines for more information:
[http://journals.plos.org/plosone/s/supporting-
information. ](http://journals.plos.org/plosone/s/supporting-information. )
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Partly
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: Overview:
The work brings a historical rescue of fishing data for one of the largest
production regions at national level (Santa Catarina). Although the approach
does not bring methodological novelties, the work is relevant considering the
scarcity/fragmentation of information at the local/national level.
The work is well structured, however, below are some suggestions to mitigate the
bias related to the search for information in newspapers. I believe that authors
should look for ways to compare these historical records with official fishing
statistics existing at the regional level. In this way, it will be possible to
assess whether, in this specific study, newspaper records reflect (or not)
official statistics, at least for the most recent periods (20th and 21st
centuries).
Methods:
Page 5, Lines 131-132: It is necessary to indicate which were the keywords used
for the search of all the resources (fish, crustaceans, molluscs, mammals,
reptiles), since the results show several resources and not just 'fish'.
P 6, L 141-143: Please include how the search was performed on this platform
(keywords, etc.).
P 6, L 165-167: Did you use the ratio between abundance, catch weight
(landings)? Make it more clear to the reader.
Results:
P 11, L 272-273: This result may be related to the projects that promoted the
implementation of the industrial productive segment of shrimp in Santa Catarina
in the 1970s (e.g., SUDEPE). In addition to projects aimed at growing mangrove
oysters in association with shrimp in the 1980s. In this way, there is a need
for a greater deepening in the discussion about public policies directed to the
productive sector that promoted the cultivation of these aquatic organisms,
bearing in mind that this may influence the publicity of journalistic articles
on the subject.
Discussion:
P 15, L 397-421: This paragraph is outside the scope of the study, as it
provides an overview of fishing at the national level, while the study focuses
on the regional level (Santa Catarina). Is the pattern described at the national
level also observed at the regional level? I suggest that this paragraph be
revised according to the purpose of the study.
P 16, L 433-435: this may be related to what was pointed out above (see comment
in Results section).
P 17, L 451-452: Is this trend also observed in Santa Catarina?
P 18, L 505-506: As the authors themselves recognize above, the records obtained
from newspapers can suffer from several biases. One possibility of mitigating
this bias and verifying whether newspaper records actually reflect catches is
through cross-analysis with historical sources of fisheries statistics. I agree
that statistical records are incomplete, fragmented and scattered, but it is
possible to use some official data sources that can serve to assess general
trends. For example, it is possible to use ICMBio/CEPSUL records
(<https://www.icmbio.gov.br/cepsul/biblioteca/acervo-
digital/38-download/artigos-cientificos/112-artigos-cientificos.html>), IBGE
(<https://biblioteca.ibge.gov.br/biblioteca-
catalogo.html?id=7132&view=detalhes>) and IBAMA (<https://www.gov.br/ibama/pt-
br/assuntos/biodiversidade/biodiversidade-aquatica/gestao-da-biodiversidade-
aquatica/estatistica-pesqueira>). I believe it might be possible to check the
general trend between invertebrates/fishes with this database. Thus, we can
assess whether the methodology used in the work reflects (at least partially)
the official statistics (albeit fragmented).
Figure 3A,B: include in the legend the meaning of the colors present in the
figure (A, B). There are two axes but three colors.
Reviewer \#2: This is an interesting paper that is scientifically sound. My
comments are minor and mostly relate to clarifying parts of the text to ensure
accurate interpretation of methods and results by readers.
L43: ‘…while ensuring fundamental ecosystem functions, structures and services’
Please provide a reference for this.
L50: ‘This sort of historical amnesia creates misconceptions…’ This sentence is
very long. Suggest splitting up to improve readability.
L107: ‘…scrutinised more than twenty thousand digitised editions in the
Brazilian Digital Newspapers and Periodicals Library (Hemeroteca Digital
Brasileira)’. What do you mean by ‘scrutinised’? If you did not examine at all
of these (rather, you conducted key-word searches via OCR across this number of
newspapers) this phrasing is rather misinformative.
Fig 1 Legend: The coloured dots should be labelled as \>1 – 10 reports, \>10 –
20 reports… \>30 – 200 reports etc for greater clarity.
Also, ‘The colour gradient of the localities represents the number of reports
IDENTIFIED per municipality’.
L133: what dates did you undertake data collection? You mention dates in the
results section but it is not clear if these were dates of collection – this is
important to know given that more newspaper articles/editions are being uploaded
to digital collections all the time.
Given you identified animals from articles initially located by keywords fishing
and fish, how likely is it that you’ve missed accounts of species that were
gathered or cultured, or otherwise exploited/identified using alternative words
to ‘fishing’ or ‘fish’?
L159: Suggest ‘Species richness REPORTED by decade’ for clarity.
L184: Suggest restructuring of this paragraph as it initially reads that you
individually screened the \>20,000 articles, rather than identify the ca. 1200
from SC which were then individually screened. Regarding the 4.7% of the total
newspapers you mention, were the 95.3% of papers available from the SC region
but that did not get identified from the OCR searches (i.e. did not mention
fishing or fish)? In general, this paragraph is unclear.
L198: I.e. ‘(v = 203, s = 107)’: Do you mean that a total of 310 species were
identified, or are these two numbers not additive? Same question for the other
numbers that follow.
L199: ‘frequency (n = 1,041)’: Do you mean frequency of mentions?
L234: ‘The number of items reporting marine animals using the keywords fishing
(n = 269) and fish (n = 329) were significantly positively correlated with the
number of newspapers (fishing r = 0.61; R2 = 0.37; p \< 0.005; fish r = 0.52; R2
= 0.27; p \< 0.02)’ Can you explain this more clearly? Are you referring to the
total number of newspapers available (i.e. published online) in the region, or
those identified through OCR searches as containing the words ‘fishing’ or
‘fish’? This is clarified somewhat by the legend in Fig 3 but it needs to be
clear in the text, too.
Fig. 3A and 3B – there are three colours in this panel figure, the black I
assume correlates to the black text on the y axis descriptor (fig 3a), but there
are also two red block colours in this figure and I am now sure how these align
with B and the red text on the secondary y axis (#items). If these are
aggregated per the legend description, why two red colours? Also, what does
‘items’ mean? Is this referring to individual articles within a newspaper
edition?
Fig. 3C-E – there seems to be very little difference between absolute species
counts and species richness. It may be worth briefly repeating in the text (or
legend description) the difference between these two measures, as it gets a bit
confusing when examining the figure.
In general, the way your results are written it reads as absolute species
richness or species numbers, when actually it is richness or numbers reported in
newspapers. I think this needs to be stated more clearly throughout the results.
I.e., L256: By contrast, the richness and frequency of invertebrates REPORTED
increased… L263: The WATL shows the prevalence of high trophic level species
REPORTED over the last 180 years… L287: The diversity and frequency of fishing
gear REPORTED did not change…
L466: you state the potential for newspapers to uncover species composition,
better to clarify here that it is composition of fishery catch and/or landings?
This of course reflects to some extent underlying ecological composition, but
acknowledges the influences of social (in terms of what is reported) and market
forces and technological trends (in terms of what is caught) on newspaper
reporting.
L473: misspelling of ‘unsustainable’.
L482: The relevance of this paragraph on LEK to the wider paper is unclear and
it doesn’t tie in overly well. The historical context of conflicts you mention
regarding LEK will undoubtedly also play out in popular media, it being a window
into past cultures. But I’m not sure if you’re mentioning this to say that this
is indeed the case with newspapers or to say that historical newspaper sources
can mitigate this issue?
L485. Your definition of LEK seems more akin to traditional ecological knowledge
in terms of intergenerational transmission. While I am aware that TEK can be
defined as a form of LEK, I think this needs to be clarified.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: **Yes: **Cleverson Zapelini
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0284024.r002
Author response to Decision Letter 0
26 Feb 2023
PONE-D-22-32178
180 years of marine animal diversity as perceived by public media in southern
Brazil
PLOS ONE
Dear Academic Editor
Thank you for considering our manuscript entitled 180 years of marine animal
diversity as perceived by public media in southern Brazil, by Herbst et al. for
publication in PLOS ONE.
We have now completed the revision of our manuscript according to the comments
made by Reviewer \#1 and \#2 and the Academic Editor. We would like to thank you
in the quality of Academic Editor and both reviewers for your constructive
comments which helped to improve the quality of the manuscript and to clarify
some of our statements.
Please find below our rebuttal. All changes to the manuscript are marked in red
to facilitate their identification.
We would like to update our financial statement with the statement below:
This work was funded by the ERC Consolidator project TRADITION, which has
received funding from the European Research Council (ERC) under the European
Union’s Horizon 2020 research and innovation programme under Grant Agreement No
817911. This work was also funded by EarlyFoods (Evolution and impact of early
food production systems), 2021 SGR 00527. This work contributes to the ICTA-UAB
“María de Maeztu'' Programme for Units of Excellence of the Spanish Ministry of
Science and Innovation (CEX2019-000940-M).
We hope the manuscript can now be accepted for publication.
Kind regards,
Herbst et al.
-------------------------------
Dear Dr. Herbst,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
Please consider the comments of reviewer 1 regarding potential use of official
fishery statistics to support and complement your findings. This should be
possible for some of the more recent decades though probably not for the
earliest decades where official records may be more limited or non-existent.
Also please make changes according to comments of both reviewers regarding
several points for clarification and readability.
Please submit your revised manuscript by Mar 04 2023 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:
● A rebuttal letter that responds to each point raised by the academic editor
and reviewer(s). You should upload this letter as a separate file labeled
'Response to Reviewers'.
● A marked-up copy of your manuscript that highlights changes made to the
original version. You should upload this as a separate file labeled 'Revised
Manuscript with Track Changes'.
● An unmarked version of your revised paper without tracked changes. You should
upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Brian R. MacKenzie, Ph. D.
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and <https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatt
ing_sample_title_authors_affiliations.pdf>
2\. We note that you have stated that you will provide repository information
for your data at acceptance. Should your manuscript be accepted for publication,
we will hold it until you provide the relevant accession numbers or DOIs
necessary to access your data. If you wish to make changes to your Data
Availability statement, please describe these changes in your cover letter and
we will update your Data Availability statement to reflect the information you
provide.
3\. We note that Figure 1 in your submission contain map image which may be
copyrighted. All PLOS content is published under the Creative Commons
Attribution License (CC BY 4.0), which means that the manuscript, images, and
Supporting Information files will be freely available online, and any third
party is permitted to access, download, copy, distribute, and use these
materials in any way, even commercially, with proper attribution. For these
reasons, we cannot publish previously copyrighted maps or satellite images
created using proprietary data, such as Google software (Google Maps, Street
View, and Earth). For more information, see our copyright guidelines:
<http://journals.plos.org/plosone/s/licenses-and-copyright>.
We require you to either (1) present written permission from the copyright
holder to publish these figures specifically under the CC BY 4.0 license, or (2)
remove the figures from your submission:
a\. You may seek permission from the original copyright holder of Figure 1 to
publish the content specifically under the CC BY 4.0 license.
We recommend that you contact the original copyright holder with the Content
Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-
permission-form.pdf>) and the following text:
“I request permission for the open-access journal PLOS ONE to publish XXX under
the Creative Commons Attribution License (CCAL) CC BY 4.0
(<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this
license allows unrestricted use and distribution, even commercially, by third
parties. Please reply and provide explicit written permission to publish XXX
under a CC BY license and complete the attached form.”
Please upload the completed Content Permission Form or other proof of granted
permissions as an ""Other"" file with your submission.
In the figure caption of the copyrighted figure, please include the following
text: “Reprinted from \[ref\] under a CC BY license, with permission from \[name
of publisher\], original copyright \[original copyright year\].”
b\. If you are unable to obtain permission from the original copyright holder to
publish these figures under the CC BY 4.0 license or if the copyright holder’s
requirements are incompatible with the CC BY 4.0 license, please either i)
remove the figure or ii) supply a replacement figure that complies with the CC
BY 4.0 license. Please check copyright information on all replacement figures
and update the figure caption with source information. If applicable, please
specify in the figure caption text when a figure is similar but not identical to
the original image and is therefore for illustrative purposes only.
The following resources for replacing copyrighted map figures may be helpful:
USGS National Map Viewer (public domain):
<http://viewer.nationalmap.gov/viewer/>
The Gateway to Astronaut Photography of Earth (public domain):
<http://eol.jsc.nasa.gov/sseop/clickmap/>
Maps at the CIA (public domain): <https://www.cia.gov/library/publications/the-
world-factbook/index.html> and <https://www.cia.gov/library/publications/cia-
maps-publications/index.html>
NASA Earth Observatory (public domain): <http://earthobservatory.nasa.gov/>
Landsat: <http://landsat.visibleearth.nasa.gov/>
USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public
domain): <http://eros.usgs.gov/#>
Natural Earth (public domain): <http://www.naturalearthdata.com/>
R: The figures were generated using free access images (Public Domain or CC BY
4.0 licence) and references to their sources are included in the revised figure
captions. We provide more information about the individual licences below:
● Natural Earth (<https://www.naturalearthdata.com/about/terms-of-use/>)
● National Institute for Space Research - INPE
(<http://terrabrasilis.dpi.inpe.br/citacoes-e-licenca-de-uso/>)
● CGIAR Consortium for Spatial Information
(<https://cgiarcsi.community/data/srtm-90m-digital-elevation-database-v4-1/>)
4\. We note that Figure 2 in your submission contain copyrighted images. All
PLOS content is published under the Creative Commons Attribution License (CC BY
4.0), which means that the manuscript, images, and Supporting Information files
will be freely available online, and any third party is permitted to access,
download, copy, distribute, and use these materials in any way, even
commercially, with proper attribution. For more information, see our copyright
guidelines: <http://journals.plos.org/plosone/s/licenses-and-copyright>.
We require you to either (1) present written permission from the copyright
holder to publish these figures specifically under the CC BY 4.0 license, or (2)
remove the figures from your submission:
a\. You may seek permission from the original copyright holder of Figure 2 to
publish the content specifically under the CC BY 4.0 license.
We recommend that you contact the original copyright holder with the Content
Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-
permission-form.pdf>) and the following text:
“I request permission for the open-access journal PLOS ONE to publish XXX under
the Creative Commons Attribution License (CCAL) CC BY 4.0
(<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this
license allows unrestricted use and distribution, even commercially, by third
parties. Please reply and provide explicit written permission to publish XXX
under a CC BY license and complete the attached form.”
Please upload the completed Content Permission Form or other proof of granted
permissions as an ""Other"" file with your submission.
In the figure caption of the copyrighted figure, please include the following
text: “Reprinted from \[ref\] under a CC BY license, with permission from \[name
of publisher\], original copyright \[original copyright year\].”
b\. If you are unable to obtain permission from the original copyright holder to
publish these figures under the CC BY 4.0 license or if the copyright holder’s
requirements are incompatible with the CC BY 4.0 license, please either i)
remove the figure or ii) supply a replacement figure that complies with the CC
BY 4.0 license. Please check copyright information on all replacement figures
and update the figure caption with source information. If applicable, please
specify in the figure caption text when a figure is similar but not identical to
the original image and is therefore for illustrative purposes only.
R: The figures were generated using free access images (Public Domain or CC BY
4.0 licence) and references to their sources are included in the revised figure
captions. We provide more information about the individual licences below:
● PhyloPic (<http://phylopic.org/>)
5\. Please include captions for your Supporting Information files at the end of
your manuscript, and update any in-text citations to match accordingly. Please
see our Supporting Information guidelines for more information:
<http://journals.plos.org/plosone/s/supporting-information>.
R: Done, captions for Supporting Information files now reported
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
Comments to the Author
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Partly
Reviewer \#2: Yes
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The PLOS Data policy requires authors to make all data underlying the findings
described in their manuscript fully available without restriction, with rare
exception (please refer to the Data Availability Statement in the manuscript PDF
file). The data should be provided as part of the manuscript or its supporting
information, or deposited to a public repository. For example, in addition to
summary statistics, the data points behind means, medians and variance measures
should be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: Overview:
The work brings a historical rescue of fishing data for one of the largest
production regions at national level (Santa Catarina). Although the approach
does not bring methodological novelties, the work is relevant considering the
scarcity/fragmentation of information at the local/national level.
The work is well structured, however, below are some suggestions to mitigate the
bias related to the search for information in newspapers. I believe that authors
should look for ways to compare these historical records with official fishing
statistics existing at the regional level. In this way, it will be possible to
assess whether, in this specific study, newspaper records reflect (or not)
official statistics, at least for the most recent periods (20th and 21st
centuries).
R: We thank the reviewer \#1 for his/her/their suggestion. We want to highlight
that the emphasis of our paper is on the perception of mass media on marine
biodiversity changes, for this reason, we believe that attempts to validate data
from newspapers (and derivatives) with independent landing records may risk to
open more questions than answers, and the nature of these questions may remain
largely contentious. Moreover, official fishing statistics could also carry
other analytical and statistical biases complex to resolve, as exemplified by
Freire et at \[1,2\]. However, following suggestions by the Reviewer \#1 we have
now compared our Inv/Fis index with the estimated index from reconstructed and
officially reported industrial and artisanal catch data (volume in tons) for
Santa Catarina from 1950 to 2015 \[1\] (see lines 184 to 186, page 6). We have
revised the text which now reads (lines 474 to 488, page 15): “Significantly,
long-term catch reconstructions for the coast of Santa Catarina show a similar
trend in Inv/Fis, with catches of invertebrates increasing in the 1970’s and
1980’s, although this is followed by a downtrend in more recent decades \[1\].
This possibly reflects fiscal incentives provided to the fisheries by SUDEPE
from 1967 onwards, along with fishing agreements between Brazil, Uruguay and
Argentina, and the increased investment in shrimp and mollusc aquaculture
\[3–6\]. For example, between 1966 and 1972 the number of fishing vessels
employed in the catch of pink shrimp (Farfantepenaeus sp.) in Rio Grande (Rio
Grande do Sul) increased from 80 to 396\[4\]. In Santa Catarina shrimps were
intensively exploited between 1970 and 1990 to the extent that coastal stocks
declined considerably (A Ponta, July 1993,\[5\]). Moreover, increased market
opportunities and public investment for farming of molluscs (e.g. mussels,
oysters) and crustaceans (e.g. prawn and shrimps) accelerated production from
the second half of the 20th century, and notably from the late 1980s\[6,7\]
onward, which may explain their increased popularity in public media.
Methods:
Page 5, Lines 131-132: It is necessary to indicate which were the keywords used
for the search of all the resources (fish, crustaceans, molluscs, mammals,
reptiles), since the results show several resources and not just 'fish'.
R: The keywords used are those presented in the original text (lines 131 and
132, page 5 of the original manuscript): “pesca” (fishing) and "peixe" (fish).
We have added the following texts to clarify the importance of these two
keywords:
Material and Methods (Lines 141 to 151, page 5)
“The keywords “pesca” (fishing) and "peixe" (fish) were chosen for the following
reasons: i) The keyword “pesca” captured several types of marine resources, and
also captured the word "pescado" which categorically addresses different types
of resources exploited by fisheries; ii) within Brazilian folk taxonomy
(ethnotaxonomy), various marine animals ("pescado") are classified as
“fish”\[8,9\]; iii) the popular association of fish such as shrimp, lobster,
oysters, octopus and squid with crustaceans and molluscs is something very
recent and thus this nomenclature is infrequently used in everyday life; iv)
given the large diversity of organisms captured by coastal fisheries in Brazil
and the general scope of the paper (not targeting a specific species), it would
be unfeasible to extend the keywords to all potential captured organisms.”
Results (Lines 215 to 217, page 7)
“The keywords “pesca” (fishing) and "peixe" (fish) captured animals from
different taxonomic groups (fish, crustaceans, molluscs, mammals, reptiles),
which is significant since in folk taxonomy several taxa are also considered as
“fish”.”
P 6, L 141-143: Please include how the search was performed on this platform
(keywords, etc.).
R: The method is reported in detail in Galardo et al. \[10\], and succinctly
described in the Material and Methods. We have now expanded it to clarify the
steps and process, please see lines 131 to 169 (Pages 5 and 6).
P 6, L 165-167: Did you use the ratio between abundance, catch weight
(landings)? Make it more clear to the reader.
R: We used the absolute abundance of species per decade. The sentence has been
revised for clarification. Now it's reads (lines 176 to 179, page 6):
“In addition, we computed fish-based piscivores/planktivores (Pis/Pla)\[11\] and
invertebrates/fish (Inv/Fis) to explore changes in overall catch composition
through time. For this we used the absolute abundance of species reported in
newspapers per decade.”
Results:
P 11, L 272-273: This result may be related to the projects that promoted the
implementation of the industrial productive segment of shrimp in Santa Catarina
in the 1970s (e.g., SUDEPE). In addition to projects aimed at growing mangrove
oysters in association with shrimp in the 1980s. In this way, there is a need
for a greater deepening in the discussion about public policies directed to the
productive sector that promoted the cultivation of these aquatic organisms,
bearing in mind that this may influence the publicity of journalistic articles
on the subject.
R: Yes, we agree and have now expanded the argument in the discussion, see
please lines 477 to 488, page 15.
The impact of public policies, as well as of evolving ideological and economic
agendas on the quality and number of news is acknowledged in lines 459 and 464
(page 17 original version). We have expanded the argument (lines 507 to 515,
page 16):
“Our study reinforces the value of historical newspapers in providing insightful
information on long-term species composition, perceived abundance and the
drivers of change in marine biodiversity in Brazil. However, contrary to other
records such as official landing statistics, species composition in newspapers
reflect distinct socio-ecological contexts, spanning from production to
consumption systems, as well as considerations on the cultural and ecological
values of some species, which are subject to evolving political, ideological and
economic agendas, notably in social contexts with high levels of illiteracy as
was the case in the late 19th and early 20th centuries in Brazil\[12–14\].”
Discussion:
P 15, L 397-421: This paragraph is outside the scope of the study, as it
provides an overview of fishing at the national level, while the study focuses
on the regional level (Santa Catarina). Is the pattern described at the national
level also observed at the regional level? I suggest that this paragraph be
revised according to the purpose of the study.
R: We disagree with the Reviewer \#1. The evidence discussed in this paragraph
is highly relevant and within the scope of the paper. It enabled us to scale up
our showcase (Santa Catarina) with the widespread ecological effects of
increased fishing effort in Brazil. In the discussion, by considering the
results of the reports from the Ministry of Agriculture (responsible for
fisheries management in Brazil during the analysed timeframe), we enlarge the
context of fishing to national and international levels, which is also crucial
for tracking the development of fishing in Santa Catarina. We have slightly
modified the text to emphasise its relevance and now it reads (lines 534 to 537,
page 14):
“Newspaper evidence of fishing intensification in the early 20th century is
largely corroborated by the official reports of the Ministry of Agriculture,
which enable linking the study region discussed here (Santa Catarina) with the
widespread ecological effects of historical fishing subsidies.”
P 16, L 433-435: this may be related to what was pointed out above (see comment
in Results section).
R: Thanks, the comment has been addressed above.
P 17, L 451-452: Is this trend also observed in Santa Catarina?
R: Yes, this references mentioned analysis and trend of Santa Catarina.
P 18, L 505-506: As the authors themselves recognize above, the records obtained
from newspapers can suffer from several biases. One possibility of mitigating
this bias and verifying whether newspaper records actually reflect catches is
through cross-analysis with historical sources of fisheries statistics. I agree
that statistical records are incomplete, fragmented and scattered, but it is
possible to use some official data sources that can serve to assess general
trends. For example, it is possible to use ICMBio/CEPSUL records
(<https://www.icmbio.gov.br/cepsul/biblioteca/acervo-
digital/38-download/artigos-cientificos/112-artigos-cientificos.html>), IBGE
(<https://biblioteca.ibge.gov.br/biblioteca-
catalogo.html?id=7132&view=detalhes>) and IBAMA (<https://www.gov.br/ibama/pt-
br/assuntos/biodiversidade/biodiversidade-aquatica/gestao-da-biodiversidade-
aquatica/estatistica-pesqueira>). I believe it might be possible to check the
general trend between invertebrates/fishes with this database. Thus, we can
assess whether the methodology used in the work reflects (at least partially)
the official statistics (albeit fragmented).
R: Done, comparison of Inv/Fis was performed with data published in Freire et
al. \[1\] that includes data of different sources. See previous comments
Figure 3A,B: include in the legend the meaning of the colors present in the
figure (A, B). There are two axes but three colors.
R: Done, colours made clear now.
Reviewer \#2: This is an interesting paper that is scientifically sound. My
comments are minor and mostly relate to clarifying parts of the text to ensure
accurate interpretation of methods and results by readers.
L43: ‘…while ensuring fundamental ecosystem functions, structures and services’
Please provide a reference for this.
R: Done!
L50: ‘This sort of historical amnesia creates misconceptions…’ This sentence is
very long. Suggest splitting up to improve readability.
R: Done, it now reads (lines 49 to 55 page 2):
“This form of historical amnesia creates misconceptions that have far-reaching
consequences for sustainability and conservation actions. For example, it may
conceivably increase tolerance for progressive environmental degradation and
contribute to setting inappropriate sustainability targets and responses by
ocean stakeholders; and hence underpin their expectations as to what is a
desirable and achievable state of social-ecological systems\[15–17\].”
L107: ‘…scrutinised more than twenty thousand digitised editions in the
Brazilian Digital Newspapers and Periodicals Library (Hemeroteca Digital
Brasileira)’. What do you mean by ‘scrutinised’? If you did not examine all of
these (rather, you conducted key-word searches via OCR across this number of
newspapers) this phrasing is rather misinformative.
R: The search via OCR with the keywords "pesca" and "fish" found 9,190 and
14,168 matches respectively (see in the results), in other words, more than
twenty thousand digitised editions (newspaper reports) were accessed with these
keywords. Scrutinised means that we examined closely and thoroughly all the news
items.
Fig 1 Legend: The coloured dots should be labelled as \>1 – 10 reports, \>10 –
20 reports… \>30 – 200 reports etc for greater clarity.
Also, ‘The colour gradient of the localities represents the number of reports
IDENTIFIED per municipality’.
R: Thank you for your suggestion! Done!
L133: what dates did you undertake data collection? You mention dates in the
results section but it is not clear if these were dates of collection – this is
important to know given that more newspaper articles/editions are being uploaded
to digital collections all the time.
R: From March 2021 to March 2022. This information has now been added to the
text (Lines 196 to 197, page 6)
Given you identified animals from articles initially located by keywords fishing
and fish, how likely is it that you’ve missed accounts of species that were
gathered or cultured, or otherwise exploited/identified using alternative words
to ‘fishing’ or ‘fish’?
R: It is possible that we could have had a more extensive database. However,
within a long list of complementary and/or alternative keywords, the use of two
generic keywords (fishing and fish) that can be applicable elsewhere covered a
broad range of marine organisms.
L159: Suggest ‘Species richness REPORTED by decade’ for clarity
R: Done!
L184: Suggest restructuring of this paragraph as it initially reads that you
individually screened the \>20,000 articles, rather than identify the ca. 1200
from SC which were then individually screened. Regarding the 4.7% of the total
newspapers you mention, were the 95.3% of papers available from the SC region
but that did not get identified from the OCR searches (i.e. did not mention
fishing or fish)? In general, this paragraph is unclear.
R: The text has been revised for clarity. About the other 95.3% of newspapers
available from SC did not meet the inclusion criteria, namely i) the items
focused on coastal and ocean areas, including estuaries and coastal lagoons, or
coastal rivers; and ii) the items reported marine animals (e.g. fish,
crustaceans, molluscs, mammals, reptiles), including non-native taxa
(Supplementary Information 1, SI1).
L198: I.e. ‘(v = 203, s = 107)’: Do you mean that a total of 310 species were
identified, or are these two numbers not additive? Same question for the other
numbers that follow.
R: These are two independent classifications, therefore they are not additive.
We have amended the text for clarification, and now it reads (lines 215 to 227,
pages 7 and 8):
“The keywords “pesca” (fishing) and "peixe" (fish) captured animals from
different taxonomic groups (fish, crustaceans, molluscs, mammals, reptiles),
which is significant since in folk taxonomy several taxa are also considered as
“fish”. Native and non-native animals were mostly reported as vernacular (v)
and, to a lesser extent, as scientific (s) names, the latter sporadically
appearing in more recent decades. We found 1655 mentions of marine animals,
totaling 277 and 203 vernacular and scientific taxa respectively (SI2). As
reported by Feire and Pauly\[18\], we also found evidence that a single folk
nomenclature was used for several species (e.g. Hypanus sp., Dasyatis sp.,
Fontitrygon sp., Bathytoshia sp. = raia prego), and several folk nomenclatures
were also used for a single species (e.g. Mugil liza = tainha, tainhota,
tanhota, do corso, facão, tainha-assú). As a consequence, attempts to correlate
scientific and vernacular names were complex and not always possible with an
equal level of confidence.”
L199: ‘frequency (n = 1,041)’: Do you mean frequency of mentions?
R: We have amended it for “abundance”. In Material and Methods it now reads
(lines 164 to 169, page 5):
“The catalogued animals and gear were quantified for their absolute and relative
abundances (the number of times a species or type of gear occurred in a given
number of newspaper items) and richness (the number of different species and
gear types in a given number of newspaper items) aggregated per decade. If
species X was reported more than once in a single item, its abundance in the
given item was counted as one.”
L234: ‘The number of items reporting marine animals using the keywords fishing
(n = 269) and fish (n = 329) were significantly positively correlated with the
number of newspapers (fishing r = 0.61; R2 = 0.37; p \< 0.005; fish r = 0.52; R2
= 0.27; p \< 0.02)’ Can you explain this more clearly? Are you referring to the
total number of newspapers available (i.e. published online) in the region, or
those identified through OCR searches as containing the words ‘fishing’ or
‘fish’? This is clarified somewhat by the legend in Fig 3 but it needs to be
clear in the text, too.
R: Thanks, the sentence has been amended. Now it reads (lines 265 to 274, page
9):
“The number of items reporting marine animals using the keywords “pesca”
(fishing) (n = 269) and "peixe" (fish) (n = 329) were significantly positively
correlated with the number of newspapers for Santa Catarina available in the HDB
archives (pesca r = 0.61; R2 = 0.37; p \< 0.005; peixe r = 0.52; R2 = 0.27; p \<
0.02), a pattern also observed by Gallardo et al.\[10\] (Figure 3A-B).
Similarly, species richness and their abundances were also significantly
positively correlated with the number of newspapers (species richness, r = 0.73;
R2 = 0.53; p \< 0.001, frequency, r = 0.68; R2 = 0.46; p \< 0.001) in Santa
Catarina (Figure 3C-D), indicating that, in absolute terms, our data is affected
by the amount of digitised newspapers available in the HDB database.”
Fig. 3A and 3B – there are three colours in this panel figure, the black I
assume correlates to the black text on the y axis descriptor (fig 3a), but there
are also two red block colours in this figure and I am now sure how these align
with B and the red text on the secondary y axis (#items). If these are
aggregated per the legend description, why two red colours? Also, what does
‘items’ mean? Is this referring to individual articles within a newspaper
edition?
R: There were only two variables, but the transparency in the plot created a
third colour. The figure has been amended. “Items” refer to “articles, opinion
letters, regulations and sanctions”, see lines 136 (page 5). We revised the
figure caption for clarity.
Fig. 3C-E – there seems to be very little difference between absolute species
counts and species richness. It may be worth briefly repeating in the text (or
legend description) the difference between these two measures, as it gets a bit
confusing when examining the figure.
R: Their trends are similar but the numbers are different (please see their
respective y-axes). However we noticed that we had switched the labels, which
have now been corrected.
In general, the way your results are written it reads as absolute species
richness or species numbers, when actually it is richness or numbers reported in
newspapers. I think this needs to be stated more clearly throughout the results.
I.e., L256: By contrast, the richness and frequency of invertebrates REPORTED
increased… L263: The WATL shows the prevalence of high trophic level species
REPORTED over the last 180 years… L287: The diversity and frequency of fishing
gear REPORTED did not change…
R: Yes, but it is implicit that these refer to reported species and gear in
newspapers, not in absolute terms. However, for clarity we have revised the
terminology through the text and in the Figure 3D-E. Absolute (relative)
frequency has been replaced with absolute (relative) abundance (the amount of a
species/gear in newspaper items aggregated per decade)
L466: you state the potential for newspapers to uncover species composition,
better to clarify here that it is composition of fishery catch and/or landings?
This of course reflects to some extent underlying ecological composition, but
acknowledges the influences of social (in terms of what is reported) and market
forces and technological trends (in terms of what is caught) on newspaper
reporting.
R: The text has been revised to address this particular comment and now it reads
(lines 509 to 515, page 16):
“However, contrary to other records such as official landing statistics, species
composition in newspapers reflect distinct socio-ecological contexts, spanning
from production to consumption systems, as well as considerations on the
cultural and ecological values of some species, which are subject to evolving
political, ideological and economic agendas, notably in social contexts with
high levels of illiteracy as was the case in the late 19th and early 20th
centuries in Brazil\[12–14\].”
L473: misspelling of ‘unsustainable’.
R: Thanks!
L482: The relevance of this paragraph on LEK to the wider paper is unclear and
it doesn’t tie in overly well. The historical context of conflicts you mention
regarding LEK will undoubtedly also play out in popular media, it being a window
into past cultures. But I’m not sure if you’re mentioning this to say that this
is indeed the case with newspapers or to say that historical newspaper sources
can mitigate this issue?
R: Thanks. The sentence has been revised for clarification. Our point here is
about understanding how LEK are formed through time. The sentence now reads
(lines 535 to 542, pages 17):
“Newspapers provide valuable insights into the changing nature of long-term
human interaction with marine biodiversity, helping to track the origin and
evolution of Traditional Ecological Knowledge. This knowledge plays a
fundamental role in fisheries management\[19\], biological conservation\[20,21\]
and coastal livelihoods\[22–24\], and newspapers reveal that it developed in a
historical context of conflicts with institutions and political and economic
actors, who often associated local fishers with backwardness, poverty, and
destitution, and attributed the richness of their fishing practices with
detrimental impacts and economic underdevelopment\[10\].”
L485. Your definition of LEK seems more akin to traditional ecological knowledge
in terms of intergenerational transmission. While I am aware that TEK can be
defined as a form of LEK, I think this needs to be clarified.
R: Yes, it is on ecological knowledge that is transmitted through generations.
We have replaced LEK for TEK.
References
1\. Freire KMF, Almeida Z da S de, Amador JRET, Aragão JA, Araújo AR da R,
Ávila-da-Silva AO, et al. Reconstruction of Marine Commercial Landings for the
Brazilian Industrial and Artisanal Fisheries From 1950 to 2015. Frontiers in
Marine Science. 2021;8: 946.
2\. Freire KMF, Aragão JAN, Araújo ARR, Ávila-da-Silva AO, Bispo MCS, Velasco G,
et al. Reconstruction of catch statistics for Brazilian marine waters
(1950-2010). University of British Columbia. Fisheries Centre; 2015. Report No.:
23 (4). doi:10.14288/1.0354313
3\. Abdallah PR, Sumaila UR. An historical account of Brazilian public policy on
fisheries subsidies. Mar Policy. 2007;31: 444–450.
4\. Reis EG, D’Incao F. The present status of artisanal fisheries of extreme
Southern Brazil: an effort towards community-based management. Ocean Coast
Manag. 2000;43: 585–595.
5\. D’Incao F, Valentini H, Rodrigues LF. Avaliação da pesca de camarões nas
regiões Sudeste e Sul do Brasil (1965-1999). 2002. Available:
<http://repositorio.furg.br/handle/1/5716>
6\. Lopes PFM. Extracted and farmed shrimp fisheries in Brazil: economic,
environmental and social consequences of exploitation. Environ Dev
Sustainability. 2008;10: 639.
7\. Valenti WC, Barros HP, Moraes-Valenti P, Bueno GW, Cavalli RO. Aquaculture
in Brazil: past, present and future. Aquaculture Reports. 2021;19: 100611.
8\. Souza SP, Begossi A. Whales, dolphins or fishes? The ethnotaxonomy of
cetaceans in São Sebastião, Brazil. J Ethnobiol Ethnomed. 2007;3: 9.
9\. Previero M, Minte-Vera CV, Moura RL de. Fisheries monitoring in Babel: fish
ethnotaxonomy in a hotspot of common names. Neotrop Ichthyol. 2013;11: 467–476.
10\. Sandoval Gallardo S, Fossile T, Herbst DF, Begossi A, Silva LG, Colonese
AC. 150 years of anthropogenic impact on coastal and ocean ecosystems in Brazil
revealed by historical newspapers. Ocean Coast Manag. 2021;209: 105662.
11\. Caddy JF, Garibaldi L. Apparent changes in the trophic composition of world
marine harvests: the perspective from the FAO capture database. Ocean Coast
Manag. 2000;43: 615–655.
12\. Pallares-Burke MLG. A imprensa periódica como uma empresa educativa no
século XIX. Cadernos De Pesquisa. 2013;104: 144–161.
13\. Oliveira RS. A relação entre a história e a imprensa, breve história da
imprensa e as origens da imprensa no Brasil (1808-1930). Historiæ. 2011;2:
125–142.
14\. Marchelli PS. As minorias alfabetizadas no final do período colonial e sua
transição para o império: um estudo sobre a história social e educação no
Brasil. EU. 2006;10: 187–200.
15\. Soga M, Gaston KJ. Shifting baseline syndrome: causes, consequences, and
implications. Front Ecol Environ. 2018;16: 222–230.
16\. Fulton EA, Sainsbury K, Noranarttragoon P, Leadbitter D, Staples DJ,
Porobic J, et al. Shifting baselines and deciding on the desirable form of
multispecies maximum sustainable yield. ICES J Mar Sci. 2022 \[cited 27 Sep
2022\]. doi:10.1093/icesjms/fsac150
17\. Campbell L, Gray N, Hazen E, Shackeroff J. Beyond Baselines: Rethinking
Priorities for Ocean Conservation. Ecol Soc. 2009;14.
doi:10.5751/ES-02774-140114
18\. Freire KMF, Pauly D. RICHNESS OF COMMON NAMES OF BRAZILIAN MARINE FISHES
AND ITS EFFECT ON CATCH STATISTICS. Journal of Ethnobiology. 2005;25: 279–296.
19\. Tietze U. Technical and socio-economic characteristics of small-scale
coastal fishing communities and opportunities for poverty alleviation and
empowerment. FAO Fisheries and Aquaculture Circular; Rome N.o C.
search.[proquest.com](http://proquest.com); 2016. pp. 1–88. Available:
<https://search.proquest.com/openview/72e02c4d532ae5760e1481415b405b1b/1?pq-
origsite=gscholar&cbl=237324>
20\. Reyes-García V, Fernández-Llamazares Á, Aumeeruddy-Thomas Y, Benyei P,
Bussmann RW, Diamond SK, et al. Recognizing Indigenous peoples’ and local
communities' rights and agency in the post-2020 Biodiversity Agenda. Ambio.
2022;51: 84–92.
21\. Begossi A. Temporal Stability in Fishing Spots: Conservation and Co-
Management in Brazilian Artisanal Coastal Fisheries. Ecol Soc. 2006;11.
doi:10.5751/ES-01380-110105
22\. Begossi A. Cultural and ecological resilience among caiçaras of the
Atlantic Forest coast and caboclos of the Amazon. Linking social and ecological
systems for resilience and sustainability The Beijer International Institute of
Ecological Economics, Stockholm. 1998; 129–157.
23\. Diegues ACS. Pescadores, camponeses e trabalhadores do mar. Editora Ática;
1983.
24\. Diegues AC. A pesca construindo sociedades. NUPAUB-USP; 2004.
10.1371/journal.pone.0284024.r003
Decision Letter 1
MacKenzie
Brian R.
Academic Editor
2023
Brian R. MacKenzie
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
23 Mar 2023
180 years of marine animal diversity as perceived by public media in southern
Brazil
PONE-D-22-32178R1
Dear Dr. Herbst,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Brian R. MacKenzie, Ph. D.
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Reviewers' comments:
10.1371/journal.pone.0284024.r004
Acceptance letter
MacKenzie
Brian R.
Academic Editor
2023
Brian R. MacKenzie
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
21 Jun 2023
PONE-D-22-32178R1
180 years of marine animal diversity as perceived by public media in southern
Brazil
Dear Dr. Herbst:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Prof. Dr. Brian R. MacKenzie
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Since their identification eukaryotic Transposable Elements (TEs) developed into
an important field of genetic and genomics investigation. Nevertheless, recent
advances in sequencing technologies offer a unique and somewhat unappreciated
opportunity to increase our understanding of several aspects of the TEs biology,
e.g. structure, evolution and regulation (see for a review). Besides their
detrimental role as an endogenous source of mutations, TEs transposition and
accumulation serve as an evolutionary substrate for genes and genomes evolution.
Indeed, inactive TEs play a significant role in macroevolution, contributing in
chromosomal rearrangements or being recruited to evolve novel functions. In
addition, defective elements and ancient relics of autonomous copies are quite
informative to trace the evolution of single TEs families.
The *Tc1-mariner* constitutes one out of 17 super-families of the class II
transposons. *Tc1-mariner* elements are widespread among all life kingdoms and
their diffusion is mainly due to their simple transposition mechanism, and their
proposed ability for cross-species diffusion by horizontal transfer mechanisms.
The *Bari* family of transposons belongs to the *Tc1-mariner* superfamily and
*Bari*-like elements have been identified in several species of the Drosophila
genus. Based on their structural and evolutionary features *Bari*-like elements
fall into three distinct subfamilies, *Bari1*, *Bari2* and *Bari3* after the
founder elements discovered in *D*. *melanogaster*, *D*. *erecta* and *D*.
*mojavensis* respectively. The *Bari1* and *Bari3* subfamilies contain
autonomous elements able to perform transposition due to the presence of
Terminal Inverted Repeats (TIRs) sequences surrounding a central sequence
encoding a functional transposase. On the other hand, *Bari2*-type elements are
non-autonomous due to the accumulation of inactivating mutations. Besides the
functional criterion, *Bari* elements can be classified standing to the
structural differences of the terminal sequences. *Bari1*-type elements harbor
short TIRs, usually 28 nucleotides long, called Short Inverted Repeats (SIR)
while *Bari2* and *Bari3* possess Long terminal Inverted Repeats (LIR), roughly
250 nucleotides long. Interestingly, non-autonomous *Bari1* elements possessing
LIRs have been described in *D*. *ananassae*, a species of the melanogaster
group, suggesting that the ancestor of the *Bari1* subfamily had LIRs that were
lost during *Bari1* evolution. Regardless their length, both SIR- and LIR-
containing elements share three highly similar 18 nucleotides long domains,
called Direct Repeats (DRs). DRs are found within the 250 terminal
nucleotides at both ends and are responsible for the transposon-transposase
interaction, a crucial step in the transposition event. Such interaction has
been previously demonstrated for *Bari1* and *Bari3*.
An interesting genomic feature of the *Bari1* subfamily is the presence of a
heterochromatic array in the *D*. *melanogaster* species. It was known from
previous studies that at least two distinct clusters exist in the reference
genome of *D*. *melanogaster*. The first cluster maps to the h39 region, a
cytological band adjacent to the centromere of the second chromosome of *D*.
*melanogaster*, the same cytological band where the *Responder* satellite maps.
It contains several tens of *Bari1* copies and is interrupted by a MAX
insertion. The second cluster contains few copies and had uncertain
heterochromatic map location. Heterochromatic *Bari1*-*Bari1* junctions (Right
TIR-Left TIR) are characterized by the deletion of the first two nucleotides
(CA) in the left terminus of each element. The terminal copies of both clusters
have been also previously characterized thus helping in the reconstruction of
their origin.
Genome-scale comparison studies are an important tool for both understanding the
forces that shaped modern forms of transposable elements, and highlight non-
mendelian modes of transposons’ transmission. Early investigations on
*Bari*-like transposable elements at the genomic level were essentially
performed in 12 Drosophila sequenced genomes available at that time. The
availability of 11 additional Drosophila genome draft sequences together with
the availability of new assembly releases and data from re-sequencing projects
prompted us to investigate the genomic distribution of the *Bari* transposon
family in a wider pool of studied and unexplored genomes.
In this study, we performed an extensive annotation of the *Bari*-like elements
in 23 Drosophila genomes analyzed, and uncovered additional structural
variability as compared to previous analyses. In addition, we disclosed the
presence of MITE-like forms of the *Bari* transposons in 7 Drosophila species
including, interestingly, species apparently devoid of full-length *Bari*
elements. Analyses of the integration site of *Bari* elements revealed a
preference for AT-rich sequences in which the TA target is duplicated upon
integration. Furthermore, annotation of unrelated TEs insertions in the
proximity of *Bari* elements revealed significant co-occurrence of other
*Tc1-mariner* elements while class I TEs avoid these regions. Finally, we
propose that incongruences revealed by our phylogenetic analyses could be
explained by horizontal transfer events. Taken together our results
significantly increase our understanding of the evolution of *Bari* elements.
# Materials and Methods
## Bari transposon search strategy and sequence analyses
Searches for *Bari* homologous elements were carried out in Drosophila species
listed in. A BLAST strategy was applied to identify of *Bari*-like elements at
the NCBI WGS (Whole Genome Shotgun) database
(<http://www.ncbi.nlm.nih.gov/genbank/wgs/>) or at the FlyBase database. Query
sequences for tBLASTn searches were either the *Bari1* or *Bari3* transposases
(GenBank CAA47913 and conceptual translation of GenBank accession CH933806
position 6274049–6275068 respectively). Queries for BLASTn searches were
performed using either the whole DNA sequence or the 250 terminal nucleotides
containing the three DR sequences of *Bari1* or *Bari3*. All BLAST analyses were
performed using the default parameters. Subject sequences from tBLASTn searches
with E \< 10<sup>−120</sup> and similarity greater than 75% over the whole
transposase length (339 amino acids), were further analyzed. The threshold
E-value was set to higher values in BLASTn searches aimed at MITEs
identification (E \>10<sup>−20</sup>).
Two criteria were used to identify full-length *Bari*-like elements; 1) the
detection of a high-scoring subject sequence by tBLASTn search, using either the
*Bari1* or the *Bari3* transposase protein as query sequence; 2) the presence of
homologous DRs in the terminal sequences, surrounding the coding region of the
elements. Terminal inverted repeats and homologous DRs in the transposon’s
termini were identified by a combined analysis using the Dot Plot matrix
analyses implemented in the DNA Strider package software, the Einverted software
(<http://embossbioinformaticsnl/cgi-bin/emboss/einverted>) and by multiple
sequence alignment of terminal ends of *Bari*-like elements as previously
described.
Elements’ names were assigned according to the binary nomenclature used in
Repbase, consisting of the subfamily identifier (either *Bari1*, *Bari2 or
Bari3*) followed by the species identifier (i.e. the first letter of the genus
and three letters of the species name to avoid ambiguity for some species).
Similarly, MITE’s elements names look like Bari_Dxyz_MITE-# (where “xyz” is a
three-letters species identifier) followed by a number (#) to distinguish
different MITEs subfamilies, where necessary.
Once a novel full-length element was identified, it was used to identify other
full-length copies as well as truncated elements, by BLASTn analyses against
species-specific WGS database. Each copy was then carefully annotated.
Additional BLASTn searches were performed using as query the *mel-ER*
(consensus), the *sim-ER* and the *sec-ER* elements (here named *Bari2_Dmel*,
*Bari2_Dsim* and *Bari2_Dsec* in the text) described in, three *Bari2*-type
elements in the genomes of *D*. *melanogaster*, *D*. *simulans*, and *D*.
*sechellia* respectively. Redundancy can be excluded for all elements except for
split elements, i.e. sequences overlapping either the beginning or the end of a
genomic scaffold in which they have been identified. These sequences have been
annotated as “partial” elements in and were counted as elements. No further
analysis was performed using partial elements. Redundant elements were removed
on the basis of the flanking sequences comparison. Global alignments were
performed using LALIGN (<http://wwwchembnetorg/software/LALIGN_formhtml>). The
Open Reading Frames (ORFs) were inferred using ORF Finder
(<http://wwwncbinlmnihgov/gorf/gorfhtml>) or using a custom script (available
upon request) written in Biopython (version 1.63). The similarity with
previously reported sequences was established using CENSOR at the RepBase
database.
dS analysis was performed using the Nei and Gojobori method implemented in
MEGA5. Fisher’s exact test (one-tailed) was conducted using 2 x 2 tables to
verify if transposon dS values were statistically lower than those presented by
the host genes.
The number of base substitutions per site between sequence pairs was calculated
using MEGA 5.0. Analyses were performed using the Kimura 2-parameter model. Rate
variation among sites was modeled with a gamma distribution (shape parameter =
1). All ambiguous positions were removed for each sequence pair. The whole
transposon sequence alignment was used to perform Plotcon analyses
(<http://emboss.bioinformatics.nl/cgi-bin/emboss/help/plotcon>) by moving a
window of 100 nucleotides along the aligned sequences. Sequences marked as
“partial sequence” in were excluded from p-distance and Plotcon analyses. Data
analysis was carried out with the R System (R version 3.1.0)
([https://www.r-project.org](https://www.r-project.org/)). The non-parametric
Kruskal-Wallis test and Tukey test were used to assess significance for the
observed differences, considered significant at p values\<0.05. Hartigan dip
test was carried out to assess unimodality/multimodality of the observed
similarity values distributions.
## Insertion sites analyses
WebLogo analyses were performed in those species where it was possible to
retrieve at least four flanking sequences of equally oriented *Bari* elements. A
larger scale insertion site analysis was also performed. Regions of 2500 bp
flanking downstream and upstream the insertion sites of *Bari* elements, when
available, were analyzed with RepeatMasker-open-4.0.5
([http://www.repeatmasker.org](http://www.repeatmasker.org/)) using the
RepBase20.02 dataset. The same analysis was performed, as control, on 1000, non-
overlapping, random sequences, 2,5 kb in length, irrespective of their gene
content selected from species containing at least four *Bari* insertions, taking
care to avoid regions with internal sequencing gaps. The distance of each masked
transposon from the sequence origin (fixed at the first base flanking *Bari*
elements or to the first nucleotide of the randomly-selected scaffold) was
calculated and used to create a positions dataset. The detected distances were
then classified in 5 distance ranges from the sequence origin, considering a 500
bp cumulative increment (0–500; 0–1000; 0–1500; 0–2000 and 0–2500). Poisson
distribution has been applied to the data, given that the repeat frequency in
1000 random regions was considered as the expected value, and the frequency in
the *Bari* flanking regions as the observed value to test. Sequence accessions
and coordinates of the control dataset are reported in. Relative probability was
calculated to identify a significant association between *Bari* and the selected
repeat families.
## Multiple alignments and phylogenetic analysis
Multiple sequence alignments were performed using ClustalW2 with default
parameters. Nucleotide sequences relative either to the Coding Sequence (CDS) or
to the terminal sequences were used in the analyses of *Bari* elements. The
*Bari1_Dsim* and *Bari1_Dsec* elements were not included in the multiple
alignment of terminal sequences and transposase sequences because they are
identical in sequence to the *Bari1_Dmel* element. The *D*. *yakuba* element was
excluded from the alignment of TIR sequences because it has been re-classified
as MITE, and thus included in the MITE elements’ analysis. The BioEdit software
was used for alignment editing and visualization. Alignment slices were obtained
using the Alignment Slicer tool
(<http://www.hiv.lanl.gov/content/sequence/Slice_Align/>).
Species phylogeny was based on the alignment of nine concatenated orthologous
CDSs encoding subunits of the V-ATPase complex, for which orthologous genes
could be identified in the 23 species analyzed. FlyBase annotation symbols,
GenBank accession of mRNA and length of *D*. *melanogaster* CDSs used in this
analysis are the following: CG3762 NM_143747 (1845 bp), CG2934 NM_130724 (1054
bp), CG7071 NM_142770 (909 bp), CG34131 NM_001043279 (483 bp), CG12403
NM_001273497 (1845 bp), CG1088 NM_169073(681 bp), CG7007 NM_143753 (639 bp),
CG3161 NM_057453 (480 bp), CG6213 NM_058089 (354 bp). The jModelTest program v
2.1.7 was used to select the simplest evolutionary model that fitted
adequately the sequence data. A Bayesian Markov chain Monte Carlo (MCMC) method
implemented in BEAST package 1.8.0 was used for Bayesian analysis. The MCMC
chains were run for at least 50 million generations and, sampled every 5.000
steps. Convergence was assessed on the basis of the effective sampling size
after a10% burn-in. Phylogenetic trees were visualized and edited using FigTree
1.4.2 software (<http://treebioedacuk/software/figtree/>). Paris and S elements
were used as outgroups.
# Results
## *Bari* elements identification and their structural diversity in 23 sequenced genomes
We applied a BLAST-based search to identify insertions of *Bari*-like elements
in 23 Drosophila genomes. The evolutionary time of the species analyzed in this
work spans roughly 40 million year. We used the full-length *Bari1* and *Bari3*
transposase as query in tBLASTn analyses, and the whole transposon DNA sequences
in BLASTn analyses against the genome shotgun database or reference genomes.
Using this approach, we identified 401 *Bari*-like elements comprising full-
length copies, truncated elements and MITEs. The actual number of *Bari*
insertions annotated in the species analyzed could be slightly inflated because
we have also annotated partial sequences (53 out of 249 sequences), i.e. split
sequences overlapping either the beginning or the end of a genomic scaffold in
which they have been identified, for which we cannot exclude redundancy.
Redundancy can be instead excluded in the remaining sequences for which we
compared the flanking sequences to establish uniqueness in the dataset.
Inflation is particularly relevant in *D*. *pseudoobscura* (22/33 total
insertions) and in *D*. *miranda* (10/16 total insertions). However, inflation
could be compensated by the possible underestimation of the *Bari* copy number
due to the draft status of the genome assembly in some species. New
*Bari*-related sequences were annotated in 11 species (namely *D*. *biarmipes*,
*D*. *bipectinata*, *D*. *rhopaloa*, *D*. *takahashii*, *D*. *kikkawai*, *D*.
*eugracilis*, *D*. *ficusphila*, *D elegans*, *D*. *suzukii*, *D*. *miranda*,
and *D*. *albomicans*). For clarity purposes, data concerning full-length and
truncated elements are presented separately from data concerning MITEs. The
features of representative elements (i.e. the top scoring and the most complete
subjects after BLAST search) are summarized in, while information concerning all
the annotated insertions can be found in and Tables.
A snapshot of the distribution of *Bari* subfamilies and the presence of
potentially active elements in the species analyzed is reported in. Details
relative to individual insertions identified in this study are reported in and
Tables. The presence of *Bari*-like elements in every genome analyzed, with the
exception of *D*. *grimshawi*, confirms previous evidence on the widespread
diffusion of this transposon family in the Drosophila genus. As can be observed
in, distinct *Bari* subfamilies have colonized specific genomes, with little
subfamilies overlaps, as can be observed in the species of the melanogaster
complex (*D*. *melanogaster*, *D*. *simulans*, *D*. *sechellia*) for the *Bari1*
and *Bari2* subfamilies.
*Drosophila melanogaster* contains the highest number of *Bari*-like element
copies (84 elements annotated) mainly clustered in a specific heterochromatic
region, (best described in the next paragraph), followed by *D*. *pseudoobscura*
(33 insertions detected), while *D*. *albomicans* (1 element) virtually lacks
*Bari* elements and *D*. *grimshawii* is devoid of *Bari* elements. A
preliminary analysis of all the elements identified suggests that *Bari*-like
elements have variable length ranging from 17 bp (*D*. *melanogaster* sheet,
element \#25) to 4353 bp (*D*. *ananassae* sheet, element \#12), due to the
existence of canonical copies, truncated copies (i.e. transposon chunks and
elements overlapping the extremities of the sequence contigs) or other mobile
elements nested within *Bari* elements. The median length of all annotated
*Bari* elements is 696 bp (IQR = 1635 bp; max. length = 4353; min. length = 17).
In more details, the median length of full-length and truncated elements is 1704
bp (IQR = 593; max. length = 4353; min. length = 17), while the median length of
MITEs is 82 bp (IQR = 394; max. length = 939; min. length = 69). Considering
only those elements containing two terminal sequences (each one containing three
DRs) framing an intervening sequence, irrespective of its coding potential (134
elements) *Bari*-like elements look more homogeneous (median length = 1723 bp;
IQR =; min. length = 746 bp in *D*. *pseudoobscura*; max length = 4353 bp in
*D*. *ananassae*). The TA dinucleotide TSD, a feature of the *Tc1-mariner*
superfamily, was identified in 60 out of these 134 sequences. Twenty-four copies
of *Bari*, distributed in seven species (*D*. *melanogaster*, *D*. *simulans*,
*D*. *rhopaloa*, *D*. *persimilis*, *D*. *pseudoobscura*, *D*. *miranda* and
*D*. *mojavensis*) can be considered as autonomous elements due to the presence
of two terminal sequences (either with LIR or SIR structure) bracketing a CDS
encoding homologous *Bari* transposase.
The presence of three conserved DR sequences within the 250 terminal nucleotides
bracketing the transposase gene, typical of the *Bari* family, suggest that all
the new elements identified are *bona fide Bari*-like elements. We performed a
comparative analysis to estimate the sequence variability of *Bari* elements and
the deterioration profile both at the inter-species and intra-species level. We
calculated the pairwise distance (p-distance) relative to the left and right
terminal sequences, comprising the DRs, and to the transposase coding sequence.
At the inter-species level, no significant differences can be observed among the
CDS and the terminal sequences in the three *Bari* subfamilies, suggesting the
uniform distribution of point mutations in the three regions analyzed. However,
some differences were observed by analyzing the same elements at the intra-
species level, where the p-distance analysis was also coupled with the
determination of the degradation level of the *Bari* elements in each species.
As an example, three representative results obtained are shown in (see for
complete results). In two species (*D*. *willistoni* and *D*. *simulans*) the
p-distances at the terminal sequences are significantly different if compared to
the central region, suggesting an increased mutational load at the terminal
sequence level. In four species one of the TIRs has a significantly higher
distance if compared to the CDS (*D*. *ananassae D*. *erecta*, *D*.
*pseudoobscura*, *D*. *miranda*). In the remaining three species (*D*.
*melanogaster*, *D*. *persimilis*, *D*. *mojavensis*) no significant difference
was observed, suggesting uniform mutation pattern. The respective degradation
profiles show that truncated elements are generated in each of the analyzed
species by deletion and/or unrelated TEs nested insertions, occurring without
any obvious positional preference pattern.
A description of *Bari* elements in those genomes containing few copies, and
thus not analyzed as described above, is given below.
The genome of *D*. *takahashii* contains two inactive elements due to insertions
and deletions. The *Bari1_Dtak* element was reconstructed removing an unreported
MITE insertion (not shown). *Bari1_Dtak* includes a 912 bp-long ORF encoding a
protein that shares 81% and 72% similarity with *Bari1* and *Bari3* transposase
respectively framed by two LIRs containing 3 DRs.
The *Bari1*\_*D*.*rho* element coding sequence encodes a protein 84% similar to
the *Bari1* transposase, framed by LIR-type terminal sequences. *Bari1*-like
elements with a similar structure have been identified in the genomes of *D*.
*bipectinata*, *D*. *biarmipes*, *D*. *suzukii*, *D*. *takahashii* and
previously in *D*. *ananassae* but all them are inactive, while the
*Bari1*\_*D*.*rho* can be considered as a putatively active element (although
the presence of the very last two nucleotides in the right TIR has not been
confirmed, see also).
The *D*. *miranda Bari* element encodes a *Bari3*-like transposase (73%
similarity, see) and shows divergent terminal sequences (71.8% similarity). A
single putatively autonomous element can be found in the current genome assembly
of *D*. *miranda* along with several defective elements carrying internal
deletions.
In *D*. *albomicans* a 109 bp long fragment can be only identified on the basis
of its nucleotide similarity (75%) with the *Bari2_Dere* element (*Bari2*). This
sequence, arbitrarily assumed to be a left terminus, contains the left middle
(Lm) and left inner (Li) DRs, that can be easily recognized with multiple
alignment analysis and allow its classification in the *Bari* family, and
specifically its assignment to the *Bari2* subfamily (see last paragraph of the
section).
The putative ancestral sequence of *Bari* elements of *D*. *suzukii* and *D*.
*bipectinata* element were reconstructed from truncated elements (*Bari1_Dsuz*
element reconstructed from AWUT01004624 and AWUT01009036; *Bari1_Dbip* element
reconstructed from contigs AFFE02004473 and AFFE02005005. See for sequence
coordinates). Both the *Bari1_Dbip* and the *Bari1_Dsuz* elements are members of
the *Bari1* subfamily and possess LIR-type terminal sequences.
In *D*. *eugracilis* a low-scoring sequence contained a truncated copy of a
*Bari* element with single terminal sequences with three DRs ( and).
While in *D*. *grimshawi* we were not able to detected elements related to the
*Bari* family, in *D*. *ficusphila* and *D*. *elegans* we have identified
*Bari*-related MITEs, described in a specific paragraph. In *D*. *grimshawi* the
absence of *Bari*-like elements is possibly due to the actual absence of the
transposon or early draft status of the genome sequencing.
## New insights into the *Bari1* heterochromatic cluster in *D*. *melanogaster*
We identified 61 independent heterochromatic *Bari1* copies in heterochromatic
tandem repeat configuration. The contig JSAE01000772 contains the LTR-
retrotransposon *MAX* embedded in 20 *Bari1* copies repeated in tandem. This
observation matches with previous findings concerning the discontinuity in the
*Bari1* repeat. Two additional contigs identified in this study (ac. nos.
JSAE01000400 and JSAE01000412) contain respectively 18 and 17 *Bari1* copies in
tandem repeat configuration. These contigs map to the borders of the *Bari1*
cluster and contain terminal copies matching also identified in previous
studies. We can orient of these contigs with respect to the centromere of the
second chromosome considering that: 1) the *Responder* repeats, representing the
major satellite DNA in this heterochromatic region are abundant in the
JSAE01000412 contig (388 copies); 2) *Responder* maps proximally to the
centromere with respect to the *Bari* repeat as demonstrated by previous
studies. It can be concluded that contigs JSAE01000400 and JSAE01000412 map,
respectively, distally and proximally to the centromere of the second
chromosome.
Scaffold JSAE01000412 contains two adjacent truncated *Bari1* copies (position
169962–173070, corresponding to elements \#31 and \#32,). We hypothesized that
either inter-monomer recombination or unequal crossing over events involving
adjacent or non-adjacent copies of the cluster and occurring at short homologous
sequences, as shown in (panel A). Comparison of these two adjacent elements to
two canonical adjacent *Bari1* heterochromatic copies (i.e. containing two full-
length *Bari1* elements carrying the deletion of the fist two nucleotides)
revealed a 340 bp deletion flanked by short stretches of identical sequences
that could mediate recombination leading to the observed deletion (panel B).
The last *Bari1* copy of the cluster toward the centromere of chromosome 2
represents an additional defective *Bari1* element. This truncated copy retains
only 16 terminal nucleotides of the right TIR, previously described in. A
possible origin of the terminal copies of the h39 cluster, linked to an aberrant
activity of the transposase has been previously proposed.
The last worth-noting scaffold (JSAE01000184) contains six *Bari1* copies
arranged in a tandem repeat configuration, embedded in more than 200 kb of
repetitive DNA. RepeatMasker analyses revealed the presence of transposable
elements belonging to the R1 and the R2 class, typically inserted into rDNA
sequences as well as few unmasked sequences related to rDNA genes (at least 4
copies). As previously suggested, this short *Bari1* cluster could either map in
a distinct h39 sub-region or could be located on the X chromosome, in the region
of the nucleolar organizer region. Based on the recent findings that no rDNA
repeat nor type 1 rDNA insertions exist outside the nucleolar organizer regions
*D*. *melanogaster*, it could be concluded that the small *Bari1* cluster may be
located in the heterochromatin of the X or Y chromosomes, where the nucleolar
organizers map.
## MITE elements related to *Bari* transposons
The tBLASTn strategy described above fails in detecting *Bari* copies carrying
extensive deletions of the transposase gene, as can be observed in MITEs. Dias
and Carareto recently described two MITE elements related to *Bari1*
(*msechBari1* and *msechBari2*, hereafter *Bari_Dsec_MITE1* and
*Bari_Dsec_MITE2*) present in multiple copies in the genome of *D*. *sechellia*,
therefore, the existence of *Bari*-related MITEs in other species cannot be
excluded. To test this possibility we performed a BLASTn-based search of
*Bari*-like sequences in the species in which *Bari*-like elements were not
found on the first attempt (namely *D*. *ficusphila*, *D*. *elegans* and *D*.
*grimshawi*). The genomes of *D*. *ficusphila* and *D*. *elegans* harbor 36 and
4 *Bari*-related MITEs respectively. We, therefore, searched for *Bari*-related
MITEs in all the available sequenced Drosophila genomes. We identified and
annotated 152 copies of *Bari*-related MITEs in nine genomes, including *D*.
*sechellia*. Names were assigned according to the rule given in the Materials
and Methods section. In the genomes of *D*. *simulans*, we identified a
*Bari*-related MITE identical in sequence to *Bari_Dsec_MITE1* of *D*.
*sechellia*. However, while *Bari_Dsim_MITE* is present as single copy element
in the genome of *D*. *simulans*, more than twenty *Bari_Dsec_MITE1* copies are
found in *D*. *sechellia* ( and this study). In *D*. *melanogaster*, we
identified two *Bari*-related MITE families based on their length. The
*Bari_Dmel_MITE1* family is an 116 bp long element with nearly identical, 46 bp
long, terminal inverted repeats. The *Bari_Dmel_MITE2* family contains longer
elements (692 bp) and has 50 bp long terminal inverted repeats. *D*. *suzukii*
harbors a single family of *Bari*-related MITEs, nearly 500 bp long, sharing
high sequence similarity if compared to each other. A retrospective analysis of
the single copy element previously identified in *D*. *yakuba* led us to
conclude that it can be classified as a *Bari*-related MITE. A peculiar feature
of this MITE consists in the presence of two DR sequences in the left terminus
while all the other *Bari*-related MITEs display a single DR in each terminus.
An overall comparison of the terminal sequences of the *Bari*-related MITEs with
the terminal sequences of *Bari1_Dmel*, *Bari2_Dere* and *Bari3_Dmoj*,
representative of the *Bari1*, *Bari2* and *Bari3* subfamilies respectively, is
shown in. All the terminal sequences of *Bari*-related MITEs are very similar to
each other and share similarity with the corresponding full-length elements.
*Bari*-MITE sequences contain an intervening sequence between the two terminal
that can be either short or long but with poor sequence similarity if compared
to reference elements, suggesting that complex mechanisms might cause their
origin from master elements. Although the sequence similarity at the terminal
sequences level suggests that these MITEs belong to the *Bari* family, no
obvious ancestor can be inferred using this approach. MITEs with identical
sequence have been identified in different species (i.e. *Bari_Dsec_MITE1* and
*Bari_Dsim_MITE*) while in other cases MITEs from different species have a very
similar sequence (*Bari_Drho_MITE* and *Bari_Dtak_MITE* share 75 out of 78
nucleotides).
To investigate the mechanisms of MITEs expansion, we postulated that the
analyzed MITEs derived from the same ancestor and performed pairwise nucleotide
diversities analysis of these elements. Rogers and Harpending reported that
episodes of population growth leave a characteristic signature in the
distribution of nucleotide differences between pairs of individuals, and this
concept was used to describe the mode of amplification of MITEs in *Oryza
sativa*. We adapted this type of analysis to the *Bari*-derived MITEs and
statistically evaluated whether the wave-like form of the histograms could fit
unimodal distribution. Our data do not allow rejection of unimodality in three
species (*D*. *sechellia*, *D*. *ficusphila*, *D*. *rhopaloa*; Hartigan dip test
for unimodality: Drho p = 0,598; Dfic, p = 0,2135; Dsec, p = 0,4119) suggesting
single burst of transposition in these genomes. In the genomes of *D*. *suzukii*
and *D*. *takahashii*, a multimodal distribution of the pairwise differences
(Hartigan dip test for unimodality: Dsuz, p = 0,01805; Dtak, p = 0, 01374)
suggests that multiple rounds of MITEs transposition occurred.
## Bari-like elements and their target site selection preferences
To gain insight into the choice of integration target sites for *Bari*-like
elements, we performed flanking sequences analyses. It is well established that
*Tc1-mariner* elements integrate themselves into the TA target, which is
duplicated upon element insertion. Multiple alignment of 15 bp long sequences
encompassing the *Bari* elements insertion sites we identified, showed that this
is also true for *Bari* elements, as also highlighted by the WebLogo analyses.
Furthermore, the *Bari* transposase targets AT-rich sequences irrespective of
the *Bari* subfamily and of the host species, as can be observed in.
We further investigated the target site preferences of *Bari*-like elements on a
larger sequence scale by analyzing the sequence context in which *Bari*
transposons insert themselves.
The presence of transposable elements belonging to three LTR-retrotransposons
superfamilies (*Copia*, *Gypsy* and *PAO*), three non-LTR retrotransposons
superfamilies (*LOA*, *I* and *Jockey*), the *Tc1-mariner* superfamily and to
the *Helitron* superfamily, was annotated within a 2,5 kb long sequence flanking
upstream and/or downstream the *Bari* elements in each species analyzed. To
assess whether the observed distribution of transposable elements within the
neighborhoods of *Bari*, significantly differ from their genomic distribution in
the respective genomes, we collected 1000, non-overlapping, random sequences, of
the same length (2,5 kb), irrespective of their gene content, and recorded the
occurrence of tested TEs. This analysis was performed in genomes containing a
minimum of 4 *Bari* insertions (an arbitrarily chosen threshold), resulting in
15 investigated genomes. In these genomes, the *Bari* transposon insertions
occur in genomic loci depleted in *Copia*, *LOA* and *I* elements and enriched
in *Tc1-mariner* elements. In 5 genomes we also found a significant tight
association (within 500 bp from the *Bari* elements) with elements of the
*Jockey* and *PAO* families; however in 7 genomes, taking into account the same
sequence range, *Bari* elements insertions occur in genomic regions
significantly depleted in *Jockey* and *PAO* elements. *Gypsy*-like
retrotransposons do not display significant enrichment or depletion within the
2,5 kb range considered. *Helitron*-like elements also significantly co-occur
within 2,5 kb from *Bari* elements.
## Evolutionary analyses of *Bari* transposons
We multi-aligned the transposase-coding sequences from 16 representative *Bari*
copies and built a phylogenetic tree using Bayesian inference methods. The
phylogenetic tree created recovered three clades with significant statistical
support (left tree) and corresponding to the previously described *Bari1*,
*Bari2* and *Bari3* clades. This analysis placed the newly identified *Bari*
elements of *D*. *suzukii*, *D*. *takahashii*, *D*. *rhopaloa*, *D*.
*bipectinata*, *D*. *biarmipes*, *D*. *kikkawai* and of *D*. *eugracilis* in the
*Bari1* clade while the element of *D*. *miranda* cluster together with other
*Bari3* elements.
We also performed phylogenetic analyses based on the terminal sequences of
*Bari*-like elements. Roughly 250 nucleotides containing the three DRs from the
left terminal sequence of *Bari*-like elements were analyzed in a Bayesian tree
(right tree). The phylogenetic tree obtained displays a topology similar to that
obtained for the transposase gene-based tree, with three distinct and well-
supported clades consisting of the three *Bari* subfamilies.
A careful inspection of the transposase-based phylogenetic tree revealed an
inconsistency in a well-supported *Bari1* sub-clade if compared to the phylogeny
of species. The *Bari1_Dbia* and *Bari1_Dbip* elements are indeed very close to
each other in the transposase tree, while their respective host species, *D*.
*biarmipes* and *D*. *bipectinata*, are more distantly related, being members of
the suzukii and ananassae subgroups respectively. These elements share high
sequence similarity and are part of a highly supported clade in the tree. In
order to discern if the incongruences observed in the phylogeny of *Bari*-like
elements and host species were due to vertical transmission or horizontal
transfer, the divergence at synonymous sites (dS), taken as a measure of neutral
evolution in the absence of a strong codon usage bias, was compared between TEs
and *Adh* or *Gapdh1* genes of the two species. Fisher exact test-based
comparisons were performed to verify whether the dS of the *Bari*-like elements
was significantly lower than the dS of nuclear genes. The dS of *Bari* elements
(0,0603) was significantly different (p\<0,005) if compared to dS of *Adh*
(0,3281) or *Gapdh1* (0,4006) genes in these species, supporting the hypothesis
of horizontal transfer of *Bari*-like elements between these species.
# Discussion
This work aimed to identify *Bari* transposon insertions in the sequenced
Drosophila genomes, a step forward in the annotation of the complete set of TEs
insertions in these genomes. We have annotated 401 copies ( and Tables) of
*Bari*-like transposon in the genomes of 22 Drosophila species out of 23
available sequenced genomes. Although this data may seem as an overestimation of
the actual number of *Bari* elements in the analyzed species, we expect that
elements being missed due to the early draft status of some genome assembly
(especially in the heterochromatin) would somewhat compensate any number
discrepancies. Importantly, Southern blot experiments testing the genomic
distribution of *Bari* elements in some of the genomes analyzed in this work are
in substantial agreement with our sequence analyses, suggesting that *Bari* is
present in low copy number in these genomes and that *D*. *melanogaster* is the
only species (among those studied) containing heterochromatic clusters.
This work provided a number of novel insights into the biology of the *Bari*
transposon’s family:
1. high sequence variability of the terminal sequences coupled with high
conservation of the DRs and wide diffusion in the Drosophila species’
genomes.
2. MITE-like forms of this transposon, arising occasionally during the
species evolution.
3. strong target site preference for AT-rich DNA regions, which is also the
case for other Tc1-mariner elements, that are instead avoided by class I
transposable elements.
4. occasional horizontal transfer events involving *Bari*-like elements.
## Bari structural diversity
Transposons structural diversity is an obvious evolutionary phenomenon if large
families or super-families of mobile elements are taken into account. However,
the emergence of structural variants can also be detected in small transposons’
families, such as the *Bari* family.
The dynamic processes leading to TEs replication, amplification, degradation and
elimination from a given genome are difficult to be elucidated. However the
graphic representation of the deterioration pattern of TEs proposed by Fernandez
Medina et al., can be used to shed light into this task. Our results suggest
that *Bari* elements have undergone deterioration in different ways depending on
the host genome. Point mutations and indels probably weighted differently in
producing non-functional *Bari* copies during evolution, because mutations in
the terminal sequences are more tolerated if compared to the coding sequence.
Despite some degree of diversification observed at the terminal sequence level,
a strong conservation of the DR sequences in all elements’ subfamilies from all
species, including those containing only MITEs suggests that these sequences may
have acquired a potential role during the evolution. The observed differences in
the p-values of the terminal sequences can be ascribed either to the
transposition activity of *Bari* elements or to the presence of functional
elements in the terminal sequences. For example *D*. *mojavensis* contains 8
potentially active and 7 inactive *Bari3*-like elements and a median p-distance
value of 0 for both terminal sequences, while *D*. *miranda* contains 1
potentially active and 4 inactive *Bari3* elements and a median p-distance
values of 0,171 and 0,06 for left and right terminal sequences respectively.
Similarly *D*. *melanogaster* contains 4 potentially active and 1 inactive
*Bari1*-type elements with a median p-distance value of 0 for both terminal
sequences while *D*. *simulans* contains two potentially active elements with a
median p-distance value of 0,01 for both terminal sequences. In conclusion, it
can be speculated that species displaying lower p-distance values host active
*Bari* elements, which produce identical copies upon transposition thus lowering
the p-distance. By contrast, species with higher p-distance values contain many
dead or almost dead elements, which rapidly accumulate more mutations and become
divergent in sequence. However, we have evidence of *Bari* transposition only in
*D*. *melanogaster* and in *D*. *mojavensis*, needing additional studies in
order to establish if *Bari* is active in non-model species. The presence of
functional elements could also explain the differences observed in p-distance
values between the terminal sequences if compared to the CDS. While both the
left and right termini contain DRs able to bind the transposase, the left
terminus might carry the promoter or part of it, and the right terminus might
contain important signals for the termination of transcription. Interestingly in
the context of the terminal sequences the DRs appear strongly conserved in
sequence even in species lacking active *Bari* elements. Based on this it could
be speculated that DRs have acquired a new function (e.g. production of siRNA,
binding of different protein partner etc) in the genomes where *Bari* elements
have been completely inactivated.
There is evidence from previous studies suggesting a well-defined structural vs
phylogenetic relationship among *Bari*-like elements. While elements of the
inactive *Bari2* subfamily contain LIR-type terminal sequences, elements of the
*Bari1* and *Bari3* subfamilies usually harbor SIR and LIR respectively. The
non-autonomous *Bari1* elements identified in *D*. *ananassae* represent an
exception as they harbor LIR. In this paper, we show the existence in *D*.
*rhopaloa* of potentially active *Bari1* elements containing identical LIR,
which is a previously unreported feature in the *Bari1* subfamily that increases
the diversity among *Bari* elements. In addition we identified *Bari1*-type
elements with LIRs in *D*. *bipectinata*, *D*. *biarmipes*, *D*. *suzukii* and
*D*. *takahashii*, but in these species all the *Bari* elements are inactive. To
date, the *Bari1_Drho* represents the only potentially active *Bari*-1 type
element with LIRs. It was previously suggested that the identical LIRs might
represent the first stage of the evolution of the terminal repeats of
*Bari-*like elements. The LIR structure may subsequently evolve into SIR
structures as a consequence of the intrinsic instability associated with the
long terminal repeats structure. This hypothesis was best fitting with the
*Bari3* subfamily, in which the *Bari3_Dmoj* represents a “young” *Bari* element
having perfect LIR and the *Bari3_Dper* and *Bari3_Dpse* elements, representing
older elements that are going to lose the similarity between their TIRs. The
same hypothesis can be now formulated for the *Bari1* subfamily, where SIR- and
LIR-containing elements were previously identified. The two TIRs of the
*Bari_Dana* element indeed share 94% similarity and the two TIRs of the
*Bari1_Drho* element reported here are identical to each other. In this view the
*Bari1_Drho* element represents a young *Bari1*-type element, still awaiting the
divergence of its terminal sequences. This conclusion raises further questions
concerning the mechanisms that generate *Bari1*- and *Bari3*-type elements with
perfectly matching terminal sequences, which are still to be identified.
The powerful sequencing technologies developed in the last years facilitate the
molecular determination of repeat-rich genomic such as the h39 heterochromatic
region of *D*. *melanogaster* which hosts roughly 80 clustered copies of *Bari1*
and the *Responder* satellite. Our detailed analysis allowed orienting the
*Bari1* cluster with respect to the centromere of the second chromosome, thanks
to the presence of the *Responder* repeats in one of the sequences flanking the
*Bari* cluster.
It was previously observed that the *Rsp* satellite displayed an extreme
quantitative and structural variability while *Bari1* cluster showed remarkable
homogeneity. The occurrence of recombination events between clustered copies of
*Bari1*, as inferred from our data, suggests that this transposon cluster could
be subjected to expansions or contractions as observed for other complex DNA
repeats over evolutionary time. Our sequence analyses of heterochromatic copies
of *Bari1* in *D*. *melanogaster* support the hypothesis that an additional
*Bari1* cluster might exist outside the h39 region of the mitotic chromosomes,
specifically on the X or Y chromosome, since it is associated with DNA sequences
specific of the Nucleolar Organizer Region (rDNA and *R1* element insertions).
The presence of such kind of clusters in a single Drosophila species (i.e. *D*.
*melanogaster*) is peculiar and it could be speculated that the reiterated
formation of clusters, might depend on species-specific host factors
contributing to an error-prone activity of the transposase. In addition
resolving the structure of heterochromatic genomic blocks, rich in transposable
elements would help understanding important regulatory loci, as reported for the
*flamenco* locus in *D*. *melanogaster*.
## MITEs related to *Bari* elements
Miniature Inverted-repeat Transposable Elements (MITEs) are non-autonomous,
short repeats that mobilize within the host genome even without the potential to
encode the key proteins responsible for their mobilization (i.e. the
transposase). MITEs are generally smaller than 600 bp with few exceptions, have
conserved TIRs, a target site preference, do not display coding potential, are
AT-rich and amplified within the host genome. In general, they are supposed to
originate by deletions internal to autonomous elements, which leave untouched
the TIRs and, sometimes, just portions of the transposase. This origin supports
the hypothesis of their mobilization *in trans* by a transposase encoded by a
full-length element. In addition to the previously described *Bari*-related
MITEs in the genome of *D*. *sechellia*, we identified this element type in
eight additional Drosophila species. These novel *Bari*-related MITE sequences
match the definition of MITEs; however some of them (*Bari_Dmel_MITE2*,
*Bari_Dsim_MITE*, *Bari_Dyak_MITE)* lack genomic amplification while others show
only modest amplification (*Bari_Dmel_MITE1*, *Bari_Dtak_MITE*,
*Bari_Dele_MITE)*. By contrast *Bari_Dsec_MITE1*, *Bari_Dsec_MITE2*,
*Bari_Dfic_MITE* and *Bari_Drho_MITE* are quite abundant in the respective
genomes. It is possible that MITEs in *D*. *melanogaster*, *D*. *simulans* and
*D*. *takahashi* could be in a very initial stage of their amplification.
Alternatively, they might represent the product of abortive amplification.
Wallau et al., recently described 27 independent sub-lineages of
*mariner*-derived MITEs in 20 Drosophila species, which have internal sequences
and TIRs similar to the sequences of the full-length copies and a typical size
of 900–1000 bp with few exceptions. *Bari*-related MITEs are shorter than the
*mariner*-related and possess internal regions not easily comparable with
autonomous elements, reflecting a more complex rearrangement differing from
abortive gap repair. Furthermore, *Bari*-derived MITEs can be short (less than
120 bp) or long (greater than 120 bp and less than 700 bp) in sequence, and the
intervening sequence between the TIRs, where present, is apparently unrelated to
*Bari* elements. Contrarily to the *mariner* MITEs, *Bari*-related MITEs
apparently originated by deletions in the same point, with the possible
exception of the *Bari_Dyak_MITE*. It can be hypothesized that *Bari*-related
MITEs originated through internal deletion of a master element, with the
deletion breakpoints occurring between the Lo-Lm and between Rm-Ro direct
repeats, which has been possibly followed either by direct junction of the
broken extremities or by the addition of unrelated sequences. Finally, as
possible explanations for the presence of MITEs in those species lacking full-
length elements (namely *D*. *yakuba*, *D*. *ficusphila* and *D*. *elegans*), it
is plausible that these MITEs derived from the ancestral transposition of full-
length elements, followed by generation of MITEs and elimination of the original
founders. Thus, the single elements identified are just the relic of this
elimination. Expansion of MITEs has probably occurred one or multiple times
within the host genomes as suggested by sequence similarity distribution.
Notably, the *D*. *sechellia*, *D*. *suzukii D*. *ficusphila* and *D*.
*takahashii* genomes lack autonomous *Bari* elements, so it would be of
particular interest to know if transposition events involving MITEs occurred
after the elimination of autonomous elements, resulting in transposition
mediated by unrelated transposases.
## *Bari* target site preferences and the physical relationships with other mobile elements
It is widely accepted that mobile elements do not integrate themselves randomly.
Primary and secondary DNA structure, as well as chromatin status, could affect
the target site selection. Our results point out a strong preference of
*Bari*-like elements for AT-rich sequences. Similar results were obtained for
other *Tc1*-like transposons, like *SB* which has a preference for a palindromic
AT-repeat (ATATATAT) in which the central AT is the cleaved and duplicated
target.
In addition to the above-described analysis we have performed a larger-scale
analysis aiming to the identification of TEs that preferentially insert, or
preferentially avoid, the DNA neighborhood of *Bari* elements. We found that
loci in which *Bari* transposons are inserted are also populated by other
*Tc1-mariner* elements (p\<0,05). The significant association between *Bari*
elements and other transposons of the same class lead us to hypothesize a
possible correlation between the DNA (or chromatin) structure and the insertion
preferences of transposons belonging to the same superfamily. On the other hand,
the members of the *copia*, *Jockey* and *I* families are significantly under-
represented in the range of 2,5 kb around *Bari* elements in the analyzed
species. *Helitron* elements also display a preference for sites near *Bari*
insertions, while *gypsy*–like elements do not show significant
preference/avoidance respect to *Bari* elements insertion sites suggesting that
*gypsy*-like elements have a random genomic distribution. Besides its importance
in identifying the structural organization of the single loci in which *Bari*
elements lie, this kind of analyses would hopefully help understanding how a DNA
domain is built during evolution. This is especially interesting for
heterochromatic DNA blocks, which are largely composed of transposons’ arrays
and can develop to master loci producing small regulatory RNAs.
## *Bari* phylogeny inconsistencies and possible horizontal transfer events
The evolution of *Bari* elements has been extensively studied in previous works.
The non-uniform distribution of the three subfamilies across the species of the
Drosophila and Sophophora subgenera was observed by Moschetti et al., and
explained with a distinct evolutionary history in different genomes. The overlap
observed here, between the *Bari1*-*Bari2* subfamilies in some species (*D*.
*melanogaster*, *D*. *simulans*, *D*. *sechellia*), might be explained
hypothesizing two independent waves of genomic invasion: the first, most
ancient, by *Bari2* elements which probably occurred in the ancestor of the
melanogaster subgroup (comprising the melanogaster, simulans, sechellia and
erecta species analyzed in this work), the second, more recent, by *Bari1* which
have invaded the ancestor of the melanogaster complex (including the
melanogaster simulans and sechellia species). Assuming only vertical
transmission, *Bari2* elements have been inactivated while *Bari1* elements are
still active in *D*. *melanogaster* and, potentially, in *D*. *simulans*. After
these invasions, *Bari2* elements were probably inactivated resulting in the
absence of active copies in these genomes. It would be interesting to know if
*Bari2* elements are also present in non-sequenced genomes of the Drosophila
subgenus, or if *Bari2* subfamily is restricted to species of the Sophophora
subgenus.
The emergence of transposable elements in a genome can occur in three ways: *de
novo* emergence, horizontal transfer and introgression. Patchy TEs distribution,
incongruent TE vs host species phylogeny and the presence of highly similar
sequences in distantly related species are used as proofs in support of TEs
horizontal transfer. Several horizontal transfer events involving *Tc1-mariner*
elements have been described so far. In a recent paper, Dupeyron and
collaborators described horizontal transfer events between terrestrial isopod
crustaceans and hexapods involving *Tc1-mariner* elements. Horizontal transfer
events were also suggested for *Bari*-like elements between the sibling species
*D*. *melanogaster* and *D*. *simulans* as reported by former studies. Here
we present evidence of horizontal transfer events involving *Bari*-like elements
between *D*. *bipectinata* and *D*. *biarmipes*. Although these two species
diverged at least 27 million years ago, *Bari* elements within the respective
genomes are nearly identical. Analysis of synonymous substitutions differences
between transposases and host genes suggest that horizontal transfer occurred,
which explain the incongruences observed in the phylogenetic trees and the high
similarity between the *Bari* elements in these species. The geographic
distribution of the Drosophila species involved in transposon horizontal
transfer events supports this possibility, as these two species coexist in the
Indian subcontinent. Very recently Wallau et al., reported the same horizontal
transfer event described here by applying a sophisticated and statistically
supported method, called VHICA, which used 50 orthologous, vertically
transmitted genes, as a reference set to infer horizontal transposon transfer of
*Bari* between *D*. *biarmipes* and *D*. *bipectinata*. Other horizontal
transposon transfer events involving different species have been also detected
using this method suggesting that complex evolutionary mechanisms have
originated the actual distribution of *Bari* elements, complicating the
inference of their evolutionary history.
# Conclusions
Our annotation and analyses of 401 insertions unveiled sequence and structure
variability of *Bari*-like elements in the sequenced genomes of Drosophila
species. Besides the dynamic structure of the TIRs and the presence of active
and inactive elements in the three *Bari* subfamilies, we detected the presence
of MITEs derived from *Bari* elements in 9 Drosophila species, suggesting that
the generation of such inactive form can be considered as a common event in this
family. The analysis of genomic sites targeted by *Bari* transposition showed
that the same sites are also preferred or avoided by other mobile elements, and
this may be important to understand how transposons model genomic domains.
Finally our phylogenetic analysis showed that three subfamilies (*Bari1*,
*Bari2* and *Bari3*) can be recognized both in TIR- and transposase-based
phylogenetic trees and that a previously unreported horizontal transfer event
has probably occurred between *D*. *biarmipes* and *D*. *bipectinata*.
# Supporting Information
We gratefully acknowledge Dr. Kostantinos Lefkimmiatis for critical discussion
and language editing of the manuscript.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: RMM. Performed the
experiments: AP DL PDA RC RMM. Analyzed the data: AP DL PDA RC RMM. Wrote
the paper: RC RMM.
|
# Introduction
G protein-coupled receptor (GPCR) kinases (GRKs) are a family of
serine/threonine kinases that phosphorylate GPCRs and desensitize GPCR-mediated
signaling. GRK-catalyzed receptor phosphorylation leads to the recruitment of
beta-arrestins to phosphorylated receptors, induces receptor internalization,
and thus down-regulates cellular responses to extracellular signal. Many studies
indicate that GRKs are able to phosphorylate a variety of non-GPCR substrates
such as synuclein, p38, NF-κB1 p105, ezrin, arrestin-2, and p53. It has also
been shown that GRKs can regulate signaling pathways via direct interaction with
other proteins in a phosphorylation-independent manner. GRK2 is able to interact
with Gαq to regulate GPCR signaling. Binding of GRK5 with IκB inhibits NF-κB-
mediated transcription. Our earlier research showed that the kinase activity-
independent regulation of the cyclin pathway by GRK2 is essential for zebrafish
early development and GRK5 acts as a scaffold to promote F-actin bundling and
targets bundles to membrane structures to control neuronal morphogenesis. These
studies implicate that GRKs, especially GRK5, may exert multiple physiological
functions via various mechanisms including those independent of their kinase
activities.
Change in GRK protein level has been detected in a variety of human disorders
including heart failure, acute myocardial infarction, hypertension, brain
ischemia, rheumatoid arthritis, Parkinson’s disease, Alzheimer’s disease and
depression, suggesting that protein turnover plays a key role in GRK regulation.
The regulation of GRK2 turnover has been studied. Mdm2 plays a key role in
regulation of GRK2 ubiquitination and degradation. Hsp90 interacts with and
stabilizes GRK2. However, little is known about regulation of other GRK
subtypes.
Damaged DNA-binding protein 1 (DDB1) is part of an E3 ligase complex that
includes the cullin proteins CUL4A and CUL4B. The DDB1–CUL4 complex is a
conserved cullin-RING ubiquitin ligase, that regulates DNA repair, replication,
and transcription. The DDB1–CUL4 complex can also be subverted by pathogenic
viruses to benefit viral infection. CUL4 assembles ubiquitin ligase by binding
to ROC1, a RING protein, and to DDB1, a triple β propeller adapter protein,
which functions as a linker to recruit substrates or substrate receptors to CUL4
E3 ubiquitin ligase.
In an effort to identify proteins that interact with GRK5, we used a proteomic
approach to isolate GRK5 interacting proteins and identified several proteins in
the GRK5 immunocomplex including DDB1. We further demonstrated that DDB1 acts as
an adapter to link GRK5 to CUL4-ROC1 E3 ligase complex and regulates GRK5
ubiquitination and degradation.
# Results
## Identification of GRK5-interacting Proteins by Mass Spectrometry
A proteomic approach was used to identify interacting proteins of GRK5. Flag-
tagged GRK5 was affinity purified from MDA-MB-231 cells stably expressing
GRK5-Flag. As a control, cells stably expressing GFP were taken through the same
procedure. The resulting protein complexes were electrophoresed on a 4–20%
gradient polyacrylamide gel and then stained with Coomassie Blue. Protein bands
of ∼300 kDa, ∼230 kDa, ∼130 kDa, ∼85 kDa and ∼55 kDa were selectively copurified
with Flag-tagged GRK5 but not control beads. The gel bands were excised and
analyzed by mass spectrometry as indicated in. The corresponding bands in the
control lane were also excised and analyzed by mass spectrometry, and proteins
detected in both the control lane and GRK5-immuocomplex lane were excluded from
further analysis. This work led to the identification serine/arginine repetitive
matrix 2 (SRRM2, 300 kDa), Myosin-9 (MYH9, 227 kDa), AP-3 complex subunit delta
1 (AP3D1, 130 kDa), damage-specific DNA binding protein 1 (DDB1, 127 kDa), heat
shock protein Hsp90-alpha (Hsp90AA1, 83 kDa), heat shock protein Hsp90-beta
(Hsp90AB1, 85 kDa), upstream binding transcription factor, RNA polymerase 1
(UBTF4, 89 kDa), nucleolin (NCL, 77 kDa) and serine/threonine kinase 38 (STK38,
55 kDa) as the major interacting proteins of GRK5 in MDA-MB-231 cells. DDB1
functions as a linker to recruit substrates or substrate receptors to CUL4-ROC1
E3 ubiquitin ligase. Interestingly, peptides derived from other components of
DDB1-CUL4 complex were also identified in the GRK5 immunoprecipitates by mass
spectrometry including CUL4B, which interacts with DDB1 and assembles ubiquitin
ligase by binding to ROC1; WD40-repeat protein 22 (WDR22) and glutamate-rich
WD40-repeat protein 1 (GRWD1), which contain WD40 repeat domain and constitute
the substrate-specific adaptor that recruits substrates to the DDB1-CUL4
complexes through interaction with DDB1; COP9 signalosome complex subunit 7a
(COPS7A), component of the COP9 signalosome complex, which cleaves NEDD8 from
CUL4 and regulates the CUL4 ubiquitin ligase activity. Similar proteomic
approach was carried out in human umbilical vein endothelial Cells (HUVEC) cells
transiently transfected with Flag-GRK5. SRRM2, AP3D1, Hsp90, UBTF4 and NCL were
also detected in HUVEC cells by mass spectrometry (supplemental,). The DDB1-CLU4
complex proteins including DDB1, CUL4B, WDR22, GRWD1 and COPS7A were all
detected in HUVEC cells (supplemental), and two additional WD40-repeat domain
containing proteins were identified in HUVEC cells including WDR12 and WDR82.
However, STK38, which was readily detected in the GRK5 immunocomplex in MDA-
MB-231 cells by mass spectrometry, was not detected in the HUVEC cells (
and,S2,S3,S4). As we identified several components of DDB1-CUL4 complex in both
MDA-MB-231 cells and HUVEC cells by mass spectrometry, we further examined the
association of GRK5 with DDB1-CUL4 ubiquitin ligase complex.
## GRK5 Associates with DDB1-CUL4 Ubiquitin Ligase Complex
The association of GRK5 with DDB1-CUL4 complex was confirmed by
immunoprecipitation and Western analysis in MDA-MB-231 cells stably expressing
GRK5-Flag and in 293 T cells transiently transfected with GRK5-Flag. DDB1,
CUL4A, and CUL4B were detected in the immunocomplex of the Flag-tagged GRK5. The
RING finger protein ROC1 was also detected in GRK5 precipitates in 293 T cells
and MDA-MB-231 cells (data not shown). Damage DNA binding protein 2 (DDB2), a
known binding protein of DDB1, functioning in the global genome nucleotide
excision repair, was also detected in the GRK5 precipitates. Furthermore,
endogenous GRK5 was detected in DDB1 immunocomplexes in 293 T cells,
demonstrating association between endogenous GRK5 and endogenous DDB1 in vivo.
## DDB1 Targets GRK5 to CUL4 to Form a Complex
To test the idea that DDB1 acts as an adapter to recruit GRK5 to CUL4 to form a
complex, epitope-tagged CUL4A, DDB1, and GRK5 were expressed in 293 T cells and
protein associations were analyzed by immunoprecipitation. As shown in, the
association of DDB1 with GRK5 could be detected in the absence of CUL4A-HA
expression, and similarly, the association of DDB1 with CUL4A-HA could occur in
the absence of GRK5 expression, confirming the interaction of GRK5 and CUL4A
with DDB1. When CUL4A-HA, DDB1-Flag, and GRK5 were co-expressed, all three
proteins were present in a complex. However, in the absence of DDB1-Flag, the
association between CUL4A-HA and GRK5 was significantly attenuated. These data
suggest that DDB1 is required for the association of GRK5 with CUL4A. The basal
interaction of GRK5 with CUL4A-HA in the absence of DDB1-Flag expression was
likely a result from co-immunoprecipitated endogenous DDB1 by CUL4A-HA, since
significant amount of endogenous DDB1 could be detected in the CUL4A
immunoprecipitates (panel 3). Similar results were obtained when using GRK5-HA
to immunoprecipitates DDB1 and CUL4A. Furthermore, knockdown of DDB1
significantly reduced the amount of CUL4A in GRK5 immunoprecipites. However,
knockdown of CUL4A had no significant effect on the association between GRK5 and
endogenous DDB1. These results further support the notion that DDB1 acts as an
adaptor to link CUL4A with GRK5.
Based on the overall structural organization and homology of GRKs, GRK family
proteins can be divided into three subfamilies: GRK1 and GRK7; GRK2 and GRK3;
and GRK4, GRK5, and GRK6. We examined the interaction of DDB1 with other members
of GRK family proteins. As shown in, DDB1 could be detected in the
immunoprecipitates of GRK5-Flag as well as GRK6-Flag, but not in GRK2-Flag
immunoprecipitates, suggesting the specific complex formation of DDB1 with GRK4
subfamily proteins.
## DDB1 Regulates GRK5 Ubiquitination
Since DDB1 targets GRK5 to the CUL4 ubiquitin ligase complex, we tested whether
DDB1 regulates GRK5 ubiquitination and degradation. 293 T cells were co-
transfected with plasmids encoding Flag-tagged GRK5 and HA-tagged ubiquitin, in
combination with control plasmid, DDB1, or myc-CUL4A. As shown in, expression of
DDB1 alone or co-expression of DDB1 with CUL4A significantly increased GRK5
ubiquitination, while expressing CUL4A alone did not affect the ubiquitination
of GRK5. To examine the requirement of DDB1-CUL4 complex for GRK5
ubiquitination, 293 T cells were co-transfected with GRK5-Flag, HA-ubiquitin,
and shRNA targeting DDB1 or CUL4. As shown in, GRK5 ubiquitination was severely
decreased by the depletion of either DDB1 or CUL4A/B.
## DDB1 Regulates GRK5 Degradation
We next examined the effect of DDB1 on GRK5 degradation. 293 T cells were
infected by lentivirus expressing control-shRNA or DDB1-shRNA, and the
degradation of endogenous GRK5 was determined in the presence of CHX in chasing
experiment. As shown in, in the control cells, 50% of GRK5 was degraded in less
than 3 h, whereas knockdown of DDB1 markedly attenuated the degradation of GRK5
and extended the half-life of GRK5 (∼25% reduction of GRK5 in 8 h). Hsp90 has
been shown to interact with GRK2 and regulate the stability of GRK2 by
preventing it from proteasome-dependent degradation. A significant amount of
Hsp90 peptides were also detected in the GRK5 immunoprecipitates by mass
spectrometry. We next examined the role of Hsp90 in regulating GRK5 stability.
As shown in, treatment of 293 T cells with geldanamycin, an Hsp90-specific
inhibitor, significantly down-regulated the level of endogenous GRK5 in a dose-
dependent manner, suggesting that Hsp90 regulates GRK5 stability. This is
consistent with the previous report that treatment with geldanamycin resulted in
about 80% down-regulation of GRK5 transiently expressed in COS-7 cells.
Furthermore, pretreatment of cells with MG132, a proteasome inhibitor,
significantly inhibited geldanamycin-induced down-regulation of GRK5, suggesting
that GRK5 degradation induced by geldanamycin was predominantly through the
proteasome pathway. We further examined the role of DDB1 in Hsp90 inhibition-
induced degradation of GRK5. As shown in, knockdown of DDB1 significantly
inhibited geldanamycin-induced down-regulation of GRK5 in 293 T cells,
suggesting that DDB1 mediates Hsp90 inhibition-induced proteasome-dependent
degradation of GRK5.
## DDB1 Mediates UV Irradiation-induced GRK5 Degradation
We further explored the potential role of the DDB1-CUL4 ubiquitin ligase in GRK5
degradation in 293 T cells. It has been shown that DDB1-CUL4 ubiquitin ligase
promotes degradation of many proteins including p21, CDT1, and DDB2 following
ultraviolet light (UV) irradiation. The response of GRK5 following DNA damage
with UV irradiation was examined. The cellular GRK5 level was significantly
down-regulated following UV treatment with as little as 20 J/m<sup>2</sup> UV,
whereas GRK2 levels remained largely unchanged under the same condition.
Remarkably, knock down of DDB1 effectively prevented UV-induced GRK5
degradation, suggesting that UV irradiation-induced degradation of GRK5 is
mediated by DDB1. The effect of GPCR activation on the stability of GRK5 was
also examined. As shown in, treatment of cells with isoproterenol to activate
endogenous β2-adrenergic receptors in 293 T cells, had no significant effect on
GRK5 protein level (data not shown) or UV irradiation-induced GRK5 degradation.
# Discussion
In the current study, a proteomic approach was used to screen GRK5 interacting
proteins in MDA-MB-231 cells and HUVEC cells. Several proteins were detected in
the GRK5 immunocomplex including SRRM2, MYH9, AP3D1, DDB1, Hsp90, UBTF4, NCL and
STK38. Interestingly, other components of DDB1-CUL4 ubiquitin ligase complex
including CUL4B, WDR22, GRWD1 and COPS7A, were also detected in the GRK5
immunocomplex in both MDA-MB-231 cells and HUVEC cells. We further provided
evidence that GRK5 forms a complex with DDB1-CUL4-ROC1 E3 ubiquitin ligase and
DDB1 acts as an adaptor to link GRK5 to CUL4 to form the complex. DDB1 regulates
the ubiquitination and degradation of GRK5. Furthermore, depletion of DDB1
inhibited Hsp90 inhibitor-induced GRK5 destabilization and UV irradiation-
induced GRK5 degradation. Thus, our immunoprecipitation-mass spectrometry data
provide useful information about GRK5 interacting proteins in cells, and our
results reveal DDB1 as a key regulator of GRK5 stability.
Altered GRK protein expression and/or activity have profound effects on cell
signaling and physiological functions, and changed GRK expression has been
observed in a variety of human disorders. The mechanisms that govern GRK2
cellular levels have recently been addressed. GRK2 is rapidly degraded via the
proteasome pathway. The ubiquitination and turnover of GRK2 are stimulated by
β2-adrenergic receptor activation, through a mechanism involving GRK2
phosphorylation by c-Src or MAPK in a beta-arrestin-dependent manner. Mdm2 is
subsequently identified as the key E3 ubiquitin ligase involved in GRK2
ubiquitination and degradation. However, how the stability of other GRK subtypes
is controlled remains largely unknown. In the current study, we identified
DDB1-CUL4 complex as the key ubiquitin ligase responsible for GRK5
ubiquitination and degradation. Several lines of evidence support the notion
that DDB1 serves as a linker to target GRK5 to DDB1-CUL4 E3 ligase for GRK5
ubiquitination and degradation. First, DDB1 was detected in GRK5
immunoprecipitates of lysates from different cell lines. Second, a pool of
endogenous GRK5 and DDB1 can be found in the same molecular complex, as
indicated by co-immunoprecipitation. Moreover, overexpression or knockdown of
the protein reveals DDB1 is an adapter linking GRK5 to DDB1-CUL4 complex. Third,
GRK5 ubiquitination and degradation is significantly impaired in
DDB1/CUL4-knockdown cells. Finally, we found that degradation of GRK5 induced by
both Hsp90 inhibitor and UV-irradiation could be both inhibited in DDB1
deficient cells. Thus this may serve as a new regulation mechanism for GRK5
stability. It will be interesting to further explore if the DDB1-mediated GRK5
degradation is DDB1/GRK5 interaction-dependent, or if there is a direct
interaction between GRK5 and DDB1.
We also show that DDB1 preferentially associates with GRK4 family proteins. DDB1
could be observed in both GRK5 and GRK6, but not GRK2 immunoprecipitates. GRK2
has been shown to interact with Mdm2. These results suggest that different GRK
subtypes may form complexes with diverse E3 ubiquitin ligases. In addition,
Penela et al. reported that GRK2 has a half-life of about 1 h in C6 glioma and
Jurkat cells. In this study, we observed that in 293 T cells, endogenous GRK5,
but not GRK2, was rapidly degraded after CHX treatment. Our results are
consistent with previous reports showing that the half-life of GRK2 in HL60
cells is 20–24 h. This may reflect difference in degradation mechanisms of GRK2
among these cell types.
Hsp90 has been shown to interact with GRK2 and GRK3, and regulates the stability
of GRK2 and GRK3. Inhibition of Hsp90 results in rapid, proteasome-dependent,
down-regulation of GRK2 and GRK3. In this study, we found that inhibition of
Hsp90 resulted in proteasome-dependent degradation of GRK5. These studies and
our data implicate that Hsp90-mediated stabilization and proteasome-dependent
degradation may play a general role in regulation of the stability of GRK family
proteins. Hsp90 has also been reported to interact with and participate in the
regulation of other kinases, such as Erb2, Akt/PKB, and Raf-1. Inhibition of
Hsp90 by geldanamycin results in enhanced degradation of these proteins.
Therefore, stabilization of client protein seems to be a general function of
Hsp90. We further provide the evidence that the degradation of endogenous GRK5
induced by Hsp90 inhibition was mediated by DDB1. Depletion of DDB1 inhibited
geldanamycin-induced degradation of GRK5. These results suggest that disrupting
the interaction between GRK5 and Hsp90 induces DDB1-CUL4 complex-mediated
ubiquitination-proteasome dependent degradation of GRK5, and put forward the
notion that the stability of GRK5 was counter-regulated through interaction with
DDB1-CUL4 complex and Hsp90.
DDB1-CUL4 complex controls ubiquitination and stability of many cellular
substrates including p21, DDB2, Cdt1, p27, TSC2, Merlin, Chk1, c-Jun, and
histones, through DDB1 bridged interaction of substrates with CUL4 E3 ubiquitin
ligase. p21 and Cdt1 are the most established substrates of DDB1-CUL4 ubiquitin
ligase complex after UV irradiation. The degradation of p21 and Cdt1 following
UV irradiation, which promotes DNA repair and suppresses replication licensing,
is critical for the cell to respond to DNA damage. Interestingly, in this study,
we found that GRK5, but not GRK2, is degraded after UV irradiation, and DDB1
mediates UV irradiation-induced GRK5 degradation. The identification of GRK5 as
a DDB1-CUL4 complex target following UV irradiation adds it to the growing list
of cellular substrates targeted to CUL4 by DDB1. The physiological consequence
of UV irradiation-induced GRK5 degradation remains to be explored.
The current study is aimed to explore the possible regulation of GRK5 by the
DDB1-CUL4 ubiquitin ligase complex. However, the association of GRK5 with
DDB1-CUL4 complex may also result in the phosphorylation of DDB1 and/or Cul4 by
GRK5, and thus regulates the function of DDB1-CUL4 ubiquitin ligase complex
itself. In fact, cells deficient of GRK5 or DDB1 exhibit similar phenotypes,
such as apoptosis and cell growth retardation. It would be interesting to
determine whether GRK5 regulates the function of DDB1-CUL4 ubiquitin ligase
complex and the ubiquitination of other substrates of DDB1-CUL4 complex, and
investigate whether DDB1-CUL4 complex is involved in GRK5 deficiency-induced
cell growth retardation in future studies.
We also identified other new interacting proteins of GRK5, including SRRM2 and
STK38, by immunoprecipitation-mass spectrometry in MDA-MB-231 cells. SRRM2,
which has been shown to be involved in pre-mRNA splicing, , is the most abundant
among proteins identified by mass spectrometry in GRK5-immunocomplex in both
MDA-MB-231 cells and HUVEC cells (supplemental). These results implicate
possible function of GRK5 in mRNA splicing. Another interesting interacting
protein of GRK5 is STK38 which is identified in GRK5 immunocomplex in cancer
cell lines (MDA-MB-231 cells), but not in normal cells (HUVEC). STK38, also
known as NDR1, is a serine-threonine protein kinase of AGC kinase subfamily, it
has been shown to regulate many essential processes including cell division,
proliferation, centrosome duplication and apoptosis. Interestingly, GRK5 has
also been shown to be involved in proliferation and apoptosis. It will be of
interest to examine the possible role of interaction between GRK5 and STK38 in
regulating these processes.
# Materials and Methods
## Reagents and Antibodies
Dulbecco’s modified Eagle’s and Leibovitz’s L-15 media were purchased from
Invitrogen. Fetal bovine serum (FBS) was obtained from Hyclone. Mouse anti-DDB1
antibody, rabbit anti-ROC1 antibody, and mouse antibody against Myc epitope were
from Invitrogen. Rabbit anti-DDB2 antibody, rabbit anti-GRK2 antibody, and
protein A/G agarose were from Santa Cruz Biotechnology. Rabbit anti-CUL4B
antibody, rabbit anti-β-actin antibody, mouse antibody against FLAG epitope,
rabbit antibody against HA epitope, mouse IgG, anti-Flag M2 affinity gel, and
anti-HA agarose were from Sigma. Goat anti-GRK5 antibody was from R&D.
Geldanamycin and cycloheximide (CHX) were from Sigma.
## Plasmid Construction
Plasmids encoding tagged bovine GRK2 and GRK5, and human GRK6 were constructed
by PCR mutagenesis. Construction of shRNA plasmids for human DDB1, human CUL4A,
and human CUL4B was performed as described. LacZ shRNA was used as a control.
The shRNA lentivirus system, which uses the FG12 and package vector to enable
simultaneous expression of the GFP protein and shRNA were obtained from Dr. Gang
Pei (Chinese Academy of Sciences, Shanghai, China). Sequences for DDB1 RNAi are:
GCG AGA GCA TTG ACA TCA TTA (sense) and TAA TGA TGT CAA TGC TCT CGC (antisense).
CUL4A: GCA GGA CCA CTG CAG ACA AAT (sense) and ATT TGT CTG CAG TGG TCC TGC
(antisense). CUL4B: GCC ACG TAC CGA TAC AGA AGA (sense) and TCT TCT GTA TCG GTA
CGT GGC (antisense). The plasmids DDB1-Flag (Addgene plasmid 19918), CUL4A-HA
(Addgene plasmid 19907), and Myc-CUL4A (Addgene plasmid 19951) were gifts of Dr.
Yue Xiong. The plasmid DDB1 was constructed into pcDNA3.0.
## Cell Culture and Plasmid Transfection
293 T cells were cultured in Dulbecco’s modified Eagle’s medium containing 10%
FBS. Cells were seeded in 60 or 100 mm tissue culture dishes at
0.6–2×10<sup>6</sup>/dish 20 h before transfection and transfected plasmid using
calcium phosphate/DNA co-precipitation method or infected by lentivirus. Assays
were performed 48 h (for expressing experiments) or 72 h (for RNAi experiments)
after transfection. MDA-MB-231 cells stably expressing GFP or GRK5-Flag were
cultured in Leibovitz’s L-15 plus 10% FBS. For protein decay analysis, 293 T
cells were treated with CHX at 100 µg/ml.
## Generation and Titer of Lentivirus
The sequences predicted to target the human DDB1 or CUL4A were used for the
construction of shRNA lentivirus. FG12-hU6-shRNA and packaging vectors were co-
transfected into 293 T cells and the resulting supernatant were collected after
48 h. Virus was recovered after ultracentrifugation resuspension in phosphate-
buffered saline. Titers were determined by infecting 293 T cells with serial
dilutions of concentrated lentivirus. GFP expression in infected cells was
determined 48 h after infection, and for a typical preparation, the titer of
lentivirus was approximately 10<sup>8</sup> infectious units (IFU)/ml.
## Isolation and Identification of GRK5-associated Proteins
MDA-MB-231 cells were stably transfected with GRK5-Flag or GFP lentivirus. HUVEC
cells were transiently transfected with GRK5-Flag or GFP by lentivirus. About
10<sup>8</sup> cells were harvested and lysed in IP buffer (50 mM Tris.HCl, pH
7.5, 150 mM NaCl, 0.5% NP-40, 10% glycerol, 1 mM EDTA, 10 mM NaF, plus 10 µg/ml
aprotinin, 10 µg/ml benzamidine, and 0.2 mM PMSF) for 2 h. The lysate was
centrifuged and the supernatant was incubated with anti-FLAG M2 affinity gel at
4°C for 8 h. The beads were subsequently washed. Bound proteins were eluted by
addition of SDS sample buffer. The resulting protein complexes were
electrophoresed on a 4–20% gradient polyacrylamide gel and revealed by staining
with Coomassie Blue. Six selected bands were excised from the gel and analyzed
by mass spectrometry. The corresponding GFP control lane were also excised and
analyzed by mass spectrometry. The mass spectrometry analysis was performed at
the Shanghai Applied Protein Technology Co.Ltd.
## LC-MS/MS
Gel pieces were destained with 30% ACN/100 mM NH<sub>4</sub>HCO<sub>3</sub> and
dried in a vacuum centrifuge. The in-gel proteins were reduced with
dithiothreitol (10 mM DTT/100 mM NH<sub>4</sub>HCO<sub>3</sub>) for 30 minutes
at 56°C, then alkylated with iodoacetamide (50 mM IAA/100 mM
NH<sub>4</sub>HCO<sub>3</sub>) in the dark at room temperature for 30 minutes.
Gel pieces were briefly rinsed with 100 mM NH<sub>4</sub>HCO<sub>3</sub> and
ACN, respectively. Gel pieces were digested overnight in 12.5 ng/mL trypsin in
25 mM NH<sub>4</sub>HCO<sub>3</sub>. The peptides were extracted three times
with 60% ACN/0.1% TFA. The extracts were pooled and dried. EttanTM MDLC system
(GE Healthcare) was applied for desalting and separation of tryptic peptides
mixtures. In this system, samples were desalted on RP trap columns (Agilent
Technologies), and then separated on a RP column (Column technology Inc.).
Mobile phase A (0.1% formic acid in HPLC-grade water) and the mobile phase B
(0.1% formic acid in acetonitrile) were selected. 20 µg of tryptic peptide
mixtures was loaded onto the columns, and separation was done at a flow rate of
2 µL/min by using a linear gradient of 4–50% B for 30 min. A LTQ VELOS (Thermo
Electron) equipped with an electrospray interface was connected to the LC setup
for eluted peptides detection. Data-dependent MS/MS spectra were obtained
simultaneously. Each scan cycle consisted of one full MS scan in profile mode
followed by five MS/MS scans in centroid mode with the following Dynamic
ExclusionTM settings: repeat count 2, repeat duration 30 s, exclusion duration
90 s. Each sample was analyzed in triplicate. MS/MS spectra were automatically
searched against the non-redundant International Protein Index (IPI) human
protein database (version 3.53) using the BioworksBrowser rev. 3.1(Thermo
Electron).
## Immunoprecipitation and Western Blotting
Cells were washed with ice-cold PBS and lysed in IP buffer for 1.5 h as
described. The lysate was centrifuged and the supernatant was incubated with
anti-FLAG M2 affinity gel or anti-HA agarose at 4°C for 8 h. The beads were
subsequently washed, and the proteins bound to the beads were eluted. The
samples were detected in the subsequent Western procedures with the
corresponding antibody. Blots were incubated with IRDye 800CW-conjugated or
700CW-conjugated antibody (Rockland Biosciences) and infrared fluorescence
images were obtained with the Odyssey infrared imaging system (Li-Cor
Bioscience).
## Ubiquitination Assay
293 T cells seeded in 60 mm dishes were transfected with different combinations
of expression vectors for HA-ubiquitin, GRK5-Flag, and other indicated plasmids.
Cells were lysed in ubiqutination buffer (50 mM HEPES, pH 8.0, 250 mM NaCl, 0.5%
NP-40, 10% glycerol, 2 mM EDTA, 20 mM NaF, plus 10 µg/ml aprotinin, 10 µg/ml
benzamidine, and 0.2 mM PMSF). Cell lysate was immunoprecipitated with anti-Flag
M2 affinity gel and analyzed by immunobloting with anti-HA antibody.
## CHX Treatment
For protein decay analysis, 293 T cells were infected by LacZ RNAi or DDB1 RNAi
lentivirus for 48 h and then reseeded onto 60 mm culture dish at
7×10<sup>5</sup> cells per dish. After 40 h, cells were exchanged with fresh
culture medium and CHX (100 µg/ml) was added at the proper time point for CHX
treatment for 0 h, 2 h, 4 h, or 8 h. After CHX treatment, cells were washed with
PBS, and total cell lysates were prepared for Western blotting.
## UV-C Irradiation
UV-C (254 nm) irradiation was performed with a UV-C transilluminator (Hoefer UVC
500). The culture medium was replaced with complete medium two hours before the
UV-C treatment. Cells were irradiated at 80% confluency with a 20
J/m<sup>2</sup> dose or indicated dose after removal of the medium in the 60 mm
petri dish without the lid. After irradiation, cells were post-incubated in
their culture medium for the indicated time and were lysed directly in
RIPA<sup>+</sup> buffer (50 mM Tris.HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5%
Deoxycholic Acid, 0.1% SDS, 5 mM EDTA, 10 mM NaF, 10 mM Disodium pyrophosphate,
plus 10 µg/ml aprotinin, 10 µg/ml benzamidine, and 0.2 mM PMSF), and equal
amount of protein was loaded on gels.
## Statistical Analysis
Data were analyzed using two-way ANOVA for comparison of independent means with
pooled estimates of common variances.
# Supporting Information
We thank Junjun Wang and Wenqing Yao for technical assistance.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: YC LM. Performed the
experiments: ZW YC TY QG MY. Analyzed the data: ZW YC TY LM. Contributed
reagents/materials/analysis tools: QG MY. Wrote the paper: YC ZW TY.
|
# Introduction
An important issue in health geography and health policy is the evaluation of
accessibility to healthcare services, with hundreds of research papers published
on the topic since the 2000s. However, the concept of accessibility is multi-
dimensional, which often presents challenges to its operationalization in
empirical research. According to Joseph and Bantock, accessibility can be
defined by both aspatial and spatial dimensions. The first dimension considers
factors such as the quality of the services and their cost, as well as the
income, social class, ethnicity, and mobility profile of potential users of
services. From a geographical perspective, the spatial dimension is key, and
considers the distribution of available healthcare services across the
landscape, in addition to the cost or friction that potential users incur when
trying to reach these services. By taking these geographical factors into
account, estimates of accessibility can help researchers, planners, and policy
makers identify areas with high or low accessibility to healthcare services.
This, in turn, can provide valuable information related to social and spatial
inequalities and guidance for health policy and resource allocation.
Spatial accessibility can be estimated in various ways. At a high level,
provider-to-population ratios (PPR) offer an indication of the level of service
within a community. These measures conceptualize a region as a container of
population and services, and therefore are sometimes called container
approaches. PPRs are straightforward to interpret as the supply of a service
(say number of doctors, beds, etc.) divided by demand (say, number of people who
require the service). Despite this convenient and intuitive interpretation,
container approaches are limited in the amount of spatial information that they
provide, especially if applied to large regions. When applied to smaller regions
these approaches present other shortcomings, such as the assumption that the
population in the container is captive and does not cross the boundaries of the
container in search of services—and that users do not come into the container
from other regions to avail themselves of local services.
An alternative to container approaches is provided by gravity measures. Gravity
measures offer a more sophisticated approach to measuring spatial accessibility
to healthcare that moreover addresses some of the limitations of the container
approach. Instead of defining rigid container boundaries, gravity measures
consider the mobility characteristics of the public to produce flexible (and
often overlapping) catchment areas for both services and population.
Accordingly, one of the most popular approaches for estimating healthcare
accessibility in the literature is the Two-Step Floating Catchment Area (2SFCA)
method proposed by Luo and Wang after research by Radke and Mu. The 2SFCA method
is an ensemble of two gravity models with a simplified binary distance function
to account for crowding of facilities and allocation of levels of service.
Numerous applications of this methods are found in the international literature,
including work from Germany, South Korea, Japan, China, Australia, and Canada.
Accessibility to healthcare is estimated in two stages in the 2SFCA: in the
first step, a level of service at a given healthcare provider is determined
based on the supply (e.g., number of physicians in a clinic) and the estimated
demand from the surrounding population within some catchment area. This level of
service resembles a local provider-to-population ratio (PPR). In the second
step, the level of service of different healthcare providers is aggregated for
each population center. By operationalizing accessibility in terms of demand and
level of service, the 2SFCA method is appealing for health policy analysis.
Still, several improvements have been proposed that seek to address the method’s
most important perceived shortcomings. The result is a family of Floating
Catchment Areas (FCA) methods that include more realistic conceptualizations of
the friction of distance by specifying variable catchment area sizes and/or the
use of stepped, continuous, and adaptive distance-decay functions. Other authors
have added multi-modal transportation, age-adjusted healthcare demand profiles,
as well as ways to counteract the modifiable areal unit problem.
A major focus of FCA research, in addition to the improvements mentioned above,
has been the introduction of competition for available opportunities or the
allocation of services to the population. More concretely, the original 2SFCA
approach has been criticized for over-estimating the levels of demand and/or
level of service in the system. This is a consequence of the way catchment areas
for facilities and population centers typically overlap in any realistic spatial
system—an artifact of FCA methods that can lead to misleading estimates of
accessibility.
In effect, when aggregating the population within the overlapping catchment
areas of multiple facilities, the original 2SFCA framework leads to double-
counting of the population that tends to inflate the level of demand at supply
points in the healthcare system. We call this effect *demand inflation*.
Inflated demand, in turn, tends to *deflate* the level of service for
populations serviced by the facilities so affected. A similar effect, which we
call *level of service inflation*, happens when the levels of service of various
service points are aggregated for population centers. Ultimately, accessibility
estimates are affected in potentially complex ways, depending on the geography
of the problem, and their interpretation as PPRs becomes suspect.
Various solutions to the issues of demand and level of service inflation have
been proposed, including the addition of selection weights based on a travel
impedance function in the Three-Step Floating Catchment Area (3SFCA) method; the
use of a Huff model to generate probability-based estimate of the selection
weights in the 3SFCA method; and, on the supply side, a modified 2SFCA (M2SFCA)
method to address suboptimal spatial configuration of services.
In this paper we are interested in the way demand and level of service are
calculated in FCA methods. We review how different approaches deal with the
issue of inflation, and then propose a simple and intuitive approach to
proportionally allocate supply and demand. Our solution consists on adjusting
the impedance weights used in the estimation of FCA methods. More concretely, by
incorporating methods drawn from the field of spatial statistics and
econometrics, proportional allocation has the feature that it preserves the
levels of demand and service in the system. To illustrate the key aspects of our
proposal, we conduct a case study of access to family physicians in Hamilton,
Canada. Our results indicate that the proposed adjustments produce more
intuitive measures of accessibility to healthcare measured in terms of local
PPRs. Moreover, these outputs can be used to provide estimates of access
disparity across a region that are both easily understood and robust to demand
and level of service inflation.
# Background: Floating Catchment Area methods
To motivate the discussion to follow we begin by reviewing some popular FCA
methods. In general terms, FCA approaches are implemented as ensembles of two
gravity models in two steps, using an impedance function to represent the cost
required to overcome distance. Impedance functions implement a distance-decay
effect that mimics a commonly observed cost-minimization behavior, namely that
people in general prefer to spend less time/money/effort travelling to
destinations. In this way, the impedance function defines a *catchment area* for
the points of service and population centers alike.
In the first step of FCA methods, the impedance function defines catchment areas
for facilities *j*, which could be clinics, parks, libraries, etc. A weighted
sum of the population within a catchment area is allocated to the corresponding
facility or service point to represent demand. In the second step of the
algorithm, the catchment areas are “floated” to population centers *i*.
Accessibility at location *i* is calculated as the weighted sum of the level of
service at every location *j* that includes *i* within its catchment area. The
following methods are popular in the literature.
## Two-Stage Floating Catchment Areas (2SFCA)
The original 2SFCA implements a binary impedance function *W* with a threshold
cost *d*<sub>0</sub> as follows: $$W\left( d_{ij} \leq d_{0} \right) = \left\{
\begin{array}{ll} 1 & { d_{ij} \leq d_{0}} \\ 0 & { d_{ij} > d_{0}} \\
\end{array}\operatorname{} \right.$$ This function assumes equal potential
within a catchment area (i.e., *d*<sub>*ij*</sub> ≤ *d*<sub>0</sub>), and zero
beyond (*d*<sub>*ij*</sub> \> *d*<sub>0</sub>). This implies that 1) travellers
are equally likely users of a service point within the catchment area,
irrespective of how proximate or distant they are from it; and 2) no users
travel to the service point from beyond the threshold cost.
Given the impedance function, the level of demand *D*<sub>*j*</sub> is
calculated as the weighted sum of the population at *i*: $$D_{j} =
\sum\limits_{i}D_{ij} = \sum\limits_{i}{P_{i}W\left( d_{ij} \leq d_{0}
\right)}$$
The supply *S* of the service offered at location *j* (say, number of
beds/doctors in a clinic) is then divided by the demand to obtain a measure of
level of service (e.g., beds/person, sq.m of park space/person, library floor
space/person). This gives a level of service *L*<sub>*j*</sub> at the service
point: $$L_{j} = \frac{S_{j}}{D_{j}} = \frac{S_{j}}{\sum_{i}D_{ij}} =
\sum\limits_{i}\frac{S_{j}}{D_{ij}} = \sum\limits_{i}L_{ij}$$ The level of
service resembles a PPR. Aggregation of demand creates a congestion effect that
depends on the number of potential users from different origins *i* that
converge at service point *j*: at a fixed level of supply, greater demand
results in lower levels of service. The different decompositions of
*L*<sub>*j*</sub> help to understand how different population centers contribute
to the level of demand at facility *j*.
In the second step of the algorithm, catchment areas are “floated” to population
centers *i*. A second gravity model is used to calculate the accessibility at
*i*: $$A_{i} = \sum\limits_{j}{L_{j}W\left( d_{ij} \leq d_{0} \right)}$$ Since
accessibility is calculated as the weighted sum of the level of service at
facilities, it is conventionally interpreted as a PPR.
## Enhanced Two-Stage Floating Catchment Areas (E2SFCA)
A criticism of the binary impedance function of the 2SFCA is that it does not
account for the declining probability of using a facility as distance grows. As
a result of this criticism, other impedance functions have since been proposed,
including the stepwise formulation of the Enhanced Two-Stage Floating Catchment
Area method: $$W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R} \right) =
\left\{ \begin{array}{ll} k_{1} & { d_{ij} \leq d_{1}} \\ k_{2} & { d_{1} <
d_{ij} \leq d_{2}} \\ \ldots & \\ k_{R - 1} & { d_{R - 1} < d_{ij} \leq d_{R}}
\\ 0 & { d_{ij} > d_{R}} \\ \end{array}\operatorname{} \right.$$
A stepwise function does not assume identical potential within the catchment
area (i.e., the space contained within *d*<sub>*ij*</sub> ≤ *d*<sub>*R*</sub>),
but rather declining potential with increasing cost of travel. It is worthwhile
noting that impedance functions have long been studied in geographical analysis
in general, and accessibility research in particular. However, it is only
relatively recently that alternative impedance functions have been incorporated
in FCA approaches, including continuous functions and mixtures of continuous and
step functions.
Besides the use of a non-binary impedance function, the method remains the same.
In the first step, demand is calculated as a weighted sum of the population
within the catchment area: $$D_{j} = \sum\limits_{i}D_{ij} =
\sum\limits_{i}{P_{i}W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R} \right)}$$
Note that non-binary impedance functions discount the level of demand as a
function of cost more rapidly than binary functions. How rapidly this happens
depends on the definition of the cutoff values *d*<sub>1</sub>, *d*<sub>2</sub>,
⋯, *d*<sub>*R*</sub> and weights *k*<sub>1</sub>, *k*<sub>2</sub>, ⋯,
*k*<sub>*r*−1</sub> of the function.
In the second step of the algorithm, accessibility at *i* is calculated as the
weighted sum of the level of service of service points *j*: $$A_{i} =
\sum\limits_{j}{\frac{S_{j}}{D_{j}}W\left( d_{ij} \middle|
d_{1},d_{2},\ldots,d_{R} \right)} = \sum\limits_{j}{L_{j}W\left( d_{ij} \middle|
d_{1},d_{2},\ldots,d_{R} \right)}$$ Again, the use of a non-binary impedance
function discounts the level of service more rapidly compared to binary
functions.
## Three-Stage Floating Catchment Areas (3STCA)
Wan et al. proposed a Three-Stage Floating Catchment Area method (3SFCA) that
aims at refining the estimates of level of demand and accessibility by means of
the use of *selection weights*. This approach operates by introducing an
aditional step where selection weights are calculated as follows: $$G_{ij} =
\frac{T\left( d_{ij} \right)}{\sum_{j\forall d_{ij} \leq d_{0}}T\left( d_{ij}
\right)}$$ where *T*(*d*<sub>*ij*</sub>) are Gaussian weights (essentially an
impedance function), and the summation in the denominator is for all sites *j*
that are within a critical threshold *d*<sub>0</sub>. Notice that a property of
the selection weights is that their sum over *j* equals one:
$$\sum\limits_{j}G_{ij} = 1$$
Given a set of selection weights, the level of demand is caclulated by this
algorithm in the following manner: $$D_{j}^{*} =
\sum\limits_{i}G_{ij}P_{i}W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R}
\right) = \sum\limits_{i}G_{ij}D_{ij}$$ Notice how demand in this method takes
what is essentially the demand in the E2SFCA, and allocates it proportionally to
service points *j*.
Accessibility, in the final step, becomes (with the subindices of the selection
weights reversed, to reflect the displacement of the catchment area to
population centers) is calculated in the following manner: $$A_{i}^{*} =
\sum\limits_{j}G_{ji}\frac{S_{j}}{D_{ij}^{*}}W\left( d_{ij} \middle|
d_{1},d_{2},\ldots,d_{R} \right) = \sum\limits_{j}G_{ji}L_{j}^{*}W\left( d_{ij}
\middle| d_{1},d_{2},\ldots,d_{R} \right)$$
## Modified Two-Stage Floating Catchment Areas (M2SFCA)
Delamater discusses the application of FCA methods for systems that are not
optimally configured to service the whole population. To address this issue, he
proposes a modification to the second step of the 2SFCA algorithm that increases
the friction of distance. Demand in this modification is the same as in 2SFCA.
However, accessibility is calculated in the following manner: $$A_{i} =
\sum\limits_{j}{L_{j}W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R}
\right)W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R} \right)} =
\sum\limits_{j}{L_{j}\left( W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R}
\right) \right)^{2}}$$ In other words, the level of service is discounted by the
square of the impedance function, thus increasing the rate of decay. This is
done to reflect the possibility that some population centers may experience
increased friction to reach destinations in suboptimally configured systems.
# Inflation effects in FCA methods
Having reviewed a selection of FCA approaches, we now proceed to discuss the
issue of inflation. Inflation has been identified, among others, by Wan et al.
and Delamater. As discussed by these authors, inflation happens when demand or
level of service are overestimated. Inflation is a consequence of the way in
which *Dj* and *A*<sub>*i*</sub> are calculated, with some population centers
contributing to the level of demand at more than one facility and then the level
of service of facilities allocated to multiple population centers. Calculating
demand, in particular, generally fails to preserve the population, and therefore
lacks the pycnophilactic property discussed by Tobler. In practical terms, this
implies that the population used to calculate the demand component of level of
service will often exceed (but sometimes fall short of) the actual population in
a region, depending on the weighting scheme. We term the consequent effect
*demand inflation*.
Let us illustrate this inflation effect by means of a simple example using the
conventional 2SFCA approach with a binary impedance function. In this case, the
population value at *i* is multiplied by zero or one, meaning that the
contribution of *i* to demand at *j* whenever *d*<sub>*ij*</sub> does not exceed
the threshold is: $$D_{ij} = P_{i}$$
If we concentrate for a moment on a single population center that enters the
catchment areas of several service points (see, left panel), we can see that
when the demand at each of the service points is calculated, the population in
question is added two times, and the levels of service are *L*<sub>1</sub> =
*L*<sub>2</sub> = 1/*s*00.
More generally, when calculating the level of service at *L*<sub>*j*</sub>, the
population at *i* contributes to demand every time that *d*<sub>*ij*</sub> ≤
*d*<sub>0</sub> for any *j*. And, since since *D*<sub>*i*</sub> *j* =
*P*<sub>*i*</sub>, it follows that the sum of the population to be serviced over
all clinics is: $$\sum\limits_{j}D_{ij} = K_{i}P_{i}$$ where *K*<sub>*i*</sub>
is the number of service points *j* that include *i* as part of their catchment
areas. Therefore, the system-wide contribution of the population at *i* to the
level of demand implied by these calculations, vastly exceeds the actual
population at *i*, since: $$\sum\limits_{j}D_{ij} = K_{i}P_{i} > P_{i}$$
Let us consider next what happens when enhanced (i.e., non-binary) impedance
weights are used. These functions aim to capture more realistically the rule
that most members of the population prefer to travel shorter distances to reach
a destination. For the example, assume a set of weights with decay as follows
(see, right panel): $$W\left( d_{ij} \middle| d_{1},d_{2},\ldots,d_{R} \right) =
\left\{ \begin{array}{ll} {0.9} & { d_{ij} \leq d_{1}} \\ {0.8} & { d_{1} <
d_{ij} \leq d_{2}} \\ {0.4} & { d_{R - 1} < d_{ij} \leq d_{R}} \\ 0 & { d_{ij} >
d_{R}} \\ \end{array}\operatorname{} \right.$$
The population center in the example is relatively distant from the service
points. Accordingly, its potential demand is reduced by assuming that some
people do not travel at all. In this example, the contribution of the population
center to demand is only 0.8*P* to each clinic, and therefore the system-wide
demand of this center is 1.6*P*—less than the all-or-nothing allocation of the
binary impedance weights, but still in excess of the actual population.
More generally, when calculating the level of service at *j* locations, the
population at *i* contributes to demand every time that *d*<sub>*ij*</sub> is
within the service area for any *j*. The precise contribution depends on the
weights in the distance-decay function and the position of the population center
with relative to all service points. In a function with faster decay, the total
demand attributed to *i* (i.e., ∑<sub>*i*</sub> *D*<sub>*ij*</sub>) can be less
than the population of *i*. In other words, depending on the steepness of decay,
the total demand can be greater than, equal to, or less than the population at
*i*: $$\sum\limits_{j}D_{ij} \lessgtr P_{i}$$
Clearly, only when the full population at *i* is allocated exclusively to one
service point (i.e., when *K*<sub>*i*</sub> = 1) the implied demand equals the
population—something that seldom happens in practical situations.
It is important to acknowledge that demand in accessibility analysis represents
the *potential* for spatial interaction, not realized interaction. That said,
the expectation that facilities need to serve multiple times the size of the
population in a region can easily lead to misleading conclusions about the need
for resources. A logical question, however, is whether the inflation of demand
(with the consequence deflation of level of service) is not offset in the second
step of the method, when the population at *i* has potential access to multiple
service points?
Let us consider what happens in the second step of the algorithm in the example,
when catchment areas are floated to the population center (see). When a binary
impedance function is used, the aggregation of the level of service means that,
despite the inflation of demand due to double-counting, accessibility matches
the level of service *as well as* the regional PPR of 2/100 (left panel). In the
case of the stepwise function, the level of implied demand is less than the
population, but the population is also assumed to receive less of the available
level of service. In this case, again, the accessibility matches the level of
service *despite the fact that segments of the population were assumed to not
contribute to demand*.
Clearly, the example is too simplistic (in fact just a variation of the
container approach), and it is unclear what the implications would be for a
system with even just a slightly more complex geography. To explore this,
consider the addition of two population centers to the landscape. Notice how the
three population centers are in the catchment areas of the two clinics. When the
binary impedance function is used, demand at each clinic is calculated as 300,
and demand over all clinics is therefore 600, or twice the population of the
region. When the stepwise impedance function is used, the demand by each center
is: $$\begin{array}{r} \begin{matrix} {D_{1j} = 0.8 \times 100 + 0.8 \times 100
= 160} \\ {D_{2j} = 0.8 \times 100 + 0.4 \times 100 = 120} \\ {D_{3j} = 0.4
\times 100 + 0.8 \times 100 = 120} \\ \end{matrix} \\ \end{array}$$ and the
total load on the system is therefore 400, still well in excess of the total
population of the region.
When demand is used to calculate the level of service, and then accessibility in
the second step of the algorithm, the following occurs. When the binary
impedance function is used (left panel), the level of service at each clinic is:
$$\begin{array}{r} \begin{matrix} {L_{1} = \frac{10}{300} = 0.033} \\ {L_{2} =
\frac{10}{300} = 0.033} \\ \end{matrix} \\ \end{array}$$ The level of service at
the clinics is only half of the regional PPR, since each clinic is assumed to
serve the *entire* population of the region. Unfortunately, since demand has
been inflated for each clinic, these levels of service cannot be meaningfully
interpreted as local PPRs. The sum over the clinics, on the other hand, is
20/300—which is consistent with the regional PPR. Interestingly, as seen in the
figure, the accessibility of each population center matches the regional PPR—but
the sum of accessibility over all population centers exceeds the sum of the
level of service over all the clinics as a consequence of allocating the same
level of service to several population centers.
Continuing with the stepwise impedance function, we can see (right panel) that
the levels of service are calculated as: $$\begin{array}{r} \begin{matrix}
{L_{1} = \frac{10}{0.8 \times 100 + 0.8 \times 100 + 0.4 \times 100} =
\frac{10}{200} = 0.05} \\ {L_{2} = \frac{10}{0.8 \times 100 + 0.4 \times 100 +
0.8 \times 100} = \frac{10}{200} = 0.05} \\ \end{matrix} \\ \end{array}$$ Notice
how the level of service is higher in this case: this is a consequence of
assuming (as the stepwise impedance function does) that some of the population
does *not* demand service. Demand, however, is still inflated, and
interpretation of the levels of service as local PPRs is still inappropriate.
Accessibility is higher for population center 1 but lower for the two peripheral
centers. Furthermore, the sum of accessibility over all population centers
exceeds the sum of the level of service of all clinics in the region.
At issue is the interpretability of the levels of service, which as the example
illustrates do not accurately represent PPRs, and how accessibility, which is a
weighted sum of levels of service, cannot be interpreted as the PPR for a
population center either.
Two methods reviewed above, namely the Three-Stage Floating Catchment Area
method and the Modified Two-Stage Floating Catchment Area method aim to address
the overestimation of demand and/or levels of service when calculating
accessibility. As discussed previously, they do this by compounding the effect
of the impedance function. In the case of 3SFCA, demand is deflated by assuming
that demand declines more rapidly with distance. Then, when calculating
accessibility, the levels of service are allocated more locally, again, as a
consequence of steeper distance-decay. In the case of M2SFCA, demand is not
deflated, however, the levels of service are allocated more locally as a
consequence of steeper distance-decay. In other words, these methods correct for
inflation by assuming that *fewer* people demand helath care services, and that
the levels of service are allocated to fewer people too.
For comparison, the levels of service and accessibility for the example
according to these two methods are shown in. Notice how the levels of service in
the 3FSCA are considerably higher as a consequence of excluding potential users
with a steeper rate of decay. On the other hand, the levels of accessibility are
also lower, as a consequence of allocating service more locally. The levels of
service in the M2SFCA are identical to the E2SFCA, however, accessibility is
lower, again as a result of allocating service more locally.
# A simulated example
The examples in the preceding section illustrate the way demand and level of
service can be overestimaged (and in some cases underestimated) in FCA
algorithms. However, they are too simplistic to indicate what would happen in a
realistic situation. In particular, it is possible that the consequences depend
on the geography of the problem as the examples in Delamater suggest. Based on
the way demand and level of service are allocated, we conjecture that the
effects are likely more pronounced in areas with higher density of population
and service, since inflation is a consequence of overlapping catchment areas.
Furthermore, we conjecture that demand inflation will be reduced when
stepwise/continuous distance-decay functions are used, since their effect is to
reduce the overlap by reducing the contribution of population at different
distances, and to allocate levels of service more locally as well. We explore
these issues further by means of a simple but realistic simulated example.
The setup for the simulated example is shown in. There are three clinics and
nine population centers. Assume that the supply at the three clinics is one
physician at clinic 1, three physicians at clinic 2, and two physicians at
clinic 3. Further, assume that the population at 1, 2, 8, and 9 is 250;
population at 3, 4, and 6 is 250; and population at 5 and 7 is 1000. The total
population in the region therefore is 4, 500. Under this setup, the level of
service across the whole system is 1.33 physicians per thousand people, which we
will refer to as the Regional PPR.
For this experiment, we consider binary and stepwise impedance functions. The
former is simply the traditional 2SFCA method, whereas the latter is the
Enhanced 2SFCA approach. The catchment areas for the first step of the algorithm
(demand allocation) are shown in (binary impedance) and (stepwise impedance).
Notice that some population centers are inside the catchment areas of more than
one clinic. For instance, Population Center 5 is in the catchment areas of
Clinics 2 and 3, whereas Population Center 4 is in the catchment areas of all
three clinics.
To see how the overlap of catchment areas impacts the calculations in the first
step of the algorithm, we define impedance matrices using the same criteria as
for the buffers seen in Figs and. These matrices are shown in.
The demand for each clinic is calculated as the population of the centers
multiplied by the values of the corresponding impedance weight with respect to
that clinic, and then aggregated for all population centers. The level of
service is the supply divided by the demand, multiplied by 1, 000. The last row
of the table shows the total population as well as the total demand at each
clinic.
First we discuss the results according to the binary impedance function. As seen
in, the population of Center 3 (which is in the catchment area of three clinics)
is assumed to contribute 1, 500 patients to the demand across the system,
whereas Center 1 (which is in the catchment area of only one clinic) contributes
exactly its population of 250. Since the population of several centers is
counted multiple times, the apparent demand exceeds the actual population. In
effect, when we calculate the total demand (the sum of the demand across
clinics), we find that this is 9,750 according to the binary impedance function,
which far exceeds the actual population.
Turning now to the stepwise function, we see that Center 3 contributes 500 ×
0.242 + 500 × 0.600 + 500 × 0.242 = 542 to the demand across the system, but
Center 1 contributes only 250 × 0.242 = 60.5. The total demand now is 4,316,
which is *less* than the total population.
This example illustrates a vexing effect in how FCA methods operate: when
multiple service points are within the threshold travel cost of a population
center, it is assumed that some (and possibly all) of the same persons crowd
more than one service point, resulting in inflated demand and deflated levels of
service. On the other hand, when stepwise or continuous functions (e.g., E2SFCA)
are used to weigh down the population of distant population centers, the
apparent effect is that some segments of the population do *not* demand service,
even when clinics are within their threshold travel cost. This effect is even
more marked in the case of 3SFCA, which produces considerably higher levels of
service, as a consequence of stacking the effects of two impedance functions. In
effect, demand is deflated and the level of service is inflated. While the
assumption that some members of the population drop out from the total demand
pool may be acceptable for discretionary services, it is suspect when it comes
to essential services such as many health care services, and particularly
primary health care.
Recall as well that the Regional Average PPR in this example is 1.33 physicians
per thousand. If the total implied demand according to the binary impedance
function is 9,750 the corresponding PPR is 0.615 physicians per thousand, or
about half of the regional ratio. The corresponding PPR for the stepwise
impedance function (implied demand = 4315.5) is 1.39 physicians per thousand,
much closer to the Regional Average PPR. However, this PPR is misleading in that
it assumes that some segments of the population are served multiple times, and
some are not served at all.
Clearly, the first step of the algorithm can lead to inflation or deflation of
the levels of demand. But do these matter? Or do they somehow average out when
the levels of service are aggregated in the second step of the algorithm? Again,
the situation is not clear-cut when multiple population centers and/or service
clinics interact through overlapping catchment areas.
To illustrate this, we proceed to estimate the accessibility for the example
using the binary and the stepwise impedance matrices. The results appear in.
Accessibility in the table is calculated as the level of service of the clinics
multiplied by the the values of the impedance function with respect to a
population center, and then aggregated for all clinics. As seen in the table,
the levels of accessibility vary considerably depending on the method. As
anticipated, use of non-binary impedance functions reduces the inflation effect,
and can even lead to deflation. Consider for instance the case of the binary
impedance matrix: the total level of service in the system is the sum of the
level of service at the three clinics, or 1.87. The level of service *allocated*
to population centers, on the other hand, is the sum of the accessibility in the
system, or 11.8. When using the stepwise impedance function, the total level of
service in the system is 4.3, and the level of service allocated to population
centers is 11.2. Compare this to the case of 3SFCA, where the total level of
service in the system is 8.71, but the level of service allocated to population
centers is only 2.21; or the case of M2SFCA, which estimates the total level of
service in the system as 4.3 (same as E2SFCA) but allocates 5.74 to population
centers.
Clearly, all the methods give qualitatively similar results, with peripheral
centers displaying lower accessibility and more central places higher. But there
are important differences in how demand and level of service are allocated
throughout the system to calculate accessibilty. shows how the different methods
penalize peripheral centers at different rates. And, since the demand is not
consistent with the population and the accessibility is not consistent with the
level of service of the clinics, it is difficult to interpret the results in
terms PPRs. For instance, when we inspect the results for the binary impedance
matrix (2SFCA), we can see in the table that the accessibility of Population
Center 1 is simply the level of service of Clinic 1. But, as we saw before, this
level of service was deflated by double counting the population of Centers 2, 3,
and 4, which contribute to the calculation of demand at multiple clinics. Things
become more complex as the number of overlapping catchment areas grows. For
example, Population Center 2 contributed to the congestion effect of two
clinics. However, demand at one of those clinics was calculated using the
population of eight out of nine population centers. What this suggests is that,
at the very least, some population centers (likely those in the periphery of
regions) will have artificially low accessibility levels as a consequence of
demand inflation.
# A method for proportional allocation of demand and supply
As the examples in the preceding subsection illustrate, FCA methods can induce
quite substantial inflation (or deflation) of demand and level of service. This,
in turn, can affect the estimates of accessibility in potentially complex ways.
The results, furthermore lack a clear interpretation. In this section, we
propose a simple and intuitive adjustment to avoid the inflation artifacts
inherent in current implementations of FCA methods.
Refer again to. Demand inflation occurs because of the overlap in catchment
areas—with the underlying assumption that a service location services the
population within its catchment area. More realistically, only a fraction of
that population will demand service at the location if other service points are
within reach (i.e., inside its “floated” catchment area).
For instance, assuming (as the binary impedance function does), that individuals
at Population Center 1 are indifferent between Clinics 1 and 2, then it is
reasonable to think that the population will sort itself proportionally to these
two clinics—in this example, this means that half of the population will attend
one of two different clinics (importantly, this assumes that the services on
offer are undifferentiated; one would not generally consider cancer screening
and hair removal clinics competitors). This suggests the following adjustment to
the way the level of demand is calculated. Given an impedance function, a set of
adjusted weights, say $W_{ij}^{i*}$, are precalculated by dividing the original
impedance weights by the sum of the weights for population center *i* over all
service points *j*: $$W_{ij}^{i} = \frac{W_{ij}}{\sum_{j}W_{ij}}$$
Please notice that these weights are identical to the selection weights of the
3SFCA method. A key property of the adjusted weights is the following:
$$\sum\limits_{j}W_{ij}^{i} = 1$$
This adjustment procedure has the effect that, when the level of demand of *i*
is summed over all service points *j*, the aggregated level of demand due to *i*
is identical to its population: $$\sum\limits_{j}P_{i}W_{ij}^{i} = P_{i}$$
As a result of standardizing the impedance weights, population is allocated
*proportionally* to clinics.
On the supply side, inflation happens because the level of service available at
location *j* is assumed to be available to every population center *i* within
its catchment area. To adjust this, another set of weights, say $W_{ij}^{j*}$,
is pre-calculated by dividing the original impedance weights *W*<sub>*ij*</sub>
by the sum of the weights for service point *j* over all population centers *i*:
$$W_{ij}^{j} = \frac{W_{ij}}{\sum_{i}W_{ij}}$$
Again, the resulting weights have the property that: $$\sum\limits_{i}W_{ij}^{j}
= 1$$
As before, the result of this procedure is that, when the level of service of
*j* is aggregated by population centers, the total level of service for that
service point is preserved: $$\sum\limits_{i}L_{j}W_{ij}^{j} = L_{j}$$
Note that, since the weights add up to one, they can be interpreted as a
*probability* or *frequency* of contact, similar to the Huff model of.
In reference to (left panel), we can see that the original binary (unadjusted)
weights for Population Centre 1 are *W*<sub>11</sub> = 1, *W*<sub>12</sub> = 1,
the weights of population center 2 are *W*<sub>21</sub> = 1, *W*<sub>22</sub> =
1, and the weights of population center 3 are *W*<sub>31</sub> = 1,
*W*<sub>32</sub> = 1.
On the demand side, the adjusted weights become for Population Center 1,
$W_{11}^{i} = 1/2$, $W_{12}^{i} = 1/2$, for Population Center 2 $W_{21}^{i} =
1/2$, $W_{22}^{i} = 1/2$, and for Population Center 3 $W_{31}^{i} = 1/2$,
$W_{32}^{i} = 1/2$. Using the adjusted weights, it can be seen that the level of
demand due to each population center equals its respective population:
$$\begin{array}{r} \begin{array}{l} {\sum\limits_{j}D_{1}j = 1/2P_{1} + 1/2P_{1}
= P_{1}} \\ {\sum\limits_{j}D_{2}j = 1/2P_{2} + 1/2P_{2} = P_{2}} \\
{\sum\limits_{j}D_{3}j = 1/2P_{3} + 1/2P_{3} = P_{3}} \\ \end{array} \\
\end{array}$$
Coming next to the supply side, the adjusted weights for Clinic 1 are
$W_{11}^{j*} = 1/3$, $W_{21}^{i*} = 1/3$, and $W_{23}^{i*} = 1/3$; for Clinic 2
the adjusted weights are $W_{12}^{j*} = 1/3$, $W_{22}^{i*} = 1/3$, and
$W_{32}^{i*} = 1/3$. It can be seen that the level of service is preserved
across clinics, and therefore across the system: $$\begin{array}{r}
\begin{array}{l} {\sum\limits_{i}L_{i1} = L_{1}/3 + L_{1}/3 + L_{1}/3 = L_{1}}
\\ {\sum\limits_{i}L_{i2} = L_{2}/3 + L_{2}/3 + L_{2}/3 = L_{2}} \\ \end{array}
\\ \end{array}$$
The method to adjust the weights used above is identical to a procedure that
will be familiar to readers acquainted with the literature in the fields of
spatial statistics and econometrics. The same adjustment is widely used there
under the names of row- and column-standardization of a weights matrix.
The proposed adjustment can be easily implemented. We will present next the
implementation using a compact matrix notation. Begin by defining the following
impedance matrix: $$\begin{array}{r} {\mathbf{W} = \begin{pmatrix} W_{11} &
\cdots & W_{1J} \\ \vdots & \ddots & \vdots \\ W_{N1} & \cdots & W_{NJ} \\
\end{pmatrix}} \\ \end{array}$$ where *W*<sub>*ij*</sub> is an impedance
function evaluated at *d*<sub>*ij*</sub>. Subindex *i* is for population centers
(*i* = 1, …, *N*) and subindex *j* is for service points (*j* = 1, …, *J*). Note
that the matrix does not need to be square. A row-standardized set of weights is
obtained as follows: $$\begin{array}{r} {\mathbf{W}^{i} = \begin{pmatrix}
\frac{W_{11}}{\sum_{j}W_{1j}} & \cdots & \frac{W_{1J}}{\sum_{j}W_{1j}} \\
\vdots & \ddots & \vdots \\ \frac{W_{N1}}{\sum_{j}W_{Nj}} & \cdots &
\frac{W_{NJ}}{\sum_{j}W_{Nj}} \\ \end{pmatrix}} \\ \end{array}$$
Next, a column-standardized set of weights is calculated as: $$\begin{array}{r}
{\mathbf{W}^{j} = \begin{pmatrix} \frac{W_{11}}{\sum_{i}W_{i1}} & \cdots &
\frac{W_{1J}}{\sum_{i}W_{iJ}} \\ \vdots & \ddots & \vdots \\
\frac{W_{N1}}{\sum_{i}W_{i1}} & \cdots & \frac{W_{NJ}}{\sum_{i}W_{iJ}} \\
\end{pmatrix}} \\ \end{array}$$
In the first example above, the binary impedance matrix is: $$\begin{array}{r}
{\mathbf{W}_{binary} = \begin{pmatrix} 1 & 1 \\ 1 & 1 \\ 1 & 1 \\ \end{pmatrix}}
\\ \end{array}$$
The row-standardized weights that correspond to this matrix are:
$$\begin{array}{r} {\mathbf{W}_{binary}^{i} = \begin{pmatrix} {1/2} & {1/2} \\
{1/2} & {1/2} \\ {1/2} & {1/2} \\ \end{pmatrix}} \\ \end{array}$$ and the
column-standardized weights are: $$\begin{array}{r} {\mathbf{W}_{binary}^{j} =
\begin{pmatrix} {1/3} & {1/3} \\ {1/3} & {1/3} \\ {1/3} & {1/3} \\
\end{pmatrix}} \\ \end{array}$$
The stepwise impedance weights in the example are: $$\begin{array}{r}
{\mathbf{W}_{stepwise} = \begin{pmatrix} {0.8} & {0.8} \\ {0.8} & {0.4} \\ {0.4}
& {0.8} \\ \end{pmatrix}} \\ \end{array}$$
The row-standardized weights in turn are: $$\begin{array}{r}
{\mathbf{W}_{stepwise}^{i} = \begin{pmatrix} {1/2} & {1/2} \\ {2/3} & {1/3} \\
{1/3} & {2/3} \\ \end{pmatrix}} \\ \end{array}$$ whereas the column-standardized
weights are: $$\begin{array}{r} {\mathbf{W}_{stepwise}^{j} = \begin{pmatrix}
{4/10} & {4/10} \\ {4/10} & {2/10} \\ {2/10} & {4/10} \\ \end{pmatrix}} \\
\end{array}$$
Once that the impedance weights have been adjusted, a vector of adjusted level
of demand **D**\* can be obtained by multiplying the *transposed* impedance
matrix by a vector of population values as follows: $$\mathbf{D}^{*} =
\left\lbrack \mathbf{W}^{i} \right\rbrack^{T}\mathbf{P}$$ where the
<sup>*T*</sup> operator is for “transpose”, and **P** is: $$\begin{array}{r}
{\mathbf{P} = \begin{pmatrix} P_{1} \\ \vdots \\ P_{N} \\ \end{pmatrix}} \\
\end{array}$$
The level of demand for the service points in the binary impedance function
example is (in vector form): $$\begin{array}{r} {\mathbf{D}_{binary}^{*} =
\begin{pmatrix} {1/2} & {1/2} & {1/2} \\ {1/2} & {1/2} & {1/2} \\
\end{pmatrix}\begin{pmatrix} 100 \\ 100 \\ 100 \\ \end{pmatrix} =
\begin{pmatrix} {300/2} \\ {300/2} \\ \end{pmatrix} = \begin{pmatrix} 150 \\ 150
\\ \end{pmatrix}} \\ \end{array}$$ Notice how each clinic is expected to service
only 150, and the level of demand over the system is identical to the total
population.
The level of demand for the service points in the stepwise impedance function
example is (in vector form): $$\begin{array}{r} {\mathbf{D}_{sw}^{*} =
\begin{pmatrix} {1/2} & {2/3} & {1/3} \\ {1/2} & {1/3} & {2/3} \\
\end{pmatrix}\begin{pmatrix} 100 \\ 100 \\ 100 \\ \end{pmatrix} =
\begin{pmatrix} {50 + 200/3 + 100/3} \\ {50 + 100/3 + 200/3} \\ \end{pmatrix} =
\begin{pmatrix} 150 \\ 150 \\ \end{pmatrix}} \\ \end{array}$$ As can be seen,
the aggregated level of demand, after the adjustment, equals (as desired) the
actual population of the region. In the case of the stepwise function, total
demand has been adjusted to the population of the region without the restrictive
assumption that some people are excluded from the system. This is achieved by
assuming an assortative process that leads to proportional allocation of the
demand.
The levels of demand can then be used to calculate the level of service at the
individual clinic locations by performing Hadamard division (⊘) of the vector of
supply by the vector of adjusted demand. This is the first step of the 2SFCA
(aggregating demand over catchment areas for service points): $$\mathbf{L}^{*} =
\mathbf{S} \oslash \mathbf{D}^{*}$$
Since Hadamard division is an element-by-element operation, the adjusted levels
of service in the first example (using the binary impedance function) are:
$$\begin{array}{r} {\mathbf{L}_{b}^{*} = \begin{pmatrix} 10 \\ 10 \\
\end{pmatrix} \oslash \begin{pmatrix} 150 \\ 150 \\ \end{pmatrix} =
\begin{pmatrix} {10/150} \\ {10/150} \\ \end{pmatrix} = \begin{pmatrix} {0.067}
\\ {0.067} \\ \end{pmatrix}} \\ \end{array}$$
The levels of service in the second example, when using the stepwise impedance
function, are also: $$\begin{array}{r} {\mathbf{L}_{sw}^{*} = \begin{pmatrix} 10
\\ 10 \\ \end{pmatrix} \oslash \begin{pmatrix} 150 \\ 150 \\ \end{pmatrix} =
\begin{pmatrix} {10/150} \\ {10/150} \\ \end{pmatrix} = \begin{pmatrix} {0.067}
\\ {0.067} \\ \end{pmatrix}} \\ \end{array}$$
Unlike the 2SFCA, E2SFCA, and 3SFCA methods that produce levels of service that
resemble PPRs but with values that are inconsistent with total demand given the
population, this operation returns values that are genuinely local PPRs that are
consistent with the population of the region. As we saw above, the demand equals
the population. Here, the supply also equals the number of physicians in the
region. Because both demand and supply are not inflated or deflated in this
rectified method, these values are easily interpretable relative to the Regional
Average PPR of 20/300 or 0.067 physicians per person. In the case of the
example, it is clear that both clinics have PPRs that are identical to the
Regional Average PPR.
Accessibility, finally, is calculated as the matrix product of the column-
standardized weights and the adjusted level of service: $$\mathbf{A}^{*} =
\mathbf{W}^{j}\mathbf{L}^{*}$$ which, continuing with the example, gives the
following for the binary impedance function: $$\begin{array}{r}
{\mathbf{A}_{b}^{*} = \begin{pmatrix} {1/3} & {1/3} \\ {1/3} & {1/3} \\ {1/3} &
{1/3} \\ \end{pmatrix}\begin{pmatrix} {10/150} \\ {10/150} \\ \end{pmatrix} =
\begin{pmatrix} {10/450 + 10/450} \\ {10/450 + 10/450} \\ {10/450 + 10/450} \\
\end{pmatrix} = \begin{pmatrix} {0.044} \\ {0.044} \\ {0.044} \\ \end{pmatrix}}
\\ \end{array}$$ Notice how the sum of accessibility over the region is
consistent with the total level of service over all clinics (i.e., 0.133). The
level of service has been allocated in its totality.
When using the stepwise impedance function, accessibility is calculated as:
$$\begin{array}{r} {\mathbf{A}_{sw}^{*} = \begin{pmatrix} {4/10} & {4/10} \\
{4/10} & {2/10} \\ {2/10} & {4/10} \\ \end{pmatrix}\begin{pmatrix} {10/150} \\
{10/150} \\ \end{pmatrix} = \begin{pmatrix} {4/150 + 4/150} \\ {4/150 + 2/150}
\\ {2/150 + 4/150} \\ \end{pmatrix} = \begin{pmatrix} {0.053} \\ {0.040} \\
{0.040} \\ \end{pmatrix}} \\ \end{array}$$ Again, the sum of accessibility is
consistent with the level of service available from all clinics in the region.
As with the Local PPRs, accessibility is interpreted as population-to-provider
ratios for each population center in such a way that all calculations are with
total demand and total level of service. In particular, accessibility can be
interpreted as the share of level of service that a population center receives
from all the clinics that service it.
For the sake of comparison, levels of service and accessibility are reported for
the simulated example in Tables and.
An important point to remark is the following. The use of row- and column-
standardized impedance weights assumes that the full population of every
population center within the catchment of a clinic will receive service.
However, the allocation, although proportional, is different when binary or
stepwise impedance weights are standardized. When binary weights are employed,
the underlying idea is that potential for use is identical within the catchment
area irrespective of distance. When stepwise weights are used, proportionally
more of the population is allocated to closer clinics. Depending on the
definition of cost of travel, this allows a research to accommodate directional
effects as well. For example, use of network travel time would tend to favor
movement away from congested locations.
## Suboptimal systems
The research of Delamater illustrates how accessibility estimates can be
misleading when systems are not optimally configured. We understand this to mean
that some population centers are located too far away from service points to
actually benefit from them. In the modified 2SFCA method (M2SFCA), Delamater
addresses this issue by increasing the friction of distance. A slight
inconsistency in this approach is that some of the centers that contribute to
demand fail to benefit from the service due to the increased friction to which
the allocation of the level of service is subjected. Our suggestion in the case
of suboptimal systems is to use an impedance function that reflects limiting
conditions. For instance, in urban settings a travel time longer than 2 hours
might be considered too long to be serviced by any clinic.
## System efficiency
The approach proposed in this paper allocates population and level of service
proportionally and exactly. This assumes that the population sorts itself into
clinics in the most efficient way. But what if some members of the population
lack full information about the spatial distribution of clinics? Or have some
bias towards centric locations? The vagaries of human behavior could create
excess demand in some locations, and as a consequence supply surpluses in
others. Situations like this can be accommodated in a relatively straightforward
way using our approach.
Here, we describe the use of *slack factors*. Demand and level of service are
allocated proportionally and exhaustively (i.e., 100%). But the standardization
could allow for some slack, by inflating demand and/or supply in a controlled
way.
Our proposal to standardize the weights was as follows, for the case of rows and
columns respectively: $$\begin{array}{r} {\mathbf{W}^{i} = \begin{pmatrix}
\frac{W_{11}}{\sum_{j}W_{1j}} & \cdots & \frac{W_{1J}}{\sum_{j}W_{1j}} \\
\vdots & \ddots & \vdots \\ \frac{W_{N1}}{\sum_{j}W_{Nj}} & \cdots &
\frac{W_{NJ}}{\sum_{j}W_{Nj}} \\ \end{pmatrix}\text{and}\mathbf{W}^{j} =
\begin{pmatrix} \frac{W_{11}}{\sum_{i}W_{i1}} & \cdots &
\frac{W_{1J}}{\sum_{i}W_{iJ}} \\ \vdots & \ddots & \vdots \\
\frac{W_{N1}}{\sum_{i}W_{i1}} & \cdots & \frac{W_{NJ}}{\sum_{i}W_{iJ}} \\
\end{pmatrix}} \\ \end{array}$$
A set of slack factors, say $k_{i}^{i}$, could be introduced in the following
manner: $$\begin{array}{r} {\mathbf{W}^{i} = \begin{pmatrix}
\frac{k_{1}^{i}W_{11}}{\sum_{j}W_{1j}} & \cdots &
\frac{k_{1}^{i}W_{1J}}{\sum_{j}W_{1j}} \\ \vdots & \ddots & \vdots \\
\frac{k_{N}^{i}W_{N1}}{\sum_{j}W_{Nj}} & \cdots &
\frac{k_{N}^{i}W_{NJ}}{\sum_{j}W_{Nj}} \\ \end{pmatrix}} \\ \end{array}$$ A
value of $k_{1}^{i} = 1.10$ would inflate the demand of population center *i* =
1 by 10%, whereas a value of $k_{1}^{i} = 1.20$ would inflate the demand by 20%.
In a similar way, a set of slack factors $k_{i}^{j}$ could be introduced to
modulate the allocation of supply: $$\begin{array}{r} {\mathbf{W}^{j} =
\begin{pmatrix} \frac{k_{1}^{j}W_{11}}{\sum_{i}W_{i1}} & \cdots &
\frac{k_{J}^{j}W_{1N_{J}}}{\sum_{i}W_{iJ}} \\ \vdots & \ddots & \vdots \\
\frac{k_{1}^{j}W_{N1}}{\sum_{i}W_{i1}} & \cdots &
\frac{k_{J}^{j}W_{NJ}}{\sum_{i}W_{iJ}} \\ \end{pmatrix}} \\ \end{array}$$ A
value of $k_{1}^{j} = 0.9$, for example, would deflate the supply of clinic *j*
= 1 by 10%. The use of slack factors provides an interesting way of modulating
demand and level of service allocation in a very precise and controlled way, and
presents interesting opportunities as well to introduce expert opinion or other
empirical approaches to callibrate slack factors.
# Empirical example
In the reminder of the paper we present an empirical example to illustrate the
application of the methods presented above. Based on the preceding discussion,
the adjusted 2SFCA method employed can be summarized as: $$L_{j} =
\sum\limits_{i}\frac{S_{j}}{P_{i}W_{ij}^{i}}$$ with row-standardized impedance
weights $W_{ij}^{i}$ in the first step, and: $$A_{i} =
\sum\limits_{j}{L_{j}W_{ij}^{j}}$$ with colum-standardized impedance weights
$W_{ij}^{j}$ in the second step. The same approach is used to re-weight the
impedance function for the stepwise approach (i.e., E2SFCA).
The case study is based on accessibility to family physicians in the Hamilton
Census Metropolitan Area (CMA), in Ontario, Canada. For this, we use data
collected about the distribution of the population and primary health care
clinics (i.e., family physicians) in the region. Time use data from Canada’s
General Social Survey (GSS) was also used to inform the selection of thresholds
for the impedance functions. The data collection and preprocessing protocols are
described next.
## Family physicians and clinic locations
In regards to the supply of clinics, the locations of family physicians were
obtained using the College of Physicians and Surgeons of Ontario (CPSO) database
for the Province of Ontario. We chose this organization beacuse all physicians
practicing in Ontario are required to register with the CPSO, as set out in the
Ontario Regulation 865/93: Registration.
Our search of CPSO’s database was conducted attending to the following
criteria.
1. Only physicians who are registered as family physicians were selected
(this excluded specialists such as pediatric physicians).
2. The spatial extent of the search was determined using forward sortation
areas (FSAs), which are the first three initial characters of a postal code.
Using a GIS, the regions of interest were selected by choosing FSAs within a
10 kilometer buffer distance from the Hamilton CMA boundary. This involved
72 different FSA regions. Each FSA region code was then searched in the CPSO
database in addition to the family physician specification.
The parameters of the search were deliberately conservative, and the search
identified a total of 2,224 family physicians practicing in the region, of
which, 864 are located in the Hamilton CMA. The resulting dataset was manually
verified by the third author to ensure that the information was consistent and
suitable for geocoding. Prior to geocoding, locational information was organized
in three columns, containing street address, city name, and province name. After
family physicians were geocoded, locations were further examined. When family
physicians overlapped or were within a 50 meter distance of each other we merged
the records to identify 535 unique locations that we term “clinics”. Many of
these clinics are not in the Hamilton CMA proper, but provide a buffer to
minimize edge effects in the analysis. The distribution of clinics and family
physicians is shown in for the Hamilton CMA.
## Population
Population information was obtained from the 2011 Canadian Census. To maximize
the spatial resolution, population data were acquired at the Dissemination Area
(DA) level of geography for all DAs within the selected FSAs. As a result, this
includes DAs not in the Hamilton CMA proper, but that provide a buffer against
edge effects. From this, the region contains a population of 2,959,090, of which
720,725 are in the Hamilton CMA. The distribution of population in the Hamilton
CMA is shown in.
## Travel time matrix
Calculation of impedance weights requires that we evaluate an impedance function
at values of *d*<sub>*i*</sub> *j*, that is, the cost of travel between DA *i*
and clinic *j*. In this research we used travel time as our cost variable. To
this end, we computed a matrix of travel times measured over the road network.
To calculate the travel time between population centers and clinics we used the
DA centroids and the geocoded locations of clinics. Shortest paths on the
network and subsequently travel times were computed using a Geographic
Information System.
## Impedance functions
For the experiments we use two different impedance functions, corresponding to
the 2SFCA and E2SFCA algorithms. We do not implement the 3SFCA or the M2SFCA
methods because, as noted above, they are equivalent to using steeper
impedances. For the 2SFCA apprach, impedance is given by a binary function,
whereas for E2SFCA it is given by a stepwise function. The impedance functions
require that we define cost (i.e., travel time) thresholds to implement them. To
select the thresholds, we retrieved time use data from Canada’s General Social
Survey Cycle 24 (see <http://odesi2.scholarsportal.info/webview/>).
From the time use files, we filtered all activity episodes corresponding to
respondents living in CMAs/CAs (metropolitan regions) in Ontario. Next, we
filtered all episodes taking place in a car (as driver) while traveling for
personal care activities for household adults (which includes traveling to see a
doctor) and traveling for shopping or obtaining services (which includes
traveling to go to health clinic or doctor’s office). It is worthwhile noting
that travel by car accounts for over 95% of trips for the selected purposes in
Ontario CMAs/CAs.
Once episodes were filtered by mode of travel and purpose of the trip, their
durations (in minutes) were examined by means of quantile analysis, using
episode weights to ensure the representativeness of the analysis. From the
results, we learned that 50% of all trips by car for the aforementioned purposes
are less than 15 minutes long, and we selected this value as the threshold
*d*<sub>0</sub> for the binary function. In other words, this part of the
analysis assumes that any person who has to travel longer than 15 minutes to
reach a clinic is outside its catchment area. We deem this value appropriate for
the scale, density, and level of congestion of Hamilton CMA.
Quantile analysis of trip durations was also used to calibrate a Gaussian
function with standard deviation set at 15 minutes, to match the value selected
for the binary impedance above. This produced the following stepwise function,
with any trips longer than 45 minutes assumed to be outside of catchment:
$$W\left( d_{ij} \right) = \left\{ \begin{array}{ll} {0.946} & { d_{ij} \leq 5}
\\ {0.801} & { 5 < d_{ij} \leq 10} \\ {0.607} & { 10 < d_{ij} \leq 15} \\
{0.411} & { 15 < d_{ij} \leq 20} \\ {0.135} & { 20 < d_{ij} \leq 30} \\ {0.011}
& { 30 < d_{ij} \leq 45} \\ {0.00} & { 45 < d_{ij}} \\
\end{array}\operatorname{} \right.$$
Notice how the stepwise function has weights greater than 0.5 for
*d*<sub>*ij*</sub> ≤ 15*min* and less than 0.5 for *d*<sub>*ij*</sub> \>
15*min*. This means that it will count fewer people than the binary function
when *d*<sub>*ij*</sub> ≤ 15*min*, but more when *d*<sub>*ij*</sub> \> 15*min*.
## Results
We begin our discussion of the results by noting that with a total population of
the region of 2,959,090 and 2,222 family physicians, the Regional Average PPR
ratio is 0.751 family physicians per 1,000 people. This value is somewhat lower
than the value of 1.16 for Ontario reported by CIHI and lower than the 1.20
estimated based on the population and physician data for the Hamilton CMA, which
we attribute to our conservative search criteria of family physicians in the
rest of the region.
The nominal levels of demand, service, and accessibility are calculated for the
2SFCA and E2SFCA using both the unadjusted and adjusted impedance matrices.
summarizes the results by each impedance matrix. As seen there, when no
adjustment is made, the nominal demand explodes to several times the actual
population in the region. However, when the impedance weights are standardized,
demand is now only slightly less than the total population for the region, since
the system is not optimal in the sense discussed by Delamater, and a small
proportion of the population turns out to be outside of catchment. The nominal
demand under binary impedance is lower due to the stricter catchment area
condition (i.e., less than 15 minutes), compared to the stepwise function (i.e.,
less than 45 minutes). This, in turn, is somewhat lower than the total demand in
the Regional Average PPR, which does not impose catchment area constraints
within the region.
It is clear that the rectified demand leads to results that are considerably
more realistic than the conventional approaches. In addition to the nominal
system-wide demand, this is seen as well when calculating the regional provider-
to-population ratios for each case (i.e., Family Physicians per 1,000 people).
As seen in the table, the mean levels of service for clinics in the region in
the case of the adjusted binary and stepwise weights are in line with their
corresponding Regional Average PPRs. Since the levels of service in the case of
the adjusted weights can be interpreted as local PPRs, this indicates that the
average clinic offers approximately the same level of service as the regional
system does for the whole population. Furthermore, the mean accessibility of a
DA according to the adjusted weights is identical to the mean LOS: this is
because the LOS is allocated completely to DAs. The total LOS and accessibility
in the region match when the adjusted weights are used. This is not the case
when the unadjusted weights are used. Clearly, the use of the unadjusted weights
can lead to a substantial amount of accessibility inflation, by factors as high
as five or six times the estimates of the proposed proportional allocation
approach.
These results demonstrate how inflation of the supply (i.e., the level of
service) leads to much higher values of accessibility in the case of the
conventional 2SFCA and E2SFCA methods. The procedure to rectify the population
and level of service, on the other hand, leads to accessibility outputs that are
consistent with the regional population and overall supply of health care
services. This, in turn, makes interpretation of the output more robust and
intuitive.
Another important issue is that spatial distribution of inflation of demand and
level of service. If inflation happened in a uniform way, the upward bias in the
estimates could to some extent be ignored, as long as relative differences by
location remained relatively constant. Unfortunately, as seen in Figs and,
demand inflation is far from uniform. In fact, inflation of demand tends to
happen, as per our earlier conjecture, in areas with higher population density.
Inflation factors are also substantially higher when the binary impedance
function is used. Since this function lacks a gradual distance-decay mechanism,
it is more generous in terms of counting population serviced. Notice the
magnitude of the inflation factors: since the inflation of demand depends on the
number of overlapping catchment areas, a factor of 160, for instance, would
suggest that a clinic is expected to *simultaneously* serve approximately that
number of DAs in the conventional 2SFCA method, and a proportionally similar
number in the conventional E2SFCA method.
The map of accessibility for the implementation of 2SFCA is shown in and with
the adjusted weights for proportional allocation in. The general patterns
observed in the figures are as expected, with higher accessibility in denser,
better connected parts of the region. Relatively high accessibility in the north
and west of the CMA is due to proximity to other major population centers such
as Oakville, Kitchener, and Waterloo. A question, however, is the degree of
inflation of accessibility in the original 2SFCA? plots the ratio of the binary
and adjusted binary accessibility measures. Here it can be seen that the
unadjusted accessibility values are at least three times greater than their
adjusted counterparts within the study area. This inflation, moreover, is not
uniform across space, with inflation of the binary accessibility values up to 8
times greater than those from the adjusted model at the edges of the city where
the 15-minute catchment areas begin to overlap with neighboring municipalites.
Why is this important? As noted by various authors, in traditional FCA methods,
the sum of the population-weighted average of accessibility across all
population centers is equal to the regional average provider-to-population
ratio. In the present case, the weighted sum of accessibility in the unadjusted
binary and stepwise measures is 0.751. However, while this value is indeed
identical to the regional average provider-to-population ratio, it is
problematic because the share of the population correlates poorly with the
pattern of inflation observed. The key issue here is that accessibility is
deflated by the share of the population in a DA *i*; however, the degree of
inflation of demand and supply depends not only of the population DA *i*, but on
the population of every DA *j* with which DA *i* interacts via overlapping
catchment areas. As a consequence, deflating accessibility using population
shares in previous FCA methods does not accurately offset demand and supply
inflation.
Figs and present the results for the stepwise E2SFCA with and without the
rectification. The results are qualitatively similar to the 2FSCA, with the
expected differences. The inflation factors are even more substantial, given the
larger catchment areas used.
## Disparity analysis
An advantage of the use of adjusted weights for proportional allocation of
demand and level of service it that, after rectifying the inflation artifact,
they make it is possible to conduct accessibility disparity analysis in a very
intuitive way.
For instance, an analyst interested in equity analysis could allocate the total
level of service uniformly to every DA. In other words, the total level of
service (which equals the sum of accessibility over the system) can be divided
by the number of population centers in the system to return the Average Local
Population Center PPR. The resulting mean value, call it $L_{i}^{e}$ then would
be assigned to the population centers as their “equitable” share of the total
level of service in the system. Next, the equitative distribution of the level
of service in each population center is substracted from the estimated mean
accessibility to arrive at a disparity index. When the difference between these
two quantities is positive, this would indicate that a DA’s accessibility
exceeds its equitable share of level of service. On the other hand, when the
difference is negative, the DA’s accessibility is below its equitable share of
the level of service.
This approach is reminiscent of the Spatial Access Ratio (SPAR) proposed by Wan
et al., which is calculated as the ratio between a population center’s
accessibility and the mean accessibility across all population centers. Wan et
al. calculate SPAR based on the results of their 3SFCA method, by rescaling the
accessibility measures to reflect the percentage difference in each population
center’s accessibility relative to the mean. This measure is designed to
overcome the sensitivity of existing FCA metrics to the impedance function. In
contrast, the approach proposed here, enables more intuitive and interpretable
results by preserving the system-wide population and level of service. In this
way, a disparity index is useful to highlight the absolute difference in
accessible provider-to-population ratios across population centers.
Disparity maps for the adjusted binary and stepwise impedance functions are
shown in Figs and. These figures reveal the spatial distribution in disparity,
with levels of access that are lower than the mean in more rural parts of the
city (where travel times are longer and the distribution of physicians is more
spatially disperse) compared to levels of access that are greater than the mean
in the higher-density and more connected urban center.
# Conclusion
Accessibility to healthcare is an issue of continued interest in health
geography. One of the most popular approaches to estimating accessibility is the
2SFCA method and its associated family of FCA models due to their simplification
of more complex gravity models and their interpretation as proxies for provider-
to-population ratios. These properties make FCA approaches particularly
appealing for health policy. In this paper, we have argued that the
overestimation of demand and level of service in FCA approaches poses a
challenge to the interpretation of accessibility and the identification of
spatial disparities in access, with potentially deleterious consequences for
policy analysis.
The issue of overestimation of demand and level of service has been recognized
before, notably by Wan et al. and Delamater, and alternative approaches have
been proposed that seek to offset or reduce the problem. Nevertheless, the
present paper has shown that the inflation of demand is present in all existing
FCA methods. Moreover, we also show that in some cases, demand is deflated, and
detail the potential for inflation/deflation on the supply side. To overcome
these issues, we draw from the fields of spatial statistics and econometrics, to
incorporate row-standardized impedance weights in the calculation of demand, and
column-standardized impedance weights to adjust the level of service. These
adjustments ensure that allocation of demand and level of service are
proportional. As a result, both the system-wide population and level of service
are preserved in the estimation of accessibility.
The case study in Hamilton CMA reveals the extent of inflation in accessibility
inherent in the unadjusted approaches compared to the adjusted binary and
stepwise FCA methods. Furthermore, the adjustments result in local provider-to-
population ratios which can be easily understood relative to the system-wide
equitable level of service through the calculation of a disparity index. The
applicability of these values is particularly enhanced by the use of a travel
survey to inform the estimated impedance functions. Taken together, these
innovations provide estimates of spatial accessibility and disparity that are
robust to the regional distribution of supply and demand, as well as observed
travel behaviour. By extension, these properties mean that the adjusted approach
employed here can offer more rigorous recommendations for health policy.
Finally, 1) we proposed a set of slack factors to modulate the estimates of
demand and/or level of supply to account for system inefficiencies; and 2)
demonstrated the use of a disparity index to conduct equity analysis.
In conclussion, the research presented in this paper demonstrates how a
relatively simple adjustment of the impedance weights can help to overcome the
inflation/deflation issue inherent in previous FCA approaches. By incorporating
these methods into the estimation of accessibility to healthcare services,
future research can help to ensure that the FCA approach continues to live up to
its promise as an intuitive and policy-relevant method for investigating access
and disparity.
# Replicable research
This research was conducted and the paper prepared using `R` and RStudio, along
with the following packages: `tidyverse`, `knitr`, `rgdal`, `sf`, `gridExtra`,
`raster`, `readr`, `kableExtra`, `ggthemes`, `ggrepel`. Data and source code
used in this research are available at <https://github.com/paezha/Demand-and-
Supply-Inflation-in-Floating-Catchment-Area-FCA-Methods->.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Vocal nodules (VN) belong to the most common benign vocal cord disease, and is
characterized by bilateral nodular protrusions in the anterior 1/3 of the vocal
cords and voice disorder. Researches have suggested potential associations
between VN and phonetic trauma/abuse, while their exact etiopathogeneses remain
unknown. Due to hoarseness, vocal fatigue and pharyngeal discomfort, VN
decreases patients’ quality of life, physiologically and socially. According to
a Korean epidemiological report, the incidence of VN was 0.99%-1.72%, while it
was more frequent in male children and adult female, which was same as a Turkish
survey (diagnosed in 30.3%, 187 cases, of school age children).
Formally, therapies for VN are divided into surgical and non-surgical
approaches, and specific superiority or inferiority concerning any of them were
still not evaluated in a Cochrane systematic review. However, clinically, non-
surgical therapies are more selected and better preferred by medical staff and
patients, which may owe to its non-invasive nature. Among them, evidence showed
that voice training (VT) is beneficial in improving voice quality, while it was
not popular in most of the world due to insufficient (or without) speech
pathology specialty and limited medical resources. In addition to VT and other
non-surgical therapies, some VN patients have been turning to complementary and
alternative therapies, acupuncture and Chinese herbal medicine (CHM) especially,
for better efficacy, longer duration and fewer costs.
In traditional Chinese medicine (TCM), VN lies in *Qi* stagnation, phlegm, fluid
retention, and blood stasis, which are resulted from unbalanced visceral
function, and gather in vocal cord. Originating about three thousand years ago,
acupuncture could regulate *Yin*, *Yang*, and visceral function based on the
principles of meridians and acupoints of TCM, as well as circulate qi and blood.
As a frequently used adjuvant, trials suggested potential benefits of
acupuncture for benign nodular/hyperplasia diseases, such as benign prostatic
hyperplasia, hyperplasia of mammary glands, and thyroid nodule.
However, no systematic review has been published to explore efficacy and safety
of acupuncture for VN. The aim of this systematic review and meta-analysis is to
fill the vacancy above with rigorous design and comprehensive analyses, and
incorporate new evidence about acupuncture for VN. In addition, potential
variations between studies, quality of outcomes and strength of evidence
recommendations were also measured for better clinical application.
# Material and methods
## Protocol and registration
This systematic review was registered in PROSPERO with the registration number
CRD42022350916 (available from
<https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=350916>).
## Search strategy
Four English databases, including PubMed, Embase, Cochrane Library, Web of
Science, and four Chinese databases, including Chinese Biomedical Literature
Database, VIP Database for Chinese Technical Periodicals, China National
Knowledge Infrastructure, and Wanfang Database, were searched from inception
until December 10<sup>th</sup>, 2022. The PRISMA agreement was followed in
decision of search strategy and inclusion criteria. Two subsets of terms were
searched with the term ‘AND’, including the experimental intervention
(‘acupuncture’, ‘needle’, ‘electro-acupuncture’, ‘electropuncture’,
‘electroacupuncture’, ‘acusector’, and ‘acupoint’) and terms of the disease
(‘vocal nodule’, ‘behavioral voice disorder’, ‘voice disorder’, ‘voice’, ‘vocal
cord’, ‘hoarseness’, ‘speech disorder’). Two authors processed the searches
independently, and we also searched the references of the original and review
studies manually for trials.
## Inclusion criteria
1\) Trials in which participants were diagnosed with vocal nodules by
laryngoscopy, and there was no limitation on type of laryngoscopy and vocal
nodules;
2\) Prospective randomized controlled trials (RCTs).
3\) Trials in which acupuncture (manual or electro type) was applied as the only
therapy in experimental groups. The participants in control groups received sham
acupuncture, blank (wait-list) controls, western medicine (WM), TCM, VT, etc..
There was no restriction on duration, frequency, acupoint, or stimulation of
acupuncture, while trials with other acupoint-based therapy (e.g., acupressure,
moxibustion, acupoint injection, catgut embedding) designed as the control were
excluded.
4\) Primary outcomes included clinical effective rate (CER). Secondary outcomes
included scales on objective sound quality and scores of subjective symptoms.
5\) Trials published in Chinese or English.
## Study selection and data extraction
Two reviewers (RZ and QF) searched the online databases listed above and
recorded the titles and abstracts of all the articles. Two evaluators (XL and
YL) assessed the eligibility of these articles and made decisions on every
research (inclusion or exclusion) independently. If they did not reach the same
decision, the concerned articles were discussed with a fourth reviewer (ZX). Two
reviewers (QP, and XX) extracted data independently from each study. Differences
of extracted data were solved after discussion with a third reviewer (LZ).
## Quality assessment
Quality assessment of all the trials included in this review was independently
evaluated by three reviewers (QF, XL and RZ) using the Cochrane Collaboration
risk of bias tool by RevMan 5.4 software. Any disagreement was resolved by
discussions with a fourth reviewer (ZX or LZ).
## Statistical analysis
Statistical analyses were measured with RevMan V.5.4, Stata V.14 and TSA 0.9
software. Effect sizes were determined as weighted mean difference (WMD) or
standard mean difference for continuous outcomes, and risk ratio (RR) for binary
outcomes with their 95% confidence intervals (CI). The Q and I<sup>2</sup> test
statistics were conducted to examine heterogeneity, with I<sup>2</sup>\>50%
indicating significant heterogeneity, with fixed or random-effects model
applied, with P \<.05 indicating significant differences for effect sizes. If
the heterogeneity was still obvious (I<sup>2</sup>\>50%) and more than two
trials were included, then meta-influence analysis (for sensitivity analysis)
was conducted.
Further, meta-regression and regression-based sub-group analyses for the primary
outcome were performed to identify potential variables leading to high
heterogeneity with interpretation. Exploration of publication bias by Egger’s
tests were planned for the primary outcome, together with trim and fill test for
further identification of the stability. P \<.05 indicates significant
differences for meta-regression, and p\<0.1 for Egger’s test.
For the primary outcome, trial sequential analyses were performed by TSA 0.9
with type I error α = 0.05 and type II error β = 0.1, aiming at examining and
minimizing the impact of type 1 errors due to sparse data and repeated
significance testing following updates with new trials. We also conducted
penalized test for further verification. Strength of evidence recommendations
for effect estimation in each outcome was evaluated by The Grading of
Recommendations Assessment, Development and Evaluation system (GRADE) pro GDT.
In addition, cluster analyses and correlation coefficient of the variables were
performed concerning acupoints applied among the included trials by R 4.1.3.
# Results
## Study inclusion
Originally, 4161 studies were retrieved from the seven databases, of which 2363
were removed due to duplication, and 1352 studies were eliminated according to
titles and abstracts. The remaining 446 studies were downloaded for further
consideration, and among which 311 studies were excluded with reasons. Finally,
15 trials from 12 studies (three three-arm studies were recombined to six trials
for comparison) were included.
## Study characteristics
All of the 15 trials were conducted in China and published in Chinese, with the
range of publish years from 1999 to 2022. Specifically, 1118 participants aging
from 12 to 65 with VN from 20 days to 6 years were involved. As for experimental
intervention, acupuncture alone was performed in all of the groups, with WM
alone applied in six trials, CHM alone applied in eight trials, and VT alone in
one trial. Though some of the specific prescriptions of the acupoints and TCM
decoction applied were different among the included trials, their principles and
theories showed similarity according to the theory of TCM. detailed
characteristics of the included trials are listed in. In addition, two specific
acupoints, *Kai yin yi hao* and *Sang yin point*, were applied among the trials.
Located on neck, the two acupoints are widely selected for improving quality of
voice during acupuncture concerning VN. Location of *Kai yin yi hao* and *Sang
yin point*, and summary of acupoints applied and frequency in the included
trials are listed in.
## Assessment of quality and bias
According to the Cochrane Handbook and risk of bias tool, the randomization
methods were described clearly and appropriately in 10 trials, but were not
detailed in the other trials. The manners of allocation concealment, blinding of
outcome assessment, and selective reporting were assessed as unclear bias in all
the trials due to insufficient reporting in full-text. The situation was same
concerning blinding of participants and personnel, but we evaluated it as high
bias in all the trials because it was impossible to perform the blinding between
acupuncture and the controls (WM, CHM, and VT), obviously. In addition, all
included trials were better reported in terms of completeness of outcome data,
which were rated as low risk ( and Figs).
## Pooled results of acupuncture for patients with vocal nodules
### Effects of acupuncture vs. WM
Pooled results favored acupuncture groups with significantly (p \< 0.05) higher
CER (RR = 1.27, P for RR = 0.002, 95%CI:1.12–1.43, I<sup>2</sup> = 60%).
Heterogeneity was still high (I<sup>2</sup> \> 50%) with random-effects model
applied, and without extreme trial evaluated in meta-influence analysis.
Furtherly, meta-regression and sub-group analysis according to variations of
age, gender, duration of disease, frequency of treatment, course of treatment,
selection of acupoints, and report of *Deqi* were designed. Results showed that
the heterogeneity was reduced to acceptable level (I<sup>2</sup> \< 50%) with
statistical significance for meta-regression (tau<sup>2</sup> = 0,
I<sup>2resid</sup> = 0%, Adjusted R<sup>2</sup> = 100%, *P* = 0.04) when were
sub-grouped based on selection of acupoints (local acupoints only, or local and
remote acupoints).
### Effects of acupuncture vs. CHM
Compared with CHM, results of systematic reviews favored acupuncture groups with
significantly (p \< 0.05) higher CER (RR = 1.16, P for RR = 0.001,
95%CI:1.06–1.26, *I*<sup>*2*</sup> = 0%). Findings of meta-analyses also showed
that acupuncture could reduce symptom scores (WMD = 3.92, P for WMD \< 0.001,
95%CI:2.65–5.19, *I*<sup>*2*</sup> = 0%), and improve scores of voice analyses
(WMD = 3.70, P for WMD \<0.001, 95%CI:2.26–5.15, *I*<sup>*2*</sup> = 0%) more,
significantly (p \< 0.05).
### Effects of acupuncture vs. VT
However, results of one trial suggested that acupuncture was inferior to VT
concerning lower CER (RR = 0.78, P for RR = 0.09, 95%CI:0.59–1.04,
*I*<sup>*2*</sup> = NA). Similarly, during follow-ups, results also suggested
fewer reduction on scores of grade, roughness, and breathiness (GRB) in one
month after treatment (WMD = -0.75, P for WMD \< 0.001, 95%CI:-1.13 - -0.37,
*I*<sup>*2*</sup> = NA), scores of GRB in two months after treatment (WMD =
-0.65, P for WMD = 0.09, 95%CI:-1.41–0.11, *I*<sup>*2*</sup> = NA), scores of
voice handicap index (VHI) in one month after treatment (WMD = -5.67, P for WMD
\< 0.001, 95%CI:-9.00 - -2.34, *I*<sup>*2*</sup> = NA), and scores of VHI in two
months after treatment (WMD = -3.75, P for WMD = 0.17, 95%CI:-9.14–1.64,
*I*<sup>*2*</sup> = 0%) for the experimental compared with VT ( and – Figs).
### Meta-regression based sub-group analyses of the effects
For the outcomes of CER (acupuncture vs. WM and acupuncture vs. CHM), sub-group
analyses based on meta-regression were performed to explore characteristics
which might influence sizes of effect and heterogeneities, potentially. Sub-
group analyses were also designed based on variations of age, gender, duration
of disease, frequency of treatment, course of treatment, selection of acupoints,
and report of *Deqi*. Results of sub-group analyses revealed some common
findings concerning the two comparisons. Firstly, groups with older ages (40 ±
2.5, years) yielded comparatively higher RR than younger ages (30 ± 2.5, years
and 35 ± 2.5, years). Secondly, results favored the experimental with
comparatively higher RR when more proportions of male patients were included.
Thirdly, as for duration of disease, results favored the experimental with
comparatively higher RR when the time was shorter than one year, compared with
those were not shorter than one year. Fourthly, as for course of treatment,
results favored the experimental with comparatively higher RR when it was
shorter than one month, compared with those were one month. Finally, groups with
local and remote acupoints applied yielded comparatively higher RR than those
with local acupoints applied only.
## Trial sequential analysis and penalized test
Trial sequential analysis and penalized tests were conducted for CER of
acupuncture vs. WM and acupuncture vs. CHM. For the two outcomes, results
favored exclusion of the possibility of false positive before and after
penalized test. However, the results need to be interpreted with caution because
of the lack of inclusion (≤10 trials), more inclusion was needed to reach enough
superiority and to meet the required information size for them.
## Adverse event reported in trials
Among the included trials, six of them reported that there was no acupuncture
specific adverse event, and it was not mentioned in other nine trials.
## Publication bias and trim and fill test
Egger’s test was performed in two comparisons, and publication bias was not
detected in both of them ( and Figs). Trim and fill test showed that statistical
significances of the two comparisons were not reversed after certain number of
missing studies filled, indicating the stability of them ( and Figs).
## Levels of evidence
As for acupuncture vs. CHM, levels of evidence were suggested as moderate (⨁⨁⨁◯,
GRADE B) for all of the three comparisons. However, levels of evidence for all
comparisons concerning acupuncture vs. WM and acupuncture vs. VT were low (⨁⨁◯◯,
GRADE C).
## Cluster analyses and correlation coefficient of the variables
As for cluster analyses, results of heat map showed some clustering effects
between acupoints selected for acupuncture in the trials. In addition to several
one-time application of acupoints \[including Shui tu (ST-10), Fu tu (LI-18),
Sang yin point, Jia ji (EX-B2), Xue hai (SP-10), Feng long (ST-40), Lie que
(LU-7), Zhao hai (KI-6), Yu ji (LU-10)\], *Kai yin yi hao* and He gu (LI-4) were
the most frequently applied matching-acupoints in trials (as component or
alone). Other frequently selected acupoints including Zu san li (ST-36) and Ren
yin (ST-9). Results of correlation coefficient between the acupoints were also
showed in.
# Discussion
VN, which is also known as singer’s nodules, teacher’s nodules, or “shouting
(caused) nodules” when occurred in children, is a special type of chronic
laryngitis induced by inflammatory lesions. The main clinical symptom of VN is
hoarseness, and in research with patients were suffering from voice disorders,
vocal nodules was diagnosed among 40% of them. However, Shah, et al. revealed
that objective and subjective voice measurements were not different in various
vocal nodule sizes statistically, other than pitch reduction. Meanwhile, in a
study with 79 VN patients showed that there was little evidence to suggest that
the nodules themselves were “driving” the severity of the dysphonia. In this
review, results of meta-regression based sub-group analyses suggested that sizes
of effect were varying in different ranges of ages, genders, duration of
disease. As a result, we also believe that the variables above are also
associated with sizes of VN, and further researches concerning relationships
between different sizes of VN and severities of voice disorder are needed to
improve this study and provide more objective evidence of subgroups.
A diagnosis of VN can be made through laryngoscopy clinically, and modern
artificial intelligence technologies, such as deep-learning-based computer-aided
diagnosis, could provide valuable references for diagnosis of benign,
precancerous, and cancer lesions during laryngoscopy examination. Treatments for
VN worldwide are divided into two categories, mainly, as surgery and non-surgery
therapy, while surgery therapy and drug therapy (such as antibiotic, steroid, or
anti-reflux medications) are not routinely recommended in guidelines.
Different from considerable one-off expenditure and physical quality
requirements of VN surgery, VT has a high status in non-surgical therapies for
VN. However, in China and many other developing countries, there are no specific
speech pathology specialty, and VT is poorly developed or absent.
Results of this review indicate that compared with oral WM alone and oral CHM
alone, pooled results of our study covering 15 trials with 1118 participants
favored acupuncture alone concerning higher CER (acupuncture vs. WM, and
acupuncture vs. CHM), more reduction on symptom scores (acupuncture vs. CHM),
and more improvement on scores of voice analyses (acupuncture vs. CHM). However,
VT exhibited favorable improvements compared with acupuncture for VN, including
higher CER, and more reduction on scores of GRB and VHI during follow-ups.
Among all of the trials included in this study, acupuncture was performed
manually. After pooling all the acupoints applied in the trials, two types of
acupoint protocols were noticed, including local acupoints (located at face and
neck) and remote acupoints (located at upper and lower limbs). In TCM,
primarily, acupoints are classified into 1) acupoints of fourteen meridians, 2)
extra acupoints (in addition to the fourteen meridians), and 3) ashi acupoints.
For the first and second types, there are names, locations and indications for
each of the acupoints, while there is no fixed name, location or indication for
ashi acupoints, the third type. Based on these, in terms of general efficacy of
certain disorder or disease, the classifications above can be recombined and
divided into 1) local (effects) acupoints, 2) remote (effects) acupoints, and 3)
*specific* (effects) *acupoints*. Local effects are equipped by all acupoints
(including acupoints of fourteen meridians, extra acupoints, and ashi
acupoints), such as head acupuncture for post-stroke aphasia, acupuncture at
Jingming (BL1) for dry eye disease, and local acupressure for diabetic
peripheral neuropathy of lower limbs. Remote effects are equipped by acupoints
of fourteen meridians and extra acupoints, especially those located at distal
end of elbow joints of upper limbs and distal end of knee joints of lower limbs,
with effects of their belonging meridians, such as acupuncture at Qu chi (LI-11)
and Zu san li (ST-36) for left hemiplegia after ischemic stroke, and wrist-ankle
acupuncture for hypertension after intubation during induction of general
anesthesia. In addition, from clinical experience to medical evidence, in
thousands of years, many *specific acupoints* were discovered, tested, and
summarized for acupuncture with good efficacy, long duration, fewer needles,
such as acupuncturing at sphenopalatine ganglion acupoint for allergic rhinitis.
In this review, cluster analyses and correlation coefficient of the acupoints
revealed that *Kai yin yi hao* and He gu (LI-4) were the most frequently applied
matching-acupoints in the included trials, followed by Zu san li (ST-36) and Ren
yin (ST-9). Commonly, local acupoints are selected and matched with remote and
(or) *specific acupoints* in acupuncture, which is beneficial for achieving
enough acupuncture stimulation, longer efficacy duration, and balanced meridian
effects per treatment. Our results of meta-regression for CER (acupuncture vs.
WM and acupuncture vs. CHM) also suggested superiorities of local acupoints plus
remote acupoints, compared with local acupoints applied alone.
In our study, only six of the included trials reported that there was no
acupuncture specific adverse event, while it was not mentioned in other nine
trials. Sometimes, patients may feel local and mild sensations of sour, numb,
distension, painful during or after acupuncture. The sensations are associated
with *De Qi* (obtaining *Qi*) in TCM, and will clear up several days later
without specific medical care required. Such mild and self-limited events
include local bruising and radiating pain. In addition, severer events may
appear on very few first-time acupuncture patients due to fasting state,
uncomfortable position, overstrain, or movement during acupuncture, including
fainting, sticking of needle, broken of needle, vascular injury, nervous system
injury, or even visceral injury. As a result, detailed communication between
doctors or acupuncture practitioners and patients before acupuncture, required
preparations, and complete post treatment orders are necessary.
As for study quality and risk of bias, all the 15 trials are RCTs, but none of
them implied placebo control. Randomization method was clear and appropriate in
10 trials, while it was in unclear risk of bias for the other 5 trials.
Allocation concealment and blinding (for outcome assessment) method were of
unclear risk of bias in all trials. No study reported drop-out, and a protocol
or registration ahead of experiment was not mentioned. Publication bias (by
Egger’s tests) or instability (by trim and fill tests) was not suspected in
results, and more inclusions were required to meet the required information size
for all comparisons according to trial sequential analyses and penalized tests.
According to the GRADE, levels of evidence were moderate (⨁⨁⨁◯, GRADE B)
concerning acupuncture vs. CHM, but were low (⨁⨁◯◯, GRADE C) concerning
acupuncture vs. WM and acupuncture vs. VT. As a result, more placebo or blank-
controlled, double-blind, prospective, randomized trials of acupuncture for VN
are urgently needed.
# Conclusion
Our study, the first one with RCT evidence from 15 trials involving 1,118
participants, proved that applying acupuncture yielded better improvement for
patients with VN compared with WM and CHM. However, negative results were
discovered in acupuncture vs. VT groups in this study. There is also need for
RCTs with improvements on designing and interventions in experimental and
controls.
## Limitations
This study had several limitations. Firstly, most of the trials included were of
moderate to high risk of bias, with reasons such as without mentioning details
of random sequence generation method, allocation concealment, and blinding of
participants, personnel and outcome assessment. This is the main reason for low
quality of the included trials. Secondly, interventions and follow-up periods
were short among most of the trials, while longer treatment duration and follow-
up periods for VN, a chronic and recurrent disorder, is essential and required.
Finally, inclusion of trials and participants were limited due to the few
numbers of published trials and small sample sizes, relatively.
# Supporting information
VN Vocal nodules
VT Voice training
CHM Chinese herbal medicine
TCM Traditional Chinese medicine
WM Western medicine
CER Clinical effective rate
GRB Grade, roughness, breathiness
VHI Voice handicap index
RR Risk ratio
WMD Weighted mean difference
CI Confidence interval
GRADE The Grading of Recommendations Assessment, Development and Evaluation
system
[^1]: The authors have declared that no competing interests exist.
[^2]: ‡ QF share Co first authorship on this work.
|
# Introduction
Tuberculosis (TB) is a serious global health problem and is one of the leading
causes of death worldwide. In 2013, an estimated 9.0 million people were
infected with TB disease and 1.5 million (approximately 17%) died from this
disease. Importantly, these recent epidemiological estimates are higher than
what were previously estimated. Notably, of the 1.5 million deceased cases,
360,000 recorded among people with HIV infection.
Despite of its life-threating pathogenesis, TB is a curable disease when it is
correctly diagnosed and effectively treated. However, rapid and accurate
diagnosis of TB can be difficult due to the paucibacillary characteristics of
the disease (especially for cases with smear-negative, co-infection with HIV and
drug-resistance) and the challenge of sample collection from deep-seated
tissues. In fact, approximately 35% of all the worldwide TB infections are
undiagnosed. Furthermore, the ratio of patients with undiagnosed multi-drug
resistant TB remains much staggering (\~75%). Less than 3% of patients who are
diagnosed with TB infection are proved to have certain pattern of drug
resistance.
Solid and/or liquid culture is generally considered as the standard reference
for TB diagnosis. However, limited laboratory facilities in resource-limited
settings and prolonged culturing period restrict the utility of culture-based
diagnosis in clinical practice. Histology is widely applied to the diagnosis
of TB where the technical expertise exists, but this is technically demanding,
time-consuming and it lacks specificity. In early 2011, a novel, automated,
rapid, cartridge-based nucleic acid amplification test, named the Xpert® MTB/RIF
assay (Cepheid, Sunnyvale, USA) was authorized by the World Health Organization
(WHO) to be used for TB diagnosis. Xpert® MTB/RIF can simultaneously test
both TB and rifampicin resistance through examination of the DNA of
*Mycobacterium* tuberculosis and detection of major mutations which confer
rifampicin resistance. This assay was first endorsed by WHO as an initial
diagnostic test in patients with human immunodeficiency virus (HIV)-associated
pulmonary TB or suspected pulmonary MDR-TB. Xpert® MTB/RIF showed a
substantial accuracy for detection of pulmonary TB in adults with 89%
sensitivity and 99% specificity. In late 2013, WHO expanded its
recommendations to include the diagnosis of TB in some special subjects such as
children and patients with certain forms of extrapulmonary TB. A systematic
review by Detjen et al. revealed that Xpert offers a better sensitivity (62%)
and specificity (98%) for the diagnosis of pulmonary tuberculosis in
children. However, the information concerned the accuracy of Xpert MTB/RIF
in different TB endemic areas is lacking.
In fact, the prevalence of TB is clearly varying among different regions. Based
on global TB epidemiology in 2013, 56% of TB cases worldwide were in the Western
Pacific Regions and South-East Asia while 25% of the cases were in the African
Region, which also had the highest rates of cases and deaths relative to
population. Notably, India and China alone had 24% and 11% of total cases,
respectively. Therefore, in this systemic review, we aimed to determine the
diagnostic accuracy of Xpert MTB/RIF assay in different regions with different
TB prevalence regardless of sample type, subject’s age, HIV co-infection or
smear-positivity.
# Methods
Following the standard guidelines, we designed a protocol before commencing the
study.
## Literature search strategy
MEDLINE, EMBASE, the Cochrane Library, and Web of Knowledge were used to
retrieve published work without language or date restrictions. The last search
was done on June 20, 2015. The keywords used for searching were: ‘‘Xpert”,
‘‘Gene Xpert”, “Xpert MTB/RIF”, ‘‘Cepheid”, ‘‘tuberculosis” and
‘‘*Mycobacterium* tuberculosis”.
## Study selection and data extraction
Two researchers (Shiying Li and Bin Liu) carried out the process of study-
retrieval and data extraction independently. Any disagreements in the process
were solved by discussing with a third researcher (Peng Hu).
### Inclusion criteria
Inclusion criteria used in this meta-analysis were: (i) peer-reviewed, full-
text, randomized controlled trials, cohort studies and cross-sectional studies,
which used Xpert MTB/RIF for TB detection; (ii) specimens were tissues or body
fluid collected from suspected TB patients; (iii) the number of cases ≥30; (iv)
original data were sufficient to calculate the true positive (TP), false
positive (FP), true negative (TN) and false negative (FN); (v) culture and/or a
composite reference standard (CRS) was used as the reference standard in each
individual study; and (vi) nationalities of individuals were clearly described.
### Exclusion criteria
The initially selected articles were further screened based on the following
exclusion criteria: (i) non-clinical research; (ii) abstract of any conference;
(iii) case report; and (iv) review.
### Data extraction
The basic characteristics of selected studies such as the year of publication,
the number of the study population, number and type of samples, patients’
epidemiological and laboratory results, were collected. Additionally, the
diagnostic characteristics of Xpert MTB/RIF such as TP, FP, TN, and FN were
extracted. If data were insufficient in any study to perform a meta-analysis, we
contacted the authors by e-mail for further information. If we were unable to
obtain target data for certain studies, these studies were excluded.
## Imperfect reference standard
Culture is a gold standard for many infectious diseases except TB due to its
paucibacillary characteristics, which may lead to a misdiagnosis of tested
sample. Assuming that Xpert MTB/RIF typically identifies TB in specimens
with negative culture, this result would be considered as FP causing an
underestimation of Xpert MTB/RIF’s true specificity. However, a CRS, which
diagnoses the TB based on comprehensive results of clinical manifestations,
signs and laboratory tests, might sometimes confirm the positivity of Xpert
MTB/RIF for a sample with negative-TB culture and hence overestimate Xpert
MTB/RIF’s accuracy. On the other hand, a CRS itself might reduce the accuracy of
Xpert MTB/RIF by considering the result as FN. Thus, to provide a more
credible range of accuracy, we compared the accuracy of Xpert MTB/RIF to both
the culture and CRS.
## Statistical analysis
MIDAS, a professional module of diagnostic test in STATA statistical software
(version 12.0; STATA Corporation, College Station, TX, USA), was used to carry
out the meta-analysis. The summary receiver operating characteristic model and
bivariate random-effects model were carried out in this study to estimate the
diagnostic accuracy of Xpert MTB/RIF. We calculated the sensitivity and
specificity of Xpert MTB/RIF to diagnose TB for each individual study, then a
pooled sensitivity, specificity, and area under the curve (AUC) were obtained,
comparing with culture or CRS, along with 95% confidence intervals.
## Assessment of methodological qualities
The Review Manager software (version 5.3, The Nordic Cochrane Centre,
Copenhagen, Denmark), which contains a Quality Assessment of Diagnostic Accuracy
Studies-2 (QUADAS-2) tool, was used to evaluate the quality of selected studies.
In QUADAS-2 tool, each question has three choices: yes, unclear or no. If1338
there was at least one ‘no’ or ‘unclear’ answer to a given question of a given
domain, the risk for bias was considered as high or unclear, respectively.
## Publication bias
In a systematic review, publication bias should be assessed to estimate whether
the relevant studies with positive results are more likely to be published than
the ones with negative results. However, there is no validated method for
publication bias in test accuracy reviews yet. So in this research, we did not
estimate the publication bias.
## Heterogeneity analysis
A bivariate boxplot was used to assess the heterogeneity between included
studies. It describes the degree of interdependence including the central
location and identification of any outliers with an inner oval representing the
median distribution of the data points and an outer oval representing the 95%
confidence bound (by visually examining the position of each individual study,
within the range of boxplot suggesting more heterogeneity). We predicted pre-
existing heterogeneity in terms of sample types, patient age, status of HIV and
smear-positivity. Therefore, studies were pre-specified into four subgroups:
pulmonary versus extrapulmonary, adults versus children, HIV positive versus
negative, and smear positive versus negative. Meta-analysis in each subgroup was
only performed when at least four studies were available.
# Results
## Description of studies
In total, we identified 106 studies (PRISMA flow chart and Supplementary
reference) that included 52,410 samples for TB detection. All studies were in
English except for two which were in Turkish. Among the 106 studies, 54 studies
(47.8%) were carried out in 22 countries with high TB burden.
The median number of specimens was 494 for TB detection. The proportions of HIV-
positive patients ranged from 0% to 100%. In particular, two studies only
included HIV patients, one study had no HIV patients and HIV status was unknown
in 39 studies. Children were included in 21 studies, while patient’s age was
unknown in another 30 studies. For sample type, pulmonary samples (such as
sputum and bronchoalveolar lavage) were included in 71 studies, extrapulmonary
samples (such as body fluid, fine needle aspiration, stool, and blood) were
included in 25 studies and a mixture of pulmonary and extrapulmonary samples
were used in 9 studies. The information of smear-positivity was reported in 44
included studies. The details of diagnostic accuracy of each individual study
were shown in.
## Methodological quality of selected studies
The methodological qualities were estimated based on the culture and CRS. The
overall methodological quality of included studies is summarized in (details of
the quality assessment for each study are individually shown in and Figs). In
the majority of studies, data was collected consecutively or randomly (n = 72;
67.9%). All included studies were carried out either at reference laboratories
or at tertiary care centers. Based on index tests, 11 studies (9.7%) were
considered to carry an unclear risk of bias. Accordingly, the results of index
test were interpreted blindly regardless of the reference standard results.
The result of heterogeneity analysis was shown in. A significant heterogeneity
was found based on the bivariate box plot (culture, I<sup>2</sup> = 99.90; CRS,
I<sup>2</sup> = 99.88).
## Sensitivities, specificities and AUCs of Xpert MTB/RIF for TB detection
For the overall diagnostic accuracy of Xpert MTB/RIF, culture was used as the
gold reference standard in 95 studies, while CRS was used in 20 studies. Pooled
sensitivity, specificity and AUC were 0.85 (95% confidence interval \[CI\]
0.82–0.88), 0.98 (95% CI 0.96–0.98) and 0.97 (95% CI 0.95–0.98) compared to
culture reference standard, respectively, while they were 0.59 (95% CI
0.44–0.77), 0.99 (95% CI 0.92–0.96) and 0.95 (95% CI 0.92–0.96) compared to CRS,
respectively.
Since included studies were significantly heterogeneous, thus we further
performed a separate meta-analysis for each of the four pre-identified subgroups
based on the type of sample (pulmonary and extrapulmonary), subject’s age, HIV
co-infection and smear-positivity. In the pulmonary and extrapulmonary subgroup,
74 studies included pulmonary samples while 26 studies included extrapulmonary
samples. Pooled sensitivity, specificity and AUC of Xpert MTB/RIF for detecting
pulmonary TB (PTB) were 0.87 (95% CI 0.83–0.90), 0.97 (95% CI 0.96–0.98) and
0.97 (95% CI 0.95–0.98) compared to culture reference standard, respectively;
while they were 0.76 (95% CI 0.53–0.90), 0.97 (95% CI 0.87–1.00) and 0.95 (95%
CI 0.92–0.96) compared to CRS, respectively. Likewise, pooled sensitivity,
specificity and AUC of Xpert MTB/RIF for extrapulmonary TB (EPTB) detection were
0.80 (95% CI 0.69–0.88), 0.97 (95% CI 0.94–0.98) and 0.97 (95% CI 0.95–0.98)
compared to culture reference standard, respectively; while they were 0.49 (95%
CI 0.32–0.67), 0.99 (95% CI 0.97–1.00) and 0.94 (95% CI 0.92–0.96) compared to
CRS, respectively.
For different HIV co-infection status, diagnostic accuracy parameters could be
collected on 26 studies and 18 studies that included HIV positive and negative
cases, respectively. Pooled sensitivity, specificity and AUC of Xpert MTB/RIF
for detecting TB in HIV positive patients were 0.81 (95% CI 0.73–0.87), 0.98
(95% CI 0.96–0.99) and 0.96 (95% CI 0.94–0.97) comparted to culture reference
standard, respectively; while they were 0.63 (95% CI 0.45–0.87), 0.94 (95% CI
0.87–0.97) and 0.94 (95% CI 0.92–0.96) compared to CRS, respectively. Likewise,
pooled sensitivity, specificity and AUC of Xpert MTB/RIF for detecting TB in HIV
negative patients were 0.77 (95% CI 0.67–0.85), 0.99 (95% CI 0.97–0.99) and 0.98
(95% CI 0.96–0.99) comparted to culture reference standard, respectively; while
they were 0.44 (95% CI 0.08–0.87), 0.99 (95% CI 0.93–1.00) and 0.98 (95% CI
0.97–0.99) compared to CRS, respectively.
For smear-positivity status, samples of 38 studies were positive while they were
negative in 43 studies. Compared to culture reference standard, pooled
sensitivity, specificity and AUC of Xpert MTB/RIF for detecting TB in patients
with positive smears were 0.99 (95% CI 0.97–0.99), 0.88 (95% CI 0.76–0.94) and
0.99 (95% CI 0.98–1.00), respectively; while they were 0.70 (95% CI 0.64–0.75),
0.98 (95% CI 0.96–0.99) and 0.89 (95% CI 0.86–0.929) in patients with negative
smears, respectively. Similarly, compared to the CRS, Xpert MTB/RIF’s pooled
sensitivity, specificity and AUC of for TB detection in patients with negative
smears were 0.52 (95% CI 0.41–0.63), 0.99 (95% CI 0.95–1.00) and 0.68 (95% CI
0.63–0.72), respectively. We were unable to determine diagnostic accuracy
parameters of Xpert MTB/RIF compared to CRS in patients with positive smears due
to the lack of this information.
Diagnosis of TB in children is rather difficult due to its typical
paucibacillary characteristics and the difficulty of collecting sputum sample.
Microscopic examination has a little value in diagnosis TB in children. Culture
methods have a greater benefit, yet have a highly variable sensitivity. Clinical
diagnosis of children TB relies mainly on a combination of symptoms,
radiological findings, and identification of a tuberculosis contact. Thus,
the assessment of diagnostic accuracy of Xpert MTB/RIF for detecting TB in
children is importantly needed. In the subgroup of subject’s age, there were 48
studies that included adults while 18 studies included children. Compared to
culture reference standard, pooled sensitivity, specificity and AUC of Xpert
MTB/RIF for detecting TB in adults were 0.82 (95% CI 0.76–0.86), 0.98 (95% CI
0.96–0.99) and 0.97 (95% CI 0.95–0.98) respectively; while they were 0.76 (95%
CI 0.70–0.81), 0.98 (95% CI 0.96–0.99) and 0.90 (95% CI 0.87–0.93) in children,
respectively. Likewise, compared to CRS, pooled sensitivity, specificity and AUC
of Xpert MTB/RIF’s for TB detection in adults were 0.52 (95% CI 0.35–0.69), 0.99
(95% CI 0.97–1.00) and 0.96 (95% CI 0.94–0.97), respectively; while they were
0.55 (95% CI 0.41–0.65), 0.99 (95% CI 0.97–1.00) and 0.92 (95% CI 0.89–0.94) in
children, respectively.
## Sensitivities, specificities and AUCs of Xpert MTB/RIF in TB detection at different endemic degree regions
To evaluate the diagnostic accuracy of Xpert MTB/RIF assay in different regions,
multiple meta-analyses were further carried out based on different TB
prevalence. Since the data on CRS were limited within studies of different
endemic regions, therefore all analyses were only relied on culture reference
standard. As shown in, 54 studies were carried out in 22 high TB burden
countries while 56 studies were carried out in middle and low prevalence
countries. Pooled sensitivity, specificity and AUC in highly endemic countries
were 0.84 (95% CI 0.80–0.88), 0.97 (95% CI 0.95–0.98) and 0.96 (95% CI
0.94–0.98), respectively; while they were 0.89 (95% CI 0.84–0.93), 0.98 (95% CI
0.97–0.99) and 0.99 (95% CI 0.97–0.99) in countries with middle/low endemics,
respectively.
Additionally, we sought to re-evaluate the diagnostic accuracy of Xpert
MTB/RIF’s for the four subgroups among regions with different TB endemic level.
However, data are quite limited for children; therefore, analyses were carried
out considering the other 3 subgroups (sample’s type, HIV co-infection, and
smear-positivity). For studies including PTB samples, pooled sensitivity,
specificity and AUC were 0.84 (95% CI 0.80–0.88), 0.97 (95% CI 0.95–0.98) and
0.96 (95% CI 0.94–0.98) in high TB endemic countries, respectively; while they
were 0.92 (95% CI 0.88–0.95), 0.98 (95% CI 0.96–0.99) and 0.99 (95% CI
0.97–0.99) in middle/low endemic countries, respectively. For studies including
EPTB samples, pooled sensitivity, specificity and AUC were 0.82 (95% CI
0.67–0.91), 0.92 (95% CI 0.84–0.96) and 0.94 (95% CI 0.92–0.96) in high TB
endemic countries, respectively; while they were 0.81 (95% CI 0.63–0.91), 0.98
(95% CI 0.96–0.99) and 0.99 (95% CI 0.97–0.99) in middle/low endemic countries,
respectively.
For different HIV co-infection status, pooled sensitivity, specificity and AUC
in high TB endemic countries were 0.80 (95% CI 0.75–0.84), 0.97 (95% CI
0.90–0.99) and 0.86 (95% CI 0.83–0.89) in HIV positive patients, respectively;
while they were 0.75 (95% CI 0.66–0.82), 0.98 (95% CI 0.96–0.99) and 0.96 (95%
CI 0.94–0.97) in HIV negative patients, respectively. Among middle/low TB
endemic countries, pooled sensitivity, specificity and AUC were 0.81 (95% CI
0.61–0.92), 0.99 (95% CI 0.97–1.00) and 0.99 (95% CI 0.98–1.00) in HIV positive
patient, respectively; while they were 0.76 (95% CI 0.47–0.92), 0.99 (95% CI
0.96–0.99) and 0.99 (95% CI 0.97–0.99) in HIV negative patients, respectively.
Based on smear-positivity, pooled sensitivity, specificity and AUC in studies
including positive smears were 0.97 (95% CI 0.95–0.98), 0.89 (95% CI 0.60–0.98)
and 0.97 (95% CI 0.96–0.99) for countries with high TB endemic, respectively;
while they were 0.99 (95% CI 0.97–1.00), 0.88 (95% CI 0.75–0.94) and 0.99 (95%
CI 0.98–1.00) for countries with middle/low TB endemic, respectively. For
studies including negative smears, pooled sensitivity, specificity and AUC were
0.68 (95% CI 0.60–0.75), 0.96 (95% CI 0.90–0.98) and 0.84 (95% CI 0.81–0.87) for
regions with high TB endemic, respectively; while they were 0.73 (95% CI
0.63–0.81), 0.99 (95% CI 0.97–1.00) and 0.93 (95% CI 0.91–0.95) for countries
with middle/low TB endemic, respectively.
# Discussion
Major advantages of this systemic review were the use of a pre-designed
protocol, a comprehensive search, independent researchers, an effective model
for meta-analysis (a bivariate random-effects model) and analyzing of four pre-
identified subgroups to investigate the heterogeneity. In addition, effective
communication with authors of studies with insufficient information resulted in
a more efficient data analysis.
The comprehensive meta-analyses carried out in this systemic review revealed
that Xpert MTB/RIF is a highly sensitive diagnostic tool for TB detection
regardless sample’s type, status of HIV co-infection, subject’s age and smear-
positivity. In addition, our analyses revealed that the sensitivity of Xpert
MTB/RIF for TB detection compared to culture reference standard was higher than
that compared to CRS, which was consistent with previous studies. Culture is
an imperfect reference standard for TB detection, however, it requires more
strict skills and long time. On the other hand, CRS is a composite of clinical
investigations and laboratory examinations which offer more information to make
a decision. However, there is a possibility that CRS could lead to a false
positive diagnosis. Therefore, a combined application of the two reference
standards (culture and CRS) may help to make more accurate clinical decisions.
Heterogeneity of diagnostic accuracy of Xpert MTB/RIF among all included studies
was significantly higher when either compared to culture reference standard or
CRS indicating the variability of Xpert MTB/RIF’s diagnostic accuracy among
different populations. Notably, the impact of sample type, age of
patients, and status of HIV co-infection and smear-positivity are the main
factors studied for their impact on Xpert MTB/RIF’s diagnostic accuracy. In this
context, our results showed that Xpert MTB/RIF has higher sensitivity in
patients with positive smears (0.99, 95% CI 0.97–0.99), in patients with PTB
samples (0.87, 95% CI 0.83–0.90), in adults (0.82, 95% CI 0.76–0.86) and in HIV-
positive patients (0.81, 95% CI 0.73–0.87). Overall, the sensitivities,
specificities, and AUCs were ≥0.70, ≥0.97 and ≥89%, respectively, indicating a
high diagnostic accuracy of Xpert MTB/RIF for TB detection which is consistent
with previous reports. Given the extraordinary prevalence of TB worldwide
since it is estimated that every year, nearly 10 million people fell ill with
TB, Xpert MTB/RIF would be a perfect quick and accurate diagnostic assay for TB
diagnosis. Notably, we found that Xpert MTB/RIF was more sensitive in HIV-
positive than in HIV-negative individuals (81% versus 77%, compared to culture),
which disagrees with the results of a previous review by Steingart et al., (HIV-
positive versus HIV-negative: 79% versus 86%, compared to culture). This
difference could be attributed to the fact that Steingart et al addressed the
accuracy of Xpert MTB/RIF only in the pulmonary samples of adults, while in our
study, we addressed the overall diagnostic accuracy of Xpert MTB/RID regardless
the sample type and subject’s age.
TB remains one of the world’s deadliest communicable diseases. There are some
reviews that have addressed the accuracy of Xpert MTB/RIF either among specific
population, such as adults or in children, or by testing specific samples,
such as pulmonary, or extrapulmonary samples. Therefore, it is
important to evaluate the overall diagnostic accuracy of Xpert MTB/RIF among
countries with different levels of TB prevalence as well as different ages,
sample sites, and HIV and smear statuses. To the best of our knowledge, our
study was the first to investigate this issue. Based on our study, the overall
pooled sensitivity of Xpert MTB/RIF for TB detection was lower in high TB
prevalence countries than that of middle/low ones. Also, the same trend was
found when different four subgroups were considered. Taken together, our results
suggested that the diagnostic accuracy of Xpert MTB/RIF has a higher efficiency
in countries with middle/low TB endemic burden than in countries with high
endemic.
There are still some limitations in the current analysis such as there was no
protocol available on how to handle non-respiratory specimens, specimen
processing was extremely variable across studies and the CRS standard differed
between studies. Therefore, the overall outcome should be interpreted with
caution.
In conclusion, based on our meta-analyses using a bivariate model and the
sufficient number of specimens, the diagnostic accuracy of Xpert MTB/RIF for TB
detection was quite high. The overall sensitivity of Xpert MTB/RIF was lower in
high TB burden countries than that of the middle/low burden. The results
obtained in the current study will significantly help the physicians especially
those in high-risk regions to make their clinical decision.
# Ethics approval and consent to participate
The experimental protocol was established, according to the ethical guidelines
of the Helsinki Declaration and was approved by the Human Ethics Committee of
Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing
Medical University. Written informed consent was obtained from individual
participants.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
For the past decade, the removal of the internal limiting membrane (ILM) has
been an important step for anatomical and functional success in macular hole,
macular pucker, and even retinal detachment surgeries. Because of its anatomical
characteristics, the ILM is challenging to identify during surgical procedures.
With the assistance of a vital dye such as indocyanine green (ICG) or brilliant
blue G (BBG), the technique is much easier. Therefore, the use of dyes to
identify structures during vitreoretinal surgery, “chromovitrectomy,” has become
a popular technique in recent years. Although the dyes are used temporarily
during the operation, some of the dyes may remain on the unpeeled part of the
ILM. Several groups have reported that ICG may persist in the ocular cavity up
to 6 weeks after its application during surgery. Several groups reported
toxicity to retinal pigment epithelial cells and the neurosensory retina, as
well as cases of optic nerve atrophy, after the use of ICG. Therefore, several
alternative dyes have been introduced for use in vitreoretinal surgery,
including infracyanine green (IfCG), trypan blue (TB), bromophenol bue (BPH),
patent blue, and BBG.
Even so, all of the previously mentioned dyes were reported to exhibit toxicity
on RPE cells following acute exposure during surgical doses. IfCG, BBG, and BPH
have been shown to be less toxic on retinal ganglion cells and RPE cells
compared with ICG. BBG, it was claimed, provided a good staining to the ILM and
was not toxic in experimental studies and a case series in humans. However,
recent reports showed a selective toxicity to photoreceptors related to BBG
after intravitreal injection in rabbit eyes and RPE changes on fluorescein
angiography, as well as macular damage following accidental subretinal dye
injection in humans. Another report of the intraocular safety of ICG, TB, Evans
blue (EB), and BBG on ARPE-19 cell lines and murine retinal ganglion/Müller
glial (RGC) primary cell cultures showed that all dyes demonstrated relatively
safe viability profiles in both cell lines at surgically relevant concentrations
and times. BBG was the only dye that caused toxicity in ARPE-19 cell lines after
short exposure times, and ICG had a favorable viability profile at almost all of
the concentrations and times tested. Mitochondria have been implicated in the
cytotoxicity caused by the dyes. Mitochondrial membrane potential
(ΔΨ<sub>m</sub>) was altered after exposure to surgical does of ICG, TB, PB, or
a four-fold surgical dose of BrB. An *in vitro* RPE cell study by Penha *et al*.
revealed that expression of Bax, cytochrome c, and caspase-9 was upregulated at
the mRNA and protein level after ICG exposure, but Bcl-2, an anti-apoptotic
protein, was downregulated; however, brilliant blue (BriB), resulted in
upregulation of Bcl-2. During real-life procedures, not only the RPE, but also
the photoreceptors may be exposed to the dyes cause cytotoxicity in the these
cells. Until now, no study had focused on the effect of the intraoperative dyes
on the *in vitro* safety of photoreceptor cells. Cultures of 661W cells, an *in
vitro* model that mimics photoreceptor cells, have been widely used in the study
of retinal degeneration, retinal neuroprotection, and retinal regeneration.
Macroautophagy is typically referred to as a degradation process that proceeds
in a lysosome-dependent manner by which microtubule-associated proteins 1A/1B
light chain 3B (LC3) facilitates elongatation of autophagosome and fuses with
lysosomes for degradation and recycling. Sequestome 1 (SQSTM1) contains LC3 and
ubiquitin-binding motifs to recruit ubiquitinated proteins to the autophagosome,
which serves as an autophagy receptor, for selective bulk degradation. Autophagy
plays a beneficial role in several ocular cell types to maintain the eye’s
normal physiological function. Autophagy is involved in maintaining inner
segment turnover in photoreceptors, and it protects cells from stress and
melanin degradation in RPE cells. However, autophagy is activated to promote
autophagic cell death in retinal ganglion cells during chronic intraocular
pressure elevation, suggesting the role of autophagy might be varied depending
on types of ocular cells or stress. The role of autophagy in RPE and
photoreceptor cells in response to vital dyes remains unknown. Here, we examine
the autophagic effects of vital dyes in RPE and photoreceptor cells and showed
that autophagy was inhibited and induced in ARPE-19 and 661W cells,
respectively, when exposed to ICG and BBG. Nevertheless, ablation of autophagy
enhanced ICG and BBG-induced cytotoxicity in both ARPE-19 and 661W cells.
Administration of dietary supplements, including resveratrol, lutein, and CoQ10,
induced autophagy and diminished the cytotoxic effects of ICG and BBG,
suggesting autophagy may play a cytoprotective role in RPE and photoreceptor
cells during exposure to ICG or BBG.
# Material and methods
## Compounds
The dyes ICG (I2633) and BBG (B0770) and the dietary supplements resveratrol
(R5010), coenzyme Q10 (CoQ10, C9538), and lutein (xanthophyll from marigold,
X6205) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Reagents and
materials for cell culture were obtained from GIBCO (Life Technologies; City,
Country). CellTiter-Glo Luminescent Cell Viability Assay (G7572) was purchased
from Promega Corporation (Madison, WI, USA).
## Dye preparation
ICG and BBG (5mg each) was dissolved in 100 μL dimethyl sulfoxide (DMSO) and
phosphate-buffered saline (PBS) was added to obtain a stock of 5 mg/mL. The ICG
solution should be made fresh before use. ICG and BBG were mainly used at
concentrations of 0.05 mg/mL in this study. The surgical concentrations of ICG
and BBG solutions are 0.5 mg/mL and 0.25 mg/mL, respectively.
## Cell culture of human RPE cells
Adult human RPE cell cultures (ARPE-19) were obtained from the American Type
Culture Collection (CRL-2302; ATCC, Manassas, VA, USA). These cells were
maintained in a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM) and
Ham's F12 medium supplemented with 10% fetal bovine serum (Life Technologies),
sodium bicarbonate (1.2 g/L), L-glutamine (2.5 mM), HEPES (15 mM), and sodium
pyruvate (0.5 mM). The cells were cultured at 37°C in a humidified atmosphere of
95% air and 5% CO<sub>2</sub>. The mouse photoreceptor–derived 661W cell line
was generously provided by Dr. Muayyad Al-Ubaidi (University of Oklahoma,
Norman, OK, USA). Cells were grown in DMEM supplemented with 10% fetal bovine
serum in 100-mm tissue culture dishes in which cells typically were seeded at a
concentration between 1 × 10<sup>5</sup> and 1 × 10<sup>6</sup> in 10 mL of
growth medium. They were allowed to grow to 80%–90% confluence before harvesting
for use in experiments.
## CellTiter-Glo luminescent cell viability assay
ARPE19 and 661W cells were plated at 3000–5000 cells/well in 96-well plates and
incubated at 37°C in an incubator containing 5% CO<sub>2</sub>. Cell viability
was assessed using the CellTiter-Glo luminescent cell viability kit (G7572) from
Promega Corporation according to the manufacturer’s instructions. The method is
based on quantitation of the adenosine triphosphate present in the cells,
detected by the generation of A luminescent signal. All experiments were
repeated at least three times.
## Autophagic flux measurement and immunoblotting
For more precise monitoring of autophagic activity, cells were treated with or
without 20 μM chloroquine (CQ; Sigma-Aldrich, C6628), an inhibitor of autophagy,
for 2 h prior to harvesting. The cell lysates were used to detect LC3-II
accumulation by immunoblotting to verify autophagic flux. For immunoblotting,
the cells were briefly rinsed in PBS (02-023-1, Biological Industries, City,
Country) and lysed with RIPA buffer (1% NP40 \[MDBio, City, Country,
101-9016-45-9\], 50 mM Tris HCl, pH 7.5, 150 mM NaCl, 0.25% sodium deoxycholate
\[Sigma-Aldrich, D6750\], 0.1% sodium dodecyl sulfate \[SDS; Calbiochem, City,
Country, 428015\], and protease inhibitor cocktail \[Roche, City, Country,
11873580001\]). The cell lysates were resolved by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and transferred electrophoretically
onto nitrocellulose membranes. The membrane was blocked with 5% skim milk and
then incubated with primary antibodies against LC3 (L7543), and ACTB (β-actin,
A5441) (all from Sigma-Aldrich), SQSTM1 (BD Pharmingen, 610832), ATG5 (8540) and
ATG7 (8558) (all purchased from Cell Signaling Technology) overnight at 4°C. The
proteins were probed with an HRP-labeled secondary antibody (Santa Cruz, sc-2004
or sc-2005) and detected with an ECL reagent. The membrane was scanned and
analyzed for the protein expression level with the ChemiDoc XRS Imaging System
(Bio-Rad, Hercules, CA, USA).
## GFP-LC3 punctuation
GFP-LC3 plasmids (1500 cells/40 μL) were purchased from Addgene and were
transfected into human ARPE-19 cells or mouse 661W cells for stable selection
with G418 (600 μg/mL). The stable cells were seeded with ICG or BBG in plates
for 30 min and recovered for 6 h. The cells were then fixed with 3.7%
paraformaldehyde and cell images were collected with a 40× objective for GFP-LC3
puncta. Next, GFP-LC3–labeled autophagosomes were detected with fluorescence
spot numbers and areas in each cell after ICG or BBG treatment. The percentages
of changes of GFP-LC3 were calculated. Alternatively, the cells expressing GFP-
LC3 were exposed to vital dyes and trypsinized for cell harvest. The cells were
washed with PBS once and then resuspended with 200 μL 0.05% saponin to remove
nonlipidated GFP-LC3 from cells. One mL PBS was added to the cells to
quantificate membrane-bound GFP-LC3-II with flow cytometry as reported
previously.
## Transfection and shRNA infection
For siRNA transfection, the cells were seeded at 20% to 30% confluence and
reversely transfected with RNAiMAX (Life Technologies; 13778–150) in the
presence of 10 nM scrambled siRNA (Life Technologies, 12935–112), siRNA against
ATG5 (GE Healthcare Dharmacon, City, Country, 9474) or ATG7 (Life Technologies,
s20652) or BECN1 (Life Technologies, 4392420) for 72 h. For shRNA infection,
shRNAs against *ATG5* (TRCN0000151963, The RNAi Consortium, Taiwan), *ATG7*
(TRCN0000007584, The RNAi Consortium, Taiwan), and pLKO.1 Scrambled shRNA
(Addgene, 1864). The plasmids were transfected into HEK293FT cells with
Lipofectamine 2000 (Life Technologies, 11668–027) for 2 days, and the
supernatant were used to infect ARPE-19 cells. The infected ARPE-19 cells were
selected with puromycin (1 μg/ml) for 10 days to obtain stable knockdowned
cells. The cells were harvested for knockdown efficiency by immunoblotting.
## Statistical analysis
All the data are expressed as the mean ± standard error of the mean from at
least 3 individual experiments. The statistical analysis was performed using a
nonparametric 2-tailed Student’s *t* test with Prism 5.0 (Graph-Pad, La Jolla,
CA, USA). *P* values \<0.05 were considered significant (\* indicates *P*\<0.05,
\*\* indicates *P*\<0.01, and \*\*\* indicates *P*\<0.001).
# Results
## ICG and BBG diminish cell viability and modulate autophagy in ARPE-19 and 661W cells
ARPE-19 and 661W cells were exposed to various concentrations (0.05, 0.5, or 1.0
mg/mL) of ICG or BBG for 5 or 30 min. The treated cells were then recovered for
24 h to determine the cytotoxic effects of ICG and BBG with CellTiter-Glo. Both
ICG and BBG reduced cell viability in ARPE-19 cells. In contrast with ICG, BBG
treatment is relatively more cytotoxic to ocular cells. Because the cells
treated with ICG and BBG at the dose of 0.05 mg/mL for 30 min reached the
minimal cytotoxicity, these conditions were used in the subsequent experiments.
Moreover, to corroborate whether ICG and BBG modulate autophagy in ocular cells,
ARPE-19 and 661W cells expressing GFP-LC3 were exposed to ICG and BBG to examine
the membrane-bound GFP-LC3 puncta (GFP-LC3-II) with confocal microscope. ICG and
BBG increased the GFP-LC3 puncta in both ARPE-19 and 661W cells. The GFP-
LC3–expressing cells treated as above were also rinsed with the detergent
saponin to remove nonlipidated GFP-LC3-I, and retained GFP-LC3-II, likely
autophagosome associated form, were analyzed by flow cytometry. As with the
results of fluorescent microscopy, the flow cytometry results showed that ICG
and BBG increased lipidated GFP-LC3-II in ocular cells. Further, the cells
treated with vital dyes were harvested to detect the level of the autophagy
marker LC3 and adaptor SQSTM1 with immunoblotting. ICG increased the ratio of
LC3-II/actin and the SQSTM1 level in ARPE-19, suggesting ICG and BBG may inhibit
autophagy in ARPE-19 according to the guideline of autophagy assays reported
previously. Although SQSTM1 was undetectable in 661W cells, the effects of vital
dyes on lipidated LC3-II in 661W cells were similar to those in ARPE-19,
suggesting that ICG and BBG modulate autophagy in ocular cells.
## ICG and BBG inhibited autophagic flux in ARPE-19 cells but induced autophagic flux in 661W cells
Autophagy induction transiently increases the GFP-LC3-II puncta and LC3-II/actin
ratio in cells, whereas a block in autolysosomes causes an accumulation of GFP-
LC3-II puncta and increases the LC3-II/actin ratio. To precisely evaluate the
autophagic effects of the vital dyes ICG and BBG in ARPE-19 cells and 661W
cells, these cells were exposed to ICG and BBG in the presence or absence of the
autophagy inhibitor CQ. The net difference in LC3-II levels between cells
treated with and those without CQ was used to determine autophagic flux in the
treated cells. Like the autophagy inhibitor CQ, ICG and BBG significantly
increased the SQSTM1 protein level in ARPE-19 cells. LC3-II flux was
significantly decreased in ARPE-19 cells treated with ICG or BBG. Conversely,
ICG and BBG increased the LC3-II flux in photoreceptor 661W cells compared with
the control cells, indicating that vital dyes may suppress autophagy in retinal
pigment epithelial ARPE-19 cells but induce autophagy in photoreceptor 661W
cells. These results suggest vital dyes differentially modulate autophagy, which
may depend on cell types.
## Autophagy protected ocular cells from ICG or BBG-induced damage
Autophagy can be protective or detrimental for cells in response to stresses. We
examined the role of autophagy in ocular cells after treatment with ICG and BBG.
Autophagy ablation with CQ notably enhanced the cytotoxicity of ICG and BBG in
ARPE-19 and 661W cells. Knockdown of *ATG5* or *ATG7 or BECN1*, which are
essential genes for autophagy signaling, with shRNA or siRNA enhanced cytotoxic
effects of ICG and BBG in ARPE-19 cells. Additionally, we examined the effect of
three dietary supplements on autophagy in ocular cells, including resveratrol,
lutein, and CoQ10. Among these dietary supplements, resveratrol has been
reported to be an inhibitor of mechanistic target of rapamycin (mTOR) that
induces autophagy. As shown in, resveratrol, lutein, and CoQ10 induced
autophagic activity in both retinal pigment epithelial ARPE-19 cells and in
photoreceptor 661W cells. Resveratrol and CoQ10 are reportedly to facilitate
cell proliferation in neural progenitor cells and fibroblast, respectively.
Indeed, pretreatment with the dietary supplements increased cell viability,
likely due to promotion of cell proliferation as mentioned above. Furthermore,
resveratrol, lutein, and CoQ10 diminished the cytotoxic effects of ICG and BBG
in ocular cells compared to the untreated cells. These results suggest that
autophagy may play a cytoprotective role in ocular cells in response to the
damage of ICG and BBG.
# Discussion
Vital dyes have been reported to cause cytotoxicity in RPE cells, likely through
mitochondrial damage and ROS production. The role of autophagy in survival and
death in ocular cells during stresses has been documented. However, the
involvement of autophagy in vital dyes–induced cytotoxicity in ocular cells
remains unclear. Our study is the first to show that ICG and BBG induced
cytotoxicity and modulated autophagy in both ARPE-19 and 661W cells.
Interestingly, ICG and BBG inhibited autophagic flux in ARPE-19 cells, whereas
the vital dyes induced autophagic flux in 661W cells. In addition, genetic and
pharmacological ablation of autophagy diminished cell viability in both ARPE-19
and 661W cells. Dietary supplements, including resveratrol, lutein, and CoQ10,
induced autophagy and diminished the cytotoxic effects of vital dyes in the
ocular cells.
Autophagic response in the same stimuli might be varied in different cells. For
example: doxorubicin induces autophagy in rat cardiac myocytes, whereas it
reduces autophagy in mouse cardiac myocytes. However, the mechanisms for
differential autophagy regulation in difference cells remain unknown. Similarly,
one of the interesting findings in our study is that ICG and BBG inhibited
autophagic flux in ARPE-19 cells, whereas the vital dyes induced autophagic flux
in 661W cells. Thus, the discrepancy in the responses to dyes between ARPE-19
and 661W cells may be through the different signaling pathways. In addition, ROS
play a dual role on autophagy in various cells.
Autophagy is induced in cells in response to oxidative stress via several
factors, such as Protein kinase RNA-like endoplasmic reticulum kinase (PERK),
Hypoxia-inducible factor 1 (HIF1), p53, nuclear factor erythroid-2-related
factor (NRF2), ATG4, and Forkhead box O3 (FOXO3). Conversely, ROS also down-
regulates ULK1, a homologue of yeast ATG1, to inhibit autophagy via
phosphorylation of p53 in NB4 cells. We also noticed that ROS was induced by ICG
and BBG in both ARPE-19 and 661W cells. Nevertheless, elucidating these
mechanisms requires further work to identify if ROS is involved in differential
effects of vital dyes on autophagy in different ocular cells.
On the other hand, autophagy can reduce oxidative stress through the nuclear
factor erythroid 2–related factor 2 (NRF2)/kelch-like ECH-associated protein 1
(KEAP1) and the SQSTM1 pathway. NRF2 is a transcription factor of the leucine
zipper family and can activate antioxidant-defense genes such as glutathione
peroxidase, superoxide dismutase, and thioredoxin. Under normal conditions, NRF2
is sequestered by KEAP1 ubiquitination and degradation. Following oxidative
stress, either the ubiquitin activity of KEAP1 is inhibited or SQSTM1 interacts
with KEAP1 for its degradation, leading to the liberation and activation of
NRF2, which in turn limits ROS production and cell damage. These results raise
the possibility that the vital dyes may initially inhibit autophagy to elevate
ROS and cause oxidative damage in ARPE-19 cells.
The RPE is a single layer of epithelial cells lining the posterior segment of
the eye. It is located between the light-sensing photoreceptors and the
choriocapillaris and serves essential function for vision. A failure of any one
of these functions can lead to degeneration of the retina, loss of visual
function, and blindness. Our results suggest that both ICG and BBG at the
routine dose used in chromovitrectomy can affect autophagy not only RPE but also
photoreceptor cells. Autophagy ablation with CQ or silencing ATG genes notably
enhanced the cytotoxicity of ICG and BBG in ocular cells, indicating autophagy
might be a survival mechanisms in ocular cells exposed to vital dyes. Moreover,
Autophagy is a stress responsive pathway to limit damage-induced death, whereas
autophagy may not be sufficient to block death in cells during excessive
stresses. For example: autophagy is enhanced in cardiac cells during
ischemia/reperfusion. Pretreatment with autophagy inducer rapamycin protects
cells from ischemia/reperfusion injury. Besides, many antioxidants are
reportedly to promote cell proliferation and resistant to oxidative stress-
induced cell death, Three dietary supplements, which are reported to be
antioxidants, induced autophagic activity and increased cell growth in both
ARPE-19 cells and photoreceptor 661W cells. Pretreatment with the dietary
supplements diminished the cytotoxic effects of ICG and BBG in ocular cells
compared to the cells that did not receive the dietary supplements. Several
mechanisms may be involved in cytoprotective effects of the dietary supplements
in cells exposed to ICG or BBG, such as reduction of oxidative stress and
promotion of mitochondrial biogenesis. Our current results imply that dietary
supplements-induced autophagy could be one of the mechanisms for protecting
ocular cells from stress caused by ICG and BBG.
In conclusion, autophagy plays a protective role in ARPE-19 and 661W cells
treated with vital dyes. The dietary supplements studied may protect the ocular
cells against the vital dye–induced cytotoxicity via induction of autophagy.
# Supporting information
ICG Indocyanine green
BBG brilliant blue G
ILM internal limiting membrane
LC3 microtubule associated protein 1 light chain 3
SQSTM1 sequestosome 1
ATG autophagy-related
BECN1 beclin 1
CQ chloroquine
RPE retinal pigment epithelial cells
ROS reactive oxygen species
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** SJS CWS. **Data curation:** SHL YAC. **Formal
analysis:** CWS YSB. **Funding acquisition:** SJS CWS. **Investigation:**
JLC YSB. **Methodology:** SJS CWS. **Project administration:** SJS CWS.
**Resources:** JLC YSB. **Software:** CWS. **Supervision:** SJS CWS.
**Validation:** JLC YSB. **Visualization:** SJS CWS. **Writing – original
draft:** SJS CWS. **Writing – review & editing:** SJS CWS.
|
# Introduction
Ophiobolins (OPs) are a family of sesterpenoid phytotoxic metabolites produced
mainly by fungi of the *Bipolaris* genus, pathogen of rice, maize and sorghum.
In plants, OPs induce a wide array of toxic effects, such as inhibition of
coleoptiles and root growth and seed germination inhibition. At the cellular
level, OPs affect membrane permeability, causing electrolytes and nutrients
leakage, proton extrusion inhibition, decrease of CO<sub>2</sub> photosynthetic
assimilation and inhibition of protein and nucleic acid synthesis.
In the last years, accumulating evidence demonstrates that OPs are able to
affect cellular functions also in mammalian cells. Ophiobolin A (OP-A) results
strongly cytotoxic to mouse leukaemia cells, where it induces shrinkage of cell
soma, chromatin condensation and DNA laddering, typical features of apoptotic
cell death. Moreover, ophiobolin O (OP-O) from *Aspergillus ustus* induces
apoptosis in multidrug-resistant MCF-7 breast cancer cells..
By contrast, OP-A displays the same cytostatic effect on both apoptosis-
sensitive and apoptosis-resistant cancer cells, whereas in human glioblastoma
cells it is able to induce cell death, through a paraptosis-like mechanism.
Melanoma is a highly malignant tumour induced by transformation of melanocytes,
whose incidence rate is rapidly increasing in the world. Due to its high
resistance to cytotoxic agents, metastatic melanoma has a very poor prognosis.
Therefore, finding new anti-cancer molecules able to integrate or enhance
chemical treatments of drug-resistant tumours such as melanoma is a relevant
research issue.
In the present study we characterized the OP-A effects on A375 (BRAF V600E) and
CHL-1 (BRAF wt) melanoma derived cell lines, as compared to the HaCaT
(immortalised keratinocytes) cell line. To this purpose, we analysed cell
viability, nuclear and mitochondria morphology and functionality, cell death
induction, as well as cell cycle progression. Finally, we performed a
comparative proteomic analysis on A375 cell line treated with OP-A.
# Materials and Methods
## Cell culture and treatments
A375 human melanoma cell line was grown in RPMI 1640 medium (Lonza, Switzerland)
supplemented with 2 mM L-glutamine (Thermo Fisher Scientific, MA, USA), CHL-1
human melanoma and HaCaT immortalised human keratinocytes cell lines were grown
in DMEM medium (Lonza), both supplemented with 10% Foetal Bovine Serum (FBS,
Thermo Fisher Scientific), and penicillin/streptomycin (Sigma Aldrich, MO, USA)
in an humidified 5% CO<sub>2</sub> atmosphere at 37°C. Cell treatments:
1x10<sup>5</sup> or 2x10<sup>6</sup> cells were seeded in 12 wells plates or 100
mm dishes and the next day treated with the indicated amount of OP-A, diluted in
fresh culture medium, for the indicated times. For the necrostatin treatments
cells were incubated for 2 h with 20 μM necrostatin-1 (Santa Cruz Biotechnology,
TX, USA) in complete medium, before the addition of OP-A.
## MTS viability assay
Cell viability was assessed by Acqueous One Solution Proliferation Assay (MTS
assay, Promega, WI, USA), following the manufacturer indications.
## Western blotting
Whole cell extracts were prepared by lysis in RIPA buffer (50 mM Tris-HCl, pH
7.4, 150 mM NaCl, 0.5% Na-deoxycolate, 0.1% SDS, 1% NP-40, 2 mM
Na<sub>2-</sub>EDTA), supplemented with protease inhibitors (Roche, Germany).
Protein concentration was determined by Bio-Rad protein assay (Bio-Rad, CA, USA)
and 10–25 μg of proteins were separated on 4–12% Nu-PAGE pre-cast gels (Thermo
Fisher Scientific). After blotting on PVDF and 1 h saturation in PBS containing
0.05% Tween-20 and 5% skim milk, membranes were incubated for 1 h or overnight
with primary antibody, diluted in PBS containing 0.05% Tween-20 and 0.5% skim
milk, washed three times for 10 min in PBS containing 0.05% Tween-20, incubated
for 1 h with the appropriate horseradish peroxidase-conjugated secondary
antibody (Bio-Rad) and the signals detected with Chemiglow by means of a
FluorChem SP system (Alphainnotech, Germany). Primary antibodies were against:
PARP, (BioMol, Germany, 1 μg/ml), Caspase 3 (9662, Cell Signaling, MA, USA, 1
μg/ml), Caspase 9 (9502, Cell Signaling, 1 μg/ml), LC3 (2775, Cell Signaling, 1
μg/ml), LC3B (D11 XP, Cell Signaling, 1 μg/ml), PINK1 (D8G3, Cell Signaling, 1
μg/ml), BAX (2D2 and N-20, Santa Cruz, 0.5 μg/ml), BAK (N-20, Santa Cruz, 0.5
μg/ml), cytochrome *c* (556432, Becton Dickinson, NJ, USA, 1 μg/ml). β-Tubulin
(Sigma Aldrich, 1 μg/ml) was used as a loading control for cell extracts.
## Mitochondrial imaging, mitochondrial membrane potential, mitochondrial mass, lysosome contents, and mitochondrial reactive oxygen species (ROS) measurement
Mitochondrial network imaging was performed by incubating untreated and treated
cells for 20 min at 37°C with 1 μM MitoTracker Red CMXRos regent (Thermo Fisher
Scientific) in RPMI medium and nuclei counterstained with 1 μM HOECHST 33342
(Thermo Fisher Scientific). Images were captured by means of a Floid Instrument
(Thermo Fisher Scientific).
For mitochondrial membrane potential, mitochondrial mass, lysosome content and
mitochondrial ROS measurement, cells were detached with trypsin and, after
washing with PBS, 1x10<sup>6</sup> cells were incubated for 30 min at 37°C with
2 μM JC-1 (5,5’,6,6’-tetrachloro-1,1’,3,3’tetraethylbenzimidazolylcarbocyanine
iodide), or 100 nM MitoTracker Green FM (Thermo Fisher Scientific), or 100 nM
LysoTracker Red DND 99 (Thermo Fisher Scientific), or 5 μM MitoSOX Red (Thermo
Fisher Scientific), diluted in pre-warmed complete medium. At the end of the
incubation, samples were acquired by means of a FACSCalibur (Becton Dickinson).
## Flow cytometry analysis of cell death
Cells, untreated or treated with OP-A for the indicated times, were detached
with trypsin, washed twice with PBS and after suspension in propidium iodide
solution (50 μg/ml propidium iodide, 0,1% Triton X-100, 0,1% Na-citrate in PBS),
incubated 8 h or overnight at 4°C in the dark. Samples were acquired by means of
a FACSCalibur and flow cytometry data analysed with the FlowJo software
(TreeStar, [www.flowjo.com](http://www.flowjo.com)).
## 2D electrophoresis
Cells were treated with 0.6 μM OP-A for 24 h. After incubation, cells were
detached with trypsin, washed twice with ice-cold PBS and centrifuged. Cell
pellet was resuspended in Lysis Buffer (50 mM Tris-HCl pH 7.4, 1% Triton-X-100,
250 mM NaCl, 5 mM EDTA) and incubated overnight at 4°C. Cell lysates were
centrifuged at 14,000 x g for 20 min and protein concentration in the
supernatant was determined by Bradford assay. Equivalent protein amounts (300
μg) of control and treated cell samples were desalted by precipitation with cold
ethanol (overnight at -20°C). Precipitates were centrifuged at 15,000 x g for 15
min. Protein pellets were dissolved in IEF buffer (9 M urea, 4% w/v CHAPS, 0.5%
v/v Triton X-100, 20 mM DTT, 1% w/v Bio-Rad carrier ampholytes pH 3–10 NL).
Protein concentration was estimated by using the Bradford assay, modified
according to Ramagli and Rodriguez. IPG strips (17 cm pH 3–10 NL, Bio-Rad
ReadyStrip) were rehydrated overnight with IEF buffer containing 350 μg of total
proteins. Proteins were focused using a Protean IEF Cell (Bio-Rad) at 12°C, by
applying the following voltages: 250 V (90 min), 500 V (90 min), 1000 V (180
min) and 8000 V for a total of 52 KVh. After focusing, proteins were reduced by
incubating the IPG strips with 1% w/v DTT in 10 ml of equilibration buffer (50
mM Tris-HCl pH 8.8, 6 M urea, 30% w/v glycerol, 2% w/v SDS and a dash of
bromophenol blue), for 20 min, and then alkylated with 2.5% w/v iodoacetamide in
10 ml of equilibration buffer, for 20 min. Electrophoresis in the second
dimension was carried out on 12% T polyacrylamide gels (180 x 240 x 1 mm)
running on a Protean apparatus (Bio-Rad) in 25 mM Tris-HCl pH 8.3, 1.92 M
glycine and 1% w/v SDS, with 120 V (for 12 h), until the dye front reached the
bottom of the gel. 2-DE gels were then stained with colloidal Coomassie G250;
resulting images were acquired by using a GS-800 imaging systems (Bio-Rad). For
quantitative analysis, each biological sample was analyzed in technical
triplicates.
## Gel image analysis
Digitalized images of Coomassie-stained gels were analyzed by using the PD Quest
(vers. 7.3.1) 2-D analysis software (Bio-Rad), which allowed spot detection,
landmarks identification, aligning/matching of spots within gels, quantification
of matched spots and their analysis, according to manufacturer's instructions.
Manual inspection of the spots was performed to verify the accuracy of automatic
gel matching; any error in the automatic procedure was manually corrected prior
to the final data analysis. The spot volume was used as the analysis parameter
for quantifying protein expression. The protein spot volume was normalized to
the spot volume of the entire gel (i.e., of all the protein spots). Fold-changes
in protein spot levels were calculated between spot volumes in the treated
group, relative to that in the control gels. Statistically significant changes
in protein expression were determined by using two sequential data analysis
criteria. First, a protein spot had to be present in all gels for each sample to
be included in the analysis. Next, statistically significant changes in protein
expression were determined by using the distribution of fold-change values in
the data. Spots were determined to be statistically significant if the
difference between the average intensity of a specific protein spot in the
treated and control cells (three technical replicates of three biological
samples) was greater than one standard deviation of the spot intensities for
both groups. An absolute two-fold change in normalized spot densities was
considered indicative of a differentially represented component; values 2 or 0.5
were associated with increased or decreased protein amounts after treatment,
respectively.
## Protein digestion and mass spectrometry analysis
Spots from two-dimensional electrophoresis were manually excised from gels,
triturated and washed with water. Proteins were in-gel reduced, S-alkylated and
digested with trypsin, as previously reported. Protein digests were subjected to
a desalting/concentration step on microZipTipC18 devices (Millipore, Bedford,
MA, USA). Peptide mixtures were then analyzed by nano-liquid chromatography
coupled to electrospray-linear ion trap-tandem mass spectrometry (nanoLC-ESI-
LIT-MS/MS) using a LTQ XL mass spectrometer (Thermo Fisher Scientific) equipped
with Proxeon nanospray source connected to an Easy-nanoLC (Proxeon, Denmark).
Peptide mixtures were separated on an Easy C18 column (100 x 0.075 mm, 3 μm)
(Proxeon) using a gradient of acetonitrile containing 0.1% formic acid in
aqueous 0.1% formic acid; acetonitrile ramped from 5% to 35% over 15 min, and
from 35% to 95% over 2 min, at a flow rate of 300 nl/min. Spectra were acquired
in the range m/z 400–2000. Acquisition was controlled by a data-dependent
product ion scanning procedure over the three most abundant ions, enabling
dynamic exclusion (repeat count 2 and exclusion duration 1 min). The mass
isolation window and the collision energy were set to m/z 3 and 35%,
respectively.
## Protein identification
MASCOT software package version 2.2.06 (Matrix Science,
[www.matrixscience.com](http://www.matrixscience.com)) was used to identify
proteins within spots from an updated human non-redundant sequence database
(NCBI 2014/12). NanoLC-ESI-LIT-MS/MS data were searched by using a mass
tolerance value of 2 Da for precursor ion and 0.8 Da for MS/MS fragments,
trypsin as proteolytic enzyme, a missed cleavages maximum value of 2, and Cys
carboxamidomethylation and Met oxidation as fixed and variable modification,
respectively. Protein candidates with at least 2 assigned unique peptides with
an individual MASCOT score \>25, both corresponding to *p* \< 0.05 for a
significant identification, were further evaluated by the comparison with their
calculated Mr and pI values, using the experimental ones obtained from two-
dimensional electrophoresis.
## Data analysis
All the data reported were verified in at least six different replicates and are
reported as mean ± SEM. Statistical analysis on flow cytometry data was
performed by means of ANOVA and Bonferroni post-test. Analysis of gel spot
quantitative differences was carried out using the Student's *t* test.
# Results
## OP-A induced cell death in human melanoma cells by activating the mitochondrial pathway of apoptosis
We first assessed the effect of OP-A on A375 human melanoma cell line, by
analyzing cell viability by means of MTS assay in a dose-response treatment
(0.3, 0.6, 1.2 μM OP-A) for 24 and 48 h. shows that administration with 0.3 μM
OP-A for 24 h was effective in reducing cell metabolic activity at about 60% of
control cells; metabolism was quite completely inhibited by 0.6 and 1.2 μM. The
effect was slightly increased after 48 h administration. These results suggested
that OP-A treatment resulted in an impairment of mitochondrial functionality, an
effect that could lead to the induction of the intrinsic pathway of apoptosis.
To verify this hypothesis, we then analyzed mitochondrial and nuclear morphology
of cells treated as above using MitotrackerRed and Hoechst staining. shows that
OP-A did not lead to the appearance of the cytoplasmic vacuolization observed
during paraptosis induction, but resulted in a fragmentation of the
mitochondrial network, even at the lowest dose used, and in the clustering of
mitochondria. Moreover, we detected the appearance of picnotic and apoptotic
nuclei (black and white arrowheads) when cells were treated with 0.6 and 1.2 μM
OP-A.
Taken together, these results suggest that OP-A treatment of A375 cell line
might lead to apoptosis induction through the activation of the mitochondrial
pathway, and prompted us to expand our analysis to other melanomas and normal
cell lines. To this purpose we compared OP-A-dependent cell death induction of
A375 (BRAF V600E) with CHL-1 (BRAF wt) melanoma, and HaCaT (immortalised
keratinocytes) cell lines., shows that OP-A was able to induce cell death in the
three cell lines. Nevertheless, treatment with 0.3 and 0.6 μM OP-A did not
induce significant cell death levels in the HaCaT cell line, whereas these doses
were effective in the two melanoma cell lines. At the highest dose tested (1.2
μM), OP-A caused massive cell death in all the three cell lines.
Western blot analysis of proteins involved in apoptosis, revealed the activation
of the mitochondrial apoptotic pathway. In fact, we could detect PARP and
caspase-9 and -3 cleavage (quantified), respectively. In addition, we checked
for the induction of autophagy using the specific marker LC3II, whose levels
increase upon LC3I cleavage. shows that OP-A induced autophagy in all the three
cell lines, as demonstrated by the increase of LC3II/LC3I ratio (panel B).
Densitometric analysis revealed that autophagy induction was particularly
efficient in the A375 cell line.
In order to exclude the possibility that other types of death could be
responsible for the effects we observed, we performed the same OP-A treatments
in presence of 20 μM necrostatin-1., right panel, shows that necrostatin-1 did
not inhibit OP-A-induced cell death, thus excluding the possible induction of
necrosis or necroptosis.
The OP-A-dependent mitochondrial perturbation we observed in the A375 cell line
should be coupled not only to mitochondrial network rearrangements, but also to
other alterations such as loss of mitochondrial membrane potential, which could
result in mitophagy induction, and ROS generation. To verify these hypothesis,
we first analysed mitochondrial membrane potential, mitochondrial mass, lysosome
content and mitochondrial ROS production, by means of flow cytometry after
staining with JC-1, MitoTracker Green, LysoTracker Red or MitoSOX Red,
respectively. shows that OP-A treatment resulted in a reduction of mitochondrial
membrane potential in all the three cell lines. As far as the HaCaT cell line,
significant reduction of membrane potential occurred already at 0.6 μM OP-A,
with a complete loss of the potential at 1.2 μM. On the other hand, the two
melanoma cell lines showed a significant reduction of membrane potential only at
1.2 μM.
Mitochondrial damages resulting in loss of membrane potential are frequently
coupled to mitophagy induction, in order to remove the damaged organelles. For
this reason, we measured mitochondrial mass and lysosome content. Surprisingly,
even if we observed significant induction of autophagy we were not able to
detect any significant decrease of the mitochondrial mass, and for the HaCaT
cell line we revealed a significant increase of the mass in samples treated with
0.6 and 1.2 μM OP-A. Nevertheless, we observed a significant reduction of the
lysosome content in cells treated with 1.2 μM OP-A, thus suggesting autophagy
(mitophagy) induction. We measured also mitochondrial-derived ROS, by means of
MitoSOX Red. shows that OP-A induced ROS production in the HaCaT and A375 cell
lines, while no significant ROS levels were detected for the CHL-1 cell line.
Taken together these results suggest that OP-A damaged mitochondria, causing
loss of mitochondrial membrane potential and ROS production, even though at
different extents in the three cell lines. As far as the observed increase of
mitochondrial mass, we could speculate that the reported effect of OP-A on the
Endoplasmic Reticulum (ER) dilation coupled with alteration of the cell’s
membranes permeability, could determine MitoTracker Green accumulation also in
the ER, thus leading to an apparent increase in the mitochondrial mass. In order
to confirm the occurrence of mitochondrial damage and induction of the
mitochondrial pathway of apoptosis, we performed a western blot analysis on
different cellular fractions of HaCaT, CHL-1 and A375 cell lines treated with
OP-A for 24 h. shows the results of the analysis of PINK1, a marker of
mitochondrial depolarization, Bax, Bak and cytochrome *c*, markers of the
mitochondrial pathway of apoptosis.
OP-A induced significant PINK1 accumulation on the mitochondria in all the
three cell lines, thus confirming the mitochondrial damage and induction of
mitophagy. Furthermore OP-A caused relocalisation to mitochondria of Bax and Bak
proteins, as well as, the release of cytochrome *c* in the cytosol. The
activation of the mitochondrial pathway of apoptosis in melanoma cell lines was
also corroborated by the analyses of the autophagy marker LC3II, which was
increased in all the three cell lines upon OP-A treatment.
## OP-A induced alteration of the cell cycle
In order to test the effect of OP-A on cell cycle progression, we analysed the
distribution of cells in each phase of the cycle after 24 h of OP-A
administration, by means of flow cytometry after propidium iodide staining.
As shown in, OP-A induced alterations of the cell cycle in all cell line tested.
As far as the HaCaT cell line, the only significant alteration was an increase
of the percentage of cells in the G1 phase, from 47% (ctrl) to 57% (0.6 μM,
p\<0.01), coupled to a decrease of the percentage of cells in the S phase, from
33% (ctrl) to 22% (0.6 μM, p\<0.01). A similar behaviour was observed for the
CHL-1 cell lines, but at a lower dose. In fact, OP-A induced an increase of the
percentage of cells in the G1 phase, from 61% (ctrl) to 75% (0.3 μM, p\<0.05),
coupled to a decrease of the percentage of cells in the S phase, from 28% (ctrl)
to 15% (0.3 μM, p\<0.05). Differently, in the A375 cell line, OP-A induced
alteration of the cell cycle at the highest doses of the treatment. The
percentage of cells in the G2/M phase, increased from 8% (ctrl) to 12% (0.6 μM,
p\<0.05) and to 12% (1.2 μM, p\<0.001), coupled to a decrease of the percentage
of cells in the G1 phase, from 57% (ctrl) to 50% (1.2 μM, p\<0.001).
Taken together, our results suggest that prolonged exposure to OP-A leads to an
impairment of mitochondrial functions, which are reflected in the alteration of
cell cycle progression, induction of autophagy and ultimately in cell death by
apoptosis, even if with different timings and modalities in the three cell
lines.
## Effect of OP-A treatment on the protein repertoire of melanoma cells
In order to obtain information about the molecular mechanisms underlying OP-A
effect, a proteomic analysis on the A375 cell line was carried out. Total
proteins were extracted from control or 0.6 μM OP-A treated cells and resolved
by two-dimensional gel electrophoresis (2-DE). To detect quantitative changes in
relative protein spot volume, colloidal Coomassie-stained gels were subjected to
software-assisted image analysis. Statistical evaluation of the relative volumes
allowed to detect spots whose representation varied significantly (*p* \< 0.05).
The 2-D Master gel of the A375 human melanoma cell proteome is shown in , upper
panel, where encircled spots indicate differentially represented proteins.
The overall 2-DE profiles of control and treated cells were very similar;
however, 24 protein spots whose abundance varied at least two-fold in response
to OP-A challenge were detected. These differentially represented spots were
excised from the gel, proteolyzed and subjected to MS analysis. Database
searching with results from nanoLC-ESI-LIT-MS/MS experiments allowed the
identification of the proteins migrating within these spots. The list of the
identified polypeptides is reported in.
Globally, spots assayed were associated with 16 non-redundant protein entries.
Analysis of spot 1, 11, 17, 18, 21 and 24 resulted in a multiple identification,
and they were not further discussed. One protein, peptidyl prolyl isomerase was
present in multiple spots (4–6) whose structural differences were not further
characterized; probably, they resulted from post-translational modifications or
sequence-related isozymes. Fifteen proteins resulted down-regulated, whereas 1
was up-regulated. Functional categorization according to Gene Ontology
annotation and literature data (data not shown), showed that differentially-
represented proteins grouped into different functional categories, including
components involved in glucose metabolism, protein folding, mitochondrial
transport, cytoskeleton organization and cell proliferation.
Reprogramming of metabolism, involving enhanced glycolysis is a hallmark of
cancer. Hence, down-regulation of glycolytic enzymes can contribute to reduce
energy fuelling to cancer cells. Two enzymes of the glycolytic metabolism have
been identified, namely fructose 1,6 bisphosphate aldolase A (ALDOA, spot 3) and
triose phosphate isomerase (TPI, spots 13 and 15). Notably, ALDOA is highly
expressed in a variety of malignant cancers, including renal cancer, human lung
squamous cell carcinoma, and hepatocellular carcinomas, suggesting it could
promote cancer growth by enhancing glycolysis. It is worth to note that OP-A has
been described as a calmodulin inhibitor and that calmodulin antagonists induce
a reduction of ALDOA levels, coupled to cell death in melanoma cell lines.
TPI catalyzes the conversion of dihydroxyacetone phosphate into D-glyceraldehyde
3-phosphate, a key substrate of the glycolytic pathway. This enzyme is up-
regulated in different types of lung and urinary cancers and in ovarian
carcinoma. In etoposide-treated HeLa cells, inhibition of TPI by cyclin A/Cdk2
phosphorylation hampers energy production, thereby inducing apoptosis.
Interestingly, a recent body of evidence supports the idea that glycolytic
enzymes play also non-glycolytic roles, which are essential for promoting cancer
cell proliferation and chemoresistance.
Six proteins involved in protein folding were down-regulated by OP-A, namely
peptidyl-prolyl cis-trans isomerase A (spots 4–6), prefoldin (spot 7), heat
shock protein (HSPA8) (spot 16), mitochondrial 60 kDa and 10 kDa heat shock
proteins (spot 19, 23), and tapasin (spot 22). Peptidyl-prolyl cis-trans
isomerases A (PPIase A) belongs to the cyclophilins class of PPIases. Recently,
evidence of the involvement of members of this family in cancer development has
been reported. In fact, knockdown of cyclophylin A reverses chemoresistance in
endometrial cancer cells, while the over-expression of peptidyl-prolyl
isomerase-like 1 is associated with growth of colon cancer cells. Prefoldins
(PFDs) are hetero-oligomer chaperones involved in cancer development, since
their main targets are actin and tubulin. Up-regulation of members of the PFD
protein family has been reported in different tumours, such as glioblastoma,
breast, pancreatic, colon, bladder and cervical carcinomas. The heat shock
proteins (HSPs) have been reported to be significantly elevated in many kind of
human cancers and their over-expression has been correlated to therapeutic
resistance and poor survival. HSP71 (HSPA8, spot 16) is a constitutively
expressed isoform of the HSP70 protein family, essential for normal protein
homeostasis in unstressed cells. In addition to facilitating folding, HSC70 is
involved in the degradation of misfolded proteins. Although HSC70 is over-
expressed in cancer cells, little is known about how it contributes to their
survival. A recent proteomic investigation of human colon cancer cells showed
that HSC70 interacts with and prevents the degradation of key proteins involved
in cancer survival. As far as mitochondrial HSPs isoforms (spot 19, 23), they
can enhance tumourigenicity by promoting the retention into the mitochondria of
pro-apoptotic factors.
Mitochondrial voltage-dependent anion channel 1 (VDAC-1, spot 2) is the most
abundant and physiologically relevant isoform of the VDAC family of pore-forming
proteins, located at the outer membrane of mitochondria (OMM). VDACs are
voltage-sensitive ion channels that regulate the energy flux across the OMM by
facilitating the diffusion of key molecules such as nucleotides, pyruvate and
malate. Altering VDAC-1 levels may lead to opposite effects in tumour cells. In
fact, VDAC-1 favours the release of pro-apoptotic proteins from the
mitochondrial inter-membrane space to the cytosol. On the other hand, VDAC-1
sustains the high glycolytic rates of tumour cells by associating with
hexokinase, and inhibits the formation of the mitochondrial permeability
transition pore (MPTP) in the OMM, which is necessary for the release of pro-
apoptotic factors. Recently, a systematic analysis demonstrated that VDAC-1 is
up regulated in breast, colon, liver, lung, pancreatic, and thyroid tumour
tissues. VDAC-1 is considered a marker of mitochondrial mass, and its decrease
in OP-A treated A375 cells fairly correlates with the mitochondrial damage and
reduction of mitochondrial mass due to mitophagy induction.
Three proteins involved in cytoskeleton dynamics regulation have been found as
differentially represented after treatment with OP-A, namely Pr22 protein (spot
8) and calumenin (spot 20) (both down-represented), and P1725 protein (spot 9)
(over-represented). Microtubule destabilization is a crucial process during
cancer progression. Pr22 protein is over-expressed in different highly malignant
tumours, such as breast or ovarian cancers and leukaemias, whereas its reduction
can reverse the malignant phenotype. Calumenin is involved in the regulation of
cytoskeleton and localization of intracellular proteins. In a recent proteomic
study concerning the effect of the anti-tumoural natural drug gambogic acid on
breast carcinoma cells, levels of calumenin were consistently decreased.
Other proteins with different functions were observed as down-represented after
treatment with OP-A. Among that, translationally-controlled tumour protein
(TCTP, spot 12) that is an ubiquitous eukaryotic component involved in pivotal
cell functions like growth, cell cycle, apoptosis and stem cells pluripotency.
TCPT is over-represented in diverse tumours, and its down-regulation hampers
tumour viability. Recent data indicate that TCTP has a chaperone-like structure
that makes it able to interact with anti-apoptotic proteins like Bcl-xL, thereby
functioning as a pro-survival factor in cancer cells.
# Discussion
In this study, we analysed the effect of OP-A on A375 (BRAF V600E) and CHL-1
(BRAF wt) human melanoma cell lines, as compared to the HaCaT immortalised
keratinocytes cell line. In fact, despite a growing body of evidence indicates
that OPs possesses anti-proliferative activity towards different cancer-derived
cell lines, the specific mechanism underlying this action remains unclear.
Our results demonstrated that OP-A induced mitochondrial network fragmentation,
membrane potential dissipation and mitochondrial ROS production, leading to
induction of autophagy and ultimately resulting in activation of the
mitochondrial pathway of apoptosis. Although flow cytometry analysis did not
allow to show any significant reduction of mitochondrial mass, probably due to
dye accumulation also in swelled ER, evidence of mithocondrial damage was
obtained by western blot analysis. In fact, the strong increase in the
mitochondrial levels of PINK1 protein, a marker of mitochondrial membrane
potential depolarization, and of the autophagy marker LC3II, strongly put
forward the occurrence of mitochondrial damage and induction of autophagy. A
further piece of evidence resulted from proteomic investigation of A375 cell
line, in which a dramatic reduction of the mitochondrial mass marker VDAC-1 was
observed.
Mitochondrial damage and consequent mitophagy ultimately resulted in cell death
by the activation of mitochondrial pathway of apoptosis, as indicated by the
analysis of specific markers.
In fact, western blot analysis demonstrated caspase-9 and -3 activation, PARP
cleavage, as well as relocalisation of the pro-apoptotic members of the Bcl-2
family Bax and Bak. The activation of the mitochondrial pathway of apoptosis was
further supported by cytochrome *c* release in the cytosol.
Prolonged exposure to OP-A leads to an impairment of mitochondrial functions,
induction of autophagy and ultimately in cell death by apoptosis in both
melanoma cell lines, even though with different timings and modalities in
different cell lines. In particular, CHL-1 cells appeared more sensitive to
OP-A. This difference could be related to survival signalling pathways activated
by the BRAF V600E mutation present in the A375 cell line.
Furthermore, the proteomic approach on A375 cell line allowed us to identify
down-regulation of different proteins, essential to maintain cell integrity and
viability, whose levels normally increase in different types of cancer.
Taken together, our results demonstrate that OP-A possess a strong cytotoxic
activity on melanoma cells, even on recalcitrant A375 cell line, where it is
able to induce mitochondrial damage and cell death by apoptosis. Under this
respect, it is noteworthy that OP-A is effective at nanomolar/micromolar
concentrations after 24 h of treatment, whereas the BRAF inhibitor vemurafenib,
the elective drug for treatment of recalcitrant melanomas is not (data not
shown). However, the mechanism of action of the toxin deserves further
investigation. In fact, even though mitochondria appear as the primary site of
action, the apparent lack of mitochondrial mass reduction and the proteomic
identification of many down-regulated proteins regulating fundamental cellular
processes suggest that other cell death mechanisms may be involved, such as for
instance the ER stress.
In conclusion, even further investigation is needed, OP-A appears as a promising
molecule to be studied for its potential use in the treatment of melanoma,
possibly in association to other type of anti-cancer agents.
We thank prof. Maurizio Mattei, University of Rome Tor Vergata, for providing
the A375 human melanoma cell line, and dr. Marco Corazzari, University of Rome
Tor Vergata, for providing the CHL-1 human melanoma and HaCaT immortalised human
keratinocytes cell lines.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** CR LC MM. **Data curation:** AS MS MR. **Formal
analysis:** CR MR AS MS LCat. **Funding acquisition:** AS.
**Investigation:** CR MS MT LCat MR. **Methodology:** CR MM LC. **Project
administration:** MM AS LC PA. **Resources:** PA AS MM MR. **Software:** AS
MS MT CR. **Supervision:** MM AS PA. **Validation:** AS MR LC MM.
**Visualization:** CR MR LC. **Writing – original draft:** LC CR MM.
**Writing – review & editing:** LC CR MM AS.
|
# Introduction
Nowadays obesity has become epidemic in developed and even in developing
countries worldwide.This disease is characterized by low-grade systemic
inflammation. Regarding this affirmation, it is fully accepted that the adipose
tissue is a metabolically active endocrine organ secreting a variety of
bioactive substances known as adipokines, that could act as functional links
between energy balance and insulin resistance. Visfatin is a recently described
adipocytokine, also known as pre-B cell colony-enhancing factor (PBEF) or
nicotinamide phosphorybosil transferase (NAMPT).NAMPT was cloned by Samal
and his colleagues in 1994 from activated human peripheral blood lymphocytes
during their attempt to discover new factors for the earliest events in B-cell
development. This protein of 52–55 KDa, was described as a growth factor for
early B cells called pre-B cell colony–enhancing factor 1 (PBEF1). Recently, it
has been identified as an intracellular enzyme and called nicotinamide
5-phosphoribosyl-1-pyrophosphate transferase (NAMPT) that catalyzes the rate-
limiting step in nicotinamide adenine dinucleotide (NAD) biosynthesis and
mediates the conversion of nicotinamide to nicotinamide mononucleotide.It has
been proposed that this adipose derived hormone exerts insulin mimicking effects
and play a positive role in attenuating insulin resistance. However, the precise
mechanisms underlying the beneficial effects of visfatin on insulin sensitivity
remain largely unknown. It has been suggested that visfatin might have both
endocrine and paracrine effects, mostly related to obesity and insulin
sensitivity although there are important discrepancies in the literature. As
regards to obesity, Fukuhara et al. reported that, in adipose tissue, visfatin
is predominantly expressed by visceral fat as estimated by abdominal computed
tomography; and also its circulating levels correlate with the amount of
visceral fat in both humans and mice. However, these observations were not
confirmed by other authors. Furthermore, the significance of the correlation
between visfatin levels and body mass index (BMI) is still unclear probably due
to deficiencies in the specificity of the applied immunoassays.
As it relates to the impact of visfatin on insulin sensitivity, Fukuhara *et al*
reported that visfatin binds to and activates the insulin receptor explaining
the reported metabolic effect of this citokyne on peripheral organs. Recently,
these authors retracted from the original paper, being this hypothesis currently
under debate. Moreover, other groups have reported on the presumed insulin
mimetic effects of visfatin in osteoblasts and cultured mesangial cells.
Visfatin is a proinflammatory mediator and might participate in a variety of
inflammatory conditions, such as autoimmune diseases and adipose tissue
inflammation-induced insulin resistance.
The human visfatin gene is located on chromosome 7q22.3 and includes 11 exons
encompassing 34.7 kb. Interestingly, this region appears to be linked to
metabolic syndrome–related phenotypes in several populations including non
diabetic Mexican-Americans, Mexicans–American families and hypertensive Hispanic
families according to multipoint variance component analysis. Our aim was to
investigate if genetic variations in the visfatin gene could be associated with
obesity, glucose tolerance (Diabetes Mellitus Type 2) and cardiovascular
(CV)risk–related alterations on a large sample of a population–based study in
Spain.
# Methods
## Participants
The Segovia Study was designed as a cross-sectional, population–based survey of
the prevalence of anthropometric and physiological parameters related to obesity
and other components of the metabolic syndrome. It was conducted in rural and
urban areas of the province of Segovia, in Central Spain. A detailed report of
this study has been previously published. In brief, a random sample of 2,992 men
and non—pregnant women aged 35–74 years were selected from a target population
of 63,417 inhabitants. A total of 587 individuals gave written consent after
receiving detailed information on the purposes and the objectives of the study.
The protocol was approved by the Ethics Committee of the Hospital Clínico San
Carlos in Madrid.
## Anthropometrical and biochemical measurements
The BMI and waist circumference (WC) were used as estimations of total body fat
mass and visceral obesity, respectively. Those individuals with a BMI higher
than 30 kg/m<sup>2</sup> were classified as obese. Systolic and diastolic blood
pressures were measured three times in a seated position after 10 min of rest to
the nearest even digit using a random-zero sphygmomanometer. 20 ml of blood were
obtained from an antecubital vein without compression after about a ten-hour
overnight period. Plasma glucose was determined twice by a glucose-oxidase
method adapted to autoanalyze (Hitachi 704, Boehringer Mannheim, Germany). An
oral glucose tolerance test (OGTT) was performed following the criteria of the
American Diabetes Association. The categories of glucose values were as follows:
1) normoglycaemia (NG): fasting plasma glucose \< 100 mg/dl or 2-h postload
glucose lower than 140 mg/dl; 2) impaired fasting glucose (IFG): fasting plasma
glucose levels ≥ 100 mg/dl but \<126 mg/dl and 2h postload glucose lower than
140 mg/dl; 3) impaired glucose tolerance (IGT): 2-h postload glucose between 140
and 200 mg/dl; 4) diabetes: fasting plasma glucose levels ≥ 126 mg/dl or 2-h
postload glucose ≥ 200 mg/dl. Total serum cholesterol, triglycerides and high-
density lipoprotein cholesterol (HDL-C) were determined by enzymatic methods
using commercial kits (Boehringer Mannheim, Germany). Low-density lipoprotein
cholesterol (LDL-C) was calculated by the Friedewald formula. Plasma visfatin
concentrations were measured with a human visfatin (COOH-terminal) enzyme
immunometric assay (Phoenix, Belmont, CA). The minimum detectable concentration
was 2.3 ng/ml and the intra / inter-assay variation´s coefficient \<5% and \<14%
respectively. Insulin, proinsulin, leptin and adiponectin serum concentrations
were determined by highly specific / sensitive RIAs (Linco Research Inc., St
LouisMO, USA). Insulin resistance (IR) was estimated by the homeostasis model
assessment (HOMA-IR) method according to the formula: insulin (μU/ml) x glucose
(mmol/l) / 22.5, using a cut-off point for HOMA-IR ≥ 3.8 as described in the
Spanish population.
To estimate high CV risk we chose: a) Framingham chart by D´Agostino et al in
which the top sex-specific quintiles of predicted CVD risk identifies \~ 48% of
men and 58% of women who experienced a first CVD event on follow-up
(sensitivity) and proportions of men and women without events who were not in
the top quintile of risk were 85% and 83% respectively (specificity); b) SCORE
Cholesterol risk chart for low risk regions: the 5% threshold has a 35%
sensitivity and 88% specificity and the ROC area is 0.74 (95%CI 0.72–0.76). A
CVR ≥20% according to the Framingham chart is associated with high risk of
cardiovascular morbidity and a CVR ≥5% with the SCORE chart indicates high risk
of cardiovascular mortality.
## Genotyping
Three previously described (<http://www.ncbi.nlm.nih.gov/SNP>) visfatin gene
variants were genotyped. In order to select the polymorphic sites in the NAMPT
gene that would be genotyped in our sample, we used information from the HapMap
database. Previous studies have reported association of NAMPT variants with
homeostasis glucose, fasting insulin and metabolic disorders. Among these, the
SNPs rs7789066 and rs11977021 reside within the promoter region and the SNP
rs4730153 is located in an intronic region. DNA was extracted from venous blood
using a kit by Qiagen. Genotyping was performed using the ABI PRISM 7900
Sequence Detection System by TaqMan for allelic discrimination assay (Applied
Biosystems). Genotyping was done using Assays–on Demand, and SNP Genotyping
Products (Applied Biosystems). The reaction was amplified on a GeneAmp
polymerase chain reaction system: cycling conditions were as follows: an enzyme
heat activation step at 95°C for 10 min, 40 two-step amplification cycles at
95°C for 15 second for denaturation and a last heating step at 60°C for 1 min
for annealing and extension. To assess genotyping reproducibility, a random
\~20% selection of the samples was genotyped, again in three SNPs with 100%
concordance.
## Statistical Analysis
Genotypic and allelic frequencies were analysed as categorical variables. Hardy-
Weinberg equilibrium was computed to the expected genotype distribution.
Triglycerides, fasting insulin, HOMA-IR, and leptin values were log-transformed
because of their skewed distributions. The one-way analysis of variance (ANOVA)
was used to compare continuous variables expressed as the mean ± standard
deviation (S.D.), while categorical variables were compared using the Chi-
squared test. Successive multiple linear regression analyses, adjusted for
potential confusion factors, were carried out to asses the effect of clinical
variables and genetic variants on glucose tolerance and obesity–related
alterations. The null hypothesis was rejected in each statistical test when the
p value was less than 0.05. The statistical analysis was performed using the
Windows SPSS version 15.0 software (SPSS, Inc, Chicago, IL, USA).
# Results
## Segovia study sample characteristics
The clinical characteristics of the studied population are shown in Tables and.
One hundred and forty-nine participants were obese, and the remaining ones (438)
were non–obese. Statistical significant differences were found for most of the
clinical parameters when comparing obese against normal weight subjects,
although only 2 hours glucose, fasting insulin and proinsulin, 2 hours insulin
and proinsulin, HOMA-IR and fasting leptin could be considered of different
significant clinical relevance between groups. Fasting visfatin and adiponectin
were similar in both categories subjects. Women showed lower mean values of WC,
triglycerides, fasting glucose, HOMA-IR, fasting proinsulin and proinsulin 2
hours than men. However, fasting HDL-C, leptin and adiponectin levels were
higher in women than men.
## Circulating visfatin levels and clinical parameters
Plasma visfatin levels were significantly higher in obese subjects with type 2
diabetes than in other categories of glucose tolerance: Normoglycaemia (NG):
9.69±3.77 ng/ml, prediabetes: impaired fasting glucose/impaired glucose
tolerance (IFG/IGT): 9.61± 2.72 ng/ml, and Diabetes Mellitus (DM): 13.48±
9.66ng/ml; global p = 0.018, NG vs DM p = 0.007; IFG/IGT vs DM p = 0.016. This
association between elevated visfatin levels and type 2 diabetes mellitus was
confirmed by a lineal regression analysis adjusted for gender, age, BMI, and WC
(β = 0.064, 95%CI: 1.002–1.135, p = 0.021). No evidence of that association was
found in non obese subjects (β = 1.03, 95% CI 0.89–1.19, p = 0.067).
## Genotype distributions and association study
Genotype distributions of the analyzed SNPs are shown in. None of theSNPs
deviated significantly from the Hardy-Weinberg, and our genotype distributions
are similar to those reported in the NCBI (National Center for Biotechnology
Information) for European populations (<http://www.ncbi.nlm.nih.gov/entrez/>).
The analysed SNPs were in Hardy–Weinberg´s equilibrium (data not shown). In
order to detect some possible associations between these genetic variants of the
visfatin gene, obesity and other glucose tolerance status–related disturbances,
the association study was performed in two groups of obese and non–obese
individuals. Evidence of some associations with insulin sensitivity–related
parameters was detected in the subgroup of obese participants. The significant
associations found by ANOVA were confirmed by linear regression analysis showing
that, in obese participants, the genotype AA of the rs4730153 SNP was
significantly associated with fasting glucose (β = 10.84, p = 0.040), fasting
insulin (β = 9.004, p = 0.003) and HOMA-IR (β = 0.173, p = 0.031) after
adjustment for gender, age, BMI and WC. We performed the same analysis excluding
diabetic subjects and the results were similar. On the other hand, the obese
individuals carrying the CC genotype of the rs11977021 SNP showed higher
circulating levels of fasting proinsulin (β = 4.231, p = 0.029) after adjustment
for the same variables. No evidence of these associations was found in the non-
obese subgroup or between the analysed genotypes and the other metabolic
parameters (data not shown).
## Cardiovascular risk
The genotype AA of the rs4730153 SNP offers protection against CV risk either
estimated by Framingham or SCORE charts in general population as well as in
obese and non-obese.No associations with CV risk were observed for the other
studied SNPs (rs11977021,rs7789066).
# Discussion
Most recently it has been demonstrated that the systemic visfatin-mediated
nicotinamide adenine dinucleotide synthesis is necessary for β cell function. In
this study, we performed a genetic association analysis to investigate whether
the visfatin gene is a candidate gene influencing glucose tolerance, obesity and
CV risk. The results here reported show for the first time, that in obese adult
population, the SNP rs4730153 is associated with insulin resistance as estimated
by HOMA-IR regardless of BMI, WC, age and gender. Moreover, another SNP, namely
rs11977021 is independently associated with serum proinsulin levels. On the
other hand the genotype AA of the rs4730153 SNP seemed to be protective for CV
risk in either Framingham or SCORE in general population as well as in obese and
non-obese.
As for the significance of circulating visfatin levels, several authors have
reported higher circulating visfatin levels in type 2 diabetic subjects than in
non diabetic individuals from Caucasian and non–Caucasian populations, though it
was unclear if this association was primarily related to obesity. Moreover, no
associations between insulin sensitivity related parameters and circulating
visfatin levels have been found in most of the reported studies or, when they
found significance, it was lostafter adjusting for BMI. Chen et al, in a
case–control study on 120 non–obese individuals, reported higher plasma levels
of circulating visfatin in patients with type 2 diabetes mellitus than in non
diabetic subjects after adjustment for gender, age and BMI. Similarly, García-
Fuentes et al showed that plasma visfatin levels are increased in patients with
severe obesity but only when it is accompanied by some degree of impaired
glucose tolerance. Using the same EIA commercial kit (Phoenix Pharmaceuticals),
we found that elevated visfatin levels were associated with a higher prevalence
of type 2 diabetes mellitus just in obese subjects. However, the conclusions
derived from our study and the above referred reports must have some limitations
because of the specificity of this particular assay, as well as others currently
available, has been recently questioned as the different immunoassays might
detect distinct visfatin compounds.
On the other hand, the analysis of genetic variants in the visfatin gene might
help knowing if visfatin plays an important physiological role in glucose
homeostasis–related alterations. We found that, in our obese subpopulation, the
SNPs rs11977021 and rs4730153 are associated with glucose metabolism–related
parameters regardless of BMI, WC, age and gender. As for the rs4730153 variant,
the allele frequency was in agreement with that reported in other Caucasian
populations. The homozygous subjects for the A allele had higher mean values of
fasting glucose, fasting insulin and HOMA index. These associations have been
previously explored in 626 subjects without type 2 diabetes mellitus and in 167
obese and 508 non-obese children from Germany, but no statistically significant
associations were found. The physiological mechanism by which an intronic
polymorphism such as the rs4730153 affects changes in glucose metabolism remains
unclear. So far, there are only 2 SNPs located in the promoter region of the
visfatin gene (-948C/A, rs9770242) which have been found to be associated with
type 2 diabetes–related parameters, but no proof of its functionality is yet
available. Of further interest is to consider that polymorphisms in the
phosphoinositide 3 –kinase gene is a potential candidate gene to develop type 2
diabetes also located in the chromosome region 7q22.3.
The rs11977021 had been previously associated with total and LDL cholesterol but
its possible association with proinsulin has not been previously analysed. We
report here a significant association between the CC genotype of the rs11977021
and higher levels of fasting proinsulin. This finding might be of relevance
since there is data indicating that the rs11977021 variant might be a functional
polymorphism key in type 2 diabetes mellitus.
On the other hand, in the last years, several studies have established positive
associations between enhanced circulating visfatin/NAMPT levels and atherogenic
inflammatory diseases, therefore supporting a role for visfatin as a potential
biomarker of cardiovascular complications associated to metabolic disorders. In
another study, Belo et al explored different SNPs (rs1319501 and rs3801266) in
obese children and adolescence with and without ≥ 3 traditional metabolic risk
factors (MRFs). They found that the SNPs rs1319501 had no effect on plasma
visfatin levels in obese and obese children with ≥ 3 MRFs as compared to lean
children. In contrast, rs3801266 was associated with higher plasma visfatin
concentrations in lean and obese children but not in obese children with ≥ 3
MRFs, suggesting that obesity and MRFs are more influential than genetic
polymorphisms in the determination of visfatin levels in obese children. Other
study in obese Chinese children and adolescents found that rs4730153 GG genotype
polymorphism was related to an increase in insulin sensitivity and a decrease in
triglycerides in response to exercise. So previous described results focused on
obesity in earlier stages of life, need to be corroborated in larger studies and
the comparison to our results here reported is difficult. Finally, Dou et
al. suggested that NAMPT may play an important role in the development of
dilated cardiomyopathy. Our study shows that visfatin genotype AA SNP rs4730153
is associated with a lower estimated CV-risk, although the precise mechanism by
which the SNP influence CV-risk remains to be established.
In summary, this is the first study which concludes that the genotype AA of the
rs4730153 SNP appear to protect against CV events in obese and non-obese
individuals, estimated by Framingham and SCORE charts. Our results confirm that
the different polymorphism in the visfatin gene might be influencing the glucose
homeostasis in obese individuals. Additional genetic studies in large obese
population samples and functional characterization of the genetic variants are,
however, warranted to corroborate our results.
The authors also wish to thank María Peiró-Camaró Adán who helped revise the
English.
We gratefully acknowledge Members of the Segovia Insulin Resistance study Group
(SIRSG) lead author: Manuel Serrano Ríos.e-mail:
<[email protected]>: Ángel Agudo-Benito, Juana Alonso-Barbolla,
Eva M Álvarez-de Castro, Mónica Álvarez-González, María José Andrés-Francés, Paz
de Andrés-Luis, Juan Manuel de Andrés-Rubio, Enrique Arrieta-Antón, Yolanda
Artiñano-del Pozo, Maria de los Ángeles Benito-Benito, Pinal Benito-Zamarriego,
Miguel Ángel Betés-Ruíz, Teresa Calvo-Navajo, Juan José Cañas-Sanz, Ovidio
Campo-Hernández, María Jesús Cardiel-Mañas, Rosario Cayuela-Caravaca, Tomás
Conde-Macías, Lucia Corral-Cuevas, Rafael Cuervo-Pinto, Máximo Durán-Ramos, Raúl
Fernández-Lambea, Eva M García-Arahuetes, Eugenio P García-de Santos, Francisco
J García-de Santos, José García-Velásquez, Luís García de Yébenes-Prous,
Magdalena Garrido-Mesa, Esther González-Aispiri, Esther González-Garrido, Pedro
González-Sastre, Luis Gonzálvez-López, Enrique Guilabert-Pérez, Argimiro
Gutiérrez-Mata, Benito de la Hoz-García, Mariana Egido-Martín, Belén Estampa-
Santiago, Lucia Fuentes-Fuentes, José María García Arres, Belén García-Márquez,
Julia García Múgica, Juan F Gil-García, Carmen González-Ferreiro, Mercedes
Herranz-Rosa, María Carmen Herrero-de la Cruz, María de la Infanta-Pérez,
Mariano Illana-Sanz, Jesús Izquierdo-Sánchez, Carlos de la Lama López-Areal, Ana
M de Lucas-Herrero, José Carlos Martín-Cuesta, Maria M Martín-García, Elena
Martín-Muñoz, Elvira Martín-Tomero, Manuel Monsalve-Torrón, Agustín Moreno-
Aragoneses, Vicente Negro-Dimas, Luis Ortega-Suárez, Felipe de la Osa-Plaza,
José de Pablo-Álamo, José Luis Palacio, María Luz Pardo-Duque, Jesús Pérez-
Tarrero, José M.ª Pinilla-Sánchez, Dolores Piñuela-de la Calle, Gloria Poza-
Martín, Rosa Amparo Ramos-Herranz, María de los Ángeles Requejo-Grado, Laura
Rincón-Heras, Javier Roca-Bernal, María Rodríguez-Herrera, José Rojas-Mula,
Jesús Ruiz-Barrio, Noelia Sánchez-Jiménez, Belén Sánchez-Martín, Luis A Santos-
López, César Sanz-Herrero, Juan José Sanz-Vicente, Marina Silva-Guisasola,
Virginia Silva-Guisasola, Carlos Solís-Camba, Carmen Tapia-Valero, Antonia
Valverde-Martín, María del Pilar de Vega-Codes, Saturio Vega-Quiroga, Cristina
Velarde-Mayol, Julio Zamarrón-Moreno and Laura Zamarrón-Sanz.
**Collaborating centers (allin the Province of Segovia)**: Villacastín, El
Espinar, Segovia I, Segovia II, Segovia III, Segovia Rural, Cantalejo, Carbonero
el Mayor, Sacramenia, Sepúlveda, Cuéllar, Nava de la Asunción, Riaza and San
Ildefonso Primary Care Centers.
CV risk Cardiovascular-risk
PBEF1 Pre-B cell colony–enhancing factor 1
NAMPT nicotinamide 5-phosphoribosyl-1-pyrophosphate transferase
NAD nicotinamide adenine dinucleotide
HOMA-IR Homeostasis model assessment- insulin resistance
BMI Body Mass Index
CV cardiovascular
WC waist circumference
OGTT oral glucose tolerance test
NG normoglycaemia
IFG impaired fasting glucose
IGT impaired glucose tolerance
HDL-C high-density lipoprotein cholesterol
LDL-C Low density lipoprotein cholesterol
IR Insulin resistance
SCORE Systematic Coronary Risk Evaluation
NCBI National Center for Biotechnology Information
[^1]: The authors received funding from a commercial source (Eli Lilly Lab,
& Bayer Pharmaceutical Co.) but this does not alter their adherence to PLOS
ONE policies on sharing data and materials. No conflict of interest related
to this work is declared.
[^2]: Conceived and designed the experiments: MSR. Performed the
experiments: ACA MTML MPB YLR. Contributed reagents/materials/analysis
tools: MTML MPB YLR. Wrote the paper: MTML MSR ACA. Study concept and
design: MSR. Acquisition of data: ACA MTML MPB YLR. Analysis and
interpretation of data: CFP MTML MSR. Drafting of the manuscript: MTML MSR
ACA. Analysis and interpretation of data: CFP MTML MSR.
[^3]: ¶ Membership of the SIRSG is provided in the Acknowledgments.
|
# Introduction
Fecal hormone analysis has become a widely used technique for measuring an
animal’s endocrine status and can provide valuable information to conservation
and monitoring programs. Fecal samples are often easily found and identified to
the species level and can be collected without disturbing wildlife. Analysis of
hormones in these samples can provide a variety of stress, reproductive, and
metabolic status measures that can be correlated with environmental pressures
over time. Noninvasive sample collection, however, often includes samples that
have been exposed to variable environmental conditions for varying and unknown
time periods. Understanding how time and exposure in the natural environment
affect hormone degradation is a prerequisite to reliable interpretation of fecal
hormone levels, particularly if the same natural conditions causing variation in
hormone levels (e.g., ambient temperature) also promote hormone degradation.
Physiological measures of climate-related thermoregulatory demands provide a
case in point. Monitoring effects of climate change can be difficult because
cumulative effects take place on large geographic scales over long time frames.
Noninvasive physiological measures of thermoregulatory demands and associated
impacts from habitat shifts in wildlife over large landscapes could provide a
sensitive tool for early detection and monitoring of such impacts. Fecal
glucocorticoids (fGC: cortisol, corticosterone, and their metabolites) could
provide one such measure, having been shown to reflect physiological responses
to ambient temperature and thermal exposure in mammals. Monitoring these impacts
in nature can be difficult, however, because warmer ambient temperatures and
environmental exposure may also hasten fGC degradation, and both temperature and
exposure effects are likely to vary with time of year. Nutritional status, which
is likely to vary with time of year, can also be detected through fGC levels.
Yet, diet composition itself can impact steroid excretion rates. Here, we ask:
can we detect a biological relationship between thermoregulatory demands or
nutrition and fGC concentrations in bears? How does fGC degradation change with
time, temperature, and exposure? Are these degradation effects large enough to
mask fGC biological indices of thermoregulation and nutrition?
We separate thermoregulatory from degradation-related effects on fGC levels in a
study of grizzly bears (*Ursus arctos horribilis*) and American black bears (*U.
americanus*) in Glacier National Park, MT. Julian date (estimating ambient
temperature) plus aspect, slope, and elevation (collectively estimating thermal
exposure), and precipitation at sample collection locations were used to predict
thermoregulatory impacts by measuring fGC levels in fresh fecal samples at time
0 (i.e., samples \<24 hours old) compared to fGC in those same samples left
under the same natural field conditions for an additional, randomly assigned
period of 1–28 days. Scat contents were also used in those samples to examine
how fGC varies with diet/nutrition, as well as to separate diet impacts from
effects of thermoregulation and degradation on fGC.
# Methods
## Study Area
We collected bear scats from 2 sections of trail located near the southern
boundary of Glacier National Park (GNP), MT. Generally, these trails paralleled
the park boundary with a mix of National Forest and private lands along the
opposite side of the Middle Fork of the Flathead River. This area has very
little human development; however, U.S. Highway 2 and the Burlington Northern
Santa Fe railroad experience intermittent heavy human use. Our study occurred at
the end of the tourist season when highway traffic volumes were well below the
peaks experienced in mid-summer.
The study area was located just west of the Continental Divide, in a relatively
moist climate reflecting a maritime influence. Elevation ranged from
approximately 950 m to 1250 m. Surveyed trails ran mostly on westerly or
southerly facing slopes through mature forest consisting largely of Douglas fir
(*Pseudotsuga menziesii*), Engelmann spruce (*Picea engelmannii*), lodgepole
pine (*Pinus contorta*), and western larch (*Larix occidentalis*).
Although GNP provides a high level of security for wildlife within its borders,
bears are known to readily move outside the park and across the U.S. Highway
2/railroad corridor. Outside GNP bears are exposed to a variety of stressors
related to human activities such as train and highway traffic, private
residences and small public lodgings, and various forms of outdoor recreational
and industrial activities such as logging.
## Sample Collection and Processing
The study period was from Julian date 250 (early September), when day time
temperatures were 27° to 35°C, until Julian date 300 (end of October), when
temperatures were near freezing, ca. 0° to −5°C. Two trails, approximately 19 km
in length each, were surveyed daily to ensure that each new scat found was \<24
hours old.
When a fresh scat (\<24 hrs) was encountered, the sample was divided in half.
One half was mixed thoroughly to equalize the distribution of hormone throughout
the sample and stored frozen immediately upon returning from the field (within 4
hrs of collection on average with an 8 hr maximum). This was referred to as the
“time 0” subsample. The second half of the sample was left intact to retain its
original characteristics until collection, and in its original position in the
environment (or moved slightly \[\<1 m\] if at risk of being trampled). The
second half, referred to as the “time 1” subsample, was randomly assigned to one
of five time exposure groups: 1, 2, 7, 14, or 28 days. Field crews returned to
the second half of each sample at the designated exposure time, thoroughly mixed
the remaining half sample and stored it frozen, as described above. Although
hormones are not evenly distributed in scat, we assumed that each sample was
sufficiently large that hormone concentrations would be relatively comparable
between the sample halves. At the least, hormone concentrations would have
varied randomly between the two halves.
We collected the following information about each sample: GPS location,
elevation, date, primary and secondary food contents, moisture, odor, odor
strength, presence of mold, substrate, and initial exposure conditions. We used
date and location information to derive proxies for thermal stress based on
average temperatures and exposure (i.e., aspect, slope, and elevation). We
transformed aspect, which reflects microclimate, to a continuous variable
ranging from +1 to −1 using the following formula:. Thus, +1 is the hottest
aspect (west-facing) and −1 (NE facing) the coolest. We used a geographic
information system to average aspect across every 30 m pixel that intersected a
100 m buffer around each sample’s location. Aspect would be important if bears
seek out and compete for these locations to better regulate thermal demands. Our
method assumes that fecal sample location is a reasonable proxy of the bear’s
average location. Any random error associated with this assumption should
decrease rather than increase the significance of the covariates in our model.
All fecal samples were freeze-dried within 30 days post-collection and stored at
−80°C until extracted and analyzed for glucocorticoid concentration. In other
omnivores, freeze-drying samples and expressing hormone content per g of dry
feces has been shown to minimize dietary impacts on fecal hormone excretion
rates, independent of nutrition.
All samples were extracted and assayed for fGC using the method described by
Wasser et al.. Briefly, a 0.2 g subsample of dried, pulverized, well-mixed
sample was weighed to the nearest 0.0001 g and transferred to a 15 ml vial.
After adding 4 ml of 90% methanol to the sample, the vial was capped and then
shaken for 30 min in a pulsing vortexer. Samples were subsequently centrifuged
(20 min) and 1 ml of supernatant removed per sample and stored at −20°C until
assayed. Extracts were then diluted four-fold in assay buffer and quantified for
fGC with a double antibody <sup>125</sup>I radioimmunoassay kit (MP Biomedicals
\[previously ICN\], Solon, OH, catalog \#07-120103). We used the manufacturer’s
protocol except with half-volumes throughout. Low and high controls were
included in every assay. Non-specific binding tubes and blanks were assayed in
quadruplicate, and standards, controls, and samples in duplicate; any sample
with a CV\>10% between duplicates was re-assayed to confirm results. This assay
has previously been validated for black and grizzly bear fGC. For other assay
details, see Wasser et al. and Hunt and Wasser.
## Statistical Analyses
Fecal glucocorticoid measures were normalized by log transformation (log10(X+1))
in all analyses. We used generalized linear models (GLM) to first predict fGC
concentrations in fresh (time 0) samples based on proxies of nutrition (berry
and meat\>vegetation), ambient temperature (Julian date;), and thermal
exposure (e.g., aspect, slope, elevation, and heat load index). Degradation
effects were assumed to be negligible in the time 0 samples (≤24 hrs old)
because previous work showed GCs in bear scat to be highly stable. We found
support for this assumption by showing that precipitation (from time of
defecation to sample collection) had no effect on fGC concentrations of the time
0 samples after discovering precipitation to be the principle cause of
degradation in the time 1 samples (see results). The covariates from the time 0
GLM were next used to predict fGC concentrations in the exposed sample halves to
determine whether the same environmental covariates still reliably predict fGC
concentrations, with and without including effects of exposure time and
precipitation. All variables included in our final models were derived from two
separate GLMs, support for which was based on AIC<sub>c</sub> values.
All significant variables in these two GLMs were then included in a repeated
measures multivariate analysis of variance (MANOVA) to identify the
environmental variables that affected both between-sample variation in fGC
(independent of exposure time), and the within-sample degradation effects of
exposure time. This enabled us to determine whether degradation impacts were
severe enough in the time 1 subsamples (i.e., the sample halves that were left
in the field for 1–28 days) to mask differences in fGC levels due to
environmental stressors detected in time 0 (fresh) subsamples.
Effect size was also examined in the MANOVA analyses to compare the whole models
as well as all variables included in each model, using Cohen’s statistic, where:
By convention, effect sizes of 0.02, 0.15, and 0.35 are termed small, medium,
and large, respectively.
# Results
## Analysis 1: Factors Influencing fGC Levels at Time 0
The main effects explaining variation in fGC concentrations at time 0 (i.e.,
prior to degradation effects), based on AIC<sub>c</sub> model support, were food
contents (vegetation vs berries or meat), Julian date, aspect, as well as an
interaction between Julian date and aspect. Time 0 fGCs increased with Julian
date, being lowest at earlier dates (warmer temperatures) and highest at later
dates (colder temperatures;). The interaction with aspect, however, indicated
that fGCs were lowest in cooler aspects at earlier dates (higher temperatures),
and in warmer aspects at later dates (colder tempteratures). Essentially, fGCs
were lower in scats collected in cool locations (aspects) during hot weather and
in warm locations during cold weather.
Time 0 fGCs also appeared to reflect nutritional quality of the diet; fGCs were
highest for scats containing primarily vegetation (grass, leaves, stems, roots,
tubers, and corms, presumably indicating relatively poor nutrition and/or high
stress) and lowest for scats containing berries and meat (implying relatively
good nutrition and/or low stress;).
As expected, precipitation had no effect on fGC concentrations in the time 0
samples, supporting our assumption that degradation effects were undetectable in
the time 0 samples.
## Analysis 2: Factors Influencing fGC Levels at Time 1
We examined fGC stability over time by assessing whether the same variables
predicting fGC concentrations in the time 0 samples remained significant in the
time 1 samples, with or without the addition of all degradation measures (e.g.,
exposure time, precipitation, and their interactions with aspect). All
predictors of fGC in the time 0 samples remained significant predictors in the
time 1 samples. Adding precipitation and its interaction with aspect, however,
significantly improved the model predicting fGC concentrations in the time 1
samples. Increased cumulative precipitation between time 0 and time 1 decreased
fGC concentrations of the time 1 samples and the cooler the aspect, the more
this effect was exacerbated.
## Analysis 3: Covariates Influencing GC Degradation
The repeated measures MANOVA was consistent with the above findings. Diet,
Julian date, and the interaction between Julian date and aspect remained
significant predictors of between-sample variation in fGC. Cumulative
precipitation, which significantly affected fGC concentrations in the time 1 but
not time 0 samples, was also a significant predictor of between-sample variation
in fGC in the MANOVA. However, only diet and the interaction between cumulative
precipitation and aspect were significant predictors of within-sample variation
over time. Cumulative precipitation in samples exposed in cooler aspects showed
increased degradation over time.
# Discussion
The biological effects of temperature (Julian date) and thermal exposure
(aspect) on bear fecal hormones at time 0 suggested that fGC may be a good
indicator of thermoregulatory demands in ursids. In particular, fGC increased
linearly with Julian date, indicating increased fGC in the fall as ambient
temperatures declined. Similar effects of elevated cortisol levels related to
thermoregulation have been described for other mammals. The interaction between
Julian date and aspect also suggests that fGC during the hottest temperatures
were lowest in bears that presumably spent more time in the coolest aspect.
Similarly, fGC in the coldest temperatures were lowest in bears that spent more
time in the hottest aspect. The colder the temperature, the greater the effect
that aspect had on fGC levels. This reversal in effect of aspect on fGC would
not be expected if Julian date were simply reflecting fGC degradation occurring
up until the time 0 sample was first located (i.e., ≤24 hours post defecation).
If degradation resulted from hotter ambient temperature, fGCs should be lower,
not higher, in samples collected in the hotter aspect during the hottest time of
year. If degradation resulted from cooler temperatures and/or greater
precipitation, fGCs should be lower, not higher, at later Julian dates and
particularly in cooler aspects at that time. Degradation effects from
precipitation were also ruled out in these time 0 samples. Overall, our data
suggest that bear fGC concentrations may be affected by thermoregulatory
demands. These patterns suggest that fGC measures should be investigated as a
potential technique for landscape-wide assessments of thermoregulatory load in
free-ranging animals, for example, in studies of climate change and related
effects.
We also found a significant effect of diet on fGC concentrations at time 0,
indicating that fGC concentrations also corresponded to diet quality in ursids,
as has been found in other vertebrates. We found that fGC concentrations were
highest for the least nutritious diet (coarse vegetation) and lowest for the
most nutritious diets (berries and meat). An alternative possibility is that
dietary fiber content might affect steroid excretion rates directly via changes
in gut transit time or fecal mass. We controlled for excretion rate effects by
freeze-drying samples prior to extraction, as this has proved effective in other
omnivores. Moreover, berries and vegetation both contain high amounts of dietary
fiber compared to meat, but only vegetation had elevated fGC. Gut transit time
is also faster in grizzly bears fed vegetation diets compared to meat diets,
which would tend to decrease fGC in vegetation-based scats, yet we observed an
increase. We therefore conclude that the patterns we observed reflect
nutritional impacts on circulating GC as opposed to effects of gut transit time
or fiber content on fGC excretion rates per se. Vegetation diets are known to be
a less preferred diet for grizzly bears, and vegetation diets have substantially
lower protein content and digestibility. Vegetation-based diets appear to
represent a nutritional stressor for grizzly bears that is accurately reflected
in fGC content of fecal samples.
It is possible that the part of the between-sample variance in fGC explained by
Julian date was also due to seasonal changes in diet, as nutritionally important
berries were most abundant earlier in the sampling season when fGC was lowest.
Such nutritional effects would not, however, explain the interaction between
Julian date and aspect on fGC; those can only be reconciled by the joint effects
of temperature and exposure. Further, scats had a mixture of high and low
quality food items throughout the sampling season. For example, highly
nutritious berries were the primary contents in some scats as late as mid-
October.
Some fGC degradation did occur over the 28 day exposure period, largely due to
cumulative precipitation, particularly in cooler aspects where evaporation would
be reduced. Overall, fGC declined in the time 1 samples as a function of aspect
interacting with precipitation. Yet in time 0 samples, this relationship was
reversed; fGC increased in time 0 samples when aspect interacted with Julian
date (cold temperatures), despite greater precipitation at later Julian dates.
These differing relationships in time 0 vs. time 1 samples strongly support our
conclusions that (a) fGC reflects thermoregulatory demands and (b) that some fGC
degradation does occur in samples exposed to cumulative precipitation for
periods of weeks prior to collection. These latter effects, however, were still
insufficient to mask the effects of the biological covariates predicting fGC
concentrations in the time 1 samples.
Finally, autocorrelation of fGC measurements is unlikely to contribute to study
results because multiple samples were collected in close proximity to each other
on only one occasion. Future field studies could genotype scat as an added
safeguard against autocorrelation, as done by Wasser et al..
## Conclusions
Scat can provide a wide variety of physiological and genetic information and is
the most accessible biological product from wildlife in nature. Collectively,
this provides the opportunity to partition impacts from a number of multiple
environmental pressures, given the right study design. Our results suggest that
fGC analyses can provide insight about thermoregulation and nutrition in grizzly
bears and black bears, and may serve as an index of physiological response to
climate change. We further showed that some sample degradation impacts do occur
in the wild. These effects were, however, insufficient to mask detection of the
biological environmental impacts on ursids in samples exposed for up to one
month. Regardless, controlling for cumulative precipitation over the sample
exposure period can be used as an added precaution against such degradation
impacts masking biological effects. Similar studies examining other hormones,
environments, diets, and species will be important to evaluate how far our
findings can be generalized.
We thank our field technicians L. Erickson, J. Hebert, J. Mascia, D. Reding, B.
Wollenzien, and K. Yale for hiking the same trail every day for 6 weeks
regardless of weather or boredom. We thank J. Reimers at the University of
Montana for access to and assistance with lyophilizing samples. We thank Liz
Addis for assistance in laboratory and data analyses. We thank Tyler Coleman,
Clayton Miller, and two anonymous reviewers for providing helpful comments on
early drafts of this manuscript. This research was conducted under Glacier
National Park collections permit GLAC-2001-SCI-0024.
[^1]: In accordance with PLOS ONE‚s policy on documenting conflicts of
interest, the authors herewith declare that there are no competing interests
with any authors. Specifically, the author affiliated with a private entity
(JBS) has no vested interests in any of the methods or results included in
this manuscript. As such, author affiliations do not alter the authors‚
adherence to all of the PLOS ONE policies on sharing data and materials.
[^2]: Conceived and designed the experiments: JS SW. Performed the
experiments: JS KH SW. Analyzed the data: JS KH SW. Contributed
reagents/materials/analysis tools: JS KH KK SW. Wrote the paper: JS KH KK
SW.
[^3]: Current address: New England Aquarium, Boston, Massachusetts, United
States of America
|
# Introduction
Smoking is a major public health problem worldwide. There have been thousands of
studies investigating the impact of active smoking on health, and the overall
toxic effects of active smoking are generally recognized. In comparison, the
effects of passive smoking on health are not fully understood. Existing studies
suggest that passive smoking and active smoking might equally increase the risk
of certain diseases, such as female breast cancer, allergic rhinitis, allergic
dermatitis, and food allergy. As early as 1928, Schonherr suspected that
inhalation of husbands’ smoke could cause lung cancer among non-smoking wives.
Since then a substantial body of research about environmental tobacco smoke and
health has appeared. But the impact of passive smoking on health remains largely
inconclusive and has not been systematically summarized.
Due to the relative small health risks associated with exposure to passive
smoking, investigation of this issue requires large study sizes. Difficulties in
measuring passive smoking and controlling various confounding factors further
add to the uncertainty in any investigation of the effects of passive smoking.
Consequently, a meta-analysis, pooling together individual original studies
quantitatively, has played an important part in establishing the evidence about
the health effects of passive smoking. Since Zmirou evaluated the respiratory
risk of passive smoking by a meta-analysis in the early 1990s, many meta-
analyses of observational epidemiological studies have been published to
identify the impact of passive smoking on health.
Recognizing that the evidence is accumulating constantly worldwide, we conducted
an overview of systematic reviews that have summarized the evidence from
observational epidemiological studies on the health effects of passive smoking.
# Methods
No protocol exists for this overview of systematic reviews.
## Ethics
Data for this research was acquired from previously published papers. Written
consent and ethical approval were not required.
## Literature search strategy
We attempted to conduct this overview of systematic reviews in accordance with
the rationale and guideline recommended by Cochrane handbook 5.1.0. A systematic
literature search of PubMed, Embase, Web of Science, and Scopus was conducted in
January 2015 using the following search terms with no restrictions: passive
smoking, secondhand smoking, environmental tobacco smoke, involuntary smoking,
and tobacco smoke pollution. The reference lists of the retrieved articles were
also reviewed. We did not contact authors of the primary studies for additional
information.
## Selection of relevant systematic reviews
Systematic reviews meeting the following criteria were regarded as eligible: (1)
the design was meta-analysis, (2) passive smoking was an exposure variable and
the outcome was the incidence of certain diseases or health problems, (3) the
included original studies were cross-sectional, case-control, or/and cohort
study design, (4) the literature search was international or worldwide, and (5)
the pooled relative risk (RR) or odds ratio (OR) and the corresponding 95%
confidence interval (CI) of specific diseases relating to exposure to passive
smoking were reported or could be calculated from the data provided. Systematic
reviews in which all included original studies were conducted in one country or
region were excluded. We also excluded the meta-analyses that investigated the
association between maternal smoking in pregnancy and the health risk of
offspring. All potential meta-analyses were independently screened by two
authors (SC and CY), who reviewed the titles or/abstracts first and then
conducted a full-text assessment. Disagreements between the two reviewers were
resolved through discussion with the third investigator (ZL).
## Data extraction
The following information was extracted from the studies by two investigators
(SC and CY): first author, publication year, country, number and design of the
included original studies, and main quantitative estimates of the association of
interest.
## Quality appraisal
We appraised all the included meta-analyses using the Assessment of Multiple
Systematic Reviews (AMSTAR) standard, an 11-item assessment tool designed to
appraise the methodological quality of systematic reviews. The maximum score is
11, and 0–4, 5–8, and 9–11 respectively indicates low, moderate, and high
quality. Disagreements on assessment scores were resolved by discussion among
the authors.
## Synthesis of the evidence
There may be more than one meta-analysis published regarding the association
between passive smoking and risk of a specific disease. We only included the
latest meta-analysis and excluded all the previous ones. For each included meta-
analysis, we summarized the number and design of the included original studies,
the main quantitative estimates of association of interest, heterogeneity
between original studies, and so on. In any included meta-analyses, when
estimates of association between passive smoking and certain diseases were
reported separately for subgroups, we combined the results of the subgroups and
calculated common estimates using a fixed-effects model if appropriate.
# Results
## Literature search
shows the process of study identification and inclusion. Initially, we retrieved
2,079 articles from Pubmed, Emabse, Web of Science, and Scopus. After 1,105
duplicates were excluded, 974 articles were screened through titles and
abstracts, of which 858 were excluded mainly because they were original studies
or irrelevant reviews. After full-text review of the remaining 116 articles, 100
were further excluded because they did not report the outcomes of interest or
their findings were already updated by newer systematic reviews. Finally, 16
meta-analyses were included.
## Characteristics and quality of the included systematic reviews
The main characteristics of the sixteen meta-analyses were summarized in. These
meta-analyses covered a total of 130 cohort studies, 159 case-control studies,
and 161 cross-sectional studies. They were published between 1998 and 2014. The
quality scores of these meta-analyses appraised using AMSTAR ranged from 3 to
10. The numbers of meta-analyses with high quality, middle quality, and low
quality were 5, 9, and 2 respectively.
## The Main Health Consequences of Passive Smoking
shows the integrated results on the impact of passive smoking on specific
diseases. The included 16 meta-analyses covered 25 diseases or health problems.
There was statistically significant positive relationship between exposure
environmental tobacco smoke and the risk of eleven diseases, especially invasive
meningococcal disease in children (OR 2.18; 95% CI 1.63–2.92) and other three
diseases or health problems with a 1.5 to 2.0-fold increase in the risk:
cervical cancer (OR 1.73; 95% CI 1.35–2.21), Neisseria meningitidis carriage (OR
1.68; 95% CI 1.19–2.36), and Streptococcus pneumoniae carriage (OR 1.66; 95% CI
1.33–2.07). The increase in the risk of other seven diseases associated with
exposure to passive smoking was statistically significant but small in impact
size (OR was less than 1.5): lower respiratory infections in infancy (OR 1.42;
95% CI 1.33–1.51), food allergy (OR 1.43; 95% CI 1.12–1.83), childhood asthma
(OR 1.32; 95% CI 1.23–1.42), lung cancer (OR 1.27; 95% CI 1.17–1.37), stroke (OR
1.25; 95% CI 1.12–1.38), allergic rhinitis (OR 1.09; 95% CI 1.04–1.14), and
allergic dermatitis (OR 1.07; 95% CI 1.03–1.12). Of these 25 diseases or health
problems, eight diseases were not found to be significantly associated with
passive smoking. They were invasive Haemophilus influenzae type B (Hib) disease,
invasive pneumococcal disease, Crohn's disease, pancreatic cancer, ulcerative
colitis, breast cancer, bladder cancer, and pharyngeal carriage for Hib. In
addition, the effects of passive smoking on increased risk of coronary heart
disease, tuberculosis, diabetes, and middle ear disease in children (recurrent
otitis media, middle ear effusion, and glue ear) were not conclusive, because
the number of included studies was small or the quality of the corresponding
meta-analysis was low.
## Passive smoking and cancer risk
We investigated the association of passive smoking with the risk of lung cancer,
cervical cancer, pancreatic cancer, breast cancer, and bladder cancer. Based on
55 observational studies (7 cohort studies, 25 population-based case-control
studies and 23 non-population-based case-control studies), passive smoking were
found to be associated with the increased risk of lung cancer (OR 1.27; 95% CI
1.17 to 1.37). The ORs for lung cancer in North America, Asia, and Europe were
similar. 11 case-control studies, involving 3,230 cases and 2,982 controls,
suggested a positive relationship between passive smoking and cervical cancer
(OR 1.73; 95% CI 1.35–2.21). Pancreatic cancer, breast cancer, and bladder
cancer were not found to be associated with passive smoking.
## Passive smoking and allergic diseases
A meta-analysis of observational studies published in PLOS Medicine
systematically reviewed the effects of exposure to environmental smoke on
allergic diseases. The pooled ORs of 63 studies for allergic rhinitis, 58
studies for allergic dermatitis, and 6 studies for food allergies were 1.07 (95%
CI 1.03–1.12), 1.09 (95% CI 1.04–1.14), and 1.43 (95% CI 1.12–1.83)
respectively. Another meta-analysis investigated the association between passive
smoking and the risk of physician-diagnosed childhood asthma, and suggested that
there was consistent evidence of a modest positive association between them (OR
1.32; 95% CI: 1.23–1.42).
## Passive smoking and pediatric invasive bacterial disease and bacterial carriage
Passive smoking was also thought to be associated with pediatric invasive
bacterial disease and bacterial carriage. A meta-analysis involving 30 case-
control studies for invasive bacterial disease and 12 cross-sectional studies
for bacterial carriage indicated that the risk of invasive meningococcal
disease, pharyngeal carriage for Neisseria, meningitidies and Streptococcus
pneumoniae were significantly associated with passive smoking, and the ORs were
2.18, 95% CI 1.63 to 2.92), 1.68 (95% CI, 1.19–2.36), and 1.66 (95% CI
1.33–2.07), respectively. The risk of invasive pneumococcal disease, invasive
Hib disease, and pharyngeal carriage for Hib were not found to be related to
exposure to environmental smoke.
# Discussion
The health effects of environmental tobacco smoke are attracting more and more
attention worldwide. Increasing numbers of original studies and meta-analyses
are being published focusing on this important issue. In the present overview of
systematic reviews based on sixteen systematic reviews involving 450 original
observational studies, we found that passive smoking could significantly
increase the risk of eleven diseases, especially invasive meningococcal disease
in children, cervical cancer, Neisseria meningitidis carriage, and
Streptococcus. pneumoniae carriage, but not associated with other eight
diseases. Cancers were one of the most common investigated health outcomes
associated with passive smoking. We found that exposure to environmental tobacco
smoke could increase the risk of lung cancer and cervical cancer, but was not
the risk of pancreatic cancer, breast cancer, or bladder cancer. It appears that
passive smoking could increase the risk of some diseases among children,
especially bacterial infections (e.g., lower respiratory infections in infancy,
middle ear disease in children, invasive meningococcal disease in children,
allergic diseases in children, and childhood asthma).
Previously, there were some reviews focusing on the health effects of exposure
to environmental tobacco smoke. But they were qualitative or only involved
children or limited to several diseases. We used a systematic overview to
summarize the quantitative estimates of the associations between passive smoking
and various diseases based on all latest available meta-analyses. It should be
noted that, in the present overview, we excluded meta-analyses evaluating the
effects of smoking during pregnancy on fetus or offspring health, because the
effects was obviously different from the health effects of active smoking or
conventional passive smoking in the general population.
The quality of included original studies influences the reliability of the
results and conclusions of the corresponding meta-analysis; similarly, the
validity of the results of an overview of systematic reviews depends on the
quality of the included systematic reviews. We used AMSTAR protocol, an
internationally recognized assessment tool, to appraise the methodological
quality of all included meta-analyses, and found that there were two meta-
analyses with low quality. Accordingly, the conclusions drawn based on these two
meta-analyses involving middle ear disease in children and coronary heart
disease need to be interpreted with caution.
The evidence level of meta-analyses partly depends on the number and the design
type of included original studies. Although there was no consensus about the
minimum number of original studies included in meta-analysis, but more caution
is needed when an association is assessed based on a small number of original
studies. In our overview, we found a significant positive association between
passive smoking and tuberculosis (OR 4.01; 95% CI 2.54–6.34), but it was only
based on 4 case-control studies. More studies should be conducted to further
assess the relationship between them. Similarly, the effect of passive smoking
on diabetes was based on 6 cohort studies (OR 1.21; 95% CI 1.07–1.38), and more
original studies are also needed.
There were several strengths in our research. Firstly, we followed the primary
rationale and method of Cochrane overviews of reviews to summarize the health
consequences of certain exposure. Overview of systematic reviews is primarily
intended to summarize multiple reviews addressing the effects of two or more
potential interventions for a single condition or health problem. Up to now,
most of overviews have been conducted to evaluate the effects of several
interventions, and very few overviews have addressed the effects of a single
exposure factor on multiple diseases or health problems based on observational
studies. Our present overview expands the application of overviews of systematic
reviews. Additionally, our study provides robust and comprehensive scientific
information for smoking ban in public places and for educational pamphlets about
passive smoking.
Some limitations in our overview should be noted. Firstly, we only included
systematic reviews but not original studies. The associations of passive smoking
with some diseases might have been investigated by original studies but not
synthesized by meta-analyses and, therefore, were not summarized in this
overview. Secondly, the mechanism on the health effects of passive smoking was
not be examined since our study only intended to summarize relevant
observational epidemiological evidence.
In summary, our overview of systematic reviews of up-to-date epidemiological
evidence suggests that passive smoking is significantly associated with an
increasing risk of many diseases and health problems, especially diseases in
children and cancers. This study provides comprehensive population-based
evidence about toxic effect of exposure to environmental tobacco smoke and
should benefit developing health promotion strategies of smoking control.
Stricter regulations against cigarette smoking should be formulated and
implemented, because smoking harms not only own health but also the health of
neighboring people.
# Supporting Information
# Access to data
All the data in this review are from publicly published papers, and we take
responsibility for the integrity of the data and the accuracy of the data
analysis.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: ZL. Performed the experiments:
SC CY. Analyzed the data: SC YG. Contributed reagents/materials/analysis
tools: CY. Wrote the paper: SC.
|
# Introduction
Myxoviruses are enveloped, negative-strand RNA viruses that are transmitted
through the respiratory route. The orthomyxovirus family comprises five
different genera of which the influenza viruses are clinically most relevant. Of
the paramyxoviridae, respiratory syncytial virus (RSV), measles virus (MeV),
mumps virus (MuV), human parainfluenzaviruses (HPIV) and the recently emerged,
highly pathogenic zoonotic henipaviruses constitute major human pathogens.
Although clinical complications associated with some myxoviruses involve
persistent infections, the viruses predominantly induce acute respiratory or
systemic disease.
Collectively, myxoviruses are responsible for the majority of human morbidity
and mortality due to viral respiratory illness globally. In particular,
influenza virus is the leading cause of morbidity and mortality from respiratory
disease in North America despite the existence of vaccine prophylaxis. This is
due to the fact that the vaccines currently in use reduce illness in
approximately 70% of healthy adults when homologous to the prevalent circulating
virus, but protection in the elderly reaches only approximately 40%. Vaccine
efficacy is reduced substantially when the circulating strains differ from those
constituting the vaccine.
Despite extensive research and in contrast to, for instance, MeV and MuV, no
vaccines are currently available against several major pathogens of the
paramyxovirus family such as RSV or different HPIVs. Infection with RSV is the
leading cause of pneumonia and bronchiolitis in infants, both associated with
significant mortality, while HPIV types 1 and 2 are the primary cause of croup
syndrome and can likewise result in serious lower respiratory diseases such as
pneumonia and bronchiolitis.
The availability of effective antiviral therapy for most clinically significant
myxovirus infections is limited. Licensed neuraminidase inhibitors for influenza
therapy, Zanamivir and Oseltamivir, show efficacy when administered within a
48-hour window after the onset of symptoms, but are increasingly compromised by
pre-existing or emerging viral resistance. Ribavirin, although approved for RSV
treatment, shows limited utility due to efficacy and toxicity issues. The
polyclonal immunoglobulin RSV-IVIG and the humanized monoclonal antibody Synagis
provide RSV prophylaxis, but use is limited to high-risk pediatric patients.
Considering the high mutation rates seen in particular with RNA viruses, the
development of novel types of myxovirus inhibitors that circumvent the rapid
development of resistance is highly desirable.
Of the strategies conceivable towards this goal, targeting host factors required
for completion of the viral life cycle rather than pathogen-encoded factors
directly has received heightened interest in recent years. This approach is
expected to establish a significant barrier against spontaneous viral escape
from inhibition, since individual viral mutations are less likely to compensate
for the loss of an essential host cofactor than to prevent high-affinity binding
of a conventional, pathogen-directed antiviral. Given some degree of overlap of
host cell pathways required for successful replication of related viral
pathogens, host-directed antiviral approaches also have the potential to move
beyond the one-bug one-drug paradigm by broadening the pathogen target range of
a chemical scaffold.
Naturally, targeting host factors for antiviral therapy bears an inherently
higher potential for undesirable drug-induced side effects than conventional
pathogen-directed strategies. While the approach is nevertheless under
investigation for the treatment of chronic viral infections such as HSV-1 and
HIV-1, an application to the inhibition of infections by pathogens predominantly
associated with severe acute disease, such as most members of the myxovirus
families, is anticipated to render drug-related side effects tolerable to some
extent, since the necessary treatment time and concomitant host exposure to the
drug remain limited. In the case of influenza infections, for instance, typical
neuraminidase inhibitor regimens consist of twice daily administration for a
five-day period for treatment, or a 10-day period for prophylaxis.
Relying on a broadened anti-myxovirus target spectrum as the main selection
criterion in secondary screening assays, we have mined results of a recently
completed high throughput chemical library screen to identify hit candidates
with a possible host-directed mechanism of action. This has yielded a compound
class with broad anti-viral activity, which was subjected to synthetic scaffold
optimization, quantification of active concentrations for a select group of
clinically relevant ortho- and paramyxovirus family members, testing against a
panel of exposed host cells of different species origin, and characterization of
the compound-induced point-of-arrest in viral life cycle progression. Viral
adaptation to growth in the presence of inhibitor has been employed to compare
escape rates from inhibition by this new compound class with those from a well-
characterized, pathogen-directed antiviral.
# Results
To identify small-molecule hit candidates that block the myxovirus life cycle
through a host-directed mechanism, we analyzed the results of a high-throughput
cell-based anti-MeV screen of a 137,500-entry library of the NIH diversity set
that we recently reported. The primary screening agent, serving as the myxovirus
representative, was the wild type MeV isolate MVi/Alaska.USA/16.00 (MeV-Alaska).
It was chosen based on its ease of growth and readily quantifiable cytopathic
effect in the automated system. In search of candidates with a host-directed
antiviral profile, we anticipated three distinct features of desirable
compounds: a) potent inhibition of virus replication at the screening
concentration (3.3 µM); b) a primary screening score, representative of the
selectivity index (CC<sub>50</sub>/EC<sub>50</sub>), close to the cut-off value
for hit candidates due to some anticipated host-cell interference ( = 1.9); and
c) a broadened viral target spectrum in counterscreening assays that extends to
other pathogens of the myxovirus families.
## Identification of a chemical scaffold with broad anti-viral activity
When inhibition of paramyxovirus family members was assessed, six compounds
efficiently blocked the closely related canine distemper virus (CDV) and the
more distantly related human parainfluenzavirus type 3 (HPIV3) in addition to
MeV-Alaska, while leaving cell metabolic activity essentially unaffected. Of
these independent hits, three share a common molecular scaffold. Since HTS
scores of these analogs best matched the target criteria and antiviral activity
was highest in this group, we subjected them to further characterization and
developmental efforts. Synthetic optimization and structural confirmation of the
scaffold returned a lead analog JMN3-003, which showed potent activity against
MeV, a selection of clinically significant members of the para- and
orthomyxovirus families, and, albeit to a lesser degree, representatives of
positive strand RNA virus (sindbis virus of the *Alphaviridae*) and DNA virus
(vaccinia virus of the *Poxviridae*) families (inhibitory concentrations for a
larger panel of myxovirus family members are summarized). As observed for the
primary hit compound, metabolic activity of different established cell lines
exposed to JMN3-003 was unchanged at 75 µM, the highest assessable concentration
based on solubility of the substance in growth media. Of different primary human
cells examined, metabolic activity was unaffected (PBMCs, smooth muscle cells)
or only slightly affected (bronchial epithelial cells) by the compound. These
data support potent anti-myxovirus activity of the compound with active
concentrations ranging from 10 to 80 nM depending on the target virus.
## Antiviral activity of lead compound JMN3-003 is host cell-specific
To further explore whether JMN3-003 meets the profile of a host-directed
antiviral, we examined whether the extent of inhibition is determined by the
species origin of the host cell used for virus propagation. Based on its broad
host cell range, inhibition of influenza A/WSN replication was monitored. In
addition to higher mammalian (HT1080 (ATCC CCL-121), HeLa (ATCC CCL-2), MDCK
(ATCC CCL-34)) cell lines, cells of rodent (NIH-3T3 (ATCC CRL-1658), MEL B16
(ATCC CRL-6322), BHK-21 (ATCC CCL-10), CHO (ATCC CCL-61)) and avian (DF-1 (ATCC
CRL-12203)) origin were tested, which are all permissive for influenza A/WSN
infection. While inhibitory concentrations obtained for all higher mammalian
cell lines examined were similar, A/WSN inhibition by JMN3-003 was found
inactive on some rodent cell lines and when virus was propagated on murine or
avian cells. However, inhibitory activity extended fully to primary human PBMCs.
For the latter, inhibition of MeV-Alaska was monitored due to efficient growth
of MeV isolates on PBMCs. The host cell species effect of antiviral activity of
JMN3-003 is consistent with specific targeting of cellular factors by the
compound, while arguing against docking to conserved viral factors or an
undesirable promiscuous, unspecific mode of activity.
## JMN3-003 shows high metabolic stability *in vitro*
The central 2-thio-connector found in the chemical scaffold of JMN3-003 may
render the compound susceptible to rapid phase I oxidation *in vivo* , thus
possibly compromising its developmental potential. To test metabolic stability
of the substance early in development, we exposed JMN3-003 to human S-9
hepatocyte subcellular fractions as an *in vitro* indicator for phase I
metabolism. After a 60-minute exposure, approximately 80% of the input material
remained intact, corresponding to an extrapolated half-life of approximately 200
minutes. Unstable analogs of JMN3-003, JMN5-165 and JMN5-166, returned half
lives of 38 and 5 minutes in this assay, respectively, confirming metabolic
competency of the S9 fractions used.
Assessment of JMN3-003 stability in human plasma in comparison with unstable
Procaine and stable Procainamide corroborated these results, since JMN3-003
integrity was virtually unaffected after a 120-minute incubation period. Taken
together, these findings suggest desirable metabolic stability for the JMN3-003
scaffold, recommending it for further mechanistic characterization. The data are
corroborated by the good metabolic stability reported for the structurally
similar compound RDEA-806, a non-nucleoside inhibitor of HIV reverse
transcriptase and clinical precedent, which shares the 2-thio-connector of
JMN3-003 but lacks MeV inhibitory activity in our assays (data not shown).
## Temporary arrest in cell cycle progression
Since direct cytotoxicity of JMN3-003 was low for all cell lines examined, we
next tested the effect of the substance on cell cycle progression. Analysis of
the DNA content of cells continuously treated with JMN3-003 for 36 hours by flow
cytometry revealed accumulation of cells in a single population with 2N DNA
content, which closely resembled the profile of a reference cell population
exposed to hydroxyurea but markedly differed from the 4N DNA content of
nocodazole-treated cells. Nocodazole interferes with microtubule polymerization,
resulting in a G<sub>2</sub>/M arrest, whereas hydroxyurea is thought to lead to
an arrest in the G<sub>1</sub>/S-phase through depletion of cellular dNTP pools.
To further explore the effect of JMN3-003 on cell cycle progression, we
monitored the phosphorylation status of the cdc2-cyclin B kinase after exposure
of cells to either the compound, hydroxyurea, nocodazole, or alsterpaullone, a
nanomolar small molecule inhibitor of cyclin-dependent kinases that reportedly
induces a potent G<sub>1</sub>/S-phase cell cycle arrest. Pivotal in regulating
the G<sub>2</sub>/M transition, cdc2-cyclin B kinase is inactivated through
phosphorylation during the G<sub>2</sub>-phase. Accumulation in its
phosphorylated form thus indicates a G<sub>1</sub> arrest. As in hydroxyurea-
and alsterpaullone-treated controls, exposure of cells to JMN3-003 resulted in
increased steady state levels of phosphorylated cdc2-cyclin B kinase, supporting
a G<sub>1</sub>-phase arrest.
To test whether this JMN3-003-induced arrest is permanent or temporary, we next
incubated cells in the presence of compound or vehicle alone for 30 hours,
followed by removal of the substance and reseeding of cells at identical
densities. Monitoring cell growth over an additional 72-hour incubation period
in the absence of JMN3-003 revealed that proliferation rates resumed those of
untreated control cells after removal of the compound, indicating reversibility
of the growth arrest.
In contrast to members of the orthomyxovirus family, paramyxovirus replication
takes place in the cytosol and, thus, is considered not to be immediately
dependent on active cell proliferation. In fact, MeV itself has been shown to
induce a G<sub>1</sub>/S arrest in infected T lymphoyctes, confirming that cell
cycle progression is not required for virus replication. To directly test
whether the JMN3-003-mediated growth arrest *per se* is causal for the antiviral
effect of the compound, we generated MeV-Alaska inhibition curves of JMN3-003 in
comparison with the cyclin-dependent kinase inhibitor alsterpaullone. Even at
the highest concentration assessed (50 µM), alsterpaullone caused only a
marginal reduction in MeV yields. These findings indicate that the antiviral
effect of JMN3-003 is based on an upstream effect of the compound rather than
being a consequence of the cell cycle arrest itself.
## Cellular mRNA production and protein biosynthesis are unperturbed by JMN3-003
To explore whether growth arrest of treated cells coincides with reduced host
cell RNA synthesis or overall cell protein biosynthesis, we next assessed the
effect of JMN3-003 on host mRNA and protein production. Relative levels of three
signature host mRNAs with short half lives, MCL1, ASB7 and MKP1, were determined
by real time PCR after incubation of cells in the presence of different JMN3-003
concentrations ranging from 0.01 to 10 µM. In all cases, mRNA levels of
JMN3-003-exposed cells were similar to those of the vehicle-treated references,
while exposure to Actinomycin D, which blocks RNA synthesis through arrest of
the transcription initiation complex, resulted in a major reduction in relative
mRNA levels.
Immunodetection of cellular GAPDH and plasmid-encoded MeV F protein under the
control of the CMV promoter demonstrated that productive transcription in the
presence of the compound furthermore coincides with uninterrupted translation
and, in the case of F, co-translational insertion into the host secretory
system. Furthermore, equivalent levels of proteolytically processed
F<sub>1</sub> material in JMN3-003 and vehicle-exposed cells indicated that
intracellular vesicular transport remains intact in the presence of JMN3-003,
since cleavage is mediated by the cellular protease furin in a late-Golgi
compartment. In contrast to host-encoded or transiently expressed proteins,
expression of virus-encoded proteins in the context of paramyxovirus or
orthomyxovirus infection was fully blocked by 100 nM JMN3-003. Thus, these
observations demonstrate that the compound efficiently suppresses the expression
of virus-encoded proteins, but that this is not due to general interference of
the inhibitor with cellular mRNA synthesis or translation. This phenotype
suggests possible interference of JMN3-003 with early steps of the viral life
cycle, such as entry or viral RdRp activity, as the basis for antiviral
activity.
## Inhibition of a post-entry step of the viral life cycle
To differentiate between those alternatives and identify the point of arrest in
the viral life cycle induced by JMN3-003, we first examined whether the compound
blocks membrane fusion and thus viral entry. Expression of plasmid-encoded
paramyxovirus envelope glycoproteins in receptor-positive cells typically
results in extensive cell-to-cell fusion, the hallmark cytopathic effect
associated with most paramyxovirus infections *in vitro*. Transient membrane
fusion assays allow a quantitative assessment of whether an inhibitor blocks
viral entry or post-entry steps of the viral life cycle. When we examined MeV
glycoprotein-mediated cell-to-cell fusion microscopically and in a luciferase
reporter-based quantitative cell-to-cell fusion assay in the presence of
JMN3-003, we observed extensive membrane fusion indistinguishable from that seen
in vehicle-treated controls, indicating that the compound does not act as an
entry inhibitor.
To determine whether JMN3-003 predisposes host cells against viral infection by
inducing an antiviral state, we pre-treated cells with the compound, followed by
wash-out of the substance and virus infection after different time periods.
Independent of incubation time after removal of the compound, we could not
detect any substantial inhibitory effect in this set-up, arguing against priming
of the innate antiviral response by JMN3-003. Likewise, preincubation of viral
particles with JMN3-003 prior to removal of the article and infection lacked any
appreciable antiviral effect, excluding direct virucidal activity of the
substance.
When added in a time-of-addition experiment at distinct time points post-
infection in comparison with two previously characterized, pathogen-targeted
antivirals, the inhibition profile of JMN3-003 was distinct from that of the
entry inhibitor AS-48 but very closely resembled the profile of the AS-136A RdRp
blocker class. Thus, these data point towards inhibition of the viral RdRp
activity by JMN3-003 as one possible underlying mechanism for antiviral activity
of the compound.
## Host-directed inhibitor of viral RdRp activity
For myxovirus infection, the viral RdRp complex mediates both genome
transcription and replication to express viral proteins and generate progeny
genomes, respectively. Replication occurs through generation of an antigenome of
positive polarity, which then serves as template for negative strand genome
synthesis. To directly test whether JMN3-003 affects viral RdRp activity in the
context of virus infection, we determined the copy numbers of MeV-Alaska mRNA
and antigenome in infected, compound-treated cells relative to vehicle-treated
controls by quantitative RT-PCR. Presence of JMN3-003 caused a dose-dependent
reduction in viral RNA levels. At a concentration of 100 nM, for instance, we
observed a \>100-fold reduction of viral mRNA and antigenome copy numbers
relative to vehicle-treated samples, indicating potent inhibition of viral
replication. For comparison, a concentration of 25 µM of the RdRp inhibitor
AS-136A, a nanomolar blocker of MeV replication, was required to achieve
comparable mRNA and antigenome reduction levels.
When this assay was applied to orthomyxovirus infection, we likewise observed a
dose-dependent inhibition of influenza A/WSN antigenome levels relative to
vehicle treated controls. Parallel quantification of genome copy numbers of
released progeny virus demonstrated that an approximate \>100-fold drop in
relative viral antigenome levels correlates to a \>10,000-fold reduction in
genome copies of released progeny virions.
Assessment of viral RdRp activity in a plasmid-based minireplicon reporter
system confirmed dose-dependent inhibition of RdRp by JMN3-003 also in a sub-
infection setting, since luciferase reporter expression was fully blocked at
compound concentrations of approximately 100 nM. Taken together, these data
suggest indirect inhibition of the viral polymerase complex through interaction
of the compound with a cellular cofactor required for RdRp activity as the basis
for the antiviral effect of JMN3-003.
## JMN3-003 does not induce rapid emergence of viral resistance
It has been suggested for different viral pathogens that a host-directed
antiviral approach has the potential to reduce the frequency of viral escape
from inhibition compared to direct targeting of pathogen components. To explore
whether resistance to JMN3-003 could be induced experimentally, we attempted
stepwise viral adaptation to growth in the presence of the compound in
comparison with the pathogen-specific MeV RdRp inhibitor AS-136A. Following an
escalating dose scheme, inhibitor concentrations were doubled when virus-induced
cytopathicity became detectable microscopically. While robust resistance to the
pathogen-targeted AS-136A control emerged rapidly in an approximate 15 to 20-day
time window (tolerated dose at the end of adaptation was ≥30 µM, equivalent to
≥100-fold resistance), only marginal increases in the tolerated dose could be
detected for JMN3-003 after 90 days of continued viral incubation in the
presence of the substance. These results are consistent with a host-directed
mechanism of action of JMN3-003 and suggest the existence of a systemic barrier
that prevents rapid viral escape from inhibition by the article.
# Discussion
In recent years, host cell-directed antivirals have experienced growing
recognition as a new concept for the development of advanced generation
antivirals with the potential to counteract the challenge of preexisting or
rapidly emerging viral resistance. Novel automated genomics and proteomics
analyses have greatly advanced our insight into host-pathogen interactions.
These studies have underscored the notion that several cellular pathways are
exploited for virus replication, supporting the hypothesis that a host-directed
antiviral may enjoy an expanded viral target range, rendering it effective for
the treatment of several related viral diseases.
Technologies applied for host-directed drug discovery include cDNA and siRNA-
based microarray analyses combined with pathway-guided data mining , loss-of-
function screens using aptamers or small oligonucleotides, protein array
analyses and chemical library screening. By combining automated library
screening with counter screens against a variety of related viral pathogens of
the myxovirus families, we have identified a candidate scaffold that, after
moderate hit-to-lead chemistry, adheres to the profile of a host-directed
antiviral based on several lines of evidence: I) antiviral activity is host cell
species-dependent, indicating specific interaction with a distinct host factor
rather than a viral component. Host cell-specific activity is incompatible with
compound docking to conserved viral factors. For example, carbohydrate
structures exposed on viral envelope glycoproteins that are targeted by
antiviral lectins such as pradimicin A. Furthermore, it is incompatible with an
undesirable unspecific, promiscuous mode of action of the compound ; II)
affinities against a panel of human pathogens of the paramyxovirus family as
well as laboratory adapted and wild type influenza virus isolates were very
similar throughout (average EC<sub>50</sub> concentrations are ∼40 nM).
Equivalent active concentrations argue against compound docking to distinct
viral components and suggest that inhibition of distinct myxovirus families
follows the same mechanism of action; III) *in vitro* adaptation attempts to
induce viral resistance were unsuccessful even after extended exposure times to
the drug. A full assessment of the frequency of viral escape from inhibition by
JMN3-003 will certainly need to include *in vivo* virus adaptation attempts in
suitable animal models, since the rate of resistance build-up may vary between
tissue culture and *in vivo* settings. We nevertheless reliably induced
resistance in less than 30 days to a pathogen-directed MeV RdRp inhibitor that
was analyzed in parallel, which is fully consistent with our previous experience
and provides confidence for the validity of our overall experimental design for
viral adaptation.
Mechanistic analysis of the bioactivity of the JMN3-003 compound class through
characterization of exposed cells and time-of-addition experiments revealed two
distinct phenotypes, a temporary cell cycle arrest in the G<sub>1</sub>/S phase
and an arrest in the myxovirus life cycle at a post-entry step. Current
libraries of chemical analogs of JMN3-003 do not yet permit a definitive
conclusion as to whether both activities adhere to discrete structure-activity
relationships or are causally linked, but a bulk of experimental data
demonstrate that host cell cycle arrest *per se* has no inhibitory effect on
replication of paramyxoviruses such as MeV. Not only does the virus itself
induce a G<sub>1</sub>/S-phase arrest in infected T lymphocytes, we also found
that exposure of infected cells to alsterpaullone, a potent blocker of
G<sub>1</sub>/S-phase cell cycle progression through nanomolar inhibition of
cellular cyclin-dependent kinases, did not affect the extent of virus
replication even at concentrations exceeding reported alsterpaullone
EC<sub>50</sub> values by more than 1,000-fold. Likewise consistent with the
notion that the antiviral activity of JMN3-003 is not based on cell cycle arrest
itself, virus inhibition was not restricted to the context of immortalized,
rapidly dividing tissue culture cell lines but extended with equal potency to
primary human PBMCs.
Reversible cell cycle arrest and block of virus replication indicate non-
covalent docking of JMN3-003 to its target structures, which is corroborated by
the compound's stability, low chemical reactivity profile and the complete
absence of virucidal activity in pre-incubation settings. An inhibition profile
of JMN3-003 closely mimicking that of AS-136A, the pathogen-directed blocker of
MeV RdRp targeting the viral L polymerase protein, and the block in viral RdRp
activity in the context of viral infection and minireplicon reporter assays by
JMN3-003 consistently point towards interaction of the compound with a host
cofactor essential for RdRp function as the basis for its antiviral activity.
While viral RdRp depends on a variety of host cell components , unperturbed
cellular mRNA synthesis and, thus, uninterrupted host RNA polymerase function in
the presence of compound exclude interference of JMN3-003 with essential
transcription initiation factors.
Recently, accumulating evidence has implicated host cell kinases as regulators
of the activity of RdRp complexes of different negative-strand RNA viruses :
host cell kinases of the PI3K-Akt pathway manipulate paramyxovirus RdRp activity
through Akt-mediated phosphorylation of the viral phosphoprotein, an essential
component of the RdRp complex. Furthermore, Akt activity itself is upregulated
through activation of PI3K during influenza A infection via direct interaction
of the viral NS1 protein with PI3K. In the case of MeV, however, published data,
and our own observations (Krumm and Plemper, unpublished) demonstrate that Akt
inhibition causes a moderate reduction in virus release, whereas titers of cell-
associated progeny particles remain unchanged. While this rules out the PI3K-Akt
pathway as a direct target for JMN3-003, it illuminates the intricate regulatory
interactions between pathogen and host, which provide a wealth of possible
points of entry for antiviral intervention. Future identification of the
molecular target of JMN3-003 carries high potential to further our understanding
of these interactions and may conceivably provide a basis for pharmacophore
extraction and structure-driven scaffold optimization.
We note that the central sulfur in the JMN3-003 chemical scaffold could
potentially render the molecule vulnerable to rapid phase I oxidation and thus
compromise both metabolic stability and bioavailability. For instance, it has
been reported that flavin-containing monooxygenases, dioxygenases and cytochrome
P-450 enzymes catalyze oxidation of alkylaryl sulfides to sulfoxides
(R<sub>2</sub>S = O). However, the high stability of JMN3-003 in the presence of
human hepatocyte subcellular fractions and human plasma argues against an
undesirable short *in vivo* half-life of the substance. This is corroborated by
good metabolic stability of the structurally similar HIV reverse transcriptase
inhibitor RDEA-806, which shares the central 2-thio-acetamide connector with
JMN3-003 and has achieved success in clinical trials: the compound was well
tolerated in both Phase 1 and 2a studies after single or multiple oral doses and
showed no drug-related CNS toxicity, creating a clinical precedence for the
applicability of the broader scaffold. Although RDEA-806 follows a different
mechanism of action than JMN3-003 and lacks any anti-paramyxovirus activity, the
structural similarities provide sufficient confidence for the overall
developmental potential of the JMN3-003 class to recommend it as a promising
candidate for advanced synthetic optimization towards preclinical validation and
development.
*In toto*, we have identified a novel chemical class of viral inhibitors that
block viral RdRp activity with a host factor-mediated profile. A complete
activity workup after synthetic identification of a clinical lead analog will be
required to fully appreciate the range of the different viral families inhibited
by the substance. However, we consider human pathogens of the myxovirus families
that are primarily associated with acute disease among the most suitable for
host-directed antiviral efforts due to anticipated short treatment regimens.
While we cannot exclude that resistance to JMN3-003 may eventually emerge in *in
vivo* settings, our *in vitro* adaptation efforts support the hypothesis that
the mechanism of action of this compound class establishes a strong barrier
against rapid viral escape from inhibition.
# Materials and Methods
## Cells and viruses
All cell lines were maintained at 37°C and 5% CO<sub>2</sub> in Dulbecco's
modified Eagle's medium supplemented with 10% fetal bovine serum. Vero (African
green monkey kidney epithelial) cells (ATCC CCL-81) stably expressing human
signaling lymphocytic activation molecule (CD150w/SLAM), called in this study
Vero-SLAM cells, and baby hamster kidney (BHK-21) cells stably expressing T7
polymerase (BSR-T7/5 (BHK-T7) cells) were incubated at every third passage in
the presence of G-418 (Geneticin) at a concentration of 100 µg/ml. Lipofectamine
2000 (Invitrogen) was used for cell transfections. Peripheral blood mononuclear
cells (PBMCs) were prepared through overlay of whole blood samples from mixed,
healthy human donors (Emory University Institutional Review Board approval
IRB00045690, Phlebotomy of Healthy Adults for Research in Infectious Diseases
and Immunology) on Ficoll Hypaque solution, followed by centrifugation at 240×g
for 30 minutes at room temperature and removal of the interphase material. Red
blood cells were lysed with RBC lysis solution (Sigma), followed by repeated
washing of extracted PBMCs with phosphate buffered saline and transfer to tissue
culture plates pre-coated with poly-L-lysine (Sigma). Other primary human cell
lines were obtained from PromoCell, Germany. Virus strains used in this study
were MeV isolate MVi/Alaska.USA/16.00, genotype H2 (MeV-Alaska), HPIV3, MuV
strain South Africa, RSV strain Long, laboratory adapted influenza A strains WSN
(H1N1) and PR8/34 (H1N1), swine-origin influenza virus isolates S-OIV Texas and
Mexico, vaccinia virus and sindbis virus. To prepare virus stocks, cells
permissive for the virus to be amplified (Vero-Slam, Vero, HepG2 (ATCC HB-8065),
and Madin-Darby canine kidney (MDCK)) were infected and incubated at 37°C. Cell-
associated paramyxovirus and vaccinia virus particles were harvested by scraping
cells in OPTIMEM (Invitrogen), followed by release of virus through two
consecutive freeze-thaw cycles. Influenza virus and sindbis virus particles were
harvested from cell culture supernatants. Titers of MeV and MuV were determined
through 50% tissue culture infective dose (TCID<sub>50</sub>) titration
according to the Spearman-Karber method as described, titer of all other viruses
were determined by plaque assay on permissive cells.
## Influenza A titration by TaqMan RT-PCR
To determine genome copy numbers of released progeny influenza A particles
(strains WSN, PR8/34, S-OIV Texas and Mexico), culture supernatants of infected
MDCK cells (4×10<sup>5</sup> cells/well in a 12-well plate format) were
harvested and total RNA prepared using a QIAcube automated extractor and the
QIAamp viral RNA mini kit reagent. Purified RNA was then subjected to
quantitative real time (qRT) PCR analysis using an Applied Biosystems 7500 Fast
real-time PCR system and the qRT-PCR TaqMan Fast Virus 1-Step Master Mix
(Applied Biosystems). Primers and probe are based on recent reports and
universally reactive with all influenza A strains including the recent S-OIV
(H1N1) isolates. To generate a qRT-PCR standard, genome segment seven of
influenza A/WSN was subcloned into pCR2.1-TOPO vector (Invitrogen) and copy
numbers of the resulting standard calculated using Promega's BioMath Calculator
tools (<http://www.promega.com/biomath/>). For each TaqMan reaction, 10-fold
serial dilutions of the linearized plasmid ranging from 10<sup>7</sup> to
10<sup>1</sup> were amplified in parallel.
## Compound synthesis
Chemical synthesis of compounds AS-48, AS-136A and RDEA-806 was achieved as
previously described. Synthesis of JMN3-003, N-(4-methoxyphenyl)-2-nitroaniline
(substance (3) in), and analogs JMN5-165 and JMN5-166 was achieved as outlined
schematically in. To prepare inhibitor stocks, compounds were dissolved at 75 mM
in DMSO.
## Viral CPE-reduction assay
Vero-SLAM cells were infected with MeV-Alaska at an MOI of 0.4 pfu/cell in the
presence of the inhibitor analyzed ranging from 75 µM to 293 nM in two-fold
dilutions. At 96 hours post-infection, cell monolayers were subjected to crystal
violet staining (0.1% crystal violet in 20% ethanol), and the absorbance of
dried plates at 560 nm determined. Virus-induced cytopathicity was then
calculated according to the formula \[% rel. CPE = 100−(experimental-
minimum)/(maximum-minimum)\*100\], with minimum referring to infected, vehicle-
treated wells and maximum to mock-infected wells.
## Virus yield reduction assay
Cells were infected with the specified myxovirus at an MOI = 0.1 pfu/cell (all
paramyxoviruses assessed), 0.05 pfu/cells (influenza viruses), 1.0 (vaccinia
virus), or 10 sindbis virus) in the presence of a range of compound
concentrations or equivalent volumes of solvent (DMSO) only, and incubated in
the presence of compound at 37°C. When vehicle treated controls approached the
end of the logarithmical growth phase, progeny viral particles were harvested
and titered by TCID<sub>50</sub> titration, plaque assay or TaqMan real-time
PCR, respectively, as described above. Plotting virus titers as a function of
compound concentration allowed quantitative assessment of resistance. Where
applicable, 50% inhibitory concentrations were calculated using the variable
slope (four parameters) non-linear regression-fitting algorithm embedded in the
Prism 5 software package (GraphPad Software).
## Quantification of compound cytotoxicity
A non-radioactive cytotoxicity assay (CytoTox 96 Non-Radioactive Cytotoxicity
Assay, Promega) was employed to determine the metabolic activity of cell after
exposure to the compound. In a 96-well plate format, 10,000 cells per well were
incubated at 37°C for 24 hours in four replicates per concentration tested in
the presence of compound in two-fold dilutions starting at 75 µM. Substrate was
then added and color development measured at 490 nm using a BioRad plate reader.
Values were calculated according to the formula \[%
toxicity = 100−((experimental-background)/(maximum(vehicle
treated)-background)\*100)\]. Values were plotted in dose-response curves and,
if applicable, CC<sub>50</sub> concentrations calculated.
## *In vitro* assessment of metabolic and plasma stability
JMN3-003 was mixed with liver S9 fractions (protein concentration 2.5 mg/ml)
from pooled mixed gender humans (XenoTech) at a final concentration of 1 µM and
reactions initiated by the addition of cofactors (1.14 mM NADPH, 1.43 mM
glucose-6-phosphate, 1.43 mM uridine 5′-diphosphoglucuronic acid, 9.42 mM
potassium chloride, 2.28 mM magnesium chloride) in 100 mM potassium phosphate
buffer, pH 7.4. Samples were incubated at 37°C with mixing, aliquots removed
after 0, 15, 30 and 60 minutes and subjected to reversed-phase LC-MS/MS (Applied
Biosystems API 4000 QTRAP with heated nebulizer; Turbo IonSpray for JMN5-166)
analysis. Peak areas were measured to calculate half life and percent of input
compound remaining according to the formulas t<sub>1/2</sub> = (−0.693/slope of
linear regression analysis of log transformed peak area versus) and % input
remaining = (peak area of test compound at t<sub>x</sub>/peak area of test
compound at t<sub>0</sub>)\*100. Positive controls to assess the metabolic
competency of the liver S9 fractions were 7-Ethoxycoumarin, Propranolol, and
Verapamil (Sigma), which were analyzed in parallel to the article. To determine
compound plasma stability, articles were mixed with freshly prepared human
plasma at a final concentration of 0.5 mM and incubated at 37°C for up to 120
minutes. Aliquots were removed at distinct time points as indicated and analyzed
by LC-MS/MS with detection of the compound at 254 nm. Values are expressed as
percent of compound remaining at each time relative to the amount of that
compound present at the starting time point.
## Flow-cytometric analysis of cell cycle progression
Actively proliferating HeLa cells were exposed to JMN3-003 (10 µM), hydroxyurea
(4 mM), or nocodazole (200 ng/ml) for 36 hours, followed by resuspension in
buffer I (20 mM citrate/PO, pH 3.0, 0.1 mM EDTA, 0.2 M Sucrose, 0.1% Triton
X-100) and staining in buffer II (10 mM Citrate/PO, pH 3.8, 0.1 M sodium
chloride, 20 µg/ml acridine orange) as described. Green fluorescence at 525 nm
resulting from DNA intercalating acridine orange was then measured using a BD
LSRII flow cytometer and FlowJo software (Tree Star) for data analysis. For
comparison, unstained and stained, solvent-only exposed cells were examined in
parallel.
## SDS-PAGE and immunoblotting
Cells were lysed with RIPA buffer (50 mM Tris/CL, pH 7.2, 1% deoxycholate, 0.15%
sodium dodecylsulfate, 150 mM sodium chloride, 50 mM sodium fluoride, 10 mM
EDTA, 1% NP-40, 1 mM PMSF, protease inhibitors). Aliquots with equal total
concentrations of cleared lysates (20,000×g; 10 min; 4°C) were mixed with
2x-urea buffer (200 mM Tris, pH 6.8; 8 M urea; 5% sodium dodecyl sulfate (SDS);
0.1 mM EDTA; 0.03% bromphenol blue; 1.5% dithiothreitol) and denatured for 25
min at 50°C. Samples were then fractionated on 10% SDS-polyacrylamide gels,
blotted to polyvinylidene difluoride (PVDF) membranes (Millipore) and subjected
to enhanced chemiluminescence detection (Pierce) using specific antisera
directed against phosphorylated or non-phosphorylated cdc2-cyclin B kinase (Cell
Signaling Technology), GAPDH (Abcam), the cytosolic tail of the MeV F protein,
or influenza A/WSN virus M2 (Thermo Scientific). Immunostained PVDF membranes
were developed using a ChemiDoc XRS digital imaging system (Bio-Rad) and
horseradish peroxidase conjugated anti-species IgG (mouse or rabbit) antibodies.
For densitometry, signals were quantified using the QuantityOne software package
(Bio-Rad).
## Assessment of cell growth rates
Vero cells were seeded at a density of 6×10<sup>5</sup> cells and incubated in
the presence of 10 µM JMN3-003 or vehicle only for 30 hours at 37°C. Cells were
then washed extensively and reseeded at a density of 1×10<sup>5</sup> cells per
well, followed by continued incubation at 37°C and assessment of life/dead cell
numbers every 24 hours using a Countess automated cell counter (Invitrogen).
Cells were reseeded as before when fastest growing cultures approached
confluency. Growth rates were calculated for each 24-hour time interval using
the Prism software package (GraphPad Software Inc.) based on the formula
Y = Y<sub>0</sub>\*exp(K\*X) with Y equaling life cell numbers, Y<sub>0</sub>
the Y value at the starting time (t<sub>0</sub>), and K the growth constant
equaling ln(2)/doubling-time.
## Quantification of cellular and viral mRNA levels
Cells were infected with either recombinant MeV Edmonston (recMeV-Edm) (Vero
cells, MOI = 1.0) or influenza A/WSN (MDCK cells, MOI = 0.05), followed by
removal of inocula one hour post-infection and addition of JMN3-003 in growth
media at 0.1 µM or 1 µM. All MeV infected wells received in addition fusion
inhibitory peptide (FIP, Bachem) at 100 µM to prevent premature breakdown of the
monolayer through viral CPE in the vehicle control wells prior to RNA
extraction. Twenty-four (influenza A/WSN) or forty (recMeV-Edm) hours post-
infection, total RNA was prepared from all wells using the QIAcube automated
extractor and the RNeasy Mini Kit (Qiagen), and subjected to reverse
transcription using Superscript II Reverse Transcriptase (Invitrogen). For RNA
samples originating from recMeV-Edm infected cells, antigenome-specific primer
5-GGCTCCCTCTGGTTGT or oligo-dT primer (viral mRNA and GAPDH quantification) were
used for cDNA priming. In the case of samples originating from influenza A/WSN
infected cells, primers for cDNA synthesis were 5-AGTAGAAACAAGGTAGTTT
(antigenome) or oligo-dT (mRNA and canine GAPDH). Real-time reactions were
carried out using an Applied Biosystems 7500 Fast real-time PCR *system and iQ*
Fast SYBR Green Supermix with ROX (Bio-Rad). Probes were a fragment at the N/P
junction (MeV antigenomic RNA, 5-AACCAGGTCCACACAG and 5-GTTG TCTGATATTTCTGAC), a
fragment of MeV F mRNA (5-GTCCACCATGGGTCTCAAGGTGAACGTCTC and
5-CAGTTATTGAGGAGAGTT), a fragment of human GAPDH (SABiosciences proprietary
primers), a fragment of influenza A/WSN segment seven (influenza A/WSN
antigenomic RNA, 5-tagctccagtgctggtct and 5-AAGGCCCTCCTTTCAGTCC), and a fragment
of canine GAPDH (Qiagen proprietary primer). Melting curves were generated at
the end of each reaction to verify amplification of a single product. To
calculate ΔΔC<sub>T</sub> values, CT values obtained for each sample were
normalized for GAPDH as reference and then ΔC<sub>T</sub> values of
JMN3-003-treated samples normalized for the FIP-treated controls. Final
quantification was based on three independent experiments in which each
treatment condition and RT primer setting were assessed in triplicate. To assess
the relative quantities of cellular mRNA, 9×10<sup>5</sup> HeLa cells were
incubated in the presence of JMN3-003 (0.01, 0.1, 1.0, 10.0 µM final
concentration), AS-136A (25 µM), Actinomycine D (5 µg/µl), or vehicle only for
six hours at 37°C, followed by preparation of total RNA as described above.
Quantitative TaqMan RT-PCR was again achieved using the TaqMan Fast Master Mix
(Applied Biosystems) combined with proprietary primer and probe sets specific
for Induced myeloid leukemia cell differentiation protein 1- (MCL1), MAPK
phosphatase 1 (MKP1), and ankyrin repeat and SOCS box-containing protein 7-
(ASB7) encoding mRNAs (Applied Biosystems). Samples were standardized for GAPDH
as before and normalized values expressed relative to the equally analyzed
vehicle-treated controls.
## Quantitative cell-to-cell fusion assays
An effector cell population (3×10<sup>5</sup> cells/well) was cotransfected with
2 µg each of MeV H and F expression plasmids. To inhibit fusion until the cell
overlay, the effector cells are incubated in the presence of 100 µM fusion
inhibitory peptide (Bachem). Single transfections of plasmids encoding MeV F
served as controls. Target cells (6×10<sup>5</sup> cells/well) were transfected
with 4 µg of the reporter plasmid encoding firefly luciferase under the control
of the T7 promoter. Two hours post-transfection, modified vaccinia virus Ankara
expressing T7 polymerase at an MOI of 1.0 PFU/cell was added to the effector
cells. Following incubation for 16 h at 37°C, target cells were detached and
overlaid on washed effector cells at a 1∶1 ratio and incubated at 37°C in the
presence of different JMN3-003 concentrations as indicated. Four hours post-
overlay, cells were lysed using Bright Glo lysis buffer (Promega), and the
luciferase activity determined in a luminescence counter (PerkinElmer) after
addition of Britelite substrate (PerkinElmer). The instrument's arbitrary values
were analyzed by subtracting the relative background provided by values of the
controls, and these values were normalized against the reference constructs
indicated in the figure legends. On average, background values were \<1% of the
values obtained for reference constructs. For qualitative assessment,
transfected Vero-SLAM cells were photographed 18 hours post-transfection at a
magnification of ×200.
## Time of compound addition analysis
For virus pre-incubation assays, 10<sup>7</sup> infectious MeV-Alaska particles
were incubated for 60 minutes at 37°C in the presence of JMN3-003 (1.0 µM final
concentration) or vehicle only, followed by 1,000-fold dilution in growth media
and transferred to 3×10<sup>5</sup> Vero-Slam cells/well (corresponding to final
compound concentrations after pre-incubation of 1 nM and an MOI = 0.033).
Reference wells were kept at 1.0 µM JMN3-003 for the duration of the experiment.
Cell-associated viral particles were harvested 24 hours post-infection and
infectious titers determined by TCID<sub>50</sub> titration. To assess cell
priming, Vero-Slam cells (3×10<sup>5</sup>/well) were incubated in the presence
of JMN3-003 at 1.0 µM for one hour at 37°C at the indicated time points pre-
infection, followed by washing and further incubation in growth media.
Immediately before infection, cells were reseeded at a density of
2.5×10<sup>5</sup> per well and infected with MeV-Alaska at an MOI = 0.2
pfu/cell. Inocula were replaced with growth media four hours post-infection and
cells incubated for approximately 20 hours. Cell-associated viral particles were
then harvested and infectious titers determined by TCID<sub>50</sub> titration.
For post-infection time-of-addition studies, 3×10<sup>5</sup> Vero-Slam
cells/well were infected with MeV-Alaska as before, followed by addition of
JMN3-003 (1.0 µM final concentration), entry inhibitor AS-48 (75 µM), or RdRp
inhibitor AS-136A (25 µM). Controls received vehicle only. All wells were
harvested 19 hours post-infection and titers of cell-associated progeny virus
determined by TCID<sub>50</sub> titration.
## Minireplicon assays
BSR T7/5 cells (5×10<sup>5</sup>/well) were transfected with plasmid DNAs
encoding MeV-L (0.24 µg), MeV-N (0.94 µg) or MeV-P (0.29 µg) and 2 µg of the MeV
luciferase minigenome reporter plasmid. Control wells included identical amounts
of reporter and helper plasmids but lacked the L-encoding plasmid. At the time
of transfection, JMN3-003 was added as specified, while control wells received
vehicle only for comparison. Thirty-six hours post-transfection, cells were
lysed with Bright GLO lysis buffer and relative luciferase activities determined
using the Britelite substrate and a luminescence counter as outlined above.
## *In vitro* virus adaptation
Adaptations were carried out essentially as we have previously described.
Briefly, Vero-SLAM cells were infected with MeV-Alaska at an MOI of 0.1 pfu/ml
and incubated in the presence of gradually increasing JMN3-003 concentrations
starting at 0.5 µM. Equally infected cells treated with the virus polymerase
targeted RdRp inhibitor AS-136A were examined in parallel. When cultures became
over confluent, cells were reseeded for continued incubation in the presence of
the same compound concentration as before. At detection of extensive cell-to-
cell fusion, cell-associated viral particles were harvested, diluted 10-fold and
used for parallel infections of fresh cell monolayers in the presence of
compound at unchanged and doubled concentrations. Cultures treated with the
highest compound concentrations in which virus-induced cytopathicity became
detectable were used for further adaptation. The approach was terminated after
90 days of continued incubation or when virus-induced cytopathicity was readily
detectable in the presence of 30 µM compound in accordance with previous
results.
# Supporting Information
We are grateful to D. C. Liotta and R. W. Arrendale (Emory University and Emory
Institute for Drug Development) for support and LC-MS/MS analysis of compound
samples, and A. L. Hammond for critical reading of the manuscript. MuV strain
South Africa, sindbis virus, and SO-influenza isolates Texas and Mexico were
kind gifts of P. A. Rota (Centers for Disease Control and Prevention), W. J.
Bellini (Centers for Disease Control and Prevention) and D. A. Steinhauer (Emory
University), respectively. We also thank Scynexis Inc. for assistance with
experimentation involving human S9 hepatocytes.
[^1]: Conceived and designed the experiments: SAK MN JPS RKP. Performed the
experiments: SAK JMN J-JY MD AS RKP. Analyzed the data: SAK JMN JPS RKP.
Contributed reagents/materials/analysis tools: AS MN. Wrote the paper: SAK
JMN RKP.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
HIV misdiagnosis can lead to severe individual and public health consequences. A
false-positive HIV diagnosis may lead to stigma and discrimination, strains on
family relationships and reproductive choices, and unnecessary lifelong use of
medication. From a public health perspective, HIV misdiagnosis can undermine the
public’s trust in HIV test results and in testing programs, and, can lead to
inefficient spending associated with costly antiretroviral treatment (ART) and
large settlements from lawsuits brought on by cases of misdiagnosis.
The use of recommended HIV rapid testing algorithms, comprised of at least two
consecutive reactive assays in a high prevalence settings, or at least three
consecutive reactive assays in a low prevalence settings, minimizes false-
positive results. However, a variety of factors, including but not limited to:
user error, poor recordkeeping, inadequate management and supervision, use of
incorrect testing algorithms, cross-reactivity and over-interpretation of weak
reactive results, contribute to HIV misdiagnoses. In global settings, studies
have reported HIV misdiagnosis rates ranging from less than 1% to more than 10%.
The World Health Organization (WHO) recommends retesting for verification of all
HIV-positive cases prior to ART initiation, in order to reduce the frequency of
HIV misdiagnosis and prevent unnecessary initiation of ART. The recommendation
calls for repeating the same nationally validated rapid testing algorithm on all
HIV cases initially diagnosed, using a second blood sample, and a different
tester. Retesting for verification is additional and subsequent to the two or
three assays used as part of a rapid HIV testing algorithm leading to an initial
HIV-positive diagnosis. Retesting for verification applies only to persons not
on ART because HIV diagnostic tests validated for use on persons taking ART are
not available. And, once persons are on ART, rapid tests may give false negative
results due to waning of antibodies.
WHO’s 2015 “Treat All” guidelines call for the immediate initiation of ART for
all HIV-diagnosed persons, irrespective of their CD4 count. The benefits of
“Treat All” include improved health outcomes for persons living with HIV, a more
efficient linkage to treatment process and population benefit of reduction in
transmission. ART initiation upon testing positive for HIV, does not allow a
health care provider to observe the natural history of CD4 levels and question
the diagnosis in the absence of a CD4 decline. Therefore, the adoption of “Treat
All” and the associated surge in ART initiations creates an imminent window of
opportunity and impetus for adopting retesting for verification as a manageable
component to strengthening the quality of HIV care services.
While WHO first recommended retesting for verification of new diagnoses in 1997,
the recommendation has been re-emphasized with the introduction and adoption of
the “Treat All” guidelines. Retesting for verification has not been widely
adopted nor implemented. This slow adoption may be related to: lack of knowledge
about the retesting recommendation; providers’ reliance on other clinical
assessments as required under previous ART guidelines that were indicative of
HIV infection; lack of data about the magnitude of misdiagnosis; concerns of the
additional costs and resources needed to implement retesting for verification or
suspicions that the operational requirements of re-testing could be an
impediment to rapid ART initiation.
An analysis among pregnant women suggests that retesting is less expensive than
treatment of those with false HIV-positive status. A study of misdiagnosis also
among pregnant women suggests that laboratory-based confirmation of HIV among
those with an undetectable pre-ART viral load, is cost-saving when compared to
lifetime cost of ART program enrolment for those misdiagnosed. Another study of
HIV misdiagnosis modeled the effect of retesting on a low- and high-prevalence
cohort of 10,000 persons and suggests that the cost of retesting is recouped
quickly when compared to the cost of ART for those misdiagnosed over 30 years.
Our study estimates the costs of implementing retesting across countries in
Africa, and, to our knowledge, is the first cost analysis to base data inputs on
reviews of misdiagnosis rates and testing costs, and the gap in the number of
persons needing to be initiated on ART to reach 90% coverage by 2020.
We conducted a cost analysis to estimate and compare the total costs of
implementing the WHO HIV retesting for verification recommendation in Africa, to
the costs of not retesting. We define the positive result of an initial testing
algorithm, as an initial diagnosis, and the positive result following retesting
for verification as a verified diagnosis. We do not use the terms confirmatory
testing or confirmed diagnosis to avoid confusion. We compared the cost of
retesting individuals for verification of an initial diagnosis, to the cost of
ART associated with the cases who would be HIV misdiagnosed, without retesting
for verification. With this model-based evaluation, we aim to provide policy-
makers in governments of low- and middle-income countries, and other resource-
constrained settings, with evidence to support their decision-making process
around HIV retesting for verification strategies.
# Methods
We conducted a cost analysis of HIV retesting for verification, from the
perspective of the health care provider. We compared two scenarios: *retesting*,
implementing retesting for verification of all initially diagnosed HIV-positive
cases prior to ART initiation; and *no retesting*, which is the current practice
in most developing countries. In terms of ART costs, we considered only the
costs incurred for those misdiagnosed as HIV-positive because the cost of ART
for true positives would be the same in both scenarios. We considered all
countries in Africa listed as member states of the United Nations African Group,
except Equatorial Guinea, and the Seychelles, Cape Verde and São Tomé & Príncipe
islands. We presented both the total costs and per person cost of these
scenarios for these 50 African countries, grouped by income level: 26 low-income
countries (LICs), 15 lower-middle income countries (LMICs) and 9 upper middle-
income countries (UMICs). Regions outside of Africa were not evaluated due to
paucity of data.
We assumed retesting for verification would largely be conducted in facility-
based settings, even when the initial diagnosis is provided in community-based
settings because the recommendations for retesting call for a different person
to administer the verification test. We used facility-based testing costs, which
do not typically include recruitment and mobilization efforts, to approximate
retesting costs. We reviewed the literature for studies, set in African
countries, published in the last ten years and reporting facility-based HIV
testing costs per person. We searched PubMed using the terms: cost, HIV,
testing, and facility, and limited the publication year from 2007 to present. To
identify further literature, we searched reference lists. We identified five
relevant studies, from two systematic review of HIV testing costs, and an
additional three relevant studies published subsequent to those systematic
reviews. We present the facility-based cost per person tested resulting from
these eight studies in. HIV counseling and testing services in these studies are
largely provided by trained counselors, occasionally supported by nurses or
laboratory assistants, and all are using rapid diagnosis testing in the initial
algorithm. All eight studies considered costs from the perspective of the heath
care provider, and, all but one study adopted an economic costing approach. For
each of the three income level country groups, we used the average cost per
person tested to estimate the cost of retesting for verification, in our base-
case analysis. In sensitivity analysis, we varied the retesting costs, between
the lowest and the highest reported facility-based cost per person tested, by
country income level.
To estimate the resources needed to fund the 2016 UNAIDS Fast-Track Approach,
Stover et al. conducted a review of published ART cost studies. We used this
review, limited to Africa, to estimate the average annual cost of ART for each
of the three income level country groups. The average annual cost of ART per
client included antiretroviral drugs, other drugs, laboratory services and other
service delivery costs. All cost data were adjusted to 2017 United States
Dollars. In sensitivity analysis, we varied these costs between the lowest and
the highest reported average annual cost of ART, by country income level.
A recent systematic review found 30 studies reporting a false positive HIV
diagnostic error rate, with a median rate of 3.1%. We used a subset of those
studies to determine the false positive misdiagnosis rate following an initial
testing algorithm. From those 30 studies, we excluded seven not set in Africa;
ten were excluded for reporting on misdiagnosis following discordant rapid test
results, including use of a tie-breaker algorithm which are known to have lower
specificity. Further reasons for exclusion were reporting on acute infection
among negative samples, and reporting on oral fluid testing, or insufficient
data. The remaining 11 studies were deemed relevant and allowed for pooling of
the individual study estimates. For each country income level, we estimated a
weighted mean false positive misdiagnosis rate by summing the number of false
positives reported across studies and dividing by the number of positives, also
summed across studies. These data are presented in. For LICs, the misdiagnosis
rate ranged from 0.7% to 10% and the weighted mean was 2.7%. For LMICs, the
misdiagnosis rate ranged from 0.3% to 5% and the weighted mean was 1.1%. For
UMICs, the misdiagnosis rate ranged from 0.3% to 2% and the weighted mean was
0.85%. In sensitivity analysis, we evaluated the results across these ranges.
Few studies indicate the reduction in misdiagnoses that could be obtained from
retesting. Reports from Malawi show that misdiagnosis has decreased from 7% to
1% following the implementation of retesting for verification and related
quality assurance measures. Another study reported that re-testing for
verification prevented six out of eight false positive misdiagnoses. In our
model, we assumed a 75% reduction in misdiagnoses would result from retesting
for verification, and varied this parameter in sensitivity analysis and
threshold analysis. Varying the reduction in misdiagnosis following retesting
can also serve to capture any loss to follow-up attributable to the extra step
of retesting for verification, and to correct any overestimate resulting from
the concurrent effects associated with the implementation of other quality
improvement measures.
To close the HIV treatment gap and reach 90% ART coverage by 2020, UNAIDS
reports the number of persons who would need to be initiated on ART, by 2020 and
by country. We used these data to estimate the number of initially diagnosed
HIV-positive persons who are not on ART, and the total ART costs of the
projected misdiagnosed cases, for each of the three country income level groups.
Our analysis is presented in the context of “Treat All” and assumes that all
those diagnosed as HIV-positive, would be initiated and incur ART costs.
We define costs per person initially diagnosed as the average per person costs
across the total number of initially diagnosed, ART-naïve HIV cases, prior to
retesting for verification. We estimate the per person costs and total costs of
the *retesting* and *no retesting* scenarios over a ten year time horizon, as
the base case. In sensitivity analysis, we explored a 5-year and 20-year time
horizon. We assumed that all those initially-diagnosed HIV-positive persons who
are not on ART would incur costs from the start of the time horizon. Future
costs were discounted at rate of 3%.
To gauge the robustness of the findings, we conducted univariate sensitivity
analysis and threshold analysis on the model input parameters. All input values
for the base-case analysis and ranges examined in sensitivity analysis are
presented in.
# Results and discussion
Using the base-case values, total costs under the *no retesting* scenario exceed
the total costs under the *retesting* scenario in all three country groups,
suggesting that cost savings are associated with the adoption of retesting for
verification. Over the ten-year horizon, the estimated number of misdiagnoses in
the absence of retesting for verification was 156,117, 52,720 and 29,884, for
LICs, LMICs and UMICs, respectively, totaling 238,721 for Africa. Using a 75%
reduction in misdiagnosis from retesting for verification, the estimated number
of misdiagnosed cases with retesting for verification was 39,029, 13,180 and
7,471 for LICs, LMICs and UMICs, respectively, totaling 59,680 for Africa, over
the ten-year horizon.
The total cost of treatment for those misdiagnosed cases under the *no
retesting* scenario was \$727 million, \$199 million, and \$266 million (2017
United States Dollars (USD)) for LICs, LMICs and UMICs, respectively, over the
ten-year horizon. And, costs per person initially diagnosed under the *no
retesting* scenario, defined as the total costs divided by the estimated of
number of positives to be initiated on ART, were: \$125, \$43, and \$75 for
(2017 USD) for LICs, LMICs, and UMICs, respectively. Total costs under the
*retesting* scenario include the cost of retesting all positives and the costs
of ART for those who would be misdiagnosed in spite of the retesting efforts;
these are: \$231 million, \$98 million, and \$146 million (2017 USD) for LICs,
LMICs and UMICs, respectively. Costs per person initially diagnosed under the
*retesting* scenario, defined as the total costs divided by the estimated of
number of positives retested, were: \$40, \$21, and \$42 for (2017 USD) for
LICs, LMICs, and UMICs, respectively. When comparing, the two scenarios, the
estimated savings from *retesting* totals \$717 million over the ten-year
horizon, across all country income levels when compared to the *no retesting*
scenario. And, the savings per person retested are \$85, \$21, and \$33 for
LICs, LMICs, and UMICs, respectively, when retesting for verification is
implemented. Results of the base-case analysis are presented in.
In one-way sensitivity analysis, we varied the base-case input parameters,
across the ranges indicated in, and the time horizon to 5 and 20 years, for all
three country groups. In all sensitivity analysis scenarios explored, the total
cost of *no retesting* exceeded the total cost of *retesting*, with three
exceptions. First, at a per person cost of treatment as low as \$257, the
estimated cost of *retesting* in UMICs would exceed the cost *no retesting* by
\$29 million. Also, in both LMICs and UMICs, the lower bound on the rate of
positive misdiagnosis causes the cost of *retesting* to exceed the cost *no
retesting* by \$6 million and \$5 million, respectively.
We conducted threshold analysis on the input parameters to establish the
parameter values for which for the total cost of both scenarios would be the
same. For the total cost of *retesting* to equal the total cost of *no
retesting*, with other parameters held constant, the per person cost of HIV
retesting would have to increase from \$9 to \$98 in LICs, from \$11 to \$33 in
LMICs, and from \$23 to \$58 in UMICs. Also, for the total costs to be the same
in both scenarios, the mean annual cost of ART would have to decrease from \$532
to \$48 in LICs, from \$432 to \$139 in LMICs, and from \$1,016 to \$405 in
UMICs. Moreover, for the total cost of *retesting* to equal the total cost of
*no retesting*, with other parameters held constant, the misdiagnosis rate at
initial diagnosis would have to be reduced to less than 0.2% in LICs, less than
0.4% in LMICs, and less than 0.3% in UMICs. Alternatively, the reduction in
misdiagnosis rate following retesting would have to be reduced from 75% to less
than 30%, 24% and 7%, in UMICs, LMICs, and LICs, respectively. Lastly, the cost
of HIV treatment for misdiagnosed cases would have to be cumulated over a time
horizon of less than ten months for the total cost of *retesting* to equal the
total cost of *no retesting* in LICs, less than 3 years in LMICs, and, less than
four years for UMICs. Results of the sensitivity analyses and threshold analyses
are presented in.
Our results indicate that adopting retesting for verification leads to
significant savings in medical costs averted, even under conservative cost and
outcome assumptions. While there is uncertainty in the value of the model’s
input parameters, sensitivity analyses and threshold analyses demonstrate that
the conclusion holds under a majority of scenarios. For each scenario, reviewing
where threshold lies relative to the range defined by the lower and upper bound
in sensitivity analysis, provides an indication of the stability of the
analysis. For LICs, all threshold values lie considerably outside of the range
explored in sensitivity analysis indicating that reasonable variations in
parameter input values, would not alter the findings; this is critical because
of the three country groups considered, LICs have both the highest rate of
positive misdiagnosis and the most number of positives to be initiated, and thus
the greatest potential for misdiagnosis in the absence of retesting. Among
LMICs, the threshold value for misdiagnosis rate is 0.36%, and a lower bound of
0.31% misdiagnosis was set based on a study, in Nigeria which found one
misdiagnosis among 318 tested. All other ranges of input values explored for
LMICs excluded the threshold. Lastly, for UMICs, the threshold for misdiagnosis
rate was 0.34% which lies faintly beyond the lower bound of 0.32%, and the
threshold for the treatment costs was \$405 while the lower bound in was \$257.
These trends in country income levels suggests that, while *retesting* is cost-
saving, the case for retesting is greater where resources are more constrained.
It is possible, but not known, whether any correlation exists between country
income level and misdiagnosis rates. Better resourced countries may be able to
afford more quality assurance activities such as training and proficiency
testing.
Our findings are also consistent with those of a recent analysis by Eaton, in
spite of the different approach taken. Our analysis considers discounted ART
costs over ten years, rather than a 30-year time horizon, by which antibody and
viral load testing technologies are likely to have changed the landscape of HIV
diagnosis and treatment. Our study also benefited from a systematic review to
establish a baseline rate and range for false positive diagnosis, while the
aforementioned study relied on assumptions based on rapid test specificity data.
Lastly, our study provides the total costs of retesting using the estimated
numbers of persons requiring ART initiation across 50 countries in Africa,
grouped by income level, while the Eaton study evaluates the costs of retesting
assuming a 1% and 10% HIV prevalence among a cohort of 10,000. In spite of these
differences both analyses, along with another, suggest that, at present,
retesting for verification is cost-saving relative to the treatment of false
positive HIV cases.
Our analysis has limitations. First, the costs considered are those incurred by
the health care provider only, and broader societal costs were not considered.
At the individual level, the consequences of an HIV diagnosis may include stigma
and discrimination, violence, psychological trauma, and productivity losses; and
it can influence partner, reproductive, and professional choices. Published case
reports and media accounts of HIV misdiagnosis suggest that significant jury
awards have been made to victims of HIV misdiagnosis and this negative publicity
can lead to credibility loss for the public health system and its providers. We
did not attempt to quantify or cost the effects of these repercussions. However,
considering these costs would increase the total cost of *no retesting*, and
would serve to encourage the implementation of HIV retesting for verification
prior to ART initiation. Second, the model considered the cost of the retesting
events but did not consider the costs associated with the adoption and rollout
of a retesting for verification strategy such training and dissemination.
Training is an integral component of introducing new operating procedures in HIV
testing, and, all HIV testing services must be implemented along with
supervision and quality assurance programs. Third, retesting would call for a
two-test algorithm, in high prevalence settings, or a three-test algorithm, in
low prevalence settings. To save time and labor costs when retesting, we assumed
that all tests would be run in parallel, and therefore the impact on cost of a
two- vs. three-test algorithm is the cost of the rapid test kit itself, which is
typically a small fraction of testing costs. Also, in our analysis, retesting
for verification was defined as repeating the same testing algorithm. And,
retesting can rule out possible technical or clerical errors, including specimen
mix-up through mislabeling and transcription errors, as well as random error by
either the provider or the test device, though retesting for verification will
not exclude misdiagnosis related to poor choice of a testing algorithm or cross-
reactivity. However, this risk should be reduced assuming the testing
algorithm used is validated. The WHO recommends following the approved
national HIV testing algorithm and ensuring adherence to a quality-testing
program with continuous quality assurance.
Retesting may provide significant correction from multiple sources of errors
including, lack of training, quality assurance and over interpretation of weakly
reactively test lines, as a different provider should be reading the results
using a new blood sample. Retesting is common for diseases, including HIV,
by reference laboratories in Western countries, but was not practiced routinely
in resource-limited countries. Given the wide adoption of “Treat All”
guidelines, it is critical to incorporate retesting for verification as part of
quality assurance programs, to avoid misdiagnosis and unnecessary costs. Other
approaches to prevent misclassification include viral load testing, and
supplemental HIV testing methods, that are more expensive and more specific than
a rapid testing algorithm. We did not explicitly model these approaches as they
are used to address different points in the diagnostic error cascade from those
addressed by retesting. Viral load testing, may further confirm a positive
diagnosis when provided to ART-naïve individuals, is not a substitute for HIV
retesting for verification because it addressed a different portion of errors.
Also, an undetectable viral load at baseline cannot be used to rule out
infection because up to 10% of HIV-positive persons may have an undetectable
viral load as their initial baseline measurement, without having been on ART.
Therefore, an undetectable viral load at baseline can include both true HIV-
positive and false positives. And, the turnaround time to obtain viral load
testing results is, at present, much greater than that of obtaining results from
retesting using a rapid HIV testing algorithm, and any delay introduced in
getting patients diagnosed and initiated on treatment increases the risk of
losing patients to follow-up and puts the achievement of 90% ART coverage by
2020 in peril. Lastly, in low- to middle-income country settings, there is
little capacity to provide viral load testing prior to initiation of ART, and it
will take several years to ramp up this capacity sufficiently to cover all newly
diagnosed HIV cases. In the future, viral load testing may have a role in
diagnosing HIV, but at present, given current technology and capacity, detection
of HIV antibody testing is the most appropriate method to diagnose and confirm
infection, especially in developing countries.
# Conclusion
In sum, this analysis suggests significant savings in HIV treatment costs
averted from the adoption of WHO’s retesting for verification guidelines and the
consequent reduction in misdiagnosis. Our study ought to drive attention to the
incorporation of retesting for verification as part of quality assurance for
“Treat All” services, and to the policy and operational needs for routinizing
retesting.
Beyond adoption of the guidelines, participating in continuous quality
improvement and adhering to the nationally validated HIV testing algorithm also
plays a key role in reducing HIV misdiagnosis rates, and a comprehensive
approach to quality assurance of HIV testing is critical whether for initial
diagnosis or for verification purposes. Implementation and operational aspects
of retesting for verification may present complexities, for example, where HIV
testing is conducted in community settings, or where health care facilities do
not have an another person qualified to administer retesting for verification.
We suggest that program managers proactively design the implementation of
retesting for verification to overcome any hurdles to operationalizing the
strategy. For countries adopting a phased approach, retesting for verification
may be prioritized to testing sites that appear to indicate poor performance on
external quality assessments and areas where higher level of discordant results
are observed. We also recommend that countries review their data, consider the
long term financial, personal, and societal costs associated with not retesting
for verification, and include retesting for verification as an integral quality
assurance component in the development or revision of their “Treat All” plans.
This work has been supported by the President’s Emergency Plan for AIDS Relief
(PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC).
# Disclaimer
The findings and conclusions in this report are those of the author(s) and do
not necessarily represent the official position of the Centers for Disease
Control and Prevention.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Fusarium head blight (FHB) is a notorious wheat disease prevailing in warm and
humid environments, exerting global impact on food and feed safety due to the
presence of mycotoxins produced by *Fusarium* species, the causal agents of FHB.
Deoxynivalenol (DON) has been considered the most important FHB-related
mycotoxin and legislation has been set up in many countries/organizations for
controlling DON content in food and feed.
Host resistance to FHB is of quantitative inheritance and influenced
significantly by environment, making breeding for this trait a difficult task.
Multiple mechanisms of host resistance to FHB has been recognized, including
Type I for resistance to initial infection, Type II for spread of pathogen in
spike tissues, Type III for DON accumulation, Type IV for kernel infection, and
Type V for yield reduction. In relation to food safety, Type III resistance is
the most important; but so far no validated QTL specific for this resistance
mechanism has been identified, and some researchers still regard it as a
consequence of FHB infection and not an independent trait. Of the first two
resistance mechanisms, Type I resistance exhibited more frequent association
with phenological, morphological, and flower biology traits, such as days to
heading (DH), plant height (PH) and anther extrusion (AE).
The negative association between PH and FHB susceptibility in wheat has long
been observed, and it happened also in barley and oat. Three possible mechanisms
have been proposed for the association, i.e. disease escape, pleiotropy of
reduced height (*Rht*) genes, and tight linkage. In the last decade researches
provided molecular evidence for this relationship and several QTL responsible
for both FHB and PH were identified, including *Rht-B1*, *Rht-D1* and *Rht8*.
Dwarfing genes *Rht-B1b* and *Rht-D1b* (formally known as *Rht1* and *Rht2*,
respectively) were derived from the Japanese cultivar ‘Norin 10’ and contributed
greatly to the Green Revolution. Strong evidences are available for the
association between *Rht-D1b* and Type I FHB susceptibility in European
varieties. For example, *Rht-D1b* increased FHB severity by 52% in a ‘Mercia’
background and 38% in a ‘Maris Huntsman’ background. Lu et al. demonstrated in a
mapping population that two major resistant QTL may be required to counteract
the negative effect of *Rht-D1b*. In an association mapping study on European
winter wheat materials, Miedaner et al. also reported the significant
association of *Rht-D1b* with increased FHB susceptibility, but to a lesser
degree than reported previously; the authors concluded that the negative effects
of *Rht-D1b* in bi-parental populations may have been overestimated. In the case
of *Rht-B1b*, Srinivasachary et al. found that it showed little or no negative
impact on Type I FHB resistance under moderate FHB pressure, but exerted
negative effects similar to *Rht-D1b* under severe infection. Miedaner and Voss
also reported the different performance of *Rht-B1b* under different genetic
backgrounds. In the three mapping populations tested by Buerstmayr et al.,
*Rht-B1b* was associated with increased FHB susceptibility, with phenotypic
effects ranging from 3–18%. The negative effects of the two dwarfing genes on
field FHB resistance have also been reported in Chinese and US wheat materials.
In point inoculated experiments, *Rht-B1b* exhibited significant effects on Type
II resistance, whereas *Rht-D1b* showed little or no effects on this type of FHB
resistance. Many researchers ascribed the association to the pleiotropic effects
of dwarfing genes; but Yan et al. claimed that it was the micro-environmental
condition around spikes that contributed to the relationship, since the negative
effects on Type I resistance disappeared when *Rht-B1b* and *Rht-D1b* near-
isogenic lines were physically raised to the same heights as their tall
counterparts.
The importance of anthers in FHB infection has long been observed. Pugh et al.
observed that retained anthers were the first tissues to be colonized as a base
for further infection. Strange and Smith also found this phenomenon and reported
that the presence of anthers favoured greatly the FHB infection, whereas
emasculation significantly reduced the disease severity. They ascribed this to
the fungal growth stimulants in anthers, of which choline and betaine were the
two major components. Based on these findings, Strange et al. suggested the
selection of wheat lines with low anther retention (or high AE) to facilitate
FHB resistance breeding. Three decades later, Skinnes et al. and Graham and
Browne reported the association of FHB with AE in European wheat varieties,
where those having high AE tended to had low FHB severity. The positive
correlation between AE and FHB resistance has also been reported in Chinese,
Japanese and CIMMYT germplasm. QTL mapping studies revealed the underlying
mechanisms for this relationship by identifying linked or coincided QTL for the
two traits. Like PH, AE was also found to be associated with Type I FHB
resistance.
Considering the associations of Type I FHB resistance with both PH and AE, it is
tempting to investigate the association between the latter two traits, and clues
do exist in literature. In the Shanghai-3/Catbird x Naxos population, *Rht-B1*
explained 10% of the phenotypic variation of AE, and in the Hermann × Skalmeje
population, lines with *Rht-B1b* or *Rht-D1b* showed reduced AE and double
dwarfs (*Rht-B1b*/*Rht-D1b*) had a high degree of anther retention (+99%)
compared to tall lines with *Rht-B1a*/*Rht-D1a*. It was also observed by hybrid
wheat breeders that PH and AE are positively correlated. The objectives of the
current study were to map QTL for FHB and its related traits and to evaluate the
impacts of dwarfing genes *Rht-B1b* and *Rht-D1b* on field FHB resistance and AE
in two mapping populations.
# Materials and Methods
## Plant material
Two doubled haploid populations were used in this study. The first one was
developed from a cross between ‘TRAP#1/BOW//Taigu derivative’ and ‘Ocoroni F86’
with 135 progenies (referred to as the TO population hereafter), while the
second was from ‘Ivan/Soru#2’ and ‘Ocoroni F86’ with 92 progenies (the IO
population). Both the two female parents were FHB resistant lines bred at
CIMMYT, while ‘Ocoroni F86’ (pedigree JUPATECO-73/(SIB)EMU//(SIB)GRAJO) is a
CIMMYT breeding line moderately susceptible to FHB. Both of the two resistant
parents carried *Rht-B1b*/*Rht-D1a* whereas the susceptible parent had the
*Rht-B1a*/*Rht-D1b* genotype, resulting in both dwarfing genes segregating in
the two populations.
## Field trials and phenotyping
The field FHB experiments were conducted at the El Batán experimental station
(altitude of 2,240 meters above sea level, coordinate 19.5°N, 98.8°W, with an
average annual precipitation of 625 mm) of CIMMYT, Mexico, during the summer
season (May to September) when rainfall is concentrated. The two populations
were evaluated from 2010 to 2012, sown in 1 m double rows with randomized
complete block design with three replications. Each year, a mixture of 5
aggressive *F*. *graminearum* isolates were collected, characterized, and used
for field inoculation, following the protocols described by He et al.. Spray
inoculation was targeted to each line’s anthesis stage with an inoculum of
50,000 spores/ml and was repeated two days later. From anthesis to early dough
stages, the nursery was misted from 9am to 8pm with 10 minutes of spraying each
hour, to create a humid environment favourable for FHB development. A
wheat/maize rotation and conservation agricultural practices were followed in
the nursery to enhance natural inoculum.
FHB symptoms were evaluated at 25 days post inoculation (dpi) on the 10 spikes
that had been tagged at anthesis. Numbers of infected spikes and symptomatic
spikelets of each spike were counted for calculating FHB index with the formula:
*FHB index* = *Severity* x *Incidence*, where *Severity* stands for the averaged
percentage of diseased spikelets, and *Incidence* for the percentage of
symptomatic spikes. Plots were sickle harvested and threshed with a belt
thresher set at low wind speed to retain scabby kernels. Fusarium damaged
kernels (FDK) was estimated only in 2012 for the two populations through
visually evaluating a random sample in a petri dish, where both scabby and
shrivelled kernels were regarded as FDK. DON content was quantified in 2010 and
2012 for the TO population and in 2011 and 2012 for the IO population, based on
2 g flour sampled from 20 g ground grain of each accession, using the Ridascreen
Fast DON ELISA kit (RBiopharm GmbH, Darmstadt, Germany) following the
manufacturer’s instructions. AE and PH were scored in 2011 and 2012 for the IO
population and in 2012 for the TO population. In 2015, the TO population was
planted in 40x15 cm hill plots with two replications for an additional
evaluation of AE and PH. AE was rated with a linear scale from 0 (no extrusion)
to 9 (full extrusion) according to Skinnes et al., and PH was measured before
harvest from ground to the average spike tips excluding awns in each plot. Days
to heading (DH) was scored for the two populations in all the experiments.
## Statistical analyses
The phenotypic data was analysed by the SAS program ver. 9.2. Analysis of
variance (ANOVA) was carried out with the PROC GLM module, and Pearson
correlation coefficients were calculated using the PROC CORR function. The
results of ANOVA were used for calculating the heritability estimates, using the
formula $h^{2} = \sigma_{g}^{2}/\left( \sigma_{g}^{2} + \frac{\sigma_{e}^{2}}{r}
\right)$ for single years and $h^{2} = \sigma_{g}^{2}/\left( \sigma_{g}^{2} +
\frac{\sigma_{g*y}^{2}}{y} + \frac{\sigma_{e}^{2}}{ry} \right)$ for multiple
years; in which $\sigma_{g}^{2}$ stands for genetic variance, $\sigma_{g*y}^{2}$
for genotype-by-year interaction, $\sigma_{e}^{2}$ for error variance, *y* for
the number of years, and *r* for the number of replications.
## Genotyping
The two populations were genotyped with the DArTseq genotyping-by-sequencing
(GBS) platform at the Genetic Analysis Service for Agriculture (SAGA) in
Guadalajara, Mexico. This genotyping method is a combination of complexity
reduction methods developed for array-based DArT and sequencing of resulting
representations on next-generation sequencing platforms, for detailed
information please check Li et al.. Additionally, two dwarfing genes *Rht-B1*
and *Rht-D1* were also genotyped, using the KASPar technology (KBioscience)
based SNP markers developed at CIMMYT. A few SSR markers linked to known FHB
resistance QTL were also applied. Markers with missing data points greater than
20% and segregation ratio beyond the range 0.5–2.0 were discarded from further
analysis.
## Linkage and QTL analysis
Linkage groups (LGs) were constructed using the JoinMap v.4 software, where
groupings were based on LOD values from 5 to 10, and ordering within each LG was
done with the Maximum Likelihood algorithm. LGs were assigned to chromosomes
according to the consensus GBS map by Li et al.. QTL mapping was carried out
with MapQTL v6.0, in which interval mapping (IM) was first performed to detect
potential QTL for each trait, followed by multiple QTL mapping (MQM) for each
QTL, using the closest linked markers to each QTL detected in IM as cofactors.
QTL were taken as significant and were reported if they were over the LOD
threshold of 3 in at least one environment or over the threshold of 2 in
multiple environments. LGs and LOD curves were drawn by the software MapChart
ver. 2.3.
# Results
FHB development of the two populations was satisfactory, ranging from slight
infection to around 50% of FHB index in all the three years. The resistant
parents ‘TRAP#1/BOW//Taigu derivative’ and ‘Ivan/Soru#2’ showed always
significantly higher resistance than the susceptible parent ‘Ocoroni F86’, in
terms of all three FHB parameters. In both populations, ‘year’ effect
contributed the most variation of FHB and DON, followed by ‘genotype’ and
‘genotype x year’ effects which were also significant except for DON in the TO
population. Usually high heritability estimates were obtained for the FHB
parameters, but DON in the TO population had a value of merely 0.22.
Significantly positive correlations were found among all the FHB traits,
although in several cases the *r* values were low.
AE and PH showed wide segregation in both populations. High heritability
estimates of 0.79 and 0.87 were obtained for AE in the TO and IO populations,
respectively, and in the case of PH the values were even higher. The two traits
showed significantly negative correlations with FHB in the TO population (*r* =
-0.73 for PH vs. FHB, and *r* = -0.65 for AE vs. FHB, *p*\<0.0001), and the
corresponding correlations were also significant in the IO population but with
lower *r* values (*r* = -0.63 for PH vs. FHB, and *r* = -0.48 for AE vs. FHB,
*p*\<0.0001).
In the TO population, 1,858 GBSs together with seven SSRs and the two dwarfing
genes were used for LG construction. Thirty three LGs were generated, covering
4,053cM with an average density of 2.2 cM/marker. All but 1D chromosome were
represented in this map and three LGs were not assigned to a chromosome due to a
lack of anchored markers. Regarding the IO population, 1,986 GBSs, *Rht-B1*,
*Rht-D1* and four SSRs were used for linkage mapping and 35 LGs were obtained.
Total length of the LGs was 4,430cM with a very similar density as that of the
TO population. In this case, only chromosome 6D was not represented and six LGs
were not assigned to chromosomes.
Three QTL with major effects were identified in both populations, i.e. *Rht-B1*
on 4BS, *Rht-D1* on 4DS and a QTL on 5AL. The latter was most likely at
*Vrn-A1*, due to its strong effects on heading time, explaining 48.2% of the DH
variation in the TO population and 14.9% in the IO population. The expression of
the three QTL was more stable in the TO population, being associated with FHB
parameters in most environments, accounting mostly 10–20% of phenotypic
variation. Comparably, the magnitude of their phenotypic effects was similar in
the IO population, but their expression was not detected in certain
environments, e.g. the 5AL QTL was not identified in 2012 and the *Rht-B1* QTL
was significant mainly in 2012. The two dwarfing genes showed similar negative
effects on FHB resistance in the two populations, although the phenotypic
variations explained by *Rht-B1* were often a bit higher than those by *Rht-D1*.
A QTL on 2AL was also shared by the two populations based on common markers, but
it was only a minor QTL accounting for phenotypic variations less than 10%.
Additional minor QTL were found in the IO population, located on 1BL, 3BL (LG
3B_2), 3BS (LG 3B_3) and 5BL. It could be observed that for DON in the TO
population, QTL on 2AL and 5AL in 2010 were significant, but the ones at
*Rht-B1* and *Rht-D1* were identified in 2012, explaining the non-significant
‘genotype’ effect and low heritability estimate for this trait.
Several QTL for AE were localized and three were shared by the two populations,
viz. *Rht-B1*, *Rht-D1* and a QTL on 2AL, all associated with FHB resistance.
Additional QTL were found on 2BL in the TO population and on 2DS and 3BL in the
IO population. The two dwarfing genes collectively explained around 20% of AE
reduction in both populations and *Rht-B1b* was always more strongly associated
with reduced AE than *Rht-D1b*. As for PH, *Rht-B1* and *Rht-D1* collectively
accounted for about 60% variation in the two populations, while additional QTL
were found on 5AL (*Vrn-A1*) and 7B in the TO population and on 5BS in the IO
population.
# Discussion
FHB index after field spray inoculation was generally considered as for a
combination of Type I and Type II resistance; but in our study it appeared that
mainly the former took place considering the significantly high correlation of
FHB with PH and AE that did not happen in point inoculated experiments for Type
II resistance. Therefore, we considered that the results obtained in this study
were based mainly on Type I resistance.
Dwarfing genes *Rht-B1* and *Rht-D1* and the vernalisation gene *Vrn-A1* were
segregating in both populations used in this study, resulting in that most of
the phenotypic variation for FHB parameters was explained by these three loci,
whereas other QTL only explained a small fraction of the variation. The latter
category comprised QTL with phenotypic effects below 10%, which were likely
known QTL based on their locations.
The association between the two dwarfing genes and FHB susceptibility has been
reported in many studies, and three possible mechanisms including disease
escape, pleiotropy and tight linkage have been proposed; but a conclusion has
not been drawn as to which mechanism was actually taking place. Intuitionally,
this could be ascribed to PH per se or escape since tall plants were farther
from soil surface where the inoculum was present (in the case of natural
infection or spawn inoculation where FHB infected grain kernels were scattered
in the field as inoculum) and ventilation was reduced that lead to high humidity
favourable to FHB development. This mechanism must have contributed to the
association in this study since the correlation remained significant in the sub-
populations with homozygous *Rht-B1* and *Rht-D1* alleles (data not shown);
despite the utilization of spray inoculation in this study, huge quantity of
*Fusarium* inoculum was present on soil surface due to the adoption of
wheat/maize rotation and conservation agricultural practices, supporting the
escape mechanism. With the accumulation of molecular evidences in the last
decade, more researchers took pleiotropy as the main mechanism for this
association. Being DELLA protein producers, *Rht-B1b* and *Rht-D1b* have shown
association with reduced resistance to biotrophic diseases including Type I FHB
resistance (although FHB is regarded as a necrotrophic disease, it behaves more
like a biotrophic disease at the early stages when Type I resistance takes
place) but increased resistance to necrotrophic diseases like Type II FHB
resistance. Another evidence for the genetic effects of dwarfing genes instead
of disease escape was that in sub-populations with homozygous *Rht* alleles, the
correlation between PH and FHB disappeared or was significantly reduced, which
was obviously not the case of the current study. However, this does not
necessarily mean that the pleiotropic effects had no impacts on FHB in our
study; it could function through controlling AE, which will be further explained
below. Due to the limitation of map resolution, currently it is very difficult
to separate pleiotropy and tight linkage; nevertheless clues supporting the
latter have been reported. In the Soissons x Orvantis mapping population,
Srinivasachary et al. found that the peaks of FHB QTL were constantly located in
a short distance away from the *Rht-D1* locus. Similarly in our previous
research, a QTL for FHB in close linkage with *Rht-D1* appeared when PH was used
as covariate. So it appears that all the three mechanisms exist, but they are
not necessarily simultaneously present in a single wheat line and their
different combinations are expected.
The importance of AE in FHB resistance has long been recognized, but genetic
studies on AE were performed only in the last few years. In all these
studies, the accumulated phenotypic variation explained by identified QTL for AE
rarely exceeded 50% (usually around 30%), in accordance with the current study,
demonstrating a typical quantitative inheritance of AE. In the aforementioned
four studies, totally 18 AE QTL have been identified, but only the QTL on 7AL
found by Skinnes et al. and Lu et al. may be the same, and the one found on 4AL
in He et al. could be the same as reported by Buerstmayr and Buerstmayr. In the
current study, six more AE QTL were found, and not unexpectedly only the one on
2DS might be the same as found in our previous study, whereas others were all
from new chromosome regions. Similar to previous results, four out of the six AE
QTL were associated with FHB resistance (Tables), supporting the phenotypic
association of the two traits.
The two dwarfing genes showed consistent effects on reducing AE in both
populations across environments, collectively contributing about 20% of AE
variation. The association may have its physiological basis. In Arabidopsis, the
elongation of anther filament is stimulated by GA and repressed by DELLA
proteins which are orthologous to wheat *Rht-1* gene products. Thus it is
reasonable to speculate that the GA insensitive mutants *Rht-B1b* and *Rht-D1b*
in wheat have similar function in repressing anther elongation through over
expression of DELLA proteins, resulting in the phenotype of anther retention or
low AE. This finding partly explained the pleiotropic effects of *Rht-B1b* and
*Rht-D1b* on Type I FHB susceptibility, i.e. the two dwarfing genes lead to low
AE, which in turn caused increased Type I FHB susceptibility. The results have
also implications for hybrid wheat breeding, in which the selection of male
parent, the pollen provider, is very important. A good male parent is expected
to have high AE and high pollen production, and these two traits were reported
to be significantly positively associated with *r* = 0.82 by Joppa et al. and
was later validated by Johnson and Patterson and Atashi-Rang and Lucken. Thus
the utilisation of wild type *Rht* alleles *Rht-B1a* and *Rht-D1a* will improve
both traits. Still more, the tall stature of such lines is favourable for
efficient pollination, since it was suggested that the male parent be taller
than the female parent in hybrid seed production.
# Supporting Information
Financial support by the CGIAR Research Program on Wheat and ‘Seeds of
Discovery’-Sustainable Modernization of Traditional Agriculture project
(MasAgro) is gratefully acknowledged. The first author was financially supported
by a CGIAR scholarship, provided by the Research Council of Norway, through NFR
project 208340/H30—Breeding for Fusarium resistance in wheat. The authors are
grateful to Prof. Åsmund Bjørnstad, Norwegian University of Life Sciences, for
his kind instruction on AE phenotyping, and to Francisco Lopez, Javier Segura
and Nerida Lozano for technical assistance.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** PS ED XH. **Formal analysis:** XH.
**Methodology:** XH PS ED SD SS. **Resources:** ED PS ML SD SS. **Writing –
review & editing:** XH ML PS.
|
# Introduction
Today, agriculture plays an important role in many developing countries,
especially in Southeast Asia. It is estimated that these enterprises account for
a considerable proportion of a country’s gross domestic product and a large
proportion of its employed population. Vietnam and Thailand are the world’s
largest agricultural exporters. Rice is one of the most famous agricultural
products. Along with coffee, cocoa, corn, fruits, vegetables and other
commodities, it contributes a large portion of the local GDP. Palm oil, for
example, is an important agricultural product for Indonesia and Malaysia, both
members of the Association of Southeast Asian Nations. Insects are the biggest
hazard in agricultural production. Crops such as rice and wheat are vulnerable
to pests, which bring huge economic losses to farmers. Therefore, in order to
ensure that ASEAN countries can obtain more food from agriculture every year,
the identification of crop diseases and pests in the process of agricultural
production plays an important role in the early prevention and control of crops
and damage to crops. Manually identifying pests in large-scale farming is a
time-consuming and costly undertaking. Now, with the spread of high-quality
image capture devices and advances in pattern recognition by machine learning,
image-based automatic pest recognition systems promise to reduce human costs and
perform the task more efficiently. When classifying insects, it is difficult to
extract effective features. There are many kinds and forms of insects, which
bring great difficulty to their classification and recognition. In recent years,
artificial features (GIST, HOG, SIFT, SURF, etc.) have been thoroughly studied.
However, the artificial characteristics lack the representation of large-scale
morphological changes of multiple objects. At the same time, the deep learning
based agroforestry data processing technology also provides a new way for
researchers with strong generalization performance, and effectively avoids over-
reliance on artificial features. In recent years, convolutional neural network,
as an effective classification method, has been regarded as an effective
classification method because it can automatically extract useful features from
images without human guidance. Moreover, it performs well in recognizing complex
features and different objects, and has high generalization performance. In
addition to the new CNN architecture, Such as Alexnet, DenseNets, EfficientNets,
GoogleNets, MobileNets, NasNets, ResidualNet-works(ResNets), SqueezeNet,
eometric Group Networks(VGG), etc., are all hot spots in deep learning research.
They have different advantages, for example Alexnet can take image
classification tasks to new levels; EfficientNets enable the integration of
multi-tier networks. GoogleNets achieves great success in the image
classification task; MobileNets can recognize small objects; NasNets can realize
image classification and image retrieval. ResidualNet-works(ResNets) enables
end-to-end prediction models; SqueezeNet can implement multitasking learning;
Visual Geometric Group Networks(VGG) enable object recognition in a number of
different areas. Their appearance not only brings new changes to the field of
deep learning, but also provides new ideas for solving more problems.
The proposed fine-grained mode of simulation attention mechanism enables
efficient reuse to provide a new entry point for solving a certain problem and
greatly reduces the requirement for massive computing resources. This project is
based on the existing PlantVillage database and adopts the network framework of
Alexnet and GoogleNets to improve the accuracy and efficiency of vegetation pest
identification methods. In addition, the technique can better handle higher-
dimensional data and can more efficiently leverage correlations between data. In
recent years, deep neural networks have played an increasingly important role in
the classification of vegetation pests in some crops, For example, apple,
cassava, corn, cucumber, grape, corn, mango, rice, millet, guava and so on,
which benefit from their high recognition accuracy and strong robustness.
Disease identification and classification can be carried out effectively.
However, current methods are mostly focused on depth and complexity, rather than
learning from traditional machine learning methods to improve detection
accuracy. Therefore, it is of great significance to further study the
application of deep neural network in crop vegetation insect classification.Cnn-
based features are widely used to classify insects in the ImageNet Large Visual
Recognition Competition (ILSVRC). WU and colleagues have demonstrated that CNN-
based features are more efficient than hand-drawn ones in this work. Secondly,
the developmental process of metamorphosis includes egg, larva, pupa, adult and
so on. Also, there are strong similarities between the two species. For each
category, efficient algorithms need to capture features that express a large
number of morphologic variations. So far, there has been no research on insect
identification. In order to solve this problem in the classification of bird
species or insect models, a fine-grained image classification algorithm is
adopted in this paper. Fine-grained image classification is to extract
distinguishable features from the information area of objects and classify them
in the form of vectors.
Considering the influence of geographical environment and changeable weather on
image information, the existing mainstream image segmentation methods are not
applicable. Considering the main moving position of the target and the safety
protection area of the track, combined with the actual background, this paper
proposes an optimization algorithm based on the fusion of recursive attention
convolutional neural network and adaptive particle swarm optimization. For the
information loss caused by traditional convolution in the process of image
classification and region sampling, attention learning is used to recursively
operate under multi-scale, and the adaptive particle swarm optimization
algorithm is used to synthesize the feature information of different scales, and
continuously recursively generate regional attention from rough to fine, so as
to realize the localization and detection optimization of the target region.
Specifically, the attention module is used to plan the target area of the image,
considering the information loss generated at each scale in the process, and
introducing it into the cyclic convolution, so that it can more closely
aggregate the convolution information before and after, improve the target
segmentation performance of the network and reduce the amount of calculation.
Attention every scales module division are on a level area location and the
influence of information loss, to ensure that the final output is approaching
the target location information of the image. In the whole cyclic convolution
process, the above output results are processed through five pooling layers to
obtain a number of attention maps that feedback the clustering correlation from
different scales. Then the adaptive particle swarm optimization algorithm is
introduced for weight ratio, and finally the Softmax function is used to
identify and classify vegetation diseases and pests.
In this study, the superiority of the proposed optimization method in the
detection of vegetation pests and diseases is verified. Based on the traditional
recursive attention convolutional neural network, an accurate identification
method is proposed to gather the convolution information before and after, so as
to perfectly segment the target from the background, and a high performance test
is achieved in the dataset. In this paper, the main contribution of the summary
is as follows:
1. First, we apply the CNN model with attention mechanism to create a
feature extraction program focusing on insects. Since images of insects on
crops often contain complex backgrounds of leaves, dust, and branches, the
mechanism of attention is crucial.
2. Secondly, this project intends to use multi-scale convolutional neural
network to capture insects of different sizes.
3. Third, we propose a fine-grained image classification algorithm based on
multi-scale learning to solve the problem of high inter-class similarity.
4. Finally, we will adopt the "soft voting" method to integrate the above
models to further improve the performance of the system.
The rest of the article is arranged this way: In the related work section, we
will explore the literature that is currently available to substantiate our
motives. The experimental process section describes our proposed method in
detail, and the results section gives some conclusions which show the
correctness of the method we have introduced. In the conclusions section, we
summarize the shortcomings of this paper and make suggestions for future
researchers.
# Related work
In recent years, in agricultural production, a large number of visual research
work is through a certain degree of training to solve the classification
problem. In the field of insect classification, Cheng et al. has proposed a new
method of crop feature extraction based on deep residual network. In the complex
scene, the recognition accuracy of 10 kinds of insects is 98.67%, which is
better than the conventional deep learning algorithm. Liu et al. proposed a new
method, that is, using the obvious feature extraction algorithm to determine the
object of the pest, and using the deep convolutional neural network to classify
the pest. The test results show that this technique can be performed with an
average accuracy of 0.951 for the calculation (" mAP "). Wang et al. adopted a
deep convolutional neural network (Dependency Networks) based on crop pest
images. They compared two alternative deep neural
networks,Lenet-5,Alexnet,convolutional cores, and the number of alternative
cores. The difference of test results has great influence on classification
accuracy. studied the classification of crop pests and analyzed their
performance. At the same time, several pre-learning deep learning systems
(ResNet, GooleNet, VGG-Net) were also studied. Experiments show that the
proposed method is much improved compared with other pre-training methods. In,
the author uses DC-GAN to generate enhanced images for training. Another method
described in is feature extraction of CNN based on prototype network, and
Euclidean operation is carried out on it. This architecture uses triples to set
up loss functions. Another recent study uses FSL to model small sample data. In,
the author trained CNN to extract general plant leaf features, and combined
Siamese network with triplet loss for classification calculation. In, two
authors tested their data set using PlantVillage. Currently, there is only one
ideal image of vegetation with distinct background, single leaf, unshaded and
continuous light in the existing FSL data set. This method includes two core
contents: 1) Embedding based on generalized samples; 2) Calculation based on the
distance between the sample and the query sample. In many work-learning postures
embedded, simple classifiers such as nearest neighbor method and linear
classifier are used for further classification. In, the author adopts the
nearest neighbor method. MetaoptNet adopted a Linear Sequencer SiamianI network
uses a shared feature extractor and uses the shortest distance between the
queried sample and the truth value for classification. Wu et al. proposed a new
insect-based large-scale reference dataset (IP102). The database contains more
than 75,000 categories, including 19,000 tagged target detection images. In
IP102, it was tested on the basis of manual (GIST, SIFT, SURF) and CNN (ResNet,
GooleNet, VGG-Net) based functions. Ren proposed a new method of interlayer
features of residual data based on residual information, namely, to establish a
residual network based on the interlayer features of residual data. Tests on the
previous version of IP102 showed improved performance. Liu et al. also proposed
a new block-based multi-branch fusion residual network (Dmf-ResNet) to learn
multi-scale representation. The basic residue is bonded to the bottle and the
residue is pressed into the residue so that the residue forms a residue of
multiple branches. The output of these branches can be linked to new modules to
achieve adaptive recalibration of the response so that it can be simulated. A
multi-branch fusion residual net method based on deep learning was proposed and
applied to classify pests.
However, there are great similarities and differences between multiple species.
Existing research algorithms are aimed at each category and need to capture
features that can express a large number of morphologies. So far, there has been
no research on insect identification. In order to solve this problem in the
classification of bird species or insect models, a fine-grained image
classification algorithm is adopted in this paper. Fine-grained image
classification is to extract distinguishable features from the information area
of objects and classify them in the form of vectors.
# Experimental process
## A. Circular attention convolutional network
The basic convolutional neural network performs convolution processing on the
target image with the help of convolution kernels of different scales, and
extracts various feature information including edges and textures, which
provides help for subsequent information analysis and target recognition. Its
basic structures include input layer, volume at the grass-roots level, pooling,
the whole connection layer and output layer. In the convolution operation, the
appropriate convolution kernel specification and the number of steps are
selected to weighted sum the pixels, and the corresponding feature information
is obtained. Then after pooling layer zone, processing, data dimension
reduction, prevent over fitting phenomenon. After repeated volume base layer and
pooling layer, image information was continuously simplified, and finally
entered the fully connected layer to determine the results.
On this basis, the introduction of attention mechanism formation of recursive
convolution neural network. The mechanism of attention stems from the study of
human vision. In cognitive science, due to the bottleneck of information
processing, humans will selectively focus on some information while ignoring
other information. The mechanism is often referred to as attention mechanism. In
neural networks, the attention module is usually an additional neural network
that can hard select some parts of the input, or assign different weights to
different parts of the input. Through the repeated training of the neural
network, the weight features are strengthened, so that the computer can identify
the area that needs to be focused on in each image, so as to form attention.
The proposed structure mainly includes three levels. The network structure of
the three levels is the same but the parameter information is not related to
each other. Each of these levels contain classification module (VGG) and
regional sampling module (APN). Classification module of input image feature
extraction and classification of regional sampling module based on attention to
extract the characteristics of information area, and as the next level of input;
Reciprocating operation under different level results output. When training
data, it is a weakly supervised behavior that relies on information labels for
classification and judgment, which consumes a lot of time and energy. The
framework of attention region determination in the region sampling module is
single, which is not suitable for processing all kinds of multi-shape feature
information. It will cause the loss of image information during classification
and region sampling, which will affect the classification and sampling of the
next level. Based on this, this paper proposes an optimization algorithm based
on the fusion of recurrent attention convolutional neural network and adaptive
particle swarm optimization.
In, a unified preprocessing operation is performed on the input image, and all
the pictures of the training set and the test set are resized to the scale of
224×224. In order to make the classification information more accurate and
reduce the information loss, the optimized model replaced the original
classification module with the classification structure of multivariate
comprehensive evaluation on the basis of maintaining the original three-layer
network structure and regional sampling module. Take three-scale network
structure as an example: the original input image (SCALE1) is used as the input
to participate in the convolution operation of the next layer network structure
(SCALE2) through one-scale image classification and feature information
extraction. Reciprocating cycle three times, finally get output the results of
three different scales. The specific results are shown in :
In, the input image is continuously classified and sampled, and the fine-grained
information of the image is constantly refined. Where P<sub>t</sub> is the
output result after the pooling layer processing of the convolutional model. N
is the sampling of attention area according to the extracted feature
information, which is used as the input of classification and sampling at the
next level. Y<sup>(m)</sup> is the classification label of the output result at
the MTH layer; $P_{t}^{(m)}$ is the probability that the classification label of
the m-th layer is accurate; L<sub>cls</sub> is the loss of the classification
module; L<sub>rank</sub> is the loss of the region sampling module.
## B. Target segmentation
The core operation of machine vision is to realize the directional segmentation
of the target image, and the fully convolutional neural network is the first
research paper that uses convolution calculation and multi-level image
segmentation. Its completely made up of multiple volumes base, there is no
connection layer to implement the mapping of the input image segmentation for
different specifications. Moreover, researchers use a leap-forward structure
when constructing the network, so that the network can obtain high-level and
low-level image features to enrich the feature information of the target image,
and many famous network structures are involved. However, full convolutional
neural network also has certain defects. It cannot closely connect feature
regions at different scales and limit its performance. On this basis, the
relevant achievements of subsequent development are constantly exploring richer
information extraction and aggregation.
The size and specification of the convolution kernel determine the range of the
received information domain. Richer information requires a larger acceptance
range, but it also causes an increase in computational cost and has a negative
impact on the timeliness of the network structure. The convolution kernel
specification used in global cyclic convolution effectively saves the
computational cost and the number of parameters. On the premise of not
increasing the amount of calculation and the number of parameters, the extended
convolution kernel can receive a wider range of information domain. Extended
convolution introduces the expansion coefficient into the initial convolution
kernel to determine the distance parameter between the weights in the
convolution kernel. Similar methods are used in subsequent related works.
The traditional encoder-decoder structure is a common method in image
segmentation. The input image is converted into a probability map of pixel
categories by using the encoder-decoder structure and the connection layer,
which can realize the information fusion of the front and back background at
different scales. Learning deconvolution network is the first image cutting
using coding-decoder and achieves high performance test without using external
data. SegNet is also a network structure using encoder-decoder, and it proposes
an innovative method of upsampling to achieve a network structure with a smaller
number of parameters under the same performance. U-net is widely used in the
field of medicine, and many articles in this field are further based on it. In
addition, the multi-level pyramid network structure is common used methods,
characteristics of the pyramid network structure in the process of target
detection has achieved good performance. In image segmentation, the pyramid
scene parsing network extracts feature information through ResNet, and then
inputs the feature information into the pyramid pooling module to process
feature maps of different scales and perform fusion sampling operations.
Traditional RNN is often used to solve natural language processing methods, but
there are also papers that use RNN to realize the segmentation operation of
image objects. With the rapid development of GAN, relevant researchers have
realized various machine vision tasks, including image segmentation. Other Angle
image segmentation methods include the DecoupleSegNets decouple the information
feature and divide it into the main part and the edge part, and realize the
optimization of the main part and the edge feature by the method of display
modeling. SNE-RoadSeg use a surface normals estimator, from the depth of dense
information to calculate the surface normals feature space partition.
The classification module of the traditional model usually uses the output
result P<sub>5</sub> of the fifth pooling layer to calculate the loss function
and determine the classification label. However, the image feature information
contained in P<sub>5</sub> is lost due to the change of the size of the sampling
module area after multi-layer convolution. Therefore, the comprehensive
multivariate algorithm is introduced on the basis of the VGG module, so that the
network structure can select the appropriate convolution kernel for
classification, and reduce the loss of feature information caused by the
classification and sampling process. The specific results are shown in :
## C. Attention model
Recently, researchers have begun to conduct in-depth research on the attention
mechanism, and the proposal of attention module has been widely used in various
fields of machine vision. Common attention modules include channel attention and
spatial attention, in which channel attention enhances the network structure by
strengthening the feature relation between different channels, and spatial
attention enhances the network structure by extracting the feature information
from a single pixel to a local area. GANet constructed a spatial gating
attention module to realize the adaptive evaluation of multi-scale feature
interaction mechanism. FocusNet the encoding—decoder module, the attention of
the parallel branch association and generate a gradient flow segmentation mask
to achieve optimization. The multi-modal fusion network uses multi-channel
independent coding to extract feature information respectively, and designs an
attention mechanism fusion module to fuse these information. GSANet using
selective attention extraction under different spatial location and different
levels of information of pixels. Researchers proposed a bilateral attention
module, in which the foreground and background are respectively focused in
different ways to obtain information. There is also a parallel reverse attention
module to solve the polyp segmentation operation of colonoscopy images, and the
reverse attention module is used to realize the division of target area and
boundary area. Staff based on attention mechanism itself, by calculating the
objective function space build focus area of each feature information.
When determining the area to be sampled on the input image, the upper left point
of the image is first assumed to be the origin of the coordinate, and the right
and down are set as the positive direction of the X axis and Y axis,
respectively. The upper left of the area to be sampled is t<sub>tl</sub> and the
lower right is t<sub>br</sub>, and the specific Formulas and as follows:
$$t_{x({tl})} = t_{x} - t_{l},\mspace{22mu} t_{y({tl})} = t_{y} - t_{l}$$
$$t_{x({br})} = t_{x} + t_{l},\mspace{22mu} t_{y({br})} = t_{y} + t_{l}$$
After determining the area to be sampled, the element multiplication method is
used to cut and enlarge the operation, where ⊙ represents the element
multiplication, X<sup>att</sup> is the area to be sampled, and M represents
attention recurrence and the specific Formulas and as follows: $$X^{att} = X
\odot M\left( {t_{x},t_{y},t_{l}} \right)$$ $$M = \left\lbrack {H\left( {x -
t_{x({tl})}} \right) - H\left( {x - t_{x({br})}} \right)} \right\rbrack \bullet
\mspace{9mu}\left\lbrack {H\left( {y - t_{y({tl})}} \right) - H\left( {y -
t_{y({br})}} \right)} \right\rbrack$$
In order to reduce the information loss generated in the classification module
and sampling module, the derivative mapping is used to reflect the direction of
attention recurrence, and the darker the color is, the more consistent it is
with the direction of attention recurrence. t<sub>x</sub> for example, which
M′(t<sub>x</sub>) is the focus of recursive t<sub>x</sub> derivative, piecewise
function is as follows: $$M^{\prime}\ \left( t_{x} \right) = \left\{
\begin{array}{l} \left. < 0\mspace{22mu} x\rightarrow t_{x({tl})} \right. \\
\left. > 0\mspace{22mu} x\rightarrow t_{x({br})} \right. \\ {= 0\mspace{22mu}
otherwise} \\ \end{array} \right.$$
Considering that the mapping result of the attention derivative is a negative
transformation from the image boundary to the interior, the
$L_{rank}^{\prime}\left( t_{x} \right)$ result is positive, so t<sub>x</sub>
becomes smaller in the recursion of the lower structure, which represents the
direction of human attention. The specific results are shown in :
Based on the attention recursion network model, the label classification within
the level and the region sampling between the levels will cause information
loss, in which the loss function is defined as follows: $$L = {\sum_{m =
1}^{3}{\left\{ {L_{cls}\left( {Y^{(m)},Y^{*}} \right)} \right\} +}}{\sum_{m =
1}^{2}\left\{ {L_{rank}\left( {P_{t}^{(m)},P_{t}^{({m + 1})}} \right)}
\right\}}$$
Particle swarm optimization(PSO) is a stochastic optimization algorithm, which
simulates the behavior of birds flying and foraging, and makes the group achieve
the optimal purpose through the collaboration between the flocks of birds. It is
suitable for solving complex nonlinear optimization problems. The particle swarm
optimization algorithm solves the optimization problem, and a single particle
represents a feasible solution. The fitness of the particle is calculated
according to the optimization objective function, and all individuals in the
population are constantly moving to seek the optimal solution according to
certain rules. The particle in the particle swarm moves according to the
following rules and: $$v_{i}^{(t)} = \omega(t)v_{i}^{({t - 1})} +
Mr_{1}\left\lbrack {x_{i}^{best} - x_{i}^{({t - 1})}} \right\rbrack +
Lr_{2}\left\lbrack {x^{best} - x_{i}^{({t - 1})}} \right\rbrack$$ $$x_{i}^{(t)}
= x_{i}^{({t - 1})} + v_{i}^{t}$$
Where, t is the time step of particle movement $\left( {t > 0} \right);\
x_{i}^{(t)}$ is the position vector of the particle at time step t,
$x_{i}^{best}$ is the historical optimal position vector of the particle in the
moving process, $x_{i}^{best}$ is the historical optimal position vector of the
whole population, $v_{i}^{(t)}$ is the velocity vector of the particle at time
step t. M and L correspond to the attention recurrence function and information
loss function, respectively. r<sub>1</sub> and r<sub>2</sub> are random numbers
with interval \[0.1\]; ω(t) for adaptive inertia weight coefficient, according
to the Formula is as follows: $$\omega(t) = \left( {\omega_{max} - \omega_{min}}
\right)P_{s}(t) + \omega_{min}$$
Where ω<sub>max</sub> and ω<sub>min</sub> are the maximum and minimum values of
the inertia weight, respectively, and generally the initial values are 1.0 and
0.3. P<sub>s</sub>(t) is the proportion of particles that move to a better
position, and f<sub>i</sub>(x) is the fitness value of the particle at time step
t, which is calculated according to the following functional Formulas and:
$$f_{i}(x) = \frac{1}{n}{\sum_{i = 1}^{n}{P_{s}(t)}}$$ $$f(I) =
\omega_{1}^{c}*f_{1} + \omega_{2}^{c}*f_{2} + \cdots\omega_{5}^{c}*f_{5}$$
In the convolution model, there are a total of five pooling layers to obtain
five classification prediction results P<sub>t</sub>, in which the adaptive
weights are calculated according to the recursive function of attention and the
information loss function of each level, and then the target region is divided
according to the five weight ratios corresponding to their respective self-
fitness. Finally, the classification results of the input image are predicted by
multi-level VGG-PSO labels. The classification label Y<sup>(m)</sup> of each
layer is put into the fully connected layer and Softmax is used to obtain the
final classification result. The specific process of weighted heat map is shown
in :
## D. Data preprocessing and experimental equipment
The experiment was carried out in Windows10 environment based on Tensorflow deep
learning framework. Computer configuration: Inter Core i7, 1080Ti graphics card.
In learning, we use a classification based on cross entropy. Using Adam
algorithm, the initial learning rate can be obtained as 5x10−5, with 16 training
batches and 40–45 training cycles. When the damping is 0.96, the learning rate
decreases exponentially. If, after 20 cycles, it is confirmed that the
performance of the set has not improved, the training phase is over. To solve
the overfitting problem, we use dropout technology with a dropate value of 0.45.
Data sets including experiments are divided into training sets, verification
sets and test sets in a ratio of 6:3:1. The details are shown in below:
The photo gallery contains 15,905 images in 10 categories. Among them, there
were 1,888 palatine bugs, 973 palatine bugs, 1,759 wheat aphids, 715 noctuidae,
1,559 Oriental mole mantis, 1,269 rice planthopper, 363 rice locust bugs, 4,526
diasteridae bugs, 1,528 beet leucophora borer, and 1,325 palatine bugs. The
image of the original data set is 224x224. Details are shown in below:
In addition, we will add samples for each type and improve with a set of
enhancement features including: randomly rotating different types of samples,
mirroring (horizontal, vertical), varying brightness, etc. Details are shown in
below:
By optimizing multi-level attention region extraction, the extracted region can
not only contain the overall target structure information, but also save the
local location information. It can also be clearly felt that when the input
image is extracted at the second and third levels, the difference in the
information it contains is more obvious, and the extracted attention area is
similar to that of humans.Sense of direction is consistent, which help the exact
granularity classification. As shown in below:
When considering the balance of information loss and clipping elements among
multiple convolution layers, an adaptive optimization algorithm is needed to
select the optimal solution for calculation. Genetic algorithm (GA), ant colony
algorithm (ACO), particle swarm optimization (PSO), artificial bee colony
algorithm (ABC), cuckoo search (CS) and so on are all based on population
optimization algorithms. The probabilistic search algorithm of optimization step
is implemented by iterative method. The experimental heat map obtained by the
above five optimization algorithms combined with the proposed algorithm is shown
in below:
As can be seen from, the temperature curve of insulator identified by particle
swarm optimization algorithm coincides with the actual target detection point,
so particle swarm optimization algorithm is adopted in this paper. Particle
swarm optimization (PSO) is a random optimization method that simulates the
flight and foraging of birds. This method is suitable for solving complex
nonlinear optimization problems.
## E. Evaluation index
This metric consists of macromean precision (MPre), macromean recall (MRec),
macromean F1-composition score (MF1), accuracy (Acc), and geometric mean (GM).To
be equally important, we calculated the recall rates for each category and then
averaged them to obtain the MRec shown below and: $${Rec}_{c} =
\frac{{TP}_{c}}{{TP}_{c} + {FN}_{c}}$$ $${MRec}_{c} = \frac{{\sum_{c =
1}^{C}{Rec}}_{c}}{C}$$
C represents the number of a category. TP<sub>c</sub> and FN<sub>c</sub> denote
pseudo-negative and pseudo-negative values.Also, we will carry out calculations.
Pre<sub>c</sub> and MPre<sub>c</sub> look like this and: $${Pre}_{c} =
\frac{{TP}_{c}}{{TP}_{c} + {FP}_{c}}$$ $${MPre}_{c} = \frac{{\sum_{c =
1}^{C}{Pre}}_{c}}{C}$$
Class C of FPc is a false positive. MF1 is the average of MPre and MRec, such as
follow: $$MF1 = 2\frac{MPre \bullet MRec}{MPre + MRec}$$
Acc is computed by the true positive value among all classes as follow : $$Acc =
\frac{TP}{N}$$
Where N is the number of samples. GM is calculated according to the sensitivity
(S<sub>c</sub>). S<sub>c</sub> and GM are as follows and : $$S_{c} =
\frac{{TP}_{c}}{{TP}_{c} + {FN}_{c}}$$ $$GM = {\prod_{c =
1}^{C}\sqrt[c]{S_{c}}}$$
If only one S<sub>c</sub> is 0, then GM is 0.To avoid this problem, we replaced
the S<sub>c</sub> with 0.001.
# Results
It can be seen from the above figure that with the multi-level recurrent
convolution operation, the deeper the network structure is, the stronger the
ability to extract the feature model is. The changes of the recursive attention
function and information loss function under different levels are shown in :
In order to make the experimental effect more obvious, considering the results
of target detection and recognition between different models, the classical
model is introduced to compare the experimental results between different
algorithms and verify the performance of the algorithm optimization algorithm.
The specific results are shown in and :
And the detection results between different scales of the optimal model, the
three layers of scales are tested by permutation and combination, and the
relevant experimental results are shown in :
As can be seen from the above table, the target detection accuracy under
different scales is different. The accuracy of single-scale first layer, second
layer and third layer is 80.99%,83.02% and 80.62% respectively, which is
6.02%,3.86% and 6.63% respectively compared with the best 86.35% obtained by the
complete three-layer scale (scale 1+2+3) connected network model. Although there
is a 0.14% difference between MSSN(scale 2+3) and MSSN(scale 1+2+3) in the
detection accuracy, MSSN(scale 1+2+3) has a macro mean accuracy (MPre) of 91.02%
in addition to ACC index. The macro average recall rate (MRec) was 85.56%, the
macro average F1-score (MF1) was 89.35% and the geometric average (GM) was
92.23%. In terms of the overall performance evaluation index, MSSN(scale 1+2+3)
had a better effect. At the same time, the performance of different algorithms
is compared in the Pest dataset, as shown in :
It can be seen from that when other benchmark networks are used for comparison
experiments, the indexes of 4.14FLOP/s, mAP72.3% and 26.5fps are the best, but
it also results in the huge volume of the overall training network of 32.8M and
the multifold increase of training time to 19.2hours.The results of agricultural
pest detection on the data set achieved by the innovative algorithm proposed in
this paper are shown in below:
# Conclusions
This paper proposes a recursive convolution neural network and adaptive particle
swarm optimization algorithm of fusion, in view of the traditional convolution
in the image classification and regional information loss during the process of
sampling, through the study of attention under the multiscale recursive
operations, with the help of adaptive particle swarm optimization algorithm
integrated the characteristic information of different scales, from coarse to
fine is recursive generation regional focus, Optimized by testing the
positioning of the target area. The experimental results showed that the
accuracy rate of the The test set reached 86.35%, which improved the accuracy of
the detection of vegetation disease and insect pests entering the limited area.
However, compared with other basic models, this method not only improves the
recognition accuracy, but also reduces the memory capacity and computing speed
of the model. Considering the balance between recognition accuracy and system
speed is one of the future research directions of the author. In the future,
this paper will further explore the diagnosis of plant diseases under the
influence of various environmental factors such as image pollution, information
defects and blurring, so as to ensure the safety of agricultural production.
# Supplement
In the supplementary material, in addition to the pest identification study
involved in in the main text, the detection of agricultural pests can still be
achieved in the case of different sizes, body types and appearances of pests,
demonstrating the generalization ability of the test method, as shown in detail
in :
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
The discovery and design of effective drugs for infectious and chronic
biological diseases, like cancer and cerebral malaria, require a deep
understanding of behaviorial and structural characteristics of underlying
biological entities (e.g., cells, molecules and enzymes). Traditional
approaches, which rely on verbal and personal intuitions without concrete
logical explanations of biological phenomena, often fail to provide a complete
understanding of the behavior of such diseases, mainly due to the complex
interactions of molecules connected through a chain of reactions. *Systems
biology* overcomes these limitations by integrating mathematical modeling and
high-speed computing machines in the understanding of biological processes and
thus provides the ability to predict the effect of potential drugs for the
treatment of chronic diseases. System biology is widely used to model the
biological processes as pathways or networks. Some of the examples are signaling
pathways and protein-protein interaction networks. These biological networks
such as gene regulatory networks (GRNs) or biological regulatory networks
(BRNs), are analysed using the principles of molecular biology. This analysis,
in turn, plays an important role for the investigation of the treatment of
various human infectious diseases as well as future drug design targets. For
example, the BRNs analysis has been recently used for the prediction of
treatment decisions for sepsis patients.
Traditionally, biologists analyze biological organisms (or different diseases)
using wet-lab experiments. These experiments cannot provide reliable analysis
due to their inability to accurately characterize the complex biological
processes in an experimental setting. Moreover, the experiments take a long
execution time and often require an expensive experimental setup. One of the
other techniques used for the deduction of molecular reactions is the paper-and-
pencil proof method (e.g. Boolean modeling or kinetic logic). But the manual
proofs in paper-and-pencil proof methods, become quite tedious for large
systems, where several hundred proof steps are required in order to calculate
the unknown parameters, thus prone to human error. Other alternatives for
analyzing system biology problems include computer-based techniques (e.g. Petri
nets and model checking). Petri net is a graph based technique for analyzing
system properties. In model checking, a system is modeled in the form of state-
space or automata and the intended properties of the system are verified in a
model checker by a rigorous state exploration of the system model. Theorem
proving is another formal methods technique that is widely used for the
verification of the physical systems but has been rarely used for analyzing
system biology related problems. In theorem proving, a computer-based
mathematical model of the given system is constructed and then deductive
reasoning is used for the verification of its intended properties. A
prerequisite for conducting the formal analysis of a system is to formalize the
mathematical or logical foundations that are required to model the system in an
appropriate logic.
*Zsyntax* is a recently proposed formal language that supports the modeling of
any biological process and presents an analogy between a biological process and
the logical deduction. It has some pre-defined operators and inference rules
that are used for the logical deductions about a biological process. These
operators and inference rules have been designed in such a way that they are
easily understandable by the biologists, making Zsyntax a biologist-centered
formalism, which is the main strength of this language. However, Zsyntax does
not support specifying the temporal information associated with biological
processes. *Reaction kinetics*, on the other hand, caters for this limitation by
providing the basis to understand the time evolution of molecular populations
involved in a biological network. This approach is based on the set of first-
order ordinary differential equations (ODEs) also called *reaction rate
equations* (RREs). Most of these equations are non-linear in nature and
difficult to analyze but provide very useful insights for prognosis and drug
predictions. Traditionally, the manual paper-and-pencil technique is used to
reason logically about biological processes, which are expressed in Zsyntax.
Similarly, the analysis of RREs is performed by either paper-and-pencil based
proofs or numerical simulation. However, both methods suffer from the inherent
incompleteness of numerical methods and error-proneness of manual proofs. We
believe that these issues cannot be ignored considering the critical nature of
this analysis due to the involvement of human lives. Moreover, biological
experiments based on erroneous parameters, derived by the above-mentioned
approaches may also result in the loss of time and money, due to the slow nature
of wet-lab experiments and the cost associated with the chemicals and
measurement equipment.
In this paper, we propose to develop a formal reasoning support for system
biology to analyze complex biological systems within the sound core of a theorem
prover and thus provide accurate analysis results in this safety-critical
domain. By formal reasoning support, we mean to develop a set of generic
mathematical models and definitions, a process that is usually termed as
formalization, of commonly used notions of system biology using an appropriate
logic and ascertain their properties as formally verified theorems in a theorem
prover, which is a verification tool based on deductive reasoning. These
formalized definitions and formally verified theorems can then in turn be used
to develop formal models of real-world system biology problems and thus verify
their corresponding properties accurately within the sound core of a theorem
prover. The use of logic in modeling and a theorem prover in the verification
leads to the accuracy of the analysis results, which cannot be ascertained by
other computational approaches. In our recent work, we developed a formal
deduction framework for reasoning about molecular reactions by formalizing the
Zsyntax language in the HOL4 theorem prover. In particular, we formalized the
logical operators and inference rules of Zsyntax in higher-order logic. We then
built upon these formal definitions to verify two key behavioral properties of
Zsyntax based molecular pathways. However, it was not possible to reason about
biological models based on reaction kinetics due to the unavailability of the
formal notions of reaction rate equations (a set of coupled differential
equations) in higher-order logic. In order to broaden the horizons of formal
reasoning about system biology, this paper presents a formalization of reaction
kinetics along with the development of formal models of generic biological
pathways without the restriction on the number of molecules and corresponding
interconnections. Furthermore, we formalize the transformation, which is used to
convert biological reactions into a set of coupled differential equations. This
step requires multivariate calculus (e.g., vector derivative, matrices, etc.)
formalization in higher-order logic, which is not available in HOL4 and
therefore we have chosen to leverage upon the rich multivariable libraries of
the HOL Light theorem prover to formalize the above mentioned notions and verify
the reactions kinetics of some generic molecular reactions. To make the
formalization of Zsyntax consistent with the formalization of reaction kinetics
in HOL Light, as part of our current work, we ported all of the HOL4
formalization of Zsyntax to HOL Light. In order to illustrate the usefulness and
effectiveness of our formalization, we present the formal analysis of a
molecular reaction representing the TP53 Phosphorylation, a molecular reaction
of pathway leading to the death of cancer stem cells (CSC) and the analysis of
tumor growth based on the CSC.
# Related work
In the last few decades, various modeling formalisms of computer science have
been widely used in system biology. We briefly outline here the applications of
computational modeling and analysis approaches in system biology, where the main
idea is to transform a biological model into a computer program.
Process algebra (PA) provides an expressive framework to formally specify the
communication and interactions of concurrent processes without ambiguities.
Biological systems can be considered as concurrent processes and thus process
algebra can be used to model biological entities. Some recent work in this area
includes the formalizations of molecular biology based on *K*-Calculus and
*π*-Calculus. The main tools that support PA in biology are sCCP, BioShape and
Bio-PEPA. Even though PA based biological modeling provides sound foundations,
it may be quite difficult and cumbersome for working biologists to understand
these notations.
Rule-based modeling offers a flexible and simple framework to model various
biochemical species in a textual or graphical format. This allows biologists to
perform the quantitative analysis of complex biological systems and predict
important underlying behaviors. Some of the main rule-based modeling tools are
BioNetGen, Kappa and BIOCHAM. These tools are mainly based on rewriting and
model transformation rules along with the integration with model checking tools
and numerical solvers. However, these integrations are usually not checked for
correctness (for example by an independent proof assistant), which may lead to
inconsistencies.
Boolean networks are used to characterize the dynamics of gene-regulatory
networks by limiting the behavior or genes by either a truth state or false
state. Some of the major tools that support the Boolean modeling of biological
systems are BoolNet, BNS and GINsim. The discrete nature of Boolean networks
does not allow us to capture continuous biological evolutions, which are usually
represented by differential equations.
Model checking has shown very promising results in many applications of
molecular biology. Hybrid systems theory extends the state-based discrete
representation of traditional model checking with a continuous dynamics
(described in terms ODEs) in each state. Some of the recently developed tools
that support the hybrid modeling of biological systems are S-TaLiRo, Breach
toolbox and dReach. Recently, Petri nets have been widely used to model
biological networks and some of the important associated tools include Snoopy
and GreatSPN. However, the graph or state based nature of the models in these
methods only allow the description of some specific areas of molecular biology.
Moreover, the model checking technique has an inherent state-space explosion
problem, which makes it only applicable to the biological entities that can
acquire a small set of possible levels and thus limits its scope by restricting
its usage on larger systems.
In a system analysis based on theorem proving, we need to formalize the
mathematical or logical foundations required to model and analyze that system in
an appropriate logic. Several attempts have been made to formalize the
foundations of molecular biology. The first attempt at some basic axiomatization
dates back to 1937. *Zanardo et al.* and *Rizzotti et al.* have also done some
efforts towards the formalization of biology. But all these formalizations are
paper-and-pencil based and have not been utilized to formally reason about
molecular biology problems within a theorem prover. In our recent work, we
developed a formal deduction framework for reasoning about molecular reactions
by formalizing the Zsyntax language in the HOL4 theorem prover. However, a major
limitation of this work is that it cannot cater for the temporal information
associated with biological processes and, hence, does not support modeling the
time evolution of molecular populations involved in a biological network, which
is of a dire need when studying the dynamics of a biological system. *Reaction
kinetics* provide the basis to understand the time evolution of molecular
populations involved in a biological network. To overcome the limitation of the
work presented by *Sohaib et al.*, we provide the formalization of reaction
kinetics in higher-order logic and in turn extend the formal reasoning about
system biology.
# Higher-order-logic theorem proving and HOL Light theorem prover
In this section, we provide a brief introduction to the higher-order-logic
theorem proving and HOL Light theorem prover.
## Higher-order-logic theorem proving
Theorem proving involves the construction of mathematical proofs by a computer
program using axioms and hypothesis. Theorem proving systems (theorem provers)
are widely used for the verification of hardware and software systems and the
formalization (or mathematical modeling) of classical mathematics. For example,
hardware designers can prove different properties of a digital circuit by using
some predicates to model the circuits model. Similarly, a mathematician can
prove the transitivity property for real numbers using the axioms of real number
theory. These mathematical theorems are expressed in logic, which can be a
propositional, first-order or higher-order logic based on the expressibility
requirement.
Based on the decidability or undecidability of the underlying logic, theorem
proving can be done automatically or interactively. Propositional logic is
decidable and thus the sentences expressed in this logic can be automatically
verified using a computer program whereas higher-order logic is undecidable and
thus theorems about sentences, expressed in higher-order logic, have to be
verified by providing user guidance in an interactive manner.
A theorem prover is a software for deductive reasoning in a sound environment.
For example, a theorem prover does not allow us to conclude that “$\frac{x}{x} =
1$” unless it is first proved or assumed that *x* ≠ 0. This is achieved by
defining a precise syntax of the mathematical sentences that can be input in the
software. Moreover, every theorem prover comes with a set of axioms and
inference rules which are the only ways to prove a sentence correct. This purely
deductive aspect provides the guarantee that every sentence proved in the system
is actually true.
### HOL Light theorem prover
HOL Light is an interactive theorem prover used for the constructions of proofs
in higher-order logic. The logic in HOL Light is represented in meta language
(ML), which is a strongly-typed functional programming language. A theorem is a
formalized statement that may be an axiom or could be deduced from already
verified theorems by an inference rule. Soundness is assured as every new
theorem must be verified by applying the basic axioms and primitive inference
rules or any other previously verified theorems/inference rules. A HOL Light
theory is a collection of valid HOL Light types, axioms, constants, definitions
and theorems, and is usually stored as an ML file in computers. Users
interacting with HOL Light can reload a theory and utilize the corresponding
definitions and theorems right away. Various mathematical foundations have been
formalized and stored in HOL Light in the form of theories by the HOL Light
users. HOL Light theories are organized in a hierarchical fashion and child
theories can inherit the types, constants, definitions and theorems of the
parent theories. The HOL Light theorem prover provides an extensive support of
theorems regarding Boolean variables, arithmetics, real numbers, transcendental
functions, lists and multivariate analysis in the form of theories which are
extensively used in our formalization. The proofs in HOL Light are based on the
concept of tactics which break proof goals into simple subgoals. There are many
automatic proof procedures and proof assistants available in HOL Light, which
help the user in concluding a proof more efficiently.
# Proposed framework
The proposed theorem proving based formal reasoning framework for system
biology, depicted in, allows the formal deduction of the complete pathway from
any given time instance and model and analyze the ordinary differential
equations (ODEs) corresponding to a kinetic model for any molecular reaction.
For this purpose, the framework builds upon existing higher-order-logic
formalizations of Lists, Pairs, Vectors, and Calculus.
The two main rectangles in the higher-order logic block present the foundational
formalizations developed to facilitate the formal reasoning about the Zsyntax
based pathway deduction and the reaction kinetics. In order to perform the
Zsyntax based molecular pathway deduction, we first formalize the functions
representing the logical operators and inference rules of Zsyntax in higher-
order logic and verify some supporting theorems from this formalization. This
formalization can then be used along with a list of molecules and a list of
*Empirically Valid Formulae* (EVFs) to formally deduce the pathway for the given
list of molecules and provide the result as a formally verified theorem using
HOL Light. Similarly, we have formalized the flux vectors and stoichiometric
matrices in higher-order-logic. These foundations can be used along with a given
list of species and the rate of the reactions to develop a corresponding ODEs
based kinetic reactions model. The solution to this ODE can then be formally
verified as a theorem by building upon existing formalizations of Calculus
theories.
The distinguishing characteristics of the proposed framework include the usage
of deductive reasoning to derive the deduced pathways and solutions of the
reaction kinetic models. Thus, all theorems are guaranteed to be correct and
explicitly contain all required assumptions.
# Results
## Formalization of Zsyntax
Zsyntax is a formal language which exploits the analogy between biological
processes and logical deduction. Some of its key features are that: 1) it
enables us to represent molecular reactions in a mathematical rigorous way; 2)
it is of heuristic nature, i.e., if the initialization data and the conclusion
of a reaction is known, then it allows us to deduce the missing data based on
the initialization data; and 3) it possesses computer implementable semantics.
Zsyntax has three operators namely *Z-Interaction*, *Z-Conjunction* and
*Z-Conditional* that are used to represents different phenomenon in a biological
process. These are the atomic formulas residing in the core of Zsyntax.
*Z-Interaction (\*)* represents the reaction or interaction of two molecules. In
biological reactions, the Z-interaction operation is not associative. i.e., in a
reaction having three molecules namely A, B and C, the operation (*A* ∗ *B*) ∗
*C* is not equal to *A* ∗ (*B* ∗ *C*). *Z-Conjunction (&)* is used to form the
aggregate of the molecules participating in the biological process. These
molecules can be same or different. Unlike the Z-Interaction operator, the
Z-Conjunction is fully associative. *Z-Conditional (→)* is used to represent a
path from *A* to *B* when condition *C* becomes true, i.e., *A* → *B* if there
is a *C* allowing it. To apply the above-mentioned operators on a biological
process, Zsyntax provides four inference rules that are used for the deduction
of the outcomes of the biological reactions. These inference rules are given in.
Zsyntax also utilizes the EVFs which are the empirical formulas validated in the
lab and are basically the non-logical axioms of molecular biology. A biological
reaction can be mapped and then these above-mentioned Zsyntax operators and
inference rules are used to derive the final outcome of the reaction as shown
in.
We start our formalization of Zsyntax, by formalizing the molecule as a variable
of arbitrary data type (*α*). Z-Interaction is represented by a list of
molecules (*α* *list*), which is a molecular reaction among the elements of the
list. This (*α* list) may contain only a single element or it can have multiple
elements. We model the Z-Conjunction operator as a list of list of molecules
((*α* *list*) *list*), which represents a collection of non-reacting molecules.
Using this data type, we can apply the Z-Conjunction operator between individual
molecules (a list with a single element), or between multiple interacting
molecules (a list with multiple elements). Thus, based on our datatype,
Z-Conjunction is a list of Z-interactions for both of these cases, i.e.,
individual molecules or multiple interacting molecules. So, overall,
Z-conjunction acts as a set of Z-interaction. When a new set of molecules is
generated based on the EVFs available for a reaction, the status of the
molecules is updated using the Z-Conditional operator. We model each EVF as a
pair of data type (*α* *list* \# *α* *list* *list*) where the first element of
the pair is a list of the molecules represented by data type (*α* *list*) and
are actually the reacting molecules, whereas, the second element is a list of
list of molecules ((*α* *list*) *list*), which represents a set of molecules
that are obtained as a result of the reaction between the molecules of the first
element of the pair and thus act as a set of Z-Interactions. A collection of
EVFs is formalized using the data type ((*α* *list* \# *α* *list* *list*)
*list*), which is a list of EVFs.
Next, we formalize the inference rules using higher-order logic. The inference
rule named elimination of the Z-Conditional (→E) is equivalent to the Modus
Ponens (the elimination of implication rule) law of propositional logic.
Similarly, we can infer introduction of Z-Conditional (→I) rule from the
existing rules of the propositional logic present in a theorem prover. Thus,
both of these rules can be handled by the simplification and rewriting rules of
the theorem prover and we do not need to define new rules for handling these
inference rules. To check the presence of a particular molecule in an aggregate
of some inferred molecules, the elimination of the Z-Conjunction (& E) rule is
used. We apply it at the end of the biological reaction to check whether the
product of the reaction is the desired molecule or not. We formalized this rule
by a function (: `zsyn_conjun_elimin`), which accepts a list `l` and an element
`x` and checks if `x` is present in this list. If the condition is true, it
returns the given element `x` as a single element of that list `l`. Otherwise,
it returns the list `l` as is, as shown in.
The Z-Interaction and the introduction of Z-Conjunction (& I) rule jointly
enable us to perform a reaction between different molecules during the
experiment. This rule is basically the append operation of lists, based on the
above data types defined in our formalization. The function `zsyn_conjun_intro`,
given in, represents this particular rule. It takes a list `l` and two of its
elements `x` and `y`, and appends the list of these two elements on its head as
shown in.
According to laws of stoichiometry, we have to delete the initial reacting
molecules from the main list, for which the Z-Conjunction operator is applied.
Our formalization of this behavior is represented by the function `zsyn_delet`,
given in and depicted in. The function `zsyn_delet` accepts a list `l` and two
numbers `x` and `y` and deletes the *x*<sup>*th*</sup> and *y*<sup>*th*</sup>
elements of the given list `l`. The function checks if the index *x* is greater
than the index *y*, i.e., *x* \> *y*. If the condition is true, then it deletes
the *x*<sup>*th*</sup> element first and then the *y*<sup>*th*</sup> element.
Similarly, if the condition *x* \> *y* is false, then it deletes the
*y*<sup>*th*</sup> element first and then the *x*<sup>*th*</sup> element. In
this deletion process, to make sure that the deletion of first element will not
affect the index of the other element that has to be deleted, we delete the
element present at the higher index of list before the deletion of the lower
indexed element.
We aim to build a framework that takes the initial molecules of a biological
experiment along with the possible EVFs and enables us to deduce its
corresponding final outcomes. Towards this, we first write a function
`zsyn_EVF`, given in and depicted in, that takes a list of initial molecules and
compares its particular combination with the corresponding EVFs and if a match
is found then it adds the newly resulted molecule to initial list after deleting
the instance that have already been consumed. The function `zsyn_EVF` takes a
list of molecules `l` and a list of EVFs `e` and compares the head element of
the list `l` to all of the elements of the list `e`. Upon finding no match, this
function returns a pair having first element as false (`F`), which acts as a
flag and indicates that there is no match between any of the EVFs and the
corresponding molecule, whereas the second element of the pair is the tail of
the corresponding list `l` of the initial molecules. If a match is found, then
the function will return a pair with its first element as a true (`T`), which
indicates the confirmation of the match that have been found, and the second
element of the pair is the modified list `l`, whose head is removed, and the
second element of the corresponding EVF pair is added at the end of the list and
the matched elements are deleted as these have already been consumed.
Next, we have to call the function `zsyn_EVF` recursively, for the deduction of
the final outcome of the experiment and for each of the recursive case, we place
each of the possible combinations of the given molecules (elements at indices
`x` and `y` of list `l`) at the head of `l` one by one. This whole process can
be done using functions `zsyn_recurs1` and `zsyn_recurs2`, given in. In the
function `zsyn_recurs1`, we first place the combination of molecules indexed by
variables `x` and `y` at the top of the list `l` using the introduction of
Z-Conjunction rule. Then, this modified list `l` is passed to the function
`zsyn_EVF`, which is recursively called by the function `zsyn_recurs1`.
Moreover, we instantiate the variable `p` of the function `zsyn_EVF` with the
length of the EVF list `(LENGTH e - 1)` so that every new combination of the
list `l` is compared with all the elements of the list of EVFs `e`. The function
`zsyn_recurs1` terminates upon finding a match in the list of EVFs and returns
true (`T`) as the first element of its output pair, which acts as a flag for the
status of this match. The second function `zsyn_recurs2` checks, if a match in
the list of EVFs `e` is found (if the flag returns true (`T`)) then it
terminates and returns the output list of the function `zsyn_recurs1`.
Otherwise, it recursively checks for the match with all of the remaining values
of the variable `x`. In the case of a match, these two functions `zsyn_recurs1`
and `zsyn_recurs2` have to be called all over again with the new updated list.
This iterative process continues until no match is found in the execution of
these functions. This overall behaviour can be expressed in HOL Light by the
recursive function `zsyn_deduct_recurs`, given in. In order to guarantee the
correct operation of deduction, we instantiate the variable of recursion (`q`)
with a value that is greater than the total number of EVFs so that the
application of none of the EVF is missed. Similarly, in order to ensure that all
the combinations of the list `l` are checked against the entries of the EVF list
`e`, the value `LENGTH l - 1` is assigned to both of the variables `x` and `y`.
Thus, the final deduction function for Zsyntax can be modeled as the function
`zsyn_deduct`, given in. The function `zsyn_deduct` accepts the initial list of
molecules `l` and the list of valid EVFs `e` and returns a list of final
outcomes of the experiment under the given conditions. Next, in order to check,
if the desired molecule is present in this list (the output of the function
`zsyn_deduct`), we apply the elimination of the Z-Conjunction rule presented as
function `zsyn_conjun_elimin`, given in. More detail about the behavior of all
of these functions can be found in our proof script.
These formal definitions enable us to check recursively all of the possible
combinations of the molecules, present in the initial list `l`, against each of
the first element of the list of EVFs `e`. Upon finding a match, the reacting
molecules are replaced by their outcome in the initial list of molecules `l` by
applying the corresponding EVF. This process is repeated on the current updated
list of molecules until there are no further molecules reacting with each other.
The list `l` at this point contains the post-reaction molecules. Finally, the
elimination of the Z-Conjunction rule `zsyn_conjun_elimin`, given in, is applied
to obtain the desired outcome of the given biological experiment.
In order to prove the correctness of the formal definitions presented above, we
verify a couple of key properties of Zsyntax involving operators depicting the
vital behaviour of the molecular reactions. The first verified property captures
the scenario when there is no reacting molecule present in the initial list of
the experiment. As a result of this scenario, the post-experiment molecules are
the same as the pre-experiment molecules. The second property deals with the
case when there is only one set of reacting molecules in the given initial list
of molecules and in this scenario we verify that after the execution of the
Zsyntax based experiment, the list of post-experiment molecules contains the
products of the reacting molecules minus its reactant along with the remaining
non-reacting molecules provided at the beginning of the experiment. We formally
specified both of these properties, representing the no reaction and single
reaction scenarios in higher-order logic using the formal definitions presented
earlier in this section. The formal verification results about these properties
are given in and more details can be found in the description of their
formalization. The formalization presented in this section provides an automated
reasoning support for the Zsyntax based molecular biological experiments within
the sound core of HOL Light theorem prover.
## Formalization of reaction kinetics
Reaction kinetics is the study of rates at which biological processes interact
with each other and how the corresponding processes are affected by these
reactions. The rate of a reaction provides the information about the evolution
of the concentration of the species (e.g., molecules) over time. A process is
basically a chain of reactions, called pathway, and the investigation about the
rate of a process implies the rate of these pathways. Generally, biological
reactions can be either irreversible (unidirectional) or reversible
(bidirectional). We formally define this fact by an inductive enumerating data-
type `reaction_type`, given in.
In order to analyze a biological process, we need to know its kinetic reaction
based model, which comprises of a set of *m* species, *X* = {*X*<sub>1</sub>,
*X*<sub>2</sub>, *X*<sub>3</sub>,…, *X*<sub>*m*</sub>} and a set of *n*
reactions, *R* = {*R*<sub>1</sub>, *R*<sub>2</sub>, *R*<sub>3</sub>,…,
*R*<sub>*n*</sub>}. An irreversible reaction *R*<sub>*j*</sub>, {1 ≤ *j* ≤ *n*}
can generally be written as: $R_{j}:s_{1,j}X_{1} + s_{2,j}X_{2} + \ldots +
s_{m,j}X_{m}\overset{k_{j}}{\rightarrow}{\acute{s}}_{1,j}X_{1} +
{\acute{s}}_{2,j}X_{2} + \ldots + {\acute{s}}_{m,j}X_{m}$. Similarly, a
reversible reaction *R*<sub>*j*</sub>, {1 ≤ *j* ≤ *n*} can be described as:
$R_{j}:s_{1,j}X_{1} + s_{2,j}X_{2} + \ldots + s_{m,j}X_{m}\underset{{k_{j}}^{r}}
{\overset{{k_{j}}^{f}}{\rightleftarrows}}{\acute{s}}_{1,j}X_{1} +
{\acute{s}}_{2,j}X_{2} + \ldots + {\acute{s}}_{m,j}X_{m}$. The coefficients $s_{
1,j},s_{2,j},\ldots,s_{m,j},{\acute{s}}_{1,j},{\acute{s}}_{2,j},\ldots,{\acute{s
}}_{m,j}$ are the non-negative integers and represent the stoichiometries of the
species taking part in the reaction. The non-negative integer *k*<sub>*j*</sub>
is the kinetic rate constant of the irreversible reaction. The non-negative
integers ${k_{j}}^{f}$ and ${k_{j}}^{r}$ are the forward and reverse kinetic
rate constants of the reversible reaction, respectively. In a biological
reaction, we model a biological entity as a pair ($\mathbb{N}$, $\mathbb{R}$),
where the first element represents the stoichiometry and the second element is
the concentration of the molecule. We formally model a biological reaction as
the type abbreviation `bio_reaction`, given in.
The dynamic behavior of the biological systems is described by a set of ordinary
differential equations (ODEs) and the evolution of the system is captured by
analyzing the change in the concentration of the species (i.e., time
derivatives): $\frac{d\left\lbrack X_{i} \right\rbrack}{dt} = \sum_{j =
1}^{n}n_{i,j}v_{j}$, where *n*<sub>*i*, *j*</sub> is the stoichiometric
coefficient of the molecular species *X*<sub>*i*</sub> in reaction
*R*<sub>*j*</sub> (i.e., $n_{i,j} = {\acute{s}}_{i,j} - s_{i,j}$). The parameter
*v*<sub>*j*</sub> represents the flux of the reaction *R*<sub>*j*</sub>, which
can be computed by the law of mass action, i.e., the rate (also called flux) of
a reaction is proportional to the concentration of the reactant (c) raised to
the power of its stoichiometry (s), i.e., *c*<sup>*s*</sup>. We define the
function `gen_flux_irreversible`, given in, to obtain the flux of an
irreversible reaction.
A reversible reaction can be divided into two irreversible reactions with the
forward kinetic rate constant and the reverse kinetic rate constant,
respectively. The rate/flux of a reversible reaction is obtained by taking the
differences of the fluxes of the two irreversible reactions. We formally define
the flux of a reversible reaction by the function `gen_flux_reversible`, given
in. Next, we combine the functions `gen_flux_irreversible` and
`gen_flux_reversible` into one uniform function `flux_single` to obtain the
flux of a single reaction.
For all reactions from 1 to *n* of a biological system, the flux becomes a flux
vector as **v** = (*v*<sub>1</sub>, *v*<sub>2</sub>,…,
*v*<sub>*n*</sub>)<sup>*T*</sup> and the system of ODEs can be written in the
vectorial form as: $\frac{d\left\lbrack \mathbf{X} \right\rbrack}{dt} =
N\mathbf{v}$, where \[**X**\] = (*X*<sub>1</sub> *X*<sub>2</sub>,…,
*X*<sub>*n*</sub>)<sup>*T*</sup> is a vector of the concentration of all of the
species participating in the reaction and *N* is the stoichiometric matrix of
order *m* × *n*. We can obtain the flux vector **v** for a chain of reactions of
a biological system by the function `flux`, given in.
Next, we formalize the notion of stoichiometric matrix *N* by the function
`st_matrix` given in. Finally, in order to formalize the left-hand side of above
vector equation, i.e., $\frac{d\left\lbrack \mathbf{X} \right\rbrack}{dt}$, we
define a function `entities_deriv_vec` which takes a list containing the
concentrations of all species and returns a vector with each element represented
in the form of a real-valued derivative.
We can utilize this infrastructure to model arbitrary biological networks
consisting of any number of reactions. For example, a biological network
consisting of a list of `E` biological species and `M` biological reactions can
be formally represented by the following general kinetic model:
$$\begin{array}{r} {\left( \left( \texttt{entities}\_\texttt{deriv}\_\texttt{vec
}\mspace{720mu}\mathtt{E}\mspace{720mu}\mathtt{t}
\right):\texttt{real}\hat{\mspace{720mu}}\mathtt{m} \right) =
\texttt{transp}\left( \left(
\texttt{st}\_\texttt{matrix}\mspace{720mu}\mathtt{M} \right):{\texttt{real}\hat{
\mspace{720mu}}\mathtt{m}}\hat{\mspace{720mu}}\mathtt{n}
\right)\mspace{720mu}**\mspace{720mu}\texttt{flux}\mspace{720mu}\mathtt{M}} \\
\end{array}$$
We used the formalization of the reaction kinetics to verify some generic
properties of biological reactions, such as irreversible consecutive reactions,
reversible and irreversible mixed reactions. The main idea is to express the
given biological network as a kinetic model and verify that the given solution
(mathematical expression) of each biological entity satisfies the resulting set
of coupled differential equations. This verification is quite important as such
expressions are used to predict the outcomes of various drugs and to understand
the time evolution of different molecules in the reactions of the biological
systems.
### The irreversible consecutive reactions
We consider a general irreversible consecutive reaction scheme as shown in. In
the first reaction, `A` is the reactant and `B` is the product whereas `k1`
represents the kinetic rate constant of the reaction. Similarly, in the second
reaction, `B` is the reactant, `C` is the product and `k2` is its kinetic rate
constant. We formally model this reaction scheme as a HOL Light function
`rea_sch_01`, given in, and the formalization details are available as a
technical report. We moreover verify the solution of its kinetic model in HOL
Light. The formal verification results are given in.
### The consecutive reactions with the second step being reversible
The second reaction scheme consists of the consecutive reactions with the second
step being reversible as shown in. In the irreversible reaction, `A` and `B` are
the reactant and product, respectively, whereas `k1` is the kinetic rate
constant of the reaction. Since any reversible reaction can be written as two
irreversible reactions, so the first irreversible reaction has `B`, `C` and the
forward kinetic reaction constant `k2` as the reactant, product and the kinetic
rate constant, respectively. Similarly, the parameters `C`, `B` and `k3` are the
reactant, product and kinetic rate constant of the second irreversible reaction,
respectively. We formally model this scheme as a HOL Light function `rea_sch_02`
and then verified the solution for its ODE model given in.
### The consecutive reactions with the first step as a reversible reaction
In this scheme, the first reaction is reversible and the second reaction is
irreversible as shown in. The reversible reaction can be equivalently written as
two irreversible reactions with `k1` and `k2` as their kinetic rate constants.
In the first irreversible reaction, `A` and `B` are the reactant and product,
respectively, whereas in the second reaction, `B` and `A` are the reactant and
product, respectively. For the second step, `B`, `C` and `k3` are the reactant,
product and kinetic rate constant, respectively. The verified solution of the
ODE model corresponding to this reaction scheme (`rea_sch_03`, given in) is
given in.
### The consecutive reactions with a reversible step
In this reaction scheme, we consider the consecutive reactions with one
reversible and one irreversible reaction step as shown in. The ODE model and
solution corresponding to this reaction scheme (rea_sch_04, given) are given in.
This completes our formal verification of some commonly used reaction schemes.
The verification of these solutions requires user interaction but the strength
of these theorems lies in the fact that they have been verified for arbitrary
values of parameters, such as *k*<sub>1</sub> and *k*<sub>2</sub>, etc. This is
a unique feature of higher-order-logic theorem proving that is not possible in
the case of simulation where such continuous expressions are tested for few
samples of such parameters. Another important aspect is the explicit presence of
all assumptions required to verify the set of ODEs. For example, such
assumptions for the above-mentioned reaction schemes are not mentioned in
*Korobov et al.*’s paper. More details about the formalization of all above-
mentioned types and functions and the formal verification of all above
properties, and its source code can be found on our project’s webpage.
## Case studies
In this section, we use our proposed framework to formally reason about three
case studies: In the first, we formally analyse the reaction involving the
phosphorylation of TP53 using our formalization of Zsyntax. In the second, we
formally derive the time evolution expressions of different tumor cell types,
which are used to predict the tumor population and volume at a given time
instant, using our formalization of reaction kinetics. In the third, we take
another model for the growth of tumor cells and perform both the Zsyntax and
reaction kinetic based formal analysis using our proposed formalizations
presented in the *Result* section of the paper.
### TP53 phosphorylation
TP53 gene encodes p53 protein, which plays a crucial role in regulating the cell
cycle of multicellular organisms and works as a tumour suppressor for preventing
cancer. The pathway leading to TP53 phosphorylation (p(TP53)) is shown in. The
green-colored circle represents the desired product, whereas, the blued-colored
circles describe the chemical interactions in the pathway. Similarly, each
rectangle in contains the total number of molecules at a given time. It can be
clearly seen from the figure that whenever a biological reaction results into a
product, the reactants get consumed, which satisfies the stoichiometry of a
reaction. Now, we present the formal verification of pathway deduction from TP53
to p(TP53) using our formalization of Zsyntax, presented in the last section.
In classical Zsyntax format, the reaction of the pathway leading from TP53 to
p(TP53) can be represented by a theorem as `TP53` `&` `ATP` `&` `Kinase` `⊢`
`p(TP53)`. Based on our formalization, it can be defined as follows:
**Theorem 1**. The reaction of the pathway leading from TP53 to p(TP53)
⊢ `DISTINCT` `[TP53;` `ATP;` `Kinase;` `ADP;` `pTP53]` `⇒`
`zsyn_conjun_elimin (zsyn_deduct [[TP53];[ATP];[Kinase]]`
`[([Kinase;ATP],[[ATP;Kinase]]);`
`([ATP;Kinase;TP53],[[Kinase];[pTP53];[ADP]])]) [pTP53] = [[pTP53]]`
In the above theorem, the first argument of the function `zsyn_deduct`
represents the list of initial aggregate (IA) of molecules that are present at
the start of the reaction, whereas the second argument is the list of valid EVFs
for this reaction specified in the form of pairs and include the molecules (ATP,
Kinase, etc.). These are obtained from wet lab experiments, as reported by
*Boniolo et al.*. We use the HOL Light function `DISTINCT` to ensure that all
molecule variables (from IA and EVFs) used in this theorem represent distinct
molecules. Thus, the final list of molecules is deduced under these particular
conditions using the function `zsyn_deduct`. Finally, if the molecule `pTP53` is
present in the post-reaction list of molecules, it will be obtained after the
application of the function `zsyn_conjun_elimin`, as previously described.
Additionally, in order to automate the verification process, we developed a
simplifier `Z_SYNTAX_SIMP`, which is based on some derived rules and already
available HOL Light tactics that simplified the manual reasoning and thus
allowed us to formally verify Theorem 1 automatically. It is important to note
that formalization of Zsyntax was quite a tedious effort but it took only 6
lines of code for the verification of the theorem of pathway deduction from
`TP53` to `pTP53` in HOL Light, which clearly illustrates the effectiveness of
our foundational work.
We have shown that our formalization is capable of modeling molecular reactions
using Zsyntax inference rules, i.e., given an IA **A** and a set of possible
EVFs, our proposed framework can derive a final aggregate (FA) **B** from **A**
automatically. If it fails to deduce **B**, our formalism still provides all the
intermediate steps to the biologist so that he can figure out the possible
causes of failures, by carefully examining the intermediate steps of the
reaction.
### Formal analysis of tumor growth based on Cancer Stem Cells (CSC)
According to the Cancer Stem Cell (CSC) hypothesis, malignant tumors (cancers)
are originally initiated by different tumor cells, which have similar
physiological characterises as of normal stem cells in the human body. This
hypothesis explains that the cancer cell exhibits the ability to self-renew and
can also produce different types of differentiated cells. The mathematical and
computational modeling of cancers can provide an in-depth understanding and the
prediction of required parameters to shape the clinical research and
experiments. This can result in efficient planning and therapeutic strategies
for accurate patient prognosis. In this paper, we consider a kinetic model of
cancer based on the cancer stem cell (CSC) hypothesis, which was recently
proposed in *Molina-Pena et al.*’s paper. In this model, four types of events
are considered: 1) CSC self-renewal; 2) maturation of CSCs into P cells; 3)
differentiation to D cells; and 4) death of all cell subtypes. All of these
types of reactions are driven by different rate constants as shown in.
In the following, we provide the possible reactions in the considered model of
cancer: Expansion of CSCs can be accomplished through symmetric division, where
one CSC can produce two CSCs, i.e.,
$\text{CSC}\overset{\text{k}_{1}}{\rightarrow}2\text{CSC}$. A CSC can undergo
asymmetric division (whereby one CSC gives rise to another CSC and a more
differentiated progenitor (P) cell). This P cell possesses intermediate
properties between CSCs and differentiated (D) cells, i.e.,
$\text{CSC}\overset{\text{k}_{2}}{\rightarrow}\text{CSC} + \text{P}$. The CSCs
can also differentiate to P cells by symmetric division, i.e.,
$\text{CSC}\overset{\text{k}_{3}}{\rightarrow}2\text{P}$. The P cells can either
self-renew, with a decreased capacity compared to CSCs, or they can
differentiate to D cells, i.e.,
$\text{P}\overset{\text{k}_{4}}{\rightarrow}2\text{P}$,
$\text{P}\overset{\text{k}_{5}}{\rightarrow}2\text{D}$. All cellular subtypes
can undergo cell death (M), i.e.,
$\text{CSC}\overset{\text{k}_{6}}{\rightarrow}\text{M}$,
$\text{P}\overset{\text{k}_{7}}{\rightarrow}\text{M}$,
$\text{D}\overset{\text{k}_{8}}{\rightarrow}\text{M}$.
In order to reduce the complexity of the resulting model, only three subtypes of
cells are considered: CSCs, transit amplifying progenitor cells (P), and
terminally differentiated cells (D) as shown in. This assumption is consistent
with several experimental reports. Our main objective is to derive the
mathematical expressions, which characterize the time evolution of CSC, P and D.
Concretely, the values of these cells should satisfy the set of differential
equations that arise in the kinetic model of the proposed tumor growth. Once the
expressions of all cell types are known, the total number of tumor cells (*N*)
in the human body can be computed by the formula *N*(*t*) = *CSC*(*t*) +
*P*(*t*) + *D*(*t*). Furthermore, the tumor volume (*V*) can be calculated by
the formula *V*(*t*) = 4.18 × 10<sup>6</sup> *N*(*t*), considering that the
effective volume contribution of a spherically shaped cell in a spherical tumor
(i.e., 4.18 × 10<sup>−6</sup> *mm*<sup>3</sup>/*cell*).
We formally model the tumor growth model and verify the time evolution
expressions for `CSC`, `P` and `D` that satisfy the general kinetic model. We
formally represent this requirement in the following important theorem:
**Theorem 2**. Time Evolution Verification of Tumor Growth Model
⊢ `∀` `k`<sub>`1`</sub> `k`<sub>`2`</sub> `k`<sub>`3`</sub> `k`<sub>`4`</sub>
`k`<sub>`5`</sub> `k`<sub>`6`</sub> `k`<sub>`7`</sub> `CSC` `P` `D` `M` `t`
`k`<sub>`8`</sub>.
`A1: ((−k`<sub>`1`</sub> `+k`<sub>`3`</sub> `+k`<sub>`4`</sub>
`−k`<sub>`5`</sub> `+k`<sub>`6`</sub> `−k`<sub>`7`</sub> `)(−k`<sub>`1`</sub>
`+k`<sub>`3`</sub> `+k`<sub>`6`</sub> `−k`<sub>`8`</sub> `)(−k`<sub>`4`</sub>
`+k`<sub>`5`</sub> `+k`<sub>`7`</sub> `−k`<sub>`8`</sub> `)≠0) ∧`
`A2: (k`<sub>`1`</sub> `−k`<sub>`3`</sub> `−k`<sub>`4`</sub> `+k`<sub>`5`</sub>
`−k`<sub>`6`</sub> `+k`<sub>`7`</sub> `≠0) ∧`
`A3: ∀t. CSC(t) = e`<sup>`(k`<sub>`1`</sub> `−k`<sub>`3`</sub>
`−k`<sub>`6`</sub> `)`</sup> `∧`
`A4:` $\!\forall\mathtt{t}.\mspace{720mu}\mathtt{P}\left( \mathtt{t} \right) =
\frac{\left\lbrack \left( \mathtt{e}^{(\mathtt{k}_{1} - \mathtt{k}_{3} -
\mathtt{k}_{6})\mathtt{t}} - \mathtt{e}^{(\mathtt{k}_{4} - \mathtt{k}_{5} -
\mathtt{k}_{7})\mathtt{t}} \right)\left( \mathtt{k}_{2} + 2\mathtt{k}_{3}
\right) \right\rbrack}{\left( \mathtt{k}_{1} - \mathtt{k}_{3} - \mathtt{k}_{4} +
\mathtt{k}_{5} - \mathtt{k}_{6} + \mathtt{k}_{7} \right)}\mspace{720mu} \land$
`A5:` $\forall\mathtt{t}.\mspace{720mu}\mathtt{D}\left( \mathtt{t} \right) =
\frac{\left( 2\mathtt{e}^{- \mathtt{k}_{8}\mathtt{t}}\left( \mathtt{k}_{2} +
2\mathtt{k}_{3} \right)\mathtt{k}_{5}\left\lbrack \left( - 1 +
\mathtt{e}^{(\mathtt{k}_{4} - \mathtt{k}_{5} - \mathtt{k}_{7} +
\mathtt{k}_{8})\mathtt{t}} \right)\mathtt{k}_{1} + \mathtt{k}_{3} +
\mathtt{k}_{4} - \mathtt{k}_{5} + \mathtt{k}_{6} - \mathtt{k}_{7} \right\rbrack
\right.}{\left( - \mathtt{k}_{1} + \mathtt{k}_{3} + \mathtt{k}_{4} -
\mathtt{k}_{5} + \mathtt{k}_{6} - \mathtt{k}_{7} \right)\left( - \mathtt{k}_{1}
+ \mathtt{k}_{3} + \mathtt{k}_{6} - \mathtt{k}_{8} \right)\left( -
\mathtt{k}_{4} + \mathtt{k}_{5} + \mathtt{k}_{7} - \mathtt{k}_{8}
\right)}\mspace{720mu} +$
$\frac{\left( 2\mathtt{e}^{- \mathtt{k}_{8}\mathtt{t}}\left( \mathtt{k}_{2} +
2\mathtt{k}_{3} \right)\mathtt{k}_{5}\left\lbrack \mathtt{e}^{(\mathtt{k}_{1} -
\mathtt{k}_{3} - \mathtt{k}_{6} + \mathtt{k}_{8})\mathtt{t}}\left( -
\mathtt{k}_{4} + \mathtt{k}_{5} + \mathtt{k}_{7} - \mathtt{k}_{8} \right) +
\mathtt{e}^{(\mathtt{k}_{4} - \mathtt{k}_{5} - \mathtt{k}_{7} +
\mathtt{k}_{8})\mathtt{t}}\left( - \mathtt{k}_{3} - \mathtt{k}_{6} +
\mathtt{k}_{8} \right) \right\rbrack \right.}{\left( - \mathtt{k}_{1} +
\mathtt{k}_{3} + \mathtt{k}_{4} - \mathtt{k}_{5} + \mathtt{k}_{6} -
\mathtt{k}_{7} \right)\left( - \mathtt{k}_{1} + \mathtt{k}_{3} + \mathtt{k}_{6}
- \mathtt{k}_{8} \right)\left( - \mathtt{k}_{4} + \mathtt{k}_{5} +
\mathtt{k}_{7} - \mathtt{k}_{8} \right)}\mspace{720mu} \land$
`A6: real_derivative M(t) = k`<sub>`6`</sub> `CSC(t) + k`<sub>`7`</sub> `P(t) +
k`<sub>`8`</sub> `D(t)`
`⇒ entities_deriv_vec [CSC; P; D; M] t =`
`transp (st_matrix (tumor_growth_model CSC P D M k`<sub>`1`</sub>
`k`<sub>`2`</sub> `k`<sub>`3`</sub> `k`<sub>`4`</sub> `k`<sub>`5`</sub>
`k`<sub>`6`</sub> `k`<sub>`7`</sub> `k`<sub>`8`</sub> `t))`
` ∗ ∗ flux (tumor_growth_model CSC P D M k`<sub>`1`</sub> `k`<sub>`2`</sub>
`k`<sub>`3`</sub> `k`<sub>`4`</sub> `k`<sub>`5`</sub> `k`<sub>`6`</sub>
`k`<sub>`7`</sub> `k`<sub>`8`</sub> `t))`
where the first two assumptions (A1-A2) ensure that the time evolution
expressions of `P` and `D` do not contain any singularity (i.e., the value at
the expression becomes undefined). The next three assumptions (A3-A5) provide
the time evolution expressions for `CSC`, `P` and `D`, respectively. The last
assumption (A6) is provided to discharge the subgoal characterizing the time-
evolution of `M` (dead cells), which is of no interest and does not impact the
overall analysis as confirmed by experimental evidences. Finally, the conclusion
of Theorem 2 is the equivalent reaction kinetic (ODE) model of the CSC based
tumor growth model. To facilitate the verification process of the above theorem,
we developed a simplifier, called `KINETIC SIMP`, which sufficiently reduces the
manual reasoning interaction with the theorem prover. After the application of
this simplifier, it only takes some arithmetic reasoning to conclude the proof
of Theorem 2. More details about the verification process can be found on our
project’s webpage.
The formal verification of the time-evolution of tumor cell types `CSC`, `P` and
`D` in Theorem 2 can be easily used to formally derive the total population and
volume of tumor cells. The derived time-evolution expression, verified in
Theorem 2, can also be used to understand how the overall tumor growth model
works. Moreover, potential drugs are usually designed using the variation of the
kinetic rate constants, such as *k*<sub>1</sub>, *k*<sub>2</sub>⋯*k*<sub>8</sub>
in Theorem 2, to achieve the desired behavior of the overall tumor growth model
and thus Theorem 2 can be utilized to study this behavior formally. On similar
lines, the variation of these parameters is used to plan efficient therapeutic
strategies for cancer patients and thus the formally verified result of Theorem
2 can aid in accurately performing this task.
### Combined Zsyntax and Reaction kinetic based formal analysis of the tumor growth model
In this section, we consider another model for the growth of tumor cells and
formally analyze it using both of our Zsyntax and Reaction kinetics
formalizations, presented in the *Results* section of the paper.
**Pathway Leading to Death of CSC**
The pathway leading to death of CSC is shown in. The green-colored circle
represents the desired product, whereas, the blued-colored circles describe the
chemical interactions in the pathway. We use our formalization of Zsyntax to
deduce this pathway. In the classical Zsyntax format, the reaction of the
pathway leading from CSC to its death can be represented by a theorem as `CSC`
`&` `P` `⊢` `M`. Based on our formalization, it can be defined as follows:
**Theorem 3**. The Reaction of the Pathway Leading from CSC to its Death (M)
⊢ `DISTINCT` `[CSC;` `P;` `M]` `⇒`
`zsyn_conjun_elimin (zsyn_deduct [[CSC];[P]]`
`[([CSC],[[CSC;P]]);`
`([CSC;P],[[M]])]) [M] = [[M]]`
In the above theorem, the first argument of the function `zsyn_deduct`
represents the list of IA of molecules that are present at the start of the
reaction, whereas the second argument is the list of valid EVFs for this
reaction specified in the form of pairs and include the molecules (CSC, P,
etc.). We use the HOL Light function `DISTINCT` to ensure that all molecule
variables (from IA and EVFs) used in this theorem represent distinct molecules.
Thus, the final list of molecules is deduced under these particular conditions
using the function `zsyn_deduct`. Finally, if the molecule `M` is present in the
post-reaction list of molecules, it will be obtained after the application of
the function `zsyn_conjun_elimin`. We use the simplifier `Z_SYNTAX_SIMP` to
formally verify Theorem 3 automatically.
**Reaction Kinetic based Formal Analysis of a Tumor Growth based on CSC**
We perform the reaction kinetic based formal analysis of a tumor growth model,
which is shown in. In this model, two types of events are considered: 1)
maturation of CSCs into P cells; 2) death of all cell subtypes. All of these
types of reactions are driven by different rate constants as shown in.
In the following, we provide the possible reactions in the considered tumor
growth model: A CSC can undergo asymmetric division (whereby one CSC gives rise
to another CSC and a more differentiated P cell), i.e.,
$\text{CSC}\overset{\text{k}_{1}}{\rightarrow}\text{CSC} + \text{P}$. All
cellular subtypes can undergo cell death (M), i.e.,
$\text{CSC}\overset{\text{k}_{2}}{\rightarrow}\text{M}$,
$\text{P}\overset{\text{k}_{3}}{\rightarrow}\text{M}$.
In order to reduce the complexity of the resulting model, only two subtypes of
cells are considered: CSCs and transit amplifying progenitor cells (P) as shown
in. Our main objective is to derive the mathematical expressions, which
characterize the time evolution of CSC and P. Concretely, the values of these
cells should satisfy the set of differential equations that arise in the kinetic
model of the proposed tumor growth. Once the expressions of all cell types are
known, the total number of tumor cells (*N*) in the human body can be computed
by the formula *N*(*t*) = *CSC*(*t*) + *P*(*t*). We formalize the reaction
kinetic based tumor growth model and verify the time evolution expressions for
`CSC` and `P` that satisfy the general kinetic model. We formally represent this
requirement in the following HOL Light theorem:
**Theorem 4.** Time Evolution Verification of a Tumor Growth Model
⊢ `∀` `k`<sub>`1`</sub> `k`<sub>`2`</sub> `k`<sub>`3`</sub> `CSC` `P` `M` `t.`
`A1: (k`<sub>`3`</sub> `−k`<sub>`2`</sub> `≠0) ∧`
`A2: ∀t. CSC(t) = e`<sup>`−k`<sub>`2`</sub> ` ∗ t`</sup> `∧`
`A3:` $\forall\mathtt{t}.\mspace{720mu}\mathtt{P}\left( \mathtt{t} \right) =
\frac{\left\lbrack \left( \mathtt{k}_{3} - \mathtt{k}_{2} - \mathtt{k}_{1}
\right)\mathtt{e}^{- \mathtt{k}_{3}\mathtt{t}} + \mathtt{k}_{1}\mathtt{e}^{-
\mathtt{k}_{2}\mathtt{t}} \right\rbrack}{\left( \mathtt{k}_{3} - \mathtt{k}_{2}
\right)}\mspace{720mu} \land$
`A4: real_derivative M(t) = k`<sub>`2`</sub> `CSC(t) + k`<sub>`3`</sub> `P(t)`
`⇒ entities_deriv_vec [CSC; P; M] t =`
`transp (st_matrix (tumor_growth_rk_model CSC P M k`<sub>`1`</sub>
`k`<sub>`2`</sub> `k`<sub>`3`</sub> `t))`
` ∗ ∗ flux (tumor_growth_rk_model CSC P M k`<sub>`1`</sub> `k`<sub>`2`</sub>
`k`<sub>`3`</sub> `t))`
where the first assumption (A1) ensures that the time evolution expression of
`P` does not contain any singularity. The next two assumptions (A2-A3) provide
the time evolution expressions for `CSC` and `P`, respectively. The last
assumption (A4) is provided to discharge the subgoal characterizing the time-
evolution of `M` (dead cells), which is of no interest and does not impact the
overall analysis as confirmed by experimental evidences. Finally, the conclusion
of Theorem 4 is the equivalent reaction kinetic (ODE) model of the CSC based
tumor growth model. To facilitate the verification process of the above theorem,
we use the `KINETIC_SIMP` simplifier, which sufficiently reduces the manual
reasoning interaction with the theorem prover. After the application of this
simplifier, it only takes some arithmetic reasoning to conclude the proof of
Theorem 4. More details about the verification process can be found at.
# Discussion
Most of the existing research related to the formal analysis of the biological
systems has been focussed on using model checking. However, this technique
suffers from the inherent state-space explosion problem, which limits the scope
of this success to systems where the biological entities can acquire only a
small set of possible levels. Moreover, the underlying differential equations
describing the reaction kinetics are solved using numerical approaches, which
compromises the precision of the analysis. To the best of our knowledge, our
work is the first one to leverage the distinguishing features of interactive
theorem proving to reason about the solutions to system biology problems. We
consider the concentration of the species of the biological systems in reaction
kinetic based formal analysis as a continuous variable. Besides formalizing
Zsyntax and the reaction kinetics of commonly used biological pathways, we also
formally verified their classical properties. This verification guarantees the
soundness and the correctness of our formal definitions. It also enables us to
conduct formal analysis of real-world case studies. In order to illustrate the
practical effectiveness of our formalization, we presented the automatic Zsyntax
based formal analysis of pathway leading to TP53 Phosphorylation and a pathway
leading to the death of CSCs in the tumor growth model, and reaction kinetics
based analysis of the tumor growth model. Our source code is available online
and can be used by other biologists and computer scientists for further
applications and experimentation.
The distinguishing feature of our framework is the ability to deductively reason
about biological systems using both Zsyntax and reaction kinetics. The soundness
of interactive theorem proving ensures the correct application of EVFs or the
simplification process as there is no risk of human error. The involvement of
computers in the formal reasoning process of the proposed approach makes it more
scalable than the analysis presented in *Boniolo et al.*’s and *Molina-Pena et
al.*’s paper, which is based on traditional paper-and-pencil based analysis
technique. Another key benefit of the reported work is the fact that the
assumptions of these formally verified theorems are guaranteed to be complete,
due to the soundness of the underlying analysis methods, and thus enables us to
get a deep understanding about the conditions and constraints under which a
Zsyntax and reaction kinetics based analysis is performed. Also, we have
verified generic theorems with universally quantified variables and thus the
analysis covers all possibilities. Similarly, in the case of reaction kinetics
based analysis, the theorems have been verified for arbitrary values of
parameters, such as *k*<sub>1</sub> and *k*<sub>2</sub>, which is not possible
in the case of simulation where these expressions are tested for few samples of
such parameters. A major limitation of higher-order logic theorem proving is the
manual guidance required in the formal reasoning process. But we have tried to
facilitate this process by formally verifying frequently used results, such as,
simplification of vector summation manipulation and verification of flux vectors
and stoichiometric matrices for each of the reaction schemes, and providing
automation where possible. For example, we have developed two simplifiers,
namely `Z_SYNTAX_SIMP` and `KINETIC_SIMP`, that have been found to be very
efficient in automatically simplifying most of the Zsyntax or reaction kinetic
related proof goals, respectively. In the first case study, the simplifier
`Z_SYNTAX_SIMP` allowed us to automatically verify the theorem representing the
reaction of the pathway leading to TP53 Phosphorylation. Similarly, in the
second case study, i.e., time evolution verification of the tumor growth model,
the simplifier `KINETIC_SIMP` significantly reduced the manual interaction and
the proof concluded using this simplifier and some straightforward arithmetic
reasoning. These simplifiers are also used to automate the verification process
of the third case study, i.e., the automatic verification of the theorem
representing the reaction of the pathway leading to the death of CSC and a
significant simplification of the verification of the theorem representing the
time evolution for the growth of the tumor cell.
In future, we plan to conduct the sensitivity and steady state analysis of
biological networks that is mainly based on reaction kinetics. We also plan to
integrate Laplace and Fourier transforms formalization in our framework that can
assist in finding analytical solutions of the complicated ODEs.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** OH US. **Formal analysis:** AR US. **Funding
acquisition:** OH ST. **Investigation:** AR. **Methodology:** OH US AR.
**Project administration:** ST. **Software:** AR. **Supervision:** OH ST.
**Validation:** AR US. **Visualization:** AR. **Writing – original draft:**
AR. **Writing – review & editing:** OH ST.
|
# Introduction
*Acinetobacter baumannii* is a Gram-negative coccobacillus pathogen linked to
severe nosocomial infections including pneumonia, bacteremia, urinary tract
infections and necrotizing fasciitis. *A*. *baumannii* infections have been
commonly associated with immunocompromised patients; however, cases of
community-acquired *A*. *baumannii* infections in healthy individuals have also
been reported. Reports have also associated *A*. *baumannii* with wound
infections acquired by combatants deployed to Iraq earning it the popularized
name ‘Iraqibacter’.
Treatment of *A*. *baumannii* infections is exceedingly difficult due to
increasing multi-drug resistance and the limited understanding of its virulence
factors, conditions that have a paramount impact on human health worldwide.
While the mechanisms of antibiotic resistance associated with this emerging
pathogen have been extensively studied, there is a troublesome paucity of
literature reporting the molecular mechanisms of virulence associated with *A*.
*baumannii* pathogenicity. Among the more understood properties that make *A*.
*baumannii* a successful pathogen is its versatility in acquiring iron.
The majority of iron in a host is intracellular; thus the availability of
intracellular iron-containing molecules such as hemin, hemoglobin and ferritin
is dependent on the lysis of host cells and their subsequent release due to cell
and tissue damage found in wounds. The liberation of intracellular nutrients may
be accomplished by bacterial-mediated cell damage such as that described in *V*.
*cholerae* infections, in which hemolysin-based cytotoxicity lyses intestinal
epithelial cells and erythrocytes releasing intracellular iron compounds into
the extracellular environment for bacterial utilization. One avenue by which
bacterial pathogens can lyse host cells is by producing phospholipases, which
act on phospholipids in host membranes resulting in membrane destabilizing
products thereby leading to cytolysis and the release of host intracellular
contents.
The *A*. *baumannii* ATCC 19606<sup>T</sup> strain genome contains genes
encoding proteins harboring phospholipase domains including four with a patatin-
like protein (PLP) phospholipase domain, one outer membrane protein with a
phospholipase A1 domain and two with a phospholipase C domain
(<http://www.broadinstitute.org/>). A more recent report showed that the genome
of this strain also includes three genes the products of which are proteins that
harbor PLD domains. These phospholipases differ in the types of reactions they
catalyze; PLP phospholipases are non-specific acyl lipid hydrolases that cleave
the acyl ester bond of a phospholipid, phospholipase A1 specifically cleaves
phospholipids through the hydrolysis of the fatty acyl ester bond at the *sn*-1
position of the glycerol moiety, and phospholipase C and phospholipase D cleave
before and after the phosphate, respectively.
Patatins are plant storage glycoproteins with lipid acyl hydrolase activity that
account for 30–40% of the total soluble proteins in potatoes. The first, and one
of the few, PLPs to be characterized in bacteria was the ExoU protein from
*Pseudomonas aeruginosa*, which was shown to have phospholipase activity. While
bacterial PLPs have not been linked to cytolysis, their presence in the genomes
of animal and plant pathogens/symbionts is significantly higher than in the
genomes of non-pathogens. The bacterial phospholipase A1 (PhlA) from *Serratia
marcescens* has been implicated in hemolysis of human erythrocytes and
cytotoxicity to cervical cancer HeLa and 5637 human bladder epithelial cells.
The phospholipase C of *Clostridium perfringens*, which is also known as the α
toxin, causes cytolysis, tissue destruction and necrosis. The phospholipase C
produced by *P*. *aeruginosa* has been linked to hemolysis, tissue destruction
and pathologies reminiscent of burn infections. Purified phospholipase D, such
as that produced by *Corynebacterium pseudotuberculosis*, is dermonecrotic and
fatal when injected into animals. While many of the phospholipases encoded
within the *A*. *baumannii* ATCC 19606<sup>T</sup> genome have possible
implications in cytolysis and the ultimate release of iron-rich intracellular
contents, the roles of only a few of these phospholipases have been elucidated
in this pathogen. Specifically, the role of a phospholipase C and a
phospholipase D has been associated with cytolytic activity to the FaDu
hypopharyngeal carcinoma epithelial cell line and serum survival and invasion
into both human bronchial epithelial BEAS-2B cells and HeLa cells, respectively.
A recent report showed that three phospholipase D proteins play a critical role
in the pathobiology of the ATCC 19606<sup>T</sup> strain.
Taken together, these observations indicate that bacterial pathogens can gain
access to additional intracellular iron pools and other nutrients present in
erythrocytes and tissues through the expression of hemolytic/cytolytic
activities. Supernatants of *A*. *baumannii* cultures grown under iron-chelation
are hemolytic to horse erythrocytes and possess phospholipase C activity. Our
report describes the characterization of *plc1* and *plc2* and the involvement
of the protein products of these two genes in the hemolytic, cytolytic and
virulence phenotypes displayed by the *A*. *baumannii* ATCC 19606<sup>T</sup>
strain and isogenic derivatives affected in the expression of these two genes.
# Materials and Methods
## Bacterial strains, plasmids, media and culture conditions
The bacterial strains and plasmids used in this work are listed in. All
bacterial strains were routinely stored as Luria-Bertani (LB) broth/glycerol
stocks at -80°C. *Escherichia coli* DH5α recombinant clones were cultured in LB
broth or on LB agar (LBA) supplemented with appropriate antibiotics and
incubated overnight (12–14 h) at 37°C. *A*. *baumannii* strains as well as the
*E*. *coli* MG1655 strain were subcultured from LBA into Chelex 100-treated
trypticase soy broth dialysate (TSBD) and grown for 24 h at 37°C with shaking at
200 rpm. These cultures were then used to inoculate fresh TSBD or TSBD
containing 10% erythrocytes at a 1/100 ratio and grown for 24 h at 37°C with
shaking at 200 rpm unless otherwise indicated. Bacterial cells were enumerated
after 24 h using flow cytometry. Culture medium supplemented with erythrocytes
was prepared by centrifuging whole blood at 1,000 *x g*, resuspending and
washing the erythrocyte pellet three times in erythrocyte wash buffer (20 mM
KH<sub>2</sub>PO<sub>4</sub>, 60 mM Na<sub>2</sub>HPO<sub>4</sub> and 120 mM
NaCl, pH 8.0) and then resuspending the pellet to a final erythrocyte
concentration of 10% in TSBD. Iron-repleted culture conditions were accomplished
through the addition of 50 μM FeCl<sub>3</sub> dissolved in 0.01 N HCl, while
iron-chelated conditions were generated by treating TSB with Chelex 100 (Bio-Rad
Laboratories). Bacterial growth curves were determined in octuplet using 96-well
microtiter plates containing TSBD under the aforementioned culturing conditions
over a 24-h time period. OD<sub>600</sub> values of these cultures were recorded
hourly.
Defibrinated sheep and horse erythrocytes were obtained from Cleveland
Scientific, Ltd., and sodium citrate-treated whole human blood was purchased
from Bioreclamation, LLC. A549 human alveolar epithelial cells were passaged
three times in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
heat-inactivated fetal bovine serum, 100 IU penicillin, and 100 μg/ml
streptomycin at 37°C in the presence of 5% CO<sub>2</sub>. Approximately
1x10<sup>5</sup> A549 cells, as enumerated using a hemocytometer, were seeded
into each well of a 96-well, white, opaque tissue culture plate for a fourth
passage that was incubated at 37°C in the presence of 5% CO<sub>2</sub> for 24 h
without antibiotics. A549 cell monolayers were infected with 10<sup>6</sup>
bacteria suspended in DMEM and incubated at 37°C in the presence of 5%
CO<sub>2</sub> for 24 h. The cell monolayers were washed three times with DMEM
prior to performing cytolysis assays.
## General DNA procedures
Total genomic DNA was isolated using an adapted mini-scale procedure from a
previously published method, and plasmid DNA was isolated using commercial kits
(Qiagen). Restriction digests were performed as suggested by the supplier (New
England Biolabs) and size-fractionated by agarose gel electrophoresis. PCR
primer pairs 3824/3826 and 3822/3827, which hybridize internally of *plc1* and
*plc2*, respectively, were used to confirm the presence of these two genes in 19
*A*. *baumannii* clinical isolates.
## Sequence acquisition and phylogenetic analyses
Nucleotide sequences were analyzed with DNASTAR (DNASTAR, Inc.), BLAST and data
available from the Broad Institute. *In silico* identification of potential
ferric uptake repressor (Fur)-binding sites upstream of *plc1* and *plc2* was
performed using a small training set of predicted Fur-binding sites, which were
analyzed using MEME Suite 4.10.0. GLAM2 PSSM was used to generate a WebLogo
representing the *A*. *baumannii* Fur-binding motif, and MAST was used to search
nucleotide sequences upstream of *plc1* and *plc2*. The PLC1 and PLC2 amino acid
sequences from *A*. *baumannii* ATCC 19606<sup>T</sup> were used as queries for
BLASTp to obtain similar sequences, excluding additional amino acid sequences
from *A*. *baumannii*. A total of 101 amino acid sequences were retrieved by
setting an arbitrary cutoff of approximately 40% amino acid identity for
phylogenetic comparisons to PLC1, PLC2, and the hemolytic (PLCH) and non-
hemolytic (PLCN) *P*. *aeruginosa* phospholipase C proteins (GI 489205171 and GI
489204069), which were added manually. These sequences, which were aligned with
MUSCLE using default settings, were analyzed with the multiple sequence
alignment (MSA) MEGA6 software package. The MSA analysis was done using
an apparent-maximum-likelihood method encompassing the WAG (Whelan Goldman)
model with a discrete Gamma distribution and rate calculations among invariable
sites with FastTree. The phylogenetic tree, which was drawn to scale with the
highest log likelihood (-714043.274), represents 109 residues analyzed with
1,099 positions in the final dataset.
## Site-directed insertional mutagenesis of *plc* genes
The 2.2-kb *plc1* gene (A1S_0043 following the *A*. *baumannii* ATCC 17978
genome annotation) was amplified from ATCC 19606<sup>T</sup> genomic DNA with
*Taq* DNA polymerase and primers 3824 and 3825. The *plc1* amplicon was cloned
into pCR8/GW/TOPO generating pMU1042. Inverse PCR was performed using pMU1042 as
a template, Phusion DNA polymerase (New England Biolabs) and primers 4017 and
4018, which hybridize within the *plc1* gene. The *aph-FRT* cassette, which
codes for kanamycin resistance (Km<sup>R</sup>), was amplified from pKD13 with
Phusion DNA polymerase and primers 4003 and 4004 and ligated within *plc1* using
the inverse PCR amplicon described above to generate pMU1089. The *ermAM*
cassette, which codes for erythromycin resistance (Em<sup>R</sup>), was
amplified from pIL252 with Phusion DNA polymerase and primers 4046 and 4047 and
ligated within the *plc1* coding region using the inverse PCR amplicon described
above to generate pMU1101. Phusion DNA polymerase and primers 3824 and 3825 were
used to amplify *plc1*::*aph-FRT* and *plc1*:: *ermAM*, which were each
subcloned into the *Sma*I site of pEX100T to generate pMU1091 and pMU1108,
respectively.
The 2.2-kb *plc2* gene (A1S_2055 following the *A*. *baumannii* ATCC 17978
genome annotation) was PCR amplified from ATCC 19606<sup>T</sup> genomic DNA
using *Taq* DNA polymerase and primers 3822 and 3823 ( and), and the resulting
amplicon was ligated into pCR8/GW/TOPO to generate pMU1039. Phusion DNA
polymerase and primers 3171 and 3172 were used to amplify the *aph* cassette
from pUC4K, which was inserted into the unique *Nsi*I site of the *plc2* gene
after end repair of *Nsi*I-digested pMU1039 with the End-It Kit (Epicentre)
resulting in pMU1040. Phusion DNA polymerase and primers 3822 and 3823 were used
to amplify *plc2*::*aph*, which was subsequently cloned into the *Sma*I site of
pEX100T to generate pMU1076.
Electrocompetent ATCC 19606<sup>T</sup> cells were electroporated with pMU1091
and pMU1076 as described before to generate the 3452 *plc1*::*aph-FRT* and 3430
*plc2*::*aph* isogenic derivatives, respectively. For the generation of the 3494
*plc1*::*ermAM/plc2*::*aph* double insertion isogenic derivative,
electrocompetent 3430 cells were electroporated with pMU1108. The ATCC
19606<sup>T</sup> 3430 and 3452 isogenic derivatives were selected on LBA plates
containing 40 μg/ml kanamycin, while the 3494 derivative was selected on LBA
supplemented with 40 μg/ml erythromycin. All isogenic derivatives were plated on
LBA plates supplemented with 10% sucrose to ensure loss of pMU1076, pMU1091 and
pMU1108. Proper allelic exchanges were confirmed with PCR using external primers
3905 and 3906 (*plc1*) and 3815 and 3918 (*plc2*).
## Genetic complementation of the *plc1* and *plc2* isogenic derivatives
The *A*. *baumannii* ATCC 19606<sup>T</sup> *plc1* and *plc2* genes were PCR
amplified from ATCC 19606<sup>T</sup> genomic DNA using Phusion DNA polymerase
and primers 3894 and 3895 (*plc1*) and 3892 and 3893 (*plc2*), all of which
included *Bam*HI restriction sites. The respective *plc1* and *plc2* amplicons
were ligated into pCR-Blunt resulting in pMU1073 and pMU1074. Both pMU1073 and
pMU1074 were digested with *Bam*HI and the *plc1* and *plc2* fragments were each
subcloned into the cognate *Bam*HI site of the *E*. *coli-A*. *baumannii*
shuttle vector pWH1266 generating pMU1079 and pMU1080.
Electrocompetent 3452 (*plc1*::*aph-FRT*) and 3430 (*plc2*::*aph*) cells were
electroporated with the empty shuttle vector pWH1266 resulting in the 3452.E and
3430.E transformants, respectively, which were selected on LB agar supplemented
with 1 mg/ml of ampicillin. Electrocompetent 3452 (*plc1*::*aph-FRT*) and 3430
(*plc2*::*aph*) cells were also electroporated with pMU1079 and pMU1080,
respectively, and the 3452 and 3430 complemented derivatives (3452.C and 3430.C)
were selected on LB agar supplemented with 1 mg/ml of ampicillin. The presence
of pMU1079 and pMU1080 was confirmed by restriction analysis of plasmid DNA
recovered from transformants grown in LB containing 150 μg/ml of ampicillin.
## Transcriptional analyses
Bacterial strains were each grown as five independent 1-ml cultures for 24 h in
TSBD or TSBD supplemented with 50 μM FeCl<sub>3</sub> at 37°C with shaking at
200 rpm. The 24-h time point was chosen for RNA isolation because there was not
apparent hemolytic activity until this time. RNA isolation, cDNA synthesis and
qRT-PCR analyses were performed as previously described. Briefly, bacterial
cells were lysed in lysis buffer \[0.3 M sodium acetate (pH 4.0), 30 mM EDTA and
3% SDS\] previous to RNA purification following the manufacturer’s protocol
included with the Maxwell 16 LEV simplyRNA Tissue Kit (Promega). Total RNA
concentrations and the OD<sub>260/280</sub> ratios of each RNA sample were
assessed using a NanoDrop 2000 UV-Vis spectrophotometer (Thermo Fisher
Scientific). RNA integrity was assessed using a RNA 6000 NanoKit for the
Bioanalyzer 2100 (Agilent Technologies) and the manufacturers’ protocols. Only
RNA samples with OD<sub>260/280</sub> ratios \> 1.7 and RNA integrity numbers
(RINs) \> 5 were further processed for qRT-PCR analysis. The iScript cDNA
synthesis kit (Bio-Rad Laboratories) was utilized for cDNA synthesis from 100 ng
of total RNA template following the manufacturer’s protocol, and iQ SYBR Green
(Bio-Rad Laboratories) was used to examine gene transcription following the
manufacturer’s recommendations. The 10-μl reaction mix included 0.4 μl cDNA, 5
μl iQ SYBR-Green supermix and 300 nM of forward and reverse primers.
Primers 3966 and 3967 were used to amplify a 179-bp internal fragment of the 16S
ribosomal RNA gene, which served as an internal control of gene expression,
while primers 3970 and 3971 were used to amplify a 156-bp internal fragment of
*bauA*, which served as a positive control for gene expression under iron
chelation. Primers 3972 and 3973 or 3974 and 3975 were used to amplify a 197-bp
internal fragment of *plc1* and a 181-bp internal fragment of *plc2*,
respectively. The cycling conditions for qRT-PCR assays, which were performed on
a Bio-Rad CFX Connect real-time PCR detection system, were as follows: 95°C for
3 min followed by 40 cycles of 95°C for 10 s and 60°C for 45 s. Relative
expression of *plc1* and *plc2* between iron-chelated and iron-repleted
conditions was quantified by the standard curve method in which serial dilutions
of cDNA samples served as standards. Samples containing no cDNA template were
used as negative controls. qPCR efficiencies were as follows: 16S, 82.4%;
*bauA*, 100.9%; *plc1*, 106.7%; and *plc2*, 97.7%. All samples were analyzed in
triplicate and melting curve data were included in the analysis to confirm
primers specificity. Data analysis also showed that there were no significant
differences in 16S expression between iron-chelated and iron-repleted
conditions. Therefore, the expression of *plc1* and *plc2* was normalized to
that of the 16S ribosomal RNA gene.
## Cell-type phospholipid content
The Bligh-Dyer method was utilized to extract total lipids from sheep, human,
and horse erythrocytes, A549 pneumocytes, and *G*. *mellonella*. Erythrocytes
were extracted by the addition of 2:0.8:2 parts of methanol, water and
chloroform. A549 cells were processed with 2:1.8:2 parts of methanol, water and
chloroform. *G*. *mellonella* larvae were homogenized and extracted with 2:0.8:2
parts methanol, water, and chloroform. The lipid-containing chloroform fraction
was analyzed by normal-phase HPLC. Phosphatidylcholine and
phosphatidylethanolamine levels in the samples were calculated using an Ultimate
3000 high performance liquid chromatography system (Thermo, Germering, Germany)
coupled with a Corona charged aerosol detector instrument (Thermo, Chelmsford,
MA, USA). Chromatographic separation was carried out using a Phenomenox Silica
(150 x 4.6 mm; 3μ) column at a flow rate of 1 ml/min. The mobile phase consisted
of (A) butyl acetate/methanol (4:1) and (B) butyl acetate/methanol/water (1:3:1)
with the following gradient elution: 0%-100% B at 0–15 min, 100% B at 15–17 min,
100%-0% B at 17–21 min, and then equilibrated with 100% A for 4 min. The column
temperature was set at 50°C and the injection volume was 10 μl. The nitrogen gas
pressure and response range of the detector was set at 35 psi and 500 pA,
respectively. The Chromeleon 6.8 software was used for data processing.
Identification of isolated compounds was based on retention times of authentic
standards.
## Phospholipase C and cytolysis assays
The presence of phosphatidylcholine-specific phospholipase C activity in *A*.
*baumannii* culture supernatants obtained after centrifugation at 15,000 *x g*
for 30 min was tested with the Amplex Red PC-PLC assay kit (Molecular Probes)
using lecithin as a substrate and following the conditions suggested by the
manufacturer’s protocol. Erythrocytes incubated in the presence of bacteria were
diluted 1:1000 into filter-sterilized FACSFlow sheath fluid (BD Biosciences) for
differential interference microscopy (DIC) and enumeration using flow cytometry.
Erythrocyte morphological changes were observed in these samples using DIC
microscopy on a Zeiss 710 Laser Scanning Confocal System (Carl Zeiss Microscopy
GmbH). The number of erythrocytes present in each analyzed sample was quantified
using a FACScan flow cytometer (BD Biosciences). Flow Cytometry Absolute Count
Standard beads (Bangs Laboratories, Inc.) were added 1:40 to diluted samples to
standardize volumes amongst 5-second samplings. Erythrocyte populations were
gated using the forward and side scatter channels.
The relative number of A549 cells remaining in cell culture following incubation
with *A*. *baumannii* strains was assessed using the CellTiter-Glo luminescent
cell viability assay (Promega) following the manufacturer’s instructions.
Briefly, the number of A549 cells remaining after incubation with bacteria was
assessed by measuring the luminescence resulting from the reaction of the
provided Ultra-Glo recombinant luciferase with ATP released from metabolically
active A549 cells. The relative luminescence units (RLUs) produced, and thus the
relative number of viable A549 cells remaining following infection, was
quantified using a FilterMax F5 microplate reader (Beckman Coulter) and reported
as a ratio of RLUs produced following lysis of infected A549 cells versus the
RLUs produced following lysis of uninfected A549 cells.
## Galleria mellonella virulence assays
Virulence assays were conducted using the *G*. *mellonella* model as previously
described. Briefly, assays were performed by injecting in triplicate 10 randomly
selected healthy final-instar *G*. *mellonella* larvae (n = 30) injected with
10<sup>5</sup> CFUs/larva (± 0.5 log) of the ATCC 19606<sup>T</sup> or its
isogenic derivatives suspended in sterile phosphate-buffered saline (PBS). Non-
injected larvae or larvae injected with five microliters of sterile PBS were
included as controls. After injection, larvae were incubated in darkness at
37°C, and the numbers of dead larvae were assessed at 24-hour intervals over 5
days with removal of dead larvae at times of inspection. Trials were repeated if
more than two deaths were observed in any of the control groups.
## Statistical analyses
The Student’s *t*-test or one-way analysis of variance (ANOVA), both provided as
part of the GraphPad InStat software package (GraphPad Software, Inc.), were
used to analyze the statistical significance of data, as appropriate for the
data set. Means of experimental data were compared to the means of the
respective control groups using the Tukey-Kramer multiple comparisons post-hoc
test. Survival curves were plotted using the Kaplan-Meier method and analyzed
for statistical significance using the log-rank test of survival curves (SAS
Institute Inc.). Significances for all data analyses were set *a priori* at *P*
≤ 0.05.
# Results
## Membrane lipid preference for *A*. *baumannii* hemolytic activity
DIC microscopy of horse erythrocytes incubated in the presence of ATCC
19606<sup>T</sup> cells shows that the presence of this strain significantly
decreases the number of intact red blood cells remaining in TSBD culture after
incubation at 37°C for 24 h (panels A and B). In addition, the horse
erythrocytes showed morphological changes characteristic of cell membrane damage
following incubation with ATCC 19606<sup>T</sup>. In contrast, the number and
morphology of sheep erythrocytes did not change after co-incubation under the
same conditions. These data prompted us to quantitatively determine the number
of sheep, horse or human erythrocytes remaining as well as the number of
bacterial cells present after 24-h co-incubations in TSBD medium. Flow cytometry
analyses of samples obtained from *A*. *baumannii* ATCC 19606<sup>T</sup>, LUH
13000 or AYE cultures containing sheep erythrocytes showed that AYE was the only
strain, of the three tested strains, to be significantly hemolytic (*P* \< 0.05)
to sheep erythrocytes, as compared to *E*. *coli* MG1655, which was used as a
hemolysis-negative control. A comparison of the mean amounts of sheep
erythrocytes remaining after 24-h incubations with ATCC 19606<sup>T</sup>, LUH
13000 or AYE under iron-chelation demonstrated a 5%, 3% and 17% reduction in
sheep erythrocytes, as compared to the *E*. *coli* MG1655 hemolysis-negative
control, respectively. In contrast, flow cytometry analyses showed that ATCC
19606<sup>T</sup>, LUH 13000 and AYE were hemolytic to human erythrocytes as
demonstrated by 41%, 23% and 41% reductions in the numbers of intact human
erythrocytes, respectively, with only the hemolysis caused by ATCC
19606<sup>T</sup> and AYE being statistically different from the hemolysis-
negative *E*. *coli* control (*P* \< 0.001). All three *A*. *baumannii* strains
were significantly hemolytic to horse erythrocytes (*P* \< 0.001) with the
percentage reduction of intact horse erythrocytes ranging from 95% after
incubation with ATCC 19606<sup>T</sup> or LUH 13000 to 98% after incubation with
AYE. Since *A*. *baumannii* was the most hemolytic to horse erythrocytes when
grown in iron-chelated TSBD, horse erythrocytes were chosen to test the effects
of iron-repletion on *A*. *baumannii* mediated hemolysis. The data demonstrated
a significant decrease in the hemolytic activity of ATCC 19606<sup>T</sup> (*P*
\< 0.001), LUH 13000 (*P* \< 0.01) and AYE (*P* \< 0.01) when TSBD was repleted
with free inorganic iron. Together, flow cytometry analyses of the hemolytic
activity of the three tested strains indicate that *A*. *baumannii* is poorly
hemolytic to sheep erythrocytes, intermediately hemolytic to human erythrocytes
and almost completely hemolytic to horse erythrocytes. This increasing
hemolytic activity showed a direct correlation with 0.27, 0.99 and 3.43
phosphatidylcholine/phosphatidylethanolamine ratios for sheep, human and horse
erythrocytes, respectively. Taken together, the data show that the extracellular
iron concentration as well as the erythrocyte phosphatidylcholine content are
critical factors in the detection of *A*. *baumannii* hemolytic activity.
## *A*. *baumannii* harbors two phospholipase C genes and produces phosphatidylcholine-specific phospholipase activity
The direct correlation between the amount of phosphatidylcholine in the
erythrocyte membrane shown above and the extent of hemolysis after incubation
with *A*. *baumannii* suggests the potential role of a phosphatidylcholine-
specific phospholipase C as the hemolytic effector. Analysis of the ATCC
19606<sup>T</sup> genome available through the Broad Institute website
(<http://www.broadinstitute.org/>) showed that this strain has two genes
predicted to code for phosphocholine-specific phospholipase C enzymes. One of
them (annotated as HMPREF0010_03297 and referred to as *plc1*) has a 2169-nt
open reading frame (ORF) coding for a potential 722-amino acid protein, which is
located downstream of a gene transcribed in the same direction and predicted to
code for an RNase PH. A gene coding for a putative nicotinate-nucleotide
diphosphorylase is located downstream of *plc1* and transcribed in the opposite
direction. The *plc1* gene corresponds to the *plc* ortholog reported as
A1S_0043 in ATCC 17978, the expression of which is enhanced by 2.5-fold when
bacteria are cultured in the presence of ethanol. The other ATCC
19606<sup>T</sup> phosphocholine-specific phospholipase C gene (annotated as
HMPREF0010_00294 and referred to as *plc2*) encompasses a predicted 2229-nt ORF
coding for a 742- amino acid protein. This gene corresponds to the ATCC 17978
A1S_2055 gene identified by Camarena *et al*.. A 48-nt intergenic region
containing an inverted repeat resembling a Rho-independent transcription
termination sequence follows *plc2* and separates this coding region from a
potential bicistronic operon, containing a thioesterase and a lactaldehyde
reductase coding region, which is transcribed in the opposite direction of
*plc2*. Based on ATCC 17978 genomic data, a 480-nt intergenic region separates
*plc2* from a predicted gene transcribed in the same direction and coding for
the DNA polymerase III tau and gamma subunits. These observations indicate that
the ATCC 19606<sup>T</sup> *plc1* and *plc2* are coded for by monocistronic
operons as it was reported for ATCC 17978. Other *A*. *baumannii* genomes
including AB0057, ACICU, ATCC 17978 and AYE show similar gene arrangements for
the chromosomal regions harboring *plc1* and *plc2*, an observation that
suggests the conservation of this genomic region across different *A*.
*baumannii* isolates.
Currently, it is unknown if other nosocomial *A*. *baumannii* strains that have
yet to be sequenced possess *plc1* and *plc2*; therefore, the presence of these
genes in additional *A*. *baumannii* strains that had not yet been sequenced was
tested by PCR using total genomic DNA and primers which hybridize within the
respective coding regions of both phospholipase C genes. Amplicons of the
predicted sizes, 993 bp for *plc1* and 1,167 bp for *plc2*, were obtained for
all 19 tested isolates confirming the presence of these genes in a variety of
*A*. *baumannii* strains. This screening study was further complemented by
testing the expression of hemolytic, PC-PLC and cytolytic activities in the same
19 *A*. *baumannii* strains. Hemolysis assays using horse erythrocytes showed
that all these strains had significant (*P* \< 0.001) hemolytic activity as a
compared to the negative control. The Amplex Red PC-PLC tests showed that the
PC-PLC activity of TSBD culture supernatants of all 19 strains was significantly
higher (*P* \< 0.001) than the negative control. Finally, the CellTiter-Glo
luminescent cell viability assays showed that all strains displayed cytolytic
activity against A549 human alveolar epithelial cells. Interestingly, HPLC
analysis of lipids extracted from these cells showed a
phosphatidylcholine/phosphatidylethanolamine of 2.58, which is significantly
higher than the 0.27 and 0.99 ratios detected in sheep and human erythrocytes,
respectively, but lower than the 3.43 value detected in horse red blood cells.
It is of note that the tested strains displayed significant variations in
hemolytic activity, with the ATCC 19606<sup>T</sup> and AB3340 isolates
producing the lowest and highest activities, respectively; PC-PLC activity, with
the AB3560 and AB3806 isolates producing the lowest and highest activities,
respectively; as well as cytolytic activity, with the AB4498 and AYE isolates
being the most and least cytotoxic strains, respectively.
All these data also indicate that there is no correlation between the hemolytic,
PC-PLC and A549 cytolytic activities expressed by the tested strains. For
example, strains ATCC 19606<sup>T</sup> and ATCC 17978, which are considered
non-contemporaneous and antibiotic sensitive clinical isolates displayed less
hemolytic activity than most of the tested strains, several of which are modern
multidrug resistant isolates. However, the PC-PLC and cytolytic activities of
ATCC 19606<sup>T</sup> and ATCC 17978 are comparable to that of most of the
remaining tested strains. The comparative analysis of the AB3340-AB5197 strains,
which were isolated from different infection sites of wounded soldiers and
include the AB5075 strain considered a highly virulent strain, show that
although there are significant variations in their hemolytic activity, PC-PLC
and cytolytic activities among them are comparable to those detected in the non-
military strains shown in. Finally, the comparative analysis of the ATCC
19606<sup>T</sup>, ATCC 17978 and the AB5075 isolates, with the two ATCC strains
being considered less virulent than the latter military isolate when tested
using the *G*. *mellonella* model, shows that although there is a correlation
between their relative virulence and cognate hemolytic phenotype, such a
correlation does not exist when their PC-PLC and cytolytic activities are
compared. Taken together, these observations indicate that although PC-PLC seems
to play a role in virulence, it is most likely that this is one of several
bacterial factors responsible for the virulence of this pathogen.
Preliminary assays showed that phospholipase activity was detected only when
ATCC 19606<sup>T</sup> bacteria were cultured in TSBD, a liquid medium that was
dialyzed against Chelex 100, an insoluble polymer that binds several metals,
including iron. This observation suggested that the expression of the genes
responsible for the production of phospholipase activity could be iron-
regulated. Quantitative RT-PCR analyses using total RNA extracted from ATCC
19606<sup>T</sup> cells grown in iron-chelated or iron-repleted TSBD showed that
transcription of *plc1* and *plc2* is indeed significantly higher (*P \<* 0.01
and *P* \< 0.05, respectively) in bacteria cultured under iron-depleted
conditions when compared with TSBD supplemented with inorganic iron. The
approximately 0.94-fold and 0.64-fold increase in the transcription of *plc1*
and *plc2* when ATCC 19606<sup>T</sup> was grown in iron-chelated TSBD *vs*.
iron-repleted TSBD may seem modest; however, since the product of *plc1* and
*plc2* are enzymatic in nature these changes could have pronounced biological
significance. These analyses also showed that the iron-regulated expression of
*plc1* and *plc2* is similar to that of *bauA*, which is only increased about
0.82 fold in iron-chelated TSBD *vs*. iron-repleted TSBD and codes for the
production of the BauA acinetobactin outer membrane receptor protein, which is
the product of a proven iron-regulated gene. The observation that the addition
of FeCl<sub>3</sub> to TSBD reduced the transcription of *plc1* and *plc2* to
levels similar to those detected for *bauA* strongly indicate that iron indeed
plays a critical regulatory role in the differential transcription of these
genes.
It appears likely that the iron-regulated expression of *plc1* and *plc2* is due
to the presence of putative Fur-binding sites, which were located approximately
100 nt and 200 nt upstream of *plc1* and *plc2*, respectively, and found to be
significantly related (e-value \> 0.05) to the *A*. *baumannii* Fur motif
recently reported. This possibility is strongly supported by the observation
that hemolysin and siderophore production in *V*. *cholerae* is co-regulated by
iron through a Fur-dependent transcriptional regulatory process.
The possibility of compensatory expression between *plc1* and *plc2* was
examined using ATCC 19606<sup>T</sup> isogenic derivatives harboring the
appropriate *plc* mutation. Quantitative RT-PCR analyses of *plc1* transcription
in 3430 *plc2*::*aph* cells or *plc2* transcription in 3452 *plc1*::*aph-FRT*
cells, all grown in TSBD, showed that there is not a regulatory mechanism by
which *plc1* transcription compensates for the lack of *plc2* transcription or
*vice versa*.
Taken together, these results show that the genomes of multiple *A*. *baumannii*
strains contain two phosphatidylcholine-specific phospholipase C genes, the
presence of which could correlate with their capacity to express hemolytic
activity, preferentially toward human and horse erythrocytes. Furthermore, the
production of this activity depends on the effect of free iron on the
differential transcription of *plc1* and *plc2*, which are expressed
independently of each other at higher rates under iron limiting conditions.
## The *A*. *baumannii* PLC1 and PLC2 have diverged from a common ancestor protein
Both PLC1 and PLC2 from ATCC 19606<sup>T</sup> cluster with phospholipase C
proteins from other known pathogens. PLC1 is located within a clade that
includes proteins produced by seven different *Acinetobacter* species with two
of them, *oleivorans* and *radioresistens* not being commonly associated with
human infections. Interestingly, two of these seven species have been reported
as being hemolytic, *A*. *beijerinckii* sp. nov. and the *A*. *calcoaceticus*
strain 1318/69 that was isolated from the urine of a 70-year old male patient.
Our preliminary observations also indicate that *A*. *nosocomialis* M2 expresses
hemolytic activity (data not shown). The hemolytic activity of *A*.
*nosocomialis* M2 is not surprising since it is so closely related to *A*.
*baumannii* that it was originally identified as *A*. *baumannii* M2. PLC2
groups with a more diverse clade that includes *Achromobacter*, *Cupriavidus*
and *Acinetobacter* sequences, with *A*. *gyllenbergii* being reported to lyse
both horse and sheep erythrocytes. Interestingly, PLC2 is also in the same clade
as phospholipase C produced by bacteria belonging to different genera and
species. Although most of these bacteria are non-pathogenic environmental
microorganisms that share symbiotic relationships with invertebrates such as
*Verminephrobacter aporrectodeae*, some of them have been isolated from human
patients such as *Massilia timonae*, *Bordetella hinzii* and the Melioidosis
agent *Burkholderia pseudomallei*.
More distant branches from PLC1 and PLC2 contain clusters encompassing
phospholipase C proteins from *P*. *aeruginosa*. The non-hemolytic PLCN of *P*.
*aeruginosa* resides in a group containing *Lysobacter antibioticus* and
*Lysobacter capsici*, which play roles in the rhizospheres of rice or peppers,
respectively. The hemolytic PLCH of *P*. *aeruginosa* groups outside a cluster
of environmental isolates with *Burkholderia* spp. reported to be involved with
wound infections, bacteremia and hemolysis.
## Effect of *plc* interruption on phospholipase activity and cytolysis
The role of the ATCC 19606<sup>T</sup> PLC1 and PLC2 proteins in the lysis of
erythrocytes and human epithelial cells was tested using the 3452 (*plc1*::*aph-
FRT*), 3430 (*plc2*::*aph*) and 3494 (*plc1*::*ermAM/plc2*::*aph*) isogenic
insertion derivatives. Interruptions in one or both of these genes did not
affect the growth of these derivatives; their growth kinetics were not
statistically different from that of parental ATCC 19606<sup>T</sup> when
cultured in TSBD under non-selective conditions. Flow cytometry analyses showed
that the number of intact horse erythrocytes remaining after incubation with the
3430 or 3452 isogenic derivative is not significantly different from the number
of erythrocytes remaining after incubation with the ATCC 19606<sup>T</sup>
parental strain. However, the number of erythrocytes remaining following
incubation with the 3494 isogenic derivative, which has interruptions in both
*plc1* and *plc2*, is more than 3-fold higher (*P* \< 0.001) than the number of
erythrocytes remaining after incubation with either ATCC 19606<sup>T</sup> or
the 3430 or 3452 isogenic derivatives.
The decreased ability of the 3494 isogenic derivative to lyse erythrocytes
correlates with that observed when these strains were incubated with A549 human
alveolar epithelial cells. In these experiments, the number of A549 cells
remaining after 24 h incubation in the presence of ATCC 19606<sup>T</sup>, 3430
or 3452 were not significantly different from one another; however, the number
of remaining A549 cells following incubation with 3494 was significantly higher
(*P* \< 0.001) than the number remaining after incubation with ATCC
19606<sup>T</sup>, 3430 or 3452.
The role of *plc1* and *plc2* in the production of PC-PLC activity was further
tested using the 3452.C (pMU1079) and 3430.C (pMU1080) derivatives, which harbor
plasmid copies of the *plc1* and *plc2* parental alleles, respectively. As
expected from data described above, the Amplex Red assays demonstrated that both
3452 (*P* \< 0.05) and 3430 (*P* \< 0.05) are significantly reduced in their
ability to degrade phosphatidylcholine as compared to the parental ATCC
19606<sup>T</sup> strain. This figure also shows that the transformation of 3430
with pMU1080, which harbors the *plc2* coding region under the control of the
pWH1266 tetracycline resistance promoter, not only restored, but also
significantly enhanced the production of PLC2 (*P* \< 0.01), with the latter
effect being most likely due to a gene dosage effect. Unfortunately, several
attempts to complement the 3452 mutant with the *plc1* parental allele (3452.C)
did not restore the phospholipase activity of this derivative possibly because
of regulatory mechanisms due to the fact that pMU1079 was made by cloning only
the *plc1* coding region without any upstream sequences that could affect its
expression in this recombinant derivative. The phospholipase activity of the
3452 and 3430 strains containing the empty *A*. *baumannii-E*. *coli* shuttle
vector pWH1266 (3452.E and 3430.E, respectively) were not significantly
different from that of the 3452 or 3430 strains demonstrating the pWH1266
shuttle vector used to clone the parental *plc1* and *plc2* alleles does not
confer a phospholipase phenotype upon these strains. Taken together, these
observations indicate that the activity of the phospholipase C proteins produced
by ATCC 19606<sup>T</sup> are not host cell specific and have cytolytic activity
against different cell types this pathogen could encounter during infection.
## Role of *plc1* and *plc2* in virulence
The same strains used to test cytolytic activity were also used to examine the
role of *plc1* and *plc2* in the virulence of *A*. *baumannii* ATCC
19606<sup>T</sup> with the *G*. *mellonella* experimental virulence model we
have used previously to determine the virulence role of the acinetobactin-
mediated iron acquisition system. shows that infection of caterpillars with ATCC
19606<sup>T</sup> resulted in a 47% mortality rate, which is significantly
higher than the 16% rate scored (*P* \< 0.05) with animals that were not
injected or injected with sterile PBS as negative controls. Interestingly, HPLC
analysis of lipids extracted from larvae homogenates showed that the
phosphatidylcholine/phosphatidylethanolamine ratio in this insect is 1.49, a
value that is between the 0.99 and 2.58 values determined for human erythrocytes
and A549 cells and much higher that the 0.27 ratio detected in sheep
erythrocytes. There was also a significant difference in percent survival when
larvae infected with ATCC 19606<sup>T</sup> were compared with larvae infected
with either the *plc1*::*aph-FRT* 3452 or the *plc1*::*ermAM/plc2*::*aph* 3494
double mutant (13% mortality, *P* \< 0.01). Furthermore, the killing rates of
these two mutants were not significantly different from each other as well as
from the rates scored with animals that were not injected or injected with
sterile PBS. In contrast, the death rates of caterpillars infected with the
*plc2*::*aph* 3430 isogenic derivative, which actively expresses *plc1*, were
very similar to those recorded after infection with the ATCC 19606<sup>T</sup>
parental strain (43% vs. 47%). These observations together with those collected
with the cytolytic assays described above indicate that while PLC1 and PLC2 seem
to play similar roles in lysing different host cells when tested either under
laboratory or *ex vivo* conditions, PLC1 appears to play a more critical role
during the infection of a host that mounts an innate immune response that
resembles that of vertebrate animals.
# Discussion
*Acinetobacter baumannii* has been generally considered a non-hemolytic pathogen
because, according to our observations, the detection of such an activity
depends on two critical factors. One of these factors is the type of
erythrocytes used in the detection tests, which are normally conducted using
Columbia agar plates containing 5% sheep red blood cells. Our work demonstrates
that *A*. *baumannii* is poorly hemolytic to sheep and increasingly hemolytic to
human and horse erythrocytes. These observations, which resemble those
previously reported for the strains ACICU, AYE, ATCC 17978 and SDF using sheep
and horse erythrocytes, are in agreement with the increasing phosphatidylcholine
content we detected in these erythrocytes. Furthermore, the positive correlation
between the *A*. *baumannii* hemolytic activity and the erythrocyte
phosphatidylcholine content is reminiscent of a phospholipase C homolog in *P*.
*aeruginosa*, where a hemolytic phospholipase C (PLCH) acts exclusively on
phosphatidylcholine and sphingomyelin.
The effect of the co-incubation of *A*. *baumannii* with sensitive erythrocytes,
such as those from horse, is apparent not only because of their lysis but also
because of the generation of schistocytes due to significant cell membrane
damage. These fragmented red blood cells have been detected in blood smears
obtained from infected neonates during an *A*. *baumannii* infection outbreak in
a Saudi Arabian hospital. In this case study of seven neonates, five had a total
erythrocyte count lower than controls throughout the course of *A*. *baumannii*
infection, and two of the seven neonates succumbed to *A*. *baumannii*
bacteremia. These observations clearly underscore the potential role of
hemolytic activity in the pathobiology of *A*. *baumannii*.
The second factor that determines the detection as well as the expression of
*A*. *baumannii* hemolytic activity is the iron content of the culture media.
Our data demonstrate that this activity is detectable when bacteria are cultured
in an iron-chelated medium but not when the medium is iron rich. Columbia agar,
which is used in standard clinical bacteriology methods to detect hemolytic
activity, is considered a rich-nutrient medium that would have to be treated
with a chelating agent such as Chelex 100 to properly detect hemolytic activity.
Accordingly, the differential expression of PC-PLC activity in response to iron
chelation correlates well with the differential transcription of the *plc1* and
*plc2* gene orthologs when Chelex 100-treated media is supplemented or not with
free iron, through a regulatory process that is most likely controlled by the
interaction of the Fur transcriptional repressor that could bind to predicted
iron boxes located upstream of these two genes. The iron-regulated expression of
the *plc1* and *plc2* genes and the corresponding PC-PLC activity suggests that
*A*. *baumannii* uses PLC1 and PLC2 for iron acquisition through the lysis of
host cells and the subsequent release of iron-rich cytoplasmic contents. This
possibility is further supported by the fact that iron co-regulates the
expression of *plc1* and *plc2* genes as well as the expression of genes
involved in the acinetobactin-mediated iron acquisition system, a response that
is similar to that described in *V*. *cholerae* where the production of
hemolysin and vibriobactin are regulated by a Fur-mediated process. Whether *A*.
*baumannii* acquires iron from intracellular pools via a siderophore-mediated
system or the expression of uncharacterized hemin utilization processes remains
to be tested experimentally. Unfortunately, the role of Fur in the expression of
the *A*. *baumannii plc* genes cannot be tested using a Fur deficient derivative
since our efforts as well as that of others indicate that Fur is an essential
gene. This possibility is strongly supported by a recent report showing that
random mutagenesis of *A*. *baumannii* did not result in the isolation of *fur*
mutants, an observation that led the authors to classify this gene as an
essential genetic element in this pathogen.
All previous considerations and the observation that *plc1* and *plc2* are
present in all sequenced *A*. *baumannii* genomes as well as the genomes of the
clinical strains tested in this study, but absent in the non-pathogenic *A*.
*baylyi* ADP1strain, strongly indicate a role of these phospholipases in
bacterial virulence. Until this report, only *plc1* and its role in cytolysis
had been tested experimentally where an *A*. *baumannii* ATCC 17978
*plc1*::*aph* isogenic insertion derivative was less effective in damaging FaDu
hypopharyngeal carcinoma epithelial cells as compared to the parental strain.
Our data not only support the virulence role of *A*. *baumannii* PC-PLC as
established by this previous report, but also indicate that the modest cytotoxic
effect reported is most likely due to the fact that only the inactivation of
both *plc1* and *plc2* results in a significant reduction of host cell damage.
Our work also shows that the product of these two genes target different types
of host cells *A*. *baumannii* could encounter during the pathogenesis of
systemic infections, as well as infection of the digestive and respiratory
systems as revealed by the damage this pathogen causes to erythrocytes, and the
FaDu and A549 epithelial cell lines, respectively. Our data collected using
laboratory and *ex-vivo* experimental conditions suggest that the *plc1* and
*plc2* genes code for potentially redundant cytotoxic functions. Only a double
*plc1/plc2* mutant showed a significant reduction in cytolytic activity when
tested using horse red blood cells and A549 human alveolar epithelial cells.
However, the *G*. *mellonella* experimental infection model showed that this is
not the case in an *in vivo* infection model. This model showed that PLC1 but
not PLC2 is critical for the virulence of the ATCC 19606<sup>T</sup> strain.
Interestingly, *plc1* but not *plc2* proved to be transcribed at higher rates
when ATCC 17978 bacteria were cultured in the presence of ethanol, a condition
that also increases the virulence and the expression of virulence-associated
traits including biofilm biogenesis and bacterial surface motility. Based on all
these observations, it is possible to speculate that PLC1 and PLC2 play
different roles during the pathogenesis of *A*. *baumannii* infections, with
PLC1 being coded for by a gene the expression of which appears to be regulated
at least by iron and stress signals. These signals are critical for the
virulence of this pathogen when tested in an invertebrate host that mounts a
complex defense response that mimics that of the human host. It is also possible
that the biological role of these two enzymes depends on the nature of potential
targets, which may reflect significant differences in phospholipid and fatty
acid composition between insect and mammalian cells. Interestingly, the
phylogenetic analysis of PLC2 shows that this protein clusters with a
phospholipase C protein from the invertebrate endosymbiote *Verminephrobacter
aporrectodeae*. This finding could explain the lackluster role of PLC2 in
virulence using the invertebrate *G*. *mellonella* virulence model due to a host
adaptation process. The phylogenetic analysis also showed that although many of
the amino acid sequences used to construct the phylogenetic tree shown in are
from environmental microorganisms isolated from soil, aquatic environments, or
industrial sites, it is apparent that there is also a strong correlation of the
bacteria producing these enzymes with plants in either antagonistic or
synergistic ways (*e*.*g*., pathogenesis of blight disease in some plants or
nitrogen-fixing bacteria present in the rhizosphere).
Taking into account our experimental data together with the observations
published by other investigators using different clinical isolates \[, –\], it
is apparent that *A*. *baumannii* produces two PC-PLC and three PLD
phospholipases. In the particular case of the ATCC 19606<sup>T</sup> strain, the
three PLD phospholipases are not essential for the utilization of
phosphatidylcholine as a carbon and energy source. This finding may indicate
that the two PC-PLC produced by this strain could be responsible for the
utilization of phosphatidylcholine as a nutrient source by the triple PLD
deficient derivative. It is also apparent that the ATCC 19606<sup>T</sup> PC-PLC
and PLD enzymes play a virulence role; although they may function differently
during the infection process. The report by Stahl et *al*. shows that all single
and double PLD mutants display a virulence phenotype indistinguishable from the
parental ATCC 19606<sup>T</sup> strain and only the triple Δ*pld1-3* mutant
showed a significant reduction in the killing rates throughout the course of the
experiment when compared to the parental strain. However, the killing rate of
this triple PLD mutant (74% for day 4 after infection) seems to be high if one
considers data published by other investigators who have used the same
experimental model and included in their Kaplan-Meier plots the control data
collected with non-injected animals or animals injected with the same volume of
sterile PBS, which unfortunately were not shown in this report. Furthermore, the
lack of information regarding the CFUs injected per larva rather than
OD<sub>600</sub> also impairs the proper comparison of our results with those
recently reported using the same strain and comparable experimental conditions.
Nevertheless, it is possible to speculate that there is a residual virulence
activity in the triple Δ*pld1-3* ATCC 19606<sup>T</sup> mutant that could
account for the activity of the PLC1 but not PLC2 as we describe in this report.
This critical issue as well as the question of whether the *A*. *baumannii* PLD
enzymes are differentially produced in response to extracellular signals and
display selective cytolytic activity in response to differences in membrane
lipid composition are critical topics that remain to be tested experimentally
using the proper ATCC 19606<sup>T</sup> isogenic derivatives. Such knowledge
will not only further our understanding of the role(s) of phospholipases in the
pathobiology of *A*. *baumannii*, but also provide critical information needed
to determine whether these enzymes could be used as alternative targets to treat
the severe infections caused by this pathogen, particularly by emerging multi-
drug resistant isolates.
# Supporting Information
This work was supported by funds from Department of Defense W81XWH-12-2-0035
grant, U.S. Public Health Service AI070174 award, and Miami University research
funds. We thank Drs. D. Zurawski (Walter Reed Army Institute of Research, Silver
Spring, Maryland, USA) and L. Dijkshoorn (Leiden University Medical Center,
Department of Infectious Diseases, Leiden, The Netherlands) for providing the
wound clinical isolates and the LUH and RUH strains, respectively, which are
listed in. We are also grateful to Dr. E. Lafontaine (College of Veterinary
Medicine, University of Georgia, USA) for providing the A549 cell line. The
findings and opinions expressed herein belong to the authors and do not
necessarily reflect the official views of the WRAIR, the U.S. Army, or the
Department of Defense.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** SEF BAA LAA. **Formal analysis:** SEF BAA TT
MKSJ RG LAA. **Funding acquisition:** LAA. **Investigation:** SEF BAA RES
ACB TT MVC EJO MM MKSJ RG LAA. **Methodology:** SEF BAA RES ACB TT MVC MKSJ
RG EJO MM. **Resources:** LAA. **Supervision:** SEF BAA LAA. **Validation:**
SEF BAS RES ACB TT MVC RG EJO MM MKSJ LAA. **Visualization:** SEF BAA RES
ACB TT MVC EJO MM MKSJ LAA. **Writing – original draft:** SEF BAA LAA.
**Writing – review & editing:** SEF BAA RES ACB TT MVC RG EJO MM MKSJ LAA.
[^3]: Current address: Department of Biological Sciences, Miami University
Middletown, Middletown, Ohio, United States of America
[^4]: Current address: Biology Department, Middle Tennessee State
University, Murfreesboro, Tennessee, United States of America
[^5]: Current address: Department of Pathology, Microbiology, and
Immunology, Vanderbilt University, Nashville, Tennessee, United States of
America
[^6]: Current address: Department of Biological Sciences, University of
Idaho, Moscow, Idaho, United States of America
[^7]: Current address: Biology Department, Texas Christian University, Fort
Worth, Texas, United States of America
|
# Introduction
Many plant functions appear to cycle from low to high levels of activity on
approximately a 24-hour schedule, a phenomenon recognized centuries ago.
Virtually every physiological process in a plant undergoes at least one rhythmic
cycle within a 24-hour period. Many of these diurnal cycles appear to be a
response to external time cues, such as the light/dark or high/low temperature
cycles that naturally arise from the alternation of day and night. These
environmental time cues, termed Zeitgebers (German for “time givers”), tend to
entrain the internal timing systems of plants to a period of about 24 h,
corresponding to the period of the earth’s rotation. While some processes tend
to reach peak activity in the middle of the subjective day or night, others
reach peak activity at characteristic time points other than the middle. The
alternating phases of the cycles are accompanied by extensive reengineering of
the transcriptome, indicating a great many genes are primarily or secondarily
influenced by the clock mechanisms.
Cycles with a period of less than 24 h, or ultradian cycles, are becoming
increasingly well-known in plants and are thought to have a number of functions
including regulation of cell signaling, optimization of energy efficiency,
optimization of responses to stimuli, spatial organization, temporal
organization, the separation of incompatible processes occurring in the same
subcellular compartment, and coordination of processes occurring in separate
compartments. One school of thought holds that diurnal cycles arose through
consolidation of ultradian cycles, presumably because of an evolutionary
advantage associated with longer cycle times. Cycles with periods as short as a
few minutes occur in plants as nutrients are taken up in the roots, and as part
of carbon assimilation and partitioning during photosynthesis-related
metabolism.
Specifically, in relation to freezing tolerance in wheat (*Triticum aestivum*
L.) plants, expression levels of many of the C-repeat binding factor (CBF) genes
were observed to fluctuate in diurnal fashion in plants grown under a 16 hours
light/8 hours dark photoperiod at 20°C. The CBF genes encode transcription
factors that are intricately involved in the conditioning of the response to low
temperature, as well as other stress factors. In Arabidopsis, CBF genes
expression has been shown to cycle in diurnal fashion. Most of the 13 wheat CBF
genes examined by Badawi et al. reached minimum expression at the end of an
8-hour dark period, then reached maximum expression 10–12 hours after the start
of the light period. One of the CBF genes (TaCBFIIIa-D6) also showed a second,
cyclic increase in expression at about the middle of the 8-hour dark period. At
least 65 CBF genes are present in the wheat genome and involvement of these
genes in both above- and below-freezing low temperature tolerance of wheat has
been amply demonstrated. Campoli et al. observed that variation in expression
levels of some of wheat, rye (*Secale cereale* L.), and barley (*Hordeum
vulgare* L.) CBF genes were reduced during the dark phase of various photoperiod
regimes, leading the authors to suggest their expression “may reflect a
temperature-dependent, light-regulated diurnal response.” That observation, and
the observations of Badawi et al. of diurnal cycles of expression of several
wheat CBF genes suggests that low temperature tolerance may also show cyclic
variation in expression. Others have reported that the photoperiod significantly
affects the freezing tolerance of some wheat lines and references therein).
The wheat genes CBF14 and CBF15 have become of particular interest to freezing
tolerance investigations. These genes are part of a cluster of at least 11 CBF
genes, collectively referred to as the *Fr*2 locus, found on the long arm of the
group 5 homoeologous chromosomes of hexaploid wheat. While all of these CBF
genes presumably contribute to freezing tolerance, CBF14 and CBF15 are expressed
to the highest levels of all of the genes in the *Fr*2 locus on exposure to low
temperature, perhaps indicating they condition a greater portion of the observed
freezing tolerance. Copy number variation of CBF14 and CBF15 has been shown to
be a significant factor influencing the effectiveness of these genes with
greater numbers of copies associated with greater freezing tolerance. Each of
these lines of evidence suggest that CBF14 and CBF15 play a major role in
freezing tolerance. Indeed, Soltesz et al. demonstrated that genetically
transforming these genes individually into freezing-sensitive spring barley
plants resulted in highly significant improvement of freezing tolerance. Novak
et al., found that light quality also strongly influences CBF14 expression and
subsequently reported that “it can be assumed that temperature and light signals
are relayed to the level of CBF14 expression via separate signalling routes”.
Therefore, it appears that varying light conditions may influence the expression
of the CBF genes, especially CBF 14 and CBF 15, even at constant temperature,
implying that freezing tolerance also may vary over the course of 24 hours at
constant temperature. Accordingly, the objective of this study was to determine
whether fully cold-acclimated winter wheat plants grown under diurnal light/dark
cycles were significantly more freezing tolerant at the mid-points, or at the
end-points of the light and dark periods, and to assess the expression levels of
CBF14 and CBF15 at these time points to look for a possible relationship of
expression of these genes and freezing tolerance.
# Materials and methods
## Freezing tolerance of wheat plants
The winter wheat cultivars included in this study were ‘Eltan’, ‘Froid’,
‘Norstar’, ‘Bruehl’, ‘Centurk 78’, ‘Jagger’, ‘Lewjain’, ‘Madsen’, ‘Masami’,
‘Nugaines’, and ‘Tiber’, and germplasm line ‘Oregon Feed Wheat \#5’ (ORFW).
These cultivars represent a range of freezing tolerance with Norstar the most
freezing tolerant and ORFW the least. The freezing tolerance of most of these
lines were described previously. The ORFW germplasm line appears to carry a
major, dominant gene conditioning freezing sensitivity.
Seeds were sown into Sunshine Mix LC1 planting medium (Sun Gro Horticulture,
Bellevue, WA, USA) in 6-container packs (Model 1020, Blackmore Co., Belleville,
MI, USA); the capacity of each container in the pack was about 100 ml. Each
freezing tolerance trial was comprised of eight of the 6-container packs. Each
of the 12 wheat lines were represented four times in each freezing trial. Each
freezing trial was considered a replication and the four representations of each
line were considered subsamples within trials. Seeds were germinated and
seedlings grown at 22°C in a growth chamber (Model E15, Conviron, Pembina, ND)
under cool, white fluorescent lights (about 300 µmol m<sup>-2</sup>
s<sup>-1</sup> PAR at the soil surface) with a 12-hour photoperiod until the
seedlings reached the three-leaf stage. Relative humidity was not controlled.
The plants were then transferred to 4°C with a 12-hour photoperiod (about 250
µmol m<sup>-2</sup> s<sup>-1</sup> PAR at mid-plant height) for 5 weeks to
induce cold acclimation prior to freezing survival tests. Lights were turned on
at 6 a.m. and turned off at 6 p.m. Dawn is often defined as “ZT0” (Zeitgeber
time zero;), thus, in this study, ZT0 refers to 6a.m. Plants were irrigated
weekly with nutrient solution containing macro and micronutrients (Peters
Professional, Scotts Co., Camarillo, CA, USA). Prior to freezing, the flats were
drenched with a solution of 10mg/L Snomax snow inducer (Snomax LLC,
International, Centennial, CO, USA) maintained at 4°C, and allowed to drain
until drainage had essentially ceased, then freezing was carried out in darkness
in a programmable freezer (model LU-113, Espec Corp., Hudsonville, MI, USA). The
temperature of the plant growth medium in each container near the crowns of the
plants was monitored using thermistor-based, food piercing temperature probes
with expected accuracy of ±0.3°C, and an internet-enabled temperature monitor
(Model E-16, Sensatronics, Bow, NH, USA). The temperature was recorded every 2
min using a data capture script running on a remote computer. Freezing tests
were initiated at ZT0, ZT6, ZT12 and ZT18, i.e. at the start, midpoint, and end
of the 12-hour light and dark periods. The trials initiated at ZT18 (middle of
the dark period) were placed in the freezer at ZT12, at the start of the dark
period, and the freezer was maintained at 4°C until the start of the freezing
test at ZT18, thereby avoiding exposure to light before the start of the
freezing trial. At the start of each freezing test, the temperature in the
freezer was reduced from 4°C to -3°C and held at -3°C for 16 hours to allow all
of the soil water to be converted to ice and the heat of ice formation to
completely dissipate from the samples before the temperature was lowered to the
target temperature at a rate of -2°C h<sup>-1</sup>. The temperature was held at
the target for 2 hours, then raised to 4°C at a rate of 2°C h<sup>-1</sup>.
Plants were exposed in separate trials to target temperatures of -13.5, -14.5,
-15.5, or -16.5°C with freezing tests to each target temperature started at each
of the four time points, ZT0, ZT6, ZT12 and ZT18. A total of 1,723 containers
holding 37,236 plants were tested. After freezing, the plants were then
transferred to a growth chamber at 4°C for 24 hours to allow the soil to
completely thaw and the soil temperature to equilibrate, then were moved to 22°C
with a 16-hour photoperiod for recovery. Survival was scored after 5 weeks of
regrowth. Statistical analysis was carried out using the “Fit Model” platform of
JMP version 12 (SAS Institute Inc., Cary, NC, USA). The proportions of plants
surviving formed the response variable and wheat lines (genotypes), minimum
temperature, freezing trial start time, replications, and subsamples within
replications were the predictor variables. Means separation was determined using
least significant difference with a significance level of 0.05. For statistical
analysis of the main effects, the response was expressed as the arcsine of the
square root of the surviving proportion as recommended but are expressed in the
original scale in this report. For calculations of the LT<sub>50</sub>, the
temperature expected to result in death of 50% of the plants, the response was
expressed as the ratio of the number of plants surviving to the number of plants
frozen in each trial, estimated with binomial distribution and probit link
function specified. The minimum temperatures for the LT<sub>50</sub>
calculations were specified as the minimum temperature recorded for each
container, rounded to the nearest 0.5°C, then increased by 30°C to avoid
negative numbers in the probit calculations. The LT<sub>50</sub> values are
expressed in the original scale in this report.
## CBF gene expression analysis
At each of the time points, ZT0, ZT6, ZT12 and ZT18, seedlings of the wheat
lines Norstar, Tiber and ORFW that had been grown to 5 weeks of cold acclimation
at constant 4° C under a 12-hour photoperiod as described above were quickly
removed from the soil and plunged into liquid nitrogen. Three independent
biological samples grown at different times were collected. Total RNA was
extracted from the crown tissue (meristematic regions) using Trizol reagent and
the supplier-recommended procedure (ThermoFisher Scientific, Waltham, MA, USA),
and then treated with DNase I and further purified using the Direct-zol RNA
MiniPrep kit (Zymo Research, Irvine, CA, USA). Purified RNA was quantified using
a Nanodrop 1000C instrument (ThermoFisher Scientific, Waltham, MA, USA).
Complementary DNA (cDNA) was synthesized using the ProtoScript First Strand cDNA
Synthesis Kit (New England Biolabs, Ipswich, MA, USA) using 1µg RNA as starting
template. The resulting cDNA was diluted 1:5 prior to use as template for
quantitative real-time PCR. The qPCRs were conducted on an Applied Biosystems
7300 Real-Time PCR System (ThermoFisher Scientific, Waltham, MA, USA) using 25µl
preparations that consisted of 1X Go-Tag Colorless Master Mix (Promega, Madison,
WI, USA), 1µl cDNA, 200µM each primer, 0.85X SYBR Green I as a reporter fluor,
and 300nM ROX dye (ThermoFisher Scientific, Waltham, MA, USA) as a passive,
internal fluorescence standard. The PCR primers used for CBF14 were: forward,
`5'-AACCGATGACGAGAAGGAAA-3'`, and reverse, `5'-AACTCCGAGTAGCACGATCC-3'`. The
primers used for CBF15 were: forward, `5’-GTCGTCCATGGAAAATACCG-3’`, and reverse:
`5’-ATGTGTCCAGGTCCATTTC-3’`.
The PCR amplification profile was 3 min at 95°C, then 45 cycles of 95°C for 30
sec, 55°C for 25 sec, and 72°C for 30 sec. Two technical replications of each of
the three biological replications were performed. The qPCR software available
with the instrument was used to determine the Ct, the fractional cycle number at
which the fluorescence intensity reached an arbitrary threshold, using the
threshold determined by the software. Relative fold change was determined using
the delta-delta Ct method, with Ct values normalized to the Ct values of house-
keeping gene Ta30797, encoding phosphogluconate dehydrogenase, using the forward
primer `5’-GCCGTGTCCATGCCAGTG-3’`, and reverse `5’-TTAGCCTGAACCACCTGTGC-3’`, as
described by elsewhere.
## NMR spectra of plant extracts
Wheat plants of the cultivars Norstar, ORFW and Tiber were grown and cold-
acclimated for 5 wks at 4°C and 12-hour photoperiod as described above. After 5
wks, the plants (about 20 plants) were removed from the cell packs at each of
the ZT0, 6, 12, or 18 time points, quickly rinsed in ice water, then dropped
into liquid nitrogen. Each combination of wheat cultivar and time of day was
represented by two biological replications grown and processed at separate
times. Roots, residual caryopses, and shoots above the first node were removed
while the plant tissue was frozen, using forceps, and the crown and “stem”
tissue was ground to a fine powder with a mortar and pestle and additional
liquid nitrogen. The powdered tissue was transferred to a 15 ml screw-top tube
and transferred to a water bath at 85°C before the tissue had thawed. Samples
were maintained at 85°C for 15 min to stop intrinsic enzyme activity, then held
on ice until all samples were processed. An 18 gauge (1.3mm diameter) hypodermic
needle was used to punch a hole in the bottom of the 15 ml tube, which was then
placed within a 50 ml centrifuge tube. The samples were centrifuged at 8,000 xG
for 10 minutes and the exudate recovered from the 50 ml tube. The residual plant
tissue was transferred to a new 15 ml screw-top tube, 2 ml of pure water were
added, samples were mixed by vortexing, then placed in a boiling water bath for
15 min. Samples were then cooled to room temperature, centrifuged at 10,0000 x G
for 10 min, and the supernatant was transferred to a new tube. The recovered
plant exudate and supernatant samples were frozen to -20°C and then lyophilized
to complete dryness. The dried plant material was dissolved in deuterium oxide
(D<sub>2</sub>O; Cambridge Isotope Laboratories, Tewksbury, MA, USA) to a
concentration of 50 mg/ml. In preparation for nuclear magnetic resonance (NMR)
analysis, samples were diluted to 15 mg/ml in 1mM TMSP (2,2,3,3-d4
sodium-3-trimethylsilylpropionate; Cambridge Isotope Laboratories) in
D<sub>2</sub>O. <sup>1</sup>H NMR spectra were recorded on a Varian / Agilent
400-MR (399.763 MHz for <sup>\`</sup>H) instrument using a Varian OneNMR probe.
The data were acquired using the standard PRESAT pulse sequence where the
carrier was set to the residual water frequency. A relaxation delay of 13
seconds was followed by a weak presaturation field (30 Hz B1) for two seconds
and the data collected using a 90-degree pulse and an acquisition time of 2.6
seconds. Sixteen NMR scans were completed for each sample. The receiver gain was
kept constant for all samples.
All spectra were processed using the DataChord Spectrum Miner software (One Moon
Scientific, Westfield NJ). The raw FIDs were loaded into DataChord Spectrum
Miner and processed as a batch with no apodization and the resulting spectra
were aligned using the peak from TMSP as the standard located at 0 ppm. Spectral
regions were defined manually and integrated peak areas determined. The compound
peak areas of all spectra were standardized to TMSP as follows. The grand mean
area of all of the TMSP peaks in the experiment were determined, then for each
run, the area of the TMSP peak was divided by that grand mean, yielding a
standardizing factor for the run. Each peak area in that spectrum was multiplied
by the factor to yield standardized data. Further analysis was carried out using
JMP software ([http://www.jmp.com](http://www.jmp.com/)).
Identification of metabolites was undertaken by analysis of multidimensional NMR
data and comparison of chemical shift data with database values. Two-dimensional
<sup>1</sup>H-<sup>1</sup>H TOCSY (TOtal Correlation SpectroscopY),
<sup>1</sup>H-<sup>13</sup>C HSQC (Heteronuclear Single Quantum Correlation) and
<sup>1</sup>H-<sup>13</sup>C HMBC (Heteronuclear Multiple Bond Correlation)
spectra were recorded using a sample that contained a compound associated with
freezing tolerance based on PCA analysis. Two-dimensional data were recorded on
a Varian / Agilent VNMRS 500 (<sup>1</sup>H 499.84 MHz, <sup>13</sup>C 125.69
MHz) using the standard pulse programs zTOCSY, gHSQCAD and gHMBCAD. For the
TOCSY data 2 x 512 t1 increments (States-TPPI) using 16 scans each were acquired
using non-uniform data sampling (NUS) at 50% density giving a total acquisition
time of 4.25 hours. Residual water was reduced using a 20 Hz presaturation radio
frequency field for 1 second and the TOCSY mixing was accomplished using a
DIPSI-2 sequence for 80 ms. The sweep width was 5,660 Hz in both dimensions and
the data were processed using DataChord Spectrum Analyst (One Moon Scientific,
Westfield, NJ) using an iterative soft threshold Fourier Transform algorithm to
produce a final 2Kx2K point 2-dimensional spectrum. HSQC data were acquired
using gradient coherence selection and utilizing 2 x 256 t1 increments of 64
scans and NUS sampling (50%) for a total acquisition time of 7.75 hours.
Residual water was reduced with presaturation and the sweep width in the
<sup>1</sup>H dimension was 5660 Hz while for the <sup>13</sup>C dimension
20,736 Hz (165 ppm) was used. Data were processed similarly to the TOCSY data to
yield a 2K x 2K final spectrum. HMBC data were recorded with 2 x 256 t1
increments using linear sampling and 64 scans per t1 increment to give a total
acquisition time of 13.3 hours. A spectral with of 5,660 Hz was used for the
<sup>1</sup>H dimension and 24,510 Hz (195 ppm) was used for the <sup>13</sup>C
dimension. A long-range <sup>1</sup>H-<sup>13</sup>C J-coupling of 8 Hz was used
to develop <sup>1</sup>H-<sup>13</sup>C correlations. Residual water was
suppressed with presaturation and the data processed to produce a 2K x 2K final
spectrum. The data were anodized in the t2 domain with a sine bell function and
in the t1 domain with a gaussian function and the data were represented in the
mixed phase mode (absolute value in F2 and phase sensitive mode in F1). Once
identifications were obtained samples were compared with authentic samples of
compounds.
# Results
## Plant freezing tolerance
Tabulated survival data are provided in. Analysis of variance revealed that
wheat lines (genotypes), minimum temperature, and the time the freezing tests
were initiated all were significant sources of variation at P\<0.0001.
Replications and subsamples within replications were significant only at
P\<0.05, and together accounted for less than 1.5% of the variation. Average
survival of each of the wheat lines when freezing was initiated at each of the
time points (ZT0, ZT6, ZT12, ZT18) is shown in. These times corresponded to the
start and midpoint of the light period (ZT0 and ZT6, respectively), and the
start and midpoint of the dark period (ZT12 and ZT18, respectively). With the
exception of ORFW, which had very little survival in any of the tests, freezing
tolerance was significantly greater when the plants were exposed to the subzero
temperatures at the midpoint of the light period or the midpoint of the dark
period, compared to the start of either of those periods. The improvement of
survival in the tests conducted mid-period ranged from 7.8 to 32.4%, compared to
the tests initiated at the start of the periods, with an average improvement of
21.3% (shown by the grey bars in). LT<sub>50</sub> values calculated from the
combined data for the trials that were started at the midpoint of the light and
dark periods, and for the trials initiated at the start of those periods are
shown in. The differences in LT<sub>50</sub> between the periods ranged from
1.8 to 4.9°C, with an average of 2.5°C.
All freezing tolerance tests were initiated with a 16-hour period at -3°C to
allow the soil water to freeze and the heat of ice formation to dissipate,
followed by controlled reduction in temperature to the target, potentially
damaging, challenge temperature, as described above. This 16-hour “pre-freezing”
period and the controlled reduction in temperature to the target resulted in the
plants experiencing the potentially damaging temperature at about 24 hours after
the start of the test. Consequently, the plants were exposed to the lowest
temperature at about the same time of day as the test was started, but 24 hours
later.
## CBF14 and CBF15 expression
Expression of CBF14 in Norstar and Tiber showed upregulation from ZT6 to the
subsequent ZT0, then downregulation from ZT0 to ZT6. In contrast, expression of
CBF14 in ORFW was upregulated from ZT12 until the subsequent ZT0, then
downregulated during the ZT0 to ZT12 time interval.
Regulation of CBF15 in ORFW was very similar to regulation of CBF14. In
contrast, in Norstar and Tiber, the regulation of CBF15 was essentially 180° out
of sync with CBF14, *i*.*e*. CBF15 was downregulated from ZT6 to ZT12 and again
from ZT18 to ZT0 while CBF14 was upregulated, and CBF15 was upregulated from ZT0
to ZT6 while CBF14 was downregulated during that time interval.
## NMR spectra of plant extracts
An example of the <sup>1</sup>H NMR spectra obtained is shown in. A total of 70
compounds ranging from 1 ppm (the TMSP standard) to 9.5 ppm were identified in
all of the samples, as shown in. For overall comparison of the plant lines and
times of sample collection, the data from the two kinds of extractions (exudate
vs. boiled) were considered as one data set and analyzed with principal
component analysis (PCA). A plot of the first two principal components clearly
distinguished the three plant lines, indicating Norstar, Tiber and ORFW differed
from one another in relative content of some of the 70 compounds identified. The
four sample collection time points also were associated with consistent
positions on the PCA chart. The data points associated with the end of the light
period/start of the dark period, ZT12, and middle of the dark period, ZT18, were
clearly separated from the data points associated with the end of the dark
period/start of the light period, ZT0, and the middle of the light period, ZT6
in each of the samples. These results suggested that the cellular contents of
the plants were constantly in flux throughout the 24-hour cycle, at constant 4°C
and 12-hour light/12-hour dark photoperiod. However, in contrast to the 12-hour
cycling of freezing tolerance, cycling of the metabolites detected with NMR was
in diurnal fashion with data points associated with the dark period (ZT12 to
ZT18) consistently distinct from data points associated with the light period
(ZT0 to ZT6) on the PCA plot. Thus, there did not appear to be an overall
similarity of metabolite dynamics as detected by NMR, with the ultradian
variation in freezing tolerance. This lack of association was most apparent when
considering that the decreased levels of freezing tolerance were observed with
freezing tests initiated at ZT0 or ZT12, which consistently were widely
separated on the PCA plot of the NMR spectra.
The PCA plot represents overall similarity of the composition of the plant
extracts and may not represent the behavior of individual compounds. Further
examination of the concentration dynamics of the 70 individual compounds found
in the NMR spectra from each plant line at each time point revealed that
“compound 15”, observed as a peak at 2.06 to 2.19 ppm, varied in a manner that
was consistent with expressed freezing tolerance. Of the three lines examined
with NMR, Norstar was the most freezing tolerant, Tiber was intermediate, and
ORFW was the least freezing tolerant at each of the time points. At each of the
time points, the concentration of compound 15 was greatest in Norstar,
intermediate in Tiber, and lowest in ORFW. Also, in Norstar, the concentration
of compound 15 varied in ultradian fashion, reaching local maxima at ZT6 and
ZT18 and local minima at ZT0 and ZT12, coincident with levels of expressed
freezing tolerance. In contrast, the concentration of compound 15 remained
essentially unchanged in Tiber throughout the 24-hour period at 50–70% of the
concentration seen in Norstar. In ORFW, with very little freezing tolerance,
compound 15 reached maximum concentration at ZT6, at about 40% of the
concentration seen in Norstar, but then declined to an undetectable level by
ZT18, and increased only slightly between ZT18 and ZT0. Thus, there appeared to
be an association of the concentration of compound 15 with the observed relative
levels of freezing tolerance in these three wheat lines, especially apparent
with consistently higher concentrations and cyclic variation in parallel with
variation of freezing tolerance in Norstar.
The identity of compound 15 was revealed by analysis of several 2-dimensional
data sets starting with the TOCSY data where the signal at 2.144 ppm in the
proton spectrum correlated to a signal at 2.452 ppm and further to another at
3.777 ppm. The HSQC data showed the signal at 2.144 ppm to be a methylene group
with a carbon chemical shift of 29.0 ppm whereas the signal at 2.452 ppm was
another methylene with a carbon chemical shift of 33.7 ppm and the signal at
3.777 ppm was a methine with a carbon chemical shift of 56.8 ppm. The HMBC data
showed that the methylene at 2.144 ppm had long-range correlation to two
carbonyl groups at 176.7 and 180.3 ppm. The methine at 3.777 ppm was also
correlated by a long-range coupling to the carbonyl at 176.7 ppm. Long-range
correlations were seen between the methylene groups and the methine group but no
correlations could be seen from the methylene at 2.452 ppm to the carbonyl
groups. The signal to noise ratio of the HMBC data was not high due to the
overall low concentration of most of the metabolites in the mixture so even with
the lack of correlation from one of the methylene groups to one or more
carbonyls it was concluded that the patterns matched closely with those expected
for glutamic acid or glutamine. HSQC spectra were collected on both glutamic
acid and glutamine in D<sub>2</sub>O and compared to the spectra recorded on the
plant sample. The overlay of the data sets for the plant sample and for
glutamine are shown in. The chemical shifts in <sup>13</sup>C from glutamine
were coincident with compound 15, while signals in the <sup>1</sup>H dimension
from compound 15 were slightly shifted (2 Hz) from the authentic sample. This
small of a difference easily could be due to minute pH or concentration
differences, hence, we suggest that compound 15 is glutamine.
# Discussion
Freezing tolerance of young, fully cold-acclimated plants of the 12 winter wheat
lines investigated here was expressed in a biphasic manner in plants grown at
constant 4°C under a 12-hour photoperiod. Of the four time points studied, the
greatest freezing tolerance occurred at ZT6, the midpoint of the light phase,
and ZT18, the midpoint of the dark phase. This ultradian cycling of phenotypic
expression of freezing tolerance suggested that genes involved in freezing
tolerance also were expressed in ultradian cycles. The transcript expression
levels of CBF14 and CBF15, genes shown to play a major role in freezing
tolerance in wheat were shown to cycle throughout the day, but essentially 180°
out of phase with one another, in freezing tolerant cultivars Norstar and Tiber.
However, in wheat line ORFW, a line that develops very little freezing
tolerance, the cyclic expression levels of CBF14 and CBF15 were essentially in
phase. Thus, although both CBF14 and CBF15 appeared to be upregulated from ZT12
to the subsequent ZT0 in ORFW, there was no evidence of greater freezing
tolerance as a result of that simultaneous elevated expression of both genes. In
the case of Norstar and Tiber, freezing tolerance manifested most strongly at
ZT6, when CBF15 was expressed to high levels, concomitant with low levels of
expression of CBF14, and at ZT18, when both genes were expressed to high levels.
These results suggest that precise coordination of expression of these genes, as
opposed to simply higher levels of expression, was critical to manifestation of
greater freezing tolerance in these two wheat lines.
We previously found that ORFW is capable of responding to freezing stress in
some ways similar to Norstar and Tiber. For example, lipid dynamics in response
to six low-temperature treatments were very similar in ORFW and five other
cultivars, including Norstar and Tiber, indicating that some components of the
low-temperature response of the cold-sensitive ORFW function similarly to those
components in more cold-tolerant genotypes. This observation suggests that
different pathways may significantly contribute to freezing tolerance in the
different genotypes. The evidence of the involvement of glutamine may point to
one such pathway, suggesting that Norstar may make use of a glutamine-dependent
pathway that is not functional in Tiber or ORFW.
Others reported increased glutamine concentration in wheat plants on exposure to
low temperatures. Kan et al, reported that supplying glutamine to rice plants
grown in hydroponic culture resulted in upregulation of several genes involved
in stress response including a number of transcription factors, leading the
authors to suggest that “glutamine may also function as a signaling molecule to
regulate gene expression in plants.” Kamada-Nobusada et al. also suggested
glutamine may function as a signal molecule in rice plants, and Miranda et al.
and Molina-Rueda and Kirby reported that glutamine may function as a signal
molecule in stress response in *Sorghum* species and *Pinus* species,
respectively. Thus, a growing body of evidence suggests that plants have the
potential to activate a stress response pathway that may be regulated by
variation in glutamine concentration.
In the three wheat lines studied here, the concentration of glutamine in the
cellular fluid varied in concentration in a manner consistent with freezing
tolerance in that the concentration was greatest in Norstar, the most freezing
tolerant line, intermediate in Tiber, which is intermediate in freezing
tolerance, and lowest (sometimes undetectable) in ORFW, which is the least cold
tolerant line. Also, the concentration of glutamine in Norstar varied with two
highs and two lows in the 24-hour period, coincident with the freezing tolerance
dynamics of Norstar. Others have found diurnal fluctuation in the concentration
of some amino acids in wheat sap under warm (20–22°C) conditions and a 16-hour
photoperiod, but glutamine concentration was not found to vary in that study.
That result, considered with the results reported here, suggests that glutamine
may function as a component of the pathway(s) responsible for cyclic variation
of freezing tolerance under certain conditions of temperature and photoperiod in
genotypes capable of using that pathway; constant low temperature (4°C) and
12-hour photoperiod in the cultivar Norstar in the present case.
The observed sequential increase, then decrease in freezing tolerance is
consistent with our previous findings showing that exposing the plants to -3°C
resulted in sequential, extensive reengineering of the transcriptome, and of
cellular composition, accompanied by significant increases in freezing
tolerance. Others have shown that ice crystal formation begins at about -3°C in
wheat tissues suggesting that the variation in expression of freezing tolerance
at the time points studied probably originated in this initial response to -3°C
and ice crystal formation. Plant biological rhythms entrained to day length
usually persist for several cycles after the plants are moved to darkness and
thus the biphasic response we observed resulted from interaction of gene
products present at the time the plants were exposed to -3°C and darkness,
interacting with the gene products and altered cellular component composition
involved in the response that developed over the -3°C incubation period and
subsequent exposure to lower temperature, likely while the two cycles observed
within the 24-hour time frame continued to function. This biphasic stress
response pattern is similar to that described for genes encoding enzymes
involved in response to high light stress in Arabidopsis grown under a 16 hours
light, 8 hours dark photoperiod. Of the genes investigated in that study, two
peaks of expression were found, one in the light and a second in the dark. The
authors suggested that the gene expression “was controlled by light and a second
unidentified factor”.
Our observations of expression dynamics of CBF14 and CBF15 under low temperature
(4° C) and 12-hour photoperiod were consistent with the possibility that cohorts
of CBF genes, and consequently genes of the CBF regulon, were expressed in a
ultradian fashion, but with the expression dynamics of some out of phase with
others in some genotypes, leading to the ultradian variation in freezing
tolerance we observed. Under this hypothesis, freezing tolerance would appear to
be under the control of “light and a second unidentified factor” as described in
Arabidopsis, but the second factor simply may be the lack of light, to which
some regulatory genes, including CBF genes, respond with upregulation. In
barley, at least 20 CBF genes have been found, and have been classified into
three phylogenetic groups, designated group 1, 3 or 4. Under a 12-hour
photoperiod and constant 22°C, expression of CBF genes from group 1 was not
detected. Expression of CBF genes from group 4 cycled in diurnal fashion,
reaching peak expression 8–12 hours after subjective dawn. Expression of CBF
genes from group 3 cycled in diurnal fashion, but one of them reached peak
expression at the start of the dark period while expression of a second gene
from group 3 reached peak expression near the end of the dark period. These
observations are consistent with the ultradian cycling of freezing tolerance we
observed, again suggesting that the onset of the light phase, and the onset of
the dark phase were characterized by specific regulation of unique cohorts of
genes conditioning freezing tolerance, with the tolerance ultimately reaching
its greatest expression at the midpoint of the light, and of the dark phases.
It is likely that this kind of regulation is dependent on the temperature at
which the plants are grown in addition to the photoperiod, as has been shown
with other wheat genes. For example, expression levels of wheat genes encoding
lipocalins and similar proteins are correlated with the capacity to develop
freezing tolerance; some of these genes in wheat plants grown under 16 hours
light, 8 hours dark reached a peak of expression during the dark phase when
grown at 4°C, but not when grown at 20°C.
Whether the pathways active in the increased freezing tolerance observed after
exposure to sub-freezing temperature beginning at the midpoint of the dark phase
were the same pathways acting after exposure to sub-freezing temperature
beginning at the midpoint of the light phase is unknown. However, Bieniawska et
al., investigated the effects of low temperature and diurnal cycling on the
Arabidopsis cold-responsive transcriptome and found “stronger, more abundant
induction of TFs in the morning than in the evening,” (TFs = transcription
factors); consistent with different transcription factors and presumably
different target genes being involved in the response to cold at different time
points of the light cycle. Thus, we suggest that the 12-hour cycle from low, to
high, to low freezing tolerance in the light, and the similar cycle that
completed in 12 hours of darkness, represent distinct, possibly overlapping
signaling pathways that function as 12-hour ultradian cycles, and these pathways
may well be components of the CBF regulon. In addition, specific genotypes may
activate additional pathway(s), perhaps modulated by glutamine in some
genotypes, that contribute to the realized freezing tolerance. This complexity
of the freezing tolerance response, and apparently different pathways
functioning in different genotypes, is not surprising considering the genetic
constitution of the wheat plant. Wheat is an allohexaploid species formed by
naturally-occurring interspecific hybridization of three diploid ancestors,
first to form a tetraploid species from two of the diploids and then
hybridization of the tetraploid with a third diploid to form the allohexaploid.
The hybridization event that led to the allohexaploid occurred relatively
recently, perhaps less than 10,000 years ago. Hence, each of the three genomes
(designated A, B, or D) was contributed by a species that itself was subject to
stress-related selection pressures for many generations, including low
temperature stress, and presumably developed tolerance mechanisms independently
of the other species. The three genomes comprising *T*. *aestivum* still contain
“many (distinct) functional gene complexes” and interact in complex ways with
myriad consequences. These complex interactions include “gene silencing, gene
elimination, or gene activation and transposon activation via genetic and
epigenetic alterations”. Transposon activation was observed during the cold
acclimation process in Norstar, but not three other, closely-related, less cold-
tolerant wheat lines. The uniqueness of this response to Norstar, among four
closely-related wheat lines, suggests the specific kinds of complex interactions
that occur among the three genomes is unique to each individual allohexaploid
genome. This possibility is consistent with our observations of differing
regulation of CBF14 and CBF15 and glutamine concentration among three wheat
lines with differing freezing tolerance, perhaps indicating that the observed
freezing tolerance was predominantly determined by a different genome (A, B, or
D) in each line.
Further study of the effects of environmental factors on the expression of the
freezing tolerance that results from these pathways is needed to reveal the
genes and mechanisms involved. From a practical standpoint, these results
suggest that tests of freezing tolerance and of gene expression dynamics related
to freezing tolerance in winter wheat lines should be standardized to the
photoperiod in order to meaningfully compare the relative levels of freezing
tolerance among wheat lines.
# Supporting information
Disclaimer: Mention of product names does not represent an endorsement of any
product or company but is given only to clarify the methodology; other products
may be equally effective. USDA is an equal opportunity provider and employer.
This project was supported by USDA-ARS project 2090-21000-030-00D.
[^1]: The authors have declared that no competing interests exist.
[^2]: ‡ These authors also contributed equally to this work.
|
# Introduction
The transmissible spongiform encephalopathies, or prion diseases (PrDs), are a
family of fatal, transmissible neurodegenerative conditions. Characteristic
features of prion diseases include deposition of abnormal prion protein within
the brain, astrogliosis and spongiform vacuolation. The causative agents
(prions) arise from mis-folding of a normal cellular protein, the prion protein
(PrP), into disease-associated conformers that can then template further mis-
folding and propagation of prions. Various indications of damage are found in
terminal brain tissue, including signs of substantial oxidative stress.
Reactive oxygen and nitrogen species (referred to collectively herein as ROS)
are produced as byproducts of various cellular reactions and are known to have
critical roles as cellular signaling molecules. Oxidative damage occurs when the
mechanisms producing ROS exceed cellular detoxifying capacity. Markers of
oxidative damage within the brains of people dying from PrD include lipid
peroxidation and protein nitration. It is unclear whether oxidative damage plays
a causative role in the disease pathogenesis or whether it is a consequence of
failing detoxification pathways. There are various enzyme systems responsible
for the detoxification of ROS, including the superoxide dismutase (SOD) family.
The SOD family comprises three members; SOD1 or CuZnSOD, located ubiquitously
throughout the cell cytoplasm and mitochondrial intermembrane space, SOD2 or
MnSOD, confined to the mitochondrial matrix, and SOD3 or extracellular SOD found
in the extracellular matrix. Failure of one of these enzymes to adequately
detoxify ROS could permit oxidative damage to accumulate to toxic levels.
Animal models have been used to consider the role of ROS in PrD and the
importance of cellular antioxidant defenses. It has been shown that lipid
peroxidation begins early during the course of murine prion infection, around
the time of initial deposition of PrP and spongiform development, well before
onset of symptoms. Reduction of SOD1 protein in mouse models of PrD accelerates
disease, however, the role of SOD2 in prion infection was, until now, un-
reported. SOD2 expression is essential for life and, in its absence, mice die
perinatally of dilated cardiomyopathy. However, if SOD2 knock-out mice are kept
alive for several weeks post birth using antioxidant therapy they develop a
spongiform encephalopathy reminiscent of a PrD. At the terminal phase of murine
PrD SOD activity and SOD2 expression were previously found to be decreased. In
support of a loss of function of SOD2 during disease, a SOD2 mimetic has been
shown to significantly extend the lifespan of prion infected mice and reduce
spongiform vacuolation. Additionally, in cell culture systems modelling prion
infection, increased ROS production and damage to cellular proteins and lipids
have been found. Of interest, within this system, reduction of SOD2 protein was
associated with cytosolic localization and degradation by caspases. Caspase
activity is increased as mice approach terminal PrD and caspase 3 has directly
been shown to cleave SOD2, therefore an increased turnover and resultant loss of
function of SOD2 could be involved in disease progression or formation of
spongiform damage.
Potentially, if PrP influences SOD2 function and this function is critical for
maintaining homeostasis during prion disease, its loss toward terminal disease
could be responsible for the accumulating cellular damage including development
of spongiform change. It is not possible to consider the influence of SOD2 by
investigating disease in SOD2 knock-out mice due to their short lifespan.
However, SOD2 heterozygous mice, which express approximately 50% of the SOD2
protein levels of wild type mice, develop normally and have a normal life
expectancy with only a few reported effects of the reduced protein levels. The
SOD2 heterozygous mice do show a clinically silent underlying mitochondrial
oxidative stress, which renders them more susceptible to oxidative insults, such
as what may occur during prion infection. We hypothesized that if SOD2 is
critical for maintaining homeostasis and that this fails during disease, the
reduction of SOD2 in SOD2 heterozygous knock-out mice should be sufficient to
accelerate the disease course and exacerbate the spongiform change. Our results
indicate that SOD2 reduction does not influence acute or long-term responses to
three different scrapie prion strains.
# Methods
## Animal ethics statement
All mice were housed at the Rocky Mountain Laboratory (RML) in an AAALAC-
accredited facility in compliance with guidelines provided by the Guide for the
Care and Use of Laboratory Animals (Institute for Laboratory Animal Research
Council). All experiments were approved by the RML Animal Care and Use
Committee, protocol 2018-072-E. Mice were socially housed in groups of 3–4 mice
per box in climate controlled disposable caging with wood shavings and nestlet
bedding provided for enrichment. Room temperatures were kept at 70–72˚F and a
12-hr light-dark cycle was used. Mice had free access to food and water.
## Mice
Heterozygous B6.129S7-Sod2tmLeb/J<sup>(+/-)</sup> (Jackson Laboratories) were
crossed to produce B6.129S7-Sod2tmLeb/J<sup>(+/-)</sup> (SOD2<sup>+/-</sup>) and
Sod2tmLeb/J<sup>(+/+)</sup> (WT) littermate wild type controls. Genotypes were
confirmed by PCR analysis as described by Jackson Laboratory. Primers detecting
the mutant, `TGT TCT CCT CTT CCT CAT CTC C` (oIMR0781) and `ACC CTT TCC AAA TCC
TCA GC` (oIMR0782) along with wild type primers, `TGA ACC AGT TGT GTT GTC AGG`
(oIMR0878) and `TCC ATC ACT GGT CAC TAG CC` (oIMR0888) were used to distinguish
genotypes of littermate controls.
## Infections
Prior to experimentation we used Graphpad Statmate software to determine
reasonable group sizes to detect an estimated difference in incubation periods
of 1 week. Groups of 10–12 male mice per genotype (total = 69 mice) were
intracerebrally inoculated with 30 μl of a 1% (w/v) brain homogenate from 22L,
RML or ME7 prion strains. Mice were anesthetized with isoflurane and
inoculations were performed using a ½ inch long, 27-gauge needle on a 1 mL slip
tip syringe. The inoculum was injected into the left cerebral hemisphere,
approximately 2 mm lateral to the midline and 2–3 mm deep, near the region of
the thalamus. The titers of these scrapie stocks had been determined previously
in C57 mice and contained the following 50% infective doses (ID<sub>50</sub>) in
each 30-μl volume: 22L, 6.0 × 10<sup>5</sup>; RML, 2.4 × 10<sup>4</sup>; ME7,
5.0 × 10<sup>4</sup>. Normal control mice were either ‘mock’ inoculated with
uninfected brain homogenates (N = 4) or not inoculated (N = 4). Mice were
monitored by evaluators blind to genotype twice weekly prior to onset of
clinical signs, then every 1–3 days throughout the clinical phase (where they
begin showing decrease in body condition, increased somnolence and kyphosis) and
euthanized by isoflurane inhalation overdose followed by cervical dislocation
when they developed terminal clinical signs (signs include ataxia, tremors,
kyphosis, hyperactivity, somnolence, poor grooming, reduction in body
condition). One SOD2<sup>+/-</sup> mouse from the 22L experiment was excluded
from analysis. The mouse was euthanized at 67 dpi for unresolving dermatitis.
This time point is far prior to any clinical signs of prion disease. Log-rank
(Mantel-Cox) statistical analysis was performed for each prion strain using
GraphPad Prism 8 software.
## H&E staining, immunohistochemistry and quantification
Brain fixation, paraffin embedding, histology and immunohistochemistry for prion
protein (antibody D13) and anti-GFAP were carried out as described previously.
Positive pixel quantification was performed on brain sections from 5–6 mice per
experimental group for D13 (produced in house as described in) and GFAP stained
sections using the ImageScope positive pixel count algorithm (version 9.1) as
described with the following modification. In the current manuscript, all
positive pixels (including weak, moderate and strong) were included for the D13
analysis.
## Lesion profiling
Lesion profiling was completed on 5–6 mice from each genotype from the 22L and
ME7 infection experiments. Sagittal brain sections were cut approximately 0.5 mm
from midline and stained by routine H&E protocols. Each section was scored for
the severity of spongiform vacuolar degeneration in 4 gray matter areas
(cerebral cortex, thalamus, superior colliculus and cerebellum). Spongiosis was
scored as follows: 0, no vacuoles; 1, few vacuoles widely and unevenly
distributed; 2, few vacuoles evenly distributed; 3, moderate numbers of vacuoles
evenly distributed; and 4, many vacuoles with some confluences. An average score
and standard deviation for each experimental group was calculated and shown in.
## Western blotting
10% (w/v) brain homogenates were prepared in 1x PBS, further diluted into 1%
(w/v) for western blotting analysis. Proteins were denatured by boiling for 5
minutes in 1× sample buffer (containing 6% Beta-mercaptoethanol), resolved in
Bolt 4–12% Bis-Tris Plus gels (Invitrogen), and transferred to PVDF membrane
(Millipore). SeeBlue Pre-stained Protein Standard (Life Technologies) was
resolved alongside the protein samples. The membrane was incubated in blocking
solution (5% w/v non-fat milk in 1× TBS and 0.05% Tweens) for 1hr at room
temperature and in anti-SOD2 antibody (1:5000 dilution in blocking solution;
Abcam: ab13533), anti-SOD1 (1:4000 dilution in blocking solution; Abcam:
ab13498) or anti-SOD3 (1:4000 dilution in blocking solution; Abcam: ab83108)
overnight at 4°C. The primary antibody was coupled with the appropriate
secondary antibody (HRP conjugate), and the protein bands were visualized using
ECL Select (Amersham) and imaged by iBright imaging system (Invitrogen). Full
blot images are shown in Sup File 1.
## Proteinase K digestion and PrP immunoblotting blotting
10% (w/v) brain homogenates in PBS were digested with Proteinase K, run on 12%
tris-glycine gels and transferred to PBDF membranes as previously described.
Immunoblots were probed as described with the two following modifications, anti-
PrP antibody D13 was used at a 1:1,000 dilution and the secondary antibody
(anti-human) was used at a 1:20,000 dilution.
## Electrophysiology
As described previously, 300 μm thick hippocampal sections were collected from
12-week-old mice in an ice-cold cutting solution (3 mM KCl, 25 mM
NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 206 mM Sucrose, 10.6
mM Glucose, 6 mM MgCl<sub>2</sub>.6H<sub>2</sub>O, 0.5 mM
CaCl<sub>2</sub>.2H<sub>2</sub>O) using a vibratome (Leica VT1200S). The
hippocampal slices were incubated for 1 hr at 32°C in carbogenated (5%
CO<sub>2</sub>; 95% O<sub>2</sub>) artificial cerebrospinal fluid (aCSF: 126 mM
NaCl, 2.5 mM KCl, 26 mM NaHCO<sub>3</sub>, 1.25 mM
NaH<sub>2</sub>PO<sub>4</sub>, 10 mM Glucose, 1.3 mM
MgCl<sub>2</sub>.6H<sub>2</sub>O and 2.4 mM CaCl<sub>2</sub>.2H<sub>2</sub>O).
The slices were mounted on to 60MEA200/30iR-Ti-pr-T multi-electrode arrays (MEA;
Multichannel Systems; Germany) for the electrophysiological recording while
being continuously superfused with carbogenated aCSF. The Shäffer collateral
pathway was stimulated by electric stimulation (2000–2500 mV) to evoke the field
excitatory post-synaptic potential (fEPSP) at the CA1 region. The baseline
stimulation intensity was determined by an input-output curve obtained from
stimulating the pathway with increasing strength of electric stimulation
(input), starting at 500 mV to a stimulation intensity (4000–5000 mV) that
evoked the maximum fEPSP amplitude (output). This max response was indicated by
the point where the input-output curve reached a plateau. The stimulation
strength that evoked 30–50% of the maximum fEPSP amplitude was the baseline
stimulation intensity. The baseline fEPSP was recorded for 30 minutes by
applying the baseline stimulation intensity in 30 seconds interval. Following
the first five-minute baseline, the slices were treated with 0.5% (w/v) brain
extracts (normal brain homogenates or PrPSc-infected mouse brain homogenates in
aCSF) for 10 minutes. The 0.5% (w/v) dosage was determined based on
characterizations done for previous studies, we chose this dose after
determining that higher concentrations caused non-specific tissue damage. After
this treatment, the superfusion returned to aCSF for the rest of the recording.
After the baseline recording, the LTP was induced by Tetani, consisting of three
100 Hz trains (500 ms long per train) delivered in 20 sec interval. The post-
tetani fEPSPs were recorded for 30 minutes, with the last ten-minute recording
was averaged and used for the statistical analysis of LTP.
# Results
As expected from previous reports, the SOD2<sup>+/-</sup> mice developed
normally, lived a normal lifespan compared with their WT littermates and did not
display any overt pathology related to the reduced SOD2 level. Within the brain,
the SOD2<sup>+/-</sup> mice expressed approximately half the protein level of
SOD2 that WT mice expressed.
## Reduced SOD2 does not influence electrophysiological responses following acute exposure to 22L, RML and ME7 prions
Previous studies have shown that certain prion strains can cause acute synaptic
toxicity, which is reflected in changes to neuronal long-term potentiation
(LTP). To investigate whether the SOD2 reduction renders the SOD2<sup>+/-</sup>
mice more vulnerable to acute synaptotoxic insult by prions, we measured LTP in
hippocampal slices. shows the combined traces from the brain slices of 12-week-
old SOD2<sup>+/-</sup> and WT mice exposed to one of the three strains, 22L,
RML, or ME7 or control normal brain homogenate (NBH) in the artificial cerebral
spinal fluid (CSF). For each mouse, slices were compared for their response to
normal and infectious brain homogenate in parallel. Brain slices were assessed
for LTP following 10 minutes exposure to the inoculum. No difference was seen in
basal LTP between the genotypes in the artificial CSF, indicating that the
reduced SOD2 protein was not causing a basal level of neuroelectrophysiological
dysfunction. In the kinetic curves, LTP is significantly reduced in response to
the infectious brain homogenate compared with NBH for SOD2<sup>+/-</sup> brain
slices exposed to 22L. When the average of the last 10-minute LTP was considered
for each slice, the SOD2<sup>+/-</sup> brain slices exposed to 22L remained the
only significantly changed LTP response. Overall, exposure to scrapie prions had
limited significant effects on LTP for any strain in either WT or
SOD2<sup>+/-</sup> mice.
## SOD2<sup>+/-</sup> mice do not have reduced lifespan when challenged with 22L, RML or ME7 prions compared with WT mice
We hypothesized that the lower protein levels of SOD2 in the SOD2<sup>+/-</sup>
mice would leave them vulnerable to increased oxidative damage during disease
pathogenesis and, therefore, they might demonstrate more rapid disease
progression to death. When inoculated with 22L, RML or ME7 prions, with the
evaluator blinded to their genotype, the reduced SOD2 expression made no
difference to the disease course (P = 0.59, 0.58 and 0.88 respectively;).
Furthermore, when the disease-associated PrP was examined by western blotting
terminal brain tissue following protease digestion, accumulation was similar in
both genotypes. Thus, reduced SOD2 was not influencing disease duration or the
presence of disease-associated PrP.
## SOD2 protein levels are unchanged in SOD2<sup>+/-</sup> prion disease brains
A possible explanation for the lack of difference across genotypes was that
SOD2<sup>+/-</sup> mice maintained the ability to up-regulate SOD2 protein to WT
equivalent levels when under stress. If this were the case, at terminal disease
all mice could have the same SOD2 protein levels and, consequently, there would
be no difference in disease parameters. Western blotting brain tissue from
terminal mice showed that SOD2 protein levels were not increased in prion
infected SOD2<sup>+/-</sup> mice relative to the NBH controls. Only the WT RML-
infected mice showed a change in their SOD2 expression as a result of infection,
with a significant \~2-fold increase over NBH mice, although the ME7-infected WT
mice also showed highly variable SOD2 levels. It is unclear why SOD2 protein
levels varied so widely in WT terminal disease mice across the strains, but this
suggests the increase in the WT RML-infected mice has no relevance to
pathogenesis and that fluctuations in SOD2 protein levels are unimportant for
disease progression. We also considered protein levels of SOD1 and SOD3, finding
only SOD1 significantly increased in the ME7 infected WT mice. No significant
differences were apparent between genotypes suggesting that SOD1 and SOD3 are
not changed as a compensatory response for the lower SOD2.
## SOD2+/- mice show no overt differences in brain pathology
As SOD2 knock-out mice kept alive post birth using anti-oxidant therapy develop
a spongiform encephalopathy, we examined the PrD pathology present in the
SOD2<sup>+/-</sup> mice and WT mice infected with ME7 and 22L; representing the
longest and shortest incubation periods of the strains tested respectively. No
explicit difference was seen in PrP deposition, astrogliosis or spongiform
change as a result of the reduced SOD2.
## Lesion profiling confirms reduced SOD2 does not influence spongiform pathology
To look closer at whether the reduced SOD2 might influence the severity of
spongiform change in the SOD2<sup>+/-</sup> mice, we examined four brain
regions, grading their spongiform severity. The examiner was blinded to the
mouse genotypes. The lesion profiles of the cerebral cortex, colliculi, thalamus
and cerebellum were not different between the SOD2<sup>+/-</sup> mice and WT
controls. This confirms the observation that reduction of SOD2 protein does not
influence the development of spongiform pathology.
Additional pixel counts on the 22L infected brains also confirmed that PrP
deposition and astrogliosis was not different between SOD2<sup>+/-</sup> and WT
mice. Overall, the reduction of SOD2 did not influence neuronal function upon
challenge with infection, disease duration, or the appearance of the
neuropathology and severity of the spongiform pathology across different brain
regions in response to infection with different prion strains.
# Discussion
PrDs demonstrate increased oxidative damage within the brain that begins early
in disease, and detection of SOD2 is changed in terminal brain tissue. The
development of a PrD-like spongiform encephalopathy in SOD2 knock-out mice,
treated with antioxidants to delay their death from cardiomyopathy, indicated
SOD2 may be a contributing factor to PrD pathogenesis. However, in mice
expressing approximately 50% of the SOD2 protein present in the brains of wild-
type animals, we saw no effect of the reduced SOD2 on neuronal function or
disease pathogenesis upon trial with three prion strains. As SOD2 is essential
for life, the lack of difference in lifespan of the PrD SOD2<sup>+/-</sup> mice
strongly indicates that SOD2 plays no role in the pathogenesis of PrD in mice.
In previous studies, a decrease in SOD2 gene expression or protein has been
observed in animals infected with scrapie strains. In Bourgognon et al., the
infecting strain was RML; the same strain for which we observed an increase in
protein levels of SOD2. The discrepancy may have arisen as Bourgognon et al.
measured RNA levels rather than protein, as detected herein, or due to different
genetic backgrounds of the mice. However, in human prion disease studies that
examined protein levels in terminal brain tissue, increases in SOD2 protein were
detected, indicating that the increased SOD2 in the RML infections does mirror
what occurs in human disease. In Park et al., the strain studied was ME7 and the
reduction in SOD2 measured by western blotting. We observed a highly variable
response in SOD2 protein detection for the WT ME7 infected mice, with two of
four brains showing a decrease. The variable SOD2 detection in our ME7
infections and the genotypes of this cohort were re-checked and a reason for the
variability was not apparent. Since the WT protein intensities of SOD2 were
variable across all infections and neither WT SOD2 protein levels nor the
reduced levels in the SOD2<sup>+/-</sup> mice influenced the outcome of the
disease, fluctuations of SOD2 protein levels appear to be a secondary effect of
the disease process.
We also observed discrepancies between our current LTP data and previously
published electrophysiology studies looking at prion-induced synaptotoxicity
where, in contrast with the previously published studies, we found few
significant changes. These differences likely arise due to the different strains
examined. The original studies used the mouse-adapted human M1000 strain,
whereas in the current study we considered mouse-adapted scrapie strains.
Differences in the aggressiveness of different prion strains and regions of the
brain attacked are widely known. Even herein we found that the different strains
produced different responses in the WT mice with a significant increase in SOD2
protein only in RML infected mice and an increase in SOD1 only in ME7 infected
mice. The SOD2<sup>+/-</sup> mice showed the only significant change in LTP when
challenged with 22L inoculum, possibly because this is the most aggressive
strain we looked at with the shortest time to death. WT mice challenged with the
same dosage of M1000 inoculum as we used here die around the same time as those
challenged with 22L, although the timeframe is narrowed (145 dpi +/- 2 days for
M1000 vs 145 dpi +/- 6 days for 22L herein). Therefore, an explanation for the
discrepancy with our WT data is that 0.5% w/v does not contain enough scrapie
prions to induce toxicity but 22L, causing the most aggressive disease, is
closest to a toxicity threshold surpassed by the mouse-adapted human prions. The
difference between the WT and SOD2<sup>+/-</sup> LTP in response to 22L was not
sufficiently great that we believe it to be important to the disease process,
especially when considered in the context of the lack of change in survival time
or pathology.
That the SOD2 protein levels were only increased in the RML infected and the
SOD1 protein levels only increased in the ME7 infected WT mice is interesting.
This raises the question of whether some strains cause greater oxidative stress
than other strains or influence different redox producing/detoxifying pathways.
Whilst there is ample evidence for oxidative stress in the brains of PrD mice
infected with multiple strains, we are not aware of any studies that have found
ROS levels to be higher in in one strain over another. Comparison of indirect
markers of oxidative stress across several strains demonstrated no difference in
the detection of these markers. More investigation may be required to understand
if the strains do cause differing levels of stress and, if so, whether this is
important to disease pathogenesis.
While we showed no changes in the other SOD family members in the
SOD2<sup>+/-</sup> mice to suggest the deficit was annulled by compensation
mechanisms, this is not to say none were occurring. Potentially other redox
balancing systems, outside the SOD family, may be providing some alleviation of
increased ROS and PrP itself has been linked with protection against oxidative
stress. Heightened ROS is associated with increased processing of PrP at the
beta-cleavage site and during infection this becomes the dominant cleavage
event. Beta-cleavage and especially the released N-terminal fragment, N2, that
is not part of the protease resistant core, have been shown to have protective
properties against oxidative stress. The N2 fragment has additionally be shown
to localize to the mitochondria when administered to cells in their media,
possibly effecting a protective response within the organelle. Therefore, many
other cellular mechanisms may render the reduction of SOD2 redundant for
survival or pathology during PrD.
Our data indicates that SOD2 is not involved in PrD pathogenesis but this does
not mean that other redox pathways and cellular antioxidant molecules or
proteins are likewise unimportant. Indeed, SOD1 knock-out does reduce the
lifespan of prion infected mice and, conversely, knock-out of the oxidant
protein NADPH oxidase-2 (NOX2) was found to increase survival time and delay
symptom onset. PrP has also been functionally linked to several redox signaling
pathways, including NOX2 and neuronal nitric oxide synthase and any combination
of these may become dys-regulated during disease leading to oxidative damage.
Furthermore, a number of anti-oxidant based therapies have been found to extend
survival time in mice, including the administration of a SOD2 mimetic in
infectious disease and a combination therapy using a nanoformulation of
pomegranate seed oil with neural progenitor transplantation in a genetic disease
model. While SOD2 may contribute to the failings of these pathways in PrD,
ultimately it appears that oxidative damage caused by other failing pathways is
of greater significance to the development of disease pathology.
A clear limitation of our study is that translation to humans is not necessarily
guaranteed. For example, SOD1 knock-out mice have no overt phenotype up to six-
months of age but develop age-dependent muscle atrophy later in life. However,
human patients with mutations resulting in minimal SOD1 activity demonstrate
signs of the deficit from around 6–9 months old with severe loss of motor
functions in early childhood. Thus, the SOD1 knock-out mouse model does not
fully recapitulate human SOD1 deficiency. However, a reported genetic SOD2
deficiency patient presented similarly to what was observed in SOD2 knockout
mice, with death occurring a few days post birth. The causative mutation was
recessive and the parents of the patient, who were heterozygous, showed no signs
of the deficiency when just one functional allele was present. Consequently, the
SOD2 knock-out model might provide a close indication of how reduced SOD2
protein influences human biology in the context of PrD, but this cannot be
concluded without investigation within a human model of disease.
We cannot exclude the possibility that a heterozygous reduction of SOD2 is
insufficient to see any changes. While this is possible, and another
heterozygous mouse experiment examining cysteine string protein alpha also
showed no difference in incubation period, if the observed variations in SOD2
protein expression levels was a critical factor in PrD pathogenesis it is likely
that some pathological effect would have been observed in the SOD2<sup>+/-</sup>
mice. We conclude that reduction of SOD2 does not alter PrD pathogenesis and
changes in SOD2 protein levels are likely a down-stream effect of disease rather
than causative of damage.
# Supporting information
The authors would like to thank James Striebel and Dr. Christina Orru for
critical evaluation of the manuscript, Jeff Severson for animal husbandry, and
Lori Lubke and Nancy Kurtz for histology assistance.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Critical illness is marked by organ dysfunction, the need for vital support, and
a high risk of death, occurring against a backdrop of systemic immune
activation. This immune activation may begin as an adaptive response to the
initial injury, however, as the disease progresses, the immune response may
become maladaptive or paralyzed. Critical illness-associated immune
dysregulation has been described as the interplay between pro- and anti-
inflammatory responses, although recent evidence suggests a mixed inflammatory
state is common. While this process has been qualitatively described, there are
no quantitative diagnostic or prognostic tools that have been validated
clinically to assess immune status in the critically ill. Consequently,
infectious complications are not only common in intensive care units but also
difficult to diagnose. This has contributed to inappropriate use of broad-
spectrum antibiotics and the emergence of multi-drug resistant organisms.
A few years ago, studies employing cultured human cells suggested that instead
of a single molecule (*e.g.*, IL-6), a constellation of molecules could be used
to monitor the complexities of the inflammatory response, serving as markers of
infection. Miniaturized, multiplexed assays provide a rapid method for the
unbiased screening of thousands of molecular species in a single assay. These
technological advances provided the potential for investigators to leverage
high-throughput assays to better study the host response to and recovery from
critical illness and injury. Improved molecular diagnostics and prognostics, a
better understanding of the complexity of systemic inflammation, and new
therapeutic targets are expected deliverables, as reviewed recently.
Based upon our ability to diagnose abdominal sepsis in pilot mouse studies, we
hypothesized that the host response to infection could not only differentiate
between infected and non-infected states, but could also be used clinically to
differentiate between the host response to infectious agents and to model the
host response to and recovery from infectious perturbations. Pneumonia was
chosen as an immune system perturbation, given its relative frequency and
considerable cost in terms of patient morbidity and health care expense. A
bench-to-bedside, translational approach was employed to study the host response
to pneumonia in critically ill subjects, comparing the informational content of
standard clinical parameters and plasma cytokines to changes in the RNA
abundance in circulating leukocytes.
# Methods
## Mice, experimental procedures, and samples
Care and use of laboratory animals were conducted in accordance with a protocol
approved by the Washington University Animal Studies Committee, in compliance
with guidelines (N01-RR-2-2135) prepared by the Committee on Care and Use of
Laboratory Animals, Division of Research Resources, National Institutes of
Health. Seven to nine week-old, male C57BL/6 mice were purchased (Harlan, Inc.
Madison WI) and allowed to acclimatize for at least one week in a temperature-
and light-controlled, pathogen-free barrier facility. Treated animals and
concurrently studied controls were observed at 24 hour intervals for survival
over eight days. In additional cohorts, whole blood was collected at 24 hours
after injury.
The 5 experimental groups were selected to reflect clinically important
distinctions relevant to care of ICU patients: high mortality Gram-negative
pneumonia with *Pseudomonas aeruginosa* (40 µl of 0.3 McFarland culture, 90%
7-day mortality (∼2–4×10<sup>7</sup> organisms)), high mortality Gram-positive
pneumonia with *Streptococcus pneumoniae* (60 µl of 0.5 McFarland culture, 85%
7-day mortality (∼1.8–3.6×10<sup>7</sup> organisms)), and moderate mortality
Gram-negative pneumonia with *Pseudomonas aeruginosa* (20 µl of 0.1 McFarland
culture, 50% 7-day mortality (∼2–4×10<sup>6</sup> organisms)). To induce severe
systemic inflammation without infection, intratracheal (i.t.) injection of *P.
aeruginosa* lipopolysaccharide (500 µg in 50 µl 0.9% normal saline; Sigma, St.
Louis) was performed (LPS group, 90% 7-day mortality). Mice injected i.t. with
normal saline vehicle acted as the concurrent control group (saline group, 0%
7-day mortality). Previously reported protocols were used to intratracheally
instill fluid into the lung. The census of surviving mice was recorded at
24-hour intervals for seven days.
In three additional cohorts of animals, blood was collected into an EDTA-coated
syringe from the inferior vena cava being careful to avoid contamination of the
needle with other tissues. Blood was diluted 1∶1 with normal saline, pooled for
the 8 animals in each treatment group, and separated into cells and plasma.
Plasma was stored at −80°C until use. Erythrocytes were lysed hypotonically and
RNA from peripheral leukocytes was harvested using RLT (Qiagen) and stored at
−80°C until use. The 24 hour time point after injury was chosen as a time before
appreciable mortality develops in animals with significant lung injury.
## Target cRNA and gene expression signal
Each RNA sample was run on one GeneChip (a total of 15 mouse blood GeneChips
from 120 animals). Total RNA from mouse blood was extracted as previously
described. cRNA target for GeneChip hybridization was prepared from total RNA
(Affymetrix, Santa Clara, CA). Both total RNA and cRNA were electrophoretically
assessed for quality (Agilent Bioanalyzer). The mouse blood cRNA samples were
hybridized with the U74Av2 GeneChip (approximately 12,400 probe sets).
Fluorescent hybridization signal was detected using a GeneChip Scanner 3000
(Affymetrix). These mouse microarray data (and those for patients, see below)
have been deposited in NCBI's Gene Expression Omnibus (GEO,
<http://www.ncbi.nlm.nih.gov/geo/>) and are accessible through GEO Series
accession number GSE6377.
## Data analysis and statistical tests for differential expression
Expression values were calculated from GeneChip.cel files using Robust Multichip
Average (RMA) software. Differentially expressed genes were identified using a
mixed-model analysis of variance (ANOVA) and linear contrasts (Partek® Infer™
software) as previously reported. Leave-one out cross-validation (k-nearest
neighbors, k = 2) was used to determine the reproducibility within this
experimental set. Principal components analysis (PCA) was used to visually
explore global effects for genome-wide trends, unexpected effects, and outliers
in the expression data (Partek® Pro™ software,
[www.partek.com](http://www.partek.com)).
### Patient studies
After obtaining informed consent, venous blood (7 ml) was collected from
mechanically ventilated, non-septic patients according to a protocol approved by
the Washington University Institutional Review Board (#2004-0294). Patients were
candidates for enrollment if they were on mechanical ventilation in the surgical
ICU medical ICU, neurological ICU, or cardiothoracic ICU (CTICU) for 48 hours,
were expected by the attending ICU physician to need mechanical ventilation for
at least another 48 hours at the time of enrollment, and could provide written
informed consent (from the patient or legal surrogate). VAP was diagnosed by the
ICU attending physician, consistent with recently reported recommendations,
without input from the investigators. Clinical data were entered into a VAP
database, including gender, ethnic background, age, admitting diagnosis, type of
ICU, APACHE II score, airway sampling technique and culture results, initial
antibiotic therapy, and maximal clinical pulmonary infection score (CPIS)
calculated based upon available data (several patients lacked daily arterial
blood gas measurements to calculate
P<sub>a</sub>O<sub>2</sub>/F<sub>i</sub>O<sub>2</sub> ratios). Patient blood was
processed as described previously to minimize red blood cell RNA artifact ;
briefly, samples were centrifuged (400×g 10′ RT) to form a buffy coat and to
separate plasma from cells. Plasma was withdrawn and stored at −80°C until use.
Blood cells were diluted into EL buffer (90 ml) (Qiagen) and incubated on ice
for 15′. Leukocytes were pelleted by centrifugation (400×g 10′ 4°C), washed with
EL buffer (30 ml) and lysed into RLT buffer (Qiagen) containing 1%
β-mercaptoethanol. Genomic DNA was sheared by repeated passage through an 18
gauge needle and the resultant material was stored at −80°C.
### Patient plasma cytokine analysis
Cytokines (GRO-α, IFN-γ; IL1-β; IL1Ra; IL1sr2; IL4; IL6; IL8; IL10; IL12; IL18;
MCP1; MIP1α; MIP1β; NGF; RANTES; TNFα; TNF-sr1; TNF-sr2) were measured using a
microarray immunoassay as previously described. Procalcitonin was measured
according to the manufacturer's instruction (BRAHMS PCT LIA kit, Product number
354.1).
### Patient blood leukocyte mRNA profiling
RNA was extracted, amplified and assessed for quality as described for murine
samples. cRNA was hybridized against the HG-FOCUS array (Affymetrix, \>8700
probe sets encoding ∼8400 genes) and imaged as described for murine samples.
Orthologs of murine genes were identified by comparison of the GeneChip
Identifiers using the NetAffx Toolkit (Affymetrix). Consistent with recently
published consensus statements, , clinical data were judged to determine when
(if ever) each patient developed ventilator-associated pneumonia, with each
patient acting as her/his own control. The timeline for each patient was defined
such that the day of VAP diagnosis by the ICU attending physician was defined as
day 0. A seven day time window from the gene expression time series was chosen
as days −3, −1, 0, 1, and 3, with day 0 being the day that a patient was
diagnosed as having VAP by the attending physician. Because blood samples were
collected every other day, patients' samples were collected either on days −2,
0, +2 or on days −3, −1, +1, +3 relative to the VAP day of diagnosis described
as time 0. For the purpose of analyzing the data from those patients who had
samples collected on “odd” days, the time 0 data for these patients were
interpolated. Those mRNA species whose abundance changed concordantly among the
patients during the 7-day window surrounding the date of diagnosis were
identified using extraction of Differential Gene Expression (EDGE) software.
Online databases were used to determine gene annotation and functional
categorization (DAVID 2.0 accessed 16 November 2006).
### Clustering algorithm
Patient genes identified by EDGE were clustered as described previously.
Briefly, a gene co-expression network was constructed by connecting every gene
to the top *d* genes (*d* = 5 in this study) to which its expression profile is
most similar. The network then was partitioned into a set of communities,
*i.e.*, relatively densely connected sub-graphs, by a spectral graph algorithm.
The genes within each community formed a cluster. The number of clusters was
determined automatically by the algorithm in order to maximize a modularity
score,. Gene expression data were normalized prior to clustering such that the
expression levels of each gene for each patient had a mean of zero and a
standard deviation of one. Similarity between two gene expression profiles was
measured by Pearson correlation coefficient.
### Karhunen-Loeve decomposition of microarray gene expression data
To determine the dynamics of the host response to pneumonia, we constructed
first a raw gene expression matrix corresponding to the *i*th pneumonia patient
after RMA normalization to be *X<sub>i</sub>* = \[*x<sub>i</sub>*(1) …
*x<sub>i</sub>*(*N<sub>T</sub>*)\] where *x<sub>i</sub>*(*k*)∈ℜ*<sup>N</sup>*,
(*k* = 1,…,*N<sub>T</sub>*, *i* = 1,…11, and *N* = 8793 genes) is the gene
expression vector at *k* th time point. *k* = 1,…,*N<sub>T</sub>* where
*N<sub>T</sub>* = 11 for most patients, correspond to sample collecting days 1,
3, 5, …, 21. Note that for few patients, only a portion of the time series
(i.e., less than 11 points) was available.
For the EDGE-selected genes, the data were projected onto a smaller dimensional
space using the series expansion method similar to principal components
analysis, Karhunen-Loeve Decomposition (KLD). In order to preserve the alignment
of the time series with respect to day 0 of VAP, we first obtained the average
expression vectors, *k* = 1,2,…9, by averaging the expression values at days
corresponding to −3,−1,…,13 in all patients (corresponding to the nine time
points that most patients had samples collected). The KLD method looks for a
basis *ψ*<sub>1</sub>,*ψ*<sub>2</sub>,…*ψ<sub>N</sub>* so that one can expand
aswhere and 〈·,·〉 stands for the standard inner product.
The orthonormal basis *ψ*<sub>1</sub>,*ψ*<sub>2</sub>,…*ψ<sub>N</sub>* can be
selected as the eigenvectors of the correlation matrix
*C*<sub>1</sub>∈ℜ*<sup>N×N</sup>*, obtained asThe first principal mode
*ψ*<sub>1</sub> corresponds to a constant bias term. Hence the most important
variation is captured by *ψ*<sub>2</sub>,*ψ*<sub>3</sub>,…*ψ<sub>N</sub>*
respectively in the decreasing order. Once the orthonormal basis is obtained,
each patient data can be projected onto this basis as for patients *j = *1, 2,
…. The discrete derivative of the coefficients
### Validation of microarray results
Select genes were subjected to real-time quantitative PCR (RTq-PCR) for
independent confirmation of relative expression levels. cDNA was generated and
100 ng was subjected to routine SybrGreen RT-PCR as per manufacturer's
instruction (Applied Biosystems, Foster City, CA). In addition, 85 genes were
selected at random from the total number on the GeneChip. The gene expression
signal from these genes was analyzed in a manner identical to that described
above. This procedure was repeated 100 times to estimate the informational value
of randomly selected genes.
## Validation of the riboleukogram
After enrollment of the first 20 patients, a second cohort of 7 patients was
analyzed to validate the informational content of the leukocyte RNA species
(genes) that changed in abundance in response to critical illness complicated by
VAP. The blood handling, processing, and GeneChip analysis protocols were
identical to those described above.
# Results
## Murine model
Intratracheal (i.t.) installation of saline caused no deaths over 7-days whereas
i.t. introduction of *P. aeruginosa* endotoxin resulted in death of 90% of the
animals studied within 96 hours. The 7-day mortality caused by live *P.
aeruginosa* was adjusted by varying the size of the inoculum and injuries
causing 50% and 90% 7-day mortality were achieved. A dose of *S. pneumoniae* was
given i.t. that resulted in 85% 7-day mortality. Once these injuries were
established, three separate cohorts of mice were used for each experimental
group in the subsequent studies.
Peripheral blood was collected and pooled from groups of 4–7 mice 24 h after
surgery, prior to appreciable mortality in any group. All murine RNA were of
good quality based on the peak profiles of 18S and 28S ribosomal RNA. cRNA
generated from these samples had a uniform size distribution. All hybridizations
were of good quality; both the number of features present (35–40%) and the
signals on each array fell within acceptable ranges.
Analysis of normalized gene expression data identified 219 probe sets (40
unannotated ESTs, 10 redundant probe sets, 169 annotated genes whose expression
levels differentiated between the five groups. Leave one out cross-validation
using k-nearest neighbors (k = 2) resulted in a 93% classification accuracy. The
single misclassified sample was from the low-dose *P. aeruginosa* infection and
was classified as “saline”. These 219 genes differentiated between the host
responses to Gram-negative bacteria, Gram-negative bacterial toxin (LPS) and
Gram-positive bacteria. The probe sets clustered into six groups and these
groups defined the gene expression cartography of the murine response to
pneumonia. Genes that fell within clusters 2 and 3 exhibited increased RNA
abundance in animals responding to high lethality insults. Genes that fell
within clusters 4–6 were transcriptionally suppressed during high lethality
insults. Cluster 1 bridged the two groups. Gene ontology assignments identified
enriched molecular functions in the three distinct groups. The bridging cluster
(cluster 1) was enriched for genes involved in the immune response (N = 10,
P = 4×10<sup>−7</sup>) and genes with NTPase activity (N = 6,
P = 5×10<sup>−4</sup>). Clusters 2 and 3 were enriched for genes involved in
intracellular signaling pathways (N = 18, P = 6×10<sup>−7</sup>). Clusters 4–6
were enriched for genes that encode nuclear proteins (N = 24,
P = 9×10<sup>−4</sup>). Principal components analysis of the microarray-derived
transcript abundances of the genes selected based on cross-validation clearly
differentiated the five experimental groups based on the 7-day mortality
(principal component 1) and the type of agent used (Gram positive, sterile, Gram
negative, principal component 2).
## Clinical study—training cohort
After being mechanically ventilated for \>48 h, 27 patients were enrolled into
the study. The first 20 patients enrolled were assigned arbitrarily to a
training cohort; the other 7 were assigned to a validation cohort. Blood samples
were taken at ∼48-hour intervals during the study period and then separated into
plasma and leukocytes (see below). Of the 20 patients in the training cohort,
eight patients either were extubated without developing VAP or withdrew from the
study. Of the 12 patients in this cohort who developed microbiologically-
confirmed VAP , 11 met our analysis criteria of having samples before and after
the attending physician made a diagnosis of VAP (that is, one patient, \#9, was
excluded from analysis for developing VAP on the study entry day). Clinical
pulmonary infection scores (CPIS) increased in all 11 patients coincident with
the diagnosis of VAP. Three of the patients were culture positive for a Gram
positive agent (*S. aureus*) and the remaining eight patients were culture
positive for one or more Gram negative agents. In every case, initial
intravenous antibiotic therapy was appropriate for the cultured organism
responsible for VAP, based upon cultured organism susceptibilities. Nine of the
11 patients developed VAP 3–6 days after enrollment in the study (“early VAP”)
while two patients developed VAP after prolonged mechanical ventilation (“late
VAP”). All of the patients survived and were discharged from the ICU. Patient-
specific timelines were aligned for analysis by assigning “day 0” to the day
that the attending physician diagnosed VAP.
RNA isolated from patient samples was of high quality and hybridizations met
standard performance criteria (*vide supra*). To assess whether the genes
identified in the murine model conveyed information in the patient study, the
microarray abundance of the human orthologs of the 219 genes that distinguished
the murine pneumonias were numerically analyzed. Principal components analysis
of the average RMA-normalized expression levels of these 109 ortholog genes
resulted in gene expression trajectories that described the cohort of patients
as they developed, were treated for, and recovered from VAP. Trajectory
translocation along the X-coordinate (principal component 2) appeared to be
informative with regard to the onset of VAP – beginning immediately before the
diagnosis and ending approximately six days after appropriate antibiotic therapy
was initiated. Principal components analysis of plasma cytokine abundance in
these patients showed a qualitatively similar trajectory, but with large error
bars. Nevertheless, translocation along the X-coordinate (principal component 2)
again appeared to coincide with the onset of VAP.
Independent analysis of patient microarray data resulted in the identification
of 85 probe sets whose abundance changed significantly during the course of VAP.
Of the 109 human orthologs that were used to calculate the trajectories shown
in, probe sets (4.6%) were present in the list of human probe sets
(lactotransferrin, cathelicidin antimicrobial peptide, phospholipid scramblase
1, inhibin beta A, and hydroxyprostaglandin dehydrogenase 15-(NAD)). Network
analysis found that the expression behavior of these 85 genes segregated into
four clusters. Transcript abundance in clusters 1 and 2 generally increased and
transcript abundance in clusters 3 and 4 generally decreased around the time of
VAP diagnosis.
Molecular cartography of the human leukocyte transcriptional response to acute
bacterial infection identified two densely connected networks of genes, the
first containing clusters 1 and 2 and the second containing clusters 3 and 4.
The 26 probe sets in clusters 1 and 2 are significantly enriched with GO
biological process terms: “defense response to bacteria” (8 genes,
p-value = 2×10<sup>−11</sup>), “response to biotic stimulus” (12 genes,
p = 4×10<sup>−6</sup>), and “immune response” (8 genes, p = 0.002) and the
cellular compartment term “extracellular region” (14 genes,
p = 9×10<sup>−9</sup>). The 59 probe sets in clusters 3 and 4 are enriched with
GO molecular function terms: “ATP binding” (13 genes, p = 9×10<sup>−4</sup>),
“metal ion binding” (22 genes, p = 0.002), and “protein binding” (25 genes,
p = 0.002) and the cellular compartment terms “cytoplasm” (23 genes, p = 0.007)
and “plasma membrane” (13 genes, p = 0.02).
Principal components analysis of the microarray expression profiles of these 85
genes defined a common response to pulmonary infection complicating critical
illness. Importantly, trajectory translocation in the X-coordinate (principal
component 2) occurred days prior to the clinical diagnosis of VAP. In addition,
the informational content of 85 genes chosen at random was determined
iteratively 100 times for the first 11 VAP patients. As shown in, only the 85
genes identified by EDGE as significant (FDR≤0.10) produced a trajectory; the
other sets of genes were scattered randomly around the origin of the graph.
Three patients exhibited contrary gene expression profiles within two of these
four clusters. Patients 1, 7 and 11 showed decreased expression of genes in
cluster 2 and patients 7 and 11 showed increased expression of genes in clusters
3 and 4. Based on patient demographics ( and data not shown), the only clear
difference between patients 7 and 11 and the other patients in the study is that
these two patients developed VAP later in their ICU course (study day 18 and 14
respectively) whereas the remaining patients developed VAP between study days 3
and 6. This was also evident in PCA analysis of the 11 individual trajectories
(data not shown). The changes in transcript abundance of selected genes were
validated by quantitative RT-PCR. Finally, we tested whether host ethnicity,
host gender, host age, or the cell wall phenotype of the infectious agent had an
effect on the number of informational genes. The most informational of these
demographic variables was host ethnicity.
We observed in that the aggregate riboleukogram variance in principal component
2 decreased as patients recovered from acute infection. This finding suggested
that principal components analysis of microarray-measured gene expression
described an attractor, as gene expression time series can be described in terms
of dynamical system theory as trajectories in the phase space defined by the
main principal components. By plotting the change in PC2 against PC2 over time,
we found indeed that the mapped gene expression information appeared to converge
toward a common point, suggesting that PC2 represents the expression of the
infection-inducible genes. Consistent with differences in patient age, gender,
ethnicity, pre-existing co-morbidities, and nature of injury insult, each
patient's individual trajectory started at a different point and described a
patient-specific arc (data not shown).
## Validation cohort
A second cohort of 7 patients was analyzed to evaluate the informational value
of the 85 genes that were identified in the first 11 patients with VAP. Two of
these 7 additional patients were diagnosed with “late” VAP by the attending
physician, while another 2 cases were described by the attending as “possible”
VAP. The individual riboleukograms for these 7 patients demonstrate the
existence of immune recovery (basins of attraction) as well as the heterogeneity
of the host response. In general, the individual riboleukograms follow a path
moving from left to right, that is, from critical illness to recovery (green and
red shaded areas, respectively). The development of an infectious complication
is typically associated with a change in riboleukogram trajectory. For example,
the paths of patients 13, 14, 15, 16, and 17 change directions abruptly
coincident with changes in clinical status and concern for VAP or sepsis.
Patient 17 grew *Staphylococcus aureus* from both urine and tracheal secretions
prior to withdrawal of therapy for cure (the only death in the study). In
contrast, the riboleukograms of patients 13, 18, and 19 are atypical, in that
their paths do not start and/or do not finish with the others. Both patients 18
and 19 had pulmonary contusions secondary to polysystem trauma, maximal CPIS
scores of 7 and 9, Gram-positive cocci cultured from airway secretions, and were
treated with antibiotics, but had a clinical course labeled by the attending
physician as “possible” VAP. Their riboleukograms are in different portions of
the graph in, but have a similar shape and slope. Both patients 13 and 18 had
intracranial hemorrhage. Patient 13 was not diagnosed with VAP (no infiltrate on
CXR) but was treated with antibiotics for a fever of 39.4°C and WBC of 31,300
(day 5), tracheal secretions that subsequently grew out Acinetobacter and
Stenotrophomonas (CPIS 6), and concern for catheter-related sepsis.
In, the aggregate riboleukogram for the training cohort of VAP patients (aligned
for day of VAP diagnosis, see also) is compared to the aggregate riboleukogram
for all patients aligned for day of study entry (that is, both training and
validation cohorts, N = 11+7, irrespective of VAP day). Again noted are the PCA
domains of critical illness and recovery. The aggregate VAP riboleukogram
diverges from the aggregate critical illness riboleukogram and rejoins the
latter at the point of recovery.
# Discussion
Using a bench-to-bedside approach, we have implemented a mouse model of
pneumonia and found that RNA abundance profiles obtained from blood samples
taken prior to appreciable mortality were able to distinguish between the two
variables tested in the assay: lethality of the insult and type of infectious
agent. These data extend our previous observations in a mouse model of abdominal
sepsis, wherein microarray-measured expression profiles from circulating
leukocytes distinguished between infectious and non-infectious etiologies of
systemic inflammation in a de-identified cohort. Thus, the mouse circulating
leukocyte transcriptional response to infection can not only distinguish between
infectious and non-infectious inflammatory insults, but also the type of
infectious agent and its associated mortality. Network analysis suggested that
the pneumonia-induced transcriptional changes reprioritized mouse leukocytes for
the initiation of an immune response, the transcriptional regulation of
intracellular signaling cascades, and the induction of numerous transcription
factors and other nuclear genes.
Results from the mouse model suggested that the transcriptional activity of
buffy coat-isolated cells may be used to monitor the onset of and recovery from
acute infection. We tested this hypothesis by calculating principal components
using microarray expression profiles of RNA isolated from mechanically
ventilated patients at risk for pneumonia. Initially, we examined the behavior
of the human orthologs to the genes identified in the mouse pneumonia study. The
onset of acute infection corresponded with translation along PC 2 in.
Translation along PC2 ceased 5–6 days after appropriate antibiotic therapy in
the patients was started, consistent with recovery. These data show that there
are specific transcriptional programs instituted by circulating immune cells
during acute infection which have diagnostic potential in the setting of
critical illness. Principal components analysis of plasma cytokine abundance
generated a qualitatively similar trajectory; however, in line with previous
reports, plasma cytokine abundance (including procalcitonin) was insufficient to
diagnose acute infection in this small cohort of critically ill patients. As
with other tissues, changes in RNA abundance observed in circulating leukocyte
do not necessarily reflect changes in protein abundance, and vice versa. While
principal components analysis of informational murine genes in authentic human
disease showed there was a conserved and informational peripheral leukocyte
transcriptional response to localized infection, the information contained in
those genes would not appear to be more useful than current clinical criteria
(that is, the translation in PC2 did not begin until the day the attending
physician made the diagnosis). However, by explicitly accounting for variance
over time, a set of 85 genes were identified subsequently in our first 11 VAP
patients whose microarray expression levels changed consistently before the
clinical diagnosis of VAP.
These 85 genes clustered into four groups with their abundance either increasing
or decreasing throughout the 7-day window bracketing the onset of infection.
There was a significant association between genes known to play key roles in
defense against bacterial pathogens and those genes that increased in apparent
abundance (cluster 1 and 2 probes sets) coincident with the diagnosis of VAP.
Consistent with activation of the host response to pneumonia, all of the genes
with the “defense against bacteria” ontology were found in cluster 2 and encode
primarily granulocytic, antimicrobial proteins, and adhesion molecules. In
contrast, the genes that decreased in apparent abundance (clusters 3–4) showed
different behavior depending on whether the patient developed VAP early or late
in the study. Although no consistent biological theme emerged from this list of
the 59 transcripts, this finding provides some insight into the transcriptional
basis of differences in the critically ill host's response to early- *versus*
late-onset VAP. Of interest, the RNA abundance of five genes were altered by
pneumonia in both the mouse and human gene sets: lactotransferrin (LTF),
cathelicidin antimicrobial peptide (CAMP), phospholipid scramblase 1 (PLSCR1),
inhibin beta A (INHBA), and hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD).
Pathway analysis indicates that these five genes connect in a network rich with
interactions between important mediators of inflammation, as seen in and,
(Ingenuity Pathway Analysis, Ingenuity Systems, Redwood, CA). Principal
components analysis of the microarray expression data for the 85 transcripts
generated a curve with qualitative similarities to curves derived from either
cytokines or the 109 human orthologs; however, the patient-to-patient variance
in the measured abundance of these genes was significantly smaller and
translation along the second principal component preceded the diagnosis of VAP
by 24 to 72 hours. In contrast, equivalent analysis of randomly selected sets of
genes provided no information about the host response to critical illness
complicated by pneumonia.
Macroscopically, pneumonia is diagnosed when there are symptomatic changes in
clinical status, as manifested typically by increased CPIS scores. However,
microscopically pneumonia occurs at the transition from colonization to
infection concomitant with failure of multiple host barriers protecting the
bronchoalveolar epithelium. These events lead to tissue exposure to bacteria and
bacterial products, and in many cases to toxicosis and bacteremia. Our data
suggest that during VAP, circulating leukocytes are exposed to bacterial
products 24–72 hours prior to diagnosis by an attending physician. Initiation of
antibiotic therapy earlier during this time window is expected to significantly
improve outcome. These findings were further evaluated in a small validation
patient cohort, confirming the value of the 85-gene riboleukogram to quantitate
the host response to and recovery from critical illness. Individual
riboleukograms changed direction coincident with clinical findings of pneumonia
or sepsis (frequently days before the clinical diagnosis and maximal CPIS
scores). Nevertheless, marked heterogeneity was observed in some patient
responses that could not be linked to monitored variables (*e.g.*, patients 13
and 18). In these patients, perhaps the well-described influence of the
underlying acute illnesses (pulmonary contusion and intracranial hemorrhage) on
host immune responses could provide part of the explanation. As patients healed
from critical illness, the riboleukograms converged, a finding consistent with
the existence of an immunological “attractor” state. Comparison of the aggregate
VAP *versus* critical illness riboleukograms indicated that a large portion of
the signal for the 85 genes identified is a reflection of recovery from critical
illness (PC2). Nevertheless, VAP signal became evident among the “noise” of
critical illness once the individual riboleukograms were aligned for day of VAP
diagnosis, evident as a deflection of the VAP riboleukogram upward in PC3. Thus,
we submit that riboleukograms are a molecular analytical tool with substantial
potential to improve diagnostics, prognostics, and our understanding of the host
response to critical illness complicated by acute infection.
An important consequence of our observation that patient-specific riboleukograms
converged is that the variance in leukocyte gene expression for these 85 genes
decreased significantly over the time course in patients with VAP. Studies of
physical systems suggest that the stable states of networks can be represented
as attractors, a set of points in the phase space to which the genetic network
evolves over time. In particular, every trajectory initiated within the bounds
of an attractor terminates inside the attractor. Recently this hypothesis has
been confirmed experimentally *in vitro*. Our findings suggest that the immune
system of a critically ill patient who recovers from disease returns back to a
stable state and that the immune response trajectory can be a considered
formally as a dynamic system. Borrowing from concepts in the physical sciences,
we hypothesized that an individual's baseline immune system is within a basin of
attraction prior to injury, nosocomial infection perturbs that system, and after
the infection cleared the system would return to it's initial attractor. In
phase space analysis, we found that the patient-specific trajectories appeared
to converge and that the onset of pneumonia ‘pushes' the gene expression data
away from that basin—a perturbation that is ameliorated by appropriate
antibiotic therapy. This result provides what we believe is the first evidence
in patients for a basin of attraction for the genetic network associated with
immunological health.
Because of the heterogeneity of this patient population (for example, age,
gender, pre-existing health status, type and severity of critical illness), it
is not surprising that the error bars on the PC analysis are initially quite
large. The end-points of the trajectories, however, appear to converge in a
smaller space, suggesting that the patients' immune systems are returning to a
health attractor. As observed in the validation cohort, patient-specific
trajectories are not smooth curves, but appear to have inflection points that
may correlate with hospital intervention or the onset of infection. Our data
further suggest that differences in host ethnic backgrounds and gender are more
important than differences in infecting organism as determinants of the host
leukocyte transcriptional response. These observations are consistent with a
recent study comparing GeneChip signal from cells lines derived from Asians and
Caucasians, indicating differences in the gene expression levels of 25% of the
4000 genes studied in these two ethnic groups. Moreover, as the rate of sepsis,
the youngest age of sepsis onset, and the sepsis mortality rate are highest for
African-American males, our data suggest that further study of riboleukograms is
indicated to gain insight into these health disparities. These profiles also
suggest that there is a transcriptional component that is conserved across that
diversity of the human population.
In summary, our analysis demonstrates the plasticity of the blood leukocyte
response to bacteria *in vivo,* extending previous *in vitro* studies, into the
clinical realm. For the first time, we provide evidence that riboleukogram gene
expression analysis can be applied to a heterogeneous clinical population to
monitor the host response to and recovery from critical illness complicated by
acute infection. Moreover, we identify new, conserved gene targets that appear
to be informational for recovery at the transcriptional level, many of which are
involved with granulocyte maturation and chemokine (not cytokine)
responsiveness. This conclusion is supported by the relative weak diagnostic
information provided by the plasma cytokine data, consistent with conclusions
reached at recent a consensus conference. In particular, plasma procalcitonin
levels were not informational. There are, however, important limitations to our
study, most notably, the preliminary nature of the work, the small number of
patients, and the well-known difficulty of ruling out false-positive and false-
negative diagnoses of VAP based on clinical parameters. This uncertainty is both
the motivation for (and challenge of) developing novel molecular diagnostics for
VAP. In addition, there is no consensus on how to leverage the dynamic nature of
the clinical, RNA, and protein data collected to build hybrid models that
improve diagnostics and prognostics. Thus, we conclude that our data demonstrate
the technical feasibility and clinical potential of the riboleukogram approach,
but proof of clinical utility will require further study.
Thus, as graphs of myocardial electrical information (electrocardiograms) were
tapped over a century ago to provide an objective means to aid heart
diagnostics, we submit that riboleukograms will aid in the diagnosis and
prognosis of acute infectious and inflammatory disease. The diagnostic potential
of riboleukograms is supported by two very recent independent reports that
corroborate our mouse data, indicating that circulating leukocyte RNA signatures
in patients differentiate between the host responses to sterile *versus*
infectious causes of systemic inflammation and between the host response to
Gram-negative *versus* Gram-positive pathogens. Prospective clinical trials are
indicated to validate our results and determine the value of this new
technology; to optimize gene selection methods that account for differences in
patient ethnicity, gender, and age; and to develop computational approaches that
integrate clinical and molecular data to improve diagnostics.
# Supporting Information
The authors wish to thank Drs. Daniel G. Remick and Derek C. Angus for providing
cytokine and procalcitonin measurements, respectively. We also acknowledge the
technical and clinical expertise of Sandra MacMillan, Douglas Oppedal, Diane
Salamon, Barbara Anderson, and Sharon Daube.
[^1]: Conceived and designed the experiments: JC MC JM CC WD BG. Performed
the experiments: JM KH. Analyzed the data: JC JM KH AP NL QL AB JR WZ BG DD
WS. Contributed reagents/materials/analysis tools: JM AP NL QL AB JR WZ BG
WS. Wrote the paper: JC JM AP AB WZ CC WS. Other: Designed the study: JC.
[^2]: Current address: Pacific Northwest National Laboratory, Richland,
Washington, United States of America
[^3]: Current address: Department of Mathematics and Statistics, Texas Tech
University, Lubbock, Texas, United States of America
[^4]: The authors have declared that no competing interests exist.
|
# Introduction
Democracies are supposed to produce policies that align with the public’s
preferences. Although the ideal form of democracy provides ordinary citizens
direct control over policy and governance, in most modern democracies policy
making is left to politicians and their staffs. In recognition of the public’s
putative centrality in democratic governance, studies of policymaking treat
politicians and their staff as well-honed, career-minded machines who
strategically select behavioral responses to electorally created incentives.
Nonetheless, politicians (and their staff) do not always have an accurate
perception of what their constituents want and fill in the gaps by projecting
their preferences onto their constitutes. As a result, policymaking can end up
reflecting politicians’ wants and desires, even if elected officials are trying
to be faithful representatives to their constituents.
It is, therefore, crucial to understand how politicians form policy preferences.
Canonical models of policymaking presume that policymakers process information
in a uniform fashion—given the same facts, they should reach the same
conclusions. Differences in preferences, then, should simply reflect differences
in political philosophies. However, recent research shows that psychological
biases are more important for elite decision making than canonical models of
policymaking presume. Although there is an understandable tendency to treat
policymakers as special—after all, they are an elite group of policymakers—they
are also only human. Rather than treating policymakers as well-honed machines
who process information in a uniform way, we look to the study of how ordinary
citizens form political preferences to gain insight into the psychology of
policymaking.
According to decades of research, ordinary people do not process information
uniformly. Differences in genetics coupled with early life experiences lead to
differences in the architecture of brain and, thus, the way in which people
process external information. In the realm of politics, deep-seated differences
in how individuals process information profoundly shapes political attitudes. A
burgeoning area of research focuses particular attention to how people process
perceived threats. Some people greet reports of terrorism, crime, and the like
with a great deal of alarm, while others take them in stride. Recent work
suggests that people who are highly sensitive to threats come to see the world
as a dangerous and threatening place and tend to see conservative policies—such
as adherence to conventional morality and support for a strong military—as a way
to cope with and manage the dangerous and threatening world in which they live.
These tendencies are evident in the association between conservatism and higher
levels of electrodermal activity (i.e., sweating) in response to threatening
images. Studies of neural activity suggest that the brains of people who hold
conservative attitudes may be more attuned than liberals’ brains to potentially
threatening stimuli.
# Data and results
This research was approved by Texas A&M IRB and was administered by Professor
Johanna Dunaway who is on faculty at Texas A&M.
We extend this line of research to the study of policymakers in the United
States. We are aware of no study that investigates this central claim. Although
one study shows that center-right political elites in Iceland offered more
conservative policy opinions when induced to feel threat, it leaves unresolved
whether politicians differ in how they process and respond to threatening
stimuli. We evaluate the effects of threat sensitivity on policymakers’ policy
preferences by recruiting 173 state legislators and their staff at the 2016
National Conference of State Legislators to participate in a brief study. The
study consisted of a survey that measured state policymakers’ spending
preferences and a standard protocol for measuring physiological responses to
threatening stimuli. In particular, we measured threat sensitivity by sitting
participants before a laptop, behind a privacy partition, and asked them to wear
noise-canceling headphones to minimize distractions. Biosensors were attached to
the first to third fingers on their non-dominant hand to capture skin
conductance. Participants were then presented with four images in succession.
The first two images were selected to be neutral and non-affective so that we
could capture participants’ baseline physiological activity (a basket and a
spoon, presented in random order). The second set of images were selected for
their threatening content (a snake lunging at the camera and a close-up of a
angry, barking guard dog, presented in random order). The skin conductance
levels (SCL) captured during the images allow us to measure participants’
electrodermal activity when faced with threatening non-political images. Because
electrodermal activity is difficult to regulate consciously, it offers a valid
and reliable measure of people’s sympathetic nervous system response. See for
details about the survey and threat sensitivity protocol. shows the distribution
of our measure capturing threat sensitivity, which is the difference in SCL
observed during the two threatening photos and the SCL observed during the two
neutral photos. Higher values indicate greater sensitivity to threat. The
distribution clearly leans to the right (i.e., towards threat sensitivity), but
there is a good bit of variation as well.
The survey asked policymakers to indicate what percent of their state budget
they would devote to six policy domains that consistently divide liberals and
conservatives: assistance to the poor, elementary and secondary education,
counter-terrorism, health care, higher education, and police and public safety.
Four of these tend to be liberal priorities: spending on education, higher
education, health and the poor; two others tend to be conservative priorities:
spending on defense and terror. Our measure of spending preferences captures the
conservative-liberal difference by asking policymakers to indicate the percent
of the state budget they would allocate to each domain; and then capturing
policymakers’ spending priorities by taking the average spending preference on
the two conservative priorities and subtracting from it the average spending
preference on the four liberal priorities. We find suggestive evidence that
threat sensitivity correlates with a preference for devoting a higher portion of
the state budget to conservative spending priorities vis-a-vis liberal ones (*β*
= 78.1, *SE* = 133.9, *P* = 0.28), even after controlling for participants’
partisan affiliation (*β* = 77, *SE* = 133.2, *P* = 0.29). (See Table B in for
details). Although these findings corroborate findings from layperson samples
that threat sensitivity correlates with conservative policy preferences, we
cannot rule out sampling variability as a possible explanation.
Although the six policies that are part of this general measure clearly relate
to conservative-liberal policy priorities, we expect that some are at best only
loosely related to threat sensitivity. Pushing beyond these preliminary but
suggestive findings, then, we focused the analysis on the degree to which
policymakers prioritize spending on counterterrorism to spending on assistance
to the poor. We do so for three reasons. First, these policy domains are
primarily national, not state-level, and, therefore, do not differ widely across
states. Second, these issues lie at the center of partisan polarization in the
US that previous scholars have traced to differences in threat sensitivity, and
recent survey research shows that counterterrorism and welfare stand out in this
regard. Third, terrorism is the policy domain that should be most clearly rooted
in concerns about a looming, external threat. Welfare, in contrast, is the
social domain that is most clearly involves an empathetic giving to others, even
in the face of moral risk. Consequently, the terror-welfare tradeoff—capturing
spending on threat versus spending on targeted income redistribution—should be
more directly connected to threat sensitivity than the general spending
priorities measure.
The results reported in confirm these expectations. Here we observe a positive
and statistically significant relationship between threat sensitivity and
policymakers’ tendency to prioritize counter-terrorism over welfare spending.
This relationship is unaffected when partisan affiliation is added to the model
(Column 2 of). plots the estimated relationship between threat sensitivity and
counter-terrorism spending priority, from Model 2 of. Moving across the observed
range of threat sensitivity is associated with a shift in a preference for
prioritizing counter-terrorism over welfare spending by 30 percentage points. On
a measure that ranges from -56 to +33, with a standard deviation of 16.2, this
is a rather striking relationship.
We regard the tradeoff between counterterrorism and welfare as the most relevant
for our purposes, but note that our results are not dependent on these two
domains alone. One obvious change is to replace counterterrorism with crime
prevention. There will more regional variation in crime-related spending; and
crime prevention is less directly connected to threat sensitivity in the
existing literature. Even so, results using this slightly revised measure
produce roughly similar results. We include those results in Table C in.
The empirical evidence that we present suggests that the genesis of policy
elites’ spending preferences is more complicated than theoretical models assume.
When these individuals are making budgetary tradeoffs, threat sensitivity
correlates with prioritizing spending on counter-terrorism to welfare
spending—the classic guns versus butter tradeoff.
These findings challenge the notion that elites’ preferences can be simply
reduced to strategically selecting behavioral responses to environmentally
created incentives as well as the notion that strong incentives for policy
elites to be cold and calculating obviates the influence of psychological needs.
Instead we find that, like ordinary citizens, threat sensitivity plays an
important role in state-level policymakers decisions to prioritize spending on
government polices that are designed to minimize threats. To be clear, this is
not to say that these elites are not being “rational.” They could certainly be
behaving rationally in the sense that they are connecting their psychological
needs in a logical way to their policy preferences. What these findings show is
that elites—like all humans—vary in the way in which they evaluate the same
information, leading them to adopt different policy preferences. Individual
differences in information processing have not been incorporated into standard
theoretical models of elite decision-making, and our findings suggest that
perhaps they should. Doing so may provide insights into why some policymakers
systematically perceive their constituents to be more conservative than they
actually are.
Like all studies, ours has several limitations. First, in order to preserve
anonymity, we did not collect personal information about these participants,
such as the districts that they represent. It could be that particular
constituencies elect representatives with psychological needs that mirror the
modal member of their district. If so, it would support an “electoral
connection” between constituents and representatives, albeit one that does not
require the representative to behave in a strategic way. Second, we do not know
the level of professionalism of the legislature in which these policymakers
inhabit or their level of progressive ambition. Some state legislatures are
highly professionalized miniature versions of the US Congress, while others are
filled with mostly part-time citizen legislators. Policymakers from less
professionalized legislatures may behave in less strategic ways. On this point,
individual legislators—irrespective of the type of legislature in which they
work—vary in the degree to which they have ambitions to progress up the
electoral ladder to a higher office. Perhaps more ambitious individuals will
behave in a more calculating fashion.
Furthermore, more research is needed regarding the psychophysiological
measurement of threat sensitivity and, more generally, negativity bias in this
domain of political science. We chose images that would directly tap into threat
and, therefore, feelings of anxiety and fear. However, other researchers have
used a variety of images to tap threat sensitivity that may also tap into
disgust—making those measures better thought of as a general indicator of
negativity bias that includes threat and disgust sensitivity. We find it
noteworthy that our more tailored images point to the same conclusions as a more
general measure of negativity bias. Nonetheless, we cannot speak to the specific
effects of threat and disgust—whether both forms of negativity bias contribute
equally to inducing conservative attitudes or whether they operate differently
in different domains.
Despite these limitations, we believe that our study makes an important
contribution to the study of elite behavior. Scholars should take the
psychological needs of policymakers more seriously. In short, we find that
policymakers are people, too. Additional research should be directed at
understanding the conditions that moderate and mediate the influence of
psychological needs on elite decision making and behavior.
# Supporting information
We thank Dan Butler and the *Laboratories of Democracies* for giving us access
to study participants, and Temple University, the University of Michigan and
Texas A&M University for financial support that made this research possible. We
also thank Sarah Anderson, Nicholas Ryan Davis, Mona Vakilifathi, and Laurel
Harbridge Yong for their help in the design and implementation of the study.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Proteins play a vital role in living organisms. They are the main players in
metabolic pathways, and to understand how cells work requires insight into the
structure and knowledge of the function of a protein. A plethora of research to
determine the structure and function of proteins has been conducted, but the
rate of knowledge generated has grown much more slowly than the universe of
identified proteins has. For example, between two releases of the UniProt
Knowledgebase (from release 2015_11 to 2015_12) only 287 sequences were added to
the Swissprot section, which contains curated protein sequences with high levels
of annotation. Over the same time period, the TrEMBL section (for automatically
annotated sequences) has been augmented with more than 590,000 protein
sequences. The need for more accurate and scalable automatic methods is
compelling.
Variation in proteins comes from recombination and mutations in evolutionary
modules. These modules are generally known as *domains*. A single protein is
made up of one or more domains. Thus, the detection of domains of protein
sequences can be regarded as the initial step in domain family identification
and protein clustering, which in turn can help in function and structure
assignments. Accurate annotation of conserved regions, as building blocks of
protein sequences, can also contribute to construction of evolutionary trees.
Many current approaches perform the detection of sequence domains by detecting
only putative regions and as a part of domain family identification, i.e.,
protein clustering based on domains rather than as a separate question. To the
best of our knowledge there is no published research concentrating only on
detecting conserved regions in proteins. Although correlation between the
detection of domain regions and clustering based on domains appears to be
natural, one can argue that a cluster is a global property of the universe of
proteins, but a domain is a local property of each sequence which, as the
definition suggests, needs to be common to many sequences. Global approaches to
domain family identification also often involve the expensive operation of
sequence alignment. Hence, fast and accurate detection of domain regions will
contribute to the global operation of clustering proteins, both by improving the
accuracy of detection and reducing runtime by removing expensive sequence
alignment operations.
While the unprecedented growth in numbers of sequenced proteins has been a
challenge for integration of automated methods in proteomics, the abundance of
sequences also presents us with an opportunity: as the number of protein
sequences containing domains increases, the frequency of occurrence of a
particular domain also increases, making it easier to detect. Our task, then, is
to extract high frequency regions from within the protein sequences. As we
explain fully below, for each sequence, our alignment-free method translates its
level of similarity to other sequences into a vector and then looks through each
vector to detect the pattern within its indices. While we introduced the idea of
this translation into a vector in, our experiments showed that our simple
mathematical approach resulted in a heavy inter-dependence between the
parameters selected for the method and the protein sequences. Here, we improve
upon this previous work by integrating a machine learning approach that reduces
the dependence on parameters while improving the accuracy. We have also
augmented our work with an extensive experimental results section in which we
not only validate our proposed method but also provide comparison of our results
with the results of other existing methods.
## Related Work
While detection of structural domains as opposed to functional domains has been
an area of active research featured as a part of CASP experiments, the detection
of sequence level conserved regions has been mostly overshadowed by efforts to
cluster proteins based on their domain families. In MKDOM2, the shortest
sequence (without repetitions) is marked as a domain and then PSI-BLAST is used
to detect regions of high similarity with that domain. Sequences containing
regions similar to that domain are put in one cluster. The detected sections are
removed from the sequences and the same operation is repeated to find other
domains. The objective of MKDOM2 is expressed as identification of domain
families rather than detection of domain regions themselves. MKDOM2 is an
improvement over MKDOM which in turn succeeded DOMAINER. All three have been
used to generate the ProDom protein family database. Parallelization of MKDOM2
has been implemented using a master-worker structure.
In ADDA, an all vs. all BLAST is performed on the entire data set. Based on the
results of BLAST, a tree of putative domain regions is generated for each
sequence. An optimization target is then used to find the final partitioning for
each sequence. Unification is performed to construct a new graph based on final
partitions and to cluster similar proteins together. In ADDA, domain boundary
assessments are performed using the trees of putative domains. However, the
final goal being domain family enumeration, unification is a crucial step and
can possibly improve the partitions. An implementation of construction of ADDA
putative domain trees of protein sequences from their all vs. all BLAST results
has also been presented with support for parallel/multi-threaded executions.
In EVEREST an all vs. all BLAST on the data set is followed by runs of the
Smith-Waterman algorithm on the selected sequences to generate a set of putative
domain regions. After applying a series of different methods, including
clustering the sequences based on detected putative domain regions, filtering
low-scoring clusters using a boosting machine learning technique, and profile
construction using ClustalW for each cluster, EVEREST finds a set of HMM
profiles. The segments detected by these profiles replace the initial putative
domain list and correspond to suggested domain families. This operation is
repeated iteratively.
As can be seen, all three of these approaches focus on domain family
identification rather than domain region detection, but they also use some
methods for detection of putative domain regions as a preliminary operation for
their final objective.
In this paper we present NADDA (No-Alignment Domain Detection Algorithm), an
alignment-free, scalable method for detection of conserved regions in proteins.
In the next section we present our approach to the problem. In the Results
section we evaluate our method and compare its results with other methods. We
conclude the paper by a brief discussion on what we achieved and prospective
future work.
# Methods
Given a set *S* of *n* sequences, the problem of *conserved region detection* of
protein sequences can be expressed as the demarcation of subsequences in each of
the *n* sequences such that these subsequences are preserved over the
evolutionary process. The preservation of these subsequences can be identified
by a high local similarity score when the protein is aligned with other proteins
of the same family. These conserved subsequences appear as motifs and sequence
domains. Our method uses the frequency of short exact matching subsequences
(*k*-mers) of a protein sequence in the data set as an indicator of the
existence of a conserved region in the vicinity of that *k*-mer.
**Problem Definition:**
**Notation:** Given a sequence *s*, we denote the *i*<sup>*th*</sup> character
of *s* by *s*\[*i*\] and the substring of length *l* that starts at index *i* of
*s* by *s*(*i*, *l*). We denote the length of a sequence *s* by \|*s*\|. A
*k*-mer is a string of length *k*.
Additionally, let *S* = {*s*<sub>1</sub>, *s*<sub>2</sub>, …, *s*<sub>*n*</sub>}
denote an input set of *n* protein sequences. We define:
**Definition 1** *k*-mer frequency: *The* frequency *of a k-mer in S is defined
as the number of sequences in S that contain that k-mer at least once*.
A conserved window is then a substring of length *r*, centered at index *i*,
where the average frequencies of *k*-mers in that substring is above a certain
threshold *τ*. However, this definition is heavily dependent on the values of
the threshold (*τ*) and the window size (*r*). To compensate for these
limitations, we consider a smaller resolution of regions—indices. For each index
*i* we consider a window of size 2 × *w* + 1 centered at *i*, and based on the
frequency of *k*-mers inside this window we decide whether or not index *i* is
part of a conserved region. The decision based on *k*-mer frequencies is not
dependent on a single threshold *τ*; rather we find a set of thresholds
{*τ*<sub>1</sub>, *τ*<sub>2</sub>, …, *τ*<sub>2×*w*+1</sub>} where
*τ*<sub>*j*</sub> is used as a threshold for the *j*<sup>*th*</sup> *k*-mer in
the window, i.e., the *k*-mer originating at index *i* − *w* + *j* − 1 of the
sequence. This set of thresholds is found using our machine learning algorithm,
and the prediction is also made by a combination of comparisons based on the
thresholds.
**Definition 2** Conserved Region: *Given a sequence s ∈ S, a substring s(i, l)
is said to be a* conserved region *if*:
1. *(conservation) every* *s*\[*j*\] *for* *j* ∈ \[*i*, *i* + *l*\] *is a
conserved index, and*
2. *(maximality) neither the index* *s*\[*i* − 1\] *nor the index* *s*\[*i*
+ *l* + 1\] *(if either exists) is a conserved index*.
From the problem definition above, a simple approach is to compare each pair of
sequences ($\begin{pmatrix} n \\ 2 \\ \end{pmatrix}$ pairs) and use the results
to annotate the sequences with their conserved areas. To perform the alignment,
one can use methods such as the Smith-Waterman local alignment or related
heuristics such as PSI-BLAST. However, these approaches are not scalable when
\|*S*\| is large. Instead we generate a new representative vector for each
sequence—*k*-mer profile as defined below—and perform a binary classification
using feature vectors obtained from this representation. Rather than dissecting
the sequence itself we dissect the profile vector into putative conserved
regions and map these conserved regions onto the same indices of the sequence.
As we will see in the Results section, the detected putative conserved regions
widely correspond to the sequence domain regions of the sequences as they are
annotated in well-known protein domain databases.
**Definition 3** *k*-mer profile: *The k*-mer profile *of a sequence s is a
vector of the length of the sequence, where the value of each index is the
frequency of the k-mer originating at that index in s*.
The problem of parsing a profile vector into putative conserved regions can be
translated into a classification problem in which the task is to decide whether
or not each index of the vector should be included in a conserved region. We
generate an instance for each index of the profile vector and use a trained
model to predict whether it belongs to a conserved region; this is a binary
classification problem. Because the trained model depends only on the frequency
values of each index in its profile vector rather than on the amino acid
elements themselves, once we have a well-trained model it can be used for de
novo detection of conserved regions. The details for each of these steps is
explained below.
## Sequence *k*-mer Profile Generation
A *k*-mer profile is an alternative representation of a protein sequence. To
construct a *k*-mer profile we need to count the number of times every *k*-mer
appears in different sequences in our data set and record the counts at the same
index at which the *k*-mer originates in the profile vector. We approach the
problem using a two-pass hashing procedure. First, the algorithm reads every
protein sequence and for each position index of the sequence computes the
*k*-mer starting at that index. The computed *k*-mer is then used as a hash key
to store the position index number and sequence ID for that *k*-mer in the hash
table. If a *k*-mer appears multiple times in a sequence, we store all
appearances as one entry in the hash table. Thus, the frequency of each *k*-mer
in the data set will equal the number of entries stored for that *k*-mer in the
hash table. When reading of the sequences has been completed, we enter the
second pass of the algorithm. The algorithm uses the sequence IDs stored as hash
values in the first hash table as the keys to construct a second hash table. The
value of each sequence ID (hash key) in the second hash table is the originating
index of each *k*-mer in that sequence along with the frequency of that *k*-mer.
By ordering these frequencies in the hash table based on the index numbers, we
essentially generate the *k*-mer profile for each sequence. The serial
computation time for this step is *O*(*N*), where *N* is the total length of the
*n* sequences in the data set. Because the operation on one sequence is
independent of another, the algorithm is easily parallelizable. Later in this
section we present a MapReduce implementation.
## Classification Instance Generation
At the conclusion of the first step we have a set of *k*-mer profiles that are
vectors with index values equal to the number of sequences in the data set that
contain the *k*-mer initiating on the same index in the sequences. The next step
is to generate classificaton instances for each index in each sequence of the
*k*-mer profiles. Conversion of *k*-mer profiles to classification instances
allows us to first train a binary classificaton model using known domain data
and then to use the model to predict new domains. Given the *k*-mer profile *p*
for sequence *s*, we generate one classification instance per index *i* in *s*.
For such a profile and index, our classification instance is a vector *v*
consisting of 2*w* + 1 elements (features) where the 2*w* + 1 elements are
derived directly from the profile vector by copying the values from the window
centered on index *i* of *p* and extending from both sides for *w* indices.
These features represent the frequency of *k*-mers initiating at indices \[*i* −
*w*, *i* + *w*\] of the corresponding protein sequence.
## Classification Model Construction
We train the classification model using classification instances that include a
class label indicating whether or not the index associated with the instance is
conserved. This is determined by querying domain databases. We also use these
instances to test our model. Given the integer-valued features of our problem,
the need to handle large data sets, and the non-linearity of the problem (due to
the variable level of conservation among different domains), decision trees seem
to be a natural choice to use for training the model. They support automatic
feature selection and can learn different thresholds for different features.
However, for small *w* the decision tree will not be able to see the overall
picture of the *k*-mer profile and the model will lose robustness. The tree will
be inclined to classify any short-lived increase in frequency as a domain index
or a small local fall in frequency as a demonstration of absence of a conserved
region. On the other hand, a larger *w* can result in overfitting the training
data. To overcome the disadvantages of a simple decision tree classifier, we use
a Random Subspace ensemble method for which the base estimators are decision
trees. This ensemble method constructs multiple decision trees on random subsets
of features and classifies an instance based on the majority vote of the
decision trees.
Because we are using *k*-mer profiles in our training set rather than actual
protein amino acid sequences, our model depends only on frequencies (the values
in the *k*-mer profiles) rather than on the amino acids. As a consequence, it
can detect new conserved regions that were not present in our training set,
given that there are enough sequences in the data set containing the conserved
region to ensure the high frequency of *k*-mers in that region. In other words
our algorithm is able to detect conserved regions that are present in multiple
sequences in our data set, even if they were not annotated previously.
On the other hand, because the model is trained only once and we require
accurate performance from that model when presented with new data, the selection
of a good training set is crucial to the algorithm. First, the presence of
conserved regions in too few sequences in the training set will result in small
values in the *k*-mer profile and can be misleading to the training algorithm.
Second, as we increase the size of the training set, we will be adding
robustness to the trained classifier because conserved regions with varying
frequency profiles will be represented in the training set. Using a large data
set acquired from any of the big databases of protein conserved regions as our
training set will satisfy both our conditions for the training set and will
enable our algorithm to detect new conserved regions.
## MapReduce Algorithm for Profile Generation
We implement our algorithm in the MapReduce framework. A MapReduce program
consists of two main functions of *map* and *reduce*. In the map phase a set of
mapper tasks generate KeyValues based on the input. These KeyValue objects are
hashed based on their key and redistributed based on the result of the hash. The
intermediate hash-based grouping phase is called the *shuffle* phase. Each
reducer task then processes the set of values that are hashed to the same key. A
reducer, in turn, can also generate KeyValue objects. The MapReduce paradigm
suits data-parallel applications naturally. For our purpose, we exploit the
shuffle phase to implement many of our hash-based functionalities in parallel.
In our MapReduce algorithm, initially each mapper reads the input set of
sequences. It then generates KeyValue pairs using the *k*-mers of the sequences
as keys and sequence ids and *k*-mer positions as values. The shuffle step
subsequently sorts and redistributes these KeyValues such that each reducer
receives one KeyMultiValue object, where all the values corresponding to the
same key are sent to a single reducer. Based on the number of different sequence
ids present in its MultiValue, each reducer determines the frequency of the
*k*-mer mapped to it and emits a KeyValue, where the key is the sequence id and
the value is the frequency of the *k*-mer and the position of the *k*-mer in
that sequence. After this first complete stage of MapReduce, each reducer will
contain frequencies of *k*-mers for each position in one protein sequence and
can construct the *k*-mer profile for that sequence. The algorithm for this step
is shown in Algorithm 1.
**Algorithm 1** Construction of *k*-mer profile (*S*:{*s*<sub>1</sub>,
*s*<sub>2</sub>, …, *s*<sub>*n*</sub>}, *k*)
**for** each sequence *s*<sub>*i*</sub> ∈ *S* with id $s_{id}^{i}$ **do**
**for** each index *j* in *s*<sub>*i*</sub> **do**
*s*′ = *s*<sub>*i*</sub>(*j*, *k*)
emit KeyValue $KV = < s^{\prime},\left( j,s_{id}^{i} \right) >$
**end for**
**end for**
shuffle all KV’s
**for** each KeyMultiValue $KMV = < s^{\prime},\left( j,s_{id}^{i}
\right),\left( m,s_{id}^{k} \right),\ldots,\left( k,s_{id}^{l} \right) >$ **do**
*count* = *number* *of* *different* *s*<sub>*id*</sub> *in* *the* *KMV*
**for** each value $V = \left( j,s_{id}^{p} \right)$ in *KMV* **do**
emit KeyValue $< s_{id}^{p},(j,count) >$
**end for**
**end for**
shuffle all KV’s
**for** each $KMV = < s_{id}^{i},\left( j_{1},count_{j1} \right),\left(
j_{2},count_{j2} \right),\ldots >$ **do**
sort values based on *j*’s
return the *count*s based on sorted *j*’s
**end for**
## Implementation and Software Availability
We have implemented our method, NADDA, in C++ and Python. The C++ code uses the
*MRMPI* library for MapReduce and the *BOOST* library. The Python code uses the
*scikit-learn* (v. 0.17) machine learning library. Software is available as open
source at <https://bitbucket.org/armenabnousi/nadda>.
# Results
## Experimental Setup
Eleven different data sets were used for our experiments, one consisting of
approximately 50,000 bacterial protein sequences and the remainder consisting of
smaller sets of a few thousand protein sequences each. Some of the latter sets
consist entirely of bacterial protein sequences; others are mixtures of
sequences from bacteria, eukaryota, and archaea. The number of sequences and
percentage of bacterial sequences in each of the smaller sets are listed in.
More information regarding the domains in each of these is shown in Tables to.
The smaller sets (#1-#10) were used to evaluate *de novo* detection of conserved
regions with our model and to compare it with MKDOM2, ADDA, and InterPro. The
large data set \#11 was used to train and test our classification model. Because
both MKDOM2 and ADDA require sequence alignment, an expensive operation, it was
infeasible for us to conduct a comparison using our largest data set. For
example, MKDOM2 had not completed its run on data set \#11 after 20 days. It
should also be noted that both methods focus on clustering proteins based on
domain families rather than on detection of conserved regions. MKDOM2 clusters
are generated based on regions in sequences with high sequence similarity. These
regions represent conserved regions as defined earlier. Similarly, as an initial
step ADDA selects some putative domain regions. An optimization objective is
then used to generate final domain boundaries on each sequence. These boundaries
are later used to construct a graph and perform clustering. While each
identified region (indices enclosed between two consecutive boundaries) is
expected to contain exactly one domain, because they are used as an intermediate
result ADDA does not guarantee that a complete domain will be captured in each
domain region predicted by the optimization procedure (i.e., it does not
guarantee that there will not be any non-domain indices inside the predicted
region). However, a comparison can still be made.
To obtain our large data set (#11), we queried the SMART protein domain database
(<http://smart.embl-heidelberg.de>) using eleven common bacterial protein
domains listed in. This resulted in a list of 50,214 bacterial protein sequences
that included one or more of the eleven domains. We then queried Pfam-A release
29.0 with each of these sequences and labeled the domain indices to use as
ground-truth for our training instances. For the smaller mixed protein data
sets, we randomly selected some protein families through the Pfam webpage
(<http://pfam.xfam.org>; v.29) and then ran Pfam 29.0 on those sequences to mark
their Pfam domain regions. Similarly, for the predominantly bacterial protein
data sets, we either randomly identified bacterial protein families through the
Pfam webpage or else used domains from the other data sets that had a high
bacterial percentage. Again, we marked their domain regions using Pfam 29.0.
Tables to show the protein families selected from the Pfam online database and
the number of sequences present in each data set. Totals in these tables are
computed after removing common redundant sequences. We then queried InterPro
(v5.18-57) using each of our 10 smaller data sets.
Comparisons were performed based on the coverage of the domain indices reported
by Pfam-A in our findings and in the MKDOM2 and ADDA results as well as on the
coverage of conserved region indices reported by InterPro in the NADDA results.
We measured coverage using the three values of accuracy (AC), specificity (SP),
and sensitivity (SN) of the detected conserved indices as defined respectively
by: $$AC = \frac{\left| TP \middle| + \middle| TN \right|}{N}$$ $$SN =
\frac{|TP|}{\left| TP \middle| + \middle| FN \right|}$$ $$SP =
\frac{|TN|}{\left| TN \middle| + \middle| FP \right|}$$ where *TP*, true
positives, indicate the indices in the data set that are marked as part of a
domain region in Pfam-A, and the detection method also has classified them as
conserved indices; *TN*, true negatives, are the indices that both Pfam-A and
the conserved region detection method have not included in any domain/conserved
region; *FP*, false positives, are the indices that are not marked by Pfam-A as
contained in a domain, but the detection method has classified them as conserved
indices; and *FN*, false negatives, are the indices that are included in a
Pfam-A domain, but the detection method has fallen short of identifying them as
conserved. Finally, *N* is the total length of the sequences in the set (*N* =
\|*TP*\| + \|*TN*\| + \|*FP*\| + \|*FN*\|).
For our experiments, unless otherwise stated, values for *w* (where 2*w* + 1 is
the size of the feature vector), *k* (size of each *k*-mer), *MSS* (which
indicates the level of pruning of the decision tree—minimum number of instances
in each internal node), and *max*\_*features* (number of features used in each
decision tree for the ensemble method) are set respectively to 10, 6, 100, and
7. We discuss parameter selection in greater detail in the Supporting
Information.
## Evaluation of Results
We evaluate our results in three phases. First, we evaluate our training method
by partitioning data set \#11 into training and test sets. This is the common
practice in the machine learning community for evaluation of a training method.
The second phase includes comprehensive experiments evaluating overall
performance of NADDA by testing it using data sets with domains that are new to
NADDA (data sets \#1—#10). Here we also compare NADDA with ADDA and MKDOM2.
Finally, in the third phase, we compare NADDA against InterPro, re-evaluating
its ability to capture regions that are missed in Pfam. In addition, we provide
some example sequences from data sets \#1-#10, comparing our detected conserved
regions with the segments annotated by InterPro.
**Evaluating the training method:** In the first phase of our experiments we
perform two different types of training-set/test-set partitioning of data set
\#11, training the model on a training set and measuring the results on a test
set. First, we divide data set \#11 by randomly selecting 20% of the sequences
to be included in the test set and the rest in the training set. The second
partitioning is performed by selecting 20% of the domains from data set \#11
that are present in more than 50 sequences and including every sequence that
contains one (or more) of these selected domains in the test set. The reason for
setting a threshold for presence of a domain in a sequence in order to be
considered a candidate for the test set is explained in the Supporting
Information section. We refer to the first train/test partition as repetitive
and the second one as non-repetitive. The reason for the two different
partitions is that while our repetitive partitioning method is widely accepted
in the machine learning community, here it can result in overfitting. Because
our method depends on the frequency of repeating *k*-mers, we require that
multiple sequences possibly very similar to each other be present in our data
set. Dividing the data based on random selection of sequences might result in
having similar sequences in the training and test sets. The results achieved
might then represent the case when the domain in the query sequence has already
been discovered in similar sequences and we are only trying to retrieve this
knowledge. In contrast, for our non-repetitive partitioning, because we withhold
a set of domains from the training set, the results are better representative of
discovering new domains that were not previously known as well as domains that
were previously known. This partition is better representative of the results we
would obtain using the current knowledge-base of protein conserved regions for
new sequences.
The results for the two sets are shown in. For the repetitive case the accuracy
is 83% with 96% recall (sensitivity). For the non-repetitive case, as expected,
the numbers decrease. However, we can still predict with 80% accuracy whether or
not a location in a protein sequence is included in a conserved region.
**Comparison with other methods against Pfam:** In the second phase of the
evaluation we compare our results with final sequence segments produced by
MKDOM2 in clustering based on domain families and with final partitions found by
the optimization method used in ADDA assuming that Pfam domains represent the
ground-truth. As mentioned earlier, MKDOM2 performs clustering by selecting the
shortest possible subsequence to be considered as a conserved region and
aligning that subsequence with the remaining sequences. The final reported
subsequences that have been aligned with each other represent conserved regions
on the sequences and can be compared to our detected conserved regions.
Similarly, ADDA performs clustering by first selecting a set of putative domain
regions and optimizing the boundaries between these provisional domains to
construct a protein similarity graph based on detected domains. Although
clustering is performed after graph construction and additional filters in these
later steps can affect the quality of ADDA clustering, we can use the optimized
domain boundaries to compare their pre-computed domains with our method.
We trained our model using data set \#11 and tested using data sets \#1-#10.
Because other methods depend on pairwise sequence similarity and BLAST results,
we were forced to pick smaller sets for testing purposes. As mentioned earlier,
MKDOM2 ran for 20 days on data set \#11 without completion, and ADDA took long
even for the small data sets as we will show later in Runtime Study section. We
used MKDOM2 from the Xdom2.0 package and the ADDA implementation obtained from
its webpage (using the default settings: *K* = 73.70676, *C* = 8.33957, *E* =
0.05273, *M* = 1.417, *N* = 0.008 and *r* = 1, except for 100 maximum iterations
(*i* = 100); in many of the cases the program stopped after only a few
iterations. We also used BLAST+ v2.2.31 to generate the input files for ADDA).
represents our findings. The circle displays our three metrics of accuracy (AC),
sensitivity (SN), and specificity (SP) for the three different methods: ADDA
(blue), MKDOM2 (green), and NADDA (red). The outermost circle represents 100% of
the related measure and the center of the circle represents 0%. For each section
(AC, SN, and SP) the bacterial percentage of the protein sequences in the data
set for each point decreases in the clockwise direction; the first four points
in each section correspond to 100% bacterial data sets. shows the detailed
results for the same measurements. NADDA shows higher accuracy for all but two
of the test sets when compared to MKDOM2 and higher or comparable accuracy for
many of the sets when compared to ADDA. MKDOM2 generally has better specificity
scores (average 60.7%) than both ADDA and NADDA while its sensitivity scores are
worse (average 51.5%). The advantage of specificity over sensitivity in MKDOM2
may be a result of two factors. First, MKDOM2 uses a high-cut off value in PSI-
BLAST for the sake of runtime during its heuristic sequence alignment, thereby
trading off sensitivity. Second, the greedy nature of the MKDOM2 algorithm
inhibits precise detection of domain regions. ADDA shows higher than 99%
sensitivity in all cases but very low specificity (4.6% on average). This is
because the optimization method in ADDA tries to detect putative domain
boundaries rather than domains themselves and the results are later used for
graph construction together with some filters in order to achieve final
clustering. As a result, ADDA does not care about mislabeling extra positions as
long as the boundary between two domains is preserved. These extra indices could
possibly be filtered in the graph construction and clustering process.
In comparison to the other two methods, we can see that for 4 out of 10 test
sets, NADDA exhibits higher than 80% sensitivity. The sensitivity is
significantly low for data sets \#3 and \#4. It is noticeable that for these
sets the mean and variance for the *k*-mer frequency are also smaller than for
the other sets. In general there is a correlation between the accuracy of our
method and the variance of the *k*-mer frequency. In fact, the frequency
variance depends on our choice of *k*, and it will increase as *k* is decreased.
However, if *k* is too small, the variance will be high due to random exact
matches that do not signify real conservation. This is discussed further in the
Supporting Information section.
**Comparison against InterPro:** In the last phase of our evaluation, we compare
conserved indices detected by NADDA with regions annotated by InterPro. InterPro
uses predictive models (signatures) generated from multiple databases, including
Pfam, SMART, ProDom, prosite, TIGRFAMs, etc. InterPro annotates domains as well
as motifs (short conserved regions). As such, there should be more similarity
between NADDA and InterPro. We compared our results with InterPro regions. The
results are shown in. Because InterPro includes Pfam, replacing our Pfam
annotations with InterPro annotations will only add to the indices marked as
conserved in our data sets. This can be manifested by a decrease in our \|*FP*\|
and \|*TN*\|. Indices that we had marked as conserved but Pfam had not might be
detected as conserved in InterPro as well, resulting in a smaller \|*FP*\|.
Similarly indices that neither NADDA nor Pfam detected as conserved might be
marked as conserved in InterPro, resulting in a decrease in \|*TN*\|. A decrease
in \|*FP*\| will result in improved *SP*.
It should also be noted that for this comparison we are still using the model
trained using Pfam annotations for data set \#11. Although this can add to the
false examples in the training set, the results show an increase in *SP* as
expected, indicating the robustness of our training method.
shows some example results from our experiments. Training is performed using
data set \#11, while the sequences shown are from the smaller data sets
(#1-#10). The domains present in the smaller data sets are not present in the
training set. These examples demonstrate that in many of the indices, the output
from NADDA matches with the InterPro annotated regions.
## Parametric Study
The parameters used in our method are *k*, the size of a *k*-mer; *w*, where
2*w* + 1 is the number of features used in a classification instance; *MSS*,
indicates the level of pruning of the decision tree; and *maximum*\_*features*,
number of features used in the ensemble method. The parameters *w*, *MSS*, and
*maximum*\_*features* were set to avoid overfitting and underfitting as
explained in the Supporting Information. The optimal value for *k* was found
empirically from the set {3, 4, 5, 6, 7, 8}. We have shown the effect of varying
*k* in the Supporting Information. Varying *k* affects the mean frequency of
*k*-mers as well as their variance and, thus, is important in the performance of
the method.
## Runtime Study
We performed a runtime study by comparing the time for a serial run of NADDA
with that of ADDA and MKDOM2 and also by a scalability evaluation of NADDA in a
parallel environment.
We ran the algorithms on our in-house Linux cluster which includes 8 nodes of 64
AMD processors (2.29GHz), each node having 128GB shared memory. We used ADDA and
MKDOM2 implementations as described earlier.
lists a comparison of runtimes for NADDA, ADDA, and MKDOM2 for data set \#7 on a
single processor. The runtime for our method does not include the one-time
training time. The ADDA runtime presented in includes the time required for
running BLAST.
We can see that even for a small set of about 2,500 sequences, NADDA finishes
much more quickly than the other methods. We ran the parallel implementation of
our code on data set \#11 (50,000 sequences) and showed that it scales nearly
linearly with an increasing number of processors. NADDA took 79 seconds using 32
processors to complete this data set given an already trained model. Training
was not parallelized and on data set \#1 took 61 minutes. Parallel constructions
for decision trees are proposed. A detailed study of our parallel runtime is
presented in the Supporting Information section.
# Conclusions and Future Work
We presented the problem of detection of conserved regions in protein sequences.
In the past, multiple methods have been proposed for detection of putative
domain regions from protein sequences. However, to the best of our knowledge
there is no prior work that focuses on the detection of conserved regions, given
a large collection of protein sequences. The method proposed in this paper fills
this gap using an alignment-free approach.
We showed that rather than using an amino acid sequence of a protein, we can
utilize its vectorized representation for our computation. We presented *k*-mer
profiles of proteins as a new representation for protein sequences which can be
useful for increasing the scalability of computation. We presented a MapReduce
algorithm for generation of *k*-mer profiles. We used a random subspace ensemble
learning method to improve the accuracy of conserved region detection.
Our experiments show competitive accuracy, sensitivity, and specificity measures
for our method when compared to other methods. We also showed that our parallel
implementation is scalable and works on large data sets. Our experiments show
near-linear speedup.
We showed that our method is able to detect conserved regions of bacterial
protein sequences as well as conserved regions of eukaryota and archaea protein
sequences. The category of the species does not affect the results of our
method. Moreover, we showed that variance of the *k*-mers from their mean has a
correlation with the ability of our method to detect conserved regions. When the
variance is low, we may be able to decrease *k* to obtain higher variance and
consequently higher accuracy. Extremely small values of *k*, however, can result
in higher variance due to random exact matches and should be avoided.
Use of structured prediction techniques might increase the accuracy of our
algorithm. However, a structured prediction model will likely give higher
weights to the context (previous predictions) rather than to other features.
Another problem with use of different machine learning algorithms is the large
scale of our data.
The iterative MapReduce algorithm fits best in the Spark parallel computing
model which also provides machine learning tools. In future work, we will
implement our algorithm using the Spark paradigm.
# Supporting Information
The authors would like to thank Prof. Janardhan (Jana) Rao Doppa (Washington
State University) for his advice on the use of machine learning algorithms. This
work was funded by support from the U.S. National Science Foundation under the
Advances in Biological Informatics program, Award DBI 1262664.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** AK. **Formal analysis:** AA. **Funding
acquisition:** SLB AK. **Investigation:** AA. **Methodology:** AA AK.
**Project administration:** SLB AK. **Resources:** AK. **Software:** AA.
**Supervision:** AK SLB. **Validation:** AA. **Visualization:** AA AK SLB.
**Writing – original draft:** AA. **Writing – review & editing:** AA AK SLB.
|
# Introduction
The treatment paradigm for metastatic renal cell carcinoma (mRCC) has undergone
a dramatic evolution over the past two decades. In 1992, interleukin-2 (IL-2)
was approved for the treatment of mRCC. Although IL-2 has been shown to lead to
durable responses in a small proportion of patients, the vast majority of
patients either derive no clinical benefit or are physically too debilitated to
receive this intensive therapy. As an alternative, monotherapy with interferon-α
(IFN-α) was frequently employed. A meta-analysis of data from IFN-α trials
showed modest results at best, with a median time to progression (TTP) of 4.7
months and a median overall survival (OS) of 13 months. At the time these data
were published in 2002, it was suggested that IFN-α serve as a reference
standard for future clinical trials in mRCC.
The introduction of targeted therapies for mRCC shattered this reference
standard. A total of seven targeted agents have been approved to date by the US
FDA on the basis of phase III data – four vascular endothelial growth factor-
tyrosine kinase inhibitors (VEGF-TKIs; sunitinib, sorafenib, pazopanib, and
axitinib), one VEGF-directed monoclonal antibody (bevacizumab), and two
inhibitors of the mammalian target of rapamycin (mTOR; temsirolimus and
everolimus). With the advent of these therapies, IL-2 and IFN-α are presumably
utilized to a lesser extent in the mRCC paradigm.
It has been repeatedly observed that survival in more recent trials in mRCC has
gone far beyond the landmark of 13 months proposed in association with IFN-α.
For instance, in the randomized phase III study comparing sunitinib and IFN-α in
treatment-naïve patients, a median OS of 26.4 months was observed with sunitinib
therapy. Long-term survivors are also increasingly recognized with targeted
therapy; in a phase II study of axitinib, up to 20% of patients were still alive
5 years beyond the time of treatment initiation.
Although these data provide compelling rationale to suggest that survival has
improved since the advent of targeted therapies, this hypothesis has not been
definitively proven. In the current study, we queried the Survival,
Epidemiology, and End Results (SEER) dataset and performed generational analysis
of survival amongst patients with mRCC. With data extending from 1983 to 2009,
we segregated our analysis using two clinically relevant time points: (1) the
approval of IL-2 in 1992 and (2) the approval of the first targeted therapies
(sunitinib and sorafenib) in 2004.
# Methods
## Patient Selection
The SEER dataset was analyzed for the current study, a registry encompassing
approximately 28% of the US population. The SEER Program has extensive data
pertaining to demographics, stage, tumor histology, and grade. The current
analysis was restricted to patients 18 and older who had a diagnosis of RCC
between 1992 and 2009 (n = 60,587). The analysis was further limited to patients
with stage IV disease at the time of diagnosis, had a known surgical status, had
a known cause of death if deceased, and had a clinically relevant histology
(n = 5,150). Notably, the SEER Registry does not allow for capture of patients
who progressed from localized or regional disease to metastatic disease, thus
confining this analysis to those with *de novo* metastatic disease.
## Tumor Classification
Reporting of tumor histology, grade and stage was done in accordance with the
International Classification of Diseases for Oncology (ICD-O), version 3. Given
the heterogeneity of histologic classification of kidney tumors in SEER, we
limited our analyses to the three most clinically relevant histologic subtypes –
clear cell (ICD-O 8310), papillary (ICD-O 8260), and chromophobe (ICD-O 8317).
In our analyses, papillary and chromophobe tumors were combined in a category
termed ‘non-clear cell’. Tumor grade was characterized as well differentiated,
moderately differentiated, poorly differentiated or undifferentiated (a Fuhrman
grade is not delineated in the SEER Registry). Stage IV disease was identified
according to criteria specified within the American Joint Committee on Cancer
(AJCC) TNM staging system, 7<sup>th</sup> ed.
## Statistical Analysis
To test the *a priori* hypothesis that patients diagnosed in the targeted
therapy era have a longer survival as compared to patients diagnosed in the
cytokine era, we assessed our primary outcome, disease-specific survival (DSS),
across two time periods: (1) 1992–2004, and (2) 2005–2009. These time periods
reflect (1) the approval of IL-2 in 1992, and (2) the first approval of a
targeted therapy for mRCC (sorafenib) in 2005. Clinicopathologic characteristics
were compared between the groups using the student's t-test and chi-square test
for continuous and categorical variables, respectively. Disease-specific
survival was assessed, and defined as the time elapsed between date of diagnosis
with RCC and date of death, if attributable to RCC. Patient data were censored
at the time of last follow-up if the patient was still alive at last contact.
Patients with an unknown cause of death were excluded. The Kaplan-Meier method
and log-rank test were used to compare survival across the two time periods.
Relevant clinicopathologic characteristics were evaluated for their association
with disease specific survival using both univariate and multivariate Cox
proportional hazard models.
After a thorough review of the SEER methodology, we felt it appropriate to
exclude T-stage and N-stage from our analyses. Specifically, in 2004 SEER
adopted the Collaborative Stage Data Collections System (CS). Prior to CS,
patients with M1 stage disease were rarely coded with specifics on T- and
N-stage other than Tx and Nx, respectively. Hierarchical rules in SEER
classification implied that T- and N-stage were “trumped” by M1 status. In
contrast, from 2004 onwards, rules were set in place that called for recording
of T-stage and N-stage despite the notation of M1 disease.
All analyses were performed using SAS (SAS Institute, Cary, NC, USA). P-values
reported herein are two-sided. P-values of 0.05 or less were deemed
statistically significant.
# Results
## Patient characteristics by time period
Utilizing the aforementioned selection criteria, a total of 2,382 patients were
identified from 1992–2004 and 2,768 patients from 2005–2009. Characteristics of
the study population are noted in. The mean age was similar across the two study
periods (approximately 62 for both) and, as anticipated, a male preponderance
was observed in both groups. A greater representation of minority groups was
seen in the latter study period as compared to the earlier study period, with an
increased proportion of blacks (8.0% *vs* 7.5%) and Hispanic whites (12.4% *vs*
15.0%). A larger proportion of patients in the latter study period were noted to
have poorly differentiated or undifferentiated tumors (69.0% *vs* 58.7%).
Nephrectomy rates were similar across time periods, with 60.0% of the study
population receiving this intervention. As expected, the duration of follow-up
was substantially shorter for those patients assessed in the later time period
as compared to the earlier time period (14 months and 24.5 months, respectively;
P\<0.0001).
## Analysis of survival by time period
To test the *a priori* hypothesis of this work, DSS was compared across the two
time periods of interest. As noted in, median DSS was 13 months in patients
diagnosed from 1992–2004 compared to 16 months in patients diagnosed between
2005–2009 (P\<0.0001). At both 1-year and 5-year landmarks, survival also
appeared to be superior amongst patients diagnosed between 2005–2009 as compared
to patients diagnosed between 1992–2004 (57% *vs* 52% at 1-year, and 22% *vs*
18% at 5-years, respectively). Given that the majority of systemic therapies
have been assessed in clear cell mRCC, we then compared survival in clear cell
and non-clear cell subsets. As noted in, reflecting the substantial proportion
of patients with clear cell disease, the survival trends were akin to those
observed in the overall study population. Amongst patients with non-clear cell
disease, as was anticipated, no significant difference in DSS was observed
(P = 0.32;).
## Univariate and multivariate analysis
As shown in, univariate analyses demonstrated a number of factors beyond date of
diagnosis that were associated with DSS. Relative to patients diagnosed aged
18–49, older patients (specifically, patients between 65–79 and ≥80) had shorter
survival. Amongst clinicopathologic criteria, poorly differentiated or
undifferentiated tumors were associated with shorter survival; no significant
difference was noted in survival based on histology (i.e., clear cell *vs* non-
clear cell). Survival was improved in patients who had received cytoreductive
nephrectomy as compared to those who had not. On multivariate analysis, time
period was independently associated with survival, favoring patients diagnosed
from 2005–2009 (HR 0.88, 95% CI 0.83–0.94; P = 0.0001). Complete results of
multivariate analysis are displayed in ; as noted therein, older age, female sex
and black race were amongst the clinical characteristics independently
associated with shorter survival. Higher tumor grade and absence of nephrectomy
were also independently associated with shorter survival.
# Discussion
The results described herein suggest that survival has improved in the era of
targeted therapies as compared to the era of cytokine therapy. This suspicion
has been strongly held in the academic community for some time, given the
substantial improvement in overall survival seen in recent studies assessing
systemic therapy in treatment-naïve populations. For instance, in the recently
reported COMPARZ study assessing sunitinib and pazopanib in the front-line
setting, a median OS of 28.4 months and 29.3 months was observed in each
treatment arm, respectively. These data stand in sharp contrast to estimates of
survival generated a decade ago where, in the era of cytokine therapies, a
median survival approaching 1 year was anticipated. Our review of the SEER
registry encompasses a highly heterogeneous array of patients, and suggests a
similar survival trend in survival – diagnosis with stage IV RCC between
2005–2009, during which time several targeted therapies were approved by the US
FDA (including sorafenib, sunitinib, and everolimus), is independently
associated with improved survival. Another recent epidemiologic study utilizing
data from the California Cancer Registry has pointed towards a similar
improvement in survival; however, this study included non-metastatic patients
and further capped analysis at 2007. The latter would likely limit the effect
seen from targeted therapies, introduced from 2005 onwards.
The magnitude of difference in survival – from 13 months between 1992–2004 to 16
months between 2005–2009 – may not be interpreted as substantial progress.
However, several caveats of our analysis must be accounted for. First, patients
with metachronous metastatic disease are not captured in the SEER registry.
Thus, our analysis is restricted to those patients with *de novo* metastatic
disease. Across the commonly used classification schema for mRCC (i.e., MSKCC
and Heng criteria, etc.), a time from diagnosis to initiation of systemic
therapy less than 1 year is identified as adverse prognostic factor. Patients
with *de novo* metastatic disease inherently possess this characteristic, and by
the MSKCC or Heng risk stratification tools, this precludes them from having
“good-risk” disease. Thus, our dataset is reflective of a population of
intermediate- and poor-risk patients. The most recent risk stratification tool,
developed by the International Kidney Cancer Working Group, includes a
compilation of patient level data for 3,748 patients with mRCC enrolled in
clinical trials between 1975 and 2002. This dataset also identifies an
abbreviated time from diagnosis to treatment as an adverse prognostic factor.
Notably, in this most recent series, patients who started treatment within a
window of 506 days of diagnosis (encompassing those patients with *de novo*
metastatic disease) had a median survival of 1.31 years. These data, pooled over
clinical trials conducted over a wide span of time, are similar to what we have
observed in the current report. A recent update of this dataset, like ours,
suggests a temporal trend towards improved survival. However, it is important to
keep in mind that their analyses included patients involved in clinical trials
until 2002 – well before the widespread utilization of targeted therapies.
Several other key distinctions in the SEER data may explain the small magnitude
of difference in survival observed in our study. When reflecting upon the
aforementioned phase III studies in mRCC evaluating targeted agents, it is
critical to keep in mind that stringent eligibility criteria were set in place
for each of these studies. Patients included within the SEER registry, in
contrast to those on clinical trials, were not limited by performance status,
organ function, and comorbidity. A report from the International mRCC Database
consortium suggested that approximately 43% of patients in their experience
would not be candidates for clinical trials based on standard eligibility
criteria (i.e. presence of brain metastases, performance status, etc.).
Furthermore, patients in the SEER registry did not necessarily receive systemic
therapy. Patients with poor global health and those that did not receive
systemic treatments may account for the rather modest median DSS of 14 months
noted from 2005–2009.
Outside of the finding that survival was improved in the era of targeted
therapies, there were several other notable clinical and treatment-related
characteristics associated with survival. Perhaps most notably, nephrectomy was
independently associated with improved survival. Nephrectomies identified within
this cohort inherently represent cytoreductive procedures, as all patients had
*de novo* metastatic disease. Although its role is well established in the
setting of cytokine therapy, cytoreductive nephrectomy is controversial in the
era of targeted therapies. A selection bias may confound the observed
association with survival in the SEER dataset – patients with a poor performance
status, greater comorbidity, or aggressive and invasive primary tumors are less
likely to undergo surgery. Two ongoing studies, the French-led CARMENA study and
a separate trial by the European Organization for the Research and Treatment of
Cancer (EORTC), assess the role of cytoreductive nephrectomy as an adjunct to
therapy with sunitinib for patients with mRCC.
Other notable findings from our analysis include a shorter survival amongst
black patients relative to non-Hispanic whites. These data point towards
potential disparities in access to care, or perhaps to biological differences
across ethnicity. Substantial research in this domain is currently lacking,
although other reports allude to similar findings. A caveat of assessing the
impact of race and ethnicity within the SEER database is that the catchment area
of the database has evolved over time. Specifically, beginning in 2000, 6 new
registries were added – great California, greater Georgia, Kentucky, Louisiana
and New Jersey. If these areas had greater numbers of minorities, these could
skew the results observed herein. With respect to pathologic characteristics,
the finding of shorter survival amongst patients with poorly differentiated or
undifferentiated tumors (as compared to well differentiated tumors) was
expected. Also as anticipated, there was no substantial improvement in survival
amongst patients with non-clear cell (specifically, papillary or chromophobe)
histology. The vast majority of phase III studies assessing targeted agents
(with the notable exception of the pivotal study assessing temsirolimus)
required the presence of clear cell disease. To date, no assessment has been
made as to whether or not the therapeutic advances made amongst patients with
clear cell mRCC are applicable to those with papillary or chromophobe disease.
Prospective efforts to characterize the activity of sunitinib in papillary mRCC,
for instance, have yielded disappointing response rates.
Several limitations of the study should be noted. First, we utilized a refined
cohort within the SEER dataset based on ICD-O codes for clinically relevant
histologies – clear cell, papillary and chromophobe. Separate codes do exist
that may encompass these histologies. For instance, a search based on the ICD-O
code 8312 (“Renal Cell Adeno/Ca”) retrieved a total of 12,155 records – median
survival in this cohort was 7 months, leading us to suspect that the search term
may encompass a hetergenous array of histologies, such as upper tract urothelial
tumors. As such, we felt that it was essential in our analysis to delineate
those individuals where clear cell histology had been specified (ICD-O 8310:
“Clear Cell Adeno/Ca”), as the preponderance of targeted therapies approved
between 2005–2009 (excepting temsirolimus) were assessed in such patients. A
second limitation of our study is that the specific nature of systemic therapies
rendered is not recorded. Our underlying hypothesis, suggesting that survival is
improved in the era of targeted agents, is predicated on the assumption that
patients diagnosed from 1992–2004 received immune-based strategies, while
patients diagnosed from 2005–2009 received primarily VEGF- and mTOR-directed
therapies. Beyond systemic therapy for mRCC, it is possible that improvements in
palliative care may contribute to the survival trends observed in mRCC. Enhanced
palliative care may ease the burden of toxicities encountered with systemic
therapy, and there is an indication that early intervention with palliative care
may intrinsically contribute to improved survival in other malignancies. In all
likelihood, although targeted therapies first garnered approval in 2005, these
agents likely took time to integrate into the standard treatment paradigm for
mRCC. Thus, in the earlier part of the second time period, it is still possible
that many patients received cytokine therapy. Patients treated around the cutoff
employed in this analysis (2005) may have also been exposed to placebo control
arms on pivotal phase III studies evaluating targeted agents. It is possible
that this may have diluted the difference in survival noted between the cytokine
and targeted therapy eras. Finally, as noted previously, the follow-up in the
later study period was significantly shorter than in the earlier study period
(24.5 *vs* 14.0 months; P\<0.0001). Although this discrepancy in duration of
follow-up is substantial, this is accounted for by the statistical analysis
utilized (i.e., Kaplan-Meier analysis with the log-rank test).
These limitations notwithstanding, our data underscore that progress is being
made in the management of mRCC. Population-based studies are critical, and there
are few in the available literature. The data assembled by the International
mRCC Consortium has provided key insights related to clinical outcome in the era
of targeted therapy, and most recently, the group has provided data pertaining
to conditional survival. However, extrapolating these data to the population
with mRCC at large is challenging because (1) patients in the experience have
all received first-line VEGF-directed therapy, and (2) the data is derived
largely from experienced academic centers with robust RCC-focused programs.
Estimates provided by SEER should provide reassurance that the overarching
direction taken in mRCC therapy (most notably, a shift towards targeted
therapies) appears to have improved outcomes globally.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: SKP RAN NV. Performed the
experiments: SKP RAN NV. Analyzed the data: SKP RAN NV. Contributed
reagents/materials/analysis tools: SKP RAN NV. Wrote the paper: SKP RAN NV.
|
# Introduction
The soil microbial community holds a central position in ecosystem processes
like carbon and nitrogen cycling. The performance and shape of soil microbial
communities on one hand depend on soil properties, such as pH, temperature,
texture and moisture, but on the other hand the soil microbial community is
closely linked to plant communities through complex interactions. Plants affect
the soil microbial community through biomass production, litter quality,
seasonal variability of litter production, root-shoot carbon allocation and root
exudates. In turn, soil microbial communities mineralize organic matter and
enhance nutrient release by mineral weathering. Both processes increase the
availability of nutrients enhancing plant growth , and consequently accelerate
the matter flow between the aboveground and belowground parts of ecosystems.
Plant diversity influences a wide range of ecosystem processes, but the
underlying mechanisms are not well understood ; for example the link between
plant diversity and belowground processes is just fragmentarily explained.
Increasing plant diversity modifies resource availability for microbial
communities in soil, which might lead to higher niche differentiation and
facilitation of the soil microbial community. Beside species richness, the
number of plant functional groups, i.e. species with similar morphological,
phenological and physiological traits, impact soil microorganisms. Plant
functional groups, such as legumes and grasses, differ in litter quality and the
amount of carbon and nitrogen released to the soil, thereby affecting microbial
decomposition processes. Bacteria and fungi form most of the soil microbial
biomass and represent the main drivers of organic matter turnover. Since both
groups prefer different qualities of resources they might be differently
affected by plant diversity and plant community composition. Fungi are able to
decompose litter with high C:N ratios. Therefore, it has been suggested that
plant communities providing litter with high C:N ratio favor decomposition by
fungi, whereas plant communities producing litter with low C:N ratio favor
decomposition by bacteria. Moreover, there are differences among bacteria: Gram-
negative bacteria are mainly root-associated and thus decompose organic
molecules of low molecular weight, whereas Gram-positive bacteria are
decomposing more complex materials, such as soil organic matter and litter. As a
consequence, the presence of certain plant functional groups is likely to
promote distinct microbial groups. Therefore, higher plant diversity, as number
of species or number of functional groups, might affect the composition of the
soil microbial community by differences in litter input quantity and quality.
Most studies investigating effects of plant diversity on soil microbial
community focus on plant-originated inputs, often ignoring that differences in
diversity and composition of plant communities also affect microclimatic
conditions such as soil moisture. Conversely, studies considering plant mediated
effects on soil moisture, usually do not account for root inputs or changes in
the soil microbial composition. Identifying the relative importance of drivers
changing soil microbial communities is needed to better understand the
functioning of soils.
We assessed the effect of plant diversity and functional group composition on
soil microbial communities using phospholipid fatty acids (PLFAs). The study was
conducted in the framework of the Jena Experiment, a biodiversity experiment
established by sowing different combinations of grassland species on a fallow
agricultural soil. In addition to experimental plots with different levels of
plant diversity and vegetation-free bare ground plots, we studied long-term
meadows and on-going arable plots as adjacent to the field experiment as control
sites to assessed, how the soil microbial community developed five years after
establishing the experimental site. We hypothesized that (1) higher plant
diversity increases soil microbial biomass, caused by higher amounts of litter
input as well as by improved microclimatic conditions for soil microbes, and (2)
plant functional group composition drives composition of the soil microbial
community, exemplified e.g., by changes of fungal-to-bacterial biomass ratio
(F:B ratio). Due to the production of low quality litter, we expected plant
communities containing grasses but not legumes to favor fungi, whereas plant
communities producing litter of high quality to favor bacteria.
# Materials and Methods
## Site description and experimental design
The field site of the Jena Experiment is located close to the city of Jena
(Germany) in the floodplain of the river Saale (50°55′ N, 11°35′ E, 130 m
a.s.l.). No specific permission was required to work on “The Jena Experiment”
and no endangered or protected species were involved in this study. The soil
(Eutric Fluvisol) has developed from up to 2 m thick fluvial sediments
presenting a systematic variation of soil texture. The sand content decreases
with distance to the river from 40% to 7%, while the silt and clay content
increase (silt: 44% to 69%; clay: 16% to 24%). Experimental plots were arranged
in four blocks parallel to the river to account for these differences in soil
characteristics. Before the establishment of the Jena Experiment in 2002, the
site was used as arable land since the early 1960s and ploughed and fertilized
regularly. The Jena Experiment comprises 86 plots (82 vegetated and 4 bare
ground plots, each 20 m by 20 m). The experimental design manipulates a gradient
in sown plant species richness from 1 to 60 (1, 2, 4, 8, 16, and 60) near-
orthogonal with a gradient in plant of functional group numbers from 1 to 4 (1,
2, 3 and 4). All 60 species are typical for Central European mesophilic
grasslands. They were grouped into four functional groups according to their
morphological, phenological and physiological traits. The species pool included
16 grasses, 12 small herbs, 20 tall herbs and 12 legumes. To maintain the
diversity levels, all experimental communities have been weeded manually twice a
year. Plots are mown twice a year, in June and September and are not fertilized.
In addition bare ground plots with four replicates were established.
Furthermore, soil microbial community was determined on two adjacent regularly
mown non-fertilized meadows and two arable plots on the experimental site. The
arable plots were continuously managed according to conventional agricultural
procedures, growing cereals.
## Soil sampling and phospholipid fatty acid (PLFA) analysis
In early May 2007, six soil samples per plot were taken with a core cutter
(inner diameter: 4.8 cm, Eijkelkamp Agrisearch Equipment, Giesbeek, The
Netherlands) to a depth of 5 cm, pooled and placed immediately in cooling boxes.
Within 48 hours after sampling the soil was kept at 4°C, sieved \<2 mm, remains
of roots were manually removed and finally the samples were stored at −20°C
until further sample processing. Soil samples were shaken with a mixture of
chloroform, methanol and 0.05 M phosphate buffer (pH 7.4) to extract soil
lipids. The lipids were split into neutral lipids, glycolipids and phospholipids
by eluting with chloroform, acetone and methanol from a silica-filled solid
phase extraction column. Subsequently, phospholipids were hydrolyzed and
methylated by a methanolic KOH solution and the PLFA-methyl esters were
identified and quantified by gas chromatography with atomic emission detector
(GC-AED) (Agilent, Böblingen, Germany) and gas chromatography-mass spectrometry
(GC/MS) (Thermo Electron, Dreieich, Germany). Peak areas and the resulting
amount of PLFA were calculated relative to the internal standard PLFA 19:0. The
sum of all PLFAs was taken as total soil microbial biomass. Furthermore PLFAs
were assigned to microbial groups. The PLFAs 14:0, 14:0br, 15:0, 16:0, 17:0,
18:0 were used as general microbial markers. All monounsaturated and cyclic
fatty acids were grouped as Gram-negative bacteria (Gram-), while all branched
PLFAs were grouped as Gram-positive bacteria (Gram+). PLFA 18:2ω6 was used as a
fungal biomarker. The F:B ratio was calculated using the molar weight of the
fungal PLFA marker divided by the sum of molar weights of bacterial PLFA
biomarker.
## Covariables
Fine root standing biomass (termed as ‘root biomass’ hereafter), leaf area index
(LAI) and soil moisture were considered as potentially meaningful covariables.
Unfortunately, in 2007, the year of the PLFA sampling, root biomass was not
determined, thus we used an average of 2006 and 2008 root biomass measurements.
In both years root biomass was sampled to a depth of 30 cm. In addition, the
sampling in 2008 was stratified, so that the 0–5 cm depth increment could
directly related to the sample of the soil microbes. Based on the ratio of the
top increment (0–5 cm) to the total root biomass in 2008, we calculated the
specific root biomass in the top soil (0–5 cm). Furthermore, nitrogen
concentration of fine roots was determined using root material from ingrowth
cores from, sampled between 2007 and 2008. N concentrations in the biomass were
determined with an elemental analyzer (Vario EL Element Analyzer, Elementar,
Hanau, Germany). In the course of the PLFA soil sampling soil moisture was
determined, too, as the gravimetric soil water content. Leaf area index (LAI)
was measured approx. 5 cm above ground level using a LAI-2000 plant canopy
analyzer (LI-COR) in late May 2007 (shortly before the first mowing of the year;
see experimental design).
## Statistical analysis
Using analyses of variance (ANOVA) followed by Tukey's HSD test we assessed
microbial biomass and F:B ratio in experimental plots of the Jena Experiment,
and their relationship to those from control plots (arable fields and meadows).
ANOVA with sequential sum of squares (type I SS) was applied to test for effects
of plant diversity on microbial biomass (total, Gram+, Gram− and fungal). The
Jena Experiment is based on a factorial design with different combinations of
plant species richness and number of functional groups, where all plots are
arranged in a block design accounting for differences in soil texture among the
blocks. Therefore, ‘block effect’ was included as random factor and was fitted
first. The contrast between bare ground plots vs. sown plots was fitted next,
before testing for the effect of richness (log-linear term) and functional
groups (linear term) as continuous variables. Finally, the presence of each
plant functional group (small herbs, tall herbs, grasses and legumes) was
included into the model in a series of alternative models. Furthermore, non-
metric multidimensional scaling (NMDS) was used to compare plot-specific
patterns of PLFA profiles. The data used in the NMDS was normalized to the peak
area of the highest peak (18.1n11) set at 100%. Bray-Curtis was used as
dissimilarity index.
To investigate which mechanisms underlie the effects of plant diversity, we used
structural equation modelling (SEM, see also) with observed variables. In SEM,
all diversity levels, except bare ground, were considered. For every group of
PLFAs assigned to specific microbial taxa, a full model was set up including all
experimental variables that were significant in the preceding ANOVA. As possible
means by which the effect of plant diversity might be manifest, we included root
biomass as measure of belowground plant input, root nitrogen concentration as
measure of litter quality and LAI as a measure of plant community influence on
evaporation and thus the microclimatic conditions (e.g., soil moisture and
temperature). The categorical variable ‘block’ was substituted by the continuous
variable ‘clay’ content of soil. We considered aboveground plant inputs as
negligible, because all above ground biomass was harvested twice a year. The
minimal parsimonious models were identified using specification search, based on
the Bayes information criterion (BIC). The adequacy of the model was tested with
Chi-squared tests (*χ<sup>2</sup>* tests) and root mean square error of
approximation (RMSEA).
ANOVA and Tukey's HSD test were performed using R 2.15.2 and structural equation
modeling was performed using AMOS 18.0.
# Results
## Soil microbial biomass
The mean of the total PLFA concentration, henceforth termed total microbial
biomass, was14.4±3.5 nmol g<sup>−1</sup> soil dry weight (mean ± sd) on
experimental plots (vegetated plots and bare ground). This was significantly
higher than measured on plots of arable land (5.3±2.5 nmol g<sup>−1</sup>) and
significantly lower than on meadows (30.2±10.3 nmol g<sup>−1</sup>;).
ANOVA revealed block as a significant predictor of the total microbial biomass.
Furthermore, total microbial biomass was significantly lower on bare ground
plots (8.7±1.3 nmol g<sup>−1</sup>) than on vegetated plots (14.7±3.4 nmol
g<sup>−1</sup>). Plant species richness had a significant positive effect on the
total microbial biomass on vegetated plots. The presence of individual plant
functional groups did not affect total microbial biomass.
Structural equation modeling (SEM) showed that block (represented by the
continuous variable clay content of soil) and plant richness, the design
variables with significant influence indirectly affected total microbial
biomass. The minimal parsimonious model (*χ<sup>2</sup>*<sub>13</sub> = 21.74,
*P* = 0.060; RMSEA = 0.093, *P* = 0.147) explained 45% of the variance of total
microbial biomass. Total microbial biomass was mainly explained by its positive
relationship to soil moisture. Soil moisture increased with increasing plant
richness and higher clay content. The major effect on soil moisture was
attributed to increasing leaf area index (LAI), which itself was strongly
correlated to plant richness. The negatively influence of root nitrogen
concentration on total microbial biomass was driven by higher root biomass,
which itself was increased at higher plant richness.
## Soil microbial community structure
The F:B ratio did not differ among experimental plots, arable plots and meadow
plots (experimental plots: 0.052±0.015; arable land: 0.041±0.003; meadows:
0.049±0.016;). In contrast, the F:B ratio was significantly lower on bare
ground (0.034±0.006) than on vegetated plots of the biodiversity experiment
(0.053±0.015). F:B ratio was positively affected by an increasing number of
plant functional groups and negatively by the presence of legumes. Plant
richness did not significantly affect the F:B ratio. However, the F:B ratio
increased from low plant richness plots to medium ones with eight plant species,
and decreased again in plots with high plant richness. Regression analyses of
the relationship between F:B ratio and both, fungal and bacterial biomass
revealed that the F:B ratio was more related to fungi (R<sup>2</sup> = 0.67,
*P*\<0.001) than to bacterial biomass (R<sup>2</sup> = 0.043, *P*\<0.066).
Considering biomass of Gram+, Gram- and fungi separately, all groups differed
significantly among blocks and between bare ground and vegetated plots. Plant
diversity positively affected both bacterial groups. Gram+ as well as Gram-
bacteria were reduced on bare ground plots (Gram+ = 2.3±0.4; Gram- = 4.6±0.6)
compared to vegetation plots (Gram+ = 3.9±1.0; Gram- = 7.7±1.7) and biomass of
both bacterial groups were increased with increasing plant richness. However,
the ANOVA also revealed differences: while Gram+ were positively influenced by
the presence of grasses, Gram- were not affected by any of the plant functional
groups. Fungal biomass was positively affected by the number of functional
groups present, and negatively by the presence of legumes.
The results of the NMDS, based on the PLFA composition, confirmed the strong
dissimilarity between bare ground plots and vegetated plots. The dissimilarity
between the vegetated plots was relatively small, though we found a clear effect
of plant diversity, i.e. the higher the plant diversity on the plot the more
different were the microbial communities compared to low diverse plots.
SEM for Gram+ (*χ<sup>2</sup>*<sub>17</sub> = 24.877, *P* = 0.098;
RMSEA = 0.078, *P* = 0.231) and Gram- bacteria
(*χ<sup>2</sup>*<sub>13</sub> = 19.80, *P* = 0.100; RMSEA = 0.082, *P* = 0.217)
explained to 41% and 44% of variance, respectively, and revealed high analogy
between the groups. Both bacterial groups were mainly driven by soil moisture,
which was mostly affect by LAI. Furthermore, both groups had a negative
relationship with nitrogen concentration of fine roots, mediated by increased
root biomass. The minimal parsimonious model explains 44% the variation in
fungal biomass (*χ<sup>2</sup>*<sub>5</sub> = 5.43, *P* = 0.365; RMSEA = 0.034,
*P* = 0.475). In contrast to the bacterial groups, fungal biomass was neither
affected by the amount of root biomass nor by its quality. Although there was a
positive indirect pathway from functional groups and legumes via LAI and soil
moisture to fungal biomass, strong direct paths from functional groups and
legumes remained in the minimal parsimonious model. These direct paths indicate
that the diversity effect was driven by mechanisms other than soil moisture or
quantity and quality of root biomass. The F:B ratio was explained to 35% by the
minimal model (*χ<sup>2</sup>*<sub>2</sub> = 2.27, *P* = 0.322; RMSEA = 0.041,
*P* = 0.390). In contrast to all other models, only direct paths connected the
experimental variables to F:B ratio: it strongly decreased in the presence of
legumes, but increased with increasing number of plant functional groups to
almost the same extent. These relationships could not be explained by our
measured covariables.
# Discussion
In the framework of the Jena Experiment we investigated how soil microbial
communities are affected by plant diversity and the underlying mechanisms of
these effects. In grassland with manipulated plant species richness and number
of plant functional groups we showed that the soil microbial communities are
strongly linked to plant diversity. Corresponding to hypothesis 1, the positive
plant diversity effect on total microbial biomass was mainly driven by improved
microclimatic conditions, while we found only a minor influence of the amount of
root litter inputs on the soil microbes. Furthermore, number of plant functional
groups and the plant functional composition, in particular the presence of
legumes, highly impact the microbial community composition, referring to
hypothesis 2. Below, we will discuss in detail, how plant diversity drives the
soil microbial community.
Five years after conversion from arable land to grasslands, increased soil
microbial biomass indicates that the microbial community performs better. In
addition to the growth of the soil microbial community, it has been reported
that the community also has a higher metabolic activity compared to the initial
conditions. Lower microbial biomass on arable land probably is due to soil
disturbance by tillage and the tillage-induced changes of soil properties. The
lower organic carbon concentration in arable soils is attributed to faster
decomposition of soil organic matter, which in turn reduces the microbial
biomass in the long term. However, even in plots with highest plant diversity,
i.e., 60 species and 4 functional groups, microbial biomass was lower than in
adjacent meadows. This indicates that the time since conversion of our study
area from arable use to grassland was not sufficient to reach the state of
microbial biomass of permanent meadows. However, as total microbial biomass
significantly increased with increasing plant richness, higher plant diversity
promotes the development towards the stage of permanent meadows.
Confirming hypothesis 1, plant richness as well as clay content of the soil
indirectly increased total soil microbial biomass. Interestingly, structural
equation modeling suggests that this was mediated via soil moisture. Soil
moisture itself holds a central position in the interplay between plant
diversity, abiotic soil conditions and microbial biomass. The strong influence
of soil texture on soil moisture is well known: with smaller particle size soil
water holding capacity increases. Results of the present study suggest, however,
that the positive effect of plant diversity on soil microbial biomass may exceed
that soil texture via changes in soil moisture. Higher plant diversity increased
canopy density of the plant stands, measured as LAI, which presumably reduced
evaporation from the soil surface. Plant richness also affected soil microbial
biomass via root inputs, namely via root nitrogen concentration. The detrimental
effect of nitrogen concentration on microbial biomass was closely related to
increased root biomass; with increasing plant richness root biomass increased,
while at the same time nitrogen concentration decreased, which confirms earlier
findings.
Results of NMDS showed that the composition of PLFAs differed mainly between
bare ground and vegetated plots, while in vegetated plots (1-60 plant species,
1-4 plant functional groups) the composition of PLFAs was similar. However, the
dissimilarity of the microbial community composition was more pronounced in
plots with different diversity levels, i.e., low diverse plots differed most
from high diverse plots. Higher diversity in plant communities leads to more
diverse organic matter input in quantity, quality and timing, and this likely is
responsible for the observed changes in microbial communities along diversity
levels. The plant diversity effect on microbial community composition was also
reflected in the F:B ratio, but in contrast to total microbial biomass, the F:B
ratio was more affected by functional groups than by species richness,
supporting hypothesis 2. Moreover, this relation to plant functional groups
reflects the stronger dependency of F:B ratios from changes in fungal biomass
than in bacterial biomass. We further found legumes to be a strong predictor of
F:B ratio, which is in line with previous findings. However, neither the
underlying mechanisms of the positive effect of functional groups nor of the
negative legume effect on the F:B ratio was mediated by the considered
covariables. Similar results have been reported by Lamb *et al.*, who studied
the effect of plant species richness and evenness on soil microbial communities
in a pot experiment. The lack of relationships between F:B ratio and root litter
quantity and quality as well as soil moisture indicates that both microbial
groups are similarly affected by these variables. The strong direct link between
plant diversity and F:B ratio, however, points to other plant resources as major
drivers of soil microorganisms, such as root exudates. Indeed, root exudates
were reported to strongly influence soil microbial communities. In more diverse
plant mixtures resource supply for microorganisms may be assumed to be higher
and more diverse, while resource supply in monocultures is expected to be more
one-sided and temporally limited. Furthermore, it is known, that the number of
plant functional groups and presence of legumes may be related to turnover rates
and decomposition of fine roots , which might cause changes in microbial
community structure.
Although bacteria and fungi were similarly affected by plant diversity, we found
bacteria more related to plant diversity-controlled abiotic soil properties,
while and fungi were more affected by the input of organic materials. As shown
by de Vries *et al.* fungal-based soil food webs are more resistant to
disturbances, while bacterial communities are more resilient due to their fast
life cycle. This might explain why the bacterial community was in our study more
related to fast changing abiotic conditions, such as soil moisture.
# Conclusion
We identified changes in microclimatic conditions, in particular increased soil
moisture, as a main mechanism how plant diversity affects soil microbial biomass
in the topsoil. Furthermore, the results indicate that shifts in the microbial
community composition, namely in the F:B ratio, heavily rely on differences in
the quality and quantity of root exudates. Changes in soil microbial biomass
with plant diversity suggest that microbial communities of the established
grassland systems develop towards permanent meadows, but that reaching the state
of these meadows takes decades. Notably, however, differences in microbial
biomass indicate that high diverse plant communities promote faster transition
towards permanent meadows indicating that plant diversity is a key factor for
restoring functional grassland systems on former arable land.
# Supporting Information
We thank Janine Seyfferth, Sibylle Steinbeiss and Steffen Rühlow for their help
during sampling and for helping with the PLFA extraction, Alexandra Weigelt for
providing the LAI data and Francesca Hopkins for her helpful comments on the
manuscript. We gratefully acknowledge all the people that were involved in
planning, set up and maintaining of the experiment and the German Research
Foundation (DFG) for financial support of FOR 456 and Gl262-14.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: GG SS WW EDS CR. Performed the
experiments: MH GG HB. Analyzed the data: ML MH CR NE. Contributed
reagents/materials/analysis tools: GG. Wrote the paper: ML MH NE CR HB CE YO
SS WW EDS GG.
|
# Introduction
The posterior cruciate ligament (PCL) is one of the major passive stabilizers of
the knee joint, serving as the primary restraint to excessive posterior tibial
translation, but is also thought to act as a secondary restraint to tibial
rotation. It is likely that injuries to the PCL interfere with its normal
function and consequently lead to joint instability, as well as to possible
subsequent osteoarthritis. In order to better understand these processes, as
well as improve diagnosis, reconstruction and rehabilitation techniques, a
number of studies have investigated healthy PCL loading and injury biomechanics.
Here, the key goal is to quantify the physiological loading patterns of the
healthy PCL during sport and activities of daily living. However, despite a
number of *in vitro*, *in vivo*, and modelling approaches to provide science
based evidence, the normal loading conditions of the PCL are still
controversially discussed.
Although the PCL is the strongest ligament of the knee joint, some scientists
have dismissed it as functionally superfluous. These ideas originated mainly
from studies reporting either no or very small forces in the PCL during
activities of daily living and partially from those stating that an isolated PCL
tear may not interfere with patient movement. On the other hand, a number of
studies have reported PCL loads very close to or even higher than the failure
limit of the ligament during activities such as passive knee flexion, body
weight squats and forward lunge. These contrasting reports most likely result
from the difficulties in accessing the kinematics and kinetics of the ligament
*in vivo*. Nevertheless, this controversy indicates a clear requirement for
improved understanding of the PCL and its functionality, which is closely
related to the biomechanical function and loading behaviour of its anterolateral
(AL) and posteromedial (PM) bundles. Unfortunately, a comprehensive
investigation regarding the contributions of each bundle in providing stability
to the knee is lacking. Traditionally, the two bundles were mainly believed to
have reciprocal functions during flexion and extension of the knee. This
argument has been supported by a number of studies reporting lengthening of the
AL bundle and shortening of the PM bundle during knee flexion. However, more
recently, a co-dominant functional relationship between the two bundles has been
suggested based on simultaneous elongation observed in both PCL bundles during a
forward lunge.
The reasons for the lack of knowledge regarding loading of the PCL are manifold.
Most importantly, PCL injuries have been historically underdiagnosed due to the
high possibility of asymptomatic damage, and therefore the necessity to
investigate PCL biomechanics has been generally underestimated. Over the last
two decades, it has become apparent that PCL injuries are more prevalent than
previously believed, with its involvement in nearly 3% of all knee injuries, and
38% of acute knee injuries. Considering these findings, together with an
increasing number of vehicular traumas as the main cause of PCL rupture,
scientists and clinicians have become more interested in research regarding the
functional loading of the PCL within the knee joint.
A number of technical challenges have also limited the accurate *in vivo*
assessment of PCL function during dynamic movement. Compared to other ligaments
of the knee, investigation into the function and loading patterns of the PCL is
difficult due to its relatively inaccessible anatomical location within the knee
joint. Furthermore, the PCL possesses a complex fibrous anatomy and undergoes
differing contact conditions with neighbouring bone and soft tissue structures,
all leading to kinematics that are difficult to assess. As a consequence, a
number of both direct (sensor-based) and indirect (predominantly image-based)
approaches have been used to examine the behaviour of the PCL using *in vivo*,
*in vitro* and modelling investigations. The most common *in vivo* approach to
determine strain has been to examine the relative movement of the bony
attachment sites of the PCL. Here, the length of virtual bundles are determined
as the absolute distance between the centroids of the origin and insertion
sites, while virtual bundle strain (VBS) has been defined as the elongation from
the reference length, which is generally selected as the length of the ligament
at full extension of the knee, relative to their length measured at different
flexion angles. Here, CT and MR imaging, and even dual-plane fluoroscopy, are
generally used to track the attachment sites of the bundles.
Given the hurdles associated with *in vivo* studies, current knowledge of PCL
loading has mainly been based on *in vitro* cadaveric investigations. Here,
strain and force sensors combined with either mechanical jigs or robotic
manipulators have proven to be successful approaches for investigating the PCL.
However, due to the complexities of applying physiological loading conditions to
*in vitro* set-ups, the measurement of force or strain in the PCL has been
generally limited to passive flexion, flexion under externally applied loads, or
with simplified muscle forces only. Compared to the assessment of strain, force
is considered to provide a more realistic measure of the ligament load; however,
studies with implanted force sensors suffer from the imposed size and stiffness
of the sensors, which compromise the natural kinematics and loading within the
ligament. To avoid any interference caused by implantable sensors, an indirect
method using robotic imposed kinematics has also been introduced for estimating
total ligament force based on the principle of superposition. Although this
approach allows a contact-less measurement of the effect of the ligament force,
the in situ forces obtained do not necessarily represent the exact ligament
forces. Strain sensors have less influence on the normal ligament behaviour due
to their small size and low stiffness and therefore have been frequently used in
cadaveric investigations of PCL loading \[, –\]. The sensor output or real
bundle strain (RBS) represents the relative elongation of the real curvilinear
bundle path of the ligament. However, due to the locality of the sensor
measurement site, together with the invasive nature of sensor implantation,
researchers have recently turned to indirect approaches for strain measurement.
When used in cadaveric studies, these indirect methods have the advantage that
they are not limited to image-based assessment. To obtain more accurate results,
3D coordinate measuring machines and surgical navigation systems have also been
introduced into cadaveric investigations of ligament strain.
In addition to experimental studies, *in silico* musculoskeletal and finite
element modelling studies have also reported loading behaviour of the PCL.
Musculoskeletal models have been generally used to estimate the PCL force
patterns during dynamic physiological activities such as walking and squatting.
In contrast, finite element models of the knee have been mostly subjected to
either static or quasi-static loading conditions. Despite their ability to
strongly complement *in vivo* and *in vitro* approaches, modelling
investigations have suffered from oversimplifications of the structural
geometries, material properties and loading conditions. For example, in the vast
majority of models reported in the literature, ligaments have been represented
using one-dimensional elements which therefore preclude the prediction of non-
uniform strain distributions within the three-dimensional structure of the
ligament.
Improvements in modelling and experimental techniques have provided greater
insights into the functional loading of the PCL in the healthy knee joint.
However, differing results from *in vivo*, *in vitro* and *in silico* studies
remain controversially discussed and a clear unbiased consensus on the
biomechanics of the functional bundles for the healthy knee is still lacking. In
particular, the following three questions need to be comprehensively answered:
(1) Do the AL and PM bundles have different loading patterns during loaded and
unloaded flexion of the knee? (2) Is the loading behaviour of the functional
bundles of the PCL activity-dependent? (3) Are the observed loading patterns
dependent upon the investigation techniques used to assess them? This study
therefore aims to generate evidence-based understanding of the functional
loading of the PCL in the healthy knee joint, including its AL and PM bundles,
through systematic review and statistical analysis of the current literature.
# Methods
## Literature Search and Study Selection
For the systematic review, the databases PubMed, Embase, and Cochrane Central
Register of Controlled Trials (CENTRAL) were all searched from their inception
up to January 2016 to recruit studies that reported load data (strain or force)
for the PCL. Different combinations of the terms “knee”, ‘‘ligament”, ‘‘load”,
‘‘force”, “tension“, “length”, ‘‘strain”, “elongation” and ‘‘lengthening” were
used. To facilitate collection of the systematic review manuscripts as well as
identification of duplicate reports, all search hits were imported into the
Eppireviewer software (version 4.5.0.1). Titles and abstracts of all search hits
were screened for eligibility based on the inclusion/exclusion criteria as
follows:
## Inclusion criteria
- Subject characteristics
Human living subjects or cadaveric specimens with healthy ligaments inside
healthy knees
- Bundle definition
Common anatomical definition was used, which consisted of real or virtual
anterolateral (AL), posteromedial (PM) bundles, and the mid-PCL fibre as a
representative of the whole PCL
- Activities
Physiological activities including passive flexion, body-weight squat,
forward lunge, walking, stair ascent, stair descent
Clinical tests including passive flexion with 100 N or 134 N posterior
tibial load (PTL)
- Results
Numeric strain or force data
Length or elongation of the bundles when the reference length was specified
- Report
Journal articles and conference proceedings with full texts written in the
English language
## Exclusion criteria
- Subject characteristics
Animal subjects or specimens, deficient or reconstructed ligaments, pathologic
knees
- Load measurement techniques
Techniques that provided no quantitative data of ligament strain or force (e.g.
arthroscopic probes to assess the slack/tense status of the ligament)
- Bundle definition
Virtual bundles that did not match anatomical structure
- Results
Data collected using non-calibrated sensor outputs
Strain data where the reference length was not reported
Duplicate results (including multiple studies that report on the same cohorts)
- Report
Articles without full texts, non-English reports, and review papers
After initial screening to reduce the pool according to clearly met criteria for
exclusion, the final decision to include or exclude a specific study was made
after carefully reading the full text article. The reference lists of all
included full text articles were double-checked to identify additional reports
that were possibly missed in the initial systematic search (e.g. in cases where
reporting ligament strains and forces was not the primary focus of the
manuscript).
## Analysis of the Literature
An analysis was conducted to obtain the average load trends of the PCL and its
two functional bundles during passive and active knee flexion, as well as to
compare the reported strain and force results between direct and indirect
methods. Outcome measures used to assess the loading trends of the PCL
predominantly included measures of strain and force. It should be noted that due
to varying definitions of ligament physiological length, which relied upon lax
versus taught, knee flexion angle and insertion site definitions, the term
“strain” alone was not sufficient to report and compare the results from the
different methodologies. Therefore, we introduce the term real bundle strain
(RBS) to address the strain within the PCL that included the real curvilinear
path of the ligament. RBS can be measured either using implanted strain sensors
or by calculating the relative elongation of a curvilinear fibre that follows
the centroid-axis of the bundle based on medical images. Similarly, the term
virtual bundle strain (VBS) was used to describe the relative elongation of a
virtual straight-line fibre connecting the centroids of the two bony attachment
sites of the entire ligament or an individual bundle. VBS can be determined by
tracking and assessing the relative change in distance between the ligament
origin and insertion sites (using e.g. medical images or data from coordinate
measurement systems). As with strain data, the reported force data were also
obtained using different techniques. In this review, the term “force” was used
to describe ligament tensile forces, as measured by force sensors or calculated
by means of computational modelling, while “*in situ* force” was used to
represent forces obtained based on the principle of superposition.
Real and virtual bundle strains, force and *in situ* force data of the PCL were
thus extracted from the included articles. If numeric data were not explicitly
reported within the article, graphs were carefully digitized for data
extraction. It should be noted that while the strain and force data during
walking and stair activities were included in the systematic review for
qualitative comparison of the literature, the data were excluded from the
statistical analysis because of the inconsistent formats used for reporting
results. In order to be able to compare the data from the different studies, the
reported measures of length were converted into measures of strain by dividing
the length changes by the given reference length (bundle length at full
extension). To extract the strain patterns of the PCL bundles during passive
flexion, a weighted-regression approach was used based on the number of knees
tested in the various studies. The average load trends of the PCL bundles were
then extracted for the different activities using the weighted mean and standard
error of the mean (SEM; presented in parenthesis after the mean value) of the
extracted force and strain data at the most frequently reported angles of 0°,
30°, 60°, 90° and 120° of knee flexion.
To reduce the risk of bias, all studies with at least one author in common were
assigned to a specific research group. The articles that belonged to specific
research groups were then assessed carefully to ensure that subjects or cohorts
were not reported on more than one occasion. Those articles with no evidence of
duplicate data were removed from the specific research group and were analysed
using the routine procedure as outlined above. The data from articles with
duplicate results were averaged and only the mean trend of each group was
included in the statistical analysis.
# Results
## Study Selection
A total of 3577 articles were found through the initial electronic search.
Search results were imported into the Eppireviewer software, where 854 items
were identified as duplicates. An additional 2232 studies were excluded after
initial screening. The full-texts of the remaining 491 studies were retrieved
for further evaluation. Here, evaluation was conducted to ensure inclusion of
articles that contained PCL load data even if the main focus of a study was on
another ligament. A comprehensive full-text screening revealed that 66 articles
contained strain or force data regarding the PCL (including 9 eligible
manuscripts that were found through double-checking the reference lists of the
included full-text articles), and thus fulfilled all inclusion criteria (data
classified according to the activity types in Tables –).
## Strain Patterns of the PCL during Passive Flexion
Twenty-four studies that contained PCL strain data during passive flexion met
all inclusion criteria; from those, only three studies assessed the RBS within
the PCL, whereas in the remaining experimental studies a variety of indirect
methods was used for measuring the VBS. Most studies (16 articles) presented *in
vitro* cadaveric approaches, while modelling (6 articles) and *in vivo* (3
articles) methods were less frequently utilised.
### In vivo results
Only three studies reported on strain of the PCL during passive flexion *in
vivo*. Jeong and co-workers calculated the distances between the attachment
sites of the AL and PM bundles using CT images of ten living subjects. At 90° of
flexion, the AL and PM bundles were elongated 33% and 9% respectively compared
to their reference lengths at full extension of the knee. From 90° to 135° of
flexion, there was no considerable further lengthening in the AL bundle, but the
PM bundle continued its elongation. In another study, based on MR images of
twenty subjects in the sagittal plane, Nakagawa et al. reported lengthening of
the virtual bundles that represented the mid-PCL. With the reference length
taken at full extension, the VBS trend was upward, with a calculated strain of
29% at 90°. Further flexion beyond 90° caused a reduction of the PCL strain to a
value of 24% at 120°. These findings are in general agreement with those
reported by King and co-workers who used an open-bore MRI scanner to measure
lengthening of the virtual mid-PCL bundle in seven subjects. In addition to the
virtual mid-PCL bundle, the elongation of the curvilinear fibres on the anterior
and posterior surfaces of the PCL was calculated. Their results indicated
continuous elongation of the anterior fibre up to 22% at 120°, while the
posterior fibre lengthened up to 40° but became shorter thereafter.
### In vitro results
Two studies reported RBS data for the PCL during passive flexion of the knee.
Arms and co-workers attached Hall Effect Strain Transducers (HESTs) to the
anterior and posterior fibres of the PCL in cadaveric specimens. They found a
rapid elongation of the anterior bundle after the first 10° of flexion,
corresponding to 19% maximum strain at 120°. The posterior bundle was positively
strained only after 45° of flexion and gradually elongated thereafter. In
another sensor-based study, Dürselen and co-workers attached Ω-shaped strain
transducers to the PM bundle of the PCL in nine cadaveric specimens. Since their
study considered the zero-strain position to be at 60° flexion, this point was
referenced to full extension in order to allow an objective comparison of their
results. Given this transformation, the PM bundle was shorter than its reference
length up to 30° flexion, whereupon the strain gently increased up to 1% at
110°, with the minimum strain observed at 15° flexion.
Other *in vitro* studies have used indirect techniques for measuring the PCL
strain in cadaveric knees. Dorlot and co-workers as well as Inderster and co-
workers measured the distance between origin and insertion of the anterior and
posterior fibres of the PCL using threads passed through the centres of the
attachment sites with one end secured to the tibia and the other connected to a
displacement transducer. They found a gradual elongation of the anterior bundle
throughout the full range of knee flexion but the reported strain patterns of
the posterior bundle were not consistent in these studies. While in the first
study the posterior bundle was found slack throughout the first 50° flexion, the
second study reported a continuous elongation of the bundle with increasing knee
flexion. Using Rontgen Stereo-photogrammetric Analysis (RSA) to measure the VBS
of the PCL in cadaveric knees, Garbelotti and co-workers, van Dijk and co-
workers, as well as Blankevoort and co-workers reported lengthening of the
virtual AL bundle with increasing knee flexion. Based on their findings, the PM
bundle was generally lax throughout the studied range of flexion and had a
shortening phase up to 40°- 60° of flexion followed by an elongation trend
thereafter. Garbelotti and co-workers also found the length of the mid-PCL
unchanged during the first 30° of flexion with an elongation phase thereafter.
These results are not in agreement with those previously reported by Wang and
Walker who used lateral and anterior-posterior radiographs from 12 cadaveric
knees to calculate the relative displacement of the mid-PCL attachment sites
marked with metal pins. They found a 10% negative strain during the first 30° of
knee flexion, which remained nearly constant throughout the higher flexion
angles. Nakagawa et al. used sagittal MR-images of six cadaveric knees to assess
elongation of the mid-PCL. They reported a steady increase in the length of the
mid-PCL bundle from full extension to 120° of passive flexion with a maximum of
26% VBS.
One common approach to assess the kinematics of the PCL has been based on
superimposing or registering the geometrical data obtained by digitizing bone
surfaces and ligament attachment sites onto captured kinematic data. To capture
the joint kinematics, Trent and co-workers took photographs of the cadaveric
specimens surrounded by several mirrors. Repeating this procedure for different
flexion angles, they reported the pattern of ligament lengthening during 105° of
knee flexion. In the first 15° of flexion, the mid-PCL bundle experienced
shortening, followed by lengthening at higher flexion angles. However, recent
studies in this field have employed more advanced technologies to capture the
joint kinematics including 3D scanners, surgical navigation systems, optical
markers, and electrogoniometers etc. Using such equipment, the elongation
patterns reported by Wang et al., Zaffagnini et al. and Cross et al. suggest
lengthening of both the AL and PM bundles throughout the whole range of flexion.
Belvedere and co-workers as well as Hsieh and Draganich found similar elongation
patterns for the AL bundle but they reported a phase of shortening for the PM
bundle starting from full extension. The results of Amiri and co-workers,
however, suggest a very different loading pattern for the PCL, with negative
strains for both bundles over the entire arc of flexion.
### Modelling results
Seven studies used modelling approaches to calculate strain patterns of the PCL
during passive knee flexion. As a simple method, four-bar linkage mechanisms
formed by the tibia, the femur and the cruciate ligaments were used to simulate
passive motion of the tibio-femoral joint and investigate ligament kinematics.
Using a 2D linkage model of the knee, Zavatsky and O’Connor calculated strain
patterns of different bundles within the PCL during passive knee flexion. Their
results demonstrated that the length of the anterior bundle gradually increased
with knee flexion until 90° and remained constant thereafter, but the posterior
bundle was positively strained only after 110° of flexion. Chittajallu and Kohrt
constructed a 2D dynamic model of the knee consisting of two coupled four-bar
linkages driven by the cruciate and the collateral ligaments. Here, the
governing equations of motion were solved to minimise the generated anterior-
posterior force in the joint. The results indicated that until 60° of flexion,
the mid-PCL strain had a gentle increase with a maximum of 1% strain but with a
declining trend thereafter. Crowninshield and co-workers introduced a 3D
kinematic model of the knee that was driven by the motion of the joint centres
of rotation and calculated negative strain patterns for both the anterior and
posterior bundles throughout the whole range of flexion. Taking into account the
contact between tibia and femur, Beynnon and co-workers, Wismans and co-workers
as well as Amiri and co-workers developed quasi-static analytical models of the
knee with bones represented as rigid bodies and ligaments as flexible one-
dimensional elements. Although in these studies joint flexion was consistently
achieved by applying a small force to the femur, the obtained strain patterns of
the PCL bundles were not consistent. For instance, Wismans and co-workers
reported mid-PCL load-bearing only after approximately 40° of flexion but Amiri
and co-workers found it tense only up to 50° of flexion.
In general, considerable variation was observed across the literature for the
strain estimations within the AL, PM and mid-PM bundles. Nearly all studies
suggested a positive strain in the AL bundle throughout the range of flexion,
while both positive and negative strains were frequently reported for the PM
bundle. As a result, the weighted-regression line for the AL bundle showed the
highest strain magnitudes. The data indicate a gradual increase in AL bundle
strain up to 90°, with a maximum of 21%, after which it declines to 17% at 120°
of flexion. The regression line for the mid-PCL strain suggests a similar
behaviour to that of the AL bundle but with lower magnitudes, and with a maximum
of 14% at 90°. However, the weighted regression trend for the PM bundle strain
indicates a slightly different pattern from those of the AL and mid-PCL bundles.
In the first 80° of flexion, the bundle is shorter than its reference length,
suggesting a lax state. The bundle has its shortest length at 30° joint flexion,
with a corresponding strain of -3%. At 100°, the PM bundle presents its maximum
positive strain of only 2%, and further flexion reduces the strain once again.
### Difference between assessment techniques
Average strain patterns obtained for the virtual mid-PCL bundle varied among the
different assessment techniques. No *in vivo* strain data were reported for
bundles at 30° or 60° of flexion. At 90°, modelling studies calculated mostly
negligible strains (0%) for the mid-PCL, while *in vivo* investigations found
mean strains of 24%; approximately twice the values obtained *in vitro*.
However, all the assessment techniques suggested a declining trend for the
bundle strain above 90° of knee flexion. Compared to *in vivo* and *in vitro*
investigations, strain data estimated by means of modelling techniques had
considerably higher variation. Mean VBS and RBS patterns exhibited similar
trends. Both direct and indirect measurement techniques reported elongation of
the AL bundle throughout the first 90°, and shortening of the PM bundle during
the first 30° of flexion. Contrary to direct methods, however, indirect methods
of strain measurement showed a declining strain after 90° of flexion for both
bundles. Moreover, the strain magnitudes of the AL and PM bundles were found to
exhibit different patterns throughout flexion, with considerably higher strains
reported for the AL bundle.
## Force Patterns of the PCL during Passive Flexion
The majority of force data reported for the PCL during passive flexion has been
acquired by the same research group using cadaveric knees and attaching a load
cell to the isolated femoral attachment site of the ligament. In these studies,
the knees were mounted in multi-degree of freedom jigs and manually moved
through knee flexion. Based on their measurements, the PCL was found to be under
low tension throughout flexion. The average tension in the PCL at full
extension, 30° and 120° of flexion was approximately 15 (3), 4 (1) and 19 (5)N
respectively. Smaller forces were reported by Wang and co-workers who used a
similar assessment technique, and were in a general agreement with a study using
buckle force transducers implanted on the PM bundle. Miyasaka and co-workers
detached the PCL from its femoral attachment site and reattached it to its
anatomical position using a metal plate instrumented with 12 strain gauges. They
reported only small forces in the PCL throughout the range of passive flexion
with a maximum of 4 (1)N at 90°. In another study, a robotic manipulator
together with a universal force sensor (UFS) was used to measure the *in situ*
force of the PCL in nine cadaveric knees during passive flexion. Except for 90°
flexion, the force patterns of the PCL were close to the average force trend
extracted from the data measured *in vitro*.
Three studies presented modelling techniques to calculate the resultant PCL
force during simulated passive flexion of the knee. With a 3D quasi-static
model, Amiri and co-workers found the PCL to be slack at full extension, but the
model predicted an increase in the ligament force to 40N at 30° that remained
nearly unchanged until 90° of flexion. However, between 90° and 120° of flexion,
a dramatic increase to 290N was calculated. Different results were achieved
using a 3D finite element model of the knee, where the PCL was reported to
become load-bearing only after 20° of flexion, and a maximum of 35N was
predicted above 90° flexion. Contrary to these studies, large tensions in both
PCL bundles at full extension were calculated using a 2D quasi-static model of
the knee. Although the average force trend extracted from modelling studies had
a similar pattern to that obtained from *in vitro* cadaveric investigations,
analytical models generally overestimated the PCL tension at all flexion angles.
PCL forces in the presence of a posterior tibial load (PTL) have been examined
using load cells attached to the isolated femoral bony attachment of the PCL in
cadaveric knees. These studies indicated that the PCL is subjected to
approximately 22N tensile force at full extension, with a steady increase to
128N at 90° of flexion, followed by only a small increase (approximately 10N)
thereafter. These values were corroborated by Vahey and Draganich using an
indirect measurement technique, who estimated *in situ* forces 95N and 138N at
30° and 90° of flexion, respectively. In the presence of a 134N PTL, the PCL *in
situ* force has also been indirectly assessed using robotic manipulators
together with universal force sensors. These investigations indicated a
relatively small force (29N) at full extension that gradually increased to 123N
at 90° of flexion, and that reduced slightly thereafter. In general, the
application of PTLs produced higher PCL forces than passive flexion, with the
greatest difference at mid-flexion.
## Strain Patterns of the PCL during Active Flexion
All studies examining forward lunge or squat used image-based techniques for
strain measurement. To analyse joint kinematics during forward lunge, 3D
geometrical models of the subjects’ knees were registered to orthogonal
fluoroscopic images captured at different knee flexion angles. Lengths of the
virtual bundles were estimated by tracking the reconstructed motion of the
ligament attachment sites, reporting an increase in AL, PM and mid-PCL VBSs
throughout flexion.
At 90° of flexion, the average VBS in the AL and PM bundles were 32% and 25%.
Surprisingly, the corresponding value for the mid-PCL was reported as being
outside the values presented for the AL and PM bundles at approximately 23%. At
120° flexion, VBS for AL and PM bundles were reported as 35% and 27%
respectively. A comparison between the experimental VBS patterns of the PCL
bundles during forward lunge (loaded) with those of passive flexion (unloaded)
revealed a considerable difference in the mean strains that became larger at
higher flexion angles. Furthermore, no relaxation phase for the PM bundle could
be observed during forward lunge. Moreover, contrary to passive knee flexion,
the strain magnitudes of the PCL during forward lunge did not decline after 90°
of flexion.
For body-weight squat, the only study that contained strain data was an *in
vivo* investigation by Nakagawa et al., who included MR-imaging of the knees in
thirteen healthy subjects. They found a consistent elongation for the mid-PCL
bundle up to 31% at 120°, followed by a declining trend. At 90° of flexion, the
average VBS for the mid-PCL was calculated as 28%, which was somewhat higher
than the corresponding value for forward lunge (23%) reported by Defrate and co-
workers.
## Force Patterns of the PCL during Active Flexion
Using a 2D musculoskeletal model, Shelburne and Pandy calculated the PCL force
up to 90° flexion during squats. The model predicted zero PCL force until 10° of
knee flexion but a steadily increasing force thereafter to a peak of 650N at
80°. The estimated PCL force decreased slightly between 80° and 90° flexion.
Using similar approaches, Toutoungi and co-workers reported comparably small
forces in the PCL during early knee flexion but predicted a much larger maximum
PCL force of 2432N at 100° compared to Shelburne and Pandy. Utilizing a two-
stage procedure, Shelburne and co-workers reported peak PCL forces of 274N
during squatting, suggesting inconsistent results using musculoskeletal
modelling approaches.
## Strain and Force Patterns of the PCL during Walking and Stair Activities
All studies reporting PCL load data during walking used modelling techniques,
but with highly variable results. While some investigators calculated almost no
tension in the PCL (ranging from 0 to 27N), others found relatively high maximum
PCL forces (0.2–1 times body-weight; BW). The time-point at which the peak PCL
force occurred was also inconsistent between different studies and varied from
early stance to late swing phase. Two studies reported on the strain patterns of
the PCL during stair ascent or stair descent *in vitro*. Mahoney and co-workers
measured *in vitro* strain in the AL bundle using implanted HEST sensors while
the knee specimens were loaded to simulate stair ascent and descent. Until 40°
of flexion, no significant strain was detected within the PCL for either
activity studied. During stair ascent, the maximum RBS in the AL bundle was
measured as 3%, which occurred between 100° and 110° flexion. Similarly, during
stair descent, peak strains of 3% were measured between 100° and 110°, but these
results were somewhat lower than the results of Emodi and co-workers who
reported strains of 9% in the AL bundle at 105° flexion during stair descent
using implanted differential variable reluctance transducer (DVRT) strain
sensors.
# Discussion
The PCL is known to be one of the four major stabilizers of the knee joint. Many
aspects of PCL biomechanics have been investigated based on strain and force
measures of the ligament during different activities. However, due to the high
variability in the reported load data, controversy still surrounds the
definitive role of the ligament and its functional bundles during normal daily
activities. In this comprehensive analysis of the literature, new understanding
of the force and strain patterns within the PCL of healthy knees have been
gained that would not be possible from a single study alone. Here, we have
extracted the mean strain and force patterns of the PCL from an initial
screening of over 3500 scientific articles, to provide the foundations for
understanding PCL loading patterns during different activities. In addition, the
influence of different assessment techniques on variations of the reported load
data has been investigated as a possible source of bias.
This systematic review has revealed that current knowledge of PCL loading mainly
suffers from an insufficient number of studies, particularly during active and
deep flexion activities. For example, no *in vivo* sensor-based study exists
that have measured PCL force or strain in healthy human subjects. Only few
studies have reported lengthening patterns of the virtual PCL bundles *in vivo*
using indirect assessment techniques; and these studies have been conducted by
single research groups or were limited to quasi-static forms of passive flexion,
body-weight squat or forward lunge. *In vitro* cadaveric investigations on PCL
loading are more frequent, but the majority have assessed PCL loads using
indirect methods. While some *in vitro* studies have utilised strain or force
sensors to investigate the effects of externally applied loads or muscle
contractions on the ligament load, only a few of them have accurately captured
the physiological loading conditions. Information on PCL loading from
musculoskeletal and finite element modelling studies is limited and seems to be
highly variable. As such, this comprehensive systematic review of the literature
represents the single best understanding of loading conditions within the PCL
available. Based on the statistical analysis of the reported data, the loading
conditions in the PCL and its two main functional bundles during passive flexion
have now been characterised in detail. However, studies on PCL biomechanics
during physiological activities of daily living, as well as the extreme
conditions experienced during impact or intense sport, are clearly missing and
need additional investigation.
The average loading patterns of the PCL confirm that both PCL strain and force
magnitudes are dependent upon the knee flexion angle. During passive flexion,
strains of the virtual AL and mid-PCL bundles follow similar patterns,
consisting of an upward trend in the first 90° and a declining trend thereafter.
With the zero strain condition defined at full extension of the knee, the PM
bundle remains relatively relaxed throughout flexion. Interestingly, the
magnitudes of the mid-PCL strains were between those of the AL and PM bundles.
This fact adds confidence to the performed statistical analysis as the strain
data were almost entirely extracted from independent studies. Although VBS does
not seem to decline after 90° of flexion during forward lunges or squats, the
slopes of the average strain patterns decreased at higher flexion angles. It was
also observed that a posterior tibial load affects the PCL force more notably in
the mid-range of knee flexion compared to early or deep flexion (c.f. *in situ*
force passive *vs* 134N PTL;), due to the reduced restraining function of the
PCL at low and high flexion angles. Although we did not show PCL loading beyond
120° in this review, Li and co-workers reported only a small contribution of the
PCL to knee stability at 150° of flexion. This behaviour can be partially
explained by changes in the spatial orientation of the PCL bundles, which become
more vertically oriented at higher knee flexion angles, and therefore lose their
efficiency in restraining posterior shear forces. However, some studies have
reported an increasing trend for the posterior shear force acting on the knee
joint throughout the whole range of knee flexion. This raises the question of
which structures compensate for the weak restraining function of the PCL against
posterior tibial loads at higher knee flexion angles. Here, posterior structures
of the knee including skin, fat, hamstring muscles, joint capsule and meniscus
are thought to partially provide posterior stability to a hyper-flexed knee
joint, even though their individual contributions remain unknown.
It is known that knee kinematics are activity-specific, suggesting that PCL
strain is also affected by activity type. Our study supports this idea as the
extracted strain patterns of the ligament bundles differ between passive flexion
and forward lunge. This difference, which is more notable at higher knee flexion
angles, might originate from variations in the contributions of muscle forces to
knee joint kinematics during different activities. Both the quadriceps and the
hamstrings muscle groups are involved during a forward lunge. While, contraction
of the quadriceps can lead to a slight decrease of the PCL force, contraction of
the hamstrings has been shown to considerably increase the PCL load. Therefore,
compared to passive knee flexion, it is entirely plausible that the PCL is
exposed to higher loads during sports activities.
Variations in the reported strain and force data of the PCL during physiological
loading might originate from different sources. The anatomy of the PCL is
subject-specific, and geometrical parameters of the ligament including length,
cross sectional area and attachment sites of the bundles have been described
inconsistently. Therefore, it is likely that ligament strain varies among
different subjects performing the same activity. It is also known that the
lengthening pattern of the PCL is sensitive to the definition of its attachment
sites, which is likely accompanied by errors especially when image-based
techniques are used. In case of cadaveric investigations, specimens were
prepared in different ways depending on the type and volume of the surrounding
soft tissues resected. Furthermore, joint kinematics was simulated using a
variety of techniques including manual, mechanical and robotic approaches, as
well as internal or external poses of the bones, possibly adding to the reported
variation in outcome measures. Additionally, strain of the ligament was measured
using different direct and indirect methodologies. Given the many techniques and
methods employed in assessing PCL loading, it is therefore hardly surprising
that the reported outcomes vary considerably between the different studies.
This systematic review provided the opportunity to compare RBS of the PCL (via
direct approaches) with VBS (via indirect approaches) during passive knee
flexion. The results from the statistical analysis demonstrate that VBS patterns
during passive knee flexion are similar to RBS patterns but differ in magnitude.
This should be kept in mind when interpreting results from studies reporting
VBS; in particular, large VBS magnitudes may falsely imply failure of a ligament
that in reality experiences safe strain magnitudes. For example, at 90° of
passive flexion, the PCL was shown to be very lightly loaded; however, the
average experimental VBS of the AL bundle was calculated at 24%, which is higher
than the failure strain measured *in situ* (18%). Surprisingly, the calculated
maximum VBS during forward lunge (35%) is approximately twice the magnitude of
the bundle failure strain. The difference between VBS and RBS likely originates
from the unknown zero-strain condition. Given the technical difficulties in
identifying the accurate zero-strain condition, nearly all the included studies
chose full extension of the knee as an arbitrary reference position, while in
reality the PCL is considered lax at this position. Therefore, the selection of
the reference position may add a systematic error to the strain data obtained by
measuring the relative elongation of the virtual bundles. Moreover, in cases
where the ligament is lax or wraps around a neighbouring structure, the
straight-line representation between the attachment sites–or “virtual
bundle”–does not represent the curvilinear length of the real bundle. Another
key factor that might intensify the difference between RBS and VBS (especially
for ligaments with large cross sectional areas) is the distribution of the
strain across the ligament. RBS is generally measured using sensors attached to
the surface of the ligament and therefore represents the local superficial
strain. In contrast, VBS tends to represent the average strain of a virtual
fibre inside the ligament. King and co-workers showed that large strain
differences exist between the superficial fibres and the virtual lines that
connect the attachment sites. While VBS can be used for intra-study comparison
of the ligament strains under different loading conditions, any inter-study
comparison of VBS is limited to investigations that have used a common reference
length.
Given the difficulties in interpreting ligament strain data from different
studies, ligament force may be a more useful measure for investigating PCL
biomechanics, especially considering the role of ligament viscoelastic
properties in modulating the force—elongation relationships. PCL force can be
measured directly by implanting force sensors; however, current sensors are
somewhat large and stiff compared to the PCL structure and therefore interfere
with normal ligament function. An alternative approach includes the use of
robotic technology to measure the *in situ* force of the ligament based on the
principle of superposition, thus avoiding limitations induced by direct contact
of the force sensor and ligament. In this review, only a small difference was
found between the *in vitro* and *in situ* forces determined in the PCL during
passive knee flexion. In general, the PCL was found to be very slightly tense
throughout flexion, with the smallest tension at 30° of knee flexion. Applying a
PTL was shown to increase the PCL force at all flexion angles, but the increase
was more considerable at mid-range of knee flexion. The fact that a PTL does not
strongly affect the PCL force at full extension may explain why an isolated
rupture of the PCL does not often lead to knee instability. Previous studies
confirmed the role of meniscofemoral ligaments as well as posterolateral and
posteromedial structures of the knee in providing knee stability near full knee
extension. In the majority of reported studies, PTL had the greatest effect on
the PCL force at 90° of knee flexion. This could explain the so called
“dashboard injury” as the most common mechanism of PCL injury. During a traffic
accident, the knee hits the dashboard while it is at approximately 90° of
flexion and the posteriorly directed impact force tears the ligament. This
finding is in agreement with studies reporting that an isolated sectioning of
the PCL causes the highest change in posterior tibial translation in response to
an applied PTL at 90° of flexion. Therefore, clinical testing for the integrity
of the ligament should be performed at this position to obtain the highest
sensitivity.
We found that the choice of assessment technique affects the resulting loading
patterns in the PCL. Ideally, PCL force or strain would be measured directly *in
vivo* using implantable sensors. However, such *in vivo* procedures are
generally invasive and the outcomes are limited to relative strain at the
implantation site. Moreover, the imposed size and stiffness of the available
sensors interfere with the natural ligament kinematics. Indirect assessment of
the ligament strain via image-based tracking of the ligament attachment sites
would therefore seem to deserve more attention for *in vivo* investigation of
the ligament strain. Despite using substantially different methodologies, the
mean strain patterns extracted from data obtained using indirect techniques
follow those of direct investigations. This finding confirms the ability of
indirect techniques to estimate the ligament strains. However, a correlation
study to determine the relationship between RBS and VBS during different
activities, and based on an adequate number of specimens tested, appears to be
missing. Cadaveric investigations have provided the major contribution to our
current knowledge on PCL loading; however, physiological loading conditions are
difficult to reproduce in mechanical jigs. Finite element and musculoskeletal
modelling techniques allow the simulation of different loading conditions, but
limitations remain with respect to the accurate definition of the geometry, and
the material properties, as well as the contact conditions within the joint and
specifically with the ligament. As a consequence, compared to the load data
measured *in vivo* or *in vitro*, the highest reported variability in the load
data was obtained using modelling techniques. This fact emphasises the need to
account for the 3D geometry, viscoelastic material properties and wrapping of
the ligaments around neighbouring structures in future modelling studies.
Some limitations of this systematic review need to be recognized. Only a limited
number of activities were investigated, and also within a limited range of
flexion (0° to 120°). Due to a lack of reported strain and force data, the
loading patterns of the ligament during hyperextension and hyperflexion of the
knee were not assessed in this review. In addition to a shortage of studies, the
various assessment techniques used for measuring the ligament loading, in
combination with the large number of dependent variables (flexion angle,
bundles, activity etc.), preclude an effective statistical comparison to reveal
the role of individual parameters on PCL loading. In some studies, the standard
deviations in the reported outcome measures were not given, while in some
others, the data were difficult to extract from e.g. graphical presentations.
Consequently, standard deviations could only partially be taken into account for
proper weighting of data points in the present statistical analysis. Many of the
included studies were performed by the same research groups; a fact that might
increase the risk of bias. Finally, while we have investigated PCL loading in
the healthy knee joint, PCL function and its relationship with loading and
kinematics in pathological cases is still less well understood.
Given the insight obtained from this review, it is clear that certain
considerations could help improve comparability of future investigations towards
understanding PCL force and strain patterns. We propose that future studies
should:
- Adopt a standard definition of PCL anatomy, including the anterolateral and
posteromedial bundles.
- Use a standardised knee joint coordinate system for reporting the simulated
bone kinematics.
- Clearly report the approach taken to define zero-strain position.
- Use standardised terminology (consistent with this review) for presenting
results.
- Couple *in vivo* image-based studies with *in vitro* sensor-based studies to
relate VBS and RBS.
# Conclusions
This systematic review has provided an overview of the content and limitations
in the current knowledge on PCL loading in the healthy knee. In general, the
results of this review confirm that the individual bundles within the PCL are
subjected to different loading patterns that are affected by both activity type
and knee flexion angle. Moreover, it was found that the choice in assessment
technique might have an important effect on the resulting load data. In the
context of injury prevention, the extracted strain and force trends now provide
the foundations for improved risk of injury assessment. The extracted loading
patterns can also help determine the critical positions of the knee joint at
which clinical tests are more sensitive to ligament deficiencies. In the context
of PCL reconstruction, efforts should focus on restoring the loading patterns of
the healthy ligament as summarised in this review. Finally, for rehabilitation
of PCL injury, the range of knee joint motion during prescribed exercises can be
adjusted based on safe strain levels to prevent any possible rupture of the
reconstructed ligament.
# Supporting Information
We would like to acknowledge the Iranian Ministry of Science who have partially
funded this study.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** SHHN WRT RL. **Data curation:** SHHN. **Formal
analysis:** SHHN. **Investigation:** SHHN KO. **Methodology:** SHHN WRT RL.
**Project administration:** RL WRT. **Resources:** SHHN RL WRT.
**Software:** SHHN KO. **Supervision:** RL SFF JGS WRT. **Validation:** SHHN
WRT. **Visualization:** SHHN WRT. **Writing – original draft:** SHHN KO RL
WRT. **Writing – review & editing:** SHHN KO RL WRT SFF JGS.
|
# Introduction
Sprouty (Spry) proteins were first discovered in Drosophila melanogaster as
inhibitors of fibroblast growth factor receptor-induced tracheal branching.
Subsequently, four mammalian isoforms of Sprouty (Spry1, Spry2, Spry3, and
Spry4) were identified that are transcribed from four different genes. The
different Spry isoforms have been shown to modulate the actions of receptor
tyrosine kinases (RTKs); therefore, Spry proteins play a role in processes that
require extensive RTK signaling such as organogenesis and tumorigenesis.
Specifically in development, Spry proteins have been shown to regulate the
process of angiogenesis, patterning of the midbrain and anterior hindbrain, and
development of the kidneys, lungs, limb buds, craniofacial features, and trunk.
After development Spry proteins continue to regulate angiogenesis, cell
proliferation, migration and survival. Likewise, the role of Spry proteins,
mainly Spry1 and Spry2, in cancer has also been investigated. Previous research
has shown that the levels of Spry1 and Spry2 are decreased in cancers of the
breast, lung, liver, and prostate correlating to poor patient prognosis. Due to
the important role Spry proteins play in development and tumorigenesis, it is
crucial to understand how Spry levels are regulated.
We focused on Spry2, which is ubiquitously expressed and most studied among the
Spry isoforms. Prior studies have concentrated on the regulation of the Spry2
protein through a variety of posttranslational modifications such as
ubiquitylation or phosphorylation (reviewed). However, early on Spry expression
patterns during development were assessed and showed that the transcription of
*SPRY* is upregulated by growth factors elevating Spry protein levels in the
centers of growth factor signaling (e.g. limb buds), thereby optimizing the
ability of Spry proteins to act as negative feedback inhibitors of the enhanced
RTK signaling in these areas. Additionally, while many other transcription
factors have been predicted to bind to the *SPRY2* promoter, few have actually
been shown to bind. Ding et al. performed a functional analysis of the *SPRY2*
promoter and identified that Ap2, Ets-GATA, and SP-1 bind to the *SPRY2*
promoter enhancing its transcription. However, the functional significance of
the binding of these transcription factors to the *SPRY2* promoter remains
unknown.
Because Spry2 levels are reduced in some forms of cancer, the regulation of
Spry2 in cancer has been investigated. Most studies, however, have focused on
the post-transcriptional regulation of Spry2. The few studies that have
investigated transcriptional regulation of *SPRY2* promoter have shown that FOXO
and beta-catenin bind to the *SPRY2* promoter and induce its transcription. In
terms of epigenetic modifications, the promoters of Spry4 and Spry2 have been
shown to be hypermethylated in prostate cancer, but not breast cancer. Two
reports suggest that *SPRY2* promoter is hypermethylated in hepatocellular
carcinomas, but another report suggests otherwise.
In both development and tumorigenesis, cells experience a hypoxic environment to
which they adapt to by upregulating the transcription factors, hypoxia inducible
factors (HIFs). HIFs are composed of an oxygen-regulated alpha subunit
(HIF1α/HIF2α) and a beta subunit (HIF1β a.k.a. aryl hydrocarbon receptor nuclear
translocator (ARNT)). Opposite to the actions of Spry2, HIFs promote
proliferation, migration, and survival of cells by increasing the transcription
of a number of genes that regulate these processes (reviewed in).
Because Spry2 protein levels are decreased in hepatocellular carcinomas and
given the opposite actions of Spry2 and HIF1α/HIF2α on cell proliferation and
migration, we performed an *in silico* analysis of the *SPRY2* promoter for
hypoxia response elements (HRE) with the consensus sequence `5’-A/GCGTG-3’` and
found 10 putative HREs; five in the proximal promoter and five in the first
intron. Therefore, the purpose of this study was to determine whether
HIF1α/HIF2α regulated the transcription of the *SPRY2* promoter. Herein, we
demonstrate that, in the hepatoma cell line Hep3B, endogenous HIF1α and HIF2α
decreased the mRNA levels of *SPRY2* with a concomitant decrease in the protein
levels of Spry2. While the stability of the *SPRY2* mRNA wasn’t altered by HIF
silencing, inhibiting DNA methylation with decitabine (DAC) abolished the
increase in *SPRY2* mRNA when the expression of HIF1α/2α were silenced.
Chromatin Immunoprecipitation (ChIP) assays revealed HIF1α/2α bind to regions in
both the proximal promoter and first intron, each of which contains four and
five HIF1α/HIF2α binding sites, respectively. Methylation of the proximal
promoter of *SPRY2* was also observed and HIF1α/2α silencing decreased this
methylation. Furthermore, ChIP assays revealed association of DNA
methyltransferase 1 (DNMT1) with the proximal promoter and first intron of
*SPRY2* and silencing of HIF1α/2α diminished this interaction. Finally,
silencing of DNMT1 mimicked the actions of HIF1α/2α silencing in elevating
*SPRY2* mRNA and protein levels. However, simultaneous silencing of DNMT1 and
HIF1α/2α did not elevate *SPRY2* mRNA or protein levels additively suggesting
that DNMT1 and HIF1α/2α work through a common mechanism. These data suggest that
HIF1α/2α suppress *SPRY2* transcription, in part by increasing *SPRY2* promoter
methylation by DNMT1.
# Results
## HIF1α and HIF2α decrease the mRNA and protein levels of Spry2
To investigate if HIF1α and HIF2α regulated *SPRY2* mRNA and protein levels, we
used siRNAs to silence the expression of endogenous HIF1α and HIF2α proteins in
the hepatoma cell line Hep3B. While the silencing of HIF1α or HIF2α separately
elevated *SPRY2* mRNA levels by about 100% each, silencing of both HIF1α and
HIF2α together more profoundly (200%) elevated *SPRY2* mRNA levels (left panel);
the efficient silencing of both HIF1α and HIF2α by the siRNAs is also shown in
(right panels). Consistent with the change in *SPRY2* mRNA levels, an increase
in Spry2 protein levels was observed with HIF1α and HIF2α silencing. Here again,
silencing both HIF1α and HIF2α had a larger effect on Spry2 protein levels,
increasing them by about 150%, while silencing either HIF1α or HIF2α alone
increased Spry2 protein to a lesser extent (\~100%) (right panel).
Conversely, in HEK293T cells, ectopic expression of HIF1α or HIF2α alone or both
isoforms together decreased *SPRY2* mRNA levels. Once again, the expression of
both HIF1α and HIF2α had a more profound effect on *SPRY2* mRNA levels by
reducing them by about 50% while the expression of either HIF1α or HIF2α only
reduced *SPRY2* mRNA by 20% and 30%, respectively (, left panel). Notably, we
found that the co-expression of HIF1β, which dimerizes with HIF1α and HIF2α, is
necessary to observe the effects of HIF1α or HIF2α overexpression, probably
because endogenous HIF1β levels were not adequate to dimerize with the expressed
HIFα subunits. However, HIF1β expression by itself does not alter *SPRY2* mRNA
levels (left panel). As a positive control to ensure that overexpressed HIF1α
was modulating transcription appropriately, we monitored the mRNA levels of the
HIF1α responsive gene phosphoglycerate kinase 1 (*PGK-1*). As expected, co-
expressing HIF1α and HIF1β elevated *PGK-1* mRNA while expression of HIF1β alone
or together with HIF2α had no effect (right panel). Together, these data suggest
that both HIF1α and HIF2α contribute to the decrease of the mRNA and protein
levels of Spry2.
## HIF1α and HIF2α do not alter the stability of *SPRY2* mRNA, but HIF1α and HIF2α bind to the proximal promoter and intron of *SPRY2*
Since changes in mRNA levels may reflect either an alteration in the half-life
of the mRNA and/or the rate of its transcription, we first determined whether
silencing of HIF1α/HIF2α modulated the stability of *SPRY2* mRNA. For this
purpose, Hep3B cells transfected with control or HIF1α and HIF2α siRNAs were
treated with actinomycin D to inhibit RNA synthesis and the mRNA levels of
*SPRY2* were then monitored over 2 hours by qRT-PCR. As shown in, during the 2
hours of actinomycin D treatment, *SPRY2* mRNA levels were reduced by
approximately 80%. However, the rate of *SPRY2* mRNA degradation was not
significantly different whether or not HIF1α and HIF2α were silenced; the half-
life of *SPRY2* mRNA was 0.54 versus 0.70 hours in control versus HIF1α and
HIF2α siRNA transfected cells, respectively. Interestingly, over the entire time
course the cells with HIF1α and HIF2α silenced had higher *SPRY2* mRNA levels,
which is to be expected given the observation that *SPRY2* mRNA levels are
elevated when HIF1α and HIF2α are silenced.
Since these data suggest HIF1α and HIF2α do not alter the stability of *SPRY2*
mRNA, we next investigated if HIF1α and HIF2α regulate the transcription of
*SPRY2* mRNA. It is well established that both HIF1α and HIF2α bind to Hypoxia
Response Elements (HREs) with the consensus sequence `5’-A/GCGTG-3’` in the
promoter of the genes they regulate. We performed an *in silico* analysis to
determine if the *SPRY2* proximal promoter (-3850 to +1) or first intron (+1 to
+3395) contained putative HREs. Indeed, we found 5 putative HREs in the proximal
promoter located at positions -3271, -1360, -1319, -570, and -390 and 5 putative
HREs in the first intron located at nucleotides 1770, 1811, 1830, 1858, and
1953. Furthermore, some of the HREs are conserved amongst primates as well as
mice, rats, and rabbits.
To determine if HIF1α and HIF2α could bind any of these putative HREs, we
performed a chromatin immunoprecipitation (ChIP) assay using a HIF1β antibody to
immunoprecipitate both HIF1α and HIF2α bound DNA. We then used primers targeted
against 4 different HRE containing areas of the proximal promoter and intron of
*SPRY2* to quantify the amount of DNA that was immunoprecipitated by HIF1β. The
location of the primers is shown in. Intriguingly, there was no significant
enrichment of HIF1α/HIF2α/HIF1β on the HRE located at nt -3271 in the proximal
promoter of *SPRY2* as shown by primer set 1. However, primer sets 2 and 3,
targeting the four HREs closest to the transcription start site of *SPRY2*, and
primer set 4, targeting the intron of *SPRY2*, showed significant enrichment of
HIF1α/HIF2α/HIF1β. Furthermore, silencing of HIF1α and HIF2α significantly
reduced the DNA enrichment in ChIP assays with primer sets for these sites. As a
positive control, by identical ChIP assays, we monitored the enrichment of the
HREs located in the promoter of the HIF1α target gene phosphofructokinase (PFK)
and HIF2α target gene erythropoietin (*EPO*). As expected, the
immunoprecipitation of HIF1β was greatly enriched with the DNA corresponding to
HREs in the promoters of both PFK and *EPO* genes, and silencing of HIF1α or
HIF2α greatly diminished the DNA enrichment from PFK and *EPO* promoters,
respectively. These latter findings authenticate that the combination of ChIP
assays with HIF1β antibody and HIF1α/HIF2α silencing is a valid approach to
study HREs on promoters. Together the data in suggest that HIF1α and HIF2α do
not alter the stability of *SPRY2* mRNA, but both HIF1α and HIF2α bind to the
proximal promoter and first intron of the *SPRY2* gene.
## HIF1α and HIF2α regulate *SPRY2* mRNA levels by modulating the methylation of the *SPRY2* promoter
The data in Figs and suggest that HIF1α/HIF2α bind to *SPRY2* promoter and first
intron to repress the expression of Spry2. While studies have shown that hypoxia
represses a set of genes, not many studies have shown that HIF1α or HIF2α
specifically repress gene transcription. Furthermore, the precise mechanisms of
repression are unknown or vary depending on the gene. Methylation of promoters
is well known to repress gene transcription and hypoxia and HIF1α have been
shown to modulate methylation of genes. Therefore, we investigated whether the
methylation status of the *SPRY2* promoter: (a) altered *SPRY2* mRNA levels, (b)
modulated the ability of HIF1α/HIF2α silencing to alter *SPRY2* mRNA levels, and
(c) was regulated by endogenous HIF1α/HIF2α.
By treating cells with decitabine (DAC), an inhibitor of DNA methyltransferases,
we first determined whether the CpG islands in the proximal *SPRY2* promoter
were methylated. Using bisulphite-treated genomic DNA and primers that
specifically detect methylated (M-1, M-2) and unmethylated (U-1, U2) DNA
corresponding to the regions 1 and 2 on the *SPRY2* promoter shown in inset
(also see), we determined the methylation status of the *SPRY2* promoter after
treatment with DAC or its vehicle. As shown in, DAC treatment significantly
decreased the methylation of the *SPRY2* promoter at primer sites 1 and 2 by 80%
and 47%, respectively. Concomitantly, as expected, the amount of unmethylated
promoter monitored by unmethylated DNA-specific primers for sites 1 and 2 was
elevated by 78% and 80%, respectively. These findings demonstrate that the
*SPRY2* promoter is methylated and DAC treatment effectively reduces its
methylation.
Next, we determined whether treatment of cells with DAC altered *SPRY2* mRNA
levels and the ability of HIF1α/HIF2α silencing to further modulate the amount
of *SPRY2* mRNA. As shown in, DAC treatment of cells increased *SPRY2* mRNA
levels by nearly 2-fold. However, while HIF1α/HIF2α silencing in vehicle treated
cells (control) elevated *SPRY2* mRNA levels by \~100%, in the presence of DAC,
silencing of HIF1α/HIF2α did not significantly increase *SPRY2* mRNA levels; the
efficient silencing of HIF1α and HIF2α is shown in the right panels of. These
data in suggest that in Hep3B cells the reduction in methylation of the *SPRY2*
promoter by DAC increases *SPRY2* mRNA levels and that DNA methylation plays a
role in HIF1α/HIF2α- mediated decrease of *SPRY2* mRNA levels.
To directly assess whether silencing of HIF1α/HIF2α altered the methylation
status of the *SPRY2* promoter, using primers corresponding to regions 1 and 2
on the *SPRY2* promoter that specifically recognize methylated (M-1, and M-2)
vs. unmethylated DNA (U-1 and U-2), we determined the methylations status of the
*SPRY2* proximal promoter with and without HIF1α/HIF2α silencing. As shown in,
silencing of HIF1α and HIF2α decreased *SPRY2* promoter methylation detected by
M-1 and M-2 primers by 52% and 42%, respectively, and increased the amounts of
unmethylated *SPRY2* promoter monitored by U-1 and U-2 primers by 111% and 82%,
respectively. Overall, these data suggest that the *SPRY2* promoter is
methylated in Hep3B cells, methylation of the promoter represses the expression
of *SPRY2* mRNA, and endogenous HIF1α and HIF2α increase the methylation of the
S*PRY2* promoter to decrease Spry2 mRNA levels.
## HIF1α and HIF2α regulate binding of DNMT1 to the *SPRY2* proximal promoter and intron and DNMT1 contributes toward HIF1α and HIF2α- mediated regulation of *SPRY2* mRNA
DNA methylation is a predominant epigenetic modification in mammals and is
catalyzed by DNA methyltransferases (DNMTs), which are the enzymes that
methylate the 5-position of cytosine in DNA primarily within a CpG dinucleotide.
There are four DNMT isoforms: DNMT1, DNMT3a, DNMT3b and DNMT3L. DNMT1 is the
most abundant of these enzymes and is involved in maintaining methylation
pattern by methylating newly replicated DNA. DNMT3a and DNMT3b are considered
*de novo* methyltransferases, since they add methyl groups to completely
unmethylated DNA during development of an embryo. DNMT3L does not possess any
inherent enzymatic activity. Intriguingly, hypermethylation of specific promoter
regions has been implicated in promoting tumorigenesis (reviewed in). One
potential cause of this hypermethylation is the upregulation of DNMT’s, in
particular DNMT1. In fact, previous studies showed that expression of DNMT1 in
cultured cells increased CpG island methylation and resulted in cellular
transformation. With this in mind, we focused our studies on DNMT1.
Given our observations that HIF1α/HIF2α alter methylation of the *SPRY2*
promoter and the recent findings demonstrating that laccaic acid (LCA) is a
direct inhibitor of DNMT1 activity, we investigated whether inhibition of DNMT1
with LCA altered the ability of HIF1α and HIF2α to regulate *SPRY2* mRNA levels.
Consistent with the data shown in Figs and, silencing HIF1α and HIF2α resulted
in a 170% increase in *SPRY2* mRNA. Importantly, treatment of cells with LCA,
the DNMT1 inhibitor, also increased *SPRY2* mRNA levels by 87% and attenuated
the increase in the levels of Spry2 mRNA observed with HIF1α and HIF2α silencing
(170% in control versus 70% in LCA treated) (left panel); the efficient
silencing of HIF1α and HIF2α is shown in (right panels). These data suggest that
DNMT1 regulates transcription of *SPRY2* mRNA and is partially involved in the
ability of HIF1α and HIF2α to repress *SPRY2* mRNA levels.
To investigate if HIF1α and HIF2α altered the binding of DNMT1 to the *SPRY2*
promoter, we performed ChIP assays with the DNMT1 antibody and monitored the
amount of the proximal promoter and intron of *SPRY2* that immunoprecipitated
with DNMT1 with and without silencing the expression of HIF1α/HIF2α. The
location of the primer sets that bind to these regions is shown in. Similar to
the ChIP assays shown in, DNMT1 immunoprecipitates were enriched with *SPRY2*
gene regions corresponding to the promoter near the transcription start site
(primer set 3) and the first intron of *SPRY2* gene (primer set 4).
Additionally, silencing of HIF1α/HIF2α decreased the enrichment of DNA
corresponding to these regions of the *SPRY2* gene in ChIP assays performed with
the anti-DNMT1 antibody. These data suggest that DNMT1, either directly or
indirectly, binds to the proximal promoter and first intron of the *SPRY2* gene
and that HIF1α and HIF2α regulate the binding of DNMT1 to these regions.
One mechanism by which DNMT1 could be recruited to the *SPRY2* promoter and
first intron is via interactions with HIF1α and/or HIF2α. However, despite
numerous attempts using different conditions, we did not observe co-
immunoprecipitation of HIF1α/HIF2α and DNMT1 (not shown) irrespective of which
protein we immunoprecipitated. Thus, the precise mechanism by which HIF1α/HIF2α
regulates binding of DNMT1 to the *SPRY2* promoter and first intron remains to
be defined.
To further elucidate the role of DNMT1 in the regulation of *SPRY2* mRNA levels
by HIF1α/HIF2α, we monitored the levels of *SPRY2* mRNA in cells transfected
with either control siRNA or siRNAs targeting HIF1α/HIF2α when DNMT1 expression
was either silenced or not. In these studies, we included two hepatocellular
carcinoma cell lines, HuH7 and Hep3B, to demonstrate the generality of the
mechanisms investigated in this report. As shown in and as observed previously
(Figs, &), silencing of HIF1α/HIF2α in Hep3B cells increased *SPRY2* mRNA
levels by 130%. The silencing of DNMT1 alone also increased *SPRY2* mRNA levels
by \~50%. The latter increase is consistent with the data in with LCA,
suggesting that DNMT1, in part modulates *SPRY2* promoter activity. Of note,
silencing of HIF1α/HIF2α had no effect on DNMT1 mRNA levels and vice versa
(right panels). Most interestingly, when DNMT1 and HIF1α/HIF2α expression was
simultaneously silenced, *SPRY2* mRNA levels were not increased in an additive
manner. Similar results were observed in HuH7 cells with the exception that
silencing of HIF1α/HIF2α elevated *SPRY2* mRNA levels by \~50% instead of the
100% increase observed in Hep3B cells. Nevertheless, the other changes described
for Hep3B cells with DNMT1 silencing alone and together with HIF1α/HIF2α
silencing were also similar and statistically significant in HuH7 cells.
Consistent with changes in the *SPRY2* mRNA levels, silencing HIF1α/HIF2α or
DNMT1 alone significantly elevated Spry2 protein levels in Hep3B cells and HuH7
cells. However, as described above for *SPRY2* mRNA levels, simultaneous
silencing of DNMT1 and HIF1α/HIF2α did not additively increase Spry2 protein
levels suggesting that DNMT1 and HIF1α/HIF2α regulate Spry2 protein levels by a
common mechanism. Together, the data in Figs and suggest that HIF1α and HIF2α
regulate *SPRY2* mRNA and protein levels, in part, by regulating the binding of
DNMT1 to the promoter and intron of *SPRY2*.
# Discussion
Ever since the discovery of the first *SPRY* gene in Drosophila, it has been
clear that the Spry family of proteins, in a variety of species, play an
important role in normal development of organs. Because Spry proteins modulate
the biological actions of growth factors that mediate their signaling via
Receptor Tyrosine Kinases, a number of studies have examined the role that Spry
proteins play in disease states associated with enhanced Receptor Tyrosine
Kinase activities. Essentially, these studies have shown that in certain disease
states such as carcinomas of the breast, liver, lung and prostate, the levels of
Spry proteins, especially Spry2, are decreased and probably contribute toward
the pathogenesis of the disease. Indeed, in hepatocellular carcinoma and breast
cancer, a decrease in Spry2 levels has been correlated with poor prognosis and a
decrease in patient survival. For these reasons, it has been suggested to use
Spry2 protein levels as a prognostic marker and Spry proteins have been dubbed
“tumor suppressors”. Thus, Spry proteins play an important role in normal
development and in tumorigenesis.
During development and tumorigenesis, rapid cell proliferation that precedes
angiogenesis exposes cells to hypoxia. The cells adapt to hypoxia by stabilizing
the Hypoxia Inducible Factors, HIF1α and HIF2α, which are transcription factors
that increase the expression of certain genes that promote cell survival and
proliferation (reviewed in). As such, in cancerous states, HIFs can be
considered tumor promoters. Recently, we demonstrated that one of the mechanisms
by which Spry2 exerts its “tumor suppressor” functions is by decreasing the
stability of HIF1α and HIF2α with a corresponding decrease in their ability to
alter transcription of the HIF1α and HIF2α target genes. Herein, we asked the
opposite question i.e. do HIF1α and HIF2α regulate Spry2 levels?
The evidence presented in this report demonstrates that endogenous HIF1α and
HIF2α decrease the amounts of *SPRY2* mRNA and protein as silencing of
endogenous HIF1α and HIF2α elevate both *SPRY2* transcript and protein levels.
Conversely, ectopically expressed HIF1α and HIF2α decrease the amounts of
*SPRY2* mRNA. The increase in *SPRY2* mRNA levels is not the result of changes
in stability of the transcript, but for the following reasons, is a function of
the change in transcription of the *SPRY2* gene. First, HIF1α/HIF2α bind to the
proximal promoter and first intron of the *SPRY2* gene that contains a total of
nine putative HRE consensus sequences (4 in proximal promoter and 5 in first
intron). Second, HIF1α and HIF2α increase the methylation of the *SPRY2*
promoter and repress *SPRY2* mRNA expression. Third, the inhibitor of DNMT1,
LCA, and DNMT1-specific siRNA augment *SPRY2* mRNA and protein levels mimicking
the effect of HIF1α/HIF2α silencing had to a lesser extent. As discussed later,
simultaneous silencing HIF1α/HIF2α with DNMT1 resulted in a significant increase
only in *SPRY2* transcript and not Spry2 protein levels. However, this increase
in SPRY2 mRNA with DNMT1 and HIF1α/HIF2α silenced was not additive suggesting
DNMT1 and HIF1α/HIF2α regulate SPRY2 through a similar mechanism.
Moreover, our studies also show that DNMT1 binds the *SPRY2* promoter and
silencing of HIF1α/HIF2α decreases this association of DNMT1 with the *SPRY2*
promoter. These findings suggest that HIF1α/HIF2α, in some manner, recruit DNMT1
to the *SPRY2* promoter to alter the methylation state of the promoter and,
therefore, transcription of the *SPRY2* gene. One obvious mechanism would be the
association between HIF1α/HIF2α and DNMT1 to recruit DNMT1 to the *SPRY2*
promoter. However, despite several attempts using different immunoprecipitation
conditions to elucidate interactions between HIF1α/HIF2α and DNMT1, we have been
unable to show that these proteins reside in the same complex. It is possible
that HIF1α/HIF2α alter the expression of some other protein that then permits
the recruitment of DNMT1 to the *SPRY2* promoter.
Since HIF1α/HIF2α recruit DNMT1 to the *SPRY2* promoter and first intron, it
would be expected that silencing of DNMT1 would increase SPRY2 mRNA to the same
extent as silencing of HIF1α/HIF2α alone or together with DNMT1. However, in
both Hep3B and HuH7 cells, the silencing of DNMT1 alone elevated SPRY2 mRNA
levels to a significantly lesser extent than when HIF1α/HIF2α and DNMT1 were
silenced simultaneously. These data suggest that other DNMTs may also contribute
toward HIF1α/HIF2α-mediated methylation of the *SPRY2* promoter. Given the large
number of other members of the DNMT family and possible involvement of histone
modifications, the identification of the other mechanisms (besides DNMT1) that
may contribute toward HIF1α/HIF2α- mediated regulation of *SPRY2* promoter
methylation should be the subject of future studies. Notably, the extent to
which DNMT1 silencing alone and in combination with HIF1α/HIF2α elevated Spry2
protein is not significantly different. However, this may be the result of the
semi-quantitative nature of Western blot quantification as compared to the more
rigorous quantitative analyses of mRNA levels by real time PCR.
In the light of this report and our recently published findings, one very
important aspect of the regulatory interactions between HIF1α/HIF2α and Spry2
that emerges is that Spry2 regulates the stability of the HIF1α/HIF2α proteins
and thereby attenuates their ability to alter transcription of the
HIF1α/HIF2α-responsive genes, such as those regulating glucose uptake and
glycolysis that play a critical role in survival of cells in hypoxia.
Conversely, HIF1α/HIF2α by regulating the methylation status of the *SPRY2*
promoter repress expression of *SPRY2* mRNA and protein. Hence, there is a
reciprocal cross talk between the “tumor suppressor”, Spry2, and “tumor
promoters”, HIF1α/HIF2α. However, the extent to which one dominates over the
other may rely on the expression of other pertinent proteins that play a role
e.g. pVHL in terms of HIF1α/HIF2α stability regulation by Spry2 and forms of
DNMT that facilitate HIF1α/HIF2α-mediated alterations in *SPRY2* promoter
methylation. These elements may account for the differences in the extent to
which SPRY2 mRNA is elevated upon silencing of HIF1α/HIF2α or DNMT1 in Hep3B and
HuH7 cells Nevertheless, the cross-regulation between Spry2 and HIF1α/HIF2α
would allow equilibrium to be reached so that one protein does not overly
regulate the other to alter biological outcomes. This scenario would be
beneficial in normal development and one could envisage this cross talk to
regulate growth of tumors to some extent. In this context, Lee et al. reported
that in HuH7 and Hep3B cells cultured in normoxia the *SPRY2* gene is not
methylated. This would be expected since in normoxia HIF1α/HIF2α levels are low
and, therefore, would not facilitate the recruitment of DNMT1 to the *SPRY2*
promoter. Extending this to tumors, it would be expected that in the hypoxic
zones of tumors, elevated HIF1α/HIF2α protein levels would methylate the SPRY2
promoter and first intron to a greater extent than in normoxic areas of the
tumors. Although the stability of the Spry2 protein is enhanced in hypoxia, over
time the decreased transcription of the SPRY2 gene in hypoxic regions of tumors
would be expected to decrease the protein levels of Spry2, diminish “tumor
suppressor” actions of Spry2, and reduce the ability of Spry2 to oppose the
“tumor promoting” actions of HIF1α/HIF2α. Hence, targeting HIF1α and HIF2α in
tumors would not only suppress the “tumor promoting” actions of these
transcription factors but by elevating *SPRY2* gene transcription, elevate Spry2
protein levels and, therefore, the tumor suppressing actions of Spry2.
Interestingly, the HREs in *SPRY2* promoter are conserved in other mammalian
species and the promoters and introns of other human *SPRY* genes (*SPRY1*,
*SPRY3*, *and SPRY4*) also contain putative HREs. Also, SPRY1 and *SPRY4*
promoters have been reported to be methylated. Likewise, a previous study showed
that SPRY4 mRNA levels are increased in hypoxia, while conflicting studies,
perhaps due to cell type, showed SPRY1 mRNA levels either increased or decreased
by hypoxia. In Hep3B cells, we observed that Spry1 protein levels were increased
while Spry4 protein levels were decreased when HIF1α and HIF2α were silenced
(data not shown); Spry3 levels were undetectable in Hep3B cells (not shown).
Thus, it is tempting to speculate that *SPRY1* gene is also regulated by
HIF1α/HIF2α via mechanisms described in this report for *SPRY2*. On the other
hand, *SPRY4* may be regulated by HIF1α and HIF2α in an opposing manner to
*SPRY2* by an as yet to be identified mechanism. *SPRY3* promoter does not
contain CpG islands and is not methylated and is probably not regulated by
HIF1α/HIF2α via a methylation-dependent mechanism.
Overall, our findings described here unveil a new mechanism by which *SPRY2*
gene expression is regulated by HIF1α/HIF2α. By binding to regions of the
proximal promoter and first intron of *SPRY2*, HIF1α and HIF2α increase the
methylation of the *SPRY2* promoter. We identified DNMT1 as a contributor toward
this process as silencing or inhibiting DNMT1 attenuated HIF1α/HIF2α silencing
mediated elevations in *SPRY2* mRNA and protein. These findings demonstrate that
HIF1α/HIF2α, by repressing the expression of Spry2, can decrease the anti-
tumorigenic actions of Spry2 protein.
# Experiment procedures
## Reagents and antibodies
Actinomycin D was purchased from Calbiochem, and decitabine or
5-aza-2’-deoxycytidine (also called dacogen, DAC) was from Cayman Chemical.
Laccaic acid A (LCA) was obtained from TCI America.
All siRNAs and PCR primers, including general PCR primers, real time PCR primers
and primers for methylation specific and non-methylation specific PCR, were
synthesized by Integrated DNA Technologies Inc. The sequences of the primers are
listed in.
Antibodies used for Western blotting and chromatin immunoprecipitation were from
the following companies: Sprouty2 (against N-terminus, Sigma), HIF1α (BD
Transduction Laboratories), HIF2α (R&D Systems), HIF1β (Santa Cruz
Biotechnology), and DNMT1 (AbCam).
## Plasmids
Human full-length HIF1α is PCR amplified with primers carrying HindIII and NotI
sites from HIF1α cDNA clone (OriGene Technologies, Inc.) and inserted in pcDNA3
at HindIII and NotI sites. HIF2α is PCR amplified with primers harboring BamHI
and NotI sites from pOTB7-HIF2α (Thermo Scientific.) and inserted in pcDNA3 at
the corresponding sites. Plasmid pcDNA3-HIF1β was kindly provided by Dr. Guo-
Qiang Chen (Shanghai Jiaotong University, China). Plasmid pGL2-Pfkfb3/-3566 was
kindly provided by Dr. Ramon Bartrons, University of Barcelona.
## Cell culture, hypoxia and treatments
Hep3B and HuH7 cells were obtained from Dr. Basabi Rana, University of Illinois,
Chicago. HEK293T were incubated in DMEM supplemented with 10% FBS, penicillin
(100 units/mL), and streptomycin (100μg/mL). Hep3B cells were incubated in MEM
supplemented with non-essential amino acids, sodium pyruvate and HEPES in
addition to 10% FBS, penicillin (100 units/mL), and streptomycin (100μg/mL).
HuH7 cells were incubated in DMEM F12 1:1 supplemented with HEPES, 10% FBS,
penicillin (100 units/mL), and streptomycin (100 μg/mL). For normoxic
conditions, cells were maintained at ambient O<sub>2</sub> levels (21%
O<sub>2</sub>) and 5% CO<sub>2</sub> at 37°C. For hypoxic conditions, cells were
maintained at 3% O<sub>2</sub> and 5% CO<sub>2</sub> in a Coy Hypoxic Chamber
(Grass Lake, Michigan) at 37°C. All media used for hypoxia experiments were pre-
equilibrated under hypoxic conditions overnight before use.
To examine whether HIFs alter *SPRY2* mRNA stability, Hep3B cells treated with
3μg/mL actinomycin D after siRNA transfection and 24 h hypoxic exposure were
lysed at the indicated times with Trizol for RNA extraction. To investigate the
involvement of DNA methylation in the regulation of *SPRY2* mRNA expression by
HIFs, Hep3B cells were incubated with DNA methylation inhibitors, decitabine
(DAC) at 5μM or laccaic acid A (LCA) at 50 μg/mL, for 24 h the day after cells
were plated. Subsequently, cells were transfected with siRNAs in fresh medium
containing DAC or LCA and then maintained under hypoxia for another 24 h before
use.
## Overexpression of HIF1α and HIF2α
HEK293T cells were seeded in 3.5-cm dishes at 2 x 10<sup>5</sup> /dish and
transfected next day with 250 ng each of pcDNA3-HIF1β, pcDNA3-HIF1α and/or
pcDNA3-HIF2α as indicated using Transit2020 transfection reagent (Mirus)
following the manufacturer’s instructions. The total amount of plasmids
transfected into each dish was kept the same by adding empty vector pcDNA3.
Cells were incubated under normoxic condition for 40 h after transfection before
RNA extraction.
### Silencing with siRNAs
Hep3B cells were plated in 3.5-cm dishes at 3 x 10<sup>5</sup> /dish or HuH7
cells were plated in 3.5-cm dishes at 2 x 10<sup>5</sup>/dish. Next day, cells
were transfected with mutant siRNA or siRNAs against HIF1α, HIF2α or both at 20
nM each or for the experiments in, cells were transfected with mutant, HIF1α and
HIF2α, DNMT1 alone, or HIF1α and HIF2α and DNMT1 siRNAs (20nM each) with TKO
transfection reagent (Mirus). After overnight transfection, cells were incubated
in the hypoxic chamber for 24 h (for mRNA detection) or 32 h (for Western
blotting). The sequences of siRNAs are: mutant siRNA, sense `5'-GUC AGC AGA ACA
AAA GUA GTT-3'` and antisense `5'-CUA CUU UUG GUU CUG CUG ACT T-3'`; HIF1α,
sense `5’-GAA GGA ACC UGA UGC UUU AAC UUT G-3’` and antisense `5’-CAA AGU UAA
AGC AUC AGG UUC CUU CUU-3’`; HIF2α, sense `5'-GCU GGA GUA UGA AGA GCA AGC CUT
C-3'` and antisense `5'-GAA GGC UUG CUC UUC AUA CUC CAG CUG-3'`.
## RNA isolation and real time PCR
Total RNA was isolated with Trizol reagent following the manufacturer’s protocol
(Invitrogen). The extracted total RNA (500 ng) was then converted to cDNA with
SuperScript VILO cDNA synthesis kit (Invitrogen) according to manufacturer’s
instructions. To detect mRNA amounts for *HIF1α*, *HIF2α*, *SPRY2* and *PGK1*,
real time PCR was performed with specific primers and probes and FastStart
Universal Probe Master Mix (Roche Life Science) using the CFX96 real-time PCR
detection system (Bio-Rad). PCR conditions were optimized for the primers/probe
for each gene. The mRNA amounts of each gene were normalized with 18S rRNA.
## Chromatin Immunoprecipitation (ChIP)
Hep3B cells were plated at 5 x 10<sup>5</sup> /dish in 6-cm dishes. Next day,
cells were transfected with siRNAs as stated above. An extra dish of cells were
transfected in parallel with siRNA and trypsinized for cell counting before use.
After a 32 h hypoxic incubation (3% O<sub>2</sub>), cells were crosslinked with
1% formaldehyde for 10 min at room temperature. The crosslinking reactions were
terminated by incubating in 0.125 M glycine for 5 min at room temp. The cells
were washed twice with cold PBS, scraped into cold PBS containing protease
inhibitors (1 μg/mL aprotinin and 1 μg/mL pepstatin, 2 μg/mL leupeptin and 1 mM
phenylmethylsulfonyl fluoride) and pelleted by centrifugation at 2000 rpm for 5
min. The cell pellet was resuspended in SDS lysis buffer (1% SDS, 10 mM EDTA, 50
mM Tris-HCl, pH 8.0) containing the above protease inhibitors (200 ml/1 x
10<sup>6</sup>) and incubated for 10 min on ice. The cell lysate was sonicated
to shear DNA followed by centrifugation to remove pellet. The supernatant was
diluted 10 times with dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl plus the above protease inhibitors)
and pre-cleared with salmon sperm DNA/protein G beads. The cleared supernatant
(from 1 x 10<sup>6</sup> cells) was incubated with 2.5μg anti-HIF1β antibody or
rabbit IgG overnight at 4°C and immunoprecipitated with 25 μL protein G agarose
beads the next day. For ChIP with anti-DNMT1 antibody, 1.5 x 10<sup>6</sup>
cells were used per ChIP and mouse IgG was used as control antibody. The
immunoprecipitates were washed sequentially with the following buffers: low salt
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.0, 150 mM
NaCl), high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH
8.0, 500 mM NaCl), LiCl wash buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1% Sodium
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.0), and TE (10 mM Tris-HCl, 1 mM
EDTA). DNA was then eluted with elution buffer (1% SDS, 0.1 M NaHCO<sub>3</sub>)
and the crosslinking was reversed by adding 20 μl 5 M NaCl and incubated at 65°C
overnight. After purification with PCR purification kit (Qiagen), the amount of
DNA that was immunoprecipitated with a specific protein was quantified by real
time PCR using the indicated primers (locations are shown in Figs) and SYBR
master mix (Roche Life Sciences). The results are presented as % enrichment (%
of the input DNA was immunoprecipitated with the indicated antibody).
## Methylation-specific PCR
Genomic DNA was extracted from Hep3B cells using the DNeasy tissue extraction
kit (Qiagen) following the manufacturer’s instructions. Subsequently, 0.5–1.0 μg
of DNA from each sample was used for bisulphite conversion using the EpiTect
fast bisulfite conversion kit (Qiagen). The converted DNA was then purified with
the same kit from Qiagen. DNA methylation status of the *SPRY2* gene was
examined by PCR employing two sets of primers that match the same sites with one
specific for methylated (M) and the other for unmethylated (U) sequences. The
sequences of primers are listed in. Two rounds of PCR amplification were
performed to detect the methylation status using FastStart PCR master kit (Roche
Life sciences). The first round PCR amplification conditions used were one cycle
of 95°C for 4 min followed by 25 cycles of 95°C for 30 s, 55°C for 30 s, 72°C
for 60 s. The resultant PCR product was diluted 20 times and used as template
for the second round PCR amplification, which employed the nested forward
primers (n) and the same reverse primers as in the first round PCR. The PCR
conditions used were one cycle of 95°C for 4 min followed by 35 cycles of 95°C
for 30 s, 60°C for 30 s, 72°C for 60 s. The PCR products were loaded into
agarose gels and the DNA methylation status was quantified by densitometry of
the bands and normalized with beta-actin.
## Statistical analysis
One-way ANOVA was employed for multiple-group comparisons using GraphPad 6
software. For two-group comparison, Student’s t test was performed.
# Supporting information
We thank Dr. Basabi Rana, University of Illinois, Chicago, for providing us with
the Hep3B and HuH7 cells used in this study. We would also like to thank Dr.
Nancy Zelenik-Le, Molecular Biology Program, Loyola University Chicago for
advice on performing ChIP assays. We are also grateful to Dr. Guo-Qiang Chen,
Shanghai Jiaotong University, China and Dr. Ramon Bartrons, University of
Barcelona, Spain for kindly providing the plasmids pcDNA3-HIF1β and
pGL2-Pfkfb3/-3566, respectively.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** KH XG TP. **Data curation:** KH XG PN TP.
**Formal analysis:** KH XG TP. **Funding acquisition:** TP.
**Investigation:** KH XG PN. **Methodology:** KH XG. **Project
administration:** KH XG TP. **Resources:** TP. **Supervision:** TP.
**Validation:** KH XG PN TP. **Visualization:** KH XG. **Writing – original
draft:** KH XG TP. **Writing – review & editing:** KH XG PN TP.
|
# Introduction
*Staphylococcus aureus* is a versatile gram-positive pathogen capable of causing
a wide range of diseases, ranging from superficial abscesses to pneumonia,
endocarditis, and sepsis. In the pre-antibiotic era, serious systemic
staphylococcal infection was associated with 80% mortality. When penicillin was
introduced in 1944, over 94% of *S. aureus* isolates were susceptible. However
by 1950, 50% of *S. aureus* isolates were penicillin-resistant, further
demonstrating the remarkable ability of *S. aureus* to rapidly adapt to
antibiotic pressure.
In 1960, outbreaks of virulent *S. aureus* that were resistant to penicillin
occurred in many hospitals. These could be treated successfully with methicillin
and other newly available penicillinase-stable penicillins. However, by 1961,
two years after the introduction of methicillin, methicillin-resistant
*Staphylococcus aureus* (MRSA) had emerged. Since then, a number of distinct
MRSA strains have emerged and spread throughout the world. MRSA, in addition to
an intrinsic resistance to virtually all β-lactams, has an ability to accumulate
and develop resistance to other, unrelated antibiotics. Some variants of MRSA
have developed resistance to glycopeptide antibiotics, including vancomycin,
which is the sole antibiotic that can still be used to successfully treat most
*S. aureus*.
*S. aureus* resistance to methcillin has been attributed to the acquisition of
the *mecA* gene, which encodes a penicillin-binding protein (PBP) that is
resistance to β-lactam inactivation, namely PBP2a; the four native PBPs of *S.
aureus* are sensitive to β-lactams. Despite the efficiency with which expression
of PBP2a confers resistance to β-lactams, the PBP2a expression level does not
correlate with high levels of methicillin resistance. Other factors are
suggested to play essential roles in the phenotypic expression of methicillin
resistance. Screening for methicillin-resistance factors has resulted in the
identification of auxiliary genes including *fem, fmtA, llm*, sigma factor,
*pbpD,* and *vraSR*. These genes reside outside the *mecA* determinants and have
been shown to have direct or indirect roles in the biosynthesis or autolysis of
peptidoglycan. The *fem* genes are involved in the biosynthesis of the peptide
core of the peptidoglycan precursor subunit – and *pbpD*, which encodes PBP4 and
is involved in the synthesis of highly cross-linked peptidoglycan.
Genome-based studies of the *S. aureus* response to cell wall-specific
antibiotics identified *fmtA* as being part of the core cell wall stimulon. The
expression level of *fmtA* increases in the presence of cell wall inhibitors and
when genes involved in biosynthesis of peptidoglycan are inactivated. Insertions
in *fmtA* reduce MICs of methicillin, cefoxitin and imipenem 8 to 16 fold for
different MRSA strains. This effect is more pronounced in the presence of Triton
X-100. Insertions in *fmtA* also impair polysaccharide intercellular adhesion
production and result in significantly reduced biofilm formation. Furthermore,
the *fmtA* mutants exhibit reduced peptidoglycan cross-linking and reduced
attachment of wall teichoic acids to cell wall. The *fmtA* gene product (FmtA)
is capable of forming stable acyl-enzyme species with β-lactams, but the
interaction is weak.
Upregulation of the *fmtA* expression by perturbation of peptidoglycan
biosynthesis suggests presence of a regulatory mechanism capable of coordinating
*fmtA* expression with cell wall biosynthesis. Here, we investigate the factors
involved in regulation of *fmtA*.
In this study, we identified SarA as a transcription factor responsible for
regulation of *fmtA*. SarA is a global regulator of *S. aureus* involved in the
regulation of many virulence factors and was previously reported to be involved
in methicillin resistance. We report the DNA-binding sites of SarA in the *fmtA*
promoter. The binding specificity of SarA to *fmtA* promoter region was probed
by mutating a key functional residue of SarA (Arg90). In addition, *fmtA*-*lux*
operon reporter constructs were used to investigate the regulation of *fmtA*
expression *in vivo* in response to antibiotic stress. The activation of *fmtA*
transcription by SarA was confirmed by *in vitro* run-off transcription assays.
Together, our results show that SarA binds directly to the *fmtA* promoter and
plays a direct role in the regulation of *fmtA* expression.
# Materials and Methods
## Growth Media and Chemicals
Chemicals were purchased from Sigma (Oakville, Canada) or Thermo-Fisher (Whitby,
Canada), unless otherwise stated. Chromatography media and columns were
purchased from GE Healthcare (Quebec, Canada). The growth media was purchased
from Fisher. *Escherichia coli* Nova Blue and BL21(DE3) strains, as well as
cloning and expression plasmids were purchased from EMD4 Biosciences (New
Jersey, USA). Restriction enzymes were obtained from New England Biolabs Canada
(Pickering, Canada) or Thermo-Fisher. All primers, including biotinylated
primers, were purchased from Sigma (Oakville, Canada). The \[γ-<sup>32</sup>P\]
ATP (3000 Ci/mmol) was purchased from Perkin Elmer LAS Canada Inc. (Toronto,
Canada) or GE Healthcare (Quebec, Canada). The ProteoExtract All-in-One Trypsin
Digestion Kit was purchased from EMD4 Bioscience.
## Preparation of Cell Extracts
*S. aureus* strain RN4220 (Cedarlane, Burlington, Canada) was grown to an
optical density (OD) at 600 nm of approximately 0.9 in tryptic soy broth with or
without oxacillin (1.2 µg/mL) and incubated for 1.5 h at 37°C. The cells were
harvested at 4°C (11,000×*g*) and washed with cold TEG buffer (25 mM Tris-HCl,
pH 8.0, and 5 mM EGTA) and re-suspended in TEG buffer. After two freeze-thaw
cycles, cells were lysed with lysostaphin (0.3 mg/mL) followed by sonication.
Lysates were centrifuged at 4°C (21,000×*g*) and 20% glycerol was added to the
supernatants. The supernatants were dialyzed overnight in 1 L dialysis buffer
(10 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 mM DTT, 50 mM NaCl, and 20% (v/v)
glycerol).
## Electro-mobility Shift Assay (EMSA)
The predicted promoter region of *fmtA* (P*fmtA*) lying between the open reading
frames (orf) denoted SAV1056 and *fmtA*, encompassing 540 bp, was divided into
three DNA fragments of 270 bp, each designated *seq1*, *seq2,* or *seq3*. The
*seq1*, *seq2,* and *seq3* fragments were amplified from the *S. aureus* Mu50
genome (Cedarlane) using primers as follows: *seq1* (−342 to −70; the numbering
of the upstream and downstream elements in the *fmtA* promoter is based on a
putative transcription starting point) was amplified using Dir<sub>seq1</sub>
and Rev<sub>seq1</sub>, *seq2* (−70 to +199) with Dir<sub>seq2</sub> and
Rev<sub>seq2</sub>, and s*eq3* (−207 to +63) with Dir<sub>seq3</sub> and
Rev<sub>seq3</sub>. The PCR amplified fragments were gel-purified, 5′-end
labeled with \[γ-<sup>32</sup>P\]ATP (3000 Ci/mmol) using T4 polynucleotide
kinase, and purified by passage through ProbeQuant G-50 columns (GE Healthcare).
Binding reactions were performed by mixing oxacillin-induced or uninduced cell
extracts with 2 ng 5′-\[<sup>32</sup>P\]-labeled double-stranded DNA fragments
in the presence of 1 µg poly (dI-dC) and 200 ng sheared herring sperm DNA for 30
min in 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM dithiothreitol (DTT), 5 mM
MgCl<sub>2</sub>, and 2.5% (v/v) glycerol. The reaction mixtures were loaded
into 6% native polyacrylamide gels. Following electrophoresis, gels were dried
and imaged using an electronic radiography instant imager (Packard).
Quantitative analysis of the bands was performed using ImageJ (v 1.3, NIH).
Dissociation constants were determined as the protein concentration that
resulted in 50% bound DNA. The results were obtained from three independent
binding experiments. To ascertain which region of *fmtA* promoter is important
for binding to the SarA transcription factor, two additional DNA fragments were
generated from the *fmtA* promoter region. These sequences, referred here in as
*seqA* (−207 to −70) and *seqB* (−70 to +63), were amplified by PCR using
specific primers pairs seqADir and seqARev for *seqA*, and seqBDir and seqBRev
for *seqB*. Target DNA (2 ng) was mixed with purified SarA at concentrations
varying from 1 nM to 1.8 µM in binding reactions for EMSA as described above for
the cell extracts.
## Screening Protocol for Isolation of Regulatory Proteins
The P*fmtA* derived sequence *seq3* (−207 to +63) was amplified by using 5′
biotinylated primers and their respective reverse primers. An aliquot of 200 µg
streptavidin-coated magnetic beads (10 µg/µL) (Dynal® Biotech) was washed three
times with 20 µL washing buffer (10 mM Tris-HCl buffer pH 7.5, supplemented with
1 mM EDTA and 2 M NaCl) for 15 min at room temperature. A 40-µL aliquot of the
*seq3* target DNA at 25 ng/µL was incubated with the beads for 15 min. The
supernatant was removed and the beads were washed twice with the washing buffer.
The process of loading target DNA on the beads was repeated two more times, with
a washing step after each loading step. This process ensured 90% loading of the
beads with the target DNA. Prior to incubation with DNA-bound beads, oxacillin-
induced cell extracts were incubated with 200 µg streptavidin-coated beads in
binding buffer (10 mM Tris buffer, pH 7.5, supplemented with 150 mM KCl, 0.1 mM
EDTA, and 0.1 mM DTT) on ice for 30 min. The pre-treated cell extracts (40 µL)
were then incubated with the DNA-loaded beads for 30 min at room temperature in
the presence of 100 ng/µL herring sperm DNA.
Unbound protein was removed from the beads by three washes with 100 µL binding
buffer. The beads were then resuspended in 25 µL water and subjected to trypsin
digestion (EMD4 Biosciences). The samples were analyzed by liquid
chromatography-tandem mass spectrometry (LC-MS-MS) at the Advanced Protein
Technology Centre of Hospital for Sick Children (Toronto, Canada).
Alternatively, the beads were resuspended in 25 µL water, mixed with 0.5 µL 10%
sodium dodecyl sulfate (SDS) and boiled for 5 min. The supernatant was loaded
into SDS-polyacrylamide gels.
## Cloning of *sarA*
The 375 bp *sarA* coding region was amplified from *S. aureus* strain MRSA252 by
PCR using primers SarADir and SarARev which incorporate *Nde*I and *Hind*III
restriction enzyme sites at the 5′-end and 3′-end respectively. The amplicon was
digested with *Nde*I and *Hind*III and cloned into vector pET22b digested with
*Msc*I and *Hind*III. The resulting plasmid was digested with *Nde*I (to remove
the *pelB* leader sequence between the *Nde*I site of pET22b and the *sarA*
gene), re-ligated, and transformed into *E. coli* NovaBlue cells. The
pET22b::*sarA* construct was confirmed by sequence analysis, and transformed
into *E. coli* BL21(DE3) cells.
## Site-directed Mutagenesis of Arg90 to Ala in SarA
The Arg90 residue of SarA was mutated to Ala using the QuickChange™ Site-
Directed Mutagenesis protocol (Agilent, Mississauga, Canada). The recombinant
DNA construct pET22b::*sarA*R90A was generated using pET22b::*sarA* as template,
*Pfu* Turbo™ DNA polymerase (Agilent) and two mutagenic primers: SarAMDir and
SarAMRev. The PCR product was treated with restriction endonuclease *Dpn*I and
the resulting mixture was used to transform *E. coli* NovaBlue cells. Successful
mutation of arginine to alanine was verified by DNA sequencing and the
pET22b::*sarA*R90A plasmid was used to transform *E. coli* BL21(DE3) cells.
## Purification of SarA and SarAR90A Mutant Proteins
All steps of purification were carried out at 4°C. Seed cultures in BL21(DE3)
cells were grown overnight in Luria-Bertani media (Thermo-Fisher). A 1% starter
culture was used to inoculate 1 L Terrific Broth (TB), supplemented with 100
µg/mL ampicillin. The culture was grown at 37°C with shaking until the
OD<sub>600 nm</sub> reached 0.7. SarA expression was initiated by adding 1 mM
isopropyl-1-thio-β-D-galactopyranoside (IPTG; Rose Scientific, Edmonton,
Canada). The induced cells were harvested and resuspended in 50 mM sodium
phosphate buffer (pH 6.8). The protein was liberated by sonication and cellular
debris removed by centrifugation at 20,000×*g* for 60 min. The clarified
supernatant was loaded onto a SP-Sepharose FF column and the protein was eluted
with a linear gradient of 1.0 M NaCl in 50 mM sodium phosphate buffer (pH 6.8).
The fractions containing protein were concentrated and the buffer was changed to
20 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 1 mM DTT using a HiPrep desalting column
(26/10, GE Healthcare). The protein mixture solution was then loaded to a
Heparin Sepharose 6FF column (26/10, GE Healthcare). The protein was eluted with
a linear gradient of 1.5 M NaCl. The fractions containing protein were
concentrated and loaded onto a Superdex<sup>TM</sup>75 (10/300 GL) column (GE
Healthcare) equilibrated with 50 mM sodium phosphate buffer (pH7.0). Following
elution by the same buffer, the protein-containing fractions were analyzed by
15% SDS-polyacrylamide gel electrophoresis (PAGE). The molecular mass of the
purified SarA and SarAR90A mutant were confirmed by electrospray ionization mass
spectrometry in the Advanced Protein Technology Centre of Hospital for Sick
Children (Toronto, Canada).
The oligomerization state of SarA was determined by size exclusion
chromatrography using a gel filtration LMW calibration kit from GE Healthcare
and Superdex<sup>TM</sup>75 (10/300) column (GE Healthcare). The column was
equilibrated and run with 50 mM sodium phosphate buffer (pH 7.0) at a flow rate
of 0.4 mL/min.
## DNase I Footprinting Assay
The *seqA* and *seqB* promoter sequences were amplified by PCR from the *S.
aureus* Mu50 genome using specific primers. The primer of interest (Dir or Rev)
was 5′–end labeled with \[γ-<sup>32</sup>P\] ATP (3000 Ci/mmol). Binding
reactions were performed as described above for the EMSA, but with 8 ng DNA.
Binding reactions were incubated for 30 min at 37°C and then subjected to DNaseI
(0.024 units) for 2 min at 25°C after supplementing binding buffer with 10 mM
CaCl<sub>2</sub> and 5 mM MgCl<sub>2</sub>. The reaction was terminated by
adding stop solution (200 mM NaCl, 1% (w/v) SDS, 20 mM EDTA, and 250 µg/mL
tRNA). The digested DNA samples were extracted with phenol:chloroform and
ethanol precipitated. They were then resuspended in formamide containing loading
dye, denatured at 95°C and loaded onto 8% sequencing gel. The control A, T, C,
and G were prepared by using Therminator DNA polymerase (New England Biolabs
Canada) and a set of acyclonuleotides (acyATP, acyCTP, acyGTP, and acyTTP; New
England Biolabs Canada). Four separate reactions (one for each acyNTP
terminator) generated DNA sequencing termination ladders. Reactions contained
template DNA, 50 nM \[γ-<sup>32</sup>P\] ATP labeled sequencing primer, 50 nM
dNTP, 20 mM Tris–HCl, pH 8.8 at 25°C, 10 mM KCl, 2 mM MgSO<sub>4</sub>, 10 mM
(NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 0.1% Triton X-100, and 0.1 U/µL of
*E. coli* RNA polymerase haloenzyme (Epicentre Biotechnologies, Madison,
Wisconsin).
## *In vitro* Run-off Transcription Assay
Single round transcription by *E. coli* RNA polymerase holoenzyme (RNAP;
Epicentre Biotechnologies, Madision, Wisconsin) was carried out using a 580-bp
fragment of the *fmtA* promoter region (P*<sub>fmtA</sub>*<sub>,</sub>
nucleotide position −342 to +239 of *fmtA* promoter region) as template, in the
absence or presence of SarA. The P*<sub>fmtA</sub>* fragment was amplified using
*pfu* Turbo DNA polymerase and primers Dir-P*<sub>fmtA</sub>*,
(5′-GAGAACCAATGCTAGAAGGATCAA-3′) and Rev-P*<sub>fmtA</sub>*
(5′-TCGATGAAAAATTAACGCTATAGAAA-3′). The *in vitro* transcription reactions were
performed as described previously with some modifications. The DNA template (5
nM) was incubated with SarA (0.1 and 0.6 µM) in transcription buffer (40 mM
Tris, pH 7.5, 150 mM KCl, 10 mM MgCl<sub>2</sub>, 2 mM DTT, 100 µg/mL BSA, and
0.05% Triton X-100) for 20 min at 30°C. One unit of *E. coli* RNAP (0.5 µg) was
added to each reaction mixture and the reactions were incubated for another 20
min at 30°C. A control reaction containing only RNAP was prepared similarly.
Transcription was initiated by adding 3 µL NTP mix containing 1 mM ATP, 1 mM
CTP, 1 mM GTP, 100 µM UTP, 2 µCi of \[α- <sup>32</sup>P\]-UTP, 600 µg/µL
heparin, and 40 U/µL Murine RNase inhibitor. The reactions were placed at 30°C
for 20 min. The reactions were terminated by addition of 5 µL transcription stop
buffer (20 mM EDTA, 1% SDS, 1 mg/ml bromophenol blue, 1 mg/ml xylene cyanol, and
90% formamide). The samples were heated at 90°C for 5 min and immediately loaded
onto an 8% polyacrylamide gel containing 7 M urea. The φX174 DNA/*HinfI*
dephosphorylated DNA fragments (Promega), labeled with \[γ-<sup>32</sup>P\] ATP
(3000 Ci/mmol), were used as a molecular weight marker. The gels were dried and
exposed on phosphor screen and visualized using a Typhoon Trio<sup>+</sup>
Variable Mode Imager (GE Healthcare).
A transcription start point in *fmtA* promoter was identified the T residue
located at the 156<sup>th</sup> nucleotides upstream of the *fmtA* start codon.
A −10 box sequence of 5′-TATAAT-3′ sequence is present relative to that start
site, which is identical to the −10 sequence recognized by the *E. coli*
σ<sup>70</sup> RNAP. To investigate the role of the proposed transcription
initiation elements, we designed two mutations in the *fmtA* promoter sequence
and assessed their role in transcription by transcription run-offs experiments.
In the mutant P*<sub>fmtA</sub>*<sub>T1G</sub>, we replaced the proposed
transcription start site T (+1) with a G residue. In the
P*<sub>fmtA</sub>*<sub>T14G</sub> mutant promoter, we substituted the T at −14
with a G residue because this T/A pair at the beginning of the - 10 consensus
sequence is critical in interactions with RNAP. To accomplish the mutagenesis,
we cloned P*<sub>fmtA</sub>* sequence into the pSTBlue vector (Invivogen). The
mutagenic primers are presented in.
## Construction of *luxABCDE* Fusion Strains with Derivatives of *fmtA* Promoter Region
The three P*fmtA-*derived sequences (*seq1, seq2* and *seq3*) were amplified by
PCR from *fmtA* operon using specific primer pairs designed to introduce *Eco*RI
and *Bam*HI restriction sites at the 5′ and 3′ ends, respectively. The predicted
full length *fmtA* control region encompassing nucleotides −342 to +199
(referred to as *seq1–2*) was also amplified using primers DirP<sub>seq1</sub>
and RevP<sub>seq2</sub>. All four DNA fragments, P<sub>seq1,</sub>
P<sub>seq2,</sub> P<sub>seq3,</sub> and P<sub>seq1–2</sub>, were PCR amplified
and digested using restriction enzymes *Eco*RI and *Bam*HI. The DNA fragments
were ligated to similarly digested vector pXEN1. pXEN1 harbors the *luxABCDE*
operon from *Photorhabdus luminescens* that has been modified for *lux*
expression in Gram positive bacteria. The ligation mix was transformed into *E*.
*coli* DH5α and transformants were selected on medium containing ampicillin (100
µg/mL). Putative clones obtained were confirmed to harbor the inserts by
sequence analysis using a primer derived from *luxA* and the forward primer used
to amplify the insert fragment. The pXEN1 plasmids carrying different inserts
are referred to as *lux* fusion plasmids.
The pXEN1 plasmid and *lux* fusion plasmids were introduced into the
restriction-deficient *S. aureus* strain RN4220 by electroporation (26).
Transformants were plated on tryptic soy broth (TSB)-agar plates supplemented
with 5 µg/mL chloramphenicol (selectable marker in pXEN1). Positive colonies
were confirmed by sequencing of the plasmids using the primers described above.
The *S. aureus* strain RN4220 carrying pXEN1 is referred to as RN(::*lux*), and
RN4220 strains carrying the pXEN1 fusion plasmids, constructed herein, are
referred to as *lux* fusion strains RN(P<sub>seq1</sub>::*lux*), RN
(P<sub>seq2</sub>::*lux*), RN(P<sub>seq3</sub>::*lux*), and
RN(P<sub>seq1–2</sub>::*lux*).
In *S. aureus* PC1839 (parent strain *S. aureus* RN4220), the *sarA* gene has
been knocked out and replaced with a kanamycin resistance cassette. PC1839 was
transformed with the *lux* promoter constructs P<sub>seq1,</sub>
P<sub>seq2,</sub> P<sub>seq3,</sub> P<sub>seq1–2</sub>, and pXEN1 isolated from
strain RN4220. The resultant colonies were resistant to kanamycin and
chloramphenicol. The *S. aureus* strain PC1839 carrying the empty vector pXEN1
is referred to as PC(::*lux*), and PC1839 strains carrying the pXEN1 fusion
plasmids are referred to as *lux* fusion strains PC(P<sub>seq1</sub>::*lux*),
PC(P<sub>seq2</sub>::*lux*), PC(P<sub>seq3</sub>::*lux*), and PC
(P<sub>seq1–2</sub>::*lux*). The effect of pXEN1 and *lux* fusion plasmids on
the growth of *S. aureus* RN4220 and PC1839 fusion strains was investigated by
monitoring the growth profiles. Briefly, *lux* fusion strains RN(::*lux*),
PC(*::lux*), RN4220, and PC1839 were inoculated into TSB and grown overnight at
37°C with 5 µg/mL chloramphenicol, except for RN4220 and PC1839. Next, 1%
culture was inoculated in fresh TSB supplemented with 5 µg/mL chloramphenicol
for the *lux* fusion strains except for RN4220 and PC1839. Then the OD(<sub>600
nm</sub>) was measured at 1 h intervals for the next 7 h.
## Measuring Bioluminescence from *S. aureus* Strains
After overnight growth, RN4220, PC1839, RN(::*lux*), and PC(::*lux*), were
diluted into fresh TSB and grown at 37°C with shaking at 200 rpm. The strains
were grown to an OD<sub>600 nm</sub> of approximately 0.3 and induced with
oxacillin at 10 µg/mL or 100 µg/mL for 1 h. The optical densities were measured
at 600 nm for all the samples. The cultures with higher OD(<sub>600 nm</sub>)
were diluted such that the cell density in each culture was the same. A 300-µL
aliquot from each sample (in triplicates) was transferred to opaque 96-well
optiplates and analyzed in a HT-Analyst (Molecular Devices, California).
Bioluminescence was measured immediately after dispensing the samples into the
plates over a period of 10 min. The data points collected over 10 min were
averaged for each strain at each oxacillin concentration, and the standard
deviations were determined from three independent measurements. The promoter
activity was plotted as luminescence over time using the mean values from the
readings taken over a period of 10 min calculated by subtracting values from
blank medium controls. These experiments were repeated three times.
## Viability Testing of the Induced Versus Uninduced Cultures
Cultures of RN4220, PC1839, RN(::*lux*), and PC(::*lux*) were inoculated at
1∶100 with an overnight culture into TSB with chloramphenicol (no antibiotic was
added to RN4220 and PC1839). When the OD<sub>600 nm</sub> of the cultures
reached approximately 0.3, oxacillin was added to a final concentration of 10 or
100 µg/mL, and the cultures were grown for 1 more hour. The OD of each culture
was normalized to the sample having the lowest OD. A 20-µL aliquot from each
culture was diluted 5000-fold with TSB to dilute the antibiotic, and a 50-µL
aliquot of the dilution was plated on TSB-agar plates without antibiotic and
incubated at 37°C. These experiments were repeated three times.
## RNA Extraction and c-DNA Synthesis
Overnight-grown wild-type *S. aureus* RN4220 and PC1839 were diluted (200-fold)
separately in 30 mL tryptic soy broth (TSB) in 125-mL Erlenmeyer flask. Cultures
were incubated at 37°C with shaking at 200 rpm and growth was measured at
regular intervals until the optical density (OD<sub>600</sub> nm) reached to
early-exponential phase (∼0.4). Cultures were then distributed in 2 flasks (10
mL each), where one culture flask was used as control, and other was treated
with 10 µg/mL of oxacillin for 15- and 60-min. Control cultures were incubated
along with the treated culture for 15-min and 60-min. Aliquots of 2 mL cultures
from each flask were taken, and mixed with 4 mL of bacterial RNA Protect
solution (Qiagen, Valencia, CA). The mixtures were further vortex briefly for 5
s and incubated for 5 min at room temperature, followed with centrifugation at
5000×*g* for 20 min in a swinging-bucket rotor centrifuge to collect the cells.
Cells were washed with fresh TSB and used for isolation of RNA.
Cells were further suspended in 200 µL of TE (30 mM Tris-HCl; 1 mM EDTA, pH 8.0)
buffer containing lysostaphin (50 µg/mL), mixed by vortexing for 10 s, and
incubated at room temperature for 10 min on a shaker–incubator. Subsequently, 10
µl Proteinase K (100 µg/mL, solution) was added in the solution and total RNA
was extracted and purified using an RNeasy minikit (Qiagen) following the
manufacturer recommendation for bacterial RNA isolation. For RNA isolation of
both antibiotic treated and untreated cultures, two independent bacterial
cultures were prepared. cDNA was synthesized using a high capacity RNA-to-cDNA
kit (Applied Biosystems, Foster City, CA). RNA concentrations were determined by
absorbance readings at 260 and 280 nm, using a Nanodrop ND-1000 UV
spectrophotometer (Nanodrop Technologies, Wilmington, DE).
## Quantitative Real-time PCR (qRT-PCR)
qRT-PCR was used to characterize the transcript levels in the cells in response
to oxacillin treatment. qRT-PCR was performed with Rotor-Gene Real-Time PCR
Cyclers (Qiagen) using SYBR green technology. RT-PCRs were performed in a 20 µL
reaction volume containing 1 µL of template DNA (25 ng), 1 µL of gene specific
primers (10 µM, Table1), 10.0 µL of Power SYBR green PCR Master Mix (Applied
Biosystems, Foster City, CA) and 8.0 µL of H<sub>2</sub>O. The following PCR
conditions were used: 50°C for 2 min, 95°C for 10 min, 40 cycle of 95°C for 15
s, 60°C for 30 s, 72°C for 30 s and one final extension step of 72°C for 10 min.
The transcript levels of the *fmtA* and *sarA* genes were normalized using the
*16S rRNA* transcript level of *S. aureus* RN4220 as an internal control. Each
gene assay was performed in triplicate. The data analysis was carried out with
Rotor-Gene Q software (Qiagen).
## Determination of MIC
Minimum inhibitory concentration (MIC) assays were performed as follows.
Oxacillin dilutions were made using sterilized water and then aliquotted (1.5
µL) into 96-well plates. An overnight culture of RN4220 and *sarA* mutant were
diluted 1/1000 into fresh TSB medium to give ca. 5×10<sup>5</sup> CFU
mL<sup>−1</sup>, and 150 µL aliquots were added to each well of the 96-well
plate. Plates were incubated at 37°C for ∼18 h. MIC determinations were carried
out on two different times in duplicate.
# Results
## Screening for the Transcription Factor(s) of *fmtA*
We divided the predicted 540 bp *fmtA* promoter region into three DNA fragments
of approximately 270 bp each, referred to as *seq1*, *seq2,* and *seq3*, with
*seq3* overlapping *seq1* and *seq2* at the 5′ and 3′ ends respectively. When
radioactively labeled *seq1*, *seq2,* and *seq3* were incubated with oxacillin-
induced and uninduced cell extracts from *S. aureus* RN4220, electrophoretic
mobility shifts were observed. Presence of oxacillin has a clear effect on the
electrophoretic mobility profile of DNA considering the multitude of non-
specific interactions that these DNA fragments could be subject of. Further,
introduction of unlabeled DNA targets eliminated the mobility shifts of the
labeled target DNA fragments. These observations suggest that the promoter
region of *fmtA* is the target of regulation by transcription factors.
We developed a screening protocol to isolate the transcription factor(s) of
*fmtA*, using biotinylated *seq3* (−207 to +63) immobilized on streptavidin-
coated magnetic beads. These beads when incubated with oxacillin-induced cell
extracts pulled down several proteins that were identified by analyzing LC-MS-MS
data using the MASCOT program and a probability based Mowse score of \>45. The
analyses showed the presence of staphylococcal accessory regulator A (SarA),
pyruvate carboxylase, biotin carboxyl carrier protein of acetyl-CoA carboxylase,
DNA-direct RNA polymerase alpha chain, DNA polymerase I, translation elongation
factor Tu, translation elongation factor G, elongation factor TS, chaperone
protein dnaK, chaperonin GroEL, cell division proteins FtsZ, DNA binding protein
II, putative DNA-binding protein, and 30S ribosomal protein S5.
To confirm that SarA is pulled down by this protocol we incubated the oxacillin-
induced cell extracts with *seq3* and boiled the magnetic beads in SDS-loading
buffer after they were washed twice with washing buffer. Then, we loaded the
supernatant to a 15% SDS-PAGE. The SDS-PAGE was stained by commassie blue, and
the gel in the region of 14 kD was cut and subjected to trypsin digestion and
LC-MS-MS. This process resulted in only one hit, SarA. Seven SarA peptides were
identified, which covered 69% of the protein sequence (79/113 amino acids). We
then focused on the SarA protein, a 14-kD global regulatory protein involved in
regulation of virulence factors, to investigate the transcriptional regulation
mechanism of *fmtA*.
## Purification of SarA and Characterization of its Oligomerization State
SarA belongs to the family of transcription factors called the “wing-helix”
proteins. Full-length SarA gene was cloned, expressed, and purified to
homogeneity. The identity of the protein was confirmed by mass spectrometry. The
observed molecular mass of SarA was 14,635 D (theoretical mass, 14,586 D).
The oligomeric state of SarA was investigated using gel filtration
chromatography. Based on the elution times of four standards, the molecular mass
of SarA was estimated to be 30 kD, which shows that SarA is dimer in our
solution as shown previously, hence we are working with a functional protein.
## SarA Binding to P*fmtA*
To elucidate whether purified SarA binds directly to the P*fmtA* promoter, we
performed EMSA experiments with *seq1*, *seq2*, *seq3*, *seqA* and *seqB*. The
dissociation constant of each DNA sequence was determined as the concentration
of SarA that resulted in 50% DNA bound. We estimated the dissociation constants
of SarA with respect to *seq1*, *seq2*, *seq3*, *seqA*, and *seqB* to be 63±9
nM, 54±12 nM, 66±7 nM, 147±18 nM, and 139±17 nM, respectively. As a control, we
used a 45-bp sequence derived from the promoter region of *agr* that harbors the
SarA binding consensus sequence (underlined), P*agr*:
5′-GTAAATTTT<u>TTTATGTTAAAATATTAAATACAAAT</u>TACATTTAAC-3′ (*47*). The SarA
binding affinity for the P*agr* sequence was about 400 nM.
Supershifts were observed in the EMSA experiments with *seq1*, *seq2*, *seq3*,
*seqA*, *seqB,* and P*agr* at SarA concentrations higher than 300 nM.
Interestingly, in the case of *seq3*, which covers the 3′-end of *seq1* and
5′-end of *seq2*, the supershift starts at 150 nM SarA. This observation
indicates that either there is more than one SarA binding site in these
sequences, which are saturated at higher protein concentrations, or there are
different oligomers of SarA binding to the fragments; SarA is known to form
dimers and dimers of dimers in target promoters and is proposed to oligomerize
at its binding sites (*45*).
## Identification of SarA Binding Sites on P*fmtA* by DNase I Footprinting
Two fragments of P*fmtA* spanning the regions −207 to −70 (*seqA*) and −70 to
+63 (*seqB*) were used to investigate SarA binding to P*fmtA*. The SarA
protection sites on the bottom strand of each sequence are shown in. SarA
provided a protection of the DNA at concentrations higher than 200 nM. A similar
DNase I protection profile was observed on the top strand of each DNA sequence
(data not shown). Alignment of these sequences against the proposed 26 bp SarA
consensus binding site, 5′-ATTTGTATTTAATATTTATATAATTG-3′, revealed that the
SarA-protected sites in P*fmtA* encompass the SarA consensus binding site.
Interestingly, the SarA-protected sites in P*fmtA* also included the 7-bp DNA
sequence 5′-ATTTTAT-3′, recognized by the winged-helix proteins, and also
suggested to be recognized by SarA.
Additional three DNA fragments (obtained through primer annealing) were derived
from the *fmtA* promoter region to investigate the putative SarA binding sites,
referred to as *seqA1*, *seqA2* and *seqB1*. The *seqA1* fragment harbors the
26-bp SarA consensus binding sequence identified in *seqA*, whereby the
nucleotides −186 to −178 were omitted. The *seqA2* fragment harbors two 7-bp
SarA binding sequences and *seqB1* is downstream of the putative transcription
starting point. The SarA binding affinities determined for *seqA1* fragment is
≥1.8 µM (no binding saturation was observed up to 3.6 µM) and 550 nM for *seqA2*
fragment. No SarA binding was observed to *seqB1* at concentrations as high as
1.8 µM SarA. The lower binding affinity for *seqA1* in comparison to P*agr*
could be due to the removal of the four nucleotides however binding of SarA to
*seqA1* suggests that the 26 bp SarA consensus binding site identified in
*seqA1* recruits SarA and these nucleotides may be involved in the SarA binding.
## Analysis of the DNA-binding Properties of SarAR90A Mutant
Arginine at position 90 is essential for the SarA regulatory activity *in vivo*.
It is located within the winged region of SarA and is part of the conserved
basic region of SarA, the motif DER (*45*). We mutated this residue to alanine,
purified the mutant protein, and confirmed the substitution by mass
spectrometry. We then analyzed the binding affinity of the SarAR90A mutant
protein to *seq1, seq2* and *seq3* by EMSA. The mutant protein failed to bind to
these three DNA sequences.
## SarA Promotes *in vitro* Transcription of *fmtA*
We used *E. coli* RNA polymerase holoenzyme (RNAP) in these experiments. Several
lines of evidence lead us to conclude that *E. coli* RNAP is a good substitute
for *S. aureus* RNAP in the case of *fmtA*. The *E. coli* RNAP is a complex of
the RNAP core enzyme and the β<sup>70</sup> factor protein. The DNA sequence of
the putative −10 box in the *fmtA* promoter is identical to the consensus −10
box recognized by *E. coli* β<sup>70</sup>, suggesting that the *fmtA* promoter
may recruit a β<sup>70</sup>-like factor for transcription. The β<sup>70</sup>
homolog in *S. aureus* is SigA factor, in turn suggesting that regulation of
*fmtA* could be SigA-dependent. Incidentally, SarA regulates its own promoter in
a SigA-dependent mechanism. Our hypothesis that *E. coli* RNAP is a good
substitute for that of *S. aureus* was confirmed by *in vitro* run-off
transcription experiments with P*ftmA* and P*fmtA* mutated at the putative +1
and −14 sites. We observed that while *E. coli* RNAP could poorly initiate
transcription from P*<sub>fmtA</sub>*, there was a complete lack of
transcription for the T(+1) to G and T(−14) to G P*fmtA* variants. Furthermore,
the presence of SarA increased the production of the transcript from the P*fmtA*
fragment in a concentration-dependent manner (data not shown).
## SarA Regulates Expression of *fmtA–lux Fusion in vivo*
To investigate the role of the *fmtA* promoter in recruiting SarA *in vivo,* we
fused P*fmtA*-derived sequences (P<sub>seq1</sub>, P<sub>seq2</sub>,
P<sub>seq3</sub>, and P<sub>seq1–2</sub>) upstream of the *lux* operon in the
reporter vector pXEN1. The *lux* fusion plasmids and the control vector pXEN1
were introduced into *S. aureus* RN4220. We hypothesized that SarA exerts direct
regulation of *fmtA* via the SarA binding sites identified in our *in vitro*
experiments. If this hypothesis were correct, we would expect that the
disruption of SarA would reduce *lux* operon expression.
To test this hypothesis, we introduced the *lux* fusion plasmids into a SarA-
deficient strain, PC1839, and compared the luminescence of the RN4220
(*sarA*<sup>+</sup>) strains and PC1839 (*sarA*<sup>-</sup>) strains under
oxacillin-induced and uninduced growth conditions. Strains harboring different
fusion constructs showed comparable growth rates (data not shown). The
luminescence data are shown in. In the absence of oxacillin, a low level of
luminescence signal over the background level, set as the RN4220::*lux*- strain,
was observed in any lux-fusion strain. Presence of 10 µg/ml oxacillin increased
the *lux* operon expression especially in the case of the *seq*3::*lux* and
*seq*1–2::*lux* fusions, where a 5.8 and 4.5-fold increase in luminescence was
observed, respectively, in comparison to the *lux* expression in the absence of
oxacillin. The same trend was observed in the presence of 100 µg/ml oxacillin.
Overall, luminescence of RN(P<sub>seq1–2</sub>::*lux*) and
RN(P<sub>seq3</sub>::*lux*) exhibited the highest increase in luminescence in
the presence of oxacillin. In contrast, none of the *sarA* mutant strains
\[PC(P<sub>seq1</sub>::*lux*), PC(P<sub>seq2</sub>::*lux*),
PC(P<sub>seq3</sub>::*lux*) or PC (P<sub>seq1–2</sub>::*lux*)\] showed any
significant luminescence, even at 100 µg/ml oxacillin.
## Deletion of *sarA* Enhances *S. aureus* Sensitivity to Oxacillin
To understand whether the lack of functional SarA protein alters the sensitivity
towards oxacillin, we tested the oxacillin MICs of wild type *S. aureus* RN4220
and *sarA* mutant. The *sarA* mutant showed modest, but significant decrease
(2-fold) in MIC. The measured MICs of oxacillin for wild-type RN4220 and *sarA*
mutant were 0.3 µg/mL and 0.15 µg/mL, respectively.
## Transcript Levels of *sarA* and *fmtA* in *S. aureus* RN4220 and PC1839
Our data revealed that *sarA* transcript level in *S. aureus* RN4220 did not
change upon oxacillin treatment compared with corresponding untreated control
culture. However, *fmtA* transcript level was increased 3-fold upon oxacillin
treatment (3.5±0.7). This finding is in good agreement with the previously
published data where no change in *sarA* transcript level, but increased
transcript level of *fmtA* was observed. Increased expression of *fmtA* in
response to several cell wall active antimicrobials was observed in several
studies. On the other hand, in the *sarA* mutant strain, PC1839, the transcript
level of *fmtA* did not change upon oxacillin treatment compared with
corresponding untreated control culture.
# Discussion
Genome-based studies have shown that *fmtA* levels in *S. aureus* are
upregulated in the presence of cell wall inhibitors and by the knock-out of the
genes involved in peptidoglycan biosynthesis. A study by Kuroda et al. suggested
that *fmtA* is under the regulation of the two component signal transduction
system VraSR. However, the mechanism by which *fmtA* expression is regulated
remains unknown. In our study DNA fragments derived from P*fmtA* region showed
retardation in their electrophoretic mobilities when incubated with cell
extracts isolated from *S. aureus* RN4220 with clear differences from the
instance when bacteria were subjected to oxacillin. The electrophoretic mobility
shifts were eliminated in the presence of a competing DNA fragment.
Herein, we report a screening protocol designed to identify the transcription
factor(s) involved in regulation of *fmtA* expression. A 269-bp fragment of the
*fmtA* promoter region (*seq3*) was immobilized on streptavidin-coated beads and
used to capture proteins from extracts of *S. aureus* cells treated with
oxacillin to induce *fmtA* expression. Protein binding and washing steps were
performed at physiological ionic strength and in the presence of nonspecific DNA
to reduce nonspecific interactions. A relatively small number of non-DNA-binding
proteins were identified in the screen, including pyruvate carboxylase and
biotin carboxyl carrier protein of acetyl-CoA carboxylase which both have biotin
as a cofactor and could be binding to the beads through streptavidin. The
presence of RNA polymerase alpha chain, DNA polymerase I, translation elongation
factor Tu, translation elongation factor G, elongation factor TS, and 30S
ribosomal protein S5 could be due to the presence of the *fmtA* ribosomal
binding site in *seq3*. The presence of DNA binding protein II, a protein that
recognizes polyA DNA regions, could bind nonspecifically to the *seq3* fragment
which contains several polyA sites, and proteins such as chaperone protein DnaK,
GroEL and FtsZ could bind nonspecifically to DNA or streptavidin.
SarA was the only transcription factor identified by our screening protocol.
DNase I footprinting demonstrates that SarA binds to specific sites in the
*fmtA* promoter region. Specificity of SarA binding to P*fmtA* was probed by
mutation of one of the conserved residues located in the winged region of SarA,
Arg-90. The mutant SarAR90A protein, which is unable to regulate the SarA target
promoters *in vivo*, failed to bind to the *fmtA* promoter region.
The role of SarA in regulation of *fmtA* was corroborated by *in vivo* studies.
Fusion of the *lux* operon to the various regions of the *fmtA* promoter
indicated that the *fmtA* promoter region harbors transcriptional regulatory
elements and that SarA is involved in the regulation of *fmtA* expression. These
data are corroborated by the qRT-PCR data, whereby the *fmtA* expression level
increases by 3.5-fold in the presence of oxacillin, while *sarA* level remains
unchanged. In the *sarA* mutant, *fmtA* level are not affected by the presence
of oxacillin. Interestingly, the *in vivo* data suggest that SarA is involved in
basal expression of *fmtA* as well as upregulation of *fmtA* in the presence of
cell wall stress. Further, *in vitro* run-off studies suggest that transcription
of *fmtA* may require the *S. aureus* primary sigma factor, SigA. This is in
agreement with a previous report that shows that SarA regulates promoters that
are SigA-dependent. Additional evidence of the involvement of SigA in the
transcriptional regulation of *fmtA* is provided by mutagenesis studies in which
mutation of the −14 position and the transcription starting site of P*fmtA*
resulted in drastic reduction of *fmtA* transcription.
Sequence alignment of P*fmtA*-*seq3* against the SarA consensus binding site
revealed two regions that contain this sequence, centered around −168 and −53
nucleotides. In addition, we identified three sites that harbor the 7-bp
consensus binding sequence for the winged-helix-turn-helix DNA-binding proteins,
which SarA is a member. The 7-bp consensus binding sequence appears in pairs in
P*fmtA*; two pairs are within the 26-bp SarA binding consensus sequences and the
third pair is centered on the −112 nucleotide. The EMSA studies with DNA
fragments derived from P*fmtA*, harboring the 26-bp (*seqA1*) or the 7-bp SarA
binding sequences (*seqA2*), showed that SarA is recruited to these sites. The
DNA fragment that did not contain any of these sequences (*seqB1*) failed to
recruit SarA, suggesting that SarA recognize specific sequences in P*fmtA*,
known to interact with SarA, and that it may utilize both these sites to bind to
the *fmtA* promoter.
SarA is a global transcriptional regulatory protein linked to the regulation of
numerous virulence factors. It is a 124-residue protein that forms dimers in
solution and binds as a dimer to the target promoters. SarA also belongs to the
winged helix-turn-helix family of proteins. Several *S. aureus* proteins share
high sequence similarities with SarA and are grouped into a SarA family of
proteins.
Based on the structural information on the SarA family of proteins, four
regulatory mechanisms are proposed for SarA : 1) bending of the target DNA to
facilitate contact with the regulatory proteins; 2) the formation of three SarA
dimers which hold the DNA in a closed configuration not amenable to
transcription; 3) the formation of a heterodimer between compatible family
members that may interfere with the function of the homodimer and 4) competitive
displacement of one homolog by another. In the case of the *fmtA* promoter, it
is possible that SarA may follow the first regulatory mechanism whereby SarA
could bind as a dimer at the three identified sites.
The SarA family of proteins has been recently linked to *S. aureus* autolysis,
biofilm formation, and resistance to cell wall inhibitors. A study by McAleese
et al. showed that a clinical isolate of *S. aureus* with intermediate
resistance levels to vancomycin (a VISA strain) exhibited higher *sarA*
expression levels than the vancomycin susceptible parent strain when grown in an
antibiotic-free medium. The expression levels of *fmtA* were also increased in
the VISA strain. Interestingly, the *sarA* levels in susceptible or methicillin-
resistant strains are not reported to increase in the presence of cell wall
inhibitors; our data show the same phenomenon. By contrast, *fmtA* expression
increases in the presence of cell wall inhibitors despite the strain background.
The question that arises is, how does SarA regulate the expression of *fmtA*
when its protein levels are not altered in response to cell wall stress? It has
been hypothesized that the pleiotropic regulatory capabilities of SarA could be
due to posttranslational modifications. Recently, it was reported that SarA is a
phosphorylation target by Stk1 Ser/Thr kinase. Perhaps regulation of *fmtA* in
response to stress is mediated by phosphorylated SarA or other posttranslational
modifications. However, we cannot exclude that another transcription factor may
be involved in the regulation of *fmtA* during antibiotic-induced cell wall
stress.
The *fmtA* gene is reported to be part of the VraSR regulon. However, VraR was
not isolated from our protocol. There could be two reasons for this: i) VraR is
not involved in regulation of *fmtA* or ii) our screening protocol failed to
identify VraR due to low binding affinity of VraR for the *fmtA* promoter. We
have previously shown that VraR binding affinity to its own promoter is 1 µM,
which is one order of magnitude higher than that of SarA for P*fmtA*. It is
possible that under our screening conditions the occupancy of P*fmtA* by VraR is
low. A recent study by Sengupta et al. used chromatin immunoprecipitation
techniques to investigate the promoters under the direct control of VraR.
Interestingly, VraR was not identified as the transcription factor for *fmtA*,
but the study showed that other members of the VraSR regulon, such as *pbp2*,
*murZ*, and *sgtB*, are under the direct regulation by VraR.
In conclusion, this study links the global regulator SarA with a penicillin-
binding protein that is also involved in autolysis and biofilm formation. Our
findings further extend the multiple functions of SarA and establish a link
between processes involved with *S. aureus* pathogenicity, i.e., virulence
factor expression and the cell wall stress response.
We are in debt to Professor Simon J. Foster at University of Sheffield (United
Kingdom) for providing the PC1839 strain. The authors declare that this
manuscript or a related manuscript has not been previously published and is not
currently being considered for publication elsewhere.
[^1]: The authors have declared that no competing interests exist.
[^2]: Analyzed the data: YZ VV AS. Wrote the paper: DGK VV AB. Conceived the
project: DGK. Performed the screening protocol, the EMSA experiments, DNase
I footprinting, cloning and purification of SarA, construction of the SarA
mutant: YZ. Designed the in vivo studies with the Lux reporter vector: VV.
Designed the in vitro run-off experiments: AB. Performed the qRT-PCR, MIC
experiments: AS. Performed the EMSA experiments: MF.
|
# Introduction
The SARS-COV-2 pandemic, which has gripped the world over the last three years,
has resulted in more than 530 million reported infections and 6.3 million deaths
worldwide so far \[<https://covid19.who.int/>\]. The pandemic also resulted in
unimaginable suffering to individuals, families, communities and countries
across the globe. At its peak, the pandemic stressed healthcare systems in
different parts of the globe to their limit, disrupted supply chains, destroyed
businesses, resulted in massive unemployment and poverty and a never-seen-before
upward re-distribution of wealth; which will collectively continue to impact
life on earth for possibly generations to come. Although it is arguable whether
the pandemic was foreseen and/or could have been avoided or even better managed;
still, the way in which it was handled speaks of utter incompetence and
indisputable lack of preparedness at all levels from governments and healthcare
authorities all the way to the scientific community. Therefore, the world needs
to learn its lesson, not only in terms of how to deal with future epidemics and
pandemics but also how to study and understand them and how to use cutting edge
technologies in such endeavors.
One of the puzzling questions about the COVID-19 pandemic that still lingers is
how and why some, seemingly healthy (low risk) individuals, succumbed to the
disease while others, possibly of poorer health, recovered and survived. Indeed,
most people would agree that the worst of this pandemic is, more or less, behind
us, but efforts to uncover infection and disease correlates that may have
contributed to its outcomes remain timely and needed. In this context, there is
a real need to develop and test disparate data-integrating approaches and data-
based models to understand the various aspects of COVID-19 and to easily and
quickly enlist such models in combating future epidemics and pandemics.
Polymerase chain reaction (PCR) testing of the nasopharyngeal swab for the
presence of SARS-CoV-2 RNA continues to be the gold standard in identifying
infected individuals. Based on global data input, almost 80% of SARS-COV-2
individuals end up with no symptoms to mild-to-moderate symptoms. Serological
testing in the form of differential blood count along with inflammatory marker
testing has proven partially successful in identifying patients at high risk of
disease severity or death. The experience with COVID-19 has demonstrated that
testing for serum IL-6, D-dimer, lactate dehydrogenase (LDH) and other analytes
is helpful in identifying patients at risk of sever or fatal complications. That
said, there is still a need for more specific predictive parameters of severe
infection beyond serum ferritin, prothrombin time, and fibrin degradation
products (FDP).
Serum/plasma metabolomics profiling using liquid chromatography-mass
spectrometry (LC-MS) has proven useful in identifying diagnostic, prognostic and
therapeutic biomarkers in infectious diseases. Studies have shown that serum
levels of citrate, malate and succinate increase in response to *S*. *aureus*
and *S*. *pneumonia* infections. In a study on COVID-19 intensive care unit
patients, the plasma metabolites kynurenine and arginine ratio was reported to
be helpful in predicting COVID-19 disease irrespective of age, gender or
hospital admission. However, the role of these findings in COVID-19 prognosis
remains limited given that only ICU patients were assessed. In another study,
the metabolites cytosine and tryptophan-nicotinamide were reported to be
moderately sensitive in discriminating COVID-19 patients from healthy
individuals. It is predictable that metabolomic changes resulting from SARS-
CoV-2 infection could vary widely among patients owing to differences in patient
health profiles, vis-à-vis comorbidities, medications, diet, lifestyle, etc.
Accordingly, the search for profiles of metabolic biomarkers may provide higher
sensitivity and specificity in assessing disease prognosis. In this study, we
retrospectively recruited COVID-19 patients with no known comorbidities and
divided them into three groups based on disease severity: asymptomatic, mild and
severe. We performed LC-MS metabolomics profiling in serum samples of these
patients and identified eight predictive biomarkers of COVID-19 disease
severity. We then integrated patients’ laboratory findings and metabolomics
profiles to generate a predictive model of disease severity.
# Material & methods
## Sample collection and processing
In this retrospective cohort study, blood samples were collected from donors who
tested positive for COVID-19 and presented with no, mild or severe symptoms
between March 20 until July 17, 2020. Patients were diagnosed with COVID-19
using a nasal swab PCR test and later divided into three groups (asymptomatic,
mild, and severe) based on their clinical presentation. Each donor gave a 10 mL
blood sample, one half of which was collected in a plain tube and the other half
in an EDTA vacutainer. A total of 85 samples were collected (30
COVID-19-positive asymptomatic, 10 COVID-19-positive with mild symptoms, and 45
COVID-19-positive with severe symptoms) for the purpose of this study.
COVID-19-positive asymptomatic individuals were identified as a result of the
national screening campaigns. Symptomatic COVID-19 patients were classified into
mild or severe based on guidelines published by Abu Dhabi Department of Health
(circular number 33, 19<sup>th</sup> April 2020). Patients with mild disease
presented with upper respiratory tract infection and symptoms like fever, dry
cough, sore throat, runny nose, muscle and joint pains without shortness of
breath. Patients with severe disease presented with severe pneumonia and
symptoms like fever, cough, dyspnea and fast breathing (\>30 per minute), in
addition to oxygen saturation \<90%. Patient records showed that many of the
patients with symptoms were self-medicating with aspirin prior to their hospital
visit and that some of the patients with moderate-severe symptoms were placed on
dexamethasone and/or heparin subsequent to hospital admission. Immediately upon
sample collection, the hospital laboratory staff separated and tested the serum
for CRP, D-dimer, ferritin, IL-6 and LDH; a complete blood count was also
performed on each sample. Whole blood samples were also aliquoted and frozen at
−80 °C for subsequent processing and analysis. The study was jointly approved by
the Ministry of Health, Abu Dhabi and Dubai Health Authority
(DOH/CVDC/2020/1949) on the understanding that samples will be number-coded to
hide patient’s identity, that no personal information will be shared with a
third party and that no sample analysis can be performed by entities other than
the Research Institute of Medical and Health Sciences (RIMHS), the University of
Sharjah (UOS) without prior written approval. No informed consent was required
as per the ethical approval decision (*DOH/CVDC/2020/1949*); in compliance with
the said decision, all samples were fully anonymized before accessing or
receiving them.
## Serum levels of hepcidin and soluble transferrin receptor (sTfR), sCD163 and haptoglobin (Hp) concentration and phenotype distribution
Upon receipt of frozen samples at RIMHS, UOS laboratories, whole blood samples
were thawed and centrifuged; serum was separated and levels of hepcidin (Cat
No.733228; MyBiosource, San Diego, California, United States), soluble sTfR (Cat
No. 750294; MyBiosource), sCD163 (MBS508555) and Hp (MBS763395) were measured
using commercially-available colorimetric assay kits; absorbance was read at 450
nm on a microplate reader. Hp phenotypes were determined by vertical
polyacrylamide gel electrophoresis, and the bands were visualized by staining
with benzedine solution as previously described.
## Liquid chromatography tandem mass spectrometry (LC-MS/MS)
Plasma was obtained after the collection of samples into heparinized tubes
followed by centrifugation for 5 minutes (3000*g*). The samples were stored at
–80 ºC for long-term storage until further metabolomics analysis. An aliquot of
plasma sample was first placed into a microcentrifuge tube where cold methanol
was added into the sample at 3:1 v/v (i.e., 30 μL sample, add 90 μL cold
methanol) vortex and was then stored at –20ºC for two hrs. Next, the samples
were centrifuged at 20,817 x g for 15 min at 4ºC. Then, the supernatant was
transferred to a new microcentrifuge tube. Usually, the original sample volume
is transferred three times (i.e., for 30 μL sample, add 90 μL cold methanol,
then transfer 90 μL supernatant). The sample was dried down using Speed vac at
30–40°C. The dried sample was then either stored in a –80ºC freezer for further
use or dissolved in solvent for LC-MS/MS analysis. Metabolites were analyzed by
HPLC-Q-TOF MS/MS using the auto MS/MS positive scan mode as per described in our
recent publications. Briefly, samples were chromatographically separated using a
Hamilton<sup>®</sup> Intensity Solo 2 C18 column (100 mm x 2.1 mm x 1.8 μm) and
eluted using 0.1% formic acid in water (A) and 0.1% formic acid in ACN (B) using
the following gradient: at a flow rate of 0.250 mL/min 1% B from 0–2 min, then
gradient elution to 99% B from 2–17 min, held at 99% B from 17–20 min, then re-
equilibrated to 1% B from 20–30 min using a flow rate of 0.350 mL/min. The
autosampler temperature was set at 8°C and the column oven temperature at 35°C.
The ESI source with dry nitrogen gas was 10 L/min, and the drying temperature
was equal to 220°C with nebulizer gas pressure set to 2.2 bar. The capillary
voltage of the ESI was 4500 V and the Plate Offset 500 V. MS acquisition scan
was set at 20–1300 m/z and the collision energy at 7 eV. Sodium formate was
injected as an external calibrant between 0.1 and 0.3 minutes. A total volume of
10 μL sample was injected into the TIMS-TOF MS.
Processing analysis was performed using MetaboScape<sup>®</sup> 4.0 (Bruker
Daltonics). Analyte bucketing and identification were done using the software
provided available T-ReX 2D/3D workflow with the following parameters: intensity
threshold greater than 1000 counts and peak length equal to 7 spectra or
greater. Feature quantitation performed using peak area, for features present in
at least 3 (of 12) samples (per cell type) were considered for statistical
analysis. Analyte MS<sup>2</sup> spectra were averaged on import and only
features eluting between 0.3 and 25 min with mz between 50 and 1000. For
metabolite identification, both MS<sup>2</sup> spectra and retention time (RT)
were used with the MS/MS spectra as the minimum criterion for a positive hit.
For the set of compounds meeting this criterion (either MS/MS alone or MS/MS
with RT), annotation using Bruker’s implementation of the Human Metabolome
Database (HMDB-4.0) was performed; all selected compounds were matched against
this library. Where a particular database entry was matched by multiple
features, putatively matching features were filtered by considering each of the
features against the highest annotation quality score (AQ score) among other
putative matches for the same metabolite; i.e. features exhibiting the best fit
across the greatest number of factors such as retention time, MS/MS, m/z values,
analyte list and spectral library matching were ranked first for the associated
identification as per previous publication. Pathway enrichment analyses were
performed using MetaboAnalyst V5 (<https://www.metaboanalyst.ca>). Pathway
enrichment evaluates overall pathway impact by considering the relative
importance of altered metabolite based on their position in the pathway map.
All data, including raw files, have been deposited in the Metabolomics Workbench
Repository (<https://www.metabolomicsworkbench.org/>).
## Data analysis
The metabolomics data were first tabulated in Microsoft excel format and then
exported to the Statistical Package for Social Sciences (SPSS) software, version
27. Demographics, clinical and metabolites data were all merged into one SPSS
dataset. Descriptive statistics was used to conduct univariate analysis;
frequencies and relative frequencies were used to condense categorical data
while measures of central tendency were performed for scale data. Normality of
scale data was first tested graphically, using Q-Q plots and histograms and then
statistically analyzed using the Kolmogorov Smirnov test. Mean and standard
deviations (SD) were reported for scale variables showing normally distributed
data, whereas median and interquartile range (IQR: Q1-Q3) were used to summarize
variables with skewed data. Chi-square test was performed to test for
associations between categorical variables where the strength of an association
was measured using the odds ratio (OR). To study the relationships between a
normally distributed outcome and a categorical dichotomous predictor, the
independent t-test was used. If the predictor had more than two groups, one-way
ANOVA test was used to compare three or more means. For skewed outcome
variables, similar analyses were conducted using the non-parametric tests Mann-
Whitney U test and Kruskal-Wallis test, respectively. Spearman correlation
coefficient was performed to investigate the correlation between two variables
with skewed scale data. P-values less than or equal to 0.05 indicated
statistical significance. Bonferroni correction was used to adjust p-values in
pairwise comparisons.
The receiver operating characteristic curve (ROC) and the area under the curve
(AUC) were performed to identify, from among the clinical and metabolite tests,
significant diagnostic biomarkers for predicting the severity of COVID-19
infection. An ROC AUC value above 0.70 indicated moderate to high level of
accuracy of prediction. For each test’s AUC value, statistical significance was
assessed against chance by calculating its 95% Confidence Interval (CI) and
associated p-value. For each significant diagnostic test/biomarker showing
high/moderate accuracy prediction level (AUC \> 0.70), data-driven approach was
used to determine the optimal cut-off value, specifically, by maximizing the
Youden’s index (Sensitivity + Specificity– 1). Next, the sensitivity (SN) and
specificity (SP), along with their 95% confidence intervals, were calculated for
each diagnostic test.
Optimal cut-off values were used to dichotomize each biomarker into low and high
levels. A low level was coded as zero and a high level was coded as 1. After
excluding biomarkers that were linearly related, predictors were identified to
develop a risk scoring system to define a diagnostic model for COVID-19 severity
based on a combination of important biomarkers used as predictors. The risk
score was calculated by counting, for each patient, the number of biomarkers
that were of high levels. The ROC and the AUC, using Youden’s Index, were then
used to identify the optimal risk score for predicting the severity of COVID-19.
Demographics, clinical and serum metabolite laboratory test results were first
compared between the three levels of COVID-19 infection severity (asymptomatic,
mild and severe). Preliminary analysis has shown that the asymptomatic and mild
groups were comparable on most clinical and metabolite results; no significant
differences were observed between the two groups. Accordingly, the two groups
(asymptomatic and mild) were clustered into a single group (asymptomatic/mild),
which was then compared to the severe COVID-19 group to conduct the analysis
reported in this manuscript.
# Results
## Study population demographics
In this study, we analyzed data pertaining to a total of 85 COVID-19 cases, of
whom 35.3% (n = 30) were asymptomatic, 11.8% (n = 10) were mild and 52.9% (n =
45) were severe. Males constituted the majority of patients in this study
(84.7%, n = 72) as compared to (15.3%, n = 13) females. Mean age of patients was
42 years (SD = 7.73) with a minimum age value of 27 years and a maximum of 62
years. Age was categorized into two groups where 43.5% (n = 37) were 40 years or
younger and 56.5% (n = 48) were older than 40 years. Age group and gender
distributions were comparable between the two groups (asymptomatic/mild) vs.
severe.
## Laboratory findings (clinical tests) and severity of COVID-19 disease
In the study sample as a whole, inflammatory markers including the C-reactive
protein (CRP) and D-dimer had median values of 18.2 mg/L (Q1-Q3: 5.45–115.49)
and 0.60 μg/ml (Q1-Q3: 0.31–2.24) respectively and mean values of lymphocyte and
neutrophil counts of 1.45 (SD = 0.72) and 7.56 (SD = 4.13) cells/μL
respectively. The majority of the inflammatory markers were found to be
significantly higher in the severe COVID-19 group relative to the
asymptomatic/mild group. For example, CRP had a median value of 5.90 mg/L in the
asymptomatic/mild group and 131.22 mg/L in the severe group (U = 1627.50,
p-value\<0.001). Similarly, D-dimer had median values of 0.28 μg/ml in the
asymptomatic/mild group and 1.27 μg/ml in the severe group (U = 161050,
p-value\<0.001). While lymphocytes were significantly higher in the
asymptomatic/mild group (mean = 1.94 cells/μL) than in the severe group (mean =
1.00 cells/μL; t = 7.880, p-value\<0.001), neutrophils were significantly higher
in the severe (mean = 9.35 cells/μL) as compared to the asymptomatic/mild group
(mean = 5.58 cells/μL; t = -4.773, p-value\<0.001). No significant differences
were found between the asymptomatic/mild group *vs*. the severe COVID-19 group,
vis-à-vis median values of serum hepcidin or sCD163. However, Hp and soluble
sTfR levels were significantly higher (p-value\<0.001) in the severe *vs*. the
asymptomatic/mild group; Hp median values were 138.02 *vs*. 115.73 ng/ml and
sTfR median values were 31.61 *vs*. 21.46 ng/ml.
## Metabolomics profiles of COVID-19 patients according to disease severity
To investigate the possibility of identifying serum metabolites that help in
studying the prognosis of disease severity, metabolomics profiling of plasma
samples from patients with no, mild and severe symptoms was performed. A total
of 99 metabolites were measured and compared between the asymptomatic, mild and
severe cases. Pairwise comparisons showed comparable results for asymptomatic
*vs*. mild patients, hence the grouping of data obtained from asymptomatic
patients and patients with mild symptoms as one “asymptomatic/mild” group; much
the same as was done in the previous section. Out of the 99 metabolites , 68
have shown significantly different median values between the asymptomatic/mild
group and the severe groups. Of these 68, eight (8) metabolites
(K_4\_Aminophenol, Acetaminophen glucuronide, Cytosine, Elaidic acide, Glycine,
Isobutyric, Paracetamol sulfate and Succinylacetone) were significantly higher
in the severe group. Additionally, sixty (60) metabolites showed significantly
higher values in the asymptomatic/mild group *vs*. the severe group. Next, we
conducted an enrichment analysis of the Biological Process gene ontology terms
linked with those metabolites. The enrichment pathway analysis using the "small
molecule pathway database (SMPDB)" (available in MetaboAnalyst 5.0 software)
revealed that the pathways, that the differentially abundant metabolites were
most enriched for included the citrate cycle, phenylalanine metabolism,
phenylalanine, tyrosine, and tryptophan biosynthesis, pantothenate and coenzyme
A biosynthesis, tryptophan, glycine, and serine. Additionally, the same data set
produced disease-enriched groups for Hartnup disease, acute seizures, critical
illness (major trauma, severe septic shock, or cardiogenic shock), and
hyperbaric oxygen exposure when it was searched against the "blood disease
signatures database" (available in MetaboAnalyst 5.0 software). As further
detailed in the text, the bulk of the diseases or conditions that emerged from
this research have symptoms that are consistent with those listed among the most
severe COVID-19 cases.
## Determining Cut-off values for Biomarkers
To identify clinical biomarkers of disease severity, the ROC and AUC were
performed for each clinical laboratory finding (CRP, ferritin, sTfR, LDH, etc.)
and metabolite test. For the clinical laboratory findings, the highest accuracy
level in predicting disease severity was for LDH (AUC = 1.000) followed by
Ferritin (AUC = 0.988, 95% CI: 0.966 to 1.000), D-dimer (AUC = 0.936, 95% CI:
0.876 to 0.997), CRP (AUC = 0.904, 95% CI: 0.842 to 0.966), IL-6 (AUC = 0.919,
95% CI: 0.831 to 1.000), Hp (AUC = 0.792, 95% CI: 0.696 to 0.889), sTfR (AUC =
0.756, 95% CI: 0.653 to 0.858) and Neutrophils (AUC = 0.749, 95% CI: 0.643 to
0.854). Hepcidin and Lymphocytes showed either insignificant or low AUC values
(\<0.70), indicating low accuracy in predicting COVID-19 severity. Optimal cut-
off values for the laboratory findings as determined by Youden’s index were 226
for LDH (SN = 100%, SP = 100%), 365 for Ferritin (SN = 95.6%, SP = 100%), 0.545
for D-dimer (SN = 93.0%, SP = 90.0%), 33.95 for IL-6 (SN = 87.1%, SP = 100%),
58.35 for CRP (SN = 73.3%, SP = 100%), 124.37 for Hp (SN = 79.5%, SP = 72.5%),
24.67 for sTfR (SN = 82.2%, SP = 60%), and 8.94 for Neutrophils (SN = 59.1%, SP
= 85.0%).
Of all the 99 metabolite tests, five were identified as significant diagnostic
tests in predicting COVID-19 disease severity; namely, K_4\_Aminophenol (AUC =
0.883, 95% CI: 0.803 to 0.962), Acetaminophen (AUC = 0.949, 95% CI: 0.894 to
1.000), Acetaminophen glucuronide (AUC = 0.791, 95% CI: 0.539 to 1.000),
Cytosine (AUC = 0.784, 95% CI: 0.680 to 0.887), and Paracetamol sulfate (AUC =
0.836, 95% CI: 0.660 to 1.000). Cut-off diagnostic value for
K_4\_Aminophenol was 381.5 (SN = 82.2%, SP = 90.0%), for Acetaminophen was
1595.5 (SN = 90.9%, SP = 91.2%), for Acetaminophen glucuronide was 1416.0 (SN =
78.0%, SP = 85.7%), for Cytosine was 818.0 (SN = 68.2%, SP = 90.0%), and for
Paracetamol sulfate was 652.5 (SN = 81.0%, SP = 88.9%). Each biomarker was then
dichotomized into two groups, low and high, based on its determined cut-off
value.
## Predicting COVID-19 disease severity
Predicting the severity of COVID-19 was done at two levels, first by using a
single biomarker and then a combination of biomarkers. All clinical and
metabolites tests were significantly and strongly associated with the severity
of COVID-19. The proportion of patients with severe COVID-19 in the high group
of each clinical/metabolites test was significantly higher than that in the low
group. The strength of association, as measured by the odds ratio, between
disease severity and the clinical and metabolites groups, was lowest for CRP (OR
= 4.3, 95% CI: 2.6 to 7.1) and highest for D-dimer (OR = 120.0, 95% CI: 25.1 to
572.9).
A risk scoring system was developed to define a diagnostic model for COVID-19
disease severity based on a combination of important biomarkers used as
predictors. All clinical laboratory findings and metabolites that were
significantly associated with disease severity were considered as important
biomarkers. After excluding biomarkers that were linearly related, and based on
the statistical and clinical importance of all identified diagnostic biomarkers,
we selected six predictors to conduct the risk-scoring predictive model. This
model included the five lab findings (D-dimer, Ferritin, Neutrophils, Hp, and
sTfR) and one metabolite (cytosine). A score was calculated for each patient.
This score corresponded to the number of biomarkers that were of levels above
their respective cut-off values (high group). The accuracy of predicting disease
severity in the risk-scoring predictive model was reflected in a highly
significant AUC value of 0.996 (95% CI: 0.989 to 1.000). The optimal cut-off
risk score for the risk-scoring predictive model, as determined by Youden’s
Index, was 3 with a perfect sensitivity of 100% and a specificity of 92.5%.
Accordingly, all patients with high levels of at least three of the six
predictors would be predicted as developing severe COVID-19 and none of the
severe cases would be missed out.
## Correlating ferritin with other laboratory findings and plasma metabolites
Among all patients, ferritin values were significantly correlated with the
values of all other clinical tests except for hepcidin and sCD163. The
significant correlations were all positive except for Lymphocytes that showed a
moderate indirect correlation with ferritin (rho = - 0.520, p-value\<0.001, 95%
CI: -0.664 to -0.338). The strongest direct correlations of ferritin were found
with LDH (rho = 0.785, p-value\<0.001, 95% CI: 0.682 to 0.858), followed by
D-dimer (rho = 0.630, p-value\<0.001, 95% CI: 0.475 to 0.748) and CRP (rho =
0.618, p-value\<0.001, 95% CI: 0.461 to 0.737); the weakest correlation was
between ferritin and sTfR (rho = 0.282, p-value = 0.009, 95% CI: 0.067 to
0.472). Moreover, there were significant, mild to moderate indirect correlations
between ferritin and several metabolites with serotonin showing the strongest
indirect correlation (rho = -0.697, p-value\<0.001, 95% CI: -0.836 to -0.474).
Ferritin was also found to have a significant positive correlation with
acetaminophen (rho = 0.670, p-value\<0.001, 95% CI: 0.521 to 0.780),
K_4\_Aminophenol (rho = 0.573, p-value\<0.001, 95% CI: 0.405 to 0.704) and
cytosine (rho = 0.416, p-value\<0.001, 95% CI: 0.215 to 0.583).
# Discussion
In this study, the concentration of several serum analytes and metabolites was
measured in COVID-19 patients with no, mild or severe symptoms. Consistent with
numerous previous studies, the serum concentration of analytes that are
routinely measured in infected individuals including CRP, ferritin, IL-6,
D-dimer, IL-6 and LDH was significantly elevated in patients with severe
COVID-19. Also consistent with previous work was the observation that the levels
of hepcidin, sTfR, and Hp were either slightly-moderately elevated or not
changed in COVID-19 patients with severe disease. Contrary to the suggestion of
Zhou *et al*, our analysis showed that hepcidin is not a true predictor of
disease severity in COVID-19 patients. Additionally, while data presented here
show that the levels of sCD163 were reduced in severely ill patients, other
studies have shown that sCD163 levels increase with disease severity. This
discrepancy could be a reflection of variations in methodology, sample
collection timing, and/or differences in macrophage activity. Irrespective of
these discrepancies, variations in sCD163 concentration seem to have little, if
any, impact on COVID-19 disease severity. Our data also showed that Hp phenotype
distribution was similar in severe vs. asymptomatic/mild groups, which is in
agreement with previous work which has suggested that Hp phenotype has no
bearing on COVID-19 disease severity.
With regard to the metabolomics profiling of COVID-19 patients and as noted
earlier, 60 metabolites decreased in the severe cases relative to
asymptomatic/mild patients’ group. The list of identified metabolites included
several amino acids, vitamins and few fatty acids. These are regarded as the
fundamental elements that support the rise in cellular demands during illness.
However, through catabolism pathways, they are also involved in innate and
adaptive immune responses to infection. Therefore, the decrease in some of the
reported metabolites is consistent with previous studies, that reported lower
levels of amino acids in hospitalized COVID-19 patients compared to asymptomatic
ones. The outcomes do in fact support the previously noted negative correlation
between amino acids and immune responsiveness and hyper-inflammation indicators,
which is characteristic of severe COVID 19. For example, the levels of Kynurenic
acid in severe cases was found to be lower than that in asymptomatic/mild cases.
Previous studies have suggested that the Tryptophan catabolite/ Kynurenine
pathway may play a significant role in COVID-19 and critical COVID-19. Moreover,
it appears that the increased level of kynurenine and the ratio of kynurenine to
tryptophan is strongly correlated with the severity of COVID-19 patients.
Interestingly, the ratio of Kynurenic acid/Kynurenine did not significantly
differ between COVID-19 patients compared with non-COVID-19 controls, indicating
no significant changes in Kynurenic acid activity, according to a systematic
review. This is indeed consistent with our finding that in patients with severe
COVID-19, tryptophan and Kynurenic acid levels were significantly lower than in
the counter group.
Over the last three years, much time and effort has been spent on identifying
serum biomarkers that could predict disease severity in COVID-19 patients with
high accuracy. Elevated levels of serum biomarkers such as ferritin, IL-6,
D-dimer and lactate dehydrogenase among others were reported to be valuable
predictors of disease severity and death. However, not all COVID-19 patients
showing elevated levels in one or more of these biomarkers ended up with severe
disease and death. In other words, relying on one or more serum analytes tends
to yield low prediction accuracy as evidenced by the fact that such approaches
could only account for only a significant percentage of cases. In this context,
numerous predictive models that relied on overlapping sets of variables drawn
from COVID-19 patients’ demographic data, clinical signs and symptoms, chest
X-ray imaging and co-morbidities were proposed (reviewed in. However, many of
these severity predictive models suffer from a high degree of subjectivity and
high likelihood of bias. For example, a disease severity predictive model based
on the static demographics (age, gender, occupation, urban vs. rural living,
socio-economic status, profile, etc.) of \>50000 Irish patients showed that
modeling such parameter could predict hospitalization \[(AUC 0.816 (95% CI
0.809, 0.822)\], admission to ICU \[AUC 0.885 (95% CI 0.88 0.89)\] and death
\[AUC of 0.955 (95% CI 0.951 0.959)\]. In the same study, body mass index
(BMI≥40) was shown to be a risk factor for ICU admission \[OR 19.630\] and death
\[OR 10.802\]. Moreover, while rural living was found to associate with
increased risk for hospitalization (OR 1.200 (95% CI 1.143–1.261)\], urban
living was found to associate with increased risk for ICU admission \[OR 1.533
(95% CI 1.606–1.682)\]. Another study which developed an artificial intelligence
(AI)-based model based on 41 variables relating to patient’s demographics,
physical measurements, initial vital signs, comorbidities and laboratory
findings in a cohort of 5628 Korean COVID-19 patients yielded a predictive power
of \>0.93 when 6 variables were used. Besides the fact that this model could be
skewed by the demographics components making it more population-specific than
desired, achieving 93% accuracy by relying on 6 variables is cumbersome and
difficult to apply in many poor countries and rural settings. Another AI-based
model was developed by relying on laboratory findings including LDH, IL-6,
D-dimer, fibrinogen, glucose, monokine induced by gamma interferon (MIG) and
macrophage derived cytokine (MDC) levels in 60 COVID-19 Russian patients. The
model described by the study relied on eight parameters (creatinine, glucose,
monocyte number, fibrinogen, MDC, MIG and CRP) to yield a predictive power of
83−87%. In other words, this laboratory findings-based model failed to account
for 13–17% of patients at risk of severe disease.
With the availability of six metabolite predictive biomarkers at our disposal,
we sought to develop a high accuracy prediction model based on disparate data-
integrating approaches; namely, patient laboratory findings and plasma
metabolomics profiles. The statistical model developed and tested was based on
ROC-AUC values. Although some metabolomes including acetaminophen, acetaminophen
glucuronide and paracetamol sulfate significantly predicted COVID-19 severity,
it was unlikely that these metabolomes were involved in the pathophysiology of
COVID-19. Severe cases of the disease were more likely to receive more
paracetamol than asymptomatic/mild cases. Therefore, these metabolomes were
excluded from the predictive models. Accordingly, the predictive model was
developed, and its prediction accuracy was internally validated using six
biomarkers that were not linearly-related; namely, D-dimer, ferritin, neutrophil
counts, Hp, sTfR and cytosine. Prediction accuracy of disease severity using
this model was 0.996 (95% CI: 0.989 to 1.000) with optimal cut-off risk score of
three biomarkers. In other words, out of 100 patients with severe COVID-19
showing significant elevation in at least three of the six metabolites would
predict disease severity in all 100 patients. The model has the advantage of
yielding high predictive power with small set of variables (three laboratory
findings) that can be easily and quickly acquired at minimal cost. Moreover, the
predictive model can be dynamically applied independent of non-empirical
clinical data (co-morbidities, signs and symptoms and loss of taste or smell
among others) and can be dynamically applied as the disease progresses making
timely and proper clinical interventions possible. That said, the utility of the
model remains limited by the fact that the study was conducted retrospectively
on a small number of samples. Another limitation in our study is that, with the
number of COVID-19 cases gradually dwindling to almost zero in the UAE as in
most parts of the world, we were not able to compile a new independent dataset
with the same set of predictors as means of validating our prediction model.
Future studies are recommended to test the validity of the suggested model on
multiple datasets to ensure its generalizability.
# Conclusion
By integrating laboratory findings and metabolomic profiling data, a model to
predict disease severity in COVID-19 patients was generated. The accuracy of the
model was high (\>98%), and it has the advantage of requiring three biomarkers
to yield high sensitivity and specificity in predicting disease severity. The
suggested model may prove useful in better managing COVID-19 patients at high
risk of severe disease. Lastly, the fact that the model included cytosine as a
biomarker and that cytosine is not usually included in routine laboratory
testing for COVID-19 patients, merit further work on developing reliable and
highly sensitive, yet quick and easy to perform, assays to measure serum
cytosine concentration.
# Supporting information
10.1371/journal.pone.0289738.r001
Decision Letter 0
Trongtrakul
Konlawij
Academic Editor
2023
Konlawij Trongtrakul
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
6 Nov 2022
PONE-D-22-27539Plasma metabolomics profiling identifies new predictive
biomarkers for disease severity in COVID-19 patientsPLOS ONE
Dear Dr. Hamad,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
Please submit your revised manuscript by Dec 21 2022 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:A
rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Konlawij Trongtrakul, MD, PhD
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2\. Please ensure that you have specified (1) whether consent was informed and
(2) what type you obtained (for instance, written or verbal, and if verbal, how
it was documented and witnessed). If your study included minors, state whether
you obtained consent from parents or guardians. If the need for consent was
waived by the ethics committee, please include this information.
3\. If you are reporting a retrospective study of medical records or archived
samples, please ensure that you have discussed whether all data were fully
anonymized before you accessed them and/or whether the IRB or ethics committee
waived the requirement for informed consent. If patients provided informed
written consent to have data from their medical records used in research, please
include this information.
4\. Thank you for stating the following in the Acknowledgments Section of your
manuscript:
"This work was supported by research grant CoV19-0305 (MH), seed grant
2001110138, University of Sharjah, UAE. This research is part of the -Human
Disease Biomarkers Discovery Research Group-study. The authors wish to
acknowledge the generous support of the Research Institute for Medical and
Health Sciences, University of Sharjah UAE."
We note that you have provided funding information that is not currently
declared in your Funding Statement. However, funding information should not
appear in the Acknowledgments section or other areas of your manuscript. We will
only publish funding information present in the Funding Statement section of the
online submission form.
Please remove any funding-related text from the manuscript and let us know how
you would like to update your Funding Statement. Currently, your Funding
Statement reads as follows:
"This work was supported by research grant CoV19-0305 (MH), seed grant
2001110138 (NCS), University of Sharjah, UAE. This research is part of the
-Human Disease Biomarkers Discovery Research Group-study. The authors wish to
acknowledge the generous support of the Research Institute for Medical and
Health Sciences, University of Sharjah UAE"
Please include your amended statements within your cover letter; we will change
the online submission form on your behalf.
5\. We note that Figure 1 in your submission contain copyrighted images. All
PLOS content is published under the Creative Commons Attribution License (CC BY
4.0), which means that the manuscript, images, and Supporting Information files
will be freely available online, and any third party is permitted to access,
download, copy, distribute, and use these materials in any way, even
commercially, with proper attribution. For more information, see our copyright
guidelines: <http://journals.plos.org/plosone/s/licenses-and-copyright>.
We require you to either (1) present written permission from the copyright
holder to publish these figures specifically under the CC BY 4.0 license, or (2)
remove the figures from your submission:
a\. You may seek permission from the original copyright holder of Figure 1 to
publish the content specifically under the CC BY 4.0 license.
We recommend that you contact the original copyright holder with the Content
Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-
permission-form.pdf>) and the following text:
“I request permission for the open-access journal PLOS ONE to publish XXX under
the Creative Commons Attribution License (CCAL) CC BY 4.0
(<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this
license allows unrestricted use and distribution, even commercially, by third
parties. Please reply and provide explicit written permission to publish XXX
under a CC BY license and complete the attached form.”
Please upload the completed Content Permission Form or other proof of granted
permissions as an ""Other"" file with your submission.
In the figure caption of the copyrighted figure, please include the following
text: “Reprinted from \[ref\] under a CC BY license, with permission from \[name
of publisher\], original copyright \[original copyright year\].”
b\. If you are unable to obtain permission from the original copyright holder to
publish these figures under the CC BY 4.0 license or if the copyright holder’s
requirements are incompatible with the CC BY 4.0 license, please either i)
remove the figure or ii) supply a replacement figure that complies with the CC
BY 4.0 license. Please check copyright information on all replacement figures
and update the figure caption with source information. If applicable, please
specify in the figure caption text when a figure is similar but not identical to
the original image and is therefore for illustrative purposes only.
6\. Please include captions for your Supporting Information files at the end of
your manuscript, and update any in-text citations to match accordingly. Please
see our Supporting Information guidelines for more information:
<http://journals.plos.org/plosone/s/supporting-information>.
Additional Editor Comments:
The manuscript provides an interesting issue in determining COVID-19 severity
using the patient's laboratory investigations combined with significant
metabolites from LC-MS/MS. The models provided by the authors seem optimistic,
with AUC nearly equal to 1. Unfortunately, there is a concern about needing more
statistical analysis. I recommend performing multivariable logistic regression
analysis or binary regression analysis as it is more appropriate to finalize the
model. Afterward, the author can test the AUC of the model. Nonetheless, a
suitable criterion for selecting metabolites that reflect more severe disease in
the model is necessary, rather than including acetaminophen or related
medication.
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Partly
Reviewer \#2: Partly
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: N/A
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The authors developed the predictive models of COVID-19 severity
based upon the previously common biomarkers together with plasma metabolomes. I
have a few questions and suggestions as of the following:
1\. The authors should give more details regarding sample collection and
treatment history of the enrolled cases, including 1) the blood samples were
collected at which day of their symptoms (please give the range), 2) what was
the treatment for symptomatic patients (both mild and severe cases)?, and 3) did
the patients receive treatment (by physicians or by somebody else) prior to the
sample collection? In fact, the treatment and the onset of disease at the time
of sample collection may confound the predictive models.
2\. Were there any patients who developed the progression of symptoms (from mild
to severe) and was there mortality among the severe cases? If there were, the
authors should identify the differences of biomarkers and plasma metabolomes
between the progressive cases vs. the non-progressive cases and between the
survival vs. the non-survival cases. This may contribute to the identification
of prognostic markers in this study as well.
3\. Besides age, sex, and co-morbidities, did the authors include some
demographic information of the patients in the predictive models? For example,
body mass index, smoking history, alcohol drinking history, physical activity,
and medications since these can affect pulmonary and immune function that may
determine the disease severity of COVID-19. In other words, adding these
parameters to the models may increase the accuracy of prediction.
4\. Please give the rationale why the authors ran only the positive mode on the
LC/MS. According to my previous run, the negative mode of this LC/MS condition
could provide a lot of additional endogenous metabolomes, especially free fatty
acids and phospholipids that play a crucial role in the pathophysiology of
several diseases.
5\. Considering the positive mode LC/MS used in this study, this protocol is
robust for the determination of acylcarnitines and phospholipids in human
plasma. Again, these endogenous metabolomes play an important role in
pathophysiology of several diseases. However, most of these metabolomes were not
included in the 99 identified metabolomes of this study. Therefore, the authors
should quantify these metabolomes and add them to the models.
6\. Among 99 identified metabolomes, some of them are considered exogenous
compounds, such as caffeine, chlorpheniramine, acetaminophen, acetaminophen
glucuronide, and paracetamol sulfate. It is less likely that these metabolomes
are involved in the pathophysiology of COVID-19, and hence I do not think that
they should be included in the predictive models. Specifically, the authors’
results showed that acetaminophen, acetaminophen glucuronide, and paracetamol
sulfate were 3 of 5 significant metabolomes that predicted COVID-19 severity.
According to these findings, it was likely that the severe cases received more
paracetamol than asymptomatic/mild cases. Therefore, the exogenous metabolomes
should be reported only in terms of the difference between groups of patients,
but they should be excluded from the predictive models.
7\. The authors demonstrated that LDL exerted the highest accuracy level in
predicting COVID-19 severity among the clinical biomarkers (Page 13, Lines
285-286). This finding was really interesting and should be included in the
discussion section.
8\. Since the authors showed that LDL exhibited that highest accuracy level in
predicting COVID-19 severity, it was likely that lipid status and insulin
sensitivity play a critical role in severity of COVID-19. Did the authors
include triglyceride, total cholesterol, HDL, VLDL, glucose, insulin, and HOMA-
IR in the models? If the author did, what were the results? If the authors did
not, I suggest that the authors should include them in the models.
Reviewer \#2: I have 4 major comments, added here. The remaining will be
uploaded as a document. From my perspective those 4 points are very important
blockers to a publication at this stage.
1\. As briefly mentioned at the end of the discussion session this study
requires a validation. No test / validation population was curved out from the
initial cohort and all reported results were calculated on the full set of data.
As such they are unreliably optimistic. This is hinted by the unusually high AUC
values. I would strongly recommend that the proposed model(s) performance is
validated in a new cohort prior to publication.
2\. As only few metabolites resulting from LC-MS were retained for the models I
recommend that prior to publication the identification of those is validated
against a standard. This will give the high confidence level (MSI 1) required to
be of use to the scientific community. More specifically in the case of COVID-19
patients a lot of cytosine containing compounds are elevated. For many of those
compounds the cytosine sub-structure tends to break easily at the MS source
resulting in multitude of cytosine events in an acquired TIC. Each of those
events will have a good match to cytosine based on MS/MS, but not on RT. Please
make sure that the metabolic feature you selected for you model overlap in RT
with a cytosine standard for your method i.e., column and LC-MS conditions.
3\. I strongly believe that predictive models should not rely on detecting
medication (K_4\_aminophenol, acetaminophen) in patient’s blood. This is highly
subjective to patient’s lifestyle choices and hospital practices.
4\. The study states in the abstract that “almost all such models, which relied
on serum/plasma biomarkers, clinical data or a combination of both, were
subsequently deemed as cumbersome, inadequate and/or subject to bias”. However,
very few predictive models of COVID severity were discussed in this work. I
don’t believe that this statement was well defended. A more thorough discussion
on the alignment / misalignment of this study findings with previous models will
be beneficial to the community. The LC-MS findings more specifically were
lacking coverage.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0289738.r002
Author response to Decision Letter 0
26 May 2023
Reviewer \#1 (R1): The authors developed the predictive models of COVID-19
severity based upon the previously common biomarkers together with plasma
metabolomes. I have a few questions and suggestions as of the following:
Q1. The authors should give more details regarding sample collection and
treatment history of the enrolled cases, including 1) the blood samples were
collected at which day of their symptoms (please give the range), 2) what was
the treatment for symptomatic patients (both mild and severe cases)?, and 3) did
the patients receive treatment (by physicians or by somebody else) prior to the
sample collection? In fact, the treatment and the onset of disease at the time
of sample collection may confound the predictive models.
Response (R1 Q1): We thank the reviewer for his/her suggest. More details were
provided regarding sample collection as per the reviewer’s suggestion. Regarding
the issue of patient management, please note that this was in the early stages
of the pandemic when treatment options were very limited and treatment
guidelines were constantly changing. Please see Material and Methods, sample
collection, page (P) 6-7 Line (L) 131-134.
Q2. Were there any patients who developed the progression of symptoms (from mild
to severe) and was there mortality among the severe cases? If there were, the
authors should identify the differences of biomarkers and plasma metabolomes
between the progressive cases vs. the non-progressive cases and between the
survival vs. the non-survival cases. This may contribute to the identification
of prognostic markers in this study as well.
Response (R1 Q2): While the reviewer’s comment is very relevant, patient follow
up was not possible Aas this was a retrospective study.
Q.3. Besides age, sex, and co-morbidities, did the authors include some
demographic information of the patients in the predictive models? For example,
body mass index, smoking history, alcohol drinking history, physical activity,
and medications since these can affect pulmonary and immune function that may
determine the disease severity of COVID-19. In other words, adding these
parameters to the models may increase the accuracy of prediction.
Response (R1 Q3): We thank the reviewer for his/her comment and we totally agree
with the reviewer’s comment; smoking history, alcohol consumption, etc. do
indeed complicate the clinical picture and can be useful in predicating disease
progression. In fact, previous models have evaluated the utility of some such
demographic variables and showed that they are indeed very useful. (please see
Boudou, M., et al. Sci Rep 11, 18474 (2021).
<https://doi.org/10.1038/s41598-021-98008-6>). In this study however, no
demographic parameters were included as the focus of the study was to test
whether combining key routine lab findings such as plasma ferritin levels plus
differential metabolomics profiling can be used to predict patient severity. To
accommodate the reviewer’s concern, the reasoning behind excluding demographic
parameters was briefly described. Please see P11 L39-37
Q4. Please give the rationale why the authors ran only the positive mode on the
LC/MS. According to my previous run, the negative mode of this LC/MS condition
could provide a lot of additional endogenous metabolomes, especially free fatty
acids and phospholipids that play a crucial role in the pathophysiology of
several diseases.
Response (R1 Q4). We agree with the reviewer on the ionization mode of the
processed samples; however, the goal of the study was metabolic profiling
against our data base (HMDB), which is not comprehensive for metabolites prone
to ionization in negative mode, such as fatty acids and phospholipids; thus,
switching to negative mode will not improve the identification of certain
metabolites. Furthermore, we have previously conducted studies with negative
mode, and the results were not satisfactory.
Q5. Considering the positive mode LC/MS used in this study, this protocol is
robust for the determination of acylcarnitines and phospholipids in human
plasma. Again, these endogenous metabolomes play an important role in
pathophysiology of several diseases. However, most of these metabolomes were not
included in the 99 identified metabolomes of this study. Therefore, the authors
should quantify these metabolomes and add them to the models.
Response (R1 Q5). Typically, the formation of acylcarnitine (carriers of the
acetyl group) as an intermediate will occur in the intermembranous space of the
mitochondria, transported into the matrix of the mitochondria, then hydrolyzed
into carnitine and Acyl-CoA, so the time frame of its availability is short, and
therefore, is identified as carnitine.
Q6. Among 99 identified metabolomes, some of them are considered exogenous
compounds, such as caffeine, chlorpheniramine, acetaminophen, acetaminophen
glucuronide, and paracetamol sulfate. It is less likely that these metabolomes
are involved in the pathophysiology of COVID-19, and hence I do not think that
they should be included in the predictive models. Specifically, the authors’
results showed that acetaminophen, acetaminophen glucuronide, and paracetamol
sulfate were 3 of 5 significant metabolomes that predicted COVID-19 severity.
According to these findings, it was likely that the severe cases received more
paracetamol than asymptomatic/mild cases. Therefore, the exogenous metabolomes
should be reported only in terms of the difference between groups of patients,
but they should be excluded from the predictive models.
Response (R1 Q6): The authors thank the reviewer for this important comment and
totally agree him/her on excluding the exogenous metabolomes from the predictive
models. Accordingly, the authors decided to remove Model 1 which includes
K-4-aminophenol and acetaminophen as predictors. The manuscript now reports a
single model for predicting disease severity. The reported model includes a
total of six predictors (5 lab findings and one metabolite, cytosine). Edits are
highlighted in the manuscript in the subsection entitled “Predicting COVID-19
disease severity’ under the Results section. Furthermore, under the Discussion
section, a few statements were added to explain why these metabolomes were
excluded from the predictive model despite showing significant predictive
findings in their ROC-AUC values. All edits and additions were highlighted in
yellow in the Results, Discussion and Conclusion sections.
Q7. The authors demonstrated that LDL exerted the highest accuracy level in
predicting COVID-19 severity among the clinical biomarkers (Page 13, Lines
285-286). This finding was really interesting and should be included in the
discussion section.
Response (R1 Q7): We thank the reviewer for drawing our attention to this point.
Unfortunately, the term LDL was erroneously used a couple of times in place of
the correct term (LDH); we sincerely apologize for this error.
Q8. Since the authors showed that LDL exhibited that highest accuracy level in
predicting COVID-19 severity, it was likely that lipid status and insulin
sensitivity play a critical role in severity of COVID-19. Did the authors
include triglyceride, total cholesterol, HDL, VLDL, glucose, insulin, and HOMA-
IR in the models? If the author did, what were the results? If the authors did
not, I suggest that the authors should include them in the models.
Response (R1 Q8): The authors thank the reviewer. Unfortunately, lipid status
and insulin sensitivity were not included in the patients’ dataset. This point
was addressed as a limitation in the discussion.
Reviewer \#2: I have 4 major comments, added here. The remaining will be
uploaded as a document. From my perspective those 4 points are very important
blockers to a publication at this stage.
Q1. As briefly mentioned at the end of the discussion session this study
requires a validation. No test / validation population was curved out from the
initial cohort and all reported results were calculated on the full set of data.
As such they are unreliably optimistic. This is hinted by the unusually high AUC
values. I would strongly recommend that the proposed model(s) performance is
validated in a new cohort prior to publication.
Response (R2 Q1): The authors agree to this point and have addressed it as a
limitation under the Discussion section. P22 L455-459
2\. As only few metabolites resulting from LC-MS were retained for the models I
recommend that prior to publication the identification of those is validated
against a standard. This will give the high confidence level (MSI 1) required to
be of use to the scientific community. More specifically in the case of COVID-19
patients a lot of cytosine containing compounds are elevated. For many of those
compounds the cytosine sub-structure tends to break easily at the MS source
resulting in multitude of cytosine events in an acquired TIC. Each of those
events will have a good match to cytosine based on MS/MS, but not on RT. Please
make sure that the metabolic feature you selected for you model overlap in RT
with a cytosine standard for your method i.e., column and LC-MS conditions.
Response (R2 Q2): For untargeted metabolomics analysis we follow a standard
protocol according to the manufacturer’s recommendations “Acquisition of high
quality LC-MS/MS data follows sample preparation in non-targeted metabolomics
workflows, with the T-ReX® LC-QTOF solution, no LC-MS/MS parameter optimization
is required” and “To analyze large sample cohorts which require high retention
time stability the Elute UHPLC in combination with the dedicated T-ReX® Elute
Metabolomics-kit: RP was used”. The Reversed-Phase LC column kit enables
matching of retention times to values in the Bruker HMDB Metabolite Library.
So, we use the same column, Elute UHPLC System, mobile phase gradients, and all
parameters and settings.
The m/z measurements were externally calibrated using 10 mM of sodium formate
before sample analysis. In addition, sodium formate solution was injected at the
beginning of each sample run and used for internal calibration during data
processing.
TRX-2101/RT-28-calibrants for Bruker T-ReX LC-QTOF (Nova Medical Testing Inc.)
was injected before sample analysis to check and test the performance of the
column reversed-phase liquid chromatography (RPLC) separation, multipoint
retention time calibration, and the mass spectrometer. Also, TRX-3112-R/MS
Certified Human serum for Bruker T-ReX LC-QTOF solution (Nova Medical Testing
Inc.) was prepared from pooled human blood and injected before sample analysis
to check the performance of the LC-MS instruments.
As a standard protocol, the test mixture data files were uploaded to Metaboscape
4.0 and confirmed the presence of the entire set of metabolites in the samples
by choosing the set with a higher annotation quality score (AQ score)
representing the best retention time values, MS/MS score, m/z values, mSigma.
Based on the nearest retention time values registered in the HMDB library all
metabolites are filtered
Q3. I strongly believe that predictive models should not rely on detecting
medication (K_4\_aminophenol, acetaminophen) in patient’s blood. This is highly
subjective to patient’s lifestyle choices and hospital practices.
Response (R2 Q3): The authors thank the reviewer for this important comment and
totally agree about on excluding the exogenous metabolomes from the predictive
models. Accordingly, the authors decided to remove Model 1 which includes
K-4-aminophenol and acetaminophen as predictors. The manuscript now reports a
single model for predicting disease severity. The reported model includes a
total of six predictors (5 lab findings and one metabolite, cytosine). Edits are
highlighted in the manuscript in the subsection entitled “Predicting COVID-19
disease severity’ under the Results section. Furthermore, under the Discussion
section, a few statements were added to explain why these metabolomes were
excluded from the predictive model despite showing significant predictive
findings in their ROC-AUC values. All edits and additions were highlighted in
yellow in the Results, Discussion and Conclusion sections.
Q4. The study states in the abstract that “almost all such models, which relied
on serum/plasma biomarkers, clinical data or a combination of both, were
subsequently deemed as cumbersome, inadequate and/or subject to bias”. However,
very few predictive models of COVID severity were discussed in this work. I
don’t believe that this statement was well defended. A more thorough discussion
on the alignment / misalignment of this study findings with previous models will
be beneficial to the community.
Response (R2 Q4): We thank the reviewer for his/her comment. Firstly, the
reviewer’s comment made it clear to us that we perhaps overstated the case
regarding the lack of utility of previous models which relied on lab findings,
clinical symptoms and demographics. Our commentary on previous models both in
the abstract and in the discussion were watered down not to overstate the case.
Secondly, as the reviewer suggest, the discussion was expanded and re-organized
to better argue our case. Please see Abstract, lines 2-4 and discussion section,
page …, line …
Q5 The LC-MS findings more specifically were lacking coverage.
Response (R2 Q5): We understand the reviewer's criticism regarding the
identification of specific metabolites; nevertheless, the identification was
compared to the 800 metabolites present in our HMDB, therefore we chose to use a
more stringent set of criteria as described in M&M and keep those metabolites
assigned by MS/MS only. This reduced the risk of false positive identifications.
Accordingly, the number of metabolites here reported is comparable to other
studies using the similar workflow
10.1371/journal.pone.0289738.r003
Decision Letter 1
Trongtrakul
Konlawij
Academic Editor
2023
Konlawij Trongtrakul
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
26 Jul 2023
Plasma metabolomics profiling identifies new predictive biomarkers for disease
severity in COVID-19 patients
PONE-D-22-27539R1
Dear Dr. Hamad,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Konlawij Trongtrakul, MD PhD
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
\*\*\*\*\*\*\*\*\*\*
10.1371/journal.pone.0289738.r004
Acceptance letter
Trongtrakul
Konlawij
Academic Editor
2023
Konlawij Trongtrakul
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
3 Aug 2023
PONE-D-22-27539R1
Plasma metabolomics profiling identifies new predictive biomarkers for disease
severity in COVID-19 patients
Dear Dr. Hamad:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Konlawij Trongtrakul
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interest exist.
|
# Introduction
A considerable amount of evidence has accumulated demonstrating that personality
traits show important associations with health and longevity. Conscientiousness,
a dispositional tendency to be industrious, norm adhering, planful, and to
thoughtfully inhibit impulses, has emerged as the Big Five trait most
consistently associated with these outcomes. Mechanisms linking
conscientiousness to health are diverse and include health behaviors such as
smoking, physical activity, and diet. Conscientiousness also operates on health
outcomes via social environmental factors, such as educational attainment, and
socioeconomic status. As a result, conscientiousness has the potential to offer
a large cumulative health benefit across multiple pathways, which may account
for the now well-established association between conscientiousness and
mortality. Conscientiousness is related to patterns of states and behaviors
across a wide variety of health related domains, and as a result plays an
important role in models of successful aging.
Many of the same mechanisms linking conscientiousness to health and mortality,
including physical activity, smoking, and educational attainment, have also been
found to predict leukocyte telomere length (LTL). Telomeres are nucleoprotein
structures which cap the ends of chromosomes, maintaining their structural
integrity and preventing end to end fusion. In the absence of telomerase
activity, telomeres shorten with each cell division. Critically short telomere
length has been proposed as a mechanism leading to cell senescence or cell
death. As a result, LTL has been proposed as a marker of biological cell aging.
Consistent with this, shorter LTL is prospectively associated with mortality
from cardiovascular disease in elderly individuals. Evidence for LTL as causal
mechanism in the aging process however is limited, and at the present time it is
perhaps best viewed as a surrogate endpoint for cumulative cellular damage.
Because LTL is a cumulative outcome resulting from biological insults and
stresses across many years, dispositional traits, which may exert persistent
effects on factors related to health, are expected to also be associated with
LTL. While this view is generally accepted, most of the work to date focusing on
dispositional characteristics and variation in LTL has focused on health
damaging effects associated with depression, anxiety, and neuroticism in the
context of stressful and traumatic life events. In contrast, few studies have
considered that dispositional traits positively associated with health might be
associated LTL. Despite a large body of work suggesting overlapping correlates
across both conscientiousness and LTL, only one recent study in Japanese medical
students (mean age 23) has reported a cross sectional association between longer
LTL and conscientiousness. To our knowledge ours is the first study
investigating a prospective association between conscientiousness in childhood
and LTL in later life. Predicated on the notion that conscientiousness serves as
a stable dispositional trait which increases the likelihood that individuals
will participate in a variety of health promoting behaviors and select into
social environments that are conducive to health, we propose that
conscientiousness will have a protective effect on LTL. Accordingly, we
hypothesized that conscientiousness will predict LTL prospectively, such that
individuals higher on conscientiousness early in life will show longer LTL in
adulthood. We present pilot results using data from the ongoing Hawaii
Personality and Health Study. A small number of stored dried blood samples out
of a pool of approximately 800 available for testing were selected to validate
our methods of DNA extraction and assaying LTL; we additionally planned to use
these pilot data for an initial test of the association between childhood
conscientiousness and LTL. Previously we had demonstrated that childhood
conscientiousness predicts a global measure of physical dysregulation comprised
of 11 objective biomarkers. As LTL and physiological dysregulation may be
complimentary outcomes, we tested the degree to which childhood
conscientiousness was associated with LTL independent of physiological
dysregulation. Because LTL has been demonstrated to vary across cultural and
ethnic groups, we additionally report on differences in LTL across ethnic and
cultural groups and include this important variable in our analyses.
# Methods
## Ethics Statement
Study protocols for locating participants in adulthood, the adult clinic visit
and for follow-up questionnaires in adulthood were approved by the IRBs at both
the Oregon Research Institute and the Kaiser Permanente Center for Health
Research, Hawaii. Upon being contacted in adulthood, the participants included
in these analyses gave consent for their childhood personality data to be used
as part of an ongoing longitudinal study. Written consent was provided prior to
the clinic visit in adulthood, and participants who agreed to provide blood
samples gave additional written consent for these to be used for future genetic
analyses. Prior to completing questionnaires in adulthood, all participants
completed and returned written consent forms by mail.
## Participants
We used existing data and stored dried blood spots from the Hawaii Longitudinal
Personality and Health Study. This project began with teacher assessments of
childhood personality between 1959 and 1967 when the child sample was an average
age of 10. Elementary school teachers’ personality assessments of all the
children in their classrooms were obtained from elementary schools on the
Hawaiian islands of Oahu and Kauai (*n* = 2,418). The schools were
geographically dispersed across these islands, and represented a wide range of
socio-economic status (SES).
Beginning in 1998, efforts were initiated to locate members of the original
child cohort in adulthood. Currently, 84% of the 2,320 available participants
have been located. Of the 1,904 individuals who were living and available at the
time of initial contact, 1,387 (73%) have agreed to participate in further
research. Participants have completed several questionnaires administered
between 1999 and the present. Data from two questionnaires were used in this
report. Objective measures of physical health were collected as part of a clinic
visit conducted at the Kaiser Permanente Center for Health Research, Hawaii in
Honolulu, and also in clinics on the islands of Kauai and Hawaii. Health
assessments were conducted by qualified staff using standard protocols, and
included the collection of dried blood spots (see below for details). A total of
807 participants completed the clinic visit between 2002 and 2011, and 699 of
these participants agreed to provide dried blood samples. The average year of
assessment was 2006; approximately 40 years after the childhood assessments. The
mean age of the clinic sample at the time of assessment was 51 years. The full
adult sample reflects the ethnic diversity of Hawaii, and includes 44% Asian
Americans, 22% Native Hawaiians or part Native Hawaiians, 15% of European
ancestry, and 11% of Filipino ancestry, 4% indicating “other”, and 4% declining
to respond.
Financial constraints limited the number of samples that could be tested in the
pilot. To allow for the possibility of finding an association we performed this
initial test of the hypothesis that childhood levels of conscientiousness would
predict adult LTL using an extreme groups design. LTL tends to differ across
sexes, such that women tend to have longer telomeres at any given age.
Participants who were assessed in one school, the University of Hawaii Lab
School (*n* = 78), were excluded because they were assessed using a different
set of items in childhood. Given the concern that sex difference could confound
our findings, we elected to limit the current study to only one sex. The pilot
sample was selected from women rather than men, and the choice of women instead
of men was arbitrary. gives a flow diagram of the selection process for the
pilot sample. The subsample for the current study was selected from those adult
women who had provided a dried blood spot during the clinic visit and had also
consented to allow this material to be used for future genetic analyses (n =
323). We ranked this subset of participants on childhood conscientiousness
scores. Of these we selected the 30 scoring highest, and the 30 scoring lowest
on childhood conscientiousness. In terms of standardized scores, this
corresponded to cutoff points at 1.23 standard deviations above, and 1.40
standard deviations bellow the mean for childhood conscientiousness.
## Measures
### Childhood personality
For the sample included in our analyses, a common set of 39 items across the
samples was assessed across schools. Attributes were selected for their
observability and focus groups of teachers developed definitions for each item.
For each childhood item, teachers were presented with the definition and a list
of their students’ names. At the end of the school year, teachers ranked every
student in their class using a fixed nine-step quasi-normal distribution.
Students were in grades 1, 2, 5 or 6. The majority of the sample, including all
those in the pilot sample, were assessed on only one occasion in childhood.
Example items assessing childhood conscientiousness include *Careful of personal
belongings*, *Planful*, and *Persevering*. Although the items were selected
prior to the widespread acceptance of the Big Five model of personality, Big
Five personality factors have been robustly identified in these data, as is
described in detail by Goldberg. Of these, the conscientiousness scale
demonstrates acceptable reliability with α =.77. The stability of personality
traits tends to increase with age. For a subset of the child sample assessed on
more than one occasion, conscientiousness demonstrated adequate one year
stability for childhood traits with a test re-test correlation of *r* =.53. Over
long spans of time, personality traits are moderately stable. The best available
estimate for the expected stability of personality traits over a 40 year span
derived from a meta-analysis of over 150 longitudinal studies of personality is
moderate with an estimated correlation of *r* =.25. Conscientiousness
demonstrates a level of stability in our full sample that is directly in line
with this estimate. Across a variety of instruments used to collect self-ratings
of conscientiousness in adulthood and the teacher assessments in childhood, we
find a 40 year stability coefficient of *r* =.25. In more recent research,
teacher ratings of conscientiousness in childhood converge with parent ratings
at levels similar to that observed for multiple observers rating adults they
know well. Moreover, childhood conscientiousness in the Hawaii study shows
predictive validity with respect to outcomes decades later in adulthood
including educational attainment, the selection of occupational environments,
health behaviors, and objectively measured physical health. This provides strong
evidence for the reliability and validity of the teacher assessments.
### Adult personality
As part of a mailed questionnaire, participants completed 120 items from the
International Personality Item Pool (IPIP; items, scoring information, scale
reliability, and convergent validity estimates available at
[http://ipip.ori.org](http://ipip.ori.org/).) designed to assess the Big Five
personality factors. Scores on conscientiousness were based on 24 items selected
to replicate the facet structure of the NEO-PI-R conscientiousness scale.
Participants rated these on a 1 (*not at all like me*) to 5 (*a lot like me*)
scale. Adult conscientiousness scores were the sum of these 24 items.
Reliability of the IPIP-NEO conscientiousness scale is excellent (α =.90), and
the scale shows high convergence with the corresponding NEO-PI-R scale (*r*
=.80). The NEO-PI-R is one of the most widely used measures of the Five Factor
model and has established reliability and validity. Similarly the IPIP-NEO has
demonstrated concurrent and criterion validity. Recent reports linking IPIP-NEO
conscientiousness measured in adulthood to health behaviors, objective health
outcomes, and mortality further support the validity of the measure. Ten
participants in the pilot sample failed to complete and return the adult
personality assessment.
### Demographics
Demographic variables including date of birth, sex, self-identified culture, and
educational attainment were assessed by questionnaire. Educational attainment
was measured on a 9-point scale ranging from 1 *(eighth grade or less)* to 9
(*postgraduate or professional degree)*. Five participants did not respond to
the educational attainment item.
Participants self-selected their own cultural identity from 12 options, and were
instructed to select the one cultural group that they most identified with in
cases where individuals identified with more one group. For the current
analyses, cultural groups were collapsed into five groups: Caucasian (n = 10),
Asian American (n = 21), Hawaiian/part Hawaiian (n = 9), Filipino (n = 11), and
other (n = 4). Three participants in the pilot sample declined to indicate their
cultural identity.
We performed a series of chi-square goodness of fit tests in order to evaluate
whether the observed proportions for cultural groups in pilot sample, and in the
selected extreme groups (both high and low) differed from the sample from which
these were drawn (n = 323). The proportion of participants in each cultural
group did not differ in the pilot sample (χ<sup>2</sup> = 7.34, df = 5, p =.197)
in the low conscientiousness group (χ<sup>2</sup> = 5.59, df = 5, p =.349), or
in the high conscientiousness group (χ<sup>2</sup> = 9.25, df = 5, p =.100) when
compared to the proportions observed in the sample from which these were drawn
(n = 323).
### Smoking
Lifetime history of smoking behavior was assessed via questionnaire. Pack years,
defined as smoking one pack a day for one year, were derived from these. To
create a smoking variable incorporating cumulative pack years with current
smoking status, participants’ self-reported smoking histories were coded into a
five point scale based on the distribution of smoking history in the full sample
*(0 = ≤ 100 cigarettes smoked*, *1 = previously smoked \< 8 pack- years*, *2 =
previously smoked ≥ 8 pack years*, *3 = currently smoke ≤ ½ pack a day*, *4 =
currently smoke \> ½ pack a day)*. Eight participants provided incomplete
smoking data.
### Physical activity
Three questionnaire items assessed strenuous, moderate, and mild physical
activity via questionnaire. Participants were asked to rate their activities
over a typical seven day period in the past year, including only activities
lasting 15 minutes or more. For each item, a list of example activities was
provided. Frequency for each item was rated on a five point scale *(0 = zero
times*, *1 = one or two times*, *2 = three or four times*, *3 = five or six
times*, *4 = seven or more times)*. Scores on these three items were aggregated
by a weighted sum. Four participants failed to complete these items. Twelve
additional participants were administered a shortened questionnaire that did not
include the physical activity items.
### BMI
Height and weight were recorded as part of the clinic visit using a stadiometer
and a balance beam scale. Scores for BMI were calculated using the standard
formula (kg/m<sup>2</sup>).
### Physiological dysregulation
Global health status was indexed using an aggregate score of 11 clinical
indicators assessed during the clinic visit. These are systolic and diastolic
blood pressure (measured twice and averaged), HDL cholesterol, total
cholesterol/LDL ratio, fasting triglycerides, fasting blood glucose, body mass
index (BMI), waist/hip ratio, urine protein (log transformed), and whether or
not the participant was using prescription drugs for cholesterol or blood
pressure.
Participants arrived at the clinic in a fasting state. Blood from a venous arm
draw, as well as urine samples, were collected and immediately sent for lab
analysis. Waist circumference was measured at the point midway between the
lowest rib and the iliac crest. Measures of hip circumference were made at the
point where the gluteal muscle showed the greatest protrusion. Blood pressure
was measured after five minutes of rest in a seated position using a
sphygmomanometer. Two measures were taken with a one minute interval.
Measures were scored such that higher scores corresponded to worse health. For
some biomarkers, scores at either extreme can be unhealthy. We evaluated the
number of participants in the full sample falling into the low/unhealthy range
for each biomarker, and found that in all cases less than 1.2% met this
criterion. Each measure was standardized and converted to a deviation score from
the mean. The 11 biomarkers were not highly correlated with each other, and
factor analysis did not reveal a single factor solution. Following
recommendations for aggregating uncorrelated indicators we constructed an index
by summing standardized scores, such that higher scores corresponded to greater
physiological dysregulation, and worse health. Participant in the full sample
who had more than 3 biomarkers missing were not scored on dysregulation. Of the
participants included in the pilot sample, all but one had complete data on the
dysregulation measure, and one participant was missing 3 biomarkers. More detail
on the derivation of the physiological dysregulation scale can be found in
Hampson, et al..
### Leukocyte telomere length
During the clinic visit, blood from a venous arm draw (125 μL) was blotted onto
Whatman FTA Micro-cards (cat# WB120210) specifically designed for long-term
preservation of dried blood and nucleic acids for quantitative DNA analysis.
Following the manufacturer’s instructions, the dried blood spots were air dried,
placed in plastic bags with an appropriate desiccant, and stored in the dark at
room temperature. Specimens for the current study were identified, then shipped
overnight in a room temperature-controlled box to Dr. Côté’s lab at the
University of British Columbia (UBC). Researchers who assayed the samples
remained blind to all participant data. Six 2mm punches were removed from each
blood spot. DNA was extracted from these punches using QIA Amp kit on a QIA Cube
(QIAGEN), and LTL was assayed using qPCR following methods described by Cawthon
which have been modified and recently extended for use on dried blood spot
samples. Samples were assayed in duplicate, on two 96-well plates, using the
undiluted DNA extracted from the dried blood spots. The DNA concentrations
ranged from 3 to 7 ng/μL. The standard curve was built from a serial dilution of
human genomic DNA pooled from frozen whole blood from 24 healthy donors. Three
internal controls (one DNA from a human cell line, one from pooled genomic DNA,
and the other from a single volunteer) were included in each run and used for
quality control related to the Lightcycler run; these were not used to
normalize, and their T/S ratio was not incorporated into the standard curve. All
samples were amplified successfully and met our quality control criteria. All
runs had a PCR efficiency between 1.88 (94%) and 1.95 (97.5%). The intra-run
(n-12) coefficient of variation (CV) for this assay is 5%, and based on the
internal control included in each of the 22 runs performed, the inter-run CV was
8.5%. The assay produces an arbitrary count for telomeric DNA (T), and for a
specific single copy nuclear gene DNA (S). The ratio of these (T/S) was then
used as a measure of average relative LTL. We previously showed that DBS LTL is
highly correlated with whole blood LTL.
## Statistical Analysis
SPSS version 19 was used for statistical analysis. Group comparisons were
evaluated using *t*-tests and ANOVAs. Standardized group differences were
estimated using Cohen’s *d*. Tests of normality were conducted using the
Shapiro-Wilk statistic. Non-parametric tests were conducted using a Mann-Whitney
U test. Effect sizes were estimated by Pearson correlations, biserial
correlation, and partial biserial correlations where appropriate, and all
significance tests (α =.05) were two tailed. To maximize the sample size, all
analyses employed pairwise deletion in the presence of missing data, hence
sample size varied across analyses.
# Results
Initial examination of the distribution of the study variables revealed two
extreme outliers, each with LTL exceeding 3.5 standard deviations above the
mean. The two dried blood spots used for DNA extraction for these participants
had been stored on filter paper designed for neonatal blood samples rather than
the Whatman micro cards used for the rest of the sample. Because these LTL
measurements seemed implausible, and the difference could be attributed to the
difference in filter paper, they were excluded from our main analysis. provides
descriptive information on the full sample from which the subsample was drawn,
as well as the high and low childhood conscientiousness groups after removing
the two extreme outliers, one from each group. The subsample (n = 58) did not
differ from the full sample (n = 323) on any of the variables tested, and LTL
was normally distributed (*W* =.96, *p* =.09). Consistent with our previous work
with the Hawaii cohort, higher childhood conscientiousness was associated with
higher educational attainment, lower BMIs, and healthier (lower) levels of
overall physiological dysregulation. The high and low childhood
conscientiousness groups did not differ with respect to age at the time of the
childhood assessment, or at the time of the blood draw in adulthood. The two
groups did not differ in levels of adult conscientiousness, smoking, or physical
activity levels. Due to the use of an extreme groups design based on childhood
conscientiousness, childhood conscientiousness was not normally distributed (*W*
=.81, *p* \<.00). Because of this, associations with childhood conscientiousness
were estimated using biserial correlations. The correlation between childhood
conscientiousness and adult conscientiousness was similar in magnitude to that
observed in our full sample (*r* =.19, *p* =.20, *n* = 48). The correlation was
not significant at the level of *p* =.05, likely due the small sample size.
A *t*-test to evaluate differences in LTL between the two groups was significant
(*t* = 2.38, *df* = 56; *p* =.02), such that adult women who had been described
by their teachers as higher on conscientiousness 40 years earlier had longer LTL
(Cohen’s *d* =.62). This difference is illustrated in. We obtained a similar
result using a non-parametric test including the two previously removed
outliers. Specifically, a Mann-Whitney U test demonstrated that the high
childhood conscientiousness group (*n* = 30, median LTL = 7.32) differed from
the low childhood conscientiousness group (*n* = 30, median LTL = 6.01) on adult
LTL (*U* = 303.00, Z = -2.17, *p* =.03).
We next tested for associations between potential covariates and LTL. provides
correlations for all study variables and LTL. The only significant correlation
reported is the biserial correlation between LTL and childhood conscientiousness
(*r* =.30; *p* =.02). Age, physiological dysregulation, educational attainment,
and adult conscientiousness were not significantly correlated with LTL.
The subsample did not have sufficient power to use multiple regression to test
potential confounding variables or mediators for the effect of interest. None of
the potential covariates or mediators in were significantly associated with LTL.
However, because we expect that these variables may account for some portion of
the association between childhood conscientiousness and LTL, we report the
partial biserial correlations between childhood conscientiousness and LTL
controlling in turn for age, physiological dysregulation, educational
attainment, adult conscientiousness, smoking, BMI, and physical activity
separately in. We contrasted these with the raw biserial correlation between
childhood conscientiousness and LTL reported in. Controlling for age did not
attenuate the raw biserial correlation, likely due to the narrow age range in
the sample. Similarly, controlling for adult conscientiousness had no
appreciable effect. Partial biserial correlations controlling for physiological
dysregulation and educational attainment tended to attenuate the association. In
the case of educational attainment, the partial biserial correlation failed to
reach significance (*r* =.27, *p* =.05). Separately controlling for smoking,
BMI, and physical activity attenuated the association between childhood
conscientiousness and LTL in adulthood in a similar manner.
To evaluate the degree to which LTL might vary across cultural groups, we used a
one-way ANOVA. We found differences in LTL across groups, *F*(4, 50) = 3.27, *p*
=.02. A post hoc analysis using Tukey’s HSD test revealed that individuals who
described themselves as Native Hawaiian tended to have shorter LTL in comparison
to all other groups (*p* \<.05), with the exception of those classified as
other. We next tested ethnicity and childhood conscientiousness in a two-way
ANOVA using type II sums of squares to partially adjust for unequal groups. The
overall ANOVA was significant *F*(9,45) = 3.39, *p* =.00. Both childhood
conscientiousness *F*(1, 45) = 5.06, *p* =.03 and cultural identity *F*(4, 45) =
3.04, *p* =.03 remained significantly associated with LTL. There was no
significant interaction between ethnicity and childhood conscientiousness.
We additionally tested a series of one-way ANOVAs in order to evaluate the
degree to which study variables might have differed across cultural groups. Two
variables showed cultural differences. For educational attainment, a one way
ANOVA *F*(4, 47) = 3.05, *p* =.026 showed group differences across cultural
groups. Post-hoc analyses using Tukey’s HSD showed one significant differences
across groups such that Asian Americans (*M* = 7.70, *SD* = 1.35) reported
higher educational attainment than participants identifying themselves as Native
Hawaiian (*M* = 5.29, *SD* = 1.25). In the case of, BMI a one way ANOVA *F*(4,
47) = 3.05, *p* =.026 showed group differences across cultural groups. Post-hoc
analyses using Tukey’s HSD showed that Native Hawaiians (*M* = 35.99, *SD* =
6.35) had significantly higher BMI scores in comparison to Asian Americans (*M*
= 25.60, *SD* = 8.43).
# Discussion
To our knowledge, this is the first study to demonstrate an association between
a Big Five trait in childhood and LTL in adulthood. Our findings suggest that
childhood conscientiousness assessed by teachers predicts LTL 40 years later in
adulthood.
Controlling separately for age, physiological dysregulation, educational
attainment, smoking, and BMI, attenuated the biserial correlation between of
childhood conscientiousness and adult LTL. The association remained significant
when controlling for age and dysregulation, but failed to reach significance
when controlling for educational attainment, smoking, BMI, or physical activity.
While the partial biserial correlation was not significant in this case, the
degree to which the observed association was attenuated was small. While it is
tempting to view the transition of significant to non-significant as meaningful,
this does not constitute a formal test of mediation. Partialing out adult
conscientiousness slightly increased the observed biserial correlation (*r* =.32
versus *r* =.30). This difference is likely due to sampling error and the
smaller sample size available for this analysis (*n* = 45). Partialing out
physical activity similarly increased the magnitude of the observed biserial
correlation slightly, although in this case the effect was no longer significant
(*r* =.32, p =.05), which is likely attributable to the reduction in sample size
due to missing data on physical activity (*n* = 43). We found significant
variation in LTL across ethnic groups, such that those identifying as native
Hawaiian tended to have the shortest LTL. Both childhood conscientiousness and
cultural group identity independently predicted LTL with no evidence of an
interaction.
These results suggest a novel pathway linking dispositional traits in childhood
to cumulative health that has not previously been incorporated into research on
LTL. Childhood personality traits have moderate to low levels of stability
across the life-course. Our best estimates of the rank order stability of
conscientiousness over 40 years corresponds to a correlation of *r* =.25. Both
trait level conscientiousness and cognitive features of self-regulation develop
and improve from childhood to young adulthood. Despite this, childhood
conscientiousness predicts outcomes in adulthood including physical health,
substance use, career attainment, and financial outcomes. In the broader context
of lifespan development, LTL complements the growing list of consequential
objective outcomes in adulthood associated with childhood conscientiousness.
We did not find an association between adult levels of conscientiousness and
LTL. This must be due in part reality that selecting on child conscientiousness
for an extreme groups design magnifies effects for childhood conscientiousness
but, given the moderate stability of the trait over 40 years, does not
necessarily do so for adult conscientiousness. Sadahiro et al. reported a cross
sectional association between conscientiousness and LTL in a sample of young
adults at an age intermediate to the two points of personality assessment in our
sample. It is possible that conscientiousness assessed at different points in
the lifespan may show associations of differing magnitudes with respect to LTL.
Personality and health researchers investigate models of the underlying
psychosocial and biological processes that mediate associations between
personality traits and health outcomes over the lifespan. LTL assessed in
adulthood has several advantages as an objective measure of health status when
studying these models: LTL can reflect cumulative insults, changes dynamically
over time, and can be readily measured. These features, along with
demonstrations that biological stressors, physical morbidity, and subjective
states of distress predict LTL, suggest that LTL may be viewed as a
psychobiomarker. As such, LTL offers an outcome variable that reflects the
accumulation of health effects associated with numerous psychosocial and
demographic variables. An important next step for lifespan developmental
researchers involves evaluating the degree to which associations with childhood
conscientiousness operate independently of adult trait levels and if so, whether
these depend entirely on chains of events following from child trait levels and
self-regulatory capacities. In models of effects related to health and aging,
LTL may play a unique role as an integrative objective outcome.
Particular strengths of the current study are the use of a prospective design
with a 40 year interval, and the well-executed assessment of child personality.
Although these are preliminary results, they are consequential in suggesting
future directions and methods for incorporating LTL research into lifespan
developmental models of dispositional traits related to health. Consistent with
a lifespan mediation hypothesis, we found that controlling for potential
mediators tended to attenuate the strength of association between childhood
conscientiousness and LTL.
The current study has specific limitations. An extreme groups design was
selected to enhance our ability to detect an association between childhood
conscientiousness and LTL in a preliminary sample. However, extreme groups
designs do not necessarily produce accurate estimates of effect sizes and tend
to inflate effects sizes associated with the selection variable. As a result the
raw biserial correlation between childhood conscientiousness and LTL is likely
inflated. Similarly, effect sizes for variables correlated with the selection
variable can be distorted. In our analyses, partial biserial correlations
controlling for variables associated with childhood conscientiousness are likely
to be overcorrected. We might expect the true effect size of this effect to be
reduced in magnitude in a larger sample. We have secured funding to assay
telomere length in our larger sample, and in the future we will test this
directly. Additionally, our small sample did not allow us to test multiple
competing predictors, account for confounding variables, or test mediation
hypotheses. We limited our sample to women, because there is evidence that LTL
differs across genders. As a result, our results cannot be generalized to men.
Our pilot sample is unlikely to give accurate estimates of effects related to
cultural group and these results need to be interpreted with caution. Despite
this limitation, our results do suggest the importance of investigating
differences in LTL across cultural and ethnic groups, and for controlling for
these effects when investigating predictors of LTL. Future analyses using our
full sample will allow us to accurately evaluate effects across cultural groups.
For all of these reasons, we view the present results as preliminary. Finally,
we measured LTL using a qPCR-based assay which may have a higher variability
than some other methods but is the appropriate option given the type of sample
studied here and the large number of samples to be assayed in the future.
Despite these limitations, the finding of a putative association between
childhood conscientiousness and adult LTL is remarkable. There is a paucity of
research linking personality at any stage in the life course to biomarkers of
health; more so for childhood personality traits. Our results suggest a variety
of future directions involving lifespan developmental trajectories of
dispositional traits, physical health, and LTL. In addition to providing a more
accurate estimate of the effect size of the associations presented here, future
research will allow for testing lifespan mediation models where behavioral and
environmental mechanisms can be evaluated as explanations of prospective
associations between personality traits and LTL. Pathways such as smoking,
physical activity, and diet may explain associations between dispositional
traits in childhood and LTL years later. Joint or interactive effects of
personality traits and sex, socio-economic status, and ethnicity may further
explain variability in LTL.
The authors thank all past and present members of the Lifestyle, Culture and
Health team at the Kaiser Permanente Center for Health Research, Hawaii, the
members of Dr. Côté’s lab at the University of British Columbia, and the team at
Oregon Research Institute, for their many efforts that have led to this report.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: GWE SEH. Performed the
experiments: GWE SEH HCFC. Analyzed the data: GWE. Contributed
reagents/materials/analysis tools: HCFC. Wrote the paper: GWE SEH HCFC.
|
# Introduction
From 2001 to 2006, *Salmonella enterica* serovar Enteritidis was implicated in
three outbreaks linked to raw almond consumption. Epidemiologic and traceback
investigations of a 2000 to 2001 (denoted 2001) salmonellosis outbreak in Canada
and in the United States identified a rare phage type (PT) of *Salmonella*
Enteritidis, PT 30, from clinical samples, raw almonds sampled at retail,
environmental (swab) samples at an almond processor and a huller-sheller
facility, and environmental drag swabs obtained from multiple orchards in
California. *Salmonella* Enteritidis PT 30 was recovered in 2001 (three of six
samples collected)) and, in a subsequent study, at least two times in each year
between 2002 and 2006 from environmental drag swabs collected in one of these
orchards (eight to 96 samples collected each year). Raw almonds were
epidemiologically linked to clinical cases of *Salmonella* Enteritidis PT 30
reported in Sweden in 2005 to 2006 (denoted 2006) but *Salmonella* was not
isolated from the implicated California almonds. Between 2003 and 2004 (denoted
2004), another rare phage type, *Salmonella* Enteritidis PT 9c, was linked to
consumption of raw California almonds in the United States.
Excluding the farms linked to the 2001 outbreak, the prevalence and levels of
*Salmonella* were determined in a multi-year survey of raw almond kernels.
Samples of individual lots of raw almond kernels were collected as they were
received by handlers (processors) located throughout the almond-growing regions
of California from 2001 to 2007, and in 2010 and 2013. Inshell almonds were
included in the survey in 2006 and 2007. The prevalence of *Salmonella* in
14,949 lots of raw almond kernels was 0.98% ± 0.29% over the 9 years (146
positive 100-g samples). Levels of *Salmonella* were estimated for 118 of the
positive lots; mean and median levels of *Salmonella* were 1.14 ± 1.69 and 0.79
most probable number (MPN)/100 g, respectively, with single lots at 9.25 and
15.4 MPN/100 g. Of the small number of raw inshell almond lots (455) evaluated
in 2006 and 2007, 1.5% (seven 100-g subsamples) were positive. Using classical
serological nomenclature, the *Salmonella* isolates retrieved from these surveys
were serotyped into 45 different serovars, including *Salmonella* Enteritidis PT
30 and PT 9c.
Pulsed-field gel electrophoresis (PFGE), multilocus variable-number tandem
repeat analysis (MLVA), and comparative genomic indexing (CGI) were applied to
*Salmonella* Enteritidis strains associated with the 2001, 2004, and 2006 almond
outbreaks, including clinical and environmental isolates. The *Salmonella*
Enteritidis PT 30 and PT 9c strains could be separated from each other and from
other *Salmonella* Enteritidis phage types based on DNA enzyme restriction
profiles, MLVA types, and genes identified by CGI. However, neither PFGE nor
MVLA could discriminate among the *Salmonella* Enteritidis PT 30 isolates
associated with the 2001 and 2006 almond-associated outbreaks. *Salmonella*
Enteritidis PT 30 almond-associated outbreak strains could not be distinguished
from epidemiologically unrelated *Salmonella* Enteritidis PT 30 clinical strains
included in the study. Among *Salmonella* Enteritidis PT 30 strains with
identical genotypes, metabolic analyses with Biolog revealed differences between
clinical and environmental isolates, indicating the discriminatory limit of the
then current genotyping methods. Environmental *Salmonella* Enteritidis PT 30
isolates, collected between 2001 and 2006 from one of the 2001 outbreak-
associated orchards, clustered in two groups based on the separation by PFGE of
their XbaI-digested DNA.
Whole genome sequencing (WGS) has replaced PFGE for investigating foodborne
outbreaks because of its higher resolution, and this methodology has been
incorporated into routine public health surveillance since 2014. Clonality of
pathogen strains determined by WGS analyses can provide information about
contamination during food production and distribution. Different workflows have
been developed to assess levels of genetic relatedness of foodborne pathogens by
the National Center for Biotechnology Information (NCBI) with the Pathogen
Detection Pipeline (<https://www.ncbi.nlm.nih.gov/pathogens/>), the U.S. Food
and Drug Administration with the Center for Food Safety and Applied Nutrition
CFSAN SNP Pipeline, and the U.S. Centers for Disease Control and Prevention with
Lyve-SET, based on the specific needs of the respective agencies. The CFSAN SNP
Pipeline creates high quality SNP matrices from WGS data that allow connection
between clinical isolates to food or environmental isolates based on their
evolutionary relationship. Resident pathogen strains in facilities will have
closely related WGS profiles, whereas transient pathogen strains will have
unique or unrelated WGS profiles.
The objective of the present study was a comparative genomic analysis of 171
*Salmonella* (45 serovars) isolated from raw inshell almonds and almond kernels
in 9 years of surveys conducted between 2001 and 2013; 30 *Salmonella*
Enteritidis PT 30 isolates recovered between 2001 and 2006 from a 2001 outbreak-
associated almond orchard were included in the analysis. The CFSAN SNP Pipeline
was selected to measure the genetic distances among the isolates. WGS was used
to predict antimicrobial resistance (AMR), virulence genes, and presence of
plasmid DNA.
# Materials and methods
## Isolate selection
Isolates were retrieved from enrichment of raw almond kernels and inshell
almonds (survey isolates), and from swabs that were dragged across the floor of
one of the 2001 outbreak-associated orchards (orchard isolates). A total of
15,505 ∼1-kg samples from different lots of raw almond kernels (14,949) and
inshell almonds (455) were collected upon receipt at several almond processors
located throughout California from the 2001–2005, 2006–2007, 2010 (; present
study), and 2013 (; present study) harvests, as described previously. All
samples were coded to keep the identities of the processors confidential; the
geographic origins of the samples were unknown. The Safe Food Alliance,
Kingsburg, CA (formerly American Council for Food Safety and Quality, Fresno,
CA) analyzed a 100-g subsample from each lot of almonds by enriching for the
presence of *Salmonella*. In addition, the MPN of *Salmonella* was determined
for 118 samples by enriching one or more additional samples weighing from ∼0.25
to 100 g. *Salmonella* isolates were stored at −80°C.
A total of 171 *Salmonella* survey isolates were selected for the present study:
for each individual positive almond lot, a single *Salmonella* isolate retrieved
from the initial 100-g subsample (153 positive samples, 148 isolates; three,
one, and one isolate from 2001, 2002, and 2003, respectively, were lost), any
isolates recovered from MPN or secondary enrichments that differed from the
initial serotype (12), and unique isolates recovered from secondary enrichments
of initially negative samples (11) (Tables and S1). Traditional serotyping was
done for each banked *Salmonella* by the California Animal Health and Food
Safety Laboratory System (Davis, CA), and phage typing for *Salmonella*
Enteritidis isolates was done by the National Veterinary Services Laboratory
(Ames, IA). *Salmonella* Enteritidis PT 9c LJH1024 (obtained from Robert
Mandrell, U.S. Department of Agriculture, Agricultural Research Service; RM4635
or G04-101, raw almond isolate from the 2004 outbreak) and *Salmonella*
Enteritidis PT 30 LJH0608 (raw almond isolate from the 2001 outbreak that was
deposited to the American Type Culture Collection as ATCC BAA-1045) were also
included in some of the analyses (S2 Table).
Several 2001 outbreak-associated almond orchards sampled by investigators during
the 2001 outbreak investigation were positive for *Salmonella* Enteritidis PT
30. One of these orchards was sampled every year from 2001 through 2006.
Briefly, sterile gauze swabs attached to a string and soaked in full-strength
evaporated skim milk were pulled along the orchard floor in a standardized
manner. Four individual swabs were pooled and a procedure designed for
recovering *Salmonella* from poultry houses was used to enrich the samples.
Three of six (50%) pooled swab samples collected in 2001 and 53 of 228 (23%)
samples collected between 2002 and 2006 were positive for *Salmonella*; every
isolate was identified as *Salmonella* Enteritidis PT 30. A total of 30
*Salmonella* Enteritidis PT 30 orchard isolates from 2001 (3), 2002 (12), 2003
(10), 2005 (2), and 2006 (3) were analyzed in the present study (S2 Table). One
orchard isolate from 2002 and all orchard isolates from 2004 (25) were not
available and thus not included.
Using the pathogen detection tool associated with the NCBI database
(<https://www.ncbi.nlm.nih.gov/pathogens>), the sequence read archive (SRA) data
were downloaded for 12 *Salmonella* Enteritidis PT 30 clinical isolates from the
2001 almond outbreak and for four clinical isolates from the 2006 almond
outbreak (S3 Table).
## Whole genome sequencing
Isolates were retrieved from frozen glycerol stock and plated on tryptic soy
agar (TSA). Following overnight incubation at 37°C, one colony was inoculated
into 2 ml of tryptic soy broth (TSB) and incubated for 24 h at 37°C, with
shaking at 120 rpm, before being pelleted by centrifugation at 14,000 × g for 2
min. Genomic DNA, for the isolates in S2 Table, was extracted with the QIAamp
DNA minikit (Qiagen, Valencia, CA) following the manufacturer’s directions. The
150-bp paired-end libraries were constructed for each purified DNA with the
Illumina Nextera DNA flex library kit following the manufacturer’s directions
(Illumina Inc., San Diego, CA). Pooled samples were sequenced on an Illumina
4000 HiSeq system by the DNA Technologies and Expression Analysis Core at the UC
Davis Genome Center. DNA, for all the survey isolates, was sequenced as
described by Emond-Rheault et al. in 2020. All sequence data obtained in this
study were deposited to the NCBI pathogen database under the BioProject
accession number PRJNA941918 (Tables and S2) and PRJNA951760 (S2 Table).
## Quality control and genome assembly
Raw read quality was assessed with FastQC (v0.11.8)
(<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). Illumina adapter
sequences and low-quality sequences were trimmed using Trimmomatic version 0.36.
Reads were assembled de novo with SPAdes version v3.13.0 Genome Assembler. Draft
*Salmonella* genome assemblies were serotyped with SeqSero and by aligning with
BLASTn against the nonredundant nucleotide sequence database.
## Core genome SNP typing
De novo genomes were used to build core genome single nucleotide trees using the
Parsnp aligner v1.2 with default parameters and the requirement for all genomes
to be included in the analysis. The 171 *Salmonella* genomes from the survey
were mapped to the complete reference genome *Salmonella* Typhimurium str. LT2
(NCBI accession: AE006468), resulting in an alignment of 50% of the core genome.
The whole-genome phylogeny was constructed with FastTree2. iTOL
(<http://itol.embl/de/>) was used to visualize the tree and annotate it with the
AMR genes.
## Genetic distance
Genetic distance between multiple isolates of the same serovar was evaluated as
the number of SNP differences detected with the CFSAN SNP Pipeline. The CFSAN
SNP Pipeline v2.0.2 was installed on a local ubuntu platform with all the
executable software dependencies. Prior to analyzing our data, we used the data
set provided for testing the reproducibility of the software to confirm that our
installation of the CFSAN SNP Pipeline was correct. Reference-based alignments
were created for a set of samples and used to generate the SNP matrix. Because
the software was developed for closely related genome sequences, where
available, complete assembled reference genomes were downloaded from NCBI (20;
S4 Table). The phylogenies were inferred with MEGA7 using the neighbor-joining
method based on the obtained SNP matrix formatted as a FASTA file generated by
the CFSAN SNP pipeline v2.0.2.
## Virulence and antibiotic resistance (AMR) gene prediction
The presence of resistance genes, as well as point mutations, were determined
using ResFinder 4.1 (Center for Genomic Epidemiology,
<https://cge.food.dtu.dk/services/ResFinder>) with a setting threshold of 90%
and minimum length of 60%. The assembled draft genomes for the survey isolates
(171) were used as an input to identify *Salmonella* AMR genes associated with
resistance to aminoglycoside, β-lactam, chloramphenicol, colistin,
fluoroquinolone, fosfomycin, glycopeptide, macrolide, sulfonamide, tetracycline,
and trimethoprim antibiotics. The VF analyzer pipeline was used to screen the
assembled draft genomes against the Virulence Factor Database (VFDB) for
potential virulence factors.
## Plasmid detection and reconstruction
Plasmids from genome assemblies were typed and reconstructed using MOB-suite
v3.1.0 with the default parameters. To determine the AMR and virulence genes
that were plasmid-borne, the reconstructed plasmids were screened against the
CARD ([https://card.mcmaster.ca](https://card.mcmaster.ca/)) and VFDB databases,
respectively, using Abricate v0.5 (<https://github.com/tseemann/abricate>) with
the same parameters as described above.
# Results
## Phylogenetic analysis of *Salmonella* isolates retrieved from raw almonds
Genomes were initially compared with Parsnp because the CFSAN SNP Pipeline is
not recommended for relatively distant bacteria (greater than a few hundred SNP
differences). A maximum-likelihood phylogeny tree was constructed with Parsnp
based on alignment of the 171 *Salmonella* assembled genomes. All the isolates
belonged to the species *enterica*, with most (165) belonging to the subspecies
*enterica* ( and). Three isolates were classified as subspecies *diarizonae*
and three as subspecies *arizonae*. The phylogenetic tree clustered the isolates
by serovar. The serovars identified by classical serotyping matched the serovars
predicted by WGS for 92% of the isolates. However, 14 isolates clustered with
serotypes that differed from those to which they were initially assigned by
traditional serotyping. To eliminate the possibility of manipulation errors,
these isolates were resequenced and their serotype was confirmed with SeqSero
and with BLASTn against the nonredundant nucleotide sequence database. Results
were consistent with the initial WGS serovar prediction.
Based on the core genome SNP typing, a total of 32 unique *Salmonella* serovars
were identified. Of these, 22 *Salmonella* serovars were isolated two or more
times between 2001 and 2013: Enteritidis (*n* = 16), Muenchen (*n* = 16),
Newport (*n* = 15), Montevideo (*n* = 14), Typhimurium (*n* = 12), Thompson (*n*
= 11), Give (*n* = 10), 1,4,,12:i- (*n* = 9), Oranienburg (*n* = 7),
Heidelberg (*n* = 6), Infantis (*n* = 5), Senftenberg (*n* = 5), Anatum (*n* =
4), Cerro (*n* = 4), Brandenburg (*n* = 3), Duisburg (*n* = 3), Horsham (*n* =
3), Manhattan (*n* = 3), Tennessee (*n* = 3), Agona (*n* = 2), Braenderup (*n* =
2), and Mbandaka (*n* = 2). Three isolates initially identified as *Salmonella*
Othmarschen (LJH0752, LJH1143, and LJH1276-1) clustered with *Salmonella*
Oranienburg. Both serotypes have a similar antigenic formula, 6,7,14:m,t:-,
which makes them difficult to distinguish by serological methods. Serovar
1,4,,12:i:- is a monophasic variant of *Salmonella* Typhimurium, and three
of 14 isolates initially identified as Typhimurium (LJH0738, LJH1662-1, LJH1676)
clustered with 1,4,,12:i:-. One *Salmonella* initially identified as
1,4,,12:i:- (LJH1144) clustered with Typhimurium.
Among the five isolates that were untypeable by classical serotyping, two
clustered with serovar Muenchen (LJH1151, LJH1620-1), one with Enteritidis
(LJH1029), and one with Manhattan (LJH1026). A single untypeable isolate
(LJH1624-1) clustered with *Salmonella diarizonae* (LJH1664) and was identified
as *Salmonella diarizonae* with BLASTn and SeqSero. Fifteen unique serotypes,
predicted with BLASTn and SeqSero, matched the serological serotyping. It was
difficult to predict some serovars due to the limited number of representative
genomes in the SeqSero database. *Salmonella* Zerifin LJH0724 was identified as
*Salmonella* Istanbul with SeqSero and clustered with the Istanbul isolates in
the Parsnp phylogeny tree. Conflicting serotyping results between traditional
methods and WGS have been reported in previous studies. Serotyping based on WGS
has been increasingly used by public health laboratories and federal agencies to
replace the current standard of phenotypic serotyping. In the present study,
serotype was assigned based on the WGS analysis when the serovar assignment was
identical among the phylogenetic relationship, SeqSero, and BLASTn analyses.
Except for a single strain of *Salmonella* Zerifin, all isolates (170 of 171)
were assigned a serotype based on the WGS analysis.
## Genetic distance within each serovar
The CFSAN SNP Pipeline was used to evaluate the genetic distance among multiple
isolates within each serotype. *Salmonella* Enteritidis isolates clustered in
three groups by phage type: PT 8, PT 9c, and PT 30. All five *Salmonella*
Enteritidis PT 8 isolates were retrieved in 2005 from separate almond lots and
had less than three SNP differences, classifying them as clonal isolates.
*Salmonella* Enteritidis PT 9c isolated in 2005 (LJH1028) and 2010 (LJH1272),
differed by 5 and 13 SNPs, respectively, from a 2004 *Salmonella* Enteritidis PT
9c outbreak isolate (LJH1024;).
The genomes of *Salmonella* Enteritidis PT 30 recovered from survey almonds
(eight isolates: LJH0762 \[2003\], LJH1023 \[2005\], LJH1104 \[2006\], LJH1059
\[2006\], LJH1096 \[2006\], LJH1109 \[2006\], LJH1633 \[2013\], LJH1673
\[2013\]), the 2001 outbreak-associated orchard (30 isolates; S2 Table), and a
2001 outbreak-associated almond isolate (LJH0608) were compared to *Salmonella*
Enteritidis PT 30 genomes of clinical isolates from almond outbreaks in 2001 (12
isolates) and 2006 (four isolates) (S3 Table).
*Salmonella* Enteritidis PT 30 isolates formed two clusters. One consisted of a
single survey isolate (LJH0762), recovered in 2003, that differed from LJH0608
by 48 SNPs ( and S5 Table). All other survey and clinical isolates (*n* = 38)
clustered in a single group with LJH0608 that differed from each other by ≤18
SNPs indicating that the isolates are from a common origin. Almond isolates from
2001 to 2013 had 2 to 13 SNP differences compared with the 2001 outbreak-
associated almond isolate *Salmonella* Enteritidis PT 30 LJH0608 ( and S5 Table
in). Although this isolate was recovered from recalled almonds in 2001, the
almonds were harvested in the fall of 2000, a span of 14 years (2000–2013). The
orchard isolates from 2001 to 2006 differed by 0 to 12 SNPs within their genomes
and by 3 to 13 SNPs with the clinical genomes. The SNP differences ranged from
zero to eight within the 12 clinical isolates from the 2001 outbreak and from
one to 13 within the four clinical isolates from the 2006 outbreak. Among the
clinical isolates from 2001 and 2006, the SNP differences ranged from four to
13, indicating that the isolates are from a common origin.
Almond, orchard, and clinical isolates of *Salmonella* Enteritidis PT 30
isolated from 2001 through 2013 are closely related strains. The persistence of
*Salmonella* Enteritidis PT 30 in an almond orchard over 6 years was reported
previously. The SNP analysis confirmed the PFGE results obtained for these
isolates. Almonds from the 2001 outbreak-associated orchards were purposefully
excluded from the raw almond survey. Because survey samples were coded and the
sources unknown, it is possible that samples harvested from outbreak-associated
orchards were inadvertently included. It is also possible that survey almonds
were cross contaminated with almonds harvested from outbreak-associated orchards
via harvest equipment or at a common almond huller-sheller, or that *Salmonella*
Enteritidis PT 30 was spread over a broader geographic region than recognized as
associated with the 2001 outbreak.
*Salmonella* Enteritidis was not the only serovar for which clonal isolates were
recovered from almonds in different years. *Salmonella* Montevideo survey
isolates clustered into three groups, with more than 100 SNPs between them.
Within each of these clusters there were isolates separated by one or more years
(including isolates from 2001 and 2013) that differed by ≤9 SNPs, indicating
that they share a common ancestor. *Salmonella* Newport (S6 Table) and
*Salmonella* Muenchen (S7 Table) each clustered into two groups separated by
more than 100 SNPs. A small number of SNP differences (\<3) between *Salmonella*
Newport genomes (S6 Table) were identified in isolates retrieved in 2003
(LJH0751), 2006 (LJH1084), 2007 (LJH1133), 2010 (LJH1248, LJH1273 and LJH1278).
Nine isolates of *Salmonella* Muenchen were retrieved in 2006; eight of these
isolates from six different almond lots had nearly identical genomes, with ≤3
SNP differences (S7 Table), and differed from single isolates in 2007 (LJH1135)
and 2013 (LJH1661) by ≤8 SNPs. Closely related genomes for single isolates of
*Salmonella* Anatum (S8 Table) and *Salmonella* Thompson (S9 Table) were
identified 2 and 1 years apart, respectively. Several *Salmonella* Oranienburg
(S10 Table) and *Salmonella* Typhimurium were identified 5 and 3 years apart,
respectively. Closely related genomes (≤13 SNPs) were identified for isolates
retrieved from separate almond lots during the same year for *Salmonella*
serovar Cerro (S11 Table), Give (S12 Table), Infantis (S13 Table), Heidelberg
(S14 Table) and Tennessee (S15 Table). For *Salmonella* serovar Brandenburg (S16
Table in S1 File), Braenderup, Manhattan (S17 Table in S1 File), Mbandaka, and
Senftenberg (S18 Table), isolates were separated by more than 13 SNPs.
Multiple SNP-based approaches have been developed to analyze the large number of
short reads produced by various sequencing platforms. The CFSAN Pipeline was
selected because it is less sensitive to coverage changes and has good
discriminative power. Its high resolution, however, strongly depends on an
appropriate reference genome. In addition to outbreak source attribution, this
tool can reveal similarity among isolates and their persistence in food
facilities or in the production environment.
Differences of more than 100 SNPs were sometimes observed among isolates within
each serovar. Survey isolates that were genetically similar (≤13 SNPs) were
recovered in multiple years, up to 13 years for *Salmonella* Enteritidis PT 30
and *Salmonella* Montevideo and 10 years for *Salmonella* Newport. Because the
survey samples were collected after hulling and shelling and prior to entering a
processing facility or storage, the contamination source would have to be at
production or harvest (orchard), during postharvest handling (transportation to
huller, during storage, or during hulling and shelling), or transportation from
huller to processor. Although the exact geographic locations of the almond
survey samples were unknown, clonal strains of *Salmonella* Enteritidis PT 8
(five; 2005) and *Salmonella* Muenchen (eight; 2006) were isolated from
different lots of almonds in the same year.
The diversity of serovars and unique strains within serovars was expected in a
survey that likely reflects broad environmental contamination (e.g., almond
orchard during production or harvest). Common harvest and postharvest practices
may also lead to distribution of *Salmonella* in almonds from geographically
diverse orchards that share the same equipment or facilities. At maturity,
almonds are shaken to the ground where they dry for several days. They are then
harvested by windrowing and sweeping off the orchard floor. The in-hull, inshell
almonds are then transported to facilities where the hull and shell are removed.
Kernels mix with hulls and shells before sorting, separation, and bulk
transportation to processing facilities. Once kernels are delivered to almond
processing facilities, commingling of almond lots may occur prior to or during
storage. These practices may explain the clusters of *Salmonella* Enteritidis PT
8 and *Salmonella* Muenchen isolated from different lots in 2005 and 2006.
U.S. regulations were implemented in 2007 that require all California-grown
almonds sold in North America (U.S., Canada, and Mexico) to be processed with a
treatment capable of achieving a minimum 4-log reduction in *Salmonella*. While
there have been outbreaks associated with almond-containing products such as
blended nut butters, none have been associated with contaminated almonds since
2006, likely due to effective implementation of these regulations.
The persistence of *Salmonella* has been described for other pre- and
postharvest scenarios. A narrow range of *Salmonella* serovars has been
associated with California pistachio outbreaks, outbreak investigations, and
industry and retail surveys. Pistachio-associated isolates of *Salmonella*
Senftenberg and *Salmonella* Montevideo recovered over multiple years (2009 to
2017) and from multiple facilities differed (within each serovar) by 0 to 31
SNPs, and the authors suggested that the organisms may have established
residence in the primary production environment or orchards.
## Plasmid prediction and characterization
Plasmids contribute significantly to the emergence and spread of genes encoding
AMR, virulence, and other metabolic functions in multiple scales across
*Salmonella* serotypes. Plasmid carriage in the *Salmonella* strains under study
were assessed by screening and reconstructing the plasmid sequences from
assembled genomes using the clustered plasmid reference database-based pipeline.
A total of 106 of the 171 *Salmonella* isolates (62%) carried one to seven
plasmids (total plasmids 161;) with sizes of 1,030 bp to 303,322 bp ( and S19
Table). Using the presence of relaxase and mate-pair formation marker genes
and/or *oriT* sequence, most of these plasmids were predicted to be either
mobilizable (*n* = 51/161; 32%) or conjugative (*n* = 83/161; 52%). In total, 61
plasmid clusters with 27 different plasmid families were identified, with IncFII
and IncFIB being the most predominant types in the collection.
Thirty eight *Salmonella* strains distributed across six serovars (Duisburg,
Enteritidis, Lomalinda, Muenchen, Typhimurium, and 1,4,,12:i:-) carried
plasmids that contained two to seven virulence genes, but no AMR genes (S20
Table). The IncFIB-IncFII plasmid family combination was common among these
strains, predominantly in *Salmonella* Enteritidis (*n* = 15), Typhimurium (*n*
= 8), and 1,4,,12:i:- (*n* = 9). Comparative analysis of the plasmid
sequences with known plasmids using mash and BLASTn revealed that these plasmids
are similar (nucleotide sequence homology = 100%) to plasmid pCFSAN076214_2
(accession number CP033342.1) described previously in *Salmonella* Enteritidis
strain ATCC BAA-1045 isolated from raw almonds (also LJH608 in this study) and
to plasmid p11-0972.1 (accession number CP039855.1) reported in *S*. *enterica*
serovar 1,4,,12:i:- recovered from a human stool sample. IncF plasmids are
among the most common plasmids found in *Salmonella* and are reported to carry
multiple antibiotic resistance and/or virulence genes, suggesting their role in
the dissemination of these genes across *Salmonella* serotypes and
Enterobacteriaceae by extension.
Thirteen *Salmonella* strains belonging to seven serotypes (Agona, Anatum,
Heidelberg, Istanbul, Newport, Typhimurium, and Zerifin) carried plasmids with
at least one AMR gene but no virulence genes. The most common among these was
within the IncC plasmid family and was associated with six to 10 AMR genes (S20
Table). The IncC plasmid identified in the present study was predicted to be
conjugative, predominant in *Salmonella* Anatum and *Salmonella* Newport and was
almost indistinguishable (99.99% by BLASTn) from *Salmonella* Anatum plasmid
pSAN1-1736 (accession number: CP014658.1). IncC plasmids are known to be widely
distributed across *Salmonella* serotypes from diverse sources and often carry
multiple AMR genes.
A unique *Salmonella* Kentucky strain LJH1044 carried a large conjugative
plasmid (146 Kb) with IncFIB-IncFIC-rep_cluster_2244 plasmid replicons and
contained multiple virulence and AMR genes ( and S20 Table in). This plasmid
carried three AMR genes encoding resistance to aminoglycoside and tetracycline,
a complete *iroBCDEN* operon that encodes salmochelin siderophore, and an
*iucABCD-iutA* operon that has been described to be associated with aerobactin
synthesis essential for virulence and stress response in *Salmonella* (S20
Table). Comparative analysis showed that this plasmid had 99.99% nucleotide
sequence similarity to plasmid pCVM29188_146 (accession number CP001122.1)
reported previously in several *Salmonella* Kentucky strains from poultry in the
United States.
## Antimicrobial resistance profile
Among the isolates retrieved from the almond survey, a total of 24 AMR genes
were identified with the ResFinder and CARD database, which classified into nine
different antimicrobial protein groups: aminoglycosides, β-lactams, colistin,
fosfomycin, glycopeptide, phenicol, sulfonamide, tetracycline, and trimethoprim.
One gene, *aac(6’)-Iaa*, which confers resistance to aminoglycosides, was
detected in the chromosome of all *Salmonella* subspecies *diarizonae* (3) and
*enterica* (165) but not in *arizonae* (3). The frequency of *Salmonella
enterica* subspecies *enterica* isolates that carried an aminoglycoside
acetyltransferase *aac(6’)-Iaa* has been reported to be high (\>95%) in multiple
WGS analysis. However, in a surveillance study of non-typhoidal *Salmonella
enterica*, 11 isolates out of 3,491 (0.3%) showed phenotypic resistance to an
aminoglycoside antimicrobial.
The other 23 AMR genes were detected in 35 isolates, with *fosA7* being the
most common. The gene *fosA7*, which confers resistance to fosfomycin, a broad-
spectrum cell wall synthesis inhibitor, was first identified in the chromosome
of *Salmonella* Heidelberg isolated from broiler chickens. In the present study,
all *Salmonella* Heidelberg isolates (*n* = 6), and some isolates of
*Salmonella* serovars Agona (*n* = 2), Meleagris (*n* = 1), Montevideo (*n* =
8), Oranienburg (*n* = 2), and Tennessee (*n* = 3), carried the chromosomal
*fosA*7 gene. Ten aminoglycoside resistance genes were detected in 16 isolates:
*aac(6’)-Iaa*, *aadA2*, *aadA3*, *aadA7*, *aadA12*, *aadA13*, *ant(2”)-Ia*,
*aph(3")-IIa*, *aph(3’’)-Ib*, *aph(6)-lc*, and *aph(6)-*Id. The
*bla*<sub>*CMY-2*</sub> and *bla*<sub>*CARB-2*</sub> genes, which confer
resistance to β-lactams, and the *floR* gene, which confers resistance to
phenicol, were found in nine isolates. Three tetracycline efflux resistance
genes were identified in 16 isolates: *tetA*, *tetB*, and *tetG*. Sulfisoxazole
resistance, encoded by *sul1* or *sul2*, was detected in 11 isolates. The
dihydrofolate reductase resistance gene, *dfrA12*, which confers resistance to
trimethoprim, was detected in one *Salmonella* Newport isolate. The plasmid-
mediated colistin resistance and phosphoethanolamine transferase *mcr*-9.1 gene
was detected in one *Salmonella* Agona isolate. Resistance to bleomycin, encoded
by the bleomycin-binding protein gene (*ble*), was predicted for one
*Salmonella* Heidelberg isolate. All the isolates, except *Salmonella* serovars
Enteritidis, Irumu, Lomalinda, Typhimurium, and 1,4,,12:i-, contained a
missense mutation in *parC* associated with resistance to quinolone. Multiple
mutations in the quinolone resistance determining region are usually required to
confer resistance to ciprofloxacin, but one mutation confers resistance to
nalidixic acid. One *Salmonella* Senftenberg isolate had a point mutation in the
16S rRNA that is thought to confer resistance to spectinomycin.
Most of the predicted AMR genes were identified in a small number (16 out of
171; 9%) of survey isolates and were plasmid encoded in 11 of 16 cases.
Multidrug-resistant isolates (putative resistance to at least one antibiotic in
three or more drug classes; <https://www.cdc.gov/narms/resources/glossary.html>)
were identified among *Salmonella* serovars Agona (LJH1100 and LJH1106), Anatum
(LJH0720, LJH0787, LJH1012, and LJH1063), Heidelberg (LJH1622), Newport
(LJH0656, LJH1138, and LJH1107), and Typhimurium (LJH0788 and LJH1141).
Antibiotic resistance profiles by the calibrated dichotomous sensitivity method
were determined for *Salmonella* isolated from 2001 through 2005 but not for
isolates from 2006, 2007, 2010, and 2013. Ten of the *Salmonella* survey
isolates from 2001 to 2005 were resistant to three or more antibiotics.
Resistance genotype and phenotype correlated highly for five of these isolates:
*Salmonella* Anatum (*n* = 3), *Salmonella* Istanbul (*n* = 1), and *Salmonella*
Typhimurium var. Copenhagen (*n* = 1).
## Analysis of virulence factors
*Salmonella* serovars infect a wide range of hosts with different degrees of
disease severity, with Enteritidis, Newport, Typhimurium, Javiana, and
1,4,,12:i- being significantly more likely to cause illness in humans in the
United States. Differences in virulence factors contribute to the severity and
outcome of salmonellosis and can be specific to serovars. The Virulence Factor
Database (VFDB) was used to detect a total of 303 virulence genes among the 171
*Salmonella* assembled genomes (Figs –). Genes were classified under major
virulence factors, including the secretion system, fimbrial and non fimbrial
adherence, macrophage inducible genes, magnesium uptake, serum resistance,
stress proteins, toxins, immune invasion, and two component regulatory systems.
The *Salmonella* pathogenicity island 1 (SPI-1) and 2 (SPI-2), responsible for
the type III secretion system, are ubiquitous in *S*. *enterica* subsp.
*enterica* and were common to all 171 survey isolates.
Among the fimbrial adherence factors, the genes encoding the curli fimbriae,
*csgA*, *csgB*, and *csgE*, the *bcfABCDEFG* operon, and the genes that encode
type 1 fimbriae, *fimA*, *fimB*, *fimC*, *fimD*, *fimH*, *fimI*, *fimW*, and
*fimZ*, were also present in all the isolates. The two- component regulatory
system *phoP*-*PhoQ* genes and the magnesium uptake genes, *mgtB*-*mgtC*, (part
of SPI-3) were present in all the isolates. All the isolates had the microphage
inducible gene, *mig-14*, but *mig*-*5* was mainly detected in isolates of
*Salmonella* serovars Enteritidis, Typhimurium, and 1,4,12:I:-.
The typhoid toxin genes, *cdtB* and *pltA*, originally identified in serotype
Typhi, were found in all *Salmonella* serovar Brandenburg, Duisburg, Horsham,
Montevideo, Sandiego, and Schwartzengrund isolates and in nine of 10
*Salmonella* Oranienburg isolates. However, *pltB*, required for forming
holotoxin, was not present in any of these isolates. In *Salmonella* Horsham
isolates, two genes were identified as homologs of the enterotoxin hemolysin
genes of *Escherichia coli* (*hylE*/*clyA*).
A virulence plasmid that harbored a combination of *pef*, *rck*, and *spv*
virulence genes was identified in 23% of the isolates (S20 Table in). The
assembly of the major Pef fimbriae depends on the *pefBACDorf5orf6* operon,
which encodes PefA fimbriae subunit, PefC usher protein, and the pefD
periplasmic chaperone. Eight of 10 *Salmonella* Typhimurium and all nine
*Salmonella* 1,4,12:I:- isolates carried a plasmid encoding *pefA*, *pefB*,
*pefC*, and *pefD* genes ( and S20 Table).
The *spv* genes play a role in suppression of the innate immune response and are
often associated with invasive disease and increased virulence. The *spv* genes
were detected in all *Salmonella* serovar Lomalinda, Enteritidis, and
1,4,12:I:- isolates, in eight of 10 *Salmonella* Typhimurium isolates, and
one of 10 *Salmonella* Give isolates ( and S20 Table). The *rck* gene, which
provides protection against the complement-mediated immune response of the host,
was found in one of 10 *Salmonella* Give isolates, in all *Salmonella*
Enteritidis PT 30 and PT 8 isolates, in eight of 10 *Salmonella* Typhimurium
isolates, and all *Salmonella* 1,4,12:I;- isolates.
This study provides one of the first in-depth longitudinal characterizations of
*Salmonella* strains isolated from a single product (almonds) or production
environment (almond orchard), in a single geographical region (Central
California). This isolate collection is important for understanding *Salmonella*
populations in a significant food production region of the United States.
Several clonal strains of *Salmonella* were isolated over multiple years, adding
to a growing body of evidence that enteric pathogens may persist over long
periods of time (years) in agricultural environments and in postharvest or food
processing facilities (<https://www.cdc.gov/ncezid/dfwed/outbreak-response/rep-
strains.html>)).
# Supporting information
We thank Sylvia Yada for editing the manuscript and Vanessa Lieberman for
technical assistance.
10.1371/journal.pone.0291109.r001
Decision Letter 0
Karunasagar
Iddya
Academic Editor
2023
Iddya Karunasagar
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
27 Jun 2023
PONE-D-23-14605Genetic diversity of * Salmonella enterica * isolated from raw
California almonds and from an almond orchard over 13 YearsPLOS ONE
Dear Dr. Harris,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
Please submit your revised manuscript by Aug 11 2023 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:A
rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.If you would like to make changes to your financial disclosure,
please include your updated statement in your cover letter. Guidelines for
resubmitting your figure files are available below the reviewer comments at the
end of this letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Iddya Karunasagar
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2\. Thank you for stating the following in the Acknowledgments Section of your
manuscript:
"This research was supported by the Almond Board of California Grant
18-HarrisL536 AQFSS-01. The DNA Technologies and Expression Analysis Core at UC
Davis Genome Center is supported by NIH shared Instrumentation Grant
1S10OD010786-01. L. Goodridge and RC Levesque were funded by Genome Canada and
Genome Québec. We thank Sylvia Yada for editing the manuscript and Vanessa
Lieberman for technical assistance."
We note that you have provided funding information that is not currently
declared in your Funding Statement. However, funding information should not
appear in the Acknowledgments section or other areas of your manuscript. We will
only publish funding information present in the Funding Statement section of the
online submission form.
Please remove any funding-related text from the manuscript and let us know how
you would like to update your Funding Statement. Currently, your Funding
Statement reads as follows:
"LJH 18-HarrisL-AQFSS-01 Almond Board of California
(<https://www.almonds.com>)
LG/RCL Genome Canada (<https://genomecanada.ca>) and Genome Quebec
(<https://www.genomequebec.com/en/home/>)
The funders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript."
Please include your amended statements within your cover letter; we will change
the online submission form on your behalf.
3\. We note that you have stated that you will provide repository information
for your data at acceptance. Should your manuscript be accepted for publication,
we will hold it until you provide the relevant accession numbers or DOIs
necessary to access your data. If you wish to make changes to your Data
Availability statement, please describe these changes in your cover letter and
we will update your Data Availability statement to reflect the information you
provide.
4\. Please review your reference list to ensure that it is complete and correct.
If you have cited papers that have been retracted, please include the rationale
for doing so in the manuscript text, or remove these references and replace them
with relevant current references. Any changes to the reference list should be
mentioned in the rebuttal letter that accompanies your revised manuscript. If
you need to cite a retracted article, indicate the article’s retracted status in
the References list and also include a citation and full reference for the
retraction notice.
Additional Editor Comments:
Please see the reviewer comments. Please revise addressing all comments point by
point
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: N/A
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: PONE-D-23-14605
Genetic diversity of Salmonella enterica isolated from raw California almonds
and from an almond orchard over 13 years
This study compared the whole genome sequences of 171 Salmonella isolates that
included 30 isolates of S. Enteritidis PT30 involved in almond-associated
outbreaks. SNP analysis, serovar identification, antimicrobial resistance genes,
plasmid types and virulence genes were determined. The main goal of this study
was to see if S. Enteritidis PT30 outbreak isolates could be distinguished from
similar environmental isolates.
The study emphasizes the discriminatory power of WGS over traditional genotyping
methods. The study identified clonal isolates of Salmonella Enteritidis and
Salmonella Montevideo. The persistence of clonal strains of certain serovars
suggest contamination of post-harvest processing areas with these strains.
1\. The manuscript is straightforward presentation of the WGS comparison. The
study assumes significance in few contexts; that Salmonella Enteritidis PT 30
isolates belong to a long time line of over 13 years, comprise of outbreak
strains and their environmental counterparts, and as the result suggest, these
strains were phylogenetically closely related.
The study aimed to solve three important issues with the traditional genotyping
methods as stated in the introduction section and listed below.
2\. Lines 80-82:. “However, neither PFGE nor MVLA could discriminate among the
Salmonella Enteritidis PT 30 isolates associated with the 2001 and 2006 almond-
associated outbreaks”
Now, the WGS analysis clustered (lines 275-276) clustered them together in one
group with ≤18 SNPs. Is this not similar to PFGE results? Or does a difference
of 18 SNPs make them different from each other?
3\. Lines 82-84: Salmonella Enteritidis PT 30 almond associated outbreak strains
could not be distinguished from epidemiologically unrelated Salmonella
Enteritidis PT 30 clinical strains included in the study
Again, the fact that the WGS analysis put them together in one group suggests
the same thing.
4\. Lines 87-89: Environmental Salmonella Enteritidis PT 30 isolates, collected
between 2001 and 2006 from one of the 2001 outbreak-associated orchards,
clustered in two groups based on the separation by PFGE of their XbaI-digested
DNA
As could be seen from the results in lines 274-276, one survey isolate formed a
separate group.
5\. Lines 294-295: With less than ≤18 SNPs, are they still termed “closely
related strains”. In a �4 Mb genome sequence, what would be the NGS contribution
to SNPs? Although this depends on the depth of sequencing, still there would be
contribution from the sequencing itself.
6\. Although AMR genes were identified from the WGS, these are not correlated
with the antibiotic resistance phenotype of isolates.
7\. Only two pathogenicity islands (SPI-1 & SPI-2) were identified in WGS. What
about the rest?
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
\*\*\*\*\*\*\*\*\*\*
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0291109.r002
Author response to Decision Letter 0
4 Aug 2023
PONE-D-23-14605
Genetic diversity of Salmonella enterica isolated over 13 years from raw
California almonds and from an almond orchard
Editor and Reviewer comments are in italics. Author responses are not in
italics.
Please submit your revised manuscript by Aug 11 2023 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:
Editor c1. A rebuttal letter that responds to each point raised by the academic
editor and reviewer(s). You should upload this letter as a separate file labeled
'Response to Reviewers'.
Response: Done
Editor c2. A marked-up copy of your manuscript that highlights changes made to
the original version. You should upload this as a separate file labeled 'Revised
Manuscript with Track Changes'.
Response: Done.
Editor c3. An unmarked version of your revised paper without tracked changes.
You should upload this as a separate file labeled 'Manuscript'.
Response: Done.
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
JR 1. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
JR 2. Thank you for stating the following in the Acknowledgments Section of your
manuscript: "This research was supported by the Almond Board of California Grant
18-HarrisL536 AQFSS-01. The DNA Technologies and Expression Analysis Core at UC
Davis Genome Center is supported by NIH shared Instrumentation Grant
1S10OD010786-01. L. Goodridge and RC Levesque were funded by Genome Canada and
Genome Québec. We thank Sylvia Yada for editing the manuscript and Vanessa
Lieberman for technical assistance."
We note that you have provided funding information that is not currently
declared in your Funding Statement. However, funding information should not
appear in the Acknowledgments section or other areas of your manuscript. We will
only publish funding information present in the Funding Statement section of the
online submission form. Please remove any funding-related text from the
manuscript and let us know how you would like to update your Funding Statement.
Currently, your Funding Statement reads as follows: "LJH 18-HarrisL-AQFSS-01
Almond Board of California (<https://www.almonds.com>) LG/RCL Genome Canada
(<https://genomecanada.ca>) and Genome Quebec
(<https://www.genomequebec.com/en/home/>). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the
manuscript."
Please include your amended statements within your cover letter; we will change
the online submission form on your behalf.
Response: We have deleted the funding information from the Acknowledgement
section in the manuscript.
Amended Funding Statement: “LJH 18-HarrisL-AQFSS-01 Almond Board of California
(<https://www.almonds.com>), LG/RCL Genome Canada (<https://genomecanada.ca>)
and Genome Quebec (<https://www.genomequebec.com/en/home/>), NIH shared
Instrumentation Grant 1S10OD010786 (<https://orip.nih.gov/construction-and-
instruments/s10-instrumentation-programs>). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the
manuscript."
JR 3. We note that you have stated that you will provide repository information
for your data at acceptance. Should your manuscript be accepted for publication,
we will hold it until you provide the relevant accession numbers or DOIs
necessary to access your data. If you wish to make changes to your Data
Availability statement, please describe these changes in your cover letter and
we will update your Data Availability statement to reflect the information you
provide.
Response: We included all relevant accession numbers in the manuscript and have
now released those data.
JR 4. Please review your reference list to ensure that it is complete and
correct. If you have cited papers that have been retracted, please include the
rationale for doing so in the manuscript text, or remove these references and
replace them with relevant current references. Any changes to the reference list
should be mentioned in the rebuttal letter that accompanies your revised
manuscript. If you need to cite a retracted article, indicate the article’s
retracted status in the References list and also include a citation and full
reference for the retraction notice.
Response: Reference list has been reviewed and is complete and correct.
Reviewer \#1:
This study compared the whole genome sequences of 171 Salmonella isolates that
included 30 isolates of S. Enteritidis PT30 involved in almond-associated
outbreaks. SNP analysis, serovar identification, antimicrobial resistance genes,
plasmid types and virulence genes were determined. The main goal of this study
was to see if S. Enteritidis PT30 outbreak isolates could be distinguished from
similar environmental isolates.
The study emphasizes the discriminatory power of WGS over traditional genotyping
methods. The study identified clonal isolates of Salmonella Enteritidis and
Salmonella Montevideo. The persistence of clonal strains of certain serovars
suggest contamination of post-harvest processing areas with these strains.
The manuscript is straightforward presentation of the WGS comparison. The study
assumes significance in few contexts; that Salmonella Enteritidis PT 30 isolates
belong to a long timeline of over 13 years, comprise of outbreak strains and
their environmental counterparts, and as the result suggest, these strains were
phylogenetically closely related.
The study aimed to solve three important issues with the traditional genotyping
methods as stated in the introduction section and listed below.
Response: Thank you for your comments and manuscript overview. As stated in the
last paragraph in the introduction, the objective of the study was a comparative
genomic analysis of almond-related Salmonella isolates. The study did not aim to
solve issues with traditional genotyping methods. However, we have addressed
each comment related to statements in the introduction below.
R1c1a Lines 80-82: “However, neither PFGE nor MVLA could discriminate among the
Salmonella Enteritidis PT 30 isolates associated with the 2001 and 2006 almond-
associated outbreaks”. Now, the WGS analysis clustered (lines 275-276) clustered
them together in one group with ≤18 SNPs. Is this not similar to PFGE results?
Or does a difference of 18 SNPs make them different from each other?
R1c1b Lines 82-84: Salmonella Enteritidis PT 30 almond associated outbreak
strains could not be distinguished from epidemiologically unrelated Salmonella
Enteritidis PT 30 clinical strains included in the study. Again, the fact that
the WGS analysis put them together in one group suggests the same thing.
R1c1c Lines 87-89: Environmental Salmonella Enteritidis PT 30 isolates,
collected between 2001 and 2006 from one of the 2001 outbreak-associated
orchards, clustered in two groups based on the separation by PFGE of their XbaI-
digested DNA. As could be seen from the results in lines 274-276, one survey
isolate formed a separate group.
Response: The statement regarding the PFGE or MVLA was specific to clinical
isolates of Salmonella Enteritidis PT 30 which could not be distinguished from
each other using PFGE or MVLA (refers to Parker et al. \[8\]).
With one exception (LJH0762), we were also unable to distinguish the Salmonella
Enteritidis PT 30 isolates assessed in the present paper by WGS (beyond 18 SNP
differences). Our analysis consisted of 55 isolates: eight almond survey
isolates, 30 orchard isolates and 16 outbreak isolates. We did not include some
of the non-almond associated clinical isolates that were evaluated in the Parker
et al \[8\] study and thus are unable to know if WGS could distinguish among all
the isolates used in that study.
To clarify, we made minor modification to the concluding paragraph of the
introduction to specify that 171 isolates (45 serovars) were evaluated (not just
Salmonella Enteritidis PT 30). We provided additional information under “Genetic
Distance Within Each Serovar” (copied below) to highlight the number of
Salmonella Enteritidis PT 30 isolates that were assessed. We added a new
supplemental table (S5 Table) that complements Figure 2 and provides more
granularity to SNP differences. We also further clarified that almond isolates
from 2001 to 2013 differed from the 2001 outbreak-associated almond isolate
LJH0608 (from almonds harvested in 2000) by 2 to 13 SNPs and that this
represents isolates collected over a span of 14 years.
We also modified the following sentence to remove the statement “with higher
resolution”:
“The persistence of Salmonella Enteritidis PT 30 in an almond orchard over 6
years was reported previously \[2\]. The SNP analysis confirmed the PFGE results
obtained for these isolates.”
The reviewer’s statement (R1c1c) regarding environmental Salmonella isolates was
related to orchard isolates (refers to Uesugi et al., 2006 \[2\]). The comment
refers to only the environmental samples retrieved from the outbreak-associated
almond orchard. The orchard isolates from 2001 to 2006 differed by 0 to 12 SNPs
in our analyses, which is now more clearly stated in the modified results
section (copied below). We believe that the changes outlined above adequately
address the reviewer’s comments.
“The genomes of Salmonella Enteritidis PT 30 recovered from survey almonds
(eight isolates (Table 1): LJH0762 \[2003\], LJH1023 \[2005\], LJH1104 \[2006\],
LJH1059 \[2006\], LJH1096 \[2006\], LJH1109 \[2006\], LJH1633 \[2013\], LJH1673
\[2013\]), the 2001 outbreak-associated orchard (30 isolates; S2 Table), and a
2001 outbreak-associated almond isolate (LJH0608) were compared to Salmonella
Enteritidis PT 30 genomes of clinical isolates from almond outbreaks in 2001 (12
isolates) and 2006 (four isolates) (S3 Table).
Salmonella Enteritidis PT30 isolates formed two clusters (Fig 2). One consisted
of a single survey isolate (LJH0762), recovered in 2003, that differed from
LJH0608 by 48 SNPs (Fig 2, S5 Table). All other survey and clinical isolates (n
= 38) clustered in a single group with LJH0608 that differed from each other by
≤18 SNPs (Fig 2) indicating that the isolates are from a common origin. Almond
isolates from 2001 to 2013 had two to 13 SNP differences compared with the 2001
outbreak-associated almond isolate Salmonella Enteritidis PT 30 LJH0608 (Fig 2,
S5 Table). Although this isolate was recovered from recalled almonds in 2001,
the almonds were harvested in the fall of 2000 \[1\], a span of 14 years
(2000–2013). The orchard isolates from 2001 to 2006 differed by 0 to 12 SNPs
within their genomes and by 3 to 13 SNPs with the clinical genomes. The SNP
differences ranged from zero to eight within the 12 clinical isolates from the
2001 outbreak and from one to 13 within the four clinical isolates from the 2006
outbreak. Among the clinical isolates from 2001 and 2006, the SNP differences
ranged from four to 13.”
R1c2 Lines 294-295: With less than ≤18 SNPs, are they still termed “closely
related strains”. In a �4 Mb genome sequence, what would be the NGS contribution
to SNPs? Although this depends on the depth of sequencing, still there would be
contribution from the sequencing itself.
Response: There isn’t a standard cutoff for SNP differences with respect to
strain separation (Brown et al. 2019) (9). Parameters defined in the CFSAN
pipeline for filtering the SNPs should minimize the contribution of NGS to SNPs.
The CFSAN pipeline constructs a high-quality SNP matrix for closely related
sequences (\<100 SNP differences) with a higher recovery rate of SNPs for
datasets with 100x coverage compared to 20x, as described by Davis et al., 2015
(12). Our genomes were sequenced with an average coverage of 50x.
We believe that modifications to this section (as described above) have
addressed this question.
R1c3 Although AMR genes were identified from the WGS, these are not correlated
with the antibiotic resistance phenotype of isolates.
Response: Throughout the section on AMR we specifically note the WGS refers to
genotype and not phenotype. However, in the last paragraph of the “Antimicrobial
resistance profile” section we discuss the information that is available on
genotypic vs phenotypic expression of AMR genes in some of the isolates
associated with the study (copied below). We believe this addresses the reviewer
concerns and have not made changes to the manuscript.
“Antibiotic resistance profiles by the calibrated dichotomous sensitivity method
were determined for Salmonella isolated from 2001 through 2005 but not for
isolates from 2006, 2007, 2010, and 2013. Ten of the Salmonella survey isolates
from 2001 to 2005 were resistant to three or more antibiotics \[5\]. Resistance
genotype and phenotype correlated highly for five of these isolates: Salmonella
Anatum (n = 3), Salmonella Istanbul (n = 1), and Salmonella Typhimurium var.
Copenhagen (n = 1).”
R1c4 Only two pathogenicity islands (SPI-1 & SPI-2) were identified in WGS. What
about the rest?
Response: SPI-1 and SPI-2 were present in all the isolates and we made note of
this. Genes from other known pathogenicity islands were present but we did not
assess the presence of complete islands in every isolate. The magnesium uptake
genes (mgtB-mgtC) were present in all isolates (line 502) and are part of SPI-3.
The hlyE hemolysin (lines 511) is part of SPI-18 and was identified in S.
Horsham.
10.1371/journal.pone.0291109.r003
Decision Letter 1
Karunasagar
Iddya
Academic Editor
2023
Iddya Karunasagar
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
22 Aug 2023
Genetic diversity of * Salmonella enterica * isolated over 13 years from raw
California almonds and from an almond orchard
PONE-D-23-14605R1
Dear Dr. Harris,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Iddya Karunasagar
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
All reviewer comments have been addressed.
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The manuscript has been sufficiently revised, and all my querries
in the previous review have been addresssed. The authors have made relevant
changes in the revised manuscript.
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
\*\*\*\*\*\*\*\*\*\*
10.1371/journal.pone.0291109.r004
Acceptance letter
Karunasagar
Iddya
Academic Editor
2023
Iddya Karunasagar
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
29 Aug 2023
PONE-D-23-14605R1
Genetic diversity of *Salmonella enterica* isolated over 13 years from raw
California almonds and from an almond orchard
Dear Dr. Harris:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Iddya Karunasagar
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Internalizing and externalizing behavior problems are considered a substantial
risk factor for students’ social and academic well-being. Both dimensions are
consistently associated with difficulties on different levels in schools.
Children and adolescents with externalizing and/or internalizing behavior
problems are exposed to higher risks of academic failure. In addition to
academic difficulties, subtypes of externalizing as well as internalizing
behavior problems are associated with a range of short- and long-term
developmental risks, such as higher rates of social exclusion/rejection, school
suspension, lack of bonding to school, or criminal arrest. Therefore, the early
and adequate identification of students at-risk for the development of severe
externalizing and internalizing behavior problems in educational practice is of
high relevance. The gained insights in students’ behaviors might at the same
time serve as a reference for designing appropriate behavioral interventions.
Teachers and school psychologists consequently play an important role in
supporting and identifying students who suffer from behavioral problems.
Among others, the Strengths and Difficulties Questionnaire (SDQ) is a frequently
used screening instrument for behavioral and emotional problems in children and
adolescents and is commonly applied in educational research and practice. The
SDQ comprises 25 items that can be grouped into subscales for emotional
symptoms, peer problems, conduct problems, hyperactivity, and prosocial
behavior, containing five items each. The narrowband subscales for emotional
symptoms and peer problems can be combined into the broadband scale
*internalizing* behavior and the narrowband subscales of hyperactivity and
conduct problems can be subsumed into the broadband scale *externalizing*
behavior. Correlations of behavioral and emotional problems, measured by means
of sum scores on the SDQ, with academic outcome variables have been addressed in
recent research. Previous studies have highlighted negative associations between
the SDQ scales and academic achievement. Metsäpelto et al. found that higher
externalizing behavior (broadband scale) was related to lower reading skills.
Similarly, Palmu et al. highlighted that externalizing behavior (broadband
scale) was associated with lower academic grades. Similarly, DeVries et al.
concluded that peer problems (narrowband scale) are negatively associated with
academic grades. Higher internalizing and externalizing behavior (broadband
scales) were linked to lower scholastic performance. Hyperactivity and conduct
problems (narrowband scales) were negatively correlated with reading and
mathematical skills. Not only are the associations between the SDQ scales and
academic performance of interest from a pedagogical standpoint, but also their
relation to social outcomes, such as social integration within the classroom,
the well-being of students in their families, school absenteeism, and feelings
of self-worth and self-efficacy. Higher emotional symptoms, peer problems,
conduct problems, and hyperactivity (narrowband scales) are associated with a
lower social preference within the classroom and with more difficulties within
the family and lower feelings of self-worth. Students rejected by peers are more
likely to show internalizing behavior problems (broadband scale) and
controversial students are more likely to exhibit externalizing behavior
(broadband scale). Higher emotional symptoms (narrowband scale) are associated
with lower feelings of self-efficacy. Lenzen et al. highlighted the association
of greater conduct problems and emotional symptoms (narrowband scales) with
increased school absenteeism. School absence was also linked to internalizing
behavior (broadband scale) while school discipline referrals were related to
externalizing behavior (broadband scale). Moreover, students with special
educational needs, especially those with learning disabilities, have greater
peer problems (narrowband scale).
Although the originally proposed 5-factor structure of the SDQ (5 narrowband
subscales) is often applied in research, the narrowband subscales are sometimes
subsumed into broadband behavior scales (internalizing and externalizing
behavior), which has resulted in an ongoing controversy, not only in educational
research, regarding the factor structure of the SDQ. This controversy implies a
discussion about the usefulness of broadband and narrowband scales of behavior.
# Broadband and narrowband scales of behavior
Some studies on the psychometric properties of the SDQ have confirmed the
original 5-factor structure (emotional symptoms, peer problems, conduct
problems, hyperactivity, and prosocial behavior) proposed by Goodman. At the
same time, several studies have highlighted potential model fit shortcomings of
the 5-factor structure. As a reaction to these concerns, several authors have
proposed a 3-factor model as a possible alternative to the original 5-factor
model. In the revised 3-factor model, the narrowband subscales of emotional
symptoms and peer problems are combined into the broadband scale for
*internalizing* behavior, and the narrowband subscales of hyperactivity and
conduct problems are subsumed into the broadband scale for *externalizing*
behavior (the narrowband subscale of prosocial behavior remains unchanged).
Recent research has provided partial support for the appropriateness of the
revised 3-factor model. In studies comparing the different factor structures (3
vs. 5) in terms of model fit, the superiority of either the 3-factor structure
or the 5-factor structure or also the adequateness of both factor structures
have been documented. Goodman et al. ( p. 1189) conclude that “*there may be
no single best set of subscales to use in the SDQ; rather*, *the optimal choice
may depend in part upon one’s study population and study aims*.”
Subsuming narrowband subscales into broadband scales takes place from a clinical
perspective and represents the well-known hierarchical model of child and
adolescent psychopathology. For example, the SDQ narrowband scales of
hyperactivity and conduct problems describe distinctive psychopathological
phenomena but are often co-occurring, which is why both scales form a broadband
externalizing scale. The broadband perspective on child and adolescent behavior
and emotions leads to a two-dimensional taxonomy of psychopathology
distinguishing between internalizing and externalizing behavior. The question of
whether child and adolescent psychopathology is best described by narrowband or
broadband measures is the subject of ongoing debate:
> *“\[…\] the once plausible goal of identifying homogeneous populations > for
treatment and research resulted in narrow diagnostic categories > that did not
capture clinical reality*, *symptom heterogeneity within > disorders*, *and
significant sharing of symptoms across multiple > disorders*. *The historical
aspiration of achieving diagnostic > homogeneity by progressive subtyping within
disorder categories no > longer is sensible \[…\]”* ( p. 12)
However, it must also be considered that different narrowband dimensions of
behavior (e.g., aggressive vs. non-aggressive rule-breaking behavior) are
related to different etiological factors. Vice versa, different narrowband
dimensions of behavior might explain educational outcome variables to varying
degrees, for example, conduct problems are associated with arithmetic skills
(*r* =.20), while the association is stronger for hyperactivity (*r* =.38).
Subsuming these narrowband dimensions of behavior into a broader category of
behavior might therefore lead to a loss of information; that is, differentiated
effects (between narrowband scales) in predicting educational outcomes are not
described by a broadband scale. The usage of narrowband scales could provide a
nuanced description of the association between dimensions of behavior and child
and adolescent outcomes.
# Aims
Empirical evidence concerning the superiority of the narrowband scales of
behavior in the prediction of child and adolescent outcomes is lacking.
Comparisons between the narrowband scales (5-factor structure) and broadband
scales (3-factor structure) with regard to the prediction of outcomes is sparse.
The question remains: Which factors (narrowband vs. broadband) are better
predictors? In addition, the vast majority of previous research using the SDQ
has focused on parent- or teacher-reported student behavior. There is a lack of
studies that examine the associations between self-reports of students on the
SDQ and relevant outcomes. However, children and adolescents can be considered
experts of their own well-being and consequently might depict a valid and
important source of information on their own behavior.
In the present study, therefore, we examined how behavioral and emotional
problems, measured by means of the different self-report SDQ scores (narrowband
and broadband scales), are associated with child and adolescent outcomes, such
as measures of academic success (grades), well-being (school, friends, and
family), and self-belief (self-esteem and self-efficacy). We thereby assume that
narrowband scales of behavior are more informative predictors of outcomes than
broadband scales of behavior. This comparison (narrowband vs. broadband
dimensions of behavior) seems of particular importance for emphasizing the need
to differentiate behavioral problems when examining associations with child and
adolescent outcomes.
# Method
## Study design and participants
The analyzed cross-sectional sample was obtained from the baseline of the German
Health Interview and Examination Survey for Children and Adolescents (KiGGS
study). The KiGGS study is a nationally representative health survey comprising
children and adolescents. The survey’s main objective is to obtain information
on key physical and mental health indicators, risk factors, health service
utilization, health behavior, and living conditions of children and adolescents
in Germany. Study participants were not recruited in schools (non-nested data
structure) but randomly selected from the official registers of local residents.
The data were collected from 2003 to 2006. The KiGGS sample consists of 17641
children and adolescents aged 0 to 17 years. The children were given a physical
examination and the parents as well as the children and adolescents themselves
(from age 11 on) were interviewed via written questionnaires. The study was
approved by the Charité/Universitätsmedizin Berlin ethics committee and the
Federal Office for the Protection of Data.
The present analysis represents a secondary data analysis with a focus on
behavior/emotions and child and adolescent outcomes such as measures of well-
being (school, friends, and family), academic success (grades), and self-belief
(self-esteem and self-efficacy), which are factors of interest to professionals
in educational contexts. We will focus on the child/adolescent-reported data and
refer to children and adolescents of compulsory education age. Compulsory
education in Germany usually ends with the completion of grade 9 (usually
15-year-old adolescents). The survey’s questionnaires were addressed to children
and adolescents from the age of 11 years onwards (usually children in grade 5
and above). The present sample therefore includes children and adolescents with
a minimum age of 11 years in grades 5 to 9 (*N* = 4642; 52% boys; age in years:
*M* = 13.46, *SD* = 1.47, *Min* = 11.00, *Q*<sub>1</sub> = 12.17, *Md* = 13.42,
*Q*<sub>3</sub> = 14.67, *Max* = 17.92). The distribution of the children and
adolescents across grades 6 to 9 is nearly equal (approximately 21.5% in each
grade, but 14% in grade 5). The proportion of children and adolescents in grade
5 (usually 10- and 11-year-olds) is small, as individuals under the age of 11
are not included in the present sample.
## Measures
### Child and adolescent behavior and emotions
The German self-report version of the Strengths and Difficulties Questionnaire
(SDQ) was used to assess child and adolescent behavior and emotions. This
questionnaire (25 items) quantifies emotional symptoms, peer problems, conduct
problems, hyperactivity, and, as a dimension of strength, prosocial behavior
(original narrowband scales). Emotional symptoms and peer problems can be
combined into a broadband internalizing behavior subscale, while conduct
problems and hyperactivity can be subsumed into a broadband externalizing
behavior subscale. The prosocial behavior subscale was not considered in the
present study, because the focus was on a comparison of the two broadband
subscales with the underlying narrowband subscales. SDQ items are rated on a
three-point scale (0 for "*not true*," 1 for "*somewhat true*," and 2 for
"*certainly true*"). High subscale scores indicate elevated behavioral problems.
The children and adolescents with the highest subscale scores, which are the
upper 10% of the normative sample, can be categorized as “*abnormal*” and are
considered to be at risk for psychiatric disorders. We therefore refer to these
individuals as *at-risk* children and adolescents. A conservative classification
rule, which minimizes false positive cases by selecting a cutoff value below
10%, was used to identify at-risk children and adolescents (emotional symptoms ≥
6, peer problems ≥ 5, conduct problems ≥ 5, hyperactivity ≥ 7, internalizing
behavior ≥ 9, and externalizing behavior ≥ 10; calculations based on KiGGS
baseline data,). With regard to the self-report version used in the KiGGS study
(data at hand), the internal consistencies for the subscales of peer problems
and conduct problems are insufficient (*α* and *ω* ≤.50), but moderate for the
subscales of emotional symptoms, hyperactivity, and internalizing and
externalizing behavior (*α* and *ω* ≥.60).
### Child and adolescent outcomes
*Health-related quality of life*. The self-report version of the KINDL-R is a
brief questionnaire to measure the health-related quality of life of children
and adolescents. The subscales school (e.g., “doing my schoolwork was easy”),
friends (e.g., “I played with friends”), self-esteem (e.g., “*I was proud of
myself*”), and family (e.g., “*I got on well with my parents*”) describe the
students’ well-being related to daily school life, friendship, family life, and
feelings of self-worth. Each subscale consists of 4 items. Items are rated on a
five-point scale (1 for “*never*,” 2 for “*seldom*,” 3 for “*sometimes*,” 4 for
“*often*,” and 5 for “*all the time*”). High scores indicate a positive quality
of life in the specific domain. With regard to the KiGGS study (data at hand),
the internal consistencies of the mentioned subscales are mediocre (*α* and *ω*
range from.53 to.69). The subscales physical and emotional well-being are not
used in the present study.
*School grades*. The school grades (math and German) received on the last report
card (half-year term) were reported by the parents. Germany uses a 6-point
grading scale. School grades vary from 1 (excellent) to 6 (insufficient), which
were reversed so higher values indicate a better academic performance.
*General self-efficacy*. The general self-efficacy scale is a 10-item
questionnaire that was designed to assess optimistic self-beliefs in coping with
a variety of difficult demands in life (e.g., “*I can always manage to solve
difficult problems if I try hard enough*”). In the KiGGS study, the scale was
only used in adolescents aged 14 years and older (*N* = 1750). Items are rated
on a four-point scale (1 for “*not at all true*,” 2 for “*hardly true*,” 3 for
“*moderately true*,” and 4 for “*exactly true*”). High scores indicate stronger
self-efficacy. With regard to the KiGGS study (data at hand), the internal
consistency of the scale is good (*α* and *ω* \>.80).
## Statistical analysis strategy
Ordinary least square regression models will be formulated with regard to the
prediction of child and adolescent outcomes (outcomes regressed on SDQ
subscales). The term “prediction” and cognate terms are used here in a
statistical sense and shall not be confused with the concept of predictive
validity, which describes the ability of a measure to forecast outcomes in the
future. To judge the statistical predictive performance of the different
subscales of the SDQ (broadband vs. narrowband), the regression model with the
broadband subscale (model 1: outcome regressed on broadband subscale, e.g.,
internalizing behavior) will be compared to the regression model with both
underlying narrowband subscales jointly as predictors in one regression model
(e.g., model 2: outcome regressed on emotional symptoms and peer problems). This
model comparison (narrowband vs. broadband) will be conducted with regard to
each predicted outcome and separately for internalizing and externalizing
behavior (internalizing behavior vs. emotional symptoms and peer problems;
externalizing behavior vs. conduct problems and hyperactivity). To evaluate the
predictive performance of the different models (predictive performance of the
broadband and narrowband subscales), we report two goodness-of-fit indices for
each regression model. The adjusted *R*<sup>*2*</sup> is the proportion of
variance in the outcome that is predictable from the predictors (SDQ subscales).
The Akaike Information Criterion (AIC) takes into account both model complexity
(total number of estimated model parameters) and goodness of model fit
(maximized likelihood) and balances these two. The individual AIC values are not
interpretable. However, the smaller the AIC value, the better the model fit.
Consequently, models with less complexity (fewer predictors) along with a high
goodness of fit are deemed to be good models. If the difference in AIC values
between the models is less than 3 (model with broadband scale vs. model with
underlying narrowband scales), then the model with the higher AIC value is
almost as good as the model with the smaller AIC value. For the application of
AIC model selection in the fields of psychology and psychometrics, see Vrieze.
The SDQ subscales are used as dummy variables. The reference is the at-risk
category (“abnormal”). Therefore, the intercept (constant) of each regression
model is interpretable as the expected average outcome for the at-risk children
and adolescents. Since all the outcomes are standardized (*M* = 0, *SD* = 1),
the intercept represents the average outcome for the at-risk group as a
deviation from the overall sample mean in units of standard deviation. The
regression parameters (*B*) for all the other SDQ subscale scores are
interpretable as the average difference in the outcomes (in units of standard
deviation) between the at-risk group and the children and adolescents with the
particular SDQ subscale score. These types of analyses emphasize the clinical
category “abnormal” (at-risk). In some additional regression analyses, we will
use the SDQ subscales as continuous predictors. If the SDQ subscale is a
continuous predictor, the intercept represents the average outcome for children
without behavioral problems (SDQ subscale score equals zero) as a deviation from
the overall sample mean in units of standard deviation, and the regression
parameter (*B*) is the average change (slope) of the outcome (in units of
standard deviation) when the SDQ score increases on average by one unit. All
statistical analyses were conducted in R 3.6.0.
# Results
## Preliminary results
### Model fit and measurement invariance of the 3- and 5-factor structures of the SDQ
Confirmatory factor analyses (weighted least square mean and variance adjusted
estimation) reveal an appropriate model fit (*RMSEA* \< 0.08, for details see)
for both the 3- and 5-factor structures of the SDQ, although the 5-factor
structure shows a better model fit (*RMSEA* =.05, *CFI* =.89, *TLI* =.88,
*χ*<sup>2</sup> = 3250.87, *df* = 265, *p* =.00) than the 3-factor structure
(*RMSEA* =.06, *CFI* =.85, *TLI* =.83, *χ*<sup>2</sup> = 4540.10, *df* = 272,
*p* =.00). However, *CFI* (\<.90) and *TLI* (\<.95) do not indicate good fit for
both the 3- and 5-factor structures. Both the 3- and 5-factor structures meet
the standards for metric invariance across gender and age groups (multi‑group
confirmatory factor analysis; comparison of metric and configural model:
difference in the models’ CFI ≤.01), which can be interpreted to indicate that
the measured dimensions of behavior (narrowband and broadband scales) manifest
in the same way across boys and girls as well as different age groups (quartile
age groups in years: \[11,12.2\], (12.2,13.4\], (13.4,14.7\], and (14.7,17.9\]).
As the goal of the present paper is to compare the statistical predictive
performance of the broadband (3-factor structure) and narrowband (5-factor
structure) scales of behavior and as it is not the goal to highlight differences
between boys and girls or different age groups, sex and age are not considered
as predictors of the child and adolescent outcomes.
## Descriptive results
Based on the SDQ narrowband subscales, the proportion of at-risk children and
adolescents ranges between 5.3% and 9.2% (conduct problems: 5.3%; emotional
symptoms: 6.2%; peer problems: 6.5%; hyperactivity: 9.2%), while the SDQ
broadband subscales reveal a proportion of 7.9% (internalizing behavior) and 10%
(externalizing behavior) of at-risk children and adolescents. The correlations,
means, and standard deviations of the SDQ subscales and the child and adolescent
outcomes are displayed in. All outcomes are positively associated. Increased
positive correlations are observed between the grades in math and German (*r*
=.47), as well as between the KINDL-R subscales of family and school (*r* =.35).
The general self-efficacy scale is likewise considerably correlated with the
KINDL-R subscales of self-esteem (*r* =.40) and friends (*r* =.32). The
different SDQ subscales were negatively correlated with all outcomes, which
means that increased behavioral problems measured by means of the different SDQ
subscales are associated with lower values for the outcomes, indicating adverse
outcomes. The KINDL-R friends subscale is highly correlated with the SDQ
subscales of peer problems (*r* =.49) and internalizing behavior (*r* =.48). The
grades (math and German) were only weakly correlated with the SDQ subscales of
peer problems and internalizing behavior (*r* ranges from.04 to.10). Also, the
correlation between the German grades and emotional symptoms is close to zero
(*r* =.03). Another small correlation is between the KINDL-R subscale for
friends and hyperactivity (*r* =.08).
## Main results: Predictive performance of the SDQ subscales
### Internalizing behavior vs. emotional symptoms and peer problems
Each child and adolescent outcome is regressed on the different SDQ subscales,
which are the broadband subscale for internalizing behavior (model 1) and both
underlying narrowband subscales, i.e., emotional symptoms and peer problems
jointly as predictors in one regression model (model 2). The regression
coefficients (*B*) and model fit parameters (*R*<sup>2</sup> and AIC) are
displayed in.
With regard to the results of models 1 and 2, it can be stated that the
associations between the outcomes and the SDQ subscales are negative, which
means that increased behavioral problems as indicated by high SDQ subscale
scores are associated with lower values of the outcomes, indicating adverse
outcomes. Taken as a whole, the at-risk children and adolescents have the lowest
average outcome values (the intercept ranges from -1.61 to -0.11).
With reference to the model fit parameters, the narrowband subscales of
emotional symptoms and peer problems (model 2: jointly as predictors in one
regression model) outperform the broadband subscale of internalizing behavior
(model 1) in the prediction of all outcomes (comparable *R*<sup>2</sup> and
lower AIC values), except for the prediction of general self-efficacy (AIC value
favors the predictive performance of the broadband subscale).
However, the predictive performance of the narrowband and broadband scales is
poor with regard to the prediction of the grades (math and German), i.e., the
proportion of explained variance is close to zero (*R*<sup>2</sup> ≤.01).
Therefore, it is hard to judge the predictive superiority of one of the SDQ
subscales (with regard to grade prediction), although the AIC values favor the
predictive performance of the narrowband subscales of emotional symptoms and
peer problems (model 2).
Besides this, model 2 offers a deeper insight into the magnitude of the effect
sizes of the two narrowband subscales. For example, in the prediction of the
KINDL-R school subscale, the regression coefficients for emotional symptoms are
remarkably higher (*B* ranges from 0.37 to 1.30) than the coefficients for peer
problems (*B* ranges from 0.04 to 0.32). As well, in the prediction of the
KINDL-R family subscale and in the prediction of the math grade, the emotional
symptoms subscale shows noticeably higher coefficients than the peer problems
subscale (family: *B* ranges from 0.22 to 0.86 vs. 0.06 to 0.26, math: *B*
ranges from 0.04 to 0.34 vs. 0.03 to 0.06). The situation is reversed in the
case of predicting the KINDL-R friends subscale, i.e., higher coefficients are
observable for peer problems (*B* ranges from 0.62 to 1.66), while lower
coefficients are detected for emotional symptoms (*B* ranges from 0.23 to 0.69).
Also in the prediction of the German grade, the peer problems subscale shows
higher coefficients than the emotional symptoms subscale (*B* ranges from 0.02
to 0.30 vs. -0.10 to 0.00). This detailed information about the differences in
effect sizes between the two narrowband subscales (model 2) is not depicted when
the broadband subscale for internalizing behavior is used as a predictor (model
1).
The results are almost the same when the SDQ subscales are considered as
continuous predictors. With regard to the model fit parameters, the narrowband
subscales of emotional symptoms and peer problems (model 2: jointly as
predictors in one regression model) outperform the broadband subscale for
internalizing behavior (model 1) in the prediction of all outcomes (comparable
or lower *R*<sup>2</sup> and lower AIC values), except for the prediction of
self-esteem and general self-efficacy (AIC values favor the predictive
performance of the broadband subscale). Differences in effect sizes (*B*)
between the two narrowband subscales (model 2) are apparent.
### Externalizing behavior vs. conduct problems and hyperactivity
Each child and adolescent outcome is regressed on the different SDQ subscales,
which are the broadband subscale for externalizing behavior (model 1) and both
underlying narrowband subscales, i.e., conduct problems and hyperactivity
jointly as predictors in one regression model (model 2). The regression
coefficients (*B*) and model fit parameters (*R*<sup>2</sup> and AIC) are
displayed in.
With regard to the results of models 1 and 2, it can be stated that the
associations between the outcomes and the SDQ subscales are negative, which
means that increased behavioral problems as indicated by high SDQ subscale
scores are associated with lower values for the outcomes, indicating adverse
outcomes. Taken as a whole, the at-risk children and adolescents have the lowest
average outcome values (the intercept ranges from -0.93 to -0.18).
With regard to the model fit parameters, the narrowband subscales for conduct
problems and hyperactivity (model 2: jointly as predictors in one regression
model) outperform the broadband subscale of externalizing behavior (model 1) in
the prediction of all outcomes (comparable or higher *R*<sup>2</sup> and lower
AIC values).
In addition, model 2 offers a deeper insight into the magnitude of the effect
sizes of the two narrowband subscales. For example, in the prediction of the
KINDL-R friends subscale, the regression coefficients for conduct problems are
remarkably higher (*B* ranges from 0.12 to 0.57) than the coefficients for
hyperactivity (*B* ranges from -0.05 to 0.20). Similarly, in the prediction of
the KINDL-R family subscale, the conduct problems subscale shows considerably
higher coefficients (*B* ranges from 0.20 to 1.14) than the hyperactivity
subscale (*B* ranges from 0.10 to 0.52). The situation is reversed in the case
of predicting the math grade, i.e., higher coefficients are observable for
hyperactivity (*B* ranges from 0.17 to 0.72), while lower coefficients are
detected for conduct problems (*B* ranges from 0.18 to 0.31). In addition, in
the prediction of general self-efficacy, the hyperactivity subscale shows
noticeably higher coefficients (*B* ranges from 0.02 to 0.97) than the emotional
symptoms subscale (*B* ranges from -0.07 to 0.33). This detailed information
about the differences in effect sizes between the narrowband subscales (model 2)
is not depicted when the broadband subscale for externalizing behavior is used
as a predictor (model 1).
If the SDQ subscales are considered as continuous predictors, the broadband
subscale for externalizing behavior (model 1) outperforms the narrowband
subscales (model 2) in the prediction of the KINDL-R subscales of school and
self-esteem as well as in the prediction of the German grade (comparable
*R*<sup>2</sup> and lower AIC values). In these predictions (KINDL-R school and
self-esteem subscales as well as the German grade), there are no differences in
effect sizes (*B*) between the two narrowband subscales, but they are apparent
in the predictions of the other outcomes (KINDL-R subscales for friends and
family, as well as math grades and general self-efficacy).
# Discussion
For the first time, the SDQ broadband and narrowband scales were compared with
regard to their criterion validity in predicting child and adolescent outcomes.
The results of the study indicated the relevance of the different SDQ subscales
for the description of students’ socio-emotional and academic situation. At the
same time, the results could not support a superiority of the broadband
subscales with regard to prediction of the outcomes. This interpretation can be
described for the internalizing and externalizing behavior subscales (except for
the prediction of general self-efficacy, where the internalizing behavior scale
shows the best model fit). If the SDQ scales are considered as continuous
predictors, the broadband scale for internalizing behavior outperforms the
narrowband scales in the prediction of general self-efficacy and self-esteem.
The same holds true for the prediction of the KINDL-R subscales of school and
self-esteem, as well as for the prediction of the German grade, where the
continuous externalizing subscale shows the best model fit. At any rate, in all
cases where a continuous broadband scale outperforms the underlying narrowband
scales, the difference in AIC values between the models is less than 3, i.e.,
the models with narrowband scales are almost as good as the models with the
broadband scales.
The use of sum scores for the narrowband subscales of emotional symptoms and
peer problems is more informative with respect to the range of predicted
outcomes. The models using the narrowband scales indicate that there are
differences between emotional symptoms and peer problems with regard to their
effect on different outcome variables. This information is not depicted through
the use of the broadband subscale of internalizing behavior, which might
therefore lead to a loss of information. At the same time, it must be stated
that children and adolescents might exhibit symptomatic behaviors related to
emotional symptoms but not have major peer problems or vice versa. Similar
observations can be made for conduct problems and hyperactivity. It can be
assumed that different categories of behavioral problems (e.g. conduct problems
and attention deficit/hyperactivity) also go in hand with the development of
different outcomes over time. Similarly, different conditions and predictors
might lead to either the one or the other narrowband behavior. Moreover,
different developmental trajectories become clear when focusing different
narrowband behaviors problems (e.g. emotional problems and peer problems),
Aggregating scores of narrowband into broadband scales might therefore run the
risk of blending distinctive behaviors associated with different developmental
outcomes. This evidence seems to strengthen the assumptions of Tandon et al.
( p. 593) who argue that:
> *“\[…\] a major shift*, *and advance in this area, has been the study > of
more discrete differentiated disorders instead of lumping of all > internalizing
symptoms into one broad category of the two-dimensional > internalizing versus
externalizing taxonomy of childhood > psychopathology.”*
Therefore, the differentiation between different narrow facets of internalizing
behavior seems to be of particular importance in the description of child and
adolescent psychopathology and the prediction of relevant outcomes. With respect
to the broadband subscale of externalizing behavior, these assumptions can also
be partially supported. In line with similar previous findings, differences
between the narrowband subscales of conduct problems and hyperactivity with
regard to their effect on the outcomes can also be described for most
predictions.
## Limitations
In this context, however, it must be noted that the chosen outcome variables do
not fully describe the levels of educational development of children and
adolescents. Further research is desirable that applies in-depth assessment of
educational outcomes, such as domain-specific academic achievement, social
integration, cognitive or self-regulation processes and uses a multi-informant
approach (especially data reported by educators and teachers are of relevance).
Compared to school grades, a domain-specific assessment (e.g., reading
comprehension) would provide a more detailed picture of the academic
performance. Besides this, the reporting of school grades from the last report
card by the parents might be prone to recall bias. In addition, some of the
chosen outcome variables (KINDL-R scales school and friends) show only low
internal consistencies and might therefore not be reliable. Unsatisfactory
internal consistency can also be described with regard to some of the SDQ scales
used (conduct problems and peer problems). However, it is important to note that
poor reliability does not necessarily affect the goodness of predictive
analysis.
## Conclusion
Despite the aforementioned limitations of the study at hand, the results shed
light on the predictive abilities of different subscales of the SDQ. In addition
to previous studies, these insights can be used for a further discussion of the
advantages and disadvantages of different factor structures of the SDQ. In the
sense of predicting educational outcomes, no advantage of the broadband scales
(resulting from the 3-factor structure) become clear. The application of
narrowband scales (resulting from the 5-factor structure), providing a more
differentiated picture of the socio-emotional and academic situation of
students, seems to be more appropriate for the prediction of child and
adolescent outcomes. This interpretation is of course limited, as it refers to a
selection of criteria and needs to be replicated with further educational
outcome variables. Furthermore, future research should examine the validity of
these results when using parent- or teacher-reported student behavior. In
addition, the finding that differentiation of behavioral problems might be a
benefit for the description of educational outcomes should be replicated using
other behavior assessment tools than the SDQ. Nonetheless, for the purpose of
identifying students at risk of struggling in educational contexts, using the
set of narrowband dimensions of behavior seems to be more appropriate in
educational research and practice.
## Implications
The study at hand indicated the need of focusing narrowband behaviors in
educational practice in order to gain the most differentiated insights into
possible predictors of the emotional-social as well as academic development of
children and adolescents. It becomes clear, that different narrowband behaviors
are more or less associated with different outcome variables. Subsuming
behaviors into broadband categories in educational practice might lead to the
fact that students, who might have been identified as at-risk because of salient
narrowband behavior, might not be identified as at-risk in broadband categories
(classification accuracy). In extension to these results of our analysis, the
question arises, whether in educational practice, focusing narrowband behaviors
might also be the most appropriate approach with regard to educational planning.
Consequently, Casale et al. argue, that the early identification of at-risk
students and the provision of individualized intervention might be a key
advantage of applying universal screening procedures (e.g. the SDQ) in schools.
Gaining insights in specific behaviors might offer the most detailed information
on educational needs, which might be addressed in subsequent behavioral
interventions. Subsuming behaviors might however lead to a loss of relevant
information.
We thank Jannis Bosch, Linda Kuhr, Anja Schwalbe and the reviewers for comments
that greatly improved the manuscript.
10.1371/journal.pone.0240312.r001
Decision Letter 0
Slobodskaya
Helena R.
Academic Editor
2020
Helena R. Slobodskaya
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
16 Jul 2020
PONE-D-20-15994
Prediction of School-Relevant Outcomes with Broadband and Narrowband Dimensions
of Internalizing and Externalizing Behavior Using the Child and Adolescent
Version of the Strengths and Difficulties Questionnaire
PLOS ONE
Dear Dr. Kulawiak,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
After thoroughly considering the reviews and reading the paper myself, I offer a
number of points to consider in a potential revision, as well.
1. Please enter a Financial Disclosure statement: The author(s) received no
specific funding for this work.
2. The use of the term “school relevant outcomes” for measures of subjective
well-being, self-esteem and self-efficacy seems problematic. These constructs in
themselves are the focus of important areas of research, therefore, for a
multidisciplinary journal such as PLOS ONE, it would be preferable to use a
wider term, for example “child outcomes” or “developmental outcomes”. I would
also suggest to change the ambiguous term “social and personal factors” to more
specific terms.
3. What are reliabilities and cut-offs for the externalizing and
internalizing scales?
4. Please describe the KINDL-R in more detail: How many items are there? How
many scales? What are the reliabilities?
5. Grades. What time period is covered by the last report card?
6. Please present the reliability of the general self-efficacy scale.
7. Please provide chi square statistics and CFI for the CFA. Reviewer 2 also
addresses this issue.
8. Please provide the significance levels for the correlations in Table 2:
Please submit your revised manuscript by Aug 30 2020 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions
see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>
We look forward to receiving your revised manuscript.
Kind regards,
Helena R. Slobodskaya, M.D., Ph.D., D.Sc.
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2.Thank you for stating the following financial disclosure: \[NO\].
At this time, please address the following queries:
a\) Please clarify the sources of funding (financial or material support) for
your study. List the grants or organizations that supported your study,
including funding received from your institution.
b\) State what role the funders took in the study. If the funders had no role in
your study, please state: “The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.”
c\) If any authors received a salary from any of your funders, please state
which authors and which funders.
d\) If you did not receive any funding for this study, please state: “The
authors received no specific funding for this work.”
Please include your amended statements within your cover letter; we will change
the online submission form on your behalf.
3\. We note that you have indicated that data from this study are available upon
request. PLOS only allows data to be available upon request if there are legal
or ethical restrictions on sharing data publicly. For more information on
unacceptable data access restrictions, please see
<http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-
access-restrictions>.
In your revised cover letter, please address the following prompts:
a\) If there are ethical or legal restrictions on sharing a de-identified data
set, please explain them in detail (e.g., data contain potentially sensitive
information, data are owned by a third-party organization, etc.) and who has
imposed them (e.g., an ethics committee). Please also provide contact
information for a data access committee, ethics committee, or other
institutional body to which data requests may be sent.
b\) If there are no restrictions, please upload the minimal anonymized data set
necessary to replicate your study findings as either Supporting Information
files or to a stable, public repository and provide us with the relevant URLs,
DOIs, or accession numbers. For a list of acceptable repositories, please see
<http://journals.plos.org/plosone/s/data-availability#loc-recommended-
repositories>.
We will update your Data Availability statement on your behalf to reflect the
information you provide.
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: No
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: No
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: No
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The authors present an interesting question: how do the different
factor-structures of the SDQ predict school grades. It is a question of interest
to many educational researchers. However, it is difficult to assess how this
question is answered based upon the unclear analyses used. It is necessary to
further describe the methods in detail. It may be advised to conduct additional
analyses to account for the complex data structure and to provide analyses that
correspond more clearly to the goals of the article. Below are my more detailed
comments:
Introduction:
1\) The authors argue that the literature linking SDQ scales to academic
achievement is sparse - there is research linking subscales of it to
achievement, as well as SDQ to other related scales. Additional work describing
some of these works may be useful for the reader. (e.g., DeVries, Rathmann,
Gebhardt, 2018). Failing the specific comparisons of SDQ subscales to
achievement, perhaps a discussion about the underlying constructs relationships
to achievement could be expanded upon further.
2\) In general the literature review is a bit brief, but to the point. It may be
worth adding a section about predictive validity of the SDQ to other variables -
who made what predictions and did they use narrow or broad scales?
Methods/Results:
3\) Alpha and omegas in the.6 range while technically considered acceptable are
still quite low - it may be worth making a cautionary note somewhere about this.
4\) Also, why not give the exact values, as you do in other places (lines 170,
171, 173).
5\) Alpha of for the KiGGS study is also very low, do you have the available
omega? (line 191).
6\) It appears you dropped prosocial behavior from all results. It may be worth
a sentence somewhere explaining this and that it was done because it does not
relate to the goals of the study.
7\) It is altogether unclear exactly what analyses were done. Judging from the
text and output tables, the authors appear to have run separate regressions for
each dependent and independent variables. A multiple linear regression technique
would be more appropriate here. It may be advised to run multiple linear models
where the predictors are combined into the model, instead of a separate model
for each predictor. Regardless, more information is required as the precise
models that were developed and tested.
8\) Is there no attempt to asses possible clusters and group effects? For this,
a multilevel multiple regression may be advised.
Discussion
8\) Without a clear picture to the exact analyses run, it is impossible to
evaluate the validity of any conclusions made. The general argument appears to
be that the more differentiated model(s?) has(have?) a better fit and moreover
there is a variation in the betas for the subscores. This line of reasoning is
possibly convincing, but it requires some additional details. can you provide
some theoretical connection to this reasoning? The discussion itself is
altogether brief, and would benefit from this as well as a deeper connection to
previous work (which may be needed also in the Intro).
9\) Some discussion of the predictive power of variables with low reliability
may be relevant - either as a limitation or a caution. Essentially, the low
reliability of the scales may have a major impact on predictive validity, which
is a major focus of the article.
other notes:
line 84: provide to provided
Reviewer \#2: The study entitled “Prediction of School-Relevant Outcomes with
Broadband and Narrowband Dimensions of Internalizing and Externalizing Behavior
Using the Child and Adolescent Version of the Strengths and Difficulties
Questionnaire” is of great interest in the field of Child and Adolescent
Psychological Health. The questionnaire SDQ is one of the most frequently used
in this field and the approach is very stimulating. It contains new scientific
knowledge and provides comprehensive information for further development in this
productive line of research. This paper is well-argued and clearly worthy of
publication.
It has several strengths, amongst others:
The background is adequate and up to date. The sample used is adequate and
cross-sectional self-report data was obtained. Regression models have been
compared with regard to the prediction of school-relevant outcomes using
narrowband vs. broadband scales of behavior. The data are presented in a clear
and easy-to-understand fashion. The results are clear and related to main goals.
The conclusions are supported by data.
As minor comments I would like to say:
Introduction
The literature review could include some more recent research on the use of the
SDQ questionnaire, as well as provide a stronger rational for the study of
internalizing and externalizing behavior problems in this specific population.
Method
The age group is not clearly defined. It would be necessary to include
frequencies and percentages of the age and sex distribution.
Results
In the result section, the authors informed that models for both 3 or 5 factors
show good fit indices. Please include more than one indicator of model fit
besides the RMSEA, such as Chi-square (χ2); degrees of freedom (df); p-value,
CFI or TLI. In addition to this information, factor invariance of gender and age
would be interesting to include in the analyses.
In table 1, in addition to the percentages of "abnormal" scores, it would be
interesting to include those that are within the normal range and those that are
at the limit.
Please, provide a better rational for choosing this type of regression and the
AIC measure rather than, for example, other types of regression such as
hierarchical regressions. Why did you test so many different regression models?
Please clarify the purpose.
Discussion
In the discussion section, please describe in more detail the contribution of
your study and its implications for practice in the educational context.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: **Yes: **J M DeVries
Reviewer \#2: **Yes: **Inmaculada Montoya-Castilla
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0240312.r002
Author response to Decision Letter 0
14 Sep 2020
Points raised by the academic editor
1\. Please enter a Financial Disclosure statement: The author(s) received no
specific funding for this work.
We added the statement to the current cover letter: “The author(s) received no
specific funding for this work.”
2\. The use of the term “school relevant outcomes” for measures of subjective
well-being, self-esteem and self-efficacy seems problematic. These constructs in
themselves are the focus of important areas of research, therefore, for a
multidisciplinary journal such as PLOS ONE, it would be preferable to use a
wider term, for example “child outcomes” or “developmental outcomes”. I would
also suggest to change the ambiguous term “social and personal factors” to more
specific terms.
We changed the term “school relevant outcomes” to “child and adolescent
outcomes”. We removed the term “social and personal factors”. Instead, we use
the term “self-belief”, for example (l. 157): “measures of academic success
(grades), well-being (school, friends, and family), and self-belief (self-esteem
and self-efficacy).”
3\. What are reliabilities and cut-offs for the externalizing and internalizing
scales?
Cut-offs (l. 206): “A conservative classification rule (37), which minimizes
false positive cases by selecting a cutoff value below 10%, was used to identify
at-risk children and adolescents (emotional symptoms ≥ 6, peer problems ≥ 5,
conduct problems ≥ 5, hyperactivity ≥ 7, internalizing behavior ≥ 9, and
externalizing behavior ≥ 10).” Reliability coefficients (Cronbach’s α and
McDonald’s ω calculated with the data at hand) are reported in Table 2.
4\. Please describe the KINDL-R in more detail: How many items are there? How
many scales? What are the reliabilities?
Items (l. 230): “Each subscale consists of 4 items.”. Additional information
about the subscales (l. 234): “The subscales physical and emotional well-being
are not used in the present study.” Reliability coefficients (Cronbach’s α and
McDonald’s ω calculated with the data at hand) are reported in Table 2.
5\. Grades. What time period is covered by the last report card?
l\. 235: “The school grades (math and German) received on the last report card
(half-year term) were reported by the parents.”
6\. Please present the reliability of the general self-efficacy scale.
Reliability coefficients (Cronbach’s α and McDonald’s ω calculated with the data
at hand) are reported in Table 2.
7\. Please provide chi square statistics and CFI for the CFA. Reviewer 2 also
addresses this issue.
Additional model fit parameters have been included (l. 307).
8\. Please provide the significance levels for the correlations in Table 2.
Table note (Table 2): “Significant correlations (p \<.05) are in bold.”
Reviewer \#1
1\. The authors argue that the literature linking SDQ scales to academic
achievement is sparse - there is research linking subscales of it to
achievement, as well as SDQ to other related scales. Additional work describing
some of these works may be useful for the reader. (e.g., DeVries, Rathmann,
Gebhardt, 2018). Failing the specific comparisons of SDQ subscales to
achievement, perhaps a discussion about the underlying constructs relationships
to achievement could be expanded upon further.
The point we want to address is not that the literature that links SDQ scales to
academic achievement is sparse, but that the literature that compares the
narrowband and broadband scales in the prediction of outcomes is sparse. We
added more information for clarification. We hope this clarifies your query. We
have updated the literature to describe the issue in more detail: (Aanondsen et
al., 2020; DeVries et al., 2018; Essau et al., 2012; Jones et al., 2020;
McAloney-Kocaman & McPherson, 2017; Niclasen & Dammeyer, 2016; Zarrella et al.,
2018)
2\. In general the literature review is a bit brief, but to the point. It may be
worth adding a section about predictive validity of the SDQ to other variables -
who made what predictions and did they use narrow or broad scales?
We now make it clear (introduction) which studies used narrowband scales and
which broadband scales.
3\. Alpha and omegas in the.6 range while technically considered acceptable are
still quite low - it may be worth making a cautionary note somewhere about this.
We updated the limitations (l. 502): “In addition, some of the chosen outcome
variables (KINDL-R scales school and friends) show only low internal
consistencies and might therefore not be reliable. Unsatisfactory internal
consistency can also be described with regard to some of the SDQ scales used
(conduct problems and peer problems). However, it is important to note that poor
reliability does not necessarily affect the goodness of predictive analysis
(67).”. 67 = Smits, N., van der Ark, L. A., & Conijn, J. M. (2018). Measurement
versus prediction in the construction of patient-reported outcome
questionnaires: Can we have our cake and eat it? Quality of Life Research,
27(7), 1673–1682. <https://doi.org/10.1007/s11136-017-1720-4>
4\. Also, why not give the exact values, as you do in other places (lines 170,
171, 173).
Reliability coefficients (Cronbach’s α and McDonald’s ω calculated with the data
at hand) are reported in Table 2.
5\. Alpha of for the KiGGS study is also very low, do you have the available
omega? (line 191).
Reliability coefficients (Cronbach’s α and McDonald’s ω calculated with the data
at hand) are reported in Table 2.
6\. It appears you dropped prosocial behavior from all results. It may be worth
a sentence somewhere explaining this and that it was done because it does not
relate to the goals of the study.
l\. 199: “The prosocial behavior subscale was not considered in the present
study, because the focus was on a comparison of the two broadband subscales with
the underlying narrowband subscales.”
7\. It is altogether unclear exactly what analyses were done. Judging from the
text and output tables, the authors appear to have run separate regressions for
each dependent and independent variables. A multiple linear regression technique
would be more appropriate here. It may be advised to run multiple linear models
where the predictors are combined into the model, instead of a separate model
for each predictor. Regardless, more information is required as the precise
models that were developed and tested.
Each outcome is predicted by the SDQ scales: Outcome regressed on broadband
scale (Model 1) and outcome regressed on both underlying narrowband scales
(Model 2). Hence, model 2 is a multiple linear model (two predictors: two
narrowband scales). Both models are compared (AIC comparison) to judge the
statistical predictive performance of the different subscales of the SDQ
(broadband vs. narrowband), whereby this type of model comparison is conducted
separately for internalizing and externalizing behavior (internalizing behavior
vs. emotional symptoms and peer problems; externalizing behavior vs. conduct
problems and hyperactivity). We reorganized the section “Statistical Analysis
Strategy” (starts at l. 248) and added more information for clarification. We
hope this clarifies your query.
8\. Is there no attempt to asses possible clusters and group effects? For this,
a multilevel multiple regression may be advised.
l\. 171: “Study participants were not recruited in schools (non-nested data
structure) but randomly selected from the official registers of local
residents.” A multilevel regression is not necessary because the data structure
is non-nested (random sample).
9\. Without a clear picture to the exact analyses run, it is impossible to
evaluate the validity of any conclusions made. The general argument appears to
be that the more differentiated model(s?) has(have?) a better fit and moreover
there is a variation in the betas for the subscores. This line of reasoning is
possibly convincing, but it requires some additional details. can you provide
some theoretical connection to this reasoning? The discussion itself is
altogether brief, and would benefit from this as well as a deeper connection to
previous work (which may be needed also in the Intro).
Your summary of our research describes exactly the main point. We are glad that
our main point is understandable. We added more information to highlight the
research question and aims. In addition, we tried to address the need of a
stronger theoretical connection as well as a stronger connection to previous
work. Therefore, we extended the discussion with regard to previous findings on
the independence of narrowband behaviors (ll.47 and 470) as well as the
implications for educational planning (l. 520)
10\. Some discussion of the predictive power of variables with low reliability
may be relevant - either as a limitation or a caution. Essentially, the low
reliability of the scales may have a major impact on predictive validity, which
is a major focus of the article.
We updated the limitations (l. 502): “In addition, some of the chosen outcome
variables (KINDL-R scales school and friends) show only low internal
consistencies and might therefore not be reliable. Unsatisfactory internal
consistency can also be described with regard to some of the SDQ scales used
(conduct problems and peer problems). However, it is important to note that poor
reliability does not necessarily affect the goodness of predictive analysis
(67).” 67 = Smits, N., van der Ark, L. A., & Conijn, J. M. (2018). Measurement
versus prediction in the construction of patient-reported outcome
questionnaires: Can we have our cake and eat it? Quality of Life Research,
27(7), 1673–1682. <https://doi.org/10.1007/s11136-017-1720-4>
11\. line 84: provide to provided
Done
Reviewer \#2
1\. The literature review could include some more recent research on the use of
the SDQ questionnaire, as well as provide a stronger rational for the study of
internalizing and externalizing behavior problems in this specific population.
We have updated the literature: (Aanondsen et al., 2020; DeVries et al., 2018;
Essau et al., 2012; Jones et al., 2020; McAloney-Kocaman & McPherson, 2017;
Niclasen & Dammeyer, 2016; Zarrella et al., 2018). We see the need of providing
a stronger rational for the study of internalizing and externalizing behavior in
this specific population. Therefore, we revised parts of the theoretical
background (l. 47) and added some references emphasizing the need and rational
for the study of internalizing and externalizing behavior problems in this
specific population.
2\. The age group is not clearly defined. It would be necessary to include
frequencies and percentages of the age and sex distribution.
Minimum, maximum and quartiles have been included to describe the distribution
(age), l. 185: “The present sample therefore includes children and adolescents
with a minimum age of 11 years in grades 5 to 9 (N = 4654; 52% boys; age in
years: M = 13.46, SD = 1.47, Min = 11.00, Q1 = 12.17, Md = 13.42, Q3 = 14.67,
Max = 17.92).”
3\. In the result section, the authors informed that models for both 3 or 5
factors show good fit indices. Please include more than one indicator of model
fit besides the RMSEA, such as Chi-square (χ2); degrees of freedom (df);
p-value, CFI or TLI. In addition to this information, factor invariance of
gender and age would be interesting to include in the analyses.
Additional model fit parameters have been included (l. 307). Factor invariance
(also referred to as measurement invariance): “Both the 3- and 5-factor
structures meet the standards for metric invariance (47,48) across gender and
age groups (multi‑group confirmatory factor analysis; comparison of metric and
configural model: difference in the models’ CFI ≤.01), which can be interpreted
to indicate that the measured dimensions of behavior (narrowband and broadband
scales) manifest in the same way across boys and girls as well as different age
groups (quartile age groups in years: \[11,12.2\], (12.2,13.4\], (13.4,14.7\],
and (14.7,17.9\]).” (l. 309)
4\. In table 1, in addition to the percentages of "abnormal" scores, it would be
interesting to include those that are within the normal range and those that are
at the limit.
Done (see Table 1)
5\. Please, provide a better rational for choosing this type of regression and
the AIC measure rather than, for example, other types of regression such as
hierarchical regressions. Why did you test so many different regression models?
Please clarify the purpose.
We have added an important source: “For the application of AIC model selection
in the field of psychology and psychometrics, see Vrieze (53).” (l. 271).
Vrieze, S. I. (2012). Model selection and psychological theory: A discussion of
the differences between the Akaike information criterion (AIC) and the Bayesian
information criterion (BIC). Each outcome is predicted by the SDQ scales:
Outcome regressed on broadband scale (Model 1) and outcome regressed on both
underlying narrowband scales (Model 2). Hence, model 2 is a multiple linear
model (two predictors: two narrowband scales). Both models are compared (AIC
comparison) to judge the statistical predictive performance of the different
subscales of the SDQ (broadband vs. narrowband), whereby this type of model
comparison is conducted separately for internalizing and externalizing behavior
(internalizing behavior vs. emotional symptoms and peer problems; externalizing
behavior vs. conduct problems and hyperactivity). We reorganized the section
“Statistical Analysis Strategy” (starts at l. 248) and added more information
for clarification. We hope this clarifies your query.
6\. In the discussion section, please describe in more detail the contribution
of your study and its implications for practice in the educational context.
We have added a subsection on the “Implications” of our study (l. 520 discussing
the advantages of applying broad- or narrowband categorizations of behavior in
schools with regard to diagnostic practice and educational planning.
10.1371/journal.pone.0240312.r003
Decision Letter 1
Slobodskaya
Helena R.
Academic Editor
2020
Helena R. Slobodskaya
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
24 Sep 2020
Prediction of Child and Adolescent Outcomes with Broadband and Narrowband
Dimensions of Internalizing and Externalizing Behavior Using the Child and
Adolescent Version of the Strengths and Difficulties Questionnaire
PONE-D-20-15994R1
Dear Dr. Kulawiak,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Helena R. Slobodskaya, M.D., Ph.D., D.Sc.
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: All recommended changes have been addressed. The exact analyses
and procedures are now quite clear, as well as the conclusions and limitations.
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
10.1371/journal.pone.0240312.r004
Acceptance letter
Slobodskaya
Helena R.
Academic Editor
2020
Helena R. Slobodskaya
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
29 Sep 2020
PONE-D-20-15994R1
Prediction of child and adolescent outcomes with broadband and narrowband
dimensions of internalizing and externalizing behavior using the child and
adolescent version of the strengths and difficulties questionnaire
Dear Dr. Kulawiak:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Helena R. Slobodskaya
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Phenolic glycolipids (PGL) are found in a limited group of pathogenic
mycobacteria including the members of the *M. tuberculosis* complex, *M.
leprae*, and a few other slow-growing mycobacteria (*M. kansasii, M. gastri*,
*M. ulcerans, M. marinum*, *M. microti* and *M. haemophilum*),. These
substances, located in the outermost layer of the mycobacterial cell envelope,
have been shown to play important functions in the pathogenicity of these
bacteria. PGL are composed of a mixture of long chain β-diols, esterified by
multimethyl-branched fatty acids, named mycocerosic acids or phthioceranic acids
depending on the configuration of the asymmetric centres bearing the methyl
branches. The β-diols chain is terminated by an aromatic nucleus, which in turn
is glycosylated. The sugar moiety of PGL consists of 1 to 4 sugar residues,
depending on the mycobacterial species, and most are *O*-methylated deoxysugars.
In *M. tuberculosis* the carbohydrate domain of the major variant of PGL, named
PGL-tb, is 2,3,4-tri-*O*-Me-α-L-Fuc*p*(1→3)-α-L-Rha*p*(1→3)-2-*O*-Me-α-L-
Rha*p*(1→). *M. tuberculosis* also secretes a family of smaller molecules that
contain the same glycosylated phenolic moiety as PGL-tb, the glycosylated
*p*-hydroxybenzoic acid methyl esters (*p*-HBAD).
Although PGL-tb are absent from many *M. tuberculosis* strains, due to a natural
frameshift mutation within *pks15/1*, a gene encoding a type-I polyketide
synthase specifically involved in the biosynthesis of PGL-tb , several lines of
evidence indicate that they may contribute to the pathogenesis of *M.
tuberculosis*. For instance, it was reported that a *M. tuberculosis* strain
producing PGL-tb induced more severe tuberculous meningitis in infected rabbits
than did strains devoid of PGL-tb. Moreover, the production of PGL-tb in one *M.
tuberculosis* isolate was associated with a hypervirulence phenotype in the
mouse model. This observation was correlated with the finding that PGL-tb
inhibits the production of several pro-inflammatory cytokines by infected mouse
macrophages. This phenotype was dependent on the structure of the saccharide
moiety of PGL-tb since the structurally related monoglycosylated PGL produced by
*M. bovis* BCG, the so-called mycoside B, did not produce a similar effect. The
putative role of the saccharide moiety in the immunomodulation activity of PGL-
tb was further highlighted by the finding that *p*-HBAD inhibits the pro-
inflammatory response of infected macrophages. Thus it appears that the
carbohydrate moiety of PGL-tb and of *p*-HBAD likely plays an important role in
the pathogenesis of mycobacterial infections.
The genes involved in the biosynthesis of the lipid core of PGL-tb are clustered
on a 70 kb region of the mycobacterial chromosome, the so-called DIM+PGL locus.
This chromosomal region also contains three glycosyltransferase-encoding genes,
namely *Rv2957*, *Rv2958c* and *Rv2962c*, and another gene (*Rv2959c*) encoding
a methyltransferase required for the formation of the carbohydrate part of PGL-
tb and *p*-HBAD. Two additional genes (*Rv1511* and *Rv1512*) located outside of
the DIM+PGL locus and responsible for the formation of L-fucose in *M.
tuberculosis*, have been shown to be involved in the biosynthesis of the
terminal fucosyl residue of PGL-tb. Despite these advances, the genes involved
in the *O*-methylations of the fucosyl residue of PGL-tb remain uncharacterized.
In this study, we report the identification of the three methyltransferases
responsible for modifying the hydroxyl groups at positions 2, 3, and 4 of the
terminal fucosyl unit of PGL-tb.
# Materials and Methods
## Bacterial Strains, Growth Media and Culture Conditions
Plasmids were propagated at 37°C in *E. coli* DH5α or HB101 in LB broth or LB
agar (Invitrogen) supplemented with either kanamycin (Km) (40 µg/ml) or
hygromycin (Hyg) (200 µg/ml). The *M. tuberculosis* H37Rv Pasteur wild-type
strain and its derivatives were grown at 37°C in Middlebrook 7H9 broth (Difco)
containing ADC (0.2% dextrose, 0.5% bovine serum albumin fraction V, 0.0003%
beef catalase) and 0.05% Tween 80 when necessary and on solid Middlebrook 7H11
broth containing ADC and 0.005% oleic acid (OADC). For biochemical analyses,
mycobacterial strains were grown as surface pellicles on Sauton’s medium. When
required, Km and Hyg were used at a concentration of 40 µg/ml and 50 µg/ml,
respectively. Sucrose 2% (w/v) was used to supplement 7H11 for the construction
of the PMM115 and PMM116 mutants.
## General DNA Techniques
Molecular cloning experiments were performed using standard procedures.
Mycobacterial genomic DNA was extracted from 5 ml saturated cultures as
previously described. PCR experiments for plasmid construction or genomic
analysis were performed in standard conditions on a GeneAmp PCR system 2700
thermocycler (Applied Biosystem). PCR was performed in a final volume of 50 µl
containing 2.5 units of Pfu DNA polymerase (Promega).
## Construction of *M. tuberculosis* H37Rv Gene-disrupted Mutants
The Δ*Rv2954c* and Δ*Rv2956 M. tuberculosis* H37Rv mutants (PMM115 and PMM116)
were constructed by allelic exchange using the Ts/*sacB* procedure. Two DNA
fragments containing either the *Rv2954c* gene or the *Rv2956* gene were
amplified by PCR from *M. tuberculosis* genomic DNA using oligonucleotides 2954A
and 2954B (for *Rv2954c*) and 2956A and 2956B (for *Rv2956*) and subsequently
cloned into pGEM-T (Promega). An internal 463 bp *Rv2954c* fragment and an
internal 487 bp *Rv2956* fragment were removed by double-strand site-directed
mutagenesis with the inverse PCR technique using oligonucleotides 2954IP1 and
2954IP2 for *Rv2954c* and oligonucleotides 2956IP1 and 2956IP2 for *Rv2956* and
substituted by a *km* resistance cassette formed by the Ω*km* cassette flanked
by two *res* sites from transposon γδ. The DNA fragments containing the
disrupted *Rv2954c* and *Rv2956* genes were inserted into pPR27, a mycobacterial
thermosensitive suicide plasmid harboring the counterselectable marker *sacB*
and the resulting plasmids were transferred by electrotransformation into *M.
tuberculosis* for allelic exchange. PCR screening for disruption of *Rv2954c*
and *Rv2956* were performed with a set of specific primers (2954C, 2954D, 2954E,
res1, and res2 for *Rv2954c* and 2956C, 2956D, 2956E, res1, and res2 for
*Rv2956*, and) after extraction of the genomic DNA from several Km and sucrose-
resistant colonies. Two clones giving the expected pattern for disruption of
*Rv2954c* and *Rv2956* were selected for further analyses and named PMM115
(*Rv2954c::res-km-res*) and PMM116 (*Rv2956::res-km-res*), respectively.
To construct a *Rv2955c M. tuberculosis* mutant of H37Rv, we used the strategy
described by Bardarov *et al.*. A 2369 bp fragment containing the *Rv2955c* gene
was amplified from *M. tuberculosis* genomic DNA using primers 2955H and 2955I
and inserted within the vector pGEM-T. The *km* resistance cassette was then
inserted between the *Bst*EII and *Eco*RI sites of the *Rv2955c* gene and the
fragment containing the *Rv2955c* disrupted allele was cloned within the cosmid
vector pYUB854. The resulting cosmid, was cut with *Pac*I and ligated with the
mycobacteriophage phAE87. The ligation products were encapsidated *in vitro*
using the Gigapack III XL kit (Stratagene) and the mix was used to infect *E.
coli* HB101 following the manufacturer recommendations. Transfectants were
selected on LB plates containing Km. A recombinant phagemid containing the
disrupted gene construct was selected and transferred by electroporation in *M.
smegmatis* and phage particules were prepared as described previously. These
particles were then used to infect *M. tuberculosis* H37Rv and *M. tuberculosis*
allelic exchange mutants were selected by PCR analysis using primers 2955J,
2955K, 2955L, res1 and res2. One clone, named PMM126 (*Rv2955c::res-km-res*),
gave the pattern corresponding to allelic exchange and was retained for further
analysis.
The recovery of the *res*-Ω*km-res* cassette from *M. tuberculosis* PMM115,
PMM116 and PMM126 was performed as previously described using the
thermosensitive plasmid pWM19 that contains the resolvase gene of transposon γδ.
Several clones were selected and analyzed by PCR using various primers (2954C
and 2954D for *Rv2954c*, 2955J and 2955K for *Rv2955c*, and 2956C and 2956D for
*Rv2956*). Three clones giving the expected pattern for excision of the
*res*-Ω*km-res* cassette in *Rv2954c*, *Rv2955c* and *Rv2956*, were selected and
named PMM144 (*Rv2954c::res*), PMM145 (*Rv2955c::res*) and PMM122
(*Rv2956::res*), respectively.
## Construction of Complementation Plasmids
To construct pRS18 and pRS19, a region covering the *Rv2954c* gene and a region
covering the *Rv2955c* gene were PCR-amplified from *M. tuberculosis* H37Rv
genomic DNA using oligonucleotides 2954F and 2954G (for *Rv2954c*) and 2955F and
2955G (for *Rv2955c*). The PCR products were digested with *Nde*I and *Hind*III
endonuclease restriction enzymes and cloned between the *Nde*I and *Hin*dIII
sites of pMV361e, a pMV361 derivative containing the *pblaF*\* promoter instead
of the original *phsp60* promoter and carrying a *km* resistance marker. For the
construction of complement plasmids pRS26 and pRS27, two DNA fragments
overlapping either the *Rv2957* (pRS26) gene or the *Rv2956* and *Rv2957* genes
(pRS27) were amplified by PCR from *M. tuberculosis* H37Rv genomic DNA using
oligonucleotides 2957A and 2957B or 2956F and 2957B and cloned between the
*Nde*I and *Hind*III sites of pMV361e.
## Extraction and Purification of Glycolipids
Mycobacterial cells obtained from culture on Sauton’s medium were left in 60 ml
of CHCl<sub>3</sub>/CH<sub>3</sub>OH (1∶2, v/v) for 48 h to kill bacteria.
Lipids were then extracted twice with CHCl<sub>3</sub>/CH<sub>3</sub>OH (2∶1,
v/v) for 24 h each, washed twice with water, and dried. Extracted mycobacterial
lipids were suspended in CHCl<sub>3</sub> at a final concentration of 20 mg/ml
and analyzed by thin-layer chromatography (TLC). Equivalent amounts of lipids
from each strain were spotted on silica gel G60 plates (20×20 cm, Merck) and
separated with CHCl<sub>3</sub>/CH<sub>3</sub>OH (95∶5, v/v). Glycolipids were
visualized by spraying the plates with a 0.2% anthrone solution (w/v) in
concentrated H<sub>2</sub>SO<sub>4</sub>, followed by heating. Crude lipid
extracts were subjected to chromatography on a Sep-Pak Florisil cartridge and
eluted with a series of concentrations of CH<sub>3</sub>OH (0, 10, 20, 30%) in
CHCl<sub>3</sub>. Each fraction was analyzed by TLC on Silica Gel G60 using
CHCl<sub>3</sub>/CH<sub>3</sub>OH (90∶10, v/v) as the solvent system and
glycolipids were visualized as described above. For MALDI-TOF mass spectrometry
analyses, glycolipids were additionally purified by preparative chromatography
on silica gel G60 plates using CHCl<sub>3</sub>/CH<sub>3</sub>OH (90∶10, v/v) as
the developing solvent and recovered by scraping silica gel from the plates.
## Matrix-assisted Laser Desorption-Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry
MALDI-TOF mass spectrometry analyses were performed in reflectron mode, with an
Applied Biosystems 4700 analyzer mass spectrometer (Applied Biosystems,
Framingham) equipped with an Nd:YAG laser (wawe-length 355 nm; pulse\<500 ps;
repetition rate 200 Hz). A total of 2500 shots were accumulated in positive ion
mode, and mass spectrometry data were acquired with the default calibration for
the instrument.
## Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR spectroscopy experiments were carried out at 300° K on a Bruker AVANCE
spectrometer operating at 600,13 MHz with a 5-mm triple resonance TCI
<sup>1</sup>H <sup>13</sup>C <sup>15</sup>N pulsed field z-gradient cryoprobe.
Samples were dissolved in 99,9% CDCl<sub>3</sub>. <sup>1</sup>H NMR studies on
the native and the per-*O*-acetylated glycolipids were performed using one-
dimensional and two-dimensional chemical shift correlation spectroscopy (COSY).
Chemical shifts are expressed in ppm using chloroform signal as an internal
reference (7.265 ppm).
# Results
## *Rv2954c, Rv2955c* and *Rv2956* are Involved in the Biosynthesis of PGL-tb in *M. tuberculosis*
In an attempt to identify the protein(s) responsible for the *O*-methylation of
the fucosyl residue in PGL-tb, we searched the *M. tuberculosis* genome for
genes encoding methyltransferases and mapping within the DIM+PGL locus. We
identified three genes (*Rv2954c*, *Rv2955c* and *Rv2956*) encoding proteins
sharing similarities to S-adenosylmethionine (SAM)-dependent methyltransferases.
These genes are located in the same chromosomal region as those previously shown
to be involved in the synthesis of the sugar moiety of PGL-tb. Proteins encoded
by *Rv2954c* and *Rv2956* are similar in length with 241 and 243 residues,
respectively, whereas *Rv2955c* encodes a protein of 321 amino acids. Although
their amino acid sequences share little identity (about 15%), secondary
structure prediction analyses revealed that these proteins are composed of
alternative α-helices and β-sheets that are characteristic to the SAM
methyltransferase core fold (data not shown). In addition a glycine-rich
sequence, close to the E/DXGXGXG motif (motif I) found in a number of SAM-
methyltransferases and an acidic region (motif II) located 17–19 amino acid
residues downstream from the end of motif I are present in the sequence of each
protein. Interestingly, motif I starts at position 45 for Rv2954c and Rv2956 but
is located at position 132 for Rv2955c suggesting that the latter protein has an
additional N-terminal domain.
To investigate the role of these putative methyltransferases in the biosynthesis
of PGL-tb, we constructed three *M. tuberculosis* knock-out mutants with
insertion within *Rv2954c*, *Rv2955c* and *Rv2956*. These genes were disrupted
by insertion of a *km* resistance gene cassette flanked by two *res* sites to
yield three recombinant strains, named PMM115 (*Rv2954c::res-km-res*), PMM126
(*Rv2955c::res-km-res*) and PMM116 (*Rv2956::res-km-res*). Since *M.
tuberculosis* H37Rv and derivatives are naturally deficient in the production of
PGL-tb due to a mutation in the *pks15/1* gene, the mutant strains and the H37Rv
wild-type strain were transformed with plasmid pPET1 that carries a functional
*M. bovis* BCG *pks15/1* gene. Lipids were extracted from the resulting strains
and analyzed by TLC. These analyses showed that the production of PGL-tb was
affected in the three mutant strains. The PMM115:pPET1 mutant produced a
glycolipid (product A) that exhibits a relative mobility lower than that of PGL-
tb. The PMM126:pPET1 mutant produced a major (product B) and a minor (product C)
glycoconjugates, both exhibiting a lower mobility than that of PGL-tb. Finally
the lipid profile of the PMM116:pPET1 recombinant strain contained a single spot
(product D) with a lower mobility than that of PGL-tb. These data suggested that
*Rv2954c*, *Rv2955c* and *Rv2956* are involved and play different roles in PGL-
tb biosynthesis.
## Rv2954c Catalyses the *O*-methylation of Position 3 of the Fucosyl Residue of PGL-tb
To determine the nature of product A produced by the PMM115:pPET1 mutant strain,
theglycolipid was purified and analyzed by MALDI-TOF mass spectrometry and
<sup>1</sup>H-NMR. The MALDI-TOF mass spectrum of product A showed a series of
major pseudomolecular ion (*M*+Na<sup>+</sup>) peaks at *m/z* 1850, 1864, 1878,
1892, 1906 and 1920, 14 mass units lower than those observed with PGL-tb from
H37Rv:pPET1 suggesting that this compound may differ from PGL-tb by the absence
of one methyl group. As expected, data from one dimensional (1D)
<sup>1</sup>H-NMR analysis of compound A were in agreement with the hypothesis.
Compared to the NMR spectrum of the native PGL-tb, only three signals (3.4–3.7
ppm), instead of four, attributable to the proton resonances of methoxyl groups
linked to the sugar moiety were seen in the spectrum of compound A, confirming
the loss of one methoxyl group in compound A. The other NMR data are consistent
with the proposed structure, notably (i) the presence of a *p*-substituted
phenolic nucleus (two doublets centered at δ = 6.9–7.1); (ii) polymethyl-
branched fatty acids (1.14 ppm) esterifying a β-glycol (4.83 ppm); (iii) a
methoxyl group borne by the aliphatic chain (3.32 ppm) that characterize a
phenolphthiocerol structure. Finally, the presence of three deshielded anomeric
protons (5.1–5.6 ppm) confirmed the occurrence of a trisaccharide in the
glycolipid. That compound A lacks a methoxyl group was also supported by the
occurrence, upon per-*O*-acetylation of four distinct methyl groups of acetyl
substituents (signal resonances at 1.9–2.2 ppm), indicating the presence of four
non-substituted hydroxyl groups in the native compound A. Moreover, the
per-*O*-acetylation resulted in a shift of the resonance of protons linked to
the carbons bearing the acetyl group downfield by about 1.0–1.4 ppm; it was thus
possible to distinguish free from substituted hydroxyl groups. 2D-COSY NMR
analyses of native and per-*O*-acetylated compound A were performed to assign
the resonances (Table). On the basis of chemical shift correlations, we
established that it was the position 3 of the fucosyl residue that was
per-*O*-acetylated, indicating that this position was free in the native
compound A. This suggested that Rv2954c is involved in the methylation of this
position.
To firmly establish that production of product A relies to the disruption of the
*Rv2954c* gene, we performed gene complementation studies by transferring a
wild-type allele of *Rv2954c* into the mutant strain. Due to the limited number
of antibiotic resistance genes available for use in mycobacteria, the *res-km-
res* cassette was first recovered from the PMM115 strain by site-specific
recombination between the two *res* sites. A new strain, named PMM144
(*Rv2954c::res*) harboring only a *res* site at the *Rv2954c* locus was
generated. This strain was transformed either with plasmid pPET1 or with both
pPET1 and pRS18 carrying a wild-type allele of *Rv2954c*. TLC and MALDI-TOF
analyses revealed that the PMM144:pPET1 strain produced the same PGL-like
substance (product A) than PMM115:pPET1 whereas the production of PGL-tb was
restored in the PMM144:pPET1:pRS18 strain ( and). Altogether these data
established that *Rv2954c* is involved in the *O*-methylation of position 3 of
the fucosyl residue of PGL-tb in *M. tuberculosis*.
## Rv2955c Catalyses the *O*-methylation of Position 4 of the Fucosyl Residue of PGL-tb
The structures of products B and C, which accumulated in the *M. tuberculosi*s
PMM126:pPET1 mutant were solved by both MALDI-TOF mass spectrometry and
<sup>1</sup>H MNR analyses of the purified compounds. The mass peaks from the
major (product B) and from the minor (product C) products were, respectively, 28
and 14 mass units lower than those of PGL-tb from the H37Rv:pPET1 strain
suggesting that the PMM126:pPET1 mutant produced two PGL-like substances that
may differ from PGL-tb by the absence of two and one methyl group(s),
respectively. All the proton resonances typifying a phenolphthiocerol structure
linked to a trisaccharide were observed in the 1D <sup>1</sup>H-NMR spectra of
native compounds B and C (data not shown). Importantly, only two and three
signals attributable to proton resonances of methoxyl groups linked to the sugar
part (3.4–3.7 ppm) were observed in the spectra of native compound B and C (data
not shown), respectively. This was in agreement with the presence of five and
four signals of distinct methyl groups of acetyl substituents observed in the
spectra of per-*O*-acetylated compounds B and C (data not shown), respectively,
indicating the loss, compared to PGL-tb, of two and one methoxyl groups in the
native compounds B and C, respectively. The positions of these free hydroxyl
groups were assigned by 2D-COSY spectroscopy of native and per-*O*-acetylated
compounds B and C (Tables). The resonances of the protons 3 and 4 of the fucosyl
residue were shifted after per-*O*-acetylation, indicating that the hydroxyl
groups in positions 3 and 4 were free in the compound B. Likewise, it was
possible to establish that position 4 of the fucosyl residue was the free
hydroxyl group in the compound C.
These data demonstrate that *Rv2955c* is involved in the *O*-methylation at
position 4 of the fucosyl residue of PGL-tb. However the accumulation in the
PMM126:pPET1 strain of a major glycolipid that differs from PGL-tb by the
absence of two methyl groups (product B) was surprising because *Rv2955c*
encodes an enzyme that was expected to methylate the fucosyl residue at only one
position. One explanation could be that disruption of *Rv2955c* in *M.
tuberculosis* exerts a partial polar effect on the expression of *Rv2954c*
involved in the *O*-methylation of position 3 of the fucosyl residue.
Alternatively, it is possible that methylation of position 3 catalyzed by the
product of *Rv2954c* occurs only after the *O*-methylation of position 4 by the
methyltransferase encoded by *Rv2955c*. To discriminate between these
hypotheses, we generated a new recombinant strain, named PMM145, with an
unmarked mutation in *Rv2955c* and we performed genetic complementation studies
with plasmids pPET1 and pRS19 that contains a wild-type allele of *Rv2955c*. The
PMM145:pPET1 strain synthetized two glycolipids that correspond to products B
and C previously characterized in the lipids from the PMM126:pPET1 mutant.
Introduction of *Rv2955c* in the PMM145:pPET1 mutant restored the biosynthesis
of a major glycoconjugate, which exhibits TLC mobility identical to that of PGL-
tb. The MALDI-TOF mass spectrum of this lipid showed a series of pseudomolecular
ion (M+Na<sup>+</sup>) peaks at *m/z* values identical to those observed in the
mass spectrum of PGL-tb purified from the wild-type strain. Since the
introduction of *Rv2955c* in the mutant strain was sufficient to restore the
wild-type phenotype, we concluded that the disruption of *Rv2955c* in *M.
tuberculosis* did not exert a polar effect on the expression of *Rv2954c*. These
findings strongly support the conclusion that i) the product of *Rv2955c* is
responsible for the *O*-methylation of the hydroxyl group located at position 4
of the fucosyl residue of PGL-tb and ii) the *O*-methylation of position 3 is
dependent on the *O*-methylation of position 4 by the product of *Rv2955c*.
## Rv2956 Catalyses the *O*-methylation of Position 2 of the Fucosyl Residue of PGL-tb
Product D, which accumulated in the *M. tuberculosis* PMM116:pPET1 mutant, was
analyzed by MALDI-TOF mass spectrometry. Surprisingly, the mass peaks from this
glycoconjugate were 188 mass units lower than those of PGL-tb. This difference
corresponded to the mass of the tri-*O*-methylfucosyl residue of PGL-tb,
suggesting that product D was a diglycosylated glycolipid. We reasoned that the
insertion of the *km* cassette within *Rv2956* may exert a polar effect on the
expression of the downstream *Rv2957* gene that encodes a glycosyltransferase
involved in the transfer of the fucosyl residue in PGL-tb, making it impossible
to determine the putative function of *Rv2956* in the methylation of PGL-tb. To
circumvent this problem, we generated a mutant with an unmarked mutation in
*Rv2956*. This strain, named PMM122 (*Rv2954c::res*), was transformed either
with pPET1 or with both pPET1 and pRS26, a plasmid harbouring a wild-type copy
of *Rv2957*. The PMM122:pPET1 strain produced a glycolipid that showed a
mobility on TLC identical to that of compound D from PMM116:pPET1. MALDI-TOF
analyses confirmed that it was indeed the same lipid (data not shown). In
contrast the PMM122:pPET1:pRS26 strain accumulated four glycoconjugates. The
major one was identified as product D by MALDI-TOF mass spectrometry indicating
a partial complementation of the polar effect on *Rv2957* expression by the
wild-type *Rv2957* gene carried by plasmid pRS26. The PMM122:pPET1:pRS26 strain
also produced two new PGL-like compounds, named E and F, and a small amount of
PGL-tb.
The structures of products E and F were solved by both MALDI-TOF mass
spectrometry and NMR analyses following purification. MALDI-TOF mass
spectrometry analyses indicated that products E and F differ from PGL-tb by the
absence of one and three methyl group(s), respectively. The 1D <sup>1</sup>H-NMR
spectra clearly demonstrate the presence of phenolphthiocerol in compounds E and
F. The presence of three deshielded anomeric proton signals (5.1–5.6 ppm)
confirmed the occurrence of a trisaccharide moiety in both glycolipids. Focusing
on the signals attributable to proton resonances of methoxyl groups linked to
the sugar units (3.4–3.7 ppm), only one signal was observed in the spectrum of
product F attributable to the methoxyl group linked on position 2 of the
rhamnosyl residue linked to the phenol ring. This clearly indicates the loss in
product F of the three methoxyl groups usually present on the PGL-tb fucosyl
residue. For product E, three methoxyl signal resonances were observed, compared
to PGL-tb, confirming the absence of one methoxyl group in this compound. The
position of the resulting free hydroxyl group was then identified by 2D-COSY
spectroscopy of native and per-*O*-acetylated product E (Table). The resonance
of the proton 2 of the fucosyl residue was shifted after per-*O*-acetylation,
indicating that the hydroxyl group in position 2 was free in product E. The
finding that products E and F were not methylated at position 2 of the fucosyl
residue indicated that *Rv2956* is involved in the 2-*O*-methylation of the
terminal fucosyl residue of PGL-tb. In addition accumulation of product F which
lacks *O*-methylation on the fucosyl residue, suggested that Rv2955c and Rv2954c
display partial activities when position 2 of the fucosyl residue is
unmethylated.
The PMM122: pPET1 strain was also transformed with plasmid pRS27 carrying the
wild-type allele of *Rv2957* and that of *Rv2956* to complement both the polar
effect on the *Rv2957* expression and the deletion of *Rv2956*. The resulting
strain exhibited two major glycolipids that were identified as product D and
PGL-tb by TLC and MALDI-TOF analyses. The presence of product D indicated that
the *Rv2957* gene carried by pRS27 weakly complemented the polar effect on the
expression of the *Rv2957* chromosomal allele as observed with pRS26. However,
the absence of PGL-tb like substance lacking a methoxyl group at position 2 of
the fucosyl residue and the accumulation of large amounts of PGL-tb confirmed
that Rv2956 is indeed involved in the *O*-methylation at position 2 of PGL-tb.
Thus from these data it can be conclude that i) *Rv2956 O*-methylates the
position 2 of the terminal fucosyl residue of PGL-tb and ii) Rv2954c and Rv2955c
exhibit higher catalytic activity in the presence of Rv2956.
# Discussion
In this study, we provide genetic and biochemical evidences that *Rv2954c*,
*Rv2955c* and *Rv2956* encode enzymes capable of *O*-methylating the terminal
residue of PGL-tb at the 3-, 4-, and 2-position, respectively. Indeed,
disruption of *Rv2954c* and *Rv2955c* in *M. tuberculosis* results,
respectively, in the production of a glycoconjugate with a fucosyl residue that
is not *O*-methylated at position 3 and 4. Interestingly, the lack of a
functional *Rv2955c* gene also prevents efficient *O*-methylation of position 3
in *M. tuberculosis*. This effect was not due to a polar effect on the
expression of *Rv2954c* in the mutant strain since introduction of a wild-type
allele of *Rv2955c* in the PMM126:pPET1 mutant was sufficient to fully restore
the wild-type phenotype.
Disruption of *Rv2956* in *M. tuberculosis* led to the accumulation of a
glycolipid lacking the terminal fucosyl residue (product D) suggesting a polar
effect on the expression of *Rv2957*. Complementation of the PMM122:pPET1 strain
with *Rv2957* or with both *Rv2956* and *Rv2957* partially suppressed the polar
effect, likely due to a weak expression of *Rv2957* from plasmids pRS26 and
pRS27. Interestingly, the PMM122:pPET1 strain complemented with *Rv2957*
synthesized faint amounts of PGL-tb raising the possibility that an unidentified
methyltransferase would partially fulfil the role of Rv2956. Rv2956 shares a
high degree of sequence identity with the product of *Rv1513* (68.7% identity)
in *M. tuberculosis*. *Rv1513* is likely not required *per se* for the
*O*-methylation of position 2 of the fucosyl residue because transfer of
functional *Rv1511*, *Rv1512* and *Rv2958c* genes from *M. tuberculosis* in *M.
bovis* BCG that naturally lacks an *Rv1513* ortholog, led to the formation of a
glycolipid that is structurally identical to PGL-tb. However in a genetic
context where Rv2956 is absent, it is possible that Rv1513 could partially
*O*-methylate the 2-position of the terminal fucosyl residue of PGL-tb in *M.
tuberculosis.*
Accumulation of product E which contains a terminal 3,4-di-*O*-methyl-fucosyl
residue in the PMM122:pPET1:pRS26 strain and its absence in the PMM122:pPET1
strain complemented with both *Rv2956* and *Rv2957* is consistent with the role
of Rv2956 in the *O*-methylation of position 2. Moreover the presence of product
F indicated that Rv2954c and Rv2955c have reduced enzymatic activities when the
position 2 of the fucosyl residue is not *O*-methylated. Therefore, Rv2956 is
likely to be the first methyltransferase that acts on the fucosyl residue of
PGL-tb. Consistently the various PGL-like variants that accumulated in the
*Rv2954c* and *Rv2955c* mutant strains were *O*-methylated on position 2.
Altogether these data suggest that *O*-methylation of the fucosyl residue of
PGL-tb is a sequential process: the product of *Rv2956* catalyses the
*O*-methylation of position 2, to yield a 2-*O*-Me-α-L-Fuc*p*(1→3)-α-L-
Rha*p*(1→3)-2-*O*-Me-α-L-Rha*p*(1→)phenolphthiocerol dimycocerosates; this
latter product is then sequentially methylated at position 4 by the
*Rv2955c*-encoded enzyme and later on at position 3 by the product of *Rv2954c*
to give PGL-tb. Sequential *O*-methylation of sugar residue has been described
in other bacteria such as *Streptomyces olivaceus* and *M. smegmatis*. For
instance *M. smegmatis* produces cell-wall-associated components, named
glycopeptidolipids (GPLs) which contain a lipopeptide core that is modified with
*O*-methylated rhamnosyl units and an *O*-acylated 6-deoxy talosyl residue. The
rhamnosyl residue of GPLs can be *O*-methylated with up to three methyl groups
at positions 2, 3 and 4 by the methyltransferases Rmt2, Rmt3 and Rmt4. It has
been shown that *O*-methylation by Rmt3 at the C3 carbon of the rhamnose was
necessary for subsequent methylation by the 4-*O* methyltransferase Rmt4 and the
2-*O*-methyltransferase Rmt2.
The proposed roles of *Rv2954c*, *Rv2955c* and *Rv2956* are consistent with the
organization of the DIM+PGL chromosomal region in the various sequenced
mycobacterial species producing PGL. Indeed conservation of these genes within
the DIM+PGL locus correlates with the ability of these strains to synthesize a
PGL containing an *O*-methylated fucosyl residue. For instance highly conserved
*Rv2954c*, *Rv2955c* and *Rv2956* orthologs (*BCG2975c*, *BCG2976c* and
*BCG2977*) are found in the DIM+PGL locus of *M. bovis* BCG. This mycobacterial
species naturally produces a monoglycosylated PGL due to the lack of functional
*Rv1511*, *Rv1512* and *Rv2958* orthologs; Consistently, transfer of these genes
from *M. tuberculosis* in *M. bovis* BCG allows synthesis of PGL-tb in the
resulting strain, indicating that *M. bovis* BCG possesses the enzymatic
machinery necessary for the *O*-methylation of the fucosyl residue. These
reactions are most likely performed by the products of *BCG2975c*, *BCG2976c*
and *BCG2977*. In contrast no *Rv2954c*, *Rv2955c* and *Rv2956* orthologs are
present in the DIM+PGL loci of *M. marinum* and *M. leprae*, two mycobacterial
species that produced PGL with no terminal *O*-methylated fucosyl residue.
Finally, the involvement of *Rv2956* in the *O*-methylation of position 2 of
PGL-tb is supported by the genetic organisation of the DIM+PGL locus in *M.
kansasii*. This chromosomal region contains several genes encoding putative
*O*-methyltransferases but none of these display significant amino acid sequence
homology to Rv2954c and Rv2955c. In contrast one gene encodes a protein
exhibiting a high degree of sequence identity (about 84%) with Rv2956.
Interestingly, the carbohydrate domain of the major form of PGL produced by *M.
kansasii* consists of four sugar residues, the third one being a
2-*O*-Me-4-*O*-Ac fucosyl residue.
The data presented in this study provide insights on the biosynthesis of
compounds that are important for the pathogenesis of *M. tuberculosis*. The
generation of mutants producing PGL-tb derivatives, and thereby *p*-HBAD
derivatives, with a modified carbohydrate moiety could be useful tools to
decipher the mechanisms by which these compounds act in the course of infection.
# Supporting Information
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: RS GH PC CC. Performed the
experiments: RS GH PC WM AL FL CC. Analyzed the data: RS GH PC MD CG CC.
Contributed reagents/materials/analysis tools: RS GH PC WM AL FL. Wrote the
paper: CC CG MD.
[^3]: Current address: Present address: Unité de Pathogénomique
Mycobactérienne Intégrée, Institut Pasteur, Paris, France
[^4]: Current address: Present address: Laboratoire des Interactions
Plantes-Microorganismes (LIPM), Castanet-Tolosan, France
|
# Introduction
Tegumentary Leishmaniasis (TL) is a neglected tropical disease caused by
different species of the genus *Leishmania* (Kinetoplastea: Trypanosomatidae),
transmitted to vertebrate hosts by sand flies (Diptera: Psychodidae). TL is
considered an emergent and re-emergent disease, since a worrisome increase in
its incidence has been reported. On a the global scale, the number of new
autochthonous TL cases reported annually to the World Health Organization (WHO)
increased from 71,486 to 251,553 during 1998 to 2018. Several factors are
involved with the spread of TL, such as human migration from rural to urban
areas, conflicts and wars, disturbances in microenvironments due to climate
change and human intervention and deterioration of socioeconomic conditions in
endemic countries.
TL comprises a broad spectrum of clinical manifestations ranging from single or
multiple ulcerative skin lesions (cutaneous leishmaniasis—CL), to diffuse
(diffuse leishmaniasis-DL) and mucosal (mucosal leishmaniasis—ML) lesions, with
the last two being typical in the Americas. TL is associated with physical
deformities and psychological alterations, affecting the health and wellness of
the patient.
The range of clinical manifestations can hinder rapid and accurate diagnoses, a
key step to initiate treatment promptly and control the disease. Although
several advances, TL-diagnosis remains based on the triad of epidemiological
background, clinical signs and laboratory diagnosis, including direct and
histopathological examination of skin biopsy and molecular detection of
*Leishmania* DNA. Despite high specificity, low sensitivities have been
described for direct and histopathological examination, especially in New World
countries, where chronic cases and ML are frequent. Molecular techniques are
complex, expensive, still without a standardized protocol for routine use and
are restricted to reference and research centers. Therefore, these limitations
make the TL-diagnosis scenario restricted, particularly in resource limited
settings.
In this sense, immunological tests may present remarkable advantages for TL-
diagnosis, due to the use of less invasive sampling compared to skin biopsy and
their potential to be automated, quantitative and used as point-of-care tests.
The anti-*Leishmania* delayed-type hypersensitivity reaction, known as the
Montenegro skin test (MST), has been the most used immunological test for CL-
diagnosis in Brazil, even though it presents significant limitations such as
positive results associated with previous leishmaniasis or asymptomatic
infections. Nonetheless, the production of the MST antigen was discontinued in
Brazil, hampering even more CL-diagnosis in the country. Other immunological
tests, mainly Enzyme-Linked Immunosorbent Assay (ELISA), have presenting
promising results in the Americas and beyond.
Several studies using soluble *Leishmania* antigen (SLA) in ELISA for TL-
diagnosis, have presented variable sensitivity especially due to antigen
preparation and antigenic differences among *Leishmania* isolates and species.
Moreover, reduced specificity due to the cross-reactivity with other infectious
diseases has been frequently reported. Since CL-patients commonly produce low
levels of anti-*Leishmania* antibodies, there is growing interest in high
sensitivity antigens for immunological tests. Different methodologies have been
employed, such as bioinformatics tools, cDNA expression library, phage display,
immunoproteomic approach and isolation and purification of glycoconjugates to
identify potential antigens. Furthermore, immunological tools have already been
used to detect *Leishmania* antigens using monoclonal and polyclonal antibodies
by immunochromatographic test (ICT) or immunohistochemistry (IHC), such as the
CL Detect Rapid Test (InBios International Inc., Seattle, WA, USA), which
detects peroxidoxin from *Leishmania* and has been used especially in Old World
countries, with limited sensitivity.
In this sense, we consider immunnodiagosis as potential tools to increase the
access and improve TL-diagnosis. Although systematic reviews have been conducted
on some aspects of this form of diagnosis, it is essential to identify potential
antigenic targets that have been evaluated as TL-immunodiagnostic, point out
knowledge gaps that still remain and encourage other studies to allow its
application in clinical practice. In this way, we performed a worldwide
systematic review to identify potential antigenic targets, with reported
sensitivity and specificity, used as TL-immunodiagnostic.
# Material and methods
## Protocol and registration
The review protocol was registered in the International Prospective Record of
Systematic Reviews (PROSPERO: CRD42020213311) and was developed based on the
Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. This
review followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA).
## Information sources and study selection
Structured searches were conducted in the following databases: MEDLINE, Virtual
Health Library, Embase and Cochrane. A comprehensive list of key terms including
tegumentary leishmaniasis and its different clinical forms AND immunological
diagnosis or targets (antigens and antibodies) AND techniques or outcomes
(sensitivity and specificity), was constructed in MEDLINE. Similar searches were
adapted to each database. Complementary searches were performed by analysis of
reference lists of selected articles. Searches were performed on 23<sup>rd</sup>
March 2020, without restriction of publication date.
## Inclusion and exclusion criteria
Original research articles reporting on the performance (sensitivity and
specificity) of immunological tests based on the detection of antibodies or
antigens using purified or recombinant proteins, synthetic peptides or
polyclonal or monoclonal antibodies for diagnosis of human-TL, CL or ML were
included. Exclusion criteria were: evaluation of serological tests based on SLA;
only non-human samples were tested (e.g. canine samples); both sensitivity and
specificity of the immunological tests were not presented or were impossible to
be calculated; less than five samples were tested; the absence of information
about the reference test and a non-specific *Leishmania* antigen was used.
## Selection process
For each database, all publications were retrieved and duplicate citations were
excluded by EndNote software. Based on the inclusion and exclusion criteria, two
independent reviewers analyzed each publication by title and abstract using
Rayyan software. Articles with no reason for rejection were included for full
text reading. All discrepancies were solved by consensus after discussion.
Selected studies were read in full to confirm their eligibility, to extract data
or to exclude if exclusion criteria were identified during this step.
## Data extraction
Data were independently extracted by two researchers (MLF and FDR) directly from
full-length articles and were checked by a third researcher (EO). In case of
disagreements, the final decision was reached by consensus. In this study, data
were extracted and a 2x2 contingency table set up for immunological tests,
containing the true positives, false positives, true negatives and false
negatives. Furthermore, the following items were extracted: origin of the
participants; the immunological test used; antigen or antibody types;
*Leishmania* species and reference standard test used for disease confirmation.
The phase of development of each study was classified according to Leeflang &
Allerberger (2019).
## Study quality assessment
The quality of the studies was assessed using the second version of Quality
Assessment of Studies of Diagnostic Accuracy Approach (QUADAS-2). This tool
allows a more transparent rating of risk of bias for studies included in
systematic reviews on diagnostic accuracy.
## Data synthesis
The performance of antigenic targets was presented in four groups according
immunological tests and clinical form: 1) ELISA for TL; 2) ELISA for CL; 3)
Other immunological tests for CL and 4) ELISA for ML. The performance outcomes
for each antigen or antibody were sensitivity (probability of a positive test
among cases or disease confirmed individuals) and specificity (probability of a
negative test among controls or individuals without disease). Forest plots
showing sensitivity and specificity values of all antigens, including 95%
confidence intervals (CI) and Summary Receiver Operating Characteristic (SROC)
curves were created using RevMan 5.3.
Several studies considered a set of results for the same antigen (e.g. different
cut-off points were available or different non-case groups were used in the
analysis, such as healthy patients and those with other diseases). If possible,
these results were grouped and only one sensitivity rate and one specificity
rate including all evaluated patients. When impossible, we chose to present data
that reflect the best field conditions (e.g. non-case group of patients with
other diseases) or the better performance (e.g. cut-off point with best
performance).
# Results
## Literature search
A total of 1642 articles from four databases were initially identified. Of this
total, 261 were excluded due to duplicity (the same study was found in different
databases). The title and abstract of each of the 1381 articles were checked and
139 were selected for full text reading. Finally, 98 articles presented
exclusion criteria and so 38 were included.
## Descriptive analysis of included studies
The characteristics of all included studies are presented in. In several
studies, test performance was analyzed according to the clinical form (CL and
ML) or globally (TL). In 19 studies, the antigenic targets were evaluated for
TL-diagnosis, in 21 for CL and in 9 for ML. Sample size ranged from 26 to 500
patients. A total of three different immunological tests using purified or
recombinant proteins, synthetic peptides or polyclonal or monoclonal antibodies
were reported: ELISA, ICT and IHC. Different reference standard tests were used
to confirm leishmaniasis cases. Thirty-one studies (81.6%) considered at least
one parasitological method as a reference standard test, such as microscopy
examination or *in vitro* culture for isolation of the parasite. On the other
hand, seven studies (18.4%) considered some immunological or molecular tests as
a reference standard. A total of 89.5% (34 out of 38) of the studies was
classified as phase I (proof-of-concept), and the remaining 10.5% (4 out of 38)
was classified as phase III.
## ELISA for TL diagnosis
Nineteen studies used ELISA to evaluate the performance of a total of 56
antigens for TL-diagnosis, without specification of the clinical form (CL or
ML). These studies evaluated 38 recombinant proteins, 14 synthetic peptides and
4 purified proteins. Forty-seven antigens were evaluated in studies that
considered at least one parasitological method, such as microscopy examination
or *in vitro* culture isolation of the parasite, as a reference standard test.
The number of TL-patients ranged from 20 to 219 and the number of non-TL
patients ranged from 8 to 281. The highest performance (100% of sensitivity and
specificity) was reported for four recombinant proteins (cytochrome c oxidase;
hypothetical protein XP_003886492.1; putative IgE histamine releasing factor;
tryparedoxin peroxidase) and four synthetic peptides (A10, B7, C12 and H7)
selected by the phage display technique. Nine other antigens were evaluated in
studies that considered at least one immunological method as a reference
standard test. For these antigens the sensitivity ranged from 39.8% to 76.9% and
the specificity from 53.4% to 97%. The forest plots for sensitivity and
specificity of ELISA considering parasitological methods and other tests as
reference standard tests for TL-diagnosis are presented in ; more details about
each evaluated antigen are available in.
## ELISA for CL diagnosis
Seventeen studies used ELISA to evaluate the performance of 44 antigens for CL-
diagnosis, which comprised 20 recombinant proteins, 13 synthetic peptides and 11
purified proteins. The performance of 35 antigens was evaluated considering at
least one parasitological method as a reference standard test. Among these, the
sample size for studies of CL-patients ranged from 12 to 74 and for non-CL-
patients from 10 to 177. Peroxidoxin was the only antigen presenting 100%
sensitivity and specificity. Nine antigens were evaluated considering at least
one immunological test as a reference standard. Overall, HSP83 presented the
highest performance (100% sensitivity and specificity).
## Other immunological tests for CL diagnosis
The performance of ICT and IHC using different monoclonal and/or polyclonal
antibodies is presented in and detailed in. Four studies evaluated the CL Detect
Rapid Test (InBios International Inc., Seattle, WA, USA) in different countries.
The sensitivity ranged from 35.6 to 67.6 and the specificity was higher than
80%. For IHC, two monoclonal antibodies were employed to detect antigens in
fixed skin fragments. The highest performance was reported for IS22B4/XLVI5B8
mAbs, with 96% and 100% sensitivity and specificity, respectively.
## ELISA for ML results
Nine studies used ELISA to evaluate the performance of 23 antigens for ML-
diagnosis, which comprised 19 recombinant proteins, three synthetic peptides and
one purified protein. The sample size from ML-patients in these studies ranged
from 14 to 53 and from non-ML-patients from 20 to 92. At least one
parasitological method was used as a reference standard test for the evaluation
of sixteen antigens. The highest performance was obtained for Hypothetical
protein XP_001467126.1, with 100% sensitivity and 98% specificity. Seven
antigens were evaluated in studies considering at least one immunological test
as a reference standard. As noted for CL-diagnosis, 100% sensitivity and
specificity were reported for HSP83. The performance of these antigens is
presented in and more details are available in.
The SROC curves with the antigen performances for the diagnostic of different
clinical forms, using parasitological or other tests (such as ELISA and MST) as
a reference standard, are presented in. The antigens tended to have greater
accuracy in studies that have used the parasitological methods as reference
standard tests, regardless of TL-clinical manifestation.
## Quadas-2 based quality assessment
Quality assessment of the study according to risk of bias and concern with
applicability (low, high and unclear) is shown in. Of the 38 studies assessed,
21 had high risk of bias in patient selection. The risk was unclear for the
index test in 34 studies and for flow and timing in 30 studies. Nineteen studies
had high concerns regarding applicability of patient selection criteria.
# Discussion
TL is considered a multifactorial disease, responsible for psychological and
social impacts due to scars and mutilating lesions generating stigma and self-
deprecation in affected patients. Improvements in healthcare access and
laboratory diagnosis are needed to overcome the impacts of this disease and
should be encouraged. According to WHO’s Special Programme for Research and
Training in Tropical Diseases (TDR), the ideal test must be affordable,
sensitive, specific, user-friendly, rapid, equipment-free and delivered to end-
users (ASSURED). Immunological tests may fill these criteria since they are
usually easy to perform, accessible and require minimally invasive sample
collection. Therefore, the identification of sensitive and specific antigenic
targets seems to be a promising step toward the improvement of TL-diagnosis.
The studies analyzed here were conducted from 1996 to 2019, however, almost 50%
of them were conducted in the last five years, mostly in Brazil or another
country in the Americas. The increase in the number of studies is coincident
with the interruption of the production of MST antigen in Brazil in 2015, which
extinguished the simple and rapid immunodiagnostic for TL. This fact may have
boosted research aimed at finding new diagnostic tools.
Parasitological diagnosis was considered a reference standard test in 89.5% of
the studies. Despite this technique being highly specific for TL-diagnosis, its
sensitivity is limited and inversely correlated with disease duration. However,
no test seems to present sufficiently high sensitivity and specificity to be
used as a gold standard test. We observed a tendency for index tests to be more
accurate if parasitological tests were used as a reference standard than other
reference test such as MST and histopathology. Polymerase chain reaction (PCR)
was used as a reference standard test in 18 studies, generally in association
with parasitological diagnosis. Overall, PCR appears to be a more suitable
reference test, however, a standard protocol is urgently needed and encouraged,
since distinct extraction methods, protocols and molecular targets have been
used overtime.
The ability to accurately identify TL-patients is essential for a diagnostic
test, in view of the range of clinical forms, disease severity and treatment
toxicity. Several studies have included patients with Chagas disease as non-TL
cases, however, despite phylogenetic proximity, the inclusion of patients with
clinical signs that do not resemble TL is at least questionable. For tests with
diagnostic purposes, a better sample panel needs to be encouraged, including
diseases such as sporotrichosis, paracoccidioidomycosis, hanseniasis,
vasculitis, syphilis and other dermal or mucosal diseases, that represent
confounding factors in clinical practice.
Despite the distinct profiles in immune response usually reported for each
clinical form of TL, some antigens presented high values of sensitivity, even
for CL-patients. In general, higher levels of antibodies have been reported for
ML-patients compared to CL-patients, the latter being characterized by a
moderate Th1 immune response. In this way, it seems that problems related to
antibody detection in CL-patients may be reduced by using sensitive targets and
well-standardized procedures. Some antigenic targets were evaluated for TL-
diagnosis without distinction of clinical form and, consequently, immune
response profile. We believe that the accuracy of these antigenic targets may be
improperly estimated in these specific cases.
This systematic literature review found 79 different antigens, comprising 40
recombinant proteins, 24 synthetic peptides and 15 purified proteins. The
identification and more refined selection of protein targets using recombinant
proteins or synthetic peptides allows the development of more standardized
techniques due to the possibility of generating the purest inputs. Some protein-
families have been widely evaluated as antigenic targets for TL-immunodiagnosis,
such as heat shock proteins (HSPs), histones and peroxiredoxins, with promising
results.
HSPs represent a highly conserved family of intracellular proteins of varying
molecular weights in prokaryotic and eukaryotic cells, including cytosolic,
mitochondrial, nuclear and endoplasmic reticulum resident proteins. They act as
a chaperon in peptide folding and in the translocation of proteins to
organelles, the prevention of protein aggregation, and the stabilization and
degradation of proteins. HSPs have usually been identified by amino acid
sequence homology and molecular weight, with HSP70 and HSP83 being the most
abundant. These proteins are constitutively expressed throughout the life cycle
of *Leishmania*, increasing expression in the vertebrate host due to variation
in temperature and pH. The recombinant proteins HSP70 and HSP83, and the
synthetic peptides extracted from those proteins, have been widely evaluated for
TL-diagnosis. The performance of these targets seems to be promising, with HSP83
presenting sensitivity of over 90% and high specificity with few cross
reactions.
Histones are conserved proteins bound to DNA establishing chromatin structure
in eukaryotes. Several biological functions have been described for histones
during *Leishmania* infection in susceptible hosts. Core nucleosomal
*Leishmania* histones have been proposed as prominent intracellular
pathoantigens, since immunological responses against histones seem to be
involved in the pathological mechanisms of visceral leishmaniasis (VL). In this
way, this protein family has been extensively employed in ELISA for both human
and canine VL. The presence of antibodies against rH2B of *L*. *peruviana*, rH1
of *L*. *braziliensis* and rH2A, rH2B, rH3 and rH4 of *L*. *infantum* have been
detected in sera from CL or ML patients. CARMELO et al. (2002) demonstrated that
the antibody against histone H1 was specific for the parasite without cross
reaction with human histones. However, moderate cross reactivity has been
observed in a sample panel composed of Systemic Lupus Erythematosus (SLE) and
Chagas disease.
Peroxidoxin, also known as thiol-specific antioxidant protein, as well as
tryparedoxin peroxidase, are peroxiredoxins, an antioxidant enzyme family. This
protein family has been described in a wide variety of organisms and several
biological functions have been reported for *Leishmania* parasites, such as
virulence factor and protection against reactive oxygen and nitrogen species. In
this manner, they are directly associated with cell proliferation, senescence,
apoptosis, and circadian rhythms. These proteins have been described in the
secretome of *L*. *braziliensis* and the antigenicity of tryparedoxin peroxidase
has also been evaluated for both human and canine VL-diagnosis. Peroxidoxin is
the protein target identified by the CL Detect Rapid Test (InBios International
Inc.) for CL-diagnosis. Variable performance has been reported for this ICT,
according to endemic region and, consequently, the *Leishmania* species
involved, with better results for infections caused by *L*. *tropica*, with
sensitivity ranging 65.4–73% and specificity 92–100%. This test, however, has
not been evaluated in Brazil.
Other recombinant proteins, such as cytochrome c oxidase, putative IgE histamine
releasing factor, prohibitin, eukaryotic initiation factor 5a, cathepsin L-like
peptide and small myristoylated protein-3, as well as hypothetical proteins,
were evaluated in preliminary studies demonstrating potential as candidates for
TL-immunodiagnosis, and so more studies are desirable.
Some promising synthetic peptides have been identified and employed in ELISA.
The use of small fragments containing potent antigenic determinants is able to
minimize non-specific reactions. LINK et al. (2017) identified three peptides by
phage display, probably from GP63 glycoprotein, and presented 79% sensitivity in
ELISA. COSTA et al. (2016) found high performance for three clones (A10, C12 and
H7) in discriminating TL-patients from patients with other diseases and healthy
individuals (100% sensitivity and specificity). However, these short linear
peptides may have some drawbacks, such as limited passive adsorption on
polystyrene titration plates (ELISA-standard procedure), inability to identify
serum antibodies that recognize conformational epitopes and problems considering
reproducibility due to variation in inter-assay reactivity producing different
batches.
Despite the advantages, the absence of post-translational modifications of
bacterially-expressed and chemically synthesized proteins comprises an important
limitation for the employment of this biotechnology for immunodiagnosis. In this
way, purified proteins can represent significant advantages, especially
regarding immunoreactivity. This review found iron-superoxide dismutase to be a
purified protein with interesting results, with more than 80% sensitivity for CL
or ML diagnosis. However, being purified proteins, sensitivity and specificity
may vary according to the type, source, and purity of the antigen used.
Three polyclonal and monoclonal antibodies were evaluated for detecting
*Leishmania* antigen by ICT and IHC. The phase III studies included were ICT
tests, that is, prospective studies in which the index and reference test were
performed simultaneously in patients with clinical suspicion. This is a
commercial test that, despite its low sensitivity, has been useful in some
localities due to the simple realization and high specificity, reducing the
number of CL patients referred for diagnosis confirmation. High performance was
observed in phase I studies for species-specific monoclonal antibody
(IS2-2B4—A11/ XLVI-5B8-B3) employed in IHC, with 96% sensitivity and 100%
specificity. More robust studies using monoclonal or polyclonal antibodies for
TL-diagnosis need to be encouraged evaluating the performance in clinical
practice.
The strength of the present literature review is that it employed a
comprehensive search strategy with four databases. One of the meaningful
limitations may be the limited number of studies evaluating the same protein
target, and so results need to be interpreted with caution. For this reason, a
meta-analysis was not performed here. Additionally, it is important to consider
that the risk of bias for many of the included studies was unclear and/or was
high for some of the evaluated parameters: “Patient selection”, “Flow and
Timing” and "Index test". Here, we identified a large number of antigenic
targets that could help clinical diagnosis. However, the high number of proof-
of-concept and phase I studies highlights the need to move forward with more
refined and mainly prospective studies including patients with clinical
suspicion of TL from different endemic regions and the most sensitive reference
standard tests, to evaluate the diagnostic accuracy of antigenic targets
reported in clinical practice.
# Supporting information
We are grateful for support from the Programa de Pós Graduação em Ciências da
Saúde of the Instituto René Rachou and Coordination for the Improvement of
Higher Education Personnel (CAPES).
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and
the second in females, with over 1.2 million new cancer cases estimated to have
occurred worldwide in 2008. Clinically, distant tumor dissemination and
metastasis are the most important factors in prognosis: whereas non-invasive
stage I carcinomas present a 90% five year-survival, stage IV carcinomas with
distant metastasis correlate with a dramatic drop to a 10% survival rate.
Consequently, new therapeutic strategies improving the efficacy against
metastatic disease and accurate biomarkers for the follow-up of CRC patients are
major challenges, together with early detection and screening in high-risk
populations.
The spread of cancer relies on the detachment of aggressive malignant cells from
the primary tumor into the bloodstream as a principal source of the further
metastasis. It is widely accepted that Circulating Tumor Cells (CTC) own or
acquire the ability to evade the host immune system and to reach a distant
organ, usually the liver in CRC, where they establish a secondary tumor growth
site in a highly inefficient but dramatic process. Concordantly, the presence of
CTC in peripheral blood has been associated with poor prognosis in different
types of cancer, including CRC. As presumptive founders in the generation of
metastasis, CTC are becoming a field of interest, and the understanding of their
biology may open new perspectives in oncology. Concerning their molecular
characterization, in the last few years a number of groups have presented
expression data focused on specific genes or signalling pathways related to
cancer for the improvement of sensitivity and specificity of the detection.
Smirnov et al. approached the profiling of CTC through a miscellaneous breast,
prostate and colorectal metastatic perspective. In addition, data is emerging on
the possibility of studying the biology and the utility to evaluate targeted
therapies based on the genomic profiling of CTC.
Within this scenario, defined by a limited efficacy of current chemotherapies in
the treatment of metastatic CRC (mCRC) and CTC as key players in the management
of metastatic disease, specific molecular profiling of the CTC population was
approached. The combination of CTC EpCAM-based immunoisolation and accurate
extraction of RNA from the very small number of CTC plus whole transcriptome
amplification, made it possible to hybridise cDNA from the CTC population onto
gene-expression microarrays. By applying this procedure to a group of mCRC
patients compared to the background of unspecific isolated hematopoietic cells,
the population of immunoisolated CTC was profiled specifically. In addition to
the molecular characterization of CTC for the understanding of the biology of a
main source of metastasis in CRC, these data provided potential therapeutic
targets and diagnostic/prognostic biomarkers.
# Results
## CTC Immunoisolation and Molecular Profiling
The procedures for CTC immunoisolation, RNA extraction and amplification for
hybridisa;tion onto cDNA microarrays are depicted in. Briefly, CTC were
immunoisolated from 7.5 ml of peripheral blood from stage IV mCRC patients
(n = 6;). Magnetic beads were used, which were coated with a monoclonal
antibody towards the human Epithelial Cell Adhesion Molecule (EpCAM), a surface
molecule highly expressed in epithelium-originated tumors such as CRC. RNA from
isolated CTC was purified using a kit specifically designed for low abundance
samples. In parallel, the same protocol was applied to blood samples from
healthy donors (n = 3) to establish the baseline of background from unspecific
non-CTC immunoisolation. Prior to gene expression analysis, the presence of
isolated CTC was confirmed by direct immunofluorescence visualization using a
cocktail of antibodies against cytokeratins 8, 18 and 19, and by a combination
of two biomarkers validated for the accurate quantification of CTC in mCRC
patients (GAPDH-CD45;) (Mann-Whitney U, p-value \<0.05). Moreover, the accuracy
of the methodology assessed as the recovery rate during immunoisolation resulted
in a median of 91.56% (Methods S1).
In order to characterize the CTC population isolated from mCRC patients, the
methodology described by Gonzalez-Roca et al. was adapted, for accurate gene
expression profiling of very small cell populations. Basically, purified RNA was
further treated with DNaseI, amplified using the WTA2 whole transcriptome
amplification method, and complementary DNA was labeled and hybridized onto
Agilent expression arrays (Gene Expression Omnibus, GEO. Accession number:
GSE31023). After the initial pre-processing of raw data, an average of 21,070
spots were filtered according to the criteria described in Materials & Methods,
which represented 47.35% of the spots in the microarray with a maximum of 32,443
and a minimum of 13,247. Upon filtration, the % coefficient of variation (CV)
for replicated probes ranged from 5.98% to 12.13%. Normalization within each
microarray was carried out using the Loess method, which assumes that most genes
in microarrays are not differentially expressed in comparison to the control, so
normalization among all microarray data was performed by the Aquantile method
implemented in the Limma package of the R statistical software. This method
ensured that the A values (average intensities) had the same empirical
distribution across microarrays whilst leaving M values (log-ratios) unchanged.
Correlation analysis of RTqPCR GAPDH-CD45 levels before and after amplification
indicated a robust linearity during the process of transcriptome amplification
(Spearman coefficient: 0.8667; p-value \<0.005).
The next step involved gene-expression profiling of CTC isolated from mCRC
patients against the background of contaminating cells during the
immunoisolation. For this, normalized gene-expression intensities from mCRC
patients and from the group of controls were processed using MeV
(MultiExperiment Viewer) software (see Methods S1). The signals obtained from
healthy controls were considered as the background from non-specifically
isolated blood cells, which were mainly lymphocytes. The signal obtained from
mCRC patients represented the sum of this non-specific background plus the
specific gene-expression pattern of the CTC. By subtracting this background, the
contaminating non-CTC population was removed, and the resulting genes showing
statistically significant expression were considered to characterize the CTC
population from mCRC patients. Concordantly, all significant genes presented
positive expression in mCRC patients upon subtraction of the background from
healthy donors, which was consistent with the presence of CTC only in the mCRC
samples. This strategy led to the identification of a final set of 410 genes
that were specific to the CTC population, with hierarchical clustering analysis
clearly discriminating between mCRC patients and controls.
Bioinformatic analysis with Ingenuity Pathway Analysis (IPA) and Genecodis (for
Gene Ontology) software served to interpret the resulting list of genes
characterizing the CTC population. The main cellular functions defined by these
CTC-specific genes were related to cell movement, cell adhesion, cell death and
proliferation, cell-cell signalling and interaction, and cytoskeleton
reorganization. Interestingly, the IPA analysis of canonical pathways, which was
representative of these genes, also highlighted a number of known signaling
pathways involved in cell migration/invasion and cell adhesion, as Protein
Kinase A, RhoA, Integrins, ILK, or Actin cytoskeleton signaling molecules.
Moreover, the analysis of gene-gene interactions rendered biological networks
that characterize the CTC population from mCRC patients. Among them, cancer and
cellular movement and morphology were found to be the principal events
associated with a CTC phenotype, while this interpretation might be biased by
the important contribution of cancer to databases. All of these analyses point
to a balance among the genes underlying cell survival, interaction with the
environment and cellular movement as the fundamental biological processes that
must converge in the population of CTC for the successful development of
metastasis in CRC.
## Real-Time Quantitative PCR Validation and Identification of Diagnostic and Prognostic Biomarkers
The next step involved the RTqPCR validation of eleven genes presenting high
log2 ratios in mCRC patients and a functional relevance in the biological
processes characterizing the CTC population in an independent series of mCRC
patients and controls. The specific expression of these genes was evaluated by
comparing the CTC populations from the group of mCRC patients (n = 20) with the
background from healthy controls (n = 10), once they had been normalized to CD45
as a marker of unspecificity during CTC isolation. These genes included APP, CLU
and TIMP1, which are associated with cell death and anti-apoptotic activity;
VCL, ITGB5, BMP6 and TGFβ1, which are genes involved in cell migration and
invasion and cellular morphology; and TLN1, ITGB5, LIMS1, RSU1 and CD9, which
are associated with cell adhesion. As observed in (black bars), all of the
selected candidate genes were validated in this new series of samples by RTqPCR
with significant differences between the group of patients and the group of
controls (p-value \<0.0001).
Importantly, to ensure that the expression of the selected genes was
characteristic of CTC and not an artefact due to the variation of gene
expression in lymphocytes in cancer patients, their expression was compared in
the remaining non-isolated fraction upon CTC enrichment in a set of mCRC
patients (n = 5) and controls (n = 5). As shown in (white bars), no differences
were found between both groups for the eleven candidate genes, reinforcing their
specificity of expression in the CTC population. When five samples in the CTC
isolated fraction were randomly selected, significantly higher levels were
consistently found in mCRC samples, demonstrating that the lack of differences
between patients and controls in the non-isolated fraction was not due to sample
size artefacts (data not shown).
To further evaluate the involvement of the candidate genes in the metastatic
potential of CTC in CRC, their expression was compared in a series of primary
carcinomas (n = 14) and lung (n = 7) and liver (n = 7) metastases. As shown in,
all of the selected genes were up-regulated in metastases compared to primary
lesions, with seven out of the eleven genes presenting statistical significance.
Among them, CLU and TIMP1 presented a specific up-regulation in liver
metastasis, suggesting a potential role for these genes in the tissue-specific
ability of mCRC CTC to colonize the liver. In addition, three out of the eleven
selected genes demonstrated a significantly increased expression at the invasive
front of the primary tumors compared to the paired non-invasive superficial
area, suggesting a link to the acquisition of an aggressive phenotype. All of
these results validated the strategy to molecularly profile the CTC in mCRC
patients, confirming the presence of the CTC population and the efficient
immunoisolation of CTC from mCRC patients, as well as the capability to
specifically characterize these cells at the molecular level.
Finally, the molecular profiling of CTC should result in the identification of
potentially reliable biomarkers for the detection of the CTC population from
mCRC patients. To evaluate this point, the accuracy of the RTqPCR validated
genes in the detection of metastatic disease was evaluated in the series of mCRC
patients and controls. As shown in, all of the validated genes presented
excellent discriminating values in terms of AUROC (values ranging from 0.94 to
1; p-value \<0.0001). Moreover, and with the exception of CD9 and TLN1, the
selected biomarkers demonstrated an excellent behavior as predictors of disease
progression. These data guarantee further studies in large cohorts of patients
for the use of these biomarkers in the clinical setting.
# Discussion
Molecular profiling is widely employed as a powerful strategy to characterize
specific types of tumors, specific subtypes of carcinomas or specific events
associated with carcinogenesis. In addition to contribute to the understanding
of molecular events associated with the genesis and progression of cancer, gene-
expression profiling has led to the identification of therapeutic targets and
biomarkers in an effort to improve the management of cancer patients at the
clinical setting. In this work, we aimed to tackle with a very specific and
attractive population of tumor cells that are at the origin of metastasis, the
circulating tumor cells (CTC). A combination of CTC immunoisolation, accurate
RNA extraction from very low number of cells, whole-genome amplification and
massive gene-expression profiling for the characterization and interpretation of
the biology of CTC in metastatic colorectal cancer is presented here. To
technically validate this strategy, the profiling of CTC from mCRC patients was
approached by subtracting the background of non-specific isolation from a group
of healthy controls. The next challenge is to compare the gene-expression
profile of the CTC population with the primary CRC lesions and with the overt
metastases, in order to better understand the mechanisms of adaption of tumor
cells during the process of metastasis and the crosstalk with the environment.
The subtraction of the background from a group of controls was also considered
to be more relevant than the background from the same mCRC patients as it would
require two rounds of CTC isolation within the same samples, representing a
significant source of technical artefacts. Differences in the background could
not be excluded due to the systemic metastatic disease, although the analysis of
the remaining fraction after CTC isolation did not render any differences within
the selected genes.
Regarding immunoisolation, and although CTC enrichment with EpCAM-coupled
antibodies has demonstrated to be superior to other cytometric methods and a
reliable method for CTC detection in mCRC patients, this CTC capture procedure
has raised some debate due to the reliance of this technique on the expression
of EpCAM. Initially described 30 years ago as a dominant antigen in human colon
carcinoma tissue, it is assumed that a decreased expression of epithelial
markers occurs during the epithelial to mesenchymal transition (EMT) associated
with tumor invasion. Importantly, EpCAM is apparently needed to maintain
distinct cancer cell attributes and, potentially, the cancer stem cell
phenotype. CD133+ cells, currently one of the best markers for the
characterization of colon cancer stem cells and an independent prognostic marker
that correlates with low survival, are positive for EpCAM. Likewise, antibodies
against EpCAM can efficiently target colorectal Tumor-Initiating Cells,
conferring a considerable value to the EpCAM-isolated CTC population in terms of
therapeutic intervention. The data presented here conclusively demonstrated the
effective isolation of CTC from mCRC patients.
A main achievement of this work was the translation of the method described by
Gonzalez-Roca et al. for the accurate expression profiling of very small cell
populations, into a clinically relevant cell population. Whole transcriptome
amplification allowed the characterization of the CTC population isolated from
metastatic CRC patients at the molecular level. To date, the majority of studies
have described the expression levels of a limited number of genes in different
CTC populations, principally for detection purposes. The approach used here
allowed the molecular profiling of CTC from mCRC, and their definition as a
population of cells with presumed migratory and adhesive capabilities. This is
consistent with a subpopulation of tumor cells that must acquire an aggressive
and invasive phenotype allowing dissociation from the primary lesion, leading to
the invasion of the surrounding stroma and their intravasation and survival in
the blood flow. In addition, these cells may also extravasate and successfully
implant in the distant tissue target to generate a micrometastasis. The list of
genes phenotypically characterizing the CTC population from mCRC patients
includes candidates related to all the above described functions, warranting
further studies to define their implication in the metastatic behavior of the
CTC population in CRC. Genes such as VCL, ITGB5, BMP6 or TGFβ1 have been
associated with the acquisition of an invasive phenotype, in part through EMT.
Likewise, TLN1, APP, CD9, LIMS1 and RSU1 have been related to adhesion and
migration, with CD9 modulating the localization of TLN1, a critical regulator of
integrin activation, to focal adhesions, or LIMS1 being associated with cell
adhesion and integrin signaling, and, in particular, with RSU1 and the Ras
pathway during cell migration. A key step in the process of cancer dissemination
is the ability to migrate and to progress towards and intravasate nearby blood
capillaries. Once in the circulation, CTC must overcome the host immune system
by enhancing their apoptosis resistance among other mechanisms. Genes like TIMP1
and CLU are key molecules related to this process. Interestingly, TIMP1 has been
linked to the process of anoikis resistance in different cancer models, enabling
the evasion of cell death in the absence of substrate anchorage. Upon reaching a
target organ, CTC must be able to extravasate and form colonies, and CD9 has
been described as critical to the process of implantation and micrometastases
formation associated with stem cell attributes, which is related to these
events. Interestingly, a significant overlap was found with a liver-specific
metastasis signature in CRC, suggesting an active implication in the tropism and
micrometastasis potential of CTC to this organ in CRC. In particular, and
consistent with the correlation of TIMP1 expression in CTC and liver metastasis,
it has been described as a regulator of the liver microenvironment, increasing
the susceptibility of this organ to tumor cells. Overall, the involvement of the
selected genes in the metastasis capacities of CTC has also been reinforced by
their up-regulation in lung and liver metastases compared to primary colorectal
carcinomas. *In vitro* primary CTC cultures and *in vivo* models for CTC in CRC
will definitely provide researchers with robust evidence to validate the role of
these genes in the ability of CTC to generate micrometastases, and to define
strategies specifically targeting this population of metastatic CTC.
Likewise, in terms of biomarkers for the management of mCRC patients, the
molecular profiling of CTC from mCRC patients rendered valuable tools for the
detection and quantification of metastatic disease, as well as for the
prediction of disease progression. The high specificity and sensitivity
demonstrated by the above described validated genes in the CTC population from
mCRC patients warrant the study of these biomarkers in the evaluation of
therapeutic responses or in the selection of patients for targeted therapies.
In conclusion, this study described, to our knowledge, the first specific
molecular profiling of CTC isolated from mCRC patients. This gene-expression
analysis was applied to the characterization of this specific population with
presumed adhesive, migratory and invasive capabilities, as well as a modulated
response to cell death for the successful completion of the process of
metastasis. Moreover, the identification of therapeutic strategies specifically
targeting the CTC population should improve the efficacy in the eradication and
prevention of CRC metastasis, while an armamentarium of highly specific and
sensitive valuable markers should impact on the management and follow-up of
metastatic CRC patients.
# Materials and Methods
## Patients
All participants signed an informed consent specifically approved for this study
by the Ethical Committee of the Complexo Hospitalario Universitario of Santiago
de Compostela (code of approval: 2009/289). Inclusion criteria for mCRC patients
were the presence of measurable mCRC and an Eastern Cooperative Oncology Group
(ECOG) performance status not greater than 2. Healthy controls with an absence
of a previous cancer episode and an age matched with patients were selected.
Detailed information about patients included in the analysis is available in.
## CTC Immunoisolation
CTC were isolated by using the CELLection™ Epithelial Enrich kit (Invitrogen,
Dynal) according to manufacturers’ instructions. Briefly, 7,5 mL of blood from
mCRC patients and healthy controls were incubated for 30 minutes at 4°C with 100
µl of magnetic beads. After washing, CTC coupled to the magnetic beads were
directly resuspended in 100 µl of RNAlater® solution (Ambion) and stored at
−80°C until processed for RNA extraction.
## Gene Expression Analysis
Total RNA from CTC was extracted with the QIAmp viral RNA mini kit (Qiagen),
specifically designed for very low cellularity samples. Purified RNA was next
subjected to a whole transcriptome amplification reaction (WTA2, Sigma Aldrich),
Cy3 labeled and hybridized onto Agilent 4×44 k gene-expression arrays. Signal
processing and filtering as well as gene expression data analysis are described
in detail in Supplemental Material. Gene expression data is accessible at the
NCBI Gene Expression Omnibus (GEO) database (Accession Number: GSE31023).
## Real-Time Quantitative PCR Validation
RTqPCR validation was performed in an independent set of 10 healthy controls and
20 stage IV metastatic colorectal cancer patients. CTC were isolated as
described, and RNA was purified with a RNA carrier to improve yield and
stability. cDNA was synthesized by using SuperScriptIII chemistry (Invitrogen)
following manufacturer’s instructions. To further optimize the sensibility of
detection, we performed a preamplification step by using the TaqMan® PreAmp
Master Mix kit (Applied Biosystems) with 14 reaction cycles. Preamplified
products were subjected to TaqMan® real-time PCR amplification for eleven
candidate genes (see for assay details).
In addition, we evaluated by RTqPCR the expression levels of the candidate genes
in the cellular fraction remaining upon CTC immunoisolation, in 5 mCRC patients
and 5 healthy controls. Briefly, we performed a red blood lysis in the fraction
remaining after EpCAM immune-bead incubation and CTC isolation, and RNA was
purified from the remaining nucleated blood cells with the RNeasy mini kit
(Qiagen). RNA quantity and purity were assessed by NanoDrop measurement, cDNA
was synthesized using MuLV reverse transcriptase system (Applied Biosystems) and
TaqMan® qPCR was performed for the eleven candidate genes.
Expression values for each gene were normalized to CD45 as a marker of non-
specific isolation. Fold change differences between patients and controls were
statistically analyzed with the GraphPad Prism software, applying the Mann-
Whitney non-parametric t-test and considering a p-value\<0.05 as significant.
## Gene Expression Analysis in Primary Tumors and Metastases
Primary colorectal carcinomas (n = 14) and metastasis (liver metastasis, n = 7;
lung metastases, n = 7) were processed by the Pathology Department of the
Complexo Hospitalario Universitario of Santiago de Compostela. The superficial
non-invasive zone and the deep invasive area of the primary tumors were
macroscopically dissected, ensuring similar tumor percentages. RNA was purified
(TRIZOL reagent, Invitrogen; RNeasy kit, Qiagen), cDNA was synthesized (MuLV
reverse transcriptase, Applied Biosystems), and gene expression was evaluated
(TaqMan RTqPCR, Applied Biosystems). Data was represented as fold change
relative to the expression in the superficial non-invasive area. GAPDH was used
as loading control. Non-parametric Mann-Whitney t-test was used for statistical
significance considering p-value \<0.05.
## Area under the ROC Curve (AUROC) and Kaplan-Meier Analysis
The accuracy of the eleven candidate genes as biomarkers for diagnosis was
evaluated with ROC curves, while Kaplan-Meier curves were built for their
evaluation as markers for prognosis. Cutoff values were set as the best-fit
values for each marker. Patients Progression Free Survival times were
established as the time elapsed between chemotherapy line start and disease
progression evaluated by imaging, or patient dead by any cause.
# Supporting Information
We gratefully thank the patients for their willingness to participate in the
study and the nurses from the Medical Oncology Department for their
collaboration.
[^1]: Conceived and designed the experiments: JB RL-L MA. Performed the
experiments: JB AA LA-A. Analyzed the data: JB MV AGT MAC RL-L LMR MA.
Contributed reagents/materials/analysis tools: EG SC IA BF MA-N. Wrote the
paper: JB MA.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
Humans often use un-observable variables like beliefs, desires, and intentions
to disambiguate agents’ behavior, attributing mental states to other people and
to oneself. These mentalizing abilities emerge during early childhood and
variations in mentalizing skills appear to be related to social environmental
factors. Among these factors, collaborative experiences of a child with adult
group members might play a crucial role. These interactions might allow children
to gradually construct knowledge of the world, as well as knowledge of other
people’s mental states, by capturing cognitive regularities that cooperative
agents try to make transparent to the child. Eventually, children start using
this knowledge to manipulate the mental states of other agents during
referential communicative interactions. For instance, 4-year-old children use
presumed knowledge of an interlocutor to select linguistic behaviors designed to
change those mental states, producing more explicit descriptions of a toy when
speaking to a blind as compared to a non-blind addressee, and simpler utterances
towards a toddler than an adult. Five-year-old children can produce verbal
requests that take into account the presumed knowledge of their interlocutor.
However, it remains largely unknown how children learn to adjust their
referential communicative behaviors to their mental model of an addressee.
Here we elaborate on the suggestion that the extent and nature of the social
interaction children experience will influence the development of children’s
social understanding. Humans are exceptional among existing hominids for
experiencing early developmental exposure to cooperative nonkin, i.e.
conspecifics that lack a genetic reason for collaborating, and it has been
suggested that this developmental feature might boost motivational
predispositions to share mental states with others. We quantify one aspect of
this faculty through audience design, i.e. adjustments of communicative acts to
the presumed abilities and knowledge of an interlocutor. Given that audience
design presupposes control of the ability to share mental states with others, we
focus on five-year-old children, i.e. children with fully-fledged theory of mind
capacities. We quantify developmental exposure to two main sources of social
interactions experienced by children between zero and four years of age, namely
familial and non-familial experiences. The former were quantified in terms of
years of experience with siblings, and parents’ level of education. The latter
were quantified in terms of days per week of attendance to daycare.
Audience design effects were quantified in a controlled experimental setting
involving the production of referential non-verbal behaviors with a
communicative goal, exploiting a protocol previously validated in adults. In
contrast to linguistic communication, the communicative behaviors evoked under
these experimental conditions could not be directly based on previous concrete
experiences. Accordingly, the novel communicative situation experienced by the
children in this study allowed us to directly tap into their ability to
influence the mental states of others through behaviors generated ex-novo. Five-
year-old participants were told they were playing an online interactive game
with a 2-year-old toddler and with a same-age peer, in alternation. In fact, a
confederate performed the role of both addressees, while remaining blind to
which one of the two roles he was performing in any given trial. Accordingly,
both performance and response times of the two presumed addressees were matched.
This feature of the protocol allowed us to test whether the mere belief that the
child is communicating with addressees of different ability induces internally
generated adjustments in the child behavior, over and above performance-related
mutual adjustments. Furthermore, the precise quantification of children behavior
afforded by this protocol distinguished between belief-driven adjustments
restricted to the communicative components of the actions, and generic priming
effects. These procedures allowed us to test whether the social environment
experienced by a child early during his development influences his ability to
adjust a self-generated communicative behavior to his mental model of the
addressee.
# Materials and Methods
## Participants
The experiment was approved by the local medical ethical committee (ECG,
Nijmegen, The Netherlands). Parents with 5-year-old children (N = 24, 12
females, mean age 5.09, range 5.02–5.16) were recruited from a database of the
Baby Research Center Nijmegen. The children’s parents provided written informed
consent for participation of their children in the study, and all participants
received a book or monetary compensation for their visit.
## Experimental Design
The game involves a Communicator (a 5-year-old participant, displayed as a bird
on the game board) and an Addressee (the confederate, displayed as a squirrel)
interacting on a digital game board with a 3×3 grid layout. On each trial, their
joint goal was for the Addressee to collect an acorn from the game board. Given
that knowledge of the acorn’s location in the game board was available to the
Communicator only (on a printed copy of the game board, visible throughout the
trial, see), a successful trial of this game required the Communicator to
inform the Addressee where the acorn was located. Given the experimental setup,
the Communicator could inform the Addressee only by moving the bird across the
game board (event 2). The Addressee could then move the squirrel to the acorn’s
location only by interpreting the meaning of the Communicator’s movements on the
game board (event 3). For details on the experimental procedure see the
Supplemental Material.
By touching a square on the screen with his/her finger, the Communicator could
move the bird token to that square, and this movement was also visible to the
Addressee. The bird could only move to the center of each of the nine grid
squares, and only through vertical or horizontal displacements. This feature of
the task was introduced to create a spatial disparity between the movements of
the bird and the potential locations of the target object (any of the thirteen
white circles, see). Namely, the bird could not be overlaid on the precise
location of the acorn when a square contained more than one white circle (see
Manipulation of task difficulty of the Supplemental Material for details). The
Communicator had no restrictions on planning time (event 1 in) or on movement
time (event 2). The end of the movement epoch was marked by the return of the
bird on the central square of the game board (nest). At this point, the token of
the Addressee (the squirrel) appeared, in the center of the digital game board,
visible to both players. The Addressee moved the squirrel to the location deemed
appropriate given the movements of the Communicator (event 3). The Addressee had
no temporal or spatial restrictions on the movements of the squirrel on the game
board. Successful trials, in which the Addressee had moved to the location of
the target, resulted in the presentation of a large acorn on the screen (event
4). A red “no” icon was presented over a small acorn for unsuccessful trials.
There were a total of 50 trials, subdivided in blocks of five trials (∼35 min).
Each child was informed that he would be playing an interactive game with two
addressees in turns; either a toddler (‘2-year-old’) or a same–age peer
(‘5-year-old’). They were told that the game partners were sitting in other
rooms and that they could see the bird token and the digital game board on their
monitors. There were two pairs of fictitious child-toddler addressees, two
presentation orders of child-toddler addressees, and two sets of target
configurations, counterbalanced over participants.
## Quantification of the Social Environment
Given that the extent and nature of the social interactions experienced by
children is widely thought to influence the development of their social
understanding, we considered two main sources of social interactions experienced
by children, namely familial and non-familial experiences, reconstructed from
interviews with the parents of the children. Familial experiences were indexed
with the parents’ level of education (11 levels, 7.4±1.6, group mean ± SD, range
4.5–10.5) and years of experience with siblings (i.e. the product of age and
number of siblings: 4.3±3.4, range 0–15.2; number of siblings: 1.2±0.7, range
0–3). Non-familial experiences were indexed with the time spent at daycare (days
per week) between the age of 0 and 4 (mean over these four years; 1.7±0.9 days
per week, range 0.25–3). We did not consider between ages 4 and 5 given that in
the Netherlands it is customary to start primary school at age 4.
## Data Analysis
Audio- and video-recordings of the participant’s behavior were analyzed offline.
Those trials in which the child behavior revealed procedural uncertainties (e.g.
failing to return to the nest within 15 seconds, or interrupting the bird
movements to look at the location of the acorn in the instruction game board)
were excluded, leaving 80.1±13.4% (mean ± SD) of the original trials for further
analysis (∼40 trials; four participants interrupted their performance after 30
trials).
This study builds on the findings of a previous report involving the same task
and obtained in a group of women, showing that the communicator’s belief about
age of the addressee changed communicative behavior. More precisely, these
adults spent longer time on communicatively relevant locations of the game board
when interacting with a presumed child addressee (vs. an adult addressee), i.e.
using time as a tool to place emphasis on target information. The first goal of
this study was to replicate this finding in a group of five-year-old children.
Accordingly, we considered the same dependent variable (namely, Time spent on
game board locations), using the same statistical comparison, namely a two-way
ANOVA with factors Addressee (Toddler, Child) and Location (Target, Non-target).
The Time spent on game board location by the Communicator was calculated as the
time interval between the first contact of the finger on the touch screen within
the area of a square of the game board (either a Target or a Non-target
location) and the subsequent contact of the finger within the area of a
neighboring square of the game board. We considered the mean time spent on those
location types per trial. It should be emphasized that, given the absence of
temporal restrictions on the total time the children could spend on the game
board, the time spent on target locations and the time spent on non-target
locations could vary independently.
Having replicated the findings of in this group of five year-olds, we used a
multiple linear regression analysis to assess the differential contribution of
familial and non-familial sources of social interactions experienced by these
children in the first four years of their life. These three independent
variables (i.e. parents’ level of education, years of experience with siblings,
and time spent at daycare, see above) were jointly considered in the multiple
regression analysis, with the degree of communicative adjustment observed in
each child as dependent variable (i.e. the relative difference, \[toddler –
child\]/\[child\], in time spent on Target locations between presumed toddler
and child Addressee). This statistical approach allows one to make specific
inferences on the inter-subject variance accounted for one variable, over and
above the variance accounted by the other variables included in the multiple
regression model.
# Results
## Communicative Success
The percentage of successfully communicated trials was 63.4±8.0% (mean ± SD).
This is well above chance level (7.7%; 13 potential target locations).
## Communicative Adjustments
We tested whether 5-year-old children are able to adapt their referential
communicative behavior (event 2) to the presumed age, or cognitive level, of
their interlocutor. A two-way analysis of variance revealed a significant
interaction of the factors Addressee (Toddler, Child) and Location (Target, Non-
target) on the mean time spent on game board locations during the movement
epochs, *F*(1,23) = 5.4, *p* = .03. This interaction was driven by the fact that
the 5-year-old children spent more time on the Target locations (containing the
acorn) when they thought to be interacting with the toddler Addressee as
compared to the child Addressee, *t*(23) = 2.6, *p* = .014, two-sided paired
*t*-test. There was no difference between the two Addressee types for the mean
time spent on the Non-target locations (other visited locations),
*t*(23) = 0.04, *p* = .97; see.
## Effects of Social Environment
We evaluated whether quantitative indexes of developmental exposure to social
interactions of the child could explain inter-individual variability in the
communicative adjustment observed over the whole group. A multiple linear
regression analysis indicated that daycare attendance (i.e. mean days per week
spent at daycare before starting school) predicted the communicative adjustments
made by the 5-year-old participants, *R<sup>2</sup>* = .34, *F*(3,23) = 3.4,
*p* = .039 (full model), *Beta = *.598, *p* = .005,
*R<sup>2</sup><sub>adj</sub>* = .24 (daycare attendance); see. Parents’ level of
education (*Beta* = −.14, *p* = .45) and years of experience with siblings
(*Beta = *.04, *p* = .84) did not significantly account for inter-subject
variance in communicative adjustments.
# Discussion
We have tested whether the expression of audience design abilities in 5-year-old
children is modulated by their previous history of social interactions.
Participants were asked to influence the behavior of an addressee, in an
experimental setting where no pre-existing communicative conventions were
immediately available. In fact, the communicative means made available to the
children were purportedly limited, challenging them to devise new communicative
behaviors that could be understood by the addressees. There are three main
results. First, 5-year-old children were able to influence the mental states of
others even at their first encounter with a novel communicative setting. This
communicative behavior was internally generated by the children, and motorically
different from the behavior of the two presumed addressees. Second, the mere
belief of communicating with addressees of different ages selectively influenced
the communicative behavior of the participants. The children spent longer at
communicatively relevant locations when interacting with a presumed toddler
addressee as compared to a presumed child addressee. This communicative
adjustment was not a generic priming effect, being absent in communicatively
irrelevant locations of the game-board. Third, the communicative adjustment
observed in the children was predicted by the time spent at daycare during the
previous years of their life. This latter finding refines the notion that human
communicative skills might be shaped early during development, emphasizing the
fundamental role of non-familial interactions in the gradual construction of
children’s social understanding and abilities to influence the mental states of
others.
It has been suggested that children gradually construct mental variables through
the regularities they experience within social interaction. In contrast to a
large body of work focusing on verbal reports of children’s ability to
*attribute* mental states to other people, as during Theory of Mind tasks, here
we considered children’s ability to *influence* the mental states of others
through non-verbal behaviors, i.e. the magnitude of their communicative
adjustments. These spontaneous adjustments provided a sensitive index for
quantifying inter-individual differences in communicative abilities close to the
onset of those abilities. This sensitivity might arise from the implicit nature
of the index of audience design used in this study, in line with findings
previously obtained during language comprehension in children of similar age.
Namely, in contrast to previous work exploring how a child’s inhibitory control
handles the conflict between the knowledge of the child and that of the
addressee, in this study we manipulated the presumed abilities of the addressee,
minimizing demands on the control abilities of the child.
The magnitude of communicative adjustments in 5-year-old children was predicted
by the time spent in daycare during previous years of their life, over and above
the effects accounted for by measures of the familial social environment
(sibling experience, educational level of the parents). One possible mechanism
accounting for this observation might relate to the importance that overheard
communicative interactions have on the linguistic development of a child.
Namely, kindergarten attendance might considerably boost the variety of
children’s experience with this source of pragmatic inputs, enhancing their
communicative skills. More generally, the structured social interactions
afforded by a daycare environment (e.g. cooperative play, frequent integration
of new group members) might provide the child with a larger set of communicative
challenges than those experienced within a relatively stereotyped familial
environment. These challenges might differ substantially from those experienced
in a familial environment. In kindergarten, a child needs to communicate with a
multitude of agents, and those agents lack a genetic reason for collaboration.
Finally, kindergarten provides children with caregiving ‘alloparents’ that might
boost their socio-emotional development.
It remains to be seen how the present findings, showing stronger effects of non-
familial over familial experiences on the development of referential
communicative adjustments, can be reconciled with previous reports, showing that
measures of familial interactions predicted ‘false belief understanding’, as
assessed with verbal reports. One possibility is that the communicative
adjustments observed in this study might be mainly driven by children’s
assumptions on the presumed cognitive capacities of the addressees, rather than
by children’s understanding that the beliefs, desires, or intentions of other
agents differ from reality. Differences in outcome measures might also play a
role, e.g. implicit measures of knowledge about a communicative interaction (as
gathered through eye movements, reaction time, or movement times) vs. explicit
verbal reports requiring a degree of executive control.
This study opens the way for systematic and sensitive investigations into the
contributions of early social experiences towards children’s communicative
abilities, raising the possibility to chart the developmental trajectories
generated by familial and non-familial social interactions (e.g. siblings,
parents, non-sibling peers, alloparents) through longitudinal studies with
objective measures of the time spent on those interactions.
# Supporting Information
We thank the Baby Research Center Nijmegen, Annelies van Wijngaarden, Evelien
Akker, and the families who participated.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: AS SH IT. Performed the
experiments: AS. Analyzed the data: AS IT. Wrote the paper: AS SH HB IT.
|
# Introduction
Gallid herpesvirus 2 (GaHV-2), more frequently referred to as Marek’s disease
virus (MDV), is an alphaherpesvirus (type species of the genus Mardivirus) and
the causative agent of a highly infectious lymphoproliferative disease termed
Marek’s disease (MD) affecting many birds in the *Phasianidae* family. Despite
global vaccination campaigns that are effective to prevent disease development,
MDV field strains continue to spread in poultry and appear to evolve towards
increased virulence. The dissemination of MDV in poultry is mediated by
infectious viral particles associated with dander and feather debris. With the
exception of the feather follicle epithelium, the site where free infectious
viral particles are shed, the virus remains strictly cell-associated and
progression of the infection is restricted to viral cell-to cell spread. The MDV
particle is composed of a 180-kbp double-strand DNA genome packaged in an
icosaedric capsid surrounded by a tegument layer, which insures the
morphological and functional continuity between the capsid and the host cell
derived viral envelope. By homology with other alphaherpesviruses, a number of
viral proteins composing the tegument have been identified, including a major
tegument protein, VP22 (pUL49), various trans-activators and two protein kinases
(pUL13 and pUS3). The UL49-encoded VP22 protein is abundantly expressed in
infected cells and is essential for MDV replication. VP22 is a specific tegument
protein of alphaherpesviruses and conserved among this subfamily. To date, the
absolute requirement of the UL49 gene for viral replication was initially
demonstrated for MDV and afterwards for Varicella Zoster virus (VZV). The
deletion of VP22 in other alphaherpesviruses including Herpes Simplex virus 1
(HSV-1), Pseudorabies virus (PRV), Bovine herpesvirus 1 (BoV-1) still allows
viral replication, even though viral spread is reduced in some cell types. While
its role in virus infection remains unclear, it was demonstrated for HSV-1 that
VP22 interacts with and recruits various viral proteins, such as the trans-
activators ICP0, ICP4 and viral glycoproteins composing the infectious virions.
Furthermore, VP22 was shown to interact with cellular proteins involved in the
organization of microtubules and nucleosome assembly. The VP22 protein encoded
by MDV shares common functional features with VP22 encoded by other
alphaherpesviruses. It was previously shown that MDV-VP22 shows both a
cytoplasmic and nuclear location in infected cells and accumulates in the
nucleus upon overexpression in cells. Moreover, MDV-VP22 exhibits a strong
affinity to DNA, especially heterochromatin, and to microtubules. We previously
demonstrated the role of VP22 in MDV cell-to-cell spread, which could explain
the necessity of VP22 in MDV replication. It was recently shown that recombinant
MDV viruses expressing VP22 with a C or N-terminal GFP-tag are highly attenuated
*in vivo* suggesting that VP22 might play a role in MDV-induced lymphomagenesis.
However, the precise role of VP22 in MDV replication and MD pathogenesis remains
unclear. Notably, the functional significance of the VP22 nuclear distribution
is still unknown, even if previous reports on VP22 encoded by alphaherpesviruses
evoke a possible regulatory function of VP22 within nuclei.
Virus infection frequently results in the disturbance of key cellular processes
within the host cell. The subversion of cell cycle pathways is a well-
established mechanism by which viruses create the most suitable environment for
their replication. Especially, the induction of S-phase is either mandatory or
at least advantageous for lytic replication of a number of viruses. The eminent
role of cellular factors from the DNA synthesis machinery in viral replication
was demonstrated for viruses from different families such as the Flaviviridae,
Retroviridae, Parvoviridae, and Polyomaviridae. In contrast, herpesviruses
encode their own DNA polymerase and accessory proteins, and thus theoretically
do not require an S-phase environment to support their replication (reviewed
in). Nevertheless, several studies have demonstrated the importance of the
S-phase in the life cycle of VZV and Epstein-Barr virus (EBV). For EBV, S-phase
cyclin-dependent kinase activity is essential for the expression of immediate
early and early viral proteins and is thus required for viral replication. *Vice
versa*, EBV lytic replication is able to provide a S-phase-like cellular
environment by modulating DNA damage pathways. The impact of the S-phase
environment on the viral life cycle is not restricted to lytic viral replication
but is also involved in the episomal genome maintenance during viral latency or
reactivation processes, as was recently shown for EBV and the Kaposi’s Sarcoma-
associated herpesvirus (KSHV). Strikingly, infections with oncogenic viruses
(e.g., SV40, HPV, HTLV-1, EBV) are often associated with S-phase deregulation
and genomic instability, preferentially occurring during this critical phase of
the cell cycle.
In relation with cell cycle delay, DNA damage signaling is often triggered upon
viral infections (reviewed in). Particularly, DNA damage response (DDR) pathways
are preferential targets of herpesviruses, including HSV-1, EBV, KSHV, human
cytomegalovirus and murine gamma-herpesvirus 68. The role of DDR in
herpesviruses life cycle is complex. On the one hand, recent evidence suggests
that DDR acts as an efficient antiviral response. On the other hand, DDR
modulation can be beneficial for herpesviruses by facilitating viral
replication, viral genome processing or latency establishment. Moreover, during
the course of cellular infections with large DNA tumour viruses, such as human
papillomaviruses (HPV) or gammaherpesviruses (e.g. EBV and KSHV), the generation
of DNA damage and/or activation of DDR were found to be associated with genomic
instability which in turns can participate to virus-induced tumorigenesis
(reviewed in).
In the present study, we set out to elucidate an important aspect of MDV-host
cell interaction by analyzing the impact of MDV and virus-encoded proteins on
the regulation of the cell cycle. We demonstrate that MDV lytic infection
activates the proliferation of chicken primary skin cells concomitant with a
delay in S-phase. By studying the effects of transient vector-driven
overexpression in a proliferating chicken cell line, we identified the VP22
tegument protein as a potent cell cycle modulator encoded by MDV. A comparative
experimental approach employing VP22 variants with a C- or N-terminal eGFP-tag
allowed us to show that an unmodified C-terminus of VP22 is required to elicit
the observed S-phase arrest. Moreover, the cell cycle regulating activity of
VP22 relies on its ability to be associated with chromatin in the nucleus. In
order to define the mechanisms underlying the drastic S-phase arrest observed in
VP22 expressing cells, we investigated the impact of VP22 expression on DNA
integrity. Strikingly, we found that the DNA of cells expressing this viral
protein showed significant DNA damage, as was assessed by comet assay. Together,
these data provide new insights into the interaction of MDV with the host cell
during lytic replication and pinpoint to a novel powerful function of VP22 that
may help to better understand the pre-eminent role of VP22 in MDV replication
and more generally in the life cycle of the virus.
# Materials and Methods
## Cell Culture and Viruses
Chicken Embryo Skin Cells (CESC) were prepared from 12-days-old chicken embryos
(LD1 Brown Leghorn chicken strain) and maintained in culture as previously
described. This procedure was carried out in strict compliance with the French
legislation for animal experiments and ethics stating that the use of embryos
from oviparous species before the last third of their normal development (i.e.
before day 14 for chicken embryos) is not submitted to regulation (Art.
R.214-88). Thus, the preparation of CESC from 12-days-old chicken embryos does
not require the permission of governmental or local authorities. Embryos were
sacrificed by opening the eggshell, cervical dislocation and immersion in
William’s Medium E (Lonza) supplemented with collagenase as described by Dorange
*et al*., 2000. The chicken hepatocellular carcinoma cell line LMH was cultured
on gelatin-coated flasks in William’s Medium E (Lonza) supplemented with 2 mM
glutamine and 10% fetal bovine serum (FBS) at 37°C in a 5% CO2 atmosphere. As
positive controls for DNA damage analyses, LMH cells were treated for 24 h with
1.5 µM etoposide, a topoisomerase IIα inhibitor potent inducer of DNA double
strand breaks.
Recombinant viruses were generated from the avirulent MDV-BAC20 strain cloned as
bacterial artificial chromosome (BAC). The recEGFPVP22 recombinant virus
harboring the UL49 gene fused at its 5′ end with the eGFP gene was previously
described.
Parental BAC20 and recEGFPVP22 viruses were produced after transfection of BAC-
DNA into CESC as previously reported. Infections were performed by co-culture of
7×10<sup>6</sup> fresh CESC in a 100-mm diameter plate with infected cells at a
ratio of 10<sup>4</sup> PFU/plate.
## Plasmids
The pcDNA3-UL49 and pcDNA3-UL48 plasmids encoding the wild-type (wt) VP22 and
VP16 tegument proteins of the RB-1B oncogenic MDV-RB-1B strain, have been
previously described. Two plasmids harboring the VP22 protein cloned in frame
with the enhanced green fluorescent protein (eGFP) were used: (i) the peGFP-
UL49, encoding a VP22 tagged with eGFP at its N-terminal extremity and (ii) the
pUL49-eGFP in which VP22 is tagged with eGFP at its C-terminus. The latter
construct was generated by PCR amplification of the UL49-eGFP fragment from the
purified rUL49-eGFP BAC-DNA kindly provided by B. Kaufer (Institut für
Virologie, Freie Universität Berlin, Germany). The primer pairs used for
amplification were UL49FCLBamHI/eGFPendNotI. The PCR product was inserted into
the PCR2.1 TOPO TA cloning vector (Invitrogen) and the BamHI/NotI fragment was
then sub-cloned into the peGFP-N1 vector (BD Biosciences, Clontech) where the
internal eGFP cassette was previously removed by BglII/NotI enzymatic cleavage.
The pGE109 plasmid harbouring the UL49 gene encoded by HSV-1 was kindly provided
by G. Elliott. The HSV1-UL49 gene was cloned in frame with eGFP at the Bgl II
site in the peGFP-C1 vector (BD Biosciences, Clontech). The VZV-ORF63 encoding
the VZV orthologue of UL49 was amplified from pcDNA63wt (kindly provided by C.
Sadzot-Delvaux) with the primer pair 5FUL49VZVXhoI/3RUL49VZVBamHI. The PCR
product was T/A-cloned into the pGEMT-easy cloning vector (Promega) and
subsequently subcloned in fusion with eGFP in the peGFP-C1 vector at the Xho I
and Bam HI sites.
The genes encoding UL37 (pUL37), UL54 (encoding the ICP27 trans-activator), and
the two viral kinases UL13 (pUL13) and US3 (pUS3) were amplified from RB-1B
genomic DNA with the primer pairs UL37F/UL37R; UL13F/UL13R; UL54F/UL54R, and
US3F/US3R, respectively. Amplification products were inserted into the pGEMT-
easy cloning vector (Promega). The UL37, UL13, and US3 genes were sub-cloned
under control of the cytomegalovirus immediate early promoter into the pcDNA3.1
vector (Invitrogen) at the NotI site, and the UL54 gene was cloned into the
pcDNA3.1 vector at the EcoRV site. All intermediate and final constructs were
verified by sequencing (Eurofins, MWG Operon).
## Transient Expression
The different eukaryotic expression vectors were transfected into CESC or LMH by
using Lipofectamine 2000, according to the manufacturer’s instructions
(Invitrogen). Briefly, cells at 80% of confluency plated on 60-mm dishes were
rinsed twice with OptiMEM (Fischer Scientific) and were transfected with 5 µg of
the plasmid of interest. After 6 h of incubation at 37°C, the transfection mix
was removed and serum complemented fresh medium was added. Cells were harvested
24 h or 48 h after transfection for further analysis. Each transfection was
performed in triplicate.
## Cell Cycle Analysis
At the time points indicated, 1.10<sup>6</sup> vector-transfected or infected
cells were trypsinized and washed twice in phosphate-buffered saline (PBS) prior
to fixation with 70% ethanol at 4°C for 24 h. Cells were then washed twice in
cold PBS and incubated in PBS containing 500 µg/ml Ribonuclease A (Sigma-
Aldrich) at 37°C for 1 h. After filtration through a 30-µm pore size membrane,
cells were stained with 10 µg/ml propidium iodide (Invitrogen) for 15 min in the
dark. Flow cytometry analysis was performed using a MoFlo high-speed cell sorter
(Beckman Coulter, Fort Collins, CO, USA) equipped with a solid-state laser
operating at 488 nm and 100 mW. Cellular DNA content was analyzed with a 740 nm
long-pass filter. Doublets were discarded on the basis of combination of pulse
width and area/peak fluorescence. eGFP autofluorescence was detected with a
530/40 nm band-pass filter and the cell cycle distribution was specifically
analyzed for eGFP-positive versus eGFP-negative cells. Cell cycle profiles were
analyzed with the MultiCycle AV software (Phoenix Flow Systems, California,
USA).
## Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and Real Time Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from 10<sup>6</sup> cells with Trizol according to the
manufacturer’s instructions (Sigma-Aldrich). RNAs were treated with RNAse-free
RQ1 DNAse (Promega, France) and RNA concentration was measured with a NanoDrop
spectrophotometer. One µg of each total RNA preparation was reverse transcribed
using 100 µg/mL oligo(dT) primers (Promega) and M-MLV reverse transcriptase
according to the manufacturer’s recommendations (Promega).
The expression of the different cellular genes involved in cell cycle regulation
was analyzed by qPCR. Amplification of the cDNA by qPCR (CFX96 Touch Real-Time
PCR Detection System; Bio-Rad) was performed in triplicate, using 200 ng of
cDNA, 7.5 µl 2×iQ Supermix SYBR green (Bio-Rad), 1 µl ultrapure water (Sigma-
Aldrich) and 0.75 µl of each specific primer (10 µM) selected according to the
EST data deposited in Genbank (described). The PCR program consisted of a 5 min
activation step at 95°C, followed by 39 cycles of 95°C for 10 s and 60°C for 10
s. Expression of the chicken glyceraldehyde phosphate dehydrogenase (GAPDH) was
used for the normalization of all target gene mRNAs to enable cross-comparisons
among the samples. The relative changes in gene expression were determined by
the 2(−ΔΔCT) method.
The expression of MDV genes (ICP4, UL13, US3, UL49, UL37, UL54 and UL48) was
assessed by RT-PCR performed with 100 ng of the synthesized cDNA prepared from
LMH or CESC cells transfected with the corresponding expression vector and 10 µM
of specific primers. The GAPDH gene was used as internal control. Specific PCR
products were resolved by agarose (2%) gel electrophoresis.
## Immunofluorescence Microscopy
At 24 h or 48 h post-transfection, cells grown on glass coverslips were fixed
with 4% paraformaldehyde (PFA) for 20 min at room temperature (RT),
permeabilized with 0.5% Triton X-100 for 5 min at RT and blocked with PBS, 0.1%
Triton X-100, 2% Bovine Serum Albumin (BSA). Immunostainings were performed with
monoclonal antibodies directed against phospho-histone H2AX (Ser139) (Millipore;
clone JBW301) and tubulin (Sigma-Aldrich; catalog number T9026) at a dilution of
1∶250 and 1∶500, respectively. Goat anti-mouse IgG Alexa-Fluor 594 secondary
antibody (Invitrogen) was used at 1∶2000. Cell nuclei were counterstained with
Hoechst 33342 dye (Invitrogen). Cells were observed under an Axiovert 200 M
inverted epifluorescence microscope equipped with the Apotome imaging system
(Zeiss). Images were captured with an Axiocam MRm camera and analyzed by using
the Axiovision software (Zeiss). To determine the cellular distribution of eGFP-
tagged proteins, a minimum of 100 transfected cells were observed and the
results were presented as percentage reflecting the nuclear and/or cytoplasmic
distribution of the protein.
## Cell Sorting
RecEGFPVP22-infected cells or LMH cells transfected with peGFP vectors were
trypsinized 24 h post-transfection and filtered on a 30-µm-pore-size membrane.
eGFP positive and negative cells were sorted with a MoFlo (Beckman Coulter, Fort
Collins, CO, USA) high-speed cell sorter equipped with a solid-state laser
operating at 488 nm and 100 mW. Damaged cells and debris were eliminated on the
basis of morphological criteria. eGFP fluorescence was analyzed with a 530/40 nm
band-pass filter. The sorting speed was around 15,000 cells/s and cells were
collected in appropriate media supplemented with 10% of FBS.
## Alkaline Comet Assay
LMH cells transfected with the peGFP, peGFP-UL49 or pUL49-eGFP were harvested 24
h post-transfection and eGFP positive and negative cell were sorted by flow
cytometry. After sorting, 2.10<sup>5</sup> cells were used to prepare 3 slides
for comet assays, realized as previously described with minor modifications.
Electrophoresis was performed at 0.7 volts/cm for 26 min with the Sub-cell GT
agarose gel electrophoresis system (Bio-Rad). DNA was then stained with a 20
µg/ml ethidium bromide solution and slides were observed using the Axiovert 200
M inverted epifluorescence microscope (Zeiss). Images were captured with an
Axiocam MRm camera (Zeiss) and comets were analyzed with the CometScore software
version 1.5 (TriTek). The Tail Extend Moment (TEM) was calculated on the basis
of the comet tail length and the relative proportion of DNA contained in the
tail. Experiments were carried out 3 times and for each experiment, a minimum of
50 comets was analyzed on each of the 3 slides. Results are presented as the
mean (±SD) of the TEM calculated for each condition or as a distribution of the
comets with respect to their respective TEM value.
## High Salt Extraction of Histones
Salt extraction of histones from chromatin was performed as previously
described. Briefly, 1.10<sup>7</sup> cells were resuspended in 1 ml extraction
buffer (340 mM Sucrose, 10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl<sub>2</sub>,
10% glycerol) containing 0.2% Igepal (Sigma-Aldrich) and 1X protease inhibitors
(Complete Mini EDTA free, Roche). After incubation on ice for 10 min, the
soluble fraction was separated from the nuclei by centrifugation at 6,500×g for
5 min. Nuclei were resuspended in 1 ml no-salt lysis buffer (3 mM EDTA, 0.2 mM).
After incubation at 4°C for 30 min, the chromatin was pelleted by centrifugation
at 6,500×g for 5 min, and incubated in 500 µl of high-salt solubilization buffer
(50 mM Tris-HCl pH 8.0, 2.5 M NaCl and 0,05% NP40) for 30 min at 4°C. Nuclear
debris were pelleted by centrifugation at 16,000×g for 10 min and the
supernatant containing the histones fraction was collected. The proteins
included in this fraction were separated in a 10% SDS-PAGE gel and revealed with
colloidal coomassie blue staining (Sigma-Aldrich). Detection of VP22 was
accomplished by immunoblotting using the monoclonal anti-VP22 antibody (L13a)
diluted 1∶1000 and an anti-mouse IgG conjugated to horseradish peroxidase (HRP)
(Sigma-Aldrich). Specific protein signals were detected with the Pierce ECL2
Western Blotting Substrate (Thermo Scientific) and the Fusion-FX7 imaging system
(Vilber Lourmat). Quantification was carried out using the Bio-profil 1D++
software (ChemiSmart 5000).
## Statistical Analysis
All graphs and statistics were performed using the GraphPad Prism software
version 5.02 (San Diego, USA). Data are presented as means and standard
deviations (±SD). Significant differences were determined using Student’s
*t*-test. *P* values \<0.05 were considered statistically significant.
# Results
## MDV Infection Delays Cell Cycle Progression in S-phase
In order to analyze the influence of MDV infection on cell cycle progression,
chicken embryonic skin cells (CESC) were infected with the parental BAC20 virus.
At days 1, 4, and 6 post-infection (pi), mock- and virus-infected cells were
fixed in ethanol, DNA was stained with propidium iodide and DNA content was
analyzed by flow cytometry. While no significant difference in the cell cycle
progression was observed in the early steps of infection (1 dpi), at day 4 pi
the cell population in S-phase in BAC20-infected cells was about 3-fold higher
than in mock-infected cells. At day 6 pi, the proportion of cells in S-phase as
well as in the G2-phase remained 3-fold higher in BAC20-infected cells,
suggesting that MDV infection activates cell cycle progression of CESC that
normally exhibit a low proliferating rate (3 to 4% of cells in S-phase) and that
MDV may delay the cell cycle in S-phase. In order to ascertain viral
replication, mRNA expression of the early ICP4 viral gene was followed by qRT-
PCR ( lower panel). To confirm the activation of the cell cycle progression
assessed by DNA content analysis, and to define the molecular mechanisms of this
process upon infection, we examined the expression of key factors involved in
cell cycle regulation including cyclins and cyclin dependent kinases (cdk). CESC
were mock-infected or infected with BAC20, and qRT-PCR analyzes were performed
on total mRNAs extracted at 1, 4, and 6 days pi. At 4 dpi, BAC20-infected cells
showed an increase of the mRNA expression of cyclin D (of about 6 fold), cdk6
(2.3-fold), pRb (3-fold), E2F1 (3.5-fold) and c-myc (3.1-fold) compared to mock-
infected control cells. A slight up-regulation of cyclin A (1.7-fold), cyclin B
(1.5-fold) and cdk1 (1.6-fold) mRNA expression was also detected at 1 dpi in
infected cells compared to non-infected cells, while the level of cyclin E mRNA
expression was comparable to that in mock-infected cells. These observations are
in good agreement with the DNA content analyses showing an activation of the
proliferative capacities of infected CESC, since cell cycle progression markers,
especially cellular factors involved in the progression into G1 and S-phases
(cyclin D, cyclin A, cdk6, pRb, c-Myc, and E2F1) were up-regulated during MDV
infection. Interestingly, analysis of the mRNA expression pattern of p53, a
protein crucially involved in cell cycle checkpoints and DNA damage pathways,
revealed a strong up-regulation (of about 5.9 fold) of its expression at 4 dpi.
Of note, we also observed a down-regulation of the mRNA expression of cdk6, pRb,
E2F1 and c-myc at 6 dpi that reflect the non-progression of the cell cycle in
G1/S phase.
To specifically determine the regulation of the cell cycle in infected cells and
to preclude problems associated to asynchronous infection and moderate
infectivity titers, CESC infected with the recEGFPVP22 virus, an MDV recombinant
virus expressing an eGFP-VP22 fusion protein, were sorted by flow cytometry.
Infected cells monolayers were harvested at 6 days pi, and the DNA content in
non-infected (eGFP-negative) and infected cells (eGFP-positive) was analyzed by
flow cytometry. Using this approach, we could observe that 34.4% of the eGFP-
positive cells were delayed in S-phase, while in the eGFP-negative population
the percentage of cells in S-phase was equivalent to that in mock-infected cells
(up to 5%). In addition, a slight increase of cells in G2-phase was detected in
infected cells (8% compared to 2.8% in eGFP-negative cells or mock-infected
cells). All together, these data clearly demonstrate that lytic MDV infection
drives primary avian cells into an active proliferating state. Furthermore, the
significant increase of MDV-infected cells accumulating in S-phase is also
indicative of a virus-mediated delay in S-phase progression.
## VP22 is a Major Cell Cycle Regulator
To identify viral factors involved in the regulation of the cell cycle during
MDV infection, we tested the impact of the overexpression of six different viral
proteins in CESC (low rate proliferating primary cells) and LMH cells (a cell
line with high proliferative rate). Putative candidates were selected either on
the basis of their biological activities that might influence host cell-encoded
cell cycle regulators and/or on the basis of their essential role in the MDV
life cycle. Because of the central role of cellular kinases in cell cycle
progression, we were interested to test the two kinases encoded by MDV, pUL13
and pUS3. The ICP27 protein, encoded by the UL54 gene, was also included in the
study as a multifunctional viral regulatory protein that has previously been
shown to contribute to cell cycle modulation during HSV-1 infection. Three
tegument proteins were also tested: the UL48-encoded viral trans-activator VP16,
as well as pUL37 and VP22, both of which were shown to be essential for MDV
growth (J-F Vautherot, unpublished data;). Eukaryotic expression vectors
harboring the viral candidate genes UL37, UL48, UL49, and UL54 (encoding pUL37,
VP16, VP22 and ICP27, respectively) were transiently transfected into LMH or
CESC cells. At 48 h post-transfection, the cell cycle status was analyzed as
outlined earlier and the expression of each of the transfected MDV genes was
verified by RT-PCR from total RNA extractions. No significant differences in the
proportion of cells in each cell cycle phase was observed (left panel) for
transfected CESC, suggesting that none of the overexpressed proteins was able to
impact the cell cycle in quiescent CESC. In LMH cells, we also did not observe
any cell cycle regulation in response to the expression of UL13, US3, UL37, UL54
and UL48, despite an effective expression of their respective mRNA ( lower
panel). However, VP22 (pUL49) overexpression had a substantial effect on the
cell cycle in the LMH cell line (right panel), as shown by the strong
accumulation of cells in S-phase compared to control cells transfected with the
empty vector pcDNA (35% versus 18% of cells in S-phase). Next, we tried to
confirm our finding that VP22-expression alone results in an increase of cells
in S-phase by transfecting LMH cells with plasmids encoding the VP22 protein
fused to a eGFP-tag at its N- or C-terminus. Using an N-terminal eGFP-tagged
VP22 protein (peGFP-UL49), we could confirm our finding that VP22 modulates the
cell cycle, since more than 90% of LMH cells expressing VP22 (eGFP-positive
cells) were blocked in S-phase. However, cells transfected with the plasmid
encoding VP22 tagged at its C-terminus did not show any difference in cell cycle
regulation compared to empty vector (peGFP)-transfected cells, which indicates
that the location of the eGFP-tag at the carboxy-terminal extremity of the VP22
protein abrogates its activity on the cell cycle. Of note, the dramatic intra
S-phase arrest observed with the N-terminal eGFP-tagged VP22 protein could be
reproduced after overexpression of VP22 in two other avian cell lines: the
chicken fibroblast cell line DF1 and the quail myoblast cell line QM7 (data not
shown).
To verify whether the S-phase promoting activity of the MDV-encoded UL49 is
conserved in other alphaherpesvirus orthologues, we tested the ability of VP22
encoded by HSV-1 and VZV to regulate the cell cycle. The HSV-1 and VZV-UL49
genes were cloned in-frame with eGFP and transiently overexpressed in the LMH
cell line. At 48 hours post-transfection, the flow cytometry-based cell cycle
analysis targeting transfected cells (eGFP-positive population) showed a
significant S-phase arrest upon expression of all VP22 orthologues tested. VP22
orthologues derived from MDV and VZV proofed to be equally efficient, as
approximately 80% of the cells expressing these VP22 were blocked in S-phase.
Although HSV-1-VP22 substantially blocked the cell cycle progression in S-phase
(61.8% of the transfected cells), it appeared slightly less efficient than other
VP22 orthologues (especially MDV-VP22) in this process.
We thus identified a novel function for MDV-VP22 as a potent cell cycle
modulator, with a strong S-phase promoting activity. We also revealed that an
unmodified C-terminal extremity of VP22 is required for this process. Moreover
this biological feature seems to be conserved among the human alphaherpesvirus,
even though the two VP22 orthologues tested does not exhibit equal activity.
## Subcellular Localization of the VP22 Protein Encoded by MDV
We took advantage of the differential cell cycle modulating activities of the C-
or N-terminally eGFP-tagged VP22 fusion proteins to decipher which VP22
properties are crucial to mediate S-phase arrest. One hypothesis for different
activity patterns could rest on differential subcellular distributions of the
two proteins. To test this hypothesis, the two constructs peGFP-UL49 and
pUL49-eGFP were transfected in LMH cells and the respective locations of the
proteins were analyzed based on the eGFP signal by fluorescence microscopy at 48
h post transfection. In order to visualize more accurately the distribution of
the two proteins, nuclei were stained with Hoechst 33342 and the cytoskeleton
was stained with an anti-α-tubulin. Upon overexpression in LMH, the control eGFP
protein (peGFP) was distributed all over the cells; the two VP22 proteins tagged
at the N- or C-terminus did not show any significant difference in their
cellular localization, with respectively 74,4% or 72,6% of eGFP-positive cells
presenting an exclusive nuclear distribution and 17,2% or 25% showing a combined
nuclear/cytoplasmic staining. Thus, the location of the eGFP tag, at the amino-
or carboxy-terminus of VP22, does not seem to affect VP22 cellular distribution
in LMH cells.
Another interesting feature of VP22 is its ability to bind to chromatin,
especially to histones as it has previously been shown for the VP22 encoded by
BoHV-1. By performing a high-salt histones extraction protocol from cells
transfected with either pcDNA-UL49 or pcDNA3.1 (empty vector), we found VP22 to
be included in the histones fraction, as it is demonstrated by a 27 kDa band in
the colloidal coomassie blue SDS-PAGE gel and by the VP22-specific antibody
(L13a)-probed Western blot (shown in -left panel). This result indicates that
MDV-VP22 shares the ability of the VP22 encoded by BoHV-1 to interact with
histones. In order to investigate the impact of the position of the eGFP tag on
the ability of VP22 to associate with chromatin, we carried out a similar
experiment using LMH cells transfected with peGFP, peGFP-UL49 or pUL49-eGFP. We
observed that the VP22 tagged at its amino terminus could be co-extracted with
histones and visualized as a specific 55 kDa band in coomassie blue-stained SDS-
PAGE gel (-right panel). However, the protein tagged at its carboxy terminus
appeared to be significantly less retained in the histones fraction. These
observations were confirmed by immunoblotting experiments using the anti-VP22
L13a antibody that show the presence of VP22 in the histone extracts prepared
from cells expressing peGFP-UL49 and at a far lesser extent (about 4.5 fold)
from the pUL49-eGFP transfected cells ( lower panel). All together, these data
indicate that VP22 is predominantly targeted to the nucleus of LMH transfected
cells independently of the eGFP tag location. However, the fusion of eGFP at the
C-terminus of the VP22 protein affects its capacity to associate with chromatin.
## Accumulation of DNA Damages in VP22 Overexpressing Cells
Arrest or delay in S phase can arise either from the occurrence of DNA damages,
especially double strand breaks (DSB), or replication fork stalling. Since VP22
is able to drastically arrest the cell cycle in S phase and moreover seems to be
associated to chromatin, we tested whether the overexpression of VP22 in LMH can
induce DNA damages. LMH cells were transfected with pcDNA-UL49 or pcDNA3.1 (as a
negative control) and DNA damages were analyzed by alkaline comet assay at 24 h
post-transfection. This method, based on a single-cell gel electrophoresis,
allows the detection of DNA breaks that are visualized as fragmented DNA
exhibiting the shape of a comet’s tail. We could observe an increased number of
comets in the population of cells transfected with VP22 compared to the cells
transfected with the empty vector pcDNA3.1. To estimate the extent of DNA
damages, a more precise analysis with the Comet Score software was performed and
the tail extent moment (TEM) was calculated. This parameter is calculated on the
basis of the tail length, reflecting the severity of the damages and the amount
of DNA in the tail relative to the head, which is an indicator of DNA break
frequencies. The calculation of the TEM could show that cells expressing VP22
presented a significant higher TEM (12.62±0.62) than the cells transfected with
pcDNA3.1 (4.11±0.25), indicating that the expression of VP22 seems to be
associated with the occurrence of DNA damages in LMH cells ( lower panel).
However, it should be stressed that this result reflects the DNA damage analysis
on the whole population of pcDNA-UL49 transfected and non-transfected cells.
Consequently to corroborate these findings and to determine whether the VP22
protein tagged at the C- or N-terminus was also able to induce DNA damage in LMH
cells, we transfected the peGFP (empty vector), peGFP-UL49 or pUL49-eGFP
plasmids in LMH cells and examined the onset of DNA damages by alkaline comet
assay at 24 h post-transfection specifically in the eGFP positive cells sorted
by flow cytometry. As positive control, LMH cells were treated with etoposide
and as negative control, non-treated and non-transfected LMH cells were
analyzed. We could readily observe comets from cells treated with etoposide and
most of the cells overexpressing eGFP-UL49 and, to a lesser extent, from cells
expressing the UL49-eGFP protein, whereas cells expressing peGFP produced almost
no comets or comets with a shorter tail similar to the non-transfected cells.
Calculation of TEM revealed that the mean tail moments of cells expressing eGFP-
UL49 (27,73±2,11) or UL49-eGFP (11,99±1,52) is significantly higher than for
cells transfected with peGFP (4,739±0,54), indicating that the expression of
both tagged-VP22 proteins increases DNA damage in cells ( left panel). However,
the damages were significantly more pronounced in cells expressing the protein
tagged at its amino-terminal extremity than in cells expressing the C-terminally
tagged version of VP22. Of note cells treated with etoposide showed a TEM of
77.47±0.55 thereby affirming the drastic induction of DNA damages by this DNA
topoisomerase II inhibitor. In addition, we were interested to analyze the
frequency distribution of tail moments (i.e. the percentage of cells presenting
a defined TEM), which is representative for the number of cells encompassing
damages. About 63% of cells transfected with peGFP had a tail moment inferior at
5, indicating that the majority of the cells contain non-damaged DNA or DNA with
very limited damages. However, this cellular population decreased when VP22 was
expressed both with the eGFP tag at the N-terminus or C-terminus (10% and 29%,
respectively), and we could observe a marked increase of the proportion of cells
presenting TEM values above 5 (89,6% and 71%, respectively). In particular, the
expression of eGFP-UL49 tends to increase the frequency of cells with highly
damaged DNA, more than 50% of the cells having a TEM\>20 and 13,7% presenting
TEM\>50. In comparison, 19,7% of cells expressing UL49-eGFP showed a TEM\>20 and
only 1,9% a TEM\>50. These observations indicate that the expression of VP22 in
cells leads to an increased incidence DNA damaged cells and that damages are
more severe when the VP22 is fused to eGFP at its N-terminal extremity. It
should be however stressed that although the expression of VP22 leads to the
occurrence of significant DNA damage, those damages are relatively less heavy
than the ones induced by drugs such as etoposide that are responsible of potent
damages (more than 55% of the comet having a TEM\>50).
In order to specify the nature of the DNA damages generated in cells expressing
VP22, we monitored by immunofluorescence staining the expression and
localization of γ-H2AX in LMH cells transfected with peGFP-UL49, pUL49-eGFP or
with the empty vector peGFP. Because histone H2AX is rapidly phosphorylated
(γ-H2AX) after generation of DNA double strand breaks (DSB), γ-H2AX is a
preferential marker used to reveal these damages. As positive control, the
expression of γ-H2AX was also examined in cells exposed to etoposide. We
observed an overall increase of the staining intensity of the γ-H2AX DSB-marker
in cells treated with etoposide and specifically in cells expressing eGFP-UL49
compared to non-transfected cells, peGFP transfected cells or UL49-eGFP
expressing cells. Moreover, with higher magnification we could visualize that
γ-H2AX formed discrete foci in the nucleus of eGFP-UL49 transfected cells as was
also observed in etoposide-treated cells. This typical punctuated staining of
γ-H2AX reflects its recruitment to sites of DNA damage and thus indicates that
cells expressing VP22 tagged at its amino-terminus undergo multiple DSB.
# Discussion
In the present report, we show for the first time that MDV lytic infection leads
to a dysregulation of the cell cycle progression of the host cell. MDV infection
not only promotes the proliferation of primary embryonic skin cells, but also
leads to an accumulation of infected cells in S-phase. This modulation of the
cell cycle is accompanied by a significant up-regulation of cellular genes
involved in G0/G1 transition (cyclin D, cdk6) and in G1 to S-phase progression
(pRb, E2F1, c-myc, cyclins A). A substantial mRNA up-regulation of the cell
cycle regulator p53 was also observed early after infection. Cell cycle
modulation is a mechanism that is frequently exploited by viruses in order to
facilitate viral replication. In contrast to small DNA viruses, a cellular
S-phase environment is not mandatory for herpesviruses encoding their own DNA
polymerase and accessory factors required for optimal viral replication.
Consequently, for most of alphaherpesviruses it has been demonstrated that they
prevent the S-phase entry and rather activate the G1/S checkpoint. MDV is an
alphaherpesvirus that shares a number of biological features with
gammaherpesviruses, notably the viral lymphotropism and the ability to induce
tumors. With respect to cell cycle modulation, our data suggest that MDV has
adapted a similar strategy than EBV and KSHV, both of which were shown to
promote cell cycle progression, especially into S-phase. It is conceivable that
the MDV-mediated cell cycle modulation might also play a role in the multi-
factorial events eventually leading to transformation and tumorigenesis. The
S-phase is in fact the most vulnerable period of the cell cycle and a defect or
inactivation of the key components of the intra S-phase checkpoint may
predispose cells to oncogenic transformation (for review).
The most unexpected discovery of our study is the identification of the MDV-VP22
protein as a potent trigger of cell cycle arrest in S-phase, as evidenced by the
observation that its overexpression in proliferating LMH cells lead to the
enrichment of up to 90% of transfected cells in S-phase. VP22 is a major
component of the viral tegument of the *Alphaherpesvirinae*. While VP22
orthologs exhibit functional homology, their significance for alphaherpesviruses
life cycle varies according to the virus species. This is well illustrated by
previous studies showing that VP22 is dispensable for *in vitro* replication of
PRV, HSV-1, and BoHV1, whereas it is essential for MDV and VZV replication.
However, the biological properties of VP22 that determine its key role in the
life cycle of MDV remain still unknown. One hypothesis is based on the crucial
function of VP22 in cell-to-cell spread. We can also not exclude that a rapid
distribution of VP22 after viral entry might prepare an optimal environment for
viral replication by inducing an S-phase arrest.
Several viral proteins encoded by herpesviruses have been shown to have an
impact on the cell cycle. Among the ones encoded by the *Alphaherpesvirinae*,
the ICP0 protein is probably the best studied. This multifunctional protein
required for efficient HSV-1 lytic replication and reactivation from latency,
has been identified as a major cell cycle modulator that is able to act either
on the G1/S or at the G2/M checkpoints. However, the observation that ICP0
deficient mutant viruses are still capable to elicit proliferation arrest
indicates that other viral factors also impact the cell cycle. Notably, the
immediate early protein ICP27 was shown to be essential for the G1/S cell cycle
arrest triggered by HSV-1, with ICP4, ICP0, and the virion host shutoff protein
acting as contributors. Hence, MDV and HSV-1 appear to employ differential cell
cycle modulation mechanisms as MDV does not encode a functional ICP0 protein and
we could not detect any effect of ICP27-overexpression on cell proliferation. It
is an interesting speculation that MDV may have evolved a distinct mechanism for
cell cycle modulation that crucially involves VP22 in order to compensate for
the absence of ICP0 activities. It should be noted that the overexpression of
the VP22 proteins encoded by HSV-1 or VZV also resulted in a dramatic arrest of
the cell cycle in S-phase in transfected LMH cells. This finding suggests that
VP22 might also contribute to the modulation of the cell cycle in the context of
infections with human herpesviruses. While screening for viral factors that are
involved in the MDV-associated cell cycle regulation, we also tested whether the
activity of the two MDV-encoded serine-threonine kinases pUS3 and pUL13 could
have a cell cycle regulatory effect. Indeed, it is well known that cell cycle
progression is submitted to a tight regulation mediated by kinases and
phosphatases. Overexpression of UL13 and/or US3 in low proliferating cells
(CESC) or high proliferating cells (LMH) had no effect on the cell cycle, thus
excluding a direct involvement of these kinases in the cell cycle modulation.
However, pUS3 and pUL13 are able to phosphorylate various cellular and viral
proteins, including the VP22 proteins encoded by HSV-1 and -2, as well as
BoHV-1,. So far, the phosphorylation status of MDV-VP22 during infection has
not been investigated, and we cannot exclude post-translational modifications of
MDV-VP22 by UL13 and/or US3, as previously shown for other alphaherpesviruses.
Intra-S checkpoints activation mainly reflects DNA breaks or stalled replication
fork formation. In order to identify the molecular mechanisms underlying the
VP22-driven S-phase arrest, we focused on the impact of VP22 expression on the
generation of DNA damage in the host cell genome. Following overexpression of
VP22 in proliferating cells, we could indeed show by comet assay that the
presence of VP22 coincided with the occurrence of massive DNA damage. Moreover,
VP22-expressing cells showed an increased staining of the phosphorylated form of
H2AX, suggesting that the DNA lesions observed are double strand breaks.
Interestingly, the VP22-mediated generation of DNA damages seems to be tightly
associated to the cell cycle modulation property of VP22. This was evidenced by
our comparative experimental approach using two versions of the VP22 protein
tagged either at its N- or C-terminus. The data from this experiment show that
virtually all cells expressing eGFP-VP22 (N-terminal eGFP-tag) are arrested in
S-phase and present severe DNA damage, whereas cells expressing VP22-eGFP
(C-terminal eGFP-tag) are not affected in their cell cycle progression and show
significantly less DNA lesions. Of note, all our attempts to generate a LMH
stable cell line overexpressing the MDV-VP22 protein failed due to a high level
of cellular mortality. These observations raised the question of the potential
toxicity of VP22, which might find an explanation in the induction of double
strand breaks in cells overexpressing VP22.
The mechanisms by which VP22 induces S-phase arrest and DNA breaks still remain
to be elucidated. However, among the characteristics of VP22, we can speculate
that its capacity to interact with chromatin and histones might participate to
those processes. Interactions of VP22 protein with nucleosomes were previously
demonstrated for the BoHV-1-encoded VP22, which physically interacts with
nucleosome-associated histones and thereby causes an impaired acetylation of
histone H4. In addition, for MDV-VP22, the regions allowing interaction with
heterochromatin were previously defined. In the present study, we confirmed that
MDV-VP22 is found predominately in the nucleus of cells following overexpression
in LMH cells. We also found that an N-terminally eGFP-tagged MDV-VP22 can be
extracted from chromatin preparations together with histones. However, for a
C-terminally eGFP-tagged MDV-VP22, the efficiency of recovery from histones
extracts was far less, suggesting that an unmodified C-terminal extremity of
VP22 is necessary for the association of VP22 with chromatin. Together, these
observations suggest that the abilities of VP22 to arrest the cell cycle in
S-phase and to effect DNA damage are linked to its direct or indirect
interaction with histones and/or chromatin. According to this model, it is
conceivable that the interaction of VP22 with chromatin or histones may disturb
the unwinding of DNA in a similar fashion than cellular helicases or
topoisomerases by preventing access to the DNA replication machinery.
Alternatively, it can be speculated that an association of VP22 with
DNA/histones may cause physical tension of the DNA double helix eventually
leading to DNA breaks.
Activation of DNA damage response (DDR) pathways is well documented for a number
of viruses, especially tumorigenic viruses and plays a central role in viral
replication. While our data only provide clear evidence for a role of VP22 as a
powerful inducer of DNA damage in a non-infectious context, it can be assumed
that DDR activation might play a role in MDV replication and/or MD pathogenesis.
Due to the critical role of VP22 for MDV-replication, it is so far impossible to
evidence the function of VP22 as a major cell cycle regulatory factor during MDV
infection by using a VP22-deleted virus. However, Jarosinsky *et al*. have
demonstrated that a recombinant MDV harboring a VP22 protein tagged with eGFP at
the C-terminus (a construct that is identical to the VP22-eGFP used in the
present study) showed a drastic decrease in its ability to induce MD in infected
chickens, with only 10% of the chicken developing tumors. In addition, we have
recently observed that a recombinant virus with the VP22 protein tagged at the
N-terminus is also attenuated, but in a lower extent, with 33 to 66% of the
infected chickens developing MD lymphoma. Although the impairment of
pathogenicity of the recombinant MDV studied by Jarosinski *et al*. could in
parts be explained by a lower viral replication efficiency *in vivo*, in view of
our data, it can also be speculated that the defect in tumor development
observed by the authors might be due to the loss of the ability of the
C-terminally tagged VP22 protein to induce S-phase arrest and DNA damage.
In conclusion, our findings provide new insights into herpesvirus-cell host
interactions by demonstrating that the oncogenic alphaherpesvirus MDV affects
the cell cycle progression in infected cells. Moreover, we could assign a novel
role to the VP22 tegument protein as a potent cell cycle modulator, property
that seems to be associated to its ability to induce DNA damages in cells.
Current efforts are under way to elucidate the detailed mechanisms of
VP22-induced DNA damage response, and its role during viral infection,
especially with respect to a possible involvement of DDR in MDV replication
and/or the establishment of MDV-latency and subsequent lymphoma formation.
We thank S. Trapp (INRA, Nouzilly, France) and J. Vignard for their constructive
comments and corrections on the manuscript.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: LTF. Performed the
experiments: LTF DB DCV YLV SR EBR. Analyzed the data: LTF JFV CD GM.
Contributed reagents/materials/analysis tools: JFV CD EBR GM. Wrote the
paper: LTF.
|
# Introduction
*Cynodon dactylon* (Linnaeus) Persoon (Family: Poaceae, bermudagrass in English)
is a perennial, creeping grass. Although it is widely found in the tropical and
warm temperate regions, bermudagrass is predominantly distributed between 45°
North and 45° South latitudes. Currently, *C. dactylon* is globally used as a
turf grass, fodder and medicinal plant, and it was also used for removal of
heavy metals from contaminated soils –. This grass is adapted to extremely
variable environments, such as fertile fields, arid land, saline land, wet
irrigation canals and even contaminated wastelands with high levels of Pb, Cd,
Zn and Cu. In addition, the extracts from bermudagrass are well known for
various medicinal properties including antimicrobial, anti-inflammatory,
immunomodulatory, and anti-diarrhea activities. It has been therefore used to
treat traumatic wounding, kidney calculi, hypoglycemia, depression and cancer.
Seed germination percentage is a major criterion used for evaluating suitability
of an environment for grass cultivation. Previous studies showed that extreme
temperatures could lead to seed dormancy and significantly decreased germination
percentage. Constructing a precise mathematical model that correlates the
germination percentage with temperature may avoid failure of plantation due to
inappropriate sowing timing or mismatch between the grass species and climate
zone. Hence it would be very helpful for decision-makers to select grass species
and sowing time for lawn, erosion control and forage cultivation. Using thermal
time approach, Bradford constructed temperature/water potential based seed
germination and dormancy models. This study showed that germination experiments
under temperature regime with discrete (stepwise) changes could also be used to
accurately predict thermal responses of seeds in field environment with
continuously changing temperature. Hardegree and Van Vactor, used the Piece-wise
linear (PWL) regression equations to confirms that constant-temperature
experimental results derived mathematical models could be used to predict the
germination/growth responses to the combined effects of multiple environmental
factors in the field. Although various experimental procedures have been
established to generate data for the development and validation of reliable
prediction models, the R<sup>2</sup> values of temperature-germination
percentage functions in some of the previous studies were relatively low
(0.61–0.80), and more accurate predictions are desired.
Recently, the Geographic Information System (GIS) based spatial prediction
approach was introduced for the creation of quantitative and accurate grass
suitability maps. The grid data of mean minimum and maximum temperatures were
used for calculating suitability values of regions *via* the temperature-
germination percentage functions. Therefore, the suitability of grass for
different regions could be appropriately visualized on the map. However, the
visualization of time scale (season) of these maps remains to be streamlined for
readability to facilitate their practical application.
The objectives of this research were to: (i) explain the correlation error
between temperature and seed germination percentage caused by selection of
functions (ii) provide a new program for optimizing the temperature-germination
function, (iii) use temperature-based seed germination percentage function in
combination with national temperature grids in China for predicting the
suitability of three bermudagrass cultivars, *C. dactylon*, ‘Savannah’ and
‘Princess VII’.
# Results
## Germination response to Diurnal Fluctuations of Temperature
The germination response of the three bermudagrass cultivars was similar. All
the three cultivars were capable of germinating in warm-period temperature
(T<sub>2</sub>) from 25 to 35°C and cool-period temperature (T<sub>1</sub>)
ranging from 5–40°C. The optimal temperature for seed germination is defined as
that which is not lower than the maximum germination minus one-half of its
confidence interval (P = 0.05). For example, the maximum germination percentage
(the optimal temperature for seed germination) of *C. dactylon* was 87.3% at
15/35°C; and the germination percentage at 5/30°C was only 80.7%, but it was
still accepted as the optimal temperature for seed germination since the one-
half of its confidence interval was 7.0% and 80.7%\>(87.3%–7.0%). Fluctuating
between 5–25°C cool-period temperature and 30–40°C warm-period temperature gave
rise to the optimal temperature for seed germination. On the other hand,
germination percentage was usually lower than 50% at constant temperature
ranging from 20 to 40°C (except the “Savannah” at constant 25/25°C), for example
the germination percentages of “Princess VII”, were 0, 36.0%, 5.3%, 12.7% and
20.0% at constant temperature regimes of 20/20, 25/25, 30/30, 35/35 and 40/40°C,
respectively. Interestingly, germination percentage of *C. dactylon* seed at a
constant 30°C only reached 1.3%.
The maximum germination and the mean of germination of the three bermudagrass
cultivars are presented in. The germination percentage of ‘Princess III’
appeared to be the highest (96.7%), but it was not significantly different
(P\>0.05) from that of the other two cultivars (87.3% and 94.0% for *C.
dactylon* and ‘Savannah’, respectively). Depending on the cultivar, 25%–27.8% of
the temperature regimes supported the optimal temperature for seed germination.
Only eight temperature regimes, 30/5, 30/10, 35/5, 35/10, 35/15, 35/20, 40/15
and 20/40°C, supported the optimal temperature for seed germination for all
three tested cultivars.
## Performance of Different Regression Models
All the regression equations of temperature treatments that assess the
germination suitability of the three bermudagrass cultivars are summarized in.
Quadratic and quintic general equations were used for data simulation. The
bisquare and BP-ANN approaches were utilized for optimizing these equation
coefficients. There was no significant difference between the quintic functions
and bisquare optimized quintic functions. Bisquare quintic functions of
cultivars *C. dactylon*, ‘Savannah’ and ‘Princess VII’ showed lower
R<sup>2</sup> than quintic functions (data not shown). Similar optimization
results were observed for all the cultivars tested. Generally, quintic equations
performed better than quadratic equations. The highest R<sup>2</sup> values were
generated by the back propagation artificial neural networks aided dual quintic
equation (BP-ANN-QE) model (0.9439 to 0.9813). In contrast, the dual quadratic
equation model (DQEM) generated the lowest R<sup>2</sup> values (0.6940 to
0.8177).
Contour plot maps were then used to visualize the prediction errors generated
from different simulation functions. The blue spot represents the experimental
germination percentage associated with particular fluctuating temperature
combinations. Obviously, DQEM is the one most prone to produce prediction errors
among the compared models. However, some weakness in functional convergence of
quintic equations was observed, a small portion of observed temperature-
germination spots were still out of their equation derived surfaces.
## Spatial Mapping of Optimal Planting Times
The temperature–germination functions derived from our experimental data were
used to predict germination percentage for various regions in China in different
seasons using the 25 years mean minimum and mean maximum earth surface
temperature grids as input. The percentage reflected the likelihood of
germination suitability at each grid cell of the maps *via* FreeMicaps. The
results reveal that most of the Chinese regions are not suitable for seed
germination of all the tested bermudagrass cultivars from November to March.
Although ‘Savannah’ has the narrowest geographic range of germination with
percentages arranging from above 0 to 100%, it was predicted to have optimal
temperatures for germination in widest geographic range in China. In contrast,
*C. dactylon* had the narrowest range for the optimal temperatures for seed
germination. For both *C. dactylon* and ‘Princess VII’, the widest range with
the optimal temperatures for seed germination was in the month of June, whilst
for ‘Savannah’ it was in May.
# Discussion
Simulation models have been widely used to correlate cultivation conditions and
plant germination/growth. These regression models were generally used to predict
the plant suitability to particular regions where climate and soil environment
information is available. These mathematical models could help grass cultivation
in three major aspects. First, these functions combined with a visual
suitability map may help decision makers in selecting a grass species and
planning its seeding timing. Second, they may serve as useful tools for
identifying and evaluating desirable quantitative characteristics for specific
grass breeding objectives, which is helpful in coupling genotype and phenotype
of a target cultivar, a technology with significant application value in the
rapidly expanding turf industry. Third, these grass-condition models may improve
our understanding of how changes in agricultural systems would quantitatively
influence grass germination/growth.
## Comparison of Regressions Using Quadratic and Quintic Equations
The quadratic equation was broadly accepted as an effective statistical tool for
simulating continuous variable-response relationship, and quadratic response
surface has been a predominant method to analyze germination performance of
grass seeds under various temperature regimes, especially to test the seed
germination affected by diurnal temperature treatments. However, the weakness of
quadratic equation is also obvious. Since the two-dimensional quadratic response
surface cannot display some errors in the global fitting between quadratic
function and experimental data, the weakness of low R<sup>2</sup> values
(0.61–0.80) was ignored. In this study, quintic equation was employed for
regression to simulate diurnal temperature-germination responses of three
bermudagrass cultivars. Compared to quadratic surfaces, quintic approaches had
significantly lower fitting errors and higher confidence. This may be due to the
nonlinear temperature-germination correlation. Hence these quintic equation
models could provide more reliable predictions for field performance of grasses,
further improving the reliability of the suitability map of grasses tinted with
different color based on predicted germination percentage data.
## BP-ANN and Bisquare for Intercept and Coefficients Fitting
Artificial Neural Network (ANN), an algorithm for simulating the thinking
processes of the human brain which usually have multiple networks that are
logically arranged as fundamental units. The information of any unit can be
learnt, recalled, concluded and speculated. Hence, the ANN has many advantages
such as distributed storage of information, self-adaptability, self-organization
and fault-tolerance properties. As a computer based program, it could be used to
perform large-scale parallel calculations to simulate nonlinear correlation.
Therefore, ANN is broadly used in various of fields including biomedical
research, optimization of soil nutrient distribution coefficient, forecasting of
microorganism community assemblages, prediction of animal metabolism and diets
correlation, and simulation of fruit post-ripening process.
Currently, there are tens of ANN models. Amongst them, the back propagation (BP)
network is the most widely used one for simulation of nonlinear relationship.
The BP-ANN model belongs to supervised study and its training process has two
phases, forward propagation and backward propagation. In the forward
propagation, the weighted value and threshold value of each layer is calculated
by iteration and passed into the BP three-layer network. Subsequently, the
backward propagation uses the weighted value and threshold values for revision.
These two phases commonly occur repeatedly for about 10, 000 times, and the
weighted value and threshold values alternate until they converge. The target of
these training processes is to generate a function that can globally
‘distinguish’ and ‘remember’ all the input raw data. Therefore, the simulated
BP-ANN functions could be used to predict proposed parameter with appropriate
input variables.
The robust bisquare estimator, also known as Tukey's bi-weight function, was a
popular choice for nonlinear function fitting. This estimator was often used for
smoothing the nonlinear response surface. It was reported that bisquare
estimator could be adapted to process noisy data with outliers.
In our study, both BP-ANN and bisquare methods were used to optimize the
temperature-germination functions for three bermudagrass cultivars. We did not
find significant difference between general quintic functions and bisquare
fitted quintic functions. Furthermore, most bisquare quintic functions in this
study had slightly lower R<sup>2</sup> values than the quintic functions.
Therefore, the BP-ANN optimized quintic equations were found to be the best
option for fitting temperature-germination functions of the tested bermudagrass
cultivars.
To some degree, the BP-ANN based temperature-germination functions could be
evaluated by the visualized suitability map and the observed temperature-
germination results. Generally, the cultivar “Savannah” could germinate under
the widest temperature regimes, from about 20/5°C to 40/40°C, it also present
the highest suitability with widest geographic regions in China (eg.). On the
other hand, the predicted suitability map worked in concert with the
observations that all the three cultivars preferred warm temperature above
15/15°C, and little germination could be found during the cool seasons in China
(eg.).
# Conclusions
This study tested the influence of diurnal fluctuations of temperatures on seed
germination of three bermudagrass cultivars (*C. dactylon*, ‘Savannah’ and
‘Princess VII’). Eight temperature regimes, 5/30, 10/30, 5/35, 10/35, 15/35,
20/35, 15/40 and 20/40°C, supported the optimal temperature for seed germination
for the three cultivars. However, the germination percentage of all the three
cultivars was lower than 50% under conditions of constant temperatures ranging
from 5 to 40°C.
To simulate the grass germination-temperature response function, both quadratic
and quintic equations were employed. Quintic functions performed significantly
better (R<sup>2</sup> were around 0.9439) than the quadratic ones (R<sup>2</sup>
ranging from 0.6940∼0.8177) for the tested cultivars. The main objective of this
study was to test the nonlinear fittin\g approaches, bisquare and BP-ANN, for
optimizing the regression functions. Our results suggested that BP-ANN has
significant advantages over bisquare for fitting the intercept and coefficients
of the temperature-germination functions.
Based on the experimentally derived BP-ANN functions and available climate data,
we prepared a seed suitability map of three bermudagrass cultivars for
cultivation in the People’s Republic of China. We observed that most of the
regions in China are not suitable for bermudagrass seed germination from
November to March. The cultivar ‘Savannah’ had the widest geographic range of
the optimal temperature for seed germination, whilst *C. dactylon* had the
narrowest range of the optimal temperature for seed germination percentage. The
month with widest range of the optimal temperature for seed germination for *C.
dactylon* and ‘Princess VII’ is June, whilst for ‘Savannah’, it is May.
# Materials and Methods
## Seeds and Conditioning
The bermudagrass cultivars (*C. dactylon*, ‘Savannah’ and ‘Princess VII’) were
planted widely in China. All the grass seeds were purchased from Shanghai
Chunyin Turf Inc., (Shanghai, China) and stored at room temperature until use.
Seed viability was tested on sterilized wet filter paper at 25°C in darkness.
Briefly, seeds were surface sterilized in 0.01% HgCl<sub>2</sub> for 1 min
followed by four rinses with distilled water. The seeds were subsequently placed
on wet filter papers in Petri dishes. The Petri dishes were placed in incubators
set up for 36 different regimes of diurnal fluctuations of temperature
treatments: 16 h at temperature T<sub>1</sub> and 8 h at temperature
T<sub>2</sub>. The T<sub>1</sub> and T<sub>2</sub> ranged from 5 to 40°C with
5°C increments. Germinated seeds were counted daily until no further germination
occurred (about 15–20 days) for viability analysis (Supplementary file –). For
each experiment, three replications of 50 seeds were used in a randomized block
design.
## Statistical Analysis
In this study, quadratic and quintic response surfaces were constructed with
estimated means and confidence intervals. The quadratic equations were first
used for estimating germination percentages. The generalized equation was :

where Y<sub>1</sub>: predicted germination percentage, A<sub>0</sub>: intercept,
A<sub>1</sub> through A<sub>5</sub>: coefficients, T<sub>1</sub> and
T<sub>2</sub>: two temperature in the diurnal regime.
Meanwhile, quintic equations with the following generalized equation were also
used to simulate the temperature-germination function:, where
A<sub>0</sub><sup>′</sup>: intercept, f(A): coefficient function. Temperature
inputs were normalized by dividing the maximum value. Subsequently, the
intercept and coefficients were optimized using Bisquare, a default curve
fitting method of MATLAB 7.9-R2009b software and back propagation artificial
neural networks (BP-ANN) approach described in, respectively. The BP-ANN (or
feed-forward network) has the capability to learn arbitrary nonlinearity and
great potential for adaptive control applications. In the BP-ANN, the
correlations among the input variables do not need to be specified. Instead,
they learn from the examples fed to them. In addition, they can generalize
correct responses that only broadly resemble the data in the learning phase.
## Spatial Mapping
The suitability of a grass is represented by seed germination percentage. The
grass suitability maps were created using the FreeMicaps software
(<http://bbs.121323.com/guojf/FreeMicaps20111001.rar>). Like the Surfer
software, FreeMicaps also uses grid data at selected points (station) that is
compatible with GIS. The temperature data of adjacent regions around the station
are generated using regression functions. The data used to construct the
temperature grid are curated in the database in National Aeronautics and Space
Administration (NASA, <http://power.larc.nasa.gov/cgi-
bin/cgiwrap/solar/[email protected]#s11>) which are composed of minimum
and maximum daily temperature of earth surface from 313 Chinese weather stations
for a period of 25 years (from 1983 to 2007). These mean values of minimum and
maximum daily temperatures were used as the T<sub>1</sub> and T<sub>2</sub>
variables, respectively in the BP-ANN-Quintic functions for calculating
germination percentages (grass suitability).
# Supporting Information
We are grateful to Xi Tang and Meixia Ruan for their kind assistance during seed
germination tests. Thanks are also due to Dr Jiang-Feng Guo (Agricultural
Technology Extension Station of Qingfeng County, Henan Province, China) for
providing the FreeMicaps software and for his kind guidance on software
application.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: HL EP. Performed the
experiments: EP. Analyzed the data: EP. Contributed
reagents/materials/analysis tools: HL EP. Wrote the paper: EP HL LD SN NM.
|
# Introduction
Although it is well known that improvement of health behaviour is necessary for
the management of non-communicable diseases (NCDs) such as hypertension,
diabetes, and dyslipidaemia, it is challenging to modify health behaviour.
However, there is no lack of opportunities for health behaviour improvement, and
the theory of health behaviour recommends taking advantage of such cues to
action. In particular, the situation of being diagnosed with an NCD and treated
is recognised as a good opportunity for becoming aware of the health crisis and
thus preventing the exacerbation of the disease and the development of comorbid
diseases (i.e., what is known as the ‘wake-up call’ or a teachable moment).
Despite various efforts to improve NCD patients’ health behaviour, there
is currently insufficient evidence to suggest that their health behaviours are
significantly better than those of the general population. In a study that
followed the trends of three health behaviours (current smoking, alcohol
consumption, and walking) in major NCD patients (hypertension, diabetes, and
dyslipidaemia) and compared them with those of the general population by
analysing the relevant Korea Community Health Survey data covering the period of
2008–2017, major NCD patients showed only marginally more health behaviour
improvement compared with the general population, partially showing a lower
level of improvement than the general population. Regarding nutrition-related
behaviours, some studies reported that patients improved their dietary behaviour
through education or counselling after diagnosis of NCDs. In other studies,
patients have complained of difficulties in correcting and continuing to fulfil
their dietary behaviours that were formed over a long period of time.
The present study focused on major NCD patients’ nutritional behaviours as a
follow-up analysis of prior research, in which smoking, drinking, and physical
activity (i.e., three typical health behaviours) were analysed; however, no
analysis of nutrition-related health behaviours was undertaken. The World Health
Organization (WHO) emphasises the importance of reducing unhealthy food and
drink consumption, along with reducing tobacco use, harmful use of alcohol, and
physical inactivity; these are the ‘best buys’ of the strategies to reduce the
burden of NCDs. Therefore, this study compared low-salt preference, which is a
typical nutrition-related health behaviour, between major NCD patients and the
general population, using the analysis methodology adopted in prior research.
# Materials and methods
## Data source
In this study, we used data extracted from the Korea Community Health Survey
(KCHS) during the period of 2008–2019. The KCHS is a nationwide survey that was
first conducted in 2008 by the Korea Centers for Disease and Control and
Prevention to evaluate the health status of community residents and to establish
evidence-based health-related statistics. This survey was conducted each year
from August to October at 255 community health centres across the country to
evaluate anthropometrical parameters, smoking status, alcohol use, physical
activity, health behaviours (e.g., diet and use of healthcare services), and
quality of life in Korean adults (≥19 years of age). The sample size of KCHS is
about 900 people in each community health center, for a total of about 220,000
people.
## Participants
Thirteen major types of NCD patients (hypertension, diabetes, dyslipidaemia,
stroke, myocardial infarction, angina, arthritis, osteoporosis, asthma, allergic
rhinitis, atopic dermatitis, cataract, and depression) were defined as
participants who responded clinically diagnosed from physicians in the KCHS.
Depression was subdivided into patients who had been diagnosed by a physician
and those who had experienced symptoms. The general population was defined as
all the participants in the Korea Community Health Survey.
## Low-salt preference
Low-salt preference was measured using four items: the percentage of respondents
who answered that they 1) usually eat less salty food, 2) do not add salt or soy
sauce at the table, 3) do not dip fried food in soy sauce, and 4) stick to a
low-salt diet in the three previous items, that is, they have a low-salt
preference (Type III).
## Data analysis
Descriptive statistical analysis of data was conducted to determine the low-salt
preferences of NCD patients and the general population according to the year
(2008–2019) and region (municipalities and provinces). A Chi-square test was
performed to compare the low-salt preferences of patients with major NCDs and
the general population. The 2018 Korea Community Health Survey data were
excluded from the analysis because there were no survey items on low-salt
preferences. Since the 2018/2019 data for the prevalence of dyslipidaemia were
missing, we used the 2017 data. Joinpoint regression was applied to detect
significant changes in annual low-salt preference, with a maximum of one
joinpoint allowed. The annual percentage change (APC) (i.e., the average annual
percentage change \[AAPC\] in the case of one joinpoint) was computed using
joinpoint analysis, and each p-value is presented.
Analysis data were tabulated using Microsoft Excel 2014 (Microsoft Corporation,
Seattle, WA). Stata/SE13.1 (StataCorp, Texas, TX) were used for descriptive
statistics and Joinpoint Regression Program (version 4.6.0; US National Cancer
Institute, Bethesda, MD, USA) were used for joinpoint regression.
## Ethical considerations
Since this study used a publically available secondary data source (Korea
Community Health Survey, Available from: <https://chs.kdca.go.kr/chs/main.do>),
we did not seek approval from the institutional review board. We also did not
have to ask for the consent of the participants.
# Results
As of 2017, low-salt preference among major NCD patients was generally higher
than that of the general population, however, overall statistical significance
was not reached. The percentage of respondents who answered that they usually
eat less salty food was 23.6% in the general population and 25.2%, 27.7%, and
24.4% in patients with hypertension, diabetes, and dyslipidaemia, respectively.
The percentage of respondents who answered that they did not add salt or soy
sauce at the table was slightly higher in patients with hypertension and
dyslipidaemia (72.2% and 74.0%, respectively) than in the general population
(71.9%), though the percentage was slightly lower (71.5%) in patients with
diabetes. The percentage of respondents who answered that they did not dip fried
food in soy sauce was slightly higher in major NCD patients than in the general
population (36.0%). The percentage of respondents who indicated that they
preferred a low-salt diet for all three items was highest in patients with
diabetes (15.6%), followed by patients with hypertension (14.1%), dyslipidaemia
(13.4%), and the general population (11.3%).
## Overall low-salt preference
The overall low-salt preference rate (usually eat less salty food) showed an
upward trend until 2013 and declined thereafter. In the general population, it
peaked in 2013 at 24.9% (APC: 2.654, p = 0.063) and decreased to 21.6% by 2019
(APC: -2.347, p = 0.195). In patients with hypertension, it peaked in 2013 at
27.6% (APC: 1.857, p = 0.136) and decreased to 21.6% by 2019 (APC: -2.649, p =
0.126). In patients with diabetes, it peaked in 2013 at 29.8% (APC: 1.859, p =
0.122) and decreased to 23.6% by 2019 (APC: -2.849, p = 0.093). Lastly, in
patients with dyslipidaemia, it peaked in 2013 at 27.2% (APC: 5.690, p = 0.048)
and decreased to 24.4% by 2017 (APC: -2.528, p = 0.023).
## Low-salt preference at the table
The rate of low-salt preference at the table (not adding salt and soy sauce at
the table) gradually increased and tended to remain elevated; in patients with
some diseases, the rate slightly decreased by 2019. In the general population,
it peaked in 2013 at 74.4% (APC: 11.788, p-value: \<0.001) and decreased to
68.4% by 2019 (APC: -0.964, p = 0.010). In patients with hypertension, it peaked
in 2013 at 73.5% (APC: 11.401, p = 0.001) and decreased to 68.1% by 2019 (APC:
-0.523, p = 0.225). In patients with diabetes, it peaked in 2013 at 72.7% (APC:
10.914, p \<0.001) and then gradually decreased to 68.3% by 2019 (APC: -0.567, p
= 0.113). In patients with dyslipidaemia, there was a slight decrease from 75.9%
in 2011 to 74.0% in 2017 (APC: -0.390, p-value: 0.109).
## Low-salt preference for fried food
The rate of not dipping fried food in soy sauce increased until 2013 and then
decreased. No significant changes were observed in the general population
between 2008 (36.8%) and 2019 (36.4%), and there were fluctuations in some years
(APC: 0.214, p = 0.693). In patients with hypertension, the rate peaked in 2013
at 50.3% (APC: 2.993, p = 0.023) and then decreased to 44.9% by 2019 (APC:
-1.585, p = 0.092). In patients with diabetes, it peaked in 2013 at 50.3% (APC:
2.494, p = 0.035) and then decreased to 45.2% by 2019 (APC: -1.634, p = 0.070).
Lastly, in patients with dyslipidaemia, it peaked in 2013 (47.9%) and then
decreased to 44.2% by 2017 (APC: -0.152, p = 0.847).
## Low-salt preference rate (type III)
Low-salt preference (type III) increased until 2013 and decreased thereafter. In
the general population, it peaked in 2013 at 13.2% (APC: 7.528, p = 0.009) and
then decreased to 10.4% by 2019 (APC: -3.422, p = 0.71). In patients with
hypertension, it peaked in 2013 at 16.3% (APC: 4.621, p = 0.011) and decreased
to 12.8% by 2019 (APC: -4.638, p = 0.037). In patients with diabetes, the low-
salt preference rate (type III) peaked in 2013 at 18.1% (APC: 4.761, p = 0.024)
and decreased to 13.7% by 2019 (APC: -3.634, p = 0.027). Although no consistent
rate was observed in patients with dyslipidaemia, a slight decrease was observed
from 14.2% in 2011 to 13.4% in 2017 (APC: -0.759, p = 0.603).
## Regional variations
Greater regional variations in low-salt preference were observed in major NCD
patients compared to the general population. In 2019, Seoul and Jeonnam had the
highest and lowest percentages of respondents who answered that they usually ate
bland or less salty food (24.3% and 18.3%, respectively; standard deviation
\[SD\]: 1.7%). For patients with diabetes, Jeju and Gyeongnam were the regions
with the highest and lowest percentages (30.1% and 20.8%, respectively; SD:
2.4%). Gwangju and Daejeon were the regions with the highest and lowest
percentages of the general population who answered that they did not add salt or
soy sauce at the table in the same year (77.0% and 54.1%, respectively; SD:
5.7%). Similar regional variations were observed in patients with hypertension:
Gwangju, 81.1%; Daejeon, 58.2%; SD, 5.8%. Jeonnam and Daegu were the regions
with the highest and lowest percentages of the general population who answered
that they did not dip fried food in soy sauce, at 55.8% and 23.6%, respectively
(SD: 8.0%). For patients with diabetes, Geonnam and Sejong were the regions with
the highest and lowest percentages (65.0% and 20.3%, respectively; SD: 11.4%).
With regard to the low-salt preference rate (type III), Seoul and Daegu were the
regions with the highest and lowest percentages, at 12.3% and 7.6%, respectively
(SD: 1.4%). In patients with diabetes, the regions with the highest and lowest
percentages were Jeonnam (17.0%) and Gangwon (8.6%), respectively (SD: 2.5%).
# Discussion
In this study, we investigated the low-salt preferences of major NCD patients
(e.g., hypertension, diabetes, and dyslipidaemia) from various angles and
compared them with those of the general population based on the relevant
datasets extracted from the Korea Community Health Survey. Data analyses
revealed that major NCD patients had a higher low-salt preference compared with
the general population; however, the difference was not statistically
significant. Despite an overall upward trend in low-salt preferences, the low-
salt preference rates of patients with different major NCDs and the general
population was gradually decreasing after peaking mainly in 2013; thus, the low-
salt preference rates leave much room for improvement. In addition, we found
greater regional variations in low-salt preferences among major NCD patients
compared to the general population. This finding highlights the need to prepare
a region-specific strategic approach to improve low-salt preferences.
Excess sodium intake is a risk factor for developing NCDs such as hypertension
and cardio-cerebrovascular disease, as well as alcohol use, smoking, and lack of
physical activity. Reducing sodium intake can contribute to reducing the
prevalence and mortality caused by these diseases. Low-salt preference is known
as an index reflecting individual’s attitudes and reactions to salty taste.
Therefore, low-salt preference influences an individual’s sodium intake
behaviour, such as the amount of salt that can be adjusted during the cooking
process or at the table, the frequency of eating out and consumption of instant
foods, and the amount of soup in the daily diet. The significance of this study
lies in the fact that it demonstrated the need to develop more effective
strategies for the formation of low-salt dietary habits in major NCD patients by
identifying the trend of low-salt preferences of major NCD patients using big
data from the Republic of Korea.
In this study, the low-salt preference of patients with major NCD was found to
be higher than that of the general population. From this finding, it can be
inferred that NCD patients were interested in a low-salt diet after being
diagnosed with NCDs, or that they received nutrition education in healthcare
facilities. However, no significant differences in low-salt preference were
observed between NCD patients and the general population, and the low salt
preference rates gradually decreased after peaking in 2013. In Republic of
Korea, the multicomponent national programs to reduce salt intake has been
steadily promoted since the 2010s. In particular, in 2012, a national plan was
established to reduce sodium intake. However, we estimated that this effect
appears to have gradually weakened. This highlights the need to establish and
implement more active interventions for a low-salt diet in NCD patients as well
as the general population.
More specifically, among the items used to determine a low-salt preference, NCD
patients showed higher rates for the item regarding the overall low-salt diet
preference (usually eating bland or less salty food) when compared to the
general population; however, the absolute value was lower than 30%. Sensitivity
and familiarity to salty taste is affected by the concentration of sodium in
foods that have been frequently exposed recently, to form the habit of eating
less salty food, efforts are needed to reduce the sodium content of the foods
provided at home, school, workplace, and at other places regularly visited. In
addition, efforts should be made to reduce the sodium content in convenience
foods and delivery foods whose consumption continues to increase due to the
coronavirus disease 2019 pandemic. Government-led policies to reduce sodium
intake through food service companies may be of great help in getting
individuals to comply with a low-salt diet. However, given the lack of publicity
for this policy and limited voluntary participation in the turnover-driven
foodservice industry, stronger measures (e.g., a sodium tax) are required.
Another noteworthy finding of this study is that the rate of not adding salt and
soy sauce at the table was higher than 70%. Since Korean food is mainly seasoned
with salt or soy sauce during cooking, sodium intake can be significantly
increased if it is added to the table. The high rate of a low-salt preference at
the table is a desirable trend because, according to the health belief model,
NCD patients recognise the severity of their diseases and make efforts to adhere
to a low-salt diet, which is reflected in their avoidance of using salt and soy
sauce. However, due to the low percentage of a low-salt preference (type III),
it may be inferred that they do not add salt or soy sauce at the table because
they usually eat sufficiently salted food. On the other hand, the rate of not
dipping fried foods in soy sauce was lower than 50%. Fried foods are served with
soy sauce because they are not strongly salted during cooking, and people tend
to dip them in soy sauce. Therefore, to promote a low-salt diet, it is necessary
to create a supportive environment such as educating cooks and foodservice
professionals on recipes that use less salt or providing publicity about the
importance of low-sodium diets for health.
It is also worth noting that greater regional variations were observed in low-
salt preference among NCD patients compared to the general population. This gap
may be attributable to the differences in disease prevalence, income level, and
medical resources from one region to another, but may also be associated with
sodium reduction policy programs run by local governments. Furthermore, it is
necessary to pay attention to various characteristics related to salt intake,
such as average temperature and diet, in order to explain these variations. Just
as there is variation in salt intake between countries, within a country, there
may be differences in salt intake or salt preference from region to region.
However, it is difficult to find studies examining which factors are most
strongly associated with these variations. In the future, it would be meaningful
to conduct studies to identify the causes of the regional differences in low-
salt preference among NCD patients and to narrow the regional gap. The findings
from these studies would ultimately contribute to resolving the regional
disparities in healthy life expectancy.
This study has three limitations. First, only the variables included in the raw
data were considered for the analysis because of the characteristics of the data
source. In particular, the incidence of NCDs was identified by self-report, and
the timing of diagnosis was unknown. In future research, it will be necessary to
follow changes in dietary behaviours before and after diagnosis of the disease
using other data sources such as panel data or patient cohort data. Second,
although various policies regarding sodium intake reduction have been put in
place in the Republic of Korea, their effects could not be examined in this
study. To more effectively promote a low-sodium diet, it is necessary to conduct
long-term follow-up studies that consider changes induced by such policies.
Third, this study included 13 patients with NCDs, including hypertension and
cardiovascular disease, which are closely associated with sodium intake.
However, given that patients with cancer (e.g., stomach cancer) are also
affected by a low-salt diet. The KCHS does not include a question asking whether
participants have cancer. In future research, it is necessary to examine the
health behaviours of cancer patients by using other data sources that include
cancer patients.
# Conclusion
The results of this study highlight the need to improve the low-salt preference
rate in patients with major NCDs as well as in the general population.
Specifically, it is necessary to consider expanding various low-salt policies
and programs such as education on a low-salt diet, salinity monitoring to create
a low-salt environment, certification for low-sodium restaurants, and sodium
tax. In these contexts, the low-salt preference rates among major NCD patients,
as determined in this study, will serve as baseline values for evaluating the
effectiveness of various low-salt policies and programs. These findings can also
be used as reference values for setting project targets. Therefore, it is
necessary to continuously monitor the low-salt preferences of patients with
major NCDs and the general population.
# Supporting information
10.1371/journal.pone.0276655.r001
Decision Letter 0
Mogi
Masaki
Academic Editor
2022
Masaki Mogi
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
14 Aug 2022
PONE-D-22-18808Comparison of low-salt preference trends and regional variations
between patients with major non-communicable diseases and the general
populationPLOS ONE
Dear Dr. Ock,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
==============================
Two reviewers well assessed this manuscript.However, there are still corrections
existed in the present form of the manuscript.
Read the suggestions carefully and respond them appropriately.
==============================
Please submit your revised manuscript by Sep 28 2022 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:A
rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.If you would like to make changes to your financial disclosure,
please include your updated statement in your cover letter. Guidelines for
resubmitting your figure files are available below the reviewer comments at the
end of this letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions see:
<https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>. Additionally, PLOS ONE offers an option for publishing peer-reviewed
Lab Protocol articles, which describe protocols hosted on protocols.io. Read
more information on sharing protocols at
<https://plos.org/protocols?utm_medium=editorial-
email&utm_source=authorletters&utm_campaign=protocols>.
We look forward to receiving your revised manuscript.
Kind regards,
Masaki Mogi
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2\. Thank you for stating in your Funding Statement:
"This work was supported by the Research Program funded by the Korea Disease
Control and Prevention Agency. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript."
Please provide an amended statement that declares \*all\* the funding or sources
of support (whether external or internal to your organization) received during
this study, as detailed online in our guide for authors at
[http://journals.plos.org/plosone/s/submit-
now. ](http://journals.plos.org/plosone/s/submit-now. ) Please also include the
statement “There was no additional external funding received for this study.” in
your updated Funding Statement.
Please include your amended Funding Statement within your cover letter. We will
change the online submission form on your behalf.
3\. Please review your reference list to ensure that it is complete and correct.
If you have cited papers that have been retracted, please include the rationale
for doing so in the manuscript text, or remove these references and replace them
with relevant current references. Any changes to the reference list should be
mentioned in the rebuttal letter that accompanies your revised manuscript. If
you need to cite a retracted article, indicate the article’s retracted status in
the References list and also include a citation and full reference for the
retraction notice.
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: I Don't Know
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: Dear Authors,
The article provides a good insight into the trends in low-salt preference and
regional differences in Korea among patients with the main non-communicable
diseases.
For a better understanding of the work, I have some suggestions:
Line 118.
Can the authors explain the background or give a reference why the 13 NCD listed
are the main ones?
Line 208:
To the reader who does not know Korea well, the names of the regions do not give
useful information.
Would it make sense to describe each region (in few words) background that could
influence salt consumption?
For example,
-a coastal region, traditionally lot of fish are consumed,…
-an inland region, …
-rural region... intensive urban region..
-a region where traditionally few meat is consumed...
Lines 234 235:
The low-salt preference rates of patients with different major NCDs and the
general population was gradually decreasing after peaking mainly in 2013
The trend is evident from figures 2,3,4,5, can you comment the reasons for the
trend?
Line 305:
In the title of the article you "regional variations" are "highlighted
Can you briefly comment the reasons for the differences in patient behavior
between regions?
Best regards.
Reviewer \#2: This study deals with an important issue within Korea as well as
worldwide. The study uses the results of a large survey to analyze trends over
time in the differences in low salt preference between major NCD patients and
the general population, and offers suggestions for future environmental
improvement and education. However, there are some concerns in this paper.
1\. Abstract: Result: The authors specifically describe the low salt preference
rate. Since the survey years for this study are 2008-2019, Please indicate the
year of the survey.
2\. Introduction: 87: The survey years are 2008-2017, but is it 2008-2019?
3\. Materials and methods: What is the size of The Korea Community Health
Survey? Please provide sample size information for each survey year.
4.Materials and methods: Participants: The authors do not include cancer as
Major NCD Patients, although they mention it in the study limitations. Why not
include cancer in this analysis?
In addition, since the results and discussion focus on hypertension, diabetes,
and dyslipidemia, it would be better to exclude other diseases. I think it would
be better to have the data of Fig2-Fug5 to grasp the overall trend of NCD, but I
feel it is difficult to confirm the data.
5.Results:178-179: “In the general population, it peaked in 2013 at 74.4% (APC:
-11.788, p-value: \<0.001)”. Isn't the APC value 11.788?
6.Results:184-185:Other NCD results are not mentioned in the results that
follow. If the relevant data set is not always available, then it may be
possible to remove it.
7\. Results:194:Please list the ACP values for 2013.
8\. Results:201:Please correct the p-value.
9\. Discussion: The low salt preference rate and the adherence rate of not
adding salt or soy sauce at the table have changed since 2013, but the reasons
for this have not been mentioned. Is there any possible reason for this change,
such as a change in the survey methodology, the selection method of the target
population, or a change in government policy policy regarding salt reduction?
10\. Discussion:260-261:“the reaction to a salty taste is influenced by the
sodium concentration in the food”. It would be helpful to the reader's
understanding if you could describe the specific impacts while presenting the
reports of the cited references.
11\. Discussion:260-261:Please describe in detail the contents of your education
to cooks and foodservice professionals.
12\. Disccussion:287-288:Please cite any reports showing that low-salt
preference is related to temperature.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0276655.r002
Author response to Decision Letter 0
23 Sep 2022
Reviewers' comments:
Reviewer's Responses to Questions
Comments to the Author
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: I Don't Know
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The PLOS Data policy requires authors to make all data underlying the findings
described in their manuscript fully available without restriction, with rare
exception (please refer to the Data Availability Statement in the manuscript PDF
file). The data should be provided as part of the manuscript or its supporting
information, or deposited to a public repository. For example, in addition to
summary statistics, the data points behind means, medians and variance measures
should be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: Dear Authors,
The article provides a good insight into the trends in low-salt preference and
regional differences in Korea among patients with the main non-communicable
diseases.
For a better understanding of the work, I have some suggestions:
Response: We really appreciate the careful and thorough review of this
manuscript and for the thoughtful comments and constructive suggestions, which
help to improve the quality of the manuscript. Our responses are as follows.
Line 118.
Can the authors explain the background or give a reference why the 13 NCD listed
are the main ones?
Response: Thirteen major types of NCD patients (hypertension, diabetes,
dyslipidaemia, stroke, myocardial infarction, angina, arthritis, osteoporosis,
asthma, allergic rhinitis, atopic dermatitis, cataract, and depression) were
defined as participants who responded clinically diagnosed from physicians in
the KCHS. We have revised the sentences (line 117-120).
Line 208:
To the reader who does not know Korea well, the names of the regions do not give
useful information.
Would it make sense to describe each region (in few words) background that could
influence salt consumption?
For example,
-a coastal region, traditionally lot of fish are consumed,…
-an inland region, …
-rural region... intensive urban region..
-a region where traditionally few meat is consumed...
Response: Thanks for the constructive suggestion. As suggested, we have added
regional characteristics of Republic of Korea, including sodium intake, as a
Supplemental file. Sentences that further research on regional variation are
needed have been added to the Discussion section (Line 292-297). However, we ask
for your understanding that we cannot cover various regional characteristics due
to data limitations.
Lines 234 235:
The low-salt preference rates of patients with different major NCDs and the
general population was gradually decreasing after peaking mainly in 2013
The trend is evident from figures 2,3,4,5, can you comment the reasons for the
trend?
Response: In Republic of Korea, the multicomponent national programs to reduce
salt intake has been steadily promoted since the 2010s. In particular, in 2012,
a national plan was established to reduce sodium intake. However, we estimated
that this effect appears to have gradually weakened. These contents were further
reinforced in the Discussion section (Line 256-259).
Line 305:
In the title of the article you "regional variations" are "highlighted
Can you briefly comment the reasons for the differences in patient behavior
between regions?
Response: As mentioned in the previous response, the need for additional studies
on regional variation was emphasized in the Discussion section (Line 292-297).
Reviewer \#2: This study deals with an important issue within Korea as well as
worldwide. The study uses the results of a large survey to analyze trends over
time in the differences in low salt preference between major NCD patients and
the general population, and offers suggestions for future environmental
improvement and education. However, there are some concerns in this paper.
Response: We really appreciate the careful and thorough review of this
manuscript and for the thoughtful comments and constructive suggestions, which
help to improve the quality of the manuscript. Our responses are as follows.
1\. Abstract: Result: The authors specifically describe the low salt preference
rate. Since the survey years for this study are 2008-2019, Please indicate the
year of the survey.
Response: In the Materials and methods section, we have already mentioned that
the Korea Community Health Survey is conducted annually (Line 110). The Korea
Community Health Survey results for each year were used for analysis.
2\. Introduction: 87: The survey years are 2008-2017, but is it 2008-2019?
Response: In the previous study (Reference number 10), the results of the Korea
Community Health Survey from 2008 to 2017 were analyzed to analyze health
behaviors, such as smoking and drinking, among major NCD patients. This content
is a description of prior study.
3\. Materials and methods: What is the size of The Korea Community Health
Survey? Please provide sample size information for each survey year.
Response: As suggested, we added information about sample size from the Korea
Community Health Survey to the Materials and methods section (Line 113-114).
4.Materials and methods: Participants: The authors do not include cancer as
Major NCD Patients, although they mention it in the study limitations. Why not
include cancer in this analysis?
Response: Unfortunately, the Korea Community Health Survey does not include a
question asking whether participants have cancer. We emphasize this point
further in the part on limitations in the Discussion section (Line 312-314).
In addition, since the results and discussion focus on hypertension, diabetes,
and dyslipidemia, it would be better to exclude other diseases. I think it would
be better to have the data of Fig2-Fug5 to grasp the overall trend of NCD, but I
feel it is difficult to confirm the data.
Response: As you know, among various NCDs, hypertension, diabetes, and
dyslipidemia are important diseases that act as risk factors for other diseases.
Also, these diseases have a higher prevalence than other diseases. So, Figure 1
focused on hypertension, diabetes, and dyslipidemia. In addition, a Supplemental
file 1 is attached so that readers can check the specific values for each
disease.
5.Results:178-179: “In the general population, it peaked in 2013 at 74.4% (APC:
-11.788, p-value: \<0.001)”. Isn't the APC value 11.788?
Response: As you pointed out, this is a typo. We have corrected that value (Line
182).
6.Results:184-185:Other NCD results are not mentioned in the results that
follow. If the relevant data set is not always available, then it may be
possible to remove it.
Response: As suggested, we have deleted that sentence.
7\. Results:194:Please list the ACP values for 2013.
Response: It has a single APC with respect to its content. That is, the APC is
-0.152.
8\. Results:201:Please correct the p-value.
Response: We have modified the p-value (Line 202).
9\. Discussion: The low salt preference rate and the adherence rate of not
adding salt or soy sauce at the table have changed since 2013, but the reasons
for this have not been mentioned. Is there any possible reason for this change,
such as a change in the survey methodology, the selection method of the target
population, or a change in government policy policy regarding salt reduction?
Response: In Republic of Korea, the multicomponent national programs to reduce
salt intake has been steadily promoted since the 2010s. In particular, in 2012,
a national plan was established to reduce sodium intake. However, we estimated
that this effect appears to have gradually weakened. These contents were further
reinforced in the Discussion section (Line 256-261).
10\. Discussion:260-261:“the reaction to a salty taste is influenced by the
sodium concentration in the food”. It would be helpful to the reader's
understanding if you could describe the specific impacts while presenting the
reports of the cited references.
Response: As suggested, we revised the sentence (line 265-266).
11\. Discussion:260-261:Please describe in detail the contents of your education
to cooks and foodservice professionals.
Response: The content of the sentence you pointed out has been modified to be
more specific (Line 286-287).
12\. Disccussion:287-288:Please cite any reports showing that low-salt
preference is related to temperature.
Response: We have corrected the sentence and added a sentence that additional
research on regional variation is needed (Line 292-297).
6\. PLOS authors have the option to publish the peer review history of their
article (what does this mean?). If published, this will include your full peer
review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
Do you want your identity to be public for this peer review? For information
about this choice, including consent withdrawal, please see our Privacy Policy.
Reviewer \#1: No
Reviewer \#2: No
10.1371/journal.pone.0276655.r003
Decision Letter 1
Mogi
Masaki
Academic Editor
2022
Masaki Mogi
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
12 Oct 2022
Comparison of low-salt preference trends and regional variations between
patients with major non-communicable diseases and the general population
PONE-D-22-18808R1
Dear Dr. Ock,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Masaki Mogi
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
The authors well responded to the Reviewers' comments.
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
Reviewer \#2: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: Dear Authors,
Thanks for the comments and inclusion of reccomendations.
I wish you successful further research work.
Best regards
Reviewer \#2: (No Response)
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: No
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
10.1371/journal.pone.0276655.r004
Acceptance letter
Mogi
Masaki
Academic Editor
2022
Masaki Mogi
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
17 Oct 2022
PONE-D-22-18808R1
Comparison of low-salt preference trends and regional variations between
patients with major non-communicable diseases and the general population
Dear Dr. Ock:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Masaki Mogi
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Diffusion kurtosis imaging (DKI) is a new in vivo method for diffusion imaging
that originated from diffusion tensor imaging (DTI). DTI provides a way for
probing the microstructure of biological tissues by measuring the diffusion
coefficient of water molecules using Gaussian models. Gaussian models can only
be used to depict free diffusion processes. However, water diffusion in
biological tissues is normally restricted, which constitutes the basis of DTI
tractography, and therefore is not exactly Gaussian. To address this self-
contradiction, DKI is proposed to model the Gaussian coefficient of diffusion as
well as the deviation from the Gaussian model, thereby providing new insights
into the microstructures,,. DKI has already been successfully used in
a wide range of clinical studies, including studies in Parkinson’s disease,
Huntington’s disease, epilepsy, aging, attention deficit hyperactivity disorder
and cerebral gliomas.
DTI data are composed of baseline images without applying a diffusion gradient
and a series of diffusion-weighted (DW) images with diffusion gradients applied
along different directions. Typically, DW images are acquired at one b-value,
which is an index calculated based on the strength and duration of the diffusion
gradient field, and the interval between the two opposite gradients. The
diffusion coefficient along a certain direction can be calculated using the
following equation: $$\text{S}_{\text{n}} = S_{0}\exp( - bD_{n})$$ where
*S*<sub>*0*</sub> is the baseline signal, *S*<sub>*n*</sub> is the DW image
acquired with diffusion gradient along the n<sup>th</sup> direction, b is the
b-value of the applied diffusion gradient and *D*<sub>*n*</sub> is the diffusion
coefficient along the n<sup>th</sup> direction. To construct a diffusion tensor,
at least seven DW measurements are needed, including a baseline image.
In DTI, only one DW image is needed for each direction. However, DKI requires
multiple DW images at different b-values along each direction. DKI uses the
following equation to depict the change of the signal intensity with respect to
b-values: $$S_{n}(b) = S_{0}\exp( - bD_{n} + b^{2}D_{n}^{2}K_{n}/6)$$ where
*S*<sub>*0*</sub>, *S*<sub>*n*</sub>, b, and *D*<sub>*n*</sub> remain the same
as in *Eq*., and *K*<sub>*n*</sub> is the kurtosis coefficient, which depicts
the deviation from a Gaussian model. For each direction, both *D*<sub>*n*</sub>
and *K*<sub>*n*</sub> can be calculated by curve fitting using the baseline
image and the corresponding DW images. Then mean diffusion (MD) and mean
kurtosis (MK) values can be calculated by averaging the *D*<sub>*n*</sub> and
*K*<sub>*n*</sub> along each direction. The MD and MK can also be calculated
from diffusion and kurtosis tensor respectively, which are reconstructed using
*D*<sub>*n*</sub> and *K*<sub>*n*</sub> along all directions. The two methods
generate similar MD and MK values, while the direct averaging method makes no
restriction on the number of diffusion gradient directions and therefore is more
efficient in computation.
To profile the kurtosis deviation, a typical DKI setting would employ the
maximum b-value from 2000 to 2500 s/mm<sup>2</sup>, which is much higher than
the 1000 s/mm<sup>2</sup> that is typically used in DTI. DW images in a DKI
dataset therefore often suffer from heavier noise, resulting in low signal-to-
noise ratios (SNR) at these higher b-values. The noise, which is Rician,,
in turn, may significantly affect the reliability of parameter estimation. A
previous study showed that Rician noise in DW images may lead to significant
overestimation of the kurtosis coefficients.
Various denoising methods have been developed to improve the quality of DW
images, such as the Gaussian filter,, anisotropic diffusion filter,,
, linear minimum mean squared error filter, and non-local means (NLM)
filter. The NLM filter outperforms most other filters in both denoising and edge
preserving, and thus has been used extensively in magnetic resonance (MR) image
denoising,. While DW images are often denoised on an image-wise basis,
correlation between DW images should also be exploited, as it contains spatial
cues of the imaging data. Wiest et al. proposed a vector non-local means (VNLM)
filter based on the NLM filter for denoising DTI data. It bundles all DW images
in a DTI dataset into a vector image and applies NLM to denoise it as one whole
entity.
To identify the best denoising algorithm among the existing algorithms or to
further tailor them for treating a specific type of image, a method to assess
their performance is required. Both visual,, and quantitative,,
comparisons can be used for this purpose. In a visual comparison, a good
denoising algorithm should have (1) minimized image noise; (2) preserved image
details; and (3) introduced no artifacts. Quantitative comparisons often use
noise-free images as ground truth, to which noise of a known distribution is
added for simulating phantom data for testing purposes. In this way, a denoised
image can easily be compared quantitatively with the ground truth. Because DTI
and DKI contain high dimensional information in each voxel, ground truth based
on the maps of diffusion-derived parameters is often favorable for evaluating
the performance of denoising algorithms for diffusion imaging data. In previous
studies of DTI denoising, DTI phantoms were constructed for denoising DTI data
by evaluating the reliability of estimating DTI-derived parameters.
However, to the best of our knowledge, no such phantom has been reported for DKI
denoising, although various DKI schemes were previously evaluated systematically
using a specifically designed simulation dataset of diffusion parameters.
To evaluate how denoising algorithms can affect the precision of DKI parameter
estimation, we developed a pipeline for constructing DKI phantoms and
consequently created a DKI phantom from real brain data. We used it to
quantitatively evaluate NLM and two different VNLM schemes. The first VNLM
scheme combined DW images at the same b-value as a vector whereas the second
combined DW images along the same diffusion gradient direction as a vector. We
conducted evaluations using our phantom to check which VNLM performs the best.
# Materials and Methods
## Materials
This study was approved by the Institutional Ethics Committee of East China
Normal University. Four local volunteers were recruited to the study and
informed written consents were obtained from all these volunteers. A 12-channel
head coil was used in data acquisition. DKI data from the volunteers were
collected on a 3T Siemens Trio system (maximum gradient strength = 40 mT/m,
maximum slew rate = 200 mT/m/ms). A bipolar single-shot EPI sequence was used
for DW image acquisition to minimize the eddy current artifacts. Dataset 1,
which contained DKI data from one volunteer, was acquired using conventional
acquisition parameters for DKI data, with DW images at 6 b-values (0, 500, 1000,
1500, 2000, 2500 s/mm<sup>2</sup>) along 30 diffusion gradient directions, 35
slices, NEX = 2 (averaged in image domain), spatial resolution = 2 × 2 × 3
mm<sup>3</sup>, FOV = 256 × 256 mm<sup>2</sup>, acceleration factor of parallel
imaging = 2 (GRAPPA). The other parameters were: TR / TE = 6000 ms / 112 ms,
diffusion time Δ = 39.1 ms, and diffusion gradient duration δ = 37.5 ms. The
diffusion time Δ here is defined not exactly the same as that in standard
Stejskal–Tanner (monopolar) sequence because we used the bipolar single-shot EPI
sequence here, while Δ has been calculated according to the conventional
expression b = -(γGδ)<sup>2</sup> (Δ – δ/3). The acquisition time was 30 min 32
sec. Thirty extra baseline images (therefore a total of 32 baseline images) were
collected for generating one baseline image of high SNR. This dataset was later
used for DKI phantom construction. Dataset 2 contained DKI data from the other
three volunteers that were acquired with slightly different parameters. DW
images were collected along 12 / 12 / 20 diffusion gradient directions, TR =
6100 / 12000 / 5300 ms, TE = 114 ms, Δ = 40.1 ms, δ = 38.5 ms, 35 / 40 / 40
slices, and NEX = 1. The other parameters were the same as those used for
Dataset 1. In addition, we applied physical constraints to the participants
during the data acquisition, and screened the acquired data afterwards to
prevent motion-induced artifacts. All the raw data are available at
<http://pan.baidu.com/s/1ntMD68x#path=%252F>.
## DKI Phantom Construction
Because no noise-free DKI image is readily available as ground truth, we
developed a pipeline to construct a DKI phantom based on a real DKI dataset of
the human brain.
The process consists of 8 steps: **(1)** denoise each DW image (non-brain region
was removed through the BET tool of FSL (<http://www.fmrib.ox.ac.uk/fsl/>))
using a 3D UNLM filter (see next subsection) after eddy current correction and
motion correction using ACID Toolbox (<http://www.diffusiontools.com>); **(2)**
average the DW images from repeated scans; **(3)** estimate D and K value maps
for each gradient direction using *Eq*.; **(4)** apply 3D Gaussian filter to D
maps using a Gaussian kernel of 2 mm *full-width-at-half-maximum* (FWHM), and
consequently obtain D’; **(5)** recalculate K’ with obtained D’ using *Eq*.;
note that in step 4) and 5), we do not directly smooth K but recalculate K using
a smoothed D as the noise in the D map may significantly influence K estimation,
especially for voxels with small D values; **(6)** reconstruct diffusion tensors
and kurtosis tensors using the D’ and K’ maps of all gradient directions, and
the tensor data were then used to recalculate D and K maps, which are denoted by
D” and K” respectively; **(7)** use D”, K” and baseline image to calculate DW
images with nonzero b-values (again, using *Eq*.) which forms our noise-free DKI
phantom; **(8)** add noise to the noise-free phantom, Rician noise can be added
using *Eq*.: $$I_{n} = \sqrt{{(I + n_{1,\sigma})}^{2} + n_{2,\sigma}^{2}}$$
where *n*<sub>*1*,*σ*</sub> and *n*<sub>*2*,*σ*</sub> are both Gaussian
distributed noise with standard deviation of *σ*. A fixed *σ* is used for all DW
images when noises are added. A discussion on noise adding can be found in
Section of Discussion and Conclusion.
## Non-Local Means (NLM) Filter Family
NLM is a spatial domain filter that replaces each pixel *P(i)* in the image with
a weighted average of every pixel *P(j)* in its “search region” *Ω*: $$NLM(P(i))
= Z_{0}{\sum\limits_{\forall j \in \Omega}{\omega(i,j)P(j)}}$$ where
*Z*<sub>*0*</sub> is the normalization coefficient, defined as:
<img src="info:doi/10.1371/journal.pone.0116986.e005" id="pone.0116986.e005g" />
Z
0
=
1
/
∑
∀
j
∈
Ω
ω
(
i
,
j
)
The weight *ω(i*,*j)* assigned to *P(j)* is based on the weighted Euclidean
distance *d* between the neighborhoods of pixels *i* and *j*, named
*R*<sub>*f*</sub>*(i)* and *R*<sub>*f*</sub>*(j)* respectively: $$d(i,j) =
G_{\rho}\left\| {R_{f}(i) - R_{f}(j)} \right\|^{2},(i \neq j)$$ $$\omega(i,j) =
\exp( - d(i,j)/h^{2}),(i \neq j)$$ where *h* is a parameter that controls the
degree of smoothing and is normally set proportionally to the standard deviation
of noise. *G*<sub>*ρ*</sub> is a Gaussian kernel of standard deviation *ρ*. In
theory, the search region *Ω* in *Eq*. can cover the whole image (thus non-
local). However, a limited radius t is commonly adopted with regard to
computational efficiency,. When calculating the weight of the center pixel
itself, the distance is simply set to the minimum distance found in the search
region.
Similar to other weighting average filters, larger weights are assigned to
pixels with higher similarity. NLM is unique in that it uses the distance
between neighborhoods of pixels instead of the distance between pixels
themselves. Thus, it can make use of redundant information in texture patterns
in the image for robust denoising.
Manjόn and his colleagues proposed an unbiased non-local means (UNLM) filter to
correct the gray level bias introduced by Rician noise that is typical in MR
images. UNLM subtracts the bias from the NLM filtered image, which can be
expressed as: $$UNLM(P(i)) = \sqrt{{(NLM(P(i)))}^{2} - 2\sigma_{r}^{2}}$$ where
*σ*<sub>*r*</sub> denotes the standard deviation of Rician noise. In this work,
all algorithms involved in the comparison use bias subtraction as in UNLM.
Wiest et al. proposed the VNLM filter to denoise the DTI dataset. As previously
mentioned, DTI acquires DW images using at least six different diffusion
directions. VNLM groups these images into a vector image and denoises the vector
image as a whole. Therefore, the distance in NLM is redefined as the distance
*d*<sub>*v*</sub> between neighborhoods of two vectors: $$d_{\nu}(i,j) =
G_{\rho}{\sum\limits_{\nu = 1}^{V}\left\| {R_{f,\nu}(i) - R_{f,\nu}(j)}
\right\|}^{2}/V,(i \neq j)$$ where *v* and *V* denote the index and total number
of DW images, respectively.
We realize that when VNLM is applied to DKI dataset, there are two different
ways to combine DW images into vector images. One is to combine images of the
same b-value but of different directions of diffusion gradient as a vector
(VNLM-b), and the other is to combine images of the same direction of diffusion
gradient, but of different b-values (VNLM-d).
When applying NLM to MRI, Coupe et al. extended it to 3D, in which both the
neighborhood window and the search region become cubes centered at the pixel in
concern. While this makes better use of the redundant structure information in
the 3D MRI data, parameters of the 3D NLM filter should be carefully set for
balancing the denoising effect and computational efficiency.
# Experiments and Results
We adopted 3D NLM-based filters in the evaluation. Regarding the parameter
setting, previous work showed that no significant improvement can be achieved
with a search region greater than 11 × 11 = 121 pixels for a 2D NLM filter, and
using a larger search region will significantly increase computational time.
Thus, we adopted a 5 × 5 × 5 search region (125 voxels in 3D instead of 121 in
2D case), which is the same parameter used in previous work. In addition, a 3 ×
3 × 3 neighborhood window was employed in our work. A neighborhood window of
such a size is common in 3D NLM processing,, which is normally smaller than
the search region. The parameter *ρ* was set to commonly used value 1.0. The
value of the parameter h for NLM, VNLM-b, and VNLM-d was set to 1.0*σ*, 0.8*σ*,
and 1.2*σ* respectively according to their optimal performance based on an
exhaustive search. The search result of NLM agrees with those in previous
reports. The standard deviation of noise *σ* in real data was calculated
from a background region of the image. Assuming that the signal in the
background region consists of only Rician noise, *σ* can be estimated from:
$$\sigma\text{=}\sqrt{\mu/2}$$ where *μ* is the mean value of squared signal
intensity in the background region. A discussion on noise estimation can be
found in Section of Discussion and Conclusion.
We used Mean Square Error (MSE), Bias and standard deviation (Std) for
quantitative comparison of the denoising methods, which reflect precision and
accuracy of the denoising methods by their definitions: $$MSE =
\frac{1}{N}{\sum\limits_{i}^{N}{(I_{i} - Q_{i})}^{2}}$$ $$Bias =
\frac{1}{N}\left\| {\sum\limits_{i}^{N}{I_{i} - Q_{i}}} \right\|_{1}$$
$$\text{Std} = \sqrt{\frac{1}{N}{\sum\limits_{i}^{N}{(I_{i} -
\frac{1}{M}{\sum\limits_{\text{j}}^{M}I_{j}})}^{2}}}$$ where *I* and *Q* denote
noise-free and denoised image respectively, and *N* is the number of voxels. The
MSE, Bias and Std are calculated only in the brain region.
## DKI Phantom Construction
We created a DKI phantom from Dataset 1 using the aforementioned process.
Compared with the original images, the constructed phantom is visually cleaner.
In the phantom, noise is successfully suppressed, and anatomical structures are
well preserved.
## Filter Comparison with DKI Phantom
We compared the three NLM-based denoising algorithms mentioned earlier, NLM,
VNLM-b and VNLM-d. First, five different levels of Rician noise (with standard
deviations at 5, 10, 15, 20, 25) were added to DW images of the noise-free
phantom. The resulting SNRs are different for DW images with distinct b-values,
which are approximately 60, 30, 20, 15, 12 for baseline image (b = 0), or 12, 6,
4, 3, 2 for DW images with b = 2500 s/mm<sup>2</sup>. The noise-corrupted images
were then denoised using the three filters, and results were evaluated both
visually and quantitatively using the phantom and real dataset. Quantitative
comparisons can be performed in multiple ways. For example, the denoised DW
images can be compared with phantom DW images by calculating the MSE between
them. Parameter maps calculated from denoised DW images can also be compared
with those of the phantom. The latter approach allows a more comprehensive
assessment of the filters with respect to parameter evaluation and should be
favored in cases like DKI, in which producing a reliable parameter map is often
the target of denoising. In this study, MD and MK maps, which were calculated by
averaging D and K maps respectively along all diffusion gradient directions, are
used to evaluate the denoising results. For robust statistical results, we
repeated the above process that adds noise, denoises, and conducts performance
evaluation for 500 times.
The quantitative comparison of MD and MK maps shows that VNLM-d filter achieves
lower MSE, Bias and Std than the original NLM and VNLM-b filters at almost all
noise levels. Moreover, the MSE, Bias and Std values of MK produced by the
VNLM-d filter increase most slowly with the increase of noise level. When
standard deviation of noise reaches 25, the MSE, Bias and Std values from the
VNLM-d filter are only 40.6% (MSE), 10.9% (Bias) and 60.6% (Std) respectively of
those from the NLM filter.
Meanwhile, it is interesting that comparing with the other two filters, the
VNLM-d filter shows equivalent or even poorer performances concerning MSE and
Std of the denoised DW images, which is contrary to its good performance for MD
and MK maps as discussed above.
A similar conclusion can be drawn from visual comparison. For MK maps, results
from these three filters have different visual appearances. MK maps of NLM and
VNLM-b filters contain black holes, which represent incorrectly estimated
voxels,. The MK map from VNLM-d filter is almost free of black holes and
has a consistent visual appearance with the phantom MK map (see middle row of).
Moreover, the DW image denoised by the VNLM-d filter show clearer those finer
structural details than do those denoised by NLM and VNLM-b filters (see upper
row of). The VNLM-d filter produces visually satisfying results even for low
SNR DW images acquired with b = 2500 s/mm<sup>2</sup>.
## Denoising of Real dataset
To further validate the observation obtained from the phantom dataset, we also
applied the NLM, VNLM-b and VNLM-d algorithms to Dataset 2 and evaluated the
results for their performance. The parameters to these algorithms were set the
same as described previously.
Visual comparison of the real dataset has revealed an impression similar to the
information shown from the simulation data. While all filters can significantly
reduce noise in the DW images and parameter maps, VNLM-d produces DW images with
clearer brain structure and MK map with fewer black holes for all three
volunteers. In addition, we may see that the MK map provides microstructural
information in gray matter, which is not visible in MD or fractional anisotropy
(FA) maps of diffusion tensor imaging model.
# Discussion and Conclusion
In this work, we propose a processing pipeline for constructing DKI phantoms
using datasets of real human brains. The pipeline produces a high-SNR DKI
phantom with clear image structure that can be used as ground truth for
evaluation of DKI denoising methods. In addition, the proposed pipeline can also
be used to generate a DKI dataset with a customized combination of b-values and
diffusion gradient directions, different from those used in acquisition. This
flexibility will be useful to evaluate the performance of various DKI
acquisition schemes, such as 3-b-value fast scheme and also non-uniform schemes
with different gradient directions at each b-value. For these purposes, after
the diffusion tensors and kurtosis tensors have been calculated in step (6), we
can first apply a customized gradient table to recalculate D and K maps at the
specified directions. DW images with desired b-values can then be calculated
with D, K maps and baseline images using *Eq*..
We should pointed out that Rician noise was used in step (8), because magnitude
of MR signal is intrinsically corrupted by Rician noise, which is a model
frequently adopted in MRI denoising and parameter estimation studies,.
Nevertheless, the potential use of our DKI phantom is not limited to removal of
Rician noise, as discussed above.
Furthermore, we quantitatively evaluated three NLM-based denoising algorithms
using the constructed phantom. The simulation based on our phantom indicates
that VNLM-d outperforms NLM, and the VNLM-b algorithms, generating more reliable
MK and MD maps, with the lowest MSE, Bias and Std values for most of the noise
levels. Visual comparison of these filters using a real dataset produces results
consistent with this conclusion. While compared with the other methods, VNLM-d
algorithm produces DW images with equal or higher MSE and Std. This can be
explained by the fact that VNLM-d tends to smooth more conservatively the
structure in gray matter regions of the DW images. This lowers the level of
image denoising but preserves more fine structures (Figs.) which are helpful in
the following parameter evaluation process. Thus, it yields less black hole
effects and preserves structure better in MK maps.
We think the good performance of VNLM-d filter can be attributed to the reason
that the DKI parameter is calculated from diffusion decay curve, which means
similar shape of the decay curves generate similar DKI parameters. VNLM-d filter
treats DW images of different b-values at one direction as a unit in similarity
calculation, thus voxels with similar decay curves, which means similar DKI
parameters, tend to contribute more in the weighted average process. This
efficiently exploits the similarity of DKI parameters.
The structural preserving ability of VNLM-d filter may be attributed to the
higher level of structural similarities between DW images, because VNLM is
effective only when images with similar structures are grouped together, which
have similar weights for averaging. We found DW images along the same direction
but at different b-values (column b and c) generally demonstrate higher
similarities than do the DW images acquired at the same b-value but along
different directions (column a and b). Although the voxel intensities of DW
images at the same b-values fall in a similar value range and are therefore more
consistent with one another, it is the similarity between structures that leads
to the superior performance of VNLM.
To further improve this work, several considerations can be taken into account.
Firstly, DW images are often acquired with partial Fourier techniques, which can
produce correlation between noises in neighboring pixels. This may present a new
challenge to the denoising algorithms because many algorithms make an assumption
of non-correlated noise. Despite of this, NLM filter has already been
successfully applied to denoising DW images. This is understandable since
when NLM calculates the weighted average to denoise a pixel, it considers the
similarity between the neighborhood window of this pixel and those of the
contributing pixels. The correlation between noises in neighboring pixels does
not necessarily lead to similar neighborhood of these pixels, thus NLM filters
are more robust to process correlated noise. Recently, NLM filter has also been
improved to address correlated noise, and it is also suggested that
denoising filter be used before partial Fourier reconstruction is carried out to
avoid correlated noise. Incorporating these results into our work may produce
better results.
Secondly, in the procedures of adding and estimating noise, we assumed that the
levels, spatial and statistical distributions of noise are all the same for all
DW images at different b-values and along different diffusion gradient
directions, which has been a commonly adopted hypothesis in previous studies
. However, this assumption may become invalid in certain cases. For example,
the eddy current and off-resonance effects in a DWI sequence may potentially
affect the noise, and these effects may substantially vary with b-value and
diffusion gradient direction. In addition, the spatial and statistical
distribution of noise can also be affected by the use of multi-element surface
coils and parallel imaging. For example, the noise distribution of parallel
imaging is associated with a geometry factor (g-factor), which depends on coil
geometry, phase-encoding direction and its acceleration factor. Thus, to
more accurately evaluating the effects of simulating and estimating the noise in
DW images, we must do a more careful simulation and inspect the influences that
may be imposed by these factors. Limited by the length of this paper, and
considering that this paper’s focus on reporting the general framework of
providing a DKI phantom system, we decided not to pursue it in this study but to
include it in our next step work.
Thirdly, motion artifacts, eddy current and geometrical distortion are major
challenges in preprocessing of diffusion imaging data. Navigator based methods
can be used to minimize motion artifacts prospectively. Multi-shot EPI or
fast spin echo sequences can also be used to reduce geometry distortion due to
susceptibility changes at tissue interfaces. Thus these methods should be
considered in our further work to improve the quality of DKI estimation. In our
constructed phantom data, signal dropout can be found in medial frontal and
bilateral gray matter. We think this can be attributed to individual variations
that this particular individual happened to introduce some motion between the
averages of data, and consequently motion artifacts. Retrospective Motion
correction may not completely eliminated these artifacts.
[^1]: Author Xu Yan is employed by a commercial company, Siemens Healthcare,
was a MR collaboration scientist doing technique support in this study under
Siemens collaboration regulation without any payment and personal concern
regarding to this study. All other authors declare no conflict of interest.
There are no patents, products in development or marketed products to
declare. This does not alter the authors’ adherence to all the PLOS ONE
policies on sharing data and materials.
[^2]: Conceived and designed the experiments: MZ XY GY. Performed the
experiments: XY HZ. Analyzed the data: MZ XY. Contributed
reagents/materials/analysis tools: MZ XY HX HZ. Wrote the paper: MZ XY GY
DX.
|
# Introduction
The ubiquitously expressed non-receptor protein-tyrosine phosphatase (PTP1B)
plays an important role in regulating diverse cellular signaling pathways,
including those initiated by receptor tyrosine kinases (RTKs), cytokine
receptors, integrins and cadherins. Major insights into the physiological role
of PTP1B were gained through the generation of knockout (KO) mice, which showed
that PTP1B is a critical regulator of insulin sensitivity and energy balance *in
vivo*. However, other functions for PTP1B have also been suggested, including
roles in regulating cell-matrix and cell-cell, interactions. Given the salutary
metabolic effects of PTP1B deletion, it has emerged as a potential target for
anti-diabetic and anti-obesity drug development. Consequently, it is important
to understand its mechanism of action in detail.
PTP1B is anchored to the cytosolic face of the endoplasmic reticulum (ER) via a
hydrophobic C-terminal targeting sequence, which constrains its access to key
substrates. Consistent with this localization, PTP1B dephosphorylates the
activated epidermal growth factor receptor (EGFR), platelet-derived growth
factor receptor (PDGFR) and insulin receptor (IR) only after endocytosis, as
they transit past the ER. PTP1B activity also is spatially regulated in the
cell, thus creating distinct microenvironments that enable RTK signal
propagation, followed by signal termination. Recently, PTP1B has been identified
as a potential regulator of RTK endocytosis. Eden *et al.* reported that
PTP1B-EGFR interaction occurs through direct membrane contact between
multivesicular bodies (MVB) and the ER, with PTP1B activity promoting the
sequestration of EGFR to MVB internal vesicles. Consistent with these findings,
Stuible *et al.* identified the endosomal protein STAM2, which regulates sorting
of activated RTKs for degradation, as a PTP1B substrate. Collectively, these
studies reveal that PTP1B is a major regulator of RTK endocytosis and signaling.
Although activated RTKs gain access to PTP1B only after endocytosis, PTP1B also
can interact with some plasma membrane (PM)-bound substrates. For example,
PTP1B targets forming cell-matrix adhesion contacts and contributes to the
stabilization of focal adhesions. This process appears to involve dynamic
extension of the ER via a microtubule-dependent process. PTP1B also can access
substrates at points of cell-cell contact, although how these interactions are
regulated remains largely unexplored. In the present study, we assess the
dynamics of PTP1B mobility and investigate its spatial-temporal regulation of
signaling at regions of cell-cell contact. Through the combined use of PTP1B
mutants, advanced cell imaging and mathematical modeling, we show that ER-
anchored PTP1B can reach PM-localized substrates, but only at regions of cell-
cell contact. These studies strongly suggest that the ER is structured and
polarized towards cell-cell junctions, and identify these PM-proximal sub-
regions of the ER as important sites of cellular signaling regulation by PTP1B.
# Results
## PTP1B Substrate-trapping Mutant Localizes to Regions of Cell-cell Contact
We transiently expressed green fluorescent protein (GFP)-tagged wild type (WT)
PTP1B and its “substrate-trapping” mutant D181A (D/A), which retains substrate-
binding but is catalytically impaired, in PTP1B-null fibroblasts, and monitored
their sub-cellular localization using confocal microscopy. Consistent with
previous reports, each localized to the ER network. However, PTP1B D/A, but not
PTP1B WT, also accumulated at regions of cell-cell contact, labeled using anti-β
catenin antibodies. Studies using another PM marker, Cherry-tagged G protein-
coupled receptor 43 (Grp43-Cherry), confirmed that PTP1B D/A accumulated at
regions of cell-cell contact in live cells (lower panel). Quantification of
fluorescence intensity showed that about 10–15% of total cellular PTP1B D/A was
found at cell-cell contacts. Similar findings were obtained using Cos-7, MDCK,
293T cells and 3T3-L1 preadipocytes (data not shown).
## The ER Extends to Regions Proximal to PM at Cell-cell Contacts
These observations raised the question of how an ER-bound PTP might access
substrates on or near the PM at regions of cell-cell contact. In platelets,
PTP1B can be cleaved by calpain to release an active cytosolic fragment.
However, serial confocal images of tissue culture cells expressing PTP1B
D/A-GFP, acquired at successive focal planes, revealed a “honeycomb” pattern at
regions of cell-cell contact which is characteristic of the reticular structure
of the ER and consistent with its extension to these regions. Experiments in
which PTP1B D/A was co-expressed in MDCK cells with the general ER marker,
stress-related ER protein (SREP), confirmed that the ER extends out to the PM at
regions of cell-cell contact (arrows). Comparable results were obtained when
PTP1B D/A was co-expressed with a marker (Sec61) for rough ER. Exposure of cells
to pervanadate, which oxidizes the essential cysteinyl residue found at the
catalytic center of PTPs, abolished the localization of PTP1B D/A at cell-cell
contacts without altering its ER localization (or that of PTP1B WT in the ER).
The latter findings indicate that PTP1B D/A enrichment at regions of cell-cell
contact is mediated by interactions with one or more substrate(s).
Electron microscopy using immunogold-coupled anti-human PTP1B (FG6) antibodies
revealed labeling of PTP1B D/A in the ER, providing direct evidence that PTP1B
resides in this compartment (arrows, left image). Prominent labeling also was
detected at regions of cell-cell contact (, right image and inset), where four
adjacent membranes were evident: two inner “thick” membranes (arrowheads)
corresponding to the PMs of adjacent cells and two flanking “thinner” membranes
(arrows), corresponding to the ER. The few gold particles that appeared to label
the PM probably reflect the antigen-gold particle linker distance: because PTP1B
should be separated from the gold particle by the distance of the antibody
molecule in three dimensions, the particle can lie directly over PTP1B or up to
10 nm away. No significant labeling was detected in PTP1B-null fibroblasts,
confirming the specificity of the immunogold labeling. To ask whether the
observed proximity of ER to PM at regions of cell-cell contact is caused by
PTP1B D/A expression, we performed routine EM and high resolution cryo-EM on
vitreous sections from HeLa cells. These studies confirmed that the ER is in
close proximity to the PM at regions of cell-cell contact even in the absence of
PTP1B D/A. Collectively, these studies show that the ER is in close proximity to
the PM at regions of cell-cell contact and that ER-anchored PTP1B engages
substrate(s) at these locations.
## PTP1B Mobility on ER Membranes
To determine how an ER-bound phosphatase accesses PM substrate(s) at regions of
cell-cell contact, we examined the mobility of PTP1B fused to photoactivatable
GFP (PhAc), which can be used to mark a population of molecules in a region of
interest and track them over time in live cells. PTP1B WT-PhAc and PTP1B
D/A-PhAc were transiently co-expressed in PTP1B-null cells with the
corresponding RFP-tagged PTP1B, which served as a general ER marker and helped
to identify transfected cells. Prior to photoactivation, no significant
fluorescence attributable to PTP1B-PhAc (excitation at 488 nm) was detected.
Photoactivation (excitation at 413 nm) of selected regions resulted in pools of
PTP1B WT or PTP1B D/A that became highly fluorescent upon excitation at 488 nm.
Continuous imaging of the photoactivated pools revealed rapid, non-directional
movement of PTP1B WT throughout the ER, with fluorescence intensity increasing
gradually at regions distal from the photoactivation site (note intensity gain
in distal region marked “4”). PTP1B D/A-PhAc (but not PTP1B WT-PhAc) that was
initially photoactivated in the ER (away from sites of cell-cell contact) became
detectable at regions of cell-cell contact, indicating that the ER is contiguous
with these areas and is the source of PM-proximal PTP1B. By contrast, PTP1B D/A
that was photoactivated at regions of cell-cell contact (rectangle) diffused
away more slowly compared with pools activated in the ER (see below for detailed
discussion of this apparent difference in speed). Thus, the movement of PTP1B is
consistent with non-directional diffusion throughout the ER. Moreover, these
studies show that the ER network is continuous, but lies proximal to the PM only
at regions of cell-cell contact.
## PTP1B Mobility is Affected by Transient Interactions
The photoactivation experiments were complemented with fluorescence recovery
after photobleaching (FRAP) studies. GFP-labeled PTP1B WT or PTP1B D/A,
expressed in randomly growing PTP1B-null cells, was photobleached irreversibly
at the ER (circular area, 4 µm diameter) or at regions of cell-cell contact
(rectangular area, 5 µm length/1 µm width), and the recovery of fluorescence in
the photobleached area, caused by the diffusion of unbleached PTP1B, was
monitored. Diffusion and binding parameters were determined from the acquired
data by fitting the recoveries to an exact mathematical solution based on a
simplified geometry ( and mathematical modeling section). For assessing
intracellular diffusion, recoveries for each molecule were fit to a cylindrical
model that had two free parameters: the effective diffusion constant and the
immobile fraction. The effective diffusion constant measures the combined
effects of actual diffusion speed (cytoplasmic or along the ER, in the absence
of interactions), as well as any transient binding interactions that can slow
molecular mobility. The immobile fraction reflects the fraction that does not
recover (at least on the timescale of several minutes). The fitted effective
cytoplasmic diffusion constant (D<sub>eff</sub>) of PTP1B WT was
0.23<u>+</u>0.01 µm<sup>2</sup>/s with an immobile fraction of 0.12<u>+</u>0.02
(mean <u>+</u> S.E.M.; n = 11 cells). This diffusion constant was comparable to
that of the closely related, ER-anchored TCPTP (0.20<u>+</u>0.01
µm<sup>2</sup>/s) which, however, had a statistically insignificant immobile
fraction (0.04<u>+</u>0.03; n = 12) and other ER-anchored proteins, but was
significantly lower than the predominantly cytosolic Src homology-containing
tyrosine phosphatase 2 (SHP2) (1.0<u>+</u>0.1 µm<sup>2</sup>/s with a
statistically insignificant immobile fraction of 0.04<u>+</u>0.03; n = 9). The
effective diffusion of PTP1B D/A in the ER was three-fold lower than that of
PTP1B WT: 0.070<u>+</u>0.003 µm<sup>2</sup>/s, with a highly significant
immobile fraction of 0.28<u>+</u>0.02 (n = 13). This lower diffusion constant
(due to a slower turnover for the transient interactions) and higher immobile
fraction (indicating an increased amount of stable associations) presumably
reflect interactions of PTP1B D/A with substrate(s) in the ER. The slower, but
still efficient recovery of PTP1B D/A - on a timescale of 10 seconds -
automatically sets a lower limit on the dissociation rate for transient
interactions of roughly s<sup>−1</sup> (a slower dissociation rate is
irreconcilable with the observed efficient recovery).
The recovery of PTP1B D/A fluorescence at regions of cell-cell contact was even
slower. The slower recovery might be explained in a number of ways, including
the peripheral location of the FRAP region (replenishing proteins must on
average traverse a larger distance and can approach from only one direction),
the amount of PTP1B D/A that accumulates at regions of cell-cell contact (see
mathematical model and), and/or a slow off-rate from binding sites at regions
of cell-cell contact. To help differentiate between these possibilities, we fit
the recoveries to an exact mathematical solution that employed a simplified
rectangular geometry. This model implicitly accounts for reversible binding of
PTP1B to its substrate(s) in the ER by assuming the same effective diffusion
constant determined above from the FRAP measurements for PTP1B D/A in the ER,
but *explicitly* accounts for enzyme-substrate binding (both transient and
immobilizing) of the accumulated fraction at the region of cell-cell contact
(see mathematical model). Estimation of the exact immobile fraction at regions
of cell-cell contact was hampered because we were unable to track recovery to
completion due to photobleaching and cell movement (on timescales greater than
one minute). Models assuming no immobile fraction or up to 30%-70% (depending on
the cell) fit the data equally well (the fits shown in and assume no immobile
fraction). This uncertainty concerning the exact immobile fraction did not,
however, affect our ability to estimate any of the other parameters. Assuming an
approximate accumulated amount of roughly ten percent based on the images, the
model could be reduced to the determination of two parameters: the dissociation
rate (of the transient interactions) and the cell size. Additionally, for most
cells, only a lower limit on the dissociation rate could be determined (for all
cells, the dissociation rates were consistent with s<sup>−1</sup>), implying
that the recoveries were limited only by the cell size (diffusion-limited
recovery). The average cell size determined solely from the model fits was 28
µm, which is comparable to the observed cell sizes and demonstrates the overall
self-consistency of our model with the observed properties of the cells. The
roughly factor-of-two differences in recovery speeds from cell to cell can
easily be attributed to the observed differences in cell size, though they could
also arise from slight differences in the amount of accumulation at the cell-
cell contact region. Interestingly, the required rapid turnover of transient
interactions at these cell-cell contact sites (\<10 seconds), and the fact that
limits on the immobile fraction are compatible with the actual immobile
fractions observed in intracellular regions, suggest that the affinity of PTP1B
for its substrate(s) at regions of cell-cell contact is likely similar to that
at other locations in the cell. The slower recovery at the cell-cell contact
region can therefore be completely accounted for by the geometry of the
bleaching and, in particular, the amount of accumulated PTP1B-D/A at the cell-
cell contact region. The observed accumulation of PTP1B D/A is consistent with a
higher concentration of PTP1B substrates at these regions (or generally on the
PM) as compared with the distributed substrates found throughout the cellular
interior, but is specifically not due to tighter binding of PTP1B to substrates
found at regions of cell-cell contact.
## PTP1B Recruitment to Regions of Cell-cell Contact
We next analyzed the dynamics of PTP localization at regions of cell-cell
contact in response to stimulation of the EGFR, an established PTP1B substrate.
Cos-7 cells were co-transfected with PTP1B D/A-dHcRed and EGFR-GFP, and the
localization of the two proteins was monitored by confocal time-lapse
microscopy. Although the EGFR was expressed uniformly on the cell surface, we
observed accumulation of mutant PTP1B at regions of cell-cell contacts
(arrowheads) even in the absence of EGF treatment. Stimulation with EGF led to
rapid recruitment of additional dHcRed-labeled PTP1B D/A to these regions
(arrowheads, 2, 10 min). Importantly, the rapid EGF-induced PTP1B D/A
recruitment to regions of cell-cell contact was not paralleled by increased
localization of the EGFR in these regions, as ratiometric analyses showed
increased PTP1B/EGFR fluorescence ratios at regions of cell-cell contact in
response to EGF stimulation (white regions in PTP1B/EGFR ratio images). The
increased PTP1B/EGFR ratio at the PM was observed only at regions of cell-cell
contact, even though EGFR concentration, and presumably the amount of tyrosyl
phosphorylated EGFR (also see below), was the same at both locations.
Quantification of PTP1B D/A localization at cell-cell contacts (contacts),
compared with PM regions not in contact with neighboring cells (no contacts) in
multiple cells, confirmed that the ratio of PTP1B/EGFR fluorescence intensities
was significantly higher at regions of cell contact compared to other areas of
the cell membrane; this difference between the data sets “contacts” and “no
contacts” was highly significant (p\<0.001; Kolmogorov-Smirnov test).
To determine whether ER localization of PTP1B facilitates its ability to access
substrates at regions of cell-cell contact, we analyzed the localization of
PTP1B D/A lacking its ER-targeting domain (PTP1B D/A CD-mCitrine) in MDCK cells
stimulated with EGF for 5 minutes. Unlike full length PTP1B D/A, PTP1B D/A CD-
mCitrine was found in the cytosol and could interact with substrates all over
the PM, with no apparent preference for substrates at regions of cell-cell
contact. This result provides further evidence that the density of PTP1B
substrates is similar at regions of cell-cell contact and the rest of the PM. We
then co-expressed PTP1B D/A CD-mCitrine with ER-bound PTP1B D/A mCherry, and
stimulated cells with EGF for 5 minutes. Consistent with our previous
observations, the ER-bound form of PTP1B D/A preferentially accessed the PM at
regions of cell-cell contact. On the other hand, the ER domain mutant PTP1B
(free), which is localized throughout the cell and at the cell periphery, was
actually displaced from regions of cell-cell contact. We interpret these
findings as indicating that the high local density of ER-anchored PTP1B (which
is confined to a two-dimensional surface) can outcompete the freely diffusible
(soluble) catalytic domain-only mutant in regions where the ER and PM are in
close contact. Collectively, these data demonstrate that ER-bound PTP1B can only
reach its PM-localized substrates at regions of close ER-PM contact, and
indicate that the ER anchor plays an important role in restricting PTP1B
interactions with PM substrates mainly to regions of cell-cell contact.
## The ER is Polarized Towards Regions of Cell-cell Contact
The above findings indicate that the ER is specifically organized and oriented
towards regions of cell-cell contact, which raised the possibility that PTP1B
might play a role in this process. Microtubules contribute to the formation and
stabilization of the ER network. To destabilize the ER network, we disrupted
microtubules using nocodazole, and ER retraction at the periphery and regions of
cell-cell contact was monitored using total internal reflection microscopy
(TIRF). Cos-7 cells were co-transfected with PTP1B WT-mCitrine and RFP-tagged
TK-Ras (a general PM marker to identify areas of cell-cell contact and account
for cell shape changes). Consistent with previous reports, we observed ER
collapse, specifically the loss of peripheral tubular ER through its conversion
into sheet-like structures that retracted from the cell periphery, after
nocodazole treatment. The extent of ER reorganization varied between experiments
depending on cell confluence, cell type and shape. Nevertheless, the ER always
retracted from peripheral regions but seemed to persist at regions of cell-cell
contact. In isolated cells expressing PTP1B D/A, the ER retracted only partially
after nocodazole treatment, with long stretches of tubular ER still attached to
the PM at sites of focal adhesion to the glass coverslip.
These observations raised the possibility that, rather than (or in addition to)
the ER directing PTP1B towards substrates at points of cell-cell contact, PTP1B
interactions with substrates might help polarize the ER towards these regions.
We reasoned that if this was the case, then outcompeting endogenous PTP1B for
substrate interactions by overexpressing PTP1B D/A CD should allow the ER to
retract from regions of cell-cell contact after nocodazole treatment. PTP1B WT
localization is not altered by PTP1B D/A co-expression. PTP1B D/A CD-mCitrine,
monomeric Teal fluorescent protein (mTFP)-tagged Calreticulin (ER marker), RFP-
tagged TK-Ras and EGFR were co-transfected into MDCK and Cos-7 cells. After
starvation, cells were stimulated with EGF (100 ng/ml) for 5 minutes (to
increase phosphorylation and recruitment of PTP1B D/A CD to its substrates), and
then cells were treated with nocodazole. The ER retracted from peripheral
regions as observed before, but failed to retract from regions of cell-cell
contact. To assess whether the expression of PTP1B D/A CD was high enough to
compete for substrates with the endogenous pool of PTP1B, we measured the
absolute concentration of ectopically expressed PTP1B D/A CD across the cell by
correlating the image intensity of cytoplasmic PTP1B D/A CD to its
concentration, as determined by fluorescence correlation spectroscopy. A linear
fit to this correlation enabled the estimation (by extrapolation) of PTP1B D/A
CD concentrations at any point in the cell. The maximal concentration of PTP1B
D/A CD was observed at regions of cell-cell contact and was approximately 9 µM.
In the immediate cytoplasmic vicinity of these cell-cell contacts, the
concentration of PTP1B D/A CD remained in the µM regime, which is comparable to
the K<sub>D</sub> for PTP1B D/A-substrate interactions. We therefore conclude
that over-expressed PTP1B D/A CD should efficiently compete with endogenous
PTP1B for substrates at the PM of cell-cell contacts. However, endogenous PTP1B
may have an additional advantage, as it is anchored to the 2D ER, which may give
it a geometrical advantage in its search for substrates (higher k<sub>on</sub>)
over the cytosolic PTP1B D/A CD (invalidating arguments based on the
K<sub>D</sub>, which assumes a search in 3D). To even overcome the high-local
concentration of ER-bound PTP1B, we performed competition experiments with PTP1B
D/A lacking the ER-targeting domain but fused to the C-terminal membrane
anchoring residues of K(B)Ras (TK-Ras) (hereafter referred to as PTP1B D/A-RFP-
TK). We reasoned that anchoring PTP1B D/A to the PM should give it an enhanced
geometric, and consequently kinetic, advantage in substrate interaction over the
endogenous ER-bound enzyme. We then co-expressed PTP1B D/A-RFP-TK with TFP-
tagged calreticulin and unlabeled EGFR, and treated Cos-7 cells with nocodazole
as described before. Again, the ER did not retract from regions of cell-cell
contact compared with other regions of the PM. Taken together, these findings
clearly indicate that PTP1B-substrate interactions do not by themselves
stabilize the polarization of the ER to regions of cell-cell contact. Rather,
intrinsic polarization of the ER towards points of cell-cell contact likely
directs PTP1B towards these regions.
## Regulation of Signaling at Regions of Cell-cell Contact by PTP1B
The above findings indicated that there is an orientation of the ER towards
regions of cell-cell contact, which raised the possibility that PTP1B may play a
significant role in the regulation of signaling at these cites. To test this
hypothesis, we determined the effects of PTP1B inhibition on the phosphorylation
of substrates found at regions of cell-cell contact. Cos-7 cells were
transfected with mCherry-tagged EphA2, a RTK that is closely related to EphA3 (a
recently described substrate of PTP1B). Tyrosine phosphorylation was monitored
using the co-transfected YFP fused to SH2 domain of pp60<sup>src</sup>
(dSH2-YFP). Cells were treated with an allosteric PTP1B inhibitor (539741),
which exhibits higher selectivity compared with active site inhibitors, and then
monitored by confocal time-lapse microscopy for 60 minutes. Before inhibitor
treatment, EphA2 showed typical membrane distribution of a RTK, with occasional
accumulation at regions of cell-cell contact (, panel ii). In addition, dSH2-YFP
showed expression in the nucleus, punctuate clusters surrounding the cell
typical of focal adhesions (, panel iii), and in some cases at regions of cell-
cell contact (panel iii yellow arrowheads). Minimal spatial overlap was observed
between dSH2 and EphA2 prior to inhibitor treatment, even at regions of cell-
cell contact ( panel iv cyan arrowheads). On the other hand, treatment with
PTP1B inhibitor for 1 hr led to extensive increase in spatial overlap between
dSH2 and EphA2 especially at regions of cell-cell contact (panel vii). The
increased tyrosine phosphorylation of EphA2 upon PTP1B inhibition suggests that
EphA2 is a potential PTP1B substrate at these sites. These findings reveal that
the ER-bound PTP1B, by virtue of the organization and polarization of ER towards
points of cell-cell contact, can access its potential substrates and regulate
their activity at these regions.
# Discussion
One of the earliest discoveries about PTP1B was its localization to the
cytosolic surface of the ER. This result was initially quite surprising, because
biochemical and genetic studies soon established that PTP1B dephosphorylates
several RTKs, including the PDGF, EGF and insulin receptors. We subsequently
provided an answer to this topological dilemma with the finding that RTKs
encounter PTP1B only after they are endocytosed, a finding confirmed and
extended by several other groups. Nevertheless, other work indicates that PTP1B
can access PM substrates at points of cell-cell contact. These results raise an
apparent paradox: why can PTP1B dephosphorylate some substrates only after
endocytosis, whereas others can be targeted while at the PM? The results herein
provide a solution to this paradox and present a novel mechanism of how ER-PM
signaling at regions of cell-cell contact is regulated. This regulation is
important in that it is observed in different cell types, including those that
do and do not form tight junctions. Our findings clearly demonstrate that
interactions between the PM and the ER are not ubiquitous, but rather are
restricted to regions of cell-cell contact. In these regions, the ER network
appears to be specifically organized and oriented such that it is juxtaposed to
the PM. An analogous mechanism might also account for PTP1B interactions with
substrates at cell-matrix contacts.
If we envision that the ER can reach the PM everywhere in a stochastic, dynamic
way, then the local concentration of substrates should determine the amount of
PTP1B D/A at regions of cell-cell contact. Conceivably, substrate concentrations
at regions of cell-cell contact are higher than elsewhere in the PM, in which
case a critical amount of substrate(s) must be present to enable the ER-bound
phosphatase to access them while they are still localized to the PM. Our
photoactivation and FRAP studies show that PTP1B D/A rapidly moves in and out of
regions of cell-cell contact (replenished by the ER pool), with a residence time
of \<10 s. These findings are consistent with the presence of a large
number of PTP1B binding sites, presumably representing substrates in these
regions. Nevertheless, when the EGFR is at the same concentration in the PM and
regions of cell-cell contact, interaction (without prior endocytosis) occurs
only at the latter location. Furthermore, expression of the soluble cytosolic
domain of PTP1B D/A does not result in a specific enrichment of this protein to
points of cell-cell contact after EGF stimulation; rather, this protein labels
the PM uniformly, thereby excluding the possibility that substrate density alone
dictates where PTP1B interacts with substrates at the PM. Varying rates of
endocytosis (at cell-cell contacts versus other areas of the PM) also might
account for the differential ability of PTP1B to access substrates at the PM.
Arguing against this model, though, we previously blocked RTK endocytosis using
dominant negative dynamin, but were unable to detect direct interaction between
PTP1B and PM-bound RTKs using fluorescence lifetime imaging microscopy (FLIM).
Taken together, these findings strongly suggest that additional factors are
instrumental in enabling ER-bound PTP1B to access substrates specifically at
regions of cell-cell contact. These factors are likely responsible for
polarizing the ER towards regions of cell-cell contact, thereby creating
specialized zones of ER-PM interaction at cell-cell contacts in which PTP1B (and
conceivably, other ER proteins) may access the PM.
There are precedents for the existence of specific ER-PM signaling compartments.
Studies using *S. cerevesiae* indicate that membrane curvature may help to
define functionally distinct sub-domains in the ER. Whether an analogous
mechanism creates ER sub-domains near regions of cell-cell contact in mammalian
cells remains to be determined. In skeletal muscle, the sarcoplasmic reticulum
junctophilin proteins bind to PM components to form junctional contacts. A new
paradigm for ER-PM signaling has been proposed for the ER calcium sensor;
stromal interaction molecule 1 (STIM 1). After ER calcium depletion, STIM 1
oligomerizes, and due to enhanced avidity, binds to and activates store-operated
calcium channels at the PM. Ultrastructural studies reveal that upon calcium
depletion, STIM 1 induces the formation of cortical ER (cER), which is composed
of large sheets that are closely opposed to the PM but still connected to
conventional ER cisternae. The distance between cER and PM (on average 8.3 nm in
Epon sections) is comparable to the distance between ER-bound PTP1B and the PM
in our EM studies. Moreover, mammalian STIM proteins have a lysine-rich sequence
that is similar to the yeast peripheral protein Ist2 (a transmembrane protein
that is localized to cER in yeast). Remarkably, Ist2 enrichment at the cER of
mammalian cells directly modulates the formation and maintenance of this ER
subregion, and cER induction *in vivo* is dependent on microtubules and the coat
protein complex I (COPI). It will be important to determine whether cER or some
other higher order ER structure promotes PTP1B interactions with substrates at
cell-cell contacts. The identity of these substrates and their contribution to
cell-cell signaling requires further investigation. Recent studies identified
interactions between PTP1B and EphA3 and revealed that the interaction can occur
at the plasma membrane at areas of EphA3/ephrin-mediated cell-cell contact. In
the current study, we report increased EphA2 tyrosine phosphorylation at regions
of cell-cell contact upon PTP1B inhibition, suggesting that EphA2 is putative
substrate of PTP1B at these sites. Other proteins known to reside at cell-cell
contacts, such as p120 catenin and Zonula Occludens (ZO-1), are hyper-
phosphorylated in PTP1B-null fibroblasts, and represent additional candidate
PTP1B substrates in these regions. Collectively, our studies suggest that the ER
plays a dynamic role in regulating signaling at regions of cell-cell contact via
PTP1B and highlight ER-PM interactions as an emerging new paradigm in cellular
signaling.
# Materials and Methods
## Cell Culture, Antibodies and Reagents
PTP1B-null fibroblasts (Haj et al. 2003), MDCK and Cos-7 cells (both obtained
from ATCC) were cultured on 35 mm glass bottom culture dishes (MatTek
Corporation) or 4-well Lab-Tek chambers (Nunc) in Dulbecco’s modified Eagle
medium (DMEM) with 10% fetal calf serum (FCS). Unless otherwise indicated, cells
were transfected using Lipofectamine 2000 (Invitrogen), as described by the
manufacturer, and incubated at 37°C and 5% CO<sub>2</sub> for at least 12–18
hours before imaging. For live cell experiments, the culture medium was replaced
with CO<sub>2</sub>-independent imaging medium. Antibodies against mouse
β-catenin (#610153) were purchased from BD Biosciences, fluorescein-conjugated
secondary antibodies were from Jackson Immunoresearch, and nocodazole was
purchased from Sigma. PTP1B allosteric inhibitor 3-(3,5-Dibromo-4-hydroxy-
benzoyl)-2-ethyl-
benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-amide (Cat \#539741)
was purchased from Calbiochem.
## Plasmid Constructs
PM-anchored PTP1B D/A was generated by inserting cDNA encoding the catalytic
domain of human PTP1B (residues 1–407) flanked by Age I restriction sites into
pRFP-tkB-C1 vector (gift of Dr. M. Lackmann). pRFP-tkB-C1 (hereafter referred to
as RFP-TK) consists of the C-terminus membrane targeting domain and part of
linker domain of K(B)Ras downstream of mRFP.
## Immuno-electron Microscopy
Cells were fixed with 4% paraformaldehyde in 0.2 M sodium phosphate buffer, pH
7.4 for 5 min, followed by 2% paraformaldehyde in 0.1M sodium phosphate buffer
for 30 min, then rinsed with PBS and quenched with 50 mM glycine in PBS for 10
min. After adding 2 ml of 1% gelatin, the cells were collected by scraping the
monolayer, centrifuged, resuspended in 10% gelatin, and then centrifuged again
for 1 min. After cooling on ice for 30 min, the pellet was cut into small cubes,
which were infiltrated with 2.3 M sucrose overnight, mounted on pins and frozen
in liquid nitrogen. Cryosections were prepared using an ultra-cryomicrotome
(Leica) and collected with a 1∶1 solution of 2.3 M sucrose and 2% methyl
cellulose. Immunogold labeling with anti-PTP1B (FG6) antibodies (diluted
1/10–1/50) was performed and revealed with protein-A gold conjugate (Utrecht
University). Cryosections were viewed at 100kV on a Biotwin EM scope (FEI)
equipped with a SIS Keen View 1.3×1 K CCD camera.
For cryo-electron microscopy of vitreous sections (CEMOVIS), samples were
treated as previously described. Briefly, cells were grown on ACLAR film
(Science Services, Eppelheim, Germany), fixed using HPM100 high pressure freezer
(Leica Microsystems, Germany) and cut at –150°C. Samples were analyzed using a
JEM-1400 electron microscope (JEOL Germany) at 120 kV equipped with F-416 CCD
camera (TVIPS, Gauting, Germany). For vitreous sections, a cryo-holder model 626
(Gatan, Pleasanton, CA) was used.
## Confocal Imaging, Photoactivation and Time Lapse Microscopy
Confocal imaging and photoactivation were performed using an Olympus FlowView FV
1000 microscope with a 63×/1.4 N.A oil objective. Experiments were performed in
an environmental box in which live cells were maintained at 37°C and 5%
CO<sub>2</sub>. Photoactivation was performed in the region of interest using a
413 nm laser in the region of interest, and continued imaging of the
photoactivated pool was performed using a 488 nm laser. All studies were
conducted on randomly growing cells.
For confocal time-lapse microscopy, Cos-7 cells were transiently co-transfected
with EGFR-GFP and PTP1B-dHcRed using Fugene 6 (Roche Biochemicals). Cells were
serum-starved, stimulated with EGF (100 ng/ml) and then subjected to confocal
time-lapse imaging. Images were captured using a confocal laser microscope
(Leica TCS-SP5) with a 63×/1.4 N.A oil objective at 12-bit resolution. Image
processing and quantitative analysis were performed using Image J. For
ratiometric analysis, images were converted to 32-bit (floating point) format
and thresholded. Background was defined as not a number (nan) and ratio images
were then generated by dividing PTP1B D/A dHcRed by EGFR-GFP images.
## Fluorescence Recovery after Photobleaching
Photobleaching was performed on the temperature-controlled stage of a Leica SP2
AOBS Sirius microscope equipped with a 63×/1.4 N.A oil immersion lens. GFP was
excited using a 488 nm Argon laser, and fluorescence was monitored at 0.203 sec
intervals. Fifty pre-bleach images were recorded with 4% laser power of the 488
line every 0.203 sec. Consequently, a region of interest (outlined in the
figure) was photobleached using 100% laser power of the 456, 476, 488 and 496
lines. Recovery of fluorescence was monitored over the course of 300 whole-cell
scans (with a scan interval of 0.203 sec).
For bleaching of PTP1B WT-GFP and PTP1B D/A-GFP in the ER, a circular region of
4 µm diameter was used, whereas for bleaching at cell-cell contacts, we used a
rectangular area of 5 µm length and 1 µm width. Cells with varying levels of
transfection ranging from high to low PTP1B WT and D/A expression were studied.
Mean fluorescence intensities in the FRAP region and for the whole cell
(including the FRAP region) were recorded, and the background was subtracted.
The FRAP region and whole cell profiles were then individually normalized to
their pre-bleach values (obtained by averaging the 11 images immediately
preceding bleaching), and the final FRAP recovery profile was obtained by
dividing the normalized FRAP region intensity by the normalized whole cell
intensity. This final step removed the global fluorescence decrease due to
photobleaching during initial bleaching (∼5% for FRAP experiments in the ER and
5–20% for FRAP experiments in the cell-cell contacts), as well as any gradual
bleaching occurring during acquisition of the recovery (less than a few percent
for all experiments). Mathematical modeling was used to fit the recoveries (see
Supplementary Materials).
## Total Internal Reflection Fluorescence Microscopy
Cos-7 cells were transiently co-transfected with RFP-TK and PTP1B WT-mCitrine or
PTP1B D/A-mCitrine using Effectene (Qiagen). Cells were plated onto glass-bottom
35 mm dishes (MatTek) and then were incubated in CO<sub>2</sub>-independent
medium supplemented with 10% FCS and 2.5 mM L-glutamine. Images were acquired
with an inverted Olympus CellˆR microscope configured for triple line total
internal reflection fluorescence, using a 60× PLAPO/TIRFM-SP oil immersion
objective, with 1.45 N.A at 16-bit resolution in each channel.
## Fluorescence Calibrated Confocal Time-lapse Microscopy
Fluorescence-calibrated time lapse imaging was performed on a Zeiss LSM 510 Meta
confocal microscope equipped with a ConfoCor 3 unit and a C-Apochromat 40×/1.2
N.A water immersion objective. Experiments were performed in an environmental
box in which the sample and objectives were maintained at 37°C. mTFP and
mCitrine were excited with 458 nm and 514 nm argon lasers, respectively, whereas
RFP was excited with a 561 DPSS laser. The fluorescent light was passed through
a NFT 565 beam splitter and detected with PMT detectors through a BP 475–525
band pass filter for mTFP, a LP 530 long pass filter for mCitrine, and a LP 575
long pass filter for RFP. To minimize cross-talk between individual channels,
mTFP and RFP were recorded simultaneously, whereas mCitrine was imaged
separately. Pinhole diameter was set to 192 µm for mTFP, 296 µm for RFP, and
1000 µm for mCitrine. Images were recorded at a resolution of 512×512 pixels
(0.15 µm/pixel) and a bit depth of 12 bit. For time-lapse imaging, single-plane
multi-color images were recorded at 1 minute intervals.
To correlate the image intensity of mCitrine to absolute protein concentrations,
we acquired single-channel images of cells expressing mCitrine-PTP1B D/A CD at
exactly the same settings as for the time-lapse experiments. Fluorescence
correlation spectroscopy (FCS) measurements were performed at randomly chosen
positions in the cytoplasm of the same cells. Background-corrected average image
intensities were determined in a 1 µm radius around the FCS measurement point.
For FCS, mCitrine was excited with the 514 nm line of an argon laser, while an
APD detector recorded the fluorescence through a LP 530 long pass filter and a
70 µm pinhole. The raw intensity data were correlated using the microscope
manufacturer’s software, and for each measurement, correlation curves were
averaged for ten consecutive 10-second intensity recordings. Averaged
correlation curves were fit by using a model accounting for anomalous diffusion
and a triplet term in order to determine the average number of particles in the
confocal observation volume, using a non-linear least squares minimization
algorithm implemented in Matlab (MathWorks). Confocal volume was determined from
calibration measurements of an Alexa 546 dye solution, assuming a diffusion
coefficient of 280 µm<sup>2</sup>/s at 25°C that was extrapolated to 308
µm<sup>2</sup>/s at 37°C.
## Mathematical Model for Fitting FRAP Data
For the circular FRAP in the ER (PTP1B WT and PTP1B D/A), we used the analytic
formula for a cylindrical region in an infinite medium :where denotes the FRAP
recovery (recovering from 0 to 1), I<sub>0</sub>(*x*) and I<sub>1</sub>(*x*) are
the standard modified Bessel functions, and is the diffusion timescale with *r*
the radius of the FRAP region and *D* the diffusion constant. Considering the
case of imperfect bleaching and the possibility of an incomplete recovery due to
an immobile fraction leads to the following formula:where is the bleaching
efficiency (with corresponding to complete bleaching) and is the immobile
fraction. The initial FRAP bleaching in the region of interest in our cells
removed less than a few percent of the total cellular fluorescence. This
justifies the use of the “infinite cell” approximation implicit in Eq. 2.
We obtained the following values for diffusion constants and immobile fractions
for the four intracellular/ER FRAP data sets (taking µm for the radius of the
FRAP region):
D (µm2 s<sup>−1</sup>) n
PTP1B WT-GFP 11
PTP1B D/A-GFP 13
TCPTP-GFP 12
SHP2-GFP 9
Each FRAP profile was fit independently, and the above values quoted are the
mean and standard error of mean (S.E.M) for the indicated number of cells, *n*
(individual cell profiles shown). The mean and S.E.M of the diffusion constant
were based on the statistics of the logarithm of The above parameters also fit
well the mean cell profile obtained by simply averaging all of the single cell
recovery profiles (see in the main text). PTP1B D/A, therefore, has a three-fold
lower diffusion constant and a two-fold greater immobile fraction than PTP1B WT,
consistent with the “trapping” nature of its catalytic region mutation. The
diffusion of PTP1B WT is similar to that of another ER-bound phosphatase, TCPTP;
however, the immobile fraction of TCPTP is insignificant (consistent with the
few percent removal of fluorescence from the initial FRAP bleaching). All of the
ER-bound proteins diffuse much more slowly than the cytosolic SHP2 (which also
has an insignificant immobile fraction).
For the FRAP experiments at the cell-cell interface, we employed a Laplace
transform approach similar to that used previously. In the latter, a 2D
cylindrically-symmetric geometry was explored. Here, we have a 1D system with a
non-trivial boundary condition (due to the location of the binding sites there).
Because this important case was not examined before and, in particular, because
the inclusion of boundary conditions is subtle, we provide a full derivation for
the sake of clarity and completeness. The following equations describe the
concentration of a freely diffusing fluorescent protein, free binding sites, and
binding sites bound with the fluorescent protein,
Because the binding sites are localized to the cell-cell interface, and,
similarly, where is area of the cell-cell interface (at) and is the cell
volume. This gives:
At steady state, the concentration of free binding sites, is unaffected by the
FRAP process. We therefore need consider only the time dependence of and
Following bleaching, the free and bound fluorescent protein concentrations split
into bright and dark fractions:
Upon substituting back into the differential equations above, these equations
can be dissected into separate sets of equations (of the same form) for both the
bright and dark fractions. Of course, we are only able to monitor the bright
fraction:
These equations are best solved by the Laplace transform, which gives:where the
bar indicates the Laplace-transformed function dependent on the Laplace
transform variable *p*. Rearranging,
The initial concentration of the free protein is just We assume an initial
bleaching of the bound protein, giving where is the bleaching efficiency, with
denoting complete bleaching. Substituting into the differential equation for now
gives:
For with general solution:
The boundary condition at (using Gauss’s law) isand at is simply 0 (hard wall,
Neumann boundary condition). Using the boundary conditions to solve for the
coefficients of the general solution yields:
These give the following for the specific solution (at):
This can then be substituted into the equation for yielding
Normalizing to the pre-bleach amount of bound protein and rearranging gives the
following dimensionless form for the Laplace transform of the recovery of
fluorescence at the cell-cell interface:where is the diffusion timescale and is
the contrast, which is equal to the ratio of the total protein bound at the
interface to the total free protein in the cell. The full recovery is then:
with
From the fitting, we find that the “tanh” term is effectively 1 in our case,
implying:with the recovery effectively depending on only two unknown parameters:
and (the contrast and diffusion timescale are degenerate). But this is just the
recovery one gets assuming an “infinite” cell. Here, the general solution is
just:
The boundary condition at (using Gauss’s law) is
giving:
And, again,now with the exact equality:
The recovery (normalized only to the pre-bleach fluorescence in the FRAP region)
asymptotically approaches the following value:which for complete initial
bleaching of the bound protein is just or the ratio of free protein to total
protein. However, for our data analysis, we additionally normalized to the total
cellular fluorescence at each time point:which removes the reduction in
intensity caused by the bleaching of the total cellular fluorescence. The
bleaching efficiency is directly observed, and the diffusion constant can be
obtained by FRAP in the interior of the cell (hence, our FRAP experiments with
PTP1B D/A in the ER, which yielded µm2 s−1). Assuming that the confocal plane we
observe is representative, we find that for most cells (this value, true for the
entire stripe, can also be used for our experiments wherein only one third of
the interface was bleached). This implies that the additional normalization in
is only a few percent. It is therefore safe to ignore this (the “ is small”
limit where) and simply fit to
Assuming zero immobile fraction (see below), we have independently fit the
recovery curve for each of the 12 cells, obtaining mean and S.E.M values (based
on the logarithmic values) for the two remaining free parameters s<sup>−1</sup>
(residence half-life of s) and s<sup>−1</sup>. For most of the recovery curves,
needed only to be greater than some minimal value in order to fit the data,
hence the lower limit. The mean values again fit well the mean profile resulting
from averaging the recovery profiles of all of the cells, as shown in. Using
s<sup>−1</sup>, µm<sup>2</sup> s<sup>−1</sup>, and gives an effective cell
length of µm, which is comparable to the observed cell sizes. The FRAP recovery
of PTP1B D/A at the cell-cell interface is therefore consistent with rapid
turnover ( s), the ER-determined diffusion constant, the observed level of PTP1B
D/A accumulation at the interface, and the cell size. From the raw images
themselves, it is already clear that the recovery we observe is not an artifact,
but represents a real turnover of bound protein at the cell-cell interface. As
mentioned above, an immobile fraction at the cell-cell interface is not required
in order to fit the recovery (in all of our displayed fits, we assume no
immobile fraction). Recoveries assuming an immobile fraction also fit the data
(not shown), and on a cell-by-cell basis these fits provide a useful upper limit
to the immobile fraction at the cell-cell interface ranging from \<30% to \<70%.
Theoretically, a longer acquisition time would help eliminate most of the
parameter degeneracy and place a tighter limit on the immobile fraction, but
observation of the actual long-term recovery is severely complicated by cell
movement and morphological changes occurring on minute timescales.
All of the analysis was performed in Mathematica (Mathematica, Inc.), where we
have used the inverse Laplace transform algorithms described in:
<http://library.wolfram.com/infocenter/MathSource/4738/and>
<http://library.wolfram.com/infocenter/MathSource/5026/>.
# Supporting Information
We thank Drs. I. Yudushkin, M. Bentires, R. Pepperkok, and B. Geiger for
PTP1B-PhAc, PTP1B-GFP, SREP/Sec61 and dSH2YFP cDNA constructs, respectively.
[^1]: Conceived and designed the experiments: FH BN PB. Performed the
experiments: FH OS AK SWK VR HMH MG. Analyzed the data: FH OS AK VR MG CA BN
PB. Contributed reagents/materials/analysis tools: MB CA. Wrote the paper:
FH OS AK BN PB.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
Several landmark studies have indicated that our behaviour can be biased or
indeed driven by subliminal information. While the extent to which subliminal
information affects behaviour is still a contentious topic (see for a review),
there is a large body of evidence supporting the influence(s) of subliminal
information on behaviour. Examples of such influences are (here named as
originally described on the respective articles): implicit attitudes or biases,
subliminal priming, unconscious evidence accumulation in decision making,
unconscious learning, perceptual adaptation from invisible stimuli, and
voluntary actions and choices triggered by non-conscious brain signals.
Subliminal information thus can have a wide range of effects on our behaviour
contributing to negative behaviour, in the case of unconscious biases to
language and motor skills learning in the case of implicit and statistical
learning and direct actions in the case of blindsight and agnosia.
Research suggests that subliminal information might be processed at variable
depths in several brain areas. ‘Invisible objects’ can still be processed
through the visual system, especially in dorsal areas—see however for a critical
review. Suppressed emotional facial expressions are processed by subcortical
structures, in particular the amygdala (for a review see, while masked words are
semantically processed in the temporal gyrus in the fusiform word area.
Subliminal primes have been shown to facilitate or bias behaviour in several
cognitive tasks. Subliminal information can accelerate reaction times for
semantically related targets, improve the accuracy of motion discrimination and
speed up reaction times at detecting spoken words after the presentation of
subliminal speech, among others.
Crucially, research thus far has focused on showing that decisions can lean
*towards* subliminal primes. This begs the question of whether choices following
subliminal priming are rigidly biased *towards* the subliminal information or
could they be trained away, by reversing the bias from the prime. In other
words, do we inevitably choose, on average, the same stimuli (or stimuli that
share properties with the prime) that were presented subliminally? Another
possibility is that we could learn to choose away from subliminal biases, which
would mean that such biases and choices are separable. If choices invariably
lean *towards* such subliminal primes, this will imply that the subliminal prime
triggers a rigid cascade of steps towards a stereotyped behaviour, which
determines choosing the primed stimuli. On the other hand, if behaviour can
diverge *away* from subliminal biases, this would suggest that the intermediate
steps from subliminal perception to behaviour are subject to influence (such as
learning) and not always rigidly biased in the same manner.
The present exploratory study aims to test whether decisions towards a
subliminal prime can diverge from it after going through an implicit learning
protocol. Specifically, we tested two hypotheses: (1) subliminal primes can bias
imagery-content decisions, and (2) participants can be trained to reverse the
bias from subliminal primes. We developed a paradigm in which primes were
suppressed from awareness using Continuous Flash Suppression (CFS,). After the
presentation of the subliminal prime, participants had to choose one of two
gratings and imagine it as vividly as possible. In a subsequent experiment, we
gave feedback to a small cohort of participants about their decisions to test
whether we could reverse the priming away from the subliminal primes.
# Materials and methods
## Participants
Experimental procedures were approved by the University of New South Wales Human
Research Ethics Committee (HREC#: HC17031). All methods in this study were
performed in accordance with the guidelines and regulations from the Australian
National Statement on Ethical Conduct in Human Research
(<https://www.nhmrc.gov.au/guidelines-publications/e72>). All participants gave
written informed consent to participate in the experiments. Participants were
recruited during 2017. We tested a total of 29 participants (18 females, ages
18–39) with normal or corrected-to-normal sight for the main experiment. An
additional 26 participants (22 retained) were tested in the no-imagery control
experiment. Participants’ data were deidentified by assigning them a number so
authors could not identify participants after data collection.
## Exclusion criteria
We employed 3 independent selection criteria with the aim of monitor that
participants did not consciously perceive the primes. First, we used realistic
catch detection trials in which very faint gratings were presented to both eyes
to measure participants ability (and willingness) to report subtle suppression
breaks that were designed to be as similar as possible to real ones. In catch
trials, the luminance of each one of the monocular gratings was lowered to 25%
of the intensity of the standard monocular grating. The grating presented to the
dominant eye was alpha blended with the CFS Mondrian masks and the other was
presented on a black background. This design made catch trials perceptually
similar to normal suppression breaks and thus hard to detect in some trials due
to monocular suppression. This was done to verify that participants would report
even the faintest breakthroughs of the primes. We rejected participants who
failed to report at least 80% of catch trials (N = 8). Secondly, we discarded
participants who did not report any broken suppression trials (N = 5). While we
cannot be sure that some of these participants truly did not experience any
suppression breaks, we imposed this criterion in the hope of making sure that
participants were not refraining from reporting suppression breaks. Finally, we
rejected participants who showed differences in priming between red and green
higher than 40% (N = 1). This was done to ensure participants were not biased
towards any choice (i.e., choosing red on most trials). Thus, we retained 17
participants who satisfied all these criteria in the main experiment for further
analyses. For the no-imagery control experiment, we tested 26 participants. We
rejected 4 participants (0 based on criterion 1, 2 based on criterion 2 and 2
others on criterion 3). Despite the use of these criteria, we cannot definitely
rule out that participants were able to perceive the primes. While this
shortcoming is not unique of our study, there are other controls currently
regarded as better suited to detect suppression breaks which were not used in
this study (see for a discussion on the subject).
## Power and effect size analyses
We performed post-hoc power and effect size analyses using G\*Power 3.1 on the
main results of the study. For the subliminal priming experiment, we tested the
priming of 17 participants (M = 0.6277, SD = 0.1253) against chance (0.5). The
achieved effect size was d = 1.019 and power (1-β) = 0.98, one sample, two-
tailed t-test against chance, α error probability = 0.05. For the priming
differences post and pre-training, we tested a subset of participants that had
significant priming on the main experiment (n = 7). While we acknowledge that
this is a rather small sample size, the effect size and power analyses indicate
that our results are robust, nonetheless. For the difference between pre-
training and training, the effect size was dz = 1.788 (M = 0.298, SD = 0.167)
and the power (1-β) = 0.973, two-sample, two-tailed t-test, α error probability
= 0.05. Finally, for the difference between pre and post training, the effect
size was dz = 1.118 (M = 0.2729, SD = 0.2442) and power (1-β) = 0.694, two-
sample, two-tailed t-test, α error probability = 0.05.
## Subliminal prime experiment
The tasks were carried out on a Windows 7 PC running Psychophysics Toolbox 3 in
MATLAB (The MathWorks, Inc., Natick, Massachusetts, USA) on a 85Hz Dell
Trinitron P1130 CRT monitor 1280x1024 resolution. We presented participants with
gratings (red/green, horizontal/vertical, \~7 deg of visual angle, 0.33
monochromatic contrast at its maximum) suppressed using continuous flash
suppression (CFS, \~10 deg of visual angle, flickering at 10Hz, square wave). We
chose to use coloured gratings instead of grayscale as colour has been shown to
promote subliminal priming, thus our stimuli had two dimensions that could
generate subliminal priming: orientation (horizontal/vertical) and colour
(red/green). We started testing perceptual isoluminance of the green and red
gratings with the heterochromatic flicker test in which participants were
presented with flickering red and green squares (temporal frequency 10Hz) while
adjusting the luminance of green against red (constant at 0.33 contrast) until
the perceived flickering was minimal. Perceptual isoluminance for green gratings
was systematically lower than for red gratings. Subsequently, we tested
participants’ eye dominance with the Miles eye dominance test and presented
gratings to the non-dominant eye and the dynamic Mondrian patterns (CFS) to the
dominant eye to maximize suppression. We used a stereoscope adjusted for each
observer until the overlap of each monocular image was achieved while their
heads were stabilized using a chinrest. We added a checkerboard pattern square
frame around the stimuli (\~12 deg of visual angle, \~2 deg width) to aid
vergence and thus overlapping of the monocular images. We presented grayscale
Mondrian patterns (instead of coloured ones as normally used) and added random
noise on them (60% amplitude, zero-centred), which increased the suppression of
gratings. The CFS/grating presentation lasted for 6s. To avoid suppression
breaks due to abrupt onsets, we linearly increased the opacity of the grating
from 0 to a max of 33% (depending on the heterochromatic flicker test) for 2.5s.
Importantly, at any moment of the prime presentation as well as in the decision
waiting period (see below), participants could abort the trial whenever a prime
broke suppression. We used empty trials (40%), where no gratings were presented
as baseline for vividness and agency ratings. We also presented catch trials
(20%) in which gratings were shown to both eyes to control for decision biases
on reporting suppression breaks. We used realistic catch detection trials in
which very faint gratings were presented to both eyes. The intensity of each
monocularly presented grating was 25% of the gratings presented in a standard
trial. This design was used to replicate real suppression breaks, because break-
through gratings can be difficult to detect. Thus, we expected that catch trials
could be missed in some trials. A total of 150 trials per participant were
tested divided in 5 blocks of 30 trials each, with trials from different
conditions pseudorandomized within blocks. After the prime presentation,
participants had to decide which grating to imagine. During this waiting period,
we presented grayscale plaids matching the position of the primes to mask any
after images of the prime that could influence the decision. After participants
decided which grating to imagine, indicated by pressing space bar (independently
of which one of the gratings was chosen), they imagined it as vividly as
possible for 5 seconds. After the imagery period, participants communicated
their choice by pressing different keys on a computer keyboard. After this,
participants were required to rate the strength of their visualizations or
vividness on a scale from 1 to 4. Finally, they rated on the same scale the
sense of agency felt while deciding which grating to imagine.
## Prime and decision dissociation training experiment
We implicitly trained participants to switch their decisions away from the
subliminal prime. For this experiment, we selected a subset of the retained
participants from the main experiment. We selected participants with priming
significantly above chance across the mean priming values within each of the 8
experimental blocks (one sample, one-tailed t-test against 50% p\<0.05). See the
section for the rationale behind this choice. We thus selected 7 participants
who showed significant above chance priming and trained them in 3 sessions
performed on consecutive days plus a post-training session to test the
persistence of the training effect a week after the training. Importantly, the
selection criterion was defined, and participants were selected *before the
training session*, so no participants were discarded after the training, nor we
stopped testing participants after obtaining significant results.
During the training sessions, performed weeks after the main experiment,
participants were presented with the same paradigm as in the main experiment
except for the following changes. After participants reported the chosen
grating, written and audio feedback was given. For trials where participants
chose the same grating as the prime (congruent trials), we presented the word
“Wrong!” and played a beep sound. Inversely, in trials where participants did
not choose the priming grating (incongruent trials), we presented the word
“Right!” and played a bell sound. In catch and empty trials, decisions were
labelled as right no matter the grating chosen. We asked participants to try to
get as many right trials as possible. The instructions given to the participants
were: “you will be presented with the same paradigm as in the previous
experiment you performed weeks ago. Each trial will start with flashing stimuli
followed by a decision imagery task as previously. As in the previous
experiment, if you happen to detect a grating or red/green colour during the
flashing stimuli, you must report it. This time, however, at the end of the
trial there will be feedback: ‘right’ and ‘wrong’. Try to get as many ‘right’
feedback even if you don’t know how to do it". In post-experiment interviews,
participants reported not knowing how to perform the task, however, priming
ratios revealed that they could implicitly learn to choose the right grating
(incongruent, Figs).
## No-imagery decision control
We devised a control experiment to test to which degree the task requirement of
producing a mental image after the decision influenced the subliminal priming.
We thus presented to an independent set of participants the same task as
described in the subliminal prime experiment, except for that there was no
imagery period nor vividness rating.
## Priming analysis
We calculated priming by dividing the number of trials where the choice was
congruent with the prime by the total number of trials that were not aborted.
These ratios were subsequently multiplied by 100 to denote percentages.
Statistical analyses were thus focused on testing that the amount of priming was
either different from chance level, i.e., 50% or comparing priming levels
between different conditions/experiments.
# Results
## Paradigm
The paradigm consisted of an imagery-content decision task following the
presentation of a subliminal prime suppressed using Continuous Flash
Suppression: CFS. Details of the paradigm and stimuli generation are available
in the Materials and Methods section as well as in ‘s caption. Importantly,
participants were instructed to abort trials at any time when the gratings
(primes) became visible by pressing a key. We included control trials to test
for response bias (catch trials) and as a baseline for vividness and agency
ratings (empty trials). For a schematic of what each trial type looked like, see
S1 Fig in.
## Subliminal gratings prime decisions about the contents of future imagery
We first tested whether the presentation of subliminal gratings biased
participants’ choices towards subliminal stimuli. Our results indeed showed
significant priming by the subliminal gratings on the subsequent imagery
decision (mean 62.8% ±3.04 SEM, grey bar, one-sample t-test against 50%, C.I. =
\[56.33, 69.21%\], t(16) = 4.204, p = 6.72 · 10<sup>−4</sup>, solid dots
represent participants included in the training phase). We devised a control
experiment to test to what degree the decision priming depended on imagery. The
no-imagery control experiment was identical to the main experiment with the
exception that there was no imagery period, nor vividness rating question.
Average priming in the control condition was again significantly above chance
(mean 57.65% ±2.07 SEM, white bar, one-sample t-test against 50%, C.I. =
\[53.35, 61.95%\], t(21) = 3.6986, p = 0.0013). While the control priming was
slightly lower than in the main condition (5.15% difference) this difference was
not significant (p = 0.079, two-sample, one-tailed t-test). This result suggests
that the decision priming is essentially independent of the subsequent imagery.
We then compared the vividness ratings between primed and empty trials. We used
empty trials (where no prime was presented) to measure the baseline vividness
levels. This analysis revealed that, in primed trials, when the prime and the
choice were congruent, vividness (the subjective imagery strength) was higher
(white vs black bars, paired two-tailed t-test, C.I. = \[0.056, 0.474\], t(16) =
2.68, p = 0.0163), than when no prime was presented (empty trial). The vividness
on incongruent decisions, while lower on average when compared to congruent
decisions, was also significantly higher than the empty condition (, white vs
grey bars, paired t-test, C.I. = \[0.0035, 0.3545\], t(16) = 2.52, p = 0.0227).
No significant differences were found between vividness ratings for congruent
and incongruent decisions. This suggests that, in this particular paradigm,
showing subliminal primes boosted vividness regardless of the congruency with
the imagined item.
Analyses of agency ratings did not show significant differences among the
different conditions of the main experiment: empty (baseline), primed and non-
primed trials (S2 Fig). The lack of a difference in ratings of agency suggests
that participants were largely unaware of the influence of the subliminal primes
on their decisions, or at least they were not aware of any change in their
agency.
We used 3 exclusion criteria to strengthen the reliability of reports on the
subliminal priming task: catch detection, suppression breaks and priming
differences. Participants not satisfying any of these 3 criteria were excluded
from further consideration ( open dots and in grey). First, we used realistic
catch detection trials in which very faint gratings were presented to both eyes
(i.e., not easily detectable, see for details) to measure participant’s ability
(and willingness) to report subtle suppression breaks. As catch trials were
designed to replicate real suppression breaks, they were expected not to be
reported in some trials. We, therefore, excluded participants that failed to
report at least 80% of the catch trials (N = 8). Mean catch detection ratios for
excluded and included participants were 0.673 (±0.079 SEM) and 0.959 (±0.016
SEM) respectively and were significantly different (p = 4.32·10<sup>−4</sup>,
C.I. = \[-0.4321–0.1389\], t(28) = -3.9896, two sample t-test). We also excluded
participants who did not report any suppression breaks (N = 5). Mean suppression
break ratios for excluded and included participants 0.074 (±0.034 SEM) and 0.042
(±0.008 SEM), respectively, but were not significantly different (p = 0.305).
Lastly, we excluded participants (N = 1) that had differences in priming between
red and green gratings larger than 40% (for example 80% red) as this imbalance
could indicate that participants’ choices would be biased towards one particular
option (e.g., choosing red). Differences in priming between excluded and
included participants were 0.047 (±0.038 SEM) and 0.035 (±0.007 SEM),
respectively, but these were not significantly different (p = 0.74). Mean
priming ratios for excluded and included participants were 0.591 (±0.035 SEM)
and 0.628 (±0.023 SEM) respectively but were not significantly different (p =
0.432), indicating that priming was not explained by differences in the
exclusion variables.
We performed additional tests to ascertain if the inclusion criteria for
suppression break ratios could explain the priming results. We thus analysed
whether priming scores were correlated with suppression breaks. Our analyses did
not detect significant correlations (p\>0.1), although there was a slight
positive trend, between suppression break ratios and priming (S3 Fig), thus
suggesting that partial failure at reporting suppression breaks is not enough to
explain priming results.
## Implicit training makes decisions diverge from subliminal primes
To test whether decisions are bound to subliminal primes, we trained a subset of
participants who had significant above chance priming across blocks (N = 7, see
for details in the selection criteria details) to choose the grating that was
not primed. We used the same paradigm as in the main experiment, except that we
included a feedback section after they reported their decision. For primed
trials, where the decision matched the subliminal grating, we presented the
prompt “Wrong!” accompanied with a buzz sound. Inversely, when participants
chose the grating that was not presented as a prime, we presented the prompt
“Right!” accompanied with a bell sound. On empty and catch trials, the “Right!”
prompt was shown independent of the answer. Systematic post-experimental verbal
interviews after each session revealed that 100% of participants (7 out of 7)
responded “no” to the question “Were you aware of how to perform the task?”.
Despite this, participants learnt quickly how to make their choices diverge from
the subliminal primes. We trained participants in 3 sessions of 5 blocks each.
Pre-training priming on the participants’ subset was 69.89% ±4.66 SEM (one
sample t-test against 50%, C.I. = \[58.48, 81.3%\], t(6) = 4.265, p = 0.0053).
Training priming levels were significantly different from pre-training (paired
t-test, p = 0.0104, 0.0082, 0.0082 for sessions 1 to 3, FDR corrected for multi-
comparisons, q = 0.05), but only significantly lower than chance level (i.e.,
50%) in session 2 (one sample t-test, p = 0.0901, 0.0473, 0.0595, FDR corrected,
q = 0.05). On average, implicit training resulted in participants switching
their decisions towards the incongruent grating significantly below chance level
(average training priming = 40.11% ±4.75 SEM, one-sample t-test against 50%,
C.I. = \[31.92, 48.3%\], t(6) = -2.95, p = 0.0255).
## Implicit training effects persist over time
Finally, we investigated whether the effect of training was robust over time. We
thus tested the same trained participants one week later. We used the same
paradigm as in the main experiment, that is, *without* any feedback. During the
training phase, all participants switched their decisions towards the grating
that was not shown as prime, in other words, they chose to make incongruent
decisions. After one week, all but one participant (6 out of 7, 85.7%) kept
their decision responses incongruent with the subliminal prime. Post-training
decision priming (42.6% ±10.84 SEM) was significantly lower than pre-training
levels (paired t-test, C.I. = \[-49.87, -4.71%\], t(6) = -2.96, p = 0.025),
while training and post-training decision priming levels were not significantly
different (paired t-test, C.I. = \[-21.23, 26.21%\], t(6) = 0.257, p = 0.806).
Interestingly, agency ratings fell modestly but significantly from pre-training
to post-training levels (S4 Fig in, C.I. = \[0.0335, Inf\], t(6) = 2.053, p =
0.043). This suggests that participants may have become more aware of the
influence of subliminal information on their choices, even if they reported not
being aware of the subliminal primes or the purpose of the task. On the other
hand, we found no significant changes in vividness across the pre-training,
training, and post-training experiments (S5 Fig). Participants’ catch trial and
break suppression rates were not significantly different along training periods
(S6 Fig), ruling out major changes in strategies acquired during the training.
These results suggest that the associations made between the subliminal primes
and decisions during the training can persist over time, even in the absence of
reinforcement.
# Discussion
We developed a paradigm to test whether subliminal primes can bias decisions
about the contents of future imagery. Our results indicate that participants’
choices were biased towards the subliminal prime. It is important to highlight
that there is still debate surrounding the nature of non-conscious perception
(for a review see), and there have been a number of studies questioning the use
of CFS to study non-conscious perception based on methodological grounds. We
used controls to minimize concerns about participants performing the task
incorrectly. First, we used realistic looking catch trials where very faint (25%
of the subliminal prime contrast) gratings presented to both eyes. We excluded
participants failing to report at least 80% of catch trials. Additionally, we
also excluded participants failing to report any suppression breaks during
normal trials. While some of these participants could have genuinely experienced
no suppression breaks, we used this criterion to filter out potential
participants that could be systematically not reporting catch trials. Further,
we excluded participants that were disproportionally primed by one of the
coloured gratings as this can be evidence of a bias on their choices (see for
inclusion criteria details). Finally, we verified that, for participants passing
the inclusion criteria, the rate of suppression breaks was not significantly
correlated with priming. This analysis suggests that priming is unlikely to be a
result of partial reports of suppression breaks (S3 Fig). To the best of our
knowledge, these selection criteria have not used in combination on previous
studies, and due to the stringent nature of these criteria, we ended discarding
an important number of participants (12 out 29 or 41%). While this is not unique
to our study (see for example) we understand the need to replicate our results
to assess their full impact. As noted before, however, priming on the discarded
participants was not significantly different from priming on the included
participants, indicating that our results cannot be explained by our selection
criteria. It is also important to emphasize that despite our efforts to
ascertain that participants were unable to see the gratings, we cannot
definitively rule out this possibility. As epistemological and methodological
views on non-conscious perception continually evolve to address the shortcomings
of previous studies, it is up to future research to replicate these results with
the latest methods to date to dissociate non-conscious perception.
In the follow up experiment, we tested a subset of participants (n = 7) and
found that choices could diverge from subliminal prime after implicit training.
We gave participants feedback on their choices, rewarding divergence from the
primes while penalising congruent decisions. Despite participants systematically
reporting being unaware of how to perform adequately at the task (which was
evaluated by systematic post-experimental verbal interviews), they quickly
learnt to diverge from the primes, on average switching their decisions from the
first session. Participants implicitly learnt to choose the grating that was not
primed, leading to a significant decrease in choice priming compared to pre-
training levels. We acknowledge that, due to the selection criterion (within-
participant priming significantly above chance), we ended up with a rather small
sample size (N = 7). Calculating significant priming within participants has not
been done before in the literature, due to the variability across blocks/trials
(in this respect, our sample was comparable to previous studies) and also
because there has been no need to draw conclusions at the participant level.
Instead, previous studies have used average within participant priming and
calculated significance across participants. We however reasoned that
using within-participant significant priming as a selection criterion would
allow us to highlight changes produced by the implicit training at the
participant level while maximizing the sensitivity of our experimental procedure
by avoiding floor effects (i.e., if a participant’s priming was only barely
above chance level, it would have been hard to detect a change after training if
the effect size was small). While in hindsight this selection criterion might
have been too stringent (another option could have been selecting participants
with average priming above 50%, no matter whether significant or not), we chose
it because we could not anticipate the effect size, which ended up being rather
large, with most participants reversing their choices (i.e., priming below 50%).
Therefore, a larger sample study will be needed to reveal the full scope of
these findings, despite that our analyses showed remarkable large effect sizes
and satisfactory power values (see for details).
Our results suggest that decisions are not determined to be congruent with
subliminal representations but can diverge through learning. This capacity of
learning can seem surprising given that non-conscious behaviour has been
classically regarded as rigid and stereotyped. However, recent studies have
shown rather complex learning in the absence of awareness such as fear
conditioning, sequence regularity learning and instrumental conditioning, see
however for evidence against unconscious instrumental conditioning. Our results
can be seen as another case of instrumental learning in the absence of
awareness, this time implicit learning to diverge from subliminal primes.
Implicit training effects persisted after a week despite the lack of
reinforcement. This is consistent with reports on the robustness and long-
lasting effects of the non-conscious learning. This result suggests that the
ability to dissociate subliminal information from choices can last long enough
to change behaviour in a meaningful way. This can be of potential interest for
the treatment of mental conditions in which non-conscious material affects
behaviour, such as in depression.
Participants’ agency felt modestly but significantly when comparing pre-
training with post-training (but not when comparing pre-training vs training nor
training vs post-training), which could suggest that participants may have
become more aware about the influence of subliminal information on their
choices. Participants, however, consistently reported not being aware of the
subliminal primes nor the purpose of the task. In addition, participants’ catch-
trials detection remained high and didn’t significantly change across the
training stages, indicating that participants were reporting suppression breaks
appropriately. Further, the instruction given to the participants did not hint
at the relationship to-be-learned (i.e., choose the grating opposite to the
prime) and was basically “try to get more right feedback” (see for details on
the instructions), suggesting that participants learnt the new association
between the subliminal prime and their decision outside of awareness, thus
learning implicitly. As for the agency reports falling through the training
process, this is consistent with studies reporting dissociations between agency
ratings and non-conscious information. That is, participants have been shown to
rate their agency lower while not being aware of external influences on their
behaviour.
In summary, this proof-of-concept study opens new possibilities in the study of
the effects of subliminal information on decision-making.
# Supporting information
We thank Gadiel Dumlao for his help with participant testing.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
In order to maintain homeostasis and promote survival, the circadian clock
coordinates and maintains the 24-hour rhythmicity of various physiological
processes, the most evident are the sleep/wake and fasting/feeding cycles.
Disruption of the clock has been associated with an increased susceptibility
and/or development of sleep and metabolic disorders. Proper circadian
function occurs in response to synchronous expression of the molecular machinery
of the circadian clock, composed of a central pacemaker in the suprachiasmatic
nucleus (SCN) residing in the hypothalamus. While the master clock is entrained
by light, almost all cells in the body harbor peripheral clocks that are
entrained by both signals from the master clock and environmental cues. This
molecular machinery is comprised of core clock proteins that control each
other’s expression and function in a transcriptional/translation feedback loop;
two transcriptional activators, BMAL1 and CLOCK, heterodimerize and drive the
expression of *Cryptochrome* (*Cry1*, *2*) and *Period* (*Per1-3*). Once
Cryptochrome and Period proteins reach a critical threshold, PER:CRY complexes
translocate to the nucleus to repress *Bmal1*:*Clock* transactivation. In
addition to these core clock components, the nuclear receptors (NR) RORs (α, β,
and γ) and the REV-ERBs (α and β) compete to activate and repress, respectively,
the transcription of *Bmal1* and *Clock* genes, completing an integral accessory
loop which helps maintain circadian rhythmicity\[–\].
The REV-ERBs also participate in the regulation of a diverse set of metabolic
processes, thus linking control of our daily rhythms with maintenance of
metabolic homeostasis. Both REV-ERBs are ubiquitously expressed with very
high expression patterns in the liver, adipose tissue, skeletal muscle, and
brain, with both NRs exhibiting circadian patterns of expression\[–\]. The REV-
ERBs are unique within the NR superfamily in that they lack the carboxy-terminal
tail of the ligand binding domain (LBD called activation function 2 (AF-2, helix
12), which is required for coactivator recognition. As a result, both REV-ERBs
are transcriptional repressors, recruiting corepressors such as NCoR in a
ligand-dependent fashion. Both REV-ERBs bind to identical DNA response elements
(termed RORE/RevREs) either as monomers to an AGGTCA “half site” with a 5’ AT-
rich extension, or as homodimers to a DR2 element \[direct repeat (DR) AGGTCA
sequence with a 2 base pair spacer\]. The retinoic acid receptor-related
orphan receptors \[RORs (α, β, and γ)\] recognize the same DNA response element
and are often coexpressed in the same tissues as the REV-ERBs. Due to the
limited availability of genetic models to explore REV-ERBβ’s function,
significantly more is known about REV-ERBα’s role in mammalian physiology. As a
consequence, REV-ERBβ is considered functionally redundant to REV-ERBα and its
role has, by default, been considered almost identical to REV-ERBα’s.
Recent work has demonstrated that REV-ERBα is highly expressed in oxidative
skeletal muscle and plays an integral role in mitochondrial biogenesis and
oxidative function. Skeletal muscle accounts for \~40% of body mass, more
than 85% of total insulin-stimulated glucose uptake, and is one of the most
metabolically demanding major mass peripheral tissues. Consequently,
skeletal muscle has a significant role in insulin sensitivity and the
development of obesity. Due to REV-ERBα’s role in skeletal muscle, REV-ERBα-
deficient mice display changes in daily energy expenditure, pre-disposing them
to diet induce obesity. Work performed by Ramakrishnan and colleagues also
demonstrated that REV-ERBβ was highly expressed in skeletal muscle, regulating
genes involved in fatty acid and lipid absorption. Importantly, data
presented by Ramakrishnan and colleagues implicated REV-ERBβ in the control of
lipid and energy homeostasis in skeletal muscle.
Given the overt skeletal muscle phenotype observed in REV-ERBα-deficient mice,
coupled with their metabolic abnormalities and the general view held by some in
the field that REV-ERBβ is functionally redundant to REV-ERBα, we sought to
determine the extent of functional redundancy of REV-ERBβ to REV-ERBα in
skeletal muscle and metabolism. Loss of REV-ERBβ resulted in increased
mitochondrial biogenesis and genes involved in muscle metabolism both *in vitro*
and *in vivo*. Characterization of REV-ERBβ-deficient mice demonstrated a
metabolic profile opposite to that of REV-ERBα-deficient animals, including
failure to gain weight despite increased food consumption during the day. This
increased food consumption correlated with increased utilization of
carbohydrates for energy as well as increased energy expenditure during the day.
These data indicate that, at least in terms of muscle, REV-ERBβ is not
functionally redundant to REV-ERBα, instead playing a distinct role in the
regulation of skeletal muscle metabolism. Furthermore, these data suggest
development of dissociated REV-ERB modulators (REV-ERBα-specific versus REV-
ERBβ-specific) may be beneficial for the treatment of metabolic syndrome.
# Materials and methods
## Animals
The following mouse strains used were either purchased from the Jackson
Laboratory and/or were bred at the Scripps Research Institute–Florida (Scripps
Florida). Male B6.Cg-*Nr1d1*<sup>*tm1Ven*</sup>/LazJ, stock \# 018447 (REV-
ERBα<sup>-/-</sup>); Male and female REV-ERBβ KO mice were generated as
previously described. Wild-type (WT) littermates were used as controls for
both knock out strains. This study was carried out in accordance with the
recommendations in the *Guide for the Care and Use of Laboratory Animals* of the
National Institutes of Health. Animal care and experimental protocols used in
this study were approved by the Scripps Florida Institutional Animal Care and
Use Committee (Assurance number: D16-00726). Mice were housed in groups of 3–5
in 12 h light/12 h dark cycles at 23°C and fed standard chow (Harlan 2920X),
unless otherwise stated. Mice had access to chow and water *ad libitum*. Mice
were sacrificed by CO<sub>2</sub> asphyxiation for tissue processing.
## Food intake
Food intake was monitored in normal chow-fed mice using the BioDAQ system
(Research Diets) following vendor recommended procedures. The feeding patterns
of pre-acclimatized, individually housed mice were continuously recorded for 3
consecutive days. The daily number of bouts, percent of time spent in bouts and
total chow consumed were obtained. A bout constitutes a visit or set of visits
(no more than 5 seconds apart) to the food hoppers. Each bout has a duration and
amount of food obtained during it. Data represent the average day or night
intake. Average values are compared by 2-tailed Student’s *t* test to determine
significance.
## CLAMS
Mice were individually placed and acclimatized in a Comprehensive Laboratory
Monitoring System (CLAMS; Columbus Instruments) at 23°C for 48 h. Afterwards,
VO2, VCO2, food intake, and spontaneous locomotor activity were measured for the
indicated time periods. Respiratory exchange ratio (RER) and energy expenditure
(EE) were calculated using the following equations: RER = VCO2/VO2; EE (kcal/h)
= (3.815 + 1.232 X RER) x VO<sub>2</sub>. EE was normalized by lean body mass.
Both raw and average values for RER are presented.
## Body composition studies
Total, fat, lean, and fluid mass of mice was measured by Nuclear Magnetic
Resonance using the Minispec LF-NMR (Brucker Optics) analyzer.
## Viral production, cell culture, and infection
To generate murine REV-ERBα or REV-ERBβ retroviral vectors, mouse REV-ERB
sequences were inserted into the MIGR1 vector (Addgene) using the XhoI site and
further screened for orientation. MIGR1 empty vector was used as a control.
MIGR1 was a gift from Warren Pear (Addgene, plasmid \# 27490). To knock down
REV-ERBβ expression, 3 different shRNAmirs (TransOmic Technologies, Inc.) were
inserted, individually into the pLMPd-Ametrine vector. The shRNAmirs used
were top-scoring designs from shERWOOD analysis (TransOmic Technologies, Inc.).
Each shRNAmir insert was PCR amplified using primers specific for common regions
in the flanking miR-30 sequences, which included XhoI and EcoRI sites. pLMPd-
Ametrine containing a CD8 shRNA was used as a control.
Plat-E cells (Cell Biolabs, Inc.) were cultured in DMEM containing 10% fetal
bovine serum, 2mM L-glutamine, and 1% penicillin/streptomycin at 37°C under
standard culture conditions. Plat-E cells were seeded at 350,000 cells per mL in
a 10cm dish the day before transfection. 5μg total plasmid DNA was transfected
via Fugene6 reagent (Promega) according to manufacturer’s protocol. Viral
supernatant was harvested 48 and 72 hours post transfection and stored at -80.
C2C12 myoblasts were obtained from ATCC (Manassas, VA) and grown in Dulbecco
modified Eagle’s medium (DMEM; 4.5 g/l D-Glucose; Gibco) supplemented with 10%
fetal bovine serum, 2mM L-glutamine, and 1% penicillin (50units/mL)/streptomycin
(50ug/mL). Prior to myogenic differentiation, C2C12s were plated at 30,000
cells/mL in 24 well plates and left to adhere overnight. The following day,
cells were washed once with PBS and incubated overnight in 1mL total of 50%
retrovirus conditioned media and 50% normal culture media containing Polybrene
(8ug/mL, Santa Cruz Biotech). 24 hours later, retrovirus was removed and
replaced with normal growth media for another 24 hours before myogenic
differentiation was induced. One transduction was sufficient to obtain \>90%
GFP/Ametrine-positive cells. Myogenic differentiation into myotubes was induced
after cells reached confluency by adding DMEM supplemented with 2% horse serum
(HS), 2mM L-glutamine, and 1% penicillin/streptomycin at 37°C in a humidified
incubator under 5% CO<sub>2</sub> for 6 days. Overexpression and knock down was
verified by qPCR analysis.
## MitoTracker and flow cytometry
Retrovirally transduced C2C12 cells were washed with PBS, trypsinized and
incubated at 37°C for 20 min with 100nM MitoTracker Red<sup>FM</sup> dyes
(Molecular Probes). MitoTracker Red probe is a red-fluorescent dye that stains
mitochondria in living cells and its accumulation is dependent upon membrane
potential (Molecular Probes). To measure viability in the samples, a Fixable
Viability Dye (Invitrogen/Thermo Fisher) was added to the cultures during the
Mitotracker staining step. This dye can be used to stain both live and fixed
cells to irreversibly label dead cells prior to analysis. Samples were washed
three times in PBS and flow cytometric analysis was performed on a BD LSRII (BD
Biosciences) instrument and analyzed using FlowJo software (TreeStar).
## mtDNA quantification
Mitochondrial content was measured using methods previously described.
Briefly, genomic DNA was extracted using the Blood & Cell culture DNA Mini Kit
(Qiagen) per manufacturer’s instructions from C2C12 samples. DNA was quantified
via a standard curve method in order to dilute all samples to 3ng/ul in TE
buffer. Once normalized for concentration, samples were subject to RT-qPCR using
a cocktail of SYBR green PCR master mix, template DNA, and mtDNA target specific
primer pairs, plus H2O. Each sample was run in triplicate and data were
averaged. This step was repeated in separate wells using nuclear DNA specific
primers and the ratio between mtDNA and nuclear DNA was quantified. Dissociation
curves were calculated for all samples to ensure the presence of a single PCR
product.
## RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR)
Muscle was harvested from WT and REV-ERBβ KO mice after a 5 hour fast, at ZT6
(Zeitgeber 6–6 hours into the murine nocturnal period). Total RNA was isolated
from tissues by guanidinium thiocyanate/phenol/chloroform extraction. RNA
concentrations were adjusted in order to load 500ng of RNA per cDNA reaction.
Total RNA was isolated from C2C12 cells using a Quick-RNA MicroPrep kit (Zymo
Research) using the manufacturers protocol. RNA concentrations were adjusted in
order to load 1μg of RNA per cDNA reaction. cDNA was synthesized using
qScript<sup>TM</sup> cDNA SuperMix synthesis kit (Quanta Biosciences).
Quantification of each transcript by quantitative real time-polymerase chain
reaction (qRT-PCR) was performed using SYBR Green dye (Quanta Biosciences) to
detect dsDNA synthesis, and analyzed using cycling threshold (Ct) values.
Relative expression was determined using the ΔΔCT method and normalized to the
housekeeping gene 18s. Quantitative RT-PCR was performed with a 7900HT Fast Real
Time PCR System (Applied Biosystems) using SYBR Green (Roche) as previously
described. Primers were designed using Primer3
([primer3.sourceforge.net](http://primer3.sourceforge.net)). Specificity and
validation of the primers were determined using an *In silico* PCR software
program ([genome.ucsd.edu](http://genome.ucsd.edu)) and melting curve analysis
to eliminate the possibility of primer-dimer artifacts and check reaction
specificity. Primer sequences can be found in.
## Statistical analysis
All data are expressed as mean±S.E.M. Statistical analysis was performed using
GraphPad Prism6 software. For multiple comparisons, two-way ANOVA was performed.
Post-test analysis (ANOVA) was performed correcting for multiple comparisons
using the Sidak-Bonferroni method. For all other independent data sets, since
the data analyzed were not random, statistical significance was determined using
two-tailed unpaired Student’s *t*-tests with no correction for multiple
comparisons. ANCOVA analysis was performed using SPSS Statistics (IBM). (N
per group per study is indicated in each figure legend). Significance was
assessed as follows: *\*p*\<0.05, \*\* *p*\<0.01, \*\*\* *p*\<0.005, \*\*\*\*
*p*\<0.001.
# Results
## Overexpression of the REV-ERBs drives mitochondrial biogenesis
We previously demonstrated that REV-ERBα was a critical regulator of muscle
mitochondrial biogenesis. To determine the cell autonomous role of REV-ERBβ
versus REV-ERBα, we utilized the C2C12 cell line, a well-studied cell culture
model commonly used to investigate myogenesis\[–\]. We retrovirally
overexpressed REV-ERBα, REV-ERBβ, or empty vector retrovirus in proliferating
C2C12 myoblasts two days prior to the induction of differentiation. MitoTracker
Red staining, indicative of functional mitochondria, revealed that
overexpression of both REV-ERBs enhanced mitochondrial biogenesis, demonstrated
by increased fluorescence in the REV-ERB overexpressing cells relative to empty
vector control. Compared to undifferentiated cells (Day 0; D0), the cells had
differentiated and acquired a muscle specific phenotype by Day 6 (D6). Very
little difference was observed in expression of *Myogenin* (*Myog*), Troponin I
slow (*Tnni1*) and Troponin 1 fast (*Tnni2*), at Day 6 (D6) between groups.
No overt viability issues were observed by day 6. Overexpression of both REV-
ERBs also resulted in increased mitochondrial content, indicated by the
increased expression of mitochondrial NADH dehydrogenase I (*mt-Nd1*),
Cytochrome c oxidase I (*mt-Co1*,) and Cytochrome c oxidase II (*mt-Co2*),
compared to empty vector control cells. These data suggest that the REV-ERBs can
drive mitochondrial biogenesis *in vitro*.
## Overexpression of the REV-ERBs regulates the molecular clock and mitochondrial metabolism genes
The REV-ERBs have been demonstrated to be core members of the circadian clock
and participate in the regulation of a diverse set of metabolic processes, thus
linking control of our daily rhythms with maintenance of metabolic
homeostasis. Given the changes in mitochondrial content observed in the REV-
ERB overexpressing cells, we next wanted to determine how expression of the
clock genes correlated with expression of genes involved in mitochondrial
function. Overexpression of REV-ERBα (gene name *Nr1d1*) significantly repressed
almost all molecular clock genes, including REV-ERBβ (*Nr1d2*), Bmal1 (*Arntl*),
Clock, the Cryptochromes (*Cry1*, *Cry2*), and the Period genes (*Per1*, *Per2*,
*Per3*), which is consistent with its role as a transcriptional repressor.
Overexpression of REV-ERBα also repressed expression of *Cd36*, a gene which is
involved in lipid uptake. In contrast, RORα and PGC1α (*Ppargc1a*), the
master regulator of mitochondrial biogenesis were upregulated with REV-ERBα
overexpression. Additionally, genes encoding enzymes of fatty acid β-oxidation,
notably carnitine palmitoyltransferase 1b (*Cpt1b*), long chain acyl-CoA
dehydrogenase (*Acadl*), short chain acyl-CoA dehydrogenase (*Acads*), *Ucp2*,
*and Ucp3*, genes involved in skeletal muscle metabolism, were also upregulated
with REV-ERBα overexpression, consistent with previously published work.
REV-ERBα also repressed expression of *Sterol regulatory element binding-protein
1* (*Srebf1*), *Stearoyl-CoA desaturase-1* (*Scd1*), *Fatty acid synthase
(Fasn*), genes involved in lipogenesis, and *Il6*, a pleiotropic muscle myokine
that has been shown to be involved in muscle growth, myogenesis, and regulation
of energy metabolism. Overexpression of REV-ERBβ had similar effects on
circadian clock and mitochondrial metabolism genes, with the exception that it
potently repressed REV-ERBα expression. The negative regulation of REV-ERBα on
REV-ERBβ expression and vice-versa is consistent their ability to negatively
regulate their own expression through conserved ROREs/RevREs in their promoter
regions. Interestingly, and in contrast to REV-ERBα overexpression, REV-
ERBβ overexpression led to increased expression of *Srebf1* and *Fasn*, but had
no effects on expression of *Scd1* or *Il6*. While it appears that REV-ERBβ was
not as effective as REV-ERBα in the overexpression studies, this could be due to
the differences in overexpression levels between the two receptors, with REV-
ERBα being more highly expressed than REV-ERBβ. Regardless, the increased
expression of genes involved in mitochondrial metabolism was consistent with the
MitoTracker staining, mitochondrial content, and skeletal muscle metabolism
genes. These results demonstrate an inverse relationship between the expression
of the core circadian clock genes and the REV-ERBs and indicate that
overexpression of REV-ERBα and REV-ERBβ can modulate the expression of genes
driving fatty acid β-oxidation and lipid metabolism in C2C12 cells. However,
under some circumstances, REV-ERBβ can not completely fulfill REV-ERBα’s role.
## Knock down of REV-ERBβ drives mitochondrial biogenesis
Work previously performed assessing REV-ERBβ’s function in C2C12s suggested that
it plays a significant role in the regulation of skeletal muscle lipid
homeostasis. However, this analysis was performed in C2C12 cells using a
dominant negative form of REV-ERBβ that lacked the ligand binding domain.
Using this approach, Ramakrishnan and colleagues reported that dominant negative
REV-ERBβ largely repressed genes involved in skeletal muscle energy expenditure
and lipid catabolism. These results were in line with data demonstrating
that loss of REV-ERBα in skeletal muscle led to decreased mitochondrial content
and function. Given the overlap in function observed in our overexpression
studies, we hypothesized that loss of REV-ERBβ would yield similar results as
loss of REV-ERBα. Therefore, to fully assess how loss of REV-ERBβ affects
myogenesis, we retrovirally overexpressed a REV-ERBβ shRNA or a CD8 control
shRNA in proliferating C2C12 myoblasts 2 days prior to the induction of
differentiation. Strikingly, knock down of REV-ERBβ enhanced mitochondrial
biogenesis, indicated by the increased staining with MitoTracker Red. Analysis
of *Myog*, *Tnni1*, and *Tnni2* indicated that compared to undifferentiated
cells (Day 0, D0), the cells had differentiated and acquired a muscle specific
phenotype by Day 6 (D6). No overt viability issues were observed by day 6.
Furthermore, loss of REV-ERBβ appeared to significantly increase expression of
*Tnni2*. Knock down of REV-ERBβ also increased mitochondrial content, indicated
by the increased expression of *mt-Nd1*, *mt-Co1*, and *mt-Co2*, compared to CD8
shRNA control cells. Interestingly, while knock down of REV-ERBβ led to
increased expression of REV-ERBα and RORα, it also de-repressed all of the core
molecular clock genes. Like overexpression of REV-ERBα, overexpression of RORα
has also been shown to regulate the expression of genes involved in skeletal
muscle metabolism. Knock down of REV-ERBβ also resulted in increased
expression of almost all genes analyzed that were involved in lipid and skeletal
muscle metabolism, including *Cd36*, *Cpt1b*, *Acadl*, *Ucp2*, *and Ucp3*, genes
involved in skeletal muscle, which was consistent with the MitoTracker staining.
No change was observed in *Acads*. However, knock down of REV-ERBβ resulted in
decreased expression of PGC1α (*Ppargc1a*), *Srebf1*, *Fasn*, and *Il6*, but no
change was observed in *Scd1*. While these results were largely in contrast to
previously published work using a dominant negative REV-ERBβ construct, these
results were at least consistent with the notion that in C2C12 cells, REV-ERBβ
plays a role in the regulation of muscle metabolism and energy expenditure.
Interestingly, these data are in contrast to the overexpression data and show a
correlation between the circadian clock and skeletal muscle metabolic gene
expression.
## Loss of REV-ERBβ drives skeletal muscle mitochondrial gene expression *in vivo*
Given the surprising results we observed in C2C12 cells, we next wanted to
determine whether loss of REV-ERBβ affected skeletal muscle gene expression *in
vivo* in a similar manner. Using REV-ERBβ-deficient mice, we isolated (whole
quadriceps) skeletal muscle from wild-type (WT) and REV-ERBβ knock out (KO) mice
at Zeitgeber 6 (ZT6), 6 hours post lights-on and the time point in which peak
REV-ERB mRNA expression occurs. qRT-PCR analysis indicated that, similar to
the C2C12 data, loss of REV-ERBβ de-repressed most of the core clock genes,
including REV-ERBα, RORα, Bmal1, and Clock. We observed no effects on *Cry2* or
*Per3*. Similar results were observed in REV-ERBα KO muscle. Loss of REV-ERBβ
also led to increased expression of genes involved in lipid and skeletal muscle
metabolism (*Cd36*, *Cpt1b*, *Acadl*, *Acads*) and energy expenditure (*Ucp2*,
*Ucp3*). However, unlike the C2C12 cells, REV-ERBβ KO mice also had increased
expression of PGC1α (*Ppargc1a*). Similar to the C2C12s, REV-ERBβ KO mice also
exhibited decreased expression of *Srebf1*, *Fasn*, and *Il6*, with little
effect observed on *Scd1*. Moreover, loss of REV-ERBβ appeared to shift the
muscle towards a more oxidative phenotype as we observed increased expression of
tropomyosin 3 (*Tpm3*), a marker of oxidative type 1 fiber and myosin heavy
chain IIa (*Myh2*), a myosin heavy chain gene more associated with oxidative
fibers than others. The expression of *Myh4*, a marker of type 2b glycolytic
fibers, was unaltered. The shift towards a more oxidative phenotype in REV-ERBβ
KO mice was in stark contrast to what was observed in REV-ERBα KO mice, which
was largely a shift towards a less oxidative phenotype demonstrated by decreased
expression of PGC1α, *Cpt1b*, *Acadl*, *Acads*, *Ucp2*, *Ucp3*, *Myh2*, and
*Tpm3* and is consistent with previously published results. However, not all
changes in gene expression between REV-ERBβ KO and REV-ERBα KO mice were
conflicting. REV-ERBα KO mice also demonstrated decreased expression of the
lipogenic genes *Srebf1* and *Scd1* in muscle while loss of REV-ERBα de-
repressed *Fasn* and *Il6* However, unlike the muscle tissue, gene expression
analysis of livers from REV-ERBβ KO and REV-ERBα KO mice demonstrated similar
trends in gene expression (*G6Pase*, *Cd36*, *Clock*) or no effects (*Pepck*) on
gene expression *in vivo*. These data are consistent with previously published
work indicating that REV-ERBα and REV-ERBβ have largely overlapping roles in
liver metabolism, with REV-ERBα acting as the dominant factor. These data
suggest that in liver, REV-ERBβ appears to have overlapping functions to REV-
ERBα. However, in skeletal muscle, the effects mediated by the loss of REV-ERBβ
are in contrast to those of REV-ERBα.
## REV-ERBβ-deficient mice exhibit an altered circadian metabolism and feeding schedule
Due to the increased expression of genes involved in mitochondrial biogenesis in
the REV-ERBβ KO mice compared to WT controls, we wanted to determine whether
this translated to effects on metabolism and any other circadian driven
behavior. Real-time oxygen consumption (VO<sub>2</sub>), carbon dioxide
production (VCO<sub>2</sub>), ambulatory activity and food consumption were
monitored in twelve week-old male mice fed a normal chow diet using the CLAMS
system. Energy expenditure (EE) and RER (Respiratory exchange ratio) were
calculated based on the gas exchange as described in the Methods section. Body
composition was obtained just prior to the CLAMS analysis, with no differences
observed in lean, fat, and fluid masses or total body weight between groups. The
RER is a surrogate indicator of the caloric source being utilized for energy
production by an animal. It varies between 0.7, where lipids are the predominant
fuel source, to 1.0, where carbohydrates are the main contributors. The REV-ERBβ
KO mice showed a delay in the typical circadian drop in RER that occurs from the
dark to light phase transition when mice shift from high activity and feeding to
resting and sleep. This prolonged high RER cycle indicates an increased relative
contribution of carbohydrates as an energy source in the KO animals. This could
be due to their increased chow consumption, observed during the light phase
while in the CLAMS. This light-phase specific increase in eating was further
confirmed in REV-ERBβ KO mice tested in the BioDAQ system, which uses highly
sensitive feeding monitoring hoppers adapted to regular housing cages.
Additionally, an increase in energy expenditure was detected in association with
the observed increased daytime chow consumption in the REV-ERBβ KO mice.
Nighttime energy expenditure in REV-ERBβ KO mice was comparable to WT mice,
despite the KO animals being less active during this time. Whether the increase
in energy expenditure in the KO mice during the daytime can be attributed to
elevated feeding and digestive processes *per se* remains to be tested.
Ambulatory activity during the light-phase was similar between the groups and
thus, cannot explain that. However, upon fasting, the KO’s demonstrated
decreased RER relative to WT controls, which may be a result from a faster
transition to fat burning. Regardless, the increased caloric output can, at
least in part, account for the absence of weight gain by the KO’s in spite of
their higher caloric intake. These data indicate that REV-ERBβ regulates
circadian behaviors and metabolism *in vivo*.
# Discussion
REV-ERBα has recently been identified as a key regulator of skeletal muscle
mitochondrial function. Due to the overlapping gene expression profiles and
similarity in DNA binding domains, REV-ERBβ is thought to be redundant to REV-
ERBα. Our studies were aimed at gaining a better understanding of REV-ERBβ’s
function in skeletal muscle and overall metabolism. In this report, we utilized
the C2C12 *in vitro* cell culture model and REV-ERBβ-deficient mice to
investigate the role of this NR in comparison to REV-ERBα’s function in skeletal
muscle *in vitro* and *in vivo*. Here we report that overexpression and knock
down of REV-ERBβ drives mitochondrial biogenesis in C2C12 cells, exhibited by
increased MitoTracker Red staining and increased expression of genes involved in
skeletal muscle energy metabolism. We also showed that skeletal muscle from REV-
ERBβ KO mice exhibited a similar gene expression profile as the C2C12 cells in
which REV-ERBβ was knocked down, which was in contrast to skeletal muscle gene
expression in REV-ERBα KO mice. Furthermore, we demonstrated that REV-ERBβ KO
mice present with an altered metabolic phenotype and feeding behavior schedule,
with KO mice eating more and utilizing more carbohydrates as fuel during their
nocturnal/sleep period. In terms of muscle and energy expenditure, our data
suggest that REV-ERBβ may not be as functionally redundant to REV-ERBα as
originally hypothesized.
Our initial hypothesis was based on the view, held by some in the field, that
REV-ERBα and REV-ERBβ are functionally redundant, with REV-ERBα acting as the
dominant factor. Overexpression studies are excellent tools to determine
whether a protein, in this case REV-ERBβ, is able to perform certain cellular
functions. Our initial studies in C2C12 cells supported this hypothesis as
overexpression of each REV-ERB resulted in relatively similar functional
outputs, largely increased mitochondrial biogenesis and expression of genes
involved in skeletal muscle metabolism. However, the shRNA knock down of REV-
ERBβ drove further inquiry into REV-ERBβ’s function in skeletal muscle. The
increased MitoTracker Red staining and the changes in gene expression observed
surprised us, particularly since evaluation of C2C12 cells using a dominant
negative REV-ERBβ yielded opposite results to ours. However, this construct
still possessed REV-ERBβ’s N-terminal region, which has been shown to interact
with the transcriptional co-factor Tip60 in order to regulate gene transcription
in a ligand-independent manner. Thus, REV-ERBβ was not completely
eliminated and could have recruited co-factors to modify gene transcription in a
ligand-independent manner. Alternatively, since RORα and REV-ERBα bind the same
DNA consensus sequence as REV-ERBβ, the overexpression of the dominant negative
REV-ERBβ could have blocked the ability of RORα or REV-ERBα to bind to the RORE
and again, affect transcription. However, use of REV-ERBβ shRNA bypassed these
issues and may account for the differences.
Overexpression of REV-ERBα has been demonstrated to drive mitochondrial
biogenesis whereas loss of REV-ERBα has the opposite effect. However, the
effects rendered by overexpression and loss of REV-ERBβ were not opposite to
each other. It is possible that the increased mitochondrial biogenesis in the
absence of REV-ERBβ is a consequence of increased REV-ERBα or increased RORα.
Indeed, we consistently observed increased expression of both NRs in the absence
of REV-ERBβ. Like overexpression of REV-ERBα, overexpression of RORα has also
been shown to regulate the transcription of genes involved in lipid metabolism
and energy metabolism in skeletal muscle. REV-ERBα, RORα, and REV-ERBβ have
been demonstrated to bind to conserved ROREs/RevREs in REV-ERBα’s promoter
region, with RORα driving gene expression whereas the REV-ERBs repress
REV-ERBα gene expression. This autoregulation is likely the reason for the
dramatic downregulation of gene expression observed on REV-ERBβ when REV-ERBα
was overexpressed and vice versa. It is possible that knock down or loss of REV-
ERBβ relieved repression on REV-ERBα, hence the increased expression *in vitro*
and *in vivo*. Another possibility is that the overexpression of RORα, which can
also bind ROREs, drove gene expression and thus, increased mitochondrial
biogenesis. Alternatively, loss of REV-ERBβ could have relieved repression on
*Bmal1*, which is known to activate RORα and REV-ERBα transcription through
binding to their respective E-box regions. Increased *Bmal1* may account for
the increased expression of REV-ERBα and RORα observed both *in vitro* and *in
vivo*. Future studies need to be performed to determine the mechanism and which
NRs may be driving the increased mitochondrial function in both REV-ERBβ-
deficient C2C12 cells and in skeletal muscle *in vivo*.
The circadian clock influences a broad range of physiological processes,
including fasting/feeding cycles. Initial analysis of REV-ERBα KO versus
REV-ERBβ KO mice indicated that while loss of REV-ERBα affected circadian
output, loss of REV-ERBβ had minimal effect. However, our data indicate that
REV-ERBβ does affect circadian gene expression in a manner similar to REV-ERBα.
Overexpression and knock-out of REV-ERBβ generated a similar gene expression
profile as REV-ERBα overexpression and knock-out. However, our data indicate
that at least *in vitro*, the circadian clock is not as intimately linked to
skeletal muscle metabolism as initially thought. While overexpression and knock
down had different effects on expression of core clock components, the skeletal
muscle metabolic genes were consistently upregulated and appeared to depend more
on the expression of RORα and the REV-ERBs. While this could also be said for
the *in vivo* data, we do know that what occurs *in vivo* is significantly more
complex and REV-ERBα KO mice present with altered circadian rhythms, which could
affect the muscle phenotype. Our data also indicate that REV-ERBβ affects
circadian outputs, indicated by increased food consumption during the day. This
increased food intake could account for the shift and increased RER and EE
observed during the day when measured by indirect calorimetry. However, research
has revealed that disordered eating, or eating when we are supposed to be
sleeping, contributes to weight gain, metabolic syndrome, and obesity.
Despite this, REV-ERBβ KO mice do not gain weight over time, instead maintaining
similar weight profiles as WT littermate controls. It is possible that the
metabolic demands of the skeletal muscle may compensate for the increased food
intake. This may also explain the decreased activity observed in the REV-ERBβ KO
mice during their “active” periods. That is, moving less compensated for the
increased metabolism with no change in food intake. Alternatively, the food
intake during the day may have disrupted their sleep schedule and the decreased
movement may be a function of sleep compensation. Clearly, further in-depth
analysis of these behaviors is needed to better understand the phenotype
observed.
# Conclusions
REV-ERBβ plays a role in skeletal muscle mitochondrial biogenesis both *in
vitro* and *in vivo*. This effect on mitochondrial gene expression in REV-ERBβ
KO mice differs from that of REV-ERBα KO mice as each receptor appears to have
effects opposite to each other. Furthermore, these differences translate to
profound differences on metabolism *in vivo*. Our data suggest that REV-ERBβ may
not be as functionally redundant to REV-ERBα as originally hypothesized. Thus,
development of dissociated REV-ERB modulators (REV-ERBα-specific versus REV-
ERBβ-specific) may be beneficial for the treatment of metabolic syndrome.
# Supporting information
We would like to thank Dr. Nelson Bruno for his helpful comments and critiques
of experimental design and data analysis.
[^1]: The authors have declared that no competing interests exist.
[^2]: Current address: Institute for Genomic Medicine, Columbia University
Medical Center, New York, NY, United States of America
[^3]: Current address: Center for Clinical Pharmacology, Washington
University School of Medicine and St. Louis College of Pharmacy, St. Louis,
Missouri, United States of America
|
# Introduction
D-dimer is a degradation product of crosslinked fibrin that appears in the blood
after a blood clot is degraded by fibrinolysis. Elevated D-dimer levels in the
blood predict increased secondary fibrinolytic activity and are a principal
marker of hypercoagulation and thrombosis. Many studies have shown that high
D-dimer levels are associated with the risk of deep venous thrombosis (DVT) and
pulmonary embolism, which are serious post-surgery complications with
high mortality especially in patients with malignant tumours. Due to the injury
to vascular endothelial cells caused by toxins released from fast growing tumour
cells and the fibrinolytic activator on the surface of tumour cells, cancer
patients often exhibit abnormal coagulation and fibrinolytic activities and
their D-dimer levels tend to be higher than those in non-neoplastic populations.
The D-dimer levels of almost all cancer patients exceed the recommended limits
according to the existing reference range (0–0.5 mg/L). Therefore, the high risk
of DVT according to this range might be overestimated.
It is suggested that the current D-dimer reference range is unsuitable for
cancer patients, which limits the application of D-dimer testing in laboratory
diagnosis and the prevention of tumour venous thrombosis and venous
thromboembolism (VTE). The present prospective study measured plasma D-dimer
levels in a large sample of cancer patients to investigate the range of D-dimer
concentration in the absence of VTE. In addition, changes in D-dimer levels in
cancer patients were determined during the perioperative period and after
chemotherapy or radiotherapy.
# Materials and Methods
## Patients and controls
### Patients with malignant tumours
A total of 1368 patients treated at Hubei Tumor Hospital and Wuhan Tongji
Hospital between January, 2010 and August, 2013 were selected. The exclusion
criteria comprised the following factors that may affect D-dimer level:
hypertension; diabetes; personal or family history of thromboembolic disease;
coagulopathy; cardiovascular/cerebrovascular disease; autoimmune disease (such
as rheumatoid arthritis, systemic lupus erythematosus, or idiopathic
thrombocytopenic purpura); infection in the previous 30 days with body
temperature \> 37.5°C; surgery or trauma in the previous 30 days; blood
transfusion in the previous half year; stressful state on the day before blood
collection; and patient taking medications that may affect coagulation and the
fibrinolytic system. Each patient was diagnosed with malignant disease, most
based on pathology findings; some patients had advanced stage inoperable cancer
confirmed with CT or another imaging method. The patients comprised the
following: 142 liver cancer, 150 pancreatic cancer, 140 breast cancer, 120
stomach cancer, 120 colorectal cancer, 240 lung cancer, 120 gynaecological
tumour, 123 oesophageal cancer, and 120 head and neck tumour. The average age
was 55 years; 621 patients were male and 654 were female. Thirteen of the cancer
patients (all male) were diagnosed with DVT and excluded from the study.
### Patients with benign tumours
A total of 93 in-patients treated at Hubei Tumor Hospital from January, 2010 to
August, 2013 were selected. The selection criteria were the same as above. Each
patient received a pathological diagnosis of benign tumour. Their average age
was 48.6 years; 20 were male and 73 were female.
### Healthy control group
A total of 150 in-patients treated at Wuhan Tongji Hospital during the same
period were selected. Their average age was 44.2 years; 103 were male and 47
were female.
### Ethics Statement
This study was approved by the ethics committee of Hubei Tumor Hospital and
Wuhan Tongji Hospital. All participants joined the study voluntarily and
provided written informed consents. The committee approved the experiments and
the methods were conducted in accordance with the approved guidelines.
## Methods
### Sample collection, instruments, and reagents
Samples of 1.8 mL of elbow venous blood were collected in anticoagulant tubes
with 109 mol/L sodium citrate for an anticoagulant to venous blood ratio of 1:9.
After immediate mixing, the samples were centrifuged at 3000 × *g* for 10 min
and then tested within 2 hours. D-dimer, activated partial thromboplastin time
(APTT), prothrombin time (PT), thrombin time (TT), and fibrinogen (FiB) level
were determined using a STA-R Evolution coagulant analyser with its specific
reagents (Stago, Asnières-sur-Seine, France). Platelet levels were tested using
a five-part blood cell counter with its reagents (Sysmex, Kobe, Japan).
### D-dimer, APTT, PT, TT, and Fib assay
A STA-R Evolution coagulant analyser (Stago) was used to measure D-dimer, APTT,
PT, TT, and FiB by immune turbidimetry. All samples were handled as routine
clinical samples.
### Analysing the correlation between D-dimer levels and tumour stages or tumour pathological types
D-dimer was compared among patients with tumours of stage I-II, or stage III-IV;
moreover, in the same type of cancer, D-dimer was compared among patients with
different pathological types.
### D-dimer levels in tumour patients during the perioperative period
Of the 1275 patients with malignant tumours, 101 who underwent surgery were
selected. These comprised 39 liver cancer, 10 breast cancer, 10 stomach cancer,
10 colorectal cancer, 10 lung cancer, 17 gynaecological tumour, and five head
and neck tumour patients. Venous blood was collected on day 1, day 3, and 1 week
after surgery for measurement of D-dimer level.
### D-dimer levels in tumour patients before and after radio/chemotherapy
Of the 1275 patients with malignant tumours, 130 cases who underwent
radio/chemotherapy were selected. These comprised 39 cases of liver cancer, 19
cases of breast cancer, 14 cases of stomach cancer, 18 cases of colorectal
cancer, 35 cases of lung cancer, 2 oesophageal cancer, and 3 cases of
gynaecological tumour patients. Of these 130 patients, 29 cases were treated
with radiotherapy and 101 were treated with chemotherapy (detailed chemotherapy
regiments see supporting information 1). All plasma samples were collected after
one cycle of therapy to determine D-dimer levels.
### Analysing the correlation between D-dimer levels and cancer prognosis
Of the 1275 patients with malignant tumours, 190 patients were tracked after
being discharged from hospital to reveal the relevance of initial D-dimer levels
to cancer prognosis. These cases comprised 15 cases of gastric cancer, 26 cases
of colorectal cancer, 23 cases of liver cancer, 10 cases of pancreatic cancer,
30 cases of lung cancer, 15 cases of gynaecologic cancer, 48 cases of breast
cancer, 21 cases of head neck cancer and 2 cases of oesophageal cancer.
## Statistical analysis
SPSS16.0 (IBM, Armonk, NY, USA) was used for statistical analysis. First, the
Kolmogorov–Smirnov method was used to test the normality of the D-dimer data,
which were found to have a non-normal distribution. Therefore, simultaneous
quantile regression was performed to construct a median, 5th percentile, and
95th percentile model of normal tumour D-dimer concentration. The D-dimer levels
of the benign tumour group, the malignant tumour group, and the healthy controls
were compared using the Mann–Whitney *U* test; *P* \< 0.05 indicated
statistically significant differences. Comparisons between malignant tumours in
different locations or the same malignant tumour at different stages or of
different pathological types were performed using the Mann–Whitney *U* test; *P*
\< 0.05 indicated statistically significant differences. D-dimer levels before
and after treatment were also compared using the Mann–Whitney *U* test, with *P*
\< 0.05 indicating statistically significant differences.
# Results
## D-dimer levels in benign tumour group, malignant tumour groups, and healthy controls
displays a diagram of the entire study. The baseline characteristics of the
patients are reported in. The conventional coagulation measures (APTT, PT, TT,
Fib, and platelet count) in all cases were normal. The D-dimer level in each
malignant tumour group was higher than that in the benign tumor group (*P* \<
0.05) and in the healthy control group (*P* \< 0.05). There was no significant
difference between the benign tumour group and the healthy controls (*P* =
0.11). D-dimer levels in participants who were older than 55 years were much
higher than those in patients less than 55 years old in the healthy controls and
the benign tumour group, independent of gender. In the malignant tumour group,
participants over 65 years had higher D-dimer levels than those below 65 years,
independent of gender. Thus, gender did not affect the D-dimer level, whereas
age did. The D-dimer levels of older participants were higher than those of
younger participants.
## D-dimer range and level in tumour patients and healthy controls
The ranges of D-dimer concentration in malignant and benign tumour patients and
healthy controls were represented as the median and 5th and 95th percentile
values. D-dimer levels in liver, pancreatic, stomach, colorectal, lung, and
oesophageal cancer patients were significantly higher than those in breast
cancer patients (*P* \< 0.05).
## D-dimer level and tumour stage
When D-dimer was compared among patients with tumours of differing stage in the
same primary site, those with stage III/IV disease had significantly higher
levels than those with stage I/II disease (*P* \< 0.05), as shown in.
## D-dimer level and pathological type
When D-dimer was compared among patients with cancer in the same primary site
but of differing pathological type, there were no significant differences for
most tumour types (*P* \> 0.05). D-dimer levels were higher in bile duct cell
carcinoma patients than in hepatocellular carcinoma patients (*P* = 0.018) and
in squamous cell carcinoma compared with adenocarcinoma in patients with lung
cancer (*P* = 0.035).
## Changes in D-dimer levels of tumour patients without thrombosis in the perioperative period
Plasma D-dimer levels in 101 tumour patients without thrombosis were
significantly raised (up to 20 mg/L) on day 1 after surgery but had
significantly decreased on day 3; they had returned to within the recommended
range for cancer patients 1 week after surgery. In some cases, D-dimer levels
continued to increase after surgery with no sharp decrease after 1 week; this
was observed in one stomach cancer patient, ten liver cancer patients, and two
pancreatic cancer patients. Five of them had definitely confirmed VTE by CT
films. Ten of them recovered and three died. Continued monitoring of the 10
recovered patients showed that their D-dimer levels gradually decreased to
within the recommended range for cancer.
## Effect of radio/chemotherapy on plasma D-dimer levels
There was no significant difference between plasma D-dimer levels before and
after treatment in 101 patients who underwent chemotherapy and 29 who received
radiotherapy (*P* = 0.94 and *P* = 0.72, respectively).
## Initial D-dimer levels correlated with prognosis
Survival rate of some cancer patients were successfully tracked by the end of
2015. As shown in, cancer patients with higher initial D-dimer value were shown
poor prognosis compare with those who had lower initial D-dimer value.
# Discussion
The kit used to measure D-dimer levels in this study is commonly employed in
clinical laboratories and in its instructions defines a concentration of 0.5
mg/L as normal. This value has been shown to be appropriate for healthy people;
however, more than 60% of cancer patients with normal coagulation exhibit
D-dimer levels greater than 0.5 mg/L. In the present study we aimed to
investigate the range of D-dimer concentration in cancer patients and its
influencing factors. Even if such a range does not contribute to the diagnosis
of VTE, it can provide data to support the exclusion of this disease. All steps
in the study strictly followed the rules set out in the CLSIC28-A3 document and
subjects were selected based on rational inclusion and exclusion criteria.
To explain the differences in D-dimer level among the various cancers, we
systematically analysed all patient data, including their basic characteristics,
routine clinical laboratory tests, clinical treatment, and pathological
diagnosis. Broadly, in the cancer population D-dimer level was independent of
gender but was affected by the age of the patient and the stage of the tumour.
D-dimer was also influenced by the pathological type of the tumour in bile duct
cell carcinoma patients, who had higher levels than hepatocellular carcinoma
patients, and, among lung cancers, in squamous cell carcinoma patients, who had
higher levels than adenocarcinoma patients (*P* \< 0.05); these significant
differences may have been due to the later stage of the cancers in these cases.
Haase *et al*. showed that D-dimer levels increased markedly with age in healthy
individuals. Consistent with this study, we found that patients aged over 55
years had higher D-dimer levels than those aged less than 55 years (*P* \<
0.05). Haase *et al*. also reported a certain degree of differences were found
between the reference ranges for males and females among older people; yet they
also indicated the difference was minor and the clinical relevance was highly
questionable. Therefore, no difference of D-dimer levels between the sexes in
our study is a comprehensible result.
Interestingly, we found that the ranges of D-dimer concentration in breast
cancer and head and neck tumour patients differed from those in the other
malignancies. D-dimer levels in patients with breast or head and neck cancer
were much lower than those in patients with liver, pancreatic, stomach,
colorectal, lung, gynaecological, or oesophageal cancer (*P* \< 0.05). Some
studies have reported D-dimer levels in cancer patients to be strongly
associated with the number of metastatic nodes and patient prognosis. Compared
with liver, pancreatic, stomach, colorectal, lung, gynaecological, and
oesophageal cancer, breast and head and neck cancers have lower metastatic rates
and a more favourable prognosis based on clinical statistics. Although the
prevalence of lymph node metastasis might be high in the early stages of breast
cancer, it is generally accepted that 5-year survival in breast cancer is much
higher than that for other carcinomas. We also found that, among patients with
the same cancer, D-dimer levels were markedly higher in stage III/IV disease
than in stage I/II. The significant differences observed between tumour stages
show that D-dimer level is also strongly associated with the grade of
malignancy.
Surgery may induce embolisms. Our findings demonstrate the importance of
monitoring D-dimer levels in all perioperative cancer patients. D-dimer changes
in such patients show a specific trend, as described above. Patients whose
D-dimer changes resemble this trend may suffer VTE, and persistently elevated
D-dimer levels may indicate a poor prognosis. It is therefore crucial to monitor
the D-dimer levels of cancer patients at 3 days and 7 days postoperatively.
Clinicians should take the necessary measures to prevent VTE or DVT if levels
have not decreased to normal 1 week after surgery.
The D-dimer levels of 130 patients with malignant tumours were measured 1 week
after they underwent radio/chemotherapy. D-dimer did not appear to be influenced
by radio/chemotherapy based on our results. The use of bevacizumab combined with
chemoradiotherapy is associated with a higher risk of VTE compared with
antiangiogenic therapy alone. Among 29 patients in our study who underwent
radiotherapy and 101 who received chemotherapy, none was given bevacizumab at
any point in his or her treatment. Therefore, we suggest that the effects of
radio/chemotherapy on D-dimer levels should be evaluated in light of any drugs
that the patient has been administered.
The D-dimer level of patients whether can be served as an indicator of prognosis
is also drawing us, even though so many factors might affect 5-year survival
rate of cancer patients. As we expected, our study showed the initial D-dimer
level of dead patients were obviously higher than that of the patients who were
still alive at the end of 2015. Apart from gastric cancer patients, the initial
d-dimer levels of other dead patients were higher than 1.00 mg/L, including
patients in liver cancer, pancreatic cancer, lung cancer and gynaecologic
cancer. These results consist with other reports before \[, and \]. The previous
study with regard to lung cancer found the d-dimer median concentration was
0.84mg/L. As presented in our results, such level was 0.7mg/L. To date, our
study firstly analyzed the d-dimer ranges on the other types of cancer. However,
we couldn’t make a conclusion on the definite d-dimer range which can be served
as an indicator of poor prognosis, because the cases of tracked patients are not
idea. Hence, further studies are required to confirm our findings.
# Conclusions
We have discussed the cancer-specific concentration range for D-dimer and
evaluated factors that could influence D-dimer levels in cancer patients.
D-dimer level is independent of gender but dependent on patient age, tumour
primary site, and tumour stage. In addition, monitoring changes in D-dimer level
is critical for all perioperative cancer patients. Clinicians should take the
necessary measures to prevent VTE or DVT if the D-dimer level has not decreased
to the recommended range 1 week after surgery. The applicability of this
research should be further investigated in a large prospective study. When
sufficient cases and influencing factors are available, we may be able to
establish an acceptable “normal” D-dimer reference range for cancer patients.
# Supporting Information
We are grateful to the Department of Microbiology, School of Basic Medical
Science, Wuhan University, for supporting this work. We would like to thank
Stago Diagnosis Company for reagent support. We also thank Lang Chen and
Xianglei Wu for their excellent advices.
[^1]: We have the following interests: Anming Yu is employed by Stago
Diagnosis Company. Stago Diagnosis Company supplied partial D-dimer testing
reagents and some technic supports. There are no patents, products in
development or marketed products to declare. This does not alter our
adherence to all the PLOS ONE policies on sharing data and materials.
[^2]: **Conceived and designed the experiments:** D. Li JY YW. **Performed
the experiments:** JY D. Lei FY FP HZ KW HC. **Analyzed the data:** JY XT.
**Contributed reagents/materials/analysis tools:** AY XW LC. **Wrote the
paper:** JY D. Li.
|
# Introduction
Every year more than 50,000 women in the UK develop breast cancer, with 11,433
dying from the disease. Globally, it is the most common cause of female cancer
death worldwide, with more than 500,000 women estimated to die every year from
over 1.65 million cases. Nearly one quarter of breast cancer patients in the UK
die within 10 years, with the majority presenting with distant disease several
years after their initial breast cancer diagnosis. This highlights an urgent
need for prognostic, predictive and pharmacodynamic biomarkers to identify
patients at increased risk of recurrent disease, for early identification of
recurrence, to facilitate tailored treatment and to monitor treatment response.
Circulating tumour cells (CTCs) isolated from venous blood samples could be a
relatively non-invasive real-time liquid biomarker that allows detection,
monitoring and phenotyping of breast cancer. CTCs are rare cells (few per 10 ml
blood /100 million leukocytes and 50 billion erythrocytes), and therefore highly
sensitive assays with techniques to enrich then characterise CTCs are required.
Techniques to enrich for CTCs are based either on tumour cell antigen expression
or cell size or density. However, all these techniques are limited by their
ability to capture all CTCs given the presence of CTC heterogeneity. Once
enriched, CTC identification and characterisation can be achieved on a cellular
level through microscopy or flow-cytometry, or on a molecular level using RT-
PCR, however once again tumour heterogeneity remains the major challenge.
Currently the only FDA approved CTC technology is the antibody-based CellSearch
system. This identifies epithelial cells through their expression of the
epithelial markers Epithelial cell adhesion molecule (EpCAM), cytokeratins 8, 18
and 19, and the lack of CD45 leukocyte marker expression. A similar, widely used
technology is AdnaTest BreastCancer (AdnaGen, Langenhagen, Germany), which uses
both an anti-EpCAM antibody and an antibody against the epithelial cell surface
associated glycoprotein, mucin-1 (MUC-1). However CTCs are heterogeneous, and
such positive selection techniques based on expression of epithelial markers are
limited by the potential loss of CTC expression of such epithelial phenotype as
the CTCs develop a more stem cell-like phenotype and behaviour pattern due to
the epithelial-to-mesenchymal transition (EMT) that occurs to facilitate tumour
cell adhesion, motility and subsequent intravasation.
Although CellSearch has widespread popularity in the metastatic breast cancer
setting, its use in early breast cancer is more limited. A study of 2026 higher-
risk early breast cancer patients (66% node positive) confirmed the presence of
CTCs as an independent prognostic marker for disease-free and overall survival.
However only 21.5% of patients had CTCs, despite a large blood volume (30ml)
analysed.
In metastatic breast cancer, a major proportion of CTCs show EMT and tumour stem
cell characteristics, with such characteristics being associated with treatment-
resistance and worse prognosis. Cytokeratin-negative CTCs may represent a more
aggressive CTC subpopulation and a majority of blood-borne tumour cells.
Therefore whilst more established CTC enumeration and identification
technologies such as CellSearch and AdnaTest employ anti-epithelial marker
antibodies, more recently there has been a push towards size-based isolation to
improve the CTC capture rate and better capture CTC heterogeneity. There is a
range of promising non-epithelial based methodologies under evaluation, none of
which have yet risen to the prominence that CellSearch has in epithelial-based
CTC detection.
The ISET device (Rarecells) is a filtration based CTC enrichment technology that
collects large blood cells (\>8μm) including CTCs and circulating tumour
microemboli (CTM) on a filter membrane. Of the ‘large cells’ captured by this
technique, CTCs are routinely identified by morphology. These CTCs and CTMs
containing both epithelial and mesenchymal CTC subpopulations can then be
subjected to immunomorphological, immunofluorescence, genetic, DNA or RNA
analysis. ISET has allowed the identification of CTCs co-expressing cytokeratins
and the mesenchymal marker vimentin. Higher rates of CTC positivity by ISET than
by Cellsearch using a morphology-based approach have been reported in NSCLC,
pancreatic cancer, metastatic prostate cancer and melanoma despite larger cell
size criteria. This is consistent with the presence of non-epithelial CTC
populations. CTC enumeration by ISET has been correlated with shorter survival
in hepatocellular carcinoma.
In this exploratory study, we aimed to determine the role of CTC enumeration by
a non-epithelial marker dependent technique, using ISET in a high-risk early
(non-distant metastatic) breast cancer population, with a view to developing
novel biomarkers for response to treatment.
## Patients and methods
### Patient population
Following written informed consent, treatment-naïve, early breast cancer
patients undergoing surgical resection were recruited at University Hospital of
South Manchester (UHSM). Sex matched healthy controls were also recruited. CTC-
positive (by CellSearch) metastatic breast cancer patients with oestrogen
receptor positive disease were recruited solely for the development of an ER-
based multiplex immunocytochemistry (ICC) assay.
This study was approved by Oldham Research Ethics Committee (Ref: 09/H1011/47)
and NRES Committee North West—Greater Manchester Central Ethics Committee (Ref:
12/NW/0447) and sponsored by University Hospital of South Manchester.
### Blood sampling
A 20ml sample of peripheral venous blood was collected using CellSave
preservative and EDTA vacutainer tubes for CellSearch and ISET analysis
respectively. Blood was collected preoperatively and at surgery shortly after
tumour removal, to investigate any systemic tumour or epithelial cell release as
a result of surgical tissue handling. Blood was stored at room temperature until
analysis.
### ISET filtration
Within four hours of venesection, whole blood was diluted 1:9 with Rarecells
buffer, and left to stand for 10 minutes. This allowed lysis of erythrocytes and
fixation of nucleated cells as previously described. The mixture was then
filtered using the ISET filtration device at a pressure of 5–9 kPa as per
manufacturer’s instructions (Rarecells) to allow capture of large cells (\>8μm)
on the ISET filter membrane. The membrane was allowed to dry overnight at room
temperature before storage at -20°C.
### Immunocytochemical (ICC) staining of ISET filters: Morphology based method
Following thawing ISET ‘spots’ from filters corresponding to 1ml whole blood
were rehydrated using TBS buffer and subjected to antigen retrieval in a 99°C
water bath using pH6 retrieval solution (Cat# S1699, Dako). Following
permeabilisation (TBS + Triton X-100) and peroxidase blocking steps, the ISET
spots were incubated with a primary mouse CD45 (Monoclonal, C7230, Dako,
Glostrup, Denmark, 1/30 dilution) and CD144 (Monoclonal, 14-1449-82,
eBioscience, San Diego, USA, 1/50 dilution) antibody cocktail at 4°C overnight.
Anti-mouse-HRP secondary antibody (K4001, Dako) was applied the next day, with
DAB substrate subsequently applied and the spots counterstained with
haematoxylin. Spots were mounted onto slides using Faramount mounting media and
allowed to set overnight at room temperature.
### Multiplex immunocytochemical (ICC) oestrogen receptor alpha (ERα)-based staining
The nuclear ER receptor represents a potential non-epithelial marker of CTCs in
the ER positive subset of breast cancer patients. Enzo Life Science’s Multiview
(Mouse-HRP/Rabbit-AP) multiplex IHC Kit (ADI-050-100-0001, New York, USA) was
used in combination with a rabbit Oestrogen Receptor alpha (ERα) antibody
(Monoclonal, ab108398, Abcam, Cambridge, UK, 1/100 dilution) in a method
incorporating the antigen retrieval, permeabilisation, peroxidase blocking and
CD45/CD144 staining steps described above. ERα/CD45/CD144-stained ISET spots
were mounted onto slides using Faramount mounting media as above. Oestrogen
receptor positive MCF-7 breast cancer cells (ATCC HTB-22, obtained directly)
spiked into healthy donor blood were used in assay development.
### Scoring of CTCs
The mounted ISET spots were scanned using a Bioview automated light microscopy
scanning system based on an Olympus BX61 microscope, using Duet software
(Bioview, Rehovot, Israel). A circle of radius of 4000μm from the centre of each
ISET spot was scanned to capture all cells. Galleries of images were manually
reviewed using the Bioview Solo software. In the morphology based approach, CTCs
were identified based on a set morphology definition as per previous
publications and under the guidance of a consultant breast-specialist
histopathologist (SP). All images were reported by JC, with a subset of the
images reviewed by SP for concordance. Cells greater or equal to 16μm diameter,
with hyperchromatic nuclei and negative for CD45/CD144 brown chromogen staining
were classified as CTCs. For the multiplex immunocytochemistry (ICC) ERα-based
approach, ERα positive CTCs were defined as cells ≥16μm diameter with positive
for ERα red chromogen staining and negative for CD45/CD144 brown chromogen
staining. Four ISET spots corresponding to 4ml whole blood were ICC stained and
scored for each blood sample. The number of CTCs detected was extrapolated to
the equivalent of 7.5ml for comparison with concurrent CellSearch analysis.
### CellSearch CTC analysis
CellSave blood samples (7.5ml) were processed by the CellSearch system as
described elsewhere. Briefly, CTCs are immunomagnetically separated from other
blood components by EpCAM (epithelial cell adhesion molecule) antibody-
conjugated beads and then stained for cytokeratins (CKs 8, 18 and 19) and CD45
in a fluorescent-based approach. CTCs are defined as CK+ CD45- cells over 4μm in
diameter; exact CTC diameters were not measured as the system software does not
have this functionality.
# Results
## Early breast cancer patients
To maximise the chance of finding CTCs, a relatively higher risk group of early
breast cancer patients were recruited. At final pathology, 75% were node
positive. Of the 16 patients, six had CTCs by CellSearch and all had CTCs by the
ISET morphology-based assay at least one time-point.
Using ISET, CTCs were detected in all 27 early breast cancer patient blood
samples tested, whereas CTCs were only detected in 9 (35%) of the samples
analysed by CellSearch. ISET CTC number was greater than CellSearch number in
26/27 samples. The median (range) number of CTCs per 7.5ml whole blood detected
by CellSearch and ISET respectively were CellSearch: 0 (0–13) and ISET: 21
(2–62). The CellSearch system does not allow accurate cell size measuring so
sizes of CTCs detected by each method were not compared.
There was no correlation between number of CTCs detected by ISET and detected by
CellSearch, either preoperatively, postoperatively or when all sample time-
points were analysed together. Number of CTCs (ISET or CellSearch) did not
correlate with tumour size, node positivity or timing of blood sampling
(preoperation versus postoperation); however the limited sample size is
acknowledged.
The high number of CTCs found by ISET, independent of clinicopathological risk
factors or CellSearch CTC numbers (although possibly reflecting an underpowered
sample) raised the concern of false positive identification of CTCs by ISET.
## High CTC false positive numbers are detected in healthy volunteers by ISET morphology method
ISET filter membranes generated from three sex-matched healthy volunteer blood
samples were analysed alongside the early breast cancer samples as presumed
negative controls. Surprisingly, high numbers of false positive CTCs were
detected, including one sample with 99 ‘CTCs’/7.5ml blood. These presumed false
positives could not be morphologically distinguished from CTCs detected in the
early breast cancer samples by the consultant breast histopathologist.
## ISET healthy volunteer CTC false positives remain high in successive blood draws
It was hypothesised that epithelial cells may be shed into the bloodstream
during the first draw of venous blood collection, which could partly explain the
high numbers of CTC-false positives seen in healthy volunteer samples. In three
further sex-matched healthy volunteers the number of CTCs detected in first,
second and third blood draws were compared. A trend towards lower ‘CTC' numbers
in successive draws was observed, but in all samples ‘CTC’ number was
unacceptably high, highlighting the high false positive rate of the morphology
based ISET technique.
## Low numbers of ER+ CTCs are detected in metastatic breast cancer patients
Given the apparent high false positive CTCs identified by ISET-morphology, a
similar but non-comparable ERα-based multiplex immunocytochemistry staining
assay was employed with the aim of increasing specificity of CTC identification
in ER positive breast cancer patients. The methodology was performed on blood
taken from three ER-positive metastatic breast cancer patients. The samples from
each patient were taken at the same blood draw, and processed for ISET (EDTA)
and CellSearch CTC analysis. ISET samples from patients identified as CTC
positive on CellSearch were examined. ERα positive CTCs were identified by ISET,
however the number of CTCs identified by this methodology was markedly lower
than by CellSearch, even in a high-CTC population indicating that this assay
would be inappropriate for the low numbers of CTCs found in early breast cancer
sample analysis.
# Discussion
Using the ISET platform and an epithelial-marker independent immunocytochemical
assay we detected higher number of putative CTCs in early breast cancer samples
than CTCs detected by the EpCAM/cytokeratin dependent CellSearch. However, in an
unexpected result, by the same cell morphology based technique we also found
high numbers of false positive ‘CTCs’ in healthy volunteer blood samples. By
employing oestrogen receptor alpha as a positive marker we developed an
immunocytochemical assay which we applied to a small number of ER+ metastatic
breast cancer samples, however this technique identified minimal numbers of CTCs
despite evidence of their presence on CellSearch.
Much of the previously published literature on the use of the ISET device in
detecting supposed CTCs using morphological criteria has found higher numbers of
CTCs than are detected by epithelial antigens across a range of cancer types,
despite larger size criteria. These studies have identified ‘CTCs’ by a range of
cell and nuclear morphological criteria unlike the standard epithelial-marker
based approaches.
Vona et al. (2004) in the first clinical article using the ISET technology
described that CTCs/CTMs were detected in 53% of liver cancer samples by
cytomorphological analysis but none were detected in 107 non-cancer patients,
including many with other types of liver disease. However, the \>25μm cell
diameter criterion they used is in our view inappropriate for breast cancer.
This size would exclude most of the breast cancer CTCs we have encountered by
CellSearch and the most commonly used breast cancer cell lines. Furthermore, an
independent albeit smaller hepatocellular carcinoma study carried out in our
laboratory concurrent to this work found no significant relationships between
ISET-derived CTC number and clinical characteristics, raising doubts about the
utility of identifying CTCs by morphology alone.
In a subgroup of twenty metastatic breast cancer patients Farace et al. used a
nuclear size cut-off of ≥16μm to define CTCs in ISET, finding 17/20 patients to
be CTC-positive. However, no healthy subjects were examined in their study as
controls. Hofman et al. in large NSCLC-focused clinical studies that included a
breast cancer patient subset have developed their own ISET cytomorphology-based
scoring method. Identified ‘circulating non-haematological cells’ (CNHCs) were
further characterised as CNHCs with malignant features (CNHC-MFs, ‘CTCs’) if
they exhibited four of the following criteria: anisonucleosis, nucleus size
\>24μm, irregular nuclei, presence of tridimensional sheets, and a high nuclear-
cytoplasmic ratio. CNHC-MFs/CTCs were identified in 43% malignant disease but
only 5% of non-cancer disease patients. Although inter-observer agreement for
detection of CNHCs was an impressive 100% (κ = 1) between three assessing
cytopathologists, it is noteworthy that inter-observer agreement of CNHCs with
benign features was relatively low (κ = 0.35). El-Hilibi et al. replicated their
methodology in an alternative filtration based technology (ScreenCell) and
determined that morphological criteria alone were inadequate to distinguish
malignant from non-malignant cells.
As CellSearch cell size criteria is \>4μm, compared to our ISET definition of
≥16μm, it might be expected that CellSearch would identify higher CTC numbers.
However, like several other authors, we found higher numbers with ISET. Although
many presume this is because of identification of non-epithelial antigen
expressing CTCs, CTC false positivity is an acknowledged problem in filtration
based technologies. This is supported by our high CTC identification in normal
controls. ISET-based studies have used large cell/nuclear size criteria to avoid
misidentification of endogenous nucleated blood cells at the expense of
identifying smaller CTCs. Small CTCs (≤90 μm<sup>2</sup>) have been described in
prostate cancer with small-nuclear CTCs being associated with visceral
metastases, and therefore may represent an important subgroup where the ISET
technology produces false negatives. There are several possible causes of the
false positives seen in this study. It is possible that larger leukocytes may
have been misidentified, especially monocytes which can reach up to 20μm in
diameter, although the CD45 immunocytochemistry method employed has previously
been shown to be effective at staining these cells. Another candidate is
megakaryocytes, responsible for platelet production with a 37μm mean cell
diameter however these are usually discounted due to their round and pale
nucleus and high reported CD45 expression. Epithelial cells, which can be
collected during peripheral venous blood collection by intradermal needle could
also have been present on the filters and misidentified as CTCs. In addition,
El-Hilibi et al. suggested circulating endothelial cells as a probable cause of
misidentified CTCs in their study. Endothelial cells are released during
venepuncture, with numbers shown to decline on subsequent draws. This prompted
us to examine ‘CTC’ numbers in successive blood draws as shown in. Although
there was a trend of lower false positives in each subsequent draw, the high
numbers seen in the third draw indicates that this is not the sole cause of this
phenomenon.
Also, by using VE-Cadherin, CD144 as a negative stain, we have gone further than
the studies in in actively identifying endothelial cells using a specific
protein marker. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) as
a further endothelial marker and CD61 as a marker for megakaryocytes may provide
additional support in correctly identifying CTCs. However, approximately 90% of
all putative CTCs we observed on stained ISET filters created by standard device
operation were sucked into the 8μm pores, which plainly affected their cell and
nuclear morphology. This factor undoubtedly contributed to the high rate of
false positives seen. Based on these results, morphology based ISET CTC
enumeration is not appropriate for early breast cancer.
Oestrogen receptor alpha (ERα) expression in the primary tumour is routinely
assessed in breast cancer clinical management. Clinical studies have previously
examined ERα expression in cytokeratin/EpCAM positive CTCs, but to our knowledge
we are the first to identify CTCs primarily by using ERα as a positive marker.
The lower cell count found by ISET compared to CellSearch may reflect loss of
ERα expression by CTCs. This is supported by Babayan et al. who stated that CTCs
frequently lack ER expression in ER+ metastatic breast cancer. Atkas et al.
(2011) have also reported discordance between CTC and tumour ER expression.
However the lower CTC numbers reported by ISET compared to CellSearch when ERα
expression is included may possibly be a result of ISET failing to capture
smaller ‘true’ CTCs. This further highlights the one of the challenges of the
ISET technology. In addition, the number of ISET ERα positive identified CTCs in
the setting of metastatic disease was surprisingly low compared to ISET ‘CTCs’
identified by just morphology in the early breast cancer subgroup, as it would
be expected that CTC counts would be higher in more advanced disease. Our
finding of low CTC numbers in metastatic disease compared to early disease
further highlights the likely presence of false positives with the morphology-
only technique used in the early breast cancer group.
One of the particular challenges we encountered with this methodology is the
time required for blood analysis. To ensure the integrity of nucleated cells,
whole blood samples in EDTA vacutainers must be diluted in Rarecells buffer
within four hours of blood taking, presenting challenges in sample transport and
analyst availability. Blood processing and filtration using the ISET technology
is non-automated and requires an average of 60 minutes of technician time per
sample. However, even more challenging, the images produced from each spot
corresponding to 1ml whole blood (up to 10 spots per sample) require 30 minutes
to view and score, highlighting the limitations of this technology in its
current form.
In summary, we investigated the use of the ISET technology to enumerate CTCs by
a non-cytokeratin / epithelial marker technique in early breast cancer patients.
The high false positive rates based on morphology alone, and the low numbers
captured (presumed high false negative) by ERα plus morphology raises doubts on
its utility in this low burden disease. This study highlights the need for
caution in the use of all non-cytokeratin based CTC enumeration methodologies,
with a necessity for extensive examination of normal control samples. However,
considering the current postulated plasticity between epithelial and mesenchymal
states of migratory cancer cells the detection of non-epithelial CTCs remains an
important scientific and clinical goal.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** CCK. **Data curation:** JC CCK. **Formal
analysis:** CCK JC. **Funding acquisition:** CCK. **Investigation:** JC CCK
KM. **Methodology:** CCK KM JC. **Project administration:** CCK JC.
**Resources:** CCK KM. **Software:** KM. **Supervision:** CCK KM.
**Validation:** SP KM CCK JC. **Visualization:** JC CCK. **Writing –
original draft:** JC. **Writing – review & editing:** CCK JC SP KM.
|
# Introduction
Dengue viruses (genus flavivirus, family *Flaviviridae)* are responsible for
dengue fever and severe dengue (previously known as dengue hemorrhagic fever,
DHF and dengue shock syndrome, DSS), they are some of the most important
arthropod-borne viral diseases worldwide. Increasing incidences of transmission
in urban and semi-urban areas in the tropical and sub-tropical countries have
promoted dengue to a major public health issue with a hefty economic burden.
Dengue epidemics are largely attributed to three factors: (*i*) Increased
urbanization, (*ii*) global dissemination of the major mosquito vectors, *Aedes
aegypti* and *Aedes albopictus*, and (*iii*) the interaction and evolution of
the four DENV serotypes. Inadequate sustained vector control may partially
explain unsuccessful disease prevention in developing countries however
variables related to the viruses, the human host and the environment should also
be considered. Vaccine development is currently underway as a strategy for
controlling this worldwide health threat. Due to the complexity of DENV
dynamics, prevailing serotypes and differences in distribution of viruses within
different regions of the globe, serotype and lineage replacement events may play
an important role in the evolution of DENV viruses and, consequently must be
addressed during vaccine development.
Gene genealogy-based DENV evolutionary studies helped characterize the genetic
diversity and distribution of different serotypes/genotypes in space and time.
Also, they are important for exploring the role of selection on particular
dengue proteins. Given that serotype-specific neutralizing antibodies confer
limited, if any, protection from subsequent infection by the other three
serotypes, the appropriate choice of nucleotide residues in the variable genomic
regions is critical for the design of effective tetravalent vaccines.
Brazil is the South American country with the highest economic impact of dengue
and also accounts for the majority of reported cases in the continent as
evidenced by a 27 year-long study. The highest dengue incidence was among young
adults from 2000 to 2007. However, in 2006 the highest incidence rate of severe
dengue increased dramatically among children and remained high during severe
epidemics in 2007 and 2008 in the state of Rio de Janeiro. These circumstances
highlight the urgent need for continued studies on dengue molecular epidemiology
in order to help determine appropriate policies and effective public health
campaigns.
The municipality of São José de Rio Preto (SJRP), one of the 645 municipalities
within the State of São Paulo according to the Brazilian Institute of Geography
and Statistics (*Instituto Brasileiro de Geografia e Estatística,* IBGE), has a
tropical savanna climate (Köppen climate classification), with an annual
rainfall of 1410 mm and mean annual temperature of 23.6°C, making it a favorable
breeding ground for *Aedes* mosquitoe vectors. Our previous study on dengue in
SJRP using a 399 bp-long portion of the NS5 gene, suggested that DENV-3 was
introduced into the city in 2005. Since SJRP is one of the municipalities in São
Paulo with the highest number of dengue cases reported yearly according to the
Epidemiological Surveillance Center of the state (*Centro de Vigilância
epidemiológica Alexandre Vranjac, CVE*). We chose to further characterize the
isolated DENV-3 strains from SJRP from 2006 to 2007 to gain insights into the
viral epidemiology that may help control disease.
# Materials and Methods
## Area of study
The city of SJRP is located in the northwestern region of the state of São
Paulo, Brazil (20°49′11″ S and 49°22′46″ W), with a total area of 431
km<sup>2</sup> and an estimated population of 415,769 inhabitants in 2012 (Data
obtained from the IBGE). The infestation by *Aedes* mosquitoes was reported for
the first time in 1985 and the first autochthonous cases were reported in 1990,
with the introduction of DENV-1 in 1996 (Chiaravalloti-Neto, Superintendence of
Endemic Disease Control, SUCEN: personal communication). Unpublished reports by
the *Instituto Adolfo Lutz* (Brazilian Public Health Laboratory) point to the
introduction of DENV-2 in 1998. Dengue viruses have been endemic in the
municipality for almost ten years.
## Sequencing genomes
A total of 33 plasma samples were collected from dengue patients during the 2006
and 2007 outbreaks as described elsewhere. Viral RNA was extracted directly from
plasma using the QIAamp Viral RNA mini kit (Qiagen). cDNA was synthetized in a
20 µl reverse transcription reaction containing: 1 µl of Superscript III Reverse
Transcriptase (Invitrogen), 1 µl of random hexamers (50 ng/µl stock), 1 µL of
specific reverse primer 5′AGAACCTGTTGATTCAACAGCAC3′ (10 µM stock) and 5 µl of
template RNA. Viral cDNA were diluted to 800 µl in DEPC-treated water and 20 µl
were used as template for a 96 specific PCR reactions. Each 10 µl PCR reaction
contained: 3 µl of template, 0.03 µl of pfuUltra II polymerase 1 (5 U/µl)
(Stratagene), 100 mM dNTPs (Applied Biosystems) and 4 µl of a mixture of forward
and reverse primers (0.5 µM stock). Primers were synthesized with M13 sequence
tags (forward primers with 5′GTAAAACGACGGCCAGT3′ and reverse primers with
5′CAGGAAACAGCTATGACC3′) so that PCR amplicons could be sequenced using universal
M13 forward and reverse primers. Each PCR reaction produced 96 overlapping
amplicons, each 500–900 nucleotides in length, which were subsequently sequenced
bidirectionally using the Big Dye chemistry on ABI3730xl DNA sequencers (Applied
Biosystems). The 33 obtained genomic sequences were submitted to the Broad
Institute genome project and deposited in GenBank ( shows all GenBank accession
numbers and name of all samples).
(<http://www.broadinstitute.org/annotation/viral/Dengue/>).
## Phylogenetic Inference
The data set includes the obtained 33 genomic sequences from SJRP that were
aligned together with 33 DENV-3 worldwide genomic sequences deposited in GenBank
using the Muscle 3.8.31 program. Visual inspection of the alignment and manual
editing were done with the Se-Al v2.0 program
(<http://tree.bio.ed.ac.uk/software/seal/>). A Bayesian maximum clade
credibility tree was inferred from a set of plausible trees sampled at the
stationary phase of four independent Markov Chain Monte Carlo (MCMC) runs with
40 million generations each using a general time reversible (GTR) model of
nucleotide substitution, a gamma distributed rate variation and a proportion of
invariable sites (GTR + **Γ** + I). A relaxed (uncorrelated lognormal) molecular
clock and a Bayesian Skyline coalescent tree were used as priors. Analyses were
done with Beast v1.6.1. Convergence of parameters was assessed using Tracer v1.5
program (<http://tree.bio.ed.ac.uk/software/tracer/>) until all parameters
estimates showed Effective Sample Size (ESS) values over 100.
## Selection detection analysis
The SJRP dataset was used in a selection analysis to determine whether amino
acid positions were subject to negative or positive selection pressures.
Comparisons were made with the dengue reference strain Philippines H87/57,
following Barrero and Mistchenko general approach. Both genealogy-based, codon-
site models *Single Likelihood Ancestor Counting* (SLAC) and the Random-Effects
(REL) available in the HyPhy package
([www.datamonkey.org](http://www.datamonkey.org)) were used to estimate the
nonsynonymous (d*N*) and synonymous (d*S*) rates of substitution. Polymorphisms
were analyzed with the program DNASP v5 and subjected to the Tajima D statistic
test, as proposed by Tajima to evaluate deviations from the neutral expectation
of molecular evolution.
## Epitope and immunogenicity prediction
The amino acid sequences coding for the capsid, envelope, NS1, NS2a and NS5
proteins were aligned
(<http://multalin.toulouse.inra.fr/multalin/multalin.html>) and a consensus
sequence of each protein was submitted to B
(<http://www.cbs.dtu.dk/services/BepiPred/>) and T
(<http://www.cbs.dtu.dk/services/NetCTL/>) epitope prediction algorithms. The
Allele Frequency Net Database (<http://www.allelefrequencies.net/>) was used to
select the HLA classes most predominant in the Southeast of Brazil and used to
set up the NetCTL server. The mean value of the epitope propensity scores for
each sequence was then classified and plotted according to its potential
immunogenicity.
# Results and Discussion
## Complete genome analyzes define distinct DENV3 lineages circulating in SJRP
The availability of high throughput, parallel DNA sequencing allows for
comprehensive information on population genetics at the complete viral genome
level. In this study, we determined the sequence of 3390 codon-sites of the
complete polyprotein from 33 DENV-3 strains isolated during the 2006 and 2007
outbreaks.
The inferred phylogenetic relationship among DENV-3 strains was summarized in a
Bayesian maximum credibility tree (MCC) shown in. The majority of Brazilian
samples grouped with genotype III, as did most taxa from Latin America isolated
since 1994,. Likewise, the Brazilian strain EF629370 grouped within genotype I,
as previously described by Schreiber *et al*.. DENV-3 isolates, other than
genotype III, have been reported in Colombia and in the Brazilian states of
Minas Gerais and Rondonia, likely imported from Asia. The successive circulation
of different genotypes is of public health concern given that distinct
combinations could have different epidemic potentials and risk burdens.
The samples from SJRP all fell within genotype III. The MCC tree indicates that
SJRP sequences group with Brazilian isolates from different regions in highly
supported clades. Clade A included most of SJRP isolates and is more closely
related to an isolate from Acre in 2004 (EF629367_BR_2004). Clade B includes
four SJRP isolates grouping with (*i*) a sample from Central West Brazil
(FJ913015_BR_2001) and (*ii*) the Brazilian sample FJ898446_BR_2001 of unknown
exactly provenance. Clade C includes two SJRP isolates from 2007 that cluster
with a sequence from Rio de Janeiro (EF629369_BR_2002) sampled in 2002.
Moreover, in clades A and B there was no temporal separation, suggesting that
the 2007 isolates apparently originated from previously circulating 2006
lineages. These results suggest distinct virus introductions into SJRP with one
lineage becoming more prevalent and experiencing *in situ* evolution (clade A).
Co-circulation of multiple DENV-1 lineages has been documented in Asian and
other Brazilian cities.
## Succession of DENV-3 genotypes in Brazil
Our data also provides information on the movement of DENV-3 (genotype III) in
South America, because sample FJ850079_BR_2002 obtained in the northern part of
Brazil grouped with Colombian and Venezuelan sequences suggesting a plausible
transmission route.
DENV-3 (genotype III) was isolated for the first time in Brazil from an
autochthonous case of DF in December 2000 from Nova Iguaçu, a city located in
Rio de Janeiro (RJ) State, which is the second largest metropolitan area in the
country, in 2001- 02, a large outbreak of DENV-3 occurred in the neighboring
city of Rio de Janeiro. Following its introduction into RJ, the virus spread to
the neighboring State of São Paulo (SP), and eventually to the municipality of
SJRP. A previous introduction of DENV-3 took place in Brazil in Rondonia State
(Amazon region), but sample EF629370_BR_2002 position in the MCC tree indicates
it belongs to genotype V with its sister taxa coming from Asia. Nevertheless,
most genotype III isolates from the north of Brazil grouped with the Caribbean
strains (samples from Puerto Rico and Trinidad and Tobago), which suggests the
existence of preferential routes of spread into Brazil, possibly facilitated by
anthropogenic factors.
## The dynamics of viral change
Sequence comparisons using the reference strain Philippines H87/57 (accession
no. M93130) as an outgroup, revealed a total of 893 nucleotide changes, of which
132 corresponded to non-synonymous substitutions. The nucleotide diversity π
(that is the average number of nucleotide differences per site between two
sequences) within SJRP strains was 0.0052 ± 0.001. Nevertheless, this π value
was one order of magnitude lower than that for the complete data set used for
phylogenetic inference (n = 0.038 ± 2×10<sup>−5</sup>), which suggests a genetic
bottleneck following the introduction into a new human population, with the
virus experiencing rapid *in situ* evolution afterwards. This is a likely
scenario given that we sampled from the first documented DENV-3 outbreak in a
city where the local human population is expected to be largely susceptible to
this serotype. Likewise, the average value of Tajimas*' D* for all genes was
−1.823 (*p*\<0.05) indicating an excess of low frequency polymorphisms, which
would be the case in viral populations expanding following a selective sweep.
The Tajima's *D* value near −2 also implies the outcome of negative selection,
most likely due to functional constraints imposed on the viral proteins. In
agreement with this hypothesis, the overall d*N*/d*S* value for the entire
polyprotein coding region was 0.068 (estimated 95% CI from 0.057 to 0.080) that
implied purifying (stabilizing) selection. Zanotto *et al*. have argued that at
a coarse-grain, the most common pressure acting on DENV is purifying selection
with little evidence of recent adaptive evolution when comparing distantly
related sequences in space and time, which would be expected due to synonymous
change saturation at the serotype level. Moreover, given that arboviruses have
adapted to diverse cell types it is generally considered that most mutations
produced are likely to be deleterious. Accordingly, the per-site SLAC *dN/dS*
analyses revealed that only eight codons were non-neutral and negatively-
selected (*p*\<0.05). Nevertheless, the presence of low frequency polymorphisms
could account for adaptive changes, such as the 10 sites under significant
positive selection (Bayes factor \>50) that we found with the per-site REL
*dN/dS* analyses.
Selected sites were located in both structural (S) and nonstructural (NS)
proteins. Among the four non-neutral sites within the envelope protein, codon
355 coding for A Proline located in the central and dimerization domains, was
under negative selection suggesting its structural importance. Likewise,
positively-selected codons 404 and 581 in the envelope are near sites associated
with disulfide bonds, suggesting adaptive changes near structurally important
residues. Interestingly, Barrero and Mistchenko also identified codons 581 and
893 (within the nonstructural NS1 gene) as positively-selected. King *et al.*
detected a statistically significant positively-selected site in the NS1 gene of
DENV-3 genotype II. They also detected selective pressure in the C and NS4B
genes of genotype I and in the E and NS3 genes of genotype II. We also found
additional positively-selected codon sites; 106 (Endoplasmatic reticulum anchor
for the protein Capsid), 2191 (Lumenal domain of NS4A) and 3129 (catalytic
domain of the RNA-directed RNA polymerase) that fell within domains that are
important for membrane interactions/rearrangements and virus replication.
Polymorphism analysis of individual genomic regions indicated that the NS5 and
the envelope proteins varied the most with 24 and 22 replacement changes
respectively, followed by NS1 (17), NS2A (11), NS4B (8) and Capsid (8). Changes
found in the glycoprotein M, the AdoMet-MTase region and the NS3 serine protease
were mostly conservative, while replacements in the capsid were less
conservative. Twiddy *et al*. found codon sites 169 and 380 to be under positive
selection in DENV-3, with the latter being located within the central and
dimerization domains of the glycoprotein, which is involved in cell tropism.
Likewise, Rodpothong and Auewarakul reported one codon site in the prM gene and
twelve residues in the E gene to be under positive selection. In summary, our
findings along with others, suggest that genes other than the envelope may
experience adaptive changes following introduction into a susceptible
population, which implies a possible role for either host-immunity interaction
or vector adaptations that require further study.
## Short-term evolution of DENV-3 genotype III
Studies documenting selectively driven evolution in DENV are limited and mostly
available for serotype 2,, further studies to better characterize possible
specific adaptive strategies of each serotype are needed. Therefore we looked at
allele replacement in DENV 3 (genotype III).
The allele replacement process, from a population genetics standpoint, has an
explicit genealogic representation, since frequency increase of an allele will
be manifested by appearing deeper as a synapomorphy in a viral genealogy.
Therefore, a synapomorphy indicates a fixed allele in the clade defined by it.
To clarify this, we coded each of the ten positively-selected residues as a set
of terminal unordered character states, represented as a single capital letter.
The most parsimonious reconstruction sets of changes at each internal state in
the phylogeny were calculated with MacClade v4.07 using the MCC tree rooted with
the reference strain Philippines H87/57. The reconstructed changes are
illustrated in. They indicate that positively-selected codons (404, 449, 581,
2191, 2879 and 3129) mapped to internal nodes as synapomorphies defining the
genotype III. For example, codon 106 Met to Val, (within Protein C, the most
non-conservative region in our study) characterized the SJRP clade A and codon
404 Pro to Leu characterized the SJRP clade B. Codon 893 appeared as an
autapomorphy for the reference strain H87/57 (M93130). The synapomorphic changes
differentiating clades A and B that we observed could reflect some aspects of
the intra-genotypic interactions exposed to the human population.
Mondini *et al*. described the pattern of spread of two DENV lineages
circulating in SJRP, Brazil, during 2006. Based on 82 NS5 sequences, the
phylogenetic analysis indicated that all samples were of DENV-3 and related to
strains circulating in Martinique during 2000–2001. We have considerably
extended that analysis by further showing that different lineages, closely
relate to different Brazilian isolates, were co-circulating while experiencing
distinct adaptive changes as indicated by their positively-selected
synapomorphies. This finding is of relevance, since in several other viral
systems, positively-selected changes are adaptive in nature and indicative of
adaptive changes imposed by vectors, animal reservoirs or human hosts (*i.e.*,
immune escape and herd immunity).
When we observed that DENV-3 sequences, previously clustered in clades A, B and
C, we conducted *in silico* analysis to verify the influence of amino acids
substitutions in the immunogenicity of capsid, envelope, NS1, NS2a and NS5
proteins. We found that amino acid substitutions diminished the B/T epitope
propensity scores mainly in the DENV-3 sequences clustered in clades B and C.
These analyses suggest that amino acid substitutions in sequences grouped in
clade A increases its immunogenicity. As a consequence, DENV-3 strains grouped
in clade A should expose more antigenic epitopes and more potentially
recognized/accessed by the human immune system. We expected that the most
immunogenic strains would be negatively selected in a given population. In this
particular study we found exactly the opposite. Thus, one can hypothesize that
the ADE phenomenon, which would be responsible for an increased pathogenicity
and replication in host, can also affect the viral dynamics in a population
level. We wonder whether this increased immunogenicity of clade A can induce an
antibody dependent enhancement (ADE)-like response in the individual leading to
high titers of the virus, which can facilitate the viral transmission to the
mosquitoes and, consequently, increase this strain basic reproductive rate. Our
findings are of relevance given that ADE may be manifested by challenges imposed
by increasing viral immunogenic diversity.
While most studies document the broad geographic expansion of dengue, urban
outbreaks dynamics deserves investigation because they contribute to a better
understanding of the genetic diversity of strains during local transmission;
knowledge that could be exploited for antiviral and vaccine development. In our
analyses of 33 complete polyprotein-coding regions we revealed distinct lineages
and detected polymorphisms sites that correlated with changes in the
immunogenicity of several epitopes. The study provides fine-grain information
about the molecular epidemiology of dengue infection.
# Supporting Information
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: AM PMZ MLN IB. Performed the
experiments: DS AM CVA PMZ CECS. Analyzed the data: PMZ IB MLN CVA CECS.
Contributed reagents/materials/analysis tools: IB PMZ CECS. Wrote the paper:
CVA AM DS MN PMZ CECS.
|
# Introduction
With multidisciplinary professionals, diverse and complex medical equipment,
vulnerable patients, time pressures, and extremely high tension, the operating
room (OR) environment is susceptible to errors. Some major safety problems in
the OR include addressing incorrect surgical site/patient/procedure, retained
surgical items, medication errors, bedsores, hypothermia, burns, inadequate
emergency responses, and improperly reprocessing surgical devices. Patient
safety accidents related to surgery require particular precautions, as they can
induce serious and irreversible injuries. Hence, the Joint Commission on
Accreditation of Healthcare Organization (JCAHO) stressed the importance of
teamwork, continuous quality control, smooth communication, and information
sharing between medical professionals to ensure surgical patients’ safety.
Furthermore, the Association of periOperative Registered Nurses (AORN)
recommended quickly streamlining and standardizing work to detect and correct
errors that occur during surgery.
Despite such efforts, accidents continue to occur with surgical patients.
According to a systematic literature review of adverse events in hospitals,
surgery-related accidents accounted for 39.6%, the highest proportion of all
such events. In Korea, surgery-related cases accounted for the highest
proportion (35.1%) of all medical dispute claims filed between 2012 and 2016 and
are gradually increasing. Therefore, surgical patients’ safety is of utmost
importance.
## Literature review
The theory of planned behavior (TPB) describes individual-level predictors of
actions. This theory states that individuals’ conduct consists of their
attitudes toward behavior, subjective norms, perceived behavioral control, and
behavioral intention. The TPB is widely used not only in social sciences but
also in various healthcare fields, as it effectively predicts individuals’
behavior despite involving only a few simple constructs. However, no studies
have applied TPB to patient safety management activities. Accordingly, we
applied Ajzen’s TPB to establish a model for patient safety management
activities in the OR.
Human errors can be viewed at the individual or system level. System-level human
errors are lapses in safety behaviors attributed to conditions of the work
environment, which cannot be altered by an individual. We need to understand how
systems, which include organizational culture and policies, interact with
individuals. Thus, patient safety management activities in the OR should be
examined considering both individual and organizational factors, given that
social behaviors result from their interactions.
The most frequently examined organizational factors related to patient safety
are job and systemic factors such as the safety management system. Job factors
include excessive work demands and job complexity, which increase the physical
and cognitive burdens on healthcare professionals, thereby decreasing their
ability to engage in safety management activities. The safety management system
includes safety training, participation in safety policy, management
supervision, communication, and feedback. Therefore, when the level of safety
management system is insufficient, accurate information on safety is not
delivered, and education and management are neglected, thus resulting in lower
awareness and performance of patient safety management activities.
Therefore, we developed a hypothetical model that encompasses individual and
system dimensions of safety management activities in the OR by adding
organizational factors (i.e., job factors and safety management system) to
Ajzen’s TPB. Structural modeling studies investigating factors related to
operating room safety management activities will be useful in developing
effective strategies to enhance patient safety management activities of OR
nurses.
## Study aim
The objectives of this study were to develop a structural model for patient
safety management activities, identify the factors influencing organizational
and individual dimensions that promote patient safety management activities, and
suggest effective intervention plans.
# Materials and methods
## Design
A cross-sectional research design was used. A hypothetical model was developed
based on Ajzen’s TPB. Job factors and the safety management system were used as
organizational factors, and attitude, subjective norms, perceived behavioral
control, behavioral intention, and patient safety management activities were
used as individual factors.
## Participants and data collection
Data was collected from August 1 to October 31, 2017, using self-report
questionnaires. The recommended sample size in the structural equation model was
10–20 per observation variable. The expected number of observation variables was
32; thus, 320 to 640 participants were required. The questionnaires were
distributed by convenience sampling to 360 perioperative nurses in 12 general
hospitals in the Republic of Korea, and 347 questionnaires were returned
(response rate = 96.4%). Questionnaires that were missing \>10% of responses
were excluded (17 questionnaires). The remaining questionnaires were processed
with mean substitution. Consequently, 330 questionnaires were included in the
final analyses.
## Instruments
### Job factors
The Job Content Questionnaire developed by Karasek et al. is a commonly used
instrument to assess organizational job factors, and its validity and
reliability were verified in a previous study by Song, which examined job
factors for Korean nurses. Therefore, in this study, the instrument modified by
Song for perioperative nurses was used. As for job demand, each of the 10 items
in the questionnaire was measured on a five-point Likert scale. Cronbach’s alpha
was.87 in both Song’s study and the current study.
### Safety management system
Safety management system was evaluated using an instrument developed by
Vredenburgh and translated and adapted for use in the OR by Song and Jang. This
included management supervision, communication and feedback, and participation
system. The 9 items in the scale were measured using a five-point Likert scale.
Cronbach’s alpha was.73 in Song and Jang’s study and.82 in the current study.
### Attitude, subjective norms, and perceived behavioral control
A 12-item scale was developed based on Ajzen’s study and a scale developed by
Moon and Song for hospital nurses. Attitude was measured with three questions
regarding positive or negative feelings about certain behaviors. The subjective
norm is the perceived social pressure imposed on conduct, and was measured using
five questions. Perceived behavioral control is an individual’s confidence or
controllability of a behavior, and was measured with four questions. Each item
was rated on a seven-point Likert scale. Cronbach’s alpha for attitude was.69 in
Moon and Song’s study and.77 in the current study. Cronbach’s alpha for
subjective norms was.76 in Moon and Song’s study and.91 in the current study.
Similarly, for perceived behavioral control, Cronbach’s alpha was.81 in Moon and
Song’s study and.88 in the current study.
### Behavioral intention
A 4-item scale was developed based on Ajzen’s study and a scale developed by
Moon and Song for hospital nurses. Each item was rated on a 7-point Likert scale
for willingness, planning, and thinking. Cronbach’s alpha for behavioral
intention was.80 in Moon and Song’s study and.90 in the current study.
### Patient safety management activities
Safety management activities were measured using an instrument developed by Kim
and Jeong based on six international patient safety goals. The scale consisted
of items pertaining to infection management, specimen management, patient
identification, medical equipment and product management, surgical counting, and
injury prevention. The 36 items were measured on a five-point Likert scale.
Cronbach’s alpha was.95 in Kim and Jeong’s study and.94 in the current study.
## Data analyses
Collected data were analyzed using SPSS 25.0 (SPSS; IBM, Armonk, NY, USA) and
AMOS 21.0 (SPSS Amos; IBM, Chicago, IL, USA). Participants’ general
characteristics were analyzed using descriptive statistics. Data normality was
tested using skewness and kurtosis. Correlations between measurement variables
were analyzed using Pearson’s correlation coefficient. The hypothetical model’s
goodness of fit was tested using the following: χ<sup>2</sup> statistics,
standard χ<sup>2</sup> (CMIN/DF, Normed χ<sup>2</sup>), standardized root mean
square residual, goodness-of-fit index, the normed fit index, the Tucker-Lewis
index, the comparative fit index, and root mean square error of approximation. A
covariance structure analysis was performed using the maximum likelihood method
to determine the model’s goodness of fit and test the hypotheses. The
statistical significance of the direct, indirect, and total effects of the model
was analyzed via bootstrapping. All statistical analyses with *p* \<.05 were
considered statistically significant.
## Ethical considerations
The study was approved by the institutional review board at Konyang University
Hospital (approval number: KYUH 2017-07-011) and conducted in accordance with
the Declaration of Helsinki. Questionnaires were placed in the nurses’ break
rooms for nurses to complete voluntarily. Completed questionnaires were then
placed in a collection box in the break room. All participants were provided
with an information sheet explaining the study purpose and method, management of
collected data, protection of personal information, and participants’ right to
withdraw from the study. Participants who provided written consent were enrolled
in the study.
# Results
## Participants’ general characteristics
The valid response rate was 91.7% (N = 330). Participants’ demographic
characteristics are presented in. There was a difference in the mean of patient
safety management activities between the group with less than 5 years of career
experience and the group with more than 5 years of career experience (F = 5.98,
*p* =.001). No other statistical significance of the small group mean according
to general characteristics was confirmed.
## Verification of normality and validity of the measurement variables
The absolute value of skewness was between 0.40–1.35 and the absolute value of
kurtosis was between 0.17–2.03. As the absolute values of skewness and kurtosis
did not exceed 3 or 10, respectively, the data satisfied univariate normality.
The correlation coefficients for the measurement variables did not exceed.80;
therefore, multicollinearity was not a concern. Discriminant validity was
established as the average variance extracted for each observed variable was
greater than its coefficient of determination (*r*<sup>2</sup>).
## Confirmatory factor analysis of the conceptual model
Although the goodness-of-fit and normed fit indices were slightly lower than the
required values, we determined that the model showed a good fit considering the
other indices.
Eight out of the eleven paths were significant. The safety management system
showed a significant path to attitude, with an explanatory power of 14.5%.
Safety management system showed a significant path to subjective norms, with an
explanatory power of 34.5%. Job factors and safety management system showed
significant paths to perceived behavioral control, with an explanatory power of
10.1%. Attitude, subjective norms, and perceived behavioral control showed
significant paths to behavioral intention, with an explanatory power of 50.0%.
Behavioral intention showed a significant path to patient safety management
activities, with an explanatory power of 38.1%.
shows the direct and indirect relevance of the hypothesis model. The safety
management system has a direct influence on attitudes and subjective norms. Job
factors and the safety management system had a direct influence on perceived
behavioral control. Attitude, subjective norms, and perceived behavioral control
were directly related to behavioral intention. Perceived behavioral control
showed indirect relevance to patient safety management activities, and
behavioral intention showed direct relevance to patient safety management
activities.
# Discussion
The modified TPB model explained patient safety management activities in the OR
relatively well. The explanatory power of the model for behavior was high;
adding organizational factors as antecedents to personal factors further
increased the model’s explanatory power.
The higher the job demands, the lower the perceived behavioral control of
patient safety management activities. The physical and cognitive burdens of
excessive job demands undermine one’s problem-solving abilities related to
safety performance and are, therefore, associated with increased accident
occurrence. Regarding organizational factors, higher scores for safety
management system were associated with more positive attitudes, stronger
subjective norms, and perceived behavioral control in patient safety management
activities. Organizational factors, including management values, the safety
system, safety practice, education and training, and communication, could impact
individual factors such as safety motivation and knowledge. Further, stronger
behavioral intention regarding patient safety management activities was
associated with more positive attitudes toward patient safety management
activities, stronger subjective norms, and greater perceived behavioral control.
These findings were similar to those of previous studies based on the TPB, in
which attitude, subjective norms, and perceived behavioral control predicted
behavioral intention. These results confirmed that the modified TPB is a valid
model for explaining patient safety management activities in the OR.
Perceived behavioral control was the most influential factor on the behavioral
intention for patient safety management activities in the operating room,
followed by subjective norms and attitudes. These results were contrary to a
study examining alcohol abstinence in patients with chronic liver disease and
one that examined hidden agendas in the use of mental health services for
depression. In these two studies, attitude appeared to have the greatest
influence on behavior. In predicting behavioral intention, the influence of
attitude, subjective norms, and perceived behavioral control could vary
depending on the extent to which behavior and situations are controlled by an
individual. In previous studies, factors influencing behavioral intentions
showed varying results depending on the characteristics and type of behavior.
Unlike individual behavior, perceived behavioral control and subjective norms
could be key factors in behavioral intention related to social behavior; these
factors are difficult to control through an individual’s will alone.
Moreover, the results showed that perceived behavioral control did not directly
relate to patient safety management. Thus, perceived behavioral control may not
be directly related to behavior if one’s perception is not consistent with
actual behavioral control; hence, the relationship between behavioral control
and behavior is indicated by dotted lines in the TPB. A meta-analysis of the TPB
also showed conflicting results for perceived behavioral control depending on
the type of behavior involved. Nurses expect to be able to control patient
safety management activities, but they may not be able to do so if there are
uncontrollable environmental factors such as a heavy workload and a lack of
necessary supplies. Conversely, since they may not deliberately perform safety
management activities as a result of excessive trust in their skills or reckless
behavior, an analysis of the specific path between attitudes, subjective norms,
and perceived behavior control needs to be researched. Organizational actions
required to improve patient safety management activities in the OR include
reducing job demands and enhancing the organizational safety management system.
Individual actions required include fostering a positive attitude and increasing
one’s behavioral intention by strengthening subjective norms and perceived
behavioral control. Hospitals should recognize that individuals comprise the
organization and devise strategies accordingly to improve patient safety
management activities. Specific and practical education tailored to the
conditions of the OR should be provided, and standardization of the OR patient
safety management protocol and information management are necessary to enhance
the efficiency of communication systems.
## Limitations
The data for this study were collected from perioperative nurses working in
large hospitals; therefore, future studies should include nurses from small and
medium-sized hospitals with varying OR sizes and types of work. In addition,
since the research was conducted using self-reported subjective data, casual
effects between variables could not be confirmed. Therefore, further research
using objective data on factors such as reporting of patient safety accidents
(near miss, adverse events, sentinel events) is necessary. Moreover, we
established a model based on a modified TPB to explain patient safety management
activities in the OR; additional studies that examine other factors associated
with patient safety management activities in the OR are needed.
# Conclusions
Crucial influencing factors on patient safety management activities in the OR
were the safety management system, subjective norms, perceived behavior control,
and behavior intention. Therefore, it is necessary to prepare hospital-level
support and nursing policies to reinforce these factors. Organizations as well
as individuals and medical staff should work together to strengthen OR patient
safety management activities.
We thank the operating room nurses who participated in this study.
10.1371/journal.pone.0252648.r001
Decision Letter 0
Delcea
Camelia
Academic Editor
2021
Camelia Delcea
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
15 Feb 2021
PONE-D-20-31121
Perioperative patient safety management activities: A modified theory of planned
behavior
PLOS ONE
Dear Dr. Jeong,
Thank you for submitting your manuscript to PLOS ONE. After careful
consideration, we feel that it has merit but does not fully meet PLOS ONE’s
publication criteria as it currently stands. Therefore, we invite you to submit
a revised version of the manuscript that addresses the points raised during the
review process.
The paper addresses an interesting topic. In the revised version of the paper
please consider the reviewers' comments listed in the following. Additionally,
please consider adding a similar analysis in which you are considering smaller
groups created based on the general characteristics in Table 1 and discuss
whether there are differences when certain groups are analyzed compared to the
whole sample.
Please submit your revised manuscript by Apr 01 2021 11:59PM. If you will need
more time than this to complete your revisions, please reply to this message or
contact the journal office at <[email protected]>. When you're ready to submit
your revision, log on to <https://www.editorialmanager.com/pone/> and select the
'Submissions Needing Revision' folder to locate your manuscript file.
Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and
reviewer(s). You should upload this letter as a separate file labeled 'Response
to Reviewers'.A marked-up copy of your manuscript that highlights changes made
to the original version. You should upload this as a separate file labeled
'Revised Manuscript with Track Changes'.An unmarked version of your revised
paper without tracked changes. You should upload this as a separate file labeled
'Manuscript'.
If you would like to make changes to your financial disclosure, please include
your updated statement in your cover letter. Guidelines for resubmitting your
figure files are available below the reviewer comments at the end of this
letter.
If applicable, we recommend that you deposit your laboratory protocols in
protocols.io to enhance the reproducibility of your results. Protocols.io
assigns your protocol its own identifier (DOI) so that it can be cited
independently in the future. For instructions
see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-
protocols>
We look forward to receiving your revised manuscript.
Kind regards,
Camelia Delcea
Academic Editor
PLOS ONE
Journal Requirements:
When submitting your revision, we need you to address these additional
requirements.
1\. Please ensure that your manuscript meets PLOS ONE's style requirements,
including those for file naming. The PLOS ONE style templates can be found at
<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main
_body.pdf> and
<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_titl
e_authors_affiliations.pdf>
2\. Please provide the names of all the participating hospitals, and a further
details regarding how these hospitals were selected.
Furthermore, Please include additional information regarding the survey or
questionnaire used in the study and ensure that you have provided sufficient
details that others could replicate the analyses. For instance, if you developed
a questionnaire as part of this study and it is not under a copyright more
restrictive than CC-BY, please include a copy, in both the original language and
English, as Supporting Information.
3\. In the submission please specify whether IRB approval was obtained from all
participating hospitals.
4.We note that you have indicated that data from this study are available upon
request. PLOS only allows data to be available upon request if there are legal
or ethical restrictions on sharing data publicly. For information on
unacceptable data access restrictions, please see
<http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-
access-restrictions>.
In your revised cover letter, please address the following prompts:
a\) If there are ethical or legal restrictions on sharing a de-identified data
set, please explain them in detail (e.g., data contain potentially identifying
or sensitive patient information) and who has imposed them (e.g., an ethics
committee). Please also provide contact information for a data access committee,
ethics committee, or other institutional body to which data requests may be
sent.
b\) If there are no restrictions, please upload the minimal anonymized data set
necessary to replicate your study findings as either Supporting Information
files or to a stable, public repository and provide us with the relevant URLs,
DOIs, or accession numbers. Please see
<http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-
identify and prepare clinical data for publication. For a list of acceptable
repositories, please see <http://journals.plos.org/plosone/s/data-
availability#loc-recommended-repositories>.
We will update your Data Availability statement on your behalf to reflect the
information you provide.
5\. PLOS requires an ORCID iD for the corresponding author in Editorial Manager
on papers submitted after December 6th, 2016. Please ensure that you have an
ORCID iD and that it is validated in Editorial Manager. To do this, go to
‘Update my Information’ (in the upper left-hand corner of the main menu), and
click on the Fetch/Validate link next to the ORCID field. This will take you to
the ORCID site and allow you to create a new iD or authenticate a pre-existing
iD in Editorial Manager. Please see the following video for instructions on
linking an ORCID iD to your Editorial Manager account:
<https://www.youtube.com/watch?v=_xcclfuvtxQ>
\[Note: HTML markup is below. Please do not edit.\]
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: Yes
Reviewer \#2: No
\*\*\*\*\*\*\*\*\*\*
2\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
3\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
4\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: Yes
Reviewer \#2: Yes
\*\*\*\*\*\*\*\*\*\*
5\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: The research question is interesting and cogent, and the research
is based on a sound literature ground concerning safety behaviors. I think the
research is worth publishing, but I address some aspects that could be clarified
by the authors.
1\. Line 83: the authors make reference to the safety management system. It si
not clearly explained how these aspects could hinder safety. The authors do not
explicitly refer to organizational culture factors, like the kind of leadership,
the blame culture, the safety climate (which are implicit in the safety
management tool used in the research).
2\. Line 125: The authors should explain why they chose the Job Content
Questionnaire developed by Karasek et al. \\\n
and no other tools. What is the rationale of this choice?
3\. Line 138: The 12-item scale is based on an unpublished study by Moon. The
authors should provide evidence of the validity of the scale
4\. Line 155. Also, the safety management activity instrument, developed by
Jeong, is an unpublished research and the authors should provide evidence of its
validity
5\. Line 279: The issue of behavioral control is controversial. The internal
locus of control is generally considered to be a better predictor of safe
performance, but in extreme situations it could also represent an excessive
trust in one’s own skills and a deliberate exposure to reckless actions. The
authors could provide a deeper explanation of these results.
Line 302: the authors mention among the limitations of the research the fact
that it was based on self-report data. Self-report tools may be biased by social
desirability, especially when they are related to errors, violations, and safety
issues. The authors mention objective measurements such as observational
surveys, however, I think it could have been useful to add other kind of
objective data to the analysis, for instance concerning the rate of adverse
events, injuries, near misses, etc.
Reviewer \#2: The current article attempts to tackle the important topic of OR
safety from the view of OR RNs. The authors provided OR RNs with surveys and
matched the results to the TPB model. However the authors' concluded cause and
effect from the survey data, rather than acknowledging that survey correlations
cannot imply causation and TPB model fit. The authors need re-structure their
conclusions to reflect this, rather than assume the survey results fit the TPB
model. Essentially, their conclusions outreach the survey data results.
\*\*\*\*\*\*\*\*\*\*
6\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: **Yes: **Fabrizio Bracco
Reviewer \#2: No
\[NOTE: If reviewer comments were submitted as an attachment file, they will be
attached to this email and accessible via the submission site. Please log into
your account, locate the manuscript record, and check for the action link "View
Attachments". If this link does not appear, there are no attachment files.\]
While revising your submission, please upload your figure files to the Preflight
Analysis and Conversion Engine (PACE) digital diagnostic
tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet
PLOS requirements. To use PACE, you must first register as a user. Registration
is free. Then, login and navigate to the UPLOAD tab, where you will find
detailed instructions on how to use the tool. If you encounter any issues or
have any questions when using PACE, please email PLOS at <[email protected]>.
Please note that Supporting Information files do not need this step.
10.1371/journal.pone.0252648.r002
Author response to Decision Letter 0
9 May 2021
Response to Reviewer’s Comments
Reviewer(s)' Comments to Author:
Reviewer \#1: The research question is interesting and cogent, and the research
is based on a sound literature ground concerning safety behaviors. I think the
research is worth publishing, but I address some aspects that could be clarified
by the authors.
1\. Line 83: the authors make reference to the safety management system. It si
not clearly explained how these aspects could hinder safety. The authors do not
explicitly refer to organizational culture factors, like the kind of leadership,
the blame culture, the safety climate (which are implicit in the safety
management tool used in the research).
Reply: Thank you for your comments. Corrected the sentence. It has been
described how the safety management system relates to safety management
activities.
� Line 90: The safety management system includes training and participation in
safety policy, management supervision, communication, and feedback. Therefore,
when the level of safety management system is insufficient, accurate information
on safety is not delivered, and education and management are neglected, thus
resulting in lower awareness and performance of patient safety management
activities \[15-17\].
2\. Line 125: The authors should explain why they chose the Job Content
Questionnaire developed by Karasek et al.
and not other tools. What is the rationale of this choice?
Reply: Thank you for your comments. Corrected the sentence. It was used in a
study on the job factors of Korean nurses in previous studies, and the validity
and reliability were verified and used in this study. In Song's study, the
fitness index of the confirmatory factor analysis for job factors was χ2=88.949
(df=5, p\<.001), TLI=.84, CFI=.92, RMSEA=.21, and SRMR=.05.
� Line 131: The Job Content Questionnaire developed by Karasek et al. \[20\] is
a commonly used instrument to assess organizational job factors, and its
validity and reliability were verified in a previous study by Song \[21\], which
examined job factors for Korean nurses. Therefore, in this study, the instrument
modified by Song \[21\] for perioperative nurses was used.
3\. Line 138: The 12-item scale is based on an unpublished study by Moon. The
authors should provide evidence of the validity of the scale.
Reply: Thank you for your comments. Corrected the sentence. In the paper
published by Moon and Song, the validity of the tool was verified, so the
references were revised.
� Line 146: A 12-item scale was developed based on Ajzen's \[23\] study and a
scale developed by Moon and Song \[24\] for hospital nurses.
4\. Line 155. Also the safety management activity instrument, developed by
Jeong, is an unpublished research and the authors should provide evidence of its
validity
Reply: Thank you for your comments. Corrected the sentence. The reference was
changed to a published article.
� Line 164: Safety management activities were measured using an instrument
developed by Kim and Jeong \[25\] based on six international patient safety
goals \[26\].
5\. Line 279: The issue of behavioral control is controversial. The internal
locus of control is generally considered to be a better predictor of safe
performance, but in extreme situations it could also represent an excessive
trust in one’s own skills and a deliberate exposure to reckless actions. The
authors could provide a deeper explanation of these results.
Reply: Thank you for your comments. Additional discussion was written.
� Line 294: Nurses expect to be able to control patient safety management
activities, but they may not be able to do so if there are uncontrollable
environmental factors such as a heavy workload and a lack of necessary supplies.
Conversely, since they may not deliberately perform safety management activities
as a result of excessive trust in their skills or reckless behavior, an analysis
of the specific path between attitudes, subjective norms, and perceived behavior
control needs to be researched.
6\. Line 302: the authors mention among the limitations of the research the fact
that it was based on self-report data. Self-report tools may be biased by social
desirability, especially when they are related to errors, violations, and safety
issues. The authors mention objective measurements such as observational
surveys, however, I think it could have be useful to add other kind of objective
data to the analysis, for instance concerning the rate of adverse events,
injuries, near misses, etc.
Reply: Thank you for your comments. Corrected the sentence.
� Line 313: In addition, since the research was conducted using self-reported
subjective data, casual effects between variables could not be confirmed.
Therefore, further research using objective data on factors such as reporting of
patient safety accidents (near miss, adverse events, sentinel events) is
necessary.
7\. The paper addresses an interesting topic. In the revised version of the
paper please consider the reviewers' comments listed in the following.
Additionally, please consider adding a similar analysis in which you are
considering smaller groups created based on the general characteristics in Table
1 and discuss whether there are differences when certain groups are analyzed
compared to the whole sample.
Reply: Thank you for your comments. Further analysis and presented in the
results and tables 1.
� Line 198: There was a difference in the mean of patient safety management
activities between the group with less than 5 years of career experience and the
group with more than 5 years of career experience (F=5.98, p=.001). No other
statistical significance of the small group mean according to general
characteristics was confirmed (Table 1).
Reviewer \#2:
1\. The current article attempts to tackle the important topic of OR safety from
the view of OR RNs. The authors provided OR RNs with surveys and matched the
results to the TPB model. However the authors' concluded cause and effect from
the survey data, rather than acknowledging that survey correlations cannot imply
causation and TPB model fit. The authors need re-structure their conclusions to
reflect this, rather than assume the survey results fit the TPB model.
Essentially, their conclusions outreach the survey data results.
Reply: Thank you for your comments. The comment part was added as a limitation
of the study, and the discussion and conclusion parts were entirely revised and
described.
� Line 276: Perceived behavioral control was the most influential factor on the
behavioral intention for patient safety management activities in the operating
room, followed by subjective norms and attitudes. These results were contrary to
a study examining alcohol abstinence in patients with chronic liver disease
\[30\] and one that examined hidden agendas in the use of mental health services
for depression \[31\]. In these two studies, attitude appeared to have the
greatest influence on behavior. In predicting behavioral intention, the
influence of attitude, subjective norms, and perceived behavioral control could
vary depending on the extent to which behavior and situations are controlled by
an individual \[32\]. In previous studies, factors influencing behavioral
intentions showed varying results depending on the characteristics and type of
behavior \[33\]. Unlike individual behavior, perceived behavioral control and
subjective norms could be key factors in behavioral intention related to social
behavior; these factors are difficult to control through an individual’s will
alone.
� Line 289: Moreover, the results showed that perceived behavioral control did
not directly relate to patient safety management. Thus, perceived behavioral
control may not be directly related to behavior if one's perception is not
consistent with actual behavioral control; hence, the relationship between
behavioral control and behavior is indicated by dotted lines in the TPB \[32\].
A meta-analysis of the TPB also showed conflicting results for perceived
behavioral control depending on the type of behavior involved \[28\]. Nurses
expect to be able to control patient safety management activities, but they may
not be able to do so if there are uncontrollable environmental factors such as a
heavy workload and a lack of necessary supplies. Conversely, since they may not
deliberately perform safety management activities as a result of excessive trust
in their skills or reckless behavior, an analysis of the specific path between
attitudes, subjective norms, and perceived behavior control needs to be
researched.
� Line 313: In addition, since the research was conducted using self-reported
subjective data, casual effects between variables could not be confirmed.
Therefore, further research using objective data on factors such as reporting of
patient safety accidents (near miss, adverse events, sentinel events) is
necessary.
� Line 322: Crucial influencing factors on patient safety management activities
in the OR were the safety management system, subjective norms, perceived
behavior control, and behavior intention. Therefore, it is necessary to prepare
hospital-level support and nursing policies to reinforce these factors.
Organizations as well as individuals and medical staff should work together to
strengthen OR patient safety management activities.
10.1371/journal.pone.0252648.r003
Decision Letter 1
Delcea
Camelia
Academic Editor
2021
Camelia Delcea
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
20 May 2021
Perioperative patient safety management activities: A modified theory of planned
behavior
PONE-D-20-31121R1
Dear Dr. Jeong,
We’re pleased to inform you that your manuscript has been judged scientifically
suitable for publication and will be formally accepted for publication once it
meets all outstanding technical requirements.
Within one week, you’ll receive an e-mail detailing the required amendments.
When these have been addressed, you’ll receive a formal acceptance letter and
your manuscript will be scheduled for publication.
An invoice for payment will follow shortly after the formal acceptance. To
ensure an efficient process, please log into Editorial Manager at
<http://www.editorialmanager.com/pone/>, click the 'Update My Information' link
at the top of the page, and double check that your user information is up-to-
date. If you have any billing related questions, please contact our Author
Billing department directly at <[email protected]>.
If your institution or institutions have a press office, please notify them
about your upcoming paper to help maximize its impact. If they’ll be preparing
press materials, please inform our press team as soon as possible -- no later
than 48 hours after receiving the formal acceptance. Your manuscript will remain
under strict press embargo until 2 pm Eastern Time on the date of publication.
For more information, please contact <[email protected]>.
Kind regards,
Camelia Delcea
Academic Editor
PLOS ONE
Additional Editor Comments (optional):
Reviewers' comments:
Reviewer's Responses to Questions
**Comments to the Author**
1\. If the authors have adequately addressed your comments raised in a previous
round of review and you feel that this manuscript is now acceptable for
publication, you may indicate that here to bypass the “Comments to the Author”
section, enter your conflict of interest statement in the “Confidential to
Editor” section, and submit your "Accept" recommendation.
Reviewer \#1: All comments have been addressed
\*\*\*\*\*\*\*\*\*\*
2\. Is the manuscript technically sound, and do the data support the
conclusions?
The manuscript must describe a technically sound piece of scientific research
with data that supports the conclusions. Experiments must have been conducted
rigorously, with appropriate controls, replication, and sample sizes. The
conclusions must be drawn appropriately based on the data presented.
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
3\. Has the statistical analysis been performed appropriately and rigorously?
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
4\. Have the authors made all data underlying the findings in their manuscript
fully available?
The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing)
requires authors to make all data underlying the findings described in their
manuscript fully available without restriction, with rare exception (please
refer to the Data Availability Statement in the manuscript PDF file). The data
should be provided as part of the manuscript or its supporting information, or
deposited to a public repository. For example, in addition to summary
statistics, the data points behind means, medians and variance measures should
be available. If there are restrictions on publicly sharing data—e.g.
participant privacy or use of data from a third party—those must be specified.
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
5\. Is the manuscript presented in an intelligible fashion and written in
standard English?
PLOS ONE does not copyedit accepted manuscripts, so the language in submitted
articles must be clear, correct, and unambiguous. Any typographical or
grammatical errors should be corrected at revision, so please note any specific
errors here.
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
6\. Review Comments to the Author
Please use the space provided to explain your answers to the questions above.
You may also include additional comments for the author, including concerns
about dual publication, research ethics, or publication ethics. (Please upload
your review as an attachment if it exceeds 20,000 characters)
Reviewer \#1: (No Response)
\*\*\*\*\*\*\*\*\*\*
7\. PLOS authors have the option to publish the peer review history of their
article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-
and-peer-review-process#loc-peer-review-history)). If published, this will
include your full peer review and any attached files.
If you choose “no”, your identity will remain anonymous but your review may
still be made public.
**Do you want your identity to be public for this peer review?** For information
about this choice, including consent withdrawal, please see our [Privacy
Policy](https://www.plos.org/privacy-policy).
Reviewer \#1: **Yes: **Fabrizio Bracco
10.1371/journal.pone.0252648.r004
Acceptance letter
Delcea
Camelia
Academic Editor
2021
Camelia Delcea
This is an open access article distributed under the terms of the
Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
18 Jun 2021
PONE-D-20-31121R1
Perioperative patient safety management activities: A modified theory of planned
behavior
Dear Dr. Jeong:
I'm pleased to inform you that your manuscript has been deemed suitable for
publication in PLOS ONE. Congratulations! Your manuscript is now with our
production department.
If your institution or institutions have a press office, please let them know
about your upcoming paper now to help maximize its impact. If they'll be
preparing press materials, please inform our press team within the next 48
hours. Your manuscript will remain under strict press embargo until 2 pm Eastern
Time on the date of publication. For more information please contact
<[email protected]>.
If we can help with anything else, please email us at <[email protected]>.
Thank you for submitting your work to PLOS ONE and supporting open access.
Kind regards,
PLOS ONE Editorial Office Staff
on behalf of
Dr. Camelia Delcea
Academic Editor
PLOS ONE
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
The first completed eukaryotic genome sequence was that of the budding yeast
*Saccharomyces cerevisiae* strain S288C, completed through the effort of a
worldwide sequencing consortium. Since that time, many *S*. *cerevisiae* genomes
have been sequenced, encompassing a wide variety of commercial and laboratory
strains, as well as wild isolates. With next-generation sequencing methods
becoming ubiquitous, whole genomes are now being analyzed *en masse*. This has
led to interesting work on the relationship between genotype and phenotype. For
example, in the studies of the adaptive evolution of freezing tolerance, Fay *et
al*. determined that an isolate taken from the soil beneath an oak tree in a
natural woodland area in southern Pennsylvania (YPS163) is freeze tolerant, a
phenotype associated with its increased expression of aquaporin AQY2. Similarly,
Doniger *et al*. studied an Italian vineyard isolate (M22), and confirmed the
presence of a reciprocal translocation between chromosomes VIII and XVI
(relative to the laboratory strain S288C); this translocation is common in wine
strains, and results in increased sulfite resistance, an adaptive trait for the
yeast since vineyards are routinely dusted with elemental sulfur as a fungicide.
Argueso *et al*. determined that a widely used Brazilian bioethanol strain that
is resistant to heat and oxidative stress contains well-characterized alleles at
several genes known to be linked with thermotolerance and fermentation
performance. Novo *et al*. studied a well-known commercial winemaking strain
(EC1118) and found three unique regions on three different chromosomes
containing 34 genes related to key fermentation characteristics, such as
metabolism and transport of sugar or nitrogen. They also noted that \>100 genes
in the reference strain S288C are absent from the EC1118 genome. Comparative
genomics work has revealed patterns of genetic variation including single
nucleotide polymorphisms, and large-scale insertions and deletions in several
wine and ale strain genomes. Functional genomic analysis has also been
undertaken in a saké yeast strain (K7), which has two large inversions and
dozens of novel open reading frames (ORFs) compared to reference strain S288C.
Genomic variation in *S*. *cerevisiae* genomes, such as single-nucleotide
polymorphisms (SNPs), small insertions/deletions (indels), and structural
variation, have been investigated. Despite much effort, the association of
genomic variations with phenotype and functional annotations remains
challenging, partly due to difficulties gaining accurate phenotypic information
and obtaining genome sequences at high quality. Fortunately, because of its
status as both a model organism and as an important industrial organism, many
different *S*. *cerevisiae* strains have been intensively studied at the
phenotypic, genetic and genomic levels and the resulting information has been
extensively curated in the *Saccharomyces* Genome Database (SGD) (See).
Genomics studies using the standard S288C yeast reference genome have produced
many informative and interesting results. However, our understanding of yeast
genetics and systems biology will widen and deepen if we can integrate new data
into a pan-genome model to account for a greater proportion of the genetic and
phenotypic variation exhibited by the global population of *S*. *cerevisiae*. A
pan-genome is defined as the set of all genes in a species, and can be
constructed from the union of gene sets over all *S*. *cerevisiae* strains.
The development and rapid expansion in the use of Next-Generation Sequencing
(NGS) technologies has created an increase in the volume of high-throughput
data. The expanding use of targeted approaches such as DNA-seq, RNA-seq, and
ChIP-seq has also increased the types of data available. These developments
allow questions and assumptions in population genetics and evolutionary biology
to be addressed directly, but fulfilling the potential of these approaches
depends on accurate and reproducible data analysis. Many computational methods
are designed to handle DNA-seq data for assembly, annotation, and variation
detection. However setting up a pipeline for these computational analyses is a
non-trivial task. Existing analysis software often produces incongruent results
even when addressing the same problems with the same data. Pipelines for the
pan-genome analysis of bacteria have been developed such as PGAP, but these are
not suitable for eukaryotic genomes, even for unicellular eukaryotes such as
yeasts, which exhibit more complex gene structures and non-genic regions than
prokaryotes. The frenetic pace at which new genomes are being sequenced has laid
the groundwork for great steps forward in our understanding of chromosomal
evolution and the extreme variability of the eukaryotic genome. However, the
sheer volume of data presents a clear challenge because it has been, and is
being, produced by different research groups using different techniques for
sequence assembly, feature annotation, and gene functional analysis. Before we
can realize the full potential of these new data and derive maximal benefit from
the ever-increasing number of sequenced genomes generated by disparate groups,
we must address the pressing need for a common standardized approach to genomic
data analysis. To that end, we report here the development of AGAPE: an
Automated Genome Analysis PipelinE for *S*. *cerevisiae*. The pipeline includes
assembly, annotation, and variation-calling steps for the genome sequence of a
given strain and generates integrative analyses among strains. We have
sequenced, or re-sequenced, and analyzed the genomes of 25 *S*. *cerevisiae*
strains that are commonly used in yeast laboratory research to initiate analysis
of the yeast pan-genome using AGAPE.
Simple eukaryotes such as fungi evolve rapidly and show presence or absence of
genes in different populations within a single species. Our initial work
can accelerate the establishment of the yeast pan-genome using AGAPE as more
genome sequences are released; assembly and annotation data from new strains can
be used to continuously update the pan-genome, and the integrative analysis
steps of the pipeline can be easily performed using the updated pan-genome.
AGAPE can also be useful for biologists with limited bioinformatics expertise
who can conduct computational analyses with their eukaryotic genomic data.
Replacement software for a specific computational step can be easily plugged
into the pipeline. All analyses, data, and the software pipeline reported here
are freely available online, see.
# Materials and Methods
## Strain sequences and genome assemblies
Twenty-five strains were selected for analysis based in part on their frequent
use in genetic research. The libraries were sequenced using Illumina HiSeq 2000,
resulting in paired-end reads of 101 nucleotides each.
We sequenced the libraries to high coverage ranging from 60- to 330-fold. Reads
with low quality or ambiguous bases were discarded using the error correction
program SGA (command line ‘sga correct-k 41—discard—learn’ version 0.9.35). In
this error correction step, on average 2–3% of the raw reads were removed. Note
that the preprocessing step before running the assembler program is important
for assembly quality control. The filtered reads were assembled to contigs using
the *de novo* assembler program ABySS (command line ‘abyss-pe aligner = map k =
41’, version 1.3.4). The resulting contigs were extended to scaffolds using an
SGA scaffolding pipeline (command lines ‘sga-align; sga-bam2de.pl-n 5-m 100-mina
95; sga-astat.py-m 100; sga scaffold-m 100—pe; sga scaffold2fasta-m 100—write-
unplaced—use-overlap’). If desired, alternative parameters can be specified for
each program in this assembly process.
## Gene annotations
Predictions of protein-coding genes (ORFs) were made using a combination of two
methods: a homology-based approach and *ab initio* prediction. For the first
approach we used the Chain and Net program to find all intervals in each strain
that are homologous to the reference genome. Next, for each matching interval we
ran a modified version of the annotation utility program included in CHAP2 (The
Cluster History Analysis Package). CHAP2 uses LASTZ for aligning the matching
regions to the reference ORF sequences. We used the thoroughly curated SGD
reference annotations, and predicted gene structures of each homologous ORF
using AUGUSTUS (<http://augustus.gobics.de>). We replaced a component of CHAP2
(<http://www.bx.psu.edu/miller_lab/dist/CHAP/README>), the Wise2
(<http://www.ebi.ac.uk>) program with AUGUSTUS, because Wise2 is no longer
available.
AGAPE also includes an *ab initio* annotation pipeline, called MAKER. Protein
and expressed sequence tag (EST) data for *S*. *cerevisiae*, required for
running MAKER, were downloaded from SGD (<http://www.yeastgenome.org>) and
FungiDB (<http://fungidb.org>) respectively.
Results from the CHAP2 and MAKER methods were combined as follows: ORFs
predicted by either method were kept. Predicted ORFs that lacked start or stop
codons were discarded. Overlapping ORFs with the same stop coordinates but with
potential alternative start sites were treated as separate annotations. ORFs
predicted to have multiple exons were verified to include either the highly
conserved splicing branch point 5’-UACUAAC-3’ or any of the unusual branch
points CACUAAC, GACUAAC, UGCUAAC, AACUAAC, UAUUAAC, and AAUUAAC. If no branch
point consensus sequence could be identified within an intron, the ORF was
discarded.
The nucleotide sequences of the predicted ORFs were compared against the S288C
reference protein database using BLASTX. Protein matches with e-values less than
1E-6, no more than 5% sequence length difference between the query and target
ORFs, and sequence similarity greater than 90% were categorized as *bona fide*
matches and were used to annotate the predicted ORFs. Predicted ORFs not
matching these criteria were considered potential novel ORFs and were labeled
‘undefined’.
Regions within the contigs, which remained un-annotated or that were labeled
‘undefined’ in the initial phase of AGAPE were analyzed with the MAKER pipeline
using all available fungal proteins (downloaded from <http://fungi.ensembl.org>)
and ESTs (downloaded from <http://fungidb.org>). The resulting expanded dataset
allowed us to capture more potential ORFs which were labeled with corresponding
gene names. We applied the same procedure described above for predicted ORFs
with potential alternative starts and for examining splicing branch point
consensus sites for predicted ORFs with multiple exons. The remaining predicted
ORFs were subjected to BLASTX analysis as above, but this time against all
fungal proteins and ESTs, and the cutoff stringency was reduced (similarity \>
80%).
Predicted ORFs that remained ‘undefined’ were consolidated with overlapping
ORFs, and only ORFs greater than 300 bp were retained. All annotations are
available in GFF3 format (<http://www.sequenceontology.org/gff3.shtml>) and the
BLASTX output is available as a text file for each strain
(<http://www.yeastgenome.org/download-data/published-datasets>).
## Identifying novel sequences and ORFs
Sequence reads for each strain in FASTQ format were aligned to the *S*.
*cerevisiae* reference genome using Burrows-Wheeler Aligner (BWA) (‘bwa aln-q
15-l 35-k 2-n 0.04-o 2-e 6-t 1’ and ‘bwa sampe’). Unmapped reads were extracted
using SAMtools programs ‘samtools sort’, and ‘samtools view’ (with parameter
settings of ‘-u-f 4-F 264’, ‘-u-f 8-F 260’, and ‘-u-f 12-F 256’). Unmapped reads
were assembled using ABySS with the same parameters as set in the whole genome
assembly. The resulting contigs were aligned to the reference genome to confirm
that they were not present in the reference. Contigs shorter than 300 bp, which
is the length cutoff for predicted ORFs, were discarded because short contigs
are more likely to be derived from reads of low quality, composed of ambiguous
bases, or represent spurious ORFs. We consider the remaining contigs as new
sequences that are not in the reference. These additional sequences were then
aligned to their own strain’s whole genome assembly using LASTZ (version
1.03.02, with parameters ‘T = 2 Y = 3400’) to find the corresponding genomic
region of each additional sequence in the whole genome assembly. We created a
set of non-reference ORFs from each strain by collecting ORFs annotated for
these additional genomic regions in the whole genome assembly.
## Integrative analyses of non-reference ORFs
The set of protein sequences of all the non-reference ORFs was aligned to itself
to identify potential homologs using BLASTP with cutoff values (e-value less
than 1E-1, sequence identity greater than 75%, and sequence length similarity
greater than 75%, note we tested different cutoff values to choose the most
appropriate combination). We made a binary matrix based on the pattern of
presence or absence of each homologue group in each strain and used the matrix
to calculate distance among 18 of the strains. The matrix did not include all 25
strains because we found no non-reference ORFs in 7 strains that are very
closely related to the reference strain. Then we constructed a dendrogram of the
18 strains using ‘dist.gene’ and ‘nj’ functions in the ape R library
(<http://ape-package.ird.fr>).
We also predicted molecular function associated with the non-reference ORFs
using sequence similarity (BLASTP against NCBI Non-Redundant (nr) database,
<http://www.ncbi.nlm.nih.gov>) and conserved protein domains using InterProScan.
## Variation identification and genome diversity
To identify SNPs and indels relative to the reference genome, we used the
HugeSeq pipeline that integrates multiple variant calling programs. We used the
Phylogenetic Tree Galaxy tool (within Galaxy’s genome diversity section) to
infer a phylogenetic relationship and population structure based on the SNP data
obtained by HugeSeq. To run this Galaxy tool, the SNP data was reformatted to
gd_snp format and used as input for generating the phylogenetic tree and
population structure to estimate relationship of the strains. Note the
Phylogenetic Tree Galaxy tool includes filtering steps for discarding SNPs of
low quality or SNPs that are in low coverage regions and we used default
settings for these options.
## Tree construction of non-reference MAL gene family
The maltose catabolic, metabolic and transport genes (MAL) that are not part of
the reference annotations were extracted from our non-reference features, from
Bergstrom *et al*.*’s* dataset, and from the NCBI Non-Redundant (nr) protein
database using BLASTP with queries of the *MAL23*, *MAL43*, *MAL63*, and *MAL64*
protein sequences. We constructed a maximum-likelihood tree of the non-reference
MAL gene family using Phylogeny.fr with default parameters.
# Results and Discussion
## Overview of AGAPE
We created an integrated pipeline to discover the full set of genomic features
of the *S*. *cerevisiae* species—the pan-genome—from whole-genome sequences of
multiple strains. AGAPE consists of three main parts: assembly, annotation, and
variation calls. Given the raw sequence reads of a given genome, a reference
genome sequence, and reference genome annotations, the pipeline generates *de
novo* assembly scaffolds and contigs, ORF annotations including non-reference
ORFs, and sequence variation calls such as additional newly inserted sequences
in the genome (not present in the reference genome) as well as SNPs relative to
the reference. The whole pipeline is performed automatically as shown in (for a
detailed breakdown see the section).
AGAPE was designed to generate genome assembly, annotation, and variation data,
with features extracted from newly analyzed genomes added cumulatively to
previously generated data. Integrative analyses can be done easily with the
updated data and features. Although some organisms may not have thoroughly
annotated reference genomes available, AGAPE can still generate the assembly and
annotation data as long as a protein database is provided for predicting gene
structure. (Note: although the NCBI Non-Redundant (nr) protein database can be
attached to the AGAPE workflow, the speed of this annotation step is related to
the number of sequences; we therefore recommend selecting a smaller protein
database that includes only those proteins that are expected to be similar to
the organism of interest). For the variation-calling steps, users can treat a
subset of their contig-level sequences as the reference genome. The components
of the pipeline can be easily substituted with alternative software as long as
the input and output formats are similar to those used in the original step.
## Running the pipeline with the reference assembly for validation
We validated the annotation steps by running the pipeline with the reference
assembly as input (rather than FASTQ reads). These data were chosen because the
reference assembly annotations have been thoroughly curated and can therefore be
used to evaluate the accuracy of our predictions. We excluded true reference
ORFs shorter than 300 bp to simplify the analysis. Since annotation steps are
designed to predict at most one ORF per locus, we also excluded some overlapping
ORFs. When two ORFs have overlapping intervals and either one is classified as
Dubious, the Dubious ORF was excluded. If both overlapping ORFs are Dubious, the
shorter one was ignored. However overlapping ORFs are kept if both are
classified as Verified ORFs. In total, we used 5684 reference ORFs as the “true”
set. The annotation pipeline predicted 5638 ORFs, 5532 of which were identical
to the reference annotations (98.1%). The FDR (False Discovery Rate) was
therefore 1.88% ((5638–5532) / 5638). Our approach outperformed the use of
either MAKER alone or the homology-based method alone, indicating that our
pipeline can generate accurate annotation results if assemblies are of high
quality.
## Genome sequences of 25 *S*. *cerevisiae* strains
To expand the *S*. *cerevisiae* pan-genome model, including those ORFs not
present in the reference strain S288C, we sequenced strains that are commonly
used in experimental yeast studies, including laboratory, wine, environmental,
and clinical strains. (The strains are identified in and and short descriptions
may be found at <http://wiki.yeastgenome.org/index.php/Commonly_used_strains>).
Note that some of the strains in our list overlap with strains analyzed in
genotype- and phenotype-based studies. Some strains are diploid. Diploidy may
not influence the identification of new features in the pan-genome, but other
types of variation analysis may be affected by heterozygosity. We subjected the
strain genomes to deep sequencing with coverage ranging from 60X to 320X.
Although our assembly contigs are still fragmented with gaps in some genomic
regions composed of repeat elements such as rDNA and subtelomeres (.), this high
coverage improved the resulting assembly compared to previous yeast sequencing
projects. The assemblies yielded N50 values ranging from 30 kb to 125 kb with
the longest scaffold reaching 580 kb.
## *S*. *cerevisiae* non-reference ORFs and their functional predictions
As expected, we did not observe any non-reference ORFs among the seven strains
(BY4741, BY4742, FY1679, SEY6210, JK9, W303, and X2180) known to be closely
related to the S288C reference genome. Among the remaining 18 non-S288C strains,
however, we found a total of 314 non-reference ORFs. We grouped the non-
reference ORFs by aligning their protein sequences to each other using BLASTP.
As a result, we identified 80 homologue groups of non-reference ORFs, including
16 unique ORFs that appear only in single strains. Eight ORFs out of the 80 non-
reference groups were already annotated as non-reference features in SGD:
*MEL1*, *RTM1*, *MPR1*, *BIO6*, *TAT3*, *XDH1*, *MAL64*, and *KHR1*. Previous
studies had shown the presence of the *BIO6* gene in saké strains and the *TAT3*
gene in RM11; our AGAPE results recapitulate these results, showing *BIO6*
occurring in the saké strain K11, and *TAT3* in RM11.
To predict functional association of the 80 non-reference ORF groups, we
searched the NCBI Non-Redundant (nr) protein database using BLASTP and used
InterProScan with the predicted protein sequences. Comparing our set of non-
reference ORFs to those found by similar studies, such as Bergstrom *et al*.,
was instructive in showing how much of the pan-genome, as indicated by non-
reference ORFs, our investigation has uncovered using AGAPE. Since annotation
accuracy can be influenced by the quality of the *de novo* assembly, the
comparison can also indirectly serve as an evaluation for the assemblies. Note
that in the Bergstrom *et al*. study, additional data such as low coverage
paired-end Sanger sequences and genetic linkage were used to improve assembly
while our pipeline used only *de novo* assembly. Of the 319 non-reference ORFs
from Bergstrom *et al*., 77% are shared with the non-reference ORFs identified
by our pipeline. Forty non-reference ORFs from our 18 “non-S288C” strain genomes
are not present in the Bergstrom *et al*. analysis, while 72 ORFs from the
Bergstrom *et al*. study (coming from 14 strains that were mostly natural
isolates and not represented in this study) were not found by our analysis. This
supports the reasonable expectation that further sequencing will extend the pan-
genome, especially if natural isolates are sequenced.
## SNP variations in the *S*. *cerevisiae* strains
SNPs identified relative to the reference genome for our 25 strains are shown
in. Strains BY4741, BY4742, FY1679, and X2180 all have less than 5 SNPs per
100,000 bp, indicating that they are essentially identical to S288C (the SGD
reference genome). This is particularly important as FY1679 contributed roughly
50% of the initial chromosomal sequence released in 1996. Strains BY4741 and
BY4742 are S288C-derivative strains were constructed to make an ORF deletion
collection. The variation between these strains and S288C was known to be
miniscule (T. Yamaguchi and F. Roth, personal communication), and our results
confirm this. These SNP-based results are also consistent with the fact that we
did not find any non-reference ORFs in these four strains (see above section).
In general, strains that have more non-reference ORFs also tend to contain more
SNPs, especially in the laboratory strains.
Interestingly, the two baking strains (YS9 and RedStar) have similar or lower
numbers of SNPs relative to the S288C reference, compared to strains isolated
from more natural environments (UWOPS, YPS163, YPS128, and DBVPG6044),
indicating that the baking strains are less diverged from S288C than the natural
environment strains. However, YS9 and RedStar contain the most non-reference
features (26 ORFs among the 2 strains), *i*.*e*. they have more non-reference
ORFs than any other environmental strains. A total of 15 non-reference ORFs are
shared by both baking strains, and are not present in any other strains (Groups
51–64).
## Phylogenetic inferences and population structure of *S*. *cerevisiae*
A binary matrix based on patterns of presence or absence of the non-reference
ORF groups in the 18 “non-S288C” strains that contained non-reference ORFs was
used to calculate distance and construct a tree of the 18 strains based on a
neighbor-joining method. This tree displays the relationships among the 18
strains based only on non-reference features. We also generated a tree based on
the genome-wide SNPs found in each strain (relative to the reference). This tree
reflects genomic distance based on the divergence of each strain from the
reference, within only reference-homologous regions.
In both trees, strains isolated from similar environments are generally located
closely together. For instance, the two baking strains (RedStar and YS9) are
grouped together, as are the three vineyard/wine strains (RM11–1A, L1528, and
BC187) and the two oak strains (YPS163 and YPS128). Lab strains that are close
to S288C such as D273 and FL100 are grouped together in both trees close to the
tightly-grouped S288C-related strains. Non-S288C-based laboratory strains, SK1
and Y55, used widely in studies of meiosis, appear as a branch off the lineage
of environmental strain DBVP6044. Interestingly, K11 and YJM339 show different
patterns in the two trees. A structure plot suggests the existence of mosaicism
in several strains, with SK1 sharing cluster identity over most of its genome
with baking and wine strains. This may be relevant to the unknown origin of
laboratory strain SK1 and may indicate that SK1 has been mixed with other
strains.
Unlike the vineyard/wine strains RM11–1A, L1528, and BC187, which are grouped
together in both trees, the saké strain K11 appears close to laboratory strains
CEN.PK and 10560–6B in the non-reference ORF-based tree, but in the SNP-based
tree it clusters more closely to other environmental strains like YPS163 and
YPS128, similar to results reported by Liti *et al*.. Most non-reference ORFs of
K11 are present in other environmental and wine strains.
## Case study of non-reference ORFs in strain K11
The distribution of 314 non-reference ORFs into 80 putatively homologue groups
enables an exploratory analysis of ORFs that are absent from the reference
strain.
As a means to link genotypes with phenotypes, strains used in the production of
alcoholic beverages are of particular merit given the intense interest in
understanding the metabolism of fermentation in these strains. Saké is made from
a rice ferment known as koji; before a saké strain of *S*. *cerevisiae* can
produce alcohols, the rice undergoes saccharification by a mold (or filamentous
fungus, viz. *Aspergillus oryzae*) that metabolizes complex carbohydrates
(starch) into sugars (glucose). Saké yeasts form a clade within *S*.
*cerevisiae* and possess distinct features such as the ability to synthesize
biotin.
In strain K11, a saké yeast, we have identified 10 non-reference ORFs belonging
to 9 homologue groups. Consistent with biotin prototrophy in saké yeast strains,
one of these (K11.ORF10) is identical at the DNA level (over its full length)
with *BIO6* (GenBank AB188681.1). The *BIO6* gene is required for biotin
biosynthesis and was identified in strain K7 from which K11 is derived.
At an intermediate stage of saké fermentation maltose is produced, potentially
selecting for the retention, evolution, or horizontal acquisition of maltose
utilization genes. Mutagenized strains of saké yeast with low maltose
utilization appear to generate higher levels of malate, an organic acid
contributing to the flavor of the beverage. Genes for maltose permease (GenBank
BAB59002.1) and maltase (GenBank BAB59003.1) have been identified in
*Aspergillus oryzae* and appear to be in a gene cluster with a regulatory gene.
Several maltose gene clusters are present in the *S*. *cerevisiae* pan-genome. A
maltose gene cluster such as *MAL6* typically consists of a maltose permease
(*MAL61*), maltase (*MAL62*), and a *MAL* regulatory/activator gene (*MAL63*).
Constitutively active forms of the regulatory proteins coded for by these genes
have also been identified and appear to relate to loss of function mutations
affecting C-terminal residues responsible for negative regulatory function. At
the *MAL6* locus an additional activator gene *MAL64* has been described. A
premature termination codon in *MAL64* confers constitutive expression although
the function of the wild-type allele is unclear.
One of the homologue groups identified by LASTZ is comprised of reading frames
similar to *MAL* activator loci. In saké strain K11, two ORFs fall into this
group. K11.ORF1 shows partial similarity to maltose activator genes from
multiple loci and its function therefore awaits further investigation, while
K11.ORF9 shows substantial similarity (\~98% at the DNA sequence level) to
*MAL64*. An alignment (not shown) indicates that, across its length, K11.ORF9
closely resembles wild-type *MAL64* in other *S*. *cerevisiae*, and a
phylogenetic tree indicates that the divergence between *MAL63* and *MAL64*
regulatory genes preceded the divergence of multiple strains.
Another interesting non-reference homologue group is represented in K11 by
K11.ORF8 and in SK1 by SK1.ORF11, both of which have 100% sequence identity with
an epoxide hydrolase-like protein previously identified in saké strain K7
(GenBank GAA21449.1;). This ORF was previously identified in K7 and *S*.
*paradoxus* and has a presumed bacterial origin, thus representing a possible
trans-kingdom horizontal transfer; it has also been identified in 2 commercial
wine strains, a sourdough strain and a fuel ethanol strain. Given the toxicity
associated with reactive epoxide compounds and the presence of a seemingly non-
homologous epoxide hydrolase in *Aspergillus oryzae* (GenBank XP_001727603.2),
it is tempting to suppose that this ORF is required in the saké environment.
# Conclusion
Rapid evolution and the mosaic structure of genomes in microorganisms makes
adequately capturing the diversity of a taxonomic group a difficult task, and
requires systematic analysis of multiple genomes. Information from multiple
bacterial isolates is frequently combined into a pan-genome, which comprises all
genes found within a particular taxon. We have adopted this approach with yeast
and have created a flexible pipeline, AGAPE, that uses a variety of tools and
sources of information to construct and update a pan-genome. Although AGAPE
generates assemblies that can be used to examine between-strain differences, a
critical additional output is non-reference ORFs, and AGAPE identifies these by
combining prediction methods.
We have explored the utility of this approach in yeast by using AGAPE to
identify non-reference ORFs through analysis of high-throughput sequencing data
from 25 *S*. *cerevisiae* genomes. This examination of a small set of non-
reference ORFs within *S*. *cerevisiae* demonstrates that an updatable pan-
genome model can be used as a starting point for analysis of function. We also
found that contrasting patterns in SNP- and ORF-based phylogenies, combined with
analysis of population structure, suggest that the dynamics of horizontal gene
transfer, recombination, or gene gain and loss may be fruitfully investigated as
more strains are sequenced and the pan-genome is expanded. Eventually it may be
possible to characterize for a particular strain whether ORFs that are not part
of the “core” genome (*i*.*e*., the set of genes shared by all *S*. *cerevisiae*
strains) arose by retention and evolution (or duplication followed by divergent
evolution) of ancestral genes, or by horizontal acquisition of “novel” genes,
e.g., by mating with diverged *S*. *cerevisiae* strains or through interspecific
hybridization.
Despite the difficulties in assembling complete chromosomes, which complicates
determination of the presence or absence of some genomic loci, AGAPE provides an
expandable pan-genome. The process includes thorough annotation and variation
steps, and thus opens a new window to genotype-phenotype association studies.
Analysis problems caused by the difficulty of generating complete assemblies,
particularly in examination of repetitive elements, can be ameliorated by
incorporating improved methods such as using mate-pair libraries and genetic
linkage.
Beyond yeast, the AGAPE pipeline can be used for genome analyses of other
eukaryotes. AGAPE can be modified to consider more complicated gene models and
more sophisticated assembly methods can be used to investigate genomes rich in
repetitive sequences. In addition, the steps defined in AGAPE can guide genomics
studies for researchers who have little experience in computational biology. Our
high-quality genome data and the analysis for 25 commonly studied strains are
also important resources for furthering yeast genetics studies. The AGAPE
package, genome annotation data, and the ongoing expansion of the yeast pan-
genome model will facilitate genetic studies in this important model organism.
# Supporting Information
We thank SGD Project staff for the creation of the high quality and detailed
database of *S*. *cerevisiae* genes and their products and Webb Miller for
helpful comments.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: GS JMC. Performed the
experiments: GS BD. Analyzed the data: GS BJAD JD. Contributed
reagents/materials/analysis tools: GS BD. Wrote the paper: GS BJAD JD SE BD
JMC.
|
# Introduction
In the control of infectious diseases by voluntary vaccination, individuals
decisions on whether or not taking the vaccine will affect the vaccination
coverage and, hence, the effectiveness of disease control, since the prevention
of disease transmission requires the vaccination coverage of a host population
to be above the level of herd immunity threshold.
Existing studies on individuals vaccination decision making have typically
focused on several determinants associated with the risks and benefits of
vaccination, including the perceived risk of disease infection, the perceived
safety and efficacy of vaccine, (e.g., vaccine side-effect rate and the related
adverse complications), as well as the social financial costs associated with
vaccination and disease infection (e.g., charge of vaccine administration,
expenses for infection treatment, and absence from work).
Besides these factors, individuals vaccination decisions are also subjected to
the impact of social influence in that an individuals behaviors or opinions are
affected by those of others. For example, the social influence on individuals
vaccination decisions can come from the interactions among them, such as
recommendations given by friends or family members, suggestions from health
professionals, and advices given by trusted colleagues. The effects of social
influence on human health related behaviors have long been observed. In the case
of 2003 SARS outbreak in China, individuals avoidance behaviors arose as a
response to the circulation of short messages about disease outbreaks. As for
vaccination, health related newscasts would change individuals perceptions of
vaccine safety and efficacy. The attitudes shared among parents would influence
the vaccination decisions of their children. In this regard, modeling
vaccination decision making should be treated as not merely a process of payoff
optimization, but also a process of individuals response to the impact of social
influence.
In order to better understand individuals vaccination decision making, in this
study, we take a dual-perspective view to address both the cost analysis of
vaccination decisions and the impact of social influence. As illustrated in, we
consider a group of individuals that make their vaccination decisions by both
minimizing the associated costs and evaluating the decisions of others (i.e.,
social influence). Specifically, we consider that the social settings of
individuals are structured with reference to their interaction relationships
(i.e., connected individuals and their social closeness). Therefore, the impact
of social influence among them will be heterogeneous with respect to the
structure of their interactions. In addition, when individuals interact with
those having similar choices, their decisions may be further affirmed;
otherwise, their decisions may be weakened. In such a case, social impact theory
(SIT) provides a computational approach to characterizing the impact of social
influence with respect to individuals interaction relationships. Generally
speaking, SIT describes how individuals change their attitudes/decisions in a
structured social environment, and further suggests that the strength of the
social impact be determined by the characteristics of the source (e.g., various
attitudes/decisions), the closeness of their social relationships, and the
number of sources holding similar attitudes/decisions. In our current work, we
propose a novel modeling framework for describing individuals vaccination
decision making by integrating an extended SIT-based characterization of social
influence with a game-theoretical analysis of cost minimization. In this model,
we use a conformity rate to describe the impact of social influence on
vaccination decision making, in terms of individuals tendency of being affected
by the social influence of others. Additionally, we represent individuals
interaction relationships with reference to a social network structure, in which
individuals are heterogeneously connected with different numbers of connected
neighbors and the social closeness of their interactions. We parameterize the
proposed model with an influenza-like disease as well as a real-world social
network.
By carrying out a series of simulations on voluntary vaccination, we examine the
steady state of individuals decision making and evaluate the vaccination
dynamics as well as the effect of disease control, in terms of vaccination
coverage and the resulting disease infection rate, respectively. By doing so, we
aim to investigate the interplay of cost minimization and social influence on
individuals vaccination decision making, and examine the impacts of different
levels of individuals conformity towards the impact of social influence.
Furthermore, we provide a new modeling framework that incorporates the impact of
social influence for investigating the effectiveness of voluntary vaccination
for infectious diseases control.
# Methods
We consider a voluntary vaccination program for controlling an influenza-like
infectious disease (e.g., seasonal flu), in which individuals need to decide
whether or not to be vaccinated each season based on their perceived risk of
disease infection. It is assumed that individuals will have some knowledge about
the vaccine and the disease (e.g., acquired from their previous experience
and/or from public media and health authorities), and about others vaccination
decisions through their social interactions. For such a situation, we construct
a computational model that describes how an individual arrives at his/her
vaccination decision with respect to the cost analysis of vaccination decisions,
and the social influence of others decisions. Based on the constructed model, we
aim to investigate the impact of social influence on individuals vaccination
decisions as well as on the disease control.
## Vaccination Decision Making
We take a dual-perspective view on modeling individuals vaccination decision
making that incorporates individuals evaluation of vaccination associated costs
as well as the impact of social influence. In doing so, we introduce an
individual-based model, as described in. In the figure, denotes an individual s
vaccination decision. There are two possible decisions that an individual can
make: corresponds to an acceptance of vaccination, and represents a rejection.
We utilize a social network to characterize the structure of individuals
interactions, in which the nodes correspond to individuals and te edges denote
the interaction relationships among them. Each edge has a weight, which
represents the closeness of interactions between individuals and.
Individuals can evaluate the costs associated with their decisions and then
arrive at their optimal choices by minimizing the costs. Meanwhile, individuals
may also convert their decisions due to the impact of social influence (i.e.,
neighbors vaccination decisions). Thus, individuals vaccination decision making
will be modeled here to include two aspects: (1) cost minimization and (2) the
impact of social influence. The parameters used for modeling individuals
vaccination decision making are summarized in.
### Cost minimization
There are two types of costs associated with an individuals vaccination
decision: (1) the cost of vaccination (e.g., the potential risk of vaccine side-
effects or the expense of vaccine administration) and (2) the cost of disease
infection if not vaccinated (e.g., disease complications, expenses for
treatment, or absence from work). We let and denote the costs associated with
vaccination and disease infection, respectively, and use represent the perceived
risk of disease infection for individual. Then, we can introduce a cost function
for individual with a decision, as follows:where denotes the cost associated
with accepting vaccination, and denotes the cost associated with rejecting
vaccination.
Next, without loss of generality, we let describe the relative ratio of and.
Thus, we can further transform the cost function in Eq. 1 into the following:
Here, we assume that individuals can estimate the risk of disease infection
based on their perceived disease severity, as reflected in the perceived disease
transmission rate, as well as their neighbors vaccination decisions, as
represented by and for the numbers of neighbors with the decisions of
vaccination or not, respectively. In addition, vaccinated individuals are
assumed to be successfully immunized from disease infection and unvaccinated
individuals will be possibly infected and thus transmit disease. Therefore, the
perceived infection risk, can be computed corresponding to the proportion of
unvaccinated neighbors as follows:
Based on the above formulation, an individual can arrive at an optimal choice by
minimizing the cost function in Eq. 2. In our proposed model, individual will
accept vaccination (i.e.) if, reject vaccination (i.e.) if, and keep his/her
decision unchanged in the previous step if. We can write this cost-minimized
choice of individual, in the following form:
If all individuals follow the same strategy of minimizing their cost functions,
after some iterations of decision making, they will reach a steady state, in
which all individuals will have no incentive to change their decisions in the
next step.
### Social influence
In addition to the above-mentioned cost minimization, an individual may affect
by those decisions of others, i.e., due to the impact of social influence, and
then convert the cost-based choice to the social opinion of his/her neighbors.
According to social impact theory (SIT), the strength of such a social influence
will be subjected to the structure of individuals interactions, e.g., the types
of opinions (i.e., acceptance or rejection), interaction relationships (i.e.,
social closeness), and the number of opinion sources (i.e., the numbers of
vaccinated and unvaccinated neighbors, and, respectively). In our social
network, for individual, the strengths of social influence for two opposite
opinions (i.e., vaccination acceptance and rejection), described by and, can be
accordingly computed based on as follows:
We use to denote the formalized social opinion resulting from the social
influence of individual s neighbors. As a modification of the standard SIT
definition (where corresponds to the opinion with the larger strength of social
influence), being either acceptance or rejection of vaccination will be
determined by comparing the influences of two opposite opinions. We let denote
the discrepancy between and. Then, we normalize as follows:
Here, we use to denote the probability that social opinion is to accept
vaccination, and to reject vaccination. Therefore, we can write in the following
form:where is computed from the Fermi function as follows:
The Fermi function is a sigmoid function that has been widely used for
describing individuals behavioral changes as a response to the payoff
discrepancy of two different choices. Here, describes individuals responsiveness
to the impact discrepancy of two opposite opinions. As shown in, a larger value
of means the choice with a higher social influence will be more inclined to
dominate the social opinion even the discrepancy of the two opposite social
influence, is relatively small.
Next, we introduce a probability, called individuals conformity rate, that
indicates the degree of individuals tendency towards adopting the social opinion
of his/her connected neighbors, that corresponds to how likely individual will
convert his/her cost-minimized choice to the social influence formalized
opinion. Thus, corresponds to the case of a cost-based decision maker, whereas
indicates that the individual is an absolute social follower (i.e., ignoring
his/her own cost evaluation). In other words, the final decision of individual
can be expressed as follows:
## Vaccination Threshold
In order to evaluate the impact of individuals vaccination decision making on
disease control, we further construct a disease model to describe the threshold
of vaccine coverage for mitigating an epidemic (i.e., the reproduction number is
less than one). The parameters used for estimating the vaccination threshold are
listed in.
For the sake of illustration, we use a standard SIR model to describe an
influenza-like disease transmission in a group of individuals that are densely
aggregated (e.g., students in a school), which can be treated as a homo-mixed
population for disease transmission. Individuals are divided into three
compartments with respect to their epidemiological states, i.e., susceptible
(S), infectious (I), and recovered (R). In addition, the number of individuals
in each compartment is denoted by, , and. When the natural birth and death of
the population are not taken into account, the overall population size is
calculated as. The disease spread dynamics is described by the following set of
differential equations:Additionally,where is the risk of disease infection for
susceptible individuals that is proportional to the percentage of infectious
population size. denotes the disease transmission rate that is the probability
of disease transmission between the mixing of infectious and susceptible
individuals. describes the recovery rate that corresponds to the time period for
an infected individual to be naturally recovered and thus immunized from
secondary infection.
Reproduction number (i.e., the number of secondary infections caused by a
typical infectious individual in a completely susceptible population,)
indicates a threshold for disease transmission; that is, if, disease
transmission will naturally decay. In such a compartmental disease transmission
model, is given as follows, :
Therefore, the vaccination threshold for mitigating an epidemic is estimated as
the reproduction number less than one (i.e.). The corresponding vaccination
coverage, denoted by, can be estimated as follows:
## Simulation Setting
For our simulations, we calibrate the parameters of individuals vaccination
decision making based on the scenario of the 2009 H1N1 influenza epidemic, in
which reproduction number was estimated as and recovery rate was set to 0.312
(i.e., a 3.2-day recovery period for disease infection). In order to focus our
studies on the impact of social influence, we assume that the perceived disease
transmission rate is equal to that of the actual disease transmission, i.e.. In
addition, we construct a social network based on the data of individuals close
proximity interactions (i.e., distance less than 3 m) at an American high
school, where the social closeness between individuals and corresponds to the
frequency of their interactions (i.e., the sum of all interactions between the
two individuals during the day). The total number of nodes is and the average
node degree (i.e., the number of connected neighbors) is 35. The average edge
weight (i.e., social closeness) is 115 units. Based on our model
parameterization, we carry out Monte Carlo simulations to experimentally study
individuals vaccination decision making and the impacts of the resulting
vaccination coverage on disease control.
# Results
Based on the proposed decision model, we have conducted a series of simulations
on vaccination dynamics to estimate the vaccination coverage at the steady state
of individuals decision making. As shown in, we first investigate the interplay
of cost minimization and the impacts of social influence on individuals
vaccination decision making with reference to three initial levels of
individuals vaccination willingness:, and. Generally speaking, the level of
vaccine uptake will be subjected to the cost ratio and individuals initial level
of vaccination willingness, when individuals conformity rate takes different
values. Specifically, the simulation results in show that when the impact of
social influence is relative weak (i.e., conformity rate is relatively small),
the cost of vaccination (i.e., cost ratio) fundamentally determines the
resulting vaccination coverage in that increasing the cost of vaccination will
lower individuals vaccination willingness (i.e., the steady state of individuals
decision making). In our considered scenario, the vaccination coverage is around
when cost ratio. Gradually, if is decreased and approaches, the vaccination
coverage will become as high as. Based on our model design, when an individual
perceives that all of his/her connected neighbors have decided for vaccination,
the individual will keep his/her previous choice of non-vaccination even if the
cost of vaccination is zero, due to the consideration that disease transmission
will no longer exist.
Furthermore, we can observe that the strength of social influence (i.e.,
conformity rate) can adjust the aforementioned impacts of cost ratio on
individuals vaccination decisions. As in the extreme case that individuals are
pure cost-based decision makers (i.e.), the resulting vaccination coverage will
be completely determined by the relative cost of vaccination (i.e., cost ratio
). On the other hand, as in the extreme case that individuals are absolute
followers of social opinion (i.e.), the impact of social influence will promote
a universal vaccination coverage, the level of which depends on individuals
initial level of willingness instead of the associated costs. In this case of
simulation, when, the vaccination coverage at the steady state of decision
making will converge to around for individuals vaccination willingness at the
initial level of (i.e., as shown), at the level of (i.e., as shown in), and at
the level of (i.e., as shown).
In addition, the impacts of varying conformity rate (i.e., individuals tendency
to adopting social opinions) are also observed as the adjustment of vaccination
decisions with reference to different situations of vaccination associated costs
(i.e., cost ratio). When individuals become more likely being affected by
social influence (i.e., gradually increasing conformity rate), as shown in, the
impact of social influence tends to increase the vaccination coverage when the
cost of vaccination is low (i.e.). On the other hand, when the cost of
vaccination is relatively high (i.e.), the impact of social influence will
reduce the resulting vaccination coverage at the steady state of individuals
decision making. Furthermore, when conformity rate approaches, the vaccination
coverage will drop/increase sharply and finally converge to a fixed level that
depends on individuals initial level of vaccination willingness.
Based on the earlier-mentioned SIR model, we have investigated the impact of
social influence on disease control by evaluating disease infection rates (i.e.,
the percentage of individuals being infected as a result of disease
transmissions) with respect to different vaccination coverage resulting from
individuals decision making.
shows the disease infection rates with respect to the interplay of individuals
cost minimization and the impact of social influence on vaccination decision
making (i.e., the values of cost ratio and conformity rate ranging between and,
respectively). With respect to our considered epidemic scenario (i.e., basic
reproduction number), the simulation results in show that disease infection can
be eliminated given a relatively lower cost of vaccination (i.e., cost ratio)
and a moderate impact of social influence (i.e., conformity rate).
Specifically, when individuals are less likely to being affected by social
influence (i.e., conformity rate), the effectiveness of disease control is
generally determined by the relative cost of vaccination (i.e., cost ratio) in
that a lower vaccination cost can lead to a reduction in the disease infection
rate due to a resulting higher vaccination coverage. Furthermore, as individuals
tendency of being affected by social influence become strengthened (i.e.,
conformity rate), the effect of vaccination cost on disease control will be
weakened accordingly, while individuals initial level of vaccination willingness
matters. In the extreme case of (i.e., individuals are absolute followers of
social influence), the disease infection rate is observed as high as for the
initial level of vaccination willingness at, as shown in. If the initial level
of vaccination willingness is set as (i.e., as shown), the disease attack rate
will be relatively higher than the situation of the initial level at (i.e., as
shown), where cost ratio and conformity rate.
Besides, we have examined the steady-state vaccination coverage and the
resulting disease attack rate with respect to different initial levels of
individuals vaccination willingness prior to their decision making, the results
of which are shown in. We can note that individuals initial level of willingness
will affect the converged level of the steady-state vaccination coverage as well
as the effectiveness of disease control when individuals are absolute followers
of social opinions (i.e., conformity rate). In our simulations, when the
initial level of individuals vaccination willingness is, the converged steady-
state vaccination coverage is around. The vaccination coverage will reach and,
if the initial levels of vaccination willingness are and, respectively. In
addition, we can observe that there exists a critical phase transition in
vaccination coverage when individuals initial level of vaccination willingness
is between and. That is to say, in the situation of individuals being absolute
social followers, there is a threshold value in terms of individuals initial
level of vaccination willingness that can be used to evaluate the effectiveness
of a voluntary vaccination program for eliminating the epidemic.
## Sensitivity Analysis
In order to investigate the sensitivity of our results, in what follows, we
further consider individuals vaccination decision making with respect to the
different values of disease reproduction number: (1) ; (2) ; (3). shows the
vaccination thresholds for eliminating the epidemic with respect to different
basic reproduction numbers.
shows the vaccination coverage at the steady state of individuals decision
making with respect to different disease reproduction numbers. Here, we can
observe the similar impacts of social influence in all three considered
situations: the impact of social influence will increase the vaccination
coverage when the relative cost of vaccination is small, decrease it when is
relatively large (see.g, 8.h, and 8.i), and bring it to a certain level when
individuals become followers of social influence (i.e., conformity rate
approaches 1). The simulation results further show that when the impact of
social influence is relatively weak (i.e., conformity rate), relatively severe
disease transmissions in terms of a larger reproduction number (i.e.) will
increase the vaccination coverage. While, if the impact of social influence is
strengthened (i.e., conformity rate approaches 1), the vaccination coverage at
the steady state of individuals decision making is mostly determined by
individuals initial level of vaccination willingness, rather than the related
costs and disease severity.
# Discussion
The phenomena of social influence that individuals behaviors or opinions are
affected by their social environment have long been observed and studied, such
as in the domains of political voting, and consumer purchasing decisions. In the
context of vaccination, social influence can affect individuals vaccination
decisions and thus the effectiveness of disease control in terms of the
resulting vaccination coverage. In this study, we address the impact of social
influence on individuals vaccination decision making, vaccination coverage, and
disease control. Towards this end, we have provided a dual-perspective view on
modeling individuals vaccination decision making by incorporating the impact of
social influence with the game-theoretical analysis of vaccination cost
minimization. In a group of individuals, the impact of social influence on an
individuals decision making relies on the structure of how he/she interacts with
others. In order to characterize the impact of social influence in such an
interactive environment, we have used social impact theory (SIT) to characterize
the strength of social influence on changing individuals vaccination decisions
with respect to their interaction relationships. We have used individuals social
network to represent the structure of their interaction relationships. Based on
our proposed model, we have examined the impact of social influence on
individuals decisions and on the effectiveness of disease control (i.e.,
vaccination coverage), with respect to three determinants: (1) the relative cost
of vaccination decision, i.e., cost ratio ; (2) individuals conformity to social
influence, i.e., conformity rate ; and (3) individuals initial level of
vaccination willingness.
By parameterizing the proposed model with a real-world contact network and with
the epidemiological scenario of 2009 H1N1 influenza, we have carried out a
series of simulations on individuals voluntary vaccination. The simulation
results have confirmed that the relative cost of vaccination (i.e., cost ratio)
is one of the determining factors in the voluntary vaccination coverage. In our
simulations, such results can be observed if individuals are less likely to be
affected by social influence (i.e., conformity rate is relatively small). While,
if individuals become more susceptible to social influence (i.e., is large), the
impact of social influence has been found to increase the vaccination coverage
when the cost of vaccination is small and, conversely, reduce the vaccination
coverage when the cost is large. In the extreme case where individuals are
absolute social followers (i.e., conformity rate), the vaccination coverage at
the steady state would converge to a certain level that merely depends on
individuals initial level of vaccination willingness, instead of the vaccination
associated costs.
In modeling individuals vaccination decision making, several mathematical models
have been earlier proposed that utilize payoff-based approaches to
characterizing vaccination decision making with respect to individuals perceived
costs and benefits of vaccination. Bauch et al. , characterized individuals
vaccination decisions as a modified minority game by exploring the herd immunity
effect; that is, in a group of mixed individuals, vaccinating a proportion of
them would decrease the infection risk for the rest of individuals. In
consideration of that, game theory has been used to describe individuals
interactive decision making in favor of optimizing personal payoffs. Cojocaru
extended the game-theoretical model of vaccination decision making by
considering a finite number of heterogeneous population groups. Perisic et al.,
further incorporated individuals contact networks into the vaccination game
analysis. Moreover, some studies have considered social and psychological
aspects of decision making (e.g., social learning process and imitation
behaviors). While, others have considered the issues of incomplete information
by adding either the potential discrepancy between individuals perceptions and
real situations (e.g., the perceived disease prevalence and the adverse effects
of vaccine) or different sources of information (e.g., previous disease
prevalence or vaccination programs –). Besides the payoff-based analysis,
Salathe et al. in investigated the clustering of vaccinated and unvaccinated
individuals with an opinion formation model. They proposed that the probability
for an individual changing his/her vaccination opinion is proportional to the
ratio of neighbors that have an opposite opinion.
As an improvement over the above-mentioned existing models, we consider an
individuals vaccination decision as a hybrid process balancing his/her self-
initiated cost minimization (i.e., individuals minority-seeking-like behaviors
by exploring the herd immunity effect) as well as the social influence of
neighbors decisions (i.e., social conformity behaviors). Our model introduces a
parameter (i.e., conformity rate) to modulate individuals tendency towards these
two decision making mechanisms: an individual will adopt his/her cost-minimized
decision, or convert to the social opinion of his/her connected neighbors.
Different from the existing studies that address individuals vaccination
decision making as a process of opinion formation (e.g., Salathe et al.), here
we further take into account the heterogeneities of individuals interaction
relationships by exploiting an extended SIT-based characterization of the
strength of social influence. Additionally, by incorporating the impact of
social influence, we are able to investigate the impact of individuals initial
level of vaccination willingness on the vaccination coverage of individuals
decision making.
By computationally characterizing the impact of social influence, this study has
practical implications for understanding individuals vaccination behaviors and
for improving the effectiveness of adopted vaccination policies. In the recent
years, the rapidly increasing use of new communication tools e.g., internet-
based social media services, has further amplified such a social influence. For
instance, the efficacy or the adverse effects of vaccines would be debated, and
the opinions on either accepting or rejecting vaccination would fast spread
among individuals. We have identified that individuals initial level of
vaccination willingness as an important factor in determining the final
vaccination coverage due to the impact of social influence (i.e., individuals
social conformity). Our results have shown that when conformity rate approaches,
the vaccination coverage at the steady state of individuals decision making will
be polarized given different initial levels of individuals vaccination
willingness. Moreover, the empirical studies that survey the determinants of
individuals vaccination decisions in a social environment can readily provide us
a practical means for measuring and evaluating individuals conformity to social
influence. As has been shown in our study that individuals vaccination decisions
can be affected by both the associated costs and their conformity to social
influence, it becomes necessary and feasible for public health authorities to
estimate the level of individuals acceptance of vaccine prior to the start of a
voluntary vaccination program, as well as to timely assess and enhance the
effectiveness of their adopted vaccination policies, e.g., providing certain
financial subsidies to reduce the cost of vaccination.
So far, our study has provided a general modeling framework for incorporating
the impact of social influence into the individuals decision making and disease
control. It should be pointed out that the obtained results of this study may be
subjected to the considered social network (e.g., students interactions within
an American high school). In our proposed model, the social influence accounts
only for the localized interactions between an individual with his/her connected
neighbors. Additionally, by utilizing the SIT-based characterization of social
impact, an implicit assumption is that individuals are passive recipients of
social influence and their active behaviors have not been taken into account.
It would be interesting for us to further consider some of the related aspects
in our future work:
##
### 1. The effects of public media
Public media represents another type of information source that will affect
individuals vaccination decision making. Due to broadcasting effect, the
transmission of social influence through public media may be faster and wider.
Related work by Breban discussed the effects of media on the fluctuation of
vaccination coverage. For the future work, it is possible to extend the current
model by incorporating the effects of public media, e.g., by adding a super node
that interacts with a large portion of nodes.
### 2. Host population heterogeneity
To focus on the SIT-based characterization of social influence, we have assumed
that individuals are homogeneous in disease infection, e.g., susceptibility,
infectivity, and infection risk. In this regard, our modeling framework will be
further extended to incorporating individual variations in disease transmission
as well as in their social characteristics (e.g., creditability). It would be
desirable to further improve our simulations by differentiating physical
contacts for infectious disease transmission from interaction relationships for
social influence. Along this line, related work by Eames constructed a parent
network for describing vaccination decision and a children network for
representing disease transmission, and found that the impact of social influence
would be influenced by the overlap of these two networks.
### 3. Dynamics of disease spread
In this work, we have only considered individuals making vaccination decisions
based on their perceived infection risk, which may come from either their
previous experience of disease and vaccine or the awareness about the upcoming
epidemic season. In the real world, real-time disease dynamics could also affect
vaccination dynamics, i.e., disease outbreaks may increase individuals
willingness for vaccination. In the future, we will extend our model by
characterizing the interplays between individuals vaccination decisions and the
dynamics of disease spread.
The authors would like to express their gratitude to the three anonymous
reviewers who provided constructive comments on further improving this article.
They would also thank other members of the AOC Research Group at HKBU for their
feedback on this study.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: JL SX. Performed the
experiments: SX. Analyzed the data: SX. Contributed
reagents/materials/analysis tools: JL SX. Wrote the paper: SX JL.
|
# Introduction
The crucial assertion of the neutral theory of community ecology is that
diversity can be maintained in the absence of species differences as long as
there is steady input of new species via speciation or immigration. More
broadly, diversity can be maintained independent of niche divergence, or in the
face of competitive dominance, given sufficient dispersal. Various models
produce predictions of species abundance distributions as they depend on
dispersal, and these have been tested against real forests, but the theory also
includes a quantitative prediction of diversity as a function of speciation.
None of the previous empirical tests of neutral theory, however, considered the
speciation parameter. In the absence of novel species input, the neutral theory
is irrelevant, and stabilizing mechanisms such as niche differentiation among
species or competitive interactions must maintain diversity.
Here we make use of repeated censuses of the Barro Colorado 50-ha forest plot in
Panama to examine the rate at which novel species appear; we call this the rate
of *species input*. There have been seven complete censuses over 30 years, and
each of the last six provides a direct estimate of the rate of input. The simple
and obvious test is whether there has been any at all: have any novel species
recruited into the 50 hectares since the initial census of 296 species in 1982 ?
The flora of Barro Colorado Island is well known, and we would certainly know
new species. The more precise test is whether the observed species input is high
enough to maintain the plot's observed diversity. The theory provides an exact
prediction about what would be sufficient.
Our aim does not end with a qualitative confirmation or rejection. We intend to
measure a rate constant that is relevant in the ecological theory that
accommodates stochastic births and deaths, dispersal, and species interactions.
Whatever value we find, the rate at which new species immigrate leads to
inferences about the forces that are key in maintaining species diversity.
# Materials and Methods
## Theory
In the basic neutral theory, a community of individuals is subject to random
deaths and births. At each time step, one individual dies, with every individual
equally likely, and then one of the survivors is chosen at random to become the
parent of a replacement. At a constant rate, the newborn mutates and becomes a
new species, hence is called the speciation rate and is equal to the probability
that any newborn is a novel species. If is constant, then species diversity and
the full species abundance distribution eventually reach a dynamic equilibrium
around which they will subsequently fluctuate randomly. The equilibrium can be
derived analytically, and a single parameter, the biodiversity parameter, fully
describes it. turns out to be asymptotically equal to Fisher's diversity
statistic, defined bywhere is the number of species in the community. Setting,
this leads to a prediction about the speciation rate that would maintain species
in the community,
This formulation holds only for a *metacommunity*: a community into which there
is no immigration and within which there is unlimited dispersal, meaning every
individual is equally likely to be the parent of any birth. To relax both
assumptions and accommodate limited dispersal, consider a small subset of the
metacommunity termed the *local community*. Any subset will do, as long as the
boundaries are unvarying so that immigration of newborn from outside has a
consistent meaning: offspring whose parents reside outside the local community.
We imagine the metacommunity as a continent of trees and the local community as
a rectangular plot with precise but unchanging borders, but the theory
accommodates more general arrangements. Define the migration rate *m* as the
proportion of births in the local community whose parents are outside, or
equivalently the probability that a newborn comes from outside. The remaining
births are from local parents. Immigration alters the local species abundance
distribution, and – no longer hold. There are various derivations of the
abundance distribution in a local community, providing estimators of both and.
Still however, refers to speciation in the entire community, and we need to know
it for the local community, where both genetic variants causing true speciation
and arrival of novel species via immigration must be considered. The former is
simply, but we need a derivation for the latter: the probability that a recruit
in the local community is the immigrant offspring of a novel species from
outside. is the ratio of new species to all immigrants, equal to the probability
that a randomly chosen immigrant is a species not present locally. We assume
genetic speciation is very rare locally, so, and henceforth consider as the only
species input parameter relevant to diversity in a small community.
To find, first define as the probability that an individual randomly selected
from outside the local community is a novel species, meaning it belongs to a
species not currently in the local community. Then we can write, because to be a
novel species, a recruit must be an immigrant , and the immigrant must be a new
species. We first derive an explicit formula for using a previously published
formula for the probability of any local abundance given the metacommunity
abundance. The leads to an expression for as a function of and :where is the
local community size and the biodiversity parameter defined above. Using
Equation 7 in, we can remove from the formula, using instead, the number of
species in the local community. Thenandwhere and is the lower branch of
Lambert's *W* function. parallels as a way of estimating species input given
species richness and community size, but with migration rate also needed because
it is a local community. It turns out, however, that is only weakly dependent on
*m*, which has an intuitive interpretation: larger *m* means more births are
from parents outside the local community, however, it also means that fewer
species are absent from the local community.
In the Barro Colorado 50-ha tree census, there were individuals and species in
1990. Using, we find. This value of has been derived several times by various
means, but always based on trees mm. Using the program Tetame
(<http://www.edb.ups-tlse.fr/equipe1/chave/tetame.htm>), we applied the
formulation from to arrive at for trees mm. This leads to, meaning that a near
four-fold increase in *m* leads to a 50% increase in. Indeed, from to, varies
only three-fold.
Hence, if the Barro Colorado forest were a community of fixed size, all species
were demographically identical, 38% of recruits came from parents outside, and
one of every recruits was a novel species, the observed equilibrium diversity
would be species. Our question is simply whether this predicted rate of species
input is in fact observed. If it is, then local diversity can be attributed to
species input, and no local diversifying mechanisms are needed. If we do not
observe species input, then we must look to local processes for the maintenance
of diversity.
# Methods
## Ethics statement
All research was conducted at the Barro Colorado Nature Monument, a forest
preserve owned by the nation of Panama and managed by the Smithsonian solely for
scientific studies and protected from all other uses. A long-term agreement with
the Government of Panama assures the Smithsonian permission to continue the
research indefinitely. No protected species were sampled during the forest
census.
## Plot census
Since 1982, a rectangle of forest 1000 m×500 m on Barro Colorado Island, Panama,
whose southwest corner is at 9.15125°N. latitude, 79.85530°W. longitude, has
been fully enumerated seven times. During the initial survey (1981–1983), every
individual mm in stem diameter was given a numbered aluminum tag and measured;
in 1985 and every 5 years since, tagged trees were remeasured or noted as dead,
and new trees mm diameter were given tags. Trees were identified to species by
three experts, and voucher specimens were collected and deposited in two
herbaria in Panama (STRI, PMA).
Since our results hinge on population changes in rare species, we considered
carefully how misidentification would affect the calculations. In a random
sample of re-identified trees, we found 0.85% misidentified (159 of 18694). In
the rarest species – the 44 having individuals (in 1990) – we double-checked
every individual (in 1995), and found just one out of 85 individuals was
misidentified, a *Hamelia axillaris* mistakenly called the rare *H. patens*.
Other *H. patens* were correctly identified, and in no case did a
misidentification either remove the last record of a species or create a novel
species. There were four rare taxa that we omitted from calculations due to
taxonomic uncertainty: one unidentified tree in the genus *Nectandra*, possibly
a novel species but never seen flowering before its death; a single tree in the
genus *Apeiba* that could not be identified before it died (it appeared to be
hybrid between the two well-known species); and both species in the genus
*Trema*, originally identified as one species but later separated (we re-
identified every living individual after 2000, but several trees that died
earlier remain forever unidentified). The remaining species subject to
extinction or invasion are very well known to us; most of them occur in our tree
plots elsewhere in Panama, and we have observed every one of them outside the
50-ha plot. We are thus confident that our estimate of species turnover is based
on true extinction and invasion, and that it is unbiased, since
misidentifications could cause either errors of omission (misidentification of a
rare species as a common species and thus failure to detect invasion or
extinction) as well as commission (misidentification of a common species as a
rare species and thus an apparent case of invasion or extinction when there was
none).
Criteria for including stems in the census were applied consistently and define
the local community of our theory: free-standing, woody stems at least 10 mm in
diameter. Species known to be lianas at maturity were never included. On the
other hand, individuals of species known to be stranglers (hemiepiphytes) at
least some of the time were tagged whenever they were free-standing. To be
consistent with the liana method, we excluded all stranglers from analyses here
(nine *Ficus* and one *Oreopanax* species). Reinserting them in the calculations
had a trivial impact on the final estimates.
Recruits were defined as newly appearing stems, those growing from mm stem
diameter in one census to mm in the next. Deaths were trees with stems mm in one
census but with no such stems alive in the next census, meaning we considered a
tree ‘dead’ even if it maintained a living base. This definition is required to
guarantee book-keeping of the population mm: adding recruits and subtracting
deaths is how populations changed.
## Observed recruitment and species input
Following the theory, we define a species input event as any case where a
species absent from the plot in one census appeared in the next, and an
extinction event as the opposite. An intuitive estimate of the rate of species
input between any pair of censuses is the number of novel species divided by the
number of recruits. Likewise, the extinction rate can be simply defined as the
number of extinctions divided by the number of deaths. But recruitment, input,
death, and extinction are continuous processes, and a more precise estimate can
be generated by solving differential equations describing their rates. The
estimated input rate based on the continuous solution differs only slightly from
the intuitive estimate because the rates are low.
Cases where species became locally extinct in one census interval, then
reappeared in a later census, were counted once as extinction and later as
species input. Such input does indeed maintain diversity. Hypothetically, there
might be a time far in the future when all species in the region have passed
through the 50 hectares at least once, when every input event would be a species
that had already been in the plot. This would still comprise a community in
which local diversity is controlled by the rate of species input from outside.
# Results
In every census interval, there was species input and extinction. A total of 308
non-strangler species mm stem diameter were observed in the 50-ha plot during at
least one of the seven censuses, but only 275 species were present in all seven
censuses. The other 33 species had some turnover: they were absent in at least
one census.
For example, in 2010 there were three new arrivals relative to 2005:
*Vasconcellea cauliflora*, *Vismia macrophylla*, and *Psychotria
hoffmannseggiana*. *Vasconcellea* is rare throughout the region but unmistakable
even to novices, having large, extremely lobed leaves like those of the related
papaya (*Carica papaya*). Prior to 2010, we had never seen it in the 50-ha plot.
*Vismia* is also easy to recognize, since it is abundant along roadsides of wet
and submontane forest nearby, but at Barro Colorado it is rare. It was found in
the plot prior to 2010, but went extinct (twice) and has now (twice) re-invaded.
The final invader, *P. hoffmannseggiana*, is a rare shrub that can only be
identified by experts; it also went extinct then reinvaded. Those three
immigrant species were found among 29243 recruits since 2005, thus the intuitive
input rate per recruit. The dynamic rate estimate was slightly lower.
Over six census intervals, varied from to new species per recruit, while
according to theory, would maintain 291 species in the 50-ha plot. That assumes
a migration parameter of, but with the lower migration rate, the input rate
needed according to theory would be only slight lower. The observed rate was
close, falling within the theoretical range twice and barely lower once. When
differing most, the observed rate was higher than predicted, though by less than
threefold.
# Discussion
Tree species have been continually input into the 50-ha plot at Barro Colorado
over 30 years, and the observed rate was consistent through time and a
quantitative match to the theoretical rate needed to maintain diversity. There
is nothing circular in our estimates of observed and predicted input: the
theoretical rate depends on local species richness , community size, and
immigration (*m*), none of which depends on novel species. Indeed, given these
values of, and *m*, an observation of no new species and thus zero input was
completely plausible.
We have known since the first census that the 50-hectare plot is a subset of a
regional community, because Croat's flora of Barro Colorado Island includes 450
tree and treelet species, leaving nearly 150 species absent from the plot. A few
of those are specialists in habitats not found within the 50 hectares, such as
the pond apple (*Annona glabra*) of the lake shore, but most are upland species
that could grow in the plot. Future censuses will capture more of those species,
while others will continue to drop out. The 2010 census included 13 singletons
(species with a single individual), and these are at obvious risk of local
extinction: 10 of the 17 singletons in 1982 are now extinct. But it is not just
singletons subject to turnover. Three species with individuals in 1982 are now
extinct, and *Cecropia longipes*, which invaded the plot in 1995, now has 13
individuals.
Had we observed a rate of species input substantially lower than the prediction
for maintaining diversity we would have concluded that stabilizing mechanisms,
i.e. rare species advantage, competition, or niche differentiation, are
important in maintaining species richness. Had the rate been too high, we would
have been forced to consider destabilizing mechanisms that drive rare species to
extinction faster than expected by chance. We conclude instead that species
input is maintaining tree richness in the Barro Colorado plot. Stabilizing
forces may be present, and they may limit abundances, but they do not contribute
to diversity. Indeed, the observed extinctions demonstrate that whatever
stabilizing forces are present are insufficient to protect rare species. These
conclusions conform with a variety of theoretical studies showing that dispersal
can overwhelm niche differences as the driver of diversity and community
structure, so that regional diversity can regulate local diversity,.
The importance of species input explains the success of the neutral model in
predicting abundances in spite of evident non-neutrality. When species input
dominates, abundances resemble the neutral prediction, particularly in the long
tail of rare species, even if there are species differences. In fact, the zero-
sum multinomial abundance distribution predicted by the neutral theory
generalizes to habitat-partitioned communities as long as there is species
input. The neutral model predicts diversity and abundance at Barro Colorado
because it properly describes what matters most – species input – while ignoring
irrelevant details. The theory also predicts exactly how much species input is
sufficient to maintain richness, and that when insufficient, diversifying
mechanisms spawned by species differences must account for abundances and
diversity.
Diversifying mechanisms at wider scales are not addressed by these results.
There is a regional species pool from which the 50-ha plot is drawing, and there
may be niche differentiation maintaining diversity in the wider region. The role
of species input (speciation of any kind) in maintaining diversity at larger
scales remains untested, because precise measures of species interactions and
species input are not now possible beyond local plots. The rate of immigration
of novel species must decline as area increases, but the rate of input needed to
maintain diversity also declines. Perhaps over the entire nation of Panama or
the continent of South America, speciation is too rare to maintain diversity
without niche segregation, or perhaps species input via true genetic speciation
is what drives diversity and abundances at continental scales.
# Supporting Information
We acknowledge R. Foster as plot founder and the first botanist able to identify
so many trees in a diverse forest, and we thank R. Pérez and S. Aguilar for
species identification, S. Lao for data management, S. Dolins for database
design, plus hundreds of field workers for the census work, now over 2 million
tree measurements. T. Zillio first produced the calculations in. The Smithsonian
Tropical Research Institute and Smithsonian Institution Global Earth
Observatories provided logistical support, and we thank S. Davies, I. Rubinoff,
and E. Bermingham for their support.
[^1]: The authors have declared that no competing interests exist.
[^2]: Analyzed the data: RC. Contributed reagents/materials/analysis tools:
SPH RC RAC. Wrote the paper: RC RAC SPH. Conceived field work: SPH.
Implemented field work: RC. Conceived database: RC. Implemented database:
RC. Generated funding: SPH. Derived theory: RAC RC SPH.
|
# Introduction
Myotonic dystrophy type 1 (DM1) can appear at any time in life and is regarded
as the human disease which probably has the most variable clinical presentation,
somehow affecting virtually all body systems. Although typically classified as a
neuromuscular disease, besides its prominent muscular system defects (including
cardiac, smooth, and skeletal muscle cell types), it also compromises cognitive,
ocular, digestive, endocrine, respiratory, reproductive, cutaneous,
haematopoietic, and immune systems to varying degrees. Characteristic muscular
symptoms include cardiac problems such as malignant arrhythmias and conduction
defects, and involvement of facial (ptosis), bulbar (dysarthria, dysphagia),
limb (steppage, gait troubles), and smooth (constipation) muscle with associated
muscular atrophy and myotonia. Patients also suffer from iridescent cataracts
and insulin resistance with metabolic syndrome. Genetically, it is an autosomal
dominant disease caused by unstable expansion of the CTG microsatellite in the
3’ untranslated region of the *dystrophia myotonica-protein kinase* (*DMPK*)
gene and is a rare disease that afflicts one in 8000 people worldwide.
Unaffected individuals carry between 5 and 37 CTG repeats whereas DM1 patients
carry between 50 and thousands of CTG triplets. Importantly, CTG trinucleotide
expansions are unstable both in the somatic and germinal lines, likely
contributing to the heterogeneity in clinical symptoms and age of onset, which
inversely correlates with the size of the triplet expansion. A further increase
in the size of the CTG microsatellite occurs in most intergenerational
transmissions of the expanded allele, which correlates with genetic
anticipation. Despite the correlation between the size of the CTG expansions in
blood cells with disease severity and age of onset, its predictive power is poor
and it is not a good parameter for characterising the disease load. Forthcoming
therapeutic trials urgently need good biomarkers to evaluate the therapeutic
response to treatments. Alternative splicing changes in skeletal muscle have
been described as potential biomarkers of disease severity and therapeutic
response, but they involve invasive techniques and it would be difficult to
routinely measure them in other sites (such as cardiac or cerebral tissues)
which are strongly involved in DM1 pathophysiology.
Expanded RNA transcripts containing CUG repeats are retained in the cell nucleus
as insoluble RNA aggregates known as ribonuclear foci. These foci are able to
sequester different RNA binding proteins that are prevented from performing
their normal functions. The alternative splicing regulators Muscleblind-like1
(MBNL1) is among the recruited proteins, which result in its functional
depletion. CUGBP, Elav-like family member 1 (CELF1), a splicing factor
antagonist of MBNL1, is not sequestered in ribonuclear foci but becomes
abnormally activated due to hyperphosphorylation. As a consequence, several
alternative splicing events are misregulated in DM1 and in some cases these
splicing defects contribute to DM1 symptoms such as myotonia, insulin
resistance, or muscle weakness. The molecular mechanism leading to DM1
pathogenesis is complex and, in addition to splicing defects, also includes
mispolyadenylation of pre-mRNA, a process that is also regulated by MBNL
proteins, repeat-associated non-ATG translation (RAN translation), bidirectional
transcription, defects in transcription and translation, epigenetic changes, and
the silencing of cardiac and muscle transcripts by changes in miRNA expression
levels. miRNAs are endogenous non-coding RNAs, approximately 21 nucleotides
long, that function as post-transcriptional gene expression regulators by
targeting the 3’ untranslated region of their complementary target mRNA. miRNAs
regulate RNA stability and translation rates via degradation or inhibition of
protein translation, respectively (reviewed in). Over 2000 miRNAs have been
identified in the human genome and have been implicated in numerous biological
processes including development, proliferation, differentiation, and stress
responses (reviewed in). Because miRNAs can be readily detected in body fluids,
and particularly in blood components, differences in serum miRNAs have been
proposed as potential non-invasive biomarkers of disease progression for several
conditions such as cancer, Alzheimer´s disease, hepatitis B infection,
retinopathies, gestational diabetes mellitus, or Duchenne muscular dystrophy.
Because several miRNAs have been detected to be altered in DM1 cardiac and
muscle tissues, and there are numerous drugs that work in DM1 animal models
pending accurate pharmacological development and clinical testing in humans, we
explored the possibility that misexpression of specific serum miRNAs could be
identified as non-invasive DM1 biomarkers. To this end, we profiled 175 miRNAs
in the peripheral blood serum of DM1-affected individuals and healthy controls
by real time qPCR. Even though none of them showed expression differences
greater than 2.6 fold, the six miRNAs with the highest fold-change score
(*miR-103*, *miR-107*, *miR-21*, *miR-29a*, *miR-30c*, and *miR-652*) were
further investigated but no significant differences between the control and DM1
conditions were found for any of them.
# Materials and Methods
## Sample collection and serum isolation
This study was approved by the Ethics Committee at the University of Valencia.
All blood samples were taken after specific written informed consent to
participate in the present study. All individuals were Subjects with DM1 were
ambulatory adults with proven CTG expansions. Peripheral blood samples were
obtained by venous punctures with a fine bore needle (21 G ¾”) of 26 DM1 and 22
healthy individuals (Tables) and placed in serum collection tubes (BD VACUTAINER
SST II ADVANCE). After 10 min centrifugation at 1200 g at room temperature, the
serum was aliquoted and kept at -80°C until use. For CTG repeat size
determination, genomic DNA was isolated from peripheral blood leucocytes and was
processed for Southern blotting with a <sup>32</sup>P-labelled cDNA25 probe or,
alternatively, the CTG-repeat region was amplified by PCR using DM101 and DM102
as primers.
## RNA extraction and cDNA synthesis
We assayed for the presence of oxyhaemoglobin in the serum samples because
haemolysis has been described to affect the levels of certain miRNAs. The
absorbance at 414 nm was determined spectrophotometrically and samples with an
absorbance higher than 0.2 were discarded, as this is the cutoff at which
samples have previously been considered to be haemolysed. Independent total RNA
extraction was performed for each serum sample using the miRNeasy Mini kit
(Qiagen). Briefly, 500 μL of serum was thawed on ice, centrifuged for 5 min at
3000 g at 4°C and 200 μL of the supernatant serum was taken and mixed with 750
μL QIAzol containing 1.25 mg/mL bacteriophage MS2 RNA as a carrier. The
extraction was performed according to the manufacturer’s instructions, except
that the final wash (with RPE buffer) was performed three times instead of once.
Total RNA was eluted with 50 μL water, and cDNA synthesis was performed with 4
μL of total RNA using the Universal cDNA synthesis II kit (Exiqon).
## MicroRNA expression profiling and validation
The miRCURY LNA™ Universal RT microRNA PCR assay and the Serum/Plasma Focus
microRNA PCR Panel (Exiqon) was used for miRNA expression profiling. These
panels contain primers for the detection of the 175 most-expressed miRNAs in
human serum. Each 384-well plate contained 2 complete panels of primers and 2
negative controls; real-time PCR was performed according to the manufacturer’s
instructions, and cDNAs from a DM1 patient and a control sample were amplified
in parallel in each plate. Expression values were calculated using the
2<sup>-∆∆Ct</sup> method using the mean Ct of miRNAs detected (Ct \< 34) for
normalisation. During the validation step, the analysis of expression of these
miRNAs used real-time PCRs with specific miRCURY LNA microRNA PCR primers
(Exiqon). The GeNorm and Normfinder algorithms were used to find optimal
reference genes to normalise the expression of the miRNAs being validated.
Expression level determinations were performed using an Applied Biosystems
7900HT Fast Real-Time PCR System.
## Statistical analysis
A logarithmic transformation (log2) was used to normalise the expression data in
the profiling experiment. Expression differences were analysed using the Student
t-test and different methods for multiple-testing correction were applied,
including Bonferroni, Benjamini-Hochberg (False Discovery Rate), Westfall-Young,
and Benjamini-Yekutieli corrections. Cluster software was used for hierarchical
clustering analysis of genes and samples. Euclidean distances and the average
linkage method were selected, using the normalised expression values of each
miRNA to represent clusters.
# Results
## MicroRNA expression profiling in human myotonic dystrophy type 1 serum
A total of 175 miRNA expression levels were obtained from each peripheral blood
serum total-RNA sample using commercial microRNA PCR panels (Exiqon;). miRNA
profiling was initially carried out with peripheral blood from 10 male
DM1-affected individuals (aged 51.3 ± 1.6; P01-P10), expressing between 333 and
1333 CTG repeats (in blood samples), and 10 sex and age-matched controls (aged
46.1 ± 1.7; C11-C20) that did not display any neuromuscular disorders. The
absorbance at 414 nm was measured in all the samples to discard the possibility
of haemolysis, which can occur during blood collection and has a potentially
substantial impact on serum miRNA content. Because two samples, P3 and C18,
generated a positive result for this parameter (absorbance \> 0.2) they were
discarded during data analysis. Expression data from each sample was initially
normalised to the mean values of all 175 miRNAs. Statistical analysis of the
results (Student t-test) showed 35 miRNAs with a *P*-value lower than 0.05, of
which 24 miRNAs were up- and 11 were downregulated when compared to controls (,
). However, only miR-21 was significantly downregulated in DM1 according to
three different statistical corrections (Bonferroni, Benjamini-Hochberg (False
Discovery Rate) and Westfall-Young). It is worth mentioning that all the
differences in expression levels detected between controls and DM1 patients were
relatively low (below 2.6-fold) compared to other described biomarkers. Given
the controversy regarding the most appropriate way to normalise data when
determining miRNA expression values, in addition to mean normalisation, we also
normalised the data to specific miRNA expression levels. For that purpose we
used two different algorithms, NormFinder and geNorm, to identify the most
stable miRNAs from our study cohort. Therefore we normalised the *miR-15a*,
*miR-23a*, *miR-28-3p*, and *miR-484* expression levels to the mean of
*miR-15a*, *miR-23a*, and *miR-484* and the mean of *miR-15a* and *miR-28-3p*.
In most cases, *miR-21* was the only miRNA with significantly different
expression between the controls and patients.
We carried out additional statistical analyses using G\*Power software to select
additional candidate miRNAs to validate by qPCR. We chose miRNAs with the
highest fold-change and with a Power value ∼1, which included *miR-21*.
Considering these parameters, we selected the six most promising miRNAs for
validation: *miR-103*, *miR-107*, *miR-21*, *miR-29a*, *miR-30c*, and *miR-652*.
## Expression quantification of six candidate miRNAs in serum
We experimentally determined individual expression levels of *miR-103*,
*miR-107*, *miR-21*, *miR-29a*, *miR-30c*, and *miR-652* in the same nine DM1
and nine control serum samples used during the initial profiling. The data were
normalised to *miR-15a*, the most and second-most stable miRNA from all of the
samples, according to geNorm and NormFinder, respectively. However, we did not
detect statistically-significant differences between DM1 and control samples,
not even for *miR-21*, the only miRNA that was positive after the profiling.
Considering that from among all of our results, data supporting *miR-21*
misexpression was the strongest, we decided to carry out further analyses on it.
To prevent potential false-negative results because of the miRNA selected as a
normaliser, we normalised *miR-21* to the expression of the miRNA with the
strongest alteration in the opposite direction because this ratio would be
independent of any endogenous control. Taking into account data from the
profiling, *miR-21* expression was downregulated 2.4 times in DM1 samples while
*miR-130a* was upregulated, with a 2.5-fold change. Next, we used serum samples
from 21 DM1 male and female individuals and 17 counterpart controls to quantify
expression levels of *miR-21* and *miR-130a*. We confirmed the absence of
haemolysis in all the samples by measuring absorbance at 414 nm. However, again,
we were unable to detect any significant difference in the *miR-21* to
*miR-130a* ratio between controls and DM1 samples.
# Discussion
The only method available for monitoring the progression of DM1 is clinical
assessment provided by semiquantitative scales, which correlates poorly with
underlying biological defects. A more targeted strategy which characterises
muscle involvement is the transcriptomic analysis of muscle biopsies via
invasive techniques. These analyses have led to the recent proposal that
suggests that alternative splicing events in skeletal muscle can serve as valid
biomarkers for quantifying the severity of DM1 and its likely response to
therapy. Nevertheless, the different patterns of muscle involvement in DM1, and
the invasive nature of the approach, inherently limits this proposal as a good
measurement of outcome. An alternative method for neuromuscular diseases is to
use blood miRNAs as biomarkers. Cacchiarelli et al. described three miRNAs that
correlated with disease severity in Duchenne muscular dystrophy where, as a
consequence of muscle-fibre damage, muscle miRNAs are released into the
bloodstream. However, cell membranes remain undamaged in DM1 muscle fibres and,
consequently, levels of myomiRs in blood in these patients are not expected to
be as dramatically increased as a result of the disease as in Duchenne muscular
dystrophy.
In the present work we profiled 175 miRNAs in serum samples but we did not
observe differences greater than 2.6-fold between DM1 patients and healthy
individuals. Owing to the novelty in the use of miRNAs as biomarkers, there is a
lack of consensus regarding different technical aspects such as sample quality.
However, it was demonstrated that haemolysis can occur during blood collection
and this can have a substantial effect on miRNA content in plasma or serum. This
fact shows the relevance of good sample quality control for the results obtained
when searching for miRNA biomarkers. Initially, we performed the profiling with
ten control and ten DM1 patient samples, however one sample from each group was
removed because of unacceptable haemolysis levels. After the profiling we
identified 35 altered candidate-miRNAs. However, after applying Bonferroni
correction only one, *miR-21*, was statistically different.
It was recently published that four muscle-specific miRNAs, *miR-1*, *miR-133a*,
*miR-133b*, and *miR-206*, were altered in serum from DM1 patients. Of these,
*miR-1*, *miR-133a*, and *miR-133b* were included in our profiling panel,
however, we did not detect differences in their expression levels. There are two
aspects that should be considered: Firstly, that in this aforementioned work the
data were normalised to *miR-16* expression, however other work has shown that
levels of this miRNA vary as a function of haemolysis levels because it is one
of the most abundant miRNAs in red blood cells, and thus *miR-16* levels may be
unacceptably influenced by haemolysis. Moreover, it was recently observed that
*miR-16* is sequestered by long CUG repeats and consequently the amount of free
*miR-16* in the bloodstream may not be equal in healthy and DM1-affected
individuals. Secondly, different methods may identify different sets of altered
miRNAs. Indeed, a recent review showed that plasma and serum miRNAs described as
breast cancer biomarkers in different publications in the literature do not
overlap with each other, and although the exact reasons remain unclear,
methodological differences in experimental procedures may be one major cause.
Another group, using a similar approach to ours, identified nine miRNAs that
were differentially expressed between healthy controls and DM1 individuals. Of
those, seven were included in our profiling panel, however, none of them were
positive. Of note, Perfetti et al. used plasma samples in their research,
whereas we used serum; this is worth mentioning because differences in miRNA and
RNA levels in serum vs. plasma have been reported. The authors suggested that
miRNAs are released from blood cells into serum during the coagulation process,
although they did not identify the reason for this. Therefore, results regarding
the biomarkers identified using serum vs. plasma are not comparable. It is also
noteworthy that we used different measurement platforms to those employed by
Perfetti et al.: the Taqman and Exiqon miRNA qPCR panels, respectively. In this
regard, Wang et al. demonstrated that the consistency between results obtained
using both platforms is low, finding that from 358 miRNAs, only ∼19% were
detected by both platforms, and that Taqman measurements were 6.7 Ct-values
higher than those from Exiqon.
After miRNA profiling we identified only one miRNA that was differentially
expressed: *miR-21*. We tried to validate five additional miRNAs by qPCR,
although the differences between controls and DM1 were not statistically
significant, and we did not observe differential expression in any case. qPCR
data were normalised to *miR-15a* because two different algorithms identified it
as the most stable miRNA from among all of the samples. In addition, *miR-21*
expression was assessed as a ratio to *miR-130a*, however, neither of these
analyses revealed significant differences. We used serum samples from males in
the profiling, and samples from both genders during the validation where a
higher number of samples was needed. However, it is unlikely this had any
significant effect on our results because the qPCR results for each gender were
similar to the results obtained from the combined sample analysis.
In summary, we conclude that, under our reported conditions, the miRNAs
*miR-103*, *miR-107*, *miR-21*, *miR-29a*, *miR-30c*, and *miR-652* are not
useful serum biomarkers for DM1. Although the successful use of miRNAs from body
fluids as disease-severity and progression biomarkers in other studies
represents an encouraging advance, several technical aspects must first be
standardised because methodological differences in the experimental procedures
seem to be the main reason that data from different studies do not coincide.
# Supporting Information
We thank Maria Goicoechea for help with the CTG repeat size determination in DM1
patients.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: JMFC BL MCAA MPA ALM ALC RA.
Performed the experiments: JMFC BL. Analyzed the data: JMFC BL ALC RA.
Contributed reagents/materials/analysis tools: ALM. Wrote the paper: AB
JMFC. Managed clinical data and processed human samples: MZ.
|
# Introduction
Inflammation has been repeatedly associated with diabetes mellitus, both in
cross-sectional and prospective studies. A meta-analysis of 20 prospective
cohorts and cross-sectional studies found that raised leukocyte concentrations
are associated with higher risk of type 2 diabetes. However, results were
inconsistent across studies \[–, \], and the authors pointed out that results
from the meta-analysis likely represent an overestimate due to publication bias
and inability to control for potential confounders in all studies. Most studies
are cross-sectional and few prospective studies have examined the role of
leukocytes in the development of diabetes. The Atherosclerosis Risk in
Communities (ARIC) study from the USA found elevated leukocyte count to be
associated with development of diabetes among 12,330 non-diabetic individuals
aged 45–64 years after a mean follow-up of 7 years. The National Health and
Nutrition Examination Survey Epidemiologic Follow-up Study (NHEFS) found
leukocyte count to be significantly and positively related to diabetes incidence
with a dose-response relationship. A high leukocyte count was found to predict
impaired glucose tolerance and type 2 diabetes in Pima Indians. In the
Cardiovascular Health Study (CHS), only C-reactive protein (CRP) and not
leukocyte count was associated with the development of diabetes.
Since gene variants are inherited and usually not subject to confounding, it is
possible to use genetic polymorphisms as instrumental variables (IV) to explore
the relationship between a trait and a certain outcome, without confounding bias
from measured and unmeasured risk factors. We used a missense polymorphism
(R262W, SNP rs3184504) in the SH2B adaptor protein 3 (*SH2B3)* gene to examine
the effect of leukocyte count on diabetes. The R262W polymorphism is known to be
associated with increased concentrations of leukocytes and its sub-populations.
The SH2B3 gene codes for a protein that negatively regulates the hematopoiesis
in knock-out models. Loss of function of SH2B3 has been identified as a risk
factor for leukemia.
The aim of this prospective study was to explore the relationship between total
and differential leukocyte count and incidence of diabetes in an urban
population.
# Subjects and Methods
## Study population
The population-based cohort Malmö Diet and Cancer study (MDC), from the city of
Malmö in southern Sweden, was used in this study. In brief, all women born
between 1923 and 1950 and men born between 1923 and 1945 living in Malmö city
were invited to the MDC study during the period March 1991 to September 1996. A
total of 30 447 individuals participated in clinical examinations at the
screening center and filled in a self-administered questionnaire out of an
eligible population of ≈74 000 individuals
<http://atvb.ahajournals.org/content/32/2/533.long-ref-17#ref-17>. DNA was
available for 28 767 subjects.
Subjects with history of diabetes (n = 1 311) at the baseline examination were
excluded. In order to exclude individuals with severe inflammation, analyses
were restricted to participants with information on total leukocyte counts less
than 20.0 × 10<sup>9</sup> cells/L. In addition, 888 participants without
complete information on covariates were excluded. Thus, the final study
population in the project consisted of 26 667 subjects (10 364 men (38.9%) and
16 303 women (61.1%), aged 45–73 years. A random subsample from the MDC cohort,
the MDC cardiovascular cohort (MDC-CV, n = 6,103), was invited to take part in a
study of the epidemiology of carotid artery disease between October 1991 and
February 1994. The additional examinations in this sub-cohort included
measurements of fasting whole blood glucose, hemoglobin A1c (HbA<sub>1c</sub>)
and CRP.
The ethics committee at Lund University Lund, Sweden, approved the study (LU
51/90) and all participants provided informed written consent.
## Baseline examinations
The examinations were performed by trained nurses at the screening center. Blood
pressure (mmHg) was measured using a mercury-column sphygmomanometer after 10
minutes of rest in the supine position. Standing height (m) was measured with a
fixed stadiometer calibrated in centimeters. Weight was measured to the nearest
0.1 kg using balance-beam scale with subjects wearing light clothing and no
shoes. Body mass index (BMI) was calculated as weight (kg) divided by the square
of the height (m<sup>2</sup>). Waist was measured as the circumference (cm)
between the lowest rib margin and iliac crest.
Information on family history of diabetes, current use of lipid-lowering, blood
pressure-lowering or anti-diabetic medications, smoking habits, leisure-time
physical activity, education level and marital status were obtained from a self-
administered questionnaire. Family history of diabetes was defined as known
diabetes in at least one first-degree relative. History of myocardial infarction
or stroke at the baseline examination was retrieved from the Swedish Hospital
Discharge Register and the Stroke register in Malmö. Subjects were categorized
into current smokers (i.e. those who smoked regularly or occasionally) or non-
smokers (i.e. former smokers and never smokers). Low level of leisure-time
physical activity was defined as the lowest quartile of a score revealed through
18 questions covering a range of activities in the 4 seasons. The evaluation of
the questionnaire has been previously reported. Educational level was divided
into three groups: school year \<9, 9–12 and \> 12, respectively. Marital status
was categorized into married or not.
## Laboratory measurements
Total and differential leukocyte counts (neutrophils, lymphocytes, and a group
of mixed cell types including monocytes, eosinophils and basophils) were counted
in heparinized blood samples using a SYSMEX K1000 automatic counter (Sysmex
Europe, Norderstedt, Germany). The analyses were performed consecutively at the
time of the screening examination, at the central laboratory of Malmö University
Hospital.
HbA1c and whole blood glucose was measured according to standard procedures at
the Department of Clinical Chemistry. HbA<sub>1c</sub> was measured by ion
exchange chromatography, with reference values of 3.9–5.3% in non-diabetic
individuals. Insulin was measured by a radioimmunoassay in mIU/ L and the HOMA
index was calculated as fasting insulin\*glucose/22.5. CRP was analyzed using a
high-sensitive assay, Tina-quant<sup>®</sup> CRP latex assay (Roche Diagnostics,
Basel, Switzerland).
### Incidence of diabetes
All subjects were followed from the baseline examination until first diagnosis
of diabetes, death, emigration from Sweden or December 31<sup>st</sup>, 2009,
whichever came first. Cases of new-onset diabetes in the MDC cohort were
identified from several sources. In short, incident diabetes was identified from
the Malmö HbA<sub>1c</sub> register (MHR) (56% of all cases), the Swedish
National Diabetes Register (NDR) (14%), the Swedish inpatient register (40%),
the Swedish outpatient register (38%), the nationwide Swedish drug prescription
register (65%) and the regional Diabetes 2000 register of the Skåne region
(22%). In addition, 44% of cases were identified at re-examinations of the
cohort. At least two independent sources confirmed the diagnosis for 71.6% of
the cases, and 53% of cases were identified in three independent data sources.
NDR and the Diabetes 2000 register required a physician´s diagnosis according to
established diagnostic criteria (fasting plasma glucose concentration of \> =
7.0 mmol/L, which corresponds to a fasting whole blood glucose of \> = 6.1
mmol/L, measured on 2 different occasions). The MHR at the Department of
Clinical Chemistry, Malmö University Hospital, analyzed and recorded all
HbA<sub>1c</sub> samples taken in institutional and non-institutional care in
the greater Malmö area from 1988 onwards. Individuals who had at least two
HbA<sub>1c</sub> recordings \> = 6.0% in the MHR with the Swedish Mono-S
standardization system (corresponding to 7.0% according to the US National
Glycohemoglobin Standardization Program) after the baseline examination were
defined as incident diabetes cases.
## Polymorphism in the *SH2B3* gene
The missense polymorphism R262W (rs3184504), which previously has been
associated with concentrations of leukocytes, neutrophils and lymphocytes was
genotyped in 24,489 subjects. Based on results from previous GWAS studies of
leukocyte count in subjects with European ancestry, we also tested whether
polymorphisms in the 17q21 locus (rs4065321, rs3859192, rs9916158, rs4794822 and
rs17609240) were useful as instrumental variables in this study. These genotypes
were studied in relation to leukocyte count in a subsample of 4600 individuals,
but none of the SNPs from the 17q21 locus reached p\<0.5 x10<sup>-8</sup> for
the association with leukocyte count. Since we also found a significant inverse
relationship between insulin resistance and the 17q21 locus, both in the
literature and in our data, we decided to use the R262W polymorphism only.
DNA was extracted from peripheral blood cells and assigned to batches without
regard to disease status or personal identity. Batches were genotyped using
real-time polymerase chain reaction (PCR) with 2.5 ng DNA as PCR template for
allelic discrimination on an ABI7900HT (Life Technologies, Carlsbad, CA, USA).
Genotype calls were obtained using SDS 2.3 software (Life Technologies,
Carlsbad, CA, USA) with manual inspection and curation of fluorescence intensity
plots. The call rate was \>90%. The Hardy-Weinberg equilibrium (HWE) was
calculated using an online calculator (chi-2 = 3.42, df = 2, *p* = 0.06).
## Statistical analysis
Subjects were categorized into sex-specific quartiles of leukocyte
concentrations, i.e., four groups with the same proportion of men and women in
each group. One-way analysis of variance (ANOVA) and logistic regression was
used to assess cross-sectional relationships of leukocyte count to diabetes risk
factors. A general linear model was used to adjust glucose and HbA<sub>1c</sub>
for potential confounding factors, in categories of the R262W polymorphism. Cox
proportional hazards regression was used to examine hazard ratios (HR) with 95%
confidence interval (CI) for incidence of diabetes by total and differential
leukocyte counts (neutrophils, lymphocytes, and mixed cells) using the lowest
quartile as the reference category. Time axis was follow-up time until death,
emigration, incident diabetes or end of follow-up. The results were adjusted for
age, sex, BMI and family history of diabetes in the basic model. Secondly, we
also adjusted for waist circumference, systolic blood pressure, using of blood
pressure- or lipid-lowering medication, history of cardiovascular disease,
smoking habits, leisure physical activity, educational level and marital status.
CRP was added to the covariates in an additional analysis in the MDC-CV sub-
cohort. Possible interaction between leukocyte count and risk factors for
diabetes was explored by introducing interaction terms in the fully adjusted
multivariate model. The Kaplan-Meier curve was used to demonstrate incidence of
diabetes in relation to total leukocyte count during the follow-up. The
association between leukocyte count, fasting blood glucose and HbA1c,
respectively, was analyzed using general linear model adjusted for age, sex and
BMI. Model discrimination was estimated with Harrell’s C-statistics.
Sensitivity analyses were performed after excluding individuals having a cold or
lung infection within two weeks before the baseline examination. We also
explored the effect of non-steroid anti-inflammatory drug (NSAID) medication on
the relationships between leukocytes and diabetes.
A Mendelian randomization analysis path diagram was presented in. R262W was used
as an instrumental variable for leukocyte count to study incidence of diabetes.
Mendelian randomization analysis was performed with two-stage least squares
regression (2SLS) using the ivreg2 command in STATA. The genetic instrument was
validated for association with total and differential leukocyte counts using
linear or logistic regression models. A power analysis was performed for the
association between R262W and incidence of diabetes. With α = 0.05, there was
64% power to detect a significant relationship, assuming a HR of 1.25 per
standard deviation increment of leukocytes, i.e., the age and sex-adjusted HR in
the present cohort.
All analyses were performed using IBM SPSS statistics (version 20; IBM Svenska
AB, Stockholm, Sweden) and STATA12 (Stata Corp, College Station, TX, USA).
# Results
## Baseline Characteristics
The mean total leukocyte count was 6.37±1.68 x10<sup>9</sup> /L, and the
proportion of neutrophils, lymphocytes, and mixed cells were 61%, 31% and 8%,
respectively. The relationships between sex-specific quartiles of total
leukocyte count and risk factors for diabetes are presented for all subjects in,
and separately for men and women in and. Increased leukocyte count was
associated with age, BMI, waist circumference, systolic blood pressure,
antihypertensive- or lipid-lowering medication, prevalent cardiovascular
disease, smoking habits, low physical activity, education level and being
married. In addition, HbA<sub>1c</sub>, glucose and insulin were positively and
significantly associated with leukocyte count (p\<0.001) in the subgroup.
## Incidence of diabetes in relation to total and differential leukocyte counts
During a mean follow-up of 14 years, 2 946 subjects (1 521 men and 1 425 women,
7.87 per 1000 person-years) developed diabetes. Kaplan-Meier curves of diabetes
free survival in relation to sex-specific quartiles of total leukocyte count is
shown in Figs and. Incidence of diabetes was significantly associated with total
and differential leukocyte counts in the basic model 1. After adjustment for
potential confounding factors, the association remained significant for total
leukocyte (4<sup>th</sup> vs 1<sup>st</sup> quartiles HR: 95% CI; 1.37;
1.22–1.53), neutrophil (1.33; 95% CI: 1.19–1.49) and lymphocyte (1.29; 95% CI:
1.15–1.44) counts, but not for mixed cells (1.04; 95% CI: 0.94–1.15, not shown
in table). Male sex, family history of diabetes, high BMI and waist
circumference, high systolic blood pressure, use of antihypertensive and lipid-
lowering medications, current smoking and low education level were all
significantly associated with incidence of diabetes in the final multivariate
model. No significant interaction was observed between total leukocyte count and
other risk factors for diabetes. Use of non-steroid anti-inflammatory drugs
(NSAID) (n = 822) at baseline was added to the multivariable adjusted model in a
sensitivity analysis, but the results were essentially unchanged. NSAID was not
a significant risk factor for diabetes in the model.
We also performed a sensitivity analysis after excluding individuals who
reported having a cold or lung infection within two weeks before the baseline
examination (n = 20 906). After adjustment for potential confounding factors,
the association remained significant for total leukocyte (4th vs 1st quartiles
HR: 1.39; 95% CI; 1.22–1.58), neutrophil (1.37; 95% CI: 1.21–1.56) and
lymphocyte (1.32; 95% CI: 1.16–1.50) counts, while mixed cells remained non-
significant (1.03; 95% CI: 0.92–1.16).
In the MDC-CV subcohort, 736 subjects developed diabetes during the follow-up.
The HR (95% CI) for total leukocyte count (4<sup>th</sup> vs 1<sup>st</sup>
quartile) was 1.95 (1.55–2.46, P for trend \<0.001) in the basic model. The HR
was reduced to 1.53 (1.20–1.95; *P* for trend 0.004) taking possible confounders
into account and remained significant also after adding CRP into the model (HR:
1.37; 1.05–1.77; *P* for trend 0.044). Among the leukocyte subpopulations, only
neutrophils remained significantly associated with incidence of diabetes after
adjustment for CRP (HR: 1.39; 1.08–1.78, P for trend 0.022).
The C-statistics value for a model with age, sex and BMI was 0.717 (0.708–0.726)
and increased to 0.722 (0.713–0.731) when leukocyte count was added to the
model. Leukocyte count significantly improved the discriminatory value
(C-statistic) for incidence of diabetes with 0.005 (0.002–0.008) (p\<0.001).
## Polymorphism in the *SH2B3* gene
The association between the R262W polymorphism and leukocyte count is shown in.
The frequency of the minor allele (T) of R262W was 48%. The T allele was
strongly associated with increased leukocytes (0.11x10<sup>9</sup> cells/l per T
allele, *p* = 1.14 x10<sup>-12</sup>, F statistics = 50.6), lymphocytes (p = 4.3
x10<sup>-16</sup>), neutrophils (p = 8.0 x10<sup>-6</sup>) and mixed cells (p =
3.0 x10<sup>-6</sup>). There was no association between the R262W polymorphism
and BMI (p = 0.154), waist (p = 0.495), systolic blood pressure (p = 0.231) and
use of lipid-lowering medication (p = 0.723).
We found no statistically significant association between the R262W polymorphism
and incidence of diabetes, fasting blood glucose or HbA<sub>1c</sub>. These
relationships remained non-significant after full adjustment for potential
confounding factors in multivariable Cox regression (diabetes) or general linear
models (glucose, HbA<sub>1c</sub>) (all p\>0.288). For glucose, the IV estimator
was -0.210 (95% CI: -0.723–0.302) (*p* = 0.421); for HbA<sub>1c</sub>, the IV
estimator was -0.201 (-0.558–0.157) (*p* = 0.272). For diabetes, the IV
estimator was -0.005 (-0.047–0.057)(*p* = 0.837).
# Discussion
The present study showed a graded association between concentrations of
leukocytes, neutrophils and lymphocytes and risk of developing diabetes among
middle-aged subjects, taking many potential confounding factors into account.
The results confirm that leukocyte count is a risk factor for incidence of
diabetes. However, a missense polymorphism in the *SH2B3* gene, strongly
associated with leukocyte count, was not related to glucose, HbA<sub>1c</sub> or
incidence of diabetes. This suggests that the relationship between leukocytes
and diabetes might not be causal.
Previous studies have reported that various inflammation markers, e.g.,
interleukin-6, tumor necrosis factor α (TNFα) and CRP are associated with
diabetes It is believed that TNFα contributes to diabetes through its
interaction with insulin signaling pathways and beta-cell function. Since human
granulocytes secrete TNFα, this could be a possible link between leukocyte count
and diabetes. A polymorphism in the IL-6 gene has been associated with total and
differential white blood cell counts. Since IL-6 is produced by human
mononuclear cells, this suggests that IL-6 might be a common link between
leukocyte count and diabetes. Hence, the relationship between leukocytes and
diabetes could be related to the actions of various pro-inflammatory cytokines.
Observational studies could be limited by unmeasured confounding. However, as
the alleles are randomly assigned at meiosis and fixed through the lifetime,
genetic association studies are usually not subject to confounding. The R262W
polymorphism, which is a non-synonymous SNP located in exon 3 of *SH2B3*, leads
to an amino acid change in the pleckstrin homology domain. *SH2B3* regulates
cytokine receptor-mediated signaling implicated in leukocyte activation. The
R262W polymorphism was strongly associated with leukocyte count (F statistics
value = 50.6), but we did not find any association between R262W and diabetes,
glucose or HbA1c. The results indicate that the relationship between leukocytes
and diabetes might not be causal. However, it should be acknowledged that the
leukocyte population is highly complex with many different subpopulations. It
remains possible that specific populations of leukocytes could be causally
associated with diabetes. In addition, even though the number of participants
was high and the SNP can be considered a fairly strong instrument, it is still
possible that the statistical power was too small in this study. The minor
allele of the R262W polymorphism has been previously associated with increased
risk of several autoimmune diseases including type 1 diabetes, multiple
sclerosis, blood pressure and MI. Some of these disorders could increase the
probability that diabetes is detected and that antihypertensive treatments are
prescribed that could increase blood glucose levels. It is not possible to
exclude the possibility of pleiotropic effects. However, a potential
relationship between the minor allele and increased risk of type 1 diabetes, MI
and hypertension should increase the risk of diabetes and cannot explain the
negative results in this study.
## Strength and limitations
The strength of the study was the large numbers of subjects and events during a
long follow-up period. A limitation of the present study is lack of information
on type of diabetes. Participants were 45–73 years old and non-diabetic at the
baseline examination. It can be assumed that almost all incident cases developed
type 2 diabetes, since type 1 diabetes usually has an early onset, and were
excluded from analyses as prevalent cases. New cases of diabetes were identified
from several independent sources. The registers of out- and in-patients cover
all hospital visits in the country and the pharmaceutical register covers all
filled prescriptions from all pharmacies in Sweden since 2005. The
HbA<sub>1c</sub> register covers the population in the city of Malmö. The
relationship between leukocytes and diabetes was largely the same for each of
the data sources. Diabetes can go undetected for several years and individuals
that do not seek medical care will be missed. However, the coverage of the
registers is very good and we have no reason to question the case validity. Lack
of information about change of exposure during the follow-up (e.g. weight
change, quitting smoking, new medication, etc.) was another possible limitation.
A further limitation is the potential pleiotropy for the *SH2B3* missense
variant, which is associated with many traits. Although this would be more
relevant in the context of a positive finding, it could be hypothesized that a
pleiotropic effect could attenuate any association with diabetes. So-called
canalization, i.e., compensatory mechanisms that counterbalance the effects of
the genetic instrument, is another possibility that hypothetically could explain
the negative results for the R262W polymorphism.
Although the leukocyte count significantly increased the model discrimination in
terms of C-statistics, it is uncertain whether measurements of leukocytes could
improve prediction of future diabetes in clinical practice. However, further
studies are needed to confirm this. In conclusion, increased leukocyte counts
are associated with incidence of diabetes. However, the negative findings for
the R262W polymorphism suggest that the associations may not be causal, although
limitations in statistical power and balancing pleiotropic effects cannot be
excluded. Further studies are needed for replication of this finding in other
cohorts.
# Supporting Information
The Swedish National Diabetes Register (NDR), the Malmö HbA<sub>1c</sub>
register (MHR), the Diabetes 2000 registers and the National Board of Health and
Welfare are acknowledged for valuable assistance in retrieval of diabetes end-
points. The study was supported by grants from the Swedish Heart and Lung
foundation and the Swedish Research council.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: YB JGS PN OM BH GE. Performed
the experiments: YB JGS GE. Analyzed the data: YB JGS GE. Contributed
reagents/materials/analysis tools: PN OM BH. Wrote the paper: YB JGS PN OM
BH GE.
|
# Introduction
*Generative models* (GMs) are a class of Machine Learning (ML) model which excel
in a wide variety of tasks. The optimization of a GM finds a function
$\mathcal{G}$ that maps a set of *M* *latent variables* in *latent space* to a
set of *d* variables in real space representing the data of interest (*e.g*.,
sets of images, music, videos, *etc*.), *i.e*. $\left.
\mathcal{G}:\mathcal{R}^{M}\rightarrow\mathcal{R}^{d} \right.$ where *d* \>\>
*M* \> 1. When building a GM, we first define the support of the latent
variables, then obtain the function $\mathcal{G}$ by iteratively optimizing a
loss function. Loss function choice depends on application, *e.g*., maximum log-
likelihood is common in Bayesian statistics, Kullback–Leibler divergence is
common for variational autoencoders (VAEs), and the Jensen-Shannon entropy and
the Wasserstein distance are common with generative adversarial networks (GANs).
The last two models are deep learning models. Deep learning is a field in
artificial intelligence which has had great success in recent years and has
pervaded many fields in science and health as well as our day to day lives. When
we fit a latent variable model to a data set, we are finding a description of
the data in terms of “independent components”. Latent variables,
\|*z*<sub>*i*</sub>〉, have a simple distribution, often a separable distribution
(*i.e*., $P\left( \left\{ z_{i} \right\}_{i = 1}^{M} \right) = \prod_{i =
1}^{M}P\left( z_{i} \right)$). Often the latent representation of data lives in
a simpler manifold than the original data while preserving *relevant*
information. There are many examples of latent representation used to understand
or describe more complicated features, ranging from statistical methods like
Latent Class Analysis to examples in statistical physics and condensed matter
such as order parameters for phase classification and even the long standing
problem of the genotype-phenotype where the genome is taken as the latent
representation of the phenotype. Other examples are, for instance, Ref. proposes
a time-frequency representation of a signal that allows the reconstruction of
the original signal, which relies in what they define as “*consensus*”. Their
proposed method generates sharp representations for complex signals.
Deep neural networks can function as surrogate propagators for time evolution of
physical systems. While the latent variables are constructed to be independent
identically distributed (i.i.d.) random variables, the training process
*entangle* these latent variables. Latent variable disentanglement is an active
area of research employing a wide variety of methods. For instance, in Ref., the
authors train a GAN including the generator’s Hessian as a regularizer in the
loss function, leading, in optimum conditions, to linearly independent latent
variables, where each latent variable independently controls the strength of a
single feature. Ref. constructs a set of *quantized* vectors in the latent space
using a VAE, known as *vector quantized variational autoencoder* (VQ-VAE). Each
*quantized* vector highlights a specific feature of the data set. This approach
has been used in OpenAI’s jukebox. A major drawback of these approaches is the
lack of freedom in relating specific features in real space with specific latent
space directions. This can be overcome by *conditionalizing* the generative
model. However, conditionalization can reduce the latent space *smoothness* and
*interpolation capacity*, since the condition is usually enforced by means of
discrete vectors as opposed to a continuous random latent vector. Diffusion-
based models have shown they can equate to GANs in performance and have become
highly popular in recent times.
Here we propose a method to relate a specific chosen labeled feature with
specific directions in latent space such that these directions are linearly
independent. Having a set of linearly-independent latent vectors associated with
specific labeled features allows us to define operators that act on latent space
(*e.g*. a rotation matrix) and correspond to feature transformations in real
space. For instance, suppose a given data set in real space corresponds to the
states of a molecular dynamic simulation, *i.e*., the *i*-th data point in the
data set can be the positions of the molecules at time *t*<sub>*i*</sub>,
\|*x*<sub>*i*</sub>〉 → \|*x*(*t*<sub>*i*</sub>)〉, where
\|*x*(*t*<sub>*i*</sub>)〉 is a vector. Let us suppose that $\left| x
\right.\left( t_{i} \right){\rangle\left. = \mathcal{G} \right|}z_{i}\rangle$
and $\left| x \right.\left( t_{i} + \Delta t \right){\rangle\left. = \mathcal{G}
\right|}z_{j}\rangle$, as depicted in. How can we construct an operator in
latent space, $\mathcal{O}_{\Delta t}$, such that $|z_{j}{\rangle
=}\mathcal{O}_{\Delta t}\left| z_{k} \right\rangle$?. For this construction to
be possible, we argue the operator $\mathcal{G}$ must be *locally* linear.
Furthermore, in order to build the operator $\mathcal{O}$, we need a basis that
**spans** latent space. While linearity might seem counterintuitive given how
NNs work, growing evidence suggests such linearity in practice. For instance, on
the one hand there is an ongoing debate on how deep should a NN be to perform a
specific task, on the other hand, it has been proposed the equivalence between
deep NNs and shallow wide NNs. For at least one image-related GAN, simple vector
arithmetic in latent space leads to feature transformations in real space
(*e.g*., removal of sunglasses, change in hair color, gender, *etc*.). However,
a complete understanding on how specific features in real space map to latent
space and how are these features arranged in latent space (*latent space
topology*) or why some GANs’ latent space behave like linear operators is
lacking. It is believed that the latent representation of data with a given
labeled feature forms a cluster. However, the tools employed to show this
clustering effect quite often consist in a dimensional reduction *e.g*., t-SNE
which collapses the latent representation into two or three dimensions. Other
methods include principal component analysis, latent component analysis and
important component analysis. Our method does not collapse or reduce
the latent space, allowing us to inspect latent space topology by spanning all
latent space directions. We strongly believe the need of a set of basis vectors
for understanding the topology of the latent space. Given the typical high-
dimensionality of the latent space, we employ the Gram-Schmidt method to
construct linearly independent vectors from a set of vectors that map to
specific features. This approach enables us to visualize the feature
entanglement in the latent space. We contend that our work contributes to a
better understanding of latent space topology in two key ways: 1) through the
method itself, which involves constructing a set of basis vectors in the latent
space that map to specific features in the real space using Gram-Schmidt, and 2)
by possessing the latent space basis vectors that map to specific features in
the real space, which enables data manipulation in the latent space via linear
algebra. As a proof of concept, we demonstrate the method by applying it to
MNIST.
In the next section we introduce our mathematical method and notation and apply
the method to the MNIST data set. In the Results section we show how we can use
this method to understand the topology of the latent space by performing
classification via principal component analysis; we apply this method to denoise
images; and finally we show how to perform matrix operations in latent space
which map to image transformations in real space. We discuss future steps and
limitations in the last section.
# Methods and materials
Assume a vector space which we call real space and denote the vectors in this
space \|*x*〉 with \|*x*〉 ∈ ℜ<sup>*d*</sup>. Assume a set $\left\{ \middle| x_{i}
\right\rangle\}_{i = 1}^{N}$, which we call the dataset with *N* the dataset
size. Similarly, we assume a vector space, which we call the latent space and
denote these vectors \|*z*〉 with \|*z*〉 ∈ ℜ<sup>*M*</sup> (in general, *M* ≤
*d*). We also consider three deep neural networks, a Generator $\mathcal{G}$, an
Encoder $\mathcal{E}$ and a Classifier $\mathcal{C}$. We can interpret
$\mathcal{G}$ as a projector from latent space to real space, *i.e*.,
$|x_{i}{\rangle\left. = \mathcal{G} \right|}z_{i}\rangle$, and interpret
$\mathcal{E}$ as the inverse of $\mathcal{G}$. However, this last statement has
to be taken with a grain of salt, due to how variational autoencoders work. In
fact, if $|z_{a}{\rangle\left. = \mathcal{E} \right|}x_{i}\rangle$ and
$|z_{a^{\prime}}{\rangle\left. = \mathcal{E} \right|}x_{i}\rangle$, in general,
\|*z*<sub>*a*</sub>〉 ≠ \|*z*<sub>*a*′</sub>〉, since these vectors are i.i.d.
random vectors, sampled from a Gaussian distribution with mean and standard
deviation dependent on \|*x*<sub>*i*</sub>〉 (the correct mathematical notation
to use would be $|z_{a}{\rangle\left. \sim \mathcal{N}\left( \middle| \mu
\right\rangle, \middle| \sigma \right\rangle)}$, where $\mathcal{N}$ is a
multivariate Gaussian distribution with mean and standard deviation \|*μ*〉 and
\|*σ*〉, respectively, which depend on $\left. \mathcal{E} \right|x_{i}\rangle$).
Finally, the Classifier projects real-space vectors into the label space,
*i.e*., $|y_{k}{\rangle\left. = \mathcal{C} \right|}x_{i}\rangle$, where
\|*y*<sub>*k*</sub>〉 ∈ *L*, where *L* denotes the label space. We assume that
each vector \|*y*<sub>*k*</sub>〉 is a one-hot-vector. The length of
\|*y*<sub>*k*</sub>〉 equals the number of labels \|*L*\| = *l* and *k* = 1, …,
*l*. Henceforth, we assume that *l* \< *M*.
We define $\left\{ \middle| \xi_{i} \right\rangle\}_{i = 1}^{M}$ to be a set of
basis vectors in latent space such that the inner product between them yields
〈*ξ*<sub>*i*</sub>\|*ξ*<sub>*j*</sub>〉 = *Cδ*<sub>*ij*</sub>, where *C* is the
norm and *δ*<sub>*ij*</sub> is the Kronecker delta function. Henceforth we call
the set of basis vectors $\left\{ \middle| \xi_{i} \right\rangle\}_{i = 1}^{M}$
the *quasi-eigenvectors* since they form a basis and each one represents a
feature *state* in latent space. Notice that we can define the operator
$\mathcal{A} = \sum_{j = 1}^{M}|\xi_{j}{\rangle\langle}\xi_{j}|$ (here
\|*κ*〉〈*γ*\| denotes the outer product between vectors \|*κ*〉 and \|*γ*〉), which
implies $\left. \mathcal{A} \right|\xi_{i}{\rangle\left. = C
\right|}\xi_{i}\rangle$. Any vector in latent space can be expressed as a linear
superposition of these quasi-eigenvectors, *viz*, $$\begin{array}{r} {\left| z
\right\rangle = \sum\limits_{j = 1}^{M}c_{j}\left| \xi_{j} \right\rangle\;.} \\
\end{array}$$ where \|*c*<sub>*i*</sub>\| = \|〈*ξ*<sub>*i*</sub>\|*z*〉\| is the
amplitude of \|*z*〉 with respect to \|*ξ*<sub>*i*</sub>〉 and gives a measure of
\|*z*〉’s projection with the quasi-eigenvector \|*ξ*<sub>*i*</sub>〉.
Constructing a set of basis vectors is straightforward. However, we wish each
labeled feature to corresponds one-to-one with a quasi-eigenvector. Since we are
assuming that *l* \< *M*, there will be a set of quasi-eigenvectors that do not
correspond to any labeled feature.
To obtain a set of orthogonal quasi-eigenvectors, we use the Gram-Schmidt
method. Specifically:
1. We train the GAN, which is composed by two NNs, namely, the Generator
and the Discriminator, using the training set $\left\{ \middle| x_{i}
\right\rangle\}_{i = 1}^{N}$ as in Ref..
2. We train the Classifier independently, using the training set.
3. We train a VAE using the trained Generator as the decoder. We also use
the Classifier to classify the output of the VAE. We include in the loss
function a regularizer $\lambda \cdot \mathcal{L}_{class}$, where λ is a
hyperparameter and $\mathcal{L}_{class}$ denotes the Classifier’s loss
function. At this stage, we only train the Encoder, keeping the Generator
and Classifier fixed. There are several options to choose from for the
$\mathcal{L}_{class}$ loss function. In our case, we used the Cross Entropy
with a softmax activation function, *i.e*., $$\begin{array}{r}
{\mathcal{L}_{class}\left. \left( \middle| y \right\rangle,
\right|y^{GT}{\rangle)} = - \sum\limits_{i =
1}^{L}y_{i}^{GT}\mspace{360mu}\text{log}\mspace{360mu}\frac{e^{y_{i}}}{\sum_{j =
1}^{L}e^{y_{j}}}\;,} \\ \end{array}$$ where *y*<sub>*i*</sub> and
$y_{i}^{GT}$ are the *i*th components of the vectors \|*y*〉 and
\|*y*<sup>*GT*</sup>〉, respectively, and \|*y*<sup>*GT*</sup>〉 is the ground
truth vector.
4. Define *n* to be an integer such that *M* = *n* × *l*. Then, for each
label, we allocate *n* sets of latent vectors and we denote each of these
latent vectors as $|z_{\alpha,i}^{k}\rangle$, where *α* denotes the label,
*i* = 1, …, *n* and *k* = 1, …, *V*. Here *V* is the number of elements
(latent vectors) in each set corresponding to the pair (*i*, *α*) ∈ *n* ×
*l*. We build each of these sets $\left\{ \middle| z_{\alpha,i}^{k}
\right\rangle\}_{k = 1}^{V}$ in two ways: Using the training set, we encode
each vector $|x_{a}{\rangle\left. \rightarrow \right|}z_{a}{\rangle\left. =
\mathcal{E} \right|}x_{a}\rangle$, then we decode the latent vector, *i.e*.,
$|z_{a}{\rangle\left. \rightarrow \right|}x_{a}{\rangle\left. = \mathcal{G}
\right|}z_{a}\rangle$, and then we classify the output, *i.e*.,
$|x_{a}{\rangle\left. \rightarrow \right|}y_{a}{\rangle\left. = \mathcal{C}
\right|}x_{a}\rangle$. For each label *l*, there is a set of latent vectors.
The goal is to have a large number of the latent vectors representation of
the data set arranged by label. Due to the large latent space
dimensionality, we may require additional latent vectors besides those
generated directly by encoding the training set. For this reason, we do the
following. We generate random latent vectors and map each of these latent
vectors to their labels using the Generator and the Classifier as in 4(a),
*i.e*., once we generated the random latent vector \|*z*<sub>*a*′</sub>〉
using a random multivariate Gaussian generator, we project it to real space
$|z_{a^{\prime}}{\rangle\left. \rightarrow \right|}x_{a^{\prime}}{\rangle\left.
= \mathcal{G} \right|}z_{a^{\prime}}\rangle$, and then we classify the
output, *i.e*., $|x_{a^{\prime}}{\rangle\left. \rightarrow
\right|}y_{a^{\prime}}{\rangle\left. = \mathcal{C}
\right|}x_{a^{\prime}}\rangle$. Notice that with this approach we can
generate as many latent vectors as desired. We denote as *V* the number of
latent vectors per set (*i*, *α*).
5. We take the average over *V* for each set of latent vectors $\left\{
\middle| z_{\alpha,i} \right\rangle\}_{k = 1}^{V}$ and denote that average
\|*η*〉<sub>*α*,*i*</sub>, *i.e*., $$\begin{array}{r} {\left| \eta
\right\rangle_{\alpha,i} = \frac{1}{V}\sum\limits_{j = 1}^{V}\left|
z_{\alpha,i}^{j} \right\rangle\;.} \\ \end{array}$$ It is worth noticing
that since the latent vectors are sampled from a multivariate Gaussian
distribution, the average \|*η*<sub>*α*,*i*</sub>〉 is finite and unbiased.
By defining operators in latent space in terms of outer products of the
\|*η*<sub>*α*,*i*</sub>〉 vectors, these latent space operators will have
encoded in them the set of latent vectors $|z_{\alpha,i}^{k}\rangle$.
6. To impose orthogonality, we use the Gram-Schmidt method. Thus, from the
vectors \|*η*<sub>*α*,*i*</sub>〉 we generate a set of quasi-eigenvectors
\|*ξ*〉<sub>*α*,*i*</sub>, *i.e*., $$\begin{array}{rcl} \left| \xi
\right\rangle_{1,1} & = & \left| \eta \right\rangle_{1,1} \\ \end{array}$$
$$\begin{array}{rcl} \left| \xi \right\rangle_{2,1} & = & {\left| \eta
\right\rangle_{2,1} - \frac{{}_{2,1}\left\langle \eta \middle| \xi
\right\rangle_{1,1}}{{}_{1,1}\left\langle \xi \middle| \xi
\right\rangle_{1,1}}\left| \xi \right\rangle_{1,1}} \\ \end{array}$$
$$\begin{array}{l} \ldots \\ \end{array}$$ $$\begin{array}{rcl}
\left| \xi \right\rangle_{l,n} & = & {\left| \eta \right\rangle_{l,n} -
\sum\limits_{\alpha = 1}^{l - 1}\sum\limits_{i = 1}^{n -
1}\frac{{}_{l,n}\left\langle \eta \middle| \xi
\right\rangle_{\alpha,i}}{{}_{\alpha,i}\left\langle \xi \middle| \xi
\right\rangle_{\alpha,i}}\left| \xi \right\rangle_{\alpha,i}\;.} \\
\end{array}$$ Such that: $$\begin{array}{r} {{}_{\alpha,i}\left\langle \xi
\middle| \xi \right\rangle_{\beta,j} = C\delta_{\alpha\beta}\delta_{ij}} \\
\end{array}$$
In, *C* is the value of the norm. The set of quasi-eigenvectors $\left\{
\middle| \xi \right\rangle_{\alpha,i}\}_{\alpha = 1,i = 1}^{l,n}$ span the
latent space and, as we will show, a subset of them map to specific features.
The key point is that the set of quasi-eigenvectors form a basis set in latent
space and each direction corresponds to a feature in real space. This structure
allows us to give a better topological description of latent space, *i.e*., how
does labeled features map to latent space similar to how molecular
configurations map to the *energy landscape*. In addition, we can use the set of
quasi-eigenvectors as tools for classification, denoising and topological
transformations. We demonstrate these applications next using the MNIST dataset.
## Applying method to MNIST
We trained a GAN, a Classifier and a VAE using the MNIST dataset which has 60*k*
and 10*k* one-channel images in the training and test set, respectively, with
dimensions 28 × 28 pixels. In we show a sample of the dataset. The MNIST dataset
can be found in many machine learning packages (*e.g*., PyTorch, Flux for Julia,
etc.) as well as in. We fixed the batch size to 25 and number of epochs to 500
during all training runs. We trained the GAN using the training set, used the
Jensen-Shannon entropy as the loss function, the ADAM optimizer with
hyperparameters *η* = 0.0002, *β*<sub>1</sub> = 0.9, *β*<sub>2</sub> = 0.999 for
both the Generator and the Discriminator, fixed the latent space dimensionality
to *M* = 100 and sampled the random latent vectors from a multivariate Gaussian
distribution centered at the origin with standard deviation equal to 1 in all
*M* dimensions. Independently, we trained a Classifier using the training set,
used crossentropy as loss function and a softmax as the activation function in
the last layer, the ADAM optimizer with hyperparameters *η* = 3 ⋅
10<sup>−5</sup>, *β*<sub>1</sub> = 0.5, *β*<sub>2</sub> = 0.99. The accuracy of
the classifier on the test set reached ≈98.9%. Using the training set, we then
trained the Encoder in a VAE and used the trained Generator as the Decoder. We
used as loss function the Kullback–Leibler divergence and the hinge loss
function. We also added as a regularizer the Classifier’s loss function and the
Lagrange multiplier, λ, as hyperparameter set to λ = 100. During the training of
the Encoder, we kept both the Generator and the Classifier fixed. In we show the
training results. To train the NNs we used Flux in Julia and the code can be
found in Ref..
The latent space dimension is *M* = 100, while the number of labels is \|*L*\| =
10. Thus, following step 4, for each label we generated *n* = *M*/\|*L*\| sets
of latent vectors, each set containing *V* = 5000 latent vectors. In we show a
sample of latent vectors for labels 0, 1, 2, 6, 7 and 8, projected to real space
using the Generator $\mathcal{G}$. Then we take the average over each set as in
step 5. We checked that the average and standard deviation over each of the
entries in the set of vectors {\|*η*〉<sub>*α*,*i*</sub>}<sub>*α*,*i*</sub>
converges. Interestingly, when taking the average over the set of latent vectors
corresponding to a label and projecting back to real space, the label holds. For
instance, in we show the projected image of the average over *V* for each set of
latent vectors $\left\{ \middle| z_{\alpha,i} \right\rangle\}_{k = 1}^{V}$ in
the case where the latent vectors were obtained following step 4(a), whereas
corresponds to the case following step 4(b). We have also plotted the
probability density function (*PDF*) per label in latent space for both cases
and added a Gaussian distribution with mean and standard deviation equal to 0
and 1, respectively, for reference. Notice that the PDF in is shifted away from
the Normal distribution, whereas in all PDFs are bounded by the Normal
distribution, because latent vectors generated directly from latent space are,
by definition, sampled from a multivariate Gaussian distribution with mean and
standard deviation equal to 0 and 1, respectively. On the contrary, encoding
real space vectors yields Gaussian vectors overall (*i.e*., the PDF over all
latent vectors over all labels yields a Gaussian distribution, by definition)
but the mean and standard deviation can differ from 0 and 1, respectively.
Step 4(a) gives robustness to this method and step 4(b) allows us to generate as
many latent vectors as wanted with a specific label. Since the latent space
dimension is *M* = 100, we need *M* averaged latent vectors
\|*η*〉<sub>*α*,*i*</sub> to generate *M* orthogonal latent vectors. Since the
number of labels is *α* = {0, …, \|*L*\| − 1}, then *n* = 10. To this end, we
generate one set (*i.e*., *i* = 1) following step 4(a) and nine sets (*i.e*.,
*i* = 2, 3, …, *n*) following step 4(b).
shows the projection to real space of all the \|*η*〉<sub>*α*,*i*</sub> vectors
while shows the inner product <sub>*α*,*i*</sub>〈*η*\|*η*〉<sub>*α*′,*i*′</sub>
as a heatmap, which shows they are non-orthogonal. At this point, we have *M*
vectors \|*η*〉<sub>*α*,*i*</sub> in latent space each i) composed of the sum of
*V* latent vectors, and ii) maps to a specific feature in real space (the image
of a number). However, these vectors are not orthogonal. Using the Gram-Schmidt
method described in step 6, we obtain a set of vectors,
\|*ξ*〉<sub>*α*,*i*</sub>, in latent space such that each
\|*ξ*〉<sub>*α*,*i*</sub> vector i) encodes *V* latent vectors, ii) maps to a
specific labeled feature and iii) the \|*ξ*〉<sub>*α*,*i*</sub> vectors are
orthogonal, as shown). Since the Generator was trained using random vectors
sampled from a multivariate Gaussian distribution centered at zero with standard
deviation 1, the value of the norm of any random latent vector will be
〈*z*\|*z*〉 ≈ *M*. Therefore, we fixed the norm of the quasi-eigenvectors to *C*
= *M*.
Notice that while the non-orthogonal vectors \|*η*〉<sub>*α*,*i*</sub> for the
MNIST GAN map to sharp images of easily-identifiable numbers in real space, not
all quasi-eigenvectors map to images of numbers in real space. Only a few of the
*M* linearly-independent directions in latent space (≈ 20) project to images of
numbers in real space. We will show how to apply this property of the quasi-
eigenvectors to the MNIST test set to classify images in latent space and to
denoise real-space images. We also show how to build a rotation operator in
latent space that generates feature transformations in real space.
# Results
## Using LSD as a classifier in latent space
We can express any latent vector \|*z*〉, in terms of the quasi-eigenvectors,
*viz*. $$\begin{array}{r} {\left| z \right\rangle = \sum\limits_{k =
1}^{M}c_{k}\left| \xi_{k} \right\rangle\;,} \\ \end{array}$$ where the
coefficients *c*<sub>*k*</sub> are given by, $$\begin{array}{r} {c_{k} =
\left\langle \xi_{k} \middle| z \right\rangle/C\;.} \\ \end{array}$$
Similar to principal component analysis, we are interested in how much
information about an image is encoded in the quasi-eigenvector with the largest
amplitude \|*c*<sub>*i*</sub>\|. We encode images from the MNIST test set into
latent space, then express the latent vectors in terms of the quasi-eigenvectors
(we call this expression *latent spectral decomposition* or *LSD*) and find the
maximum amplitude \|*c*<sub>*i*</sub>\| for each latent vector. Recall that the
amplitude \|*c*<sub>*i*</sub>\| is a measure of the projection of the latent
vector with respect to the quasi-eigenvector \|*ξ*<sub>*i*</sub>〉. Thus, the
largest amplitude corresponds to the quasi-eigenvector that contributes the most
to the latent vector. Since the quasi-eigenvectors are associated with labeled
features in real space, we use the largest amplitude as a way to classify the
image. shows a sample batch of 25 images. The blue dots corresponds to the true
labels (see y axis), while the green (red) dots correspond to the case where
label associated with the quasi-eigenvector with the largest amplitude is the
correct (incorrect) label. In this batch, only batch elements 9 and 22 have true
labels that do not agree with the label of the quasi-eigenvalue of the image
with the largest amplitude. Since each time the Encoder encodes an image it
generates a new random latent vector, then we could obtain a different outcome
for batch elements 9 and 22 as well as the rest of the batch elements for each
trial. For this reason, we perform an ensemble average over 20 trials. For each
trial we take the whole MNIST test set and compute the accuracy of the latent
space decomposition (LSD) classifier (see red dots). We also computed the
accuracy when the test set is encoded through the Encoder, then decoded through
the Generator and finally classified (see blue dots). We have included the
accuracy of the trained Classifier in as an upper bound. While the trained
Classifier has an accuracy of 98.8%, the LSD classifier has an average accuracy
of ∼92%. This difference in accuracy, however, should not be interpreted as
showing that the latent-space classifier does a poor job, but that the dominant
few quasi-eigenvectors carry most of the information in latent space regarding
the individual test-set images. In fact, the encoded 99% of the test-set data
requires only the 10 linearly-independent directions in set 1, i.e., the largest
amplitude correspond to quasi-eigenvectors in the first set.
Suppose that when we perform the LSD, we sort the amplitudes such that
\|*c*<sub>1</sub>\| \> \|*c*<sub>2</sub>\| \> … \> \|*c*<sub>*M*</sub>\| and ask
*the position of the ground-truth label?* As previously mentioned, in 92% of the
cases the ground-truth label corresponds to the first position (*i.e*.,
\|*c*<sub>1</sub>\|). In 5% of the cases the ground truth label corresponds to
the second largest amplitude (*i.e*., \|*c*<sub>2</sub>\|). In we have plotted
the cumulative of the probability for the ground-truth label being any of the
first *n* positions. The dashed red line corresponds to the trained Classifier
accuracy. Notice that the probability of the label being in position 1, 2, 3 or
4 of the LSD equals the accuracy of the trained classifier, *i.e*., in 98.9% of
the MNIST test-set images the ground truth label is associated to a quasi-
eigenvector such that the associated coefficient is either *c*<sub>1</sub>,
*c*<sub>2</sub>, *c*<sub>3</sub> or *c*<sub>4</sub>. In this sense, it is
possible that even when the amplitude of the quasi-eigenvector associated to the
ground-truth label is not the largest one, rather the 2nd or 3rd largest one,
then \|*c*<sub>1</sub>\| ≳ \|*c*<sub>2</sub>\| or \|*c*<sub>1</sub>\| ≳
\|*c*<sub>2</sub>\| ≳ \|*c*<sub>3</sub>\|. To test this idea, in we have plotted
the normalized amplitude (*i.e*.,
\|*c*<sub>*i*</sub>\|/max{\|*c*<sub>*j*</sub>\|}) *vs* the rank (*i.e*., sorted
amplitudes from largest to smallest) for all images in the test set. corresponds
to the images where the LSD amplitude of the quasi-eigenvector associated with
the ground-truth label is the largest, whereas in the amplitude is the 2nd
largest or 3rd largest, respectively. Given the large dataset, in we have
plotted the PDFs of the 2nd, 3rd, and 4th largest amplitudes for each of plots.
To be clear, from we generated PDFs for the second-, third- and fourth-largest
amplitudes in each plot and show the PDFs in, respectively. Notice that when the
largest amplitude corresponds to the ground-truth label, the second-, third- and
fourth-largest amplitude PDFs are centered below 0.6. When the second-largest
amplitude corresponds to the ground-truth label the PDF of the second-largest
amplitude is shifted towards 1, while the PDFs of the third- and fourth-largest
amplitude amplitudes are centered below 0.7. Finally, in the case where the
third-largest amplitude corresponds to the ground-truth label, the PDFs of the
second- and third-largest amplitude are shifted towards 1, while the PDF of the
fourth-largest amplitude is centered below 0.7.
The previous results give us a broad picture of latent space topology: the
labeled features project to well-defined compact domains in latent space. Let us
now consider how we can use this information to denoise images.
## Denoising with LSD
The main issue when reducing noise in images is distinguishing noise from
information. In this sense, a reliable denoiser has to learn what is noise and
what isn’t. One reason deep generative models are promising for denoising data
is that in optimum conditions the GM has learned the exact data distribution. Of
course, if the data set has noise, the GM will also learn the embedded noise in
the data set. However, by sampling the latent space we may find regions where
the signal to noise ratio is sufficiently large. For large *M*, this sampling is
computationally expensive. To avoid this cost, we propose to LSD as a denoiser.
Recall that in the previous section we showed that with a 98% accuracy the
information needed to assign a label to the image is stored in either the
first-, second-, third- or fourth-largest amplitude of the LSD. Therefore, we
propose that once the test set is encoded into latent space, we decompose the
latent vector in terms of the quasi-eigenvectors and drop the contribution from
quasi-eigenvectors with low amplitudes. In we show the results of this
truncation for 125 random sample images. In we describe how to understand these
images. shows 5 columns, where each column has 25 rows and each row has 7
images. In each row, the first image corresponds to the ground-truth image, the
second image is the image decoded from all 100 LSD components of the ground
truth image. The third, fourth, fifth, sixth and seventh images are the images
decoded after truncating the expansion after 1,2,3,4 and 10 LSD components of
the ground truth image. In this method, denoising maintains the identity of the
labeled feature in the image, *e.g*., each row shows different representations
of the same number. In most cases in , the denoised image looks clearer and
sharper. However, sometimes the LSD components project back to the wrong number.
However we can consider as many LSD components as the dimension of the latent
space, so even if taking the first *n* LSD components yields the wrong number,
taking the first *n* + 1 LSD components could yield the correct number. In the
previous section we showed that using only the first 4 LSD components gave us a
98.9% chance of obtaining the right number.
## Operations in latent space
Here we explore how to build operators in latent space that can yield feature
transformations in real space. Having a set of orthogonal vectors that span
latent space allows us to perform most operations in latent space as a series of
rotations, since we can express the operator as a superposition of the outer
product of the quasi-eigenvectors. If we construct a rotation matrix,
$\mathcal{R}$, in latent space, we can then recursively apply $\mathcal{R}$ to a
set of encoded images. After each iteration we project the output to real space
to see the effect of the latent-space rotation. We can define a projection
operator $\mathcal{B}_{\xi_{i},\xi_{j}}$, such that, $$\begin{array}{r}
{B_{\xi_{i},\xi_{j}} = \frac{1}{\left\langle \xi_{i} \middle| \xi_{i}
\right\rangle}|\xi_{j}{\rangle\langle}\xi_{i}\left| \;. \right.} \\
\end{array}$$ This operator projects from \|*ξ*<sub>*i*</sub>〉 to
\|*ξ*<sub>*j*</sub>〉, i.e., $\mathcal{B}_{\xi_{i},\xi_{j}}|\xi_{k}{\rangle
=}\delta_{\xi_{k},\xi_{k}}\left| \xi_{j} \right\rangle$, where
$\delta_{\xi_{k},\xi_{k}}$ denotes the Kroenecker delta function. Similarly, we
define the operator $\mathcal{R}_{\xi_{i},\xi_{j}}(\Delta\theta,\theta)$ as
$$\begin{matrix} {\mathcal{R}_{\xi_{i},\xi_{j}}(\Delta\theta,\theta) \propto
\left( \left. \text{cos}(\theta + \Delta\theta) \right|\xi_{i}{\rangle\left. +
\text{sin}(\theta + \Delta\theta) \right|}\xi_{j}\rangle \right)} \\ {\cdot
\left( \langle\xi_{i}\left| \text{cos}(\theta) + \langle \right.\xi_{j}\left|
\text{sin}(\theta) \right. \right)\;,} \\ \end{matrix}$$ which projects from
cos(*θ*)\|*ξ*<sub>*i*</sub>〉 + sin(*θ*)\|*ξ*<sub>*j*</sub>〉 to cos(*θ* +
Δ*θ*)\|*ξ*<sub>*i*</sub>〉 + sin(*θ* + Δ*θ*)\|*ξ*<sub>*j*</sub>〉.
Starting from a set of images with label zero, we first encoded them to latent
space, then we applied the rotation operator $\mathcal{R}$ recursively, as
follows: First, we perform the rotation from the quasi-eigenvector associated
with label zero to the quasi-eigenvector associated with label 1, *viz*.,
$\mathcal{R}_{\xi_{\alpha = 0,i = 1},\xi_{\alpha = 0,i =
1}}(\Delta\theta,\theta)$. Then, we performed a rotation from the quasi-
eigenvector associated with label 1 to the quasi-eigenvector associated with
label 2, *viz*., $\mathcal{R}_{\xi_{\alpha = 1,i = 1},\xi_{\alpha = 2,i =
1}}(\Delta\theta,\theta)$, and repeat *mutatis mutandi* until we reach the
quasi-eigenvector associated with label *α* = 9. To keep the individual
rotations in latent space small (and maintain the local linearity of the
transforms), we fixed the rotation step size Δ*θ* ≈ *π*/6 so transforming from a
direction associated with one quasi-eigenvector to a direction associated with a
different quasi-eigenvector requires three sequential rotations. In Alg. 1 we
show the pseudocode. To ensure the rotated latent vectors have constant norm
value as in, after each iteration we divide the latent vector \|*z*〉 by
$\sqrt{\frac{\left\langle z \middle| z \right\rangle}{M}}$. After each
iteration, we project the latent vector into real space. In we show this
projection for a set of sample images. Notice how the numbers transform from 0
to 9. In principle, we could rotate through any other set of sequential features
in this way. The key idea is that having a set of quasi-eigenvectors that span
latent space each mapping to a specific label, we can define a metric in latent
space defining the distance between the latent-space representation of each
label.
**Algorithm 1**: Latent space rotation pseudocode.
initialization
$\left| z \right\rangle\left. = \mathcal{E} \middle| x \right\rangle$ (initial
condition)
Δ*θ* = *π*/3 (angular rotation step)
*α* = 0 (initial label)
*i* = 1 (set index)
**for** *α* *in* {0, 1, 2, …, 9} **do**
**for** *r in* {1, 2, 3} **do**
$\left| z \right\rangle = \mathcal{R}_{\xi_{\alpha,i},\xi_{\alpha,i}}\left( r
\cdot \Delta\theta,(r - 1) \cdot \Delta\theta \right)\left| z \right\rangle$
(rotation)
$\left| z \right\rangle = \left| z \right\rangle/\sqrt{\frac{\left\langle z
\middle| z \right\rangle}{M}}$ (norm)
$\left| x \right\rangle\left. = \mathcal{G} \middle| z \right\rangle$
(projection to real space)
**end**
**end**
# Discussion
We have shown that it is possible to build a set of orthogonal vectors (quasi-
eigenvectors) in latent space that both span latent space and map to specific
labeled features. These orthogonal vectors reveal the latent space topology. We
found that for MNIST, almost all the images in the data set map to a small
subset of the dimensions available in latent space. We have shown that we can
use these quasi-eigenvectors to reduce noise in data. We have also shown that we
can perform matrix operations in latent space that map to feature
transformations in real space.
On the one hand, the deeper the NN the better its capacity in learning complex
data and as depth increases, the non-linearity increases as well. On the other
hand, it has been proposed the equivalence between deep NNs and shallow wide
NNs. From catastrophe theory, we know that in non-linear dynamical systems small
perturbations can be amplified leading to bifurcation points leading to
completely different solution families of these non-linear dynamical systems.
The results in Ref. suggest a different picture with what the authors call
*vector arithmetics* in which adding or subtracting vectors in latent space can
yield a feature addition, removal or modification (*e.g*., hair color,
sunglasses, facial hair in the case of a headshot image data set). This behavior
hints at the possibility of building a vector basis in latent space. It is not
obvious why or how the label embeddings cluster in latent space or why they do
so in a linearly independent manner. To put it in different terms, it would
appear that the training of the GAN is reminiscent of a symmetry breaking
mechanism from a rotationally invariant latent space to one where the label
embeddings are linearly independently clustered. We consider that understanding
why this pattern of clustering occurs is of great relevance and we intend to
explore it in future work. Our intuition behind using the Gram-Schmidt method
comes from the latent-space vector arithmetic and the flexibility of the method
whereby one first chooses a set of vectors from which the vector basis is built.
Our work contributes to this discussion of the emergent effective linearity of
NNs as transformations. While the NNs we used are intrinsically non-linear, they
exhibit local linearity over a region of interest in latent space. This subspace
maps to labeled features. In this sense, we say the non-linear NNs are
effectively linear over the domain of interest. As a proof of concept, we have
shown this for MNIST successfully, and our results serve as a proof of concept.
Future work is aimed at testing this method in broader data sets, such as, CIFAR
and ImageNet. Similarly, we plan to test this method for different latent space
dimensionality and the effect it can have on feature entanglement.
We have considered labeled data which is a strong assumption in real problems
since it is usually difficult to have that type of information. However, having
a set of quasi-eigenvectors potentially allows us to recreate unlabelled data
through latent superposition. We have not tested this here and we leave it for
further work as well as testing this framework in other well-known datasets.
Fundamentally, we have shown that the data clustered in the GAN’s latent space
is linearly independent by building a set of quasi-eigenvectors pointing to each
of these clusters. Further work is needed to understand the relationship between
labels and linearly-independence when the latent space dimensionality varies.
The classifier and encoder were merely tools used to be able to span latent
space and further work is aimed at simplifying this framework.
From an application standpoint, mapping to dominant quasi-eigenvectors could be
useful for medical imaging, diagnosis and prognosis if, *e.g*., the labels
denoted the severity of a disease; for predicting new materials if the labels
denoted specific material features or external physical parameters.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Neurons in the cochlear nucleus (CN), differing in their anatomical and
physiological properties, give rise to different ascending parallel auditory
pathways, each concerned with the processing of specific aspects of acoustic
information – Insights into the functional organization of the CN are therefore
essential for further comprehension of auditory brainstem processing.For the
anteroventral division of the CN (AVCN) three principal morphological cell types
have been described by Osen : spherical bushy cells, globular bushy cells and
stellate cells. Further subdivisions were postulated by Brawer et al. and
Lorente de Nó.
In parallel, electrophysiologists have commonly classified AVCN units *in vivo*
based on their temporal responses properties to acoustic stimuli as seen in
peri-stimulus time histograms (PSTH) – According to these studies, the major
response categories in AVCN were termed *primary-like*, *chopper* and *onset*
-units, where each category were subsequently further subdivided, Still, it was
shown that units exhibiting a specific PSTH also share other physiological
characteristics such as spontaneous rate, inter-spike interval histograms,
spectral response bandwidth, etc..
Intracellular labelling of CN cells combined with *in vivo* recordings provided
evidence for a relation between PSTH types and morphologically defined types of
neurons. The relationships that emanated from these studies are that *primary-
like* patterns are attributed to spherical bushy cells, *primary-like with
notch* patterns to globular bushy cells, and *chopper* patterns to stellate
cells. However, even studies in favour of the respective physio-morphological
correlation repeatedly reported cases that do not support the idea of equating
both classifications. For example, Rhode has recently shown a variation of
different PSTHs for globular bushy cells, indicating that a classification which
is exclusively based on PSTH types might not be sufficient for a comprehensive
characterization of AVCN neurons.
In an earlier attempt, Blackburn and Sachs have already evaluated a large number
of physiological properties of AVCN units to define classifying boundaries
between PSTH types. In our study, we followed along these lines, but made great
efforts to not base the analysis on any presumptions regarding different
physiological properties of the units. To achieve this goal, we used a
multivariate statistic, which allows the classification based on a uniform
evaluation of a large number of response properties. This enabled a much wider
spectrum of physiological response properties to be taken into account and at
the same time to consider potential relationships between all these parameters.
The data were collected from Mongolian gerbils, a model system that has gained
importance over the last years in auditory research due to their distinct low
frequency hearing ability. The vast majority of the previous studies
investigating cell types in the AVCN have been conducted in cats, while only
little work was done in gerbils. So, the present report provides the first
comprehensive examination of the physiological properties of neurons in the AVCN
in the Mongolian gerbil.
We find that while the neurons of the same PSTH type are generally closer to
each other than across PSTH types, no clear boundaries emerge and neurons of
different PSTH type can be quite similar with respect to their physiological
properties. We therefore conclude that at the present resolution of the analysis
and the presently observed properties, the AVCN neurons appear to form a
physiological continuum.
# Materials and Methods
All experiments were performed at the Neurobiology Laboratories of the Faculty
of Bioscience, Pharmacy and Psychology of the University of Leipzig (Germany).
The experimental procedures were approved by the Saxonian District Government
Leipzig (TVV50/06) and conducted according to European Communities Council
Directive (86/609/EEC).
## Animals and animal care
Adult pigmented (agouti) Mongolian gerbils (*Meriones unguiculatus*), aged 2–4
months and weighing 40–70 g, were used in the experiments. The animals were
obtained from the animal care facilities of the Institute of Biology II of the
University Leipzig. During the surgical preparation and the recording
experiments, the animals were anaesthetized with an initial dose of a mixture of
ketamine-hydrochloride (18 mg/100 g body weight, Ketavet®: Upjohn) and xyalzine-
hydrochloride (0.5 mg/100 g body weight, Rompun®: Bayer). A constant state of
anaesthesia was kept by supplementary injections of one-third of the initial
dose (on average once per hour). Body temperature was maintained with a heating
pad (Harvard Apparatus) at 37–38°C.
## Surgical preparation
For supporting the animal in a stereotaxic recording device the skull was
exposed along the dorsal midsagittal line, and a small metal bolt was glued to
the bone overlaying the forebrain. Two 500 µm diameter holes were drilled in the
skull 2000–2300 µm caudal to the lambda suture. Through the first drill hole,
located over the midline, the recording electrode was inserted. The second drill
hole, located 1500 µm lateral to the midline, was used to position the reference
electrode in the superficial cerebellum.
## Acoustic stimulation
Auditory stimuli were generated on a standard PC using custom written software
(Rec_thor: M. Weick, University of Leipzig; and Spike: B. Warren, University of
Washington, Seattle). The signals were then transferred to a D/A converter
(RP2.1 Enhanced Real Time Processor, 97.7 kHz sampling rate, Tucker-Davis
Technology; or DD1, 50 kHz sampling rate, Tucker-Davis Technology). Near-field
acoustic stimuli were delivered through custom made earphones (acoustic
transducer: DT 770 Pro, Beyerdynamic) fitted with probe tubes (plastic, 70 mm
length, 4 mm diameter) which were placed close to the opening of the ear canal.
The speakers were calibrated as described previously. The maximum intensity used
in the recording experiments was 90 dB sound pressure level (SPL).
## Recording setup
All experiments were performed in a sound-attenuated and electrically isolated
chamber (Type 400, Industrial Acoustics Company). The animals were placed on a
vibration-isolated table (T 251.SL, Physik Instrumente) and fixed in a custom
made stereotaxic device by means of a metal bolt. Recording electrodes were
glass micropipettes (GC150F-10, Harvard Apparatus) filled with 3 M KCl.
Targeting the AVCN, the recording electrodes were advanced through the
cerebellum and the brainstem with a piezo manipulator (PM101, Newport).
The extracellular recordings were amplified and filtered (Modell 1600,
Neuroprobe Amplifier, A-M SYSTEMS; PC1, Tucker-Davis Technology \[0.4 kHz high-
pass filter and 7 kHz low-pass filter\]; HumBug, Quest Scientific \[50 Hz notch
filter\]). For isolation of single units, action potentials thresholds were set
at voltages of at least two times the noise envelope (corresponding to approx. 4
times the S.D. of the noise), and the crossing of this level was taken as the
time of occurrence of action potentials. The crossing of the threshold level
triggered TTL-signals (SD1, Tucker-Davis Technology) which were digitized (RP2.1
Enhanced Real Time Processor, Tucker-Davis Technology; or ET1, Tucker-Davis
Technology) and stored on a standard PC for offline analysis. Simultaneously,
the voltage signals were digitized (DD1, 50 kHz sampling rate, Tucker-Davis
Technology) and stored on the PC.
## Multiunit mapping
At the beginning of each experiment, the stereotaxic coordinates of the exact
position and extent of the AVCN were determined by on-line analysis of
acoustically evoked multiunit activity recorded with low-impedance electrodes
(\<5 MΩ). In several electrode penetrations we tested for neuronal responses
evoked by ipsilateral acoustic stimulation. The characteristic frequency of
multiunits was systematically documented every 200 µm along the dorsoventral
dimension and every 200 µm in the rostrocaudal and also in the mediolateral
dimension (2° change in angle of electrode penetration). Referring to the known
tonotopic organization of the cochlear nucleus – it was possible to identify the
exact penetration coordinates for the CN and its subregions in each experimental
animal.
## Single unit recordings
The response properties of single units were examined with high-impedance
micropipettes (10–30 MΩ). Single units were identified with regard to the
bipolar shapes of their waveforms and signal constancy.
### Frequency tuning curve and related response characteristics
A unit's response area was measured by presenting pure-tone pulses (100 ms
duration, 5 ms rise-fall time, 100 ms inter-stimulus interval) within a
predefined matrix of 16×15 frequency/intensity combinations. Stimuli were
presented five times in a pseudo-random order. Spontaneous activity was acquired
in silent runs interspersed with the stimulus runs. The number of spikes was
measured during the 100 ms period of stimulus presentation. From these data
characteristic frequency (CF, frequency with the lowest threshold), best
frequency (BF, frequency with maximum discharge rate), and their difference (CF-
BF) were obtained. Additionally, the following sound-evoked response
characteristics were computed: threshold at CF (TRS), spontaneous (spontR) and
maximum discharge rates (maxR), rate-level function at CF (RLF), dynamic range
(DR), response bandwidth 10 dB above the unit's threshold (Q<sub>10</sub>-value,
Kiang 1965), the slope of the frequency tuning curve at the respective high-
frequency and low-frequency borders sites, and the occurrence of inhibitory
sidebands. For the categorical properties RLF and inhibitory sidebands we
translated each category to a number in order to include them in the cluster
analysis. For RLF the assignments were strictly monotone to 1, monotone-plateau
to 2, and non-monotone to 3. For inhibitory sidebands we assigned units that
show no sidebands to 0, units that show a sideband at the low-frequency side of
the FTC to 0.8, units with a sideband at the high-frequency side to 0.9 and
units with both, low- and high-frequency sidebands, to 1.
### Peri-stimulus time histogram (PSTH)
PSTHs were acquired in response to pure tone pulses (100 ms duration, 5 ms rise-
fall time, 100 ms inter-stimulus interval, 50 repetitions) at the unit's CF and
with 80 dB SPL.
The classification of the PSTHs was based on the definitions by Pfeiffer , Rhode
and Smith, Young et al. and Blackburn and Sachs. *Primary-like* (PL) PSTHs
display phasic-tonic discharge patterns, similar to those obtained from auditory
nerve fibres. *Primary-like with notch* (PL<sub>N</sub>) PSTHs are similar to
the PL ones, but here the initial response peak is separated from the subsequent
tonic activity by a short (\<2 ms) pause. *Chopper* PSTHs exhibit several
regularly spaced peaks with interpeak distances unrelated to the stimulation
frequency. The *chopper* units were subdivided into two subcategories:
*transient choppers* (C<sub>T</sub>) which display the regular discharge pattern
only at the beginning of the response, while in *sustained choppers*
(C<sub>S</sub>) prominent periodic discharge peaks were found throughout the
entire duration of the response. To differentiate between C<sub>T</sub> and
C<sub>S</sub> units we used the coefficient of variation (CV) as introduced by
Young et al. (1988). Units with CVs smaller than 0.35 were classified as
C<sub>S</sub>, units with larger CVs as C<sub>T</sub>. For the cluster analysis
the following parameters were quantified from the PSTH: peak-over-total value as
the number of APs occurring during the stimulus vs. the number of APs in the
onset peak (all 0.5 ms bins around the maximum peak with at least 2/3 height of
the maximum peak), average inter-spike interval (ISI) with standard deviation
(S.D.), the average first spike latency (FSL), and the jitter of the first
spike.
For the ISIs and their standard deviation only the first 20 ms of the stimulus
are consider for better comparability with previous studies. We are aware that
the ISI most likely correlate with the maximum discharge rate. However, the
maximum discharge rate corresponds to the best frequency and the ISI to the
characteristic frequency; thus both parameters could potentially carry different
information and therefore were both included in the analyses.
For the FSL the first spike of each trail is included in the analysis. Note,
that the dependency of first spike latency on CF is implicitly taken into
account by the multidimensional analysis, where covaritions between difference
parameters would produce elongated clusters, which could be identified by the
hierarchical cluster analysis we employed.
Due to the often limited single-unit recording time we had to restrict the
recordings to the minimum. We therefore choose to use only one stimulus level
for evaluating PSTHs. We decided to use 80 dB SPL for several reasons: (i) A
threshold independent stimulus level avoids presumptions about connections
between single parameters. Later on a correspondence to the threshold is always
possible and was considered in the cluster analyses, since there all parameters
are considered in parallel. (ii) At 80 dB SPL most of the units responded close
to their maximal discharge rate and thus in a comparably activated state. We are
aware that there are few units for which 80 dB SPL lies still in their dynamic
range (especially those with high thresholds) and some units which already
decrease their response at this level (units with non-monotonic RLF). (iii) The
shape of the PSTH is more likely to be fully developed at high levels. For
example, Blackburn and Sachs showed for some cases that the notch becomes only
visible for higher stimulation levels and would hence influence the
differentiation between PL and PLN.
### Sinusoidal amplitude modulation (SAM)
Temporal encoding of rapid amplitude fluctuations in the stimuli was quantified
from the responses to sinusoidally amplitude-modulated tone bursts at CF, 20 dB
above threshold. Modulation depth of the SAM signals was 100% with modulation
rates from 20 Hz to 1000 Hz (stimulus duration: 100 ms, inter-stimulus interval:
100 ms, 50 repetitions). To exclude a contamination of the units' SAM coding by
the onset response, only the steady-state response (10–100 ms) was included in
the analysis. The data were quantified by calculating the vector strengths (VS)
and entrainment (entr) of neuronal discharges.
### Waveform analysis
The waveforms of neuronal discharges were collected by triggering the voltage
trace at a visually determined, conservative level. The waveforms of the
triggered potentials were collected in intervals from 2 ms preceeding to 2.5 ms
following the trigger. The average waveforms of the units were then used to
quantify the signal-to-noise ratio (SNR, the positive peak of the AP divided by
the standard deviation of the noise) of the respective single unit recording and
the time between the maximum and minimum amplitude of the bipolar signals as an
indicator of the duration of the unit's AP (t(AP)). The averaged waveforms were
also inspected for distinct P, A, and B components as described for spherical
bushy cells.
## Verification of recording sites
The recording sites were verified histologically in 6 animals using horseradish
peroxidase (HRP, Sigma) and in 10 animals using biotinyled dextranamin (BDA,
Moleculare Probes). HRP was injected iontophoretically (+1.5 µA, 4–5 min) at the
recording site; BDA was applied by pressure injections. The animals were allowed
to survive for 24 h or one week, respectively. Then, they were given a lethal
dose of Na-pentobarbital (100 mg/100 g body weight i.p, Narcoren®, Merieux) and
perfused via the left ventricle of the heart with 0.9% NaCl solution followed by
fixative (2.5% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4). The brains
were removed from the skull and post-fixed in paraformaldehyde, and thereafter
embedded in agarose. Serial transverse sections of the brains (50 µm) were cut
using a vibratome. BDA brain sections were reacted using an avidin-HRP complex
(Molecular Probes). Accordingly, the BDA sections as well as the HRP sections
were treated with 3,3′-diaminobenzidine to visualize the HRP (Adams 1981). The
HRP sections were counterstained with cresyl violet (Nissl stain). Electrode
tracks and recording sites were reconstructed by examining the sections with the
light microscope.
## Statistics
For statistical analysis SigmaPlot 8.0, SigmaStat 3.0 (both SPSS inc.) and
MATLAB 7.3 (Mathworks Inc.) were used. If data were normally distributed
(Kolmogorov-Smirnov-test) the results are displayed as means±S.D., otherwise as
medians and the respective 25% and 75% quartiles. The statistical significance
(p\<0.05) of differences between groups was assessed using one way ANOVA
followed by Holm-Sidak *post-hoc* test if the data was normally distributed. For
data with other distributions a one way rank-based ANOVA followed by a *post-
hoc* test according to Dunn's method was used.
### Multivariate statistics
To test whether the sample can be divided into groups based on
electrophysiological response properties, hierarchical cluster analysis was
employed. This method allows a classification on the basis of a wide spectrum of
parameters simultaneously. The number of expected groups does not need to be
predefined, thus the result is not affected by prior assumptions. Before
performing the cluster analysis all parameters were standardized to remove the
effect of scaling differences between parameters. Dissimilarities between units
were expressed as distances (linkage distance) in a space of as many dimensions
as the parameters taken into account. In the present study *Euclidean distance*
between objects was used. It is the most commonly used distance and simply
figures the geometric distance in the multidimensional space. Classifications
based of other distance metrics yielded qualitatively similar results. For
joining smaller clusters into larger ones *Ward's method* was used, which
attempts to minimize the variance within the groups.
shows the aggregation procedure schematically. On the left side the units are
presented as points in the multidimensional space (here only two dimensions). On
the right side the developing dendrogram is shown for every aggregation step. It
starts with the individual cells at the bottom. First, the two closest units in
the multidimensional space were grouped together. Then, at each step, the number
of groups is reduced by merging the two groups or units whose combination gives
the least increase in the within-group sum of squared deviation. The linkage
distance is a parameter for the heterogeneity of the joined groups. When linkage
distance increases, branch points represent clusters of increasing size and
dissimilarity. The final number of groups is determined at the stage where the
maximal decrease in linkage distance is observed.
To illustrate the position of the single units in relation to each other, a
principal component analysis was performed. Principal component analysis
projects the units from the multidimensional space to a space of lower
dimensionality while attempting to preserve the distance relations between them.
Therefore the multidimensional space was rescaled in a way that the first new
coordinate (principal component 1, PC1) goes through the greatest variance by
any projection of the data, the second coordinate (principal component 2, PC2)
through the second greatest variance, etc. Besides suggesting a grouping of the
sample, this method also indicates which set of parameters best explains the
dissimilarity between groups.
Note, that both hierarchical cluster analysis and principal component analysis
can aid in uncovering structure in data sets and suggest a scheme for
classification. Yet, they do not produce a measure of statistical significance
for differences between suggested groups. To verify our results we employed (i)
different subpopulations of our unit sample and (ii) different sets of
parameters and compared the respective cluster analyses. Changes in the sample
size and in the number of parameters should be tolerated by the cluster analysis
as long as the sample provides enough information of the whole population and
the chosen parameters provide enough potential to distinguish the population.
Otherwise the analysis would result in small, only minimal separated groups. To
avoid this, our analysis is based on a broad spectrum of parameters that
potentially could separate the neuron population. Thereby we tried to not
exclude parameters that, at first, seem not to have a major impact on the
classification and also not to include parameters twice, in form of different
expressions (e.g. the CV-value additionally to ISI mean and ISI standard
deviation). We also aimed to include the parameters in their most raw form to
avoid distortions.
# Results
The analyses were based on data acquired from 233 units recorded in the AVCN of
Mongolian gerbils. The minimum requirement for a data set to be included in the
analysis was a complete acquisition of a unit's response area based on
recordings during tone burst presentations (5 repetitions of 16×15 frequency-
intensity combinations) and 16 sec (5×16×200 ms) recordings of spontaneous
discharge activity. For the majority of the units (n = 181, 78%) additional
recordings with 50 stimulus repetitions at the respective characteristic
frequency (CF) could be achieved, which enabled a refined analysis of the unit's
temporal response characteristics. Furthermore, for 60 units (26%) the discharge
activity to sinusoidal amplitude modulated signals (SAM) was registered for
modulation frequencies from 20 to 1000 Hz. The waveform of the extracellular
recorded single unit field potential was digitized in 154 units (66%). This data
set formed the basis for the analysis of the units' frequency and sound level
coding as well as their temporal coding (detailed response properties for all
units are summarized).
In analysing the data we used two strategies. First, we grouped the data based
on temporal response patterns into the ‘classical’ AVCN PSTH groups and tested
for co-variations with single other response features. Second, we performed a
cluster analysis using all evaluated parameters.
## Sample characteristics
This first part of the results gives an overview of the properties of the
recorded AVCN units based on classical classification criteria which relate to
current models of distinct pathways of auditory signal processing. These models
proceed on the assumption of neurons in the AVCN with distinct morphological and
physiological properties: spherical bushy cells, globular bushy cells and
stellate cells. However, the variability of the physiological properties within
the neuron population highlights the necessity of the cluster analysis presented
subsequently.
### Temporal response patterns
In previous studies the temporal response characteristic was an important
feature for classifying CN units. Referring to this classification, which is
based on the PSTH of responses to CF tone bursts at 80 dB SPL, our AVCN unit
sample could be subdivided into 6 classes, 4 of which are shown in. One quarter
of the units (n = 57, 25%) showed a *primary-like* (PL) response pattern.
*Primary-like with notch* (PL<sub>N</sub>) responses were obtained in 20%
(n = 48), *transient chopper* (C<sub>T</sub>) responses in 28% (n = 65), and
*sustained chopper* (C<sub>S</sub>) in 16% (n = 37) of the units. Fourteen units
(6%) displayed an *onset-inhibitory* response (O<sub>inh</sub>), characterized
by a sharp onset peak followed by strongly reduced discharge activity which was
even below the spontaneous rate (data not shown). Only a fraction (5%, n = 12)
of the units phase-locked to pure tones at their CF up to 1 kHz. Such phase-
locking made it difficult to assign these units to one of the before mentioned
PSTH types; therefore they were assigned in a separate group (PHL). In the
following analysis we focus only on the four main PSTH types, since the data
sets of the O<sub>inh</sub> and PHL units are too small for statistical
analyses.
In all PSTH types the peak-over-total ratio varied widely from 1% to 20%, but
C<sub>S</sub> units had the highest peak-over-total ratios among the units of
the four main PSTH types (13±4%). In PL units the peak-over-total ratio ranged
from \<1% to 19% (10±5%), in PL<sub>N</sub> from 1% to 22% (6±4%), and in
C<sub>T</sub> from 1% to 19% (8±3%).
The mean inter-spike intervals of both types of *chopper* units (C<sub>S</sub>:
2.0 ms \[1.6 ms; 2.8 ms\]; CT: 2.6 ms \[2.2; 3.1\]) were significantly smaller
than those of PL (3.4 ms \[2.8; 4.2\]) and PL<sub>N</sub> units (3.9 ms \[3.1;
4.6\]). Compared to the other units, both types of *chopper* units also showed a
tendency for a smaller variance in inter-spike intervals (C<sub>S</sub>: 0.6 ms
\[0.4; 0.9\], C<sub>T</sub>: 1.3 ms \[1.0; 2.0\], PL: 2.2 ms \[1.7; 2.4\],
PL<sub>N</sub>: 2.4 ms \[1.6; 2.9\]). Despite these differences the respective
values overlap strongly in the different PSTH types.
The first spike latencies were longest in PL (4.5 ms \[4.0; 6.6\]) units. Also
the jitter of the first spikes was larger in PL units (1.15 ms \[0.6; 2.1\])
than in units of other PSTH types. The values of PL<sub>N</sub>, C<sub>T</sub>,
and C<sub>S</sub> units do not differ significantly. For none of the PSTH a
dependency of the first spike latency from the characteristic frequency could be
found, also there was a slight trend to shorter latencies at higher frequencies.
In summary these results show that the consideration of the PSTH type, the
statistics of the inter-spike intervals and of latencies of the responses to
acoustic stimuli does not lead to an unambiguous separation of the unit sample.
### Waveforms of action potentials
The spike discharges acquired with electrolyte-filled glass micropipettes
typically displayed bipolar waveforms. Complex waveforms composed of a
presynaptic component (P) and two postsynaptic components (A/EPSP+B/postsynaptic
AP, inset), were observed in 17% (4/23) of the PL units and in one
PL<sub>N</sub> unit. These units exclusively responded to low frequencies (CF\<2
kHz). Only 2/7 units in this CF range lacked the presynaptic component. No such
presynaptic components were seen in units with higher CFs. Still, in 32% (11/37)
of the PL<sub>N</sub> units postsynaptic EPSP (A-component) and AP (B-component)
could be separated in the averaged AP waveforms; the same holds for 8% (4/51) of
the C<sub>T</sub> and 12% (4/32) of the C<sub>S</sub> units.
The signal-to-noise ratios of the recordings of the whole unit sample varied
between 5.2 and 16 with systematic differences in different PSTH groups. The
highest signal-to-noise ratios were obtained in C<sub>S</sub> units (12.0
\[7.9;14.5\]), which were significantly higher than in PL (7.4 \[6.3; 9.1\]) and
PL<sub>N</sub> units (6.3 \[5.5; 7.6\]). The C<sub>T</sub> units (8.4 \[6.9;
11.0\]) also had significantly higher signal-to-noise ratios than PL<sub>N</sub>
units.
However, the duration of the APs did not significantly differ between the
different PSTH groups. This was inferred from measuring the time between the
maximum and minimum of the bipolar APs signals which range from 0.11 to 0.48 ms.
The data show only a slight tendency for PL<sub>N</sub> units to have longer
APs.
### Tuning characteristics and spontaneous activity
The characteristic frequencies (CF) of the units covered the range from 0.3 to
45 kHz. In all PSTH groups the CFs spread widely, and the only significant
difference was between the lower average CF in PL units (2.3 kHz \[1.6; 7.8\])
and the rest of the unit types (PL<sub>N</sub>: 18.1 kHz \[10.1; 23.0\];
C<sub>T</sub>: 15.2 kHz \[2.6; 29.0\], C<sub>S</sub>: 14.6 kHz \[7.3; 19.6\]).
As a whole, the threshold values did not differ between the PSTH groups (means:
20–35 dB SPL). Only in the subgroup of units with CFs\>10 kHz the thresholds of
PL units were elevated (55 dB SPL \[43.75; 66.25\]) in comparison to the other
PSTH groups.
Units of all PSTH groups displayed V-shaped frequency threshold curves with low-
frequency tails. The slopes of the low-frequency flanks of the tuning curves
were typically less steep than the slopes of the high-frequency flanks. The
respective maximal values were 1.64 octaves and 1.15 octaves frequency increase
per 10 dB. There was a tendency for C<sub>S</sub> units to have more symmetric
frequency tuning curves than units of other PSTH groups. In C<sub>S</sub> units
the average difference between the slopes of the high- and the low-frequency
flank was only 0.02 octaves/10 dB. In contrast, it measured 0.16 octaves/10 dB
in PL units.
The unit's frequency selectivity was quantified by Q<sub>10</sub>-values. In all
PSTH groups Q<sub>10</sub>-values correlate strongly with the unit's CF. High-CF
units show larger Q<sub>10</sub>-values, i.e. better frequency selectivity than
low-CF units. When comparing units within specified CF-ranges, PL units showed
the best frequency selectivity.
Inhibitory sidebands could only be observed in units with sufficiently high
spontaneous discharge rates (\>10 Hz). Among those, the incidence of inhibitory
sidebands was highest in C<sub>S</sub> (77%; 14/18) and C<sub>T</sub> units
(62%, 15/24), followed by PL (58%; 23/41) and PL<sub>N</sub> units (42%; 8/19).
In most units (82%, 190/233), the CF was within the ±1 octave range of the best
frequency (defined as the stimulus frequency eliciting the highest stimulus
evoked discharge rate). In 42 of the remaining 44 units the best frequency was
below CF by up to 5 octaves. No apparent differences were observed between the
PSTH groups. However, the units' maximum discharge rates were significantly
higher in *chopper* units (C<sub>S</sub>: 410 Hz \[284; 486\], C<sub>T</sub>:
298 Hz \[255; 365\]) than in PL (163 Hz \[126; 216\]) and PL<sub>N</sub> units
(183 Hz \[140; 220\]). Still, as for the CFs, there was a wide overlap of the
respective values between different PSTH types.
The spontaneous discharge rates of PL units (32 Hz ;) were significantly higher
than in any other PSTH group. In PL<sub>N</sub> (0 Hz \[0; 27\]), C<sub>T</sub>
(0 Hz \[0; 17\]), and C<sub>S</sub> (7 Hz \[0; 26\]) units the distribution of
spontaneous rates was mostly in the same range.
Three different types of rate-level functions (RLF) were distinguished :
monotonic RLF in which the discharge rates increase with increasing intensity
level without saturation (strictly monotonic, ms, indicated as light grey);
monotonic RLF which saturates at a certain level (monotonic-plateau, mp, medium
grey), and non-monotonic RLF (nm, dark grey), in which the discharge rates reach
a maximum in the mid-level range and then decrease towards higher intensities.
In all PSTH groups, monotonic-plateau RLFs were the most frequent ones (50–69%),
the monotonic and the non-monotonic RLFs had shares of 19–28% and 11–35%,
respectively. The dynamic ranges differed between the PSTH groups: PL (30 dB ;)
and PL<sub>N</sub> units (30 dB ;) had significant smaller dynamic ranges than
*chopper* units (C<sub>T</sub>: 40 dB ;, C<sub>S</sub>: 45 dB ;). However,
these differences did not circumscribe clear borders between the PSTH groups.
### Response to sinusoidal amplitude modulations (SAM)
To quantify the ability of AVCN units to respond to rapid fluctuations in signal
amplitude, the vector strength and the entrainment to SAM stimuli varying in
modulation frequencies (f<sub>mod</sub>) from 20 to 1000 Hz were calculated.
A vector strength value of 0.3 was chosen as a cut-off criterion for classifying
a response to SAM as being phase-locked. On average, PL units phase-locked to
SAM stimuli up to 400 Hz (200; 600), while PL<sub>N</sub> units phase-locked up
to 1000 Hz (575; 1000). In PL units also the maximum vector strength values were
lowest (0.52±0.16) and they were obtained at low f<sub>mod</sub> (50 Hz \[20;
100\]). The highest vector strength values were found in C<sub>S</sub> units
(0.72±0.14) at higher f<sub>mod</sub> (200 Hz \[200; 300\]). Also the
entrainment, i.e. the proportion of SAM cycles in which at least one spike was
recorded, reached the highest values and encompassed the highest modulation
rates in C<sub>S</sub> units (0.93±0.09 at 300 Hz \[300; 400\]). Again, the
lowest respective values were found in PL units (0.59±0.15 at 100 Hz \[50;
200\]). Both SAM phase-locking and entrainment showed large overlaps between the
PSTH groups.
In summary, a separate consideration of different parameters for frequency,
sound pressure and temporal coding by AVCN units did not lead to an unambiguous
separation of physiologically defined unit types. In fact, there is a large
variability of values within each PSTH group and a strong overlap between the
groups. Therefore we pursued an alternative approach and analysed the whole data
set in a multidimensional parameter space.
## Cluster analysis
The following cluster analyses are based on the same sample of AVCN units and
the same set of discharge properties described above. Cluster analysis can
uncover structures in data sets and suggest a scheme for classifying the unit
sample. It may result in the identification of distinct groups of units with a
fixed set of distinguishing properties, or in identification of groups of units
which differ in their properties, but which are not strictly separated from each
other, or alternatively in the absence of distinct groups (continuum).
### Classification of AVCN units considering all evaluated properties
To allow a complex physiological classification of AVCN units, all 22 evaluated
properties were included in this analysis. For the cluster analysis an equalled
sample, i.e. the same number of parameters for each unit is required. To sustain
a sufficient sample size missing values, i.e. values that could not be acquired
because of limitations of single unit recording time, were substituted by the
mean of the respective property in the whole unit sample.
The result of the hierarchical cluster analysis is shown as a dendrogram in.
Individual units are lined up at the bottom of the graph. With increasing
linkage distance between units, successive branch points represent clusters of
increasing size and dissimilarity. This dendrogram suggests five main clusters
(I–V) of which one (cluster V) is characterized by a stronger separation from
the rest.
For purpose of comparison, the values for all evaluated properties of the
respective clusters are displayed in and summarized in. Cluster V is composed of
80 units which are particularly characterized by short inter-spike intervals
(2.2 ms \[1.8; 2.8\]), a low variation of inter-spike intervals (0.9 ms \[0.6;
1.4\]), high maximum discharge rates (324 Hz \[248; 428\]), and low CF-
thresholds (15 dB SPL \[0; 25\]). The units in this cluster never show waveforms
with a presynaptic component.
Units in cluster I (n = 54) are characterized by long first spike latencies (4.8
ms \[3.7; 7.0\]), relatively high CFs (21.8 kHz \[8.5; 31.9\]), high thresholds
(45 dB SPL ;), and low spontaneous rates (0.8 Hz \[0; 13.4\]). Inhibitory
sidebands were rarely seen (n = 2/54). The waveforms show two postsynaptic
components in one third of the units (11/37), a P-component was never observed.
The typical parameter combination of units in cluster II (n = 43) is low peak-
over-total values (0.04 \[0.02; 0.06\]), long inter-spike intervals (4.5 ms
\[3.8; 5.4\]), and a large variation of the latter (2.7 ms \[2.4; 3.5\]), low
maximum discharge rates (138 Hz \[113; 171\]), and high frequency selectivity
(Q<sub>10</sub> values: 2.05 \[1.38; 4.05\]). The signal-to-noise ratios of
these units (6.3 \[5.5; 7.5\]) was the lowest in the entire sample. At the same
time, most units in this cluster displayed complex waveforms; in one third of
the units (11/34) prepotentials were recorded. In 9 other units (26%) the
waveforms showed the two postsynaptic components.
Units in cluster III (n = 20) are characterized by low spontaneous (0.1 Hz \[0;
8.8\]), but high maximum discharge rates (307 Hz \[238; 376\]). The frequency
tuning curves are mostly asymmetric, i.e. they showed large differences in the
slope of the low and high frequency flanks (Δ: 0.5 octaves/10 dB \[0.1; 0.9\]),
large differences between BF and CF (Δ: 2.2 octaves \[1.1; 2.7\]), and between
the discharge rates at the respective frequencies (Δ: 151 Hz \[92; 206\]). The
RLF are mostly monotonic (47%; 9/19) or monotonic- plateau (37%, 7/19) rather
than non-monotonic (16%, 3/19). The dynamic ranges of these units (45 dB±18\])
were the largest in the entire sample. Inhibitory sidebands were seen in only
2/20 cases (10%).
Cluster IV units (n = 38) show high peak-over-total values (0.13 \[0.08;
0.18\]), short first spike latencies (3.8 ms \[3.2; 4.2\]), but at the same time
high jitter values (1.4 ms \[1.2; 1.9\]) and high spontaneous rates (68 Hz \[36;
87\]). These units had the highest incidence of inhibitory sidebands (89%,
34/38), and they responded well to fast fluctuations in signal amplitude.
In conclusion, the clusters establish well separated groups of units which
differ significantly in a sizeable number of properties (see also). Still, the
different clusters show a strong overlap in the parameter fields. Thus, it may
not be appropriate to think of the identified clusters as rigidly segregated
classes of AVCN units.
To visualize the clusters in a lower number of dimensions a principal component
analysis was performed. The principal component analysis linearly maps the high-
dimensional representation to a lower dimensional space with its axes defined by
weighted combinations of the original properties, the principal components.
Clusters which are separated in the higher dimensions often remain separated in
the lower dimensional projection.
The weights of the single units on the two first principal components (PCs) are
plotted in. The properties that contribute mostly to PC1 are the maximum
discharge rate (13%), the mean inter-spike interval (11%), and variation in
inter-spike intervals (13%). The further left a unit lies on the PC1 scale, the
higher was its maximum discharge rate (r = −0.75), the lower was its mean inter-
spike interval (r = −0.67) and the variation of its inter-spike intervals
(r = −0.76). But other properties correlate with the PC1 as well, e.g. the
entrainment (r = −0.64) and the peak-over-total values (r = −0.55). The PC2 is
influenced mostly by CF threshold (12%). The lower the value was on this PC
scale, the higher was the unit's threshold (r = −0.60). All other properties
contribute only little to PC2 (each less than 10%) and show only weak
correlations (r\<0.5).
In the two dimensional plot, the individual clusters occupy different regions,
but the separation of the cluster is not perfect. Some units of cluster I are
located in an area which contains primarily units of cluster III or V, some
units of cluster IV in an area predominantly containing cluster II units, etc.
Especially in the middle of the plot the clusters strongly overlap.
Correspondingly, the first two PCs only constitute 28% (PC1: 17%, PC2: 12%) of
the overall variance.
A potential problem of the analyses presented above is that missing values were
replenished with the mean of the unit sample. This could be the reason for the
accumulation of units in the centre. To address this issue, additional analyses
were done with a reduced set of parameters, i.e. fewer properties.
### Reducing parameters
The following ten properties were used in this analysis: peak-over-total, mean
and standard deviation of the inter-spike intervals and the first spike latency,
CF and CF threshold, spontaneous and maximum discharge rate, Q<sub>10</sub>
value and dynamic range. These physiological properties are easy to quantify
from a limited number of extracellular recordings thus reducing the number of
missing values. Consequently, all units with missing values were removed from
analysis, which reduced the sample size from 233 to 174 units.
The results of this more restricted analysis are presented in. The dendrogram of
the hierarchical-agglomerative procedure now results in four main clusters
(a–d), but still the two analyses yielded partially comparable results (compare
with). In the restricted analysis, again one of the clusters shows a stronger
separation from the rest. Here, it is cluster ‘a’ which shares some properties
with cluster V in. The units in this cluster show short inter-spike intervals
and a low variation of it; high maximum discharge rates and low CF-thresholds.
There are also partial overlaps of the other clusters with clusters of the
extended analysis. Cluster ‘b’ has its counterpart in cluster I, and ‘c’ and ‘d’
in clusters II and IV, respectively.
On average, the more restricted analysis shows smaller linkage distances within
and larger between the clusters. Consequently, the resulting clusters are more
homogeneous and differ more from each other. Still, the principal component
analysis on the whole unit sample results in one big cluster of units instead of
clearly separated groups (1+2). We verified that this is not only an artefact of
the projection into two dimensions by considering the results in three
dimensions. Similar results for hierarchical clustering and principal component
analysis were obtained when other parameter combinations were used, confirming
the reliability of the depicted results.
### Reconsidering the classification based on PSTH-types
To evaluate potential links between the hierarchical cluster analysis and the
classification based on the PSTH types, we assessed how the PSTH types fit into
the clusters obtained by the previous analysis. For this, the distribution of
the different PSTH types in the multidimensional parameter space was analysed.
None of the clusters contains exclusively one PSTH type, but the distribution of
the PSTH types differs between the clusters. Cluster I mainly includes PL (30%,
n = 16), PL<sub>N</sub> (30%, n = 16), and C<sub>T</sub> (19%, n = 10) units,
while the proportion of C<sub>S</sub> (11%, n = 6), O<sub>inh</sub> (6%, n = 3),
and phase-locking units (3%, n = 2) was low. In cluster II the majority of units
have a PL<sub>N</sub> (52%, n = 22) or a PL PSTH (24%, n = 10). In cluster III
58% (n = 11) of the units respond with a C<sub>T</sub> pattern and 16% (n = 3)
with PL and PL<sub>N</sub> respectively. Cluster IV mainly consists of PL (45%,
n = 17), O<sub>inh</sub> (24%, n = 9) and C<sub>T</sub> (18%, n = 7) units. The
dominant response patterns in cluster V are C<sub>T</sub> (38%, n = 30) and
C<sub>S</sub> (36%, n = 29).
In the principal component analysis, the PSTH types show a stronger overlap than
the clusters obtained from hierarchical clustering. Still, units of different
PSTH types tend to occupy different regions of the parameter space. The
*chopper* units generally were found at the upper left side of the plot, and PL
and PL<sub>N</sub> units more at the right side. Moreover, the PL units tend to
be located in the upper quadrant and the PL<sub>N</sub> in the lower one.
To exclude the effect of possible misleading PSTH classifications caused by
outliers, we checked the temporal response patterns of those units that were
located separated relative to units of the same PSTH type. We could confirm most
of our previous classifications, but few units we found with PSTHs that are not
unambiguously to classify. For example the unit in : This unit could either be
classified as PL unit, bases on the strong onset and the following sustained
rate which is comparable to auditory nerve fiber responses, or as CT unit since
there are two sharp peaks in the onset component and the CV value is above 0.35.
This kind of PSTH shapes could somehow described as mixture of different
‘classic’ PSTH types.
In conclusion, it can be stated that based on their physiological response
properties, AVCN units can better be described as occupying specific areas in a
coherent multidimensional parameter space, rather than forming clearly separable
groups of units.
# Discussion
The present report provides the first comprehensive evaluation of the
physiological properties of AVCN neurons in the Mongolian gerbil in vivo. More
important, this study re-evaluates the question of classifying AVCN neurons.
Based on our present results, we conclude that units in the AVCN form a
continuum concerning their physiological response properties, with each unit
having a fingerprint-like combination of several properties. Thus, the present
results challenge the conventionally held idea of separable classes of AVCN
units. However, we show that units, which stand out by their prototypic
physiological response properties, are located towards the extremes of this
continuum. The significance of a classification lies in the fact that the AVCN
is the starting point of distinct ascending auditory pathways. Hypotheses about
specific auditory processing along these pathways must consider the functional
organisation of the AVCN. We will discuss possible causes for such a continuum
and the consequences for the functional differentiation of the auditory
pathways.
## Limitations of the study
In the first part of the present study we demonstrate that our sample of AVCN
units is in most respects comparable to those previously described in other
mammalian species. There are only minor deviations, for example the relatively
long latencies in PL units. Based on the (somewhat limited) data we have from
these units for lower-level stimulation, we can rule out that level dependence
or nonlinear RLFs are the determining factors for these differences. Also, it is
unlikely that differences in spontaneous rates are casual for this result, since
PL units tended to have higher spontaneous rates than the other cell classes,
and such higher rates would cause a trend for latency shifts towards lower
values. Finally, species differences can be ruled out, since Frisina et al. also
observed shortest latencies for the PL units in the gerbil. However, in other
respects the PL units are comparable with those previously described, but we
could not finally rule out distortion effects on our analysis.
Generally, it cannot be excluded that certain cell class distinctions would only
become apparent, if a different or an even wider set of parameters/conditions
were included in the cluster analysis. The limited recording time in *in vivo*
single unit electrophysiology makes it necessary to seek a compromise between
the use of a standardized stimulus repertoire and extensive variations of
stimulus parameters. Still, in future studies it could be more revealing to
analyze responses to more complex stimuli (i.e. broadband stimuli) or to study
the system under continuous activation, e.g. via the use of long, natural
stimuli. Such an approach would require the use of more general neuronal
characterizations, e.g. spectro-temporal receptive fields or multilinear models
as recently employed in the medial nucleus of the trapezoid body. Also, PSTHs
were only collected at one common sound level (80 dB SPL) for the reasons
explained in the section. If PSTH types were to systematically change for
different relations of sound level and rate-level function of a given neuron,
some cells which currently fall far away from the majority of units in their
corresponding PSTH type might have been classified more consistently.
However, for a subset of our neurons (n = 60) we also collected the PSTH at 20
dB above their threshold. The PSTH shape for low and high intensity stimulation
was very similar when normalized for mean rate (r = 0.85). Similarly, the inter-
spike interval histograms for the low and high intensity stimulation were highly
correlated (r = 0.92). Therefore, including this low level stimulation into the
cluster analyses was unlikely to provide a better distinction between the cells.
Evidently not all possible parameters were included in the present analysis
(e.g. phase-locking filter type could have been included if more data were
available), but still we tried to include a wide range that could aid the
classification. Additionally, we reran the cluster analysis and the PCA with
different combinations of the acquired parameters to exclude distortion effects
of any single parameter. None of the respective combinations revealed distinct
physiological neuron types in our data sample.
To support the physiological data, it would also be useful to have additional
data about cell morphology and projection pattern. Unfortunately, single-unit
labeling is not easy to implement *in vivo* for a substantial number of units.
At the same time, including it would defy the purpose of achieving a
physiological classification.
The present focus on the Mongolian gerbil as a model system for human (low
frequency) hearing inherits a potential caveat, as recent studies have
reemphasized the potential deterioration of auditory processing due to
microcysts forming also in the cochlear nucleus of the gerbil. The functional
consequences of this gerbil-specific condition, which develops mostly after
sexual maturity, are not clear. However, the present study used comparatively
young gerbils (2–4 months) to avoid potential effects of altered CN morphology.
Given that the Mongolian gerbil is a well-introduced animal model, future
studies might consider the use of even younger specimen or switching to other
species.
## Variability of response properties of AVCN neurons
When dealing with physiological classifications of AVCN units *in vivo*, earlier
studies mostly relied on the units' temporal response properties to pure tone
bursts as visualized in the PSTHs. The present sample of AVCN units recorded in
the Mongolian gerbil fits well into the ‘classical’ PSTH types described for a
number of mammalian species (gerbil:, ; cat:, guinea pig:). However, the
analysis presented here is based on a larger number of physiological features,
all acquired from the same sample of AVCN units. Hence, the assessment of
potentially distinct physiological neuron types rested on a broader base.
With respect to their morphology, AVCN neurons are subdivided in at least three
different classes; spherical and globular bushy cells and stellate cells
(review:). Several studies attempted to relate these different groups of neurons
to physiological response types yielded by acoustic stimulation (gerbil: ; rat:,
; guinea pigs: ; cat: –). Most studies agree that PL responses are best
attributed to spherical bushy cells, PL<sub>N</sub> responses to globular bushy
cells, and any kind of *chopper* responses to stellate cells. However, the same
studies reported a number of cases where such a simple agreement between PSTH
type and morphological cell type does not hold. Especially globular bushy cells
are reported to show a variety of different response patterns. Besides the
PL<sub>N</sub> pattern, PL and various onset patterns are found in this cell
type. Similarly, also for spherical bushy cells and stellate cells a variety of
PSTH types have been described. Thus, either the correspondence between
morphology and PSTH types of AVCN neurons is very complex, or the PSTH alone is
not sufficient to establish the quested structure-function relationship, or the
two modes of classification are mostly independent from each other.
A correlation of PSTH types with a number of other physiological properties,
such as spontaneous rate and first spike latency, has been suggested in previous
studies. But considering these correlations, it was not possible to separate the
units into non-overlapping groups. This problem has already been addressed in a
number of earlier studies, , which attempted to develop different schemes for
classifying AVCN units based on PSTH types considering different features of the
unit's response properties (e.g. spiking regularity and response latency).
Still, the authors of these studies admitted that the “continuous filling of the
parameter map” and the “overlap of the characteristics of neighbouring unit
types” suggest that the classification schemes ”do not provide absolute borders
between response types”.
In contrast to previous studies, our study is based on a larger repertoire of
physiological parameters. Additionally, we avoided to make any assumptions on
the significance of specific parameters. By performing cluster analyses, an
unbiased analysis was possible. Even with this precautionary measure it was not
possible to identify clearly separated physiological unit types. The units
rather have a fingerprint-like combination of several properties and show a wide
distribution in the multidimensional parameter space. While this does not
preclude a correlation of some physiological properties across units, it
appeared hard to establish an unambiguous structure-function relationship on
this basis.
## Possible causes for a physiological continuum
It is widely accepted that the morphologically defined AVCN neuron types –
establish the origin for several distinct ascending auditory pathways. This is
tantamount to distinct projection patterns of the neuron types. Also, in *in
vitro* preparations the units can be differentiated with respect to their basic
physiological properties.
Hence, the question arises, what could cause the higher degree of variability in
physiological characteristics across different AVCN units *in vivo*? The more
uniform features obtained *in vitro* might relate to the reduced complexity of
the system. *In vivo* there are several levels at which the units' responses can
be modulated to show a wider range of response characteristics. With respect to
the afferent input, some variability already exists in the activity of auditory
nerve fibres. Next, the degree of convergence of auditory nerve fibres onto
single CN neurons varies, ranging from 3–5 in spherical bushy cells – to 9–69 in
globular bushy cells. Even higher degrees in convergence were reported for
stellate cells,. Furthermore, variations of the synaptic strength of auditory
nerve fibers on AVCN neurons can determine the response properties of the
postsynaptic cells. Additionally, there are secondary excitatory and inhibitory
inputs, which also can affect the response. Furthermore, postsynaptic properties
can determine a unit's response as well. The units show a certain degree of
variability in their morphology, first of all the size of their somata and
dendritic branching patterns. Moreover, the neurons differ in the expression of
specific subsets of receptors, ion channels and membrane proteins – which
influence their membrane characteristics. It is conceivable that a multifold of
these pre- and postsynaptic influences contribute to the establishment of a
continuum in response properties.
## Consequences for concepts of auditory pathways and functional implications
As discussed above, it cannot be ruled out that future studies with a different
set of stimuli will provide a basis for an unambiguous classification. However,
if the continuum of physiological properties cannot be resolved, the notion of
classifying AVCN neurons on a physiological level would have to be reconsidered.
Classification schemes have a great value in organizing our understanding of the
system, but they do not have to reflect actual boundaries. While such
classifications are often based on the description of prototypical
representatives of each class, many cells appear to fill the parameter space
between the prototypes and only fit ‘more or less’ into the classification. In
the ‘classical’ concept, the AVCN is composed of a set of distinct cell classes,
each of which occupies a well-defined location in the space of all possible
combinations of properties. While such a representation is favourable from the
perspective of a human observer (since it allows an easier conceptualization),
it need not to be favourable from a more general coding perspective. As has been
shown theoretically (e.g. liquid state machines), that a broad representation of
various parameter combinations considerably simplifies the task of extracting
many complex aspects of the original signal. In this sense the presently
observed continuum of cell properties could be advantageous for processing in
subsequent higher-order nuclei of the ascending auditory system.
The authors thank the anonymous reviewers for their dedication to improve the
manuscript. We also thank Anita Karcz and Sandra Tolnai for comments on earlier
versions of the manuscript and for their encouragement during the writing
process. Special thanks are also dedicated to Doris Freyberg and Gudrun König
for keeping the lab running.
[^1]: Conceived and designed the experiments: MT CKS RR. Performed the
experiments: MT CKS. Analyzed the data: MT BE SD MS. Contributed
reagents/materials/analysis tools: BE RR. Wrote the paper: MT BE SD CKS RR.
[^2]: Current address: Schulich School of Medicine and Dentistry, University
of Western Ontario, London, Ontario, Canada
[^3]: Current address: Neural Systems Laboratory, University of Maryland,
College Park, Maryland, United States of America
[^4]: Current address: Bernstein Focus Neurotechnology, Georg-August-
University Göttingen, Göttingen, Germany
[^5]: Current address: MRC Toxicology Unit, University of Leicester,
Leicester, United Kingdom
[^6]: The authors have declared that no competing interests exist.
|
# Introduction
Since the early observations of Darwin and von Humboldt, ecologists have
attempted to explain why species diversity increases towards the Equator.
Relationships of biodiversity with net primary productivity (*NPP*) are
frequently suggested as potential explanations, and *NPP* is usually the best
correlate of biodiversity. Productivity-diversity relationships are assumed to
be driven by the *NPP* of an ecosystem as a result of increased provision of
vital resources. For example, climates which are highly deficient in water (such
as desert) or energy (such as arctic) have both low *NPP* and low species
richness. There is, however, little consensus on the mechanisms underpinning
increases in diversity from intermediate to high levels of *NPP*. Furthermore,
the shape of productivity-diversity relationships is typically dependent on the
spatial grain of the analysis. For example, linear increases in species richness
in large sampling units (such as degree grids) contrast with the multiple ways
in which species richness within local habitats responds to *NPP*. Thus,
although productivity-diversity relationships are widespread, the underlying
mechanisms still need to be resolved.
In other cases however, biodiversity is more strongly correlated to ambient
energy than to *NPP*. In contrast to *NPP*, ambient energy does not include
water availability and can be expressed as annual mean temperature (*T*).
Possible mechanisms for increasing species richness with ambient energy include
tropical niche conservatism, dispersal limitation after glaciation and metabolic
theory. Based on the evolutionary origin of many taxa in tropical climates,
their occurrence in cooler climates depends on the evolution of cold-tolerance.
Within larger taxonomic groups, communities in warm climates often include many
basal taxa, while communities in temperate to cold climates are increasingly
restricted to few derived taxa. This results in a positive relationship of
species richness and *T*. Analyses of the phylogenetic structure of communities
provide evidence for this mechanism, notably in butterflies. Another effect of
historical climate on contemporary richness patterns has been described for
European dung beetles. Their limit of thermal tolerance during the last glacial
maximum marks a strong change in current richness with low species numbers north
of this limit. Thus, limited colonization of areas with historically unsuitable
climate can contribute to current correlations between richness and ambient
energy. Metabolic theory provides an additional mechanism for higher species
richness in warmer climates based on the influence of temperature on metabolic
rates and on rates of speciation. Metabolic theory predicts a direct, monotonic
relationship of species richness with *T*, whereby the slope of log<sub>e</sub>
–transformed species richness with inverse *T* is predicted to be −0.65.
A third framework for broad-scale patterns of species richness is biological
relativity to water-energy dynamics. It is based on the dependence of all life
on the availability of water in a liquid form. This framework suggests that
species richness is proportional to (a) the availability of liquid water (annual
rainfall, *R*), and (b) the lowest monthly value of potential evapotranspiration
(*PET<sub>min</sub>*). This “interim general model” explains almost 80% of the
variation in species richness of trees and shrubs in eastern and southern
Africa. At higher latitudes (Europe and North America) the effect of rainfall on
species richness of trees dominates (*r* = 0.64), and effects of
*PET<sub>min</sub>* or other energy variables are non-significant.
The final determinant of species richness patterns considered here is spatial
environmental heterogeneity. Its importance can be expected to increase with
increasing size of sampling units (spatial grain). For example, only limited
spatial climatic heterogeneity can be expected along a 21 m transect within one
habitat type (the small sampling grain in our study, see Methods). In contrast,
large differences in internal spatial climatic heterogeneity exist among
countries (the large sampling grain in our study). For example, *T* differs by
13.3°C between the warmest and the coldest 10×10 arc minute square within
Switzerland – more than ten times the difference within Denmark, which has a
similar surface area. Effects of spatial environmental heterogeneity on species
richness can be explained with niche theory, which assumes different
environmental preferences and tolerances among species. Among environmental
variables, climate is central to the distribution and persistence of species
worldwide. In particular, the distribution of numerous taxa is influenced by
*T*, for example plants, beetles, spiders and birds. Thus, heterogeneity of
environmental conditions (such as *T*) within large sampling units can enhance
overall species richness by providing suitable conditions for larger numbers of
species with different ecological niches. Increased species richness due to an
increased importance of spatial environmental heterogeneity will consequently
shift the focus from alpha diversity (local species richness) to beta diversity
(turnover of species in space).
Here, we explore species richness-environment relationships of European
arthropods. We combine the results of a continent-wide standardised sampling
programme of local ground-dwelling arthropod communities (local grain) with
existing coarse-grained country inventories (country grain) of comparable
spatial extent. At the local grain ground-dwelling ants (Formicidae), beetles
(Coleoptera), bugs (Hemiptera) and spiders (Araneae) were sampled in 32 habitats
at 16 locations across Europe, ranging from boreal to Mediterranean in climate.
At the country grain, inventories of 25 European countries were obtained for the
same groups. We used these data to test each of the above hypotheses by first
comparing the explanatory power of productivity, ambient energy, the interim
general model, and the best possible statistical model (drawn from all
variables) for biodiversity within local habitats (alpha diversity). Secondly,
we compared the potential for environmental heterogeneity to explain species
turnover across locations (beta diversity). Thirdly, we compared the explanatory
power of productivity, ambient energy, the interim general model, spatial
environmental heterogeneity and the best possible statistical model (drawn from
all variables) for biodiversity within countries (gamma diversity).
# Methods
## Ethics
1. Field sites were selected and established within the EU FP6 ALARM
project to form a long-lasting research network
2. Each field site had a site manager, responsible for contacts to local
authorities and/or land owners
3. In most cases the land belonged to regional research stations
4. More detailed descriptions can be found in reference
5. Protected areas or rare habitats were not included into this field site
network
6. We did not include protected species.
The employed pitfall traps capture invertebrates, with no protected species
affected in the habitats we sampled. No permissions are needed to use pitfall
traps outside of protected areas.
## Data
Ground-dwelling arthropods were sampled in 32 habitats at 16 locations across
Europe. Thirteen locations were part of the ALARM field site network, and three
sites (Bern, Silkeborg, Wien) were added to fill geographic gaps. As far as
possible, one forest as an example of a near-natural habitat and one cereal
field as an example of an intensive agricultural habitat were sampled in each
location. When unavailable, other near-natural habitats (scrubland or extensive
grassland) and other intensive agricultural habitats (intensive grassland or
olive grove) were sampled instead. Trapping took place in 2006 and started five
days after the beginning of the vegetation period (the onset of growth in the
majority of plant species) in each location. In each habitat, eight pitfall
traps of 7 cm diameter were placed along a transect and separated by 3 m from
each other. The traps were filled with 0.1 L of a 4% formaldehyde solution, to
which sodium dodecyl sulphate was added as detergent. Three sampling periods of
two weeks were separated by pauses of two weeks. Adult arthropods were
identified to species level by specialists. The following groups were
considered: ants (Hymenoptera: Formicidae), beetles (Coleoptera: Carabidae,
Curculionoidea, and Staphylinidae), bugs (Hemiptera: Auchenorrhyncha and
Heteroptera), and spiders (Araneae). In addition to the analysis of taxonomic
groups, we divided the studied arthropods into trophic groups according to the
dominant feeding type in the respective family. Herbivore families were all
Curculionoidea, all Auchenorrhyncha and the heteropteran families Berytidae,
Cydnidae, Lygaeidae, Miridae, Pentatomidae, Piesmatidae, Plataspidae,
Pyrrhocoridae, Rhopalidae, Scutelleridae and Tingidae. Spiders, ants and the
remaining beetle and bug families were carnivores. Detritivores could not be
analysed because this feeding type did not dominate in any of the sampled
families. Species numbers within 25 European countries were taken from the Fauna
Europaea database. Countries smaller than 30,000 km<sup>2</sup> were excluded,
as were all countries for which the known number of arthropod species lay below
the 95% confidence interval of the species - log area relationship, indicating
effects of insularity (Republic of Ireland) or incomplete knowledge of the
arthropod fauna (Ukraine, Belarus). We further excluded islands such as the
Balearic Islands, Corsica, Greek Islands, Sardinia and Sicily from the
respective mainland areas.
Environmental variables were extracted from a European gridded data set with a
monthly time step and a spatial resolution of 10×10 arc minutes, which
corresponds approximately to 16 km. The primary climatic variables temperature
(*T*) and precipitation were constructed through interpolation from station
observations. Annual rainfall (*R*;) was calculated as the sum of precipitation
in all months with an average temperature \>0°C. *NPP* was estimated by running
the LPJ-GUESS ecosystem model, with the same climate data, and parameterized for
the potential natural vegetation of Europe. LPJ-GUESS and the closely related
LPJ-DGVM have formerly been shown to reproduce observed variations in *NPP*
across various types of vegetation and climates. *PET<sub>min</sub>* represents
potential evapotranspiration of the coldest month of each year, and was
calculated using the Thornthwaite equation, which only requires knowledge of air
temperature. We used long-term annual means of *NPP*, *T*, *R* and
*PET<sub>min</sub>* from 1971 to 2000. For analysing species richness within
habitats and species turnover across habitats, we used *NPP*, *T*, *R* and
*PET<sub>min</sub>* values of the grid in which the habitats were located. For
analysing species richness within countries, explanatory variables were averaged
across all grids of the country. In addition, spatial heterogeneity in *NPP*,
*T*, *R* and *PET<sub>min</sub>* were calculated as ranges for each country by
subtracting the minimal from the maximal value, respectively (i.e. difference
between the grid cells with the highest and lowest value).
## Analysis
Local species richness and species richness in European countries was analysed
using linear models with standardised explanatory terms (mean = zero, standard
deviation = 1) in the statistical environment R version 2.12.0. To account for
possible differences in sampling efficiency between locations, we used the
number of captured individuals *N* as a covariate in the analyses of local
species richness. We accounted for possible effects of spatial autocorrelation
of the habitats within the locations and among the locations and countries with
generalised least squares with spatial simultaneous autoregressive error models.
Models were based on neighbourhood matrices that linked the two habitats within
a location and each location with at least one other location for the local
grain analyses and allowed each country to be in the neighbourhood of at least
one other country, i.e. at a maximum distance of about 850 km from centre to
centre. For this we used the package *spdep*. In addition, we calculated Moran’s
*I* correlograms for the residuals of models with and without correction for
spatial autocorrelation to assess if the tested theories miss important
spatially structured environmental variables. Missing crucial spatially
structured environmental variables will lead to significant residual spatial
autocorrelation of the uncorrected models.
Separate models of local species richness were calculated according to
productivity-diversity relationships, ambient energy and the interim general
model, plus one “Best” model in which all explanatory variables relevant for the
different theories (*NPP*, *NPP*<sup>2</sup>, *T*, *R*, *PET<sub>min</sub>* and
*PET<sub>min</sub>*<sup>2</sup>) entered the initial models. We included
interactions of all linear terms with habitat to test if there are different
responses in the different habitat types. We identified the minimal adequate
models by a backwards variable selection procedure according to the second order
Akaike information criterion (*AICc*). Linear terms were always kept in the
model when the respective quadratic term increased the model fit. In cases of
high collinearity (Pearsson *r* \>0.5) of linear terms we calculated separate
models always containing only one of these terms, and the best model was chosen
based on the *AICc* model selection criteria. This restricted the models to only
one energy variable (either *T* or *PET<sub>min</sub>*). It also reduced the
risk of overfitting, which is considerable given the low numbers of replicates
(*N* = 16 locations and *N* = 25 countries).
As relationships of species richness with *NPP* can be either linear or hump-
shaped, we allowed the quadratic term of *NPP* to remain in the productivity-
diversity relationship models if that resulted in lower *AICc* values. Ambient
energy models were calculated using untransformed species richness and *T*. To
test predictions made by metabolic theory, we calculated the slope of
log<sub>e</sub>(species richness) with 1/\[0.0000862(273+*T*)\] for comparison
with the predicted slope of −0.65. We used the first version of the interim
general model (IGM1), where species richness is explained by a linear term of
*R* plus a linear and quadratic term of *PET<sub>min</sub>*. At the country
grain, *R* and *PET<sub>min</sub>* had a Pearson correlation coefficient of 0.6.
Nevertheless, we also tested the full model including both variables for means
of completeness. We also performed an influence analysis using Cook’s distance.
If data points had a Cook’s distance \>0.5, indicating disproportional weight in
the regression analysis, then the effect of excluding those data points from the
model was examined.
Relationships of species turnover with environmental variables were analysed
using Mantel tests. We used presence-absence data of the trapped species per
location (natural and disturbed habitat combined). Community dissimilarities
were calculated as Morisita-Horn distances and related to Euclidean
environmental distances between all possible pairs of sites. Each environmental
variable was tested separately, and separate tests were calculated for spiders,
beetles, bugs, ants, all groups combined, herbivores and carnivores using the
function *mantel* in the package *vegan* (default settings). The significance
was based on Monte Carlo tests with 999 permutations.
Species richness of arthropods in European countries was analysed in a similar
way as local species richness, with the following additions. We corrected for
the area of the countries by including log<sub>10</sub>(area) as an additional
explanatory variable in all models. In addition to productivity-diversity
relationships, ambient energy and interim general models, we calculated a model
containing spatial environmental heterogeneity. Variables considered were the
ranges of *NPP*, *T*, *R* and *PET<sub>min</sub>*. However, all these range
variables were highly intercorrelated and thus it was not possible to include
them simultaneously in one model. Therefore, we calculated separate models
always containing one of these terms and selected the best model according to
*AICc*. Again, we calculated “Best” models in which all explanatory variables
relevant for the different theories entered the set of initial models containing
only one of the range variables characterising spatial environmental
heterogeneity.
# Results
## Species Richness in Local Habitats
The samples contained 33223 individuals of our focal taxa that comprised 83 ant
species (Formicidae), 444 beetle species (Coleoptera), 185 bug species
(Hemiptera) and 354 spider species (Araneae). Relationships between species
richness and environmental variables at the local grain were highly variable.
All arthropods combined and carnivores considered separately showed a hump-
shaped relationship with *NPP*, while lacking a significant effect of ambient
energy or variables from the interim general model. The ambient energy model was
best for spiders, while beetles conformed most to the energy term of the interim
general model. Bugs and herbivores were not significantly affected by any
environmental variable. Ants showed a negative relationship to *R* plus an
interactive effect of *T* and habitat type. Ant species richness increased with
*T* in near-natural habitats, but did not change significantly with *T* in
intensive agriculture. A more detailed examination of the response of ants to
climate and habitat type has been given elsewhere. Habitat type had a
significant effect only on spiders, with higher species richness in near-natural
than in intensive agricultural habitats. In contrast to ants, there was a
significant interactive effect of *T* and habitat type on spider richness,
whereby species richness increased with *T* in agricultural habitats but did not
significantly change with *T* in near-natural habitats. With respect to
metabolic theory, only ants in near-natural habitats and spiders in intensive
agricultural habitats had negative slopes of log<sub>e</sub> (species richness)
with *T*<sup>−1</sup> of −0.47±0.56 95% confidence interval (CI) and −0.43±0.27
95% CI, respectively. In all other cases, the slopes were positive and differed
significantly from the predicted value of −0.65 (all arthropods: 0.20±0.18 95%
CI; beetles: 0.12±0.30 95% CI; bugs: 0.05±0.21 95% CI; herbivores: 0.15±0.28 95%
CI; carnivores: 0.21±0.17 95% CI; ants in intensive agricultural habitats:
0.22±0.43 95% CI; spiders in near-natural habitats: 0.12±0.55 95% CI).
## Species Turnover
Species turnover across the 16 locations was most strongly correlated with
differences in *T*. Correlations were highest for spiders, carnivores, beetles
and all groups combined, followed by ants and herbivores. Only bugs showed no
significant relationship of species turnover with environmental variables. In
the remaining groups, correlations of species turnover with differences in *T*
were at least 49% stronger than with any other environmental variable.
Correlations of species turnover with differences in *NPP* and/or
*PET<sub>min</sub>* were significant, but substantially less strong than those
with differences in *T*.
## Species Richness in Countries
All tested environmental variables showed some significant effects on species
richness within countries. With respect to productivity-diversity relationships,
species richness of spiders, beetles, bugs and all groups combined increased
with *NPP*. The ambient energy-models revealed increased species richness of
beetles, bugs, ants, herbivores, carnivores and all groups combined with *T*.
However, for all groups combined this relationship was no longer significant
when an overly influential data point (Portugal) was omitted from the analysis.
As for metabolic theory, the slope of log<sub>e</sub> (species richness) versus
*T*<sup>−1</sup> came close to the predicted value of −0.65 for ants (−0.64±0.38
95% CI), but was shallower in the remaining cases (all groups: −0.36±0.29 95%
CI, spiders: −0.21±0.29 95% CI, beetles: −0.38±0.32 95% CI, bugs: −0.36±0.26 95%
CI, herbivores: −0.34±0.29 95% CI, carnivores: −0.38±0.30 95% CI).
With respect to biological relativity to water-energy dynamics, the full interim
general model including both variables (*R* and linear and quadratic terms of
*PET<sub>min</sub>*) had constantly higher *AICc* values than simplified models.
The reduced interim general model for spiders revealed an unexpected negative
response of species richness to rainfall. The remaining groups showed hump-
shaped relationships with *PET<sub>min</sub>* in accordance with biological
relativity to water-energy dynamics. Portugal was overly influential in the
interim general model for ants, and no significant model remained after its
removal. There were consistent positive relationships of arthropod richness with
spatial environmental heterogeneity. *T<sub>range</sub>* gave a better model fit
than *NPP<sub>range</sub>*, *R<sub>range</sub>* and *PET<sub>minrange</sub>* in
all cases.
Models with free variable selection always combined variables from several
theories. They were statistically superior to any single theory according to
their higher explanatory power and lower *AICc* values (Δ*AICc* \>6.1).
Residuals showed significant spatial autocorrelation in the majority of single-
theory models, but in none of the models with free variable selection (“Best”).
This suggests that the models with free variable selection included the majority
of relevant variables while single theories tended to miss crucial information.
In accordance with a high importance of spatial environmental heterogeneity,
species richness increased with *T<sub>range</sub>* in all models with free
variable selection.
# Discussion
Although our results from the local habitat samples were variable with respect
to environmental effects on species richness, there were numerous significant
effects of environmental variables on species richness of the same groups at the
country grain. This suggests that productivity-diversity relationships, ambient
energy, the interim general model and spatial environmental heterogeneity all
contribute to the explanation of arthropod species richness of European
countries. However, model selection according to *AICc* identified
*T<sub>range</sub>* as the strongest predictor of arthropod richness across all
studied groups. Independent support for a strong role of spatial heterogeneity
in *T* comes from the significant relationship of species turnover across
locations with differences in *T*. If species turnover across locations is
driven by *T*, then countries with a high *T<sub>range</sub>* will contain
higher beta diversity and consequently more species in total than countries with
more uniform temperatures. In the following, we will discuss the different
theories for broad-scale gradients in species richness and what can be concluded
from our data.
## Productivity-diversity Relationships
The observed increase of species richness in countries with *NPP* is in
accordance with the majority of studies on broad-scale relationships of species
richness with climate. In contrast, relationships of species richness with *NPP*
at the local grain were hump-shaped and restricted to carnivores and to the sum
of all arthropod species. This accords with a generally reduced effect size, and
with a transition from monotonous to hump-shaped productivity-diversity
relationships towards small spatial grain. The differences between grains cannot
be explained by differences in gradient length, because *NPP* varied only
slightly more among locations than among countries (locations: 0.39 g C
m<sup>−2</sup> a<sup>−1</sup> in Lesvos to 0.66 g C m<sup>−2</sup>
a<sup>−1</sup> near Kraków; countries: 0.41 g C m<sup>−2</sup> a<sup>−1</sup> in
Norway to 0.65 g C m<sup>−2</sup> a<sup>−1</sup> in France;,). Nevertheless, the
*NPP* gradient was relatively short at both grains. When gradients include areas
with very low *NPP*, stronger effects at the local grain would be expected.
Thus, any conclusions with respect to small-scale productivity-diversity
relationships from our data should be made with caution.
## Ambient Energy
We found significant effects of *T* on species richness at both local and
country grains. The increase of ant species richness with *T* in both near-
natural local habitats and in countries accords with ambient energy theories. In
contrast, spider richness increased with *T* in intensive agricultural habitats
but not at the country grain. This suggests that the richness pattern of spiders
in agricultural habitats is not indicative of other habitat types and thus of
limited relevance for their overall species richness in countries. Beetles,
bugs, carnivores and herbivores showed significant positive relationships with
*T* at the country, but not at the local grain. *T* can influence species via
its effect on *NPP*. Low temperatures limit terrestrial *NPP* in temperate to
arctic climates, and large parts of our study area lie in the temperate to
boreal region. However, the latitudinal gradient of *NPP* was unimodal in our
study, with decreasing *NPP* from temperate to Mediterranean climate. At the
country scale, all groups except spiders and beetles were significantly affected
by *T* in addition to *NPP*, suggesting direct effects of ambient energy on
species richness. Across countries, the slope of log<sub>e</sub>(species
richness) versus *T*<sup>−1</sup> accorded with metabolic theory only for ants.
Species richness of ants has been found earlier to conform with metabolic
theory. Our results suggest that this may be an exception rather than the rule
among terrestrial arthropods. Based on widespread nonlinearity, geographic and
taxonomic dependence of temperature-richness relationships, metabolic theory has
been more generally questioned. Deviations from metabolic theory can be due to
violations of its assumptions. For example, the assumption of body size
invariance with temperature is violated by the significant increase of spider
body size across Europe with temperature. Tests of tropical niche conservatism
and dispersal limitation after glaciation require phylogenetic analyses that
exceed the scope of the current investigation. These historical climatic
explanations predict more basal taxa in warm climates and high richness of few
derived taxa in cooler climate. Thus, the richness of higher taxonomic
categories such as families should increase more strongly towards warm climate
than the number of species. Such a pattern is present in our spider data: while
species richness shows no significant relationship with ambient energy at the
country grain, the number of spider families increases with *T* across countries
(*t<sub>1,23</sub>* = 4.9, *p*\<0.001). This indicates niche conservatism in
warmer climates and encourages more detailed phylogenetic exploration of the
distribution of European arthropods.
## Temperature, Species Turnover and Spatial Environmental Heterogeneity
In contrast to its variable effect on species richness within local habitats
(alpha diversity), differences in *T* had strong effects on species turnover
across locations (beta diversity;). This role of *T* confirms that it
represents an important niche dimension of European arthropods. The number of
available niches in a given area thus correlates to the range of temperatures
present in that area. Our results are consistent with the ideas that species
richness is enhanced by (i) elevational range and (ii) habitat heterogeneity in
an area. Elevation is a main driver of temperature variation in mountains,
leading to correlations between elevational range and spatial heterogeneity in
temperature (*r* = 0.92 for the countries studied here). The occurrence of the
same ecosystems at similar temperatures across the world that have contrasting
elevations demonstrates that temperature is more crucial for biodiversity than
elevation *per se*. Being difficult to measure, habitat heterogeneity is often
determined by the number of distinguishable vegetation types present in an area.
In near-natural situations, vegetation types are in turn determined by the
environmental preferences of their constituent plant species, including their
temperature preference. Thus, spatial environmental heterogeneity, elevational
range and habitat heterogeneity are interrelated, and we presume that climate
often has the most direct influence on biodiversity. In our study, variability
in *T* had a dominant effect on species turnover and gamma diversity. Apart from
the existence of more niches along large temperature gradients, climatic
heterogeneity can also buffer species extinctions by allowing species confronted
with climatic fluctuations to relocate to suitable climatic refuges. The
dominant role of *T<sub>range</sub>* for arthropod species richness in European
countries is in accordance with both enhanced niche availability and reduced
extinction during climatic fluctuations.
## Biological Relativity to Water-energy Dynamics
Biological relativity to water-energy dynamics is expressed in the interim
general model. It predicts increasing species richness with *R* (water term) and
a unimodal relationship of species richness with *PET<sub>min</sub>* (energy
term). We found only partial support for IGM, since reduced models always
resulted in lower *AICc* values compared to the full model. Numbers of spider
species per country decreased with *R* in the interim general model, but
increased with *R* in the model with free variable selection. Dominant effects
of the energy term in the interim general models at the country grain were
replaced by group-specific positive, negative (ants) or absent (herbivores)
effects of *R* in the models with free variable selection. Given these
inconsistencies, the interim general model provided no robust explanation of
arthropod richness in our study. Nevertheless, the numerous significant
relationships with *R* and *PET<sub>min</sub>* suggest that the interim general
model may apply to European arthropods, but that larger datasets are necessary
to disentangle its components. The dominant effect of the water term in the
models with free variable selection is in accordance with Hawkins et al., who
found that the energy term of the interim general model becomes dispensable in
temperate to arctic climate.
## Herbivores versus Carnivores
The strength of latitudinal diversity gradients has been found to increase
across trophic levels. In our study, the major difference between herbivores and
carnivores was at the local grain, where carnivores showed a hump-shaped
relationship to *NPP* and herbivores no significant relationship at all. At the
country grain, the results for herbivores and carnivores were similar to each
other and to those of bugs and all arthropods combined. This suggests that the
observed differences between arthropod taxa are due to their different phylogeny
or other life-history traits rather than caused by their trophic position.
## Countries versus Local Habitats
The stronger and more consistent effects in countries versus locations are in
accordance with the general decrease of species-richness environment
relationships towards small spatial grain. Ecological processes are scale-
dependent, and effects of the studied broad-scale environmental conditions may
affect regional species pools rather than local assemblages. However, species
pools can affect local species richness, especially in mobile organisms such as
the studied arthropod groups. In addition, some of the mechanisms to explain
broad-scale patterns in species richness include local processes such as
resource partitioning (productivity-diversity relationships), metabolism
(metabolic theory), or cold tolerance (tropical niche conservatism). Thus,
contrasts such as the variable role of ambient energy at locations and its
widespread positive effect across countries are remarkable and provide a
starting point for further research.
Differences in data quality could have contributed to the stronger effects in
countries versus locations. First, our pitfall traps sampled only ground-
dwelling arthropods over a limited time period. The 33223 sampled individuals of
1066 species already represent a major identification effort. Nevertheless,
sampling intensity per habitat corresponded only to a minimal effort that is
expected to encompass around 75% of all species attainable at the respective
site with pitfall traps. Even more problematic can be differences in sampling
efficiency between sites due, for example, to weather or habitat structure. We
reduced these differences by applying strictly standardized sampling methods and
by including the number of individuals captured per habitat as a factor in the
models of species richness. By using (log) individual numbers as a factor, we
assume that true abundances are similar across habitats and that observed
differences in individual numbers are due to variation in sampling efficiency.
However, true abundances may differ. Results at the local grain would change
strongly if individual numbers were excluded from the models – the only
consistency being increased ant richness with ambient energy and variable
effects between groups (results not shown). This highlights that the difficulty
to obtain large, representative arthropod samples from defined areas remains a
main obstacle in community ecology. Accordingly, conclusions from the results at
the local grain should be drawn with care. In contrast to these sampling issues
at the local grain, species inventories of countries are the results of many
decades of research and have reached asymptotes in almost all cases. A second
difference in data quality between locations and countries relates to the
environmental data. Interpolated climatic variables will result in relatively
accurate values across large areas such as countries, but have only limited
accuracy at the grain of local habitats. Sources of error include spatially and
temporally unpredictable factors such as rainfall, as well as anthropogenic
effects on productivity, especially in disturbed habitats. Thus, sampling error
at the locations is probably much higher than at the country grain, underlining
the need for additional high-quality inventories of invertebrates along
environmental gradients of large spatial extent.
# Main Conclusions
Our study supports the scale-dependence of species richness-environment
relationships. While relationships of local species richness with environmental
variables were contingent on the arthropod group, species richness patterns at
the country grain were more consistent and partly supported all tested theories.
Niche theory provides a plausible link between the two grains: On the one hand,
differences in temperature were the best correlate of species turnover across
locations. On the other hand, spatial heterogeneity in annual mean temperature
had the strongest effects on arthropod diversity within European countries.
These two independent findings suggest that temperature is an important niche
dimension and that countries with wider ranges in annual mean temperature
provide a greater breadth of niche space and so can support larger numbers of
arthropod species. Unless environmental heterogeneity is constant across
sampling units (thinkable e.g. in marine environments), we strongly suggest that
studies with large sampling units take into account environmental heterogeneity,
just as studies with variable area of sampling units nowadays routinely consider
area.
We thank Monica Wyss-Lopez for logistic support during the field survey and Eva-
Maria Gerstner from the LOEWE Biodiversity and Climate Research Centre in
Frankfurt (BiK-F) for preparing climate data. The traps were operated by
Riccardo Bommarco, Sara Bonzini, Eduardas Budrys, Torben Christensen, Dawid
Moron, Thomas Frank, Michael Greenwell, Steen Hansen, Mari Moora, Joan Pino,
Simon Potts, Laszlo Rakosy, Agnès Rortais, Jane Stout, Ivan Torres, Catrin
Westphal, and Monica Wyss-Lopez. The ALARM Field Site Network was coordinated by
Koos Biesmeijer and Bill Kunin. Arthropods were identified by Lina Almeida,
Angelo Bolzern, Antonio D. Brescovit, Thorsten Burkhardt, Christoph Germann,
Joachim Holstein, Marco Isaia, Pekka Lehtinen, Antonio Melic, Christoph Muster,
Milan Pavouk, Stano Pekar, Cristina A. Rheims, Adalberto J. Santos, Jörg
Wunderlich, and Monica Wyss-Lopez. We thank Michael Nobis for the kind provision
of the modified R package *hier.part*. The manuscript benefitted greatly from
suggestions by Jonathan Belmaker, Richard Field, Gary Mittelbach, Jason
Tylianakis, and three anonymous reviewers.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: WN. Performed the experiments:
WN XE SK MHE OS SB BAW TH. Analyzed the data: MHE OS. Wrote the paper: MHE
OS SB XE TH SK BAW WN.
|
# 1 Introduction
Brain networks derived from neuroimaging data have been shown to quantify the
level of brain atrophy, and hence the relative stage of neurological disease and
identify disease related changes. Cortical networks from structural magnetic
resonance imaging (MRI) consist of nodes which represent brain regions of
interest (ROI) and edges that link two nodes if these regions have spatial
correlation or similarity. Unlike networks from ROI volume or surface area,
cortical thickness networks have been shown to be a more stable measure along
the Alzheimer’s Disease (AD) continuum. This is because cortical thickness is a
direct measure of cortical atrophy due to cytoarchitectural features of the
cortex tissue. The resultant networks characterise alterations in the
communication processes across multiple ROI associated with morphological
changes due to disease onset and progression. Furthermore, network analysis of
cortex connectivity maps allow for the detection of ROI that serve particular
cognitive functions, thus providing a link between brain structure and function.
Such links include spatial topographical patterns typically observed between
those with and without neurological disease.
An early approach to derive a cortical correlation network is the application of
Pearson pairwise correlation (PPC) analyses for all possible pairs of ROIs. This
approach quantifies the presence or absence of a linear relationship between two
sets of observations, and a threshold (tuning parameters) is applied to the
correlation values to produce the resultant network. In addition to being
threshold dependent, another disadvantage of PPC networks is the reliance on
correlations based on independent analysis among two ROIs. While these methods
quantify the correlation between region pairs *i* and *j*, this correlation
measure ignores any relationship region *i* may simultaneously have with regions
other than *j*, potentially resulting in a loss of information.
To overcome this limitation, partial correlation networks, such as the sparse
inverse covariance estimation with the graphical least absolute and selection
operator or gLASSO have become increasingly popular. The gLASSO approach is
particularly useful in situations where the set of observations *N* is smaller
than the set of possible network connections *p* (*N* \< *p* case). However, in
order to accommodate for this case, the gLASSO enforces sparsity in the inverse
covariance estimate, and the penalised likelihood expression that needs to be
optimised is not a consistent estimator. While the gLASSO overcomes some the
shortcomings of the PPC, it too relies on a tuning parameter, a sparsity index
λ, which is often defined independent of the data and has a large effect on the
resultant network. Methods to choose the optimal value of λ have been well-
researched. One such method is the stability approach to regularisation
selection (StARS) for high dimensional graphical models. However, this approach
also relies on pre-defined tuning parameters independent of the data, such as
the size and number of sub-matrices to sample which is required by the
algorithm. For these reasons, a consistent statistical network approach that is
robust to the choice of value for the tuning parameter is needed in order to
deduce reliable data driven networks.
Furthermore, in an era of neuroimaging “big data”, Smith and colleagues foresee
the need to develop novel statistical methods, such as connectivity network
estimators, which have desirable theoretical properties such as convergence to
the true solution as the sample size increases (*N* \> *p* case). This unmet
need follows from one of the most successful and largest studies in advancing AD
research, the Alzheimer’s Disease Neuroimaging Initiative (ADNI) as well as
several other large-scale studies which are in the process of recruiting
thousands to hundreds of thousands of participants.
## 1.1 Theoretical background of the MNL algorithm
Markov random fields (MRF) are a broad class of neighbourhood based formulations
which are often included in neuroimage processing models to account for the
spatial variation among voxels or ROI. Conditional autoregressive (CAR) spatial
models are a type of MRF which assumes a known and fixed neighbourhood adjacency
structure in the form of a binary symmetric matrix *W*. The covariance structure
for the multivariate CAR model is a function of *W*, and, while the joint
distribution of the well-known intrinsic CAR model is improper (the distribution
does not integrate to one and the expected value is not defined in closed form),
variations of the CAR model yield well defined multivariate distributions. For
example, the Leroux et. al. (2000) multivariate adaptation of the CAR model was
applied by Anderson et. al. (2016) in the context of aerial disease mapping.
However these simple and fixed neighbourhood formulations of *W* may not
adequately capture the complex spatial covariance patterns between regions of
the brain.
More recently, in the context of estimating neuroimaging covariance, Cespedes
et. al. (2017) estimated the matrix *W* using a Bayesian hierarchical model.
However, as this model consisted of 595 parameters, it was found to be too
computationally intensive to estimate with Markov chain Monte Carlo methods. It
is therefore desirable to develop a method to approximate *W* using a less
computationally intensive approach, particularly for large data sets, as this
can be very useful for exploratory purposes.
The Leroux et. al. (2000) multivariate adaptation of the CAR model is a joint
probability distribution of spatial observations, **b**<sub>*i*</sub>,
conditional on the adjacency structure *W* and a spatial scale variance term,
$\sigma_{s}^{2}$, which in this work will be referred to as the network
likelihood. Maximum likelihood estimation (MLE) is a well-known statistical
approach employed in many applications for parameter estimation. One of the
advantages of this approach is that it only requires optimisation of the
likelihood function conditional on the sample data, which is straightforward to
implement in general. Furthermore, MLEs have been shown to be consistent under
certain conditions, meaning that as the sample size increases, the MLE will
converge with probability one to the true parameter value of the data generating
process.
In this work, we propose a MLE algorithm to estimate *W* in the network
likelihood, as it represents the underlying covariance connectivity brain
structure, while taking into account the variation among all participants. The
approach presented will henceforth be termed as maximisation of the network
likelihood (MNL). Unlike gLASSO and PPC networks, the MNL returns a single
binary connectivity matrix based on a consistent network estimator and is robust
to the choice of value for the tuning parameter. This avoids the threshold and
sparsity issues discussed earlier and provides a simultaneous analysis on the
connectivity of all regions, while providing network estimates whose accuracy
increases proportional to the sample size.
The layout of this manuscript is as follows. Sections 2.1 and 2.2 presents the
case study used in this research. The MNL approach is described in detail in
Section 2.3. The utility of this approach is then demonstrated through both a
simulation study (Sections 2.4 and 3.1) and an application of cortical thickness
covariance networks from structural MRI data (Section 3.3). Two network
connectivity matrices are derived for groups of healthy controls (HC) and mild
cognitive impaired (MCI), followed by a comprehensive discussion of the
comparative merits of the MNL algorithm with the PPC and gLASSO alternatives
presented in Sections 3.1 and 3.4.
# 2 Materials and methods
## 2.1 Participants of the ADNI study
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a world wide data
sharing collaboration project for AD research. ADNI is a multisite ongoing
longitudinal study designed to assist researchers develop clinical, imaging,
genetic and biochemical biomarkers for AD research. In this work, we compare
cortical connectivity’s of normal healthy ageing (HC) individuals with those who
have mild cognitive impairment (MCI). As cognitive impairment precedes dementia
onset, individuals with MCI may include prodromal AD participants where cortical
atrophy may already be present and/or in its early stages. For the current
research, we used the participant’s first visit (baseline) data from 1,383
individuals; 761 male and 622 female.
Written and informed consent was obtained from all participants and/or
authorised representatives and study partners. All ADNI studies are conducted
according to the Good Clinical Practice guidelines, the Declaration of Helsinki,
US 21CFR Part 50—Protection of Human Subjects and Part 56—Institutional Review
Boards, and pursuant to the state and federal Health Insurance Portability and
Accountability Act (HIPAA) regulations. Refer to <http://adni.loni.usc.edu/> for
full details of ADNI protocol and ethical requirements for each ADNI study.
## 2.2 Image analysis and data acquisition
In this work, we consider structural MRI scans which were undertaken at
baseline. The structural MRI T1.5 and T3 weighted images were first segmented
into grey/white matter and cerebral spinal fluid using an in-house
implementation of the expectation maximisation algorithm applied to a Gaussian
mixture model. Cortical thickness was then computed along the grey matter based
on the combined Lagrangian-Eulerian partial differential equations approach. The
automated anatomical atlas (AAL) was used to parcellate the brain into 116
cortical and sub-cortical regions. In this work, we analysed 34 cortical regions
from the left and right hemisphere (*K* = 68 regions total) for each individual.
The remaining 48 sub-cortical regions were excluded as these analyses considers
ROI cortex regions measured in *mm*, and sub-cortical ROIs such as the
hippocampus are better represented by their volume rather than thickness. The
anatomical regions are listed in. Once parcellated, the mean cortical thickness
of the voxels in each ROI was computed and used in this analysis.
## 2.3 Maximisation of the network likelihood
The MNL algorithm estimates the connectivity structure via maximising the
network likelihood. In this work, the network likelihood is the Leroux et. al.
(2000) multivariate CAR model, which is of the following form $$\begin{aligned}
\mathbf{b}_{i} & {\sim MVN\left( 0,\sigma_{s}^{2}Q \right)} \\ Q^{- 1} & {=
\gamma\left( \hat{W} - W \right) + (1 - \gamma)\mathbb{I},} \\ \end{aligned}$$
where the set of spatial observations for *K* ROIs on the *i*<sup>*th*</sup>
participant is **b**<sub>*i*</sub> and $\mathbb{I}$ is the *K* by *K* identity
matrix. The binary elements of the symmetric adjacency matrix *W* take values
*w*<sub>*jk*</sub> = 1 to denote a network link, if regions *j* and *k* have
spatial similarity, or *w*<sub>*jk*</sub> = 0 otherwise, which denotes the
absence of a link. The diagonal elements are *w*<sub>*jj*</sub> = 0 as specified
by Lee (2011) and Anderson et. al. (2014). Diagonal matrix $\hat{W}$ has zero
off-diagonals, with the *j*<sup>*th*</sup> diagonal term equal to
*j*<sup>*th*</sup> row sum of matrix *W*. The spatial scale variance is denoted
by $\sigma_{s}^{2}$ which controls the amount of spatial variation among the *K*
regions and is multiplied by the spatial covariance matrix *Q*, which is a
function of *γ* and the adjacency matrix *W*. The value of *γ* represents the
strength of spatial dependence on **b**<sub>*i*</sub> and, in this setting, it
is the tuning parameter in the MNL algorithm. Values of *γ* close to zero imply
the set of spatial observations are independent and *Q* becomes a diagonal
matrix. Alternatively, as *γ* approaches one, it forces *Q* to be a covariance
structure with non-zero off-diagonal terms. This suggests that
**b**<sub>*i*</sub> has an inherent spatial covariance structure. In practice
*γ* is seldom estimated and remains fixed as it is a difficult (in terms of
identifiability) and computationally intensive parameter to estimate. In the
context of brain connectivity estimation, *γ* is often set to 0.9 to enforce a
relatively large spatial dependence among the observations. In this work, in
addition to the simulation study described in Section 2.4, we also performed a
simulation study to assess the ability of the MNL algorithm (with *γ* fixed at
0.9) to recover the connectivity network on data generated on a range of *γ*
values. We found that the MNL algorithm adequately recovered the simulated
connectivity structure from data with various levels of spatial dependence and
is hence robust to the value of *γ*, and supports our choice for fixing *γ* to
0.9. Refer to Supporting Information for simulation results.
### 2.3.1 MNL algorithm implementation
For *N* total participants, the likelihood function is $$\begin{array}{cl}
{p\left( B \middle| W,\sigma_{s}^{2} \right)} & {= \prod\limits_{i =
1}^{N}p\left( \mathbf{b}_{i} \middle| W,\sigma_{s}^{2} \right)} \\ & {=
\prod\limits_{i = 1}^{N}\left| 2\pi\sigma_{s}^{2}Q \right|^{-
\frac{1}{2}}\exp\left( - \frac{1}{2\sigma_{s}^{2}}\mathbf{b}_{i}^{T}Q^{-
1}\mathbf{b}_{i} \right).} \\ \end{array}$$
Maximisation of is performed using 15 steps as shown in Algorithm 1. The MNL
algorithm provides iterative updates on *W*\* and $\sigma_{s}^{2*}$ *M* times.
The fast quasi-Newton algorithm implemented to update $\sigma_{s}^{2*}$ was
adapted from Byrd et. al. (1995). As this is a deterministic algorithm, Step 14
of Algorithm 1 repeats the search for *W* for *P* sets of different starting
values to mitigate being stuck in a local minima.
**Algorithm 1:** MNL algorithm
**Input:** Set of spatial observations *B*, random binary matrix *W*\* and small
positive spatial variance $\sigma_{s}^{2*}$
**Output:** *W* and $\sigma_{s}^{2}$ estimates that maximise the network
likelihood
**1** Evaluate log-likelihood $\delta^{*} = \log\left\lbrack p\left( B \middle|
W^{*},\sigma_{s}^{2*} \right) \right\rbrack$
**2** **for** *M runs* **do**
**3** **foreach** *w element of W*\* **do**
**4** Permute *w*<sup>*th*</sup> element in *W*\* to get *W*\*\*
**5** $\delta^{w} = \log\left\lbrack p\left( B \middle|
W^{**},\sigma_{s}^{2*} \right) \right\rbrack$
**6** **if** *δ*<sup>*w*</sup> \> *δ*\* **then**
**7** *δ*\* = *δ*<sup>*w*</sup>
**8** *W*\* = *W*\*\*
**9** **end**
**10** **end**
**11** Update $\sigma_{s}^{2*}$ conditional on *W*\* with a fast quasi-Newton
algorithm
**12** **end**
**13** Retain final *W*\* and $\sigma_{s}^{2*}$
**14** Repeat Steps **1** to **13** at different random starting values *P*
times
**15** Return *W*\* and $\sigma_{s}^{2*}$ estimates corresponding to the highest
*δ*\*
### 2.3.2 Data processing
To estimate the model proposed in based on real data, a linear regression was
applied to the set of ROI observations **y**<sub>.*k*</sub> =
\[*y*<sub>1*k*</sub>, *y*<sub>2*k*</sub>, …, *y*<sub>*ik*</sub>, …,
*y*<sub>*Ik*</sub>\] for each ROI over all *I* individuals. Covariates in these
linear regression models included gender, apolipoprotein (APOE) *ε*4 carrier and
non-carriers status and age in a similar manner as previous studies. The
predicted values of the regression model $\left( {\hat{y}}_{ik} \right)$ were
obtained, and the residuals for each set of ROIs were computed by
$\varepsilon_{ik} = {\hat{y}}_{ik} - y_{ik}$. These residuals were standardised
by $b_{ik} = \left( \varepsilon_{ik} - {\overline{\varepsilon}}_{k}
\right)/s_{k}$, where ${\overline{\varepsilon}}_{k}$ and *s*<sub>*k*</sub> are
the empirical mean and standard deviation of the residual for each region over
all individuals. The MNL algorithm was applied to the final set of observations
(*b*<sub>*ik*</sub>). This transformation allows for the residuals of the ROIs
to be on the same scale, (as the variance of each *ε*<sub>.*k*</sub> is set to
one) while maintaining the correlation structure of the data after accounting
for covariates. Pairwise plots and histograms of the transformed residual showed
linear relationships between certain ROIs and each ROI were approximately
Normally distributed and centred at zero (not shown).
## 2.4 Simulation study of MNL algorithm
The goal of the simulation study is to assess the ability of the MNL algorithm
described in Section 2.3 to recover binary connectivity matrices based on
simulated neural data at various sample sizes. A further assessment focused on
comparing the results of the MNL algorithm with those obtained using the gLASSO
and PPC methods applied to the same simulated data.
Our simulation study comprised of two simulated networks, *S*<sub>1</sub> and
*S*<sub>2</sub> as shown in. We combined a second order diagonal network with a
random network model as described in Bien and Tibshirani (2011). As cortical
networks, in general, have a diagonal structure, both binary solution networks
had second order connections *S*<sub>*i*,*i*−1</sub> = *S*<sub>*i*−1,*i*</sub>
and *S*<sub>*i*,*i*−2</sub> = *S*<sub>*i*−2,*i*</sub> = 1 and zero otherwise. A
random network model was used to simulate semi-sparse (*S*<sub>1</sub>) and
sparse (*S*<sub>2</sub>) off-diagonal elements, whereby the remaining off-
diagonal elements had a probability of 0.1 and 0.05 respectively, of a
connection being present. To convert these binary solution networks into
covariance matrices, in a similar manner as Bien and Tibshirani (2011), the
diagonals and off-diagonal elements of *S*<sub>1</sub> and *S*<sub>2</sub> were
multiplied by different positive constants resulting in covariance matrices
Ω<sub>1</sub> and Ω<sub>2</sub>. Data were generated from a multivariate normal
distribution *MVN*(**0**, Ω) for each covariance matrix for sample sizes *N* =
100, 250, 500, 1000. Ten independent sets of simulated data were drawn for each
sample size in order to allow for a rigorous comparison of performance of each
method at every sample size.
To assess the performance of the MNL algorithm we compared the rate of the true
positive connections (sensitivity), which was summarised by the percentage of
the connections which were correctly identified to be present. Likewise, the
true negative rate (specificity) was summarised by the proportion of absent
connections that were correctly identified by the algorithm. As the connectivity
matrices are symmetric, we only consider the upper off-diagonal elements of each
matrix. A network classifier which has a perfect recovery of the solution
network will have both sensitivity and specificity percentages close to one.
Alternatively, a poor performing algorithm will have the respective percentages
close to zero.
Comparison of the performance of the MNL, gLASSO and PPC methods for increasing
sample sizes provides insight into the consistency of each approach. A
consistent network estimator has a property that as the sample size increases,
the estimated network converges to the true solution. Mathematically, we can
demonstrate that the parametrisation of $1/\sigma_{s}^{2}Q^{- 1}$, and by
extension $\sigma_{s}^{2}Q$, is a positive definite covariance matrix for all
values of *γ*, refer to Supporting Information : *Proos MNL is a consistent
estimator* for a proof of this result. It follows from fundamental theoretical
results by Greene 2010 (Chapter 14) and Pourahmadi (2000) among others, that an
MLE estimator of a positive definite covariance matrix is a consistent
estimator, and will converge to the true solution with probability one as the
sample size increases.
In addition to assessing the MNL algorithm as a suitable candidate for network
estimation, the simulation study also provides information on the performance of
each algorithm according to different sample sizes based on two network
configurations for a range of tuning parameters (for gLASSO and PPC methods).
## 2.5 Alternative brain connectivity methods
As described in Section 1, the PPC and gLASSO are current and popular methods
used to derive connectivity networks. In this section we provide a brief
description of each approach in relation to the simulation study and its
application to the case study.
### 2.5.1 PPC approach
The PPC continues to be a popular approach to derive cortical connectivity
networks and, for this reason, this approach will also be considered in our
simulation study. The correlation between region *i* and *j* is denoted by
*ρ*<sub>*ij*</sub> and −1 ≤ *ρ*<sub>*ij*</sub> ≤ 1. All possible sets of
pairwise correlations (*ρ*<sub>*ij*</sub>) were used to populate the correlation
matrix. A binary adjacency matrix *A* was derived from the correlation matrices,
with elements *a*<sub>*ij*</sub> equal to zero if \|*ρ*<sub>*ij*</sub>\| \< *τ*
and value one if \|*ρ*<sub>*ij*</sub>\| ≥ *τ*, where the threshold range or
tuning parameter is 0 \< *τ* \< 1, similar to the threshold range described by
He et. al. (2008). Fewer spurious correlations are included as *τ* approaches
one, and this may result in disconnected networks determined by the strongest
correlations. Alternatively, if *τ* is too close to zero then the highly
connected network may include connections which arose due to spurious noise from
the data. In practice, the threshold range in cortical correlation analyses is
chosen such that the resultant networks have several organisational features
such as small-world topology and the minimum clustering coefficient is above
zero in order to make meaningful comparisons between networks. In
contrast, the estimated *W* from the MNL algorithm does not rely on tuning
parameters and organisational network features described above can be evaluated
directly on this estimated network. In this work, values for *τ* in {0.1, 0.15,
0.2, 0.25, …, 0.75, 0.8, 0.85} were initially investigated for the PPC networks,
and this was fine-tuned for the simulation study.
### 2.5.2 gLASSO algorithm
The graphical LASSO is a fast approach to estimate a sparse inverse covariance
matrix. For a set of observations **b**<sub>.1</sub>, **b**<sub>.2</sub>, …,
**b**<sub>.*I*</sub> from a multivariate normal distribution
**b**<sub>.*i*</sub> ∼ *MVN*(**0**, Γ) with precision matrix Θ = Γ<sup>−1</sup>,
gLASSO aims to find $\hat{\Theta}$ such that $$\begin{array}{r} {\hat{\Theta} =
\text{max}\left\{ \text{log}\left( \middle| \Theta \middle| \right) -
\text{trace}\left( S\Theta \right) - {\lambda \parallel \Theta \parallel}_{1}
\right\},} \\ \end{array}$$ where the sample covariance matrix is denoted by *S*
and \|\|.\|\|<sub>1</sub> is the *L*<sub>1</sub> norm. The sparsity tuning
parameter λ, also known as the penalizing parameter, determines the sparsity of
$\hat{\Theta}$. For example, high values of λ implies that \|\|Θ\|\|<sub>1</sub>
has a large contribution to the optimisation problem in. Conversely, when λ = 0,
reverts to a simpler MLE problem.
In terms of brain connectivity, the gLASSO is applied to estimate Θ, which is
then used to derive the binary connectivity matrix. Values of this network
matrix are equal to one if the corresponding values of $\hat{\Theta}$ are non-
zero, and an absent connection is defined by the zero values of $\hat{\Theta}$.
Brain connectivity networks estimated by include the work by Huang et. al.
(2010) and Cho et. al. (2017) among others. Authors Huang et. al. (2010) focused
on the investigation of network organisation and selected λ such that the
networks had a fixed number of links. Alternatively, the StARS approach was used
to derive an optimal value for the tuning parameter λ in Cho et. al. (2017) and
the effect of λ on the results were not investigated. In addition to the StARS
approach, extensive research and development in relation to the optimal λ value
has led to several novel approaches, including cross validation among others,
refer to Fan and Feng 2009 for a review.
In this work, we are interested on the effect λ has on the performance of gLASSO
and its ability to correctly identify the solution networks for *S*<sub>1</sub>
and *S*<sub>2</sub>. Values for λ in {0.1, 0.15, …, 1.7} were explored for
gLASSO networks in the simulation study, and a subset of this range was chosen
for the real data analyses. Furthermore, we also explored the optimal value of λ
which minimises the cross validation error, as this is one of many standard
approaches to derive the value of λ (See Supporting Information for results). As
the intention of this research is to present the MNL algorithm, further
investigation of networks derived by gLASSO with other approaches to derive λ is
beyond the scope of this work.
## 2.6 Statistical analysis
Via exploratory data analyses, the demographic characteristics were compared
between HC and MCI participants over age using an Analysis of Variance,
Independent Sample t-test, Chi-squared tests (gender and APOE *ε*4 allele
positive status), as well as Kruskal Wallis test (MMSE and CDR). All statistical
analyses were performed using the R statistical environment (R version 3.4.2, R
Core Team).
On both simulation and real data application, a single application of the MNL
algorithm took less than a minute to run on a single central processing unit
(CPU) on a standard computer (four core 3.40GHz Intel i7-4770 processor). We
expect this to vary for different *N* and *K* data sets. Step 5 of Algorithm 1
is executed in C<sup>++</sup> in order to improve the computational time taken
to run the MNL algorithm. The remainder of the algorithm is implemented in R. We
note that nested for-loops (Steps 2 and 3 of Algorithm 1) act as a bottle neck
and future work to profile Algorithm 1 would speed up the implementation of the
MNL algorithm. In this work, the MNL algorithm was found to be slightly slower
(in terms of seconds) than the gLASSO and PPC. Refer to
<https://github.com/MarcelaCespedes/MNL_algorithm> for the coded implementation
of the MNL algorithm, full simulation study as well as a tutorial on the
implementation of the MNL approach.
# 3 Results
## 3.1 Simulation study: Comparison of MNL, gLASSO and PPC algorithms
The aim of this simulation study was to evaluate the performance of the MNL
algorithm to correctly recover the connectivity matrices for each configuration
shown in from the simulated data described in Section 2.4. As the simulation
study described in Section 2.3 shows that for a range of *γ* the performance of
the MNL algorithm is relatively robust in terms of the the sensitivity and
specificity of the recovered network, in this simulation study we assess the
performance of the MNL algorithm against a range of threshold and sparsity
values for the PPC and gLASSO.
### 3.1.1 Simulated semi-sparse network *S*<sub>1</sub>
As described in Section 2.4, out of the two simulated matrices considered in
this work, *S*<sub>1</sub> is the semi-sparse diagonal network. Each sample size
comprised of ten replicates and Supporting Information shows the covariance
plots for randomly selected covariance matrices for each sample size. shows the
gLASSO and PPC results and their ability to correctly identify the elements of
the *S*<sub>1</sub> matrix via the sensitivity and specificity for all simulated
data over a range of tuning parameters.
The sensitivity and specificity of the MNL algorithm are shown by the red and
blue horizontal lines respectively, refer to for values. Supporting our
theoretical results which show that the MNL is a consistent estimator, our
simulation study shows that as the sample size increases, both sensitivity and
specificity approach one. It is interesting to note that for all sample sizes
the MNL algorithm in general has a specificity close to one, suggesting that the
algorithm has a high chance of detecting no link when no such link exists. The
simulation study in this work show that the MNL algorithm is better suited for
applications where it is desirable to avoid over-interpreting incorrect links.
While this trait has it obvious merits, the MNL algorithm may be unsuitable in
applications such as gene regulatory networks, where it is desirable to over-
select the network connections rather then underestimate them.
Both gLASSO and PPC approaches show a trade-off between the ability to correctly
detect the presence and absence of links over the range of values of *τ* and λ.
In general, for all sample sizes and small tuning parameters, both algorithms
show a sensitivity close to one but a specificity close to zero, suggesting that
these algorithms largely overestimated the number of links of the networks. At
the other extreme of the tuning parameters, this relationship switches, and
resultant networks approach a zero connectivity matrix reflected by specificity
close to one and a sensitivity close to zero. Our results illustrate the extent
the tuning parameters can have on the gLASSO and PPC, making the correct choice
in practice difficult; as the optimal performance of the gLASSO and PPC occurs
when the specificity and sensitivity are at their highest and this occurs within
a very narrow range of the tuning parameters. This simulation study also serves
to show the benefits of an approach that is robust to the choice of value for
the tuning parameter, as the MNL algorithm is not affected by such trade-off.
In relation to the PPC, the value of *τ* can range between zero and one,
however, a smaller range away from the extremes is often used in practice to
avoid the issues described in Section 2.5.1. It is surprising to see in our
simulation study that at small values of *τ* = 0.08, 0.09, 0.1 and 0.11, the PPC
offers superior performance compared to the other two alternatives, particularly
at a sample size of *N* = 1000. While it is unlikely that these values of *τ*
are used in practice, we note that the approach to simulate the data favours the
PPC approach. As the sample covariance matrices in Supporting Information show a
clear difference between covariance values for present and absent links. This
difference is mostly emphasised as the sample size increases to *N* = 1000.
Across all sample sizes, the optimal performance of the gLASSO occurs at
sparsity values λ = 0.55, 0.6, 0.65 and 0.8 as shown in. Outside of these
values, gLASSO shows the trade-off between sensitivity and specificity giving
poorer performance. In comparison to the MNL algorithm, particularly at λ values
where gLASSO had optimal performance, the MNL algorithm maintained similar or
superior specificity and sensitivity across all sample sizes. As the MNL
algorithm relies on the evaluation of the full likelihood, its application is
not always suitable for small sample sizes (*N* \< *p* case). As suggested in
literature the gLASSO may be better suited for brain connectivity estimation in
smaller clinical studies. Our simulation study support this result in the case
of *N* = 100 and *K* = 68 ROIs, as the gLASSO results were comparable to those
those from the MNL algorithm. We note that unlike the bounded tuning parameters
of the PPC, the range λ can take are all positive values, making the choice of λ
in practice more difficult to ascertain than the PPC approach.
### 3.1.2 Simulated highly sparse network *S*<sub>2</sub>
The data generating network for *S*<sub>2</sub> has approximately half the
connections than the *S*<sub>1</sub> network and for this reason it is of
interest to see how the MNL and PPC algorithm perform, and in particular how
they compare to the gLASSO which is specifically designed to estimate sparse
networks. Refer to Supporting Information for covariance plots for data
generated by the *S*<sub>2</sub> binary networks.
Simulation results in follow similar trends as those described in Section 3.1.1
for the gLASSO and PPC. The trade-off between sensitivity and specificity across
the tuning parameters remains and the PPC demonstrates superior performance over
the MNL and gLASSO algorithm at similar *τ* values as described above,
particularly at a sample size of *N* = 1000. In this scenario, there is a faster
improvement of the MNL algorithm as the sample size increases and we believe
this is due to the simulated covariance values are larger for *S*<sub>2</sub>
than *S*<sub>1</sub>, and this is reflected in their respective covariance
plots. Refer to for MNL algorithm results.
As the connectivity matrix we are interested in recovering is a highly sparse
network in comparison to *S*<sub>1</sub>, it is not surprising to see that the
performance of the gLASSO also improves faster as the sample size increases. In
this simulated scenario, optimal performance of the gLASSO occurs at λ = 1.55 on
a sample size of *N* = 100 and this improves for an optimal sensitivity and
specificity of 0.62 with λ = 1.1 at a sample size of *N* = 1000. The MNL
algorithm shows higher sensitivity and specificity values compared to the gLASSO
at sample sizes greater than 250. It is interesting to note, that in this
simulation study the optimal values of *τ* remain, in general, unchanged for the
PPC approach, whereas for the gLASSO, there is a large difference in the range
of λ for *S*<sub>1</sub> and *S*<sub>2</sub> matrices where optimal performance
occurs.
## 3.2 Case study: Characteristics of study participants
The results of the exploratory data analyses of the demographic features of the
participants in the study are shown in. A chi-squared test for independence
found a significant association between gender and diagnosis levels (*p* \<
0.0001), as the MCI group had a considerably higher number of males compared to
the HC group. Compared with HC, MCI participants were more likely to have the
variant APOE *ε*4 allele (*p* \< 0.0001). Cortical thickness measures for all 68
ROI were significantly higher in HC participants (mean 2.71 *mm*) compared with
MCI participants (mean 2.66 *mm*) (*p* \< 0.0001). Significant ordinal patterns
of degeneration from HC to MCI were observed as follows: cognitive Mini Mental
State Examination (MMSE) scores decreased from 29 to 28 (*p* \< 0.0001);
Clinical Dementia Rating (CDR) score values increased from 0 to 1.5 (*p* \<
0.0001). As each individual has 68 ROI observations, here, the smallest sample
size comprises of 35,156 observations which is greater than 2,278 potential
links for a 68 × 68 connectivity matrix.
## 3.3 Case study: MNL analysis
Prior to applying the MNL algorithm, we observed the histograms of the
**b**<sub>.*i*</sub> values for each region. These plots confirmed that the
transformed data follow an approximate Normal distribution centred at zero
(plots not included).
Inspection of pairwise plots of the transformed data showed the association
between regions displayed various levels of linear relationships, suggesting
there is a covariance structure in the data (plots not included). Representative
samples from these plots, such as paired regions 23 and 49, 48 and 60, 42 and 52
suggest there is a linear relationship among these regions for all diagnosis
groups, refer to for ROI names and Supporting Information for plots. Hence, the
covariance structure of the MNL algorithm in show these regions to be connected.
Likewise, the absence of a linear relationships was observed in pairwise plots
between, for example, regions 21 and 30, 36 and 57, 51 and 68, across both
diagnosis groups. The lack of association between these regions is indicated by
the corresponding absence of links in the networks of. Furthermore, as a
goodness-of-fit assessment of the MNL algorithm, we examined the residuals after
we fitted the model to the transformed data from the two diagnosis groups.
Histograms and scatter plots of the residuals show they were approximately
Normally distributed, refer to Supporting Information.
In order to assess if the MNL algorithm adequately modelled the spatial
structure of the data, we computed the Moran’s I statistic on the set of
residuals from the MNL model fitted to the data for each person within each
diagnosis group. Synonymous to Pearson’s correlation, a Moran’s I value close to
zero, contingent on spatial structure matrix *W*, indicates the data have low
spatial correlation. The median Moran’s I value for HC and MCI groups were found
to be equal to or less than 0.31. Correlation and partial correlation plots of
the MNL algorithm residuals in general had values which were substantially
small, refer to the Supporting Information for plots. In summary, the selected
pairwise, partial correlation plots and Moran’s I values suggest the covariance
structure of the data on all diagnosis groups was adequately modelled by
expression, and the histograms support the Normality assumption in.
The binary matrices from the MNL algorithm applied to the case study data are
shown in. These matrices represent the estimated general connectivity structures
for the HC and MCI diagnosis groups. The total number of potential connections
on a 68 ROI network is 2,278. The total number of links in the diagnosis
networks are 180 and 167 for HC and MCI networks, respectively. The networks in
shows a large overlap in connectivity between the networks, with 136 connections
in common. Most of the connections which are common to both HC and MCI groups
include those within each lobe, while most of the differences tend to occur
between lobe connectivity. While there was only a subtle reduction in
connectivity along the diagnosis spectrum (from HC to MCI), all estimated
networks were connected, suggesting that, at some level, all ROIs co-vary with
each other in that there were no regions independent from the rest.
Our initial investigation was performed on a clinical study with smaller sample
sizes (HC: 171, MCI: 46 and AD: 29). However, based on the simulation study
results in Section 3.1, it is clear that the performance of the MNL algorithm
improves as the sample size increases. Hence in this work we applied our method
on the ADNI case study on two large groups (HC and MCI), with expected
pathological differences in connectivity.
From the networks in, additional network analysis can be applied to the network
matrices to determine small-world topology and organisational network features
such as characteristic path length and clustering coefficient, however, this is
beyond the scope of the present study. The results from simulation studies in
Section 3.1 suggest that the obtained networks are relatively reliable, and as
the sample size increases, the performance of the MNL algorithm improves in both
the ability to correctly identify the presence and absence of connections.
## 3.4 Case study: gLASSO approach
Our intention of applying a competing algorithm to the case study is to compare
a single binary network between the MNL algorithm to a current known approach.
There are several alternatives available for estimating such a network via the
gLASSO, and for this reason we applied the gLASSO to the case study data. As we
have yet to find methods to choose a single value for *τ* given the data, in
this application we did not apply the PPC to the case study data.
shows the connectivity matrices for selected sparsity (λ) values, whose total
links were similar to the MNL results. Without knowing the correct value of λ we
first applied the glASSO for the range of sparsity values λ = {0.1, 0.15, …, 1}
to understand the effect λ had on estimated networks. The resultant networks
ranged between 2,278 to 0 in total number of links, refer to Supporting
Information for full results.
In a similar manner as Huang and colleagues (2010), the sparsity value was
chosen such that the resultant networks had a similar number of links to those
from the MNL algorithm in Section 3.3. We note that the primary intention of
applying the gLASSO to the case study data is to compare the change in
connectivity, with less focus on finding the best model fit. shows the resultant
networks for HC and MCI groups and the total number of links for each network
were 171 and 122 for HC and MCI groups respectively.
The networks in show clearer block diagonal matrices, in comparison to the MNL
algorithm, suggesting that in this work, gLASSO networks detected higher inter-
lobe connections rather than between lobe connections. No connections were
detected within or between the limbic lobe. In a similar manner as the MNL
algorithm, there was a large overlap between the connectivity within each lobe
for the HC and MCI groups, with 66 links in common. The HC network is shown to
have no connections between the parietal and occipital lobes, however, in the
MCI network there is a large change in connections between the occipital and
temporal lobes. We note that in order to appropriately assess the network
organisation (by investigating the clustering coefficient, efficiency and small
world topology of the networks) and thereby further discuss biological and
neurological differences between the MNL and gLASSO networks, a suitable range
of λ is required, and this is beyond the scope of this work.
# 4 Discussion
In this work, we propose a novel approach to estimate brain networks from
neuroimaging data. Validated on a numerical simulation study, the sensitivity
and specificity performance of the MNL algorithm was shown to improve as the
sample size increases supporting our theoretical results that the MNL algorithm
is a consistent network estimator. In the simulation study for sample sizes
greater than 100, the MNL algorithm was shown to have a higher sensitivity and
specificity compared to the results from gLASSO, over a range of sparsity
values. At the range of 0.08 ≤ *τ* ≤ 0.11, the PPC was shown to outperform both
MNL and gLASSO algorithms, particularly at a sample size of *N* = 1000.
Application of the MNL algorithm to the ADNI case study identified a loss of
connections between HC and MCI connectivity networks, suggesting evidence of
atrophy along the neurodegeneration pathway, supporting biologically meaningful
results.
Our simulation studies found that the PPC and gLASSO analyses were sensitive to
the tuning parameters in terms of the ability to recover the solution networks.
A trade-off exists between the specificity and sensitivity rates in all sample
sizes considered in this work, which showed that as the tuning parameters
(threshold *τ* and sparsity λ) increase the specificity increases, but the
sensitivity decreases and vice versa. Application of the MNL approach yields a
single connectivity structure that is robust to the value of the tuning
parameter (*γ*) which serves as a descriptive network statistic which is
beneficial for exploratory purposes. As such, interpretation of the resultant
network is limited to the specific sample used to derive the network. The brain
wombling models applied to neuroimaging data by Cespedes et. al. (2017) utilise
expression as part of a Bayesian wombling model to estimate the network
connectivity and its associated uncertainty. To compare our exploratory approach
with those from the Bayesian wombling models, we applied the MNL algorithm to
HC, MCI and AD diagnosis groups and 35 ROIs selected in the work by Cespedes et.
al. (2017), albeit to baseline data only. We found that the MNL diagnosis
networks correctly identified over 83% of the links (correctly detected the
presence and absence of connections) obtained in the wombling model (see
Supporting Information), suggesting the MNL algorithm can provide results that
are comparable to those of Bayesian probabilistic network models.
## 4.1 Extensions
Despite the substantive appeal of the MNL algorithm described in this paper,
there are several extensions that could be considered. Firstly, the current mean
of the multivariate network distribution is zero and as such the MNL algorithm
does not provide ROI mean estimates. Extending the MNL algorithm to include a
non-zero region mean vector ***μ*** may be informative as not all ROIs have the
same mean. In this work we compensated for this by applying linear regression
models to each ROI and transforming the residuals such that they have a mean of
zero (Section 2.3.2). We note that the added complexity of the proposed
extensions to the MNL approach may result in a more difficult optimisation
problem and may require more sophisticated numerical optimisation methods to
estimate the additional parameters. Secondly, analyses on longitudinal
neuroimaging studies are favoured in contrast with cross sectional analyses, as
they could potentially include information on ROI changes over time. While the
MNL algorithm presented in this work does not account for repeated measures, an
extension of expression to account for repeated measures can be achieved by
adding a random effects layer in the model. However, as the MNL algorithm is the
first brain network algorithm of its kind whose connectivity estimates improves
as the sample size increases, such an extension is left as future work.
## 4.2 Conclusion
The potential application of MNL networks is not restricted to cortical
thickness structural MRI data, and can easily be applied to any complete spatial
set of observations from any neuroimaging modality. The objective for the
methodology and application presented here is to introduce and demonstrate the
utility of the MNL algorithm, as the application of MNL method can be applied to
functional MRI, positron emission topography (PET) and electroencephalography
(EEG) data. Other than the suggestions already discussed, an additional area for
future work is the application of the MNL algorithm to assess for network
robustness as described in Bernhardt et. al. (2011) and Hart et. al. (2016).
Here, the authors investigate the loss of random or targeted nodes or edges
removed from the network, representing deterioration due to pathology.
Furthermore, additional validation of the MNL algorithm on other neurological
applications such as epilepsy and schizophrenia, as well as healthy ageing
studies over a wide age range, and analyses of network topological metrics are
needed to better understand the performance and biological insight from the
proposed MNL algorithm.
# Supporting information
We thank Dr Pierrick Bourgeat for processing the magnetic resonance images. We
also greatly appreciate the efforts from three anonymous reviewers and Handling
Editor Dr Hayasaka, whose comments and feedback has greatly improved this work.
The authors wish to thank all clinicians, scientists, participants and the
families involved in the Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Data used in preparation of this article were obtained from the ADNI database
(adni.loni.usc.edu). As such, the investigators within the ADNI contributed to
the design and implementation of ADNI and/or provided data but did not
participate in the analyses or writing of this work.
A complete listing of ADNI investigators can be found at:
<http://adni.loni.usc.edu/wp-
content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf>.
Data collection and sharing for this project was funded by the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01
AG024904) and DOD ADNI (Department of Defence award number W81XWH-12-2-0012).
ADNI is funded by the National Institute on Aging, the National Institute of
Biomedical Imaging and Bioengineering, and through generous contributions from
the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery
Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb
Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli
Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated
company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer
Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical
Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale
Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis
Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda
Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of
Health Research is providing funds to support ADNI clinical sites in Canada.
Private sector contributions are facilitated by the Foundation for the National
Institutes of Health ([www.fnih.org](http://www.fnih.org)). The grantee
organization is the Northern California Institute for Research and Education,
and the study is coordinated by the Alzheimer’s Therapeutic Research Institute
at the University of Southern California. ADNI data are disseminated by the
Laboratory for Neuro Imaging at the University of Southern California. The
funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
MIC was funded by the Research Training Program (RTP) doctoral scholarship
provided by the Australian Government and a top-up provided by the Commonwealth
Scientific and Industrial Research Organisation (CSIRO). JDD is the
Biostatistics Team Leader of the Australian e-Health Research Centre and is
funded by the CSIRO. JF is the Acting Group leader in the Biomedical Informatics
team at the Australian e-Health Research Centre and is funded by the CSIRO. JM
is funded by the Queensland University of Technology (QUT) and is affiliated
with the Australian Research Council and Centre of Excellence for Mathematical
and Statistical Frontiers (ACEMS). KM is jointly funded by QUT and the
Australian Research Council (ARC) Laureate, project ID FL150100150 Bayesian
Learning for Decision Making in the Big Data Era and is the Deputy Director of
ACEMS. CCD is affiliated with QUT and ACEMS and was supported by an Australian
Research Councils Discovery Early Career Researcher Award scheme DE160100741.
The funders provided support in the form of salaries for the authors (MIC, JM,
CCD, KM, JDD and JF), but did not have any additional role in the study design,
decision to publish or preparation of the manuscript. The specific role of these
authors are articulated in the author contributions section.
[^1]: MIC was funded by the Research Training Program (RTP) doctoral
scholarship provided by the Australian Government and a top-up provided by
the Commonwealth Scientific and Industrial Research Organisation (CSIRO).
JDD is the Biostatistics Team Leader of the Australian e-Health Research
Centre and is funded by the CSIRO. JF is the Acting Group leader in the
Biomedical Informatics team at the Australian e-Health Research Centre and
is funded by the CSIRO. JM is funded by the Queensland University of
Technology (QUT) and is affiliated with the Australian Research Council and
Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS). KM
is jointly funded by QUT and the Australian Research Council (ARC)
Laureate, project ID FL150100150 Bayesian Learning for Decision Making in
the Big Data Era and is the Deputy Director of ACEMS. CCD is affiliated with
QUT and ACEMS and was supported by an Australian Research Councils Discovery
Early Career Researcher Award scheme DE160100741. The funders provided
support in the form of salaries for the authors (MIC, JM, CCD, KM, JDD and
JF), but did not have any additional role in the study design, decision to
publish or preparation of the manuscript. There are no patents, products in
development or marketed products to declare. This does not alter our
adherence to PLOS ONE policies on sharing data and materials.
[^2]: Current address: CSIRO Health and Biosecurity/Australian e-Health
Research Centre Level 5, UQ Health Sciences Building, 901/16 Royal Brisbane
and Women’s Hospital, Herston, Queensland 4029, Australia
[^3]: ¶ Membership of the Alzheimer’s Disease Neuroimaging Initiative is
provided in the Acknowledgments.
|
# Introduction
Transforming growth factor beta (TGF-ß) signalling is involved in a wide range
of processes during development e.g. cell adhesion, bone morphogenesis and cell
motility. Upon binding of a ligand of the TGF-ß superfamily to a Type II
receptor, the Type II receptor recruits a Type I receptor and activates the Type
I receptor by phosphorylation. Then, the Type I receptor phosphorylates receptor
regulated smads (R-Smads), which then can bind to the common mediator Smad SMAD4
and translocate as a R-Smad/Smad4 complex into the nucleus, where these
complexes interact with co-activators to activate gene expression. Negative
regulators of the TGF-ß signalling pathway are inhibitory Smads (I-Smads),
Smurfs and the Ski/Sno protein family. Proteins of the latter group possess two
structural domains: the Ski/Sno homology domain and the SMAD4-binding domain.
With the help of these domains, Ski/Sno proteins can interact, among others,
with R-Smads, N-CoR, Sin3a, SMAD4 and the histone deacetylase HDAC1 and this
complex leads to transcriptional repression of target genes. By their expression
domains, Ski/Sno proteins can be further subdivided into ubiquitously expressed
genes (human Ski and Sno), and mainly neuronally expressed genes, the SKI Family
Transcriptional Corepressors (Skor1 and Skor2). The Ski/Sno proteins fulfil a
wide range of different physiological functions such as axonal morphogenesis,
Purkinje cell development, myogenesis and mammary gland alveogenesis.
However, the Ski/Sno proteins were not discovered by their physiological
functions but via the transforming capability of the viral ski (v-ski) homologue
found in the Sloan-Kettering virus. The first evidence that Ski/Sno proteins
possess oncogenic capabilities came from overexpression experiments, where it
was shown that not the truncation of v-ski is responsible for the transformation
of chicken embryo fibroblasts, but that overexpression of v-ski, Ski or Sno is
sufficient for this transformation. Despite this background, their role in
carcinogenesis is still not fully understood, if not even contradictory at
times. Ski and Sno have been found to be upregulated in different types of
cancer e.g. oesophagus squamous cell carcinoma, melanoma, and colorectal cancer.
Further evidence for a pro-oncogenic role was found in downregulation analyses
of Sno or Ski. This downregulation resulted in decreased tumour growth in breast
cancer cells and pancreatic cancer cells. But as stated before, there is some
objection that Ski and Sno function purely as oncogenes. Mice, which were
heterozygous mutant for Ski or Sno, showed an increased level of tumour
induction after carcinogen treatment. In metastatic non-small cell lung cancer,
Ski expression is significantly reduced, whereas increased expression of Ski in
these cells reduced the invasiveness inhibiting epithelial-mesenchymal
transition. Therefore, this could reflect that the outcome of Ski or Sno
expression in cancer cells is dependent on the cell type or the actual status of
the cancer cells and cancer cells often exploit Ski or Sno to inhibit the anti-
proliferative effects of TGF-ß signalling. Whereas Ski or Sno have been found to
be involved in a lot of different cancer types, there is sparse evidence for
deregulation of Skor proteins in cancer cells. Endogenously, Skor proteins have
been linked to neurodevelopmental processes. After Skor1 overexpression, genes
involved in axonal guidance or post-synapse assembly were differentially
expressed. Skor2 is important for cerebellar Purkinje cell differentiation as in
Skor2 knockout mice dendrite formation of Purkinje cells was impaired.
Pathophysiologically, Skor1 has mainly been linked to restless leg syndrome and
localized scleroderma.
In *Drosophila melanogaster*, only one homologue of Ski and Sno, which is
designated Snoo, and one homologue of Skor1 and Skor2, which is designated Fuss,
exist. We have recently shown that Fuss is interacting with SMAD4 and HDAC1. In
overexpression assays, Fuss can inhibit Dpp signalling and endogenously, the
Fuss/HDAC1 complex is required for bitter gustatory neuron differentiation and
*fuss* mutant flies pause more often during walking. However, we were interested
if the Skor/Fuss proteins retained their ability to inhibit differentiation and
induce increased proliferation. For this purpose, we overexpressed Fuss in
differentiating cells of the eye imaginal disc, an excellent model tissue to
study regulatory gene function in the context of carcinogenesis. This
overexpression impaired photoreceptor axon guidance and inhibited the
differentiation of accessory cells such as cone cells and primary pigment cells,
which are all transformed into a basal pigment cell type. In a second approach
we generated *fuss* overexpressing clones early during development in the eye
imaginal discs, when cells are still proliferating. This resulted in vast
outgrowths of undifferentiated tissue of the eye imaginal disc because *fuss*
overexpression most likely inhibited Dpp-signalling, a member of the TGF-ß
superfamily. Our work shows that Fuss retained the ability of Ski/Sno proteins
to inhibit the antiproliferative effects of TGF-ß signalling by analogous
inhibition of Dpp-signalling, allowing proliferation to be sustained.
# Results
## *fuss* overexpression leads to a smooth eye surface and impairs axonal pathfinding
As Ski/Sno proteins have been found to be involved in cancer development and
progression, we were interested if *fuss* overexpression can also inhibit
differentiation and induce increased proliferation and hyperplasia,
respectively. To answer this question, we chose the eye imaginal disc as a model
tissue, because *fuss* is not endogenously expressed in the eye imaginal disc.
Furthermore, Fuss and its homologues are negative regulators of BMP/Dpp
signalling in overexpression assays and consequently the eye imaginal disc
enables us to investigate *fuss* overexpression in a Dpp independent and
dependent context. First, we overexpressed *fuss* via the GMR-GAL4 driver line.
GMR-GAL4 is active posterior to the morphogenetic furrow, which is the source of
the Dpp morphogen during eye development and thus Fuss cannot directly interfere
with Dpp signalling.
Interestingly, in adult *Drosophila* flies, where *fuss* was overexpressed with
GMR-GAL4 during eye development, this overexpression leads to massive
differentiation defects exhibiting a smooth, red coloured eye surface devoid of
any typical eye structures such as ommatidia or bristles and we observed little
to no phenotypic variability in these flies. To see if photoreceptor induction
is also affected by *fuss* overexpression, eye imaginal discs of late third
instar larvae were stained with antibodies against Elav, a marker for neurons
and Chaoptin, a marker for photoreceptors. In eye imaginal discs overexpressing
*fuss*, neither loss of Elav nor Chaoptin was detected (arrow). This shows that
cells overexpressing *fuss* still acquired a neuronal- as well as a
photoreceptor fate. In the central nervous system (CNS), *fuss* is expressed in
postmitotic interneurons during development, and its expression is maintained in
adulthood. Therefore, we focused in more detail on photoreceptor development.
After acquiring photoreceptor fate, these cells start to protrude their axons
into the larval optic lobe. Photoreceptors R1-R6 target the lamina neuropil
(arrow), whereas R7 and R8 axons migrate deeper into the medulla neuropil
(arrowhead). This leads to a very specific pattern, which can be observed in
larval optic lobes of control larvae, but upon *fuss* overexpression in
developing photoreceptors, this pattern is strongly disturbed (arrowhead).
## RNAseq reveals downregulation of the PAX2 homolog Shaven after *fuss* overexpression
To achieve a better overview of genes and processes which become dysregulated by
*fuss* overexpression in the larval eye imaginal disc, we extracted RNA from eye
discs of late third instar larvae of controls (GMR-Gal4 \> w1118) and
experimental flies overexpressing *fuss* (GMR-Gal4 \> UAS-*fuss*), reverse
transcribed it and prepared NGS libraries, which then were sequenced. Comparing
gene expression profiles of both genotypes, we found that Fuss was highly
enriched in GMR-GAL4; UAS-*fuss* eye discs, which was a proof of principle that
the experiment was successful. Among 360 genes which showed an altered
expression in contrast to controls with an adjusted *p*-value \< 0.01, one gene,
*shaven (sv)*, was especially interesting. Sv, the Pax2 homologue in *Drosophila
melanogaster*, is needed for the proper differentiation of cone, primary pigment
and bristle cells and the loss of *sv* can result in the well-known glazed eye
phenotype. This phenotype is strongly reminiscent of the phenotype observed of
*fuss* overexpression with GMR-GAL4. Therefore, eye imaginal discs were stained
with antibodies against Sv and its expression was indeed strongly reduced
compared to controls. Another protein, which is crucial for cone cell
differentiation, is Cut (Ct), a homeobox containing transcription factor. Ct
expression is induced by the transcription factor Sv and therefore also *ct*
expression is severely reduced upon *fuss* overexpression. As mentioned before,
Fuss can also inhibit Dpp signalling, although we found no altered expression of
TGF-ß pathway components in our RNAseq data. In addition, we knocked down Medea
and the type I receptor Tkv with the GMR-Gal4 driver line and did not find any
defects in adult eyes compared to controls. Besides that, we also knocked down
*sv* and indeed, the phenotype is very similar to that of the *fuss*
overexpression. The eyes have a strong reduction in the number of lenses and
show a smoother surface than controls. The phenotype of the sv knockdown is not
as strong as the *fuss* overexpression, the reason for this might be, that the
downregulation of sv in the knockdown is not as strong as after *fuss*
overexpression or that additional processes are disrupted as there are 360 genes
significantly altered in expression after *fuss* overexpression.
## Fuss overexpression results in loss of cell types and increased apoptosis
To understand the developmental defects behind the smooth eye phenotype, pupal
development of the overexpression eyes was analysed. In control eye imaginal
discs of pupae (GMR-Gal4; UAS-*nGFP*), which have pupariated for 40 h, a highly
ordered pattern of different cell types can already be observed. In the middle
of an ommatidium, four cone cells, which secrete the lens, are surround by two
primary pigment cells. The single ommatidia are separated from each other by
secondary and tertiary pigment cells as well as bristle cells. In pupal eye
imaginal discs, where *fuss* was overexpressed via the GMR-GAL4 driver line most
distinct cell types are lost on the surface of the pupal retina in contrast to
controls, except for some single bristle cells which are visible (arrows) but
most of the cells which are present are of indefinable cell fate. However, these
cells might develop to pigment cells, because the adults develop flat,
structureless, but red eyes. With a fluorescent apoptosis sensor called GC3Ai,
the *fuss* overexpressing retinas show an increase in apoptotic events in a
deeper layer of the developing retina which could also account for the reduced
size of the adult eye field if compared to the *sv* knockdown. As observed in
larvae, the photoreceptor axons show a perturbed arrangement compared to
controls, but are still expressing the neuronal marker Elav, although the
positioning of photoreceptor nuclei is deranged. Additionally, large gaps can be
observed between individual photoreceptor cell groups, which could be the result
of apoptosis..
The final adult eye differentiation pattern was analysed by paraffin sections of
heads of GMR-Gal4; UAS*-fuss* flies as well as controls (GMR-Gal4; UAS-*nGFP*).
In *fuss* overexpressing eyes the photoreceptors and their rhabdomeres, which
can be observed by a bright fluorescent signal in the controls are completely
lost. Although they were determined to become photoreceptors as observed in,
they are probably removed by apoptosis during pupal development, which also
affects the integrity of the adult lamina. Furthermore, vacuoles can be observed
(arrows) which are probably also the outcome of the cell death observed during
pupal stage. These sections show, that the indefinable cells observed in pupal
retinas have a completely different shape than those of secondary or tertiary
pigment cells in controls, but still contain pigment granules. Thus, these cells
rather adopt a basal pigment cell fate but don´t acquire the correct shape.
Obviously, overexpressing *fuss* in differentiating cells posterior to the
morphogenetic furrow highly impacts their specification. Photoreceptors are
determined but are abolished during development and residual cells are prevented
to adopt their natural fate and nearly all are transformed to a basal pigment
cell fate. Therefore, *fuss* overexpression is able to completely inhibit
differentiation but, in this context, no striking increase in proliferation was
observed.
## Early induction of *fuss* overexpressing clones inhibits eye differentiation and leads to eye disc outgrowths
The ability of Ski/Sno proteins to function as proto-oncogenes is often linked
to their capacity to inhibit the antiproliferative effects of TGF-ß signalling.
To check for early proliferative defects, we decided to induce *fuss*
overexpression clones in first instar larvae. 48 hours after egg laying, we
heat-shocked the first instar larvae with the genotype (P{hsp70-flp}1/+; Fuss-
GFP/+; GAL4-Act5C(FRT.CD2).P) for 12 minutes to induce *fuss* overexpressing
clones. Late third instar larvae were dissected, and tissue was analysed for
*fuss* overexpressing clones and their effects on development.
Surprisingly, as shown in, we detected a completely different behaviour of
*fuss* overexpression. *fuss* overexpressing clones in eye imaginal discs result
in tissue outgrowths. To check the cellular identity of these outgrowing cells,
we first tested for the neuronal differentiation marker Elav, which would be
expected in photoreceptor cells. However, these outgrowths lack the late
differentiation marker Elav completely and can form big bulbous structures which
protrude from the eye imaginal disc. All heat shocked larvae die at the latest
during pupal stages, therefore we decreased the time of the heat shock, which
enabled us to obtain single adult survivors. Some of these survivors had
undifferentiated tissue growing out from their eye, which apparently was
generated by *fuss* overexpressing clones. To further understand the *fuss*
overexpression defects, we were searching for early retinal differentiation
markers. Dpp signalling is assumed to be required for the expression of early
retinal differentiation markers *sine oculis*, *dachshund* and *eyes absent*
(*eya*). Previous studies have shown, that overexpression of *fuss* can
interfere with Dpp signalling and we could indeed confirm that *fuss*
overexpressing clones lack *eya* expression and therefore, Fuss might inhibit
Dpp signaling in the eye imaginal disc as well. All in all, initiation of
photoreceptor differentiation is already impaired in *fuss* overexpressing
clones.
## *fuss* overexpressing clones exhibit increased proliferation
However, this does not explain, why *fuss* overexpressing clones lead to tissue
outgrowths from the eye. Generally, if eye development is inhibited, this would
lead to a transformation from eye to head capsule tissue only and not to
additional head capsule tissue as observed. In contrast to *eya* mutant eye
discs, where proliferation is strongly reduced, the *fuss* overexpressing clones
seem to show increased proliferation. To further analyse cell proliferation, we
used the Fly-FUCCI system, where degrons of E2F1 and CycB have been fused to GFP
and mRFP, respectively, to visualize the cell cycle behaviour of cells. Cells
from anaphase to the G1 to S transition are green, S phase cells are red, and
cells in G2 and early mitosis are yellow. Expressing the Fly-FUCCI system via
the Flipase technique in eye imaginal discs, we found that many cells posterior
to the morphogenetic furrow are green or red, therefore in G1 or S-Phase and
only some where yellow, thus in early mitosis. But when we coexpressed *fuss*
with the Fly-FUCCI system many more cells where yellow posterior to the
morphogenetic furrow and consequently where in G2-Phase or undergoing mitosis.
Interestingly, the shape of *fuss* overexpressing clones were highly different
to that of control clones. Whereas control clones integrate into the patterning
of the developing eye imaginal discs, *fuss* overexpressing clones might not
react to Dpp signalling as shown before, have a rather elliptical shape and are
protruding from the eye imaginal disc. Because of this experiment we expected,
that *fuss* overexpressing clones have a higher division rate than controls. We
chose to use an antibody against phosphorylated Histone H3, a marker for
mitosis, to specifically identify mitotic cells and count them. In this assay we
only counted cells, behind the second mitotic wave (smw), because after the smw
cells start to differentiate instead to proliferate. As controls we used tissue
which was not overexpressing *fuss*, therefore we counted the number of pHH3
positive cells inside *fuss* overexpressing clones and outside of it, and
measured the area in pixels of the *fuss* overexpressing clonal tissue and the
wildtype tissue and divided the number of mitotic cells by the amount of pixels.
We found significantly more pHH3 positive cells per pixel in the *fuss*
overexpressing clones than in the surrounding wild type tissue, demonstrating
that *fuss* overexpression leads to increased proliferation in developing eye
imaginal discs in contrast to controls.
## *wingless* is expressed in *fuss* clonal outgrowths
Besides eye differentiation, Dpp signalling is also required to inhibit *wg*
expression in the eye imaginal discs. In eye imaginal discs of third instar
larvae, *wg* expression can normally only be observed at the dorsal and ventral
margins of the eye disc, where it is supposed to promote head capsule structures
instead of eye tissue, but in earlier stages *wg* is expressed in the whole
prospective eye and this is around the time we induce the *fuss* overexpressing
clones. Loss of Dpp signalling leads to overgrowth and ectopic *wg* expression
in the eye imaginal disc and loss of *eya* expression might not only be the
result of *fuss* dependent inhibition of Dpp signalling, but also ongoing Wg
signalling, as it has been shown by ectopic Wingless signalling clones. To test
if *fuss* overexpression clones continue expressing *wg* from earlier stages on
via a possible inhibition of Dpp signalling, we used a wg-LacZ reporter
construct to visualise *wg* promotor activity in the eye imaginal disc and as
shown in *fuss* overexpressing clones exhibit indeed LacZ expression supporting
the hypothesis that the inhibition of Dpp signalling allows continuous *wg*
expression in these cells. Wingless signalling is also involved in promoting the
proliferation of cells anterior to the morphogenetic furrow and ectopic Wingless
signalling leads to increased proliferation. One possible hypothesis for the
overproliferation observed with *fuss* overexpressing clones might be that Fuss
acts again as an inhibitor of Dpp signalling in the eye imaginal disc allowing
continuous *wg* expression, which might lead to the excess proliferation in the
eye imaginal disc. To test this hypothesis, we tried to generate clones, which
besides *fuss*, also express a knockdown construct for *wg*, but this approach
turned out to be highly lethal. In a second approach, we generated clones which
expressed *fuss* and a dominant negative form of *Pangolin* (*dnPan*), because
the effects of *wg* overexpression can be suppressed by dominant negative
Pangolin, even when expressed from the same cell and it has been shown, that
*wg* expression can be autoregulated endogenously or ectopically in some
tissues. *fuss/dnPan* overexpressing clones were not only consistently smaller
compared to *fuss* overexpressing clones, but the clonal tissue did also not
outgrow anymore. *fuss/dnPan* overexpressing clones did not exhibit *wg*
expression anymore, as observed with the absence of LacZ staining, supporting
our hypothesis that Fuss, via inhibition of Dpp signaling, might be able to
allow *wg* expression from earlier stages to continue and *wg* expression and Wg
signalling in these clones might promote the outgrowths from the eye disc.
Similarly, overexpressing dominant negative Pan together with nuclear GFP lead
to small clones and *wg* expression was also not increased.
# Discussion
In this work, we addressed the question if Skor/Fuss proteins, members of the
Ski/Sno family, retained the function of Ski and Sno to induce uncontrolled
proliferation as observed in early stages of tumorigenesis.
First, the overexpression of *fuss* posterior to the morphogenetic furrow with
the GMR-Gal4 driver line resulted in a nearly complete loss of all cell types in
the adult eye. During development, photoreceptor axons were not able to target
the appropriate layers of the optic lobe anymore and cone cells, primary pigment
cells and bristle cells were transformed into a basal pigment cell fate. This
transformation was caused by the inhibition of *sv* expression, which is crucial
for accessory cell differentiation. Additionally, increased apoptosis during
pupal development lead to the removal of photoreceptors and lastly adult eyes
only consisted of cells containing pigment granules. This lack of
differentiation cannot be explained by the Dpp inhibiting role Fuss exerts, when
overexpressed, because inhibiting the Dpp signaling pathway via knockdown of Tkv
or Med had no effect. Photoreceptor axon guidance is impaired, if Dpp signaling
is disrupted in photoreceptors by the expression of the inhibitory Smad Dad.
Thus, the observed photoreceptor axon guidance phenotype, when *fuss* is
overexpressed with GMR, could indeed be a result of Dpp signaling inhibition.
However, the loss of nearly all eye cell types is due to other effects (e.g.
downregulation of *sv* and apoptosis) than Dpp signaling repression alone,
because loss of Dpp signaling behind the morphogenetic furrow only results in
mild patterning defects of the pupal retina. Nonetheless, the inhibition of cell
differentiation has already been shown in other cancer models e.g., when two
copies of the constitutive active form of the receptor tyrosine kinase
dRET<sup>MEN2B</sup> are expressed with the GMR-Gal4 line, pupal retinas are
devoid of any distinguishable cell types. This phenotype is indistinguishable
from the phenotype of the pupal retinas generated by the overexpression of
*fuss* via GMR-Gal4. In a screen for novel oncogenes from breast cancer
patients, human transgenes have been overexpressed with the GMR-Gal4 driver
line. Overexpression of human RPS12, a subunit of the small ribosomal subunit,
whose expression is increased in various cancer types, leads also to a glazed
eye phenotype. Therefore, different oncogenes can result in different outcomes
when expressed with the GMR-Gal4 driver line and are not always leading to
massive tissue overgrowth like the Yorkie overexpression. Most importantly, with
this approach to overexpress *fuss* in cells which already were destined for
acquiring a cell fate and have left the cell cycle, we were not able to induce
increased proliferation anymore, but could prevent cell differentiation.
Consequently, we switched to a more pluripotent cell type in the eye imaginal
disc and induced *fuss* overexpressing clones prior to the formation of the
morphogenetic furrow. These results let us assume that in this context, *fuss*
overexpressing clones do not react to the antiproliferative effects of the Dpp
morphogen anymore. Instead, *wg* expression and thus, proliferation promotion
might be maintained. This leads to outgrowths of clonal tissue from the eye
imaginal disc of third instar larvae, which showed an increased number of
mitotic events. If these flies survived to adulthood, undifferentiated, extra
tissue was visible in the complex eye.
An analogous mechanism can be observed in tumors which overexpress Ski or Sno.
The TGF-ß signaling pathway also acts anti-proliferative, but this action is
inhibited by the increased presence of Ski/Sno proteins. Therefore, the
molecular mode of action is similar to the human Ski/Sno proteins. The function
of Ski and Sno is highly context dependent, as they can fulfill an anti-
oncogenic or pro-oncogenic role depending on the cancer type or status of the
cancer. We also observed this with *fuss* overexpressing clones. Only when
induced 48h after egg laying, we found additional tissue in late third instar
larvae and only in eye imaginal discs, because here, Dpp counteracts the
proliferative effects of Wg signaling. When *fuss* is overexpressed in the wing
disc or after induction of the morphogenetic furrow differentiation is
inhibited, this results in a wing with truncated veins or in a smooth eye
surface (this work). This is also underlined by RNAseq data from eye and wing
imaginal discs, where *fuss* was overexpressed with the GMR-Gal4 and Nub-Gal4
driver line, respectively. In the eye dataset, *wg* expression in eye imaginal
discs is not significantly different from control eye discs, whereas *wg*
expression in *fuss* overexpression wing discs is significantly reduced in
contrast to control wing discs.
Thus, we were able to show that the Skor protein Fuss in *Drosophila
melanogaster* still retained the function of the Ski/Sno proteins by inhibiting
differentiation but inducing hyperproliferation. But the hallmarks of real
tumorigenesis are lacking, because at some point during pupal development,
proliferation stops, and these cells become protruding head tissue as it could
be observed in complex eyes of surviving flies. Furthermore, there was no
evidence of an epithelial-mesenchymal transition because *fuss* overexpressing
clones maintained their epithelial fate. It will be of high interest if future
studies can find similar results in overexpression studies for the vertebrate
Skor proteins or detect increased expression of these proteins in specific
cancer types.
# Material and methods
## Fly husbandry and stocks
Flies were raised at 25°C under a 12 hr/12 hr light/dark cycle. Fly lines
obtained from the Bloomington Drosophila Stock Center were: P{GAL4-ninaE.GMR}12
(BDSC \#1104), w1118; P{UAS-Stinger}2 (BDSC \#84277), w1118; snaSco/CyO,
P{en1}wgen11 (BDSC \#1672), y1 w1118; P{UAS-pan.dTCFΔN}4 (BDSC \#4784), y
w\[\*\]; P{w\[+mC\] = GAL4-Act5C(FRT.CD2).P}S (BDSC \#4780), P{ry\[+t7.2\] =
hsFLP}1, y w\[1118\]; Dr\[Mio\]/TM3, ry\[\*\] Sb (BDSC \#7), P{AyGAL4}25
(BDSC \#4412), w1118 (BDSC \#3605), y1 v1; P{TRiP.HMS05834}attP2 (BDSC \#67973),
y1 sc\* v1 sev21; P{TRiP.GL01313}attP40 (BDSC \#43961), y1 sc\* v1 sev21;
P{TRiP.HMS04501}attP40 (BDSC \#57303), w\[1118\]; Kr\[If-1\]/CyO, P{ry\[+t7.2\]
= en1}wg\[en11\]; P{w\[+mC\] = UAS-GFP.E2f1.1–230}26 P{w\[+mC\] = UAS-
mRFP1.NLS.CycB.1-266}17/TM6B (BDSC \#55122), Tb, w\*; KrIf-1/CyO; P{UAS-
GC3Ai}3 (BDSC \#84343). Additionally, Nub-Gal4 (J.F. de Celis, Madrid) was
employed.
## Immunohistochemistry
For analysis of *fuss* overexpressing clones 48 hrs after egg laying, the larvae
were heat shocked at 37°C for 12 min. Then, for all experiments late third-
instar larvae were used for dissection and immunohistochemistry. By pulling the
mouth hooks, the anterior mouth part including the eye imaginal discs still
attached to the brain were removed from the rest of the larva and then fixed by
incubation in 4% PFA in PBS for 20 min. The specimen was washed three times with
PBST (PBS with 0.1% Triton-X) for 20 min and incubated in PBST supplemented with
5% normal goat serum and primary antibodies over night at 4°C. The specimen was
washed three times with PBST for 20 min and incubated in PBST supplemented with
5% normal goat serum and secondary antibodies over night at 4°C. The specimen
was washed once with PBST for 20 min, then incubated in PBST supplemented with 1
mg/ml 4′,6-Diamidin-2-phenylindol (DAPI) for 20 min and washed three times with
PBST for 20 min. The eye imaginal discs were dissected and mounted using
VECTASHIELD Antifade Mounting Medium (Vector Laboratories). Developmental
studies Hybridoma Bank (DSHB) antibodies were: LacZ (JIE7, 1:50), Eyes absent
(eya10H6, 1:50), Elav (Rat-Elav-7E8A10, 1:50), Cut (2B10, 1:20), Chaoptin
(24B10, 1:50). Additional antibodies were: Sv/Pax2 (1:100, gift from Markus
Noll), GFP (rabbit 1:1000, ThermoFisher), pHH3 (rabbit 1:2000, Cell signaling
technology). Secondary antibodies were used with a dilution 1:200 overnight at
4°C. Secondary antibodies were goat anti-mouse, anti-rabbit, anti-rat and anti-
guinea pig Alexa Fluor 488, 555 and 594 (ThermoFisher). For anti-Cut and anti-Sv
stainings we used the Anti-Mouse / anti-Rabbit HRP-DAB IHC kit (abcam) to
increase sensitivity and reduce background.
## Generation of FLP-out clones
In general, we crossed virgins carrying the P{hsp70-flp}1 allele homozygously to
males carrying the GAL4-Act5C(FRT.CD2).P allele. Before the cross was placed for
2h on standard food supplemented with dry yeast at 25°C, flies were allowed to
mate for at least three days. The adult flies were removed from the vial and
progeny was allowed to develop for 46h at 25°C. Progeny was heatshocked for 12
minutes at 37°C and placed again at 25°C. Late third instar larvae were then
dissected.
## Retina dissection and immunostaining
White pupae were collected and aged at 25°C for 40 hrs. The brains with the
attached eye discs were dissected in PBS and placed in PBS with 4% PFA on ice
until all brains from one genotype were dissected. Afterwards the brains were
fixed for another 20 min with 4% PFA in PBS at room temperature. The brains with
the attached eye discs were stained with rat-anti-DE-cadherin (DCAD2, 1:50,
DSHB) or rat-anti-ELAV (Rat-Elav-7E8A10, 1:50) and goat-anti-rat Alexa Fluor 555
(1:200, ThermoFisher) in PBST 0.1% with 5% normal goat serum (NGS). After
staining, the eye discs were removed from the brains directly on the mounting
slide in a drop of PBST 0.1% and mounted using VECTASHIELD Antifade Mounting
Medium (Vector Laboratories).
## Quantification of pHH3 positive cells
Only eye imaginal discs where the second mitotic wave was clearly detectable via
pHH3 staining were used. Mitotic cells in *fuss* overexpressing clones and in
wildtype tissue were counted. The area of *fuss* overexpressing clones and
wildtype tissue was measured with the measurement tool of ImageJ. The number of
mitotic cells inside a *fuss* overexpressing clone was divided by its area and
the number of mitotic cells inside the wildtype tissue was divided by the
wildtype tissue´s area. The acquired data was visualized with Python and the
Matplotlib and Seaborn libraries. Statistics were calculated with the SciPy
library.
## Paraffin sections
Paraffin sections were performed from two-day old adult flies. Flies were fixed
with carnoy (ethanol:chloroform:acetic acid at a proportion 6:3:1), dehydrated
in ethanol, and embedded in paraffin. Paraffin sections (7 μm) from 10 flies of
each genotype were analysed under a fluorescence microscope.
## RNA extraction, library generation and sequencing
Per replicate and genotype 40 eye antennal discs or 30 wing discs from third
instar larvae were dissected. RNA was extracted via peqGold MicroSpin Total RNA
Kit. Library preparation and RNA-Seq were carried out according to the NEBNext
Ultra RNA Library Prep protocol, the Illumina HiSeq 1000 System User Guide, and
the KAPA Library Quantification Kit—Illumina/ABI Prism User Guide. Library
preparation and RNA-Seq were performed at the Genomics Core Facility “KFB—Center
of Excellence for Fluorescent Bioanalytics” (University of Regensburg,
Regensburg, Germany).
## RNA-Seq analysis
The reads were quantified with the R package Salmon using the release of the
*Drosophila melanogaster* genome BDGP6.22. The data was imported using tximeta
and analysed with DESeq2. Cut-off for significantly dysregulated genes was set
with an adjusted *p*-value \< 0.01. Top 21 differentially expressed genes
between control and overexpression replicates were visualized with the heatmap.2
package in R.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
There are few phytobacteria with the capacity to directly affect the health of
humans or livestock. In the rare instances where they can, the pathogenic
effects are often related to the production of toxins. One such toxin-producer
is the Gram-positive bacterium *Rathayibacter toxicus*, the causative agent of
annual rye grass toxicity (ARGT) in Australia. ARGT is an often-fatal toxicosis
of forage animals caused by ingestion of infected hay or grain. Over 10 million
hectares of Western Australian farmland has been affected and ARGT caused an
estimated \$40 million AUD in direct losses in 2010. *R*. *toxicus* produces a
highly lethal tunicaminyluracil class corynetoxin (LD<sub>50</sub> 3–5 mg/kg in
sheep) that causes severe and often fatal neurological and hepatic disease. Sub-
lethal doses are also damaging to livestock and diminish wool quality and
quantity, meat quality, and cause fetal abortions in sheep. Symptom onset can
occur up to 12 weeks after ingestion and a single exposure can cause lethality;
toxin effects are cumulative. *R*. *toxicus* corynetoxins were identified as a
new member of the tunicaminyluracil class of antibiotics, which inhibit an early
stage in prokaryotic peptidoglycan cell wall assembly. In eukaryotes,
tunicamycin reduces protein N-glycosylation by inhibiting uridine
diphospho-*N*-acetylglucoseamine:dolichol-*N*-acetylglucoseamine-1-phosphate
transferase. The dangers to U.S. agriculture presented by *R*. *toxicus* and
tunicamycin production in forage resulted in the bacterium being listed as a
U.S. Department of Agriculture (USDA) Plant Protection and Quarantine Select
Agent in 2008 and relisted in 2012 ([www.selectagents.gov/SelectAgentsandToxinsL
ist.html](http://www.selectagents.gov/SelectAgentsandToxinsList.html)).
*R*. *toxicus* is most commonly found in annual ryegrass (*Lolium rigidum*) in
association with *Anguina funesta* or other anguinid seed-gall nematodes. The
infection cycle begins with *R*. *toxicus* adhering to the cuticle of compatible
juvenile nematodes in the soil and being carried to the growing point of the
forage grass. Once in a developing seed, the nematode and bacteria compete to
form either a nematode or a bacterial gall. *R*. *toxicus* growth in developing
galls can produce a yellow exopolysaccharide “slime” or gummosis; therefore, the
plant infection is commonly called yellow slime disease. The trigger for toxin
production is unknown but toxin generally appears late in the growing season as
seed are senescing. Senesced seed, nematode galls, and bacterial galls dry and
fall to the ground to repeat the disease cycle the following year. Host range of
*R*. *toxicus* appears to be determined by the host range of the vectoring
nematode. Tunicamycin production is often associated with the presence of an
*R*. *toxicus*-specific bacteriophage NCPPB 3778, although toxin production has
also been measured in the absence of phage. The NCPPB 3778 genome has recently
been sequenced and is similar to siphoviral genomes. Although its role in nature
is unclear, NCPB3778 infection of *R*. *toxicus* can restore tunicamycin
production in the lab, where the ability to produce tunicamycin is otherwise
rapidly lost in culture (A.J. Sechler, personal observation).
Although complete genome sequences are publically available for two *R*.
*toxicus* strains, FH-145 (NZ_CP010848.1) and WAC3373 (NZ_CP013292.1), neither
sequence has been carefully annotated. In addition, the full genetic diversity
of *R*. *toxicus* is not well represented by these two strains alone. Therefore,
two additional strains of *R*. *toxicus*, FH-79 (the type strain) and FH-232
were sequenced. Because an established system for genetic modification of *R*.
*toxicus* is not available, the analysis presented here uses comparative and
structural genomics to identify the genetic basis of several previously
described phenotypes including the production of tunicamycin.
# Materials and methods
## Bacterial strains, culture, and DNA extraction
Cultures of *R*. *toxicus* FH-79 and FH-232 were obtained from Dr. Ian Riley
(University of Adelaide, South Australia); additional information about their
origins is presented in. *R*. *toxicus* was maintained on modified YGM (mYGM).
One liter of this modified media contained yeast extract 2 g, glucose 1.25 g,
K<sub>2</sub>HPO<sub>4</sub> 0.25 g, KH<sub>2</sub>PO<sub>4</sub> 0.25 g,
MgSO<sub>4</sub>·7H<sub>2</sub>O 0.1 g, and agar 16 g. Cultures were incubated
at 25°C unless otherwise noted; cryogenic stocks were stored in 15% glycerol at
-80°C. DNA was extracted using a modified Marmur method from 3 day old liquid
cultures. DNA quality was estimated by OD<sub>260/280</sub> ratio as measured on
a Nanodrop 2000 (Thermo Fisher Scientific) and only DNA with a ratio \>1.6 was
used for sequencing. Purity of the cultures used for DNA extraction was
confirmed by plating 50 μl on mYGM and monitoring for growth of non-*R*.
*toxicus* colonies. 16S rDNA was sequenced using an Applied Biosystems 3130XL
(Thermo Fisher Scientific) to test purity of extracted DNA prior to genomic
sequencing; only extracted DNA yielding a single 16S sequence was sequenced
further.
## Genome sequencing and assembly
For *R*. *toxicus* FH-79, a shotgun DNA library was constructed for the 454
Junior (Roche) according to the manufacturer’s directions and three sequencing
runs were performed. In addition, a library FH-79 was also constructed for the
PacBio RSII (Pacific Biosciences); three SMRT cells were sequenced for FH-79 at
the Washington State University Genomics Lab. The 454 sequence data was
assembled using Lasergene Ngen v12.0 (DNAStar) and PacBio reads using Pacific
Bioscience’s Hierarchical Genome-Assembly Process (HGAP); consensus sequences
from the two methods were compared using Ngen. For *R*. *toxicus* FH-232, only a
PacBio library was constructed and 3 SMRT cells were sequenced also at the
Washington State University Genomics Lab; assembly was performed using Pacific
Bioscience’s Hierarchical Genome-Assembly Process (HGAP). The putative
tunicamycin gene cluster, vancomycin resistance genes, and 16S rDNA from FH-79
and the CRISPR region from FH-232 were resequenced by primer walking on an
Applied Biosystems 3130XL (Thermo Fisher Scientific) to validate genome
assembly.
The genome sequences presented here have been deposited in GenBank under the
following accession numbers: *R*. *toxicus* FH-79 BioProject PRJNA312185 and
BioSample SAMN04495682; *R*. *toxicus* FH-232 BioProject PRJNA312185 and
BioSample SAMN06040670.
## Genome annotation and analysis
Initial automated genome annotation was obtained using the Prokaryotic Genome
Annotation Pipeline (PGAP) at National Center for Biotechnology Information
(NCBI). Custom gene models were constructed as necessary by aligning the
selected input sequences using muscle (<http://www.drive5.com/muscle/>),
followed by invocation of hmmbuild from the HMMer version 3.1.b2 package
(<http://hmmer.org/>). The hmmscan tool from the HMMer suite was used for
database scans. Predicted chromosomal origin of replication was identified using
Ori-finder (<http://tubic.tju.edu.cn/Ori-Finder/>). Standard protein family and
domain models were obtained from TBLASTN
(<https://blast.ncbi.nlm.nih.gov/Blast>), Pfam (<http://pfam.xfam.org/>),
TIGRFam (<http://www.jcvi.org/cgi-bin/tigrfams/index.cgi>) and TnpPred.
Alien_Hunter and antiSMASH were used to identify regions with anomalous
nucleotide composition and putative biosynthetic clusters, respectively;
identified regions were manually annotated with special attention paid to
transposases and known virulence factors in other Actinobacteria. Whole genome
alignments were performed with Mauve. CRISPR analysis was performed using
CRISPRFinder.
## Phylogenetic trees
For the Actinobacteria phylogenetic tree, sequences for *gyrB*, *secA1* and 16S
rDNA genes were obtained for 15 representative species of Actinobacteria.
Sequences were concatenated and aligned using three iterations of tree searching
and realignment with the Clustal Omega algorithm in Megalign Pro (Lasergene).
MEGA6 was then used to conduct model determination and maximum likelihood tree
searches (default settings) with 100 iterations of bootstrapping analyses. A
minimum bootstrap value of 50 was used as a cut-off level of support to
determine valid branches. *Rubrobacter radiotolerans* was set as the outgroup.
For the protease tree, amino acid sequences of serine proteases putatively
secreted from *R*. *toxicus* FH-79 and *Clavibacter michiganensis* subsp.
*michiganensis* NCPPB382 were aligned with MSAProbs. Aligned sequences were used
to generate maximum-likelihood trees based on the Jones-Taylor-Thornton (JTT)
model of MEGA 7.0 with bootstrapping repetitions of 1,000.
## GC content plot and statistics
Percentage GC content was plotted using GC content calculator ([www.biologicscor
p.com/tools/GCContent](http://www.biologicscorp.com/tools/GCContent)) with a
sliding window size of 2,000 bp. Statistical significance of GC content
differences was calculated by repeated random sampling of 1000 13.4 kb regions
of the *R*. *toxicus* FH-79 genome excluding rDNA and the TGC itself.
# Results
## Whole-genome sequencing, assembly, and annotation
Sequence data resolved each genome into a single circular chromosome of
2,343,780 and 2,394,755 bp for *R*. *toxicus* FH-79 and FH-232, respectively; no
plasmids or other extra-chromosomal sequences were found for either strain. The
PacBio SMRT sequencing technology was especially important for evenly closing
these high-GC genomes. compares these two genomes to the previously available
*R*. *toxicus* FH-145 (NZ_CP010848) and WAC3373. All four *R*. *toxicus* strains
have an average GC content of approximately 61%. Annotation using NCBI’s
Prokaryotic Genome Annotation Pipeline yielded 2,078 open reading frames (ORFs)
for *R*. *toxicus* FH-79 and 2,137 ORFs for FH-232. This PGAP annotation also
contained a large number of genes with the \pseudo keyword due to variations in
the placement of the stop codon. Manual comparison with carefully annotated
genomes suggest that the observed variations in gene length are typical in
Actinobacteria; therefore, the \pseudo keyword was removed.
The two sequenced genomes presented here were aligned with the two available
*R*. *toxicus* genomes using Mauve after rotating and/or reverse complementing
sequences to place *dnaA* as the first gene on the positive strand. As shown in,
the four genomes are essentially syntenic. The pink, yellow, and blue regions
represent three locally collinear blocks (LCBs). The distinction between the
pink and blue regions is an artifact arising from circular genomes being treated
as linear by the Mauve algorithm. Therefore, there are only two physically
distinct LCBs separated by short transpositions; location of transposition
region is marked by a green line in. *R*. *toxicus* FH-232 has 12 insertions not
present in the other genomes; this accounts for its larger genome size.
Predicted and annotated open reading frames spanned the typical range of
necessary biological functions, metabolism, cell wall biosynthesis, defense,
etc. Importantly, no ORFs annotated as phage genes were present, indicating no
prophages are incorporated into the bacterial genome and that samples were free
from contaminating phage. *R*. *toxicus* FH-79 and FH-232 both have two 16S rDNA
sequences and have 46 or 45 tRNAs, respectively. Because of the extensive
similarity among the four sequenced *R*. *toxicus* strains, further analysis is
only presented for *R*. *toxicus* FH-79 except for rare cases where significant
differences exist.
## *R*. *toxicus* groups with the *Microbacteriaceae*
A phylogenetic analysis based on three conserved genes clearly demonstrates that
*R*. *toxicus* is a member of the *Microbacteriaceae*, most closely related to
*Leifsonia xyli* and *Clavibacter michiganensis*. These three genes (*gyrB*,
*secA1*, and 16S rDNA) are frequently used for resolving subfamilial
relationships in Actinobacteria due to appropriate levels of within subfamily
variation. Although *L*. *xyli* and *C*. *michiganensis* have slightly larger
genomes than *R*. *toxicus* (2.6 Mb and 3.3 Mb, respectively, vs. 2.3 Mb), all
three species have GC-rich genomes and all are plant-associated.
## Tunicamycin gene cluster
A putative 13.4 kb tunicamycin gene cluster (TGC) was identified based on
homology to proteins encoded by the TGC from *Streptomyces chartreusis* NRRL
3882. As shown in, the *R*. *toxicus* TGC has a GC content markedly lower than
the genome as a whole (52% vs. 61%). Repeated random sampling of the genome
demonstrated that only 0.2% of comparably sized genome segments have a GC-
content that is lower than the TGC (p-value \< 0.002).
Although the *S*. *chartreusis* TGC appears to be a single polycystronic operon
consisting of either 12 (*tunA-tunL*) or 14 (*tunA-tunN*) genes, the *R*.
*toxicus* TGC contains two operons, one monocystronic (*tunC*) and one
polycystronic (*tunA-tunF*;). *R*. *toxicus* also lacks the *tunM*
methyltransferase and *tunN* NUDIX hydrolase; however, these genes are not
essential for tunicamycin biosynthesis. The TGC in *R*. *toxicus* does contain
two novel ORFs: *tunO*, a hypothetical gene unique to *R*. *toxicus*, and
*tunP*, a polyketide synthase with a beta-ketoacyl synthase domain. All the
predicted TGC genes are present in the same order and orientation in all four
sequenced strains. *R*. *toxicus* FH-145 and WAC3373 are identical at the
nucleotide level to the FH-79 TGC except for the addition or deletion of 2 or 3
Gs in a highly repetitive, G-rich intergenic region upstream of *tunC*. The
FH-232 TGC is more than 99% identical to the other TGC regions. FH-79 has been
previously shown to produce tunicamycin; FH-232 and FH-145 also produce toxin.
While tunicamycin production by WAC3373 has not been reported, biosynthesis is
likely given the highly conserved TGC. The hypothesized tunicamycin biosynthetic
pathway is shown in.
## Additional secondary metabolites
To identify regions with anomalous nucleotide composition that may interfere
with statistically based gene calling algorithms, Alien_Hunter was used to query
the *R*. *toxicus* FH-79 genome. Such regions are also of interest because they
may arise from horizontal gene transfer events and are more likely to contain
biosynthetic genes for secondary metabolites or virulence factors. Forty-two
regions, including the TGC described above, were identified and are listed in.
To further aid in the identification of secondary metabolite biosynthetic
clusters, antiSMASH was also used to query the *R*. *toxicus* FH-79 genome. As
shown in, 21 of the 42 regions identified with Alien_Hunter were also identified
within 14 antiSMASH regions. Regions vary from 5.2–28.7 kb and are predicted to
encode a wide variety of functions: bacteriocins (lantibiotic), type III
polyketide synthase (PKS) proteins, non-ribosomal peptide synthetase (NRPS)
proteins, multidrug efflux permeases, serine proteases, exopolysaccharide-
related proteins, Type VII secretion system (T7SS) proteins, and numerous
YD/RHS-like repeat-associated proteins.
Historically, *R*. *toxicus* has been defined based on several different
biochemical characteristics. In addition to the production of tunicamycin as
described above, these include yellow colony color, exopolysaccharide “slime”
production, MK-10 as the predominant isoprenoid quinone, and a non-mevalonate
pathway for isoprenoid biosynthesis. Although the exact biochemical nature of
the yellow pigment has not been determined, the only candidate carotenoid
biosynthetic cluster in the genome is shown in. It consists of six predicted
genes: *crtEb* (AYW78_09695, UbiA-like prenyltransferase); *crtYf* (AYW78_09700,
lycopene cyclase); *crtYe* (AYW78_09705, lycopene cyclase); *crtBI*
(AYW78_09710, bifunctional phytoene synthase/oxidoreductase); *crtE*
(AYW78_09715, geranylgeranyl diphosphate synthase); and *ispH* (AYW78_09720,
isopentyl-diphosphate delta-isomerase, type I). The only predicted
exopolysaccharide biosynthetic cluster in the *R*. *toxicus* genome is present
on antiSMASH cluster AS-8. This cluster was identified based on similarity to
proteins in the *wcm*, *wcn*, *wco*, and *wcq* exopolysaccharide biosynthetic
clusters in *Clavibacter michiganensis* subsp. *nebraskensis* NCPPB 2581
(NC_020891.1). The carotenoid pigment and the secreted exopolysaccharide may
account for the yellow slime observed during plant infection.
The menaquinone profile, along with 16S rDNA sequence and cell wall amino acid
composition, was used to justify moving the type strain from *Clavibacter* to
*Rathayibacter*. The predominant menaquinone identified by Sasaki et al., MK-10,
is also the expected product of a gene cluster from antiSMASH cluster AS-5. This
cluster contains genes with similarity to *menB-menF* and *ubiE*, the core
menaquinone biosynthetic genes first identified in *E*. *coli*, as well as
several additional genes. The ORF labeled *idsA* is predicted to encode a
geranylgeranyl pyrophosphate synthase that may be involved in both menaquinone
and carotenoid production.
Most organisms use one of two different pathways to synthesize the important
isoprenoid building blocks isopentenyl pyrophosphate and its isomer
dimethylallyl pyrophosphate, either the classical mevalonic acid (MVA) pathway
or the non-mevalonate/methylerythritol phosphate (MEP) pathway. Although Gram-
negative bacteria only use the MEP pathway, several Gram-positive organisms,
including many in the *Microbacteriaceae* family, use the MVA pathway. Studies
using the isoprenoid biosynthetic inhibitor fosmidomycin are consistent with use
of the MEP pathway by several *Rathayibacter* species. The *R*. *toxicus* genome
contains ORFs similar to the core MEP pathway proteins from *E*. *coli*: DXS
1-deoxy-D-xylulose 5- phosphate synthase, AYW78_05260; DXR/IspC 1-deoxy-D-
xylulose 5-phosphate reductoisomerase, AYW78_03715; IspE
4-diphosphocytidyl-2-C-methylerythritol kinase, AYW78_07950; and a bifunctional
IspD/IspF 4-diphosphocytidyl-2-C-methylerythritol synthetase and
2-C-methylerythritol 2,4-cyclodiphosphate synthase, AYW78_08320. The MVA pathway
appears to be absent from *R*. *toxicus*.
antiSMASH cluster AS-18 is predicted to encode a lantibiotic or class I
bacteriocin, a heavily modified, ribosomally synthesized anti-microbial peptide.
The predicted prepropeptide is encoded by the gene with locus tag AYW78_09457
and is serine and alanine rich. Neighboring ORFs AYW78_09425 and AYW78_09430
encode proteins containing lantibiotic dehydratase domains while AYW78_09455
encodes a putative peptide cyclodehydratase. AYW78_09440 and AYW78_09445 encode
FMN-dependent oxidases that may act on the cyclized thioesters. The only *R*.
*toxicus* gene that exhibits any significant similarity to the LanP-type
peptidases involved in cleaving lantibiotic leader peptides is not part of this
cluster (AYW78_08500).
Although not identified by either Alien_Hunter or antiSMASH, it is notable that
the *R*. *toxicus* genome encodes three predicted vancomycin resistance
proteins: VanH pyruvate dehydrogenase, AYW78_09940; VanA D-lactate
dehydrogenase, AYW78_09945; and VanX D-ala-D-ala peptidase, AYW78_09950. *R*.
*toxicus* FH-79 is resistant to vancomycin experimentally.
## CRISPR arrays
*R*. *toxicus* possesses a complete Type I-E CRISPR-Cas system (*E*.*coli-*type)
with eight *cas* genes and an adjacent approximately 8.9 kb CRISPR spacer array.
The four different sequenced strains have slightly different numbers of non-
repetitive spacer sequences and conserved direct repeats. *R*. *toxicus* FH-79
and FH-145 both have 145 non-repetitive spacer sequences and 146 conserved
direct repeats while WAC3373 has 144 and 145 and FH-232 has 139 and 140,
respectively. Non-repetitive spacer sequences revealed no identity to known
plasmid or phage sequences.
## Predicted pathogenicity-related genes
Relative to the related phytopathogen *Clavibacter michiganensis* subsp.
*michiganensis*, *R*. *toxicus* possesses a limited arsenal of plant-associated
cell-wall hydrolyzing enzymes, consisting of only a single polygalacturonase
(AYW78_01285) and pectate lyase (AYW78_01485). This is consistent with the life
strategy of *R*. *toxicus*, which apparently cannot infect plant leaves or stems
but most acquire nutrients in seed galls initiated by nematode infestation.
However, *R*. *toxicus* does possess numerous secreted serine proteases that
share sequence homology to the pathogenicity-associated protein Pat-1 of *C*.
*michiganensis* subsp. *michiganensis*. A total of 11 secreted serine proteases
were identified with an additional conserved pseudogene; all contain predicted
signal peptides suggesting extracellular localization as described in *C*.
*michiganensis* subsp. *michiganensis*. The corresponding genes were designated
*chpA-K* (chromosomal homology to *pat*-1) and *sbtA* (subtilisin-like serine
protease). In contrast to *C*. *michiganensis* subsp. *michiganensis*, the
secreted serine proteases are dispersed throughout the chromosome, but several
of the proteases are located in close proximity including: (i) *chpG*, *chpH*,
*chpK* (pseudogene) and (ii) *chpB*, *chpC*.
Phylogenetically, the serine proteases of *R*. *toxicus* and *C*.
*michiganensis* subsp. *michiganensis* appear distinct with the majority of *R*.
*toxicus* proteases (ChpB-E, ChpI-J) forming a subgroup. No *R*. *toxicus*
serine proteases clustered with the *C*. *michiganensis* subsp. *michiganensis*
Ppa family or plasmid-associated (PhpA-B) serine proteases. The subtilisin-like
serine proteases of *R*. *toxicus* and *C*. *michiganensis* subsp.
*michiganensis* were the only secreted proteases to cluster across species.
# Discussion
The key feature of *R*. *toxicus* is its ability to exploit a protected
environmental niche, the developing grass seed, and produce tunicamycin, a
potent toxin for grazing livestock. Prior to the work presented here, very
little was known about the biosynthesis of tunicamycin by *R*. *toxicus*. Until
the publication of the phage NCPPB 3778 sequence, it was hypothesized that
tunicamycin production could reside in the phage rather than on the bacterial
chromosome. However, no ORFs with similarity to known tunicamycin biosynthetic
genes were found in the phage genome. The discovery of a tunicamycin gene
cluster (TGC) in *R*. *toxicus* with similarity to the previously characterized
cluster from *S*. *chartreusis* is an important first step in understanding
toxin production in this bacterium. Both the lower GC content of the TGC and its
similarity to *Streptomyces* indicate that *R*. *toxicus* probably acquired the
ability to synthesize tunicamycin via a horizontal gene transfer event; however,
the TGC does not contain identifiable transposases, nor is it adjacent to a
recognizable tRNA or flanked by inverted repeats as is typical for a mobile
genetic element.
*R*. *toxicus* is regulated as a select agent because it is associated with the
production of toxin that results in the death of foraging livestock. There are
additional concerns about potential secondary effects that could manifest in
humans consuming either contaminated plant material or the meat of ARGT affected
animals. *R*. *toxicus* causes little in the way of disease symptoms on grasses,
with the accumulation of exopolysaccharide “slime” as the primary sign of
pathogen infection, and there is no indication that *R*. *toxicus* infections
result in significantly reduced plant host fitness. The lack of
phytopathogenesis-related genes in the *R*. *toxicus* genome further suggests
that this bacterial species may not be a typical plant pathogen. Rather, *R*.
*toxicus*, like other *Rathayibacter* species, has evolved a unique approach to
reaching and exploiting a desirable niche, by utilizing gall forming nematodes
as a convenient vector.
A possible biological function for toxin production is the elimination of
nematodes from the seed gall, thus eliminating competition for resources.
Tunicamycin production increases drastically when *R*. *toxicus* is inside the
seedhead at a tipping-point between the nascent gall progressing to either
nematode or bacterial dominated growth. However, while all members of the
*Rathayibacter* genus utilize gall forming nematodes as vectors not all members
of the genus produce tunicamycin, although it is not yet known whether the TGC
is present in all members of the genus. It should be noted that toxin production
comes at a significant fitness cost to *R*. *toxicus*, as toxin producing
bacteria reproduce at significantly slower rates than non-toxin producers.
Alternatively, toxin production for *R*. *toxicus* may provide an advantage
against competing microbial populations, both fungal and bacterial, at one or
more points in the life cycle from soil to seed head. Microbial competition
could also explain the repertoire and diversity of biosynthetic pathways
encoding non-ribosomal peptide synthetase (NRPS) proteins, polyketide synthase
(PKS) proteins, thiazole/oxazole-modified microcins, lantibiotics, and numerous
efflux proteins present in the *R*. *toxicus* genome. Regardless, for the select
agent *R*. *toxicus*, there would seem to be some selection pressure(s) acting
to keep the TGC and associated machinery present and active in the bacterial
genome.
It is not known how any tunicamycin producer protects itself from the toxin. It
has been hypothesized that *tunI* and *tunJ*, which are both similar to ABC
transporters, export tunicamycin outside the cell immediately after synthesis.
It is possible to express the *S*. *chartreusis* TGC in other *Streptomyces*
species and thereby confer both tunicamycin production and resistance, implying
that at least in the case of *S*. *chartreusis*, any export or detoxification
mechanisms reside within the TGC itself.
The *R*. *toxicus* strains sequenced here complement the two previously
available complete genome sequences. A previous analysis of *R*. *toxicus*
strains found three major genotypic groups based on amplified fragment length
polymorphisms (AFLP) and restriction digestion patterns using pulsed-field gel
electrophoresis (PFGE). As indicated in, the previously sequenced *R*. *toxicus*
FH-145 falls in subgroup A while FH-79 is in subgroup B and FH-232 is the sole
member of subgroup C. Many of the same *R*. *toxicus* strains, as well as some
more recently collected, were also analyzed by multi-locus sequence typing
(MLST) and inter-simple sequence repeats (ISSR). This analysis found three main
populations, RT-I, RT-II, and RT-III, with strain FH-232/FH100 again forming an
outgroup. *R*. *toxicus* FH-79 and FH-145 were not included in the MLST
analysis. However, by *in silico* PCR, they both belong to RT-III. The four
subgroup A strains also analyzed by MLST all fall into RT-III while the three
subgroup B strains examined are in RT-II. This makes *R*. *toxicus* FH-79, which
is the type strain for the species, somewhat unusual as it falls into subgroup B
and RT-III.
It is most common for bacterial chromosomes to be circular in topology. However,
a number of both Gram-positive and Gram-negative bacteria have linear
chromosomes and/or plasmids; they are especially common in the
*Actinomycetales*. The *R*. *toxicus* chromosome was hypothesized to be linear
based on its failure to enter a pulsed-field gel either before or after nuclease
S1 treatment. Whether or not large circular DNA migrates during PFGE depends on
the exact electrophoretic conditions; insufficient experimental detail is
provided to assess the conclusions of Agarkova *et al*.. The genome presented
here is most consistent with a circular topology. Virtual *Pac*I digests of a
circular genome generate the number and size of bands observed experimentally
more closely than a linear genome. Additional bands are predicted but would not
be expected to be visible on a pulsed-field gel due to their small size.
Linear chromosomes have large terminal inverted repeats on the ends; these
sequences can be up to 1 Mb each. Unless care is taken during genome assembly,
these terminal repeats can be mis-assembled on top of each other and give the
appearance of a circular genome. Terminal repeats have been observed to be
under-represented in PacBio raw reads, perhaps because of the bias toward long
DNA fragments during library construction. Therefore one clue that a genome is
linear can be the presence of contigs made up of short (Illumina or 454) reads
that do not map to PacBio consensus sequence; no such contigs were found in the
454 sequence from *R*. *toxicus* FH-79. If terminal repeats are incorporated
into the PacBio library and therefore appear once in a circular consensus
sequence, those regions would be overrepresented in short read libraries.
However, no such regions of higher coverage were observed.
Prior estimates of genome size match the sequence obtained here quite well
(2.2–2.3 Mb predicted vs. 2.3–2.4 Mb observed); if two large terminal repeats
were missing from the genomes reported here, the sequences reported here would
be expected to be significantly smaller than previous size predictions. In
general, the larger *Actinomycetales* genomes tend to be linear and the smaller
ones circular, although there are exceptions. *R*. *toxicus*, at 2.3–2.4 Mb, is
definitely on the smaller end of genome size. All of these factors taken
together tend to support the presence of a circular chromosome in *R*.
*toxicus*.
*R*. *toxicus* is most closely related to the systemic xylem-dwelling Gram-
positive phytopathogenic bacteria *Clavibacter michiganensis* and *Leifsonia
xyli*. While *L*. *xyli* subsp. *xyli* is a fastidious xylem-limited bacterium
of sugarcane, *C*. *michiganensis* subsp. *michiganensis* is an opportunistic
pathogen of tomato and colonizes both vascular and non-vascular tissue.
Regardless of differences in host and systemic lifestyles, *C*. *michiganensis*
subsp. *michiganensis* and *L*. *xyli* subsp. *xyli* possess numerous canonical
plant-associated cell wall-degrading enzymes (PCWDEs). *C*. *michiganensis*
subsp. *michiganensis* utilizes a variety of PCWDEs including hemicellulases,
xylanases, cellulases, polygalacturonases, pectate lyases, and endoglucanases.
However, *R*. *toxicus* lacks many PCWDEs, possessing only a single copy each of
pectate lyase and polygalacturonase. The relatively small arsenal of plant-
associated enzymes is surprising for a plant pathogen, but could demonstrate its
closer association and reliance on a nematode vector for plant colonization.
Despite the small arsenal of PCWDEs, *R*. *toxicus* possesses numerous serine
proteases with homology to the pathogenicity-associated protein Pat-1 of *C*.
*michiganensis* subsp. *michiganensis*. *C*. *michiganensis* subsp.
*michiganensis* harbors serine proteases on a putative 129 kb pathogenicity
island and extra-chromosomal plasmids, which are necessary for effective disease
development in tomato. However, the serine proteases from *R*. *toxicus* are
dispersed throughout the chromosome and appear distinct from the *C*.
*michiganensis* subsp. *michiganensis* disease-associated serine proteases. The
putatively secreted *R*. *toxicus* serine proteases could possess alternative
functions associated with nematode colonization, as opposed to plant
colonization or disease development, since cuticle penetrating serine proteases
are highly represented in nematode pathogenic bacteria and fungi. It is
interesting to note that Bird et al. (1984 & 1985) document the destruction of
the nematode epidermis and cortical structures shortly after *Rathayibacter*
attachment. The relative lack of PCWDEs and differing serine proteases suggest
that *R*. *toxicus* is not a typical vectored phytopathogenic bacterium.
In summary, analysis of the complete genome of *R*. *toxicus* has identified a
likely genetic pathway (TGC) for the production of tunicamycin, based on
homology to other tunicamycin biosynthetic clusters. This represents a critical
first step towards understanding the control of the key pathway that makes this
Select Agent pathogen such a significant threat to agriculture and food safety.
Sequencing the genomes of other members of the *Rathayibacter* genus, both toxin
producers and non-toxin producers, would provide corroborative evidence
implicating the TGC in tunicamycin production as well as providing some
evolutionary context for the introduction of the TGC as a likely mobile element.
The current genomic context, however, suggests that the TGC is no longer mobile
in any of the sequenced *R*. *toxicus* strains. Ultimately, the connection
between the TGC and toxin production must be assessed by expression studies,
gene knockouts, and functional restoration experiments.
# Supporting information
The authors would like to thank Dr. Ian Riley (University of Adelaide) for
providing *Rathayibacter toxicus* strains and for considerable assistance over
the years with *R*. *toxicus*. Funding for this work was from the United States
Department of Agriculture (USDA) Agricultural Research Service appropriated
project 8044-22000-040-00D and from two 2008 Farm Bill grants, Section 10201
administered through the United States Department of Agriculture, Animal and
Plant Health Inspection Service (13-8130-0247-CA and 14-8130-0367-CA). Mention
of trade names or commercial products in this publication is solely for the
purpose of providing specific information and does not imply recommendation or
endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity
provider and employer.
[^1]: The authors have declared that no competing interests exist.
[^2]: Current address: Global Institute for Food Security and the School of
Environment and Sustainability, University of Saskatchewan, Saskatoon,
Saskatchewan, Canada
[^3]: Current address: Dept. of Biochemistry, Molecular Biology, Entomology
and Plant Pathology, Mississippi State University, Mississippi State,
Mississippi, United States of America
[^4]: Current address: AIDS and Cancer Virus Program, Frederick National
Laboratory for Cancer Research and Leidos Biomedical Research, Inc.,
Frederick, Maryland, United States of America
|
# Introduction
An estimated 15% of couples are affected by infertility and male factor
infertility is the suspected cause in 30–50% of these couples. Although the
exact cause of many of these cases are unknown, chromosomal deletions,
translocations and SNPs are associated with infertility in as many as 30% of
these men. Identifying and understanding how genetic anomalies affect
spermatogenesis and fertilization will improve the likelihood of overcoming male
infertility. Conversely, effective male contraception may be developed based on
data showing associations between genetic variation, nutrient metabolism and
male factor infertility.
Although the relationship between overall nutritional status and reproduction is
well documented, the relationship between micronutrient metabolism and
reproduction is understudied. There is some evidence that aberrant micronutrient
metabolism may play a causative role in male factor infertility. Dietary
deficiencies of vitamins A, C and E as well as trace metals such as zinc and
selenium are associated with male infertility in animals and humans, Choline is
an essential nutrient for humans and is important for normal fetal development.
A link between choline metabolism and male fertility has been demonstrated in
only one paper. Geer reported both normal mating behavior and sperm motility
required adequate choline availability in Drosophila melanogaster and that
carnitine, a proposed choline substitute, was unable to support male fertility.
We discovered that choline dehydrogenase (CHDH, EC 1.1.99.1) is necessary for
normal male fertility in mice. Male choline dehydrogenase knockout mice
(*Chdh<sup>−/−</sup>*) are infertile due to severely compromised sperm motility;
decreased motility is the result of abnormal mitochondrial structure and
function in sperm cells.
Betaine (*N,N,N*-trimethylglycine), a metabolite of choline, donates methyl
groups for the formation of methionine from homocysteine and is an organic
osmolyte used by cells for regulatory volume control. Dietary sources of betaine
include wheat, shellfish, spinach and sugar beets. In addition, betaine can be
made *de novo* via the oxidation of choline in a series of reactions catalyzed
by CHDH and betaine aldehyde dehydrogenase (BADH, EC 1.2.1.8). Conversion of
choline to betaine takes place in the mitochondrial matrix following the
transport of choline across mitochondrial membranes. The betaine formed is a
zwitterion at neutral pH and diffuses out of mitochondria for use in one-carbon
metabolism.
SNPs have been identified in the human *CHDH* gene; rs12676 (G233T) is a non-
synonymous SNP located in exon 3 of the gene. Occurrence of the variant T allele
results in the replacement of arginine, a polar, hydrophilic amino acid, with
leucine, a hydrophobic amino acid. 38–40% of individuals are heterozygous and
2–9% are homozygous for rs12676. The *CHDH* minor T allele is associated with
increased susceptibility to developing clinical symptoms of dietary choline
deficiency (steatosis and muscle cell damage) as well as increased risk of
breast cancer. Although not in the *CHDH* gene, a SNP in the adjacent
interleukin 17 beta receptor (*IL17βR*) gene, rs1025689, is associated with
increased risk of developing choline deficiency specifically in men (odds ratio
13.5; see for detailed description of this study). We now present data
indicating that rs12676 genotype is also associated with dysmorphic
mitochondrial structure, changes in sperm motility patterns and decreased energy
status in human sperm. Sperm and hepatocytes harboring the TT rs12676 genotype
have less CHDH protein, suggesting that this SNP is functional. In addition,
rs1025689 is linked to changes in sperm motility patterns, suggesting that these
SNPs may be contributing factors in the occurrence of idiopathic male
infertility.
# Materials and Methods
## Chemicals and Reagents
All chemicals and reagents used were obtained from Sigma Aldrich (St. Louis,
MO), unless otherwise noted.
## Ethics statement
The study design and all procedures used in this study were approved by the
University of North Carolina at Chapel Hill Office of Human Research Ethics
Institutional Review Board. Subjects were at least 18 years of age and were
recruited from the Charlotte-Kannapolis, North Carolina region. Informed written
consent was obtained from all subjects at the initial clinic visit. Subjects
were compensated up to \$125 for their participation in the study.
## Study design and recruitment
This study was conducted at the University of North Carolina at Chapel Hill
Nutrition Research Institute (Kannapolis, North Carolina) and was implemented in
two phases – screening subjects for rs12676 and rs1025689 genotype, and analysis
of semen and sperm specimens collected from subjects with these SNPs. Subjects
were screened to determine the frequency of these SNPS in our study population
and to allow for enrichment of the homozygous variant genotypes. Participants
were recruited via mass email, advertisements in Craig's list, newspaper
articles describing the study and in-person recruiting at local community
colleges.
## Blood collection and DNA isolation
Subjects were asked to complete the health questionnaire form at the screening
visit. In order to screen subjects for the rs12676 and rs1025689 SNPs, blood was
collected into Vacutainer Cell Preparation Tubes (CPT tubes; BD Diagnostics,
Franklin Lakes, NJ) containing sodium citrate; lymphocytes were separated from
other blood components for subsequent genomic DNA extraction. All CPT tubes were
stored on ice if not processed immediately; all CPT tubes were processed within
1 hour of sample collection. Briefly, CPT tubes were centrifuged in a Sorvall
RC-3B centrifuge equipped with an H-2000B rotor (Thermo Fisher Scientific,
Waltham, MA) at 1500× *g* for 30 minutes at room temperature. Plasma was
aliquoted into 2 mL microfuge tubes and stored at −80°C for choline metabolite
analysis. The lymphocyte layer was washed with phosphate buffered saline (PBS),
transferred to a 15 mL conical tube and was pelleted by centrifugation at 1000×
*g* for 5 minutes at room temperature. Pellets were again washed with PBS,
transferred to 1.5 mL microfuge tubes and pelleted by centrifugation in an
Eppendorf 5415D microcentrifuge at 800× *g* for 5 minutes at room temperature.
Genomic DNA was purified from lymphocyte pellets using a QIAamp DNA Mini Kit
(Qiagen, Valencia, CA) according to manufacturer's instructions with some
modification. Specifically, lymphocyte pellets were equilibrated to room
temperature and resuspended in 500 µL PBS. The amounts of Qiagen Protease,
Buffer AL and ethanol (96%–100%) were adjusted proportionally as indicated by
the manufacturer's instructions. Two separate elutions of 100 µL with Qiagen
Buffer AE were performed. Samples were incubated at room temperature for 5
minutes prior to each elution. Both elutions were collected in the same 1.5 mL
microfuge tube for a final volume of 200 µL. DNA quality and concentration was
determined using a Nanodrop 8000 Spectrophotometer (Thermo Scientific,
Wilmington, DE).
## rs12676 genotyping
rs12676 genotype was determined by direct sequencing. A 260 base pair region of
the *CHDH* gene containing rs12676 was PCR amplified using Deep
Vent<sub>R</sub>™ (exo-) DNA polymerase (New England Biolabs, Ipswich, MA)
according to manufacturer's recommendations. The primers used for amplification
were: *CHDH forward* 5′-ATTCCCCTCCGTGGATCAG-3′ and *CHDH reverse*
5′-TGTCGTCGCACAGGTTGG-3′. Each 50 µL reaction contained 600 ng of genomic DNA,
primers at a final concentration of 200 nM, and 4 units of Deep
Vent<sub>R</sub>™ (exo-) DNA polymerase. The PCR conditions were: an initial
denaturing step at 98°C for 10 minutes followed by 30 cycles of denaturing at
98°C for 1 minute and annealing/extension at 72°C for 5 minutes. PCR products
were purified from other reaction components using a QIAquick PCR Purification
Kit (Qiagen, Valencia, CA) and the resulting DNA concentration was determined
using Nanodrop 8000 Spectrophotometer (Thermo Scientific, Wilmington, DE).
Purified *CHDH* fragments were sequenced using BigDye® Terminator chemistries
(Applied Biosystems, Carlsbad, CA) by Eton Bioscience, Inc (Research Triangle
Park, NC) using the *CHDH forward* primer. rs12676 genotype was determined by
examining sequencing chromatograms using Sequence Scanner software (version 1.0,
Applied Biosystems, Carlsbad, CA).
## rs1025689 genotyping
rs1025689 genotype was determined using a TaqMan® SNP genotyping assay (Applied
Biosystems, Carlsbad, CA) according to manufacturer's instructions. PCR
reactions were performed using a StepOne™ Real Time PCR System and 2× TaqMan®
Genotyping Master Mix (Applied Biosystems, Carlsbad, CA).
## Semen collection and processing
Subjects were asked to refrain from sexual activity for 48 hours prior to semen
donation. Semen was produced by masturbation and collected into 50 mL sterile
sample cups. Olive oil was provided as a lubricant to use as necessary. Samples
were incubated at room temperature for 30 minutes to allow for liquefaction.
Semen volume was measured with a pipette. Sperm were separated from other
seminal fluid components by layering the sample over a 45% ISolate®/human
tubular fluid (HTF; 190 mM NaCl, 9 mM KCl, 0.7 mM KH<sub>2</sub>PO<sub>4</sub>,
0.3 mM MgSO<sub>4</sub>-7H<sub>2</sub>0, 4 mM CaCl<sub>2</sub> –
2H<sub>2</sub>0, 0.025 mM NaHCO<sub>3</sub>, 2.78 mM D-glucose, 21.4 mM lactate,
0.33 mM pyruvate and 5 mg/mL bovine serum albumin (BSA; Fraction V), 5 M NaCl
was added as necessary to adjust osmolality) media gradient followed by
centrifugation at 300× *g* for 20 minutes at room temperature using a Beckman-
Coulter Allegra X-15R Centrifuge and SX4750A rotor. ISolate® was purchased from
Irvine Scientific (Santa Ana, CA). The supernatant was discarded and the
resulting sperm pellet was washed twice in 3 mL HTF followed by centrifugation
at 300× *g* for 10 minutes at room temperature. Sperm were resuspended in 4 mL
HTF and used for subsequent analyses.
## Sperm counts
The total number of sperm per ejaculate and sperm concentration were determined
by counting cells with a hemocytometer.
## Sperm motility
Sperm were diluted 1∶10–1∶15 in HTF for motility measurements. 200 µL of diluted
sperm were placed into a 35 mm glass bottom dish and covered with a coverslip.
For each sample, video of 10 random, unique microscope frames were recorded
using a Zeiss Axio Observer (Carl Zeiss, Inc, Thornwood, NY) inverted microscope
equipped with a temperature controlled incubation chamber equilibrated to 37°C.
Sperm were viewed under phase contrast conditions with a 20× objective lens.
Motility parameters including mean velocity (MVUS), curvilinear velocity (VCL),
straight distance velocity (VSL) and mean tortuosity (MT; MT = VCL/VSL) were
determined using Zeiss AxioVision (release 4.7) image tracking software (Carl
Zeiss, Inc, Thornwood, NY) as previously described.
## Electron microscopy
Approximately 500 µL of washed sperm were transferred to 1.5 mL microfuge tubes;
sperm were pelleted by centrifugation at 16,000× *g* for 5 minutes at room
temperature. The supernatant was discarded and sperm pellets were fixed for
transmission electron microscopy in 2% paraformaldehyde, 2.5% gluteraldehyde,
0.2% picric acid in 0.1 M sodium cacodylate, pH 7.2. The pellet was encapsulated
in 2% agarose buffered with 0.1 M sodium cacodylate buffer, pH 7.2. The
encapsulated pellet was post-fixed in 1% osmium tetroxide in 0.1 M sodium
cacodylate buffer for 1 hour. Samples were washed in deionized water, dehydrated
through an ethanol series, transferred to propylene oxide, infiltrated and
embedded in Polybed 812 resin (Polysciences, Inc., Warrington, PA). 70 nm
ultrathin sections were post-stained in 4% aqueous uranyl acetate and 0.4% lead
citrate. Samples were examined and photographed using a Zeiss EM-10A
transmission electron microscope (LEO Electron Microscopy, Thornwood, NY) with
an accelerating voltage of 60 kV.
## ATP assay
ATP concentration in sperm was measured using an ATP Bioluminescence Assay Kit
CLS II (Roche Diagnostics, Mannheim, Germany) according to manufacturer's
instructions. Luminescence was measured using a 1420 VICTOR<sup>2</sup>
microplate reader (Perkin Elmer, Waltham, MA). ATP concentration was normalized
to number of sperm analyzed.
## CHDH expression
Sperm pellets were lysed in a buffer of 2% w/v SDS, 0.375 M Tris, pH 6.8, 10%
sucrose. Lysates were boiled at 100°C for 5 minutes and clarified by
centrifugation at 16.1× *g* for 10 minutes at 4°C. Protein concentration was
determined by the BCA protein assay (Pierce/Thermo Scientific, Rockford, IL). 10
µg of protein lysate were resolved by SDS-PAGE and transferred to PVDF membrane
(Bio-Rad, Hercules, CA). Primary human hepatocyte lots, screened for rs12676
genotype as described above, were purchased from Zen-Bio, Inc. (Research
Triangle Park, NC). Three lots for each rs12676 genotype were obtained and
lysates were made in radioimmunoprecipitation assay (RIPA) buffer and protein
concentration measured using the BCA assay. Equal volumes of lysate (80–200 µg
protein) were resolved by SDS-PAGE and transferred to PVDF as described above.
The membrane was incubated with anti-CHDH antibody (1∶1000 dilution in 5%
BSA/PBS-T; ProteinTech Group, Inc., Chicago, IL) at 4°C overnight. A 1∶10,000
dilution of HRP-conjugated anti-rabbit secondary antibody (Millipore, Billerica,
MA) was incubated with the membrane for 1 hour at room temperature and bands
detected with enhanced chemiluminescence (SuperSignal® West Pico ECL, Thermo
Scientific, Rockford, IL). The number of pixels in the CHDH band was quantitated
using the lasso tool in Adobe Photoshop (Adobe Photoshop CS3 Extended v.10.0.1)
and the number of pixels per microgram of total protein loaded was calculated.
As an external control for protein integrity, the abundance of ∝-TUBULIN (sperm)
or ß-ACTIN protein (hepatocytes) was determined using mouse monoclonal
antibodies (anti-alpha-tubulin antibody: 1∶2000 dilution in 5% BSA/PBST (Sigma
Aldrich, St.Louis, MO); anti-beta-actin antibody: 1∶10,000 dilution in 5%
BSA/PBS-T; Abcam, Cambridge, MA) and an HRP-conjugated goat anti-mouse secondary
antibody (1∶5000 dilution in 5% BSA/PBS-T; Abcam, Cambridge, MA)
## Plasma and sperm choline metabolite analyses
The concentrations of choline and its metabolites \[choline, betaine,
glycerophosphocholine (GPCho), phosphatidylcholine (PtdCho), and sphingomyelin
(SM)\] in plasma and sperm were measured by liquid-chromatography ionization-
isotope dilution mass spectrometry (LC-ESI-IDMS) as previously described.
Phosphocholine was not detected in either plasma or sperm. GPCho was not
detected in plasma. SM was not detected in sperm. Plasma samples were collected
from the entire screened population on Day 1. Three million sperm per subject
were pelleted and flash frozen in liquid nitrogen on Day 2.
## Statistical analyses
Statistical differences among genotypes were determined using JMP 9.0 software
(SAS Institute, Cary, NC) using ANOVA and Tukey-Kramer HSD. Statistical tests
were performed on log 10 transformed data for semen volume, total sperm per
ejaculate and sperm concentration as these data failed a Shapiro -Wilk test of
normality. Only data from sperm recorded for at least 3 seconds were included in
motility statistical analyses. In order to address the intra-individual
variation in the sperm motility data the following method was used to determine
statistical differences. For each continuous measure (MT, MVUS, VCL and VSL)
cutpoints for quartiles were determined from all observations having the wild
type/wild type (WW) genotype for that SNP. Then using those cutpoints, all
observations were placed into a quartile and an association between SNP level
and the most extreme quartiles (1 and 4) was assessed via a repeated measures
logistic regression with quartile (1 or 4) as the response and SNP as the
predictor. The repeated measures on subject were taken into account by using a
compound symmetric correlation matrix for observations within the same subject.
P-values less than 0.05 were considered statistically significant.
# Results
## rs12676 and rs1025689 distribution frequencies
rs12676 and rs1025689 distribution frequencies were calculated for the
population of men screened for inclusion in this study. For rs12676, 52% of
subjects were GG, 41% were GT and 7% were TT. For rs102689, 22% were GG, 48%
were GC and 30% were CC. These results are in agreement with published data
regarding these two SNPs. It is important to note that 100% of men who were
homozygous for rs12676 had at least one minor C allele of rs1025689; 83% of men
with the TT rs12676 genotype were also CC for rs1025689. In addition, 91% of men
who were GT for rs12676 had at least 1 C allele for rs1025689.
## Study population
Average age, average number of biological children per subject and occurrence of
abnormal semen characteristic or infertility were calculated from self-reported
information provided by the health questionnaire form completed on Day 1. The
average age of the entire screened population was 33.5 years and subject age
ranged from 18 to 76 years. The average number of biological children per
subject was calculated by dividing the total number of children per genotype by
the number of subjects who answered this question. Men who were TT for rs12676
reported the lowest number of biological children per subject (0.33) while men
who were wild type for rs1025689 reported the highest (0.94). 33% (2 of 6) of
men with rs12676 TT genotype reported semen abnormalities or infertility; these
were reported by 9.7% (4 of 41) of men who were wild type for rs12676. For
rs1025689, 11.7% (2 of 17) of GG, 5.2% (2 of 38) of GC and 8.3% (2 of 24) of CC
subjects reported semen abnormalities or infertility.
## Semen parameters
rs12676 genotype was not associated with changes in semen volume, number of
sperm per ejaculate or sperm concentration. Men who were homozygous for
rs1025689 had decreased sperm concentration compared to men who were
heterozygous for this SNP. Mean values for these parameters were all within the
normal range expected of the general human population. All results were above
the World Health Organization 5% lower reference limit for semen parameters from
the general population except for total sperm per ejaculate and sperm
concentration for men who were CC for rs1025689.
## Sperm motility characteristics
Sperm from men who were homozygous for rs12676 had increased curvilinear
velocity and tortuosity when compared to sperm from men who were wild type for
this SNP. Sperm produced by men with the GT genotype for rs12676 traveled
greater distances at a faster rate and had more tortuous paths than sperm
collected from men who were GG for this SNP. No differences between sperm from
heterozygous and homozygous subjects were detected.
Sperm from men who were CC for rs1025689 had increased average velocity as well
as curvilinear and straight line velocity when compared to sperm collected from
men who were wild type for this SNP. Men who were homozygous for rs1025689
produced sperm that traveled in more tortuous paths (i.e. less progressively
motile) as compared to sperm from men who were heterozygous for this SNP.
Subjects who were GC for rs1205689 produced sperm with higher measures of
average velocity, curvilinear and straight line velocity compared to sperm from
men with the GG genotype. Tortuosity was decreased in sperm from heterozygous
men compared to sperm from men who were CC for rs1025689.
## Sperm mitochondrial ultrastructure and energy levels
Abnormal mitochondrial structure was observed in sperm collected from men who
have two copies of the rs12676 minor allele. Mitochondria in the midpiece of
these sperm appeared swollen with disordered cristae structure. Sperm from men
with one allele of rs12676 (GT) have 40% less ATP than sperm produced by men who
are GG for this SNP. Men carrying two alleles of the SNP (TT) produce sperm with
73% less ATP than men who are GG. 83% of subjects who were homozygous for
rs12676 were also homozygous for rs1025689, but when mitochondrial morphology
and ATP concentrations were analyzed in men who were homozygous for rs1025689
only, and we found there was no relationship between rs1025689 genotype and
these measures.
## CHDH protein expression
CHDH protein expression, relative to ∝-TUBULIN expression, was decreased in
sperm produced by men who had one or two alleles of rs12676. This effect was
observed in non-reproductive tissues as well; individuals who harbor the TT
rs12676 genotype had a lower CHDH protein in their hepatocytes compared to
individuals who were GG for this SNP. The CHDH protein levels in GT hepatocytes
were not significantly changed from either GG or TT hepatocytes. Both ∝-TUBULIN
and β-ACTIN protein expression was not changed among the genotypic groups (not
shown).
## Plasma choline metabolite concentrations
Choline metabolite concentrations in plasma and sperm were measured using LC-
ESI-IDMS. Men who were homozygous for rs12676 minor allele had a small, but
significant increase in plasma free choline concentrations. There were no
differences in plasma betaine, PtdCho or SM among the other rs12676 or rs1025689
genotypes. There was no effect of rs12676 genotype on sperm choline metabolite
concentrations. Sperm from men who were CC for rs1025689 produced sperm with
decreased betaine, GPCho and PtdCho concentrations compared to sperm produced by
men who were GC for this SNP.
# Discussion
We previously reported the novel finding that *Chdh* deletion in mice resulted
in male infertility due to compromised sperm motility. We now present evidence
demonstrating that this discovery translates, in part, to humans. A common SNP
in the human *CHDH* gene, rs12676, is associated with altered sperm motility
patterns, dysmorphic mitochondrial ultrastructure and a significant reduction in
ATP concentrations in sperm. Humans who were heterozygous or homozygous for this
SNP had less CHDH protein in their sperm. Interestingly, this association also
was observed in hepatocytes from individuals who were homozygous for this SNP.
Further studies are required to determine whether this is a result of decreased
*CHDH* mRNA translation or increased CHDH protein degradation. Either way, this
data suggests that rs12676 is a functional SNP, or that it is a tag SNP that
marks a functional haplotype of the *CHDH* gene. In addition, rs1025689, a SNP
located in the adjacent *IL17βR* gene that is highly associated with increased
susceptibility to dietary choline deficiency in men, is correlated with changes
in sperm motility patterns and reduction of betaine, GPCho and PtdCho
concentrations in sperm.
The allele frequency distributions of the screened population for both rs12676
and rs1025689 were in agreement with previously reported frequencies. The
average age among the genotypic groups was not significantly different;
therefore, we conclude that any changes detected in semen characteristics or
sperm cell function were not due to differences in age among the groups. The
rs12676 TT genotype group reported the lowest number of biological children per
subject (0.33) and the highest rate of semen abnormality/infertility diagnosis
(33%) of all groups, which suggests that men with the TT genotype may be
subfertile.
Interestingly, subjects who were homozygous for rs12676 had higher free choline
concentrations in their plasma. Although plasma choline is not a direct measure
of choline concentrations within tissues, it is a reflection of tissue
concentrations. An increase in free choline would be expected with a decrease in
CHDH activity as less choline would be converted to betaine. We did not detect a
decrease in betaine in these men, probably because we did not require that the
subjects to fast prior to their blood draw and betaine can be obtained from the
diet.
Sperm from men who harbor at least one minor allele of rs12676 were less
progressively motile, as indicated by an increase in curvilinear velocity and
tortuosity. Mean velocity was significantly increased in sperm from heterozygous
and homozygous subjects. Hyperactivated sperm are those displaying motility
patterns characterized by vigorous, non-linear trajectories and are in contrast
to progressively motile sperm which move forward in a somewhat linear path.
Sperm released from the cauda epididymis typically are progressively motile at
first and transition to hyperactivated motility when incubated in media
formulated to support this process. Sperm collected from the female reproductive
tract are generally hyperactivated. Although the HTF medium used to wash the
sperm in our experiments is designed to mimic the environment of the female
reproductive tract, we cannot definitively state whether the observed changes in
motility patterns with respect to rs12676 genotype were the result of premature
hyperactivation or a decrease in progressive motility. HTF media provides all
metabolic substrates required for capacitation and hyperactivation and it is
reasonable to assume that the sperm used for the motility analyses could have
achieved hyperactivation. Sperm produced by men who were GC for rs1025689 were
more progressively motile than sperm from men who were either GG or CC for this
SNP.
rs12676, but not rs1025689, was associated with dysmorphic mitochondrial
structure. ATP concentration was inversely correlated, in a dose-dependent
manner, with the number of rs12676 minor alleles. Although the exact mechanism
causing these changes remains unknown, these results are very similar to those
we observed in the *Chdh<sup>−/−</sup>* mice. ATP is required for sperm to be
motile, but considerable controversy surrounds the source of the ATP used for
this function. Because mitochondria are only found in the sperm midpiece, there
is some question as to whether ATP generated by oxidative phosphorylation
(OXPHOS) can diffuse the length of the tail to supply substrate for the dynein
ATPases. A creatine phosphate shuttle system has been proposed that may traffic
ATP from mitochondria through the tail, but experimental evidence supporting the
existence of this mechanism is still lacking. Alternatively, glycolytic enzymes
are localized to the principal piece of the sperm tail, thus providing a source
of ATP at the site in which it will be used. In most species there is evidence
that both pathways are active in sperm cells; however, the relative importance
of each pathway differs among species. For example, OXPHOS-derived ATP supports
bull and ram sperm motility, while mouse sperm has a definitive need for
glycolytic generation of ATP for motility. Surprisingly, sperm produced by
*Chdh<sup>−/−</sup>* mice are characterized by a reduction in both mitochondrial
oxygen consumption rates – an indication of OXPHOS activity – and glycolytic
rates indicating that loss of CHDH function perturbs the energy homeostasis in
these cells, thus resulting in an overall decrease in ATP concentration.
It is possible that the betaine molecule itself plays an important role in
maintaining testicular and sperm cell function and, in particular, spermatic ATP
concentrations. Dietary betaine supplementation of *Chdh<sup>−/−</sup>* male
mice resulted in total restoration of ATP levels in sperm and an increase in
progressive motility of these cells. Betaine is an organic osmolyte used by
cells for protection during times of osmotic stress. Sperm mature as they move
from the lumen of the testis and through the caput, corpus and cauda regions of
the epididymis. During transit, sperm accumulate molecules found within the
epididymal environment including organic osmolytes such as glycerophosphocholine
and carnitine. We measured betaine concentrations in the mouse epididymis and
found levels 10 times greater than those measured in liver. The epididymal
environment is relatively hyperosmotic (∼340 mmol/kg). In comparison, the
osmolality of unliquified whole semen and of the fluid in the female
reproductive tract is approximately 276–302 mmol/kg, indicating that epididymal
sperm experience an osmotic “challenge" within the male urethra. An inability to
regulate volume in response to the varied osmotic environments would render
sperm susceptible to swelling which can impair motility.
Evidence exists that links betaine to sperm motility. Preserving normal motility
characteristics in sperm that have been frozen and thawed is an active area of
research both in the fields of human andrology and veterinary animal husbandry.
Kroskinen, et al and Sanchez-Partida et al reported increased sperm motility in
thawed sperm when betaine was added to the cryopreservation media. It is
hypothesized that betaine may directly interact with membrane lipids and
proteins, altering the hydration status of these molecules, and thus protecting
them through the freeze/thaw cycle.
Changes in sperm membrane phospholipid composition may also contribute to
abnormal sperm cell function. For example, *Chdh<sup>−/−</sup>* sperm have half
as much PtdCho and GPCho (a metabolite formed from PtdCho) when compared to
*Chdh<sup>+/+</sup>* sperm. Increased osmotic stress due to a lack of betaine
may account for this via activation of phospholipase A<sub>2</sub>
(PLA<sub>2</sub>). PLA<sub>2</sub>, highly expressed in sperm and activated by
osmotic stress, catalyzes the hydrolysis of the fatty acid in the sn-2 position
of PtdCho resulting in the release of the fatty acid and generation of lyso-
PtdCho. The fatty acids in this position tend to be docosahexanoic acid (DHA)
and arachidonic acid (AA). All of these molecules have been shown to inhibit
sperm motility. Sperm produced by men who were CC for rs1025689 contained less
betaine, PtdCho and GPCho.
rs1025689 is a synonomous SNP located in the coding region of human *IL17βR*. In
a separate study, men who were homozygous for the minor C allele, were more
likely to develop signs of liver or muscle dysfunction when ingesting a choline-
deficient diet. Because the presence of this SNP does not result in an amino
acid change, it most likely tags a functional haplotype within this gene. *CHDH*
and *IL17βR* are situated in a head-to-head orientation on opposite strands on
human chromosome 3 and mouse chromosome 14. According to available data, rs12676
and rs1025689 are not in linkage disequilibrium; however, we noted a high degree
of concurrence of these SNPs within our study population. Although we are not
aware of any reports of copy number variations in the choline dehydrogenase gene
locus, it is also possible this occurs and should be investigated in future
studies. Because they share a promoter region, it is likely that transcriptional
regulation of *CHDH* and *IL17βR* are similar. For example, transcription of
these genes is enhanced by estrogen; an estrogen response element is located
within the shared promoter region. Aberrant expression of *CHDH* and *IL17βR*
has been associated with breast cancer survival prognosis. Ours is the first
report linking the function of this chromosomal region to male sperm cell
function.
In this study, rs12676 is the primary predictor of abnormal sperm mitochondrial
morphology and ATP concentration and this is strengthened by the finding that
CHDH protein expression is decreased in sperm from men who were GT or TT, and
hepatocytes from individuals who were TT, for this variation. No changes in
mitochondrial ultrastructure or ATP level were detected in sperm from
individuals who were CC for rs1205689, but not TT for rs12676. Together, this
evidence indicates that altered CHDH activity due to rs12676 genotype may be an
underlying cause of iodiopathic male factor infertility in men. This is an
especially interesting finding because deficits in CHDH function may be overcome
by dietary supplementation with betaine. Indeed, as noted above, sperm motility
and ATP concentration were improved in *Chdh<sup>−/−</sup>* male mice ingesting
betaine-supplemented drinking water.
# Supporting Information
We would like to thank Ms. Tondra Belevins and Ms. Julia Loewenthal, as well as
the staff of the Nutrition Research Institute and the Kannapolis, NC police
department, for their assistance in completing this study. The authors would
like to extend special appreciation to the study subjects for their willing
participation. We thank Dr. Kerry-Ann da Costa for the information regarding SNP
rs1025689.
[^1]: Conceived and designed the experiments: ARJ SHZ. Performed the
experiments: ARJ SL TW. Analyzed the data: ARJ JAG SHZ. Wrote the paper: ARJ
SHZ.
[^2]: The authors have declared that no competing interests exist.
|
# Introduction
Idiopathic pulmonary fibrosis (IPF) is usually a lethal lung disease; patient
survival after diagnosis varies around 3 years, thus being worse than that in
many cancers, although similar to that in lung cancer. Indeed, IPF has
been occasionally referred to as a malignant lung fibrosis. The principal
underlying molecular mechanisms of IPF have remained unresolved and no effective
curative pharmacological treatment is available.
IPF and lung cancer share common risk factors, like smoking, and patients with
IPF have been shown to be at a greater risk to develop a lung carcinoma as
compared to general population. Furthermore, a tyrosine kinase inhibitor, namely
nintedanib is used in the treatment of both IPF and lung cancer and moreover,
myofibroblasts, are believed to act as principal pathogenetic cell types both in
IPF and lung cancer.
The gene expressions of IPF and lung cancer have been previously evaluated
mostly with microarray studies performed on RNA isolated from whole lung
tissues. A few studies have used cultured stromal cells derived from IPF and
normal lung tissues. Stromal cells from lung cancer have been investigated in
only one microarray analysis. However, differences in gene expression profiles
between cultured stromal cells derived from IPF and lung adenocarcinoma (ADC)
have not been investigated previously in the same study.
Comparing IPF with lung cancer may provide clues to develop new therapeutic
strategies for both diseases. Thus, we aimed to quantify the gene expressions of
fibroblasts isolated from the patients with ADC from tumor and the corresponding
normal lung as well as from IPF by microarray analysis. We wanted to evaluate
even slight differences in gene expression of extracellular matrix (ECM)
associated factors, also called as the matrisome, between (myo)fibroblasts
derived from IPF, ADC and normal lung. The expression of collagen type IV alpha
1 chain (collagen α1(IV), gene name *COL4A1*), periostin (PN, gene name *POSTN*)
as well as matrix metalloproteinase-1 (MMP-1, gene name *MMP1*) and matrix
metalloproteinase-3 (MMP-3, gene name *MMP3*) were further studied with
quantitative real-time reverse transcriptase polymerase chain reaction (qRT-
PCR). Furthermore, the cell-specific expression of all of the above-mentioned
ECM associated proteins was analyzed by immunohistochemistry (IHC).
# Materials and methods
## Patients, primary lung fibroblasts and lung tissue samples
Stromal cells were cultured from tumor and corresponding tumor-free peripheral
lung of the ADC patients undergoing lung cancer-resection surgery (n = 4), and
from surgical lung biopsy samples of the patients with IPF (n = 3) in Oulu
University Hospital. In addition, one IPF sample was derived from peripheral
lung outside the tumor from a patient operated for lung cancer (n = 1). Control
samples were derived from histologically normal lung tissues from non-smoking
patients being operated for lung cancer.
Tissue samples were processed, and cells were cultured as described previously.
Briefly, the cells were cultured in medium consisting of Minimum essential
medium Eagle α modification (Sigma-Aldrich, Steinheim, Germany) supplemented
with 13% heat-inactivated fetal bovine serum (FBS-Good, Pan Biotech, Aidenbach,
Germany), 2 mM L-glutamine, 100 U/ml penicillin, 0.1 g/l streptomycin, 2.5 mg/l
amphotericin B and 10 mM HEPES (all from Sigma-Aldrich). These cell lines are
composed of both fibroblasts and myofibroblasts as previously described in our
electron microscopic analyses. Cells were passaged at near confluency and used
for experiments in passages 2–6. In the microarray and qRT-PCR analysis, cells
were plated at density of 2000 cells /cm<sup>2</sup> and cultured for 72 hours.
For IHC, lung tissue samples were obtained from the same patients whose cells
were used in microarray-analysis. In addition, lung tissue samples were analyzed
from surgical lung biopsies of 10 IPF patients as well as from 10 lung ADC
patients undergoing cancer-resection surgery. Eight out of 9 normal peripheral
lung samples were taken from the same patients who provided the cancer samples.
Thus, 14 IPF, 14 ADC and 13 normal control samples were analyzed by IHC.
The Ethical Committee of Northern Ostrobothnia Hospital District in Oulu gave a
favorable statement of the study protocol (64/2001, amendments 68/2005, 2/2008,
12/2014, 1/2015, 2/2018). All the patients gave their written informed consent.
Paraffin embedded tissue samples have been approved for research use by National
Supervisory Authority for Welfare and Health (reg. nr. 7323/05.01.00.06/2009 and
863/04/047/08).
## Microarray analysis
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions and the concentration was measured
using the NanoDrop spectrophotometry system (Thermo Fisher Scientific, Vilnius,
Lithuania). The quality of RNA was analyzed with a Qiaxcel electrophoresis
system (Qiagen). Microarray experiment was performed in Biocenter Oulu
Sequencing Center core facility. Biotinylated cRNA were prepared from total RNA
by using a 3’IVT Express Kit (Affymetrix Inc., Santa Clara, CA) according to the
manufacturer’s instructions. After labeling, cRNA was hybridized to Affymetrix
human hgu133Aplus2 chips. After hybridization, the microarray chip was washed
and stained on an Affymetrix GeneChip Fluidics Station 450, according to the
manufacturer’s instructions. The chips were then scanned using the Affymetrix
GeneChip Scanner 3000 7G. An analysis of the microarray expression data was done
using the R/Bioconductor through a graphical user interface, Chipster (3.12.5,
CSC, Finland, <http://chipster.csc.fi/>). Normalization was performed using a
custom chip description file for hgu133Aplus2. Intensity data were
log<sub>2</sub>-transformed, and quantile normalized using robust multi-array
average (RMA). Statistical analysis was performed with Chipster using empirical
Bayes. Benjamini-Hochberg was used as multiple correction for false discovery
rate. Lists of differentially expressed genes between different groups were
generated using a log<sub>2</sub> fold change lower than -1 or higher than 1.
Microarray data has been deposited in the Gene Expression Omnibus repository
(<http://www.ncbi.nlm.nih.gov/geo>) with accession number GSE144338.
Differentially expressed genes were annotated using Matrisome annotator. With
this tool each entry is annotated as being or not being part of the matrisome
and will be tagged with matrisome division (core matrisome vs matrisome-
associated) and category (ECM glycoproteins, collagens, proteoglycans, ECM-
affiliated proteins, ECM regulators, or secreted factors).
## Quantitative real-time reverse transcriptase polymerase chain reaction
Quantitative RT-PCR was performed to confirm the expression of differentially
expressed genes in the same primary lung fibroblast cells as used in the
microarray analysis. Total RNA was extracted as described above in the
Microarray analysis experiments. One-μg aliquots of RNA were reverse-transcribed
using RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). PCR
amplification was performed in triplicate as previously described, and the
threshold cycle values were averaged. Reactions were performed by using iQTM
SYBR Green Supermix (Bio-Rad Laboratories, Inc., USA). Non-template controls
were included for each gene. Samples were processed for qRT-PCR using CFX
Connect<sup>TM</sup> Real-Time PCR Detection System (Bio-Rad Laboratories) in
the following conditions: 95°C for 3 min, 40 cycles at 95°C for 10 s, annealing
phase (temperature specific for each primer pair, see) for 10 s and 72°C for 15
s, and a final extension phase of 72°C for 2 min. The melt curve was created in
the following way: 81 cycles from 55°C with 0.5 degree increments every 5 s to
95°C. Relative gene expressions were quantified by using the 2<sup>-ΔΔCT</sup>
Livak method. Gene expression levels were normalized to glyceraldehyde
3-phosphate dehydrogenase (*GAPDH*) or to hydroxymethylbilane synthase (*HMBS*)
to confirm that the data are reproducible. The normalized values were compared
to the average ΔC<sub>T</sub> value of the control cell lines to calculate the
fold changes. Two independent experiments were performed, and fold changes of
each cell line were averaged.
## Immunohistochemistry
IHC stainings were performed in serial tissue sections. The antibodies used in
this study are listed in. Formalin-fixed and paraffin-embedded lung specimens
were cut into 4-μm sections, de-paraffinized in xylene and rehydrated in a
descending ethanol series. After microwave- or enzyme-stimulated antigen
retrieval endogenous peroxidase was blocked with aqueous 0.3%
H<sub>2</sub>O<sub>2</sub> (Peroxidase-Blocking Solution, Dako, Glostrup,
Denmark) for 10 min. Stainings were performed using Envision+ System Kit (Dako)
with DAB 3,3’ diaminobenzidine chromogen. Counterstaining was performed with
Mayer’s hematoxylin (Sigma-Aldrich). Phosphate-buffered saline, mouse and rabbit
isotype controls (Invitrogen, Carlsbad, USA) were used as negative controls.
In order to identify the phenotype of the cells expressing collagen α1(IV), PN,
MMP-1 and MMP-3, all cases were also studied for the markers of macrophages and
monocyte lineage cells (cluster of differentiation 68, CD68), type II
pneumocytes (thyroid transcription factor 1, TTF-1), endothelial cells (CD31)
and myofibroblasts (alpha-smooth muscle actin, α-SMA).
## Scoring of the immunoreactivity
The extent of the immunoreactivity for collagen α1(IV), PN, MMP-1 and MMP-3 was
scored as negative or positive (+) in stromal cells with widened alveolar tips,
fibroblast foci and tumor stroma. Additionally, immunoreactivity was evaluated
in alveolar epithelium, smooth muscle cells, alveolar macrophages, endothelial
cells, epithelial cells of the bronchiole and cancer cells.
## Statistical analyses
Statistical analyses for qRT-PCR were performed by Statistical Package for the
Social Sciences (SPSS; version 25.0, Chigago, IL, USA) using Mann Whitney U test
when comparing IPF and control samples and Wilcoxon Signed Rank Test when
comparing ADC and control samples. Values of P\<0.05 were considered as
significant.
# Results
## The different mRNA expression of several ECM genes in stromal cells of IPF, ADC and normal lung
Using an Affymetrix platform (U133Aplus2), we determined gene expression levels
in fibroblasts prepared from lung tissue of 4 patients with IPF, 4 patients with
ADC as well as in 4 control samples consisting of histologically normal looking
lung collected outside of the tumor. We observed modest differences between
groups, but due to the small sample size, statistical significances were not
achieved. With our selection criteria (log<sub>2</sub> fold change lower than -1
or higher than 1) 36 genes between primary fibroblasts derived from ADC and
normal lung, 157 genes between IPF and normal lung and 152 genes between IPF and
ADC were differentially expressed (– Tables). Fourteen genes (*LINC01116*,
*GPNMB*, *CSTA*, *S100A4*, *CHI3L1*, *TIMP3*, *VAMP8*, *HOXC6*, *MEOX2*, *CD36*,
*POSTN*, *CRLF1*, *SERPINF1*, *ST6GALNAC5*) were up-regulated in both IPF and
ADC and six genes (*CHRDL1*, *TRIM55*, *ACAN*, *CHRM2*, *PCOLCE2*, *RARRES1*)
were down-regulated in both IPF and ADC in comparison to control. Forty
matrisome genes were altered in IPF and 15 in ADC as compared to control.
Matrisome genes annotated with Matrisome Annotator are shown in and Tables. Of
the matrisome genes *COL4A1* was down-regulated in IPF compared to ADC and
control, *POSTN* was up-regulated in IPF and ADC compared to control, *MMP1* and
*MMP3* were up-regulated in IPF compared to ADC and control, and because of
their differential expression profiles they were chosen for the present
research.
Microarray results were confirmed by qRT-PCR on selected ECM genes *COL4A1*,
*POSTN*, *MMP1* and *MMP3*. These factors were differentially expressed between
IPF, ADC and normal lung and they might have a role in fibrosis. The mRNA levels
of *COL4A1*, *POSTN*, *MMP1* and *MMP3* normalized to those of *GAPDH* or *HMBS*
showed a trend in the direction of a change observed in the microarray results
although statistical significance was not achieved due to the small sample size.
As compared to controls, *COL4A1* mRNA expressions were 41% in IPF and 85% in
ADC when those of *POSTN* in IPF and ADC were 308% and 191%, respectively.
*MMP1* and *MMP3* expressions in IPF were 238% and 221%, respectively, and in
ADC 84% and 90%, respectively, compared to control.
## Collagen α1(IV), PN, MMP-1 and MMP-3 were localized in stromal cells of IPF and ADC in immunohistochemistry
IHC was used to confirm the expression of collagen α1(IV), PN, MMP-1 and MMP-3
at the protein level in stromal cells within lung tissues. In particular, we
evaluated the expression of these ECM proteins in fibroblast foci of IPF, tumor
stroma of ADC, and widened alveolar tips of normal lung, since these areas
contain abundant fibroblasts and myofibroblast. Widened alveolar tips were
defined as widened endings of free interalveolar septa as previously described.
shows the IHC expression of markers of macrophages and monocyte lineage cells
(CD68), type II pneumocytes (TTF-1), endothelial cells (CD31) and myofibroblasts
(α-SMA).
Strong expression of collagen α1(IV) was observed extracellularly within stromal
cells of the widened alveolar tips in control lung. Collagen α1(IV) was also
localized in the basement membranes of alveolar epithelium and endothelium,
smooth muscle cells and in a few cases, a weak expression was observed in
bronchiolar epithelial cells and alveolar macrophages. In IPF, collagen α1(IV)
was expressed extracellularly in the stromal cells of fibroblast foci, while a
very weak immunoreactivity was observed in the hyperplastic alveolar epithelium
lining fibroblast foci. A strong collagen α1(IV) expression was observed within
stromal cells in ADC while a weak expression was detected in the cancer cells in
a few cases.
PN was observed extracellularly in some widened alveolar tips of normal control
lungs, within alveolar epithelial cells and the bronchiolar basement membrane
zone, but not in bronchiolar epithelial cells, smooth muscle cells or alveolar
macrophages. In IPF, the strongest expression of PN was observed in stromal
cells within fibroblast foci. In ADC, PN was observed in tumor stroma, but not
in the cancer cells.
A very weak extracellular MMP-1 immunoreactivity was observed occasionally in
widened alveolar tips and smooth muscle cells in controls when a strong MMP-1
expression was detected in the alveolar macrophages, some alveolar epithelial
cells, endothelial cells, and bronchiolar epithelium. Some stromal cells within
fibroblast foci were positive for MMP-1 in IPF with the strongest MMP-1
expression being observed in the hyperplastic alveolar epithelial cells lining
fibroblast foci. Both cancer cells and stromal cells were positive for MMP-1 in
ADC.
Almost negative expression of MMP-3 was detected in some of the widened alveolar
tips within normal control lung. MMP-3 was mainly expressed in alveolar
macrophages and monocyte lineage cells, and bronchiolar epithelial cells. Weak
MMP-3 expression was observed in some alveolar epithelial cells and smooth
muscle cells. Some stromal cells of fibroblast foci were positive for MMP-3 in
IPF and in addition, hyperplastic alveolar epithelial cells were positive. Both
cancer cells and stromal cells were mainly positive for MMP-3 in ADC.
# Discussion
We investigated mRNA expressions in stromal cell lines derived from IPF, ADC and
normal lung by microarray analysis and we observed that 20 genes were similarly
up- or down-regulated in IPF and ADC as compared to control, whereas most of the
altered genes in IPF and ADC were different, including several ECM genes. We
were particularly interested in the ECM associated genes and selected *COL4A1*,
*POSTN*, *MMP1* and *MMP3* since they have been previously shown to be
associated with pulmonary fibrosis. Furthermore, most of the previous studies
have focused on epithelial cells, and not on stromal cells as investigated here.
We concentrated on those genes that revealed a differential expression between
IPF and lung cancer, such as higher expression of *MMP1* and *MMP3* in IPF than
ADC, and lower expression of *COL4A1* in IPF than in ADC. Because the expression
of these factors in lung cancer and IPF has not been previously compared in the
same study, we believe that this kind of protocol may provide novel information.
*POSTN* was chosen as an example of a gene being equally highly expressed both
in IPF and lung ADC.
Previous studies have revealed differences in gene expression between IPF and
lung cancer. A study comparing gene expression in lung tissues by microarray
analysis from five patients with both lung cancer and IPF revealed five genes
e.g. *SMAD4*, *P21*, *MT1A*, *MMP7* and *TIMP1*; these were down-regulated in
cancer tissue in comparison to IPF, in at least two of the patients. Cancer
associated lung fibroblasts have been previously compared to paired normal
fibroblasts; in that study, 46 differentially expressed genes were identified.
Some of these genes e.g. *CHI3L1*, *ST6GALNAC5*, *COL11A1*, *MFAP5*, *TNFSF4*
were identified also in our analysis as differentially expressed genes between
ADC and control or between IPF and control suggesting that at least some disease
related changes in the transcriptome are maintained during *in vitro* culture.
A previous study identified 178 differentially expressed genes in stromal cells
derived from IPF and normal lung. Fourteen of these genes were also
differentially expressed in our comparative analysis between IPF and control,
and two of these genes (*S100A4* and *POSTN*) were also differentially expressed
between ADC and controls. Another study identified 547 genes which were
differentially expressed in IPF compared to controls. Thirty-nine of these genes
were also differentially expressed in our microarray analysis, but not all in
the same direction since only 14 genes were similarly up- or down-regulated in
IPF when compared to our study. Rodriguez *et al*. did not identify any
statistically significant gene expression differences between cultured
fibroblasts derived from either IPF or normal lung, but they observed that the
gene expression of cultured fibroblasts differed from that of non-cultured,
freshly isolated fibroblasts.
Our study identified a down-regulation of *COL4A1* in IPF derived stromal cells
in comparison to control cells and ADC. This finding is different from published
microarray-based and RNA sequencing studies, in which *COL4A1* was found as an
up-regulated gene in fibroblasts and tissues derived from IPF patients as
compared to control. Collagen IV expression has been shown to localize in the
fibroblast foci and early fibrotic lesions of IPF, findings which are supported
by our IHC analysis which detected intense collagen α1(IV) immunoreactivity in
the surrounding spindle shaped cells within fibroblast foci. *COL4A1* expression
in lung cancer has been previously detected in stromal fibroblasts surrounding
tumor cells by mRNA *in situ* hybridization and discontinuous collagen α1(IV)
protein expression has been detected around well-differentiated clusters in
ADCs, results which are similar to the present findings i.e. strong collagen
α1(IV) immunoreactivity in the stroma of ADC. Based on the results of our study
one can speculate that the (myo)fibroblasts might have different abilities to
produce collagen α1(IV) in IPF and ADC.
PN has been previously studied in both IPF and lung cancer, and *POSTN* up-
regulation in both cultured and non-cultured stromal cells derived from IPF as
compared to normal lung fibroblasts has been reported. The gene
expression level of *POSTN* has been shown to be higher also in IPF lung tissues
as compared to normal lungs. We confirmed the previous findings showing that PN
mRNA and protein were up-regulated in both IPF and ADC derived stromal cells.
Similarly to our results, PN immunoreactivity has been observed in areas of
active fibrosis and fibroblast foci in IPF. *POSTN* gene expression has been
claimed to be up-regulated in lung cancer tissues compared to normal lung
tissue, and it has been detected by IHC, in lung cancer stroma but not in cancer
cells, in support of our findings. However, it is still a matter of debate
whether the source of PN is cancer cells or stromal cells surrounding cancer
tissues. Some investigators have claimed that the mRNA expression of *POSTN*
occurs only in stromal cells, or in cancer cells. In lung cancer, *POSTN* mRNA
expression has been detected mainly in the stromal cells surrounding the cancer
cells, whereas very little expression was found in the cancer cells themselves.
We observed that *MMP1* was up-regulated in stromal cells from IPF compared to
ADC, which is a novel finding. *MMP1* gene expression has also been previously
shown to be up-regulated in non-cultured fibroblasts derived from IPF lung.
Several microarray-based studies have revealed that *MMP1* gene expression was
up-regulated in IPF in comparison to normal lung tissues. *MMP1* gene expression
has been shown to be up-regulated also in ADC and squamous cells carcinoma
tissues as compared to normal lung. Previous IHC studies have shown that MMP-1
was expressed mainly in epithelial cells and alveolar macrophages in IPF. In
turn, we observed MMP-1 immunoreactivity also in stromal cells in IPF and ADC,
which results were in line with previous reports.
Several microarray-based studies have reported up-regulated *MMP3* gene
expression lung tissues derived from IPF patients. In normal lung, MMP-3 was
mainly expressed by alveolar macrophages while in IPF, it was expressed in
macrophages, epithelial cells, intravascular leukocytes and fibroblasts. Our
microarray analysis did not identify any differences in *MMP3* gene expression
between stromal cells derived from ADC and normal lung, at odds with a previous
study in which an increased *MMP3* gene expression in ADC and squamous cells
carcinoma was observed. We observed also MMP-3 immunoreactivity in both tumor
cells and stromal cells whereas previous studies have shown stronger MMP-3
expression in tumor cells than in stromal cells in ADC.
The phenotypic changes in the fibroblasts during their passage in culture and
differences in the culture methods might have affected the results as was
previously speculated. Certain disease specific alterations in gene expressions
are not maintained during cell culture conditions and the disappearance of these
differences could be enhanced if cell culture conditions such as cell confluency
are not controlled. Therefore, we adopted stringently controlled conditions from
the very start of the sample collection. The most serious limitation of the
study was the small number of cell lines examined in the microarray study. It is
notable, however, that the numbers of cell lines in the previous published
studies have also been limited. A recent single-cell RNA-sequencing study showed
that human lung fibroblasts are a very heterogeneous population. The
heterogeneity of the original cell populations before culture may also explain
the differences between microarray studies.
Despite the similarities found in gene expressions of IPF and lung ADC, there
were also several differences, suggesting that the molecular changes occurring
in these two lung illnesses are at least partly different. The comparison of IPF
and lung cancer may, however, reveal new information about the pathogenesis of
these severe diseases, which may help to develop new therapies for patients.
# Supporting information
The authors thank Riitta Vuento for her technical assistance.
[^1]: I have read the journal’s policy and the authors of this manuscript
have the following competing interests: R.K. has received a congress travel
stipend from Orion Pharma, a consulting fee from Boehringer-Ingelheim, and
lecture fees from Roche and Boehringer-Ingelheim. This does not alter our
adherence to PLOS ONE policies on sharing data and materials.
[^2]: Current address: Research Unit of Biomedicine, Department of
Pharmacology and Toxicology, University of Oulu, Oulu, Finland
|
# Introduction
Considered the master regulatory cytokine of vasculogenesis and angiogenesis,
vascular endothelial growth factor (VEGF) is evolutionarily highly conserved and
identified throughout all developmental stages. The mammalian VEGF family of
ligands, VEGF-A, VEGF-B, VEGF-C, VEGF-D and placental growth factor (PlGF), bind
to homodimers or heterodimers of the transmembrane tyrosine kinase receptors
VEGFR1 (Flt-1), VEGFR2 (Flk/KDR), or VEGFR3 (Flt-4). In mice, VEGF expression
peaks embryonically in the yolk sac and embryo and steadily declines in all
organs in adults. The loss of a single allele leads to *in utero* lethality
between embryonic days 11 and 12. In contrast, VEGF expression in sheep jejunum
is elevated in term animals compared to fetal stages, suggesting a greater role
during postnatal development. Complex regulation of vasculogenesis and
angiogenesis occurs through alternative splicing of VEGF ligands and receptors,
producing pro-angiogenic and anti-angiogenic isoforms that are implicated in a
host of healthy and diseased states. In mice, alternative splicing of VEGFR1
truncates the intracellular domain and creates a soluble receptor sFlt-1, which
has a high affinity for VEGF-A, thereby reducing its bioavailability.
VEGF signaling biodiversity leads to complex regulation of not only
vasculogenesis and angiogenesis, but cell proliferation, migration, survival and
permeability. VEGF regulates branching morphogenesis in mammalian vasculature,
neurons, lung and pancreas epithelium. In human and mouse, VEGF-C activates
quiescent neural stem cells through VEGFR3 to enter the cell cycle and generate
progenitor cells. Additionally, VEGF-A influences differentiation of mesenchymal
stem cells into osteoblasts and adipocytes by regulating the levels of the
osteoblast and adipocyte transcription factors Runx2 and PPARγ, respectively.
These observations suggest that VEGF has a crucial role in regulation of stem
and progenitor cell populations, independent of vasculogenesis.
The presence of VEGF in the gastrointestinal system of organisms lacking
vascular systems suggests that VEGF may play a crucial role in the maintenance
of homeostasis in multiple organ systems, including the gastrointestinal tract.
Despite a lack of endothelium and blood cells, jellyfish (*podocoryne carnea*)
express a VEGF homolog in their gastrovascular system, suggesting a role for
VEGF in the development of the gastrointestinal system. Intrinsic platelet-
derived growth factor, also known as vascular endothelial growth factor-like
factor (Pvf), is required for homeostasis and differentiation of intestinal stem
cells in the posterior midgut of *Drosophila*. Hyperactivity of Pvf/Pvr drives
intestinal dysplasia, supporting its role as a regulator of intestinal stem
cells. The necessity of VEGF homologs in gastrointestinal development and their
augmentation causing dysplasia suggest an interaction between VEGF and the
intestinal stem cell niche.
Although embryonic VEGF augmentation in gastrointestinal epithelium has been
implicated in the development of neoplasia, the role of VEGF in postnatal small
intestinal development and homeostasis is currently unknown. The goal of this
study is to elucidate the role of VEGF on the postnatal intestinal stem cell
niche in a murine model. Triple transgenic mice were generated with the ability
to augment VEGF in epithelial cells of the gastrointestinal tract in an
inducible manner via the villin promoter (VEGF-Tg) or decrease VEGF
bioavailability through villin-driven overexpression of an inducible soluble
VEGFR-1 (sFlt-Tg).
# Methods
## Generation of Villin<sup>Cre</sup>/rtTA<sup>flox/flox</sup>/tet(o)VEGF and Villin<sup>Cre</sup>/rtTA<sup>flox/flox</sup>/tet(o)s-Flt1 (sFlt-1 mutants) mutant mice, Transgene PCR, and Tissue Collection
Transgenic mice on a C57/B6 background were maintained according to the animal
care facility protocols of the institution with approval by the Children's
Hospital Los Angeles Institutional Animal Care and Use Committee. All mice were
housed in a controlled environment in clean cages, fed mouse chow or doxycycline
chow *ad libitum* with an unlimited source of fresh water. Tail clips were
collected from mice that were P14 or older under isofluorane anesthesia and were
euthanized under CO<sub>2</sub> exposure at P21.
Triple transgenic Villin<sup>Cre</sup>/rtTA<sup>flox/flox</sup>/tet(o)VEGF
mutant mice (VEGF mutants) or
Villin<sup>Cre</sup>/rtTA<sup>flox/flox</sup>/tet(o)s-Flt1 mutant mice (sFlt-1
mutants) were established. Intestine-specific VEGF or sFlt-1 overexpression was
inducible with the administration of oral doxycycline. Villin<sup>Cre</sup> mice
were mated with tet(o) VEGF or tet(o) sFlt-1 mice. Those positive for both genes
were crossed with homozygous rtTA<sup>flox/flox</sup> mice. After birth of a
litter, the mother was fed 625 mg/kg doxycycline chow (Harlan; Cat# TD.110720)
*ad libitum*. The doxycycline chow induced overexpression of VEGF or sFlt-1 in
the pups via the mother’s breast milk.
The mice were genotyped by polymerase chain reaction (PCR) at P14. The pups were
placed under general anesthesia and a small tail clip was acquired. The specimen
was placed into Direct PCR Tail reagent (Viagen Biotech; Cat# 102-T) with 1:100
Proteinase K Solution (Invitrogen; Cat# 25530049) and moved to the 55°C
incubator overnight. The temperature was increased to 85°C in the morning for
one hour, then returned to room temperature. The genotyping PCR mix consisted of
10 μL MyTaq Red Mix (Bioline; Cat# BIO-25043), 0.1 μL 100 μM forward (F) primer,
0.1 μL 100 μM reverse (R) primer (Eurofins MWG Operon), 8.8 μL RNase-free water,
and 1 μL mouse DNA for a total of 20 μL PCR reaction. This was placed in a 0.2
μL PCR tube. PCR was performed in a thermocycler with the temperature
recommended by the manufacturer for the MyTaq Red Mix and appropriate annealing
temperatures. A 1% agarose (Denville Scientific; Cat# CA3510-8) with 1:1000
ethidium bromide (Promega Corporation; Cat# H5041) electrophoresis gel was
prepared and 10 μL of mix was run at 100V for 30 minutes and visualized under a
UV light. The mice that contained one or two alleles were named littermates (LM)
and those containing all three alleles were termed mutants.
The duodenum of the mice was harvested at P21. After euthanization of the mice
in a CO<sub>2</sub> chamber, three matched 5 cm segments of proximal duodenum
were harvested. Samples were placed in 10% formalin (Fisher Scientific;
Cat#305–510), RNAlater (Sigma-Aldrich; R0901), or flash frozen on dry ice and
placed in the -80°C freezer.
## Histology and Immunofluorescence
Formalin-fixed tissue was embedded in paraffin and sectioned at 5 μm. The tissue
was dehydrated in 30% EtOH for 30 minutes, 50% EtOH for 45 minutes, 70% EtOH for
45 minutes, 95% EtOH for 1 hour, 100% EtOH for 1 hour twice. The tissue was then
cleared with toluene twice for 45 minutes, then in 1:1 ratio of paraffin and
toluene overnight at 65°C. The following morning the tissue was placed in pure
paraffin for 1 hour twice and fixed in the cassette on a cooling plate to
solidify. The tissue was then sectioned at 5 μm. Frozen sections were procured
for confocal microscopy to evaluate angiogenesis after intracardiac FITC-dextran
labeling of the vasculature. Tissue was protected from light and placed in 4%
paraformaldehyde overnight at 4°C. The following day, tissue was placed in 30%
sucrose until it sank to the bottom the tube. The tissue was then transferred to
a 1:1 mixture of 30% sucrose:OTC compound overnight at 4°C. Tissue was
subsequently transferred to OTC compound and slowly frozen at -20°C until the
OTC was frozen. Blocks were stored at -80°C until sectioning. Frozen tissue was
sectioned at 60 μm immunofluorescence staining with DAPI was performed as
describe below.
Hematoxylin and eosin (H&E) staining was performed on the sectioned tissue.
Slides were placed in Histochoice (Amresco; H103) twice for 2 minutes, then in
100% EtOH for 2 minutes. The slides were hydrated in 70% EtOH for 30 seconds,
50% EtOH for 30 seconds, 30% EtOH for 30 seconds, and H<sub>2</sub>O for 2
minutes. The slides were placed in hematoxylin for 15 seconds and H<sub>2</sub>O
until clear, followed by eosin for 5 seconds for counterstain. The slides were
dehydrated in 90% EtOH for 1 minute, 100% EtOH for 1 minute and Histochoice for
2 minutes. The slides were imaged at 20x magnification on a brightfield
microscope. Single and multiple clusters of red blood cells (RBCs) were counted
by blind observers as previously described. The villus length, crypt depth,
circumference and number of crypts per intestinal length were measured by a
trained blinded observer with ImageJ.
Immunofluorescence was performed to locate terminal cell markers and
proliferative markers. The slides were placed in Histochoice for 10 minutes
twice. The slides were rehydrated by soaking them sequentially in 100% EtOH, 90%
EtOH, 75% EtOH, 50% ETOH, and 30% EtOH for 5 minutes each. A low pH, citrate-
based Antigen Unmasking Solution (Vector; H-3300) was used to retrieve antigens
in the microwave. The microwave heated the solution for 4 minutes at 50% three
times, with 30 seconds in between each heating session. The solution was cooled
to room temperature for 30 minutes and washed in phosphate-buffered saline
(Gibco; Cat#10010) with 0.1% Tween (Amresco; Cat# 9005-64-5) (PBS-T) for 5
minutes. Universal blocking solution (1% BSA, 0.1% cold fish skin gelatin, 0.5%
Triton-X 100 and 1x PBS) with 2% goat serum (Sigma-Aldrich; Cat# G9023) was
applied for 30 minutes at room temperature. Primary antibodies were diluted in
universal blocking solution with 2% goat serum and placed on tissue overnight at
4°C. In the morning, tissues were washed in PBS-T for 5 minutes three times.
Appropriate Cy3 or Cy5 secondary antibodies diluted in PBS with 0.05% Tween and
applied to tissue for 1 hour at room temperature. The slides were again washed
with PBS-T for 5 minutes three times. The sections were mounted on Vectashield
with DAPI (Vector; Cat# H-1200) and visualized under the fluorescent microscope.
Lysozyme was quantified by percentage of immunofluorescent-positive cells per
hemi-crypt by a trained, blinded observer with ImageJ. Ki-67-positive cells were
counted in the crypt and amplifying zone by the number of positive cells per
position by a trained, blinded observer with ImageJ.
## Confocal Microscopy and Three-Dimensional Volume Reconstruction
VEGF mutant and littermate duodenal cross sections were prepared as described
above and imaged for FITC and DAPI immunofluorescence using a Zeiss LSM 710
confocal microscope. Sixty micron sections were imaged at an individual z stack
thickness of 1 μm to allow for accurate three-dimensional volume reconstruction
using IMARIS software. Confocal images were imported into IMARIS version 7.7.2
and volume reconstruction analysis was performed using region of interest
selection of FITC-labeled vasculature of individual hemivilli. Threshold values
were obtained from littermate controls using autothresholding algorithms and
these values were applied to VEGF mutants to allow for proper comparison of
three-dimensional volume analysis. Sixty villi in total from four individual
mice per group were analyzed.
## VEGF Protein Quantification
Quantification of VEGF protein was executed via enzyme-linked immunosorbent
assay (ELISA) on frozen tissue sections for the VEGF mutants and littermate
controls or serum from VEGF mutant OU culture. Flash frozen duodenal sections
stored at -80°C were selected. The Bradford protein assay method was employed to
determine protein concentration. The frozen tissue was homogenized in 200 μL of
extraction buffer (1M Tris-HCl, 5M NaCl, 10% Triton, 10% NaDeoxycholate, 0.5M
EDTA, 1% PMSF, 10% phosphatase inhibitor, 1% protease inhibitor and distilled
water). The homogenized tissue was centrifuged at 10,000 rpm for 10 minutes at
4°C and the supernatant was transferred to a new 1.5 mL eppendorf tube. The
Bradford reagent was diluted as recommended by the manufacturer. The bovine
serum albumin protein standards (BioRad; Cat# 500–02) and the samples were
prepared in duplicates. These were placed in disposable cuvettes and absorbance
was measured at a wavelength of 595nm in a spectrophotometer (Pharmacia
Ultrospec III). A standard curve was prepared and the concentrations of the
total protein were determined. Mouse VEGF ELISA was performed in duplicates with
the suggested protocol of the manufacturer (Signosis; EA-2401). The absorbance
for the wells were read at 450 nm (PerkinElmer; Cat# Victor<sup>2</sup> 1420)
and a standard curve was plotted to find the concentration of VEGF present in
the tissue. The total VEGF protein concentration (pg/mL) was divided by the
total protein concentration (μg/mL) to determine the amount of VEGF present per
mg of total protein (pg/mg) in tissue samples. VEGF protein concentration in OU
cultures was expressed as ng/ul.
## Reverse Transcription Quantitative Polymerase Chain Reaction
The duodenal or OU samples placed in RNAlater and stored in -80°C were thawed
for RNA extraction. Tissue homogenization was performed with a rotor-stator
homogenizer (Qiagen; TissueRuptor). RNA was extracted with the RNeasy Mini Kit
according to the manufacturer protocol (Qiagen; Cat# 74104) with 350 μL as the
appropriate volume. The concentration and purity of RNA was determined with a
microvolume spectrophotometer (NanoDrop 2000; Thermo Scientific). All samples
had a 260/280 ratio of 2.0 or higher (Mean 2.1 ± 0.01), indicating high purity
of the isolated RNA. Reverse transcription was performed with the cDNA kit (BIO-
RAD; Cat# 170–8896) and the mixture contained 1 μl RNA in a 20 μl reaction
volume. The thermo cycler (BIO-RAD; Cat#C1000) temperatures were set according
to the manufacturer’s recommendations.
VEGF transcript overexpression was confirmed in VEGF mutants with RT-qPCR. SYBR
green was performed for the transgenic VEGF mutants. The cDNA for the VEGF
mutants was employed in this reaction. The reaction contained 7.5 μl of SYBR
Green I Master Mix (Roche; Cat# 0707516001), 0.2 μl Tet(o)-VEGF forward and
reverse primers, 6.1 μl RNase-free water and 1 μl of cDNA. The Roche Lightcycler
480 performed RT-qPCR with 1 cycle at 95°C for 10 minutes, 45 cycles at 94°C for
1 minute followed by 55°C for 1 minute and 72°C for 1 minute each, and 1 cycle
at 40°C for 30 seconds. The reactions were performed in triplicate and single
outliers were removed for quantification. Roche Lightcycler 480 was used to
calculate the relative gene expression of Tet(o)-VEGF related to GAPDH. sFlt-1
transcript was confirmed in sFlt-1 mutants in a similar fashion.
Quantitative PCR was performed with the resulting cDNA in the Roche LightCycler
480 system with hydrolysis probes in a multiplex reaction with GAPDH as a
reference gene. Each reaction contained 0.2 μl GAPDH primers (Roche; Cat#
05046211001), 0.2 μl GAPDH probe (Roche; Cat# 05046211001), 0.2 μl 100 μM left
primer, 0.2μl 100 μM right primer, 0.2 μl hydrolysis probe, 7.5 μl master mix
(Roche; Cat#04707494001), 5.5 μl of RNase free water and 1 μl cDNA. Gene
expression of Bmi1, Lgr5, Atoh1 and Hes1 (n = 6), as well as of Sox9, DII1,
Wdr43, EphB2 and Bmp4 (n = 6) was analyzed for VEGF and mutants. Similarly, gene
expression of Bmi1, Lgr5, Atoh1 and Hes1 (n = 6) and Sox9, DII1, Wdr43, EphB2
and Bmp4 (n = 6) was quantitated in sFlt-1 mutants. To investigate the effect of
VEGF overexpression and suppression on angiogenesis in the postnatal mouse
duodenum, quantitative RT-qPCR was performed for VE-cadherin, a marker of
endothelial-specific cell-cell adherence junctions. The reactions were performed
in clear, 96-well plates (Roche; Cat# 05102413001) under the following
conditions: 1 cycle at 95°C for 10 minutes, 45 cycles at 95°C for 10 seconds
followed by 60°C for 30 seconds and 72°C for 1 second each, and 1 cycle at 40°C
for 30 seconds. Each PCR reaction was run in triplicate and single outliers that
occurred in the technical replicates were removed for quantification. Roche
Lightcycler 480 was used to calculate the relative gene expression of the target
gene over the reference gene with advanced relative quantification calculations.
## Intravascular-Immunofluorescence Labeling by Intracardiac FITC-Dextran Injections
Mice were anesthetized using standard IACUC procedures. Once fully anesthetized,
mice were placed supine with arms and legs extended. Silk tape was placed across
the abdomen and along the upper extremities to secure the animal firmly on the
working surface. The chest was shaved to allow for visualization of the rib
cage. The mice were then prepped and draped in a sterile fashion. A 2mg/ml FITC-
dextran (Sigma FD2000S) solution was made in PBS and protected from light. Using
a 1ml insulin syringe with 26-G needle, 200 μl of air was drawn up into the
barrel followed by 200 μl of FITC-dextran solution. The needle was inserted into
the second intercostal space 3 mm to the left of the sternum, directing the tip
into the center of the chest (45° to the right, 45° to the horizontal plane and
pointing towards the right flank of the mouse) to a depth of 6 mm. Pulsatile
flow of red blood into the hub of the needle indicated correct placement of the
needle into the left ventricle and 200 μl of FITC-dextran solution was injected
per mouse while avoiding the introduction of air bubbles into the circulatory
system. The needle was quickly withdrawn and pressure placed on the chest with
alcohol wipes for 1 minute to prevent extravasation into the chest. Mice were
sacrificed 3 minutes after FITC-dextran injection and intestinal tissue
immediately harvested and fixed in 4% paraformaldehyde.
## Mouse Enteroid Cultures
We isolated mouse enteroids from VEGF mutant mice using a previously establish
protocol. Briefly, crypts were released from murine small intestine by
incubation for 30 min at 4°C in PBS containing 2 mM EDTA. Isolated crypts were
counted and a total of 500 crypts were mixed with 50 μl of Matrigel (BD
Bioscience) and plated in 24-well plates. After Matrigel polymerization occured,
500 μl of crypt culture medium (Advanced DMEM/F12 (Invitrogen) containing growth
factors (10–50 ng/ml EGF (Peprotech), 500 ng/ml R-spondin 1 (R&D systems) and
100 ng/ml Noggin (Peprotech)) was added. For sorting experiments, isolated
crypts were incubated in culture medium for 45 min at 37°C, followed by
trituration with a glass pipette. Dissociated cells were passed through a cell
strainer with a pore size of 20 μm. Growth medium was changed every 4 days.
## Mouse Organoid Units
The VEGF mutant duodenal samples were put into a 10 cm Petri-Dish with cold
Hanks’ balanced salt solution (Life Technologies, Inc.) to clean the luminal
contents. The tissue is then cut into 2x2 mm sections in the Petri-Dish. The
tissue is placed in a 50 mm centrifuge tube and centrifuged for 1 minute at 8000
rpm. The tissue is washed 3 times with cold Hanks’ salt solution, centrifuging
between washes and removing the supernatant. The tissues were then digested with
800 μg/mL collagenase (Worthington) and 0.12 mg/mL dispase (Invitrogen) for 20
minutes. The digestion was stopped by adding high glucose Dulbecco’s Modified
Eagle Medium (DMEM) with 4% Sorbitol (Sigma, Inc.) and 10% fetal bovine serum
(FBS) (Invitrogen). The digestion was triturated with a 10 mL pipette for
approximately 10 minutes. Large debris sediment was removed by centrifugation
and the supernatant was transferred to a 50 mL Falcon tube. The mixture was
centrifuged at 500 rpm for 10 minutes and the supernatant was discarded. The
pellet was resuspended in 2 mL high glucose DMEM with 10% FBS. This solution was
mixed with Matrigel (BD Bioscience) at a ratio of 1:1. 100 μL of the Matrigel-
organoid unit (OU) mixture was placed in each well of a 6-well plate. The plate
was incubated at 37°C for 30 minutes. 2 mL DMEM was then added to each well. The
cultures were incubated overnight at 37°C with 5% CO<sub>2</sub> and medium was
changed on days 1, 3, 5, 7 and 9. Experimental OU had 2 μL of doxycycline added
to the medium, while controls did not. The OU were imaged on days 1, 3, 5, 7,
and 9. On day 10, each well was scraped and individually collected and placed in
a 1.5 mL Eppendorf tube. These tubes were centrigued at 1000 rpm for 1 minute.
The media was then removed and 200 μL of RNAlater was added to the Eppendorf
tube. These were stored at 4°C until RNA extraction was performed as described
above. Diameter of OU were measured on ImageJ by a trained, blinded observer.
# Results
## VEGF overexpression resulted in elevated levels of VEGF mRNA and protein. sFlt-1 overexpression resulted in an increased expression of sFlt-1 in enteroid culture and negative feedback reduction of VEGFR1 receptor in duodenum
Following 21 days of doxycycline induction, triple transgenic VEGF mutants
(VEGF-Tg) were confirmed by demonstrating overexpression of VEGF in the
postnatal mutant duodenum by RT-qPCR and ELISA. VEGF mutant mice displayed a
7.36 ± 1.49 SEM-fold increase in the transgenic VEGF transcript (p = 0.02)
compared to littermates. Similarly, VEGF protein concentration was significantly
higher in VEGF mutant duodenum (512.51 ± 95.69 pg/mg SEM) compared to
littermates (36.81 ± 4.54 pg/mg SEM). This represents a 13.92 ± 2.60 SEM-fold
change (p = 0.008).
Following 21 days of doxycycline induction, the triple transgenic sFlt-1 mutants
(sFlt-Tg) were confirmed by demonstrating expression of sFlt-1 in the postnatal
mutant duodenum and epithelial enteroid culture by RT-qPCR. At 21 days of
doxycycline treatment, sFlt-1 mutants had significantly decreased sFlt-1
expression compared to littermates (1.21 ± 0.19 SEM versus 0.24 ± 0.04 SEM;
p\<0.001). RT-PCR and ELISA of VEGF-A in the duodenum failed to demonstrate a
significant decrease between sFlt-1 mutant duodenum (0.90 ± 0.09 SEM; p = 0.6
and -0.117 pg/mg ± 0.004 SEM; p = 0.88, respectively) versus littermates (0.99 ±
0.14 SEM and -0.123 pg/mg ± 0.003 SEM, respectively). However, sFlt-1 mutant
enteroid cultures demonstrated a significant increase in sFlt-1 expression upon
doxycycline treatment compared to controls (0.958 ± 0.02 SEM versus 0.746 ± 0.09
SEM; p = 0.019). Doxycycline addition in sFlt-1 enteroid culture did not alter
the expression of another VEGF receptor, Flk (0.156 ± 0.02 SEM versus 0.152 ±
0.02 SEM; p = 0.85) and did not promote endothelial cell growth in culture as
enteroid cultures are devoid of endothelium.
## VEGF overexpression resulted in increased villus angiogenesis and taller villi. Reduced VEGF bioavailability produced a shorter, paler intestine with a diminutive cecum and smaller villi with longer, but fewer crypts per measured length
The gross appearances of the duodenum in VEGF mutants and littermates were
distinct. Littermate duodenum was a pink to yellow color compared to a deep red
intestine seen in VEGF mutant mice. Compared to littermates, sFlt-1 mutant mice
were smaller and had decreased body mass (p\<0.001), as well as a swollen anus.
The duodenum of sFlt-1 mutant mice was paler in comparison to littermates
(respectively). The length of the intestine was also shorter with a diminutive
cecum in sFlt-1 mutant mice. The cecum of sFlt-1 mutant mice demonstrated
decreased number of goblet cells compared to littermates (, respectively).
Histological sections by H&E demonstrated significantly higher villus height in
VEGF mutant duodenum at 594.1 ± 19.03 μm SEM compared to littermates at 497.4 ±
32.00 μm SEM (p = 0.03). There was no significant difference in the crypt depth
(87.70 ± 4.47 μm SEM in VEGF mutants versus 77.41 ± 2.92 μm SEM in littermates;
p = 0.08) or in the number of crypts per length measured in VEGF mutants
compared to littermates (2.56 ± 0.14 μm SEM versus 2.77 ± 0.09 μm SEM,
respectively; p = 0.3). No significant difference in duodenal circumference
existed between VEGF mutants and littermates (5.72 ± 0.27 mm SEM versus 5.41 ±
0.19 mm SEM, respectively; p = 0.4).
Duodenum of sFlt-1 mutants displayed shorter villi compared to littermates
(293.3 ± 14.4 μm SEM versus 426.0 ± 11.7 μm SEM, respectively; p\<0.0001) and
taller crypt depth (83.6 ± 3.7 μm SEM versus 64.7 ± 1.7 μm, respectively;
p\<0.0001). There were also significantly fewer crypts per length measured in
sFlt-1 mutants compared to littermates (2.49 ± 0.02 μm SEM versus 2.86 ± 0.12 μm
SEM, respectively; p = 0.03).
## VEGF augmentation in intestinal epithelium leads to increased mucosal angiogenesis and vascular permeability
H&E histological cross sections demonstrated a significant increase in the
amount of single and multiple clusters of RBCs within the villi of VEGF mutant
mice compared to littermates (respectively). Single RBC counts (34.28 ± 3.24 SEM
versus 5.98 ± 0.54 SEM; p\<0.001) and multiple RBC clusters (9.13 ± 0.97 SEM
versus 1.29 ± 0.21 SEM; p\<0.001) per villus were significantly increased in
VEGF mutants compared to littermates, suggestive of increased vascular leak and
angiogenesis. To further evaluate vascular leak and angiogenesis, intracardiac
FITC-dextran injections were performed to label the vasculature and 60 μm cross
sections were imaged using confocal microscopy (, respectively). Three-
dimensional volume reconstruction demonstrated significant increase in
intravillus FITC-dextran volume in VEGF mutants as compared to littermates
(2259000 μm<sup>3</sup> ± 54200 SEM versus 1689083 μm<sup>3</sup> ± 75245 SEM;
p\<0.001).
## VE-cadherin expression significantly increased in VEGF mutants and decreased in sFlt-1 mutants
Given the distinct increase in intravascular volume and vascular leak in the
hemivillus of VEGF mutants, we further explored the effects on endothelial cells
in VEGF and sFlt-1 mutants by performing RT-qPCR for VE-cadherin, an endothelial
cell marker. VEGF mutant mice showed a significant increase in VE-cadherin
expression compared to littermates (p = 0.04), with a 16.5-fold increase in
expression. In contrast, the littermates of sFlt-1 mutants demonstrated
significantly increased expression of VE-cadherin compared to the sFlt-1 mutant
mice (p = 0.01), with a 22.4-fold increase in expression in littermates compared
to sFlt-1 mutants.
## VEGF mutants have increased Ki-67-positive cells per hemivillus extending higher into the transit-amplifying zone, whereas sFlt-1 mutants display Ki-67-positive cells residing lower in the crypt
Duodenal sections of VEGF mutants displayed more Ki-67-positive cells per
hemivillus compared to littermates. In the VEGF mutants, the Ki-67-positive
cells extended to a higher position in the transit-amplifying zone compared to
littermates. sFlt-1 mutants exhibited fewer Ki-67-positive cells per hemivillus
compared to littermates. Ki-67-positive cells were identified lower in the
crypts of sFlt-1 mutants compared to littermates. Caspase 3 staining revealed no
significant difference between VEGF mutants, sFlt-1 mutants and their comparable
littermates.
## sFlt-1 mutants demonstrated an increase in lysozyme-positive Paneth cell population within the intestinal crypts
Immunofluorescence of duodenal sections revealed significantly more lysozyme-
positive cells per hemicrypt in sFlt-1 mutants compared to littermates. The
percentage of lysozyme-positive cells per hemicrypt was 5.70 ± 0.70% SEM for
sFlt-1 mutants compared to 1.036 ± 0.05% SEM (p = 0.0005) for littermates. No
significant difference in lysozyme staining was appreciated in VEGF mutants
compared to littermates (2.14 ± 0.11% SEM versus 1.99 ± 0.29% SEM; p = 0.48).
## VEGF mutants demonstrate a significant decrease in expression of the intestinal stem cell marker Lgr5. sFlt-1 mutants demonstrate reduced Bmi1 and Wdr43 expression and a concomitant increase in EphB2 and Sox9 expression
RT-qPCR was performed for stem/progenitor and early differentiation markers in
VEGF mutant and sFlt-1 mutant mice. These genes included Bmi1, Lgr5, Atoh1,
Hes1, Sox9, DII1, Wdr43, EphB2, and Bmp4. Bmi1 is a marker for slow cycling
intestinal stem cells, typically located at the +4 position. Lgr5, or leucine-
rich repeat-containing G-protein coupled receptor 5, is a marker for rapid
cycling intestinal stem cells, also known as crypt base columnar cells
(CBCs). Atoh1 marks progenitor cells of the secretory lineage, while Hes1 is
expressed in progenitor cells of the absorptive lineage. Dll1 is a marker for
secretory precursors. Sox9 marks CBCs when expressed at low levels or Paneth
cells when expressed at high levels. Wdr43 is a marker for transit-amplifying
cells. EphB2 marks differentiating cells at low levels of expression and
intestinal stem cells and progenitor cells at high levels of expression. Bmp4
inhibits de novo crypt formation and is expressed in the intravillus mesenchyme.
VEGF mutants demonstrated a 0.55 ± 0.12 SEM-fold reduction in Lgr5 expression
compared to littermates (p = 0.04). There was no significant change in other
stem/progenitor cell marker gene expression in VEGF mutants compared to
littermates. sFlt-1 mutants exhibited a 0.42 ± 0.19 SEM-fold reduction in Bmi1
expression (p = 0.03) and a 0.60 ± 0.09 SEM-fold reduction in Wdr43 expression
(p = 0.004) compared to littermates. EphB2 and Sox9 expression were increased
2.47 ± 0.24 SEM fold (p = 0.02) and 1.50 ± 0.09 SEM fold (p = 0.004)
respectively in sFlt-1 mutants compared to littermates.
## VEGF mutant organoid units (OU) exposed to doxycycline are significantly larger than untreated controls. VEGF augmentation in murine OU increases expression of stem/progenitor cell markers Bmi1 and Atoh1 and decreases EphB2 expression
To further isolate the effect of VEGF on the epithelium, we generated OU
cultures from intestinal tissue and induced VEGF overexpression by exposure to
doxycycline. OU contain both epithelium and mesenchyme, but lack a vascular
supply. To evaluate the effect of VEGF overexpression on OU *in vitro*, VEGF
mutant duodenum OU were cultured and the diameters were measured every other day
for 10 days before tissue harvest. OU treated with doxycycline or medium alone
grew over the 10-day period. The doxycycline-treated OU were significantly
larger on day 5 compared to control (164.36 ± 14.43 μm versus 126.11 ± 6.57 μm;
p = 0.04). This difference did not persist after day 5. These findings
correlated with a temporal increase in VEGF protein expression by ELISA over a
period of 5 days in culture. Doxycycline treated OUs from C57/B6 mice
demonstrated no significant size difference over 10 days. After 5 and 10 days of
*in vitro* culture with or without doxycycline, expression of stem cell markers
was evaluated in VEGF mutant OU. At 5 days, a significant increase in Bmi1 (1.14
± 0.13 versus 0.96 ± 0.13; p = 0.03) and Atoh1 (2.54 ± 1.07 versus 1.38 ± 0.60;
p = 0.04) expression and decrease in EphB2 (0.68 ± 0.22 versus 1.11 ± 0.07; p =
0.001) expression was observed in doxycycline-treated VEGF mutant OU compared to
controls. No significant difference in the expression of Lgr5, Bmi1, Sox9,
Atoh1, Dll 1, Hes1, Wdr43, EphB2, or BMP4 was identified between doxycycline-
treated VEGF mutant OU compared to controls at 10 days.
# Discussion
VEGF overexpression and reduced bioavailability had distinct effects on
postnatal small intestine in a murine model. VEGF is excreted in breast milk and
decreased in the intestines of formula-fed murine and human neonates that
succumb to necrotizing enterocolitis. Mesenchymal-driven sFlt-1 mice demonstrate
significant changes in body and organ size at 21 days. Given these findings and
the dramatic phenotype demonstrated in the Villin-Cre VEGF and sFlt-1 mutant
mice at the end of the weaning period, we examined mice at 21 days to address a
physiologically important time period by which VEGF regulation may have the
greatest impact on postnatal gastrointestinal development. VEGF augmentation, as
demonstrated by increased VEGF expression by RT-PCR and ELISA, resulted in a
deep red color of the intestine, which has been previously reported in
transgenic mice that overexpressed VEGF via the villin promoter. The deeper red
color is due to increased vascular leak and angiogenesis. VEGF mutant villi
demonstrated a significant increase in single RBCs seen outside of the villus
vasculature on H&E suggestive of increased vascular permeability or leak , which
has been reported in other models overexpressing VEGF. Three-dimensional volume
reconstruction of FITC-dextran labeled vasculature demonstrated increased FITC-
dextran volume within VEGF mutant villi supporting enhanced angiogenesis and
vascular leak. Taken together with increased VE-cadherin expression by RT-PCR,
there is a notable increase in vascular permeability and angiogenesis in VEGF
mutants. Although previous studies of VEGF augmentation in the small intestine
during embryonic development resulted in the development of epithelial cysts
within the crypts and an increased frequency of intestinal adenomas, we did not
appreciate similar results in our postnatal model. However, postnatal VEGF
overexpression in the colon demonstrated epithelial cysts throughout. The
discordance between the phenotype seen in small intestine versus colon in our
model may result from changes in VEGFR expression levels during postnatal
development. We confirmed that in mice, VEGFR2 expression by immunofluorescence
is greater in colonic epithelium compared to the small intestine. As a result,
we speculate that VEGF augmentation may play a more significant role in the
development of intestinal neoplasia and alteration of stem/progenitor cell
populations during the postnatal period in the colon versus the small intestine.
Our inducible VEGF model may be an important tool for further studies to
investigate possible mechanisms by which VEGF promotes tumorgenesis in the adult
colon.
Decreased VEGF-A bioavailability was achieved by overexpressing sFlt-1 in the
brush border of intestinal epithelium using a doxycycline-inducible tet(O)
expression of sFlt-1 and rtTA expression of Villin-Cre in enterocytes. The
sFlt-1 mutants were significantly smaller in size, which has been reported in
transgenic mice that reduce VEGF bioavailability in the gastrointestinal tract
by overexpressing sFlt-1 in the mesenchyme. Villin sFlt-1 mutant mice developed
a shorter intestine and underdeveloped cecum. Further histological evaluation of
the cecum revealed a significant decrease in the number of goblet cells;
however, we did not appreciate a notable difference in goblet cells within the
small intestine. VEGF induces Dll4 expression in endothelial tip cells. Dll1 and
Dll4 are expressed in distinct patterns along the crypt-villus axis of the
gastrointestinal tract with significantly less Dll1 expression and greater Dll4
expression in colonic crypts compared to small intestine. Loss of Notch
signaling within intestinal epithelium via Dll1 and Dll4 blockade result in
complete conversion of proliferating progenitors into goblet cells with a
concurrent loss of intestinal stem and progenitor cells within the crypts of
small intestine and colon. It is therefore surprising that we would see a loss
of goblet cells within the cecum of sFlt-1 mutant mice and no appreciable effect
in goblet cell populations within the small intestine. These findings could
implicate changes in notch signaling ligand and receptor expression within
intestinal stem/progenitor cells that are reflective of the postnatal period
compared to embryonic development.
RT-PCR expression of sFlt-1 was significantly decreased in sFlt-1 mutant
duodenum after 21 days of doxycycline treatment compared to littermates with no
significant change in VEGF-A transcript or protein levels. These data suggest a
compensatory negative feedback relationship wherein chronic sFlt-1
overexpression decreases VEGFR1 expression, as the RT-PCR primer used can
amplify both sFlt-1 and full length Flt-1. VEGF-A levels within the native
duodenum were significantly low, which is likely why we were unable to see a
significant reduction in VEGF-A by ELISA. Therefore, to confirm that sFlt-1
overexpression within the intestinal epithelium does indeed occur in our
transgenic model, enteroid cultures were created from sFlt-1 mutant mice. After
administration of doxycycline, a significant increase in sFlt-1 expression was
demonstrated without altering expression of KDR, another VEGF receptor. Taken
together, the molecular and phenotypic evidence supports that villin-positive
cell overexpression of sFlt-1 leads to reduced VEGF-A bioavailability in sFlt-1
mutants, similar to our previously described mesenchymal-expressed sFlt-1 murine
model.
The murine postnatal period is important for the maturation of the intestine as
upward migration of the crypt-villus axis promotes mature crypts formation in
intervillus pockets, giving rise to intestinal stem cells. Histological analysis
of VEGF mutants revealed increased villus height, but no change in crypt depth.
In contrast, sFlt-1 mutants exhibited decreased villus height with longer
crypts. In swine, increased vascular flow rate and resistance is crucial for
normal development of villi during the postnatal period. The discordance in
angiogenesis seen between VEGF and sFlt-1 mutant mice and its inherent effects
on vascular flow and resistance might account for the significant changes in
villus and crypt architecture; however, there is likely a direct effect of VEGF
and additional angiogenic/vasculogenic signaling molecules on epithelial and
other cell types. Platelet-derived growth factor (PDGF) acts with some
coordination with VEGF in angiogenesis and contributes to proper crypt
morphology and its inhibition leads to fewer and misshapen crypts. VEGF-A binds
to PDGF receptors and induces signaling in mesenchymal cells. Therefore, the
increased villus height in VEGF mutants may be occurring through PDGF receptor
signaling in the small intestine mesenchyme, aiding in the formation and
elongation of villi. This is in contrast to sFlt-1 mutant mice, which
demonstrated shorter villi with longer crypts compared to littermates. As the
crypt-villus axis migrates upward during crypt formation, the villi are shorter,
but the crypts elongate, suggesting that VEGF could play a role in crypt-villus
axis development and migration by directly regulating epithelium gene expression
or indirectly through the mesenchyme.
VEGF augmentation and reduction had antagonistic effects on the number and
location of proliferating cells compared to littermate controls. In VEGF
mutants, Ki-67-positive cells were greater in number and extended higher into
the transit-amplifying zone compared to littermates and was not influenced by
any appreciable induction of apoptosis via caspase 3. Absorptive and secretory
progenitor cells typically reside in this region, though no change in Hes1 or
Atoh1 RNA expression was identified. Therefore, Ki-67-positive cells may be
proliferating under the direction of secondary mediators of VEGF signaling, such
as the Notch signaling ligands Dll1 and Dll4 that are required for maintenance
and of intestinal stem/progenitor cells. Moreover, increased proliferation in
VEGF mutants could be due to a reduction in epithelial cell migration along the
crypt-villus axis. In contrast, the sFlt-1 mutants displayed decreased
proliferation in the transit-amplifying zone and an increase in the number of
Paneth cells (Figs). Similar results of reduced body weight, shorter villus
height and decreased proliferation of the transit-amplifying cells with an
increase in Paneth cells have been identified in Krüppel-like factor 9
(Klf9)-deficient mice. Several signaling molecules involved in vasculogenesis
were downregulated in Klf9-deficient mice, indicating the complex interplay
between the mesenchyme and its effects on migration and proliferation of the
vasculature, epithelium and intestinal stem/progenitor cell populations. These
data also suggest a potential supportive role of angiogenic development and
proper maintenance of intestinal stem/progenitor cell progenitor homeostasis.
RT-qPCR identified differences in intestinal stem cell gene expression in VEGF
and sFlt-1 mutants. Several experimental and biological limitations are
encountered when performing gene analysis by RT-qPCR, including a discordance
between transcript expression and protein translation. Therefore, downstream
effectors with significant changes in expression still need to be identified,
but the effect at the RNA transcription level suggests an important role of VEGF
signaling in the maintenance and regulation of the intestinal stem cell niche.
Lgr5 cells are rapidly cycling and sensitive to irradiation, while Bmi1 cells
are slow-cycling and more quiescent. VEGF mutants had decreased Lgr5 expression,
but no change in expression of Bmi1. Lgr5 reduction in the VEGF mutants did not
alter the differentiated cell types in the intestinal epithelium, possibly due
to replacement by differentiating Bmi1 cells which can compensate for the loss
of Lgr5-positive cells. In contrast, sFlt-1 mutants had no change in Lgr5
expression, but a 0.42-fold decrease in Bmi1 expression compared to littermates.
The sFlt-1 mutants display a number of characteristics that can be partially
explained by decreased Bmi1 expression. *Bmi1* knockout mice have shorter small
intestines, similar to that in our sFlt-1 mutant mice. In sFlt-1 mutants,
decreased proliferation per hemicrypt is observed. Similarly, the expression of
Wdr43, a marker of transit-amplifying cells, was 0.60-fold less in sFlt-1
mutants than littermates. This decrease is consistent with the lower percentage
of Ki-67-positive cells identified in the transit-amplifying zone of the crypt.
While Bmi1 expression was decreased in the sFlt-1 mutants, the expression of
Lgr5 was unaffected. VEGF-induced expression of Dll4 in vascular endothelium
leads to the activation of Notch signaling. With reduced bioavailability of
VEGF-A, Notch signaling potentially decreases, resulting in decreased Bmi1 and
Wdr43 expression with a subsequent reduction in proliferation within the crypts
of the small intestine. VEGF/neuropilin-2 signaling as been shown to repress
insulin-like growth factor-1 receptor expression through Bmi-1. Elevated insulin
receptor B (IR-B) levels in intestinal epithelial stem cells decreased
proliferation in the crypts and enhanced epithelial barrier function. VEGF
reduction could result in decreased expression of Bmi-1 and a subsequent
increase in IR-B receptor signaling, leading to decreased intestinal stem cell
proliferation and subsequent increase in Paneth cell differentiation within the
crypts.
The sFlt-1 mutants were found to have a 1.5-fold increase in Sox9 expression.
Sox9 expression inhibits proliferation *in vivo*, which may have contributed
to the decrease in the number of proliferating cells per hemicrypt, resulting in
decreased villus height. Highly expressed in Paneth cells, Sox9 controls an
early step in Paneth cell differentiation through interactions with the Wnt
signaling pathway and affects the overall phenotype of the small intestine
crypts. Consistent with the increase in Sox9 expression, there was an increase
in the percentage of lysozyme-positive cells per hemivillus in the sFlt-1
mutants. Insulin-like growth factor 1 has been shown to enhance crypt
regeneration and increase the percentage of intestinal stem cells in S-phase
without expanding the population. Thus, IGF signaling primes intestinal stem
cells to differentiate during conditions of cell loss or injury. Moreover, SOX9
has also been shown to be a transcriptional regulator of insulin-like growth
factor-binding protein 4 (IGFBP-4), which is expressed highly in Paneth cells.
SOX9-induced activation of IGFBP-4 is directly involved in the antiproliferative
effects seen on intestinal stem/progenitor cells and may explain the phenotype
we observe in sFlt-1 mutants as loss of VEGF signaling may induce increased
expression of IGF-IR through Bmi1, thereby promoting Paneth cell differentiation
and intestinal crypt regeneration.
The sFlt-1 mutants also demonstrated a significantly increased expression of
EphB2. EphB2 expression is under control of the Wnt pathway and is usually
highly expressed in intestinal stem cells, with decreased amounts in more
differentiated cells. Increased EphB2 is associated with increased proliferation
and promotion of cell cycle re-entry. It is also found to be increased in wound
healing in inflamed intestines. The increased expression of Sox9 and EphB2 and
the decrease in proliferating cells is consistent with the ability of these
progenitor cells to self-renew and differentiate into diverse cell types.
In both VEGF and sFlt-1 mutant mice, there was no significant difference in
expression of Atoh1 and Hes1, which mark progenitor cells in the transit-
amplifying zone and regulate differentiation into secretory cell fates. Atoh1 is
important in differentiation of intestinal stem cells into secretory cell fates,
whereas Hes1 has been shown to promote proliferation and inhibit secretory cell
development. We did not identify notable differences in the ability of VEGF or
sFlt-1 mutants to differentiate into secretory cells lineages in the small
intestine.
To isolate the effects of VEGF signaling on epithelial cells without confounding
interactions from native intestinal vasculature, OU were obtained from VEGF
mutants and grown in culture over a period of 10 days. OU are comprised of
epithelium and mesenchyme and are devoid of a vascular supply. We have
demonstrated expression of VEGFR2 (Flk) within the epithelium of OU *in vitro*,
suggesting that VEGF may have direct signaling effects on intestinal epithelium.
Additionally, Caco-2 human intestinal epithelial cells are known to express VEGF
receptors. Although VEGF mutant OU exposed to doxycycline were larger in
diameter at day 5 and demonstrated a significant increase in VEGF protein
expression, differences in OU diameter were not maintained at day 10 *in vitro*.
To identify if the discordance in size at day 5 resulted from changes in
stem/progenitor cell populations, we examined several stem cell markers by RT-
PCR. Increased expression of Bmi1 and Atoh1 occurred, whereas EphB2 was
downregulated in doxycycline-treated VEGF OU compared to controls at 5 days.
Significant changes in stem/progenitor cell marker expression were lost by 10
days *in vitro*. Bmi1-positive slow-cycling ISCs have the capacity to self-
renew, proliferate, and give rise to all the differentiated epithelial cell
lineages of the small intestine. EphB2 expression within the intestinal crypt is
highly expressed in ISCs and decreases as cells proliferate and contribute to
the transit-amplifying zone. In VEGF OU, upregulation of Bmi1 and concurrent
downregulation of EphB2 suggest that VEGF stimulates ISCs to proliferate and
migrate within the transit-amplifying zone, supportive of increased
Ki67-positive cells within the transit-amplifying zone of VEGF mutant mice at 21
days. Atoh1 upregulation suggests that VEGF may prime progenitor cells within
the transit-amplifying zone to preferentially differentiate into cells of the
secretory lineage. Our *in vitro* data suggest that the increase in epithelial
cell proliferation seen in the transit-amplifying zone of VEGF mutant duodenum
could represent a direct effect by VEGF on epithelial stem/progenitor cells,
independent of effects from the native vasculature. However, the notable
discordance between stem/progenitor cell gene expression between VEGF mutant
duodenum at 21 days and VEGF OU at 5 days may occur primarily due to acute
versus chronic VEGF exposure or secondary effects from native intestinal
vasculature *in vivo*. Further exploration using OU culture as a system to
discern between primary effects of VEGF on the intestinal epithelium and
contributory secondary effects mediated through the native vasculature at
earlier timepoints is needed. Furthermore, VEGF and sFlt-1 mutant mice
demonstrate distinct phenotypic differences in stem/progenitor cells and
terminally differentiated cell types between the small intestine and colon at
the end of the weaning period. Elucidation of the mechanisms that account for
differences seen between small intestine and colon using our inducible *in vivo*
and OU culture models will provide a useful strategy to identify regulators of
intestinal stem cell/progenitor cell maintenance, homeostasis and
differentiation in discrete areas of the gastrointestinal system.
Alterations in VEGF bioavailability had unique effects on postnatal small
intestinal development in a murine model. Overexpression of VEGF led to
increased angiogenesis and vascular permeability as well as increased
proliferation higher into the transit-amplifying zone. *In vivo*, VEGF
augmentation was found to decrease expression of Lgr5 without affecting
expression of Bmi1. In OU culture, VEGF augmentation led to increased expression
of Bmi1 and Atoh1 with a reciprocal downregulation of EphB2, suggesting primary
effects of VEGF on intestinal epithelial stem/progenitor cell maintenance and
homeostasis. *In vivo*, sequestration of VEGF caused inhibited vasculogenesis
and restricted proliferation of intestinal epithelial cells within the crypts.
Decreased availability of VEGF led to increased expression of Sox9 and EphB2, as
well as a concomitant decrease in expression of Bmi1 and Wdr43. Future studies
using concurrent *in vivo* and OU culture models to explore the role of VEGF
signaling during early postnatal development may provide a useful platform to
distinguish between the direct and indirect mechanisms by which VEGF
bioavailability affects intestinal stem/progenitor cell populations and alters
postnatal intestinal development.
# Supporting Information
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: TCG. Performed the
experiments: CRS SGM KAH XH KLF. Analyzed the data: CRS SGM KAH. Contributed
reagents/materials/analysis tools: TCG. Wrote the paper: CRS TCG.
|
# Introduction
Flicker Modulation Thresholds (FMT) can provide a sensitive measure of changes
in the temporal responses of the visual system. Flickering stimuli generate
trains of neural modulation and this load accounts for an increased demand on
the blood supply and overall metabolic activity in the retina, when compared to
static stimuli. Flicker modulation thresholds can, therefore, act as a useful
photoreceptor-specific functional biomarker in early detection of diseases such
as Age related Macular Degeneration (AMD) and Diabetic Retinopathy, where
hypoxia plays an important role in disease pathogenesis. For the same reason,
these thresholds can also be useful in assessing the severity of rod and cone
dysfunction. For instance, flicker modulation thresholds measured at a single
temporal frequency such as at 14 Hz is considered to be a sensitive indicator of
cone function in patients with AMD, with regards to ease of testing and
repeatability. It has also been shown that the differences in cone FMT between
age-matched healthy individuals and patients with AMD are largest in the central
5° of fixation, which is within the region of maximum vulnerability to damage in
these patients. The absolute rod detection threshold, which is typically
measured after a period of dark adaptation (20–30 minutes), provides a useful
measure of rod function. For rod-mediated vision, this test should also overcome
the requirement of long dark-adaptation times that make the test results more
variable and unattractive for use in a clinical setting. Given the previous
literature, it is desirable to develop an efficient test to measure rod- and
cone-specific sensitivities within the central vision and to account for the
effects of normal, healthy ageing. Such data are needed to detect loss of
sensitivity that falls outside the normal limits as one might expect in patients
at risk of developing and quantify the earliest losses in patients with AMD or
diabetes.
It is well established that in normal, healthy ageing, photopic flicker
modulation thresholds increase with increasing age, although this increase only
starts to become significant beyond 40 to 45 years of age. An earlier study
reported little or no change in absolute scotopic thresholds with age. However,
the small sample size (n = 23) and the maximum age of the participants in that
study (the oldest subject was 61 years of age), might have precluded the authors
from establishing the true variation of scotopic thresholds with age. Subsequent
studies reported greater increases in scotopic thresholds with increasing age.
In particular, Jackson et al. found that the rate of age-related increase of
scotopic thresholds (-0.08 log units/decade) is faster than that measured for
photopic thresholds (-0.04 log units/decade). However, it is important to note
that the previous studies tested absolute scotopic thresholds using a static
target after a prolonged period of dark adaptation (20–30 minutes). In the
current study, we have employed a rod / cone flicker test, which makes use of
stimulus parameters such as background luminance, spectral composition, temporal
modulation frequency and stimulus size to test for rod—and cone—specific
responses at five discrete locations in central vision (5°), with minimal
adaptation time. The findings from this study characterize the existing
variability within rod- and cone-mediated thresholds in central and near
peripheral vision and establish the upper, threshold limits one can expect in
healthy, normal ageing (20–75 years). The latter can be used to detect when rod-
or cone-specific thresholds exceed normal age-matched limits as a result of
subclinical disease. In addition, the rod / cone flicker modulation threshold
test can also be used to monitor the progress of a disease or the effectiveness
of treatment.
# Materials and methods
## Participants
The study participants had normal vision with high-contrast logMAR visual acuity
(VA) equal to better than 0.0 (20/20 Snellen fraction) and no history of ocular
and systemic disease. Participants were recruited from the staff and student
cohort at the L V Prasad Eye Institute (LVPEI), Hyderabad, India and from those
patients who visited the institute for a regular eye examination, with no
specific complaints. All the participants were of Indian ethnicity. The
participants underwent ocular examination including, slit lamp biomicroscopy and
fundus examination to rule out any ocular pathology. Intraocular pressure was
measured using Goldmann applanation tonometry and was also within normal limits.
Participants with any ophthalmic pathology or with lens status (nuclear,
cortical or posterior subcapsular) graded as LOCS III, or higher were excluded.
In addition, participants who were unable to complete successfully the
‘learning’ mode of the test were also excluded. The ethics and protocol of the
study was approved by the Institutional Review Board of LVPEI and all the
procedures were conducted in accordance with the tenets of the Declaration of
Helsinki. Written informed consent was obtained from all the participants before
they took part in the study. A sample of approximately 150 participants could be
considered as a representative of the population to derive a normative database
for visual functions.
## Flicker-*Plus*
Flicker modulation thresholds (FMTs) were measured using the Flicker-*plus*
module of the commercially available Advanced Vision and Optometric Tests (AVOT)
developed at City, University of London. The AVOT tests run on a desktop
computer with two displays, one for the experimenter and the other for
generating the visual stimuli for a number of advanced vision tests. The display
used by the experimenter to run the tests and the calibrated stimulus display
viewed by the participant are separated by a black curtain, such that the
participant can only see the stimulus display. The display monitor
specifications were as follows: 24" IPS (in-plane switching) LCD monitor (EIZO,
Model ColorEdge CS2420; EIZO corporation, Japan) using a 10-bit graphics card
with 1920 X 1200 resolution at a frame rate of 60 Hz. The calibration of the
monitor is performed using a photometer (Mavo-Monitor USB, Gossen, Germany) and
a custom-built software (LUMCAL; City Occupational, Ltd., London, UK). The
stimulus was a uniform disc of appropriate size (see for details) and was
presented either at the centre (0°) of the display (as indicated by the four
guides shown), or in one of the four quadrants (5° eccentricity from fixation)
namely supero-temporal (ST), supero-nasal (SN), and inferonasal (IN) and
inferotemporal (IT) quadrant, depending on the eye that was tested. The
duration, temporal frequency, background luminance and spectral power
distribution of the background and target were selected to produce either cone-
or rod-enhanced stimuli. The chromaticities and other parameters were different
between rod and cone—enhanced stimuli. However, in each of these conditions, the
target and background had the same spectral composition. The differences in the
spatiotemporal properties between rod and cones were exploited in this test such
that the rod-enhanced condition had stimuli with relatively longer display
duration, lower temporal frequency and light levels, all relative to the cone-
enhanced conditions. The stimulus parameters for the two conditions were
selected to produce approximately the same flicker thresholds for both rods and
cones. Preliminary results in CNG-B3 patient with retinal achromatopsia confirm
that the cone-enhanced thresholds can still be detected by rods, but with
thresholds approaching the maximum that can be generated on the visual display
(currently in preparation). Five, randomly interleaved 2-down 1-up adaptive
staircases, one for each stimulus location, were used to measure the
corresponding FMTs. During each test, the five interleaved staircases determine
either the subject’s rod- or cone-mediated thresholds. Each threshold was
estimated by averaging the last six reversals. The implementation of the 5AFC
staircase with variable step sizes and the 2-down / 1-up approach reduces the
chance probability of a correct response to 1/25. The measured thresholds
correspond to just over 70% probability of a correct response. The participant
viewed the stimulus display monocularly from 1m. Only one eye (dominant eye or
eye with a visual acuity of at least 0.0 logMAR or better) per participant was
tested.
## Procedure
The Flicker-*Plus* test includes a ‘learning’ option which is used to
familiarize the participant with the bespoke, numeric keypad buttons needed to
indicate the position of the stimulus on display during the test procedure. The
test stimulus was always preceded by a briefly presented fixation stimulus at
the centre of the screen. The latter consisted of a dark square outline and a
cross, designed to attract the participant’s point of regard. The participant
was instructed to maintain their fixation on the location of this marker
throughout the test to ensure that the peripherally presented stimuli were seen
at 5° eccentricity. The raised, keypad buttons mirrored the five locations of
the stimulus on display to make the task easier. Each participant was expected
to achieve 100% correct responses in the learning mode before the full test was
administered. The order of the rod and cone flicker testing was randomized. The
rod-enhanced condition required the participant to adapt to the background field
for 1½ minutes, wearing spectrally-calibrated, 1.0 log unit neutral density
filter (Oakley Half Jacket 2.0 –Black Iridium, USA). Each test run took \~10
minutes to complete and breaks were rarely required. Pupil size was not measured
during the experiment as the flicker modulation at equal luminance remains
largely independent of pupil size. Previous research has also shown that small
pupil size changes have only minimal effects on FMTs measured at photopic and
high mesopic light levels. Pre-retinal filters such as the short-wavelength
absorption of light by the lens and the macular pigment do not affect the
stimulus modulation depth when the spectral power distribution of the test
remains unchanged and the same as that of the adjacent uniform background.
## Data analysis
The data were not normally distributed as tested by the D’Agostino & Pearson
test (p \<0.05); therefore non-parametric statistical analyses were carried out.
The age of 45 years was chosen as the demarcation point between the two groups
based on previous literature for further analyses. We have examined the results
using the point of separation as a free parameter in order to determine whether
there was a justification for using a fixed cut-off point at 45 years. We
examined all test conditions and found that the mean transition age was 46.5 ±
1.0 years. In view of this observation, the data were fitted with two separate
linear functions for age group ≤ 45 years and for group \> 45 years using a
linear regression model in GraphPad Prism (Graph Pad Software, Inc., CA, USA).
Spearman correlation coefficient was computed to analyze how FMTs vary as a
function of age separately for the two age groups (≤ 45 years and \> 45 years).
# Results
As mentioned in the methods, we aimed to recruit 150 subjects. However, we ended
up recruiting a total of 145 participants (82 males and 63 females). Out of 145,
five participants were excluded, as they had difficulties with the ‘learning
mode’ and were unable to either see the flickering stimulus or to complete the
test. Therefore, a total of 140 participants completed the study. The mean age
(SD) of these participants was 41.81 (15.11) years. Nearly 4% (5/140) of the
study participants were pseudophakic in the tested eye. The number of
participants across each decade who participated in the study is shown in. Mann
-Whitney test showed no significant differences between male and female groups
for central (p = 0.80) and parafoveal cone FMT (p = 0.17). Similarly, Mann
-Whitney test showed no significant differences between male and female groups
for central (p = 0.40) and parafoveal rod FMT (p = 0.78).
revealed no noticeable differences across the four parafoveal locations for cone
thresholds and well as for rod thresholds. Therefore, the cone and rod
thresholds in the four parafoveal locations were averaged separately, and only
the mean values were used for each participant. The slopes of the regression
lines between FMT and age were compared to determine if they were different from
zero (i.e. if there was an age-related trend in the data) and if they were
different from each other (i.e. if the rate of change in FMT’s were different
across different test conditions). A p-value of ≤ 0.05 was the requirement for
statistical significance. Except for cone thresholds (central and parafoveal) in
the younger age group and parafoveal rod thresholds in the younger age group,
all the other slopes were significantly different from zero (p \< 0.05). The
rate of increase in central cone thresholds (i.e., 2.9% per decade–) above 45
years of age is not significantly different to the rate of increase in central
rod thresholds (i.e., 4.5% per decade—; p = 0.15; See) for the same age group.
The increase in parafoveal cone thresholds (i.e., 1.6% per decade–) above 45
years is also not significantly different than the measured increase in
parafoveal rod thresholds (i.e., 2.4% per decade–; p = 0.19; See) for the same
age group.
The slopes and the y-intercepts of the regression lines were also compared
separately as a function of stimulus location (between centre and parafovea) in
cone and rod conditions. In the younger age group (≤ 45 years) cone threshold
slopes and y-intercepts between the centre (0.4% per decade) and parafovea
thresholds (0.05% per decade) were not significantly different from each other
(p = 0.24 and p = 0.36 respectively). In the elder age group (\> 45 years),
there are no significant differences in the slopes for the cone thresholds
between central (2.9% per decade) and parafoveal locations (1.6% per decade) (p
= 0.10). There was, however, a significant difference between the y—intercepts
of central and parafoveal cone FMT (p = 0.004;) in the age group \> 45 years.
Similarly, in the younger age group, the slope for rod thresholds in centre
(0.7% per decade) was not significantly different from the rod thresholds
measured at the parafoveal locations (0.2% per decade) (p = 0.15). The
y-intercepts were, however, significantly different for rod thresholds between
central and parafoveal locations (p \< 0.001) in the younger age group. In the
elder age group, the rate of change in central rod thresholds (4.5% per decade)
was significantly greater (p = 0.03) than that measured in parafoveal vision
(2.4% per decade). The y-intercepts could not be determined as the slopes
differed significantly.
There is no significant correlation between flicker (rod and cone) thresholds
and age up to the age of 45 years. However, beyond 45 years of age, there is
significant correlation for both rod and cone FMTs with age (p \< 0.05) as shown
in. Approximately 89% (125/140) of the participants showed higher rod FMTs
compared to cone FMTs both centrally and parafoveally. The linear regression
was performed between central cone and rod thresholds (central) for both age
groups (≤ 45 years and \> 45 years) separately. The slopes (≤ 45 years: y =
0.60x+4.59, R<sup>2</sup> = 0.14, \> 45 years: y = 0.92x + 5.31, R<sup>2</sup> =
0.50; p = 0.12) were not significantly different from each other. However,
parafoveally slopes were significantly different from each other (≤ 45 years: y
= 0.44x+3.64, R<sup>2</sup> = 0.16; \> 45 years: y = 0.85x+3.00; R<sup>2</sup> =
0.45; p = 0.007).
# Discussion
This study reports measured flicker modulation thresholds as a function of age
at five locations in central vision with stimulus conditions that favour either
rods or cones. The new test employed in the study benefits from minimum times of
adaption to the background luminance and the use of a statistically-efficient,
5-alternative, forced choice procedure to measure flicker modulation thresholds
that are not affected significantly by residual refractive errors, higher order
aberrations or moderate levels of scattered light The results show almost
constant rod- and cone-mediated flicker sensitivities up to 45 years of age and
a more rapid decline above this age. The age and stimulus location dependence of
rod and cone data is discussed separately in the following sections.
## Cone flicker thresholds as a function of age and test location
Our findings show that 15Hz cone FMTs measured at the point of regard remain
mostly unchanged up to 45 years, followed by a steeper increase above this age.
This finding is in agreement with earlier findings, which suggest that the
variation of foveal flicker thresholds (\< 20 Hz) across the life span has three
phases namely, the initial decrease in thresholds up to 16 years of age, the
stable phase between 16yrs until 45–50 years and an increase beyond 50 years of
age. It is well established that ageing causes significant changes in the optics
of the eye as well as structural/anatomical changes in the retina, RPE and the
choroid and neural changes in the post-receptoral pathways. Here we explore the
possible factors that contribute towards the increase in cone FMT with
increasing age. Firstly, the steady-state pupil size decreases with age, and
this causes a reduction in retinal illuminance, which in turn can potentially
affect FMT. Previous studies have, however, shown that the increase in FMTs in
the elderly is higher than predicted by age-related miosis. Besides, the
Flicker-*plus* test was designed to ensure that there is no change in the mean
luminance level during the stimulus presentation. Both E<sub>b</sub> (background
retinal illuminance) and E<sub>s</sub> (stimulus modulation retinal illuminance)
are both directly proportional to pupil size. Therefore, pupil size affects the
corresponding retinal illuminances but does not affect the temporal contrast
modulation of the stimulus or FMT (i.e., the measurement variable). Similarly,
this finding of increased FMT with ageing is unlikely to be associated with
changes in cone density, as the reported decrease in cone numbers in the central
± 5° of the retina is small. Factors such as the decrease in ganglion cell
density, especially parasol ganglion cells in the magnocellular (MC) pathway
with increasing age may be attributed to the increase in FMT. This is supported
by a previous finding that in patients with severe parvocellular lesions,
contrast thresholds for temporal frequencies (1–32 Hz) is largely mediated by
the MC pathway. However, the effect of ageing-related structural changes in
neurons in the human post-receptoral pathways is unclear and is limited to
animal studies. Previously, in monkeys and cats, it has been shown that cortical
neurons’ (V1 area) sensitivity and the signal-to-noise ratio is decreased
significantly in older age group compared to the younger age group. These
results suggest that similar ageing changes in human cortical neurons are
conceivable and which could account for an increase in FMT. Besides, the
estimated sampling efficiency related to contrast threshold task in older human
subjects is significantly poorer than younger subjects, which may also indicate
a neural basis for loss in contrast sensitivity with increasing age.
Although the results show that the rate of increase in cone thresholds with
increasing age was comparable between central and parafoveal locations (p =
0.10), it is important to explore the possible reasons for the rate of changes
in cone FMT. This finding of steeper slopes for central cone thresholds is in
agreement with the results of a recent study, carried out under similar test
stimulus conditions, where foveal photopic thresholds had steeper slopes for
those over \> 40 years of age, compared to parafoveal locations (4°). Other
studies failed to find a significant increase in thresholds in cone-mediated
central vision (0°) with increasing age. The differences could be due to
different stimulus parameters such as adapting luminance, size, temporal
frequency and presentation time. More specifically, in this study, the size of
the central flicker stimulus (30’) was smaller compared to the peripheral
stimulus (60’) to account for spatial summation.
## Rod flicker thresholds as a function of age and test location
In a way similar to cone-mediated thresholds rod thresholds (central and
parafoveal) are significantly higher for age group \> 45 years compared to the
other group (≤ 45 years) (Figs) and also significant differences are noted
between rod thresholds in central and parafoveal locations. The former findings
are in agreement with the previous studies that have studied rod sensitivity as
a function of age. Rod sensitivity corrected for the expected absorption of
light by the lens in the older group (mean age—70 years), show at least 0.4 log
unit loss in sensitivity compared to the younger group (mean age—25 years).
Similarly, Jackson and Owsley showed that the loss in scotopic sensitivity is
0.08 log units per decade. The loss in rod photoreceptors with ageing is well
documented, however, that may not fully account for the loss in rod sensitivity
with ageing and differences in sensitivity between central and parafoveal
locations. It is because the latter shows poor correlation with the magnitude of
loss in rod density at different retinal eccentricities. The neural basis for
the increase in rod thresholds with ageing could be post-receptoral in origin,
such as the steady loss of ganglion cells with increasing age. The decrease in
scotopic pattern ERG, dark-adapted scotopic b-wave and VEP amplitudes associated
with ageing, suggest the role of post-receptoral or post retinal circuitry in
decreased contrast sensitivity with ageing. Also, the role of cortical neurons
in the increase of rod FMT cannot be discounted as discussed earlier in the
manuscript.
## Comparing rod and cone flicker modulation thresholds
Although not statistically significant, the rate of increase in central rod FMTs
for the age group \> 45 years was greater than central cone FMT (p = 0.15). This
trend is consistent with the findings of Jackson et al., who also showed the
rate of increase in scotopic thresholds (-0.08 log units per decade) was greater
than photopic thresholds (-0.04 log units per decade) with increasing age in
normal healthy participants. However, it is be noted that Jackson et al. used a
linear model to describe their photopic and scotopic sensitivity data for the
age range between \~ 20–80 years, contrary to the bilinear fit we used. The
following potential differences between these studies may account for the
discrepancies. The first major difference involves the state of background
adaptation of rod photoreceptors. The earlier study measured rod thresholds when
the retina was fully dark-adapted (40 minutes), whilst in the present study, we
measured rod thresholds after adaptation to a uniform background of luminance
(0.5 cd/m<sup>2</sup>) for a brief duration (90sec). The other differences
include stimulus specifications such as briefly presented stimulus and not
flickering stimuli, area of the retina (18°) tested compared to 5° (this study)
and stimulus duration (200 ms vs 600 ms). The bilinear fit suggests that effects
of ageing in a flicker test start to manifest after the age of 45 years unlike
the functions such as photopic and scotopic flicker sensitivity measured using
pulsed pedestal stimuli and mechanisms responsible for the detection of flicker
detection and pulse stimuli are different. However, we do see an agreement with
a couple of studies with regards to the bilinear model, used to describe the
photopic flicker thresholds as a function of age. Besides, approximately 89%
(125/140) of participants in this study showed higher rod FMTs compared to cone
FMTs. This finding is similar to Jackson et al., who reported that 80% of the
normal healthy participants had higher scotopic thresholds than photopic
thresholds with increasing age. The finding of approximately similar rate of
change for rod versus cone thresholds beyond 45 years of age (indicated by
slopes), accompanied by markedly different slopes for each of these thresholds
as a function of age suggests mediation of two different mechanisms or
photoreceptors classes that may be responsible for detection these stimuli.
We are aware of a couple of study limitations. One is that we had a limited
number of participants \> 70 years and other was that testing was done in an
Indian population, whose average life expectancy is expected to be lower than
that of North American and European population. Therefore the results above 70
years of age rely largely on extrapolation. The results obtained in this study
are more likely to reflect the true changes in flicker sensitivity because of
the normal physiological ageing processes in the retina, as mentioned earlier in
the manuscript. There is no obvious reason to assume that this ageing process
would be different in the Indian population when compared to other populations.
# Conclusions
Cone-and rod-mediated FMTs remain relatively unchanged from 20 to about 45 years
of age. Beyond this age, both rod and cone thresholds increase rapidly. The
dataset obtained in this study describes the effects of normal ageing and will
be a useful reference in the detection of rod and cone losses in preclinical
disease, for the monitoring of disease progression and also help evaluate drug
efficacy in patients with wet AMD, undergoing active treatment such as the use
of the anti-vascular endothelial growth (VEGF) injections.
We would like to acknowledge Hyderabad Eye Research Foundation, for providing
infrastructure support to set up the AVOT unit. We would also like to
acknowledge Ms Gayatri Yadav for assistance in data collection for this study.
[^1]: AH and SRB received support in the form of salaries from the Hyderabad
Eye Research Foundation. AS, JB, and JRES received support in the form of
salaries from City University of London. JRES received support in the form
of a salary from QinetiQ. The authors would like to declare the following
patents/patent applications associated with this research: EU- EP08762401.1;
US- US8,322,857: 'Vision testing apparatus and method.' This does not alter
our adherence to PLOS ONE policies on sharing data and materials.
|
# Introduction
The increasing likelihood of extreme climate events with ongoing climate change
is expected to have major impacts on biodiversity at local scales. Extreme
climate events will primarily consist of periods of heat, cold, drought and
flooding with greater severity and less predictability than historical norms.
These events will act as disturbance and are likely to decrease biodiversity at
local as well as regional scales.
Floods are projected to increase with global warming in the 21st century leading
to rapid changes in soil conditions thereby detrimentally affecting soil
microorganisms by limiting soil gas diffusion and oxygen availability thus
reducing soil nutrient availability, mineralization and decomposition of dead
organic material. As a consequence, anaerobic conditions develop quickly in
flooded soils resulting in marked changes in soil chemistry including the
accumulation of toxic substances. All these changes are likely to significantly
affect the composition of soil food webs. To explore the effects of flooding on
soil food webs and, more specifically, soil microarthropods, we investigated a
severe natural flooding event in a grassland plant diversity experiment. The
flooding, resulting from heavy summer precipitation, was accompanied by the
input of sediments rich in nutrients and was associated by an unexpectedly fast
recovery of soil microorganisms within three months. Fungal biomass increased,
reflecting elevated availability of dead plant biomass. Further, flooding was
associated with enhanced plant community productivity but decreased stability,
particularly of plant communities of high diversity.
Until today understanding how short-term disturbance events affect soil
biodiversity is limited but is important as changes in soil biodiversity and
community structure impact the functioning of soils. A major component of soil
animal communities are microarthropods reaching high density and diversity in
any kind of soil, and playing a crucial role in driving belowground ecosystem
processes such as decomposition and nutrient cycling. Microarthropods, such as
Acari and Collembola, are major animal groups interacting with soil
microorganisms. Microarthropod species are likely to be differentially affected
by changes in environmental conditions such as inundation events depending on
physiological adaptations and life history traits. Although Collembola (Insecta)
and Oribatida (Acari) are often grouped into the same trophic level and are
considered to occupy similar niches in decomposition processes, the two groups
differ in a variety of ecological traits including mobility, reproduction, level
of predation pressure, and tolerance to abiotic conditions. Parthenogenesis may
facilitate quick population establishment after disturbances and is most
widespread in Oribatida. However, the general life-history traits of Oribatida
have been considered typical of K-selected species, whereas Collembola species
exhibit wider variation in life-history traits. In particular, compared to
Collembola, Oribatida species are less mobile, characterized by low reproductive
rates and recolonize disturbed habitats slowly. Collembola, in contrast, are
more sensitive than Oribatida to abiotic microhabitat conditions and recolonize
disturbed habitats more quickly. Other Acari such as Astigmata have short
developmental time and excellent dispersal ability. They feed on fungi or
bacteria, but may also consume plant tissue. Gamasida are mostly free-living
predators but also parasites or symbionts. Prostigmata are predators, herbivores
and parasites.
In this study, we focus on the response of Acari and Collembola to flooding in
grasslands of varying plant diversity. We expected the density and richness of
Collembola and Acari communities to be reduced strongly by flooding with
Collembola recovering faster than Acari due to higher reproductive potential and
dispersal ability. We further expected that surface-living Collembola species
with high dispersal ability will recover faster than species living deeper in
soil. Among Acari we expected Astigmata, Prostigmata and Gamasida to recover
faster than Oribatida due to generally faster reproductive cycles. We further
expected the immediate effects of flooding to be similar in both Collembola and
Acari and to be independent of plant species diversity. However, we expected the
recovery to be facilitated by high plant species diversity in particular in
Collembola. Collembola density and diversity have been shown to benefit from
plant diversity due to increased root and microbial biomass, and elevated
quantity and quality of plant residues serving as food resources.
# Material and methods
## Experimental setup
The Jena Experiment is a semi-natural temperate grassland on the floodplain of
the Saale River close to the city of Jena (50°55´ N, 11°35´ E; Thuringia,
Germany). Mean annual air temperature is 9.9°C and mean annual precipitation is
610 mm (1980–2010). The study site, a Eutric Fluvisol, has been used as an
arable field for over 40 years before the experiment was established with
typical Central European hay meadow plants in 2002. The experiment comprises 80
5 x 6 m plots arranged in 4 blocks to control for changes in soil texture with
distance from the river. A gradient of plant species richness (1, 2, 4, 8, 16
and 60) and plant functional group richness (1, 2, 3 and 4) was established.
Plant species are grouped according to the morphological, phenological and
physiological traits into grasses (16 species), small herbs (12 species), tall
herbs (20 species) and legumes (12 species). The established grassland is mown
twice a year and weeded three times per year. No permission was needed to take
the samples from this site. The site is rented and managed by the project and
for taking samples for analysing soil arthropods from arable systems no
permission from legal bodies is needed. The field studies did not involve
endangered or protected species.
## Flooding
The June 2013 flood in the Upper Danube Basin was one of the largest floods in
the past two centuries. Rainfall in May 2013 in southeast Germany was
exceptionally high. In Jena it amounted to approximatively 150 mm. High rainfall
resulted in the flooding of the Saale River with the flood also covering the
Jena Experiment field site and lasting for 25 days (30 May to 24 June). Flooding
caused anaerobic soil conditions with redox potentials ranging from -121 to 193
mV in some plots. Water coverage was measured daily for each plot from 31 May to
24 June and ascribed to 5 levels: 0, 25, 50, 75 and 100% (percentage of the plot
covered by water). Flooding severity was measured using a flooding index
calculated as the sum of daily percentages for the whole flooding period (24
days). After the flood in August 2013, dead material, target species, weeds and
bare ground percentage of the plot was measured. In general, we found that 78%
of the plots was covered by target species, 14% of weeds, 8% of dead material
and 23% of bare ground. Monocultures had only 41% of target species and 50% of
bare ground. In contrast, plots with 16 plant species had 88% of the plot
covered by target species and 7% covered by bare ground. In October the
vegetation was recovered totally.
## Soil biota
In November 2010, July 2013 (three weeks after the flood) and in October 2013
(three months after the flood), soil cores of 5 cm diameter and 5 cm depth were
taken from each plot using a stainless steel corer (80 samples per date). Soil
microarthropod species were extracted using a high-gradient extractor,
increasing the temperature gradually from 25 to 55°C during 14 days. The animals
were collected in mono-ethyleneglycol and transferred into 70% ethanol for
preservation. Acari were sorted into Oribatida, Gamasida, Prostigmata and
Astigmata. Oribatida were identified to species level using Weigmann and
Collembola were identified to species level using Hopkin and Fjellberg. For
identification a light microscope (Axioplan; Zeiss, Germany) with up to ×1000
magnification was used. For full list of species including authorities see
supplementary material ( and Tables). Species richness (number of species; and
Tables) and density (number of individuals per square meter; and Tables) for
Collembola and Oribatida were calculated.
## Data analysis
To improve homogeneity of variances, data on abundance (individuals per soil
core) and species richness were log<sub>10</sub> (x+1) transformed prior to
statistical analysis. The 60 plant species mixtures were excluded from the
statistical analysis due to insufficient number of replicates (four replicates
at the field site, each being differentially affected by the flood;). Linear
models (type I sum of squares) were used to analyze effects of block
(categorical variable, 4 blocks), flooding index (continuous variable, from 1 to
23 days), dead organic material, target species, weeds and bare ground
(continuous variable, percentage of the plot, only used in October 2013), plant
functional group richness (continuous variable, from 1 to 4), plant species
richness (continuous variable, from 1 to 16, log-transformed) and
presence/absence of grasses, legumes, small herbs and tall herbs (categorical
variables) on the density and richness of Collembola and Acari, the density of
Astigmata, Gamasida, Oribatida and Prostigmata (suborders of Acari) and the
density of most abundant families of Collembola (Entomobrydae, Isotomidae and
Tullbergiidae) for the data of 2010 and 2013 (three months after the flood). Due
to very low density three weeks after the flood these data were not analyzed
statistically. The full model with the lowest Akaike Information Criterion (AIC)
was selected as the best starting model. This model was simplified in a stepwise
manner by dropping non-significant variables. Although the experimental design
was set up as orthogonal as possible, there is collinearity between functional
group richness of plants and the presence/absence of individual functional
groups, which we quantified using the inflation factor (VIF) from the car
package. The analysis suggested to exclude functional group richness if there
are two or more functional groups in the model (VIF \~ 4). Therefore, functional
group richness was added after model simplification and was only included in the
final model if it improved the model significantly (principle of Occam’s Razor,
p \< 0.05). Generally, block and flooding index were fitted first followed by
plant species richness; thereafter presence/absence of grasses, legumes, tall
herbs and short herbs were fitted. F-values given in text and tables generally
refer to those where the respective factor was fitted first. Statistical
analyses were performed using R 3.2.1.
Data on Collembola species were analyzed using non-metric multidimensional
scaling (NMDS with Bray-Curtis distance) reducing the number of dimensions to
four. To identify the factors which drive Collembola community composition, the
four dimensions were further analyzed by MANOVA. In addition, discriminant
function analysis (DFA) was carried out on four NMDS axes with Statistica 13
(Statsoft, Inc., Tulsa, Oklahoma, USA). Plant species and plant functional group
richness were used as variables of discrimination. Squared Mahalanobis distances
between groups were calculated to identify differences between plant richness
levels.
The community structure of Collembola and Oribatida was analyzed using principal
component analysis (PCA) as implemented in CANOCO 5 (Microcomputer Power,
Ithaca, NY;) using the abundance of species which appeared more than in three
samples. Moreover, we correlate the factors and the axes of each PCA using
Pearson correlation.
# Results
## Collembola
In November 2010 Collembola density was 22,310 ± 15,975 individuals
m-<sup>2</sup>, whereas three weeks after the flood in 2013 it was only 515±1347
individuals m-<sup>2</sup>(mean ± SE). In contrast, three months after the flood
Collembola density (23,220 ± 17,826 individuals m-<sup>2</sup>; mean ± SE) was
similar to the level in 2010. Collembola density in 2010 was not influenced by
experimental treatments, but three months after the flood in 2013 it increased
slightly with plant species richness (F<sub>1,76</sub> = 2.97;). Moreover, dead
organic material, target species, weeds and bare ground percentage of the plot
was not significant in the density of October 2013.
In 2010 a total of 27 species of Collembola were recorded, while only 16 species
were recorded three weeks after the flood. However, three months after the flood
species number increased to 22. In 2010 Collembola species richness increased
marginally significant with plant species richness (F<sub>1,76</sub> = 3.76;)
and plant functional group richness (F<sub>1,76</sub> = 2.82;). There was no
significant effect of plant species and plant functional group richness on
Collembola species richness three months after the flood in 2013, but increased
significantly with the presence of tall herbs. Dead organic material, target
species, weeds and bare ground percentage of the plot was not significant in the
species richness of October 2013.
In 2010 the density of the most abundant family of Collembola, Isotomidae,
increased significantly with plant species richness and also in presence of
grasses, but decreased in the presence of tall herbs. In contrast, the densities
of Entomobryidae and Tullbergiidae were not significantly affected by
experimental treatments in 2010. Three months after the flood in 2013 the
density of Entomobryidae increased with flooding index (F<sub>1,73</sub> =
3.88). Further, the density of Tullbergiidae increased significantly with plant
species richness and decreased slightly with the presence of grasses
(F<sub>1,73</sub> = 3.28;). In contrast to 2010, Isotomidae were not
significantly affected by experimental treatments in 2013.
In 2010, Collembola community composition changed significantly with plant
species richness (F<sub>1,76</sub> = 5.33, P \< 0.01) and plant functional group
richness (F<sub>1,76</sub> = 4.35, P \< 0.01). Collembola community (number of
species and species composition) was similar at higher plant species richness
but less variable in the one and two species treatments. Similarly, community
composition of Collembola differed between plant functional group one and four
as well as two and four.
PCA separated Collembola communities mainly along the first axis representing
25.28% of the variability in species data, whereas the second axis represented
15.96% of the variability. Separation along the first axis mainly represents
differences between Collembola communities in 2010 and three months after the
flood in 2013 (r = - 0.75). The most abundant species before the flood compared
to 2013 were *Parisotoma notabilis*, *Mesaphorura macrochaeta*, *Ceratophysella
denticulata* and *Onychiurus jubilarius*. After the flood the most abundant
species compared to 2010 were *Lepidocyrtus lanuginosus* and *Cryptopygus
thermophilus*. The second axis represents differences between plant species
richness (r = 0.22), plant functional group richness (r = 0.13) and
presence/absence of small herbs (r = 0.16). In general, at higher plant species
richness *Lepidocyrtus cyaneus* and *Stenaphorura denisi* were more abundant.
Moreover, there were some species present at each of the sampling dates
including *Lepidocyrtus lanuginosus*, *Lepidocyrtus cyaneus* and *Willowsia
buski* (Entomobryidae) as well as *Isotoma viridis*, *Parisotoma notabilis* and
*Isotomiella minor* (Isotomidae). Other species like *Hypogastrura manubrialis*,
*Ceratophysella engadinensis* (Hypogastruridae), *Isotomurus fucicolus*,
*Proisotoma minuta* (Isotomidae), *Paratullbergia macdougalli* (Tullbergiidae),
*Protaphorura armata* (Onychiuridae) and *Sminthurus viridis* (Sminthuridae)
were present only three weeks after the flood.
## Acari
In November 2010 Acari density was 21,500 ± 23,290 individuals m-<sup>2</sup>,
but only 1,864 ± 3,059 individuals m-<sup>2</sup> three weeks after the flood in
2013(mean ± SE). In contrast, similar to Collembola, three months after the
flood in 2013 (27,350 ± 30,040 individuals m-<sup>2</sup>; mean ± SE) it was
similar to the level in 2010. In 2010 and three months after the flood in 2013,
Acari density increased significantly with the presence of grasses. Moreover,
three months after the flood in 2013 it was significantly higher with the
presence of small herbs. The Acari density of October 2013 was not affected
significantly by dead organic material, target species, weeds and bare ground
percentage of the plot.
The density of each of the suborders of Acari (Oribatida, Gamasida, Astigmata,
Prostigmata) decreased significantly three weeks after the flood in 2013. In
contrast, three months after the flood in 2013 the density of each of the Acari
suborders reached a similar level than in 2010, except of Prostigmata which
exceeded the density in 2010 by more than a factor of two.
A total of 12 species of Oribatida were recorded in 2010, but only 9 species
were recorded three weeks after the flood in 2013. However, similar to
Collembola, Oribatida species also recovered quickly with 12 species being
present three months after the flood in 2013. In 2010 Oribatida richness
increased significantly with plant species richness and plant functional group
richness. Further, in 2010 (F <sub>1,76</sub> = 2.94) as well as three months
after the flood in 2013 (F <sub>1,76</sub> = 3.04) Oribatida richness increased
with the presence of grasses, however, only slightly. Three months after the
flood in 2013 Oribatida richness was slightly reduced at higher flooding index
(F <sub>1,76</sub> = 2.86;). Furthermore, dead organic material, target
species, weeds and bare ground percentage of the plot was not significant in
Oribatida species richness of October 2013.
Oribatida density increased significantly with plant species richness both in
2010 and three months after the flood in 2013. Moreover, in 2010 Oribatida
density increased significantly with plant functional group richness and the
presence of grasses. In 2010 Gamasida density decreased slightly with the
presence of tall herbs (F <sub>1,70</sub> = 3.58), while in 2013 it increased
significantly with plant species richness and plant functional group richness as
well as the presence of legumes and slightly small herbs (F <sub>1,70</sub> =
3.01;). Prostigmata density increased slightly with plant functional group
richness (F <sub>1,70</sub> = 3.75) and significantly in presence of grasses but
only in 2010. In 2013, it was not significantly affected by experimental
treatments. Astigmata density was significantly higher at higher plant species
richness and in presence of grasses in 2010 (F <sub>1,70</sub> = 3.59) but not
in 2013.
PCA separated Oribatida species along the first axis explaining 48.2% of the
variability in species data and the second axis representing 15.99% of the
variability in species data. Separation along the first axis mostly represents
differences between Oribatida communities in 2010 and three months after the
flood in 2013 (r = 0.11) and the presence of legumes (r = 0.13) and grasses (r =
0.15). The second axis mainly represents differences with plant functional group
richness (r = 0.14) and presence of grasses (r = 0.19). Separation along the
first axis were due to e.g., *Oppiella nova* being more abundant three months
after the flood in 2013. Separation along the second axis was due to e.g.,
higher numbers of *Oribatula excavata* in plant communities with grasses.
Moreover, we found some species present at each of the sampling including
*Oppiella nova*, *Tectocepheus sarekensis*, *Oribatula excavata*, *Rhysotritia
ardua* and *Punctoribates punctum* as well as species present only three weeks
after the flood like *Zygoribatula frisiae* and *Schleloribates initialis*.
# Discussion
Collembola and Acari density as well as Collembola and Oribatida species
richness were affected drastically by the flood but recovered quickly, returning
within three months to levels recorded three years earlier (2010), despite of
the seasonal changes of the community, since generally the Collembola and Acari
abundance in autumn is higher than in summer (;). This reinforces
assumptions that microarthropods respond rapidly to environmental changes and
recover quickly. In 2010 Collembola and Oribatida species richness increased
with plant species and plant functional group richness, but these
interrelationships were absent three months after the flood. This suggests that
flooding resulted in homogenization of environmental conditions, eradicating
effects of plant community composition established before the flood. However,
three months after the flood Collembola species richness was increased in the
presence of tall herbs, and Oribatida density and richness were consistently
affected by grasses, indicating that effects of plant community composition were
in a stage of being reasserted.
As hypothesized, Entomobryidae, as epedaphic species, may benefit from their
dispersal ability thereby quickly recovering after the flood, presumably taking
advantage of increased fungal biomass in the most severely flooded plots. In
contrast to Entomobryidae, the euedaphic and hemiedaphic Tullbergiidae and
Isotomidae require habitable pore space and this likely contributed to the
delayed recolonization of the clogged flooded soils. They also are more reliant
on the recovery of the plant community. Isotomidae and Tullbergiidae are
sensitive to soil quality and root exudates, and are assumed to benefit from
increased root biomass and associated exudates in more diverse plant
communities. In 2010 the density of Isotomidae increased in presence of grasses
and tall herbs. Grasses increase root and microbial biomass, both likely
contributing to increased food resource supply to Collembola.
Oribatid mites are decomposers and have been used as indicators of soil
stability and fertility. Generally, they have low metabolic rates, slow
development and low fecundity. Consequently, they are vulnerable to
disturbances and recover slowly thereafter. However, higher densities
of Prostigmata and Oribatida than of Astigmata and Gamasida three weeks after
the flood suggest that the former two taxa are more resistant or recovered
faster to flooding than the latter. Detrimental effects of flooding may have
been alleviated by dead plant biomass functioning as shelter for them. Gamasida
are important predators of nematodes, which were negatively affected by the
flood. Moreover, ant activity was not influenced by the flood and Gamasida are
negatively affected by high ant activity. Notably, three months after the flood,
the density of Prostigmata was twice that in 2010. Prostigmata are dominant
Acari predators with a crucial role in soil food webs important as biological
control agents. Some species are known to benefit from habitat disturbance.
Prostigmata, Gamasida and Astigmata are assumed to be r-strategists frequently
occurring in disturbed habitats and quickly colonizing new habitats due to high
dispersal ability, high fecundity and fast development. However, in contrast to
Prostigmata, Gamasida and Astigmata did not take advantage of the flood. The
majority of Gamasida are mobile predators feeding on Nematoda, Collembola,
Enchytraeidae, larvae of Insecta and Acari. Conform to their assumed sensitivity
to environmental changes, their density increased with plant species and plant
functional group richness as well as in presence of legumes three months after
the flood in 2013. This likely resulted from increased availability of prey such
as Collembola (Isotomidae) and nematodes both increasing significantly with
plant diversity three months after the flood.
As ecosystems develop after disturbances, changes in soil are likely to be
associated by corresponding changes in the soil community. As indicated by the
dramatic decline in the density and species richness of Collembola and Acari,
flooding represented a strong disturbance for soil microarthropods. The
community composition of Collembola markedly changed after the flood and this
lasted for at least three months. On one hand some species were present at each
of the sampling dates, including *Lepidocyrtus lanuginosus*, *Lepidocyrtus
cyaneus and Willowsia buski* (Entomobryidae) as well as *Isotoma viridis*,
*Parisotoma notabilis* and *Isotomiella minor* (Isotomidae). Each of these
species had been recorded three weeks after the flood suggesting that they
survived the flooding in some of the plots and then recovered quickly confirming
their generalistic lifestyle. On the other hand, *Hypogastrura manubrialis*,
*Ceratophysella engadinensis* (Hypogastruridae), *Isotomurus fucicolus*,
*Proisotoma minuta* (Isotomidae), *Paratullbergia macdougalli* (Tullbergiidae),
*Protaphorura armata* (Onychiuridae) and *Sminthurus viridis* (Sminthuridae)
were present three weeks after the flood (as single individuals or in few
numbers only) but neither three months after the flood nor in 2010 before the
flood suggesting that a number of Collembola species were introduced by the
flood. In contrast, *Zygoribatula frisiae* and *Schleloribates initialis* of
Oribatida were only present three weeks after the flood. Furthermore, *Oppiella
nova*, *Tectocepheus sarekensis*, *Oribatula excavata*, *Rhysotritia ardua* and
*Punctoribates punctum* were present in all the dates and most of them quickly
increased in density suggesting they are resistant against disturbances and
respond in an generalistic way. In fact, these species are known as cosmopolitan
generalistic species present in any kind of habitat.
# Conclusion
The present study demonstrated that soil microarthropod communities (Collembola
and Acari) are affected heavily from summer flooding, but also that they are
able to recover quickly. Recovery was based in large on ubiquitous and resistant
species surviving the flood and able to form vigorous populations within short
period of time (three months). Mobile surface living species were the quickest
to recover and in part took advantage of resources made available due to
flooding (dead plant material). Widespread microarthropod species with wide
habitat niches recovered faster than those with more limited distribution and
more narrow niches. Overall, Collembola were more affected by flooding and
recovered faster than Acari. In contrast, recovery of community composition of
Collembola after flooding was slower than that of Oribatida. These conclusions,
however, were based on two sampling events following flooding and long-term
studies are needed to uncover the resilience of microarthropod communities to
extreme climate events such as flooding.
# Supporting information
We thank the gardeners and numerous student helpers for weeding and mowing of
the experimental plots and helping with data collection. We thank Tamara Hartke
and Laura Sánchez Galindo for support and helpful comments.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Liaoning Province, located in the northeast of China, is known in Chinese as
“the Golden Triangle” from its shape and strategic location. It was established
in 1907 as the name of Fengtian and changed to Liaoning in 1929, with an
estimated population of approximately 43.91 million in 2014
([www.stats.gov.cn](http://www.stats.gov.cn/)). The population is mostly Han
Chinese (83.94%) with minorities of Manchus (12.88%), Mongols (1.60%), Hui
(0.632%), Koreans (0.576%) and Xibe (0.317%). Liaoning Han individuals mainly
migrated from Shandong Peninsula during the hundred-year period starting at the
last half of the 19<sup>th</sup> century. “Chuang Guandong” is a description
that Han Chinese population, especially from the Shandong Peninsula and Zhili,
entered Manchuria. During the first two centuries of the Manchu Qing Dynasty,
Liaoning Province is the traditional homeland of the ruling Manchus with only
certain Manchu Bannermen, Mongol Bannermen, and Chinese Bannermen allowed in.
The region, now known as Northeast China, has an overwhelmingly Han population.
After the establishment of the People's Republic of China at the end of the
Chinese Civil War, further immigrations were organized by the Central Government
to "develop the Great Northern Wilderness", eventually peaking the population
over 100 million people. Thus, it is necessary and sufficient to investigate the
genetic background of Liaoning Han population and compare the genetic distance
with other population. Additionally, it is interesting to observe how much
admixture took place over the past 100 years among Han Chinese and other groups.
Y-chromosomal short tandem repeats (Y-STR) is a useful tool for inferring
genetic genealogy evolution and ancient human migration trajectories and timing.
The non-recombinant region of the Y-chromosome may play a potential role in
revealing the ethnic and regional representation of the Han Chinese population
owing to its significant phylogeographic information content. It can supply an
informative reference for investigating patterns of genetic variation in the Han
Chinese population across East Asia considering that the genetic and cultural
diversity among East Asian populations is still not fully understood. Autosomal
STR loci are usually applied in forensic personal identification and paternity
tests, which can provide a mighty powerful discrimination capability without
influenced by linkage disequilibrium. It can also be used to uncover the
population genetic backdrop and structure. The population data of autosomal STR
loci can be utilized to constructed the phylogenies and clarify the genetic
structure using genetic distance measurements, neighbor-joining dendrograms and
principal component analysis base on different genotyping frequencies.
Therefore, we investigated the frequencies of 25 Y-STR and 15 autosomal STR loci
in Liaoning Han population to expand the available population information for
forensic medicine and human genetic diversity. Population comparison was
performed between Liaoning Han population and different ethnic groups to better
understand the genetic background of the Liaoning Han population.
# Methods
## Study population
Three hundred and five blood samples were collected from unrelated healthy male
individuals living in Liaoning Province, Northeast China, after obtaining
written informed consent. The blood was then stained onto filter papers. Samples
were obtained and analyzed after approval from the Ethics Committee of China
Medical University.
## Data extraction, PCR amplification, and genotyping
Genomic DNA was extracted using Chelex-100. PCR amplification was performed
using AmpFISTR<sup>®</sup> Yfiler<sup>®</sup> Plus and Identifiler<sup>TM</sup>
PCR amplification kits (Thermo Fisher Scientific, CA, USA) in a
GeneAmp<sup>®</sup> PCR 9700 (Thermo Fisher Scientific, CA, USA) thermal cycler,
according to respective manufacturer specifications. The AmpFISTR<sup>®</sup>
Yfiler<sup>®</sup> Plus amplification kit (Thermo Fisher Scientific, Waltham,
MA, USA) can co-amplify 25 Y-STR loci with six dyes, including seven rapidly
mutating loci. The AmpFISTR<sup>®</sup> Identifiler<sup>TM</sup> PCR
Amplification kit (Thermo Fisher Scientific) can co-amplify 15 autosomal STR
loci and the Amelogenin locus with five dyes. Fragments of the 25 Y-chromosomal
and 15 autosomal STR loci were produced simultaneously. Separation and detection
of amplicons was performed on an Applied Biosystems™ 3500 Series Genetic
Analyzer (Thermo Fisher Scientific, Waltham, MA, USA). Data were analyzed using
GeneMapper *ID* v4.1 software (Thermo Fisher Scientific, Waltham, MA, USA).
Control DNA 007 was included as a standard reference in each batch of
genotyping. We strictly followed the recommendations of the DNA Commission of
the International Society of Forensic Genetics (ISFG) for Y-STR analysis.
## Data analysis
For Y-STR loci, allele frequencies and gene diversity were calculated using
PowerMarker v3.25. Haplotype frequencies, random match probabilities (sum of
squares) and haplotype diversity were calculated using Arlequin Software v3.5.
The discrimination capacity (DC) was determined as the proportion of different
haplotypes in each sample. A cluster structure of Y-STR haplotypes was generated
using the YHRD database (<http://www.yhrd.org/>). To compare data from the
studied Liaoning Han population with other published data, genetic distance
(*Rst* statistics) was measured by analysis of molecular variance (AMOVA) and
visualized using two multi-dimensional scaling (MDS) *Rst* plots via YHRD online
tools (<http://www.yhrd.org/Analyse/AMOVA>).
For autosomal loci, sample allele frequencies and exact Hardy-Weinberg
equilibrium (HWE) tests were calculated using PowerMarker v3.25. Values for
power of discrimination (DP), polymorphism information content (PIC), power of
exclusion (PE), and heterozygosity (He) were calculated using Power Stats v1.2
software that had been modified by Raquel, et al. to support and manage the
large amount of samples. Pairwise genetic distance (*Fst*) and *p values* for
each locus were calculated between populations using Arlequin v3.5 software.
Furthermore, Nei’s standard genetic distance between populations was generated
by the Phylip 3.69 package and visualized with Treeview software. Because the
published relevant data is limited, the included groups for population
comparison between Y-STR and autosomal STR are different.
# Results and Discussion
## Y-chromosomal STR
Two hundred and ninety-three different haplotypes were observed from 305
unrelated individuals. Among them, 281 were unique and 12 were shared by two
individuals. Null alleles were found in nine individuals at DYS448 and one
individual at DYS385, respectively. Haplotype diversity rendered a high value
(0.9997 ± 0.0003). Likewise, a high random match probability (0.0035) was
determined with a DC of 0.9607. Genetic diversity values of the 25 loci ranged
from 0.4525 (DYS391) to 0.9617 (DYS385). Among them, allele frequencies ranged
from 0.7016 (DYS438) to 0.0033 (DYS389I, DYS389II, DYS458, YGATAH4, DYS448,
DYS391, DYS456, DYS439, DYS481, DYS533, DYS576, DYS627, DYS460, DYS518, DYS449,
DYF387S1 and DYS385). Cluster analysis was performed for the 12 haplotypes that
were observed twice. Ancestry information showed that the haplotypes of the
Liaoning Han population most likely belonged to the East Asian-Sino Tibetan-
Chinese culture, which corresponds with its history, culture, and geographical
distribution. The powerful informative content of the 25 Y-STR loci in the
Liaoning Han population will be useful and interesting in forensic medicine and
enrich the Han Chinese population database.
## Autosomal STR
The distribution of allele frequencies, forensic efficiencies, and statistical
parameters across the 15 autosomal STR loci are presented in and Tables. Among
the 157 observed alleles, allele frequencies ranged from 0.5164 (TH01) to 0.0016
(D8S1179, D21S11, D7S820, D3S1358, D13S317, D16S539, D2S1338, D19S433, D18S51,
D5S818 and FGA). The DP ranged from 0.9621 (D2S1338) to 0.8177 (TPOX), with PE
distributing from 0.7521 (D18S51) to 0.2988 (TH01). The span of He was 0.8787
(D18S51) to 0.6066 (TH01). Except for CSF1PO (0.6993), D3S1358 (0.6775), TH01
(0.5973), and TPOX (0.5872), all autosomal STR loci were highly polymorphic (PIC
\> 0.7) with the most D18S51 (0.8435). No departures from HWE were observed
after Bonferroni’s correction for multiple testing (*p* \< 0.05/15).
## Population comparison
For Y-STR loci, we compared our haplotype data with that of the five populations
that were submitted to the YHRD database (Release 51), which included Austrian,
German, Polish, African and Native American. *Rst* values for genetic distance
demonstrated that haplotypes of the Liaoning Han population were significantly
different from those of the other five populations (all *p* values \< 0.05/5
after Bonferroni correction). As shown in the MDS plot, there were significant
differences between Liaoning Han population and the five population.
Furthermore, in order to comprehensively investigate the genetic substructure of
Liaoning Han population, the population comparison using the 16 shared Y-STR
loci except for DYS627, DYS460, DYS518, DYS449, DYF387S1, DYS481, DYS533, DYS576
and DYS570 was performed between Liaoning Han and 22 East Asian groups. They
included Anhui Han Chinese, Beijing Han Chinese, Guangdong Han Chinese, Guizhou
Han Chinese (YP001096), Jiangsu Han Chinese, Jiangxi Han Chinese, Jilin Han
Chinese, Shandong Han Chinese, Shanxi Han Chinese, Yunnan Bai (YP000902),
Xishuangbanna Dai (YP000903), Liaoning Hui (YP000819), Liaoning Korean, Liaoning
Manchu, Hunan Miao (YP001038), Liaoning Mongolian, Gansu Tibetan (YP001032),
Hunan Tujia (YP001037), Liaoning Xibe, Guangxi Zhuang (YP000591), Japanese and
Korean. *Rst* values for genetic distance demonstrated that haplotypes of the
Liaoning Han population were significantly different from those of the other 22
populations (all *p* values \< 0.05/22 after Bonferroni correction;). As shown
in the MDS plot, minor differences were observed when the Liaoning Han
population was compared to the Jilin Han Chinese, Beijing Han Chinese, Liaoning
Manchu, Liaoning Mongolian, Liaoning Xibe, Shandong Han Chinese, Jiangsu Han
Chinese, Anhui Han Chinese, Guizhou Han Chinese and Liaoning Hui populations; by
contrast, major differences were observed when the Liaoning Han population was
compared to Shanxi Han Chinese, Yunnan Bai, Jiangxi Han Chinese, Guangdong Han
Chinese, Liaoning Korean, Hunan Tujia, Guangxi Zhuang, Gansu Tibetan,
Xishuangbanna Dai, South Korean, Japanese and Hunan Miao populations.
Additionally, the populations’ distributions in the MDS plot corresponded with
their respective ethno-geographic origins. It is clear that Liaoning Han Chinese
has a close genetic distance with Southern Han population and Liaoning native
minorities, which indicated that Liaoning Han integrated gradually with natives,
such as Manchu, Mongolian and Xibe, following its geographical migration.
For autosomal STR loci, presents pairwise *Fst* and *p* values for
differentiation tests between the Liaoning Han ethnic group and nine additional
published populations; statistically significant differences (*p* \< 0.05/15)
were found between the Liaoning Han population and the China Miao population at
five STR loci, the China Bouyei population at four STR loci, the China Uygur and
Jinan Han populations at three STR loci, the Japanese population at two STR
loci, and the Korean and Shanghai Han populations at one STR locus. No
statistically significant differences were detected at any STR loci between the
Liaoning Han and the China Dong or Shaanxi Han populations. shows genetic
distances between populations. indicates clusters of unrooted phylogenetic trees
to mirror the historical and geographical backgrounds of the populations
compared. In culture custom, because most people in Northeast China trace their
ancestries back to the migrants from the Chuang Guandong era, Northeastern
Chinese were more culturally uniform compared to other geographical regions of
China. Therefore, people from the Northeast would first identify themselves as
"Northeasterners" before affiliating to individual provinces and cities
([http://chinaneast.xinhuanet.com](http://chinaneast.xinhuanet.com/)).
For Han Chinese population, the previous studies showed that it was intricately
sub-structured and clustered roughly to two (northern Han and southern Han) or
three (northern Han, central Han and southern Han) subgroups. The distinction
between southern and northern Han populations were reported by Chu et al using
the neighbor-joining method based on the data of STR loci. The Han Chinese group
has the same predecessors, the Yan Emperor and the Yellow Emperor in the Yellow
River Basin. However, the Han population has been forming a series of
relationships with different groups and coexisted with other ethnic groups since
thousands of years ago. Obviously, Liaoning Han population belonged to northern
Han subgroup according to the geographic distribution and historical cultural.
The population comparison based on Y-STR loci showed that Liaoning Han was an
independent endogenous ethnicity with a unique subpopulation structure. The
previous study showed that Liaoning Han had a close genetic distance with
Manchu, which was not as near as Han population of Jilin and Beijing, but nearer
than other ethnic groups. This result might indicate that the Liaoning Han
integrated gradually with natives, such as Manchu, Mongolian and Xibe, following
its geographical migration, which was corresponded with the historical records.
However, autosomal STR population comparison presented that there was no
significant difference between the Liaoning Han and the China Dong or Shaanxi
Han populations, which seemed to be contradictory to Y-STR results. This might
be due to the discrepancy of different genetic markers. Consequently, Liaoning
Han population owns its unique genetic characteristics that are different from
Han population from other provinces, except for Jilin Han population.
There were two potential limitations in the present study. First, the analysis
of the Y chromosomal and autosomal STR loci could not provide the precise and
reliable data for population comparison with the absence of the whole genome
data. Second, the included groups for population comparison between Y-STR and
autosomal STR are different, due to the limited available relevant data. Thus,
more genetic investigations need to do in order to better understand the
characteristics of Liaoning Han Chinese population.
# Conclusion
The population comparison demonstrates that the Liaoning Han population is an
independent endogenous ethnicity and still owns its unique genetic
characteristics. In summary, the reported genetic characteristics of the 25
Y-STR and 15 autosomal STR loci allelic frequencies and haplotype distributions
of the Liaoning Han population are informative for forensic investigation and
paternity testing. The results could help inferring the genetic genealogy
evolution and ancient human migration patterns.
# Supporting Information
STR short tandem repeat
AMOVA analysis of molecular variance
MDS multi-dimensional scaling
HWE Hardy-Weinberg equilibrium
DP power of discrimination
PIC polymorphism information content
PE power of exclusion
He heterozygosity
Fst Pairwise genetic distance
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceived and designed the experiments:** BW. **Performed the
experiments:** JY. **Analyzed the data:** JY. **Contributed
reagents/materials/analysis tools:** JY. **Wrote the paper:** BW.
|
# Introduction
*Streptococcus gallolyticus* subsp. *gallolyticus*, formally known as
*Streptococcus bovis* biotype I, belongs to the Lancefield group D Streptococci,
is a normal inhabitant of the animal and human gastrointestinal tract, and
appears in 2.5 to 15% of healthy humans. On the contrary, its frequency in the
digestive tract of animals and the absolute frequencies in various species are
not well described. To date, there is only one study, which estimated the
percentage of *S*. *gallolyticus* subsp. *gallolyticus* in feces of turkeys. The
detection rate in fecal samples of turkeys is 91%. It was also identified in
pigeon, bovine and chicken as commensal bacterium. However, *S*. *gallolyticus*
subsp. *gallolyticus* can also act as a facultative pathogen, causing sepsis,
meningitis and infective endocarditis (IE) in humans and animals. Human IE is
especially associated with colorectal cancer. The incidence of group D
*Streptococcus*-associated diseases is increasing in the south of Europe. The
detection in humans and animals as a causative agent producing the same clinical
symptoms leads to the assumption that *S*. *gallolyticus* subsp. *gallolyticus*
may be a zoonotic pathogen. Investigations in France and Spain suggest a
correlation between a rural residency and the presence of the facultative
pathogen. The transmission of the potential zoonotic pathogen may be directly by
smear or droplet infections or indirectly from surfaces contaminated with *S*.
*gallolyticus* subsp. *gallolyticus*. The transfer of the bacterium through a
closer contact with colonized or infected animals is also discussed as a
possible mechanism. It was described as an important risk factor for the
transmission of *Streptococcus suis* between infected animals and humans.
Epidemiologic analyses in a laying hen flock in North Rhine Westphalia also
contribute to the assumption that a closer occupational contact with colonized
laying hens may be a potential risk factor for the colonization of the
gastrointestinal tract with *S*. *gallolyticus* subsp. *gallolyticus*, since the
bacterium was identified as the causative agent of IE of the farm owner. In
addition to the detection of *S*. *gallolyticus* subsp. *gallolyticus* in
eukaryotic organisms, it was also identified in milk and raw milk products
(especially in dairy cows with mastitis) and red meat. The detection in food
leads to the assumption that the transmission of *S*. *gallolyticus* subsp.
*gallolyticus* between animals and humans can be connected to dietary habits.
Exemplarily, *Streptococcus equi* subsp. *zooepidemicus* was transmitted through
the consumption of unpasteurized raw milk in an outbreak setting. There have
been no investigations to date which systematically analyze the correlation
between dietary habits or the contact with animals and the detection of *S*.
*gallolyticus* subsp. *gallolyticus* in the human gut. Therefore, we conducted
an epidemiological study which is comprised of two parts: Firstly, the case-
control study to determine the prevalence of *S*. *gallolyticus* subsp.
*gallolyticus* and the associated risk factors for the colonization of the human
gut, and secondly, multilocus sequence typing (MLST) to characterize the *S*.
*gallolyticus* subsp. *gallolyticus* population structure. This analysis
identified a correlation between lifestyle habits and the human gastrointestinal
colonization with *S*. *gallolyticus* subsp. *gallolyticus*.
# Material and methods
## Sample and data acquisition
A retrospective case-control study was conducted at the Herz- und
Diabeteszentrum Nordrhein-Westfalen (Bad Oeynhausen, Germany) from December 2012
to July 2015. The case-control study used word of mouth to recruit people. All
data are collected in pseudonymous form. A total of 135 volunteers from the
north and west of Germany participated in this study. Written consent was
required for the case-control study. Fecal samples were tested and a
questionnaire was completed by each volunteer to analyze the correlation between
the fecal presences of *S*. *gallolyticus* subsp. *gallolyticus* and potential
risk factors. Furthermore, seven SGG-culture-positive tested healthy volunteers
were selected and were analyzed two to three times to estimate the
gastrointestinal presence of *S*. *gallolyticus* subsp. *gallolyticus* in a
follow-up period (follow-up study). Participants were excluded from the study if
there was no fecal sample, no completed questionnaire or no written consent. In
addition, only healthy volunteers (without gastrointestinal diseases or IE) over
18 years were included for the identification of risk factors. These data were
received from the questionnaires. People were also excluded if an antibiotic
therapy was indicated six months prior to participation.
The study was approved by the ethics commission of the Ruhr University Bochum
Faculty of Medicine.
## Stool investigations
### DNA extraction
DNA extraction of homogenized fecal samples was performed by using NucliSENS
easyMAG (Biomerieux, Nürtingen, Germany). DNA extraction was generally performed
according to the manufacturer’s instruction. The fecal samples were pretreated
by inoculating material (about 0.1 g) in 1 ml PBS in a tube with Zirconia beads,
mixed for 5 min, incubated for 10 min at room temperature and then centrifuged
at 12000 × *g* for 2 min. A quantity of 200 μl of the supernatant was used for
the extraction of the whole DNA. After prelysis within the NucliSENS easyMAG,
100 μl magnetic silica particles were added and extraction was performed as
described by the manufacturer. DNA was eluted in 55 μl elution buffer.
### Real-Time PCR
The detection of an internal fragment of the *recN* gene was used to screen
fecal specimens for the detection of *S*. *gallolyticus* subsp. *gallolyticus*.
The PCR amplification for the presence or absence of this gene was carried out
within a 50 μl reaction volume containing 5 μl template DNA, 5 μl
Platinum-*Taq*-buffer (ThermoFisherScientific, Darmstadt, Germany), 200 nM of
each primer (F-recN SGG/P: `5’-GATTTTCAAGTCCAATTCACCAAAG-3’`, R-recN SGG/P:
`5’-GGTTYGTTGAAATGTAAAATTCAACAG-3’`; LifeTechnologies, Darmstadt, Germany), 100
nm of the Pf-recN/SGG-probe (`5’-FAM-TTCAATCGTGATGGCAA-MGB-3’`;
LifeTechnologies, Darmstadt), 240 μM dNTPs (Fermentas, Leon-Rot, Germany) and
0.25 μl Platinum-*Taq*-polymerase (ThermoFisherScientific, Darmstadt). The
detection of *S*. *gallolyticus* subsp. *pasteurianus* was performed using the
Pv-recN/SGP-probe (`5’-VIC-TCAACCGTGATGGAAA-MGB-3’`) and the same primers
denoted above. The internal control used in the reaction mix was CMV-DNA (CMV-
TM2-F: `TTYTTAGCACGGGCCTTAGC`, CMV-TM2-R: `AAGGAGCTGCATGATGTGASC`; CMV-TM2-S:
`CY5-TGCAGTGCACCCCCCAACTTGTT-BHQ2`;). Diluted DNA extracted from a bacterial
overnight culture of *S*. *gallolyticus* subsp. *gallolyticus* (ATCC BAA-2069)
or *S*. *gallolyticus* subsp. *pasteurianus* (DSM 15351) was used as positive
control and water as negative control to verify the specificity of the PCR
reaction. A two-step PCR on the Rotor Gene Q platform (Qiagen, Hilden, Germany)
was performed. Amplification of PCR products was carried out as follows: initial
denaturation at 95°C (5 min) followed by 50 cycles, and a denaturation 95°C (15
s), annealing and elongation step at 60°C (60 s).
### Selective cultivation
Real-time PCR *S*. *gallolyticus* subsp. *gallolyticus* positive-tested fecal
samples were further selectively cultivated on modified trypton soya agar (TSA)
(0.5% tannic acid pure (AppliChem GmbH, Darmstadt, Germany, 0.25 g/l sodium
acetate, Merck, Darmstadt, Germany), as described previously. Briefly, the
homogenized fecal sample was streaked out onto selective medium before weighing
and suspending in PBS buffer. Then, 1 g of homogenized fecal sample was
suspended in 1 ml PBS medium, mixed and streaked out with PBS (duplicate) and
100 μl was plated as triplicate onto sodium acetate tannic acid TSA. It was then
incubated at 37°C and 5% CO<sub>2</sub> for 48 h. In parallel, an overnight
grown culture of *S*. *gallolyticus* subsp. *gallolyticus* was plated onto
modified TSA. Single putative *S*. *gallolyticus* subsp. *gallolyticus* colonies
were selected and analyzed regarding species and subspecies level by matrix-
assisted laser desorption ionization—time of flight mass spectrometry (MALDI-
TOF-MS) and *sodA* sequencing.
## Multilocus sequence typing
Multilocus sequence typing was performed, as described preciously. In brief, the
total DNA of *S*. *gallolyticus* subsp. *gallolyticus* isolates was isolated by
using a QIAamp Blood Mini Kit (Qiagen, Hilden, Germany) and 5 μl was used for
each fragment amplification. Partial sequences of the housekeeping genes *aroE*,
*glgB*, *nifS*, *p20*, *tkt*, *trpD* and *uvrA* were amplified, sequenced and
analyzed. All detailed protocols can also be found on
[www.pubmlst.org](http://www.pubmlst.org). The determination of sequence types
(STs) was undertaken using the pubMLST database and Bionumerics Software 6.6
(Applied Maths, Sint-Martens-Latem, Belgium). For the characterization of the
strains a minimum spanning tree was generated and eBURST version 3 (based upon
related sequence types; [www.mlst.net](http://www.mlst.net)) was used to
calculate clonal complexes.
## Questionnaire
The questionnaire included 25 questions and sought data on the following
aspects: personal characteristics (age, gender, gastrointestinal diseases,
residence \[urban, rural, landscape—near the forest/farm\] and antibiosis),
contact with animals (living or working on a farm, private or occupational
contact) and dietary habits (consumption and handling of minced meat, raw milk
or raw milk products). The exposure factors as well as the absolute frequencies
can be found in.
## Statistical analysis
The statistical analysis software SPSS version 21 was used. Binary logistic
regression was utilized to establish a model to determine the simultaneous
influence of potential risk factors. Six independent variables (age, gender,
consumption of raw animal products, close animal contact, usage of animal waste)
were tested within the multiple logistic regression model to verify adjusted
odds ratios (ORs). Statistical tests were considered to be significant if the
p-value was less than 0.05. A confidence interval of 95% was used for both
calculations. Forest plots were generated using Microsoft Excel. The age was
listed as mean plus/minus standard deviation.
# Results
A total of 134 participants (65 men and 69 women with a mean age of 48.4 ± 14.9
years) were included in the case-control study. After the application of
exclusion criteria, 99 healthy volunteers were included to identify potential
risk factors for the colonization of the human gut with *S*. *gallolyticus*
subsp. *gallolyticus*. The fecal samples of healthy volunteers were screened by
PCR for the presence of the facultative pathogen. *S*. *gallolyticus* subsp.
*gallolyticus* was detected in 62.5% (n = 59) of the 99 fecal specimens of
healthy volunteers. The presence of *S*. *gallolyticus* subsp. *pasteurianus*
was also estimated using the VIC labeled probe in the PCR reaction mix. This
bacterium was detected seven times out of 99 volunteers. Real-time PCR testing
also identified three subjects who were colonized with *S*. *gallolyticus*
subsp. *gallolyticus* as well as *S*. *gallolyticus* subsp. *pasteurianus*
simultaneously. These volunteers are recognized in the *S*. *gallolyticus*
subsp. *gallolyticus*-positive group.
*S*. *gallolyticus* subsp. *gallolyticus* PCR-positive specimens were cultured
on selective medium to isolate this bacterium for epidemiologic characterization
by MLST. Three isolates, namely HDZ 1323, HDZ 1330 and HDZ 1332, were detected
by culture and mass spectrometric analyses, and *sodA* sequencing confirmed *S*.
*gallolyticus* subsp. *gallolyticus*. In addition to *S*. *gallolyticus* subsp.
*gallolyticus*, three out of seven *S*. *gallolyticus* subsp. *pasteurianus*
isolates were identified by MALDI-TOF MS and sequencing of the partial fragment
of the *sodA* gene. In this regard, the real-time PCR demonstrated one
inconsistent result: *S*. *gallolyticus* subsp. *gallolyticus* was detected
instead of *S*. *gallolyticus* subsp. *pasteurianus*.
The *S*. *gallolyticus* subsp. *gallolyticus* isolates selected were further
typed using MLST. It revealed the sequence types ST 3 (HDZ1330), ST 7 (HDZ1323)
and the newly defined ST 105 (HDZ1332). Bionumerics Software 6.6 was used to
utilize for the construction of a minimum spanning tree. The minimum spanning
tree of the strains revealed no phylogenetic relationship of these detected STs.
The allelic profiles (STs) show no identical allelic numbers within the
identified sequence types of the case control study (one exception: the number
of the *nifS* allele from ST 3 and 7). The ST 3 was already identified in human
heart valve cultures and from the intestine of a bovine, which was also detected
for ST 7 isolates (, [www.pubmlst.org](http://www.pubmlst.org)).
In order to identify the *S*. *gallolyticus* subsp. *gallolyticus* status in the
gastrointestinal tract over time, a follow-up investigation of seven culture
positive tested healthy volunteers was performed until the end of the study (a
total of 2 to 3 samples per person). Initially, six fecal specimens were
screened as real-time PCR positive for *S*. *gallolyticus* subsp. *gallolyticus*
and one sample was tested as positive for *S*. *gallolyticus* subsp.
*pasteurianus*. Selective cultivation offered three *S*. *gallolyticus* subsp.
*gallolyticus* and one *S*. *gallolyticus* subsp. *pasteurianus* isolate.
Further analyses of specimens revealed *S*. *gallolyticus* subsp. *gallolyticus*
in four cases at any tested time point by using real-time PCR (volunteer 4 to
7). As an example, the first (January 2015) and second sample (March 2015) were
tested as positive and the third specimen in July 2015 was tested as negative
(volunteer 3). The fecal sample of the 7th volunteer was initially tested as
positive (April 2013) and the second sample 26 months later was detected as
positive for the presence of *S*. *gallolyticus* subsp. *gallolyticus*. At
least one exception was identified. The PCR results of the second sample from
volunteer 1 showed the presence of both subspecies, and *S*. *gallolyticus*
subsp. *pasteurianus* was isolated using modified trypton soya agar.
Based on the real-time PCR detection of the bacterium in fecal samples, cases
and controls were defined: 59 cases (male/female \[m/f\] ratio: 25/34) and 40
controls (m/f ratio: 21/19). The cases included an age distribution from 20 to
70 years with a mean value of 44.2 ± 14.6 years and controls from 22 to 82 years
with an average of 49.2 ± 15.0 years. The cases and controls were analyzed in
terms of their nutrition habits, contact with animals and residence (rural,
urban; forest or farm next to their residence). The frequencies of potential
risk factors observed in cases and controls are listed in. Logistic regression
was performed to analyze the simultaneous effect of risk factors and adjusted
ORs were calculated and presented as a forest plot.
Multiple expositions often characterize the outcome of a disease or different
event such as the *S*. *gallolyticus* subsp. *gallolyticus* colonization of the
human gastrointestinal tract. Adjusted ORs were calculated to assess the
simultaneous effect of the variables. A closer animal contact between volunteers
and animals (OR: 3.27, CI: 1.23–8.68; *p* = 0.02) and the usage of animal waste
to fertilize plants (OR: 3.43, CI: 1.08–10.94; *p* = 0.04) demonstrate
significant risk factors for the transmission between animals and humans and to
colonize the gastrointestinal tract of healthy people.
In conclusion, simultaneous testing of exposure factors indicate a higher risk
of being colonized with *S*. *gallolyticus* subsp. *gallolyticus* of
participants who have a direct contact with animals and utilization of manure.
Furthermore, two out of three *S*. *gallolyticus* subsp *gallolyticus* isolates
reveal the STs 3 and 7. These STs were previously isolated from human blood
cultures and bovine (, [www.pubmlst.org](http://www.pubmlst.org)).
# Discussion
The knowledge of transmission pathways and the zoonotic potential of the
facultative pathogen *S*. *gallolyticus* subsp. *gallolyticus* are quite
limited. Thus, a systematic approach was conducted for the first time to
determine the latter’s occurrence in the gut of healthy people and to describe
the risk factors for the transmission of the bacterium and its colonization of
the human gastrointestinal tract. *S*. *gallolyticus* subsp. *gallolyticus* is
an opportunist of the gastrointestinal tract in humans and animals with varying
prevalence in the healthy human population of 2.5 up to 15%, but the *S*.
*bovis* fecal carriage increased three to five times in patients with colorectal
cancer and inflammatory bowel disease. In comparison to the previous studies
real-time PCR screenings of fecal samples offer a much higher prevalence in
healthy volunteers of 62.5%. Spanish real-time PCR investigations of patients
who underwent colonoscopy revealed 11.1% *S*. *gallolyticus* subsp.
*gallolyticus*-positive and 13% *S*. *gallolyticus* subsp.
*pasteurianus*-positive rectal swabs. It indicates a similar portion of both
subspecies in the gastrointestinal tract, which cannot be confirmed by real-time
PCR screenings of feces from participants of the case-control study. Similar
results were detected for the presence of *S*. *gallolyticus* subsp.
*pasteurianus*. The detection of both subspecies using real-time PCR may
indicate a co-occurrence in the digestive tract, which was also suggested by
Lopes *et al*..
The divergences observed between previous studies may be a resumé of the sample
sets analyzed (colonoscopy, feces, rectal swabs) or the kind of screening
methods (cultivation, molecular techniques) to identify or isolate *S*.
*gallolyticus* subsp. *gallolyticus*. A higher sensitivity of the molecular
screening method was demonstrated by positive real-time PCR results in
comparison to selective cultivation and was also confirmed in the follow-up
study. The complexity and characteristics of the sample type and difficulties in
homogenization as well as the gut microbiota may influence the PCR results (e.
g. inhibitors) and the selective cultivation. It explains not only false
negative real-time PCR results, but also discrepancies between *S*.
*gallolyticus* subsp. *gallolyticus*-positive culture and the *S*.
*gallolyticus* subsp. *pasteurianus*-positive real-time PCR screening results.
As suggested in a 17-year follow-up study, the prospective investigations of
seven participants achieved shifts in the composition of the gut microbiome,
which was e. g. demonstrated for the participant three. Nutrition and medicines
shape the gut microflora (e. g. antibiotics), whereas antibiotics change the gut
composition up to one year. This may also be transferred to our follow-up study.
Although the participants with an antibiotic therapy were excluded it is not
known if the composition of the gut microbiome affects the presence of *S*.
*gallolyticus* subsp. *gallolyticus* in the gut. However, the sample age may be
of more importance than the sample characteristics, microbiota or processing.
The fecal samples were sent to the laboratory by mail. Consequently, samples
could be in transit for three days before processing in the laboratory. Although
a survival of *S*. *gallolyticus* subsp. *gallolyticus* was demonstrated *in
vitro* in *S*. *gallolyticus* subsp. *gallolyticus*-negative tested human stool
specimens for 14 d at RT (20°C) (real-time PCR and cultivation; data not shown)
it cannot be ruled out, that the growth of other gastrointestinal bacteria may
inhibit growth of *S*. *gallolyticus* subsp. *gallolyticus* or a less
concentration of *S*. *gallolyticus* subsp. *gallolyticus* in the feces may
effect a false negative cultivation. It is assumed that the presence of the same
diseases in animals and humans may be a hint that *S*. *gallolyticus* subsp.
*gallolyticus* is a zoonotic pathogen. This was supported by MLST, which typed a
blood culture isolate of an animal farmer and excrements of the chicken of his
laying hen farm with the same ST. Interestingly, the human fecal isolates which
were identified in this case-control study were differentiated into the STs 3
and 7 and the new identified ST 105. ST3 and 7 were associated with human blood
culture isolates and were also identified in cattle (unknown infective status).
Thus, these results support the potential transmission of *S*. *gallolyticus*
subsp. *gallolyticus* between animals and humans and highlight the zoonotic
potential of the facultative pathogen. As described previously, it might be the
case, as there seems to be some STs (as is the case of ST 7 or ST 3) that seem
more associated with humans or animals whereas other isolates are more
predominant in animals and humans (e. g. isolates of the clonal complex 45 and
6). A prevalence of 62.5% in human feces described in this study and a high
prevalence in organic turkey flocks give rise to the question if *S*.
*gallolyticus* subsp. *gallolyticus* belongs to the common gut microbiome of
animals and humans. However, for this conclusion further systematic analyses
have to be performed.
Among other diseases, *S*. *gallolyticus* subsp. *gallolyticus* causes IE and is
associated with colorectal diseases in humans. Both diseases are generally more
often observed in male patients over 50 years old and various studies
demonstrated the same positive association between the isolation of *S*.
*gallolyticus* subsp. *gallolyticus* in men and the elderly population and IE,
which was not identified in this study. To identify a relationship between the
one-year increasing age and the detection of the bacterium in the digestive
tract more people have to be tested.
The facultative pathogen is the most frequently detected agent in cases of
infective endocarditis in rural regions (especially in the cattle and milk
production area) in the south of Europe, which cannot be observed in this case
control study and should be figured out in further investigations. Joined
together with living in the countryside, a close contact with animals was
supposed to be a transmission source of the bacterium, it was demonstrated for
the first time that a closer contact with animals is a significant exposure
factor to be colonized with *S*. *gallolyticus* subsp. *gallolyticus*. It can be
assigned as risk factors for the transmission of *S*. *gallolyticus* subsp.
*gallolyticus* between animals and humans and its establishment in the human
gut. Another interesting fact is the kind of animal species which come into
contact with people. Although dogs and horses are described in the literature as
a source of isolation and are common pets, it is not known whether these animals
belonging to the volunteers are colonized with the bacterium. In this context,
it is remarkable that fertilization of plants with the excrement of animals
increases the risk of carrying *S*. *gallolyticus* subsp. *gallolyticus*
significantly. Consequently, it is imaginable that *S*. *gallolyticus* subsp.
*gallolyticus* may be transferred directly from animals to humans by smear
infections and colonizes the gastrointestinal gut and, thus, can be accounted as
a significant risk factor. However, the prevalence of *S*. *gallolyticus* subsp.
*gallolyticus* in animals is still unknown. The bacterium has often been
identified in, for example, pigeons, chicken and turkeys. Therefore, future
studies should also include investigations of animal excrement in addition to
human specimens to verify the prevalence in animals, too, and to estimate the
real risk to human health.
Derived from this hypothesis, not only the animal contact, but also the
consumption of or the contact with contaminated food, such as red meat or milk
products, may promote the colonization of the human gut and are propagated as
exposure factors for the transmission of the bacterium from animals to humans.
In total, statistical analyses demonstrate that raw food products play a minor
role the colonization process. It was assumed that eating raw minced meat may
promote the colonization of the human gut. More interestingly, because of the
high frequencies of isolation in turkeys and laying hens, the consumption and
processing of poultry and eggs and its function as a transmission source from
animals to humans should be focused on in following research perspectives and
participants should be ask about their habits in terms of processing and eating
chicken meat and eggs. At the beginning of this case-control study the high
prevalence was not known. The transmission from poultry to humans is well-known
for *Campylobacter*. The main significant risk factor for the transmission of
this species to humans is particularly bought fresh chicken (OR 5.80; 95%-CI:
2.11–15.93), whereby it was decreased by eating fruit, raw vegetables, high-
fiber cereals, vitamins and acidified milk products.
In summary, the case-control study conducted demonstrates a very high prevalence
of *S*. *gallolyticus* subsp. *gallolyticus* in the gastrointestinal tract of
healthy volunteers. In accordance with other researchers, it is essential to
determine at least the subspecies or the biotype of the *S*. *bovis* strains to
establish the identification of the frequency of *S*. *gallolyticus* in
correlation with colorectal cancer, IE and other diseases, as well as its global
impact to assess the risk to the human population. The data collected were
evaluated with the help of multivariate statistical analyses to identify risk
factors for the colonization of the human gut with the facultative pathogen. The
simultaneous observation of exposure factors identified the closer contacts with
animals and the usage of animals waste as significant risk factors for the
detection of *S*. *gallolyticus* subsp. *gallolyticus* in human feces. Further
investigations have to be performed to clarify the impact of chicken meat
products and protective factors, such as vegetables. In addition, future studies
should also include participants with e. g. gastrointestinal disorders
associated with *S*. *gallolyticus* subsp. *gallolyticus* to detect the zoonotic
pathogenicity of the Gram-positive bacterium to the health status of animals and
humans and to determine the rate of *S*. *gallolyticus* subsp. *gallolyticus*
fecal colonization. Another approach would be a prospective cohort study of
people carrying *S*. *gallolyticus* subsp. *gallolyticus* or modifications of
the gut microbiome along with environmental factors to detect the time-dependent
influences on human health.
In addition to the detected potential risk factors, the vitality outside the
gastrointestinal tract is also important for the direct or indirect transmission
of the bacterium between animals and humans or between the environment and
animals or humans, and should be pointed out in future studies.
# Supporting information
This work was supported by Ruhr-Universität Bochum Medizinische Fakultät
(FoRUM). We thank Philip Saunders (LL.B., B.Ed., FRSA) for his linguistic
advice.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** J. Dreier CK TV. **Data curation:** J. Dumke.
**Formal analysis:** J. Dumke. **Investigation:** J. Dumke. **Methodology:**
J. Dumke OA. **Project administration:** J. Dreier CK. **Resources:** CK J.
Dreier. **Software:** J. Dumke. **Supervision:** CK. **Validation:** J.
Dumke TV. **Visualization:** J. Dumke. **Writing – original draft:** J.
Dumke. **Writing – review & editing:** J. Dumke OA.
|
# Introduction
The measurement of levels of HIV viremia in blood is the cornerstone of
laboratory monitoring of anti-retroviral therapy (ART). In resource-limited
settings, where most HIV infections occur, a mere 50% of patients on ART are
currently routinely monitored using viral load testing. Improved access to this
critical laboratory assay is urgently needed as global and national initiatives
aim to provide medical care to increasing numbers of HIV-infected individuals,
including those living in hard-to-reach geographical areas.
HIV viral load determination is best achieved in fresh plasma specimens, with
viral RNA quantification performed in laboratories using sophisticated
equipment. Plasma must be separated from the cellular elements of blood within 6
hours post venesection, and then stored at -20°C or -80°C until testing in order
to prevent degradation of RNA. In resource-limited settings, especially in
primary health care centers where most HIV-infected patients seek medical care,
the separation of plasma and its timely transport to a usually small number of
distant laboratories is an overwhelming task. This is mainly due to weaknesses
in health systems, including shortage of human resources, lack of logistical
capacity and poor cold chain infrastructure.
Many countries have implemented dried blood spots (DBS) to simplify the
logistics of transporting clinical specimens to laboratories for viral load
testing. Whole capillary or venous blood is spotted onto filter paper cards to
prepare DBS. This method of whole blood collection has been very successfully
implemented for diagnosing HIV-infection among infants younger than 18 months
through the qualitative detection of HIV-1 proviral DNA. The comparative
advantages of DBS include their ease of transportation, lack of cold chain needs
and low biosafety requirements. However, HIV viral loads performed on DBS
specimens are poorly correlated to those determined in plasma since whole blood
contains also cell-associated RNA molecules and proviral DNA. Hence, viral load
results from DBS specimens at clinicaly relevant threshold of 1000 copies/ml are
frequently inaccurate and can mislead clinical-decision making. Viral load
results from DBS specimens are more acurate at the threshold of 5000
copies/ml
The cobas<sup>®</sup> plasma separation card (Roche Diagnostics GmbH, Mannheim,
Germany) (PSC) is a novel specimen collection and transport device, that allows
for simultaneous collection of whole blood and plasma separation without the use
of additional equipment. These cards maintain all the comparative advantages of
DBS, while providing plasma as a matrix for laboratory assays. A recent study
under controlled conditions in South Africa showed that viral load results
determined using PSC correlated well with those generated using plasma. Our
study aimed at evaluating the performance of the PSC for HIV-1 viral load
testing in patients attending primary health care facilities under routine
health system conditions in Maputo City, Mozambique.
# Materials and methods
## Study design and participants
This cross-sectional study consecutively enrolled 613 HIV-infected adults
receiving antiretroviral therapy (ART) between August 2018 and October 2018. The
study was conducted at two primary health care centers in Maputo City, the
Polana Caniço and the Primeiro de Maio Health Centers. These health centers
provide a range of HIV-related clinical services, including ART initiation and
follow-up. Both clinics routinely collect DBS specimens for viral load
monitoring and send these to the Instituto Nacional de Saúde laboratories
located approximately one hour driving distance from the health facilities for
testing.
For each enrolled study participant, a single viral load testing was conducted
on plasma, DBS and cobas<sup>®</sup> PSC prepared from venous blood; and
cobas<sup>®</sup> PSC prepared from capillary blood. Technicians performing
laboratory testing for one method were blinded to results generated by other
methods. Standardised data collection forms were used to collect demographic
data from all participants, including sex, age, ART regimen and length of time
on ART.
## Specimen collection
The cobas<sup>®</sup> PSC (*Roche Molecular Systems*, *Pleasanton*, *CA*, *USA*)
is a blood collection and plasma stabilizing device that facilitates the
filtration of whole blood into dried plasma spots. The device comprises a porous
membrane which allows only plasma to filter through, while retaining all other
blood components. After drying the specimen on the card, it can be transported
under a wide range of environmental conditions to a central testing laboratory.
Detailed description of how PSC works is available in a recent publication of
Carmona et al (2019).
For this study, the cobas<sup>®</sup> PSC (*Roche Molecular Systems*,
*Pleasanton*, *CA*, *USA*) was prepared using both capillary and venous blood
from each study patient. The capillary PSC specimen was collected using a single
use safety lancet blue blade with a penetration depth of 2.0 mm for finger
puncture. After puncturing, three capillary tubes marked 140μl provided with the
test kit was used to collect a total of 420 μl of whole blood per card from each
patient. After collection, blood in each capillary tube was transferred onto
each of the three delineated areas of the card. In addition, 6.0ml venous blood
was collected in a BD Vacutainer<sup>™</sup>K<sub>2</sub>EDTA (Becton, Dickinson
and Company, 1 Becton Drive, Franklin Lakes, NJ 07417–1880, US) tube from each
patient. Pasteur pipette was used to transfere one to two drops of whole blood
onto each of delineated areas to get five full spots of the DBS card (Ahlstrom
Germany GmbH) and an additional cobas<sup>®</sup> PSC was prepared using venous
blood. The remnant anticoagulated whole blood was transported to Instituto
Nacional de Saúde laboratories within 6 hours post venesection, for plasma
separation and storage at -80°C until viral load testing. All three cards (2
cobas<sup>®</sup> PSC and 1 DBS) were placed overnight in a single-usage drying
rack at room temperature. After drying, the cards were packed in separate gas
impermeable zip-lock bags with desiccant and shipped to Instituto Nacional de
Saúde laboratories for testing. All cards were stored at -80°C upon arrival at
the testing laboratory. All staff involved in specimen collection for the study
routinely collects DBS specimens for viral load, however in the context of this
study were trained on PSC and DBS specimens collection and packing. Testing of
study specimens (plasma and cobas<sup>®</sup> PSC) followed the routine schedule
of the laboratory, with DBS specimens having the priority as part of the medical
management of patients.
## Specimen preparation
Whole blood anticoagulated specimens were centrifuged at 800-1600g for 20
minutes at room temperature to obtain plasma, of which 1100μl was used for viral
load testing. One spot of DBS was eluted in phosphate buffered saline, pH 7.4
(1X) and incubated at room temperature for 30 minutes. After the incubation,
specimens were manually homogenized and immediately loaded into the CAP/CTM v2
for testing using the free virus elution Roche protocol. For the
cobas<sup>®</sup> PSC, one spot was eluted in Sample Pre-Extraction (SPEX)
solution (*Roche Molecular Systems*, *Pleasanton*, *CA*, *USA*), incubated in a
thermomixer at 56°C and 1000 rpm for 10 minutes and then immediately loaded into
CAP/CTM96 for testing.
## Viral load testing
Viral load testing on DBS specimens was performed as part of the routine patient
monitoring, whereas plasma and PSC specimens were tested for study purposes.
Testing for all specimens was carried out at the Instituto Nacional de Saúde
using the Roche CAP/CTM 96 HIV-1 Quantitative Test v2 (Roche Molecular
Diagnostics, Branchburg NJ, USA), according to the manufacturer’s instructions.
The test definition files used for HIV viral load measurement was HI2PSC96 for
cobas<sup>®</sup> PSC specimens, IFS96CDC for DBS specimens and HI2CAP96 for
plasma specimens. Interpretation of viral load results was performed according
to manufacturers’ instructions, which establish 20, 400 and 738 copies/ml of
viral RNA as the low limit of detection for plasma, DBS and PSC specimens,
respectively. These differences on limit of detection are prominent, but not
clinically relevant on perspective that all specimens with VL bellow 1000
copies/ml will have the same approach. However, a lower limit of detection of VL
in PSC specimens can be used to monitor VL in patients with low-level viremia.
The reference laboratory routinely participates in and passed external quality
assessment programs for viral load (provided by the US Centres for Disease
Control and Prevention, Atlanta, USA) prior to and during the study period.
## Statistical analysis
When viral load results (copies/ml) were log10-transformed, those with non-
quantifiable viral load results with values below the limit of detection (LOD)
for each specimen type, were assigned a value of 1 copies/ml to enable
quantitative log10 transformation and for graphic visualization. Values from
plasma testing were regarded as the reference for calculating sensitivity,
specificity and misclassification of results obtained from DBS and
cobas<sup>®</sup> PSC specimens. A threshold of 1000 (3 log) copies/ml were
considered for these calculations. All samples with viremia below 1000
copies/ml, regardless of the specimen-type used for testing, were considered as
being virally suppressed as per WHO guidelines. Concordance
correlation and Bland-Altman analyses were performed to determine
precision and agreement between plasma, DBS, and venous and capillary
cobas<sup>®</sup> PSC. Specimen results that generated a reportable result
across all specimen types were included in concordance correlation and these
results \>1 000copies/ml were included in the Bland-Altman analysis. Scatter
plots were presented for visual representation of log transformed and
untransformed data across specimen types. Analyses were performed using STATA
14.2 (StataCorp, Texas, USA) and MedCalc Statistical Software version 16.4.3
(MedCalc Software bvba, Ostend, Belgium).
## Ethical considerations
Ethical approval for the study was obtained from Mozambique’s National Health
Bioethics Committee, with the reference number 297/CNBS, in July 2018. Written
informed consent was obtained from each participant prior to conducting any
study procedure. All patients were given a copy of the signed consent form,
which contained information about the study as well as contacts details of the
principal investigator and the ethics committee.
# Results
## Study population
A total of 613 consecutive patients attending the two health care facilities for
routine ART monitoring between August 2018 and October 2018 were enrolled in the
study. The median age of study participants was 41 years, and 65.0% were female.
Most patients (93.6%, 574/613) were receiving first line ART and the median time
on ART was 51 months. The plasma viral load among participants showed that 50.9%
(312/613) had non-quantifiable virus, 2.9% (18/613) had a viremia between 1000
and 10,000 copies/ml, and 15.5% (95/613) had a viremia \>10,000 copies/ml.
From the 613 patients included in the study, 2444 specimens including DBS,
plasma, venous PSC and capillary PSC were collected, and 2407 (98.5%) generated
reportable results. Overall, 0.41% (10/2444) specimens were rejected at the
reference laboratory due to poor quality and 1.1% (27/2434) failed to report a
result due to equipment failure. From the rejected specimens, four were DBS,
four venous PSC and two capillary PSC. For all specimens, the reason of
rejection was spot not completely full, which means that the quantity of blood
transferred onto the delineated area of the card was not sufficient.
## Specimens testing
At the time of the study, the standard-of-care for HIV viral load testing used
for patient management in Mozambique was DBS, which took preference upon
specimen arrival in the testing laboratory. The median number of days between
specimen collection and testing for DBS was 48 days (range: 1–91), for plasma
was 57 days (range: 17–129), for venous cobas<sup>®</sup> PSC was 66 days (range
13–130) and for capillary cobas<sup>®</sup> PSC was 58 days (range 13–130). No
bias in batch testing for any particular viral load category was evident from
internal review of measuring the difference between DBS, cobas<sup>®</sup> PSC
and plasma over the time of storage at -80°C and testing. The analysis of viral
load difference plotted against number of days to testing, to ensure -80°C
storage did not affect the viral load yielded a random scatter, showing no trend
in specimen type and result difference with the reference plasma.
In addition, the laboratory work flow was not dependent on specimen type for
loading specimens into the equipment. The CAP/CTM instrument software used in
the laboratory was adaptable to plasma, DBS or cobas<sup>®</sup> PSC testing
protocols, and various specimen types were tested in the same run on the same
day.
## Performance of the cobas<sup>®</sup> plasma separation card
illustrates the absolute HIV VL results from study participants and shows that
DBS specimens with VL \>1000 copies/ml underestimate the true HIV viral load as
measured by the reference plasma specimen. In addition, the DBS reports several
HIV VL results \>1000 copies/ml when the plasma VL reference values are
undetectable. The cobas<sup>®</sup> PSC prepared either from capillary or venous
blood specimens, generate the same trend of higher values than plasma VL in
specimens \>1000 copies/ml.
The clinical relevance was further investigated by measuring the sensitivity,
specificity and misclassification rate as outlined in and the absolute bias by
Bland-Altman and concordance correlation in.
The sensitivity of the cobas<sup>®</sup> PSC (99.8%, capillary and 100% venous)
in identifying virological failure and success at the clinically relevant
threshold of 1000 copies/ml, as determined by plasma, was statistically
significantly better than DBS (97%), as shown by non-overlapping confidence
intervals. This is similarly evident with the specificity, with DBS (81.4%)
performing poorly compared to the cobas<sup>®</sup> PSC (97.3%, capillary and
98.2% venous). This performance is further compounded by the higher
misclassification rate for DBS (5.9%), compared to lower rates of
misclassification for the cobas<sup>®</sup> PSC (0.7%, capillary and 0.3%
venous).
Among the quantifiable VL results, the concordance correlation coefficient
showed poorer accuracy and precision for measuring VL using DBS (0.732) than
cobas<sup>®</sup> PSC (0.876 capillary and 0.880 venous). The bias among
quantifiable results across all specimen types again outlines the reduced
accuracy of the DBS compared to the reference plasma. DBS overall generates 0.86
log copies/ml lower results than plasma VL, with several outliers (n = 9) in the
clinically relevant range at 1000 copies/ml across the 107 paired specimens, and
high variability (standard deviation of the bias \>1.0log copies/ml) in the
bias. The cobas<sup>®</sup> PSC (either venous or capillary collection)
displayed minimal bias (\<0.09 copies/ml) compared to plasma with only 3
outliers across 107 data pairs. further illustrates the potential bias between
DBS and cobas<sup>®</sup> PSC capillary, that would be anticipated within a
testing program where cobas<sup>®</sup> PSC were to replace DBS in ART
monitoring of routine patients. Approximately 1.0 log copies/ml difference in VL
results would be reported across the quantifiable range of VL values for patient
care, with the cobas<sup>®</sup> PSC overall generating higher VL values than
DBS and therefore aligning the true VL result from a cobas<sup>®</sup> PSC more
closely with plasma VL.
Based on the data presented in, and the good agreement between cobas<sup>®</sup>
PSC and plasma, it is evident that the cobas<sup>®</sup> PSC is a matrix
suitable for use for VL testing. Based on the sensitivity, misclassification
rate and absolute bias analysis, we identified two discordant results for venous
PSC, three for capillary PSC and 36 for DBS.
# Discussion
The laboratory monitoring of ART in many sub-Saharan settings is currently
performed on DBS, as this type of specimen overcomes many of the logistical
challenges faced by resource-limited health systems. Our study shows that DBS
constitutes a sub-standard alternative to plasma viral load, and demonstrates
that accurate determination of viral load is feasible when cobas<sup>®</sup> PSC
is used to obtain patient specimens under field conditions.
The relatively low bias (\<0.09 copies/ml) displayed for venous and capillary
cobas<sup>®</sup> PSC at the plasma 1000 copies/ml range is an acceptable bias,
and in line with the manufacturer’s definition of acceptability of \<0.3log
copies/ml. The bias generated by cobas<sup>®</sup> PSC is similar to the viral
load differences reported previously comparing split plasma specimens across
different testing platforms or assay versions, and similar to other plasma
separation devices applied to HIV VL testing. On the contrary, the bias seen
on DBS viral load (\>1.0log copies/ml) in our study is notably higher than the
values considered to be acceptable, and similar to other findings of the
performance of DBS for HIV VL testing.
The better performance of the cobas<sup>®</sup> PSC is further evidenced by the
very low misclassification rates of viral load values below 1000 copies/ml, with
rates of 0.7% and 0.3% for capillary and venous cobas<sup>®</sup> PSC specimens,
respectively, as opposed to 5.9% for DBS specimens. This is most likely because
the use of the cobas<sup>®</sup> PSC eliminated the interference of cell-
associated viral nucleic acid and the over-quantification of HIV genetic
material, a factor that impacts the measurement of viral load around the
critical threshold of 1000 copies/ml.
The low limit of detection of 738 copies/ml in the cobas<sup>®</sup> PSC
specimens is considerably higher than the 400 copies/ml and 20 copies/ml
obtained with the DBS and fresh plasma, respectively. These limits are defined
for the CAP/CTM system used in our study, but the differences are likely to be
seen in other testing systems. Nevertheless, the limit of detection for the
cobas<sup>®</sup> PSC is still below the threshold of 1000 copies/ml used to
currently define viral suppression as per WHO recommendations. Moreover, the
limit of detection defined for DBS specimens does not take into account the loss
of specificity caused by cell-associated nucleic acid in whole blood.
In most countries of sub-Saharan Africa, specimens for HIV viral load testing
are collected at health facilities and sent to a relatively small number of
reference laboratories for testing. For example, according to the DISA Lab Viral
Load National Database, in Mozambique ten Laboratories were tasked with testing
the 801,155 specimens collected in 2018. Consequently, most laboratories have a
relatively long turnaround time for viral load testing. In this context, it is
critical that specimens be stable for periods of at least two months. In this
study, the cobas<sup>®</sup> PSC was tested between 13 and 130 days post
venesection without a loss in RNA stability, but with storage prior to testing
at -80°C.
In this study we did not investigate the stability of PSC in a variety of
temperature ranges, but previous stability data has shown that the
cobas<sup>®</sup> PSC can be stored for 56 days in a temperature range between 2
to 30°C without significant variance on the HIV viral load result.
Nurses in two primary healthcare centres performed the collection of the
cobas<sup>®</sup> PSC specimens for this study, attesting to the feasibility of
implementing this new method in resource-limited health systems. The procedures
for collecting cobas<sup>®</sup> PSC specimens are similar to those for DBS,
which health professionals throughout sub-Saharan Africa have been using in HIV
viral load testing and early infant diagnosis for many years. Additionally, in
this study viral load testing using cobas<sup>®</sup> PSC specimens was executed
in a laboratory that routinely tests for viral load and early infant diagnosis,
with no additional equipment required.
# Conclusion
In conclusion, the implementation of the cobas<sup>®</sup> PSC in primary
healthcare centers is feasible, when prepared using either capillary or venous
blood. HIV viral loads determined using this new technology for specimen
collection and transport are accurate, and therefore, cobas<sup>®</sup> PSC
constitutes a good alternative to fresh plasma for the laboratory monitoring of
patients undergoing ART in resource-limited settings.
We would like to gratefully acknowledge Lara Noble and Taskani Mhlongo from the
South African iLEAD team within the Department of Molecular Medicine and
Haematology at the University of the Witwatersrand in Johannesburg, South Africa
for cobas<sup>®</sup> PSC data analytics and training. We also acknowledge the
laboratory staff and nurses at the Primeiro de Maio and Polana Caniço Health
facilities, Maputo, Mozambique, for specimen collection.
[^1]: All authors declare no conflicts of interest.
|
# Introduction
Hypertension (HTN) is a significant public health concern globally, with its
prevalence continually rising in developing countries. According to the World
Health Organisation, an estimated 1.28 billion adults aged 30–79 years worldwide
have hypertension, with about two thirds living in low- and middle-income
countries such as Uganda. Moreover, nearly half (46%) are unaware that they have
hypertension, 42% are diagnosed and treated, and only 21% have it under control.
In Uganda, the prevalence of hypertension varies with regions of the country,
with the highest prevalence registered in the central region, estimated at about
34.3% and the lowest in Northern Uganda, estimated at 22.0% according to a
national epidemiological study published in 2018. In addition, among private
patients in the central region, the prevalence of hypertension was estimated at
41.6% and elevated blood pressure (BP) at 37.6%, but only 18.3% achieved
control.
Patients with rheumatic and musculoskeletal diseases (RMDs) such as rheumatoid
arthritis (RA), systemic lupus erythematous (SLE), osteoarthritis (OA), gout and
Sjogren’s syndrome are at an increased risk of developing HTN, with chronic
inflammation as the main driver. Chronic inflammation causes damage to the blood
vessels and contributes to salt retention in the body through the inflammatory
cytokines such as interleukin-6 and tumor necrosis factor-alpha stimulating the
renin-angiotensin-aldosterone system. Other factors associated with the
development of HTN among patients with RMDs include traditional cardiovascular
risk factors such as genetic predisposition, advanced age, obesity, physical
inactivity and use of nonsteroidal anti-inflammatory drugs and corticosteroids.
Anyfanti and colleagues, in a study conducted among patients with RMDs attending
Rheumatology Outpatient Clinics in Greece, showed a high prevalence of HTN,
estimated at 54.5%, with 21.7% being unaware that they had HTN. In addition,
patients with RMDs such as RA are at a 50% increased risk of cardiovascular
related morbidity and mortality compared to the general population. However, HTN
among most patients with RMDs is undiagnosed, and therefore poorly controlled,
yet it is the main risk factor for developing cardiovascular events. Mandatory
regular screening for HTN among all patients diagnosed with RMDs is a reliable
means for early detection, thus early and effective management of the condition.
The burden of hypertension among patients with RMDs in Uganda remains unknown.
However, many cases of hypertension go undiagnosed, and thus treatment is not
availed, increasing mortality and morbidity in this population.
Therefore, in the present study, we aimed to determine the prevalence of high
blood pressure (HBP), awareness, treatment, and BP control among patients with
RMDs seen in a Rheumatology clinic in Uganda.
# Materials and methods
## Study design, setting & population
Using the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) guidelines, we conducted a cross-sectional analytical study. Data were
collected prospectively between January and April 2022. The study was conducted
in the Rheumatology Clinic of Mulago National Referral Hospital (MNRH), Kampala,
Uganda. MNRH, located in the capital city, Kampala, is the largest public health
facility in Uganda serving as a national specialized hospital with over 1800-bed
capacity. The clinic is run by a rheumatologist (MK) assisted by other medical
officers and registered nurses and has over 200 patients with various RMDs. The
clinic is the largest in the country and serves as the national referral center
for patients with RMDs across the country.
We included patients of Ugandan nationality aged 18 years and above, with a
confirmed diagnosis of RMD, irrespective of the gender, attending the MNRH
Rheumatology Clinic after having given the consent to participate. The RMDs of
interest were: RA classified according to 2010 European League Against
Rheumatism (EULAR)/ American College of Rheumatology (ACR) criteria, SLE
classified according to the 2019 EULAR/ACR criteria, gout classified according
to the 2015 EULAR/ACR criteria, Sjogren’s syndrome classified according to the
2016 EULAR/ACR criteria, OA classified according to the 1986, 1990 and 1991
EULAR/ACR criteria osteoarthritis of the knee, hand and hip respectively,
spondyloarthropathies classified according to the 2011 ASAS criteria and Anti-
neutrophil cytoplasmic antibody (ANCA)-associated vasculitis classified
according to the 2022 EULAR/ACR criteria. We excluded patients who declined to
participate or were unable to give informed consent.
## Data collection
Data classified into socio-demographic, clinical (RMD diagnosis, duration and
treatment, BP readings, HBP and HTN awareness, HTN treatment and BP control) and
anthropometric (weight, height, and waist-hip ratio) were collected using an
interviewer administered semi structured questionnaire and direct measurements
taken by the interviewers. The questionnaires were printed out and administered
by the interviewers to the respondents at the Rheumatology clinic, to ensure
that the respondents understand the questions. Three BP measurements were taken
on the same day on two occasions, four hours apart, on both arms using a manual
sphygmomanometer because it is the recommended method for accurately assessing
BP. Each participant was at the triage station for at least five minutes to
allow them to relax and for their BP to stabilize to avoid falsely elevated
readings. BP was taken when the participant was seated upright with his/her arm
at the heart level in a quiet triage room to ensure accurate readings, and it
was done by routine care nurses to reduce the likelihood of white coat
hypertension. Office BP was determined as an average of the three readings.
Awareness was assessed by asking the patient whether they were hypertensive or
not using a single question.
## Statistical analysis
The sample size of 194 participants with RMDs was calculated using the modified
Kish and Leslie formula for finite population size, with an estimated prevalence
of HBP of 54.5% from a similar study conducted in Greece, a population size of
200, and type 1 error of 5%, and a standard deviation at 95% confidence interval
(1.96). Adjusting for the finite population, using Slovin’s formula
(N/(1+Ne<sup>2</sup>), where N = 150, and e is 5%, a final sample size of 130
participants was obtained.
Data was cleaned, coded and entered into Microsoft 2016, and exported for
analysis using the STATA version 17.0 analysis software. Numerical data were
assessed for normality using Shapiro-Wilk test. Continuous variables were
expressed as mean and standard deviation for parametric variables or median and
interquartile range for non-parametric variables. Categorical data were
presented as frequencies and percentages. Chi-square or Fischer’s exact tests
were used to compare categorical variables as appropriate and student t-tests or
Mann-Whitney U for numerical variables. Modified Poisson regression was used to
determine the factors associated with HBP and association was measured using the
prevalence ratio because the prevalence of HBP is high, which may bias odds
ratio values. We conducted bivariate analysis and variables with p\<0.20 were
considered for multivariate analysis. In the multivariate analysis, we used
manual backward elimination method until all the variables in the model had
p-value ≤ 0.05. We assessed for interaction by forming product terms and
performed a chunk test. We assessed for confounding by considering a percentage
change of \> 10% in the crude and adjusted prevalence ratios. The goodness of
fit of the model was assessed using Hosmer-Lemeshow goodness of fit test.
Variables with p\< 0.05 were considered statistically significant.
## Operational definitions
HBP was defined as an office systolic blood pressure (SBP) ≥ 140mmHg and/or
diastolic blood pressure (DBP) ≥90 mmHg. HBP awareness, as knowledge of the
participant about being hypertensive based on previous diagnosis by a qualified
health care worker. HBP treatment was defined as a patient being on
antihypertensive medicine. Hypertension, as a patient self-reporting to be
hypertensive or ongoing antihypertensive drug treatment. Uncontrolled
hypertension, as a patient with a known diagnosis of hypertension on
antihypertensive medicine whose blood pressures are ≥<u>1</u>40/90 on the day of
the current clinic visit (day of the interview).
## Ethical consideration
Ethical approval was sought from Mulago Hospital Research and Ethics Committee
(Approval number: MHREC 2162). Approved by MHREC, a modification was made to the
initial protocol from targeting only patients with RA to include patients with
RMDs. All participants provided written informed consent by signing a consent
form appended to the questionnaire. The study was conducted in observance of the
*Declaration of Helsinki-*2013.
# Results
Of the anticipated 130 participants, 110 participants turned up at rheumatology
clinic during the study period. However, only 100 participants met the
eligibility criteria and were enrolled, resulting in a positive response rate of
100/110. No significant differences were observed between the participants and
non-participants in terms of age, gender, or disease severity. The majority of
participants were female (84%, n = 84), with mean age of 52.1(SD: 13.8) years
and median BMI of 28 kg/m<sup>2</sup> (IQR: 24.8 kg/m<sup>2</sup>-32.9
kg/m<sup>2</sup>). Fifty-nine participants were employed (59%), from urban
residency (69%, n = 69), majority had no history of smoking (96%, n = 96) or use
of alcohol (67%, n = 67) and forty-nine had family history of hypertension
(49%). Eight (8%) participants had diabetes mellitus. Overall, the median SBP
and DBP were 129.3(IQR: 118.3–144.7) mmHg and 81.3(IQR: 74–90.7) mmHg,
respectively. The trends of systolic and diastolic blood pressure in
participants are shown in. summarizes socio-demographic and clinical
characteristics of all the study participants.
The prevalence of HBP was 61% (n = 61, 95% CI: 51.5–70.5). Out of the 61
participants with HBP, the majority (77%, n = 47, 95% CI: 66.5–87.6) were aware
they had HTN. The prevalence of HTN was 47% (n = 47, 95% CI: 37.2–56.8), and
none had it under control. The most frequent RMDs were RA (80.3% in patients
with HBP versus 76.9% in those without) followed by OA (9.8% in patients with
HBP versus 12.8% in those without), gout (8.2% in patients with HBP versus 0% in
those without) and other RMDs which are SLE, spondyloarthropathies, sjogren’s
syndrome and ANCA-associated vasculitis (1.6% in patients with HBP versus 10.3%
in those without). Individuals with HBP were older (p = 0.001) and had higher
BMI (p\<0.001) and median waist-to-hip ratio (0.86 vs 0.8, p = 0.009) compared
to those without.
Factors independently associated with HBP were age 46-55years (adjusted
prevalence ratio (aPR): 2.5, 95% CI: 1.06–5.95), 56–65 years (aPR: 2.6, 95% CI:
1.09–6.15), \>65 years (aPR: 2.5, 95% CI: 1.02–6.00), obesity (aPR: 3.7, 95% CI:
1.79–7.52), and overweight (aPR: 2.7, 95% CI: 1.29–5.77).
# Discussion
In this study, we aimed to determine the prevalence of HBP, awareness,
treatment, and blood pressure control among patients with RMDs seen in a
Rheumatology clinic in Uganda. However, comparability of our findings with data
from the literature of RMDs is limited because, apart from one study conducted
in Greece, this is the first study on HBP among patients with RMDs in Uganda and
sub-Saharan Africa.
We found the prevalence of HBP to be 61%, with the majority (77%) of those aware
that they had HTN, however, only 44.7% of participants had it under control.
These findings align with results of the study conducted by Anyfanti and
colleagues in Greece among patients with RMDs attending Rheumatology Outpatient
Clinics. The study reported a high prevalence of HTN among patients with RMDs,
estimated at 54.5%, with 21.7% being unaware that they had HTN. Similarly, a
study by Protogerou and colleagues investigating HTN among patients with RA in
Greece registered a high awareness level, estimated at about 80%. As such, HTN
is a common comorbidity in patients with RMDs, with high awareness of the
condition attributed to factors such as increased awareness campaigns, improved
healthcare access and effective communication between patients and health care
providers. The limited BP control observed in our study is comparable to other
studies conducted in Greece, which showed low BP control rates estimated at only
48.6% and 29% among patients with RMDs and RA respectively. Poor BP control in
patients with RMDs is attributed to various factors, including poor patient
adherence to treatment, healthcare provider awareness, and suboptimal
therapeutic approaches such as inadequate medication titration.
In our study, obesity was independently associated with HBP, consistent with
previous studies conducted in both patients with RMDs and the general
population. Notably, we found that obesity exhibited a 1.5 times stronger
association with HBP compared to overweight participants. The strong association
between obesity and HBP underscores the importance of lifestyle modifications,
including weight management, in the prevention and management of HTN in RMD
patients. Obesity is closely linked to metabolic abnormalities and increased
risk of cardiovascular diseases, including HTN. Moreover, the burden of high
BMI-related deaths and DALYs increases with age, especially in males, as
evidenced by the 26.8% and 12.7% rise in the age-standardized rate of high-BMI-
related DALYs for males and females, respectively, between 1990 and 2017.
Our study revealed a significant association between increasing age from 36
years and HBP among participants. This finding could be explained by the higher
proportion of older participants in our study. Aging is characterised by
physiological changes in the cardiovascular system, including arteriosclerotic
structural alterations and calcification, leading to large artery stiffness.
Consequently, the blood vessels become less flexible and more rigid, resulting
in elevated resistance to blood flow and higher BP levels. Moreover, aging is
associated with chronic inflammation and oxidative stress, which, in conjunction
with the chronic inflammation associated with RMDs further augments the risk of
developing HBP. Inflammation is known to be a major driver of HTN in patients
with RMDs with elevated C reactive protein (CRP) an inflammatory marker and
endothelial damage. Comparable to our findings, a recent study in China showed
that risk of HBP increased from age 35 years in the general population. In
addition, Anyfanti and colleagues also reported a high prevalence of HTN among
the elderly patients with RMDs. Thus, our study underscores the role of age as a
contributing factor to the development of HBP.
Rheumatologists, allied health professionals, and stakeholders involved in the
care of patients with RMDs should consider incorporating lifestyle changes in
patient care to reduce body fat, thereby preventing obesity. In addition,
strategies such as health education and improved communication between
healthcare providers and patients have the potential to empower patients with
RMDs to be aware of their HTN status and make informed decisions regarding the
condition, as well as to adopt healthy habits. It is crucial for elderly
patients with RMDs in the rheumatology clinic to be closely monitored with more
frequent blood pressure measurements to ensure early diagnosis and timely
treatment of HTN.
Our study was not without limitations. Despite our study site being at a
national referral hospital serving patients from across the country, it was a
single centred study. Therefore, our findings are not generalizable to the
Ugandan population. In addition, we used a non-standardized questionnaire which
was however, developed based on expertise of physicians experienced in the
management of RMDs in Uganda. We acknowledge that not measuring CRP levels among
patients with RMDs limited our ability to directly investigate the potential
link between inflammation in RMDs and HTN. Measuring CRP levels in future
studies will be valuable in understanding the role of inflammation in the
development and progression of HTN among patients with RMDs. In addition, we did
not assess the causality of the associations observed because of cross-sectional
study design. This was also the first study to assess the prevalence and factors
associated with HBP in patients with RMDs in Uganda.
# Conclusion
This study shows a high burden of HBP among patients with RMDs in Uganda, with a
considerable number being aware of their condition but experiencing poor BP
control. The high burden was associated with high BMI and increasing age in this
population. Thus, lifestyle modifications including weight management are
crucial in preventing and managing HBP and its complications such as future
cardiovascular disease and deaths. Continuous medical education and tailored
guidelines for cardiovascular risk in RMDs are recommended.
# Supporting information
The authors acknowledge the administration of Mulago National Referral Hospital
as well as the study participants and clinical care nurses.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Structural aminopolysaccharide chitin is recognized to occur as the basic
component in both non-mineralized and mineralized skeletal formations of the
cell walls of diverse fungi, diatoms, sponges, corals, annelids, molluscs, and
arthropods (see for review). This ancient biopolymer is typically cross-linked
due to the complex linkage with pigments, lipids, other polysaccharides,
peptides and proteins. As universal template in biomineralization, chitin plays
a significant role in formation of calcium- (in molluscs) and silica-based (in
diatoms and glass sponges) biominerals. Interaction between diverse organic and
inorganic molecules listed above and chitin is often the key way to
rigidification of broad variety of skeletal constructs in invertebrates.
Mechanical stiffness of skeletons remains to be crucial for surviving of sponges
as sessile and filtering organisms. Chitin plays important role in
rigidification in some sponges in both non-mineralized and mineralized states
have been recently reported in representatives of marine (see for review) and
fresh water sponges. In some demosponges, chitin has been confirmed as template
for formation of biomineralized structures in the form of aragonite-silica-
chitin composites. Silica-chitin-based skeletal structures have been identified
in glass sponges. Intriguingly, isolation of chitin-based structures have been
never reported in calcarean sponges (class Calcarea), although chitin synthase
genes have been already detected in two species. Furthermore, there is no
reports in the literature about the existence of chitin in skeletons of the
sponges belonging to the class Homoscleromorpha.
Pure chitin, which was traditionally extracted at large scale from fungi and
crustaceans, received special attention in the modern industry. The potential of
chitin application as adsorbent and biomaterial for biomedical purposes is well
known. Recent novel information concerning applied potential of chitin can be
found in numerous reviews including few reports. It is to note here that
industrially produced chitin can be mostly isolated in the form of powders and
flakes. Interestingly, sponges originally produce 3D chitinous scaffolds, which
are fibrous and macroporous due to their functional role in the skeletons of
these filter-feeding invertebrates. This feature has been observed also in the
Cambrian fossil demosponges including *Vauxia gracilenta*. Moreover, chitinous
skeleton of the demosponges origin resembles the style and form of the source
sponges. The nanofibrillar organization together with unique mechanical and
thermal properties of chitinous skeletal scaffolds is the key to their
successful applications in tissue engineering and modern biomimetics. However,
up-to-date this progress has been based exclusively on chitin isolated from
diverse representatives of only one order of marine demosponges, the Verongiida
order. The idea to propose the use of this feature for systematics of all
sponges related to Verongiida order logically appeared. However, our recent
findings of chitin in fresh water demosponges of non-verongiid origin stimulated
the monitoring of chitin also in other demosponges genera, especially in marine
species which arose prior to fresh water sponges.
Consequently, two years ago we started intensive monitoring of diverse non-
verongiid marine demosponges with the aim to find, purify and characterize and
identify chitin from different orders order of marine Demospongiae. Especially,
we have taken advantage of the worldwide distribution of the sponges of the
order Poecilosclerida which includes four suborders and 25 families. This order
is recognized as the largest and most diverse among Demospongiae orders with
species occurring in all oceans from shallow water habitats to deep seas.
Preliminary investigations with respect to chitin identification in 60 diverse
demosponges recently collected in the Red Sea showed that such representatives
of Poecilosclerida as *Acarnus woffgangi* and *Echinoclathria gibbosa* should
contain chitin within their skeletons due to their characteristic insolubility
in 2.5 M NaOH solution.
Members of the genus *Acarnus* (Gray, 1867) (Porifera: Poecilosclerida) belong
to the family Acarnidae (Dandy, 1922) with 26 representative species. *Acarnus
wolfgangii* was described for the first time by Conrad Keller in 1889 as a
sponge having rigid fiber-based skeleton which show network-like architecture
and rich on spongin. The diameter of skeletal fibers was measured as about 0.05
mm and the air dried sponge was stone hard.
*Echinoclathria* (Carter, 1885) is a genus of demosponges belonging to the
family Microcionidae (Carter, 1885). This family includes two subfamilies,
Clathriinae and Ophlitaspongiinae, with nine valid genera and 524 valid species
living worldwide in shallow waters with a few records from deeper seas.
Unfortunately, with exception of one report on the identification of secondary
metabolites from *E*. *gibbosa* no additional reports are available on this
species.
Here, we represent the first study on isolation of chitin from the skeleton of
*A*. *wolffgangi* and *E*. *gibbosa* demosponges according to the step-by-step
approach and identification of this structural aminopolysaccharide using
corresponding bioanalytical methods in comparative modus.
# Materials and methods
## Biological materials, sample collection and preparation
*Acarnus wolffgangi* Keller (Demospongiae, Poecilosclerida, Acarnidae). The
sponges was collected by SCUBA diving in July 2017 from the eastern side of the
Small Giftun Island (N 27°11′12.9′′ E 33°59′03.1′′) in the Egyptian Red Sea at a
depth of 28 m. The sponge is yellowish in color and forms a massive crust with
clathrate surface. The skeleton is formed by a reticulation of skeletal fibers,
cored by thick smooth styles and echinated by smooth cladotylotes. The fiber
diameter measuring between 50 and 100 μm. At the surface, there are tangentially
scattered tylotes. The spicules include: ectosomal tylotes with microspined
tyles measuring 215–255 x 2–3 μm, smooth and curved choanosomal styles measuring
300–330 x 15–20 μm and the cladotylotes existing in two distinct shapes and
sizes, both with smooth rounded tyles at one end, the larger with three strong
hooks at the opposite ends with overall dimensions of 220–290 x 10 μm, and the
smaller with four hooks, smooth or occasionally with spined shaft with overall
dimensions 90–125 x 3–6 μm. The toxas exist in three distinct categories,
including toxas I with oxhorn shape measuring 90–115 x 3–5 μm, toxas II, which
is thin with shallow curve measuring 55–65 x 1 μm, and oxea-like toxas III which
is barely curved measuring 500–620 x 3 μm; palmate isochelae, 15–20 μm. We were
able to study the type material of *Acarnus wolffgangi*, kept in the collections
of the Museum für Naturkunde Berlin, ZMB 1498 and 2922. The Red Sea specimen
conforms closely in shape, skeleton and spicules, with this type. The Red Sea
voucher was kept in the Naturalis sponge collection under registration number
ZMA Por. 16636 measuring 10 x 5 by 1 cm in size. Another voucher was kept at the
Red Sea Invertebrates Collection at the Department of Pharmacognosy of Suez
Canal University under the code number RS-23.
*Echinoclathria gibbosa* (Keller, 1889). The sponge was collected in July 2017
from Hurghada (N 27°17′0.53′′ E 46°22′0.8′′) in the Egyptian Red Sea at a depth
of 30 m. The live sponge is blood-red in colour and forms a mass of long
branches, which anastomose infrequently. The length of the branches in the
voucher sample measuring up to 20 cm with varied thickness due to the irregular
outline of the branches from 1 to 2 cm. The surface is pitted and clathrate. The
skeleton displayed square- to round-meshed reticulation of skeletal fibers,
cored by 1–5 spicules in cross section. The meshes measure 150–300 mm, while
connecting fibers measure 10–25 mm in diameter, respectively. The surface
skeleton showed a tangential arrangement of loose styles. The spicules are of
choanosomal styles and ectosomal subtylostyles, existing in two or three
diffeent sizes, but these are not clearly differentiated and measuring about
125–360 x 1–4 mm. The microseleres are very thin, shallow-curved toxas and
measuring up to 20 mm in length. The specimen was compared with a slide of the
Berlin Museum type and found to conform closely to it. The voucher is registered
in the collections of the Netherlands Centre of Biodiversity Naturalis under
number ZMA Por. 19793. Another voucher was kept at the Red Sea Invertebrates
Collection at the Department of Pharmacognosy of Suez Canal University under the
code no. RS-46.
## Isolation of chitin skeleton from *A*. *wolffgangi* and *E*. *gibbosa*
The isolation of chitin-based skeletons from *A*. *wolffgangi* and *E*.
*gibbosa* were carried out as previously reported. The protocol consists of four
steps: firstly, the sponge skeletons were placed, separately, in deionized water
at room temperature for 1 h in order to remove possible water-soluble sediment
particles and salts. Then, the samples were treated with 20% acetic acid at room
temperature for 12 h in order to remove residual carbonate-based debris
(microfragments of mollusc shells and crustacean carapaces) from the skeleton of
*A*. *wolffgangi* and *E*. *gibbosa*. Afterwards, the samples were washed
several times with deionized water until achieving a pH of 6.5 followed by
treatment with 2.5 M NaOH at 37°C for 72 h to remove pigments and proteins. The
siliceous spicules were observed in the samples after 72 h of alkali treatment,
thus thorough desilicification was needed. Consequently, after alkali treatment,
samples were accurately rinsed with deionized water and placed in a plastic
vessel containing appropriate amount of 2% hydrofluoric acid (HF) solution. The
vessel was covered in order to prevent the evaporation of HF. Desilicification
was conducted at room temperature for 12 h. The effect of alkaline and strong
acidic treatments on the structure of skeletons of both demosponges was
investigated using optical and fluorescence microscopy (Keyence BZ-8000).
Finally, the isolated materials were washed several times with deionized water
up to pH of 6.5. The fibrous scaffolds were put into the 250 mL large GLS 80
Duran glass bottles containing deionized water and stored at 4°C for further
analyses.
## Light and fluorescent microscopy imaging
Collected sponge samples and isolated chitinous scaffolds from *A*. *wolffgangi*
and *E*. *gibbosa* have been observed using BZ-9000 microscope (Keyence) in
white light as well as in fluorescence modes.
## Calcofluor White (CFW) test
In order to evaluate the localization of chitin in the demineralized skeleton of
*A*. *wolffgangi* and *E*. *gibbosa*, Calcofluor White (Fluorescent Brightener
M2R, Sigma) was used as a fluorescent dye for staining of β-(1→3) and β-(1→4)
linked polysaccharides. After binding to polysaccharides containing β-glycosidic
bond, such as chitin, this flourochrome emits a bright blue light under UV
excitation even using very short light exposure time (up to 1/1000 s) Selected
fragments of demineralized skeletons of *A*. *wolffgangi and E*. *gibbosa* were
placed in 0.1 M KOH-glycerine-water solution and few drops of 0.1% solutions of
CFW were added and the mixture was placed in darkness for 60 min. Afterwards,
the stained skeletons were rinsed 5 times with deionized water and dried at room
temperature followed by investigation of the scaffolds under fluorescence
microscopy.
## Scanning electron microscopy
The surface morphology and microstructure of isolated chitinous scaffolds as
well as untreated samples of both sponges were investigated on the basis of SEM
images using ESEM XL 30 Philips scanning electron microscope. Before analysis,
samples were covered with a carbon layer for 1 min using Edwards S150B sputter
coater.
## Raman spectroscopy
Raman spectroscopy was performed using a Raman spectrometer (RamanRxn1™, Kaiser
Optical Systems Inc., Ann Arbor, USA) coupled to a light microscope (DM2500 P,
Leica Microsystems GmbH, Wetzlar, Germany). For more details, see.
The samples displayed intense fluorescence, which made the acquisition of a high
quality Raman spectrum impossible. Therefore, the samples were bleached in 10%
solution of hydrogen peroxide for 3 h. After three washing steps in distilled
water, the samples were dried at room temperature. The Raman spectra were then
acquired using an accumulation time of 3 s and summing up 50 accumulations. A
baseline correction was finally applied in Matlab to remove the residual
fluorescence signal from the spectra and display the Raman scattering.
## Fourier-transformation infrared spectroscopy
FTIR spectroscopy is a powerful tool for the structural analysis of
polysaccharides. This method is sensitive to the position and anomeric
configuration of glycosidic linkages in glucans. It is worth to note that
chitin, depending on its origin and function of tissue, occurs mostly in three
main isoforms as α-chitin (fungi, sponges, arthropods), β-chitin (diatoms,
molluscs) and rarely as γ-chitin (cocoons of some insects). This vibrational
spectroscopy is also sensitive to the geometry of molecules, system of
intramolecular and intermolecular interactions. Transmission spectra of
chitinous scaffolds were made using a Nicolet 210c FTIR Spectrometer using ATR
accessory. The investigation was performed over a wavenumber range of 4000–400
cm<sup>-1</sup> (at a resolution of 0.5 cm<sup>-1</sup>). The standard α-chitin
was purchased from INTIB GmbH, Freiberg, Germany.
## Chitinase digestion test
In order to carry out chitinase digestion test, the Yatalase<sup>®</sup> enzyme
from culture supernatants of *Corynebacterium* sp. OZ-21 (Cosmo Bio, Japan) was
used. One unit of this enzyme released 1 μmol of *N*-acetyl-D-glucosamine from
0.5% chitin solution and 1 μmol of p-nitrophenol from p-nitrophenyl-*N*-acetyl-
β-D-glucosaminide solution in 1 min at 37°C and pH 6.0. The completely
demineralized fibers of *A*. *wolffgangi* and *E*. *gibbosa* were incubated in
enzyme solution containing 10 mg Yatalase dissolved in 1 mL of citrate phosphate
buffer at pH 5.0 for 2 h. The effectiveness of enzymatic digestion was monitored
using optical microscopy (Keyence).
## Estimation of *N*-acetyl-D-glucosamine (NAG) contents (Electrospray ionization mass spectrometry ESI-MS)
The Morgan–Elson assay was used in order to estimate the *N*-acetyl-D-
glucosamine content released after chitinase treatment, as previously reported.
Preparation of the samples for ESI-MS: the demineralized organic scaffolds of
*A*. *wolffgangi* and *E*. *gibbosa* were hydrolysed in 6 M HCl for 24 h at 50
<sup>o</sup>C. After hydrolysis samples were filtrated with 0.4 μm filter and
freeze-dried to remove the excess of HCl. The dried samples were dissolved in
deionized water for analysis. All ESI-MS measurements were performed on Waters
TQ Detector ACQUITYuplc mass spectrometer (Waters, USA) equipped with
ACQUITYuplc pump (Waters, USA) and BEHC18 1.7 μm, 2.1 × 50 mm UPLC column.
Nitrogen was used as nebulizing and desolvation gas. Graphs were generated using
Origin 8.5 for PC.
# Results
clearly indicates that the applied chemical treatment procedures (detailed
presented) lead to purification of the fibrous scaffolds with well-organized
anastomosing morphology from the skeletons of *A*. *wolffgangi* and *E*.
*gibbosa*, respectively. The images presented in show that the overall shape and
morphology of the extracted 3D scaffolds closely resemble the styles and forms
of the investigated sponges. This means that, the isolation procedure does not
lead to a breakdown of the–sometimes very fragile–demosponge structures, even
after HF-based removal of the skeleton supporting spicules.
SEM microphotographs of the skeletal fibers of *A*. *wolffgangi* and *E*.
*gibbosa* prior to any treatment confirmed the complex character of their
skeletons where, various forms of inorganic (spicules) as well as organic
(fibres) structures are well visible.) show that glassy spicules were still
present within skeletal scaffolds isolated from both sponges after NaOH and
acetic acid treatment. Only HF-based treatment leads to dissolution of the
spicules and purification of silica-free microfibers.
The Calcofluor white staining (CFW) was the first step for the preliminary
identification of chitin within isolated and demineralized skeletal samples.
Fluorescence microscopy analysis of the scaffolds isolated from *A*.
*wolffgangi* and *E*. *gibbosa* after CFW staining displayed very strong
fluorescence even under light exposure time as short as 1/4800 s. Corresponding
results were previously reported for chitin isolated from marine and freshwater
sponges as well as in chitin-containing fossilized remnants.
To confirm the presence of chitin in the isolated scaffolds, more sensitive
analytical techniques were applied. FTIR spectra acquired for the fibrous
scaffolds obtained from *A*. *wolffgangi* and *E*. *gibbosa*, as well for
α-chitin standard are presented in. The region of the amidic moiety, between
1700 and 1500 cm<sup>−1</sup>, yields different signatures for chitin
polymorphs. In this region, the spectra of the samples studied by us showed
strong adsorption band associated with the stretching vibrations of C = O group
characteristic of the amide band I. The amide band I showed twin peak at 1659
cm<sup>-1</sup> and 1626 cm<sup>-1</sup> for *A*. *wolffgangi*; 1659
cm<sup>-1</sup> and 1626 cm<sup>-1</sup> for *E*. *gibbosa*, as a result of the
intermolecular C = O⋯H-N and the intramolecular hydrogen bonds C = O⋯HO-
CH<sub>2</sub> which is characteristic for α-chitin polymorph. Additional
feature, the characteristic intense band at 950 cm<sup>−1</sup> assigned to γCHx
was observed in α-chitin standard as well as in the purified sponges chitin
samples. Moreover, the α-chitin indicative band assigned to a ß-glycosidic bond
is observed at a *ν*<sub>*max*</sub> 897 cm<sup>−1</sup> in the FTIR spectra of
the scaffolds isolated from *A*. *wolffgangii* and *E*. *gibbosa*. Detailed
analysis of the bands indicates that acquired spectra of both isolated chitinous
scaffolds are very similar to those of the α-chitin standard.
The results of Raman spectroscopy examinations showed that spectra of *A*.
*wolffgangi* and *E*. *gibbosa* are very comparable with the spectrum obtained
for α-chitin reference. For analytical investigations of the isolated scaffolds,
prior and after HF-treatment, Raman spectroscopy was used. Consequently, for
example, the Raman spectra of chitinous scaffold isolated from *A*. *wolffgangi
and E*. *gibbosa* prior to demineralization display intense bands of biosilica
at 443, 480, 599, 640, 805 cm<sup>-1</sup>. The bands of the organic matrices
are visible in the ranges ≈ 900–1800 cm<sup>-1</sup> and 2700–3000
cm<sup>-1</sup>. These bands are comparable with those reported for α-chitin
standard. Similar observations have been reported for chitin of demosponge
origin previously.
Chitinases possess the ability to degrade chitin directly to low molecular
weight chitin oligomers including *N*-acetylglucosamine (GlcNAc). Consequently,
such enzymatic treatment resulted in the loss of chitin integrity and in release
of residual chitin microfibers of steadily decreasing size. The activity of
chitinase is clearly visible using an optical microscope. Chitinase digestion
test which have been previously utilized in the studies for the chitin detection
in other sponges, definitely confirmed the chitinous nature of demineralized
scaffolds isolated from both *A*. *wolffgangi* and *E*. *gibbosa*.
The Morgan–Elson assay has been previously described in details and was used as
the most accurate methods to estimate the GlcNAc released after chitinase
treatment. Determination of GlcNAc in chitin-based scaffolds of *A*. *wolffgangi
and E*. *gibbosa* showed, 750 ± 1.5 μg and 730 ± 1.5 μg *N*-acetyl-glucosamine
per mg of chitinous scaffolds of these sponges, respectively. These results are
similar to those reported for chitin isolated from the demosponge *Spongilla
lacustris*.
ESI-MS of D-glucosamine (GlcN) standard showed four main peaks at m/z = 162.08,
180.09, 202.07 and 381.15. The ion peak with m/z = 180.09 corresponds to the
molecular ions \[M+H\]<sup>+</sup> of a species with a molecular weight 179.09
corresponding to GlcN (calculated: 179.1). The ion peak at m/z = 162.08
corresponds to a fragment ion \[M−H<sub>2</sub>O + H\]<sup>+</sup> after losing
one molecule of H<sub>2</sub>O from DGlcN (calculated: 162.1). Finally, the ion
peak at m/z = 381.15 corresponds to \[2M+Na\]<sup>+</sup> species which is
sodium-bound GlcN non covalent dimmer. Similar ion peak for the proton-bound
GlcN covalent dimmer was observed at m/z 359.17 \[M+H\]<sup>+</sup> in the
spectra.
The major peaks in ESI-MS spectra of the hydrolyzed samples of *A*. *wolffgangi*
and *E*. *gibbosa* observed at m/z = 162.08, 180.09, 202.07 and 381.15 are
comparable with the peaks of GlcN (Fig A). The ion peak of the sodium-bound GlcN
dominated the spectra of these sponges as expected for marine-derived samples
due to strong salt presence.
# Discussion
Previously, members of the genus *Acarnus* have been mostly investigated as a
source of pharmacologically active compounds. For example, a group of compounds
named acarnidines were isolated by extraction of the homogenized tissues of the
sponge *A*. *erithacus* with toluene-methanol (1:3) and partitioning with 1 M
sodium nitrate solution. They possess unique substituted homospermidine skeleton
with diverse fatty acid substituents. The acarnidines showed antibacterial and
antifungal properties and displayed significant antiviral activity against
Herpes simplex type 1. Two cyclic peroxide-containing polyketide C22 methyl
esters, peroxyacarnoic acid methyl esters A and B, have been isolated from the
Red Sea marine sponge *Acarnus cf*. *bergquistae*. The methanolic extract of
this sponge exhibited cytotoxicity against P-388, A-549, and HT-29 tumor cells
with an IC<sub>50</sub> of 0.1 μg/ml. Two new cyclic peroxides have been
reported in the organic extract of the sponge *A*. *bicladotylota* from India.
Furthermore, sponges of the genus *Echinoclathria* are recognized as producers
of biologically active compounds. Azaspiracid-2 was isolated from a marine
sponge *Echinoclathria* sp. collected off Amami-Oshima area in Japan. It
exhibited potent cytotoxicity against P388 cells with an IC<sub>50</sub> value
of 0.72 ng/mL and caused S phase arrest on the cell cycle. The demosponge *E*.
*subhispida* gave a new steroid sulfate, echinoclasterol sulfate with
experimentally confirmed antifungal activity against *Mortierella ramannianus*,
and cytotoxicity against PC-9 human lung cancer cells. Echinoclathrines A-C, a
new class of pyridine alkaloids possessing a 4-aryl-2-methylpyridine moiety as a
common structural element were isolated from an Okinawan sponge *Echinoclathria*
sp. The procedure of the isolation of echinoclathrines have been patented
recently. Some of echinoclathrines exhibited weak immunosuppressive activity in
a mixed lymphocyte reaction assay. Studies on marine pharmacology potential of
*Echinoclathria* demosponges habituated in Red Sea started only recently.
Investigation of the Red Sea sponge *E*. *gibbosa* resulted in the isolation of
three new compounds including β-sitosterol-3-O-(3*Z*)-pentacosenoate,
5α-pregna-3β-acetoxy-12β,16β-diol-20-one, and echinoclathriamide together
thymine and uracil. β-Sitosterol-3-O-(3*Z*)-pentacosenoate showed weak activity
against A549 non-small cell lung cancer (NSCLC), U373 glioblastoma (GBM), and
PC-3 prostate cancer cell lines. New ceramide (icosanamide) was isolated from
the Red Sea sponge *Echinoclathria* sp.. The *in vitro* growth inhibitory
activity of this ceramide against different human cancer cell lines was
evaluated.
To our best knowledge there are no reports even about attempts to search for
chitin in these species of demosponges. Till now, isolation protocols of diverse
secondary metabolites from representative members of the genera *Acarnus* and
*Echinoclathria* have followed traditional organic solvent-based extraction
approaches. There are no data on isolation methods for such metabolites which
are based on treatment with alkaline solutions as well as about structural
stability of these biomacromolecules at alkaline pH levels. It is well known
that, since the experimental work done by von Kölliker in 1864 the main skeletal
protein of demosponges-spongin is quickly soluble in alkali solutions. This
feature is crucial for extraction and isolation of poriferan chitin in purified
form due to its exceptional resistance to the treatment with alkali up to
concentration of 5% and temperatures not higher than 40°C for example, in the
case of NaOH. Such treatment showed also no electron microscopically visible
changes on the surface of siliceous spicules of the demosponges under
investigation. Moreover, our observations showed with convincing support the
localization of spicules within chitinous (Figs) and non-spongin based matrix.
Similar results have been reported before in the case of chitinous skeleton of
the fresh water demosponge *S*. *lacustris* (order Spongillida). The possible
role of poriferan chitin as structural support for spicule-producing cells as
well as in complete process of spiculogenesis in demosponges is still unknown.
Complete desilicification of the spicules can be achieved using HF-based
treatment. This study together with previously reported data showed that chitin
remains to be well preserved even after such treatment. However, logical
question about the possible presence of diverse secondary metabolites with
alkaline, or HF-based extracts remain to be open. In contrast, the experiments
with bromotyrosine- and chitin-producing demosponges representing the order
Verongiida showed that bromotyrosines and chitin-based scaffolds could be
isolated from the sponge skeletons using a stepwise extraction procedure mainly
based on the use of NaOH. Recently, a patented method for isolation of both
bromotyrosines and chitinous skeletal frameworks from selected sponges, without
disruption of the skeletons in the mortar has been reported. Here, we propose a
schematic view of the principal steps which can be now applied for isolation of
secondary metabolites and chitin from the sponges of the order Poecilosclerida.
There are no doubts about the necessity for the development of novel, more
effective technologies for extraction of biologically active compounds together
with chitinous scaffolds from sponges of the genera *Acarnus* and
*Echinoclathria*. Especially those species which could be adapted for
cultivation under marine farming conditions will possess high potential in this
case.
We suggest that the discovery of chitin within other representatives of
Poecilosclerida order would be the next step in the evaluation of the
possibility to accept these worldwide distributed demosponges as novel renewable
source for both chitin and biologically active metabolites which are perspective
for biomedicine and marine pharmacology, respectively.
# Conclusions
Chitin-producing marine demosponges are highly perspective invertebrates due to
their ability to synthetize broad variety of secondary metabolites with
antiviral, antibiotic, antidiabetic, cytotoxic and antitumor activities as well
as chitin. Here, we showed for the first time that chitin is present as a
structural component in skeletons of the Red Sea sponges *Accarnus wolffgangi*
and *Echinoclathria gibbosa* demosponges. The question of chitin synthesis among
representatives of the genera *Acarnus* and *Echinoclathria* should gain
importance as a result of our findings. Consequently, the evolution,
localization and functions of chitin in these demosponges as well as in other
representatives of Poeciloscrerida order should be examined in the future.
Additionally, separate studies should be carried out on the identification of
chitin synthase genes within genomes of diverse representatives of the genera
*Acarnus* and *Echinoclathria* as well. Also, additional investigations are
necessary to obtain a better understanding of the nature and origin of spicules-
containing skeletons of these demosponges with respect to the spongin-chitin
relationship. It is still unclear how much spongin is present in the chitin-
based skeletons of the sponges studied. Novel approaches must be proposed which
will bring together molecular biology and modern bioanalytical methods for a
better understanding of the poriferan chitins synthesis in diverse taxa on
molecular level. The best way to solve this challenging task is to bring
together coherent and synergetic collaborators and experts in marine biology,
marine chemistry, marine pharmacology, marine biotechnology and biomaterials
together with spongologists using their multidisciplinary knowledge and
experiences to answer raised questions and develop new approaches in this
interesting area of research.
# Supporting information
We thank the EEAA and the Red Sea Protectorate of Egypt for permission to make
collections of the Red Sea sponges *Acarnus wolffgangi* and *Echinoclathria
gibbosa*. Our thanks to Prof. Rob van Soest for the taxonomic identification of
the sponge samples.
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
The canonical Wnt signaling pathway is crucial for embryonic developmental
processes and adult tissue homeostasis. Consequently, aberrations in this
pathway were linked to human diseases and in particular cancer development. The
key mediator of the canonical Wnt signaling pathway is β-catenin, whose protein
levels are under tight control by a multiprotein complex known as the
destruction complex. β-catenin is phosphorylated by this complex, which
ultimately leads to its ubiquitin-proteasome-dependent degradation. In the
presence of Wnt ligands the destruction complex becomes inactivated and
β-catenin accumulates in the cytoplasm, translocates into the nucleus and
initiates transcription of mitogenic target genes leading to cell proliferation.
The core components of the destruction complex consist of Adenomatous Polyposis
Coli (APC), axis inhibition protein 1 and 2 (AXIN1 and AXIN2) and the kinases
glycogen synthase kinase 3 (GSK3) and casein kinase 1α (CK1α). In the majority
of colorectal cancers, APC is found to be mutated and the destruction complex
thereby inactivated. Interestingly, overexpression of AXIN1 or AXIN2 can
compensate for APC mutations and leads to the degradation of β-catenin in APC-
mutant cell lines, such as SW480 colorectal cancer cells. AXIN has been shown to
be the rate-limiting factor for destruction complex function in Xenopus egg
extracts and its protein levels are tightly regulated by APC and by the poly-
ADP-ribosyltransferases tankyrase 1 and 2 (TNKS1/2). The tankyrase enzymes
transfer ADP-ribose moieties onto AXIN1/2, marking it for degradation by the
ubiquitin-proteasome system. Inhibition of TNKS1/2 by small molecule inhibitors
(TNKSi) has emerged as a promising new cancer therapeutic approach as it leads
to stabilization of AXIN1/2 and a concomitant reduction in β-catenin protein
levels and transcriptional activity *in vitro* and *in vivo* \[, –\]. Of note,
*AXIN2* is also a target gene for β-catenin, adding another layer of AXIN2
regulation to the Wnt signaling pathway.
In the current study, we sought to elucidate the consequences of combining TNKSi
with proteasome inhibition, as proteasome inhibitors are extensively used in
both clinical and research settings, often in combination with other inhibitors.
# Materials and Methods
## Antibodies, plasmids, and chemicals
The following reagents were used: rabbit anti-AXIN1 (C95H11), rabbit anti-AXIN2
(76G6) (Cell Signaling Technology), mouse anti-β-catenin (BD Transduction
Laboratories); mouse anti-ubiquitin (Upstate / Millipore), mouse anti-active-β-
catenin (05–665, Millipore); mouse anti-β-Actin (Sigma Aldrich), mouse anti-
Calreticulin (Enzo lifesciences), mouse anti-Vinculin (HVIN-1, Sigma Aldrich),
rabbit anti-FoxM1 (C-20, Santa Cruz), mouse anti-LaminA (Abcam), rabbit anti-p62
(MBL / Nordic Biosite). All secondary antibodies used for confocal microscopy
studies were obtained from Jacksons ImmunoResearch Laboratories and secondary
antibodies used for Western blotting were obtained from LI-COR Biosciences GmbH.
Hoechst (Invitrogen). G007-LK (Gift from Stefan Krauss and Jo Waaler, Oslo,
Norway); MG132 (Calbiochem); Dimethyl sulphoxide (DMSO), 3-Methyladenine (3-MA),
Lactacystin, PhosSTOP (Sigma Aldrich); Epoximicin (Enzo lifesciences); Leupeptin
(Peptanova Gmbh, Peptide Insitute, Japan). Quantitech mRNA primer pairs against
TBP (QT00000721), AXIN2 (QT00037639) and FoxM1 (QT00000140) were obtained from
Qiagen. FoxM1 siRNA (Sense: `5' GGACCACUUUCCCUACUUUUU-3'`, Antisense: `5'
AAAGUAGGGAAAGUGGUCCUU 3'`, and control siRNA (cat: D-001810-01), Dharmacon.
siRNA transfections were performed using RNAiMax (Invitrogen) according to the
manufacturer's protocol.
## Cell-based assays
SW480, COLO320, CaCo-2 and LS174T cell lines were purchased from ATCC. Upon
receipt, cells were frozen, and individual aliquots were taken into cell
culture, typically for analysis within 15 passages. Cells were grown in RPMI
(SW480 and COLO320), DMEM (CaCo-2) or DMEM/F12 (LS174T) medium supplemented with
10% (SW480 and COLO320) or 15% (LS174T and CaCo-2) FBS and 1%
penicillin/streptomycin. The stable SW480 cell line expressing GFP-TNKS1 was
described earlier. Testing for mycoplasma contamination was performed every
sixth week. For inhibition of TNKS activity, cells were treated with 0.5 μM
G007-LK for 6 h. DMSO was used as a control. For inhibition of proteasomal
activity, cells were treated with 10 μM MG132, 25 nM Epoxomicin or 10 μM
Lactacystin. Other inhibitors used were: 10 mM 3-Methyladenine (3-MA, autophagy
inhibitor), or 300 μM Leupeptin (protease inhibitor) for indicated time points,
either alone or in combination with G007-LK.
## Western blot analysis
Cells were rinsed in PBS and lysed in Laemmli lysis buffer (65.8 mmol/L Tris-
HCl, pH 6.8, 2.1% SDS, 26.3% (w/v) glycerol, 0.01% bromophenol blue,
dithiothreitol (DTT)). Equal amounts of whole cell lysate were separated by SDS-
PAGE (Bio-Rad Laboratories) and blotted onto polyvinylidene difluoride membranes
(Millipore). Immunodetection was performed with IRDye-conjugated secondary
antibodies (LI-COR Biosciences). The Odyssey Imager system (LI-COR Biosciences)
was used to scan all blots. Protein bands were quantified using the Odyssey
software.
## Nucleo-cytoplasmic fractionation
Cells incubated with or without MG132 were washed with PSB and lysed in lysis
buffer (0.1 M NaCl, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 1% Triton X-100, 1 mM
EDTA (pH 7.4), 10 mM protease inhibitor cocktail, 2 mM NEM) and the lysates were
left on ice for 20 min. The cell lysates were centrifuged at 14000 rpm for 10
min at 4°C to separate cytoplasmic (supernatant) and nuclear fraction (pellet).
The fractions were then subjected for Western blotting.
## Confocal fluorescence microscopy
Cells grown on coverslips were permeabilized in PEM buffer (pH 6.8, 80 mM PIPES,
5 mM EGTA, 1 mM MgCl<sub>2</sub>x6H<sub>2</sub>O containing 0.05% saponin) for 5
min on ice before fixation in 3% paraformaldehyde for 15 min on ice and washed
twice in PBS containing 0.05% saponin or permeabilized for 5 min with 0.5%
Triton-X-100 in PBS, as indicated in the figure legends. The cells were then
stained using the indicated primary antibodies for 1 h, washed three times in
PBS/saponin, stained with secondary antibodies for 1 h, and washed three times
in PBS. The coverslips were mounted in Mowiol containing 2 μg/ml Hoechst 33342
(Sigma-Aldrich). The cells were examined with a Zeiss LSM710 or LSM780 confocal
microscope (Carl Zeiss MicroImaging GmbH) equipped with an Ar-Laser Multiline
(458/488/514 nm), a DPSS-561 10 (561 nm) and a Laser diode 405-30CW (405 nm).
The objective used was a Zeiss plan-Apochromat363/1.4 Oil DIC III. Image
processing and visualization were performed with ZEN Software (Carl Zeiss
MicroImaging GmbH), Photoshop CS4 (Adobe) and ImageJ (National Institutes of
Health). All images were taken at fixed intensity settings below saturation.
## ScanR high-throughput microscopy
Cells were grown on coverslips and further processed for antibody staining as
described for confocal microscopy samples. Images were automatically taken using
the Olympus ScanR system with an UPLSAPO 40x/0.95 objective. All images were
taken with the same settings and below pixel saturation. The Olympus ScanR
analysis software was used to detect and count the number of GFP-TNKS1 puncta in
samples treated with DMSO, G007-LK, MG132 or a combination of these, and to
measure the nuclear intensity of β-catenin, FoxM1 and active β-catenin in DMSO
versus MG132 treated samples.
## Quantitative real-time PCR of mRNA expression
mRNA expression analysis was done as described in. Primers used in the study
were AXIN2 (QT00037639), FoxM1 (QT00000140) and TBP (QT00000721).
## SDS immunoprecipitation
To investigate modifications of FoxM1 we did hot lysis immunoprecipitation as
described in. Shortly, cells were lysed in SDS (1%)–containing PBS, and
immediately incubated at 100°C for 5 min, chilled on ice and homogenized using
QIA-shredder column (QIAGEN). The lysates were added to protein G-coupled
magnetic beads (Dynabeads, Life technologies / Thermo Fisher) loaded with rabbit
anti-FoxM1 (C-20) antibody dissolved in 2x IP buffer (2% (vol/vol) Triton X-100,
0.5% (wt/vol) sodium deoxycholate, 1% (wt/vol) bovine serum albumin (BSA), 2 mM
EDTA, 40 mM NaF, 2 mM NEM, 10 mM protease inhibitor cocktail (Sigma)). The beads
and lysates were gently mixed for 1h at 4°C before the beads were washed in 1x
IP buffer and eluted in 2x sample buffer, then subjected for Western blotting.
## Electron microscopy
SW480 were seeded on coverslips and treated with DMSO or MG132 for 6 hours
before fixation in 2% glutaraldehyde in 0.1 M PHEM (240 mM PIPES, 100 mM HEPES,
8 mM MgCl<sub>2</sub>, 40 mM EGTA), pH 6.9, at room temperature for 40 min.
Cells were post-fixed in osmium tetroxide, stained with tannic acid, dehydrated
stepwise to 100% ethanol and flat-embedded in Epon. Serial sections (\~100 nm)
were cut on an Ultracut UCT ultramicrotome (Leica, Germany) and collected on
formvar coated mesh-grids. Sections were observed at 80 kV in a JEOL-JEM 1230
electron microscope and images were recorded using iTEM software with a Morada
camera (Olympus, Germany).
# Results and Discussion
## G007-LK-induced degradasome formation is counteracted by proteasome inhibition in SW480 cells
Inhibition of the TNKS enzymes by small-molecule inhibitors has previously been
shown to reduce the aberrantly high levels of β-catenin in colorectal cancer
cells such as SW480 cells by re-establishing a functional destruction complex.
Incubation of SW480 cells with the highly selective TNKSi G007-LK for 6 h
results in the formation of cytoplasmic puncta (degradasomes), which contain the
destruction complex components AXIN1, AXIN2, APC, GSK3, βTrCP, TNKS1/2,
β-catenin and phospho-β-catenin and therefore most likely represent enlarged
versions of the destruction complex, where β-catenin is phosphorylated and
thereby earmarked for degradation in the proteasome. The formation of
cytoplasmic puncta is most likely due to head-to-tail polymerization of AXIN
molecules via their DIX domain and may also involve TNKS polymers.
Surprisingly, the formation of degradasomes was reduced upon combination of
G007-LK with the proteasome inhibitor MG132 for 6 h, as shown by high-throughput
microscopy using an Olympus ScanR automated microscope. The number of GFP-TNKS1
puncta was quantified using the ScanR analysis software and revealed a rapid
induction of degadasomes after 2 h of incubation with G007-LK, while the
combination of MG132 with TNKSi severely impaired degradasome formation. To test
whether this unexpected result could be reproduced with chemically unrelated
proteasome inhibitors, we combined G007-LK with either 25 nM Epoxomicin or 10
μM Lactacystin, respectively. Like with MG132, we observed a decrease in
degradasome formation with these alternative proteasome inhibitors. On the other
hand, lysosome inhibition (300 μM Leupeptin) or phosphatidylinositol-3 kinase
class III inhibition (10 mM 3-methyladenine (3-MA)) did not interfere with
degradasome formation, indicating that specifically inhibiting the proteasome
interferes with TNKSi-induced degradasome formation.
## TNKSi-induced AXIN2 stabilization is impaired upon proteasome inhibition
TNKSi-induced stabilization of AXIN1 and/or AXIN2 is thought to mediate the re-
establishment of functional destruction complexes. Therefore, we investigated
AXIN1 and AXIN2 protein levels during 6 h of G007-LK incubation with or without
MG132. During this incubation time the protein levels of AXIN1 remained largely
unaltered, while the AXIN2 levels strongly increased upon G007-LK treatment.
This increase in AXIN2 was abrogated when G007-LK was combined with MG132,
indicating that the TNKSi-induced stabilization of AXIN2 is impaired upon
proteasome inhibition. The chemically unrelated proteasome inhibitor Epoxomicin
prevented TNKSi-induced stabilization of AXIN2, but not AXIN1, similar to MG132,
while 3-MA or Leupeptin did neither influence AXIN1 nor AXIN2 protein levels
when co-incubated with G007-LK.
Next, we tested whether this observation was restricted to SW480 cells or
whether other colorectal cancer cell lines showed the same response on AXIN2
protein level. Indeed, CaCo-2, LS174T and Colo320 responded similarly to SW480
cells to the combination of G007-LK and MG132 with abolished AXIN2
stabilization, as shown by Western blotting and verified by quantifications. We
conclude that the lack of TNKSi-induced degradasome formation upon proteasome
inhibition most likely depends on impaired stabilization of AXIN2.
## Proteasome activity inhibits transcription of *AXIN2*
To distinguish whether the lack of AXIN2 protein stabilization upon combination
of proteasome inhibition and G007-LK originates from altered mRNA levels or is
due to a regulation on the protein level, we measured relative mRNA levels of
*AXIN2* upon TNKS inhibition with or without MG132 by quantitative real-time
PCR. MG132 led to a severe reduction in *AXIN2* mRNA levels in SW480 cells and
this was not changed in the presence of both MG132 and G007-LK. To verify
whether MG132 had the same effect in other colorectal cancer cell lines with
different APC and β-catenin mutation status, we performed similar experiments in
LS174T, CaCo-2 and Colo320 cell lines. Indeed, we observed a reduction in
*AXIN2* mRNA levels in all three cell lines upon MG132 incubation for 6 h.
## Proteasome inhibition does not reduce nuclear β-catenin levels
As nuclear β-catenin promotes transcription of *AXIN2*, we investigated
β-catenin localization in SW480 cells treated with either DMSO or MG132 by
confocal microscopy and demonstrated a distinct staining of β-catenin in the
nucleus under both conditions. To investigate whether the amount of nuclear
β-catenin in MG132-treated cells was reduced compared to control cells, we
performed high-throughput microscopy that surprisingly revealed a slight
increase in the mean fluorescence intensity of β-catenin in the nuclei of SW480
cells treated with MG132. To further interrogate whether the transcriptionally
active fraction of β-catenin was altered upon MG132 treatment, we took advantage
of an antibody specifically detecting non-phospho-β-catenin (i. e. active
β-catenin, ABC). Quantitative fluorescence microscopy showed the same tendency
for active as for total β-catenin. Next, we undertook biochemical fractionation
experiments to verify our imaging results. As expected, MG132 led to an
accumulation of both β-catenin and active β-catenin in total protein lysates.
Moreover, nuclear accumulation of both total and active β-catenin verified the
results obtained by immunofluorescence. Thus, changes in nuclear β-catenin
levels cannot explain the decreased transcription of *AXIN2* mRNA upon
proteasome inhibition.
## The proteasome-regulated transcription factor FoxM1 regulates *AXIN2* transcription
Another regulator of *AXIN2* transcription is Forkhead box M1 (FoxM1). FoxM1 was
previously shown to be a positive regulator of *AXIN2* mRNA levels by two
different means: First, it can directly bind to and increase transcriptional
activity of the *AXIN2* promotor region in developing lung epithelium. Second,
FoxM1 was reported to promote the nuclear localization of β-catenin and support
β-catenin in binding to its target promotors, thereby indirectly controlling Wnt
target-gene expression in glioma cells. Interestingly, FoxM1 was also shown to
be negatively regulated by proteasome inhibition. Proteasome inhibitors such as
MG132, MG115 and bortezomib were shown to inhibit FoxM1 transcriptional activity
and FoxM1 expression, and this seems to be mediated by stabilization of a
negative regulator of FoxM1, namely HSP70. However, Chen and coworkers report an
increase in FoxM1 protein levels upon proteasome inhibition. Due to these
conflicting reports, which most likely result from use of different cell lines
and/or incubation protocols, we investigated FoxM1 mRNA and protein levels in
SW480 cells with our experimental setup. We observed a substantial reduction of
*FoxM1* mRNA levels upon 6 h MG132 treatment. However, we detected a \~2.5 fold
increase of FoxM1 at the protein level. We hypothesize that despite a decrease
in *FoxM1* mRNA transcription, the protein turnover of FoxM1 is severely
impaired by the proteasome inhibition, which leads to an accumulation of FoxM1
protein.
To investigate whether FoxM1 functions as a positive regulator of Wnt-target
gene expression in our model system, we treated SW480 cells with siRNA against
FoxM1, which efficiently reduced FoxM1 protein levels. We observed a
significant reduction in *AXIN2* mRNA levels upon knockdown of FoxM1, consistent
with the published role of FoxM1 as both direct and indirect transcriptional
activator of Wnt target gene expression.
In order to test the contribution of FoxM1 to the TNKSi-induced AXIN2
stabilization, we depleted SW480 cells for FoxM1 and incubated with G007-LK. We
observed a substantial reduction in the TNKSi-induced AXIN2 protein levels in
cells depleted for FoxM1 as shown by Western blotting , and the same effect was
true when G007-LK was combined with MG132 in FoxM1 depleted cells. This confirms
the role of FoxM1 in the regulation of AXIN2 protein levels.
## Posttranslational modifications of FoxM1 are altered upon proteasome inhibition
It was reported recently that USP5-mediated deubiquitination is required in
order to promote translocation of FoxM1 into the nucleus, where it mediates
interaction of β-catenin with target gene promotors. We therefore hypothesized
that proteasome inhibition may alter the nuclear translocation of FoxM1.
In order to investigate the subcellular localization of FoxM1, we performed
immunofluorescence stainings for FoxM1 followed by high-throughput microscopy to
quantify the nuclear fluorescence intensity of FoxM1. FoxM1 could be detected in
the nuclei of SW480 cells after MG132 treatment. Knockdown experiments verified
the specificity of the FoxM1 antibody in immunofluorescence stainings. To
substantiate our findings we performed biochemical fractionation experiments,
which showed the same tendency of a predominant localization of FoxM1 in the
nucleus upon proteasome inhibition. These data indicate that FoxM1 localization
cannot explain the reduced transcription of *AXIN2* upon proteasome inhibition,
irrespective of a possible ubiquitination of FoxM1.
Besides ubiquitination, FoxM1 is regulated by various phosphorylation events and
all phosphorylation events were shown to stabilize and activate FoxM1. To
investigate the phosphorylation status of FoxM1 in the absence (DMSO) or
presence of proteasome inhibition (MG132), we performed a hot-lysis
immunoprecipitation of FoxM1. Lysing cells in PBS containing 1% SDS with an
immediate incubation at 100°C for 5 min leads to the instantaneous denaturation
of all proteins (including phosphatases) and enables the investigation of
posttranslational modifications of the immunoprecipitated proteins. We observed
a higher molecular weight band in the DMSO-treated conditions, which was absent
in the immunoprecipitate of the MG132 treated cells. To investigate further
whether this band could represent phosphorylated FoxM1, we incubated SW480
protein lysates with or without phosphatase inhibitor mix (PhosSTOP) for 1 h at
room temperature. In the absence, but not in the presence, of the phosphatase
inhibitor mix a high molecular weight band disappeared and the lower band
increased in intensity, indicating that the higher molecular weight band is
indeed phosphorylated FoxM1. We therefore suggest that despite FoxM1 localizing
to the nucleus after MG132 treatment, it is dephosphorylated and thus
transcriptionally less active upon proteasome inhibition. As most kinases
phosphorylating FoxM1 are cell cycle kinases (CDK4/6, PLK1, CyclinA/CDK, Chk2),
we speculate that proteasome inhibition might lead to cell cycle arrest,
synchronizing the cell population in a cell cycle phase where these kinases are
not active.
Knockdown of FoxM1 has less effect on *AXIN2* transcription compared to MG132
treatment (Figs). This could either mean that FoxM1 depletion was incomplete or
that another still unknown factor influences *AXIN2* mRNA transcription. Indeed,
72 h after siRNA transfection, a minor fraction of FoxM1 protein seemed to be
left. In addition we noticed a redistribution of p62 and ubiquitin after MG132
treatment in immunofluorescence stainings. This prompted us to investigate the
general cell morphology after 6 h of treatment with MG132 at an ultrastructural
level by electron microscopy. Surprisingly, we found that various cellular
organelles were clustered around the nucleus resulting in an organelle-depleted
cytoplasm in a subset of MG132-treated cells. Such a drastic morphological
change in a subpopulation of MG132-treated SW480 cells could possibly lead to an
additional inhibitory effect on transcription and/or translation of proteins,
e.g. AXIN2. However, transcription of house keeping genes was unaffected as
judged by quantitative real-time experiments. Furthermore, protein levels were
unaltered for AXIN1, arguing against a general full inhibition of gene
transcription and protein translation upon proteasome inhibition.
Taken together, a reduction of FoxM1 activity in combination with changed
cellular morphology may explain the lack of TNKSi-induced AXIN2 stabilization
upon proteasome inhibition and thus the lack of degradasome formation when TNKSi
are combined with proteasome inhibitors. While our manuscript was in
preparation, another publication reported that proteasome inhibition prevents
degradasome formation and leads to decreased association of the PARsylated AXIN
and TNKS proteins, but also to a perinuclear enrichment of AXIN. This is in
agreement with our data, and our findings provide a further mechanistic
explanation by showing that proteasome inhibition decreases the fraction of
phosphorylated and thus active FoxM1 and that the cell morphology starts to
change after 6 h of proteasome inhibition, which has implications for cell
biological research utilizing proteasome inhibitors.
Given that proteasome inhibitors (including MG132) are used as potential
therapeutic agents in colorectal cancer, these findings are relevant regarding
combination therapies with TNKSi. The fact that proteasome inhibition
counteracts TNKSi-induced degradasomes argues against combining proteasome
inhibitors and TNKSi in cancer therapy.
# Supporting Information
The authors thank Stefan Krauss and Jo Waaler for providing G007-LK. The authors
thank The Core Facilities for Advanced Light Microscopy and Electron Microscopy
at Oslo University Hospital for providing access to relevant microscopes. We
also acknowledge Anne Engen and her co-workers in the cell lab facility for
expert handling of cell cultures.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceived and designed the experiments:** NMP TET SWS EMW HS.
**Performed the experiments:** NMP TET SWS EMW. **Analyzed the data:** NMP
TET SWS EMW HS. **Contributed reagents/materials/analysis tools:** HS.
**Wrote the paper:** EMW NMP TET HS.
|
# Introduction
There is increasing evidence that human immunodeficiency virus (HIV) infection
is a risk factor for occlusive arterial disease including myocardial infarction
(MI) – and peripheral arterial disease (PAD). A number of mechanisms may explain
this relationship. Partly through antiretroviral therapy (protease inhibitors),
patients with HIV infections may have an increased prevalence of conventional
cardiovascular risk factors, the consequence being an enhanced degree of
atherosclerosis. However, vascular pathology in HIV may occur in the absence of
risk factors through arterial wall infections, producing a vasculitis either
through direct effects or through co-infections. Whether an HIV-associated
vasculitis accounts in-part for occlusive arterial disease nevertheless remains
uncertain.
Although a number of vasculitis subtypes have been described in HIV infected
patients, the prevailing hypothesis is that HIV-associated occlusive arterial
disease (MI and PAD) is largely attributed to premature atherosclerosis. Thus,
cardiovascular risk prevention in HIV-infected patients has focused on targeting
conventional cardiovascular risk factors. Nevertheless, there is some evidence
that occlusive arterial disease in HIV-infected patients may be attributed to a
vasculitis. In this regard, in the absence of atheroma, adventitial inflammation
has been described in large vessels in a series of 16 HIV positive patients,
most of whom had aneurysmal pathology, but 3 of whom also had occlusive arterial
disease ; and in large vessels of 4 amputated limbs of HIV positive patients
with critical lower limb ischemia (CLI). However, without an HIV-sero-negative
group with matched pathology available for comparison, adventitial vasculitis in
patients with occlusive arterial disease - could be attributed to an
epiphenomenon. Hence, whether a vasculitis characterizes HIV-positive as
compared to negative patients with occlusive arterial disease is unknown. In the
present study we therefore aimed to compare large artery histopathological
characteristics in untreated HIV-sero-positive patients with CLI requiring
amputation, to large artery characteristics in HIV-sero-negative patients with
CLI requiring amputation.
# Materials and Methods
## Study groups and clinical data
The present study was conducted according to the principles outlined in the
Helsinki declaration. The Committee for Research on Human Subjects of the
University of the Witwatersrand approved the protocol (approval number:
M120739). Participants gave informed, written consent. Ten HIV positive and 10
HIV negative black African male patients with CLI requiring above knee
amputations were recruited from the Division of Vascular Surgery at the Chris
Hani Baragwanath Hospital, Johannesburg, South Africa over the period September
2012 to July 2013. None of these patients had clinical evidence of aneurysms.
All patients had ischemic pain at rest and evidence of tissue loss (necrosis as
evidenced by foot and leg ulcers and/or gangrene). Routine HIV serology (ELISA)
was performed to determine HIV status. A CD4 count was obtained in all HIV
positive patients with CLI. Participants were considered to have diabetes
mellitus if they had a fasting plasma glucose concentration ≥7 mmol/l, or in
whom glucose-lowering agents were prescribed. Brachial blood pressure (BP) was
measured according to guidelines and taken as the mean of five measurements.
Participants with a BP ≥140/90 mm Hg or in those receiving antihypertensive
medication were considered to have hypertension. Dyslipidemia was diagnosed as
the presence of either a raised triglyceride concentration (≥1.7 mmol/l) or a
reduced high density lipoprotein (HDL) concentration (\<1.0 mmol/l).
### Histopathological assessment
Specimens from the distal superficial femoral artery (SFA) were obtained at the
time of above knee amputations due to PAD where reconstruction could not be
performed resulting in end-stage CLI. One centimeter of the SFA was obtained at
the level of transection for the amputation (from the viable stump). Specimens
were fixed in 10% buffered formalin, processed according to standard methods and
4 µm sections cut and stained with hematoxylin and eosin. Sections were also
stained with Elastic Von Giesson stain for elastic fibres; a Masson trichrome
stain for collagen and an Alcian Blue stain for mucopolysaccharides.
Immunohistochemical stains for CD3 (T-cell marker), CD20 (B-cell marker) and
CD68 (histiocytic marker) were performed. The slides were assessed by a
pathologist (SN) who was unaware of (blinded to) the HIV-status and clinical
characteristics of the patients from whom the specimens were derived. The slides
were evaluated for the presence of atheroma, fragmentation and reduplication of
the internal elastic lamina, and adventitial vascular proliferation and
perivascular inflammation. All parameters were graded semi-quantitatively, as 0
(absent), 1+(focally present), 2+(moderate) and 3+(extensive).
### Data analysis
Continuous data are shown as mean ± SD. Proportions between groups were compared
using a Fischer’s Exact test and continuous data were compared using a Mann-
Whitney ranked sum test.
# Results
## Participant characteristics
The demographic and clinical characteristics of the participants are shown in.
As compared to HIV negative patients with CLI, HIV positive patients with CLI
were younger, and had a lower prevalence of traditional cardiovascular risk
factors, including hypertension and diabetes mellitus. HIV negative patients had
higher glycated hemoglobin values. A similar proportion of HIV positive patients
with CLI smoked regularly as compared to HIV negative patients with CLI and
similar average lipid concentrations were noted between the groups. A wide range
(74 to 643×10<sup>6</sup>/l) of values for CD4 count were obtained and 5 (50%)
HIV positive participants had values that would not have qualified for
antiretroviral therapy based on the current thresholds for therapy in South
Africa (\<350×10<sup>6</sup>/l), and 2 patients had CD4 counts
\>500×10<sup>6</sup>/l.
## Histopathological evidence of femoral wall inflammation
90% of HIV positive patients, but no HIV negative patient had evidence of
adventitial leukocytoclastic vasculitis of the vasa vasorum. In addition, 70% of
HIV positive, but no HIV negative patient had evidence of adventitial slit-like
vessels. Whilst in HIV positive patients T-lymphocytes were noted in the
adventitia in 80% and in the intima and media in 30% of patients, in HIV
negative patients T-lymphocytes were noted only in the intima and these occurred
in 50% of patients. No B lymphocytes were observed in either group (data not
shown). No significant differences in the mean (±SD) CD4 count were noted
between HIV positive patients ranked as having 1+(366±218×10<sup>6</sup>/l)
versus 2+(292±244×10<sup>6</sup>/l, p = 0.56) adventitial leukocytoclastic
vasculitis.
## Histopathological evidence of arteriosclerotic changes
The presence of calcified multilayered fibro-atheroma was noted in 40% of HIV
positive patients with CLI with none showing eccentric changes, whilst calcified
multilayered fibro-atheroma was noted in 90% of HIV negative patients with CLI,
60% of whom had eccentric changes. Ossification of plaque was noted in 30% of
HIV negative patients with CLI, but no ossification was noted in HIV positive
patients with CLI. A similar proportion of HIV-positive and negative patients
had evidence of macrophages and the extent of intracellular and extracellular
lipid deposits was similar in both groups. Lipid deposits were noted in HIV
positive patients with multilayered fibro-atheroma only. A similar proportion of
HIV positive and HIV negative patients with CLI had fragmentation and
reduplication of the internal elastic lamina and mucoid degeneration. The
combined thickness of the femoral artery intima and media tended (p = 0.20) to
be lower in HIV positive as compared to negative patients with CLI. However,
intima-media thickness was similarly increased in both HIV positive (1.38±0.28,
p\<0.05) and HIV negative (1.56±0.79, p\<0.05) patients with fibroatheroma as
compared to HIV positive patients without fibroatheroma (0.74±0.41).
## Relationship between risk factors and advanced atheroma
All HIV positive patients with advanced atheroma were current or previous
smokers. However, HIV positive as compared to negative patients with advanced
atheroma were younger and a trend (p = 0.05 and 0.11) for the presence of fewer
HIV positive patients to have hypertension or diabetes mellitus was noted.
# Discussion
The main findings of the present study are that as compared to femoral arteries
from HIV negative African men with CLI, femoral arteries from HIV positive
African men with CLI not receiving anti-retroviral therapy are largely
characterized by the presence of leukocytoclastic vasculitis of the vasa vasorum
and adventitial inflammation. In addition, a significant proportion of HIV
positive men with CLI not receiving anti-retroviral therapy showed advanced
femoral artery atheroma, despite a markedly lower age and a lower prevalence of
conventional cardiovascular risk factors.
To the best of our knowledge the present study is the first to compare
histopathological changes in appropriate large vessels in patients with and
without HIV and with occlusive arterial disease. Indeed, although a number of
vasculitis subtypes have been described in HIV infected patients, few studies
have reported on large vessel changes in patients with occlusive large artery
disease, such as MI, PAD or stroke. In this regard prior studies have reported
on the presence of leukocytoclastic vasculitis of the vasa vasorum and
adventitial inflammation in large vessels of patients with HIV and aneurysmal
changes in which 3 patients had occlusive large artery disease, and in large
vessels of 4 amputated limbs of HIV positive patients with critical limb
ischemia (CLI). In these studies, comparisons of histopathological features were
not made with patients admitted for similar clinical events but without HIV.
Hence, the histopathological changes reported on in HIV positive patients with
occlusive arterial disease in these studies – may reflect an epiphenomenon and
not HIV-associated pathology. However, the present study provides clear evidence
that leukocytoclastic vasculitis of the vasa vasorum and adventitial
inflammation in large vessels is a unique feature associated with HIV infection
as compared to non-HIV-infection in patients with CLI.
Our finding of a characteristic adventitial inflammatory change in HIV positive
as compared to negative patients with CLI in the present study should be
interpreted with caution. These relationships may not represent cause and
effect. A previous study reporting on leukocytoclastic vasculitis of the vasa
vasorum and adventitial inflammation in patients with mainly large artery
aneurysms and in a small number of patients with occlusive arterial disease
(n = 3), also showed adventitial and medial fibrosis and loss of medial muscle.
The authors speculated that occlusion of the vasa vasorum leads to death of
areas of large vessel walls and hence to aneurysm formation. However, in the
present study we failed to note similar changes in any of the 10 patients with
HIV and CLI. Nevertheless, to avoid the effects of ischemia on histopathological
changes, we sampled femoral artery tissue proximal to the occlusion, rather than
at the level of the occlusion. It is therefore possible that at the level of the
occlusion, adventitial and medial fibrosis and loss of medial muscle may have
been noted, the consequence being wall scarring, thrombus formation and
ultimately vascular occlusion.
The present study provides intriguing evidence to suggest that at least in a
portion of patients with HIV not receiving antiretroviral therapy who develop
CLI (4 of 10 in the present study), advanced large artery atheroma (calcified
fibroatheroma) may contribute toward vascular occlusion. In this regard,
although HIV positive patients with CLI with advanced femoral artery were
younger and tended to have less risk factors than HIV negative patients with CLI
with advanced femoral artery atheroma, all HIV positive patients with advanced
femoral artery atheroma were current or previous smokers. This is entirely
consistent with a number of studies that have reported a high prevalence of
smoking in HIV positive patients with cardiovascular disease. These data
therefore suggest that conventional risk stratification may not apply equally or
as effectively among those with as compared to those without HIV infections.
Indeed, non-human primate models of immunodeficiency virus infections are
associated with atherosclerotic lesions in the absence of conventional
cardiovascular risk factors. Large studies are required to evaluate whether
current risk assessment charts adequately risk predict in HIV positive patients
not receiving antiretroviral therapy in South Africa.
The findings that fewer HIV positive as compared to negative patients with CLI
had advanced calcific fibroatheroma, and that femoral artery intima-media
thickness tended to be lower in HIV positive as compared to negative patients,
must also be interpreted with caution. As previously emphasized, to avoid the
effects of ischemia on histopathological changes, we sampled femoral artery
tissue proximal to the occlusion, rather than at the level of the occlusion.
Hence, we may have missed areas of fibroatheroma in HIV positive patients and
consequently, it is still possible that atheroma is the major cause of CLI in
HIV positive patients not receiving antiretroviral therapy.
The clinical implications of the present study warrant consideration. In this
regard, in two large vascular units in South Africa in which we have previously
reported on very high admission rates for CLI, approximately 12% of these
patients were HIV positive with low cardiovascular risk scores irrespective of
whether or not they were receiving antiretroviral therapy. In this regard, the
present study suggests that the pathogenesis of CLI in these circumstances may
involve a combination of a vasculitis and/or advanced atheroma formation,
despite a low cardiovascular risk. These findings may have implications for both
risk prevention, where a more aggressive approach to risk management is required
in HIV positive patients who smoke, and for decisions regarding
revascularization procedures, where the causal lesions may in-part be
atheromatous in nature despite a lower overall cardiovascular risk. Moreover,
the present study suggests that a significant proportion of HIV positive
patients (50%) may develop CLI when they have a CD4 count above the threshold
that qualifies for antiretroviral therapy in South Africa. If confirmed in
larger studies, these data would suggest that specialized screening procedures,
such as measures of carotid intima-media thickness may be required in HIV
positive patients with CD4 counts above the threshold for therapy, and that
antiretrovirals are instituted before the CD4 count decreases to below the
threshold for therapy in those patients considered at risk for CLI.
There are a number of limitations to the present study that warrant
consideration. The small study sample raises the question of false positive and
negative findings and hence a much larger study is required to confirm aspects
of the present data. Nevertheless, it is unlikely that a larger study will
improve on our ability to show differences in the presence of a leukocytoclastic
vasculitis in 9 of 10 HIV positive patients and none of the 10 HIV negative
patients. In addition, because CLI is associated with disturbances of
coagulation and fibrinolytic systems before, during and up to 30 days after
surgery we were unable to assess the relationship between coagulation profiles
and HIV in CLI. Further, as a consequence of limb ischemia and the presence of
ulcers and/or gangrene (tissue necrosis) in all patients, which affects
circulating inflammatory and immune activation markers, we were also unable to
assess the relationship between inflammation or immune activation and HIV in
CLI. Hence, we cannot exclude the possibility that a pro-coagulation state, well
recognized to characterize HIV and which is associated with large artery changes
in non-human primate models of immunodeficiency virus infections, is the main
role player for CLI in HIV or whether inflammation and immune activation are
important causes of HIV-associated CLI.
In conclusion, in the present study we show that as compared to HIV negative
patients with CLI, leukocytoclastic vasculitis of the vasa vasorum and
adventitial inflammation characterize large artery pathology in HIV positive
patients with CLI not receiving anti-retroviral therapy. Moreover, we show that
a significant proportion of HIV positive patients with CLI not receiving anti-
retroviral therapy have advanced femoral artery atheromatous changes, despite a
lower cardiovascular risk. These data may have implications for both primary
prevention and for the management of occlusive arterial disease in HIV positive
patients.
# Supporting Information
This study would not have been possible without the voluntary collaboration of
the participants.
[^1]: Dr Simon Nayler is employed by Gritzman and Thatcher Inc. which is a
private pathology laboratory. The authors specifically contracted Dr Nayler
for this study because of his reputation and expertise as a
histopathologist, especially in the cardiovascular field. Dr Nayler has no
invested interests nor stands to gain from the outcomes of this study.
Hence, the authors do not believe that he has a conflict of interest.
Furthermore, this does not alter the authors’ adherence to PLOS ONE policies
on sharing data and materials.
[^2]: Conceived and designed the experiments: MB AJW FM SN MGV GRN.
Performed the experiments: MB SN. Analyzed the data: MB AJW. Contributed
reagents/materials/analysis tools: MB AJW SN GRN. Contributed to the writing
of the manuscript: MB AJW FM SN MGV GRN.
|
# Introduction
The association between birth weight and later risk of type 2 diabetes is
U-shaped. One arm comprise men and women born small, due to maternal
undernutrition or other factors. The other arm comprises of individuals born
large, due to maternal adiposity and diabetes.
South Asians have a higher prevalence of type 2 diabetes compared with
Europeans, and are diagnosed at a younger age and with a lower BMI. The
underlying mechanisms are only partly understood, but probably include that
South Asian babies are born smaller, but relatively adipose, i.e. have a reduced
lean mass, but higher fat mass, compared with Europeans. This “thin-fat”
phenotype of South Asians tracks through life, and could result in increased
insulin resistance. South Asian pregnancies present a mixture of
characteristics: on one hand shorter maternal height, lower BMI and a higher
risk of micro-nutritional deficiencies; factors which may constrain fetal
growth, on the other hand higher adiposity, insulin resistance and hyperglycemia
which may enhance growth.
The usual description of a baby born to a mother with gestational diabetes (GDM)
includes macrosomia and large for gestational age phenotypes in late pregnancy
and at birth. Some studies indicate a stronger association between maternal
hyperglycemia and offspring birth weight in ethnic South Asians than in
Europeans. However, little is known about the fetal growth trajectories in GDM
and non-GDM pregnancies, in populations universally screened for GDM, and if
this differs between these two ethnic groups.
The population-based multi-ethnic STORK-Groruddalen cohort provided a unique
opportunity to explore these relationships. We compared maternal characteristics
in early pregnancy, and fetal size and growth rate during the second half of
pregnancy, in ethnic South Asian and European pregnancies with and without GDM
in Oslo, Norway.
## Ethics statement
Pregnant women attending the Child Health Clinics for antenatal care in three
municipalities in Groruddalen, Oslo, from May 2008 to May 2010 were given oral
and written information about the Stork Groruddalen project and invited to
participate. The women who chose to participate gave informed written consent at
inclusion, on behalf of themselves and their offspring. The study protocol and
the consent-forms were approved by The Regional Committee for Medical and Health
Research Ethics for South Eastern Norway, and The Norwegian Data Inspectorate.
## Population and design
The study design has been presented in detail elsewhere. Prior to the study,
75–85% of all pregnant women in this area attended the local Child health
Clinics during their pregnancy. Questionnaire data was collected by specially
trained study midwives through interview, supported by a professional
interpreter, using translated questionnaires when needed. Information material
and questionnaires were translated to eight languages including English, Tamil
and Urdu, covering the largest South Asian ethnic groups. Women were eligible if
they were: (1) living in one of the districts, (2) would give birth at the study
hospitals, (3) were in gestational week \< 20, (4) not suffering, at the time of
enrollment, from diseases necessitating intensive hospital follow-up during
pregnancy (i.e. pre-gestational diabetes and other substantial medical,
psychiatric or obstetrical conditions) (5) not already enrolled with a pregnancy
lasting \> 22 weeks, (6) could communicate in Norwegian or any of the other
eight languages, and (7) were able to give informed consent. The final sample
consisted of 823 pregnant women. Overall participation rate was 74% (81.5% in
Europeans and 73.0% in South Asians) and the study cohort was considered
representative for women attending the Child Health Clinics with respect to
ethnicity and age.
## Maternal factors
The participating woman and fetus were defined as ethnic European or South Asian
if the participating woman or her mother were born in Europe or South Asia
respectively. Europeans also included three women of European origin born in
North-America. As few South Asians migrated to Norway before the 1970\`s, all
potential participants with South Asian ancestry were either born in South Asia,
or their mothers were born there.
Glycated haemoglobin (HbA1c) and fasting glucose were measured at enrollment.
HbA1c was measured with HPLC (Tosoh G8,Tosoh Corporation, normal reference range
4–6%). A standard 75 g oral glucose tolerance test (OGTT) was performed in
gestational week 28±2. Women were diagnosed with gestational diabetes according
to the 1999 WHO-criteria (fasting plasma glucose ≥7.0 mmol/l or 2-hour glucose
≥7.8 mmol/l). Glucose was measured on site (within 5 minutes after vein
puncture) in venous EDTA blood according to a standardized protocol, using a
patient-near method (HemoCue 201+, Angelholm Sweden) calibrated for plasma.
According to national guidelines, women with fasting glucose \< 7.0 mmol/l and
2-hour values 7.8–8.9 mmol/l were categorized as “mild GDM”, and were given oral
and written lifestyle advice and referred to their general practitioner for
follow-up. Women with fasting glucose ≥ 7.0 mmol/l or 2-hour values ≥ 9.0 mmol/l
were categorized as “moderate/severe GDM”, and referred to secondary care. Data
related to GDM-treatment have been collected from hospital records.
Maternal height was measured twice to the nearest 0.1 cm with a fixed
stadiometer at inclusion, and the mean was used. Pre-pregnant body mass index
(BMI, kg/m<sup>2</sup>) was calculated using self-reported pre-pregnant weight,
to the nearest kg, and measured height. Weight gain (WG) in kg, was calculated
from pre-pregnancy to enrollment, from enrollment to week 28 and from week 28 to
birth (see footnotes Tables and). Parity was categorized as “primiparous” or
“parous” (at least one previous pregnancy lasting \> 22 weeks). Except in 7% of
women gestational age was derived from the first day of the woman’s last
menstrual period (see footnote).
## Fetal- and neonatal measurements
At each ultrasound visit, scheduled at 24, 32 and 37 weeks of gestation,
participants were randomly allocated to one of four study-ultrasonographers. One
Voluson Pro (GE-Healthcare) machine, with a AB2-7 scan head, was used. Methods
have been described in detail elsewhere. Using standard anatomical landmarks,
abdominal circumference (AC) and head circumference (HC) were obtained by
applying computer-generated elliptical measurements to the outer surfaces, while
femur length (FL) was obtained in a longitudinal section. Each biometric
variable was measured three times, according to a study-specific standardized
protocol, and the mean value was used. Estimated fetal weight (EFW) was
calculated using Combs formula: EFW = (0.23718 x AC<sup>2</sup> x femur length)
+ (0.03312 x HC<sup>3</sup>), as used in clinical practice in the study-
hospitals at that time.
Birth weight was routinely measured on calibrated electronic scales immediately
after birth. Within 72 hours after birth, study-specific anthropometric
measurements were performed by trained study personnel, according to study
protocol, unless contraindicated for medical reasons. Crown-heel-length (CH-
length) was measured by a measuring rod, with the head firmly held, while
stretching the legs. For circumference measurements a non-elastic plastic tape
was used. CH-length, HC and AC were measured to the nearest 0.1 cm.
## Statistical methods
Z-scores for fetal measurements (differences in standard deviations from
gestational age specific mean) were calculated using formulas derived from an
ethnic Norwegian reference population. National birth weight references were
used to calculate birth weight z-scores in the total study sample. In the large
sub-sample of term neonates with study-specific anthropometric measurements at
birth, we have previously calculated individual z-scores, stratified by
gestational week and gender for birth weight, HC, AC and CH-length.
Statistical analyses were performed using SPSS version 22.0 for Windows (SPSS
Inc., Chicago, IL, USA). The significance level was set to p\<0.05. Differences
between pregnancies complicated by mild or moderate/severe GDM, compared with
non-GDM pregnancies were explored using Chi Square test for categorical and
t-tests for continuous variables.
Differences in fetal growth from week 24 until birth were examined using linear
mixed effects modelling, assessed separately for the outcomes weight, HC, AC and
length. Z-scores through four different time points (week 24, 32, 37 and at
birth) were entered. For the analysis of length we used z-scores for femur
length at three time points in pregnancy and CH-length from birth. For the
analyses of weight we used z-scores of EFW from three time points during
pregnancy and birth weight. All models were run with a random intercept and a
random slope. We first explored the impact of ethnicity on fetal growth in non-
GDM pregnancies. Ethnicity was first entered as a fixed variable together with
gestational age (weeks) and the interaction term between these two variables (to
assess the impact of ethnicity on growth velocity). A priori, we added the
covariates offspring gender and maternal parity to the adjusted models. As lower
maternal height is often perceived to explain a substantial part of ethnic
differences in fetal growth, maternal height was also included in the last
supplementary model. A second degree term for gestational age was also included
as a fixed variable in all models, due to a small, but systematic variation in
the distribution of the fetal z-scores across the four time points. Interaction
terms between other covariates and gestational age were tested for and included
if significant. We then performed similar analyses replacing ethnicity with GDM
as explanatory variable, first treated as non-GDM or GDM, thereafter stratified
into non-GDM, mild GDM and moderate/severe GDM. We then added the covariates
maternal ethnicity, parity and offspring gender to the adjusted models, and
maternal height in a final supplementary model. Lastly, we performed the
analyses in Europeans and South Asians separately. Estimated mean SD-scores from
the adjusted mixed models from each of the four time points were extracted.
## Sample size
The present study was restricted to women of European (n = 379) and South Asian
(n = 200) ethnic origin. After excluding twins and those with missing newborn
data, OGTT or ultrasound, the final study sample consisted of 349 European and
184 South Asian (63% Pakistani and 37% Sri Lankan/Indian) women (Flow chart). Of
these, 72% were delivered at term and had study-specific measurements at birth.
# Results
## Maternal characteristics
At enrollment (mean gestational week 15), South Asian women were shorter,
younger and less educated than European women. Their mean BMI was slightly
lower, but they had more subcutaneous fat represented by thicker skin-folds.
Furthermore, South Asian women had significantly higher fasting glucose and
HbA1c, with a distribution skewed to the right. Nevertheless, few women had
fasting glucose or HbA1c values at levels which may be considered indicative of
impaired glucose control, irrespective of later GDM diagnosis.
In total 39 (11%) European and 28 (15%) South Asian women were diagnosed with
GDM in week 28 according to the WHO 1999 guidelines. Relatively more South Asian
women had moderate/severe GDM (p = 0.04 for the difference between ethnic
groups). Of these, two South Asian and one European woman received insulin
treatment during pregnancy. None were treated with oral glucose-lowering drugs.
European women later diagnosed with GDM were more likely to be overweight or
obese when entering pregnancy than their non-GDM counterparts, in particular
women diagnosed with moderate/severe GDM. However, they showed less weight gain
throughout pregnancy than non-GDM women. A different pattern was seen in South
Asian women diagnosed with GDM, as no differences compared with their non-GDM
counterparts were observed for BMI, overweight and gestational weight gain. The
majority of South Asian women with moderate/severe GDM (79%) were normal weight
and only one was obese.
## Fetal growth
In week 24, fetuses of South Asian non-GDM mothers had longer femurs, but
smaller ACs than their European counterparts. From this time they grew
significantly slower, and at birth they were smaller on all measures.
Fetuses of mothers who were later diagnosed with GDM were smaller on all fetal
measures in week 24 (mean difference in EFW z-score: -0.30 SD (-0.53, -0.07), p
= 0.01), compared with fetuses of non-GDM mothers. From this time until birth
they showed faster growth. However, when we categorized GDM into “mild” and
“moderate/severe” GDM, and South Asian and European women were analyzed
separately, different patterns emerged.
South Asian fetuses exposed to mild GDM had a similar size and growth rate
during the second half of pregnancy as South Asian non-GDM fetuses. In
contrast, fetuses exposed to moderate/severe GDM were markedly smaller on all
measures in week 24. EFW was -0.95 SD (-1.53, -0.36), p\<0.001) at this time
point. From this time until birth, they showed a faster growth rate on all
measures, and birth weight was 0.45 SD ((0.09, 0.81), p = 0.01) higher than in
non-GDM pregnancies. This was also reflected in a 92 g larger placenta weight
(p\<0.05).
European fetuses exposed to GDM also tended to be smaller in week 24 and show
faster growth than their non-GDM counterparts.
# Discussion
In this study we observed that fetuses of mothers later diagnosed with GDM
tended to be smaller in week 24, compared with fetuses of non-GDM mothers. From
this time until birth they showed a faster growth. This pattern was most
pronounced in South Asian fetuses of mothers diagnosed with moderate/severe GDM,
who were the smallest for all body measures in mid pregnancy.
This study is unique, as we were able to combine longitudinal maternal and
offspring data from early pregnancy to birth, including GDM-data from universal
screening, in a well-characterized population-based cohort, in two different
ethnic groups. The smaller fetal size in mid-pregnancy in GDM, compared with
non-GDM pregnancies, was unexpected. However, an early fetal growth delay has
been reported both in Type 1 and Type 2 diabetes. There are only few reports of
fetal growth in pregnancies which are later diagnosed with GDM. A recent study
from the UK did not observe a significant association between GDM and fetal size
in week 20, in a predominantly ethnic white British cohort. They did, however,
find an accelerated fetal growth velocity between week 20 and week 28, hence
preceding the clinical diagnosis of GDM, which is in line with our study.
The slower growth in early pregnancy in Type 1 and Type 2 diabetes has been
associated with indicators of poor glucose control in early pregnancy and with
lower levels of some biomarkers indicating impaired early placentation. Few
women in our study had high HbA1c or high fasting blood glucose in early
pregnancy, irrespective of GDM-severity later in pregnancy. For a given BMI,
South Asians tend to have lower lean mass, including lower muscle mass and fewer
insulin-producing β-cells, but relatively more fat mass than ethnic Europeans.
We have previously shown from the same cohort that South Asian mothers had more
subcutaneous fat and higher serum-leptin levels in early pregnancy compared with
Europeans, despite having a lower BMI, indicating a thin-fat phenotype..
Hence, the substantial “growth delay” in mid pregnancy, observed in fetuses of
predominantly normal weight South Asian women diagnosed later with
moderate/severe GDM, could still indicate subtle metabolic and placental
abnormalities from an early stage in pregnancy.
Our results could also indicate that there may be different types of GDM. One
being GDM in an obese women, with pre-existing insulin resistance and a
sufficient capacity to produce insulin in a non-pregnant situation, but
decreased capacity to compensate for the added insulin resistance caused by
pregnancy. The other being GDM in a “thin-fat” woman, predominantly due to a
reduced capacity to produce insulin but also diminished insulin sensitivity due
reduced muscle mass.
It has also been speculated that maternal hyperglycemia during the second half
of pregnancy may in part be triggered by the fetus through the placenta, to
promote intrauterine “catch-up” after early growth failure. If such a
hyperglycemic response is aiming to compensate for early placental
insufficiency, we could further speculate that very intensive treatment of GDM,
primarily by a very strict glucose control, if followed by a low maternal weight
gain, may aggravate growth failure, in particular in normal weight GDM women.
The key challenge is that optimal fetal growth remains to be defined. Customized
fetal growth charts aim to predict the growth potential, i.e. “optimal growth”
for each baby, by adjusting for characteristics which influence birth weight,
such as maternal height, parity and ethnic origin, and by excluding pathological
factors such as smoking and diabetes. However, ethnic differences in fetal
growth are observed, and only partly explained by key maternal factors, such as
parity, socioeconomic position and height. Factors which are independently
associate with fetal size at different time points during pregnancy, and across
ethnic groups, await elucidation. Fetuses of South Asian non-GDM mothers had
longer femurs, but smaller ACs in mid pregnancy, compared with their European
counterparts. From this time until birth they showed a slower growth on all
measures. Hence, at birth South Asian neonates were thinner, represented by a
markedly smaller AC, while length and HC were modestly smaller. Whether this
growth pattern is optimal for South Asians is not known. When using the
Norwegian national birth weight references, more than 20% of the South Asian
neonates in our cohort were defined as being small for gestational age, while
few were large for gestational age, reflecting that the birth weight
distribution is skewed compared with the distribution in the native Norwegian
population. We did not observe any differences in birth complications between
pregnancies with and without GDM, or between ethnic groups in our study.
However, we have limited statistical power to answer these comparisons. In the
short run, for perinatal outcomes, growth restriction diagnosed by ethnic-
specific fetal growth charts seems to better predict adverse perinatal outcomes.
Nevertheless, for long term outcomes, such as adiposity and type 2 diabetes,
both “thinness” at birth and excess fetal growth have been associated with a
higher risk. From this we could speculate that South Asian fetuses, both those
exposed to GDM and those not, may be at increased risk of type 2 diabetes in
later life.
The study has some limitations. Most women diagnosed with GDM were treated non-
pharmacologically, indicating that there were few cases of severe GDM. However,
treatment could still have influenced the fetal growth patterns. Furthermore,
the limited number of GDM-cases, further categorized into two groups, primarily
based on elevated 2-hour-values, restricts our power to adjust for many
covariates, and to explore interactions. However, as women in the two GDM-
categories were given different follow-up after being diagnosed, the alternative
of not taking this into account could cause bias. Almost all South Asian women
with moderate/severe GDM were normal weight before entering pregnancy but had
similar weight gain as non-GDM women. Most Europeans, however, were obese and
had substantially less weight gain than their non-GDM counterparts. Adjusting
for these factors could therefore potentially also cause bias. Our findings
illustrate the complexity involved in the relationship between maternal factors
and fetal growth, should be interpreted with caution.
## Conclusions
To conclude, we observed differences in fetal size and body proportions from
before diagnosis and treatment of glucose intolerance. The most prominent growth
deviations was observed in fetuses of South Asian mothers diagnosed with
moderate/severe GDM. Their babies were small in size in mid-pregnancy but but
subsequently grew faster until birth compared with babies of non-GDM mothers.
The mechanisms underlying these differences are likely to be at least partly
present before the pregnancy. Our results highlights the need for large-scale
comparative studies of serial fetal growth from early pregnancy. This could have
implications for the timing of diagnosis and the treatment of pregnancy-related
hyperglycemia in different ethnic groups.
# Supporting information
The authors thank all the study participants, and Nanna Voldner and Jorid Bech
Barbøl for performing ultrasound examinations. We also thank study staff and
general staff at the Child Health Clinics in Stovner, Grorud and Bjerke
districts in Oslo and at the delivery- and post-natal wards at Akershus
University Hospital and Oslo University Hospital, for help with collecting the
data.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceptualization:** LS AKJ. **Formal analysis:** LS. **Funding
acquisition:** AKJ BN. **Investigation:** LS AKJ KM OHRJ SV.
**Methodology:** LS AKJ CSY SV. **Project administration:** LS AKJ KIB.
**Visualization:** LS. **Writing – original draft:** LS. **Writing – review
& editing:** LS AKJ CSY KM BN OHRJ KIB SV.
|
# 1 Introduction
Depression is one of the most common mental disorders in the United States. The
2017 US National Surveys on Drug Use and Health (NSDUH) indicated that
approximately 13.2% (3.2 million) of adolescents aged 12 to 17-year-old and 7.1%
(17.3 million) adults 18-year-old and older reported experiencing at least one
major depressive episode. Although the prevalence of depression in the US
population, especially among young adults has increased, and a variety of
pharmacological treatments are available, a large proportion of individuals with
depression delay seeking treatment or avoid it altogether. According to the 2017
NSDUH data, an estimated 35% of adults and 60.1% of adolescents who had a major
depressive episode did not receive treatment.
Current medical cannabis policies across the US do not include depression as a
medical qualifying condition for medical cannabis use. However, emerging
research indicates that coping with depression is often reported as an important
reason for cannabis use. However, the potential causal relationship and
directionality between cannabis use and depression remain uncertain. There is a
paucity of research on the topic and existing studies mainly focus on treatment
centers data. Furthermore, the on-going and rapid changes in the US cannabis
legislative landscape along with the increased potency of cannabis over the past
twenty years call for timely epidemiological monitoring of lay practices and
therapeutic uses of cannabis products in order to assess the impact of policy
changes, and identifying emerging issues and trends.
In this context, social media platforms play an important role in uncovering
experiences of individuals and their health-related knowledge. Social media data
offers the possibility to indirectly collect information about those who do not
receive treatment while having depression and using cannabis. Although user
generated content area constitutes a rich source of unsolicited and unfiltered
self-disclosures of attitudes and practices related to cannabis use, they have
not been explored to derive insights about causal relationship between cannabis
and depression.
Despite the recent improvements in Natural Language Processing (NLP) techniques,
scientific literature utilizing NLP to investigate this type of relationship
and/or focus on cannabis use remains sparse. Research has investigated the
relation between cannabis use and psychosis based on Electronic Medical Records
using NLP techniques. Basic NLP techniques were also used to assess the
frequency of experienced effects and harms of different generations of synthetic
cannabinoids in drug-focused web forums. However, and to the best of our
knowledge, no research using relation extraction has investigated the link
existing between cannabis and depression based on social media data.
Therefore, this research aims to design a relation extraction method
facilitating the identification of the causal relationship between cannabis and
depression as expressed by cannabis users using Twitter data. While we
acknowledge that correlations so derived are not to be confounded with
causation, they do provide insights on potential hypotheses that can be explored
through RCTs in the future.
We formulate this problem as the extraction of relationship between cannabis use
and depression in terms of four possible relationships namely: *Reason*,
*Effect*, *Addiction*, and *Ambiguous* (*c.f*.). Extracting relationships
between any *concepts/slang-terms/synonyms/street-names* related to
‘*cannabis*’, and similarly those related to ‘*depression*’, requires a domain
ontology. Here, we use Drug Abuse Ontology (DAO) a domain-specific hierarchical
framework containing 315 entities (814 instances) and 31 relations defining
drug-use and mental-health disorder concepts. The ontology has been utilized in
analyzing web-forum content related to buprenorphine, cannabis, synthetic
cannabinoid, and opioid-related data. The DAO included representations of mental
health disorders and related symptoms that were developed following DSM-5
classification. These terms were collected from the medical literature related
to substance use, abuse and addiction. In addition to medical terminology, DAO
included commonly used lay and slang terms that were identified using prior
clinical literature and social media-based studies on depressive symptomatology.
The DAO was expanded using DSM-5 categories covering the most common mental
health disorders by utilizing the study of for improving data collection about
mental health and cannabis use on Twitter. The lexicon for DSM-5 has been
constructed by utilizing publicly available knowledge bases, namely, ICD-10,
SNOMED-CT, and DataMed, along with enriched Drug Abuse Ontology.
For entity and relationship extraction (RE) task, previous approaches generally
adopt deep learning models, in particular, Convolutional Neural Network (CNN)
and Bi-directional Long Short Term Memory (Bi-LSTM) networks. However, Bi-
LSTM/CNN model does not generalize well and performs poorly in limited
supervision scenarios. Recently, several pre-trained language representation
models have significantly advanced the state-of-the-art in various NLP tasks.
BERT is one of the powerful language representation models that has the ability
to make predictions that go beyond the natural sentence boundaries. Unlike
CNN/LSTM model, language models benefit from the abundant knowledge from pre-
training using self-supervision and have strong feature extraction capability.
So we exploit the representation from BERT and CNN to achieve best of both the
representations using novel gating fusion mechanism. Further, we tailored our
model to capture the entities position information (using DAO knowledge) which
is crucial for the RE as established in the prior research.
We propose an end-to-end knowledge-infused deep learning framework (named,
***Gated-K-BERT***) based on widely adopted BERT language representation model
and domain-specific DAO ontology to extract entities and their relationship. The
proposed model has three modules: ***(1) Entity Locator***, which utilizes the
DAO ontology to map the input word sequence to the entities mention in the
ontology by computing the edit distance between the entity names (obtained from
the DAO) and every n-gram token of the input sentence. ***(2) Entity Position-
aware Module***, exploits the DAO to explicitly integrate the knowledge of
entities in the model. This is done by encoding position sequence relative to
the entities. Further, we make the attention layers aware of the positions of
all entities in the sentence. ***(3) Encoding Module***, jointly leverages the
distributed representation obtained from BERT and entity position-aware module
using the shared gated fusion layer to learn the contextualized syntactic and
semantic information which are complimentary to each other.
**Contributions**:
**(1)** In collaboration with domain experts, we introduce an annotation scheme
to label the relationships between cannabis and depression entities to generate
a gold standard cannabis-depression relationship dataset extracted using
Twitter.
**(2)** We propose an end-to-end knowledge-infused neural model to extract
cannabis/depression entities and predict the relationship between those
entities. We exploited domain-specific DAO ontology which provides better
coverage in entity extraction. We further augment the BERT model into knowledge-
aware framework using gated fusion layer to learn the joint feature
representation.
**(3)** We explored entity position-aware attention in the task to jointly
leverages the distributed representation of word position relative to
cannabis/depression mention and the attention mechanism.
**(4)** We evaluated our proposed model on real-world social media dataset. The
experimental results shows that our model outperforms the state-of-the-art
relation extraction techniques. We further analyzed that enhancing neural
attention with entity position knowledge improves the performance of the model
to predict the correct relationship between cannabis and depression over vanilla
attention mechanism.
# 2 Related work
Based on the techniques, recent existing works can be broadly categorized into
the following:
1. **Deep Learning (DL) framework**: Several DL approaches primarily based
on CNN and LSTM techniques has been proposed for RE. A study by develops a
hybrid deep neural network model using Bi-Directional Gated Recurrent Neural
Network (Bi-GRU), CNN, GRU, and Highway connection for classifying relations
in SemEval 2010 and KBP-SF48 dataset. exploited the dependency tree by
utilizing Graph Convolutional Neural Network (GCN) to capture rich
structural information that has been demonstrated for the RE task. advanced
the previous methods based on GCN by guiding the network through the
attention mechanism. Another prominent work by explores the adversarial
learning to jointly extract entities and their relationship. To further
enhance the performance of the DL models, various techniques has also
exploited latent features in particular the entity position information in
the DL framework.
2. **Pre-trained language representation model**: Models such as BERT,
BioBERT, SciBERT, and XLNet has shown the state-of-the-art performance on RE
task. adapted the BERT for the relation extraction and semantic role
labeling task. modified the BERT framework by constructing task-specific
MASK that control the attention in last layers of the BERT. also modified
the original BERT architecture by introducing a structured prediction layer
that is able to predict the multiple relations in one pass and make
attention layers aware of the entities position.
3. **Knowledge-base framework**: Study by saw the importance of external
knowledge in improving the relation extraction from sentences. The study
utilizes the parent-child relationships in Wikipedia and word cluster over
unlabeled data into a global inference procedure using Integer Linear
Programming (ILP). Experiments conducted on ACE-2004 dataset show that the
use of background knowledge improved F-measure by 3.9%. A study by uses
the attention model to traverse a medical knowledge graph for entity pairs
which assist in precise relation extraction. jointly learn the word and
entity embedding (obtained through the TransE) using the anchor context
model to extract the relationship and the entities. Some of the other
prominent work utilizing knowledge graph for relation extraction are.
# 3 Resource creation and annotation scheme
The corpus consists of tweets collected under the eDrugTrends project that aimed
to analyze trends in knowledge, attitudes, and behaviors related to the use of
cannabis and synthetic cannabinoids on Web forums and Twitter. Tweets were
collected from January 2017 to February 2019 using Twitter data processing,
filtering, and aggregation framework available through the Twitris platform,
which has been configured to collect tweets with relevant keywords selected by
the epidemiologists in the team and adapted to perform appropriate analysis.
Domain specialists (RD and FRL) in the team selected the most adapted keywords
to identify both cannabis and depression based on the DAO and prior research.
From the available corpus of over 100 million relevant tweets collected so far,
we further filtered tweets using DAO based on Cannabis and Depression entities
and their respective instances specifically defined by domain experts (substance
use epidemiologist) for this context. From that filtered corpus, a sample of
around 11,000 tweets was sent for expert annotation to a team of 3 substance use
epidemiologist co-authors who have extensive experience in drug use, abuse, and
addiction research. Further processing was done on this corpus based on the
tweets lacking one of the key concepts related to cannabis/depression and 5,885
tweets were annotated finally. The annotation scheme is based on the following
coding:
1. **Reason**: Cannabis is used to help/treat/cure depression.
2. **Effect**: Cannabis causes depression or makes symptoms worse.
3. **Addiction**: Lack of access to cannabis leads to depression, showing
potential symptom of addiction.
4. **Ambiguous**: Implies other types or relationships, or too
ambiguous/unclear to interpret.
The category “Addiction” is an intermediate between the first two as it
indicates that feelings of depression would be resolved if one had access to
cannabis (which relates to category 1) and also suggests potential presence of
cannabis withdrawal symptoms, thus indicating that cannabis use could lead to
depressive mood (as a part of withdrawal symptoms). Due to the brevity and
ambiguity of information provided in the tweet content, the team decided to
classify such cases as a separate category.
The sub-samples of tweets were coded independently by each coder and an inter-
coder agreement was calculated. The team went through 3 iterations of coding,
assessing and discussing, disagreement, and improving coding rules until an
acceptable level of agreement was reached among coders (Cohen’s kappa of
0.80,(*c.f*.)). Tweets that were coded differently by two primary coders were
reviewed by a third coder to resolve the disagreement. This yielded a dataset
containing 5,885 tweets out of which **(1)** 3243 tweets are annotated as
‘Reason’ **(2)** 707 tweets are annotated as ‘Effect’. **(3)** 158 tweets are
annotated as ‘Addiction’ **(4)** 1777 tweets are annotated as ‘Ambiguous’. The
mean tweet text length is 148 tokens (median 74).
The university institutional review board (IRB) approved the study under Human
Subjects Research Exemption 4 because it is limited to publicly available
tweets. To protect anonymity, cited tweet content was modified slightly. We note
that this dataset has some (inevitable) limitations: **(i)** the method only
captures a sub-population of cannabis-depression related tweets in eDrugTrends
campaign (i.e. those with terms defined in ontology), **(ii)** Tweets collected
may not be a representative sample of the population as a whole, and **(iii)**
there is no way to verify whether the tweets with self-reported cannabis related
depression or cannabis related relief from depression are truthful. The team
included researchers with extensive expertise in substance use epidemiology and
community-based research, and they contributed to development of the annotated
sample.
**Ethics**: Our project involves analysis of Twitter data that is publicly
available and that has been anonymized. It does not involve any direct
interaction with any individuals or their personally identifiable data. Thus,
this study was reviewed by the Wright State University IRB and received an
exemption determination.
# 4 Our proposed approach
In this study, a knowledge-infused RE framework, Gated Knowledge BERT (Gated-K-
BERT) is used to identify relations between entities ‘*cannabis*’ and
‘*depression*’ in a tweet. Our framework (*c.f*.) consists of three components
discussed as follows:
## 4.1 Entity locator module
Let *S* be an input tweet containing the *n* words {*w*<sub>1</sub>,
*w*<sub>2</sub>, …, *w*<sub>*n*</sub>}. Extracting relationships between any
*concepts/slang-terms/synonyms/street-names* related to ‘*cannabis*’ and
similarly those related to ‘*depression*’ require heavy dependency on the domain
knowledge model. We used domain-specific DAO to map entities in a tweet to their
parent concepts in the ontology by computing the edit distance between the
entity names (obtained from the DAO) and every n-gram token of the input
sentence. Since, DAO provides much better coverage on the entities, it is assume
that entity name will be mention in the sentence.
Later, we perform masking on the extracted entities. The reason for masking is
to explicitly provide the model with the entity information and also prevent a
model from overfitting its predictions to specific entities. For instance,
entities related to cannabis in a tweet are masked by ‘\<*cannabis*\>’.
Similarly, entities related to depression are masked with ‘\<*depression*\>’. By
this, we obtain a cannabis entity *c* and a depression entity *d* in the tweet,
corresponding to two non-overlapping consecutive spans of length *k* and *l*:
$S_{c} = \left\{ w_{c_{1}},w_{c_{2}},\ldots,w_{c_{k}} \right\}$ and $S_{d} =
\left\{ w_{d_{1}},w_{d_{2}},\ldots,w_{d_{l}} \right\}$. In effect, this
processing abstracts different lexical sequence in tweets to their meaning.
## 4.2 Entity position-aware module
This module is designed to infuse the knowledge of the entity mention in basic
neural models to effectively capture the contextual information w.r.t the
entities. The module consists of following three layers as:
### 4.2.1 Position embedding layer
Inspired by the position encoding vectors used in, we define a position sequence
relative to the cannabis entity $\left\{ p_{1}^{c},p_{2}^{c},\ldots,p_{l}^{c}
\right\}$, where $$\begin{array}{r} {p_{i}^{c} = \left\{ \begin{array}{ll} {i -
c_{1}} & {i < c_{1}} \\ 0 & {c_{1} \leq i \leq c_{k}} \\ {i - c_{k}} & {i >
c_{k}} \\ \end{array}\operatorname{} \right.} \\ \end{array}$$ Here, $p_{i}^{c}$
is the relative distance of token *w*<sub>*i*</sub> to the cannabis entity and
*c*<sub>1</sub> and *c*<sub>*k*</sub> are the beginning and end indices of the
cannabis entity, respectively. In the same way, we computed the relative
distance $p_{i}^{d}$ of token *w*<sub>*i*</sub> to the depression entity. This
provides two position sequences $p^{c} = \left\{
p_{1}^{c},p_{2}^{c},\ldots,p_{n}^{c} \right\}$ and $p^{d} = \left\{
p_{1}^{d},p_{2}^{d},\ldots,p_{n}^{d} \right\}$. Later, for each position in the
sequence, an embedding is learned with an embedding layer to producing two
position embedding vectors, $P^{c} = \left\{
P_{1}^{c},P_{2}^{c},\ldots,P_{n}^{c} \right\}$ for cannabis position embeddings
and $P^{d} = \left\{ P_{1}^{d},P_{2}^{d},\ldots,P_{n}^{d} \right\}$, both
sharing a position embedding matrix P respectively.
Further, we map each of the tokens from the input tweet *S* to the pre-trained
word embedding matrix $E \in \mathcal{R}^{V \times d}$ having the vocabulary
size *V* and dimension *d*. We used FastText, a pre-trained word embedding. Word
Embedding (Word2Vec) utilizes dense vectors to represent each word in the
vocabulary by projecting into a continuous vector space and also captures both
syntactic and semantic information associated with the words. However, in case
of a tweet, incorrect spellings, slangs, and other word forms, are out-of-
vocabulary (OOV) terms with respect to the word2vec model. In contrast,
character-level embeddings have the ability to address the OOV issues by
learning the vectors of character n-grams or parts of the words. FastText,
unlike word2vec, is trained on the character-level corpus that enables the model
to capture words that have similar meanings but different morphological word
formations in a robust manner.
We represent the input tweet after applying the word embedding as *e* =
{*e*<sub>1</sub>, *e*<sub>2</sub>, … *e*<sub>*n*</sub>}, where $e_{i} \in
\mathcal{R}^{d \times d}$. Finally each word *i* in the tweet *S* is represented
as the concatenation of the word embedding and relative distance of position
embedding with respect to cannabis and depression: $$\begin{array}{r} {x_{i} =
e_{i} \oplus P_{i}^{c} \oplus P_{i}^{d}} \\ \end{array}$$ We denote the final
representation of tweet as *x* = {*x*<sub>1</sub>, *x*<sub>2</sub>, …
*x*<sub>*n*</sub>}. The word feature and position feature representations
compose a position-aware representation.
### 4.2.2 Convolution layer
A combined representation of word and position embedding sequence *x* is passed
to the convolution layer, where filter $\textbf{F} \in \mathcal{R}^{m \times d}$
is convoluted over the context window of *m* words for each tweet. In order to
ensure that the output of the convolution layer is of the same length as input,
we performed the necessary zero-padding on the input sequence *x*. We call the
zero-padded input as $\overline{x}$. $$\begin{array}{r} {f_{i}^{m} = tanh\left(
\textbf{F}.{\overline{x}}_{i:i + m - 1} + b \right)} \\ \end{array}$$ where
*tanh* is the non-linear activation function and *b* is a bias term. The feature
map *f* is generated by applying a given filter **F** to each possible window of
words in a tweet, Mathematically, $$\begin{array}{r} {f^{m} = \left\lbrack
f_{1}^{m},f_{2}^{m},\ldots,f_{n}^{m} \right\rbrack} \\ \end{array}$$ We apply
different length of context window *m* ∈ *M*, where *M* is the set of context
window length. Finally, we generate the hidden state *h*<sub>*i*</sub> at time
*i* as the concatenation of all the convoluted features by applying a different
window size at time *i*.
### 4.2.3 Entity position-aware attention layer
The intuition behind adding entity position-aware attention layer is to select
relevant contexts over irrelevant ones. This position-aware representation of
entities in a tweet is further modulated by an ontology developed by domain
experts. This enhancement enables us to selectively model attention and weigh
entities in a tweet. The position-aware attention layer takes as an input
*h*<sub>1</sub>, *h*<sub>2</sub>, *h*<sub>3</sub>, …‥*h*<sub>*n*</sub> from the
encoding module. We formulate an aggregate vector **q** mathematically as
follows: $$\begin{array}{r} {\textbf{q} = \frac{1}{n}\sum\limits_{i =
1}^{n}h_{i}} \\ \end{array}$$ The vector **q**, thus, stores the global,
semantic, and syntactic information contained in a tweet. With the aggregate
vector, we compute attention weight *a*<sub>*i*</sub> for each hidden state
*h*<sub>*i*</sub> as $$\begin{array}{r} {u_{i} =
v^{T}\mspace{360mu}\text{tanh}\left( W_{h}h_{i} + W_{q}q + W_{c}P_{i}^{c} +
W_{d}P_{i}^{d} \right)} \\ \end{array}$$ $$\begin{array}{r} {\alpha_{i} =
\frac{exp\left( u_{i} \right)}{\sum_{j = 1}^{n}exp\left( u_{j} \right)}} \\
\end{array}$$ where, $W_{h},W_{q} \in R^{d_{a} \times d_{h}};W_{c},W_{d} \in
R^{d_{a} \times d_{p}};V \in R^{d_{a}}$ are parameters of the network, where
*d*<sub>*h*</sub> is the dimension of the hidden states, *d*<sub>*p*</sub> is
the dimension of position embedding, *d*<sub>*a*</sub> is the size of attention
vector. After applying the attention, the final tweet representation *R* is
computed as $$\begin{array}{r} {R = \sum\limits_{j = 1}^{n}\alpha_{j}h_{j}} \\
\end{array}$$
## 4.3 Encoding module
In the encoding module, we aim to obtain the semantic and task-specific
contextualized representation of the tweet. We leverage the joint representation
through BERT language representation model and Entity position-aware module.
Owing to its effective word and sentence level representation, BERT provide a
task-agnostic architecture that has achieved state-of-the-art status for various
NLP tasks. We use the pre-trained BERT model having 12 Transformer layers (*L*),
each having 12 heads for self-attention and hidden dimension 768. The input to
the BERT model is the tweet *S* = {*w*<sub>1</sub>, *w*<sub>2</sub>, …,
*w*<sub>*n*</sub>}. It returns the hidden state representation of each
Transformer layer. Formally, $$\begin{array}{r}
{H_{b}^{1},H_{b}^{2},\ldots,H_{b}^{L} = BERT\left( \left\lbrack
w_{1},w_{2},\ldots,w_{n} \right\rbrack \right)} \\ \end{array}$$ where, $H_{i}
\in \mathbb{R}^{n \times h_{b}}$ and *h*<sub>*b*</sub> is the dimension of the
hidden state representation obtained from BERT. We masked the representation of
`[CLS]` and `[SEP]` tokens with zero. We obtained the tweet representation via
BERT model as follows: $$\begin{array}{r} {B = \frac{1}{n}\sum\limits_{j =
1}^{n}H_{b}^{L - 1}\lbrack j,:\rbrack} \\ \end{array}$$ In our experiments, the
representation obtained from the second last (*L* − 1) Transformer layer
achieved the best performance on the task. The representation obtained from the
last Transformer layer is too close to the target functions (i.e., masked
language model and next sentence prediction tasks) during pre-training of BERT,
therefore may be biased to those targets. We also experiment with the `[CLS]`
token representation obtained from BERT but that could not perform well in our
experimental setting.
### 4.3.1 Gated feature fusion
The feature generated from CNN and BERT capture different aspect from the data.
These features need to be used carefully to make most out of them. The joint
feature obtained from concatenation or other arithmetic operations (sum,
difference, min, max etc) often results in the poor joint representation. To
mitigate this issue, we propose a gated feature fusion technique, which learn
the most optimal way to join both the feature representation using a neural
gate. This gate learn what information from CNN or BERT feature representation
to keep or exclude during the network training. The gating behaviour is obtained
through a *sigmoid* activation which range between 0 and 1. We learn the joint
representation *F* using the gated fusion as follows: $$\begin{array}{r}
\begin{aligned} h_{R} & {= tanh\left( W_{R}.R \right)} \\ h_{B} & {= tanh\left(
W_{B}.B \right)} \\ g & {= sigmoid\left( W_{g}.\lbrack R \oplus B\rbrack
\right)} \\ F & {= g*h_{R} + (1 - g)*h_{B}} \\ \end{aligned} \\ \end{array}$$
where, *W*<sub>*R*</sub>, *W*<sub>*B*</sub> and *W*<sub>*g*</sub> are the
parameters. Finally, the joint feature representation *F* fed into a single
layer feed-forward network with *softmax* function to classify the tweet into
one of the relation classes, *Y* = {‘*reason*’, ‘*effect*’, ‘*addiction*’,
‘*ambiguous*’}. More, formally, $$\begin{array}{r} {p\left( \hat{y} \middle| S
\right) = {softmax}\left( W.F + a \right)} \\ \end{array}$$ where $\hat{y} \in
Y$, *W* is a weight matrix and *a* is the bias.
# 5 Experimental setup and results
Here, we present results on the cannabis-depression RE task. Thereafter, we will
provide technical interpretation of the results followed by domain
interpretation of the results. We have chosen models’ hyper-parameters using
5-fold cross validation on entire dataset. The convolutional layer used filters
of lengths 2, 3 and 4 and stride of length 1. The optimal feature size is turned
out to be 128. We use Adam as our optimization method with a learning rate of
0.001. Hidden size of feed forward in relation classification layer is set to
100. The position embedding is set to 100 for position-aware attention model.
The optimal value of *d*<sub>*a*</sub> is found to be 50 in all the experiment.
We use the Adadelta optimization algorithm to update the parameters in each
epochs. As a regularizer, we use dropout with a probability of 0.3.
## 5.1 Results
The dataset utilized in our experiment is described in Section-3. We used
Recall, Precision and F<sub>1</sub>-Score to evaluate our proposed task against
state-of-the-art relation extractor. As a baseline model, we used ***BERT***,
***BioBERT***, ***BERTweet*** and its several variation such as:
**BERT<sub>PE</sub>**: We extend the BERT with the position information
(relative distance of the current word w.r.t cannabis/depression entities)
obtained through ontology, as a position embedding along with the BERT
embedding.
**BERT<sub>PE+PA</sub>**: We introduced additional component to the
BERT<sub>PE</sub> model by deploying position-aware attention mechanism.
summarizes the performance of our model over the baselines. Our proposed model
significantly outperforms the state-of-the-art baselines on all the evaluation
metrics. In comparison with the BERT & BioBERT, our model achieves the absolute
improvement of 2.9% & 3.69% F<sub>1</sub>-Score respectively. Second, the
results shows that infusing entity knowledge in the form of entity position-
aware encoding with attention can assist in better relation classification.
Among all the BERT-based approaches, we found that BERT<sub>PE</sub> did not
perform well. Thus merely including position-aware encoding in the BERT
framework does not help model to capture the entities information. This may be
due to the inbuilt position embedding layer in the BERT model which treats the
explicit position encoding as a noise. Further, our observation shows that
BioBERT did not generalize well for our task in comparison to the BERT with
minor reduction of 0.79% absolute F<sub>1</sub>-Score. Although BioBERT is
trained on huge corpus of biomedical literature (PubMed & PMC), however data
being noisy hampered to performance.
Interestingly, adding the entity position information in the form of the
attention (BERT<sub>PE+PA</sub>) boosted the model performance. We report the
performance absolute improvements of 0.92%, 2.03%, and 0.65% Precision, Recall,
and F<sub>1</sub>-Score points in comparison to the BERT model. This shows that
position encoding and position attention when used collectively can assist in
capturing complementary features. Our final analysis reveals that solely
concatenating two representation (CNN+BERT) may not be enough to capture how
much information is required from both of these representations. Our method,
which introduces the gated fusion mechanism can address this problem as
validated by the improved F<sub>1</sub>-Score (c.f.).
We also reported the class-wise performance of our proposed model in. The
performance of the classes ‘Effect’ and ‘Addiction’ comparatively lower than
other classes. It is because the classes ‘Effect’ and ‘Addiction’ have less
samples (707, 158) in the dataset which inhibits to learn and generalize the
model, in contrast to other classes. Also, in the real-life the explicit
expression of being addicted to cannabis after depression can rarely be
identified with a single tweets. It requires more contextual knowledge of users
history of at-least 2 weeks tweets to capture the implicit sense of this class.
## 5.2 Ablation study
To analyze the impact of various component of our model, we perform the ablation
study (c.f.) by removing one component from the proposed model and evaluate the
performance. Results show that excluding BERT from the model significantly drop
the recall of the model by 5.27%, and F<sub>1</sub>-Score by 3.16%. This shows
that contextualized representation is highly necessary for the cannabis-
depression classification task.
We further observed that entity position-aware attention is highly crucial for
improving the precision of the model. We report a reduction of 1.47% in terms of
precision after excluding the position attention as the model component.
Similarly, removing the position encoding from the input layer also lead to a
reduced performance. While, excluding convolution layer from the model leads to
significant drop in precision, recall, and F<sub>1</sub>-Score by 5.56%, 9.84%,
and 7.89% respectively. Thus, we show that every component in the model is
beneficial for the cannabis-depression relation extraction task.
We also evaluated our proposed entity locator module (based on edit distance)
over simple string matching technique. The results show that though the string-
matching technique performs well (94.36% F-Score), there are some cases like
‘*smokin chronic*’, and ‘*marijuana candies*’ that are not handled correctly by
basic string-matching technique, since DAO contains the standard entity names as
‘*smoking chronic*’, and ‘*marijuana candy*’. Unlike in our proposed approach,
DAO based entity locator module is build upon the domain-specific ontology which
contain medical and slang terms related to substance use, abuse, and addiction.
Further, as edit distance method allow the soft-string matching (with the
insert, delete, and update operation) within the threshold, it captures to match
the ill-formed entities (‘*smokin chronic*’ to ‘*smoking chronic*’) more
accurately over string-matching method. Our DAO based entity locator is more
focused and accurate (97.12% F-Score) in spotting entities related to cannabis
and depression in tweets.
We also compared the position-aware attention over vanilla (word-level)
attention discuss in. We called it *vanilla attention* as it weighs each word
equally regardless of the corresponding entities. Given the hidden states
*h*<sub>1</sub>, *h*<sub>2</sub>, *h*<sub>3</sub>, …‥*h*<sub>*n*</sub>, in word-
level attention, first the hidden state *h*<sub>*t*</sub> of each time step *t*
is transformed into *u*<sub>*t*</sub> using one-layer feed-forward network.
Thereafter, the importance *α*<sub>*t*</sub> of each token representation is
computed using the *softmax* layer. Formally, $$\begin{array}{r} \begin{aligned}
u_{t} & {= tanh\left( W_{u}h_{t} + b_{u} \right)} \\ \alpha_{t} & {=
\frac{exp\left( u_{t}^{\top}v \right)}{\sum_{i = 1}^{i = n}exp\left(
u_{i}^{\top}v \right)}} \\ \end{aligned} \\ \end{array}$$ where,
*W*<sub>*u*</sub> *v*, and *b*<sub>*u*</sub> are weight matrix, context vector
and bias respectively. The final tweet representation *R* is computed as
$$\begin{array}{r} {R = \sum\limits_{i = 1}^{n}\alpha_{j}h_{j}} \\ \end{array}$$
The results (*c.f*.) shows that the position aware attention achieve the better
performance (an improvement of 2.45 in F1-Score) over the vanilla attention.
## 5.3 Domain-specific analysis
To assess the performance on our model, we examined a set of correctly and
incorrectly classified, tweets and came up with the following observations:
- **Correctly classified tweets generally contained clear relationship
words**: For example, the following two tweets were correctly classified as
expressing cannabis use to treat depression:
“*weed really helps my depression so much! i get less irritable, laugh, and
so much more and people think it as the devil! f\*\*\* you mean*”;
“*marijuana is seriously my best friend rn. it helps me sooo much with my
depression and anxiety*.”
Both tweet contained word “help” that often times is used to convey a
meaning indicating usage of a drug for the treatment of a certain condition.
- The following correctly classified example represented a case where
relationship indicating “treat” was expressed with a word “for”:
“*I was forced to tell my family i have a medical for weed bc someone been
ratting me out, try explaining medical marijuana for depression to a
traditional thinking family, i wanna die*”.
- Similarly, the following tweet were correctly classified as expressing
situations where cannabis use is causing depression and/or making it worse:
“*me @ me when i realize weed is making me depressed but i keep smoking*”.
Both tweets contained clear relationship word expressing causation
“make/making”.
- **The incorrectly classified tweets generally were more ambiguous and/or
contained implied meanings**. For example, the following tweet was labeled as
expressing “cannabis use to treat depression” while our model classified it as
“ambiguous”:
“*depression is hitting insufferable levels rn and hot damn i could use some
weed*.”
This is an example, where relationship is implied, and there are no clear
relationship word expressed in the text.
- The same misclassification occurred with the following tweet:
“*me: wow i think im depressed i should really go to therapy: doesnt do any
of that and instead uses weed to increase the dopamine in my brain*.”
In this case, the expression “used weed to increase the dopamine…” implies
use of marijuana to improve mood (in this cases depressive mood).
Because DAO did not contain similar colloquial expressions to indicate
depressive mood, our model failed to correctly classify this tweet.
Overall, our model performs better than state-of-the-art algorithm in
distinguishing depression as a result of cannabis use and cannabis use as a
self-medication for depression. In turn, this model will help future works to
collect relevant information specific to the behaviors, attitudes and knowledge
of users who use cannabis to palliate their depression as well as information on
the Twitter users who suffer from depression because of their previous cannabis
usage.
# 6 Limitations
Limitations are noted. First, our work does not distinguish Cannabidiol (CBD)
use from general cannabis use. This is of importance as several studies suggest
that CBD could reduce anxiety and potentially depression. Although users tend to
be more specific regarding whether they are consuming CBD specifically rather
than other form of cannabis, future research on the topic of cannabis and
depression using social media data needs to integrate this distinction. Second,
although the goal of this study was to design a robust algorithm able to
differentiate the causal relationship between cannabis and depression as
expressed by Twitter users, our work did not aim to establish the objective
causal “directionality” in between cannabis and depression (i.e., is cannabis
causing depression or is cannabis a potential treatment for depression?). Third,
the model has been trained on Twitter data that are rather short (280 characters
maximum) form of text, and may not be as performing on other text format (e.g.,
blog, web forums pages).
# 7 Conclusion
This research explored a new dimension of social media in identifying and
distinguishing relationships between cannabis and depression. We introduced a
state-of-the-art knowledge-aware attention framework that jointly leverages
knowledge from the domain-specific DAO, DSM-5 in association with BERT for
cannabis-depression RE task. Further, our result and domain analysis help us
find associations of cannabis use with depression. In order to establish a more
accurate and precise Reason-Effect relationship between cannabis and depression
from social media sources, our future study would take targeted user profiles in
real-time and study the exposure of the user to cannabis over time informing
public health policy.
# Supporting information
[^1]: The authors have declared that no competing interests exist.
|
# Introduction
Populations exposed to mass conflict and persecution commonly experience
extensive losses, experiences that are likely to provoke feelings of injustice
and anger associated with symptoms of grief. Yet there is a dearth of research
investigating a possible nexus between grief and anger amongst populations
living in post-conflict environments. We attempt to identify a subpopulation
experiencing combined symptoms of grief and anger amongst survivors of prolonged
persecution and conflict in Timor-Leste, and whether that putative pattern is
associated with particularly high levels of traumatic loss, persisting
preoccupations with injustice, and ongoing family conflict.
Anger as an unwanted and commonly dysfunctional emotional reaction has been
associated with feelings of injustice amongst populations that have been
exploited and persecuted. Having one’s human rights violated or economic goals
systematically undermined can understandably lead to normal anger reactions,
however, anger can also be associated with a loss of control, aggression and
harm to others, including community members, intimate partners and children.
Anger has also long been regarded as a core component of the normal grieving
process. Moreover, clinical observations have suggested that a failure to
resolve anger associated with a bereavement may contribute to the persistence of
the grief reaction, presumably because of strong feelings of grievance and
injustice associated with the loss. In that regard, it is notable that studies
examining the factorial structure of the persisting grief reaction have
consistently identified anger and bitterness as core components. For example, a
confirmatory factor analysis (CFA) conducted amongst bereaved adults in the USA
identified anger/bitterness as one of six symptom domains of the construct of
prolonged grief. In keeping with this and other research, the constellation of
anger-bitterness has been included in the categories of complex bereavement
disorder (CBD), defined as a diagnosis requiring further empirical evidence in
DSM-5, as well as in the proposed ICD-11 definition of prolonged grief disorder
(PGD). Nevertheless, controversy continues about the nosological status of these
categories, particularly insofar as they distinguish pathological from normative
forms of grief.
Studies amongst post-conflict populations exposed to repeated traumatic losses
may shed further light on the role of anger in the grief response. Our past
research in Timor-Leste identified what appeared to be a high rate of explosive
anger in response to trauma exposure. Explosive anger can express itself as
physiological arousal and either verbal or physical aggression, the response
characteristically being out of proportion to environmental triggers and
experienced as uncontrollable, the subject reacting without immediate thought to
the consequences. Although in the aftermath of attacks, the person may feel a
degree of relief or vindication, feelings of exhaustion, remorse and/or
embarrassment are also common.
A population study in a rural and an urban village of Timor-Leste undertaken in
2004 recorded a prevalence of explosive anger of 38%, based on the international
threshold of at least one attack of explosive anger a month (noting that the
majority of these persons experienced much more frequent episodes). In a six-
year follow-up study, the prevalence of explosive anger remained high (36%),
suggesting that, at a population level, the reaction had a strong tendency to
persist over a prolonged period of time. Applying the stringent DSM-IV
definition of intermittent explosive disorder (IED) which mandates the
occurrence of acts of aggression in conjunction with anger, the prevalence if
explosive anger was 8%, a high rate compared to other countries where the
diagnosis has been studied at a population level. A consistent finding of our
studies in Timor-Leste is that women reported higher rates of explosive anger
and IED than men, the converse of the usual gender pattern recorded in other
countries. Although a mixed methods study indicated that a range of experiences
(exposure to conflict-related trauma and violent death of others, ongoing
adversity, exposure to intimate partner violence) were associated with IED
amongst women, these factors applied to other morbid mental health outcomes
including post-traumatic stress disorder (PTSD) and depression, suggesting that
the risk factors identified to date are not specific to anger.
Doubts remain, therefore, about the origins and nature of explosive anger and
its high prevalence in Timor-Leste, and why it is particularly common amongst
women. In our endeavour to understand this phenomenon, we draw on the Adaptation
and Development After Persecution and Trauma (ADAPT) model which highlights the
core roles of interpersonal bond disruptions and experiences of injustice,
amongst other domains, as major psychosocial challenges confronted by
populations exposed to conflict. Although the model suggests that grief and
anger represent the quintessential responses to disruptions in bonds and acts of
injustice, respectively, these two experiences are likely to overlap given the
inter-related nature and meaning of the traumatic events of conflict.
Specifically, traumatic losses are likely to occur in settings of gross
injustices, thereby provoking simultaneous reactions of anger and grief. Other
forms of adversity, for example conditions of material deprivation during and in
the aftermath of conflict, may compound and prolong anger and grief. Symptoms of
grief and anger in survivors of trauma may lead to ongoing conflict within
families, representing one of the more severe longer-term psychosocial
consequence of earlier exposure to mass violence.
The history of persecution and conflict in Timor-Leste provided a setting to
investigate possible associations between grief and anger amongst a population
exposed to extensive traumatic losses. The invasion and occupation of the
territory by Indonesia in 1975 provoked a low-grade resistance war waged by
members of the indigenous independence movement. During the period of conflict,
which culminated in a humanitarian emergency in 1999, an estimated quarter of
the indigenous population (of 600,000 persons at the time) died as a consequence
of atrocities, warfare, burning of villages, murder, famine and untreated
illness. In addition, there was widespread loss of property and livelihoods, and
forced displacement of whole communities, with kinship and family groups being
dispersed, some as refugees to other countries. In the post-conflict phase,
further episodes of violence occurred, particularly in 2006–7, when a period of
sustained internal conflict led to extensive injuries, deaths and displacement
of communities into makeshift refugee camps. Socio-economic development in the
newly independent country has been slow, with many families confronting extreme
levels of poverty and deprivation.
Our aim was to test whether it is possible to identify a combined pattern of
explosive anger and grief symptoms (grief-anger) amongst the Timorese
population. We hypothesized that a subpopulation with grief-anger would report
high levels of traumatic losses, preoccupations with injustice and ongoing
adversity including family conflict in the post-conflict environment. We also
examined whether women were more likely than men to experience the putative
grief-anger constellation.
# Materials and methods
## Participants
Between June, 2010 and July, 2011, we conducted a survey of all adults, 18 years
and older, living in every household in two administrative villages (sucos), one
in Dili, the capital, the other, a rural site an hour’s drive away. Each suco is
defined by contiguous hamlets (aldeias) falling under the administration of one
chief (chefe). GPS and aerial mapping produced by the government for census
purposes allowed us to identify all households in a setting where there is an
absence of street names and many dwellings are located in remote wooded and
mountainous areas. Both study sites were extensively affected by mass violence
during the Indonesian occupation (1975–1999) and the subsequent internal
conflict (2006–7).
## Field team and procedure
The team included 18 Timorese field workers with prior survey experience and/or
psychology/public health degrees. They received a two-week training course
followed by two months of field testing and piloting of survey measures under
supervision. Pairs of interviewers were required to achieve a consistent 100
percent level of inter-rater reliability on the core measures. One hour long
interviews were conducted in participants’ homes or another location if
preferred by respondents, the procedure ensuring maximal privacy and
confidentiality. In villages where families live in close proximity to each
other, and where overcrowding is a problem, we sought to ensure privacy by
taking participants to garden areas or away from the household to somewhere
shaded and quite. We also arranged for children to be entertained by one of our
colleagues if they were likely to cause a distraction to participants.
Households were visited up to five times in order to meet potential
participants.
## Ethics statement
The study was approved by the ethics committee of the University of New South
Wales, the Ministry of Health of Timor-Leste, and the chiefs of each village.
The majority of respondents gave written consent prior to commencement of
interviews. Verbal consent was obtained in some cases where respondents were
illiterate, trusted witnesses co-signing the forms. The procedure was endorsed
by the community and received ethical approval from the University of New South
Wales and the Ministry of Health of Timor-Leste.
## Measures
Our selection of constructs and the appropriate measures to assess them was
based on theoretical considerations and the empirical findings in our past
studies examining explosive anger in Timor-Leste.
The protocol, including the grief measure, was iteratively field tested amongst
communities geographically adjacent and similar in sociodemographic composition
to the sites of the definitive survey. In piloting, we applied an iterative
process of feedback in which responses and solicited comments by respondents in
the field were analysed and considered by a committee comprising Timorese of
diverse backgrounds (age, gender, education, position in the community) and
expatriate researchers. Measures were reviewed and revised to ensure that the
constructs were understood by the community, items were readily comprehended,
both semantically and linguistically, and response options (such as likert
scales) were appropriately graduated according to the language and culture.
### Exposure to conflict-related traumatic events
The 17 conflict-related traumatic events (TEs) listed in the Harvard Trauma
Questionnaire (HTQ) were modified to ensure their congruence with the historical
context of Timor-Leste. TEs were recorded for two periods: the Indonesian
occupation and the subsequent period (including the internal conflict) leading
up to the study. We derived four broad TE domains based on their common nature
and characteristics: conflict-related trauma, witnessing murder and atrocities,
traumatic losses, and extreme deprivations. Each TE item was scored 0–2, the
maximum score being assigned if participants endorsed a TE for both time
periods. We then generated a summary index for each of the four TE domains based
on the addition of endorsed items.
### Ongoing adversity
An inventory of daily adversities was developed based on extensive community
consultations and refinement of items during piloting. All participants rated
each adversity item on a five point scale (1 = not a problem, 2 = a bit of
problem, 3 = moderately serious problem, 4 = a serious problem, 5 = a very
serious problem). The adversity items were assigned to thematic domains:
1.poverty (insufficient food, lack of money for school fees and to meet
traditional obligations to family, poor shelter, unemployment); 2. conflict with
family (spouse, children, and extended family); and 3. conflict with community
(with young people, and the wider community). The score for each domain was
based on the summary score of constituent items (0 for lower levels of
seriousness, 1 for moderate through to a very serious problem)
### Preoccupations with injustice
Respondents were asked to identify and describe the worst human rights violation
or other event associated with injustice they had experienced during three
defined historical periods: the Indonesian occupation, the period of internal
conflict, and contemporary time. Ratings were assigned as 1 for assigning an
unjust event; 2 for experiencing preoccupations relating to the event; and 3 for
distress related to these preoccupations. The composite index of injustice
reflected the addition of scores for each of the three historical time periods
(range 0–3).
### Symptoms of explosive anger
Our community measure of explosive anger was developed, tested and modified
serially during piloting to ensure its cultural appropriateness and
comprehensibility in the local language, Tetum. The screening questions inquired
whether participants had ever experienced sudden episodes or attacks of anger
and if so, how frequently these attacks occurred. Participants who endorsed
attacks at a frequency of at least once a month were then asked about associated
characteristics of loss of control, destruction of property, verbal aggression,
and physical aggression towards others. We then applied an algorithm to derive a
diagnosis of intermittent explosive disorder (IED) according to DSM-IV. In a
convergence study, we compared our community index of IED with a blinded
diagnosis made on the Structured Clinical Interview for the Diagnostic and
Statistical Manual for DSM-IV assigned by experienced psychologists. There was a
high level of concordance between the two measures: Area Under the Curve 0.90
(95% CI: 0.83–0.98). in the latent class analysis (described hereunder), we
included the five core items of explosive anger as defined by IED each scored
categorically (1 = present; 0 = absent): explosive anger attacks, loss of
control of anger; destruction of property during attacks; verbal aggression
during attacks; physical aggression towards others during attacks.
### Grief symptoms
We inquired of all participants whether they had experienced a loss, defined as
an event (since 1975) in which someone (e.g. family member, relative, or friend)
close to the individual had died or been killed. Those who identified multiple
losses were asked to identify the death that had the most impact on their lives,
then recording the cause and time of the death. Almost all of these identified
losses were related to traumatic deaths or untreated illness occurring during
periods of mass conflict. Based on the identified loss event, participants were
then asked to rate each of four grief items on a five-point frequency scale (0 =
almost never, 1 = rarely, 2 = sometimes, 3 = often, 4 = always) as experienced
in the past four weeks. The initial item pool was derived from the literature
and contemporary criteria for assessing prolonged grief, the process of piloting
reducing the number of symptoms to those that were widely recognised and
regarded as core experiences of the Timorese people. The derived three symptom
items were: persistent yearning/longing for the deceased, feelings of intense
bitterness, and feelings emptiness in relation to the death. The fourth item
assessed the level of functional impairment associated with the endorsed
symptoms. For the latent class analysis, we assigned a score of 0 for symptoms
scored not at all, rarely or sometimes and 1 if rated as often (3 on the scale)
or always (4 on the scale).
### Post-traumatic stress symptoms and psychological distress
Posttraumatic stress disorder (PTSD) symptoms and general symptoms of
psychological distress (comprising depression, anxiety, somatic complaints) were
assessed using the Harvard Trauma Questionnaire (HTQ) and Kessler-10
respectively, widely used measures applied in our previous studies in Timor-
Leste. In our aforementioned convergence study using the SCID, a satisfactory
level of concordance was achieved for PTSD (AUC 0.82,95% CI: 0.71–0.94) and
severe distress (compared to major depressive disorder) (AUC 0.79,CI,
0.67–0.91). A score of ≥ 2.2 for PTSD, and ≥ 30 for severe psychological
distress (matching the international cut-off) produced the best balance between
specificity and sensitivity for each index. Cronbach’s alpha for the PTSD scale
was 0.95 and for the K10, 0.90.
All measures were translated into Tetum, the most widely spoken language in
Timor-Leste. Minor inconsistencies were addressed during piloting and the final
versions were translated and back-translated into English.
## Statistical analysis
We calculated intra-class correlations to assess for possible clustering within
households of indices of grief, psychological distress, PTSD and explosive
anger. All correlations were low (\<0.05) indicating negligible clustering by
households We used latent class analysis (LCA) to identify clusters of
participants according to their pattern of symptoms of explosive anger and grief
(each item scored in a binary manner as present or absent). We tested sequential
models (one class, two classes, three classes, seriatim) examining a suite of
conventional model fit indicators to assess for the best class solution: The
Bayesian Information Criterion (BIC), sample size-adjusted Bayesian Information
Criterion (SS-BIC), and the Akaike’s Information Criterion (AIC). Lower values
of these indicators indicate a better fit in comparing successive latent class
models. In addition, we applied the Vuong-Lo-Mendell-Rubin (VLMR) and the Lo-
Mendell-Rubin (LMR) adjusted likelihood ratio tests, both of which compare the
fit of a latent class model of n classes to one with n+1 classes. In judging the
best-fitting model, we took into consideration the principle of parsimony, the
degree of class separation, homogeneity of posterior probabilities within
classes, and the interpretability of the classes yielded. We draw on
conventional criteria in which conditional probabilities of 0.60 or above
indicate a high probability of endorsing a particular symptom; values falling
between 0.59 and 0.15, a moderate probability; and a value of 0.15 or less, a
low probability.
After selecting the best-fitting model, we examined for associations between
class membership (with the low symptom class as the reference category) and a
range of relevant predictors using multinominal logistic regression analysis.
The covariates included: sociodemographic characteristics of gender, residency
in urban or rural areas, educational attainment, and employment; traumatic
domains comprising conflict-related trauma, witnessing murders and atrocities,
traumatic losses, and extreme deprivations; current adversities including
indices of poverty, family conflict, and communal conflict; and preoccupations
with injustice (during the Indonesian occupation, the internal conflict, and in
contemporary times). Analyses were performed in STATA version 13 and Mplus
Version 7.
# Results
## Sociodemographic characteristics
Of the 3368 respondents approached, 2964 (men, n = 1451, 49%; women, n = 1513,
51%) completed interviews, a response rate of 83.6% (inability to contact
residents was by far the major reason for non-participation).
indicates the socio-demographic characteristics of the sample. The mean age was
36.4 years (SD = 14.4), and a larger portion (n = 1844, 62%) resided in the
rural area. Two-thirds (n = 2013, 67.9%) were married, the remainder being
single/never married (n = 756, 25.5%), widowed (n = 171, 5.8%), divorced (n = 5,
0.2%) or separated (n = 19, 0.6%). In relation to education, 11.6% (n = 343) had
completed primary, 12.3 (n = 364) junior, and 26.3 (n = 779) senior high school,
whereas 10.7 (n = 317) had received post-school education (college/university).
Nearly half (n = 1278, 43.1%) engaged in subsistence farming, domestic duties,
or were retired; 34.8% (n = 1032) were occupied with paid employment (in a range
of enterprises including government and private sectors); and the remainder were
students or unemployed (n = 654; 22.1%).
## Prevalence of explosive anger, prolonged grief, PTSD, and severe distress
Two hundred and fifty persons (8.4%) met criteria for explosive anger according
to IED criteria. A quarter (n = 779, 26.3%) endorsed one or more symptoms of
explosive anger, including sudden anger attacks (n = 1074, 36.2%), loss of
control (n = 662, 22.3%), verbal aggression (n = 637, 21.5%), destruction of
property (n = 527, 17.8%), and physical aggression (n = 423, 14.3%).
Over half (n = 1544, 52.1%) endorsed one or more symptoms of prolonged grief,
including persistent yearnings or longings for the deceased (n = 2178, 73.5%),
feelings of bitterness about the death (n = 1293, 43.6%), and feelings of
emptiness (n = 1152, 38.9%). A third (n = 957, 32.3%) reported functional
impairment associated with these symptoms.
A similar number (n = 453, 15.3%) met the threshold for PTSD (\>2.2) and severe
psychological distress (n = 447, 15.1%) (≥30).
## Exposure to conflict-related traumatic events and ongoing adversity
Over half of participants (56.1%) reported experiencing one or more conflict-
related traumas including political imprisonment, combat, physical assault,
torture, and trauma related to involvement in the resistance movement. Four out
five persons reported witnessing murders and atrocities and two fifths traumatic
losses, including forced separations and disappearances. Ninety percent
experienced extreme deprivations related to access to urgent health care (for
self or family), food, water and shelter.
## Ongoing adversity
shows the frequency of adversity items. In order, poverty-related items endorsed
were: shortage of electricity (n = 1983, 66.9%), no access to clean water (n =
1872, 63.2%), insufficient food (n = 1617, 54.6%) and money (n = 11586, 53.5%),
problems accessing transport (n = 1489, 50.2%), environmental problems (n =
1527, 51.5%), lack of shelter (n = 1372, 46.3%), being unable to meet
traditional family obligations (n = 1333, 45%); conflict with spouse (n = 446,
15.1) and extended family members (n- = 397, 13.4); youth conflict (n = 574,
19.4%); and safety issues in the community (n = 579, 19.5%).
## Preoccupations with past and present experiences of injustice
Distressing preoccupations with events associated with injustice were reported
by 13.1% (n = 388) for the Indonesian occupation (1975–1999), 24.6% (n = 729)
for the period surrounding the internal conflict (2002) and 18.5% (n = 549) in
contemporary times.
## Latent class analysis
Serial model testing concluded after assessing a four class LCA model. Fit
indicators improved up to the three-class model, the gains then being only
marginal when progressing to a four class model. Importantly, the VLMR and the
LMR adjusted likelihood ratio tests showed no statistical changes in progressing
from a three to four class model. Given these findings and the ready
interpretability of the classes, we adopted the three-class model.
shows the item probabilities for each class based on symptoms of grief and
explosive anger. In the grief class (class 1, comprising 25% of the sample),
item probabilities for preoccupations and bitterness were in the high
probability range, and feelings of emptiness and functional impairment were in
the moderate range. In contrast, all items of explosive anger items in this
class fell into the low moderate or low probability range. In the combined
explosive grief-anger class (class 2), comprising 24% of the sample, grief
symptoms fell into the high (preoccupations) or moderate (bitterness, emptiness,
functional impairment) ranges. In contrast to class 1, explosive anger symptoms
fell into the high (episodes of explosive anger, verbal aggression) or high-
moderate (loss of control, destruction of property, physical aggression)
probability ranges. In the low symptom class (class 3), comprising 51% of the
sample, there were low probabilities for the majority of symptoms of grief and
explosive anger, with only two exceptions: preoccupations/yearning were in the
moderate range and the generic item for explosive episodes was in the
low/moderate range.
## Comorbidity
In comparison to the low symptom class, both the grief and grief-anger classes
were associated with PTSD (grief class: OR = 1.68, CI = 1.26–2.25; grief-anger
class: OR = 1.99, CI = 1.49–2.67) and severe psychological distress (grief
class: OR = 1.61, CI = 1.20–2.16; grief-anger class: OR = 2.42, CI = 1.82,
3.21).
## Associations with past trauma, ongoing adversity and preoccupations with injustice
presents the findings of the multinomial logistic regression analysis testing
for associations between the designated covariates (trauma, ongoing adversity,
preoccupations with injustice) and the LCA classes.
In comparison to the low symptom reference class, women and urban dwellers were
more likely to be assigned to both the grief and grief-anger classes. The two TE
domains of witnessing murder and atrocities, and traumatic losses were both
associated with the grief and grief-anger classes (relative to the reference
class). In addition, however, the grief-anger class reported greater exposure to
traumatic losses than the grief class. Also, the grief-anger class alone
reported greater exposure to extreme deprivations related to conflict in
comparison to the reference class. In relation to ongoing adversities, both the
grief and grief-anger classes exceeded the reference class on the index of
poverty; the grief-anger class in turn reported higher rates of poverty than the
grief class. Only the grief-anger class reported greater levels of family
conflict, in comparisons with both the reference low symptom class and the grief
class. Compared to the low symptom class, both the grief and grief-anger classes
reported greater preoccupations with injustice for the two historical periods of
conflict (the Indonesian occupation and the later internal conflict). Only the
grief-anger class, however, reported a higher level of preoccupations with
injustice for contemporary times compared to the reference class.
# Discussion
Our analysis in post-conflict Timor-Leste, identified a typology comprising
three subpopulations including those experiencing grief, grief-anger and low
symptoms, the first two categories affecting a quarter of adults in the sample.
Women and urban-dwellers were more likely to be assigned to both the grief and
grief-anger classes. Compared to the low symptom reference class, both the grief
and grief-anger classes reported greater exposure to conflict-related
murders/atrocities and traumatic losses, more extreme levels of poverty, and
distressing preoccupations with injustice related to two successive historical
periods of conflict. There were important distinctions between the two morbid
classes however, in that the grief-anger class reported greater exposure to
traumatic losses (compared to the grief class), greater deprivations during the
period of conflict (compared to the reference low symptom class), higher stress
levels related to poverty (compared to the grief class), ongoing family conflict
(compared to both the reference and grief classes), and preoccupations with
injustice for contemporary times (compared to the reference and grief class).
Prior to discussing our findings, we consider the strengths and limitations of
the study. The sample is one of the largest in the contemporary post-conflict
mental health field and we achieved a high response rate. Although sampling was
restricted to two localities, the sites were identified initially as being
broadly representative of the socio-demographic profile of Timor-Leste as a
whole. Nevertheless, replication of the study in other areas of Timor-Leste and
in post-conflict countries worldwide will be needed to test the generalizability
of our findings. Caution needs to be exercised in inferring causal relationships
from cross-sectional data of this kind. Longitudinal studies may assist in
delineating the chronological sequencing of the relevant symptom constellations,
in particular, whether anger precedes and thereby acts to prolong symptoms of
grief. Recall of traumatic events can be subject to amnestic bias, although
there was a notable consistency in the pattern of traumas documented and the
known history of Timor-Leste. A systematic approach was followed in the
transcultural adaptation, translation and testing of measures. Although the
majority of losses identified as triggers of grief symptoms occurred several
years earlier, our measure did not record the course of grief symptoms (whether
fluctuating or chronic) so that judgement is reserved as to whether the reaction
was prolonged or not.
Caveats notwithstanding, our findings cast new light on the high prevalence of
explosive anger previously identified in community samples in Timor Leste, a
phenomenon that has yet to be fully unexplained. Even though previous studies
had shown associations between explosive anger and common stressors such as
conflict, poverty and injustice, these factors were common to other patterns of
mental distress including symptoms of PTSD and severe psychological distress.
Yet there were reasons to suspect that explosive anger had distinctive (albeit
unidentified) antecedents given that the reaction appeared to be relatively
independent as a construct from those of PTSD and severe psychological distress.
In that regard, the identification of a subpopulation comprising a quarter of
the sample that manifested the constellation of grief-anger offers a potential
explanation for the high prevalence of anger identified in this society.
Notably, although a grief class (with low anger symptoms) of equal size emerged,
there was no independent explosive anger class, further accentuating the close
association between anger with grief.
The grief-anger class reported the greatest exposure to traumatic losses, an
important finding given that murder, atrocities and death by untreated illness
and famine were widespread during the prolonged period of conflict in Timor-
Leste. It may be that in collectivist societies such as Timor-Leste, losses that
provoke strong and enduring feelings of injustice are particularly potent in
generating the identified combined pattern of grief-anger. To confirm this,
replication of our findings will be needed in other conflict-affected settings
where traditional family and community values prevail.
Importantly, our regression analysis involving relevant covariates added
credibility to the distinction we found between the grief-anger and grief
classes. Specifically, the grief-anger class stood out in reporting high levels
of traumatic loss, extreme deprivations during the period of conflict, severe
ongoing poverty and family conflict, and preoccupations with injustice extending
over three contiguous historical periods. In relation to the latter finding, we
have reported a similar association between the anger component of persistent
complex bereavement (PCB) disorder and a sense of injustice amongst refugees
from West Papua, a neighbouring territory that has experienced a comparable
level of prolonged mass conflict under Indonesian occupation.
The finding that a half of the population experienced relatively low levels of
grief and anger symptoms offers some insights into the factors that protect
post-conflict populations from these adverse psychological outcomes. It is
notable that the low symptom group reported a similar level of exposure to the
general traumas of conflict, indicating that they had not been sheltered from
these events. It was only in the TE domains of witnessing murder/atrocities and
traumatic losses that the low symptom group reported lower exposure, suggesting
that protection from these salient forms of trauma may act to avert risk of
developing the specific grief-anger constellation. Being male, living in a rural
environment, experiencing lower levels of poverty and not experiencing family
conflict were other factors that appeared protective, noting however, that
cause-effect relationships involved remain to be confirmed given the cross-
sectional nature of the study.
Our findings have potential implications for the individual, the family and the
society as a whole, not only in Timor-Leste but in other post-conflict settings
worldwide. In particular, confirmation of a grief-anger class and the social
factors associated with the pattern, has the potential to add support to a
cycles of violence model which postulates that exposure to the traumas of past
conflict (in this instance, specifically traumatic losses and deprivations) may
contribute to risk of subsequent family conflict in the aftermath of the
violence. We note however, that explosive anger associated with grief may be
both a cause and a consequence of family conflict, resulting in a complex
reciprocal and interacting effect that generates a vicious cycle of instability
in the household. Our past qualitative data indicated that Timorese women with
IED frequently recognized that their explosive anger led to harsh parenting
behaviours which in some instances had an adverse effect on the health and well-
being of their children. It is possible therefore, that the grief-anger pattern
we have identified contributes to the transgenerational transmission of trauma
in a manner that impacts adversely on the psychosocial development of the next
generation.
In relation to ongoing adversities, there appeared to be a stepwise relationship
between the severity of poverty and the grief-anger, grief and low symptom
classes respectively. These observations underscore the interaction between
trauma-related mental health problems and socio-economic factors in post-
conflict societies. Poverty places stress on individuals, families and
communities, compounding past interpersonal and material losses in generating a
sense of injustice and anger. In that sense, apart from the immediate hardship
incurred by poverty, conditions of extreme material deprivations jeopardise
recovery from trauma-related mental health conditions which in turn can impair
functioning and reduce the capacity of survivors to engage in gainful employment
or other opportunities to improve their economic well-being..
# Conclusions
Our study identified a grief-anger constellation comprising a quarter of the
study sample in post-conflict Timor-Leste. There were commonalities with the
grief group in reporting greater exposure to witnessing murder, traumatic losses
and poverty, and experiencing persisting preoccupations with injustice related
to two consecutive historical periods of conflict. The grief-anger group was
unique however, in reporting extreme levels of traumatic losses, exposure to
material deprivations during the period of conflict, preoccupations with
injustice in contemporary times and ongoing family conflict. It is a cruel irony
that the traumatic rupture of interpersonal bonds during periods of mass
conflict can generate a psychological reaction pattern (grief-anger) in
survivors which in turn may undermine the survivor’s capacity to achieve a
stable family environment in the post-conflict period.
# Supporting information
We thank Mr Natalino Tam our Research Manager and our research staff in Timor-
Leste their input and contributions to the project.
[^1]: The authors have declared that no competing interests exist.
[^2]: **Conceived and designed the experiments:** SR DS. **Performed the
experiments:** ES ZDC. **Analyzed the data:** AKT. **Contributed
reagents/materials/analysis tools:** AKT. **Wrote the paper:** SR AKT DS.
|
# Introduction
On March 11, 2011, a 9.0-magnitude earthquake (The Great East Japan Earthquake)
struck the east coast of Japan, near Iwate, Miyagi and Fukushima Prefectures.
The earthquake, together with the resulting tsunami, caused extensive damage to
the Fukushima Dai-ichi Nuclear Power Plant (FNPP), such that a radioactive plume
emanating from Units 1, 2, 3 and 4 of FNPP was dispersed into the atmosphere.
The total quantity of radioactive materials released into the environment is
estimated to be 10% \[1.6×10<sup>17</sup> Bq for <sup>131</sup>I (half-life: 8.0
d) and 1.5×10<sup>16</sup> Bq for <sup>137</sup>Cs (30 y)\] of that released
following the accident at the Chernobyl Nuclear Power Plant (CNPP,
1.8×10<sup>18</sup> Bq for <sup>131</sup>I and 8.5×10<sup>16</sup> Bq for
<sup>137</sup>Cs).
Due to the possible health impacts of this nuclear accident, the Fukushima
prefectural government decided to conduct the Fukushima Health Management Survey
to assist in the long-term health management of residents, and this is being
carried out by Fukushima Medical University. This survey consists of a basic
survey to estimate the individual radiation exposure of residents, and four
detailed surveys, including thyroid ultrasound examination, comprehensive health
check-up, mental health and life-style survey, and a survey on pregnant women
and nursing mothers. The thyroid ultrasound examinations on March 11, 2011,
targeting all prefectural inhabitants aged between 0 and 18 years (approximately
360,000 inhabitants), have received much attention, since it is well known that
the incidence of childhood thyroid cancer increased after the Chernobyl
accident. However, for a valid comparison of the results of the ultrasound
screening of the thyroid, it is important to understand the normal ultrasound
occurring in childhood, since ultrasound technology, including imaging quality,
has dramatically advanced in recent years.
The prevalence of incidental thyroid abnormalities detected on ultrasound
examinations in adults has been well documented. However, few reports have
studied the prevalence, spectrum of appearance, and management of ultrasound-
detected findings in children, except for the screening programs conducted
around Chernobyl. Avula et al. conducted retrospective analysis of clinical and
ultrasound findings in 287 Canadian children from 2006 to 2007, and detected
incidental thyroid findings in 52 of them (18%). Among them, 35 were small (\<4
mm) well-defined cysts, and nine were hypoechoic, solid nodules with smooth,
straight margins, and with echogenicity similar to the thymus, suggesting
intrathyroid ectopic thymus.
Given the need for large-scale ultrasound screenings of the thyroid gland, we
recently performed ultrasound thyroid gland screening in children from three
Japanese prefectures (Aomori, Yamanashi and Nagasaki Prefectures), in order to
analyze the frequencies of specific ultrasound findings of the thyroid gland,
with the same procedures for the ultrasound screenings as used in the Fukushima
Health Management Survey, and identified thyroid cysts in 56.9% of the
participants. This previous report showed only the categorized results of
thyroid findings: “A” (“A1” and “A2”), “B” or “C”, and was based on the crude
data only. It is anticipated that the detailed information presented in this
report will provide greater disclosure. The current report aims to present
further analyses of the results of ultrasound thyroid gland screening in
children from these three Japanese prefectures.
# Materials and Methods
## Ethics Statement
This study was approved by the ethics committees of Hirosaki University,
Yamanashi University and Nagasaki University, respectively. It was conducted in
accordance with the guidelines expressed in the Declaration of Helsinki. Written
informed consent was obtained from the parents of all surveyed children.
## Study Area
The survey was conducted in Aomori Prefecture by Hirosaki University, in
Yamanashi Prefecture by Yamanashi University, and in Nagasaki Prefecture by
Nagasaki University, respectively. These areas were suitable for the current
investigation, since they have thyroid ultrasound specialists and medical
facilities enabling further examination, and they are located far from each
other. More precisely, these areas are geographically dispersed throughout the
eastern, central, and western regions of Japan, and are thought to have been
unaffected by radioactive material from the FNPP accident. We did not consider
the level of iodine intake in each prefecture, because Japan is generally an
iodine-rich area.
## Study Population
Ultrasound examinations were performed between November 2012 and January 2013.
To perform ultrasound examinations in many children at once, and to match the
ages of the participants in the Fukushima Health Management Survey, we selected
a kindergarten, an elementary school, a junior high school and a high school
from each prefecture for this study. We selected these kindergartens and schools
because they are located near the center of each prefecture, and furthermore
agreed to participate in this study. All children aged 3 to 18 years, from each
kindergarten and school, were invited to participate in the study. Because we
wished to clarify the general status of the thyroid gland in children, we did
not define exclusion criteria in these participants. Children whose parents
refused to participate were excluded from the study. Because we emphasized that
potential subjects were free to decline to participate on any grounds, we did
not collect the reasons why they refused. The overall participation rate was
85.0%. In total, 4,365 children (Aomori: 1,630 children; Yamanashi: 1,366
children; Nagasaki: 1,369 children) underwent the ultrasound examinations. The
characteristics of participants in the three examination areas are shown in. The
number of children aged 3 to 4 years who were included in the study was 41 in
Nagasaki, 5 in Yamanashi and 25 in Aomori, respectively. The largest group of
children in all examination areas was 10 to 14 years. In total, 47.5%
(2,075/4,365) of the children were male and 52.5% (2,290/4,365) were female.
## Ultrasonography
In all cases, ultrasonographic examination was conducted using 7.75-MHz probes
(12L-RS linear array transducer \[GE Healthcare, Japan\] and LOGIQ e Expert
ultrasound \[GE Healthcare, Japan\]), which is the same equipment as that used
in the Fukushima Health Management Survey. The examiner in each prefecture was
defined as being an expert in thyroid ultrasonography, and was someone who had
experience conducting thyroid screening in the Fukushima Health Management
Survey. The examination protocol was the same as in the Fukushima Health
Management Survey of the Fukushima Prefecture, i.e. two or more images from each
lobe (cross section and longitudinal section) were saved from all children, and
the thyroid volume, structure, echogenicity, nodules, cysts, and the presence of
pathologies, such as congenital abnormalities (e.g. congenital defect, ectopic
thymus or ultimobranchial body) were recorded. In cases with nodules, the
assessor recorded the number of nodules and the location of the largest nodule,
and measured the greatest dimension of the nodules. In cases with cysts, the
assessor also recorded the multifocality of the cysts and the location of the
largest cyst, and measured the greatest dimension of the cysts. In cases of
questionable findings, expert panels of thyroidologists from the three
examination areas, together with thyroid specialists from related Japanese
academic societies, discussed them and reached final agreement.
## Statistical methods
In this study, the age distribution of the study population differed from that
of the standard population of Japanese children. To estimate the general
frequency, the age-adjusted prevalence was calculated by using the 2010 Japan
standard population distribution for children aged between 3 and 18 years. We
used logistic regression analysis to assess the associations between the
prevalence of thyroid cysts and nodules and age, gender and the examination
areas. We conducted all analyses with SAS for UNIX (SAS institute, Cary, NC). We
considered *P*\<0.05 to be statistically significant.
# Results
shows the number of cases with thyroid cysts and nodules identified by
ultrasound examinations in the 3 examination areas. Overall, thyroid cysts were
identified in 56.88% and thyroid nodules in 1.65% of the participants. Most
cysts were small in size, with a maximum diameter of 5 mm or less. Thyroid cysts
and nodules with a maximum diameter of more than 5 mm were identified in 4.58%
and 1.01% of the total participants, respectively.
The maximum diameter of thyroid cysts ranged from 0.8 mm to 12.1 mm and most of
the children who had cysts had 2 or more cysts (2,240/2,482, 90.25%). The
prevalence of cysts varied among the examination areas (58.04% in Aomori, 69.91%
in Yamanashi and 42.51% in Nagasaki), the difference being significant when
adjusted for age and gender (*P*\<0.001). However, no significant difference
among the examination areas was observed in the prevalence of cysts with a
maximum diameter of more than 5 mm adjusted for age and gender (5.09% in Aomori,
5.12% in Yamanashi and 3.43% in Nagasaki, *P*\>0.2).
The maximum diameter of nodules ranged from 1.9 mm to 23.5 mm. Two or more
nodules were identified in 26.39% (19/72) of nodule cases. Forty-three
participants had both nodules and cysts. The prevalence of nodules varied among
the examination areas (2.15% in Aomori, 1.98% in Yamanashi and 0.73% in
Nagasaki), the difference being significant when adjusted for age and gender
(*P* = 0.03 for Yamanashi vs. Nagasaki, *P* = 0.01 for Aomori vs. Nagasaki).
However, no significant differences among the examination areas were observed in
the prevalence of nodules with a maximum diameter of more than 5 mm adjusted for
age and gender (1.29% in Aomori, 1.10% in Yamanashi and 0.58% in Nagasaki,
*P*\>0.1).
shows the effect of age on the prevalence of thyroid cysts and nodules. The
prevalence of thyroid cysts and nodules, especially those with a maximum
diameter of more than 5 mm, significantly increased with age. Females had a
significantly higher prevalence of thyroid cysts and nodules with a maximum
diameter of more than 5 mm than males. We also estimated the prevalence of
thyroid cysts and nodules adjusted for the Japanese population aged between 3
and 18 years. As reflections of the small fraction of children aged 3 to 4 years
and the female preponderance of the study population, the age-adjusted
prevalence of thyroid cysts and nodules (52.35% for thyroid cysts and 1.54% for
thyroid nodules) were found to be less than the unadjusted prevalence (56.88%
for thyroid cysts and 1.65% for thyroid nodules).
Ultrasound findings other than cysts and nodules are shown in. The most frequent
finding was ectopic thymus. The percentage of ectopic thymus decreased with age.
Diffuse goiter, ultimobranchial body, lymph node swelling and thyroid agenesis
were identified in participants aged 5 years or older.
# Discussion
Few reports have studied the prevalence, spectrum of appearance and management
of ultrasound-detected findings in the thyroid glands of children, except for
screening programs conducted around Chernobyl. Within the framework of the
Chernobyl Sasakawa Medical Cooperation Project, ultrasound examination of the
thyroid gland was conducted around Chernobyl in Ukraine, the Russian Federation
and Belarus between 1991 and 1996. In this project, 120,605 children were
examined at five centers in three countries, and 63 cases with thyroid cancer
(0.052%) were identified. Of note, 38 cases (0.192%) of thyroid cancer were
identified in the Gomel region (Belarus), which was the area that was most
contaminated by the accident. Also, this study revealed that 42,470 (35.9%)
children showed increased thyroid volume (goiter), ranging from 18% to 54% in
the five examination centers. This relatively high frequency of goiter reflected
the iodine deficient status of this area during the study period. On the other
hand, only 502 (0.42%) showed cystic lesions, ranging from 0.19 to 0.63% at the
five examination centers, which were much lower frequencies than those observed
in our current study. Further, in 2000, we conducted ultrasound examinations of
the thyroid gland in 250 Japanese schoolchildren in Nagasaki (Japan) and
observed the presence of goiters in only 4 cases (1.60%), while 2 cases (0.80%)
had cystic degeneration and a single thyroid cyst, and no cases had thyroid
nodules. Of course, a big difference of detection sensitivity and image quality
of ultrasound machine at the different time and place of examination should be
deeply considered and a standardized method and protocol of ultrasound
examination such as common diagnostic criteria should be implemented.
In the current study, we conducted ultrasound examination of the thyroid gland
in 4,365 Japanese children (from Aomori, Yamanashi and Nagasaki) in 2013 and
identified thyroid cysts in 56.88% and thyroid nodules in 1.65% of them,
learning from the same method and protocol of the Fukushima Health Management
Survey. Following the first report that aimed at a rapid announcement of the
crude data according to sociomedical needs, our current further study added the
new information. For instance, the prevalence of cysts with a maximum diameter
of smaller than 5 mm varied among the examination areas, and the most frequent
finding other than cysts was ectopic thymus which showed a decreased prevalence
with age.
Focusing only on the subset data of Nagasaki in the current study, we identified
thyroid cysts in 42.51% and thyroid nodules in 0.73% of the children, which
indicates a gap in the frequencies of thyroid cysts and nodules between the
studies conducted in 2000 and 2013 (the current study). These gaps between
studies could be mainly due to the dramatic advances in ultrasound technology,
including imaging quality. New ultrasound technologies, such as digital beam
formers, tissue harmonic imaging and speckle reduction have greatly improved the
image quality of diagnostic ultrasound machines. These advances enable us to
perform detailed evaluation of the thyroid gland by ultrasonography, and
consequently could have resulted in the relatively high observed frequency of
thyroid cysts in our study, since most of the cysts we detected were less than 5
mm in diameter. In other words, if ultrasound technology advances further, there
is a possibility that much more small cysts could be pointed out in the future
screening.
The prevalence of both thyroid cysts and nodules varied among the three
examination areas, although no significant differences were observed in the
prevalence of thyroid cysts and nodules with a maximum diameter of more than 5
mm. This suggests that the differences in the frequency of thyroid cysts and
nodules among the three examination areas were due to different frequencies in
relatively small thyroid cysts and nodules, which were perhaps affected by
inter-observer differences.
The thyroid ultrasound examination performed in the Fukushima Health Management
Survey targeted all prefectural inhabitants who were between 0 and 18 years of
age on 11 March 2011 (approximately 360,000 inhabitants). The information
released by Fukushima Prefecture indicated that 74,216 (42.56%) of the 174,376
children who underwent thyroid ultrasound examination showed thyroid cysts and
2,014 (1.15%) showed thyroid nodules. Our sample size was much more limited, but
the frequency of thyroid cysts and nodules was relatively high in our study,
when compared with the data presented in the Fukushima Health Management Survey
(56.83% vs. 42.56% for cysts and 1.65% vs. 1.15% for nodules). Since we used the
same ultrasonography as was used in the Fukushima Health Management Survey,
other factors, such as age composition, inter-observer differences, iodine
intake of each region, socio-ecological status and family history or past
history of each study participants may associate with the differences between
studies. Further analysis, such as comparison with other conducting around
Chernobyl or other region with the latest ultrasound machines will be needed.
In this study, we observed 85 (1.95%) cases with ectopic thymus. Furthermore,
the percentage of ectopic thymus decreased with age. The thymus originates from
the 3<sup>rd</sup> pair of branchial pouches, with a rudimentary portion arising
from the 4<sup>th</sup> pair, and descends to the superior mediastinum.
Anomalies of migration can cause an ectopic thymus along the path of descent.
The descents of the thymus and thyroid are closely related because of the
proximity of the thyroid diverticulum and the 3<sup>rd</sup> branchial pouch.
Thymic tissue can therefore get sequestered within the thyroid, giving rise to
an intrathyroid ectopic thymus. The criterion for ectopic thymus in this study
was “Intrathyroid lesions showing hypoechogenicity with multiple linear
echogenic branching structures or punctate echogenic foci”, which is identical
with the criterion of the Fukushima Health Management Survey. On the other hand,
discrimination of ultrasonographic findings between ectopic thymus and thyroid
nodule, especially for papillary thyroid cancer, is sometimes difficult, and the
lack of knowledge has even led to unnecessary thyroid resection. When evaluating
ultrasound findings of the thyroid gland, especially malignancies in children,
careful observation is necessary to rule out the possibility of ectopic thymus.
A large-scaled sample number was the strength of the current study even though
the number was relatively small compared with the Fukushima Health Management
Survey. There are several limitations to this study. The current study could not
include 0 to 2 year old children. Further, the number of study participants aged
3 to 4 years was much smaller than other age groups. We also could not evaluate
autoimmunity of the thyroid gland or iodine intake, both of which strongly
influence the ultrasound findings of the thyroid gland. Although Japan is
generally an iodine-rich area due to the Japanese diet which contains a large
amount of seafood, changes in diet in children may affect iodine uptake in the
three examination areas. A further follow-up study is definitely needed in order
to evaluate the prognosis of the thyroid cysts and nodules obeserved in
childhood.
In conclusion, we conducted a sophisticated ultrasound examination of the
thyroid glands of children from three Japanese prefectures besides Fukushima,
and identified thyroid cysts in 56.88% and thyroid nodules in 1.65% of them,
respectively. All the inhabitants of Fukushima Prefecture aged 0 to 18 years on
March 11, 2011 (approximately 360,000 inhabitants) will undergo thyroid
ultrasound examination every 2 years until the age of 20 years, and every 5
years thereafter. The reference data observed in the current study and the
further data analyses (including follow-up surveys) of children in general, can
provide relevant information for the Fukushima Health Management Survey when
followed up in the future through additional population studies.
We would also like to thank Mr. Yasuo Kiryu and Ms. Yoshie Hirose, Ms. Akemi
Kiko, Ms. Kyoko Takemura, Ms. Misako Konta, and Ms. Michiko Kenmoku for
assistance with study arrangement.
[^1]: The authors have declared that no competing interests exist.
[^2]: Conceived and designed the experiments: NH MI HS NO SN MK SS N.
Taniguchi SY N. Takamura. Performed the experiments: NH HS NO YA TN SM SN AO
TA SS N. Taniguchi N. Takamura. Analyzed the data: MI KK TA. Wrote the
paper: NH MI KK N. Taniguchi N. Takamura.
|
# Introduction
Immune responses include activation and clonal expansion of relevant lymphocyte
populations to wipe up invading foreign antigens. Once the antigens are removed,
circulating activated lymphocytes, especially T cells, should be eliminated to
avoid unnecessary inflammation and to maintain immune homeostasis, while only a
few of the activated lymphocytes are fated to develop into memory lymphocytes.
In this process, apoptosis plays critical roles. Apoptosis in T cells can be
initiated either extrinsically or intrinsically. The extrinsic pathway is
initiated by ligation of cell surface death receptors, including Fas. The
intrinsic pathway involves mitochondria, where activation of pro-apoptotic
members of Bcl-2 family induces the release of cytochrome *c* (Cyt *c*)
resulting in the formation of apoptosome composed with Cyt *c*, caspase (Casp)
9, and Apaf1. In both pathways, activation of effector caspases, including
Casp3, 6, and 7, downstream either death receptors or apoptosome, leads to
degradation of cellular proteins and resultant cell death. While caspase-
dependent apoptosis occurs in activated T cells or in T cells deprived of
survival factors, caspase activation is reportedly dispensable for thymocyte
development and for T cell homeostasis, implying caspase-independent cell death
also occurs in T cells.
Apaf1, the mammalian homolog of *C*. *elegans* CED-4, participates in the
formation and activation of the apoptosome. Absence of Apaf1,
Casp9 or Apaf1-activating form of Cyt *c*, leads to the failure of
mitochondria-dependent apoptosis. The result is remarkable accumulation of
neurons during embryonic brain development, demonstrating the critical role of
Apaf1 and other components of the apoptosome in development. Roles of Apaf1
in thymocytes/T cell apoptosis have been shown in a couple of previous reports;
while Apaf1-deficient thymocytes were resistant to apoptosis induced by
mitochondria-insulting stimulations, such as γ-irradiation and corticosteroid
treatment, they were sensitive to Fas-induced apoptosis just like
Apaf1-sufficient thymocytes. In addition, successful negative selection of
Apaf1-deficient thymocytes showed that Apaf1-dependent apoptosis was not
required for the negative selection of thymocytes. Although most of the
Apaf1-deficient mice showed perinatal lethality due to the abnormal development
of the brain, there were a few survivors, which showed no abnormal accumulation
of peripheral lymphocytes, indicating that Apaf1 was not required for the
elimination of auto-reactive T cells in the periphery or in the homeostasis of
peripheral T cells in number (H. Y., unpublished data). The roles and functions
of Apaf1 in the regulation of T cell-mediated immune responses, however, have
yet to be clarified.
In this study, we took advantage of T cell-specific Apaf1-deficient mice,
Lck-*Cre*-*Apaf1*<sup>f/f</sup>, in which *Apaf1* gene was disrupted with *Lck*
promoter-driven *Cre* expression, to investigate the biological function of
Apaf1 in T cells. Apaf1-deficient T cells showed resistance to mitochondria-
dependent apoptosis but showed susceptibility to Fas-mediated apoptosis. We then
performed the delayed-type hypersensitivity (DTH) assay, using ovalbumin
(OVA)-specific T cell receptors (TCR)-expressing mice (OTII mice), and found
that antigen-specific T cell activation leads to enhanced proliferation and
Th1-type immune responses in Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice, as
compared with control Apaf1-sufficient OTII mice. Apaf1-deficient T cells showed
higher percentages of cells expressing early activation markers after
stimulation than control T cells. Surprisingly, Apaf1-sufficient T cells treated
with a pan-caspase inhibitor, z-VAD-*fmk* (carbobenzoxy-valyl-alanyl-
aspartyl-\[O-methyl\]- fluoromethylketone), did not reproduce the activation-
related phenotypes observed in Apaf1-deficient T cells, indicating caspase-
independent roles of Apaf1 during T cell activation. Our data suggested that
Apaf1 in T cells is a negative regulator of immune responses.
# Materials and methods
## Generation of T cell-specific Apaf1-deficient mice
The design of the conditional targeting vector for *Apaf1* is shown in, in which
exons 2 and 3 are flanked by two *loxP* sites. The linearized targeting vector
was electroporated into E14K ES cells and homologous recombinants were selected.
The heterozygous *Apaf1* mutant (*Apaf1*<sup>f-Neo/+</sup>) ES clones were
injected into C57BL/6 blastocysts to generate chimeric mice.
*Apaf1*<sup>f-Neo/+</sup> mice were selected and crossed into C57BL/6 mice more
than 10 times; the PGK-neo cassette was removed by mating the heterozygotes with
CAG-*Flpe* transgenic (Tg) mice (RBRC01834, RIKEN BRC). Mice heterozygous for
*Apaf1* mutation (*Apaf1*<sup>f/+</sup>) were then crossed with Lck-*Cre* Tg
mice and transgene-positive *Apaf1*<sup>f/+</sup> mice were intercrossed to
generate Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice and
Lck-*Cre*-*Apaf1*<sup>f/+</sup> mice. Lck-*Cre*-*Apaf1*<sup>f/f</sup> -OTII mice
were similarly generated by crossing Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice with
OTII-Tg mice expressing OVA-specific TCR. Lck-*Cre* Tg mice and OTII mice were
kindly provided by Dr. A. Yoshimura, Keio University, Japan. Successful
disruption of *Apaf1* gene was confirmed with genomic Southern blot analysis and
absence of Apaf1 protein in Lck-*Cre*-*Apaf1*<sup>f/f</sup> T cells was
confirmed with Western blot analysis using anti-Apaf1 antibody (PharMingen)
## Animal care
This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional Animal Care and Use
Committee of Saga University (Approval number 27-047-0). All efforts were made
to minimize suffering.
## Apoptosis assay
For induction of apoptosis in thymocytes, thymocytes (5 × 10<sup>5</sup>
cells/well) were cultured in 96-well plates with or without the following agents
or stimulation; dexamethasone (10, 30, 100 nM. Sigma), staurosporine (100, 300,
1000 nM. Sigma), γ-irradiation (100, 300, 1000 cGy), anti-Fas antibody (clone
Jo2; 1 μg/ml. PharMingen) plus cycloheximide (0.2, 1 μg/ml. Sigma). After 20
hours, apoptotic cells were detected by staining with Annexin V- FITC
(PharMingen) and propidium iodide (PI, BioLegend).
For activation-induced apoptosis of peripheral lymph node (LN) T cells, LN cells
were stained with FITC-labeled anti-Thy1.2 antibody (eBioscience) followed by
positive selection procedure using anti-FITC magnetic beads (MACS; Miltenyi
Biotec) and LS columns (Miltenyi Biotec). Purified T cells (\>90% T cells, 3×
10<sup>6</sup> cells/well) were activated with plate-bound anti-CD3ε (0.3 μg/ml;
clone 145-2C11, eBioscience) plus anti-CD28 antibodies (3 μg/ml; clone 37.51,
eBioscience) for 48 hours in 6-well plates. After removal of apoptotic cells by
staining the cells with Annexin V-APC followed by anti-APC magnetic beads (MACS)
procedure, remaining cells (Annexin V-negative cells \>97.6%) were cultured (2 ×
10<sup>5</sup> cells/200 μl/well) either in fresh medium alone, or conditioned
medium prepared from the supernatants of the primary stimulation culture (anti-
CD3ε plus anti-CD28 antibodies), or with anti-CD3ε antibody in fresh medium.
Twenty-four hours later, apoptotic cells were detected as above.
## Cell activation and cytokine production
Mice were subcutaneously (s.c.) immunized with 200 μg of OVA emulsified in
complete Freund’s adjuvant (CFA, Difco) at the tail base. Inguinal LNs were
collected and single cell suspensions were prepared. Total LN cells (2 ×
10<sup>5</sup> cells/well) were cultured in the presence of OVA protein (0, 1,
10, 100 μg/ml) or anti-CD3ε antibody (1 μg/ml) in RPMI1640 medium supplemented
with 10% fetal bovine serum. For proliferation assay, cells were pulsed with 1
μCi/well of <sup>3</sup>H-thymidine (PerkinElmer) during the last 7 hours of 48
hours of culture and incorporated radioactivity was measured. Culture
supernatants were removed before <sup>3</sup>H-thymidine pulse and IL-2, IFN-γ
or IL-17 levels in the supernatants were measured using ELISA Ready-SET-Go
(eBioscience). In some experiments, a pan-caspase inhibitor z-VAD-*fmk* (10 and
100 μM, MBL) was added into the culture.
## DTH assay
Seven days after immunization with OVA as above, mice were challenged s.c. at
right footpad with 200 μg of OVA in 20 μl PBS. As a control, the same volume of
PBS was injected into left footpad. Footpad thickness was measured with a dial
vernier caliper (Teclock) on day 1 and 2. The magnitude of the DTH response was
calculated as follows; footpad swelling (μm) = thickness of OVA-injected footpad
− thickness of PBS-injected footpad. For histological analysis of the DTH
lesions, paws were removed on day 2 and fixed with 10%-formaldehyde neutral
buffer solution (Nacalai). After decalcification by a standard protocol,
specimens were embedded in paraffin and were stained with hematoxylin-eosin
(H&E). For analysis of the tissue-infiltrating cells, paws were thoroughly
minced with scissors and then were incubated at 37°C for 1 hour in Hank's
solution containing 1.0 mg/ml collagenase II (Worthington), 1.0 mg/ml dispase
(Sigma-Aldrich) and 40 μg/ml Dnase I (Roche). After removing debris with 70 μm
cell-strainers, cells were re-suspended into 33.7% Percoll (GE Healthcare) and
pelleted by centrifugation at 1,000 *g*, for 20 minutes at 24°C. Cells were
stained with anti-CD45.2-APC (eBioscience), anti-CD11b-FITC (eBioscience), anti-
Ly6G-PE (BD PharMingen), anti-CD3ε-APC (eBioscience) antibodies, and analyzed by
flow cytometry for expression of respective molecules.
## Carboxy-fluorescein-diacetate succinimidylester (CFSE) staining
Naïve LN cells were suspended in PBS at 2 × 10<sup>7</sup> cells/ml and
incubated with CFSE (DOJINDO) at a final concentration of 5μM CFSE plus 0.1%BSA
for 10 min at 37°C, followed by washing 3 times with RPMI1640 medium. Stained
cells (2 × 10<sup>5</sup> cells/well) were cultured with anti-CD3ε or OVA
Peptide (323–339, Peptides International) for 4 days, and evaluated for CFSE
intensity.
## Flow cytometry
For detection of apoptotic cells, cells were stained as above. For detection of
CD69, CD44, and CD62L, LN cells isolated from naïve mice or mice on day 8 after
immunization were stimulated with OVA protein (0, 1, 10, 100 μg/ml) or anti-CD3ε
antibody (1 μg/ml) and stained with anti-CD69 (PharMingen), anti-CD44 (TONBO
Biosciences), and anti-CD62L (BD Biosciences) antibodies on day 0 or 2. For
detection of OTII-TCR-Tg-positive cells, cells were stained with anti-TCR
Vα2-FITC antibody (clone B20.1, BioLegend). Stained cells were analyzed with BD
FACSVerse<sup>TM</sup> (BD Biosciences) for detection of respective surface
molecules.
## Western blot analysis
For detection of capase cleavage during T cell activation, inguinal LN cells
were isolated from mice on day 8 after immunization and were stimulated with OVA
protein (0, 10, 100 μg/ml) or anti-CD3ε antibody (1 μg/ml) as above with or
without pan-caspase inhibitor z-VAD-*fmk* (10 and 100 μM). Cell lysates were
prepared, electrophoresed, and blotted. Tubulin, caspases 3, 7, and 9 were
detected with respective antibodies (anti-tubulin; Sigma Aldrich and anti-
caspases; Cell Signaling Technology) and visualized using an enhanced
chemiluminescence procedure (ImmunoStar LD, Wako).
## Statistical analysis
Experiments were repeated at least three times. Values were expressed as means +
SD. Differences between control (Apaf1-sufficient) and Apaf1-deficient samples
were analyzed using unpaired *t*-tests. Differences between two samples among
multiple samples with various experimental conditions were analyzed using
unpaired *t*-tests with Bonferroni correction (See figure legends). Alpha value
was set at 0.05 and p values below the alpha value (0.05) were considered to be
statistically significant.
# Results
## Generation of T cell specific Apaf1-deficient mice
T cell-specific Apaf1-deficient mice (Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice) were
generated as described in the Materials and methods. Genotypes of the mice were
confirmed by Southern blot analysis of the genomic DNA using two external probes
(not shown) and a probe at exon 4 and *Cre*-driven successful ablation of Apaf1
in T cells and thymocytes were confirmed by Western blot analysis. Mice
sufficient or deficient for Apaf1 in T cells were viable, healthy, and fertile
and showed no sign of brain deformity (data not shown).
Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice showed no sign of anatomical and
pathological abnormality including lymphocyte accumulation in the lymphoid
organs (not shown). In addition, total numbers of thymocytes and cellularity of
CD4<sup>+</sup> and CD8<sup>+</sup> thymocytes were comparable between
Lck-*Cre*-*Apaf1*<sup>f/f</sup> and control *Apaf1*<sup>f/f</sup> mice (not
shown). In our previous report, Apaf1-deficient thymocytes showed resistant to
drug-induced and irradiation-induced apoptosis but showed susceptibility to Fas-
induced apoptosis over WT thymocytes. As expected, thymocytes from
Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice showed similar resistance to
dexamethasone-, staurosporine-, and irradiation-induced apoptosis over control
thymocytes from *Apaf1*<sup>f/f</sup> mice but showed susceptibility to Fas-
induced apoptosis just like Apaf1-sufficient thymocytes. Activated
Lck-*Cre*-*Apaf1*<sup>f/f</sup> peripheral T cells were refractory to the
mitochondria-dependent passive apoptosis induced by growth factor deprivation as
compared with Apaf1-sufficient *Apaf1*<sup>f/f</sup> T cells; when LN T cells
that had been previously activated with anti-CD3ε antibody plus anti-CD28
antibody were placed in new medium, in which T cell-derived IL-2 was
insufficient, control *Apaf1*<sup>f/f</sup> T cells showed significant reduction
in viability whereas Lck-*Cre*-*Apaf1*<sup>f/f</sup> T cells showed higher
viability. When activated T cells were re-stimulated with anti-CD3ε antibody in
a new medium for activation-induced cell death via the extrinsic pathway of
apoptosis, Lck-*Cre*-*Apaf1*<sup>f/f</sup> T cells showed substantial
susceptibility to cell death just like control Apaf1-sufficient T cells. These
data collectively demonstrated that Apaf1 is required for intrinsic pathway of
apoptosis induced by mitochondrial insult in both thymocytes and T cells and
also that Apaf1 is not required for controlling the number of T cells in the
thymus and in the lymph nodes.
## Exacerbation of DTH responses in Lck-*Cre*-*Apaf1*<sup>f/f</sup> mice
Given the role of Apaf1 in the regulation of intrinsic pathway of apoptosis in T
cells, we then asked the pathophysiological roles of Apaf1 *in vivo*. To do so,
we took advantage of OTII mice, in which T cells express OVA-specific T cell
receptors. When control *Apaf1*<sup>f/f</sup>-OTII mice or
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice were subject to OVA-induced DTH
responses, significantly higher levels of footpad swelling were detected in
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice than in control mice. Histological
examination also revealed higher numbers of infiltrating cells in the footpad
lesion in Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice than in control mice. Flow
cytometric analysis showed that the numbers and the percentages of infiltrating
neutrophils were higher in Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice than
control mice while those for lymphocytes and monocytes were comparable. These
observations clearly showed that Apaf1 in T cells was involved in the
pathogenesis of DTH responses.
To address the cause of the exacerbated DTH response in
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice, we performed OVA-specific recall
response by T cells *ex vivo*. As shown in, an enhanced proliferative response
was observed in Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII T cells from the draining
LNs, accompanied with significantly higher levels of IL-2 production over
control Apaf1-suffucient T cells. DTH response is largely dependent on IFN-γ-
producing Th1 cells and, to a lesser degree, on IL-17-producing Th17 cells. As
expected, production of both IFN-γ and IL-17A was significantly augmented by
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII LN cells as compared with control
*Apaf1*<sup>f/f</sup>-OTII LN cells. The levels of IFN-γ and IL-17 indicated
that Th1 response was obviously dominant in this experimental system as compared
with Th17 response. Higher numbers of infiltrating neutrophils at the footpad
lesion in Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice than control mice, however,
implicated involvement of IL-17 in this system. These observations collectively
demonstrated that Apaf1 in CD4<sup>+</sup> T cells critically participated in
the attenuation of DTH response.
## Enhanced activation of Apaf1-deficient T cells
We next examined the expression of early activation marker CD69, and CD44/CD62L
as activation/effector markers on T cells from OVA-immunized
*Apaf1*<sup>f/f</sup>-OTII and Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice. The
percentages of CD69<sup>+</sup> OTII cells and those of
CD44<sup>high</sup>CD62L<sup>low</sup> OTII cells as cells with activated (or
memory) phenotype in Lck-*Cre*-*Apaf1*f/f-OTII mice were comparable to those in
*Apaf1*<sup>f/f</sup>-OTII mice. Similarly, the total numbers of
CD69<sup>+</sup> cells and CD44<sup>high</sup>CD62L<sup>low</sup> cells were
comparable between the two groups. We then evaluated these cell surface markers
following the re-stimulation of T cells *in vitro*. As expected, the expression
of activated marker CD69 rapidly up-regulated upon re-stimulation on both
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII and control cells in an antigen dose-
dependent manner (left). Expression of CD69 was higher on
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells than on control cells (left and Panel
A). The percentages of CD44<sup>high</sup>CD62L<sup>low</sup> cells also
increased after *in vitro* re-stimulation and were higher in
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells than in control Apaf1-sufficient
cells (right and Panel B).
We further addressed the impact of Apaf1-deficiency in primarily activated T
cells. When CD4<sup>+</sup> T cells from unimmunized mice were stimulated *in
vitro* with either OVA peptide or anti-CD3ε antibody,
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells showed higher or more efficient cell
division than control cells, as demonstrated by higher percentages of cells with
lower CFSE intensity. Percentages of divided cells with lower CFSE intensity
were significantly higher in Apaf1-deficient
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells than in Apaf1-sufficient control
cells. Production of IFN-γ in the supernatants was also significantly higher by
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells than by control
*Apaf1*<sup>f/f</sup>-OTII cells. These data shown in Figs and clearly
demonstrated that Apaf1 in T cells plays a regulatory role during an initial
encounter and activation of naive T cells as well as during recall activation of
primed T cells with antigen.
## Caspase-independent enhancement of activation in Apaf1-deficient T cells
The negative regulation of T cell activation by Apaf1 may or may not depend on
apoptosis. T cells activated in an inappropriate condition may be deleted by
Apaf1-dependent apoptosis. Apaf1 may, however, regulate T cell activation and
proliferation independently of caspase activation/apoptosis. Unexpectedly, pan-
caspase inhibitor, z-VAD-*fmk*, at 10 or 100 μM did not rescue the lower
proliferation (thymidine incorporation) or lower viability of control
Apaf1-sufficient cells over Apaf1-deficient cells from immunized mice after
antigenic stimulation (, upper panels). Similarly, neither lower production of
IFN-γ nor IL-17 production by Apaf1-sufficient cells were restored to the levels
by Apaf1-deficient cells with z-VAD-*fmk* (middle panels). Additionally,
percentages of CD69<sup>+</sup> and CD44<sup>high</sup>CD62L<sup>low</sup> cells
in control Apaf1-sufficient OTII T cell population were still lower over
Apaf1-deficient OTII T cells in the presence of z-VAD-*fmk* (lower panels).
Dexamethasone-induced apoptosis and caspase 3 activation in thymocytes was
completely suppressed by z-VAD-*fmk* at the same concentration (100 μM).
To address whether or not caspase activation occurs during T cell activation,
either in Apaf1-dependent or -independent way, western blot analysis was
performed to detect caspase activation during antigen-induced T cell activation.
Stimulation of LN T cells with anti-CD3ε antibody or OVA induced caspase 3
cleavage in *Apaf1*<sup>f/f</sup>-OTII cells. Perhaps counterintuitively, but in
line with the data show above, caspase 3 cleavage was similarly detected in
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII cells. The caspase inhibitor, z-VAD-*fmk*,
did not inhibit caspase 3 cleavage in either Apaf1-sufficient or Apaf1-deficient
cells, although the appearance of 17 kDa fragment was only partially inhibited
by z-VAD-*fmk* at 100 μM (, cleaved Casp3). Cleaved form of caspase 7 was also
detected in both Apaf1-sufficient T cells and Apaf1-deficient T cells almost
similarly (cleaved Casp7) and z-VAD-*fmk* at 100 μM showed no inhibitory
effects. Caspase 9 activation (cleavage), which should be shown by reduction of
pro-caspase 9, was barely detectable in both Apaf1-sufficient or -deficient OTII
cells; note that cleaved form of caspase 9 was not detectable with antibody
used. The western blot analysis clearly demonstrated that antigen-specific
activation of T cells induced caspase 3 and 7 cleavage, which was not mediated
by Apaf1 (and presumably not by caspase 9) and also was not inhibited by
z-VAD-*fmk*. As the caspase cleavage occurred similarly in both Apaf1-sufficient
and Apaf1-deficient T cells, caspase activation did not account for the
difference in proliferation and cytokine production between Apaf1-sufficient and
Apaf1-deficient T cells. These data indicated that the negative impact of Apaf1
on antigen-stimulated T cells was largely independent of caspase activities,
although the possible involvement of caspase/apoptosis was not formally
excluded.
Taken together, our data clearly demonstrated that Apaf1 is a negative regulator
of T cell responses by attenuating proliferation, activation, and cytokine
production. This negative regulatory role of Apaf1 plays a role during antigen-
specific T cell response but not in the maintenance of T cell homeostasis and
the role is caspase-independent.
# Discussion
Previous reports including ours demonstrated the role of Apaf1 in the functional
shaping of some organs and adjusting the number of cells during development\[,
–\]. While apoptosis is required for removal of unwanted or possibly hazardous
immune cells, the negative selection of self-reactive clones in the thymus was
not impaired in Apaf1-deficient mice. In addition, while almost all
Apaf1-deficient mice were perinatally lethal due to the brain deformity, a few
survivors observed showed no signs of lymph adenopathy (H. Y., unpublished
observation), implying no role of Apaf1 in the T cell homeostasis in the
periphery. In the current study, we addressed the role of Apaf1 in regulation of
antigen-specific T cell responses. Perinatal lethality of Apaf1-deficient mice
prevented us from examining the role of Apaf1 in the T cell activation. To
circumvent this problem, we generated conditional Apaf1-deficient mice, in which
Lck-driven expression of the Cre recombinase disrupted *Apaf1* gene in a T cell-
specific manner. Data shown in confirmed the requirement of Apaf1 for the
intrinsic pathway of apoptosis, induced by mitochondrial damages including
growth factor deprivation, but not for the extrinsic pathway of apoptosis,
induced by, for instance, anti-CD3ε re-stimulation or Fas ligation (data not
shown), in the thymocytes and peripheral T cells.
To examine the role of Apaf1 in T cells during antigen-induced immune responses,
we exploited OVA-specific delayed-type hypersensitivity assay using OTII mice
expressing OVA-specific T cell receptors on T cells.
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII mice showed remarkable exacerbation of DTH
responses including footpad swelling, cell infiltration, and inflammatory
cytokine production, clearly demonstrating the role of Apaf1 as a negative
regulator of T cell responses. To our knowledge, this is the first to show the
role of Apaf1 as a negative regulator of immune responses. Apoptosis occurs in
mature T lymphocytes in an antigen-driven way or growth factor-deprived way and
is required for homeostasis, tolerance, and proper regulation of immune
responses. There are a couple of different (but not mutually exclusive)
possibilities where Apaf1 plays its negative role during T cell responses. One
is that Apaf1-deficiency leads to prolonged survival of T cells after
activation, due to the impairment of Apaf1-dependent apoptosis, resulting in the
augmentation of DTH responses. Although this possibility appeared plausible, we
were unable to detect any difference in the percentages of apoptotic cell death
in the infiltrating cells into the footpad lesion between
Lck-*Cre*-*Apaf1*<sup>f/f</sup>-OTII and *Apaf1*<sup>f/f</sup>-OTII mice (data
not shown). In addition, time course of the footpad swelling between the two
groups of mice were almost comparable (data not shown). It was thus unlikely
that Apaf1 attenuated T cells responses by controlling apoptosis, although the
possibility was not formally excluded.
Our *ex vivo* and *in vitro* analyses of antigen-specific cell activation
supported another possibility that Apaf1 regulates T cell activation,
independently of cell survival. Apaf1-deficient OTII T cells upon stimulation
proliferated more efficiently and showed higher percentages of cells with
activation phenotypes (Figs and). Although these differences in activation
status could be explained by the impairment of Apaf1-dependent apoptosis in
inappropriately activated T cells, addition of a pan-caspase inhibitor,
z-VAD-*fmk*, did not affect the difference in activation and cell division of T
cells *in vitro*. It was thus indicated that the effect of Apaf1 in regulation
of cell activation and cell division was caspase-independent. As reported
previously, caspase 3 was cleaved during T cell activation, which was not
inhibited by z-VAD-*fmk*. We also detected caspase 3 and 7 cleavage during T
cell activation, on which z-VAD-*fmk* showed little, if any, inhibitory effects.
The cleavage of caspases 3 and 7 occurred similarly in both Apaf1-sufficient and
Apaf1-deficient T cells. As caspase 9 activation was barely detectable in these
cells, the cleavage of caspases 3 and 7 appeared independent of apoptosome
activation. Although the precise mechanism for this caspase activation is not
known yet, it is clear that the caspase activation was not the reason for the
difference in T cell activation between Apaf1-sufficient and -deficient T cells.
The roles of Apaf1 reside mainly but are not limited in the initiation of
apoptosis. Zermati et al. reported the non-apoptotic role of Apaf1 in that
Apaf1-deficiency resulted in the impairment of DNA damage-induced cell cycle
arrest. This non-apoptotic function of Apaf1 requires nuclear translocation
of Apaf1 and depends of checkpoint kinase-1 (Chk1) activity. Similarly, chemical
inhibitor of Apaf1 suppressed Apaf1-dependent DNA-damage checkpoint. These
reports supported anti-proliferation and/or anti-survival function of Apaf1.
Oppositely, Apaf1 plays a pro-proliferation/pro-survival role by regulating
centrosome stability. Ferraro et al. reported that Apaf1 was required for
efficient centrosome and mitotic spindle formation. The non-apoptotic roles
of Apaf1 are thus complicated and perhaps context-dependent. Although the
precise mechanisms for these non-apoptotic functions of Apaf1 are poorly
understood, Apaf1 exerts these functions through interaction with various
molecules\[, –\]. Presumably, Apaf1 plays its anti- or pro-activation/survival
function though interaction with the interacting molecule(s) depending upon cell
activation status. In our hands also, Apaf1-deficiency in some situations
resulted in enhanced cell death (e.g., Fas stimulation). This may reflect the
context-dependent (non-apoptotic) roles of Apaf1.
We were unable to detect any difference in cell cycle progression or cell
activation status in the lesion-infiltrating T cells between Apaf1-deficient and
Apaf1-sufficient cells in DTH assay (data not shown). It is possible that the
difference in individual cells was subtle and/or only a small fraction of
antigen-specifically activated cells showed difference. Alternatively, it is
possible that Apaf1 exerts its negative regulatory effect at the priming phase
where naive T cells are primarily stimulated in the draining lymph nodes, before
the effector phase. Higher percentages of cells in activation status in
Apaf1-deficient T cells at the primary stimulation phase *in vitro* may support
this idea. In any case, the impact of Apaf1-deficiency on T cell function
appeared limited. We have been unable to detect significant differences in
pathological phenotypes in other disease models, including experimental allergic
encephalomyelitis (EAE) and LPS-induced topical inflammation (data not shown).
In DTH model in the current study, the differences were small albeit their
significance and reproducibility. In our hands, we reported that the DTH
response was exacerbated in the absence of EBI-3 of IL-27. The phenotypic
difference was far worse in the EBI-3-deficient mice than in T cell-specific
Apaf1-deficient mice (compared data not shown). The role of Apaf1 and
Apaf1-mediated apoptosis in T cell function appears much limited in terms of the
intensity and/or duration, as compared with, for instance, cytokines or other
molecules directly involved in T cell activation/function. Further clarification
of the exact point(s) where Apaf1 exerts it regulatory effect during T cell
activation is a future challenge.
Collectively, our data clearly demonstrated Apaf1 as a negative regulator of T
cell responses. Further analysis of the underlying mechanisms may reveal Apaf1
as a potential target for immunosuppressive drug discovery.
# Supporting information
The authors thank Dr. Iizasa and Ms. Yoshida for technical help and animal
husbandry, Dr. Kawaguchi for advices on statistics, and Ms. Furukawa for
secretarial supports.
[^1]: The authors have declared that no competing interests exist.
[^2]: Current address: Department of Immunology, Kagoshima University
Graduate School of Medical and Dental Sciences, Kagoshima, Japan
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.